Citrus Sinensis ID: 047576
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 602 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP24 | 1120 | Probable leucine-rich rep | yes | no | 0.762 | 0.409 | 0.358 | 1e-65 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.383 | 0.221 | 0.488 | 2e-63 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.739 | 0.404 | 0.339 | 9e-59 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.764 | 0.460 | 0.348 | 1e-58 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.689 | 0.418 | 0.335 | 1e-57 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.740 | 0.408 | 0.322 | 3e-56 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.747 | 0.465 | 0.337 | 3e-55 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.740 | 0.404 | 0.336 | 8e-54 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.689 | 0.363 | 0.323 | 3e-53 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.715 | 0.434 | 0.319 | 4e-53 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 251 bits (642), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 185/516 (35%), Positives = 274/516 (53%), Gaps = 57/516 (11%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTN-------LNYMSLSRN 182
NL LR+ + +G +P+ +S L+ L+ LDLSSN + L+ M+LSRN
Sbjct: 607 NLSRLRLNG--NQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRN 664
Query: 183 MLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGN 241
G +P+ + L L +LD+ N L G IP LS L SL L L+ N LSGL P
Sbjct: 665 KFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEG 723
Query: 242 LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN-QFNSSIPNELTRLTQLFHLDLSS 300
+ L +D+ NN + GP+P T F + L N S+IP + + + +L
Sbjct: 724 MIALTNVDISNNKLEGPLPDT-PTFRKATADALEENIGLCSNIPKQRLKPCR----ELKK 778
Query: 301 NKLSGKIPSQI--ASMEDLTWLDLSNNNIKGSIPGEITKLSR----LDYLNLSGNKLSGR 354
K +G + I + L L + N I + R N+S + G+
Sbjct: 779 PKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGK 838
Query: 355 VPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELA---F 411
Y + + + + D + IGTG Y VY+A L + + A+K+L+ EE++
Sbjct: 839 FKYQDI----IESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVV 893
Query: 412 IRSFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWA 446
+ F NE + L++ ME+GSL ++L ND EA L W
Sbjct: 894 KQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWT 953
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506
KR+N+VK +AHAL+Y+HHD +VHRDISS NILL++ A ++DFGTA+LL DSSN
Sbjct: 954 KRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNW 1013
Query: 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLI 566
+ +AG+YGY+APE AYTM +TEK DVYSFGV+ LE+++GKHP DL S+LSSS + L
Sbjct: 1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLR 1073
Query: 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
+ D+R+ P + + +L + ++ CLQ+NP+S
Sbjct: 1074 SISDERVLEPRGQNR-EKLLKMVEMALLCLQANPES 1108
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 128/262 (48%), Positives = 170/262 (64%), Gaps = 31/262 (11%)
Query: 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLN--------SPETEE------------- 408
+ D KY IGTG +G VYKA+LPN + A+KKLN +P T++
Sbjct: 774 EFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIR 832
Query: 409 -------LAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAY 461
F RN V MERGSL ++L ND EA +LDW KR+N+VK +AHAL+Y
Sbjct: 833 HRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSY 892
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
+HHD SP++VHRDISS NILL EA ++DFGTA+LL DSSN + +AG+YGY+APELA
Sbjct: 893 MHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELA 952
Query: 522 YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS-YDPKIMLIDVLDQRLPPPVDRK 580
Y M +TEK DVYSFGV+TLEV+ G+HP DL STLSSS D + L + D RLP P +
Sbjct: 953 YAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTP-E 1011
Query: 581 VIQDILLVSTISFACLQSNPKS 602
+ +++L + ++ CL S+P++
Sbjct: 1012 IKEEVLEILKVALLCLHSDPQA 1033
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 9e-59, Method: Compositional matrix adjust.
Identities = 184/542 (33%), Positives = 259/542 (47%), Gaps = 97/542 (17%)
Query: 143 FTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNL 195
TG IP E+ + +Q LDLS N+ G +L L + LS N L G +P G+L
Sbjct: 535 LTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDL 594
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKI-LILAQNQLSG-LPQEIGNLKNLMLLDVGNN 253
L+EL +G N L IP+ L +LTSL+I L ++ N LSG +P +GNL+ L +L + +N
Sbjct: 595 TRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDN 654
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN----------KL 303
+ G IP+++G L ++S N ++P+ T +F SSN +
Sbjct: 655 KLSGEIPASIGNLMSLLICNISNNNLVGTVPD-----TAVFQRMDSSNFAGNHGLCNSQR 709
Query: 304 SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLS--------RLDYLNLSGNKLSGRV 355
S P S L WL I GS +I ++ + +L L + R
Sbjct: 710 SHCQPLVPHSDSKLNWL------INGSQRQKILTITCIVIGSVFLITFLGLCWT-IKRRE 762
Query: 356 PYSNKHLSSMPTPRKIDSKY----------------------CIGTGAYGSVYKAQLPNG 393
P + L P +DS Y +G GA G+VYKA++ G
Sbjct: 763 P-AFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGG 821
Query: 394 RVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------------------------MERG 428
V A+KKLNS E + SFR E L + M +G
Sbjct: 822 EVIAVKKLNS-RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880
Query: 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEA 488
SL L + LDW R I A L YLHHDC P +VHRDI SNNILL+ + +A
Sbjct: 881 SLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQA 940
Query: 489 FVADFGTARLLH-ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH 547
V DFG A+L+ + S + + +AGSYGYIAPE AYTM +TEK D+YSFGVV LE++ GK
Sbjct: 941 HVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKP 1000
Query: 548 P-------RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNP 600
P DL + + S I I++ D RL D++ + ++ LV I+ C ++P
Sbjct: 1001 PVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSP 1059
Query: 601 KS 602
S
Sbjct: 1060 AS 1061
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 192/551 (34%), Positives = 262/551 (47%), Gaps = 91/551 (16%)
Query: 135 RILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRL-------TNLNYMSLSRNMLGGL 187
R+ + +G IP L +L LL+LS N G + NL+ + +S+N G
Sbjct: 407 RVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGS 466
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLM 246
+P EIG+L +IE+ +N G IP +L +L L L L++NQLSG +P+E+ KNL
Sbjct: 467 IPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLN 526
Query: 247 LLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306
L++ NN + G IP +G+ L+YLDLS NQF+ IP EL L +L L+LS N LSGK
Sbjct: 527 ELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNL-KLNVLNLSYNHLSGK 585
Query: 307 IPSQIAS-------------MEDL---------------TWLDLSNNNIKG-----SIPG 333
IP A+ DL W+ L+ + G I
Sbjct: 586 IPPLYANKIYAHDFIGNPGLCVDLDGLCRKITRSKNIGYVWILLTIFLLAGLVFVVGIVM 645
Query: 334 EITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNG 393
I K +L L S S + H S +D K IG G+ G VYK +L G
Sbjct: 646 FIAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGG 705
Query: 394 RVFALKKLN--------------------SPETEELAFIR------------SFRNEAQV 421
V A+KKLN + E E L IR S + V
Sbjct: 706 EVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLV 765
Query: 422 LSQMERGSLFRILHNDAEA-VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480
M GSL +LH D + V L W +R+ I A L+YLHHDC P +VHRD+ S+NI
Sbjct: 766 YEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNI 825
Query: 481 LLNSKLEAFVADFGTARLLHADSSN----QTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536
LL+S A VADFG A++ S + +AGS GYIAPE YT+ + EK D+YSFG
Sbjct: 826 LLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFG 885
Query: 537 VVTLEVLMGKHP-------RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVS 589
VV LE++ GK P +D+ + ++ D K L V+D P +D K ++I V
Sbjct: 886 VVLLELVTGKQPTDSELGDKDMAKWVCTALD-KCGLEPVID----PKLDLKFKEEISKVI 940
Query: 590 TISFACLQSNP 600
I C P
Sbjct: 941 HIGLLCTSPLP 951
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 180/537 (33%), Positives = 252/537 (46%), Gaps = 122/537 (22%)
Query: 127 CFPNLESLRILAYYDGFT-GSIPSEISALSKLQLLDLSSNRLRGRLT-------NLNYMS 178
CF L+IL ++ F G +P ++ L L N L +L NL+ +
Sbjct: 388 CFG--RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLE 445
Query: 179 LSRNMLGGLLPQE-IGN--LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG- 234
L N L G +P+E GN +L ++++ +N L GPIP ++ L SL+IL+L N+LSG
Sbjct: 446 LQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQ 505
Query: 235 LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ---------------- 278
+P EIG+LK+L+ +D+ N+ G P G L+YLDLS NQ
Sbjct: 506 IPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILN 565
Query: 279 --------FNSSIPNELTRLTQLFHLDLSSNKLSGKIPS--QIASMEDLTWLD------L 322
FN S+PNEL + L D S N SG +P+ Q + + ++L
Sbjct: 566 YLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGF 625
Query: 323 SNNNIKGSI---------------PGEIT------------------------KLSRLDY 343
S+N GS GEI+ K R+
Sbjct: 626 SSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRK 685
Query: 344 LNLSGNKLSG--RVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKL 401
N + KL G ++ + ++H+ + + IG G G VYK +PNG A+KKL
Sbjct: 686 NNPNLWKLIGFQKLGFRSEHILEC-----VKENHVIGKGGRGIVYKGVMPNGEEVAVKKL 740
Query: 402 NS------------PETEELAFIRSFRNEAQVLS-------------QMERGSLFRILHN 436
+ E + L IR RN ++L+ M GSL +LH
Sbjct: 741 LTITKGSSHDNGLAAEIQTLGRIRH-RNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHG 799
Query: 437 DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496
A V L W R+ I A L YLHHDCSP ++HRD+ SNNILL + EA VADFG A
Sbjct: 800 KA-GVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLA 858
Query: 497 RLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
+ + D S + +AGSYGYIAPE AYT+ + EK DVYSFGVV LE++ G+ P D
Sbjct: 859 KFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVD 915
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (560), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 174/540 (32%), Positives = 252/540 (46%), Gaps = 94/540 (17%)
Query: 143 FTGSIPSEISALSKLQLLDLSSNRLRGRL------TNLNYMSLSRNMLGGLLPQEIGNLK 196
GSIP IS L+ LDL +N L G L +L ++ S N L LP IG L
Sbjct: 490 LVGSIPPAISGCESLEFLDLHTNSLSGSLLGTTLPKSLKFIDFSDNALSSTLPPGIGLLT 549
Query: 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLML-LDVGNND 254
L +L++ N L G IP +S SL++L L +N SG +P E+G + +L + L++ N
Sbjct: 550 ELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNR 609
Query: 255 IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM 314
+G IPS +L LD+S NQ ++ N LT L L L++S N SG +P+
Sbjct: 610 FVGEIPSRFSDLKNLGVLDVSHNQLTGNL-NVLTDLQNLVSLNISYNDFSGDLPN-TPFF 667
Query: 315 EDLTWLDLSNN------NIKGSIPGEITKLSRLDYLNL---------------------- 346
L DL++N N + P T+ S + L +
Sbjct: 668 RRLPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRAR 727
Query: 347 -SGNKLSGR-------VPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFAL 398
+G +L G Y S + + S IGTG+ G VY+ +P+G A+
Sbjct: 728 AAGKQLLGEEIDSWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAV 787
Query: 399 KKLNSPET--------EELAFIRSFRNEAQVLS-------------QMERGSLFRILHND 437
KK+ S E + L IR RN ++L + GSL LH
Sbjct: 788 KKMWSKEESGAFNSEIKTLGSIR-HRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGA 846
Query: 438 AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497
+ +DW R ++V +AHALAYLHHDC P+++H D+ + N+LL E ++ADFG AR
Sbjct: 847 GKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLAR 906
Query: 498 LLH---------ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ A +N+ +AGSYGY+APE A +TEK DVYS+GVV LEVL GKHP
Sbjct: 907 TISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHP 966
Query: 549 RD------------LHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACL 596
D + L+ DP +L LD R ++ ++L ++F C+
Sbjct: 967 LDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGR-----TDSIMHEMLQTLAVAFLCV 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 182/540 (33%), Positives = 260/540 (48%), Gaps = 90/540 (16%)
Query: 143 FTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNL 195
G IPS IS+ + L ++ N L G L +L Y++LS N G +P E+G++
Sbjct: 370 LVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHI 429
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNND 254
NL +LD+ N+ G IPLTL L L IL L++N LSG LP E GNL+++ ++DV N
Sbjct: 430 INLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNL 489
Query: 255 IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-----S 309
+ G IP+ LG +L+ L L+ N+ + IP++LT L +L++S N LSG +P S
Sbjct: 490 LSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFS 549
Query: 310 QIASMEDLTWLDLSNNNIKGSIPGEITK------------------------------LS 339
+ A + L N + GSI G + K +
Sbjct: 550 RFAPASFVGNPYLCGNWV-GSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQ 608
Query: 340 RLDYLNLSGNKLSGRVPYSNKHLSS--------MPTPRKIDSKYCIGTGAYGSVYKAQLP 391
+ L S + G H+ M ++ K+ IG GA +VYK L
Sbjct: 609 QKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALK 668
Query: 392 NGRVFALKKL------NSPETE-ELAFIRSFRNEAQV---------------LSQMERGS 429
+ R A+K+L N E E EL I S R+ V ME GS
Sbjct: 669 SSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGS 728
Query: 430 LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489
L+ +LH + V+LDW R+ I A LAYLHHDC+P ++HRDI S+NILL+ EA
Sbjct: 729 LWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAH 788
Query: 490 VADFGTARLLHADSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
++DFG A+ + A ++ T + G+ GYI PE A T + EK D+YSFG+V LE+L GK
Sbjct: 789 LSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKA 848
Query: 549 RD----LHSTLSSSYDPKIMLIDVLDQRLPPPVD----RKVIQDILLVSTISFACLQSNP 600
D LH + S D ++ V + +D RK Q LL C + NP
Sbjct: 849 VDNEANLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQLALL-------CTKRNP 901
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 174/517 (33%), Positives = 245/517 (47%), Gaps = 71/517 (13%)
Query: 141 DGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIG 193
+ F+G++PSE+ +L +L+LL LS+N L G L+ L + + N+ G +P+E+G
Sbjct: 563 NNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELG 622
Query: 194 NLKNL-IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVG 251
+L L I L++ N L G IP LS L L+ L+L N LSG +P NL +L+ +
Sbjct: 623 SLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFS 682
Query: 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311
N + GPIP L ++S N+ P TQ F S+ K G S+I
Sbjct: 683 YNSLTGPIP----LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738
Query: 312 ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRK- 370
++ + + I L R ++ + G+ S L P++
Sbjct: 739 IAITAAVI-----GGVSLMLIALIVYLMRRPVRTVASSAQDGQP--SEMSLDIYFPPKEG 791
Query: 371 ------------IDSKYCIGTGAYGSVYKAQLPNGRVFALKKL--NSPETEELAFIRSFR 416
D + +G GA G+VYKA LP G A+KKL N SFR
Sbjct: 792 FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFR 851
Query: 417 NEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNI 451
E L M +GSL ILH+ + LDW+KR I
Sbjct: 852 AEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP--SCNLDWSKRFKI 909
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH-ADSSNQTLLA 510
A LAYLHHDC P + HRDI SNNILL+ K EA V DFG A+++ S + + +A
Sbjct: 910 ALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIA 969
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP-------RDLHSTLSSSYDPKI 563
GSYGYIAPE AYTM +TEK D+YS+GVV LE+L GK P D+ + + S
Sbjct: 970 GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDA 1029
Query: 564 MLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNP 600
+ VLD RL D +++ +L V I+ C +P
Sbjct: 1030 LSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSP 1065
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 172/531 (32%), Positives = 238/531 (44%), Gaps = 116/531 (21%)
Query: 134 LRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRL-------TNLNYMSLSRNMLGG 186
+R+ ++ TG IPS I +L K+ LD SSNRL G++ + L + LS N L G
Sbjct: 469 VRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEG 528
Query: 187 LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG------------ 234
LP + +L L LDV N G IP +L RL SL LIL++N SG
Sbjct: 529 SLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGL 588
Query: 235 -------------LPQEIGNLKNLML-LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280
+P E+G+++NL + L++ +N + G IPS + + LS LDLS N
Sbjct: 589 QLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLE 648
Query: 281 SSIPNELTRLTQLFHLDLS---------SNKLSGKIPSQ--------IASMEDLTWLDLS 323
+ L + L L++S NKL ++ Q +S +D +L
Sbjct: 649 GDLA-PLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYR 707
Query: 324 NNNIKGS-------------------------IPGEITKL-SRLDYLNLSGNKLSGR--- 354
N G I G + + +R + N ++L
Sbjct: 708 KGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKW 767
Query: 355 --VPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKL-----NSPETE 407
P+ + S R + IG G G VY+A + NG V A+KKL N E
Sbjct: 768 QFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDE 827
Query: 408 ELAFIR-SFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAV 441
+ +R SF E + L M GSL +LH +
Sbjct: 828 KTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGS 886
Query: 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
LDW R I+ A LAYLHHDC P +VHRDI +NNIL+ E ++ADFG A+L+
Sbjct: 887 SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDE 946
Query: 502 DSSNQT--LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
+ +AGSYGYIAPE Y+M +TEK DVYS+GVV LEVL GK P D
Sbjct: 947 GDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 164/513 (31%), Positives = 254/513 (49%), Gaps = 82/513 (15%)
Query: 114 VNFNGRLSHLNFSCFPNLESLRILAYYDG-FTGSIPSEISALSKLQLLDLSSNRLRG--- 169
+ F+ +LS + + SL + D +G +P+ L +L ++N+L+G
Sbjct: 393 ITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIP 452
Query: 170 ----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225
+ +L+ + +S N G++P ++ +L++L +D+ NS +G IP +++L +L+ +
Sbjct: 453 PSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERV 512
Query: 226 ILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
+ +N L G +P + + L L++ NN + G IP LG L+YLDLS NQ IP
Sbjct: 513 EMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIP 572
Query: 285 NELTRLTQLFHLDLSSNKLSGKIPS----QIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
EL RL +L ++S NKL GKIPS I L +L N+ P + +R
Sbjct: 573 AELLRL-KLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETR 631
Query: 341 -------LDYLNLSG--------------------NKLS--GRVPYSNKHLSSMPTPRKI 371
L + L+G NK++ RV ++ + + T I
Sbjct: 632 YILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEEDIYPQLTEDNI 691
Query: 372 DSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
IG+G G VY+ +L +G+ A+KKL ++ FR+E + L +
Sbjct: 692 -----IGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIV 746
Query: 425 ------------------MERGSLFRILHNDAE--AVE-LDWAKRVNIVKAMAHALAYLH 463
ME GSL +LH++ E AV LDW R +I A L+YLH
Sbjct: 747 KLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLH 806
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN------QTLLAGSYGYIA 517
HD P +VHRD+ SNNILL+ +++ VADFG A+ L + ++ + +AGSYGYIA
Sbjct: 807 HDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIA 866
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
PE YT + EK DVYSFGVV LE++ GK P D
Sbjct: 867 PEYGYTSKVNEKSDVYSFGVVLLELITGKRPND 899
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 602 | ||||||
| 296085298 | 610 | unnamed protein product [Vitis vinifera] | 0.845 | 0.834 | 0.471 | 1e-129 | |
| 296087789 | 975 | unnamed protein product [Vitis vinifera] | 0.822 | 0.507 | 0.461 | 1e-124 | |
| 359488981 | 757 | PREDICTED: probable LRR receptor-like se | 0.872 | 0.693 | 0.396 | 1e-118 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.787 | 0.578 | 0.429 | 1e-116 | |
| 225452698 | 727 | PREDICTED: probable LRR receptor-like se | 0.870 | 0.720 | 0.397 | 1e-114 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.872 | 0.692 | 0.392 | 1e-113 | |
| 224065665 | 847 | predicted protein [Populus trichocarpa] | 0.762 | 0.541 | 0.448 | 1e-112 | |
| 296082878 | 1699 | unnamed protein product [Vitis vinifera] | 0.933 | 0.330 | 0.392 | 1e-111 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.813 | 0.581 | 0.406 | 1e-108 | |
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.813 | 0.621 | 0.406 | 1e-108 |
| >gi|296085298|emb|CBI29030.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1201), Expect = e-129, Method: Compositional matrix adjust.
Identities = 272/577 (47%), Positives = 361/577 (62%), Gaps = 68/577 (11%)
Query: 88 SDHCEWIGITCNSAGSIIGLHLSKDNVNFNGR---LSHLNFSCFPNLESLRILAYYDGFT 144
S HC W GITCN+ G ++ + S +G+ LS L FS FP+L L + +
Sbjct: 6 SHHCTWEGITCNTEGHVVRITYSY----IDGKMVELSKLKFSSFPSL--LHLYVSHSSIY 59
Query: 145 GSIPSEISALSKLQLLDLSSNRLRGRL-------TNLNYMSLSRNMLGGLLPQEIGNLKN 197
G IP EI L+KL L +S + G L T L + L+ N L G++P +G LKN
Sbjct: 60 GRIPDEIGMLTKLTYLRISECDVYGELPVSLGNLTLLEELDLAYNNLSGVIPSSLGYLKN 119
Query: 198 LIELDVGDN-SLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDI 255
LI LD+ N L G IP +L L +LK L L+ N+++G +P +IGNLKNL L + +N +
Sbjct: 120 LIHLDLSFNYGLSGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLTHLYLVSNSL 179
Query: 256 IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL-DLSSNKLSGKIPSQIASM 314
G IPS L S+L YL L+ N+ N SIP+E+ L L L DLS N + GKIPSQ+ ++
Sbjct: 180 SGVIPSPLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLLDLSDNLIHGKIPSQVQNL 239
Query: 315 EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPY------------SNKHL 362
+ L +L+LS+N + GSIP + L+LS N L G +P+ +NK L
Sbjct: 240 KRLVYLNLSHNKLSGSIPTLLIYDHIRPSLDLSYNDLEGHIPFELQSKFSQGSFDNNKGL 299
Query: 363 SSMPTPRKI------------DSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELA 410
KI D KYCIGTG YGSVYKAQLP G V ALKKL+ ET+E
Sbjct: 300 CVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEAT 359
Query: 411 FIRSFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDW 445
+++SF+NE Q+LS+ M RGSL+ +L N+ EA+ELDW
Sbjct: 360 YLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDW 419
Query: 446 AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505
KRVN+VK++ HA+ Y+HHDC+P ++HRDISSNNILL+SKL+AF++DFGT+RLLH DSSN
Sbjct: 420 IKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSN 479
Query: 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIML 565
QTLL+G+YGYIAPELAYTMV+TEK DVYSFGVV LE +MGKHP +L + LSSS IML
Sbjct: 480 QTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIML 539
Query: 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
D+LD RLP P D++V +D++LV ++ C+ SNP+S
Sbjct: 540 TDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 576
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296087789|emb|CBI35045.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1158), Expect = e-124, Method: Compositional matrix adjust.
Identities = 260/563 (46%), Positives = 350/563 (62%), Gaps = 68/563 (12%)
Query: 66 QLETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNF 125
Q+E +ALL +GWW+ D+DSDHC+W GITCN G +I ++ +G LS L F
Sbjct: 41 QVEKEALLESGWWSGETDHDHDSDHCDWSGITCNEEGHVIAVYYRA-----SGELSKLKF 95
Query: 126 SCFPNLESLRILAYYDG-FTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNML 184
S FP SLR + +DG +G IP +I G LT + Y+ LSRN L
Sbjct: 96 SSFP---SLRTIDLHDGRLSGRIPHQI-----------------GSLTKVIYLDLSRNEL 135
Query: 185 GGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLK 243
G +P +I L L LD+ N L G IP ++ LTSL L L+ N+L+G +PQ+IG L
Sbjct: 136 SGSIPDQIATLTKLTYLDLSRNELSGSIPPQINTLTSLNYLDLSHNELNGRIPQQIGTLI 195
Query: 244 NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303
L LD+ +N++ G IP + ++L+YLDLS N N SIP++L L +L + DLS N+L
Sbjct: 196 RLTHLDLYSNELSGSIPDEIDTLTELAYLDLSNNVLNGSIPHQLGALAKLTYFDLSWNEL 255
Query: 304 SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLS 363
SG IPS + +L L L+NN I G IP +I L L L+LS N +SG++P ++L
Sbjct: 256 SGDIPSSFGHLSNLISLCLNNNQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQNLK 315
Query: 364 SMPTPRK------------------------IDSKYCIGTGAYGSVYKAQLPNGRVFALK 399
S R+ D KYC+G G YGSVY+AQLP G+V ALK
Sbjct: 316 SAAETRRGDLFSVWDYDGTIAYQDIIQSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALK 375
Query: 400 KLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHAL 459
KL+ E EE +++SF NEAQ+LS++ ++ R+N+VK++AHAL
Sbjct: 376 KLHGWEREEPTYLKSFENEAQILSKIRHRNI-----------------RLNVVKSIAHAL 418
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
+Y+HHDCSP ++HRDISSNN+LLNS+LEAFV+DFGTARLL DSS QTLL G+YGYIAPE
Sbjct: 419 SYMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPE 478
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579
LAYTM +T+K DVYSFGVV LE +MGKHPR++ ++LSSS I+L DVLD RL P +
Sbjct: 479 LAYTMTVTKKCDVYSFGVVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRLALPENP 538
Query: 580 KVIQDILLVSTISFACLQSNPKS 602
+V +DI+ V ++ C+ SNP+S
Sbjct: 539 QVAKDIVFVVLLALKCIHSNPQS 561
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1112), Expect = e-118, Method: Compositional matrix adjust.
Identities = 275/694 (39%), Positives = 374/694 (53%), Gaps = 169/694 (24%)
Query: 68 ETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSC 127
E +AL +TGWWN++ S HC W G+ CN+AG + G+ L G LS L FS
Sbjct: 38 EAEALRSTGWWNST------SAHCHWDGVYCNNAGRVTGIALYGSGKEL-GELSKLEFSS 90
Query: 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNYMSLS 180
FP+L L + A G GSIP +I L++L +L L N L G LT L Y++L
Sbjct: 91 FPSLVELNLSAC--GLNGSIPHQIGTLTQLTVLSLHDNNLTGEIPLSLANLTQLLYLTLC 148
Query: 181 RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT------------------------L 216
N L G +P EIG +KNLI LD+G ++LIG IP + +
Sbjct: 149 SNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPSSFGNLTTLTTLYLDGNQISGFIPPQI 208
Query: 217 SRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSD------- 268
++ +LK L+L+ N L G +P EIG +KNL L++G N++ G IPS+ G ++
Sbjct: 209 GKMKNLKSLLLSYNGLHGPIPPEIGKMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFR 268
Query: 269 -----------------LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311
LSYLDLS NQ + IP E+ L +L HLD+S+N +SGKIPSQ+
Sbjct: 269 GNQISGFIPPEIGHLLNLSYLDLSENQISGFIPEEMVNLKKLSHLDMSNNLISGKIPSQL 328
Query: 312 ASMEDL------------------------TWLDLSNNNIKG-------------SIPGE 334
+++++ T +DLSNN ++G + GE
Sbjct: 329 GNLKEVKYFNLSHNNLSGTIPYSISSNYRWTLIDLSNNRLEGQARAPVEAFGHNKGLCGE 388
Query: 335 ITKLSR-------------------------LDYL----NLSGNKLSGRVPYSNKHLSSM 365
I +R L +L + N+L N L S+
Sbjct: 389 IKGWARCKKRHQITLIIVVSLSTTLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSI 448
Query: 366 -------------PTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFI 412
D KYCIGTG YGSVY+AQLP+G+V ALKKL+ E E+ ++
Sbjct: 449 WDFDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYL 508
Query: 413 RSFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAK 447
+SF NE Q+L++ ME+GSL+ +L ++ EAVELDW K
Sbjct: 509 KSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIK 568
Query: 448 RVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
RVN+VK++A+AL+Y+HHDC ++HRDISSNNILL+SKLEAFV+DFGTARLL DSSN+T
Sbjct: 569 RVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRT 628
Query: 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567
LLAG+YGYIAPELAYTMV+TEK DVYSFG+V LE +MG HP + ++LSSS L D
Sbjct: 629 LLAGTYGYIAPELAYTMVVTEKCDVYSFGMVALETMMGMHPGEFITSLSSSSTQNTTLKD 688
Query: 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
VLD RL P +V +I L+ +++ CL NP+
Sbjct: 689 VLDSRLSSPKSTRVANNIALIVSLALKCLHFNPQ 722
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 256/596 (42%), Positives = 341/596 (57%), Gaps = 122/596 (20%)
Query: 129 PNLESLRILAYYD----GFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYM 177
P+L L+ L Y D GSIPS+I L L L L SN L G L+NL Y+
Sbjct: 191 PSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLTHLYLVSNSLSGVIPSPLANLSNLEYL 250
Query: 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG--- 234
L+ N + G +P EIGNLKNL++L + NSLIG IP +L LT+L L L NQ+ G
Sbjct: 251 FLNFNRINGSIPSEIGNLKNLVQLCLSHNSLIGAIPSSLGHLTNLTYLHLFNNQIQGGIP 310
Query: 235 ----------------------LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL 272
+P I NLKNL+ L + +N++ G IPS+LG L
Sbjct: 311 LSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLHEF 370
Query: 273 DLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWL------------ 320
++S NQ + IP+ + L L LDLS N + GKIPSQ+ +++ L +L
Sbjct: 371 NISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIP 430
Query: 321 ------------DLSNNNIKGSIPGEI-TKLSRLDYLNLSG--NKLSGRVPYSNKHLSSM 365
DLS N+++G IP E+ +K S+ + N G + G ++ ++
Sbjct: 431 TLLIYDHIRPSLDLSYNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTR 490
Query: 366 PTPRKI----------------------------------DSKYCIGTGAYGSVYKAQLP 391
RKI D KYCIGTG YGSVYKAQLP
Sbjct: 491 IITRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLP 550
Query: 392 NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------------------------ME 426
G V ALKKL+ ET+E +++SF+NE Q+LS+ M
Sbjct: 551 TGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMG 610
Query: 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486
RGSL+ +L N+ EA+ELDW KRVN+VK++ HA+ Y+HHDC+P ++HRDISSNNILL+SKL
Sbjct: 611 RGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKL 670
Query: 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
+AF++DFGT+RLLH DSSNQTLL+G+YGYIAPELAYTMV+TEK DVYSFGVV LE +MGK
Sbjct: 671 DAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGK 730
Query: 547 HPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
HP +L + LSSS IML D+LD RLP P D++V +D++LV ++ C+ SNP+S
Sbjct: 731 HPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 786
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 273/687 (39%), Positives = 366/687 (53%), Gaps = 163/687 (23%)
Query: 66 QLETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNF 125
Q+E +ALL +GWW+ D+DSDHC+W GITCN G +I ++ +G LS L F
Sbjct: 17 QVEKEALLESGWWSGETDHDHDSDHCDWSGITCNEEGHVIAVYYRA-----SGELSKLKF 71
Query: 126 SCFPNLESLRILAYYDG-------------------------FTGSIPSEISALSKLQLL 160
S FP SLR + +DG +GSIP +I+ L+KL L
Sbjct: 72 SSFP---SLRTIDLHDGRLSGRIPHQIGSLTKVIYLDLSRNELSGSIPDQIATLTKLTYL 128
Query: 161 DLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP 213
DLS N L G LT+LNY+ LS N L G +PQ+IG L L LD+ N L G IP
Sbjct: 129 DLSRNELSGSIPPQINTLTSLNYLDLSHNELNGRIPQQIGTLIRLTHLDLYSNELSGSIP 188
Query: 214 LTLSRLTSLKILILAQNQLSG-------------------------LPQEIGNLKNLMLL 248
+ LT L L L+ N L+G +P G+L NL+ L
Sbjct: 189 DEIDTLTELAYLDLSNNVLNGSIPHQLGALAKLTYFDLSWNELSGDIPSSFGHLSNLISL 248
Query: 249 DVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL------------ 296
+ NN I GPIP +G DL LDLS N + IP+++ L +L +L
Sbjct: 249 CLNNNQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQNLKRLENLNLSRNKLSGAIP 308
Query: 297 ------------DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI--------PGEIT 336
DLS N L G IP ++ E + N ++ G I +IT
Sbjct: 309 PSLTYDYKWTSIDLSYNDLEGHIPFEL-QFESPPGVFEHNKHLCGEIRHWPHCKKGQKIT 367
Query: 337 -------------------------KLSRLDYLNLSGNK-----------LSGRVPYSNK 360
K+ ++ +++ S + G + Y +
Sbjct: 368 LILVISLLATLCIAFAFLKFLLLPRKMRKMRHMSASAAETRRGDLFSVWDYDGTIAYQD- 426
Query: 361 HLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQ 420
+ + D KYC+G G YGSVY+AQLP G+V ALKKL+ E EE +++SF NEAQ
Sbjct: 427 ---IIQSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENEAQ 483
Query: 421 VLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
+LS+ MERGSLF +L ++ EA+ELDW KR+N+VK++
Sbjct: 484 ILSKIRHRNIVKLHGFCLHRRSMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVKSI 543
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AHAL+Y+HHDCSP ++HRDISSNN+LLNS+LEAFV+DFGTARLL DSS QTLL G+YGY
Sbjct: 544 AHALSYMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGY 603
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575
IAPELAYTM +T+K DVYSFGVV LE +MGKHPR++ ++LSSS I+L DVLD RL
Sbjct: 604 IAPELAYTMTVTKKCDVYSFGVVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRLAL 663
Query: 576 PVDRKVIQDILLVSTISFACLQSNPKS 602
P + +V +DI+ V ++ C+ SNP+S
Sbjct: 664 PENPQVAKDIVFVVLLALKCIHSNPQS 690
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1064), Expect = e-113, Method: Compositional matrix adjust.
Identities = 273/695 (39%), Positives = 366/695 (52%), Gaps = 170/695 (24%)
Query: 68 ETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSC 127
E +AL +TGWWN++ S HC W G+ CN+AG + G+ L+ G LS L FS
Sbjct: 38 EAEALRSTGWWNST------SAHCHWDGVYCNNAGRVTGIALNGSGKEL-GELSKLEFSS 90
Query: 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNYMSLS 180
FP+L L + A G GSIP +I L++L +L L N L G LT L Y++L
Sbjct: 91 FPSLVELNLCAC--GLNGSIPHQIGTLTQLTVLSLHDNNLTGEIPLSLANLTQLLYLTLC 148
Query: 181 RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT------------------------L 216
N L G +P EIG +KNLI LD+G ++LIG IP + +
Sbjct: 149 SNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPSSFGNLTTLTTLYLDGNQISGLIPPQI 208
Query: 217 SRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSD------- 268
++ +LK L+L+ N L G +P EIG +KNL L++G N++ G IPS+ G ++
Sbjct: 209 GKMKNLKSLLLSHNGLHGPIPPEIGGMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFR 268
Query: 269 -----------------LSYLDLSCNQFNSSIPNELTRLTQLFHLD-------------- 297
LSYLDLS NQ + IP E+ L +L HLD
Sbjct: 269 GNQISGFIPLEIWYLLNLSYLDLSENQISGFIPEEIVNLKKLSHLDMSNNLISGKIPSQL 328
Query: 298 ----------LSSNKLSGKIPSQIAS-MEDLTWLDLS-----------------NNNIKG 329
LS N LSG IP I+S T +DLS N + G
Sbjct: 329 GNLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLIDLSNNRLEGQTRAPVEAFGHNKGLCG 388
Query: 330 SIPG--------EIT-------------KLSRLDYL----NLSGNKLSGRVPYSNKHLSS 364
I G +IT ++ L +L + N+L N L S
Sbjct: 389 EIKGRPRCKKRHQITLIIVVSLSTTLLLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFS 448
Query: 365 M-------------PTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAF 411
+ D KYCIGTG YGSVY+AQLP+G+V ALKKL+ E + +
Sbjct: 449 IWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTY 508
Query: 412 IRSFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWA 446
++SF NE Q+L++ ME+GSL+ +L ++ EAVELDW
Sbjct: 509 LKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWI 568
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506
KRVN+VK++A+AL+Y+HHDC ++HRDISSNNILL+SKLEAFV+DFGTARLL DSSN+
Sbjct: 569 KRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNR 628
Query: 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLI 566
TLL G+YGYIAPELAYTMV+TEK D+YSFG+V LE +MG HP + ++LSSS L
Sbjct: 629 TLLVGTYGYIAPELAYTMVVTEKCDIYSFGMVALETMMGMHPGEFVTSLSSSSTQNTTLK 688
Query: 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
DVLD RL P +V +I L+ +++ CL SNP+
Sbjct: 689 DVLDSRLSSPKSTQVANNIALIVSLALKCLHSNPQ 723
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065665|ref|XP_002301910.1| predicted protein [Populus trichocarpa] gi|222843636|gb|EEE81183.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1058), Expect = e-112, Method: Compositional matrix adjust.
Identities = 248/553 (44%), Positives = 327/553 (59%), Gaps = 94/553 (16%)
Query: 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRG------------------------------ 169
++G GSIP +I L+ L+ LDLSSN L G
Sbjct: 255 FNGINGSIPLQIGNLTNLEHLDLSSNILAGSIPSIFSLLSNLILLHLFDNQINGSISSEI 314
Query: 170 -RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228
LTNL + L N + G +P +GNL+NL LD+ +N +IG I L + LT+L+ L L+
Sbjct: 315 GNLTNLCRLFLRGNKITGSIPISLGNLRNLTFLDLSNNQIIGSIALKIRNLTNLEELHLS 374
Query: 229 QNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL 287
N +SG +P +G+L NL LD+ N I G IP + ++L L L+ N F+ SIP L
Sbjct: 375 SNNISGSVPTILGSLLNLKKLDLCRNQINGSIPLEIQNLTNLEELCLNSNNFSGSIPFML 434
Query: 288 TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347
LT L LDLS N+++G I S + + + LT+LDLS++N+ G IP ++ L L Y+N
Sbjct: 435 GSLTNLKKLDLSRNQINGSIASSLKNCKYLTYLDLSHSNLSGQIPSQLYNLPSLSYVNFG 494
Query: 348 GNKLSGRVPY--------------------------------SNKHLSSMPTPRK-IDSK 374
N LSG VP NK L +P + D +
Sbjct: 495 YNNLSGSVPLQLPQPFDVSFTCDSLHGQRTNSPEIFQATAFEGNKDLHPDFSPTENFDLR 554
Query: 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
YCIG+G YGSVY+AQLP+G++ ALKKL+ E EE AF +SF+NE ++L+Q
Sbjct: 555 YCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIRHRSIVRLY 614
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
ME+GSLF L ND AVEL W KR +I+K +AHAL+YLHH+C+P
Sbjct: 615 GFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHECNPP 674
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
+VHRDISS+N+LLNS ++FVADFG ARLL DSSN T+LAG+YGYIAPELAYTMV+TEK
Sbjct: 675 IVHRDISSSNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEK 734
Query: 530 YDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVS 589
DVYSFG V LE LMG+HP D+ LSSS I L +VLD RL PP D VIQ+I +++
Sbjct: 735 CDVYSFGAVALETLMGRHPGDI---LSSSAR-AITLKEVLDPRLSPPTDEIVIQNICIIA 790
Query: 590 TISFACLQSNPKS 602
T++F+CL SNPKS
Sbjct: 791 TLAFSCLHSNPKS 803
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082878|emb|CBI22179.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-111, Method: Compositional matrix adjust.
Identities = 268/683 (39%), Positives = 367/683 (53%), Gaps = 121/683 (17%)
Query: 24 ISMDPASSIFRLAALVWVAIFTCDNVAVRTGTIVTASALSPIQLETKALLNTGWWNNSWT 83
S+ AS I +VWV ++A + + S+ E +AL +TGWWN++
Sbjct: 355 FSIRMASFISTAGVVVWVVTMILFSLA---NAVSSPSSTD----EGEALRSTGWWNST-- 405
Query: 84 MDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGF 143
S H W G+ CN GS+ +HLS +G LS L FS FP+L L + G
Sbjct: 406 ----SAHFTWDGVVCNERGSVTEIHLSYSGKK-SGELSKLKFSSFPSLVGLFLSNC--GL 458
Query: 144 TGSIPSEISALSKLQLLDLSSNRLRGRL-------TNLNYM--SLSRNMLGGLLPQEIGN 194
GSIP +I L++L L N L G L T LN + SLS + L G + EIG
Sbjct: 459 NGSIPHQIGTLTQLTYFILPQNNLIGELPLSLANLTQLNVICHSLSYDGLHGPILSEIGK 518
Query: 195 LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNND 254
+ N L++G +L G + + LT + LIL NQ+SG +GNL NL LD+ N
Sbjct: 519 MNNFNILNLGYKNLTGVVHFSFGNLTHMTSLILRGNQISGFISHVGNLFNLSYLDLSGNQ 578
Query: 255 I--IGPIPS-TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL------------- 298
I +G + F L L+LS N SIP+++ LTQL L L
Sbjct: 579 INELGELSKLEFSSFPSLVELNLSACGLNGSIPHQIGTLTQLTVLSLHDNNLTGEIPLSL 638
Query: 299 -------------SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR----- 340
S+N +SGKIPSQ+ +++++ + +LS+NN+ G+IP I+ +R
Sbjct: 639 ANLTQLLYLTLYMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSWARCKKRH 698
Query: 341 --------------------LDYL----NLSGNKLSGRVPYSNKHLSSM----------- 365
L +L + N+L N L S+
Sbjct: 699 QITLIIVVSLSTTLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQD 758
Query: 366 --PTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS 423
D KYCIGTG YGSVY+AQLP+G+V ALKKL+ E E+ +++SF NE Q+L+
Sbjct: 759 IIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLT 818
Query: 424 Q-------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHA 458
+ ME+GSL+ +L ++ EAVELDW KRVN+VK++A+A
Sbjct: 819 RIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANA 878
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
L+Y+HHDC ++HRDISSNNILL+SKLEAFV+DFGTARLL DSSN+TLLAG+YGYIAP
Sbjct: 879 LSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAP 938
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578
ELAYTMV+TEK DVYSFG+V LE +MG HP + ++LSSS L DVLD RL P
Sbjct: 939 ELAYTMVVTEKCDVYSFGMVALETMMGMHPGEFITSLSSSSTQNTTLKDVLDSRLSSPKS 998
Query: 579 RKVIQDILLVSTISFACLQSNPK 601
+V +I L+ +++ CL NP+
Sbjct: 999 TRVANNIALIVSLALKCLHFNPQ 1021
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1027), Expect = e-108, Method: Compositional matrix adjust.
Identities = 257/632 (40%), Positives = 345/632 (54%), Gaps = 142/632 (22%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAY-YDGFTGSIPSEISALSKLQLLDLSSNRLRG-- 169
+++FN LS + S L++L+ L + GSIP +I L L L L SN L G
Sbjct: 178 DLSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVI 237
Query: 170 -----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
L+NL Y+ L+ N + G +P EIGNLKNL++L NSLIG IP +L LT+L
Sbjct: 238 PSSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTY 297
Query: 225 LILAQNQLSG-------------------------LPQEIGNLKNLMLL----------- 248
L L NQ+ G +P I NLKNL+ L
Sbjct: 298 LHLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVI 357
Query: 249 -------------DVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFH 295
++ N I G IPST+G ++L+ LDLS N + IP+++ L +L +
Sbjct: 358 PSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTY 417
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK-----------------------GSIP 332
L+LS NKLSG IP+ + LDLS+N+++ G I
Sbjct: 418 LNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIK 477
Query: 333 G-----EITKLSRLDYLNLSGNKL-------------------SGRVPYSNKHLSS---- 364
G E K +R+ ++LS + +P N + S
Sbjct: 478 GLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKEIPTKNGDIFSVWNY 537
Query: 365 ---------MPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSF 415
+ D KYCIGTG YGSVYKAQLP G V ALKKL+ E +E +++SF
Sbjct: 538 DGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSF 597
Query: 416 RNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVN 450
+NE Q+LS+ M RGSL+ +L N+ EA+ELDW KRVN
Sbjct: 598 QNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVN 657
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
+VK++ HA+ Y+HHDC+P ++HRDISSNNILL+SKL+AF++DFGTARLLH DSSNQTLLA
Sbjct: 658 VVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLA 717
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570
G+YGYIAPELAYTMV+TEK DVYSFGVV LE +MGKHP +L + LSSS IML ++LD
Sbjct: 718 GTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILD 777
Query: 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
RLP P D++V +D++LV ++ C+ SNP+S
Sbjct: 778 SRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-108, Method: Compositional matrix adjust.
Identities = 257/632 (40%), Positives = 345/632 (54%), Gaps = 142/632 (22%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAY-YDGFTGSIPSEISALSKLQLLDLSSNRLRG-- 169
+++FN LS + S L++L+ L + GSIP +I L L L L SN L G
Sbjct: 124 DLSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVI 183
Query: 170 -----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
L+NL Y+ L+ N + G +P EIGNLKNL++L NSLIG IP +L LT+L
Sbjct: 184 PSSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTY 243
Query: 225 LILAQNQLSG-------------------------LPQEIGNLKNLMLL----------- 248
L L NQ+ G +P I NLKNL+ L
Sbjct: 244 LHLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVI 303
Query: 249 -------------DVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFH 295
++ N I G IPST+G ++L+ LDLS N + IP+++ L +L +
Sbjct: 304 PSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTY 363
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK-----------------------GSIP 332
L+LS NKLSG IP+ + LDLS+N+++ G I
Sbjct: 364 LNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIK 423
Query: 333 G-----EITKLSRLDYLNLSGNKL-------------------SGRVPYSNKHLSS---- 364
G E K +R+ ++LS + +P N + S
Sbjct: 424 GLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKEIPTKNGDIFSVWNY 483
Query: 365 ---------MPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSF 415
+ D KYCIGTG YGSVYKAQLP G V ALKKL+ E +E +++SF
Sbjct: 484 DGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSF 543
Query: 416 RNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVN 450
+NE Q+LS+ M RGSL+ +L N+ EA+ELDW KRVN
Sbjct: 544 QNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVN 603
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
+VK++ HA+ Y+HHDC+P ++HRDISSNNILL+SKL+AF++DFGTARLLH DSSNQTLLA
Sbjct: 604 VVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLA 663
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570
G+YGYIAPELAYTMV+TEK DVYSFGVV LE +MGKHP +L + LSSS IML ++LD
Sbjct: 664 GTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILD 723
Query: 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
RLP P D++V +D++LV ++ C+ SNP+S
Sbjct: 724 SRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 755
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 602 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.340 | 0.196 | 0.524 | 1.4e-94 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.358 | 0.192 | 0.470 | 5e-90 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.468 | 0.250 | 0.366 | 3.2e-76 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.458 | 0.272 | 0.369 | 3.3e-73 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.514 | 0.281 | 0.310 | 7.6e-72 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.453 | 0.218 | 0.361 | 4.5e-71 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.294 | 0.160 | 0.440 | 3.7e-70 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.465 | 0.246 | 0.350 | 4.5e-69 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.435 | 0.254 | 0.352 | 6.2e-69 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.426 | 0.225 | 0.362 | 1.8e-68 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 1.4e-94, Sum P(2) = 1.4e-94
Identities = 109/208 (52%), Positives = 146/208 (70%)
Query: 397 ALKKLNSPETEEL-AFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
AL ++ +L F RN V MERGSL ++L ND EA +LDW KR+N+VK +
Sbjct: 827 ALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGV 886
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AHAL+Y+HHD SP++VHRDISS NILL EA ++DFGTA+LL DSSN + +AG+YGY
Sbjct: 887 AHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGY 946
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY-DPKIMLIDVLDQRLP 574
+APELAY M +TEK DVYSFGV+TLEV+ G+HP DL STLSSS D + L + D RLP
Sbjct: 947 VAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLP 1006
Query: 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602
P ++ +++L + ++ CL S+P++
Sbjct: 1007 EPTP-EIKEEVLEILKVALLCLHSDPQA 1033
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 5.0e-90, Sum P(2) = 5.0e-90
Identities = 103/219 (47%), Positives = 145/219 (66%)
Query: 385 VYKAQLPNGRVFALKKLNSPETEEL-AFIRSFRNEAQVLSQMERGSLFRILHNDAEAVEL 443
V K + N V AL ++ +L F R+ + ME+GSL ++L ND EA L
Sbjct: 892 VVKQEFLN-EVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRL 950
Query: 444 DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503
W KR+N+VK +AHAL+Y+HHD +VHRDISS NILL++ A ++DFGTA+LL DS
Sbjct: 951 TWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDS 1010
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI 563
SN + +AG+YGY+APE AYTM +TEK DVYSFGV+ LE+++GKHP DL S+LSSS +
Sbjct: 1011 SNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEAL 1070
Query: 564 MLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602
L + D+R+ P + + +L + ++ CLQ+NP+S
Sbjct: 1071 SLRSISDERVLEPRGQNR-EKLLKMVEMALLCLQANPES 1108
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 3.2e-76, Sum P(3) = 3.2e-76
Identities = 110/300 (36%), Positives = 157/300 (52%)
Query: 80 NSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCF--PNLESLRIL 137
++W D C WIG+ C+S GS S V + LS +N S P++ L L
Sbjct: 56 HNWN-GIDETPCNWIGVNCSSQGSSSS---SNSLVVTSLDLSSMNLSGIVSPSIGGLVNL 111
Query: 138 AY----YDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGG 186
Y Y+ TG IP EI SKL+++ L++N+ G +L+ L ++ N L G
Sbjct: 112 VYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSG 171
Query: 187 LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNL 245
LP+EIG+L NL EL N+L GP+P +L L L QN SG +P EIG NL
Sbjct: 172 PLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNL 231
Query: 246 MLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305
LL + N I G +P +G+ L + L N+F+ IP ++ LT L L L N L G
Sbjct: 232 KLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVG 291
Query: 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
IPS+I +M+ L L L N + G+IP E+ KLS++ ++ S N LSG +P +S +
Sbjct: 292 PIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISEL 351
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 426 (155.0 bits), Expect = 3.3e-73, Sum P(2) = 3.3e-73
Identities = 108/292 (36%), Positives = 155/292 (53%)
Query: 82 WTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD 141
W + SDHC W G+ CNS G++ L L+ +N G++S + S +L S I +
Sbjct: 51 WKLSDTSDHCNWTGVRCNSNGNVEKLDLA--GMNLTGKISD-SISQLSSLVSFNISC--N 105
Query: 142 GFTGSIPSEISALSKLQLLDLSSNRLRGRL---TN----LNYMSLSRNMLGGLLPQEIGN 194
GF +P I L + D+S N G L +N L +++ S N L G L +++GN
Sbjct: 106 GFESLLPKSIPPLKSI---DISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGN 162
Query: 195 LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNN 253
L +L LD+ N G +P + L L+ L L+ N L+G LP +G L +L +G N
Sbjct: 163 LVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYN 222
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313
+ GPIP G + L YLDL+ + + IP+EL +L L L L N +G IP +I S
Sbjct: 223 EFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGS 282
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
+ L LD S+N + G IP EITKL L LNL NKLSG +P + L+ +
Sbjct: 283 ITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQL 334
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 387 (141.3 bits), Expect = 7.6e-72, Sum P(3) = 7.6e-72
Identities = 103/332 (31%), Positives = 175/332 (52%)
Query: 37 ALVWVAIFTCDNVAVRTGTIVTASALSPIQLE-TKALLNTGWWNNSWTMDYDSDHCEWIG 95
A+ ++++ ++ TG + L I+ + A N WN++ DS C W G
Sbjct: 9 AVFFISLLLILLISETTGLNLEGQYLLEIKSKFVDAKQNLRNWNSN-----DSVPCGWTG 63
Query: 96 ITCNSAGS---IIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEIS 152
+ C++ S ++ L+LS ++ +G+LS + +L+ L + Y+G +G IP EI
Sbjct: 64 VMCSNYSSDPEVLSLNLS--SMVLSGKLSP-SIGGLVHLKQLDLS--YNGLSGKIPKEIG 118
Query: 153 ALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
S L++L L++N+ G +L +L + + N + G LP EIGNL +L +L
Sbjct: 119 NCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYS 178
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
N++ G +P ++ L L QN +SG LP EIG ++L++L + N + G +P +G
Sbjct: 179 NNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIG 238
Query: 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
+ LS + L N+F+ IP E++ T L L L N+L G IP ++ ++ L +L L
Sbjct: 239 MLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYR 298
Query: 325 NNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
N + G+IP EI LS ++ S N L+G +P
Sbjct: 299 NGLNGTIPREIGNLSYAIEIDFSENALTGEIP 330
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 4.5e-71, Sum P(3) = 4.5e-71
Identities = 103/285 (36%), Positives = 154/285 (54%)
Query: 82 WTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD 141
W D + ++C W G+TC++ G + L+ + G +S F F NL L + + +
Sbjct: 50 WNSD-NINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPW-FGRFDNLIHLDLSS--N 105
Query: 142 GFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEIGN 194
G IP+ +S L+ L+ L L SN+L G L N+ + + N L G +P+ +GN
Sbjct: 106 NLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGN 165
Query: 195 LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNN 253
L NL L + L GPIP L RL ++ LIL N L G +P E+GN +L + N
Sbjct: 166 LVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAEN 225
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313
+ G IP+ LG +L L+L+ N IP++L ++QL +L L +N+L G IP +A
Sbjct: 226 MLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLAD 285
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358
+ +L LDLS NN+ G IP E +S+L L L+ N LSG +P S
Sbjct: 286 LGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKS 330
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 368 (134.6 bits), Expect = 3.7e-70, Sum P(3) = 3.7e-70
Identities = 82/186 (44%), Positives = 109/186 (58%)
Query: 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484
M +GSL L + LDW R I A L YLHHDC P +VHRDI SNNILL+
Sbjct: 877 MSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDE 936
Query: 485 KLEAFVADFGTARLLHAD-SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
+ +A V DFG A+L+ S + + +AGSYGYIAPE AYTM +TEK D+YSFGVV LE++
Sbjct: 937 RFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 996
Query: 544 MGKHP-------RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACL 596
GK P DL + + S I I++ D RL D++ + ++ LV I+ C
Sbjct: 997 TGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCT 1055
Query: 597 QSNPKS 602
++P S
Sbjct: 1056 SNSPAS 1061
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 4.5e-69, Sum P(3) = 4.5e-69
Identities = 104/297 (35%), Positives = 163/297 (54%)
Query: 78 WNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL 137
WN S DSD C+W ITC+S+ + + ++ +V N S F +L+ L I
Sbjct: 61 WNPS-----DSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPP-NISSFTSLQKLVIS 114
Query: 138 AYYDGFTGSIPSEISALSKLQLLDLSSNRL-------RGRLTNLNYMSLSRNMLGGLLPQ 190
TG+I SEI S+L ++DLSSN L G+L NL + L+ N L G +P
Sbjct: 115 N--TNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPP 172
Query: 191 EIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN-QLSG-LPQEIGNLKNLMLL 248
E+G+ +L L++ DN L +PL L ++++L+ + N +LSG +P+EIGN +NL +L
Sbjct: 173 ELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVL 232
Query: 249 DVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP 308
+ I G +P +LG S L L + + IP EL ++L +L L N LSG +P
Sbjct: 233 GLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLP 292
Query: 309 SQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
++ +++L + L NN+ G IP EI + L+ ++LS N SG +P S +LS++
Sbjct: 293 KELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNL 349
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 6.2e-69, Sum P(2) = 6.2e-69
Identities = 97/275 (35%), Positives = 149/275 (54%)
Query: 90 HCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPS 149
HC W G+ C++ G + L LS N+N +G +S FP+L++L + + F S+P
Sbjct: 65 HCHWTGVHCDANGYVAKLLLS--NMNLSGNVSD-QIQSFPSLQALDLSN--NAFESSLPK 119
Query: 150 EISALSKLQLLDLSSNRLRGRL-------TNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202
+S L+ L+++D+S N G T L +++ S N G LP+++GN L LD
Sbjct: 120 SLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLD 179
Query: 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPS 261
G +P + L +LK L L+ N G +P+ IG L +L + +G N +G IP
Sbjct: 180 FRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFMGEIPE 239
Query: 262 TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD 321
G + L YLDL+ IP+ L +L QL + L N+L+GK+P ++ M L +LD
Sbjct: 240 EFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLD 299
Query: 322 LSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
LS+N I G IP E+ +L L LNL N+L+G +P
Sbjct: 300 LSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIP 334
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 400 (145.9 bits), Expect = 1.8e-68, Sum P(3) = 1.8e-68
Identities = 99/273 (36%), Positives = 145/273 (53%)
Query: 94 IGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEIS 152
I T ++ S++ L L K+ ++ G + S L L + A+ + GSIP ++
Sbjct: 362 IPTTISNCSSLVQLQLDKNQIS--GLIP----SELGTLTKLTLFFAWSNQLEGSIPPGLA 415
Query: 153 ALSKLQLLDLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
+ LQ LDLS N L G L NL + L N L G +PQEIGN +L+ L +G
Sbjct: 416 DCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGF 475
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
N + G IP + L + L + N+L G +P EIG+ L ++D+ NN + G +P+ +
Sbjct: 476 NRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVS 535
Query: 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
S L LD+S NQF+ IP L RL L L LS N SG IP+ + L LDL +
Sbjct: 536 SLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGS 595
Query: 325 NNIKGSIPGEITKLSRLDY-LNLSGNKLSGRVP 356
N + G IP E+ + L+ LNLS N+L+G++P
Sbjct: 596 NELSGEIPSELGDIENLEIALNLSSNRLTGKIP 628
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031859001 | SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (709 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 602 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-30 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.003 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.003 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 5e-47
Identities = 114/310 (36%), Positives = 164/310 (52%), Gaps = 42/310 (13%)
Query: 78 WNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLE----- 132
WN+S +D C W GITCN++ ++ + LS N++ G++S F P ++
Sbjct: 51 WNSS------ADVCLWQGITCNNSSRVVSIDLSGKNIS--GKISSAIFR-LPYIQTINLS 101
Query: 133 -----------------SLRILAYYDG-FTGSIPSEISALSKLQLLDLSSNRLRGRL--- 171
SLR L + FTGSIP ++ L+ LDLS+N L G +
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159
Query: 172 ----TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILIL 227
++L + L N+L G +P + NL +L L + N L+G IP L ++ SLK + L
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219
Query: 228 AQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNE 286
N LSG +P EIG L +L LD+ N++ GPIPS+LG +L YL L N+ + IP
Sbjct: 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNL 346
+ L +L LDLS N LSG+IP + +++L L L +NN G IP +T L RL L L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 347 SGNKLSGRVP 356
NK SG +P
Sbjct: 340 WSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-38
Identities = 87/224 (38%), Positives = 122/224 (54%), Gaps = 8/224 (3%)
Query: 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEI 192
Y+ +G IP EI L+ L LDL N L G L NL Y+ L +N L G +P I
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
Query: 193 GNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVG 251
+L+ LI LD+ DNSL G IP + +L +L+IL L N +G +P + +L L +L +
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311
+N G IP LG ++L+ LDLS N IP L LF L L SN L G+IP +
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
Query: 312 ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355
+ L + L +N+ G +P E TKL + +L++S N L GR+
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 61/255 (23%), Positives = 100/255 (39%), Gaps = 51/255 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G++G VY A+ G++ A+K + + ++ E ++L +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPNIVRLYD 64
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
E G LF +L + D A+ ++ + AL YLH S +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARF--YLRQILSALEYLH---SKGI 118
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
VHRD+ NILL+ +ADFG AR L T G+ Y+APE+ ++ + Y
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEV----LLGKGY 173
Query: 531 ----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
D++S GV+ E+L GK P L + KI + + I
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK-KIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 587 LVSTISFACLQSNPK 601
L +P+
Sbjct: 233 -------KLLVKDPE 240
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 93/289 (32%), Positives = 142/289 (49%), Gaps = 38/289 (13%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
LHL +N F G++ + + P L+ L++ + + F+G IP + + L +LDLS+N
Sbjct: 313 LHLFSNN--FTGKIP-VALTSLPRLQVLQL--WSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 167 LRGRL-------------------------------TNLNYMSLSRNMLGGLLPQEIGNL 195
L G + +L + L N G LP E L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNND 254
+ LD+ +N+L G I + SL++L LA+N+ G LP G+ K L LD+ N
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQ 486
Query: 255 IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM 314
G +P LG S+L L LS N+ + IP+EL+ +L LDLS N+LSG+IP+ + M
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 315 EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLS 363
L+ LDLS N + G IP + + L +N+S N L G +P + L+
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 66/258 (25%), Positives = 102/258 (39%), Gaps = 47/258 (18%)
Query: 376 CIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
+G+G++G+VYKA+ G++ A+K L + + R E ++L +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
E G LF L L + I + L YLH S
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE--LAYTMVMT 527
++HRD+ NILL+ +ADFG A+ L SS+ T G+ Y+APE L
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY-G 177
Query: 528 EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587
K DV+S GV+ E+L GK P + L ++ + L PP++ +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQ--------LIRRILGPPLEFDEPKWSSG 229
Query: 588 VST-ISFA--CLQSNPKS 602
CL +P
Sbjct: 230 SEEAKDLIKKCLNKDPSK 247
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 87/258 (33%), Positives = 128/258 (49%), Gaps = 33/258 (12%)
Query: 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEI 192
Y+ TG IPS + L LQ L L N+L G L L + LS N L G +P+ +
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 193 GNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVG 251
L+NL L + N+ G IP+ L+ L L++L L N+ SG +P+ +G NL +LD+
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 252 NNDIIGPIPST---------LGLFSD---------------LSYLDLSCNQFNSSIPNEL 287
N++ G IP L LFS+ L + L N F+ +P+E
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 288 TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347
T+L ++ LD+S+N L G+I S+ M L L L+ N G +P + RL+ L+LS
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLS 483
Query: 348 GNKLSGRVPYSNKHLSSM 365
N+ SG VP LS +
Sbjct: 484 RNQFSGAVPRKLGSLSEL 501
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 35/193 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G+VY A+ G+ A+K + ++ + E ++L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
E GSL +L +L + + I+ + L YLH S +
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 471 VHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTE 528
+HRD+ NILL+S + +ADFG ++LL +D S + G+ Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 529 KYDVYSFGVVTLE 541
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 43/206 (20%)
Query: 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
+G G++GSVY A G + A+K + E + + E ++LS
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRYY 65
Query: 425 --------------ME---RGSLFRILHNDA---EAVELDWAKRVNIVKAMAHALAYLHH 464
+E GSL +L E V + +++ LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYLH- 118
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH--ADSSNQTLLAGSYGYIAPELAY 522
S +VHRDI NIL++S +ADFG A+ L + G+ ++APE+
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 523 TMVMTEKYDVYSFGVVTLEVLMGKHP 548
D++S G +E+ GK P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 67/261 (25%), Positives = 99/261 (37%), Gaps = 60/261 (22%)
Query: 374 KYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G VYKA G+ A+K + E+ I NE Q+L +
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHPNIVK 61
Query: 425 -----------------MERGSLFRILHNDAEAVELDW-AKRVNIVKAMAHALAYLHHDC 466
GSL +L + + + A + K + L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLH--- 115
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S ++HRDI + NILL S E + DFG + L + T + G+ ++APE+
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPYWMAPEVINGKPY 174
Query: 527 TEKYDVYSFGVVTLEVLMGKHP-RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR------ 579
K D++S G+ +E+ GK P +L K + PP R
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIA---TNGPPGLRNPEKWS 224
Query: 580 KVIQDILLVSTISFACLQSNP 600
+D L CLQ NP
Sbjct: 225 DEFKDFLKK------CLQKNP 239
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 72/259 (27%), Positives = 110/259 (42%), Gaps = 52/259 (20%)
Query: 376 CIGTGAYGSVYKAQL-PNGRVFALKKLNSPETE--------ELAFIRS------------ 414
+G G+ G VYK + P G+++ALKK++ E EL +RS
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 415 FRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
F E + VL M+ GSL +L + E A I + + L YLH ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTK--RHII 122
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY- 530
HRDI +N+L+NSK E +ADFG +++L G+ Y++PE + E Y
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE----RIQGESYS 178
Query: 531 ---DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI--MLIDVLDQRLPPPVDRKVIQDI 585
D++S G+ LE +GK P P ++ + D P + +
Sbjct: 179 YAADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSLPAEEFSPE- 231
Query: 586 LLVSTISF--ACLQSNPKS 602
F ACLQ +PK
Sbjct: 232 ----FRDFISACLQKDPKK 246
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 58/239 (24%)
Query: 377 IGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G GA+G VYK L +V A+K L +EE F EA ++ +
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEE--REEFLEEASIMKKLSHPNI 63
Query: 425 -------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
M G L L E + L + + +A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG--SYGYIAPELAYT 523
S + VHRD+++ N L+ L ++DFG +R ++ D + G ++APE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 524 MVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
T K DV+SFGV+ E+ +G+ P Y P + +VL+ RLP P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQP----------Y-PGMSNEEVLELLEDGYRLPRP 226
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 49/218 (22%)
Query: 375 YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------ 427
IG GA+G V Q ++FA+K +N + E +R+ NE ++L ++
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 428 -------------------GSL-FRILHN---DAEAVELDWAKRVNIVKAMAHALAYLHH 464
G L + + E V+ + + AL YLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLALEYLH- 117
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
S ++HRDI +NILL+ + + DF A + D+ + +G+ GY+APE +
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS-TSGTPGYMAPE----V 170
Query: 525 VMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSS 558
+ + Y D +S GV E L GK P HS
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 64/264 (24%), Positives = 105/264 (39%), Gaps = 61/264 (23%)
Query: 377 IGTGAYGSVYKAQL----PNGRVF-ALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G GA+G VYK L V A+K L +E+ I F EA+++ +
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
M G L L EL + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS-YGYIAPELAYTMV 525
S + +HRD+++ N L+ L ++DFG +R L+ D + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 526 MTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD- 578
T K DV+SFGV+ E+ +G+ P Y P + +VL+ RLP P +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP----------Y-PGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 579 RKVIQDILLVSTISFACLQSNPKS 602
+ ++L C +P+
Sbjct: 230 PPELYKLML------QCWAEDPED 247
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 62/264 (23%)
Query: 377 IGTGAYGSVYKAQL----PNGRVF-ALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G GA+G VYK +L +V A+K L +E+ I F EA+++ +
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
ME G L L + +L + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYLE--- 119
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-QTLLAGSYGYIAPELAYTMV 525
S + +HRD+++ N L+ L ++DFG +R L+ D + ++APE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 526 MTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLP-PPVD 578
T K DV+SFGV+ E+ +G+ P Y P + +VL+ RLP PP
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP----------Y-PGMSNEEVLEYLKNGYRLPQPPNC 228
Query: 579 RKVIQDILLVSTISFACLQSNPKS 602
+ D++L C +P+
Sbjct: 229 PPELYDLML------QCWAEDPED 246
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 64/255 (25%), Positives = 111/255 (43%), Gaps = 44/255 (17%)
Query: 374 KYCIGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQM-- 425
IG G++G V+K + + RV+A+K K+N E EE +EA+VL+++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLAKLDS 58
Query: 426 -----------ERGSLFRILHNDAEAVELDWAKRV--------NIVKAMAHALAYLHHDC 466
++G L ++ K + + L L H
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S ++HRDI S N+ L++ + D G A+LL +++ + G+ Y++PEL
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 527 TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
EK DV++ GVV E GKHP D ++ + LI + + + PPV + Q +
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGVFPPVSQMYSQQL- 229
Query: 587 LVSTISFACLQSNPK 601
+ + CL + +
Sbjct: 230 --AQLIDQCLTKDYR 242
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.7 bits (226), Expect = 7e-20
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 42/263 (15%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G G++G VY A+ ++ ALK L + + F E Q+L+
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
++ GSL +L L ++ + I+ + AL YLH S +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 471 VHRDISSNNILLNSKLEAFV-ADFGTARLLHADSSNQTLLA------GSYGYIAPELAYT 523
+HRDI NILL+ DFG A+LL S ++ A G+ GY+APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 524 MV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYD-PKIMLIDVLDQRLPPPVDR 579
+ + D++S G+ E+L G P + S++ KI+L P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 580 KVIQDILLVSTISFACLQSNPKS 602
S + L +PK+
Sbjct: 243 NPELISKAASDLLKKLLAKDPKN 265
|
Length = 384 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 43/254 (16%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALK--KLNSPETEELAFIR------------------SF 415
+G G G V K P G++ A+K +L E + +R +F
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 416 RNEAQVLSQME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
N + ME GSL +IL + ++ + A+ L YLH ++H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--IIH 124
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDV 532
RD+ +NIL+NS+ + + DFG + L +S +T G+ Y+APE + K D+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGNDYSVKSDI 182
Query: 533 YSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL--PPPVDRKVIQDILLVST 590
+S G+ +E+ G+ P DP + ++L + PPP ++
Sbjct: 183 WSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPP---RLPSGKFSPDF 233
Query: 591 ISF--ACLQSNPKS 602
F CL +P+
Sbjct: 234 QDFVNLCLIKDPRE 247
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 2e-18
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 62/262 (23%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------- 425
IG G++G VY + +G+++ LK+++ E NE ++L ++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYE 66
Query: 426 ---------------ERGSLFRILHNDAEAVE-------LDWAKRVNIVKAMAHALAYLH 463
+ G L + + + + LDW V + A L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKYLH 120
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL--- 520
S ++HRDI NI L S + DFG +++L + + G+ Y++PEL
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 521 -AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579
Y K D++S G V E+ KHP + + L + KI+ + PP+
Sbjct: 178 KPY----NYKSDIWSLGCVLYELCTLKHPFEGENLLELAL--KIL------KGQYPPIPS 225
Query: 580 KVIQDILLVSTISFACLQSNPK 601
+ ++ + + LQ +P+
Sbjct: 226 QYSSEL---RNLVSSLLQKDPE 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
+G GA+G VYK +L A+K L +EE + F EA+V+ +
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60
Query: 425 -----------------MERGSL------FRILHNDAEAVELDWAKRVNIVKAMAHALAY 461
ME G L R + E L ++ +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG--SYGYIAPE 519
L S VHRD+++ N L+ L ++DFG +R ++ D + G ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ T K DV+SFGV+ E+ +G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 53/208 (25%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------- 425
IG G YG VYKA+ G + ALKK+ E E+ F + E ++L ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 426 -----ERGSLF-----------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+GS++ +L + K +K + L YLH +
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC--YMKQLLEGLQYLHSN---G 120
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ------TLLAGSYGYIAPEL--- 520
++HRDI +NIL+N+ +ADFG AR +S TL Y PEL
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-----YRPPELLLG 175
Query: 521 --AYTMVMTEKYDVYSFGVVTLEVLMGK 546
Y + D++S G + E+ +GK
Sbjct: 176 ATRY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 74/241 (30%), Positives = 114/241 (47%), Gaps = 56/241 (23%)
Query: 377 IGTGAYGSVYKAQL-PNGR---VFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G V + +L G+ A+K L S TE+ R F +EA ++ Q
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 425 -----------------MERGSLFRILH-NDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
ME G+L L ND + + + V +++ +A + YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---S 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELA 521
+ VHRD+++ NIL+NS L V+DFG +R L D+S+ T + G I APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 522 YTMVMTEKYDVYSFGVVTLEVL-MGKHPR-DLHSTLSSSYDPKIMLIDVLDQ--RLPPPV 577
T DV+S+G+V EV+ G+ P D+ S+ D +I+ ++Q RLPPP+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQD----VINAIEQDYRLPPPM 234
Query: 578 D 578
D
Sbjct: 235 D 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 56/199 (28%), Positives = 82/199 (41%), Gaps = 33/199 (16%)
Query: 376 CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG GA+G VYK L G A+K++ S E + ++S E +L
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
E GSL +I+ E A V + LAYLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLH---EQG 119
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
V+HRDI + NIL +ADFG A L+ S + + G+ ++APE+ +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 530 YDVYSFGVVTLEVLMGKHP 548
D++S G +E+L G P
Sbjct: 180 SDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 69/256 (26%), Positives = 112/256 (43%), Gaps = 53/256 (20%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQ--------- 424
CIG G++G VYKA +V A+K ++ E E E+ I+ E Q LSQ
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ---QEIQFLSQCRSPYITKY 64
Query: 425 -------------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
ME GS +L + +LD I++ + L YLH +
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE--- 117
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
+HRDI + NILL+ + + +ADFG + L + S + G+ ++APE+ E
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 529 KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP-KIMLIDVLDQRLPPPVDRKVIQDIL- 586
K D++S G+ +E+ G+ P S P +++ ++ + PP ++
Sbjct: 178 KADIWSLGITAIELAKGEPPL-------SDLHPMRVLF--LIPKNNPPSLEGNKFSKPFK 228
Query: 587 -LVSTISFACLQSNPK 601
VS CL +PK
Sbjct: 229 DFVS----LCLNKDPK 240
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 72/238 (30%), Positives = 107/238 (44%), Gaps = 59/238 (24%)
Query: 347 SGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKL--NS 403
S + SG P + K LS + +I G+GA G+VYK P GR++ALK + N
Sbjct: 58 SSSSASGSAPSAAKSLSELERVNRI------GSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 404 PET------EELAFIRSFRN--------------EAQVLSQ-MERGSL--FRILHNDAEA 440
+T E+ +R + E QVL + M+ GSL I E
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQ 168
Query: 441 VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500
D A+++ +AYLH +VHRDI +N+L+NS +ADFG +R+L
Sbjct: 169 FLADVARQI------LSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL- 218
Query: 501 ADSSNQTL-----LAGSYGYIAPELAYTMVMTEKY-----DVYSFGVVTLEVLMGKHP 548
QT+ G+ Y++PE T + Y D++S GV LE +G+ P
Sbjct: 219 ----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 57/259 (22%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLN--SPETE------ELAFIRSFRNEAQ------- 420
IG GAYG+VY+ +P GRV ALK +N +P+ + E+A + R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 421 -----------VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
++ E GS+ ++ +A + I++ + AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV---G 121
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE- 528
V+HRDI + NIL+ + + DFG A LL+ +SS ++ G+ ++APE V+TE
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VITEG 176
Query: 529 -----KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLI-DVLDQRLPPPVDRKVI 582
K D++S G+ E+ G P + +MLI RL K++
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKSKPPRLEDNGYSKLL 231
Query: 583 QDILLVSTISFACLQSNPK 601
++ + ACL PK
Sbjct: 232 REFVA------ACLDEEPK 244
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 64/216 (29%), Positives = 89/216 (41%), Gaps = 62/216 (28%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G +G VY A L G + A+K++ + + I+ +E +VL
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 425 -----------ME---RGSLFRILHN---DAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
ME G+L +L + E V RV + LAYLH S
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRV-YTLQLLEGLAYLH---S 117
Query: 468 PSVVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTL-------LAGSYGYI 516
+VHRDI NI L+ KL DFG A L +N T LAG+ Y+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYM 170
Query: 517 APELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
APE+ T + + D++S G V LE+ GK P
Sbjct: 171 APEV-ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 59/212 (27%), Positives = 84/212 (39%), Gaps = 54/212 (25%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQ------- 424
IG GA VY A LPN A+K+++ +EL R E Q +SQ
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL------RKEVQAMSQCNHPNVV 62
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
+ GSL I+ + LD A ++K + L YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL----LAGSYGYIAPELAY 522
S +HRDI + NILL +ADFG + L G+ ++APE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE--- 176
Query: 523 TMVMTE------KYDVYSFGVVTLEVLMGKHP 548
VM + K D++SFG+ +E+ G P
Sbjct: 177 --VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 29/196 (14%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKK--LNSPETE----ELAFIRSFRNEAQV-------- 421
IG GA G VYKA G+ A+KK L E E+ ++ ++ V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 422 -------LSQMERGSLFRIL-HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
+ M+ GSL I+ N E A + + + L YLH S +V+HR
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY---VCREVLQGLEYLH---SQNVIHR 140
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVY 533
DI S+NILL+ +ADFG A L + S + + G+ ++APE+ K D++
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 534 SFGVVTLEVLMGKHPR 549
S G++ +E+ G+ P
Sbjct: 201 SLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 58/258 (22%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G++G V + + G+++A+K L + + + E +LS+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
G LF L + A+ + AL YLH S +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARF--YAAEIVLALEYLH---SLGI 114
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
++RD+ NILL++ + DFG A+ L ++ S G+ Y+APE +++ + Y
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE----VLLGKGY 170
Query: 531 ----DVYSFGVVTLEVLMGKHP---RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583
D +S GV+ E+L GK P D Y+ KI+ + R P + + +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI----YE-KILKDPL---RFPEFLSPEA-R 221
Query: 584 DILLVSTISFACLQSNPK 601
D++ LQ +P
Sbjct: 222 DLIS------GLLQKDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 70/244 (28%), Positives = 105/244 (43%), Gaps = 65/244 (26%)
Query: 377 IGTGAYGSVYKA--QLPNGRVF--ALKKLN--SPETEELAFIRSFRNEAQVLSQ------ 424
IG G +G V + +LP + A+K L S + + L F+ EA ++ Q
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT----EASIMGQFDHPNI 67
Query: 425 -------------------MERGSLFRIL-HNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
ME GSL + L ND + + V +++ +A + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSE 124
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG--SYGYIAPE-LA 521
VHRD+++ NIL+NS L V+DFG +R L + T G + APE +A
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 522 YTMVMTEKYDVYSFGVVTLEVL-MGKHP------RDLHSTLSSSYDPKIMLIDVLDQRLP 574
Y T DV+SFG+V EV+ G+ P +D+ + Y RLP
Sbjct: 182 YR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------------RLP 228
Query: 575 PPVD 578
PP+D
Sbjct: 229 PPMD 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 83/221 (37%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
+ L L LDL+ NRLR LTNL + L N + + P NL
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPI 259
ELD+ DN I +P L L +LK L L+ N LS LP+ + NL NL LD+ N I +
Sbjct: 144 ELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DL 201
Query: 260 PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW 319
P + L S L LDLS N + + L+ L L L+LS+NKL +P I ++ +L
Sbjct: 202 PPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259
Query: 320 LDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360
LDLSNN I S + L+ L L+LSGN LS +P
Sbjct: 260 LDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 38/208 (18%)
Query: 375 YCIGTGAYGSVYKAQ-LPNGRVFALKKL---NSPETE------ELAFIRSFRNE------ 418
IG G++G+V K + +G++ K++ N E E E+ +R ++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 419 -------AQVLS-QME---RGSLFRILHN---DAEAVELD--WAKRVNIVKAMAHALAYL 462
Q L ME G L +++ + + +E + W I+ + AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYEC 121
Query: 463 HH--DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
H+ D +V+HRD+ NI L++ + DFG A++L DSS G+ Y++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
M EK D++S G + E+ P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 28/194 (14%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------- 425
IG G YG VYKA+ G + A+KK+ E + R E ++L ++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 426 ---ERGSL---FRILHNDAEAV------ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
+G L F + D + L + + + + LA+ H S ++HR
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM-TEKYDV 532
D+ N+L+N++ +ADFG AR + T + Y APEL + D+
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 533 YSFGVVTLEVLMGK 546
+S G + E+L +
Sbjct: 183 WSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 372 DSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--- 427
D +G G+YGSVYKA G+V A+K + E ++ E +L Q +
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYI 60
Query: 428 ----GSLFR-----IL--HNDAEAVELDWAKRVN----------IVKAMAHALAYLHHDC 466
GS F+ I+ + A +V D K N I+ L YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFG-TARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
S +HRDI + NILLN + +A +ADFG + +L + T++ G+ ++APE+ +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP-RDLHST 554
K D++S G+ +E+ GK P D+H
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 53/219 (24%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALK-----------KLNSPETEELA---------FIR-- 413
IG G++ +V A+ + +A+K K+ + E+ I+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 414 -SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+F++E VL G L + + LD + AL YLH S
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKG 122
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA------------------- 510
++HRD+ NILL+ + + DFGTA++L +SS ++
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 511 -GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
G+ Y++PEL + D+++ G + ++L GK P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-15
Identities = 35/74 (47%), Positives = 49/74 (66%)
Query: 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
IPN++++L L ++LS N + G IP + S+ L LDLS N+ GSIP + +L+ L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 343 YLNLSGNKLSGRVP 356
LNL+GN LSGRVP
Sbjct: 494 ILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 368 PRKIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME 426
P + S +G+GAYGSV A G A+KKL+ P E+ R++R E +L M+
Sbjct: 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQ 72
Query: 427 RGSLFRILHNDAEAVELDWAK---------RVNIVKAMAH----------------ALAY 461
++ +L AV D + + ++ K M H L Y
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
+H S ++HRD+ N+ +N E + DFG AR HAD+ + + Y APE+
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRW-YRAPEVI 186
Query: 522 YT-MVMTEKYDVYSFGVVTLEVLMGK 546
M + D++S G + E+L GK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 38/194 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G+G +G V++ N A+K L S + + + F+ E Q L +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKHLISLFAV 70
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME+GSL L E L A +++ +A +AYL + +
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTE 528
HRD+++ NIL+ L VADFG ARL+ D SS++ + Y + APE A +
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFST 183
Query: 529 KYDVYSFGVVTLEV 542
K DV+SFG++ E+
Sbjct: 184 KSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 42/215 (19%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGR---VFALKKLNSPETEELAFIRSFRNEAQVLS 423
P I + IG G +G V++ L GR A+K L TE+ + F +EA ++
Sbjct: 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMG 61
Query: 424 Q-------------------------MERGSLFRILH-NDAEAVELDWAKRVNIVKAMAH 457
Q ME G+L + L +D E + V +++ +A
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAA 118
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YG 514
+ YL + VHRD+++ NIL+NS LE V+DFG +R+L D +G
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ APE T DV+SFG+V EV+ G+ P
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 60/217 (27%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG+G YG VYKA+ + G + A+K + ++ I+ E +L +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67
Query: 425 -----------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAH-------ALAYLH 463
ME GSL I + +A+ LAYLH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---------QIAYVCRETLKGLAYLH 118
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA-- 521
+HRDI NILL + +ADFG + L A + + G+ ++APE+A
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 522 -----YTMVMTEKYDVYSFGVVTLEVLMGKHPR-DLH 552
Y K D+++ G+ +E+ + P DLH
Sbjct: 176 ERKGGY----DGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 75/209 (35%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEE---LAFIRSFRNEAQVLSQMERG---- 428
IG GAYG+VYKA+ L GR ALKK+ P +EE L+ +R E +L Q+E
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLESFEHPN 62
Query: 429 --SLFRILHNDA-----------EAVELDWA---KRV-----------NIVKAMAHALAY 461
L + H E V+ D A + ++++ + + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
LH S +VHRD+ NIL+ S + +ADFG AR+ Y + E+A
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI--------------YSF---EMA 162
Query: 522 YTMVMTEKYDVYSFGVVTL-----EVLMG 545
T V VVTL EVL+
Sbjct: 163 LTSV-----------VVTLWYRAPEVLLQ 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/239 (27%), Positives = 99/239 (41%), Gaps = 58/239 (24%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLN-SPETE-------ELAFIRS------------F 415
+G GA GSV K +L G +FALK + P + EL +S F
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 416 RNEAQ-----VLSQMERGSLFRILHNDAEAVELDWAKRVN------IVKAMAHALAYLHH 464
+E+ + E GSL I + R+ I +++ L+YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLH- 122
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE----L 520
S ++HRDI +NILL K + + DFG + L +S T S+ Y+APE
Sbjct: 123 --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSF-YMAPERIQGK 178
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPV 577
Y++ DV+S G+ LEV + P +P + I++L +P P
Sbjct: 179 PYSI----TSDVWSLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNMPNPE 227
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 53/231 (22%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
+++ IG G +G V +V A+K L ++ ++F EA V++
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQKV-AVKCLK----DDSTAAQAFLAEASVMTTLRH 59
Query: 425 ----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
M +GSL L + AV + A+++ + + YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYL 118
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--GYIAPEL 520
+ VHRD+++ N+L++ L A V+DFG A+ ++Q +G + APE
Sbjct: 119 E---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEA 170
Query: 521 AYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLD 570
+ K DV+SFG++ E+ G+ P Y P+I L DV+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVP----------Y-PRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 38/207 (18%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSP------ETEELAFIRSFRNEAQVLSQMERGS 429
IG+G++GSVY +G + A+K++ P + + + + + E +L +++ +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 430 LFRILHNDAEAVELDW----------------------AKRVNIVKAMAHALAYLHHDCS 467
+ + L + +A L+ N V+ + L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---N 124
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL------LAGSYGYIAPELA 521
++HRDI NIL+++K ++DFG ++ L A+S + L GS ++APE+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 522 YTMVMTEKYDVYSFGVVTLEVLMGKHP 548
T K D++S G + +E+L GKHP
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 41/202 (20%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNS--------PE--------TEELA--FI----R 413
+G G +G V ++ R FALK + E EE FI R
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 414 SFRNEAQVLSQMER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+F+++ + ME G L+ IL + D + + A YLH+ +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
++RD+ N+LL+S + DFG A+ L + T G+ Y+APE+ ++ + Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPEI----ILNKGY 169
Query: 531 ----DVYSFGVVTLEVLMGKHP 548
D +S G++ E+L G+ P
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 57/258 (22%), Positives = 114/258 (44%), Gaps = 45/258 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKL-----NSPETEELAFIRSFRNEAQVLSQMERGSL 430
+GTGA+ S Y+A+ + G + A+K++ S E EE+ + + R E ++++++ +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV--VEALRKEIRLMARLNHPHI 65
Query: 431 FRIL----HNDAEAVELDW------------------AKRVNIVKAMAHALAYLHHDCSP 468
R+L + + ++W A +N + + L+YLH +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN--- 122
Query: 469 SVVHRDISSNNILLNSKLEAF-VADFGTARLLHADSSN----QTLLAGSYGYIAPELAYT 523
++HRD+ N+L++S + +ADFG A L A + Q L G+ ++APE+
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583
DV+S G V +E+ K P + S+ ++ + P + +
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEK-HSNHLA---LIFKIASATTAPSIPEHLSP 238
Query: 584 DILLVSTISFACLQSNPK 601
+ ++ CL+ P+
Sbjct: 239 G---LRDVTLRCLELQPE 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 60/242 (24%)
Query: 377 IGTGAYGSVY--KAQLPNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G V + +LP R A+K L + TE+ R F +EA ++ Q
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 425 -----------------MERGSLFRILH-NDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
ME GSL L +D + + + V +++ +A + YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKYL---S 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYT 523
VHRD+++ NIL+NS L V+DFG +R+L D G + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 524 MVMTEKYDVYSFGVVTLEVL-MGKHP------RDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
T DV+S+G+V EV+ G+ P +D+ + Y RLP P
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------------RLPAP 231
Query: 577 VD 578
+D
Sbjct: 232 MD 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 61/215 (28%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETE---------ELAFIRSFRNEAQVLSQME 426
IG+GAYG V A GR A+KK+++ + E+ +R R+E ++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHE-NIIG--- 63
Query: 427 RGSLFRILHNDA-----------EAVELDWAKRVNIVKAM-----AH----------ALA 460
L IL + E +E D K ++K+ H L
Sbjct: 64 ---LLDILRPPSPEDFNDVYIVTELMETDLHK---VIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY----GYI 516
YLH S +V+HRD+ +NIL+NS + + DFG AR + D + L Y Y
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-YVVTRWYR 173
Query: 517 APELAYTMVMTEKY----DVYSFGVVTLEVLMGKH 547
APEL ++ + +Y D++S G + E+L K
Sbjct: 174 APEL---LLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 27/196 (13%)
Query: 409 LAFIRSFRNEAQVLSQME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL--- 462
++F +F NE + ME GSL RI + ++ + I A+ L YL
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGK--IAVAVVEGLTYLYNV 122
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY 522
H ++HRDI +NIL+NS+ + + DFG + L +S T + G+ Y++PE
Sbjct: 123 HR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYMSPERIQ 175
Query: 523 TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ-------RLP- 574
T K DV+S G+ +E+ +GK P + D + ++D+L Q RLP
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 575 ---PPVDRKVIQDILL 587
P R + LL
Sbjct: 236 SDFPEDLRDFVDACLL 251
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 33/77 (42%), Positives = 49/77 (63%)
Query: 235 LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294
+P +I L++L +++ N I G IP +LG + L LDLS N FN SIP L +LT L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 295 HLDLSSNKLSGKIPSQI 311
L+L+ N LSG++P+ +
Sbjct: 494 ILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 52/256 (20%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G G +G V++ N A+K L + F+ EAQ++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M+ GSL L A L + +++ +A +AYL + + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG-SYGYIAPELAYTMVMTEKY 530
HRD+++ N+L+ VADFG AR++ D A + APE A + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 531 DVYSFGVVTLE-VLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVD-RKVIQDIL 586
DV+SFG++ E V G+ P + ++++ ++ +DQ R+P P K + DI+
Sbjct: 186 DVWSFGILLTEIVTYGRMP---YPGMTNA-----EVLQQVDQGYRMPCPPGCPKELYDIM 237
Query: 587 LVSTISFACLQSNPKS 602
L C + +P
Sbjct: 238 L------DCWKEDPDD 247
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 30/190 (15%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLN----SPET--EELAFIRSFRNEA-----QVLSQ- 424
+G G +G V+ A+K L SPE +E ++ R++ V S+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 425 ---------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDI 475
M +GSL L + E +L + V++ +A +AYL S + +HRD+
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 476 SSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---APELAYTMVMTEKYDV 532
++ NIL+ L +ADFG ARL+ D T G+ I APE A T K DV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 533 YSFGVVTLEV 542
+SFG++ E+
Sbjct: 188 WSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 29/153 (18%)
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA---DSSNQTLLAGSYGY 515
L +HH S ++HRDI S NILL S + DFG +++ A D +T Y Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY-Y 211
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD-------LHSTLSSSYDPKIMLIDV 568
+APE+ ++K D++S GV+ E+L K P D +H TL+ YDP
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP------- 264
Query: 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
LPP + + + I A L S+PK
Sbjct: 265 ----LPPSISPE-------MQEIVTALLSSDPK 286
|
Length = 496 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 390 LPNGRVFALKKLNSPETEEL-AFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKR 448
+P+ + + KL P +L RS + + +E +L +L N L W +R
Sbjct: 729 IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERR 782
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508
I +A AL +LH CSP+VV ++S I+++ K E + LL D+
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI- 840
Query: 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS 558
S Y+APE T +TEK D+Y FG++ +E+L GK P D + S
Sbjct: 841 ---SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 360 KHLSSMPTPRKIDSKY-CIGTGAYGSVYKA-QLPNGRVFALKKLN---SPETE----ELA 410
+ + S+ P+K +++ IG GA G+VY A + G+ A+K++N P+ E E+
Sbjct: 9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL 68
Query: 411 FIRSFRNEA---------------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
+R +N V+ + GSL ++ +D + + +
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCREC 124
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AL +LH S V+HRDI S+NILL + DFG + + S ++ + G+ +
Sbjct: 125 LQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+APE+ K D++S G++ +E++ G+ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 18/100 (18%)
Query: 142 GFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201
G G IP++IS L LQ ++LS N +RG + P +G++ +L L
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNI-----------------PPSLGSITSLEVL 471
Query: 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIG 240
D+ NS G IP +L +LTSL+IL L N LSG +P +G
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 360 KHLSSMPTPRKIDSKY-CIGTGAYGSVYKA-QLPNGRVFALKKLN---SPETE----ELA 410
+ + S+ P+K ++Y IG GA G+V+ A + G+ A+K++N P+ E E+
Sbjct: 9 RTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEIL 68
Query: 411 FIRSFRNEA---------------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
++ +N V+ + GSL ++ +D A+ + +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCREC 124
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AL +LH + V+HRDI S+N+LL + DFG + + S ++ + G+ +
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+APE+ K D++S G++ +E++ G+ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 76/261 (29%), Positives = 113/261 (43%), Gaps = 20/261 (7%)
Query: 86 YDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTG 145
+ + N + L + +S L L +L L +
Sbjct: 75 LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-----ELTNLTSLDLDNNNIT 129
Query: 146 SIPSEISAL-SKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
IP I L S L+ LDLS N++ L NL + LS N L L P+ + NL NL
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDL-PKLLSNLSNL 188
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP 258
LD+ N I +P + L++L+ L L+ N + L + NLKNL L++ NN +
Sbjct: 189 NNLDLSGN-KISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-D 246
Query: 259 IPSTLGLFSDLSYLDLSCNQ-FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDL 317
+P ++G S+L LDLS NQ + S LT L LDLS N LS IA + L
Sbjct: 247 LPESIGNLSNLETLDLSNNQISSISSLGSLTNLR---ELDLSGNSLS-NALPLIALLLLL 302
Query: 318 TWLDLSNNNIKGSIPGEITKL 338
L L+ ++ ++ +
Sbjct: 303 LELLLNLLLTLKALELKLNSI 323
|
Length = 394 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 67/243 (27%)
Query: 377 IGTGAYGSVYKAQ-LPNGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQMER---- 427
+G+GA+G+VYK +P G A+K L E + +EA V++ ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDHPHVV 72
Query: 428 --------------------GSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYL- 462
G L + N + + L+W V I K M+ YL
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGMS----YLE 126
Query: 463 -HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--GYIAPE 519
+VHRD+++ N+L+ + + DFG A+LL D G ++A E
Sbjct: 127 EKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLD-----QRL 573
+ T K DV+S+GV E++ G P + I +++ D +RL
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-----------GIPAVEIPDLLEKGERL 230
Query: 574 PPP 576
P P
Sbjct: 231 PQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 360 KHLSSMPTPRKIDSKY-CIGTGAYGSVYKA-QLPNGRVFALKKLN---SPETE----ELA 410
+ + S+ P+K +++ IG GA G+VY A + G+ A++++N P+ E E+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 411 FIRSFRNEA---------------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
+R +N V+ + GSL ++ +D + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCREC 125
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AL +LH S V+HRDI S+NILL + DFG + + S ++ + G+ +
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+APE+ K D++S G++ +E++ G+ P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 37/198 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE---------ELAFIRSFRNE-------- 418
IG GA+G V+KA+ G ALKK+ E E+ +++ ++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 419 ----AQVLSQMER--GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
+ + ME L +L ++ + K ++ + +AY+H + ++H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGIMH 122
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-TLLAGSYGYIAPELAYTMVMTEKY- 530
RD+ N+L+++ +ADFG ARL + + + Y APEL Y KY
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG---ARKYD 179
Query: 531 ---DVYSFGVVTLEVLMG 545
D+++ G + E+L G
Sbjct: 180 PGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 28/199 (14%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G++G VYK V A+K ++ E E+ I + E VLSQ
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 425 --MERGSLFRILHNDAEAVELDWAKR--------VNIVKAMAHALAYLHHDCSPSVVHRD 474
++ L+ I+ LD K I++ + L YLH S +HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRD 126
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYS 534
I + N+LL+ + + +ADFG A L + G+ ++APE+ K D++S
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186
Query: 535 FGVVTLEVLMGKHP-RDLH 552
G+ +E+ G+ P DLH
Sbjct: 187 LGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG G++G V+K +V A+K ++ E E+ I + E VLSQ +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 428 -----------------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
GS +L E LD + I++ + L YLH S
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 122
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRDI + N+LL+ E +ADFG A L + G+ ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 531 DVYSFGVVTLEVLMGKHPR-DLH 552
D++S G+ +E+ G+ P +LH
Sbjct: 183 DIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 45/201 (22%)
Query: 377 IGTGAYGSVYKA--QLPNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQM------- 425
+G G +GSV K + +G+ A+K L + A + F EA V++Q+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 426 -----------------ERGSLFRILHNDAEAVELD---WAKRVNIVKAMAHALAYLHHD 465
G L + L E D A +V A +AYL
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE-- 112
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-QTLLAGSY--GYIAPELAY 522
S VHRD+++ N+LL ++ +A ++DFG +R L A S + AG + + APE
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 523 TMVMTEKYDVYSFGVVTLEVL 543
+ K DV+S+GV E
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 377 IGTGAYGSVYKAQLPNG--RVFALKKLN--SPE-----TEELAFIRSFRNEAQVL-SQME 426
+G+GA+G VYK + N + ALK++N +P E I +E ++ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 427 RGSLFR----ILHNDAEAVELDW---------------------AKRV-NIVKAMAHALA 460
++ R L ND + +D +R+ NI M AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
YLH + +VHRD++ NNI+L + + DFG A+ S T + G+ Y PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPEI 184
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM 564
EK DV++FG + ++ + P +ST S KI+
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIV 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 45/186 (24%)
Query: 375 YCIGTGAYGSVYKAQLPN---GRVFALKKLNSPETE----------ELAFIRSFRNEAQV 421
CIG G YG VYKA+ N G+ +A+KK + + E+A +R ++E V
Sbjct: 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 422 ------LSQMERG----------SLFRIL--HNDAEAVELDWAKRVNIVKAMAHALAYLH 463
L ++ L++I+ H A+ V + + +++ + + + YLH
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAG-----SYG 514
S V+HRD+ NIL+ + + D G ARL +A + L +
Sbjct: 126 ---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL--KPLADLDPVVVTIW 180
Query: 515 YIAPEL 520
Y APEL
Sbjct: 181 YRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 35/197 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK-LNSPETE--------ELAFIRSFRNEAQV-LSQ- 424
+G GAYG V K + G + A+KK S + E E+ +R R+E V L +
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 425 -MERGSLF-------RILHNDAEAVE--LDWAKRVNIVKAMAHALAYLH-HDCSPSVVHR 473
+G L+ R L EA L + + + A+AY H H+ +HR
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI----IHR 124
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADS-SNQTLLAGSYGYIAPELAYTMVMTEKY-- 530
DI NIL++ + DFG AR L A S T + Y APEL +V Y
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL---LVGDTNYGK 181
Query: 531 --DVYSFGVVTLEVLMG 545
DV++ G + E+L G
Sbjct: 182 PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 364 SMPTPRKIDSKY-CIGTGAYGSVYKA-QLPNGRVFALKKLN---SPETE----ELAFIRS 414
S+ P+K +++ IG GA G+VY A + G+ A+K++N P+ E E+ +R
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 415 FRNEA---------------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHAL 459
++ V+ + GSL ++ +D + + + AL
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQAL 128
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
+LH S V+HRDI S+NILL + DFG + + S ++ + G+ ++APE
Sbjct: 129 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ K D++S G++ +E++ G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------- 426
IG G++G V+K +V A+K ++ E E+ I + E VLSQ +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 427 ---RGSLFRILHN---DAEAVEL------DWAKRVNIVKAMAHALAYLHHDCSPSVVHRD 474
+G+ I+ A++L D + ++K + L YLH S +HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRD 126
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYS 534
I + N+LL+ + + +ADFG A L + G+ ++APE+ K D++S
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS 186
Query: 535 FGVVTLEVLMGKHPR-DLH 552
G+ +E+ G+ P D+H
Sbjct: 187 LGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLN----SPET--EELAFIRSFRNEA-----QVLSQ- 424
+G G +G V+ A+K L SPE +E ++ R+E V+S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 425 --------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476
M +GSL L + L + V++ +A +AY+ + VHRD+
Sbjct: 74 PIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER---MNYVHRDLR 129
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYTMVMTEKYDVY 533
+ NIL+ L VADFG ARL+ + + T G+ + APE A T K DV+
Sbjct: 130 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 534 SFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
SFG++ E+ G+ P P ++ +VLDQ R+P P
Sbjct: 188 SFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 225
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 55/205 (26%), Positives = 82/205 (40%), Gaps = 48/205 (23%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEE------------------------LA 410
+G G YG VYKA+ G + ALKK+ EE L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 411 FIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
I + R V + L + L + + K I+ + LAY H S +
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH---SHRI 119
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARL----LHADSSN-QTLLAGSYGYIAPELAYTMV 525
+HRD+ NIL+N +ADFG AR L + TL Y APE+ ++
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-----YRAPEI---LL 171
Query: 526 MTEKY----DVYSFGVVTLEVLMGK 546
++ Y D++S G + E++ GK
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 49/205 (23%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
+GTG +G V+ + + +ALK + PE L + NE +VL ++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 428 -----------------GSLFRILHNDAEAVELDWAKRVNIVKAMAH------ALAYLHH 464
G LF L N + R + + + AL YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIVCALEYLH- 118
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT-LLAGSYGYIAPELAYT 523
S +V+RD+ NILL+ + + DFG A+ L ++T L G+ Y+APE+ +
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVIQS 172
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
+ D ++ G++ E+L+G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 30/196 (15%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG G YG VY+A+ +G + ALKK+ + I S R E +L + ++ +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 436 ----NDAEAV-------ELDWAKRVN-------------IVKAMAHALAYLHHDCSPSVV 471
+++ E D A ++ ++ + L YLH + ++
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---II 130
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKY 530
HRD+ +N+LL K +ADFG AR + T + Y APEL T
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 531 DVYSFGVVTLEVLMGK 546
D+++ G + E+L K
Sbjct: 191 DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 45/208 (21%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG GA+G V ++ N G+V+A+K LN E + A FR E VL +R
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 428 -----------------GSLFRILHNDAEAVELDWAK--RVNIVKAM--AHALAYLHHDC 466
G L +L + + D A+ +V A+ H L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY----- 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAYTMV 525
VHRDI +N+LL+ +ADFG+ L AD + Q+ +A G+ YI+PE+ M
Sbjct: 124 ----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 526 -MTEKY----DVYSFGVVTLEVLMGKHP 548
+Y D +S GV E+L G+ P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 53/214 (24%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETE-------ELAFIRSFRNEAQVLSQMER- 427
IG G YG VY A + G + A+K++ P T + +++ R+E + L ++
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 428 ------------------------GSLFRILHNDAEAVELDWAKRVNIVKAMA----HAL 459
GS+ L E +V+ L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL---LHADSSNQTLLAGSYGYI 516
AYLH S ++HRD+ ++N+L+++ ++DFG ++ ++ + N + + GS ++
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWM 177
Query: 517 APEL--AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
APE+ +Y+ + K D++S G V LE+ G+ P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK----------------------KLNSPETEELAFIR 413
+G G YGSVYK P G A+K K SP + F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD--FYG 66
Query: 414 SFRNEAQV---LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+F E V + M+ GSL ++ + I A+ L +L + ++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE-- 528
+HRD+ N+L+N + + DFG + L A + + G Y+APE + +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNP 182
Query: 529 ----KYDVYSFGVVTLEVLMGKHP 548
+ DV+S G+ LE+ +G++P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 37/199 (18%)
Query: 377 IGTGAYGSVYKAQLPNGRV-FALKKLNSP-ETEELAFIRSFRNEAQVLSQMERG---SLF 431
+G+GAYG V A A+KKL+ P ++ A R++R E ++L M+ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA-KRTYR-ELRLLKHMDHENVIGLL 80
Query: 432 RILHNDAEA---------VELDWAKRVNIVKA--------------MAHALAYLHHDCSP 468
+ + L A NIVK + L Y+H S
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SA 137
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMT 527
++HRD+ +NI +N E + DFG AR H D +A + Y APE+ M
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVATRW-YRAPEIMLNWMHYN 194
Query: 528 EKYDVYSFGVVTLEVLMGK 546
+ D++S G + E+L GK
Sbjct: 195 QTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 40/199 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIR--SFRNEAQVLSQMERGSL--- 430
IG G+YG V+K + G++ A+KK E+E+ I+ + R E ++L Q++ +L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 65
Query: 431 ---FR---------------ILHN-DAEAVELDWAKRVNIVKAMAHALAYLH-HDCSPSV 470
FR +L+ + + I+ A+ + H H+C
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---- 121
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRD+ NIL+ + + + DFG AR+L + T + Y APEL +V +Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL---LVGDTQY 178
Query: 531 ----DVYSFGVVTLEVLMG 545
DV++ G V E+L G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 29/190 (15%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFI------------RSFRNEAQVLSQ 424
+G G +G V+ A+K L AF+ R R A V +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 425 --------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476
ME GSL L E ++L K +++ +A +A++ + +HRD+
Sbjct: 74 PIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLR 129
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYTMVMTEKYDVY 533
+ NIL++ L +ADFG ARL+ + + T G+ + APE T K DV+
Sbjct: 130 AANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 534 SFGVVTLEVL 543
SFG++ E++
Sbjct: 188 SFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 35/198 (17%)
Query: 377 IGTGAYGSV-YKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+G+GAYG+V G A+KKL P EL R++R E ++L M+ ++ +L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 436 NDAEAVELD-------------------------WAKRVN-IVKAMAHALAYLHHDCSPS 469
+ LD R+ +V M L Y+H +
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAG 138
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTE 528
++HRD+ N+ +N E + DFG AR DS + + Y APE+ M T+
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRW-YRAPEVILNWMHYTQ 195
Query: 529 KYDVYSFGVVTLEVLMGK 546
D++S G + E+L GK
Sbjct: 196 TVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLN----SPET--EELAFIRSFRNEA-----QVLSQ- 424
+G G +G V+ A+K L SPE+ EE ++ R++ V+S+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 425 --------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476
M +GSL L D E L V++ +A +AY+ + +HRD+
Sbjct: 74 PIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLR 129
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYTMVMTEKYDVY 533
S NIL+ L +ADFG ARL+ + + T G+ + APE A T K DV+
Sbjct: 130 SANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 534 SFGVVTLE-VLMGKHP 548
SFG++ E V G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 43/216 (19%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEE---------LAFIRSFRNEAQ------ 420
IG G YG VYKA G++ A+K ++ E EE L + N A
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 421 -------------VLSQMERGS---LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
V+ GS L + L + ++ +W I++ LAYLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH- 130
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL---- 520
V+HRDI NILL E + DFG + L + + G+ ++APE+
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188
Query: 521 -AYTMVMTEKYDVYSFGVVTLEVLMGKHP-RDLHST 554
+ DV+S G+ +E+ GK P D+H
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 48/271 (17%)
Query: 368 PRKIDSKYC-IGTGAYGSVYKA-QLPNGRVFALK--KLNSPETEELAF-----IRSFRN- 417
PR + Y IG G+ G V A + +GR A+K L + EL F +R +++
Sbjct: 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQ 78
Query: 418 -------------EAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
E VL + +G L + L+ + + +++ AL YLH
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGG---ALTDIVSQTRLNEEQIATVCESVLQALCYLH- 134
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
S V+HRDI S++ILL ++DFG + D + L G+ ++APE+
Sbjct: 135 --SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT 192
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS------SYDPKI--------MLIDVLD 570
+ D++S G++ +E++ G+ P S + + S PK+ +L D L+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252
Query: 571 QRLP-PPVDRKVIQDIL----LVSTISFACL 596
+ L P +R Q++L L+ T CL
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTGLPECL 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 43/203 (21%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETE------------ELAFIRSFRNE----- 418
+G G Y VYKA GR+ A+KK+ E + E+ ++ ++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 419 AQVLSQMERGSL-FRILHNDAEAVELDWAKRVNIVKAMAH----------ALAYLHHDCS 467
V +L F + D E V K +IV A L YLH S
Sbjct: 68 LDVFGHKSNINLVFEFMETDLEKV----IKDKSIVLTPADIKSYMLMTLRGLEYLH---S 120
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
++HRD+ NN+L+ S +ADFG AR + + T + Y APEL +
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG---A 177
Query: 528 EKY----DVYSFGVVTLEVLMGK 546
Y D++S G + E+L+
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 56/235 (23%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN 436
+G GA+G VYKAQ +FA K + E + F E +LS+ + ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK--IIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 437 -------------------DAEAVELDWAKRVN------IVKAMAHALAYLHHDCSPSVV 471
D+ +EL+ + + + + M AL +LH S V+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLH---SHKVI 125
Query: 472 HRDISSNNILLNSKLEAFVADFG-TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE-- 528
HRD+ + NILL + +ADFG +A+ T + Y ++APE+ V E
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY-WMAPEV----VACETF 180
Query: 529 -------KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
K D++S G+ +E+ + P H L+ P +L+ + + PP
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP---HHELN----PMRVLLKI--LKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 50/212 (23%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK----LNSPETEEL-----AFIRS------------ 414
+G GAYG V K + +P G + A+K+ +NS E + L +RS
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 415 -FRNEAQVLSQMERGS-----LFRILHNDAEAVELDWAKR--VNIVKAMAHALAYLHHDC 466
FR E V ME ++ +++ + D + V+IVKA L YLH
Sbjct: 69 LFR-EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA----LEYLHSKL 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL------ 520
S V+HRD+ +N+L+N + + DFG + L DS +T+ AG Y+APE
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELN 180
Query: 521 --AYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
Y + K DV+S G+ +E+ G+ P D
Sbjct: 181 QKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 65/219 (29%)
Query: 377 IGTGAYGSVYKAQL--PNGR-------VFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
+G GA+G VYK +L PN R + LK+ P+ ++ FR EA+++S
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-----EFRQEAELMSDLQH 67
Query: 425 ----------------------MERGSLFRIL-----HNDAEAVE--------LDWAKRV 449
+ G L L H+D A LD + +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 450 NIVKAMAHALAYL--HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS---- 503
+I +A + YL HH VHRD+++ N L+ L ++DFG +R +++
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEV 542
+++LL ++ PE T + D++SFGVV E+
Sbjct: 183 QSKSLL--PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 50/211 (23%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
I GAYG V+ A+ + G ++A+K + + + E +LSQ
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 425 -----------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
ME G L +L N +++ D A+ + + AL YLH S +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVAR--IYIAEIVLALEYLH---SNGI 114
Query: 471 VHRDISSNNILLNS----KLEAFVADFG---------TARLLHADSSNQTLLAGSYGYIA 517
+HRD+ +NIL++S KL DFG L + ++ ++ G+ YIA
Sbjct: 115 IHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIA 169
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
PE+ ++ D +S G + E L+G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 69/242 (28%), Positives = 103/242 (42%), Gaps = 62/242 (25%)
Query: 377 IGTGAYGSVYKA-QLPNGRVF----ALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF 431
+G+GA+G+VYK +P G A+K LN ET F +EA +++ M+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 432 RIL--------------------------HND--AEAVELDWAKRVNIVKAMAHALAYLH 463
R+L H D + L+W V I K M YL
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLE 126
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--GYIAPELA 521
+VHRD+++ N+L+ S + DFG ARLL D G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 522 YTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYD--PKIMLIDVLD--QRLP-P 575
+ T + DV+S+GV E++ G P YD P + D+L+ +RLP P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKP----------YDGIPTREIPDLLEKGERLPQP 233
Query: 576 PV 577
P+
Sbjct: 234 PI 235
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 46/201 (22%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER----GSLF 431
+G G G+VYKA L R+ A+K + T EL + Q++S++E S +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL--------QKQIMSELEILYKCDSPY 60
Query: 432 RILHNDAEAVE--------------LDWAKRV------NIVKAMAHALAYLHHDCSPSVV 471
I A VE LD +++ I A+ L YL S ++
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYL---WSLKIL 117
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY- 530
HRD+ +N+L+N++ + + DFG + L +S G+ Y+APE + E+Y
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPE----RISGEQYG 171
Query: 531 ---DVYSFGVVTLEVLMGKHP 548
DV+S G+ +E+ +G+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 58/222 (26%)
Query: 369 RKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKL-----NSPETE----ELAFIRS 414
+ I KY I G GAYG V+KA V ALKK+ N+ + + E+ F++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62
Query: 415 FRNEAQVLSQMERGSLFRILH--NDA------EAVELDWAK--RVNIVKAMAH------- 457
+ ++ L ++ ND E +E D R NI++ +
Sbjct: 63 LGDHPNIVK------LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQL 116
Query: 458 --ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
AL Y+H S +V+HRD+ +NILLNS +ADFG AR L N + Y
Sbjct: 117 LKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-Y 172
Query: 516 IA------PEL-----AYTMVMTEKYDVYSFGVVTLEVLMGK 546
+A PE+ YT + D++S G + E+L+GK
Sbjct: 173 VATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 43/207 (20%)
Query: 376 CIGTGAYGSVYKA-QLPNGRVFALKKL----NSPETE--------ELAFIRSFRNEAQV- 421
+G GA+G VY + GR A+K++ +SPET+ E+ +++ ++E V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 422 --------------LSQMERGSL---FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
+ M GS+ + E V + +++ + YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH- 121
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG---YIAPELA 521
S +VHRDI NIL +S + DFG ++ L S+ T + G +++PE+
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 522 YTMVMTEKYDVYSFGVVTLEVLMGKHP 548
K DV+S G +E+L K P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 48/263 (18%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+G+GAYGSV A G A+KKL+ P + R++R E ++L M+ ++ +L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 436 -----------NDAEAV-ELDWAKRVNIVKA--------------MAHALAYLHHDCSPS 469
ND V L A NIVK + L Y+H S
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 140
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTE 528
++HRD+ +N+ +N E + DFG AR H D +A + Y APE+ M +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW-YRAPEIMLNWMHYNQ 197
Query: 529 KYDVYSFGVVTLEVLMGK-------HPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581
D++S G + E+L G+ H L L P L+ +++ R
Sbjct: 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL----KKISSESARNY 253
Query: 582 IQDILLVSTISFA--CLQSNPKS 602
IQ + + ++FA + +NP +
Sbjct: 254 IQSLTQMPKMNFANVFIGANPLA 276
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 36/201 (17%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELA--FIRSFRNEAQVLSQMERGSLFRI 433
+G+G++GSVY+ L +G FA+K+++ + + ++ E +LS+++ ++ +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 434 L----HNDAEAVELDWAKRVNIVKAMAH------------------ALAYLHHDCSPSVV 471
L D + L+ ++ K + L YLH + V
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTV 124
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY- 530
HRDI NIL+++ +ADFG A+ + S ++ GS ++APE+ + Y
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEV---IAQQGGYG 180
Query: 531 ---DVYSFGVVTLEVLMGKHP 548
D++S G LE+ GK P
Sbjct: 181 LAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 52/213 (24%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--- 432
IG G YG VYKA+ G + ALKK+ +E I + R E ++L Q+ ++
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73
Query: 433 ILHNDAEAVELDWAKRV-----------------------------NIVKAMAHALAYLH 463
I+ + +A++ K + +K + L Y H
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NQTLLAGSYGYIAPE 519
+ +HRDI +NILLN+K + +ADFG ARL +++ S N+ + + Y PE
Sbjct: 134 ---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI---TLWYRPPE 187
Query: 520 LAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
L ++ E+Y DV+S G + E L K P
Sbjct: 188 L---LLGEERYGPAIDVWSCGCILGE-LFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 47/195 (24%)
Query: 370 KIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------ 422
+I K +G G +G VYKA Q+ GRV ALKK+ ++ I + R E ++L
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHP 67
Query: 423 ---------------SQMERGSLFRI-----------LHNDAEAVELDWAKRVNIVKAMA 456
S+ +RGS++ + L N +V+L ++ + +
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLL 125
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI 516
+ YLH ++HRDI + NIL++++ +ADFG AR N G
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN-----PKGGGG 177
Query: 517 APELAYT-MVMTEKY 530
YT +V+T Y
Sbjct: 178 GGTRKYTNLVVTRWY 192
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 368 PR-KIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETE-------ELAFIRSFRNE 418
PR +D+ IG G+ G V A GR A+KK++ + + E+ +R +++
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 419 AQV---------------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
V + +E G+L I+ ++ + + A+ AL++LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLH 132
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
+ V+HRDI S++ILL S ++DFG + + + L G+ ++APE+
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
+ + D++S G++ +E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 45/216 (20%)
Query: 370 KIDSKY----CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETE---------ELAFIRSF 415
+ S+Y IG+GAYG V A +G+ A+KK+ EL +R F
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 416 RNEA-------------------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMA 456
+++ V+ ME L I+H+D + + + + + +
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRY--FLYQLL 117
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--- 513
L Y+H S +V+HRD+ +N+L+N E + DFG AR L + + Y
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 514 -GYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKH 547
Y APEL ++ T D++S G + E+L +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 64/274 (23%), Positives = 103/274 (37%), Gaps = 75/274 (27%)
Query: 377 IGTGAYGSVYKAQLPNGR---------VFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
+G GA+G V+ + + V LK+ S + + F EA++L+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-----DFEREAELLTNFQH 67
Query: 425 ----------------------MERGSLFRIL-----------HNDAEAVELDWAKRVNI 451
ME G L + L D+ EL ++ + I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
+A + YL S VHRD+++ N L+ L + DFG +R ++ +++ + G
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGG 182
Query: 512 S----YGYIAPE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHST--LSSSYDPKI 563
++ PE + Y TE DV+SFGVV E+ GK P S +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
Query: 564 MLI-------DVLDQRL----PPPVDRKVIQDIL 586
+L +V D L P R I+DI
Sbjct: 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 71/267 (26%)
Query: 375 YC----IGTGAYGSVYKAQ-LPNGRVFALKKLN---SPETEELAFIRSFRNEAQVLSQM- 425
YC +G G+YG V + +G+ + +KKLN + E ++ EAQ+LSQ+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER----KAAEQEAQLLSQLK 57
Query: 426 -------------------------ERGSLFRILHNDA-----EAVELDWAKRVNIVKAM 455
E G L+ L E ++W ++
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------ 111
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
A AL YLH ++HRD+ + N+ L V D G AR+L + L G+ Y
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH---PRDLHS-----------TLSSSYDP 561
++PEL K DV++ G E+ KH +D++S + Y P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228
Query: 562 KI--MLIDVLDQRLPPPVDRKVIQDIL 586
++ ++ +L +R P R ++ IL
Sbjct: 229 ELGELIATMLSKR---PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 40/206 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRN---EAQVLSQMER------ 427
+G GAYG+VY G++ A+K++ + LA + + E +L ++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 428 -------------------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
GS+ IL+ E + K K + +AYLH++C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNQTLLAGSYG---YIAPELAY 522
VVHRDI NN++L + DFG AR L ++ +L +G ++APE+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 523 TMVMTEKYDVYSFGVVTLEVLMGKHP 548
K D++S G E+ GK P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 43/154 (27%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQV---LSQMERGSLFRILHNDAEAVELDWAKRVNIVKA 454
L + NSP + F +F ++ ++ + M+ GSL ++L +A+ + + +V+I A
Sbjct: 57 LHECNSPYI--VGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSI--A 111
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+ LAYL ++HRD+ +NIL+NS+ E + DFG + L +N G+
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRS 167
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y++PE + + D++S G+ +E+ +G++P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLN----SPET--EELAFIRSFRNEA-----QVLSQ- 424
+G G +G V+ A+K L PE +E ++ R++ V+S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 425 --------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476
M +GSL L + + L + V++ +A +AY+ + +HRD+
Sbjct: 74 PIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLR 129
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYTMVMTEKYDVY 533
+ NIL+ L +ADFG ARL+ + + T G+ + APE A T K DV+
Sbjct: 130 AANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 534 SFGVVTLE-VLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
SFG++ E V G+ P P ++ +VL+Q R+P P
Sbjct: 188 SFGILLTELVTKGRVPY-----------PGMVNREVLEQVERGYRMPCP 225
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 47/165 (28%), Positives = 68/165 (41%), Gaps = 31/165 (18%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQVLSQME--------------RGSLFRILHNDAEAVEL 443
L K+ P +AF SF + + ME RG LF E L
Sbjct: 52 LAKMKHPNI--VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF------PEDTIL 103
Query: 444 DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503
W + M + ++H V+HRDI S NI L + + DFG+ARLL +
Sbjct: 104 QWFVQ------MCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ G+ Y+ PE+ M K D++S G + E+ KHP
Sbjct: 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR---- 432
IG G +G+V + + +V A+K + T + +F E V++++ +L R
Sbjct: 14 IGEGEFGAVLQGEYTGQKV-AVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67
Query: 433 ILHNDAEAVELDWAK--RVNIVKAMAHALAYL--------------HHDCSPSVVHRDIS 476
ILHN V +K VN ++ AL + + S +VHRD++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536
+ NIL++ A V+DFG AR+ N L + APE + K DV+S+G
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKFSSKSDVWSYG 184
Query: 537 VVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
V+ EV G+ P PK+ L +V + R+ PP
Sbjct: 185 VLLWEVFSYGRAPY-----------PKMSLKEVKECVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 30/89 (33%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL- 235
+ L L G +P +I L++L +++ NS+ G IP +L +TSL++L L+ N +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 236 PQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
P+ +G L +L +L++ N + G +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 39/205 (19%)
Query: 377 IGTGAYGSVYKAQLPNG-RVFALKKLNSPETEELAFIRSFRNEAQVLS------------ 423
IG GA+G V ++ + R++A+K LN E + A FR E VL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 424 --QMER-----------GSLFRILHNDAEAVELDWAKRVNIVKAMA-HALAYLHHDCSPS 469
Q E G L +L + + D A+ +A H++ LH+
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY----- 123
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAYTMV-MT 527
VHRDI +N+LL+ +ADFG+ ++ D + Q+ +A G+ YI+PE+ M
Sbjct: 124 -VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 528 EKY----DVYSFGVVTLEVLMGKHP 548
KY D +S GV E+L G+ P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 35/201 (17%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEA--QVLSQMERGSLFRI 433
IG GAYG+VYKA+ P+ G ALK + E+ + + R A + L + ++ R+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 434 LHNDA--------------EAVELD---WAKRV-----------NIVKAMAHALAYLHHD 465
+ A E V+ D + +V ++++ L +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
C +VHRD+ NIL+ S + +ADFG AR+ + T + + Y APE+
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQST 183
Query: 526 MTEKYDVYSFGVVTLEVLMGK 546
D++S G + E+ K
Sbjct: 184 YATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 40/151 (26%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN-SPETE--------ELAFIRSFRNEAQVLSQME 426
IG G YG VYKA+ G + ALKK+ E E E++ ++ + V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV----- 61
Query: 427 RGSLFRILHNDA------EAVELDWAKRVN----------IVKA----MAHALAYLHHDC 466
L ++H++ E ++LD K ++ ++K+ + +AY H
Sbjct: 62 --RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--- 116
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTAR 497
S V+HRD+ N+L++ + +ADFG AR
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 377 IGTGAYGSVYKAQLPNG-RVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG GA+G V +L N +VFA+K LN E + A FR E VL +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 428 -----------------GSLFRILHNDAEAVELDWAK----RVNIVKAMAHALAYLHHDC 466
G L +L + + D A+ + I H L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAYTMV 525
VHRDI +NIL++ +ADFG+ L D + Q+ +A G+ YI+PE+ M
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 526 MTE-KY----DVYSFGVVTLEVLMGKHP 548
+ KY D +S GV E+L G+ P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 69/263 (26%), Positives = 104/263 (39%), Gaps = 72/263 (27%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQM--- 425
IG G++G KA L +G+ + +K++N SP+ E + R E VLS M
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-----RKEVAVLSNMKHP 59
Query: 426 ----------------------ERGSLFRILHND-----AEAVELDWAKRVNIVKAMAHA 458
E G L++ ++ E LDW V I A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLALKHV 117
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
HD ++HRDI S NI L + DFG AR+L++ G+ Y++P
Sbjct: 118 -----HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHP--------------RDLHSTLSSSYDPKI- 563
E+ K D+++ G V E+ KH R + +SS Y +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230
Query: 564 MLIDVLDQRLPPPVDRKVIQDIL 586
L+ L +R P DR + IL
Sbjct: 231 NLVSQLFKR--NPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQVLSQMER---GSLFRILHNDAEAVELDWAKRVNIVKA 454
LK L+ P E + +F + ++ ME G+L + ++ LD I+
Sbjct: 53 LKLLSHPNIIE--YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHF 106
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLLHADSSNQTLLAGSY 513
L LHH + ++HRD+ + NILL+ K+ + DFG +++L + S T++ G+
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTP 165
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
YI+PEL +K D+++ G V E+
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 53/239 (22%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQM------- 425
+G G++G V + + G+V A+K L S + ++ + F EA ++ +
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 426 -----------------ERGSLFRILHNDAEA-----VELDWAKRVNIVKAMAHALAYLH 463
GSL L DA D+A V I M YL
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA--VQIANGMR----YLE 114
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---LAGSYGYIAPEL 520
S +HRD+++ NILL S + + DFG R L + + + L + + APE
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM-LIDVLDQRLPPPVD 578
T + DV+ FGV E M + + + LS S +I+ ID +RL P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWE--MFTYGEEPWAGLSGS---QILKKIDKEGERLERPEA 225
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 37/196 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+G GA+G VYKA+ G + A K + + EEL + E ++L+ + ++L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 436 N-------------------DAEAVELDWA----KRVNIVKAMAHALAYLHHDCSPSVVH 472
DA +ELD + I + M AL YLH S ++H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133
Query: 473 RDISSNNILLNSKLEAFVADFG-TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE--- 528
RD+ + N+LL + +ADFG +A+ + + + Y ++APE+ M +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-WMAPEVVMCETMKDTPY 192
Query: 529 --KYDVYSFGVVTLEV 542
K D++S G+ +E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 41/207 (19%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIR-------------------SFR 416
+G+G YG VYKA+ L G + A+K + ++ + I+ S+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 417 NEAQVLSQMER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
+ ++ ME GSL I H EL A + + LAYLH S +HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLH---SKGKMHR 130
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY--- 530
DI NILL + +ADFG A + A + + G+ ++APE+A EK
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA----AVEKNGGY 186
Query: 531 ----DVYSFGVVTLEVLMGKHPR-DLH 552
D+++ G+ +E+ + P DLH
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPET-------EELAFIRSFRNEAQV-------- 421
+G G +G V+ N A+K L P T EE +++ +++ V
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 422 -------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRD 474
M +GSL L +D E ++ K ++ +A +AY+ + +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELAYTMVMTEKYD 531
+ + N+L++ L +ADFG AR++ + T G+ + APE T K D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 532 VYSFGVVTLEVLM-GKHP------RDLHSTLSSSY 559
V+SFG++ E++ GK P D+ S L Y
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 45/150 (30%), Positives = 66/150 (44%), Gaps = 18/150 (12%)
Query: 406 TEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
TE+L F+ F N ++ ++R F A E +A AL YLH
Sbjct: 68 TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE------------IASALGYLH-- 113
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
S ++V+RD+ NILL+S+ + DFG + A S T G+ Y+APE+
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP---RDLH 552
D + G V E+L G P RD+
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRV-FALKKLNSPETEELAFIRSFRNEAQVLSQME 426
P + + +G+GAYGSV A R A+KKL+ P + R++R E ++L M+
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMK 72
Query: 427 RGSLFRILHNDAEAVELDWAKRV------------NIVKAMA--------------HALA 460
++ +L A ++ V NIVK L
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
Y+H S ++HRD+ +N+ +N E + DFG AR AD +A + Y APE+
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATRW-YRAPEI 186
Query: 521 AYT-MVMTEKYDVYSFGVVTLEVLMGK 546
M + D++S G + E+L GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 54/197 (27%), Positives = 79/197 (40%), Gaps = 35/197 (17%)
Query: 370 KIDSKYCIGTG---AYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME 426
K DS++C+ V + + V L K+ P + F SF+ ++ ME
Sbjct: 22 KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI--VTFFASFQENGRLFIVME 79
Query: 427 --------------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
RG LF +E L W V I + H HD ++H
Sbjct: 80 YCDGGDLMKRINRQRGVLF------SEDQILSWF--VQISLGLKHI-----HD--RKILH 124
Query: 473 RDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
RDI S NI L+ + A + DFG AR L+ G+ Y++PE+ K D
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTD 184
Query: 532 VYSFGVVTLEVLMGKHP 548
++S G V E+ KHP
Sbjct: 185 IWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 368 PRK-IDSKYCIGTGAYGSVYKAQL-PNGRVFALKK--LNSPETEELAF-----IRSFRNE 418
PR +D+ IG G+ G V A + +G++ A+KK L + EL F +R +++E
Sbjct: 18 PRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 419 AQV---------------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
V + +E G+L I+ + ++ + + A+ AL+ LH
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLH 133
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
+ V+HRDI S++ILL ++DFG + + + L G+ ++APEL
Sbjct: 134 ---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575
+ + D++S G++ +E++ G+ P +P + + ++ LPP
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEEL-----------------------AFI 412
+G G YG VYK + + G++ A+K ++ E EE AFI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 413 RSFR--NEAQVLSQME---RGSLFRILHN-DAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
+ ++ Q+ ME GS+ ++ N A++ DW I + + LA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLH--- 138
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT--- 523
+ V+HRDI N+LL E + DFG + L + G+ ++APE+
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 524 --MVMTEKYDVYSFGVVTLEVLMGKHPR-DLHSTLSSSYDPKIMLIDVLDQRLPPP 576
+ D++S G+ +E+ G P D+H M L R PPP
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----------MRALFLIPRNPPP 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 371 IDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS 429
I K+ +G G YG VY+ A+K L E+ + F EA V+ +++ +
Sbjct: 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 430 LFRILH------------------------NDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
L ++L + E++ + + ++ A+ YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 121
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPE-LA 521
+ +HRD+++ N L+ VADFG +RL+ D+ T AG+ + APE LA
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLA 178
Query: 522 YTMVMTEKYDVYSFGVVTLEV 542
Y K DV++FGV+ E+
Sbjct: 179 YNKFSI-KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAH 457
L KL++ T+E +I + M +GSL L +D E + K ++ +A
Sbjct: 63 LVKLHAVVTKEPIYI--------ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAE 113
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YG 514
+A++ + +HRD+ + NIL+++ L +ADFG AR++ + + T G+
Sbjct: 114 GMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIK 168
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ APE T K DV+SFG++ +E++ G+ P
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/259 (23%), Positives = 102/259 (39%), Gaps = 54/259 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK-----LNSPETEE-------LA-----FIRSFRNE 418
+G G+YGSVYK + L + + +ALK+ ++ E E+ LA I S+ E
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY-KE 66
Query: 419 AQVLSQ-----MER---GSLFRILHNDAEAV-----ELDWAKRVNIVKAMAHALAYLHHD 465
A + ME G L + + + + W I + L LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALH-- 120
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
++HRD+ S NILL + + D G +++L + + + G+ Y+APE+
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHYMAPEVWKGRP 177
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP------RDLHSTLSSSYDPKIM------LIDVLDQRL 573
+ K D++S G + E+ P +DL + P I L + + L
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237
Query: 574 PP-PVDRKVIQDILLVSTI 591
P R IL +
Sbjct: 238 QVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 54/246 (21%), Positives = 91/246 (36%), Gaps = 55/246 (22%)
Query: 377 IGTGAYGSVYKAQLPN-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +G V + G A+K LN EE F E ++L
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEE-QHRSDFEREIEILRTLDHENIV 69
Query: 425 -----------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
ME GSL L + +++ + + + + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG- 126
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG-----YIAPE 519
S +HRD+++ NIL+ S+ ++DFG A++L D G + APE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY--VKEPGESPIFWYAPE 182
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLM----GKHPRDLHSTLSSSYDPKIMLIDVLD----- 570
T + DV+SFGV E+ + P + ++++ +L+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 571 QRLPPP 576
+RLP P
Sbjct: 243 ERLPRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 31/205 (15%)
Query: 368 PRK-IDSKYCIGTGAYGSVYKA-QLPNGRVFALKK--LNSPETEELAF-----IRSFRNE 418
PR+ +DS IG G+ G V A + G+ A+KK L + EL F +R + +E
Sbjct: 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE 79
Query: 419 AQV---------------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
V + +E G+L I+ + ++ + + ++ AL+YLH
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH 135
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
+ V+HRDI S++ILL S ++DFG + + + L G+ ++APE+
Sbjct: 136 ---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
+ + D++S G++ +E++ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQVLSQMER---GSLF-RILHNDAEAVELDWAKRVNIVK 453
L L P +A+ F ++ +L +ME G+L+ +I+ + E + + +
Sbjct: 53 LSLLQHPNI--IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV--LWYLF 108
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY 513
+ A++Y+H ++HRDI + NI L + DFG +++L ++ S + G+
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
Y++PEL + K D+++ G V E+L
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSP-----ETEELA-------------FIRS--- 414
+G G +G V Q+ G+++A KKL+ + E++A FI S
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 415 -FRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
F + V++ M G L ++N E A+ + + L +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
V+RD+ N+LL+ ++D G A L AG+ GY+APE+ V
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568
D ++ G E++ G+ P + K +++
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 49/209 (23%)
Query: 377 IGTGAYGSVYK---AQLPNGRVF---ALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G G++G VY+ + G A+K +N E + F NEA V+ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVMKEFNCHHV 71
Query: 425 -------------------MERGSL---FRILHNDAEAVEL----DWAKRVNIVKAMAHA 458
M +G L R +AE K + + +A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNQTLLAGSYG 514
+AYL + VHRD+++ N ++ L + DFG R ++ + LL
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL--PVR 186
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
++APE V T K DV+SFGVV E+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 52/204 (25%), Positives = 79/204 (38%), Gaps = 47/204 (23%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKL-------------------------NSPETEELA 410
I GA+GSVY A+ G FA+K L SP +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 411 FIRSFRNEAQVLSQMER------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
+ SF+++ + ME SL + L + DWAK + + + LH
Sbjct: 64 Y--SFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAK--QYIAEVVLGVEDLHQ 115
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
++HRDI N+L++ + DFG +R + G+ Y+APE +
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILGV 168
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHP 548
+ D +S G V E L G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 25/70 (35%), Positives = 43/70 (61%)
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355
L L + L G IP+ I+ + L ++LS N+I+G+IP + ++ L+ L+LS N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 356 PYSNKHLSSM 365
P S L+S+
Sbjct: 483 PESLGQLTSL 492
|
Length = 623 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 37/144 (25%), Positives = 68/144 (47%), Gaps = 15/144 (10%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
+ L F+ + N ++ Q+++ F+ H A E+ A L +LH
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI------------AIGLFFLH--- 118
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S +++RD+ +N++L+S+ +ADFG + D G+ YIAPE+
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 527 TEKYDVYSFGVVTLEVLMGKHPRD 550
+ D ++FGV+ E+L G+ P +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN-SPETE--------ELAFIRSFR--NEAQVL-- 422
IG G YG VYKA+ G V ALKK+ ETE E++ ++ N ++L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 423 --SQMERGSLFRILHND-------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
++ + +F LH D + + + + + LA+ H S V+HR
Sbjct: 68 IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHR 124
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYDV 532
D+ N+L+N++ +ADFG AR T + Y APE L + D+
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184
Query: 533 YSFGVVTLEVL 543
+S G + E++
Sbjct: 185 WSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKK-LNSPETE--------ELAFIRSFRNE-----AQV 421
+G G+YG V K + G++ A+KK L S + + E+ ++ R+E +V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 422 LSQMERGSLF-----RILHNDAEAVE--LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRD 474
+ +R L + +D E LD ++ + + + + H S +++HRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRD 125
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY---- 530
I NIL++ + DFG AR L A T + Y APEL +V KY
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDTKYGRAV 182
Query: 531 DVYSFGVVTLEVLMG 545
D+++ G + E+L G
Sbjct: 183 DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 61/213 (28%), Positives = 85/213 (39%), Gaps = 47/213 (22%)
Query: 371 IDSKYCIGTGAYGSVYKA--QLPNGRVFAL-----KKLNSPETEELAFIRSFRNEAQVLS 423
I CIG G +G VY+ P A+ K SP E F EA ++
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIMR 62
Query: 424 Q---------------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHAL 459
Q ME G L L + LD A + ++ AL
Sbjct: 63 QFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTAL 120
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS---SNQTLLAGSYGYI 516
AYL S VHRDI++ N+L++S + DFG +R L +S +++ L ++
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWM 175
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP 548
APE T DV+ FGV E+LM G P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA-RLLHADSSNQT 507
V IVKA+ H L H V+HRD+ +NILL++ + DFG + RL+ DS +T
Sbjct: 121 VAIVKAL-HYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKT 172
Query: 508 LLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHST 554
AG Y+APE KY DV+S G+ +E+ G+ P T
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 37/200 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN-----SPET-----EELAFIRSFRN-------- 417
IG G++G+VY A+ + V A+KK++ S E +E+ F++ R+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 418 ----EAQVLSQMER--GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
E ME GS IL + L + I LAYLH S +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLH---SHERI 137
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM---VMTE 528
HRDI + NILL +ADFG+A L+ +S G+ ++APE+ M
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEGQYDG 193
Query: 529 KYDVYSFGVVTLEVLMGKHP 548
K DV+S G+ +E+ K P
Sbjct: 194 KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 19/126 (15%)
Query: 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKL 486
G LF +L + + L A+ I++ + AL LH +++H DI N+L + +K
Sbjct: 94 GDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKD 147
Query: 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPE----LAYTMVMTEKYDVYSFGVVTLEV 542
++ D+G +++ S G+ Y +PE Y +D ++ GV+T E+
Sbjct: 148 RIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYD----VSFDWWAVGVLTYEL 199
Query: 543 LMGKHP 548
L GKHP
Sbjct: 200 LTGKHP 205
|
Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 59/200 (29%), Positives = 85/200 (42%), Gaps = 38/200 (19%)
Query: 377 IGTGAYGSVYKAQ-LPNG-RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS----- 429
IG GAYG V+KA+ L NG R ALK++ EE + + R E VL +E
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 430 -LFRIL----------------HNDAE-AVELDWAKRVNI----VKAMAH----ALAYLH 463
LF + H D + LD + +K M L +LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
S VVHRD+ NIL+ S + +ADFG AR +++ T + + Y APE+
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 524 MVMTEKYDVYSFGVVTLEVL 543
D++S G + E+
Sbjct: 184 SSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
L +LH S +V+RD+ +NILL++ +ADFG + + G+ YIAP
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
E+ D +SFGV+ E+L+G+ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPET-----------EELAFIRSFRNEAQVLSQ 424
IG GA+G V+ P +G+ ALKK+ P EL + F+++ VLS
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHD-NVLSA 64
Query: 425 ME-----RGSLFRILHNDAEAVELDWAKRV--------NIVKAMAH----ALAYLHHDCS 467
++ F ++ E ++ D K + + VK + L YLH S
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---S 121
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-NQTLLAGSYGYIAPE-LAYTMV 525
++HRDI N+L+NS + DFG AR+ D S + T + Y APE L +
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 526 MTEKYDVYSFGVVTLEVLMGK 546
T D++S G + E+L +
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQV---LSQMERGSLFRILHNDAEAVELDWAKRVNIVKA 454
L + NSP + F +F ++ ++ + M+ GSL ++L E K V+I A
Sbjct: 57 LHECNSPYI--VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--A 111
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+ L YL ++HRD+ +NIL+NS+ E + DFG + L +N G+
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRS 167
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y++PE + + D++S G+ +E+ +G++P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 10/112 (8%)
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
I LAYLH ++HRDI + NILL + +ADFG+A SS
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFV 178
Query: 511 GSYGYIAPELAYTMVMTE---KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY 559
G+ ++APE+ M + K DV+S G+ +E+ K P + +S+ Y
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK------------------------LNSPETEELAF 411
IG G + VYKA L +GRV ALKK L+ P + +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV--IKY 67
Query: 412 IRSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRV-NIVKAMAHALAYLHHDCS 467
+ SF + VL + G L R++ + + L + + + AL ++H S
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---S 124
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
++HRDI N+ + + + D G R + ++ L G+ Y++PE +
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 528 EKYDVYSFGVVTLE 541
K D++S G + E
Sbjct: 185 FKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 8/134 (5%)
Query: 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486
L+ L + + +D A + I K + L YLH + ++HRD+ + NI +N
Sbjct: 140 SSDLYTYLTKRSRPLPIDQA--LIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVD 194
Query: 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
+ + D G A+ LAG+ APE+ K D++S G+V E+L
Sbjct: 195 QVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--A 251
Query: 547 HPRDLHSTLSSSYD 560
+P + S+ +
Sbjct: 252 YPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-------RG 428
IG G++G+VY A+ + V A+KK++ + + E + L +++ +G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 429 SLFR----------ILHNDAEAVELDWAKRVNI-VKAMAHA----LAYLHHDCSPSVVHR 473
R L + ++ +E+ + + A+ H LAYLH S +++HR
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHR 149
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE---KY 530
DI + NILL + +ADFG+A + +S G+ ++APE+ M + K
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSY 559
DV+S G+ +E+ K P + +S+ Y
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-07
Identities = 22/57 (38%), Positives = 30/57 (52%)
Query: 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
LDLS+N+L+ + +L LDLS NN+ P + L L L+LSGN L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
L +LH +++RD+ +N+LL+ +ADFG + + G+ YIA
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
PE+ E D +SFGV+ E+L+G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKL-------NSPETEELAFIR--SFRNEAQVLSQ-- 424
+G G YG VY A+ L A+K++ P EE+A RN Q L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 425 --------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
ME+ GSL +L + ++ + + K + L YLH + +VHR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 474 DISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV--MTEKY 530
DI +N+L+N+ ++DFGT++ L + G+ Y+APE+
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 531 DVYSFGVVTLEVLMGKHP 548
D++S G +E+ GK P
Sbjct: 193 DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 57/229 (24%)
Query: 369 RKIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVL 422
R I K +G GA+G V+ A+ N + A+K L P LA + F+ EA++L
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELL 61
Query: 423 SQ-------------------------MERGSLFRILHN---DAEAV----------ELD 444
+ M+ G L + L DA + EL
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 445 WAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS- 503
++ ++I +A + YL S VHRD+++ N L+ + L + DFG +R +++
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 504 ---SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP 548
T+L ++ PE T + DV+SFGV+ E+ GK P
Sbjct: 179 YRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSP-------------ETEELA-----FIRS--- 414
+G G +G V Q+ G+++A KKLN E LA FI S
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 415 -FRNEAQ---VLSQMERGSL-FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
F+ + V++ M G L + I + D E + + L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
+++RD+ N+LL++ ++D G A L S AG+ G++APEL + E+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL----LQGEE 173
Query: 530 YDV----YSFGVVTLEVLMGKHP 548
YD ++ GV E++ + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQV---LSQMERGSLFRILHNDAEAVELDWAKRVNIVKA 454
L + NSP + F +F ++ ++ + M+ GSL ++L E K I A
Sbjct: 53 LHECNSPYI--VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK---ISIA 107
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+ L YL ++HRD+ +NIL+NS+ E + DFG + L +N G+
Sbjct: 108 VLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRS 163
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y++PE T + D++S G+ +E+ +G++P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 39/218 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIR-------------------SFR 416
IG+G YG VYKA+ + G + A+K + E+ A ++ S+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 417 NEAQVLSQMER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
++ ME GSL I H E A + + L YLH S +HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYLH---SKGKMHR 130
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV---MTEKY 530
DI NILL +ADFG + + A + + G+ ++APE+A +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 531 DVYSFGVVTLEV------LMGKHP-RDLHSTLSSSYDP 561
D+++ G+ +E+ + HP R L S++ P
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---LAG 511
+ AL Y+H + +V HRD+ NIL N+ + + DFG AR+ D+
Sbjct: 112 LLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 512 SYGYIAPEL--AYTMVMTEKYDVYSFGVVTLEVLMGK 546
+ Y APEL ++ T D++S G + EVL GK
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKL------------------------NSPETEELAF 411
+G G +G V Q+ N G+++A KKL NSP LA+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 412 IRSFRNEAQ---VLSQMERGSL-FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
+F ++ V+S M G L + I + +E++ + ++ + + +LH S
Sbjct: 61 --AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLH---S 113
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
+V+RD+ N+LL+ + ++D G A L D T AG+ GY+APE+ +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 528 EKYDVYSFGVVTLEVLMGKHP 548
D ++ G E++ G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 41/198 (20%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN 436
+G GA+G VYKAQ V A K+ ++EE + + E +L+ + ++ ++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70
Query: 437 -------------------DAEAVELDWA---KRVNIV-KAMAHALAYLHHDCSPSVVHR 473
DA +EL+ ++ +V K AL YLH + ++HR
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE----- 528
D+ + NIL + +ADFG + + G+ ++APE+ VM E
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV----VMCETSKDR 183
Query: 529 ----KYDVYSFGVVTLEV 542
K DV+S G+ +E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE----------ELAFIRSFRN-------- 417
IG G++G+VY A+ + N V A+KK++ + E+ F++ R+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 418 ------EAQVLSQMERGSLFRILHNDAEAV-ELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
A ++ + GS +L + + E++ A + LAYLH S ++
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH---SHNM 136
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE-- 528
+HRD+ + NILL+ + DFG+A ++ + G+ ++APE+ M +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQYD 192
Query: 529 -KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY 559
K DV+S G+ +E+ K P + +S+ Y
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 42/206 (20%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKK--LNSPETE------ELAFIRSFRN---------- 417
IG GA+G+V K P+G + A+K+ E E +L + +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 418 ---EAQVLSQMERGS-----LFRILHNDAEAV---ELDWAKRVNIVKAMAHALAYLHHDC 466
E ME ++ ++ ++V E+ V VKA+ + L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--- 128
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
++HRD+ +NILL+ + DFG + L DS +T AG Y+APE
Sbjct: 129 ---IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPS-A 183
Query: 527 TEKYD----VYSFGVVTLEVLMGKHP 548
+ YD V+S G+ EV GK P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
L +LH S +++RD+ +N++L+ +ADFG + + + G+ YIAP
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
E+ + T D +SFGV+ E+L+G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELA-FIRSFRNEAQVLSQMERGSLF 431
+GTGAYG V+ + +G+++A+K L + A R E QVL + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 432 RILHNDAEA-----VELDW----------AKRVNI--------VKAMAHALAYLHHDCSP 468
LH + + LD+ ++R + AL +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KL 124
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPELAY--TMV 525
+++RDI NILL+S + DFG ++ H D + G+ Y+AP++
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP 548
+ D +S GV+ E+L G P
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 51/215 (23%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG GAYG V A P G A+KK+ SP + R+ R E ++L + + ++ IL
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLR-EIKILRRFKHENIIGIL- 69
Query: 436 NDAEAVELDWAKRVNIVKA--------------------------MAHALAYLHHDCSPS 469
+ + V IV+ + L Y+H S +
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SAN 126
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY----GYIAPELAYTMV 525
V+HRD+ +N+LLN+ + + DFG AR + + T Y Y APE+ M+
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEYVATRWYRAPEI---ML 182
Query: 526 MTEKY----DVYSFGVVTLEVLM------GKHPRD 550
++ Y D++S G + E+L GK
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 53/254 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPET---------EELAFIRSFRNEAQV----- 421
+G GA+G V A+ G+ A+KK+ P + EL ++ R+E +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 422 ----------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
++++ L R+L + +E + + + + L Y+H S VV
Sbjct: 78 FISPLEDIYFVTELLGTDLHRLL--TSRPLEKQFIQY--FLYQILRGLKYVH---SAGVV 130
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
HRD+ +NIL+N + + DFG AR+ D ++ Y Y APE+ M+ +KYD
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRY-YRAPEI---MLTWQKYD 184
Query: 532 V----YSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587
V +S G + E+L GK L D + D PP D VI I
Sbjct: 185 VEVDIWSAGCIFAEMLEGK-------PLFPGKDHVNQFSIITDLLGTPPDD--VINTICS 235
Query: 588 VSTISFACLQSNPK 601
+T+ F +QS PK
Sbjct: 236 ENTLRF--VQSLPK 247
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 67/254 (26%), Positives = 92/254 (36%), Gaps = 67/254 (26%)
Query: 377 IGTGAYGSVYKA-----QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +GSV Q G V A+KKL E L R F E ++L
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEILKSLQHDNIV 68
Query: 425 -----------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
ME GSL L E LD K + + + YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLG- 125
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---APELA 521
S VHRD+++ NIL+ S+ + DFG ++L D + I APE
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 522 YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM---------------LI 566
+ DV+SFGVV E+ +S S S + M LI
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT-------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236
Query: 567 DVL--DQRLPPPVD 578
++L + RLP P
Sbjct: 237 ELLKNNGRLPAPPG 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--- 432
IG G YG VYKA+ ALKK+ + +E + R E +L +M+ G++ R
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 433 ILHNDA------EAVELD----------WAKRVNIVKA----MAHALAYLHHDCSPSVVH 472
++H++ E ++LD +AK ++K + +AY H S V+H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125
Query: 473 RDISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY- 530
RD+ N+L++ + A +ADFG AR T + Y APE+ ++ + Y
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI---LLGSRHYS 182
Query: 531 ---DVYSFGVVTLEVLMGK 546
D++S G + E++ K
Sbjct: 183 TPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/203 (26%), Positives = 80/203 (39%), Gaps = 40/203 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG+G +G V+ R A+K + E FI EAQV+ +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGV 67
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME G L L A+ + + + + +AYL V+
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTE 528
HRD+++ N L+ V+DFG R + D SS T + +PE+ +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYSS 180
Query: 529 KYDVYSFGVVTLEVLM-GKHPRD 550
K DV+SFGV+ EV GK P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 351 LSGRVPYSNKH--LSSMPTPRKI-DSKYCIGTGAYGSVYK-AQLPNGRVFALKKLN---- 402
L G PY++ L S+ P + IG G YG VYK +G + A+K L+
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 403 -SPETE-ELAFIRSFRNEAQVL---------SQMERGSLFRILH--NDAEAVEL-----D 444
E E E ++S N V+ ++ G L+ +L N EL
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 445 WAKRVN---IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
+R++ I + AL L H + ++HRD+ NNILL ++ + DFG + L +
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 502 DSSNQTLLAGSYGYIAPEL-----AYTMVMTEKYDVYSFGVVTLEVLMGKHPR-DLH 552
+ G+ ++APE+ Y + DV+S G+ +E+ G P D+H
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN--SPETEEL---------------------AFI 412
+G G YG VYK + + G++ A+K ++ E EE+ AFI
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 413 RSFRN----EAQVLSQME---RGSLFRILHN-DAEAVELDWAKRVNIVKAMAHALAYLHH 464
+ +N + Q+ ME GS+ ++ N ++ +W I + + L++LH
Sbjct: 74 K--KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQ 129
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT- 523
V+HRDI N+LL E + DFG + L + G+ ++APE+
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 524 ----MVMTEKYDVYSFGVVTLEVLMGKHPR-DLH 552
K D++S G+ +E+ G P D+H
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAF-IRSFRNEAQVLSQMERGSLFRI- 433
I G YG VY+A+ G + ALKKL E E+ F I S R E +L +++ ++ +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM-EKEKEGFPITSLR-EINILLKLQHPNIVTVK 70
Query: 434 ------LHNDA----EAVELDW-------------AKRVNIVKAMAHALAYLHHDCSPSV 470
+ E VE D ++ ++ + +A+LH + +
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WI 127
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY-TMVMTEK 529
+HRD+ ++N+LLN++ + DFG AR + T L + Y APEL +
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187
Query: 530 YDVYSFGVVTLEVLMGK 546
D++S G + E+L K
Sbjct: 188 IDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 42/203 (20%)
Query: 377 IGTGAYGSVYKAQLPNG-RVFALK------------------------KLNSPETEELAF 411
IG G++G V + + + R++ALK ++N P L F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 412 IRSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA---MAHALAYLHHD 465
SF++ + VL+ + G LF L + R ++ +A A L L +
Sbjct: 61 --SFQSPEKLYLVLAFINGGELFHHLQREG---------RFDLSRARFYTAELLCALENL 109
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
+V++RD+ NILL+ + + DFG +L D G+ Y+APEL
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP 548
T+ D ++ GV+ E+L G P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 47/204 (23%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTG++G V + +G+ +ALK L+ + +L + NE ++L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 425 -----------MER---GSLFRILHNDAEAVELDWAK--RVNIVKAMAHALAYLHHDCSP 468
ME G LF + A+ +V AL YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVL----ALEYLHSL--- 120
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
+V+RD+ N+LL+S + DFG A+ + T L G+ Y+APE +++++
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYT-LCGTPEYLAPE----IILSK 173
Query: 529 KY----DVYSFGVVTLEVLMGKHP 548
Y D ++ G++ E+L G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 26/166 (15%)
Query: 420 QVLSQM-ERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRD 474
Q+++Q+ GSL + ++++ L+W V I K M YL +VHR+
Sbjct: 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGMY----YLEEHR---MVHRN 134
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPELAYTMVMTEKYDV 532
+++ NILL S +ADFG A LL+ D ++A E T + DV
Sbjct: 135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDV 194
Query: 533 YSFGVVTLEVLM-------GKHPRDLHSTLSSS---YDPKIMLIDV 568
+S+GV E++ G P ++ L P+I IDV
Sbjct: 195 WSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 12/106 (11%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH-----ADS 503
V+ +A + YL S +HRD+++ N+L+ +ADFG AR +H +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
SN L ++APE + V T + DV+SFG++ E+ +G P
Sbjct: 194 SNGRL---PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 15/143 (10%)
Query: 406 TEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
++L F+ + N ++ ++R F A E+ A AL YLH
Sbjct: 68 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI------------ASALGYLH-- 113
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
S ++V+RD+ NILL+S+ + DFG + + + G+ Y+APE+ +
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP 548
D + G V E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 68/245 (27%)
Query: 377 IGTGAYGSVYKA-QLPNGR-------VFALKKLNSPETEELAFIRSFRNEAQVLSQMERG 428
+G+GA+G+VYK +P G + L++ SP+ + +EA V++ ++
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYVMASVDNP 69
Query: 429 SLFRIL--------------------------HNDAEAVE--LDWAKRVNIVKAMAHALA 460
+ R+L H D + L+W V I K M
Sbjct: 70 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN---- 123
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--GYIAP 518
YL +VHRD+++ N+L+ + + DFG A+LL AD G ++A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYD--PKIMLIDVLD--QRL 573
E + T + DV+S+GV E++ G P YD P + +L+ +RL
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------YDGIPASEISSILEKGERL 230
Query: 574 P-PPV 577
P PP+
Sbjct: 231 PQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 48/210 (22%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNS--------------PETEELAFIRS---- 414
+GTGAYG V+ + G+++A+K L E + L +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 415 ------FRNEAQ---VLSQMERGSLFRIL----HNDAEAVELDWAKRVNIVKAMAHALAY 461
F+ + + +L + G LF L H V + A+ IV A+ H
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE---IVLALDH---- 120
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPEL 520
LH +++RDI NILL+S+ + DFG ++ A+ + G+ Y+APE+
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 521 AYTMV--MTEKYDVYSFGVVTLEVLMGKHP 548
+ D +S GV+T E+L G P
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 50/210 (23%)
Query: 377 IGTGAYGSV----YKAQLPNGRVFALKK---------LNSPETEELAFIRSFRNEAQV-- 421
+G GAYG V V A+KK L EL +R FR +
Sbjct: 8 LGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 422 LSQME--RGSLFRILHNDAEAVELDWAKRVNIVKAM-----AH----------ALAYLHH 464
L M+ F L+ E +E D + I+++ AH L Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQ---IIRSGQPLTDAHFQSFIYQILCGLKYIH- 122
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY----GYIAPEL 520
S +V+HRD+ N+L+N+ E + DFG AR + Y Y APE+
Sbjct: 123 --SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGK 546
M+ + Y DV+S G + E+L K
Sbjct: 181 ---MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 15/142 (10%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
+ L F+ + N ++ Q++R F E +A V + AL +LH
Sbjct: 69 DRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTL------ALMFLHRH- 115
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
V++RD+ +NILL+++ +ADFG + + T G+ YIAPE+ +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 527 TEKYDVYSFGVVTLEVLMGKHP 548
D ++ GV+ E++ G+ P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 54/226 (23%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNSPET----------EE---LAFIRS----- 414
IG GA+G V QL + +V+A+K L+ E EE +A S
Sbjct: 51 IGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 415 ----FRNEA---QVLSQMERGSLFRILHNDAEAVELDWAK--RVNIVKAMA--HALAYLH 463
F+++ V+ M G L ++ N + WA+ +V A+ H++ +
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGF-- 163
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAY 522
+HRD+ +N+LL+ +ADFGT + A+ + A G+ YI+PE+
Sbjct: 164 -------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 523 TMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM 564
+ Y D +S GV E+L+G P +L +Y KIM
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYS-KIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 56/228 (24%)
Query: 369 RKIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVL 422
R I K+ +G GA+G V+ A+ N + A+K L E E A + F+ EA++L
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESAR-QDFQREAELL 61
Query: 423 S-------------------------QMERGSLFRILHN---DAEAVE---------LDW 445
+ M G L R L + DA+ + L
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 446 AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS-- 503
+ + I +A + YL S VHRD+++ N L+ L + DFG +R +++
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 504 --SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP 548
+T+L ++ PE T + D++SFGVV E+ GK P
Sbjct: 179 RVGGRTML--PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
++ L +LH +++RD+ +N++L+S+ +ADFG + D G+
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
YIAPE+ + D +++GV+ E+L G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 40/203 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G+G +G V+ + A+K + E FI EA+V+ +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFI----EEAKVMMKLSHPNLVQLYGV 67
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M G L L + +W +++ + A+ YL + +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTE 528
HRD+++ N L+ V+DFG AR + D SS T + PE+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA--PPEVFDYSRFSS 180
Query: 529 KYDVYSFGVVTLEVL-MGKHPRD 550
K DV+SFGV+ EV GK P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG-TARLLHADSSNQTLL 509
+VK M + + + S S +HRD+++ N +LN + VADFG + ++ + D Q +
Sbjct: 114 LVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
Query: 510 AG-SYGYIAPELAYTMVMTEKYDVYSFGVVTLEV 542
A +IA E V T K DV+SFGV E+
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 43/208 (20%)
Query: 377 IGTGAYGSVYKA-QLPNGR-------VFALKKLNSP----ETEELAFIRS---------- 414
+G+GA+G+VYK +P+G + L++ SP E + A++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 415 ----FRNEAQVLSQ-MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLHHD 465
+ Q+++Q M G L + + + + L+W V I K M+ YL
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGMS----YLE-- 126
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY--GYIAPELAYT 523
+VHRD+++ N+L+ S + DFG ARLL D + G ++A E
Sbjct: 127 -EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 524 MVMTEKYDVYSFGVVTLEVL-MGKHPRD 550
T + DV+S+GV E++ G P D
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 38/203 (18%)
Query: 377 IGTGAYGSVYKA--QLPNGRV-FALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI 433
+G+G +G V K ++ ++ A+K L + E + EA+++ Q++ + R+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--ENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 434 LH-NDAEAVEL------------------DWAKRVNIVKAM---AHALAYLHHDCSPSVV 471
+ +AEA+ L D N+V+ M + + YL + V
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG-----YIAPELAYTMVM 526
HRD+++ N+LL ++ A ++DFG ++ L AD S A S G + APE
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFRKF 175
Query: 527 TEKYDVYSFGVVTLEVL-MGKHP 548
+ + DV+S+G+ E G+ P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 40/204 (19%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPE---------------------TEELAFIR- 413
IG G +G VY+ + + R++A+K L+ E +E FI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 414 ---SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLH-HD 465
SF+ ++ V M G LF L + E R A + AL +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHLHKYD 116
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTM 524
+V+RD+ NILL++ + DFG ++ D+ G+ Y+APE L
Sbjct: 117 ----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHP 548
T+ D +S GV+ E+ G P
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 28/96 (29%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+A L +LH S +++RD+ +N++L+++ +ADFG + G+
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550
YIAPE+ + D ++FGV+ E+L G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 55/210 (26%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKL-------------------------NSP------ 404
+G G++G V A+L ++A+K L P
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 405 ---ETEE-LAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALA 460
+T++ L F+ + N ++ ++R F A E+ L
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI------------VLGLQ 110
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNQTLLAGSYGYIAP 518
+LH +++RD+ +N+LL+S+ +ADFG + +L +++ G+ YIAP
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAP 165
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
E+ D ++ GV+ E+L G+ P
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 7/85 (8%)
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSS-NQTLLAGSYGYIAPELAYTMVMTEK 529
VHRDI N+L++ +ADFG+A L A+ N L G+ YIAPE+ TM K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 530 --YDV----YSFGVVTLEVLMGKHP 548
Y V +S GV+ E++ G+ P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKL----NSPETE--------ELAFIRSFRNEAQV-- 421
+G GA+G VY + GR A K++ SPET E+ +++ ++E V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 422 ---------------LSQMERGSL---FRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+ M GS+ + E+V + +++ ++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT---LLAGSYGYIAPEL 520
S +VHRDI NIL +S + DFG ++ L + T + G+ +++PE+
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
K DV+S G +E+L K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 65/241 (26%), Positives = 88/241 (36%), Gaps = 44/241 (18%)
Query: 132 ESLRILAYYDGFTGSIP----SEISAL---SKLQLLDLSSNRLRG----------RLTNL 174
SL+ L TG IP S + L LQ LDLS N L R ++L
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 175 NYMSLSRNMLGGL-LPQEIGNLK----NLIELDVGDNSLIG----PIPLTLSRLTSLKIL 225
+ L+ N LG L LK L +L +G N L G + L LK L
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170
Query: 226 ILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDLSC 276
LA N + L + + NL +LD+ NN + + TL L L+L
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 277 NQFNSSIPNEL-----TRLTQLFHLDLSSNKL----SGKIPSQIASMEDLTWLDLSNNNI 327
N + L + L L LS N + + + +A E L LDL N
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
Query: 328 K 328
Sbjct: 291 G 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS 512
K + +AYL S +HRD+++ N L++ + V+DFG +R + D ++ GS
Sbjct: 107 KDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV--GS 161
Query: 513 ---YGYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDL 551
+ PE+ + K DV++FGV+ EV +GK P +
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 12/106 (11%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH-----ADS 503
V+ +A + YL S +HRD+++ N+L+ +ADFG AR ++ +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+N L ++APE + V T + DV+SFGV+ E+ +G P
Sbjct: 197 TNGRL---PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G YG V+ A+ + G + ALK++ +L +R E +L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 425 -----------MER--GSLFRILHNDAEAVELDWAK-----RVNIVKAMAHALAYLHHDC 466
ME G FR L N+ + D A+ V A+ H L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HELGY----- 122
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNQTLLAGSYGYIAPELAYTM 524
+HRD+ N L+++ + DFG ++ + +A+S + GS Y+APE +
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPE----V 169
Query: 525 VMTEKY----DVYSFGVVTLEVLMGKHP 548
+ + Y D +S G + E L G P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 377 IGTGAYGSVY---KAQLPN-GRVFALKKLNSPE-TEELAFIRSFRNEAQVLSQMERGSLF 431
+GTGAYG V+ K + G+++A+K L ++ + R E VL + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 432 RILH----NDAEA-VELDWA----------KRVNIVKAMAH--------ALAYLHHDCSP 468
LH +A+ + LD+ +R N + AL +LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KL 124
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPELAYTMVMT 527
+V+RDI NILL+S+ + DFG ++ ++ +T G+ Y+APE+
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184
Query: 528 EK-YDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP---PVDRKVIQ 583
K D +S G++ E+L G P L ++ + ++ D P P + ++
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPEAQDLLH 243
Query: 584 DIL 586
+L
Sbjct: 244 KLL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 37/191 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------- 425
IG G +G V +V A+K + + T + AF+ EA V++Q+
Sbjct: 14 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHSNLVQLLGV 67
Query: 426 ---ERGSLFRILHNDAEAVELDWAKR-----------VNIVKAMAHALAYLHHDCSPSVV 471
E+G L+ + A+ +D+ + + + A+ YL + + V
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
HRD+++ N+L++ A V+DFG L SS Q + APE + K D
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 532 VYSFGVVTLEV 542
V+SFG++ E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 51/208 (24%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKL-------------------------NSP------ 404
+G G++G V A+L +GR++A+K L N P
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 405 ----ETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALA 460
+ L F+ F N ++ +++ F D A+ + AL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF------------DEARARFYAAEITSALM 110
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
+LH +++RD+ +N+LL+ + +ADFG + + + G+ YIAPE+
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
M+ D ++ GV+ E+L G P
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-----NQTLL 509
+A + +L S + +HRD+++ N+LL A + DFG AR + DS+ N L
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276
Query: 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
++APE + V T + DV+S+G++ E+ +GK P
Sbjct: 277 --PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 66/278 (23%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------- 425
IG G G VY A P R ALKK+ +E + F EA++ + +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 426 ---------------ERGSLFRILHN--DAEAVELDWAKR------VNIVKAMAHALAYL 462
E +L +L + E++ + A++ ++I + + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD---------------SSNQT 507
H S V+HRD+ +NILL E + D+G A + S+ T
Sbjct: 130 H---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 508 L---LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM 564
+ + G+ Y+APE + +E D+Y+ GV+ ++L TLS Y K
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML----------TLSFPYRRKKG 236
Query: 565 LIDVLDQRLPPPVDRKVIQDI-LLVSTISFACLQSNPK 601
+ P++ ++I +S I+ L +P
Sbjct: 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508
V+ +A + YL S +HRD+++ N+L+ +ADFG AR +H +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 509 LAGSY--GYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
G ++APE + + T + DV+SFGV+ E+ +G P
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
E+L F+ + N ++ ++R F A E+ A A+ YLH
Sbjct: 69 EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV------------ASAIGYLH--- 113
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S ++++RD+ NILL+S+ + DFG + + G+ Y+APE+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 527 TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
D + G V E+L G P S D M ++L + L P + V L
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP-------FYSRDVSQMYDNILHKPLQLPGGKTVAACDL 226
Query: 587 LVS 589
LV
Sbjct: 227 LVG 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 6/110 (5%)
Query: 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
+L + V+ +A + YL S +HRD+++ N+L+ +ADFG AR +H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 502 DSSNQTLLAGSY--GYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ G ++APE + V T + DV+SFGV+ E+ +G P
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 413 RSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
R + S +++ IL D A LD ++ +A +++L S + +H
Sbjct: 183 ADKRRSVRSGSYIDQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFL---ASKNCIH 237
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSS-----NQTLLAGSYGYIAPELAYTMVMT 527
RD+++ NILL + DFG AR + DS+ N L ++APE + V T
Sbjct: 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYT 294
Query: 528 EKYDVYSFGVVTLEVL-MGKHP 548
+ DV+S+G++ E+ +G P
Sbjct: 295 FESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 29/147 (19%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS----YGYIAPELAY 522
S +HRD+++ NILL+ + DFG AR ++ D + GS ++APE +
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPLKWMAPESIF 249
Query: 523 TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL-------PP 575
V T + DV+SFGV+ E+ +L +S P + + + QRL P
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 576 PVDRKVIQDILLVSTISFACLQSNPKS 602
I I+L AC Q +PK
Sbjct: 300 ENATPEIYRIML------ACWQGDPKE 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 35/200 (17%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSP------ETEELAFIR---------------- 413
IG G++G V A+ +G+ +A+K L E + + R
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 414 -SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
SF+ + VL + G LF L + E R A +A AL YLH S
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH---SL 115
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
++++RD+ NILL+S+ + DFG + S + G+ Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 529 KYDVYSFGVVTLEVLMGKHP 548
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG-----YIAPELAYT 523
+VHRD+++ N+L+ + ++DFG +R ++ + S + S G ++A E +
Sbjct: 147 KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS---YVKRSKGRIPVKWMAIESLFD 203
Query: 524 MVMTEKYDVYSFGVVTLEVLM-------GKHPRDLHSTLSSSY 559
+ T + DV+SFGV+ E++ G P L + L + Y
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY 246
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 43/213 (20%)
Query: 371 IDSKY----CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
+D+KY IG GAYG V A A+KK+ + + R+ R E ++L +
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHL 61
Query: 426 ERGSLFRI----------LHNDAEAV-ELDWAKRVNIVKA---------------MAHAL 459
+ ++ I ND V EL I+++ + L
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
Y+H S +V+HRD+ +N+LLN+ + + DFG AR T + Y APE
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 520 LAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
L ++ +Y DV+S G + E L+G+ P
Sbjct: 179 L---LLNCSEYTTAIDVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 21/145 (14%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLF---RILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+ L F+ + N ++ + R +F R AE V AL YLH
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------------ALEYLH 112
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
S VV+RDI N++L+ + DFG + +D + G+ Y+APE+
Sbjct: 113 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
D + GVV E++ G+ P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 60/241 (24%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNS-PETEEL-AFIR----------------- 413
IG G +G VY L A+K LN + EE+ F++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 414 --SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAM-------AHALAY 461
+E VL M+ G L + ++ VK + A + Y
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEY 113
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNQTLLAGSYGYIA 517
L S VHRD+++ N +L+ VADFG AR ++ N T ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP-RDLHSTLSSSYDPKIMLIDVLDQRLPP 575
E T T K DV+SFGV+ E++ G P D+ S+D + L+ +RL
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQ--GRRLLQ 223
Query: 576 P 576
P
Sbjct: 224 P 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 45/205 (21%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V Q+ G+++A KKL ++ NE Q+L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 425 --------------MERGSL-FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
M G L F I H + + V + L LH +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA--GSYGYIAPELAYTMVMT 527
+V+RD+ NILL+ ++D G A +H QT+ G+ GY+APE+ V
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHV-PEGQTIKGRVGTVGYMAPEV----VKN 175
Query: 528 EKY----DVYSFGVVTLEVLMGKHP 548
E+Y D ++ G + E++ G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 35/126 (27%), Positives = 64/126 (50%), Gaps = 11/126 (8%)
Query: 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE 487
G L L E+ L ++ +A +A+L S + +HRD+++ N+LL
Sbjct: 124 GDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKI 179
Query: 488 AFVADFGTARLLHADSSNQTLLAGS----YGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
+ DFG AR + DS+ ++ G+ ++APE + V T + DV+S+G++ E+
Sbjct: 180 VKICDFGLARDIMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 544 -MGKHP 548
+G +P
Sbjct: 238 SLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFGTARLLHA--DSSN 505
++ A+A A H+ +VHRD+ NI+++ + A V DFG LL D+
Sbjct: 88 VLDALACA-----HN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 506 QTLLA-----GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
TL G+ Y APE +T D+Y++G++ LE L G+
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAH 457
+++L++P + I + V+ E G L + L + E + +V ++
Sbjct: 50 MQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSM 106
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG--- 514
+ YL + VHRD+++ N+LL ++ A ++DFG ++ L AD + A ++G
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWP 161
Query: 515 --YIAPELAYTMVMTEKYDVYSFGVVTLE 541
+ APE + K DV+SFGV+ E
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG G+Y V +L R++A+K + + I + E V Q LH
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 436 N--DAEAVELDWAKRVNIVKAMAH---------------------ALAYLHHDCSPSVVH 472
+ E+ + VN M H AL YLH +++
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIY 119
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDV 532
RD+ +N+LL+S+ + D+G + + G+ YIAPE+ D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 533 YSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571
++ GV+ E++ G+ P D+ + SS +P D L Q
Sbjct: 180 WALGVLMFEMMAGRSPFDI---VGSSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+A AL +LH S +++RD+ NILL+ + + DFG ++ G+
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y+APE+ T+ D +SFGV+ E+L G P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 33/197 (16%)
Query: 377 IGTGAYGSV---YKAQLPNGRVFALKKLNSPETEELAFIRSFR--------NEAQVLSQM 425
IG+GA G V Y A L R A+KKL+ P + R++R N ++S +
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 426 ERGSLFRILHN-----------DAE-----AVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+ + L DA +ELD + ++ M + +LH S
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 139
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
++HRD+ +NI++ S + DFG AR + Y Y APE+ M E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKEN 198
Query: 530 YDVYSFGVVTLEVLMGK 546
D++S G + E++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL--HADSSNQTL 508
I + + ALAYLH ++HRD+ + NI L+ A + DFG A L H D+
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+G+ +PEL K D++S G+V E+ +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 36/206 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G+G +G V+ + A+K +N E FI EA+V+ +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME G L L + D +++ + + + YL + S +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG-SYGYIAPELAYTMVMTEKY 530
HRD+++ N L++S V+DFG R + D + A + PE+ + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 531 DVYSFGVVTLEVLM-GKHPRDLHSTL 555
DV+SFGV+ EV GK P + S
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 1e-05
Identities = 22/60 (36%), Positives = 26/60 (43%)
Query: 244 NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303
NL LD+ NN + +L LDLS N S P + L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 49/193 (25%), Positives = 75/193 (38%), Gaps = 34/193 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG G +G VYK L A+K S +L R F EA++L Q
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60
Query: 425 ----------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME GSL L + L K + + A + YL S + +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD--SSNQTLLAGSYGYIAPELAYTMVMTEK 529
HRD+++ N L+ ++DFG +R + + L + APE T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 530 YDVYSFGVVTLEV 542
DV+S+G++ E
Sbjct: 176 SDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 69/246 (28%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG GA+G V+ + G+V+A+K L + + I R E +L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 425 -----------MER---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
ME G L +L + + A+ + + AL +H
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARF--YIAELVLALDSVH---KLGF 122
Query: 471 VHRDISSNNILLNSKLEAFVADFGTA------------------------RLLHADSSNQ 506
+HRDI +NIL+++ +ADFG L+ Q
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 507 T-----LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP---RDLHSTLSSS 558
G+ YIAPE+ + D +S GV+ E+L G P L T +
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN-- 240
Query: 559 YDPKIM 564
KI+
Sbjct: 241 ---KII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 26/203 (12%)
Query: 370 KIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG 428
+I+ K IG G + VY+A L + + ALKK+ E + + E +L Q+
Sbjct: 5 QIEKK--IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 429 SLFRILHNDAEAVELDWA-------------------KRV----NIVKAMAHALAYLHHD 465
++ + L + E EL+ KR+ + K + + H
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
S V+HRDI N+ + + + D G R + ++ L G+ Y++PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP 548
K D++S G + E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 377 IGTGAYGSV---YKAQLPNGRVFALKKLNSPETEELAFIRSFR--------NEAQVL--- 422
IG+GA G V Y A L R A+KKL+ P + R++R N ++
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 423 -------SQMERGSLFRILH-NDAE-----AVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
S E ++ ++ DA +ELD + ++ M + +LH S
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
++HRD+ +NI++ S + DFG AR + Y Y APE+ M E
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKEN 205
Query: 530 YDVYSFGVVTLEVLMGK 546
D++S G + E++ G
Sbjct: 206 VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS----YGYIAPELAY 522
S +HRD+++ NILL+ + DFG AR ++ D + G ++APE +
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIF 254
Query: 523 TMVMTEKYDVYSFGVVTLEVL-MGKHP 548
V T + DV+SFGV+ E+ +G P
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
EL ++ ++I + +A + YL S VHRD+++ N L+ L + DFG +R +++
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172
Query: 502 DS----SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP 548
T+L ++ PE T + DV+S GVV E+ GK P
Sbjct: 173 TDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 55/217 (25%)
Query: 377 IGTGAYGSVYKAQLPNGRV-FALKKLNSP-------------ETEELAFIR--------- 413
I GAYG+VY + R FA+KK+N E + L F
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68
Query: 414 SF---RNEAQVLSQMERGSLFRILHN----DAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
SF R+ V+ +E G +L N + + +A+ V AL YLH
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV-------LALEYLH--- 118
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFG---------TARLL--HADSSNQTLL----AG 511
+ +VHRD+ +N+L+ S + DFG T L H + + L G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 512 SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ YIAPE+ + D ++ G++ E L+G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 27/144 (18%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---LFR 432
IG G YG+V+KA+ + ALK++ + +E + R E +L +++ + L+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 433 ILHNDA------EAVELDWAKRV---------NIVKA----MAHALAYLHHDCSPSVVHR 473
+LH+D E + D K IVK+ + LA+ H S +V+HR
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 474 DISSNNILLNSKLEAFVADFGTAR 497
D+ N+L+N E +ADFG AR
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 21/145 (14%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLF---RILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+ L F+ + N ++ + R +F R AE V AL YLH
Sbjct: 68 DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS---------------ALDYLH 112
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
S +V+RD+ N++L+ + DFG + D++ G+ Y+APE+
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
D + GVV E++ G+ P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 61/223 (27%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRN-------------EAQVL 422
+G G YG V KA G++ A+KK+ E + R E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKI--IEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 423 SQMERGSLFRIL----HND-----AEAVELDWAKRVN------------IVKAMAHALAY 461
++++ ++ ++ D + + D K V+ I+ + + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG------- 514
LH +HRD+S NI +NSK +ADFG AR + TL
Sbjct: 135 LH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 515 -------YIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
Y APEL ++ EKY D++S G + E+L GK
Sbjct: 192 SKVVTLWYRAPEL---LMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA-----DSSNQTLLA 510
A + +L S +HRD+++ N+L+ +ADFG AR +H ++N L
Sbjct: 142 ARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL-- 196
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
++APE + V T + DV+SFGV+ E+
Sbjct: 197 -PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD-----SSNQTLLAGSYGYIAPELA 521
S +HRD+++ NILL+ + DFG AR ++ D + L ++APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPESI 247
Query: 522 YTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ V T + DV+SFGV+ E+ +G P
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 412 IRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
+ F++ V+ M+ +L +++H +ELD + ++ M + +LH S ++
Sbjct: 95 LEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGII 145
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
HRD+ +NI++ S + DFG AR + + Y Y APE+ M E D
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGMGYKENVD 204
Query: 532 VYSFGVVTLEVLMG 545
++S G + E++ G
Sbjct: 205 IWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 383 GSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVE 442
GS QL N + AL +LN ++ I +++Q L+ ++++A
Sbjct: 203 GSRAAIQLEN-EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA---- 257
Query: 443 LDWAKRV------NIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496
DW R I+K + A+ Y+H ++HRDI NI LN + + DFGTA
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 497 RLLHADSSNQTLLAGSYGYI------APELAYTMVMTEKYDVYSFGVVTLEVL 543
+ A YG++ +PE+ E D++S G++ L++L
Sbjct: 315 MPFEKER-----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTG++G V A+ G +A+K L E ++ ++ E +L +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 425 --MERGSLFRILHNDAEAV-------ELDWAKRV-NIVKAMAHA---LA--YLHHDCSPS 469
+ ++ +L E V L A R N V HA LA YLH S
Sbjct: 86 SFQDENRVYFLL----EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKD 138
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPELAYTMVMTE 528
+++RD+ N+LL++K V DFG A+ + ++T L G+ Y+APE+ + +
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGK 194
Query: 529 KYDVYSFGVVTLEVLMGKHP 548
D ++ GV+ E + G P
Sbjct: 195 AVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 20/145 (13%)
Query: 407 EELAFIRSFRNEAQVLSQMERGSLF---RILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+ L F+ + N ++ + R +F R AE V AL YLH
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS---------------ALDYLH 112
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
+ +VV+RD+ N++L+ + DFG + D + G+ Y+APE+
Sbjct: 113 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
D + GVV E++ G+ P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNQTLLAG-SYGYIAPELAYTMVMTE 528
+HRD+++ N +L + VADFG ++ +++ D Q +A +IA E V T
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS 194
Query: 529 KYDVYSFGVVTLEVL-MGKHP 548
K DV++FGV E+ G+ P
Sbjct: 195 KSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 59/213 (27%)
Query: 377 IGTGAYGSVYKA-------QLPNGRVFALKKLNSPETEELAFIRS---FRNEAQVLSQ-- 424
+G G++G VY+ P RV A+K +N E A +R F NEA V+ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVN-----EAASMRERIEFLNEASVMKEFN 67
Query: 425 -----------------------MERGSL---FRILHNDAEAVEL----DWAKRVNIVKA 454
M RG L R L + E + K + +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+A +AYL+ + VHRD+++ N ++ + DFG R ++ + G G
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---GGKG 181
Query: 515 -----YIAPELAYTMVMTEKYDVYSFGVVTLEV 542
+++PE V T DV+SFGVV E+
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 4/99 (4%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508
+ I +++ A+ YLH + ++HRDI + NI +N + + DFG A ++N+
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 509 -LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
AG+ APEL D++S G+V E+
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 54/211 (25%)
Query: 377 IGTGAYGSV----YKAQLPNGRVFALKKLNS-------------PETEELAFIRS----- 414
IG GA+G V +K+ + +V+A+K L+ E + +AF S
Sbjct: 51 IGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 415 ----FRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
F+++ V+ M G L ++ N V WAK + AL +H S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYT--AEVVLALDAIH---S 160
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTAR------LLHADSSNQTLLAGSYGYIAPELA 521
++HRD+ +N+LL+ +ADFGT ++ D++ G+ YI+PE+
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----VGTPDYISPEVL 215
Query: 522 YTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+ Y D +S GV E+L+G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKL----NSPETE--------ELAFIRSFRNEAQV-- 421
+G GA+G VY GR A+K++ SPET E+ +++ +E V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 422 ---------------LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
+ M GS+ L + E + ++ + + ++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLH--- 123
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA---DSSNQTLLAGSYGYIAPELAYT 523
S +VHRDI NIL +S + DFG ++ L + + G+ +++PE+
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
K D++S G +E+L K P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-05
Identities = 22/59 (37%), Positives = 27/59 (45%)
Query: 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327
L LDLS N+ L L LDLS N L+ P + + L LDLS NN+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 58/241 (24%), Positives = 88/241 (36%), Gaps = 52/241 (21%)
Query: 377 IGTGAYGSVYKAQLPNGR---------VFALKKLNSPETE-----ELAFIRSFRNEAQV- 421
+G GA+G VY+ V L + S + E E + F ++ V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 422 --------------LSQMERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLH 463
L M G L L + E L + + +A YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 464 HDCSPSVVHRDISSNNILLNSKLE---AFVADFGTARLLHADS----SNQTLLAGSYGYI 516
+HRDI++ N LL K A +ADFG AR ++ S + +L ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML--PIKWM 188
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575
PE + T K DV+SFGV+ E+ +G P + ++M RL P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP------YPGRTNQEVMEFVTGGGRLDP 242
Query: 576 P 576
P
Sbjct: 243 P 243
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 48/197 (24%), Positives = 78/197 (39%), Gaps = 40/197 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSP--------ETEELAFIRSFRNEAQVLSQME- 426
IG G + V KAQ G+ +A+K + E+ +R +L +E
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 427 -----RGSLFRILH----NDAEAVE-----LDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
G L + N E ++ L + + + + +L ++H + + H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFH 123
Query: 473 RDISSNNILLNS---KLEAFVADFGTARLLHADSSNQ--TLLAGSYGYIAPELAYTM-VM 526
RDI NIL+ KL ADFG+ R ++ S T + Y APE T
Sbjct: 124 RDIKPENILIKDDILKL----ADFGSCRGIY---SKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 527 TEKYDVYSFGVVTLEVL 543
K D+++ G V E+L
Sbjct: 177 GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---LFR 432
+G G+Y +VYK NG++ ALK + S +TEE + R EA +L ++ + L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 433 ILHNDA------EAVELDWAKRV----------NIVKAM---AHALAYLHHDCSPSVVHR 473
I+H E + D A+ + N+ M LAY+H ++HR
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHR 127
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYDV 532
D+ N+L++ E +ADFG AR S + + Y P+ L + D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 533 YSFGVVTLEVLMGK 546
+ G + +E+L G+
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 43/204 (21%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL------------------------NSPETEELAF 411
+G G +G V Q+ G+++A KKL NS LA+
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 412 IRSFRNE-AQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
++ VL+ M G L ++N D + V + L LH +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA--GSYGYIAPELAYTMVMTE 528
V+RD+ NILL+ ++D G A + +T+ G+ GY+APE+ V E
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRVGTVGYMAPEV----VKNE 176
Query: 529 KY----DVYSFGVVTLEVLMGKHP 548
+Y D + G + E++ GK P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 377 IGTGAYGSVY----KAQLPNGRVFALKK-----LNSPETEELAFIRSFRNEAQVLSQMER 427
+G G++G+VY K + R+ LK+ LN ET + EAQ+LS+++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ------EAQLLSKLDH 61
Query: 428 GSLFRI----LHNDA--------EAVELDWAKRV-----------NIVKAMAHALAYLHH 464
++ + L DA E +LD + + L +H+
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
++HRD+ + NI L + L + DFG +RLL T G+ Y++PE
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 525 VMTEKYDVYSFGVVTLEVLMGKH 547
K D++S G + E+ H
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 36/148 (24%), Positives = 59/148 (39%), Gaps = 32/148 (21%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALK----KLNSPET----EELAFIRSFRNEAQVLSQME 426
+G G +GSVY A+ G + A+K K S E E+ +R ++ E
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 427 RGSLFRI---LHNDAEAVE--------------LDWAKRVNIVKAMAHALAYLHHDCSPS 469
+FR L+ E +E + +I+ + LA++H
Sbjct: 66 ---VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---G 119
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTAR 497
HRD+ N+L++ +ADFG AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 7/99 (7%)
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA--GSYGYIAPE 519
L H + VV+RD+ NILL+ ++D G A D S + A G++GY+APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165
Query: 520 -LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS 557
L + D +S G + ++L G P H T
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 3/91 (3%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
AL YLH S VV+RD+ N++L+ + DFG + +D + G+ Y+A
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
PE+ D + GVV E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL- 434
IG+GA G V A G+ A+KKL+ P R++R E ++ + ++ +L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 435 ----------------------HNDAEAV--ELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
N + + +LD + ++ M + +LH S +
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGI 139
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRD+ +NI++ S + DFG AR + Y Y APE+ M E
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV 198
Query: 531 DVYSFGVVTLEVLMGK 546
D++S G + E++ G
Sbjct: 199 DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 7/154 (4%)
Query: 398 LKKLNSPETEELAFIRSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA 454
LK+LN P + + SF + + VL + G L R++ + + L K V K
Sbjct: 56 LKQLNHPNV--IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKY 111
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
+ L H S V+HRDI N+ + + + D G R + ++ L G+
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y++PE + K D++S G + E+ + P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 33/123 (26%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 449 VNIVKAMAHALAYLHH----DCSPSVVHRDISSNNILLNSKLE----------------- 487
V+I + + HALAY H+ V+HRD+ NI L++ +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 488 AFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY--TMVMTEKYDVYSFGVVTLEVLMG 545
A + DFG ++ + +S + + Y Y +PEL T +K D+++ G + E+ G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 546 KHP 548
K P
Sbjct: 240 KTP 242
|
Length = 1021 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 37/162 (22%)
Query: 370 KIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKK-LNSPETE--------ELAFIRSF 415
SKY IG G +G V+KA+ ++ ALKK L E E E+ ++
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL 68
Query: 416 RNEAQV--------LSQME---RGSLFRIL----HNDA-----EAVELDWAKRVNIVKAM 455
++E V + +GS + + H+ A + V+ ++ ++K +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497
+ L Y+H ++HRD+ + NIL+ +ADFG AR
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 41/201 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN------SPET--EELAFIRSFRNEAQVLSQMER 427
+G G Y +VYK + G + ALK+++ +P T E++ ++ ++E V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV------ 61
Query: 428 GSLFRILHNDA------EAVELDWAKRVNI-----------VKAMAHAL----AYLHHDC 466
L ++H + E ++ D K ++ VK+ + L A+ H +
Sbjct: 62 -RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMV 525
V+HRD+ N+L+N + E +ADFG AR + + + Y AP+ L +
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 526 MTEKYDVYSFGVVTLEVLMGK 546
+ D++S G + E++ G+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 33/109 (30%), Positives = 49/109 (44%), Gaps = 13/109 (11%)
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
M AL LH + +V RD++ NNILL+ + + F + + A
Sbjct: 94 MVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE---AVENM 147
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK-----HPRDL--HSTLS 556
Y APE+ TE D +S G + E+L GK HP + H+TL+
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN 196
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 377 IGTGAYGSVYKAQLPNGR-VFALKKL-NSPETEE--------LAFIRSFRNEAQV-LSQM 425
+G GAYG V K + + + A+KK +S E EE L +R+ + E V L +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 426 --ERGSLFRILH----NDAEAVE-LDWAKRVNIVKAMAHALAYLHHDCSPS-VVHRDISS 477
RG L+ + N E +E + V++ + L H C + +VHRDI
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 478 NNILLNSKLEAFVADFGTAR-LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536
N+L++ + DFG AR L ++N T + Y +PEL + D++S G
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188
Query: 537 VVTLEVLMGK 546
+ E+ G+
Sbjct: 189 CILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 41/203 (20%)
Query: 377 IGTGAYGSVYKAQLPNG------RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL 430
+G G +G V+ A+ + +K L + E L FR E + ++ ++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNV 70
Query: 431 FRILHNDAEA------VE-LDW----------AKRVNIVK----------AMAHALAY-L 462
R+L EA +E D + +K A+ +A +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS---NQTLLAGSYGYIAPE 519
H + VHRD+++ N L++S+ E V+ ++ ++ L+ ++APE
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLAPE 188
Query: 520 LAYTMVMTEKYDVYSFGVVTLEV 542
+ K DV+SFGV+ EV
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
AL +LH +++RD+ +N+LL+++ + D+G + + G+ YIA
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
Query: 518 PELAYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDL 551
PE+ + E Y D ++ GV+ E++ G+ P D+
Sbjct: 165 PEI----LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 39/132 (29%), Positives = 58/132 (43%), Gaps = 16/132 (12%)
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
I + AL L H +HRD+ NNILL ++ + DFG + L + +
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 511 GSYGYIAPE-LAYTMVMTEKY----DVYSFGVVTLEVLMGKHP-RDLHSTLSSSYDPKIM 564
G+ ++APE +A + Y DV+S G+ +E+ G P DLH P
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH--------PMRA 237
Query: 565 LIDVLDQRLPPP 576
L + R PPP
Sbjct: 238 LFKI--PRNPPP 247
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 27/199 (13%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG G+Y V +L N +++A+K + + I + E V Q LH
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 436 N--DAEAVELDWAKRVNIVKAMAH---------------------ALAYLHHDCSPSVVH 472
+ + + VN M H AL +LH +++
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIY 119
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDV 532
RD+ +N+LL++ + D+G + + G+ YIAPE+ D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 533 YSFGVVTLEVLMGKHPRDL 551
++ GV+ E++ G+ P D+
Sbjct: 180 WALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 12/93 (12%)
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG-----YI 516
+ + +HRD+++ N+L+ L + +ADFG +R + + + G ++
Sbjct: 132 MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKTMGRLPVRWM 185
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
A E V T K DV+SFGV+ E++ +G P
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 26/91 (28%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
L YLH + +V+RD+ +N+LL+++ +ADFG + + G+ ++A
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
PE+ T D + GV+ E+L+G+ P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 57/216 (26%)
Query: 377 IGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL 430
+G +G VYK L + A+K L + E F++EA + S+++ ++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 431 FRIL------------------------------HNDAEAVE--------LDWAKRVNIV 452
+L H+D + + L+ A V+IV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 453 KAMAHALAYL--HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
+A + +L HH VVH+D+++ N+L+ KL ++D G R ++A + L+
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYA-ADYYKLMG 184
Query: 511 GSY---GYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
S +++PE + D++S+GVV EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 35/130 (26%), Positives = 58/130 (44%), Gaps = 11/130 (8%)
Query: 443 LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502
L A+ + + + A+ Y+H + ++HRDI + N+L+N + + DFG A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 503 SSNQTL--LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS--- 557
S +AG+ APE+ T D++S G+V E + H L S
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV--HTASLFSASRGDER 371
Query: 558 -SYDPKIMLI 566
YD +I+ I
Sbjct: 372 RPYDAQILRI 381
|
Length = 461 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA--GSYGYIAPE 519
L H + VV+RD+ NILL+ ++D G A D S + A G++GY+APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165
Query: 520 -LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554
L D +S G + ++L G P H T
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 35/202 (17%)
Query: 377 IGTGAYGSVYKAQLPNG---RVFALKKLNS-----PETEELAFIRSFRN------EAQVL 422
+G G YG VYKA+ +G + +ALK++ E+A +R ++ + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 423 SQMERGS--LFRILHNDA-EAVELDWAKRVN-----IVKAMAHALAY-----LHHDCSPS 469
S +R LF +D ++ A + N + ++M +L Y +H+ +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 470 VVHRDISSNNILL----NSKLEAFVADFGTARLLHA---DSSNQTLLAGSYGYIAPELAY 522
V+HRD+ NIL+ + +AD G ARL ++ ++ + ++ Y APEL
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 523 -TMVMTEKYDVYSFGVVTLEVL 543
T+ D+++ G + E+L
Sbjct: 189 GARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 54/213 (25%), Positives = 79/213 (37%), Gaps = 57/213 (26%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG G YG VYKA+ G++ ALKK EE + R E +L QM S++ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLL-QMLSESIYIVRL 66
Query: 436 NDAEAVELDWAKRV-----------------------------NIVKAMAHAL----AYL 462
D E VE K +K+ + L A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLLAGSYG------- 514
H V+HRD+ N+L++ + +AD G R ++ SY
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPVKSYTHEIVTLW 176
Query: 515 YIAPE--LAYTMVMTEKYDVYSFGVVTLEVLMG 545
Y APE L T T D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 29/146 (19%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK--LNS-----PET--EELAFIRSFRNEAQVLSQ-- 424
IG G YG VYK + G++ A+KK L S P T E++ ++ ++ V Q
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 425 -MERGSLFRILHNDAEAVELDWAKRVNIV---KAMAHAL--AYLHHD------C-SPSVV 471
M+ L+ I E + +D K ++ + + M L +YL+ C S V+
Sbjct: 68 LMQESRLYLIF----EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 472 HRDISSNNILLNSKLEAFVADFGTAR 497
HRD+ N+L+++K +ADFG AR
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 35/202 (17%)
Query: 377 IGTGAYGSVYKAQLPNG---RVFALKKLNS-----PETEELAFIRSFRN------EAQVL 422
+G G YG VYKA+ +G R +ALK++ E+A +R ++ + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 423 SQMERGS--LFRILHNDA-EAVELDWAKRVN-----IVKAMAHALAY-----LHHDCSPS 469
S +R LF +D ++ A + N + + M +L Y +H+ +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 470 VVHRDISSNNILL----NSKLEAFVADFGTARLLHA---DSSNQTLLAGSYGYIAPELAY 522
V+HRD+ NIL+ + +AD G ARL ++ ++ + ++ Y APEL
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 523 -TMVMTEKYDVYSFGVVTLEVL 543
T+ D+++ G + E+L
Sbjct: 189 GARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 28/144 (19%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---LFR 432
+G G+Y +VYK + G++ ALK++ E EE A + R EA +L ++ + L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 433 ILHNDA------EAVELDWAK---------RVNIVK----AMAHALAYLHHDCSPSVVHR 473
I+H E ++ D + ++ V+ + LAY H V+HR
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHR 127
Query: 474 DISSNNILLNSKLEAFVADFGTAR 497
D+ N+L++ + E +ADFG AR
Sbjct: 128 DLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 377 IGTGAYGSVYKAQLPNGR-VFALKKLNSPET---EELAF------IRSFRNEA------- 419
IG GA+G V + + R V+A+K L+ E + AF I +F N
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 420 ---------QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
V+ M G L ++ N V WA+ + AL +H S
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYT--AEVVLALDAIH---SMGF 163
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAYTMVMTEK 529
+HRD+ +N+LL+ +ADFGT ++ + + A G+ YI+PE+ +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 530 Y----DVYSFGVVTLEVLMGKHP 548
Y D +S GV E+L+G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG- 514
A + YL +HRD+++ NIL+ A +ADFG +R + + + G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172
Query: 515 ----YIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
++A E V T DV+S+GV+ E++ +G P
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 29/193 (15%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---LFR 432
+G G+Y +VYK + NG++ ALK + E E F + EA +L ++ + L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKHANIVLLHD 70
Query: 433 ILHNDA------EAVELDWAKRVN-------------IVKAMAHALAYLHHDCSPSVVHR 473
I+H E V D + ++ + + L+Y+H ++HR
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHR 127
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYDV 532
D+ N+L++ E +ADFG AR S + + Y P+ L + + D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 533 YSFGVVTLEVLMG 545
+ G + +E++ G
Sbjct: 188 WGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 377 IGTGAYGSVYKAQLP----NGRVFALKKLN-----SPETEEL----AFIRSF-------- 415
+G G +GSV +AQL + + A+K L S + EE A ++ F
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 416 -----RNEAQ--------VLSQMERGSLFRIL---HNDAEAVELDWAKRVNIVKAMAHAL 459
R+ A+ +L M+ G L L E L V + +A +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNQTLLAG-SYGYIA 517
YL S + +HRD+++ N +LN + VADFG ++ +++ D Q + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
E V T DV++FGV E++ G+ P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD----SSNQTLLAGSYGYIAPELAY 522
S + VHRD+++ N+LL + DFG AR + D S T L ++APE +
Sbjct: 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIF 312
Query: 523 TMVMTEKYDVYSFGVVTLEVL 543
+ T DV+S+G++ E+
Sbjct: 313 DNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 75/242 (30%)
Query: 372 DSKYCIGTGAYGSVYKAQLPN-GRVFALK---KLNSPETEELAFIR-------------- 413
+S IG GA+G V Q + G ++A+K K + E E++A IR
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV 63
Query: 414 -----SFRNEAQVLSQME---RGSLFRILHN----DAEAVELDWAKRVNIVKAMAHALAY 461
SF+++ + ME G + +L EA + A+ V + A+ H L +
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQLGF 122
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA-------------RLLHADSS---- 504
+HRDI +N+LL++K ++DFG L H S
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 505 --------------NQTLLA----GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
N+ LA G+ YIAPE+ + D +S GV+ E+L+G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 547 HP 548
P
Sbjct: 234 PP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 50/209 (23%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKL-------NSPETEELAFIRSFRN--EA---- 419
+G G YG V++ + G++FA+K L N +T A ++ RN EA
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDT---AHTKAERNILEAVKHP 60
Query: 420 ----------------QVLSQMERGSLFRILHNDAEAVEL-DWAK--RVNIVKAMAHALA 460
+L + G LF +H + E + + D A I A+ H
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLSEISLALEH--- 115
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR-LLHADSSNQTLLAGSYGYIAPE 519
LH +++RD+ NILL+++ + DFG + +H + T G+ Y+APE
Sbjct: 116 -LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPE 170
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ + D +S G + ++L G P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT---LL 509
+ + ++YLH S +VHRDI NIL +S + DFG ++ + + T +
Sbjct: 113 RQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
G+ +++PE+ K DV+S +E+L K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 44/199 (22%), Positives = 78/199 (39%), Gaps = 33/199 (16%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+G G +G V Q+ G+++A K+L ++ NE Q+L ++ + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS----QFVV 63
Query: 436 NDAEAVELDWA-------------------------KRVNIVKAMAHALAYLHHDCSPSV 470
N A A E A + + A L L +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 471 VHRDISSNNILLNSKLEAFVADFGTA-RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
V+RD+ NILL+ ++D G A ++ +S + G+ GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 530 YDVYSFGVVTLEVLMGKHP 548
D + G + E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 39/196 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------- 427
+G G +G V+K L + A+K +EL F +EA++L Q +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60
Query: 428 ----------------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
G L + EL + V A +AYL S + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADS---SNQTLLAGSYGYIAPE-LAYTMVMT 527
HRD+++ N L+ ++DFG +R D S+ L + APE L Y +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 528 EKYDVYSFGVVTLEVL 543
E DV+S+G++ E
Sbjct: 174 ES-DVWSYGILLWETF 188
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 22/60 (36%), Positives = 28/60 (46%)
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
NL + LS N L + L NL LD+ N+L P S L SL+ L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 26/82 (31%), Positives = 46/82 (56%), Gaps = 3/82 (3%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S ++V+RD+ N+LL+ + DFG A+++ D+ TL G+ YIAPE+ +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTL-CGTPEYIAPEILLNVGH 205
Query: 527 TEKYDVYSFGVVTLEVLMGKHP 548
+ D ++ G+ E+L+G P
Sbjct: 206 GKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NQTLLAGSYGYIAPELAY 522
S + VHRD+++ N+L+ + DFG AR + DS+ T L ++APE +
Sbjct: 257 SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIF 314
Query: 523 TMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ T DV+SFG++ E+ +G P
Sbjct: 315 NNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 377 IGTGAYGSVYKAQLPN--------GRVFALKKLN--SPETEELAFIRS------------ 414
+G+GA+G VY+ + RV A+K L + + E+ F++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 415 -------FRNEAQ--VLSQMERGSLFRILHNDAEAVE-----LDWAKRVNIVKAMAHALA 460
NE Q ++ ME G L L DA L + ++I +A
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLR-DARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAF-----VADFGTARLLHADSSNQTLLAG--SY 513
YL +HRD+++ N L++ K + DFG AR ++ + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTL 555
++APE T + DV+SFGV+ E+L +G+ P +
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 75/242 (30%)
Query: 372 DSKYCIGTGAYGSVYKAQLPN-GRVFALK---KLNSPETEELAFIRSFRN---EAQVL-- 422
+S IG GA+G V Q + G V+A+K K + E E++ IR+ R+ EA L
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV 63
Query: 423 -----SQMERGSLFRILH-------------NDA---EAVELDWAKRVNIVKAMAHALAY 461
S ++ +L+ I+ D E + A+ V + ++ H L +
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQLGF 122
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA-------------RLLHADSSNQTL 508
+HRDI +N+LL+SK ++DFG L H+ S+ T
Sbjct: 123 ---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 509 ----------------------LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
G+ YIAPE+ + D +S GV+ E+L+G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 547 HP 548
P
Sbjct: 234 PP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 23/107 (21%)
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508
+++ +A + YL S + VHRD+++ N L+ L +ADFG +R L
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR---------NL 188
Query: 509 LAGSYGYIAPE-------LAYTMVMTEKY----DVYSFGVVTLEVLM 544
AG Y I +A+ ++ K+ DV++FGV E+LM
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 7/60 (11%)
Query: 156 KLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL 208
L+ LDLS+NRL L NL + LS N L + P+ L +L LD+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 24/152 (15%)
Query: 403 SPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
+P L F+R R +E F I ++ A L + ++ +A + YL
Sbjct: 90 APHGNLLDFLRKSR-------VLETDPAFAIANSTAST--LSSQQLLHFAADVARGMDYL 140
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG-----YIA 517
+HRD+++ NIL+ A +ADFG +R + + + G ++A
Sbjct: 141 SQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWMA 191
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
E V T DV+S+GV+ E++ +G P
Sbjct: 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 14/114 (12%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---QTLLAGSYG 514
AL +H ++HRD+ S NI L + DFG ++ ++DS + + G+
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPY 236
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP------RD-LHSTLSSSYDP 561
Y+APEL ++K D++S GV+ E+L P R+ + L YDP
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
|
Length = 478 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS----YGYIAPELAYTMVM 526
VHRD+++ N L+ +ADFG +R L+ SS+ + G ++A E
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKF 209
Query: 527 TEKYDVYSFGVVTLEVLM 544
T K DV++FGV E+L
Sbjct: 210 TTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 171 LTNLNYMSL--SRNMLGGLLPQEIGNLK---NLIELDVGDNSLIGPIPLTLSRLTSLKIL 225
LT L + L S+N+ +EI +L NL L + D S + +P ++ L L+ L
Sbjct: 633 LTGLRNIDLRGSKNL------KEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686
Query: 226 ILAQ-NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
+++ L LP I NLK+L L++ + S + +++S+LDL P
Sbjct: 687 DMSRCENLEILPTGI-NLKSLYRLNLSG---CSRLKSFPDISTNISWLDLDETAI-EEFP 741
Query: 285 NELTRLTQLFHL---DLSSNKLSGKIPSQIASME----DLTWLDLSNNNIKGSIPGEITK 337
+ L RL L L ++ S KL ++ M LT L LS+ +P I
Sbjct: 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN 800
Query: 338 LSRLDYLNL 346
L +L++L +
Sbjct: 801 LHKLEHLEI 809
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 51/209 (24%)
Query: 377 IGTGAYGSVYKAQL-------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G G++G VY+ RV A+K +N E+ L F NEA V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVN--ESASLRERIEFLNEASVMKGFTCHH 70
Query: 425 --------------------MERG---SLFRILHNDAE----AVELDWAKRVNIVKAMAH 457
M G S R L +AE + + + +A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD----SSNQTLLAGSY 513
+AYL+ + VHRD+++ N ++ + DFG R ++ + LL +
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEV 542
+APE V T D++SFGVV E+
Sbjct: 188 --MAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 63/221 (28%)
Query: 377 IGTGAYGSVYKAQLPN---GRVF---ALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL 430
IG GA+G V++A+ P F A+K L E F+ EA ++++ + ++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHPNI 70
Query: 431 FRIL--------------------------HNDAEAVE------------------LDWA 446
++L H A L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH-AD--- 502
+++ I K +A +AYL VHRD+++ N L+ + +ADFG +R ++ AD
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 503 -SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEV 542
S N + ++ PE + T + DV+++GVV E+
Sbjct: 188 ASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLA---GSYG 514
L Y+H S +V+HRD+ N+ +N++ L + DFG AR++ S++ L+ +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 515 YIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGK 546
Y +P L + T+ D+++ G + E+L GK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 12/128 (9%)
Query: 420 QVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNN 479
Q LSQ E S F +N + N++ + + + S + VHRD+++ N
Sbjct: 106 QFLSQREIESTFTHANN------IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159
Query: 480 ILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSF 535
L+ + +ADFG +R L+ S + + G +A+ ++ K+ DV++F
Sbjct: 160 CLVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 536 GVVTLEVL 543
GV E+
Sbjct: 218 GVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---LAGSYGYIAPELAYT 523
S VHRD+++ N+L+ S+ + + DFG + + D T+ L + APE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 524 MVMTEKYDVYSFGVVTLEVL 543
DV+SFGV E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 443 LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502
LD ++I +A + YL S VH+D+++ NIL+ +L ++D G +R +++
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 503 S----SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
++LL ++ PE + D++SFGVV E+
Sbjct: 178 DYYRVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 602 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.98 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.91 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.86 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.8 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.76 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.69 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.68 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.62 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.38 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.38 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.34 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.29 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.29 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.28 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.27 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.89 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.76 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.43 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.43 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.36 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.31 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.26 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.26 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.07 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-60 Score=563.50 Aligned_cols=210 Identities=30% Similarity=0.472 Sum_probs=154.6
Q ss_pred cccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hhhhc
Q 047576 374 KYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQMER 427 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~l~~ 427 (602)
...+|+|+||.||+|+. .++..||||++....... .+|++++ ||+++
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 34689999999999986 578999999986443211 1234444 55555
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|.++++ .++|.++.+|+.|+|+|++|+|+.++++|+||||||+||+++.++.+++. ||.+.....+ .
T Consensus 768 g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~ 836 (968)
T PLN00113 768 KNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----T 836 (968)
T ss_pred CcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----C
Confidence 55555553 27899999999999999999998778899999999999999999888875 6655433221 1
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccccc-------CCCcccchhhhhccCCCCCCChh
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS-------SYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
...+++.|+|||++.+..++.++|||||||++|||+||+.||+....... ..........++|+.+......
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 915 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV- 915 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc-
Confidence 23678999999999999999999999999999999999999964221110 0011222345566666433221
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+++.++.+++.+||+.||++
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchh
Confidence 1346677999999999999975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=342.14 Aligned_cols=230 Identities=38% Similarity=0.637 Sum_probs=187.6
Q ss_pred CCccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
+|++|+..+.+|+|+||.||+|..++|+.||||++....... .++|.+|++++
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 488999999999999999999999999999999887654321 34599999987
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
|||++|+|.+.++..... +++|.+|++||.++|+||+|||+.+.+.||||||||+|||+|+++.+||+|||+|+...
T Consensus 150 VYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 566677777777664333 78999999999999999999999888899999999999999999999999999997654
Q ss_pred C-CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc--------cCCCcccchhhhhcc
Q 047576 501 A-DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS--------SSYDPKIMLIDVLDQ 571 (602)
Q Consensus 501 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~~d~ 571 (602)
. .........||.+|+|||+...+..+.|+|||||||+|+|++||+.|.+...+.. .....+..+.+++|+
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 4 3222211179999999999999999999999999999999999999987543111 112223368999999
Q ss_pred CCC-CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLP-PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++. ..+.. .+++.+++++|.+|++.+|++
T Consensus 309 ~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~ 338 (361)
T KOG1187|consen 309 RLKEGEYPD--EKEVKKLAELALRCLRPDPKE 338 (361)
T ss_pred CccCCCCCh--HHHHHHHHHHHHHHcCcCCCc
Confidence 987 44432 157888999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=309.04 Aligned_cols=219 Identities=25% Similarity=0.404 Sum_probs=175.1
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
..++|+..+.||+|+||+||.++.. +++.+|+|++++.........+...+|..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4678999999999999999999864 6899999999988776655667788899888
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+|+.+|.|+..+.. ...+++..++.|+.+|+.||.||| +++||||||||+|||+|.+|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 44555555555543 345899999999999999999999 8999999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.++......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...+ .......+....++.+..-
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~~~~p~~- 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKLPLPPGY- 248 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcCCCCCcc-
Confidence 55556666899999999999999999999999999999999999999998532 1223344444443322110
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
-.....+++.+-+++||++
T Consensus 249 ---ls~~ardll~~LL~rdp~~ 267 (357)
T KOG0598|consen 249 ---LSEEARDLLKKLLKRDPRQ 267 (357)
T ss_pred ---CCHHHHHHHHHHhccCHHH
Confidence 1122567777888888863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.78 Aligned_cols=220 Identities=26% Similarity=0.415 Sum_probs=175.6
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.+++....||+|..|+||+++++ +++.+|+|++..... ....+++.+|++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~--~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID--PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 35666788999999999999875 788999999943322 23456777788766
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|||++|+|.+++... +++++...-+|+.++++||.|||+ +++||||||||+|||++..|++||||||.++.+..
T Consensus 157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 899999999988753 458999999999999999999995 48999999999999999999999999999988765
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ .....-.-+..+++...+...+.
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~Iv~~ppP~lP~~-- 305 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCAIVDEPPPRLPEG-- 305 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHHHhcCCCCCCCcc--
Confidence 4 44557899999999999999999999999999999999999999975411 11111233455666433322221
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....++.+++..|+++||.+
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSE 325 (364)
T ss_pred -cCCHHHHHHHHHHhcCCccc
Confidence 24455889999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.61 Aligned_cols=219 Identities=32% Similarity=0.519 Sum_probs=173.3
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
..+.....+|+|+||+||+|.+.....||||++...+..... .+.|.+|+.++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 344555669999999999999954444999999877655443 77899999988
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC-eEEeCCCCCCeeeCCCC-cceeeccccccccc
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS-VVHRDISSNNILLNSKL-EAFVADFGTARLLH 500 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~ 500 (602)
||+++|+|.++++.. ....+++..++++|.|||+|+.||| +.+ ||||||||+|||++.++ .+||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 666777777777653 3456999999999999999999999 667 99999999999999997 99999999998876
Q ss_pred CCCCCccccccccccccccccc--cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAY--TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
......+...||+.|||||++. ...++.|+||||||+++|||+||+.||..... ......++....+++.+
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIP 268 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCC
Confidence 5333334468999999999999 56899999999999999999999999986432 22223444344443333
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. +...+..++.+||+.||++
T Consensus 269 ~~---~~~~l~~l~~~CW~~dp~~ 289 (362)
T KOG0192|consen 269 KE---CPPHLSSLMERCWLVDPSR 289 (362)
T ss_pred cc---CCHHHHHHHHHhCCCCCCc
Confidence 22 5556888999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.18 Aligned_cols=230 Identities=24% Similarity=0.350 Sum_probs=177.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccch-------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEA------- 440 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~~------- 440 (602)
++|+....+|+|+||.||+++.+ +|+.||||++...+... ...+-..+|+.+++++.|.+|..+++.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~-~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP-VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH-HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 35677778999999999999986 59999999997665432 2334567899999999999999877532211
Q ss_pred ---------------hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 441 ---------------VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 441 ---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
..++...+++|..|+++|+.|+| +.++|||||||+|||++.++.+||||||+|+.+..++..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 12577888999999999999999 889999999999999999999999999999998866667
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccc-------hhhhhcc------
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM-------LIDVLDQ------ 571 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~~~~~d~------ 571 (602)
.+..+.|..|+|||.+.+ .+|+..+||||.||++.||++|.+-|.+.++..+-+..... -.+++..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 777889999999999988 67999999999999999999999999876654321111000 0111111
Q ss_pred -CCC-----CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 -RLP-----PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 -~l~-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++| .+..+........+++++..|++.||++
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~ 274 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDD 274 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccc
Confidence 112 2222222223345899999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=282.80 Aligned_cols=223 Identities=23% Similarity=0.310 Sum_probs=168.9
Q ss_pred CccccCcccccccccccceeee-cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc---------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF--------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~--------------- 431 (602)
..+|.+.+.||+|.||+||+++ ..+|..||.|.++-... +....+...+|+.+++++.|+++.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4578999999999999999997 56899999999873322 223445566677766555555544
Q ss_pred ------------cccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 432 ------------RILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 432 ------------~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
.++... ...+.+++.++.+++.|+++||.++|.. -+. |+||||||.||++|.+|.|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhH
Confidence 444332 2345589999999999999999999942 144 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
+.+..........+|||.||+||.+.+.+|+.|+||||+||++|||..-++||.+..-. .-. ..+-....++-
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~----~L~---~KI~qgd~~~~ 248 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL----SLC---KKIEQGDYPPL 248 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH----HHH---HHHHcCCCCCC
Confidence 99987766677789999999999999999999999999999999999999999863110 001 11111222212
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.. ....+.+++..|+..||+.
T Consensus 249 p~~~---YS~~l~~li~~ci~vd~~~ 271 (375)
T KOG0591|consen 249 PDEH---YSTDLRELINMCIAVDPEQ 271 (375)
T ss_pred cHHH---hhhHHHHHHHHHccCCccc
Confidence 1121 3344778889999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.94 Aligned_cols=219 Identities=22% Similarity=0.348 Sum_probs=178.9
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|...++||+|||+.||+++. ..|+.||+|++.+.........+...+|++|...+.|+++.++.+..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 78999999999887666666778899999999999999988876532
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
...+++++.+++.++.||+.|+.||| +.+|+|||||..|+++++++++||+|||+|..+..+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 12456899999999999999999999 889999999999999999999999999999999877666
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
....+|||.|+|||++....++..+||||+|||||-|++|++||+... -++.+..+.......|.. -.
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y~~P~~-----ls 242 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEYSMPSH-----LS 242 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCcccccc-----cC
Confidence 666899999999999999999999999999999999999999998421 111222222222222211 11
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
.+-.+++..-+++||.+
T Consensus 243 ~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHHHHHHHHHhcCCccc
Confidence 22457777778888864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.47 Aligned_cols=216 Identities=22% Similarity=0.377 Sum_probs=172.7
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
...+|...+.+|+|+|++||+|+. +.+++||||++.+.-.-....++....|-.+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 357899999999999999999985 47899999999876654444455555666655
Q ss_pred ---HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 423 ---SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 423 ---~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
+|.++|+|.++++.. +.|++...+.+|.+|+.||+||| ++|||||||||+|||+|+||++||.|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 667778888887753 45899999999999999999999 899999999999999999999999999999988
Q ss_pred cCCCC-----------Cc--cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchh
Q 047576 500 HADSS-----------NQ--TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 500 ~~~~~-----------~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
..... .. ..++||..|.+||++.+...++.+|+|+||||+|+|+.|++||....++ ..+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFq 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQ 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHH
Confidence 54211 11 3478999999999999999999999999999999999999999864332 2234
Q ss_pred hhhcc--CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQ--RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~--~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.|++- .+++.++ +...+|+.+-+..||++
T Consensus 298 kI~~l~y~fp~~fp-------~~a~dLv~KLLv~dp~~ 328 (604)
T KOG0592|consen 298 KIQALDYEFPEGFP-------EDARDLIKKLLVRDPSD 328 (604)
T ss_pred HHHHhcccCCCCCC-------HHHHHHHHHHHccCccc
Confidence 44443 3444443 23667777888888864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=292.52 Aligned_cols=177 Identities=29% Similarity=0.449 Sum_probs=149.7
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
...+|.....||+|+||+||+|++. ++..||||.+.+.... ...++....|+.++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3467888888999999999999975 6899999999766421 22445667788777
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC------Ccceeeccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK------LEAFVADFG 494 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~------~~~kL~DFG 494 (602)
||+.+|+|..+++.. ..+++.+++.++.|+|.|+++|| +++||||||||.|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 677777777777653 35899999999999999999999 8999999999999999764 457999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
+|+.+... ......+|++.|||||++...+|+.|+|+||.|+++|++++|+.||+.
T Consensus 161 fAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998743 344557999999999999999999999999999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=278.19 Aligned_cols=191 Identities=25% Similarity=0.393 Sum_probs=165.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|+....||.|+||.|.+++.+ +|..+|+|++.+.......+++...+|..++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 468899999999999999999865 6889999999988877777777888888877
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|+++|.++.+++. .+++++..++.||.||+.|++||| +.+|++||+||+|||+|.+|.+||.|||+|+....
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 66777888888775 345999999999999999999999 89999999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
. ....+|||.|+|||.++..++..++|+|||||++|||+.|.+||...++ ......++...+.
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK 259 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc
Confidence 3 3457999999999999999999999999999999999999999975433 4445666766665
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=298.89 Aligned_cols=216 Identities=20% Similarity=0.319 Sum_probs=176.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|.....||+|+||+|+++..+ +++.+|||++++...-....++....|..|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 568889999999999999999875 6889999999988765445566667777766
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+.+|++..+.+ ...|++..++.||+.|+.||+||| +++|||||||.+|||+|.+|++||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 7777788544443 345999999999999999999999 8899999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.....++..+|||.|||||++.+..|+.++|+|||||+||||++|+.||.+ .++++.+..++......|. .
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-------ddEee~FdsI~~d~~~yP~--~ 590 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-------DDEEEVFDSIVNDEVRYPR--F 590 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHhcCCCCCCC--c
Confidence 444556678999999999999999999999999999999999999999984 3345555666555544332 2
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+.|+.+-+.++|++
T Consensus 591 ---ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 591 ---LSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred ---ccHHHHHHHHHHhccCccc
Confidence 3334677778888888864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.31 Aligned_cols=218 Identities=27% Similarity=0.438 Sum_probs=166.8
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH------------------------hh
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------QM 425 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------~l 425 (602)
.+...+.||+|.||+||+|++. ..||||+++-..... +..+.|++|+.+++ ++
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeecccc--cceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhc
Confidence 3445678999999999999984 459999997655443 36789999999883 44
Q ss_pred hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC--CC
Q 047576 426 ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA--DS 503 (602)
Q Consensus 426 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~--~~ 503 (602)
++-+|+.++|.. ...|+..+.+.||+|||+|+.||| .++|||||||..||++.+++.|||+|||++..... ..
T Consensus 470 eGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 470 EGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred cCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 566677777753 355899999999999999999999 99999999999999999999999999999875432 22
Q ss_pred CCcccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 504 SNQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.......|...|||||+++. .+|++.+||||||+|+|||+||..||.. +.. ++.+-.+-...+.+.....
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~------dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNR------DQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CCh------hheEEEecccccCccchhh
Confidence 23344578899999999863 4689999999999999999999999973 211 1111122222222222233
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+..+|.+|+..||.++|+|
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~e 639 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREE 639 (678)
T ss_pred hccCHHHHHHHHHHHHhcCccc
Confidence 3456777999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.51 Aligned_cols=218 Identities=22% Similarity=0.312 Sum_probs=172.8
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
..++|+....||+|+||+||+|+-+ +|..+|+|++++..-.....++..+.|..+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999854 6999999999988777667777888888876
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||++||++..+|.. ...|++..++.|+.+++.|++.+| ..|+|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 88899999888875 345899999999999999999999 8899999999999999999999999999985331
Q ss_pred C----------------------CCCC-------------------------ccccccccccccccccccCcCCccchhH
Q 047576 501 A----------------------DSSN-------------------------QTLLAGSYGYIAPELAYTMVMTEKYDVY 533 (602)
Q Consensus 501 ~----------------------~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 533 (602)
. +... ....+|||.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0124699999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC--CCCCCChhhHHHHHHHHHHHhhccCcCCC
Q 047576 534 SFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR--LPPPVDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 534 SlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~--l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
|+|||||||++|.+||....+ .+....++.-+ +..|.... ...+..+++.+|+. ||+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp-------~~T~rkI~nwr~~l~fP~~~~---~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETP-------QETYRKIVNWRETLKFPEEVD---LSDEAKDLITRLLC-DPE 431 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhhhccCCCcCc---ccHHHHHHHHHHhc-CHH
Confidence 999999999999999985433 22333343333 44333322 22446678878776 664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.09 Aligned_cols=218 Identities=25% Similarity=0.396 Sum_probs=174.3
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|-..+.+|+|+||.||+|+.+ +.+.||+|.+.+....+ ...+.+++|++|+..++|+++.++++...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 46778899999999999999875 68899999987655432 34677899999999898888887765421
Q ss_pred ------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 439 ------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 439 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
....++++.+..|+.++..||.||| +.+|+|||+||.|||+++.+.+|+||||+|+.+.......
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 2344889999999999999999999 8999999999999999999999999999999998777777
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
+...|||.|||||+..+.+|+..+|+||+||++||+.+|++||....- -+-...|.....++|. ....
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d~v~~p~-----~~S~ 225 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKDPVKPPS-----TASS 225 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcCCCCCcc-----cccH
Confidence 778999999999999999999999999999999999999999963210 0001112211112221 2334
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+..+...-+++||.+
T Consensus 226 ~f~nfl~gLL~kdP~~ 241 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQ 241 (808)
T ss_pred HHHHHHHHHhhcChhh
Confidence 4777777888888863
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=278.18 Aligned_cols=216 Identities=27% Similarity=0.416 Sum_probs=169.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHH-------------------------H
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQ-------------------------V 421 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~-------------------------i 421 (602)
...|...++||+|+||.||+|.. ..++.||+|++.-..... .+...++|+. +
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45677789999999999999986 468899999997554331 2233444444 3
Q ss_pred HHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 422 LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 422 l~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|+|+.+|++.+.+.... .+++.+...|+++++.|+.|+| ..+.+|||||+.||++..+|.+||+|||.+..+..
T Consensus 90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 48888999988887532 3477788889999999999999 88999999999999999999999999999988876
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.......++||+.|||||++.+..|+.|+||||+|++.+||.+|.+||....+++-.+. +-..-+|..+.
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl--------Ipk~~PP~L~~-- 233 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL--------IPKSAPPRLDG-- 233 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe--------ccCCCCCcccc--
Confidence 55555668999999999999988999999999999999999999999986655332211 11222222222
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++..|+++||+.
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~ 253 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEF 253 (467)
T ss_pred -ccCHHHHHHHHHHhhcCccc
Confidence 13333788999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=288.27 Aligned_cols=214 Identities=26% Similarity=0.402 Sum_probs=171.4
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hh
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQ 424 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~ 424 (602)
.+...+.||+|-||+||.|++.....||+|.++..... .+.|.+|+++| ||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 45566789999999999999977779999999876433 35677899988 77
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
|++|+|.++|.. ..+..+...+.+.++.|||+|++||+ ++++|||||-++||||+++..+||+|||+|+....+..
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 888888888876 33455888999999999999999999 89999999999999999999999999999996655443
Q ss_pred Cccc-cccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 NQTL-LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
..+. ..-...|.|||.+..+.++.|+|||||||+||||+| |+.||.... . ....+.++.-.+-|.+.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n-~ev~~~le~GyRlp~P~--- 427 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------N-EEVLELLERGYRLPRPE--- 427 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------H-HHHHHHHhccCcCCCCC---
Confidence 3221 123467999999999999999999999999999999 888987422 1 12234444433333222
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.++..+.+++..||+.+|++
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~ 447 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPED 447 (468)
T ss_pred CCCHHHHHHHHHHhhCCccc
Confidence 37788999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=278.82 Aligned_cols=216 Identities=26% Similarity=0.427 Sum_probs=160.9
Q ss_pred ccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.++...+.+|+|+||.||++...+ |+..|||......... .+.+.+|+.++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 457788999999999999998754 8999999987663321 45566777766
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLL 499 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~a~~~ 499 (602)
||+++|+|.+++...+. .+++..++.+++||++||+||| +++||||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 55666666666655332 5899999999999999999999 899999999999999999 799999999999877
Q ss_pred cCC---CCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh-ccCCC
Q 047576 500 HAD---SSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL-DQRLP 574 (602)
Q Consensus 500 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-d~~l~ 574 (602)
... ........||+.|||||++..+ ....++||||+||++.||+||+.||... ......+..+. +...|
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP 242 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC
Confidence 631 1123346899999999999853 3445999999999999999999999852 11111111121 22112
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+. -.....+++.+|+++||++
T Consensus 243 -~ip~~---ls~~a~~Fl~~C~~~~p~~ 266 (313)
T KOG0198|consen 243 -EIPDS---LSDEAKDFLRKCFKRDPEK 266 (313)
T ss_pred -CCCcc---cCHHHHHHHHHHhhcCccc
Confidence 22221 2223678888999999964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=272.94 Aligned_cols=223 Identities=26% Similarity=0.385 Sum_probs=168.6
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-----------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG----------------- 428 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g----------------- 428 (602)
....|...+.||.|..++||+|+. +.+..||||++....... ..+.+++|++.+..+.|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 457899999999999999999974 678999999998776653 367889999988555554
Q ss_pred --------ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 429 --------SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 429 --------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++.+++..... ..+++..+..|.+++++||.||| .+|.||||||+.||||+.+|.|||+|||.+..+-
T Consensus 102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 44444443222 22889999999999999999999 8899999999999999999999999999988775
Q ss_pred CCCCCc----ccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 501 ADSSNQ----TLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 501 ~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
..+... ...+|+++|||||++.. ..|+.|+||||||++..|+.+|..||....++ +++..-+....+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCC
Confidence 433221 34589999999999543 35999999999999999999999999865443 222222222221
Q ss_pred -----CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 -----PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 -----~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+...--..+.+++..|+++||++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~k 283 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSK 283 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCccc
Confidence 0011111222335888999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=283.85 Aligned_cols=216 Identities=25% Similarity=0.375 Sum_probs=171.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
...|+....+|+|+.|.||.|+. .+++.||||++....... .+-+.+|+.+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 34688888999999999999974 578999999997655431 23344566555
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|||++|+|.+++.. ..+++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 78888888877754 33899999999999999999999 89999999999999999999999999999998877
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
........+||++|||||+.....|++|+||||||+|.+||+-|++||=...+.+.-+. +..--.+.+..+.
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL----Ia~ng~P~lk~~~---- 493 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGTPKLKNPE---- 493 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH----HhhcCCCCcCCcc----
Confidence 76666778999999999999999999999999999999999999999864433322111 1222223333221
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.-...+.++..+|++.||++
T Consensus 494 -klS~~~kdFL~~cL~~dv~~ 513 (550)
T KOG0578|consen 494 -KLSPELKDFLDRCLVVDVEQ 513 (550)
T ss_pred -ccCHHHHHHHHHHhhcchhc
Confidence 13344888999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=278.02 Aligned_cols=220 Identities=25% Similarity=0.320 Sum_probs=165.0
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH----HHHhhhhHhHHHHHHhhhcCcc-------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE----LAFIRSFRNEAQVLSQMERGSL------------- 430 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~~E~~il~~l~~gsL------------- 430 (602)
+.|-..+.||+|+||.|-+|.. .+|+.||||++.+..... .......++|++||+.+.|+.+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4567788999999999999975 589999999998664432 1122335689999955555554
Q ss_pred ------------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC---Ccceeecccc
Q 047576 431 ------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK---LEAFVADFGT 495 (602)
Q Consensus 431 ------------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFG~ 495 (602)
++.+-. .+.+.+...+.+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 444332 233677788999999999999999 8999999999999999765 7799999999
Q ss_pred cccccCCCCCccccccccccccccccccCcC---CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVM---TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
|+..+.. ......+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||... +........+...+
T Consensus 326 AK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~------~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 326 AKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE------YTDPSLKEQILKGR 398 (475)
T ss_pred hhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc------cCCccHHHHHhcCc
Confidence 9988643 34455799999999999987653 34789999999999999999999742 22222334555555
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..... ..+.+-.++..+++.+.++.||++
T Consensus 399 y~f~p-~~w~~Iseea~dlI~~mL~VdP~~ 427 (475)
T KOG0615|consen 399 YAFGP-LQWDRISEEALDLINWMLVVDPEN 427 (475)
T ss_pred ccccC-hhhhhhhHHHHHHHHHhhEeCccc
Confidence 54221 122334556889999999999974
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=282.78 Aligned_cols=215 Identities=21% Similarity=0.330 Sum_probs=161.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
+|.....||+|+||.||+|+.. +++.||+|++.+.........+.+..|..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999865 5789999998754332222233444455444
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|...+.. ...+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 55666666665543 234788999999999999999999 889999999999999999999999999998765433
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.+.....+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~p~~---- 223 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVAYPKS---- 223 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCc----
Confidence 3333446789999999999999999999999999999999999999975321 22223333333332211
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 224 -~s~~~~~li~~~l~~~p~~ 242 (323)
T cd05616 224 -MSKEAVAICKGLMTKHPGK 242 (323)
T ss_pred -CCHHHHHHHHHHcccCHHh
Confidence 2234788999999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=277.83 Aligned_cols=219 Identities=22% Similarity=0.279 Sum_probs=160.1
Q ss_pred ccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh------------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM------------------------ 425 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l------------------------ 425 (602)
|+..+.||+|+||.||+|.. .+|+.||+|.+.............+.+|+.++..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 47899999998765443333445677888888444
Q ss_pred -hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 426 -ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 426 -~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
++|+|...+... ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 444444433221 1224788999999999999999999 8899999999999999999999999999998754322
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........+.+.... +... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~--~~~~---~ 228 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQEE--YSEK---F 228 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccccc--CCcc---C
Confidence 2233568999999999999999999999999999999999999997532210 000001111111111 1111 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+||+.||++
T Consensus 229 s~~~~~li~~~l~~~P~~ 246 (285)
T cd05631 229 SEDAKSICRMLLTKNPKE 246 (285)
T ss_pred CHHHHHHHHHHhhcCHHH
Confidence 234788999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=281.42 Aligned_cols=215 Identities=21% Similarity=0.328 Sum_probs=160.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
+|...+.||+|+||.||+|+.. +++.||+|++...........+.+..|..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999865 5789999998754332223345566666655
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|.+.+.. ...+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 44555666555543 234788999999999999999999 889999999999999999999999999998754332
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.+.....+. .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~~~~--~-- 223 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVSYPK--S-- 223 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCC--C--
Confidence 2333345799999999999999999999999999999999999999974321 1222333333322111 1
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 224 -~~~~~~~li~~~l~~~P~~ 242 (324)
T cd05587 224 -LSKEAVSICKGLLTKHPAK 242 (324)
T ss_pred -CCHHHHHHHHHHhhcCHHH
Confidence 1223778999999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=280.29 Aligned_cols=215 Identities=20% Similarity=0.335 Sum_probs=162.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
+|+....||+|+||.||+|+.. +|+.||+|++...........+.+..|..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 6889999998754332222334455555544
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 55666666665543 234889999999999999999999 889999999999999999999999999998765433
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~~p~~---- 223 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVSYPKS---- 223 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcc----
Confidence 3333345689999999999988899999999999999999999999975321 22223333333322211
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 224 -~~~~~~~li~~~l~~~p~~ 242 (323)
T cd05615 224 -LSKEAVSICKGLMTKHPSK 242 (323)
T ss_pred -CCHHHHHHHHHHcccCHhh
Confidence 1234778999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=281.16 Aligned_cols=210 Identities=22% Similarity=0.284 Sum_probs=157.2
Q ss_pred ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------------
Q 047576 375 YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------------- 432 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------------- 432 (602)
+.||+|+||.||+|+. .+|+.||+|+++............+.+|+.++..+.|+++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999986 478999999987654333334456778888885555554443
Q ss_pred ----ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 433 ----ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 433 ----~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.+.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 3322 234788999999999999999999 889999999999999999999999999998764333333344
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+. . ....+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~--~---~~~~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPR--T---LSPEA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCCCCC--C---CCHHH
Confidence 5799999999999999999999999999999999999999964321 1111222222222111 1 12337
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|+++||++
T Consensus 223 ~~li~~~L~~dP~~ 236 (323)
T cd05571 223 KSLLAGLLKKDPKQ 236 (323)
T ss_pred HHHHHHHccCCHHH
Confidence 78999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.03 Aligned_cols=212 Identities=26% Similarity=0.364 Sum_probs=161.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
+|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999875 689999999875543333345567788887755444
Q ss_pred ----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 428 ----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 428 ----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 444444432 234788899999999999999999 8899999999999999999999999999998664321
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~----- 220 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKLEFPRH----- 220 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcCCCcc-----
Confidence 234689999999999988899999999999999999999999975321 11223333333322211
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 221 ~~~~~~~li~~~l~~dp~~ 239 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTR 239 (291)
T ss_pred CCHHHHHHHHHHcCCCHHH
Confidence 1224788999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=278.51 Aligned_cols=218 Identities=23% Similarity=0.344 Sum_probs=164.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhH-H-HHHhhhhHhHHHHHHhhh-c----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETE-E-LAFIRSFRNEAQVLSQME-R---------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~-~~~~~~~~~E~~il~~l~-~---------------- 427 (602)
..+|.....||+|+||.|+.|+. .+|+.||+|++.+.... . ....+...+|+.+++.+. |
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45788999999999999999975 47899999977654211 0 123445667888775554 4
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeecccccc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTAR 497 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a~ 497 (602)
|+|++++.. ..++.+.++..++.|++.|++||| +++|+||||||+||++|.+ +.+||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 444444443 355888999999999999999999 8999999999999999999 999999999999
Q ss_pred cccCCCCCccccccccccccccccccCc-CC-ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMV-MT-EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ...+..+......-
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKIRKGEFKI 242 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHHhcCCccC
Confidence 8743333445578999999999999977 75 789999999999999999999985221 11122233333332
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
|..- . ...+.+++.+|++.||.+
T Consensus 243 p~~~---~-S~~~~~Li~~mL~~~P~~ 265 (370)
T KOG0583|consen 243 PSYL---L-SPEARSLIEKMLVPDPST 265 (370)
T ss_pred CCCc---C-CHHHHHHHHHHcCCCccc
Confidence 2210 0 334788999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.62 Aligned_cols=208 Identities=25% Similarity=0.349 Sum_probs=156.4
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------------c
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-------------------------L 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-------------------------L 430 (602)
||+|+||.||+|+.. +++.||+|++.............+.+|+.++..+.|++ |
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 58899999987544333334566778888775554444 4
Q ss_pred ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 431 FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 431 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 444432 234788999999999999999999 88999999999999999999999999999876433333334457
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+. . ....+.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~--~---~~~~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEPLRFPD--G---FDRDAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCCCCC--c---CCHHHHH
Confidence 99999999999999999999999999999999999999974321 1122223332222111 1 1234778
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++.+|+++||++
T Consensus 223 li~~~L~~dp~~ 234 (312)
T cd05585 223 LLIGLLSRDPTR 234 (312)
T ss_pred HHHHHcCCCHHH
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=277.05 Aligned_cols=210 Identities=23% Similarity=0.291 Sum_probs=156.2
Q ss_pred ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------------
Q 047576 375 YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------------- 432 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------------- 432 (602)
+.||+|+||.||+++. .+|+.||+|++.............+.+|+.++..+.|+++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999986 468999999987554333334456677888775555544433
Q ss_pred ----ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 433 ----ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 433 ----~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 3322 234789999999999999999999 889999999999999999999999999998754333333334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+. . ....+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~~~~~p~--~---~~~~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIRFPR--T---LSPEA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCCC--C---CCHHH
Confidence 5789999999999998999999999999999999999999964321 1112222222222111 1 12336
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|+++||++
T Consensus 223 ~~li~~~L~~dP~~ 236 (323)
T cd05595 223 KSLLAGLLKKDPKQ 236 (323)
T ss_pred HHHHHHHccCCHHH
Confidence 78999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=277.58 Aligned_cols=217 Identities=21% Similarity=0.327 Sum_probs=158.6
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|+.++ ||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999864 6789999999765444334455677777766 44455
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 555444432 234889999999999999999999 88999999999999999999999999999875433233334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.................+.....+.+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~~~ 229 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-----LSVK 229 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC-----CCHH
Confidence 46799999999999999999999999999999999999999974322111111111122222222221111 1233
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|++.||++
T Consensus 230 ~~~li~~~L~~dP~~ 244 (327)
T cd05617 230 ASHVLKGFLNKDPKE 244 (327)
T ss_pred HHHHHHHHhccCHHH
Confidence 678999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=270.84 Aligned_cols=183 Identities=27% Similarity=0.391 Sum_probs=153.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|+..+.||+|.||.||+|+. .+|+.||+|++.....+ ..+.....+|+.|++.+.|+++..+..-.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 45788889999999999999985 57999999998755432 23455667899999999888876543210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....|+..+++.|++|++.||+||| .++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 12345899999999999999999999 899999999999999999999999999999988765
Q ss_pred CCC-ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 503 SSN-QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
... .+..+-|..|+|||.+.|. .|+.++|+||.||||.||++|++.|.+..+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 433 4556789999999999886 599999999999999999999999987544
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=275.14 Aligned_cols=209 Identities=24% Similarity=0.361 Sum_probs=154.2
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------HhhhcC
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMERG 428 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~g 428 (602)
.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++ ||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999864 5789999998754322222223333444433 556667
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
+|..++.. ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...........
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 82 DLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 76666543 234888999999999999999999 789999999999999999999999999999765433333344
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+ .. ....+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~--~~---~~~~~ 223 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDRPHFP--RW---ISKEA 223 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC--CC---CCHHH
Confidence 5799999999999998899999999999999999999999975321 111222222211111 11 12236
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++..|++.||++
T Consensus 224 ~~ll~~~l~~~P~~ 237 (316)
T cd05592 224 KDCLSKLFERDPTK 237 (316)
T ss_pred HHHHHHHccCCHHH
Confidence 78899999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.69 Aligned_cols=220 Identities=25% Similarity=0.346 Sum_probs=157.3
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
.++|...+.||+|+||.||+|.. .+++.||||+++..... ...+.+.+|+.++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 35788899999999999999963 24678999998754322 2234566777766
Q ss_pred --------HhhhcCccccccccccc-------------------------------------------------------
Q 047576 423 --------SQMERGSLFRILHNDAE------------------------------------------------------- 439 (602)
Q Consensus 423 --------~~l~~gsL~~~l~~~~~------------------------------------------------------- 439 (602)
||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 44455555555432110
Q ss_pred ----hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC--Ccccccccc
Q 047576 440 ----AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSY 513 (602)
Q Consensus 440 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~ 513 (602)
..++++.++..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++....... ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124778889999999999999999 88999999999999999999999999999986533221 112234567
Q ss_pred ccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHH
Q 047576 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTIS 592 (602)
Q Consensus 514 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~ 592 (602)
.|+|||++.+..++.++|||||||++|||++ |+.||...... ......+.+...... .. .....+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~~~-~~---~~~~~l~~li 310 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRMRA-PE---NATPEIYRIM 310 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCCCC-CC---CCCHHHHHHH
Confidence 8999999999999999999999999999997 99999753211 111111122111111 11 1234488999
Q ss_pred hhccCcCCCC
Q 047576 593 FACLQSNPKS 602 (602)
Q Consensus 593 ~~Cl~~dP~e 602 (602)
.+||+.||++
T Consensus 311 ~~cl~~dp~~ 320 (338)
T cd05102 311 LACWQGDPKE 320 (338)
T ss_pred HHHccCChhh
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=278.41 Aligned_cols=217 Identities=22% Similarity=0.284 Sum_probs=165.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357888999999999999999875 6889999998765443334456788899888666666555443210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 01234678888999999999999999 8899999999999999999999999999998764322
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
....|++.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.+..+..+.. .
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~p~~-----~ 238 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLKFPNW-----F 238 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcCCCCC-----C
Confidence 235689999999999998899999999999999999999999964322 11123333333332211 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..||+.||++
T Consensus 239 ~~~~~~li~~~L~~dP~~ 256 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTK 256 (329)
T ss_pred CHHHHHHHHHHhhcCHHH
Confidence 123778999999999974
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=275.57 Aligned_cols=210 Identities=24% Similarity=0.370 Sum_probs=156.3
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|..++ ||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 6889999998754332222334455565554 45555
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 666555543 234788999999999999999999 88999999999999999999999999999876433333334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~--~---~~~~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEVVYPT--W---LSQD 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCCCCCC--C---CCHH
Confidence 45799999999999998899999999999999999999999975321 1222233332222111 1 1233
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..|+++||++
T Consensus 223 ~~~li~~~L~~dP~~ 237 (320)
T cd05590 223 AVDILKAFMTKNPTM 237 (320)
T ss_pred HHHHHHHHcccCHHH
Confidence 778999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=276.46 Aligned_cols=208 Identities=21% Similarity=0.285 Sum_probs=155.7
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------------------
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------------------- 431 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------------------- 431 (602)
+.||+|+||.||+++.. +|+.||+|++.............+.+|+.++..+.|+++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 6899999998765433333456677888887555554443
Q ss_pred ---cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 432 ---RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 432 ---~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
..+.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 33321 234788999999999999999999 889999999999999999999999999998764333223334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc--cCCCCCCChhhHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD--QRLPPPVDRKVIQDIL 586 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~ 586 (602)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. ..++...+ .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~-------~ 220 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEDIKFPRTLS-------A 220 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccCCccCCCCCC-------H
Confidence 57999999999999889999999999999999999999999643211 11111111 12222222 2
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+|+++||++
T Consensus 221 ~~~~li~~~L~~dP~~ 236 (328)
T cd05593 221 DAKSLLSGLLIKDPNK 236 (328)
T ss_pred HHHHHHHHHcCCCHHH
Confidence 3778889999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=275.73 Aligned_cols=210 Identities=24% Similarity=0.354 Sum_probs=156.1
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|.+++ ||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 5789999998754332223344555666665 44445
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 555444432 234788999999999999999999 88999999999999999999999999999876433333334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~~~~p~~-----~~~~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDDVLYPVW-----LSKE 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCCC-----CCHH
Confidence 45789999999999998999999999999999999999999975321 22223333332222211 1234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..|+++||++
T Consensus 223 ~~~ll~~~L~~dp~~ 237 (321)
T cd05591 223 AVSILKAFMTKNPNK 237 (321)
T ss_pred HHHHHHHHhccCHHH
Confidence 778999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=275.63 Aligned_cols=216 Identities=21% Similarity=0.341 Sum_probs=158.2
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH--------------------------hhhcC
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS--------------------------QMERG 428 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~--------------------------~l~~g 428 (602)
.||+|+||.||+|+.. +++.||+|+++..........+.+..|..+++ |+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6899999999999864 68899999997654433334456677777763 44445
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...........
T Consensus 82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 82 DLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 55444432 235889999999999999999999 889999999999999999999999999998753322333334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCC--CcccchhhhhccCCCCCCChhhHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY--DPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
..||+.|+|||++.+..++.++||||+||++|||+||+.||+......... ..+.....+.....+.+. . ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~---~~~ 230 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--S---LSV 230 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--C---CCH
Confidence 579999999999999999999999999999999999999997432211110 111112223333322221 1 123
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+|+++||++
T Consensus 231 ~~~~li~~~L~~dP~~ 246 (329)
T cd05588 231 KASSVLKGFLNKDPKE 246 (329)
T ss_pred HHHHHHHHHhccCHHH
Confidence 4788999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=273.95 Aligned_cols=213 Identities=22% Similarity=0.325 Sum_probs=157.5
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH---------------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------- 422 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------- 422 (602)
|+....||+|+||.||+|+.. +++.||||+++..........+.+.+|+.++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456788999999999999864 6899999998755433223345566665554
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++++|...++ ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 3334444433332 234899999999999999999999 88999999999999999999999999999875433
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~~p~~--- 223 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVNDEVRYPRF--- 223 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCC---
Confidence 33333446799999999999998899999999999999999999999974321 11222233322221111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 224 --~~~~~~~li~~~L~~dP~~ 242 (324)
T cd05589 224 --LSREAISIMRRLLRRNPER 242 (324)
T ss_pred --CCHHHHHHHHHHhhcCHhH
Confidence 1233778999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=275.84 Aligned_cols=217 Identities=21% Similarity=0.348 Sum_probs=157.2
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|++++.........+.+..|+.++ ||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999864 6889999998765433333445566676665 44455
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 555444432 234888999999999999999999 88999999999999999999999999999875433333334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCC--cccchhhhhccCCCCCCChhhHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYD--PKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.......... .......+.......+.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-----~~ 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-----LS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC-----CC
Confidence 45789999999999999999999999999999999999999964321111111 011112222332222211 22
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|+++||++
T Consensus 230 ~~~~~ll~~~L~~dP~~ 246 (329)
T cd05618 230 VKAASVLKSFLNKDPKE 246 (329)
T ss_pred HHHHHHHHHHhcCCHHH
Confidence 34778999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=267.42 Aligned_cols=215 Identities=23% Similarity=0.324 Sum_probs=158.0
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------HhhhcCcc
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQMERGSL 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~l~~gsL 430 (602)
||+|+||+||+++.. +++.||+|++...........+.+..|+.++ +|+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 7889999998765443333445667788777 44555555
Q ss_pred cccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcccc
Q 047576 431 FRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLL 509 (602)
Q Consensus 431 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~ 509 (602)
...+.... ....+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 54442211 2345889999999999999999999 8899999999999999999999999999997765443333345
Q ss_pred ccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHH
Q 047576 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVS 589 (602)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 589 (602)
.|++.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.......+ . .....+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~--~---~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILNDSVTYP--D---KFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHhhcccCCCCc--c---cCCHHHH
Confidence 7899999999999999999999999999999999999999743211 011111112222211111 1 1233478
Q ss_pred HHHhhccCcCCCC
Q 047576 590 TISFACLQSNPKS 602 (602)
Q Consensus 590 ~l~~~Cl~~dP~e 602 (602)
+++..|++.||++
T Consensus 230 ~li~~~l~~~P~~ 242 (280)
T cd05608 230 SFCEALLAKDPEK 242 (280)
T ss_pred HHHHHHhcCCHHH
Confidence 8999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=248.59 Aligned_cols=217 Identities=27% Similarity=0.347 Sum_probs=172.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~----------------------- 423 (602)
.++|+..+.||+|.||.||.|+.+ ++..||+|++-+......+..+++++|++|-.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999864 68899999998877666666678888888654
Q ss_pred --hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 424 --QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 424 --~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|...|.+++.|.+. ....+++.....++.|+|.|+.|+| .++|+||||||+|+|++.++..|++|||-+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 44455555555432 2345888889999999999999999 9999999999999999999999999999887654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.......+||..|.|||...+..++..+|+|++|+..||+++|.+||+... .++...++..-++..|..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~~~~~p~~--- 244 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKVDLKFPST--- 244 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHccccCCcc---
Confidence 223445789999999999999999999999999999999999999998532 233334443333332211
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
-.....+++.+|+.++|.+
T Consensus 245 --is~~a~dlI~~ll~~~p~~ 263 (281)
T KOG0580|consen 245 --ISGGAADLISRLLVKNPIE 263 (281)
T ss_pred --cChhHHHHHHHHhccCccc
Confidence 1223779999999999975
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=265.96 Aligned_cols=222 Identities=22% Similarity=0.316 Sum_probs=172.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHH-----------HHhhhhHhHHHHHHhhhcCccccccc
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL-----------AFIRSFRNEAQVLSQMERGSLFRILH 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-----------~~~~~~~~E~~il~~l~~gsL~~~l~ 435 (602)
.++|.....+|+|.||.|-+|+.. +++.||||++.+...... ...+..++|+.||+.+.|.+++++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 567899999999999999999864 799999999986543211 11246788999999999999887654
Q ss_pred cc-----------------------cchhh-hcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 436 ND-----------------------AEAVE-LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 436 ~~-----------------------~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
.- ....+ +++.++++|++++..||+||| .++||||||||+|+|++.+|++||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEee
Confidence 21 12333 888999999999999999999 7899999999999999999999999
Q ss_pred cccccccccCCC-----CCccccccccccccccccccCc----CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcc
Q 047576 492 DFGTARLLHADS-----SNQTLLAGSYGYIAPELAYTMV----MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPK 562 (602)
Q Consensus 492 DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 562 (602)
|||.+....... ..-...+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-.. ..-
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-------~~~ 325 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-------FEL 325 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-------hHH
Confidence 999998663221 1122368999999999988743 457889999999999999999999532 112
Q ss_pred cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+-+..|+...+..|..+ +.-+.+.+++.+-+.+||++
T Consensus 326 ~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred HHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhh
Confidence 23455666666555433 24455889999999999974
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.37 Aligned_cols=179 Identities=25% Similarity=0.358 Sum_probs=154.6
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------ 423 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------ 423 (602)
+.|+.-+.||+|+||+||-++. .+|..+|.|++.+.............+|.+|++
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4588889999999999999975 469999999998877766666666777888773
Q ss_pred -hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 424 -QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 424 -~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
-|.+|+|.-.+...+. ..|++..++.||.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 3567888777765443 45999999999999999999999 889999999999999999999999999999988765
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
..... .+||.+|||||++..+.|+..+|+||+||++|||+.|+.||...
T Consensus 341 ~~~~~-rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 KPIRG-RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred Ccccc-ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 54433 48999999999999999999999999999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=267.59 Aligned_cols=227 Identities=20% Similarity=0.258 Sum_probs=172.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLF-------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~-------------- 431 (602)
-++|...+.||.|.||.||+|+. .+|..||||++++......+ -.-.+|+.-+..+. |+++.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 35788899999999999999985 57999999999876554321 12235666665554 54443
Q ss_pred -----------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 432 -----------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 432 -----------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++++. ....|++.+++.|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+...
T Consensus 87 fVfE~Md~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhhhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence 33333 2556999999999999999999999 8899999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccc-cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc--------------cCCCcccch
Q 047576 501 ADSSNQTLLAGSYGYIAPELAY-TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS--------------SSYDPKIML 565 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------------~~~~~~~~~ 565 (602)
. ....+..+.|..|+|||++. .+.|+.+.|+||+|||++|+.+-++-|.+.++.. ..+.+...+
T Consensus 162 S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 S-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred c-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 4 33456678999999999875 4568999999999999999999999998765432 223333445
Q ss_pred hhhhccCCCCCC----ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 566 IDVLDQRLPPPV----DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 566 ~~~~d~~l~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.-+++... +.-...+..+.++++.+|+++||++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~k 281 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDK 281 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCcc
Confidence 556666555211 1111224456889999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=247.23 Aligned_cols=230 Identities=24% Similarity=0.321 Sum_probs=175.2
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
.+|...+.+|+|.||.||+|+. ++|+.||||+++.....+ ..-....+|++.++.++|.++.++++...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4577788999999999999985 579999999998765432 12234567999999888888777665321
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....++...++.|+.++++|++||| ++.|+||||||.|+|++.+|.+||+|||+|+........
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 1233677889999999999999999 899999999999999999999999999999998876665
Q ss_pred ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCccc--------------ccCCCcccchhhhhc
Q 047576 506 QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHSTL--------------SSSYDPKIMLIDVLD 570 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~d 570 (602)
.+..+-|..|+|||.+.|.+ |+..+|+||.||++.||+-|.+-|.+.++. ...|.+...+.+.++
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 55557889999999988764 899999999999999999999888765432 233444444444444
Q ss_pred cCC-CCCC-ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRL-PPPV-DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l-~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
-.. +.+. ..-...+.....+++..-+.+||.+
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~ 271 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKK 271 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchh
Confidence 432 2111 1112234445688999999999863
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=271.99 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=153.7
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +|+.||+|+++..........+.+..|..++ ||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999875 6889999998754322112233444455544 55566
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 666655543 234788999999999999999999 88999999999999999999999999999875432223334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc--cCCCCCCChhhHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD--QRLPPPVDRKVIQDI 585 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~ 585 (602)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. +.++... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~-------~ 220 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDTPHYPRWI-------T 220 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCC-------C
Confidence 46789999999999999999999999999999999999999974321 111111111 1122211 2
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++..|++.||++
T Consensus 221 ~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 221 KESKDILEKLFERDPTR 237 (316)
T ss_pred HHHHHHHHHHccCCHHH
Confidence 23778999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=275.92 Aligned_cols=210 Identities=23% Similarity=0.314 Sum_probs=154.6
Q ss_pred ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------------C
Q 047576 375 YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------------G 428 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------------g 428 (602)
+.||+|+||.||+|+. .+|+.||+|++.............+.+|++++..+.| |
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 4789999999875543333334566678777754444 4
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
+|..++.. ...+++.++..++.|++.||+||| + ++|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 44333322 234789999999999999999999 5 7999999999999999999999999999875433333333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......+. . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~---~~~~ 222 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPR--T---LSPE 222 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCCCCCC--C---CCHH
Confidence 45699999999999998999999999999999999999999964321 1111222222222111 1 1223
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|+++||++
T Consensus 223 ~~~li~~~L~~dP~~ 237 (325)
T cd05594 223 AKSLLSGLLKKDPKQ 237 (325)
T ss_pred HHHHHHHHhhcCHHH
Confidence 778899999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.30 Aligned_cols=221 Identities=21% Similarity=0.302 Sum_probs=182.2
Q ss_pred CccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.+.|+....||.|.-|+||+++..+ +..+|+|++.+..........+.+.|.+|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4678888999999999999999764 589999999887766555666777777776
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|..+.+.+ ....+++..++.|+.+++-||+||| -.|||+|||||+||||-++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 888999998887764 4566999999999999999999999 88999999999999999999999999997643210
Q ss_pred ----------------------------------CC----------------------CCccccccccccccccccccCc
Q 047576 502 ----------------------------------DS----------------------SNQTLLAGSYGYIAPELAYTMV 525 (602)
Q Consensus 502 ----------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 525 (602)
.. ......+||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0011256999999999999999
Q ss_pred CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 526 MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 526 ~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.++|+|+|||++|||+.|..||.+. ..++.+..++-+.+..+... +......+++.+-+.+||++
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~-------~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGS-------NNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCC-------CchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhh
Confidence 999999999999999999999999853 44667788888877755443 24455889999999999974
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=272.39 Aligned_cols=210 Identities=23% Similarity=0.335 Sum_probs=153.3
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH-HHHhhhcC------------------------
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ-VLSQMERG------------------------ 428 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~-il~~l~~g------------------------ 428 (602)
+.||+|+||.||+|+.. +++.||+|++.+...........+..|.. +++.+.|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999874 68899999987554332223344444543 34444444
Q ss_pred -ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 429 -SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 429 -sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
+|...+.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 44333321 234778888899999999999999 78999999999999999999999999999875433223333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....+..+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~-----~~~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKPLQLPGG-----KTVA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCCCCCCCC-----CCHH
Confidence 45789999999999988899999999999999999999999974321 11223333333322211 2234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..|+++||++
T Consensus 223 ~~~li~~~l~~~p~~ 237 (321)
T cd05603 223 ACDLLVGLLHKDQRR 237 (321)
T ss_pred HHHHHHHHccCCHhh
Confidence 788999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=272.90 Aligned_cols=209 Identities=25% Similarity=0.350 Sum_probs=153.0
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH-HH-------------------------HhhhcC
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ-VL-------------------------SQMERG 428 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~-il-------------------------~~l~~g 428 (602)
.||+|+||+||+|+.. +|+.||+|++...........+.+..|.. ++ ||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6899999999999874 78999999987544332223334444443 23 444555
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
+|..++.. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++............
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 82 ELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 55544432 234788899999999999999999 889999999999999999999999999998754333333334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. ....+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~-----~~~~~ 223 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKPLRLKPN-----ISVSA 223 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCCCCCC-----CCHHH
Confidence 5789999999999998999999999999999999999999974321 11122233322221111 12337
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|++.||++
T Consensus 224 ~~li~~~l~~~p~~ 237 (323)
T cd05575 224 RHLLEGLLQKDRTK 237 (323)
T ss_pred HHHHHHHhhcCHHh
Confidence 78999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=271.88 Aligned_cols=213 Identities=21% Similarity=0.315 Sum_probs=158.7
Q ss_pred ccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhhhcCcccccccccc-----------
Q 047576 375 YCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQMERGSLFRILHNDA----------- 438 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~----------- 438 (602)
+.||+|+||.||+++. .+++.||+|+++..... .......+.+|+.+++.+.|+++..++....
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5789999999999975 35889999998754322 1223455778888887777766665432110
Q ss_pred -----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 439 -----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 439 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
....+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 1223567788889999999999999 88999999999999999999999999999875433333333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. ....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~~~~~~-----~~~~ 226 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKLNLPPY-----LTPE 226 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCCC-----CCHH
Confidence 45789999999999988899999999999999999999999974321 12233344333322211 1233
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|+++||++
T Consensus 227 ~~~li~~~l~~~p~~ 241 (323)
T cd05584 227 ARDLLKKLLKRNPSS 241 (323)
T ss_pred HHHHHHHHcccCHhH
Confidence 779999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=275.46 Aligned_cols=214 Identities=19% Similarity=0.245 Sum_probs=161.7
Q ss_pred CccccCcccccccccccceeeecC--CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF-------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~-------------- 431 (602)
.++|.....||+|+||.||+|+.. ++..||+|++...........+.+.+|+.++..+.|+++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457888999999999999999754 3468999998654433333456677888888555555444
Q ss_pred -----------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 432 -----------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 432 -----------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 33332 234788899999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.+.....+..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~~p~~-- 250 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGIIYFPKF-- 250 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCCCCCC--
Confidence 32 2235789999999999988899999999999999999999999975322 11122333333221211
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 251 ---~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 251 ---LDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred ---CCHHHHHHHHHHcccCHHH
Confidence 1123678999999999964
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.89 Aligned_cols=208 Identities=24% Similarity=0.378 Sum_probs=152.9
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++ ||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999865 5789999998754321111223344455444 55566
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 666665543 234788999999999999999999 88999999999999999999999999999875433222333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh--ccCCCCCCChhhHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL--DQRLPPPVDRKVIQDI 585 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--d~~l~~~~~~~~~~~~ 585 (602)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+. .+..+... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~~~~~~-------~ 220 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNPCYPRWL-------T 220 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccC-------C
Confidence 45789999999999998999999999999999999999999974321 11111111 11122211 1
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|+++||++
T Consensus 221 ~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 221 REAKDILVKLFVREPER 237 (316)
T ss_pred HHHHHHHHHHhccCHhh
Confidence 23678999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.87 Aligned_cols=210 Identities=22% Similarity=0.336 Sum_probs=155.5
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH--------------------------hhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS--------------------------QMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~--------------------------~l~~ 427 (602)
+.||+|+||.||+|+.. +++.||+|+++............+..|..++. |+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 57899999987554322233445566766663 3444
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 444444332 235889999999999999999999 88999999999999999999999999999875433333333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.......+. . ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~~~~~--~---~~~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEVRYPR--W---LSKE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCCC--c---CCHH
Confidence 45689999999999999999999999999999999999999974321 1112222222222111 1 2234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|++.||++
T Consensus 223 ~~~li~~~l~~dP~~ 237 (318)
T cd05570 223 AKSILKSFLTKNPEK 237 (318)
T ss_pred HHHHHHHHccCCHHH
Confidence 789999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=276.65 Aligned_cols=216 Identities=24% Similarity=0.349 Sum_probs=161.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------------ 424 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~------------------------ 424 (602)
+|.....||+|+||.||+|+.. +|+.||+|+++............+.+|+.++..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999999999875 689999999876544333345567778877744
Q ss_pred -hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 425 -MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 425 -l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 4445554444332 35788999999999999999999 8899999999999999999999999999998664432
Q ss_pred -----------------------------CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 504 -----------------------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 504 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 112335689999999999999999999999999999999999999975331
Q ss_pred cccCCCcccchhhhhc--cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLD--QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.. ..+..+.... ....+.+++..|++ ||++
T Consensus 236 -------~~~~~~i~~~~~~~~~p~~~~---~~~~~~~li~~ll~-dp~~ 274 (350)
T cd05573 236 -------QETYNKIINWKESLRFPPDPP---VSPEAIDLICRLLC-DPED 274 (350)
T ss_pred -------HHHHHHHhccCCcccCCCCCC---CCHHHHHHHHHHcc-Chhh
Confidence 111222332 2222111111 22347788889997 8864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.61 Aligned_cols=216 Identities=20% Similarity=0.332 Sum_probs=170.3
Q ss_pred CccccCcccccccccccceeeecCCC-cEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNG-RVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
..++.+.+.|.+|||+.||.|+...+ ..||+|++-..+. ...+...+|+++|
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34667889999999999999998665 9999999876643 3567778899887
Q ss_pred ---------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 423 ---------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 423 ---------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
||+++|+|.+++..... ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 66666677776664333 3389999999999999999999965 889999999999999999999999999
Q ss_pred cccccccCCCCCcc---------cccccccccccccc---ccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCc
Q 047576 494 GTARLLHADSSNQT---------LLAGSYGYIAPELA---YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 494 G~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 561 (602)
|.|........... ....|+.|+|||++ .+.+.++|+|||++||+||.|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 99876533221111 12468999999975 567799999999999999999999999985322
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..|++.....|.... ....+.+|+..||+.||++
T Consensus 264 ----laIlng~Y~~P~~p~---ys~~l~~LI~~mL~~nP~~ 297 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPN---YSDRLKDLIRTMLQPNPDE 297 (738)
T ss_pred ----eeEEeccccCCCCcc---HHHHHHHHHHHHhccCccc
Confidence 455666655333222 5556899999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.51 Aligned_cols=209 Identities=24% Similarity=0.323 Sum_probs=151.4
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH-HH-------------------------HhhhcC
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ-VL-------------------------SQMERG 428 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~-il-------------------------~~l~~g 428 (602)
.||+|+||.||+|+.. +++.||+|++.............+..|.. ++ ||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6899999999999865 67889999987543322222233333333 23 455555
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
++.+++.. ...+.+..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 82 ELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 55555543 233677888889999999999999 889999999999999999999999999998754333333344
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..|++.|+|||++.+..++.++||||+||++|||++|+.||..... ...+..+.......+. . ....+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~--~---~~~~~ 223 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPLQLKP--N---ITNSA 223 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCcCCCC--C---CCHHH
Confidence 5799999999999999999999999999999999999999974321 1112223222222111 1 12237
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|+++||++
T Consensus 224 ~~li~~~l~~~p~~ 237 (325)
T cd05602 224 RHLLEGLLQKDRTK 237 (325)
T ss_pred HHHHHHHcccCHHH
Confidence 78889999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=254.52 Aligned_cols=216 Identities=26% Similarity=0.389 Sum_probs=175.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.+-|++...||+|+||.||+|.+ +.|+++|+|.+.-.. ..+.+.+|+.|+
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 35689999999999999999976 479999999885332 246677788776
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+..|++.++++. ..+++++.++..+.+..++||+||| ...-||||||+.|||++.+|.+||+|||.|..+..
T Consensus 107 MEYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 55556666666654 3456899999999999999999999 66789999999999999999999999999987765
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.-.....+.||+.|||||++..-.|+.++||||+|++..||..|++||....+++.-. +=|.-++|..+..
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPTF~KP 252 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPTFKKP 252 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCCCCCh
Confidence 4444455789999999999999999999999999999999999999998766553321 1133344544555
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++....+.+++..|+.+.|+|
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~ 273 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEE 273 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHH
Confidence 677788999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=262.45 Aligned_cols=212 Identities=17% Similarity=0.227 Sum_probs=159.6
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------------
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------------- 437 (602)
..+|+|++|.||+|++ +|+.||||+++..........+.+.+|+.++..+.|+++..++...
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6789999999999998 7899999999765544444457788999998777666665544210
Q ss_pred ---------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 438 ---------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 438 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....+++.....++.+++.|+.|+|. ..+++||||||+||+++.++.+||+|||+++...... ..
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 012347889999999999999999993 2488899999999999999999999999998654322 22
Q ss_pred ccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 509 LAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......++....+.+.+.. ...
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~---~~~ 249 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDLIINKNNSLKLPLD---CPL 249 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCCc---CcH
Confidence 467899999999876 6789999999999999999999999974321 1112223222222222111 334
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+||+.||++
T Consensus 250 ~l~~li~~cl~~dp~~ 265 (283)
T PHA02988 250 EIKCIVEACTSHDSIK 265 (283)
T ss_pred HHHHHHHHHhcCCccc
Confidence 5889999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.67 Aligned_cols=217 Identities=24% Similarity=0.377 Sum_probs=155.9
Q ss_pred cccCcccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhh-------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQM------------------- 425 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l------------------- 425 (602)
+|+..+.||+|+||.||+++. .+++.||+|++.+.... .....+.+.+|+.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367788999999999999875 36889999998654321 122334566777777444
Q ss_pred -------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 426 -------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 426 -------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++|++.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 34444444332 234788999999999999999999 88999999999999999999999999999876
Q ss_pred ccCCCC-CccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh--ccCCC
Q 047576 499 LHADSS-NQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL--DQRLP 574 (602)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--d~~l~ 574 (602)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||....... ........+. ++.++
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRILKCDPPFP 231 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHHHHHHHhcCCCCCC
Confidence 533222 222357899999999988654 7889999999999999999999997432110 0011111122 12222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ...+.+++.+|++.||++
T Consensus 232 ~~~-------~~~~~~li~~~l~~dp~~ 252 (332)
T cd05614 232 SFI-------GPEAQDLLHKLLRKDPKK 252 (332)
T ss_pred CCC-------CHHHHHHHHHHcCCCHHH
Confidence 222 223778999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=284.62 Aligned_cols=220 Identities=27% Similarity=0.317 Sum_probs=162.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++....... .....+.+|+.++
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 46899999999999999999975 478999999986543221 1233455555443
Q ss_pred ---------HhhhcCcccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 423 ---------SQMERGSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 423 ---------~~l~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
+|+++|+|.+++.... ....+++..+..++.|++.||.|+| +++|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 5556667766665322 2345888999999999999999999 88999999999999999999999999
Q ss_pred ccccccccCC--CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 493 FGTARLLHAD--SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 493 FG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc
Confidence 9999865432 1122335799999999999999999999999999999999999999974321 111122222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+ .... ....+.+++..||+.||++
T Consensus 260 ~~~~~-~~~~---~~~~l~~li~~~L~~dP~~ 287 (496)
T PTZ00283 260 GRYDP-LPPS---ISPEMQEIVTALLSSDPKR 287 (496)
T ss_pred CCCCC-CCCC---CCHHHHHHHHHHcccChhh
Confidence 21111 1111 2234889999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=270.75 Aligned_cols=210 Identities=27% Similarity=0.346 Sum_probs=152.7
Q ss_pred ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHH-H-------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQV-L-------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~i-l-------------------------~~l~~ 427 (602)
+.||+|+||.||+|+. .+|+.||+|++.............+..|..+ + ||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999986 4789999999875433222233444445443 3 44445
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|++...+.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 555444432 234788999999999999999999 88999999999999999999999999999875433333334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....+..+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~~~~~~~-----~~~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLVLRPG-----ASLT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCCccCCCC-----CCHH
Confidence 45799999999999999999999999999999999999999974321 11222333332221111 1223
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|+++||++
T Consensus 223 ~~~ll~~ll~~~p~~ 237 (325)
T cd05604 223 AWSILEELLEKDRQR 237 (325)
T ss_pred HHHHHHHHhccCHHh
Confidence 668888999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=242.24 Aligned_cols=223 Identities=22% Similarity=0.298 Sum_probs=164.4
Q ss_pred CccccCcccccccccccceeee-cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
..+|...+.+|+|||+.||.++ ..+++.+|+|++.-...+ ..+..++|++..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4579999999999999999998 457889999998755432 334555666654
Q ss_pred ------HhhhcCccccccccccc-hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 423 ------SQMERGSLFRILHNDAE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
.|..+|++.+.+..... +..+++.+.++|+.++.+||++||+. .++++||||||.||++++.+.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 34455666665554332 33589999999999999999999954 44599999999999999999999999999
Q ss_pred cccccCCCCC---------cccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCccc
Q 047576 496 ARLLHADSSN---------QTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI 563 (602)
Q Consensus 496 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 563 (602)
+....-.-.. ......|..|+|||.+.- ...++++|||||||++|+|+.|..||+..-. ..+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgS 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGS 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCe
Confidence 8765321111 112457899999998753 4578999999999999999999999984211 1122
Q ss_pred chhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 564 MLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 564 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.-..+..+.+..|.+.. ..+.+.+++..|++.||.+
T Consensus 251 laLAv~n~q~s~P~~~~---yse~l~~lik~mlqvdP~q 286 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSR---YSEALHQLIKSMLQVDPNQ 286 (302)
T ss_pred EEEeeeccccccCCCCC---ccHHHHHHHHHHhcCCccc
Confidence 22344444554443332 3445889999999999975
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-31 Score=273.84 Aligned_cols=174 Identities=25% Similarity=0.350 Sum_probs=144.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------- 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------- 423 (602)
+|.....||+|+||.||+|+.. +++.||+|++.............+.+|++++.
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999875 58899999997654433334566778888774
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 4455555555532 234788999999999999999999 88999999999999999999999999999976543
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 223357899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=255.96 Aligned_cols=175 Identities=27% Similarity=0.381 Sum_probs=143.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~------- 439 (602)
.-.|...+++|.|+||.||+|.. .+++.||||+.-.+.. .-.+|+++|..++|+++.+++.....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 34678889999999999999986 4578999998754332 22458999999999998877653210
Q ss_pred -----------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeecccc
Q 047576 440 -----------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGT 495 (602)
Q Consensus 440 -----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~ 495 (602)
...++...++-++.||.+||.||| +.+|+||||||.|+|+|.+ |.+||||||.
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 122444556779999999999999 8899999999999999987 8999999999
Q ss_pred cccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
|+.+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+
T Consensus 173 AK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 173 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred ceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 9998765544 446789999999998875 59999999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=284.05 Aligned_cols=218 Identities=26% Similarity=0.380 Sum_probs=175.3
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
.+....+.||+|+||+||+|+. ++.+.||||.++..... +..++|++|++++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4566678899999999999975 24678999999876544 4568999999987
Q ss_pred -----HhhhcCccccccccccc-----------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC
Q 047576 423 -----SQMERGSLFRILHNDAE-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~ 486 (602)
|||.+|+|.++|..... ..+++..+.+.||.|||.|++||- ++.+|||||-.+|.||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence 99999999999875421 233889999999999999999999 78999999999999999999
Q ss_pred cceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCccc
Q 047576 487 EAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKI 563 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 563 (602)
.|||+|||+++..-..... .....-...|||||.+..++++.++|||||||+|||+++ |+.||.+. ...+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-------Sn~E 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-------SNQE 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-------chHH
Confidence 9999999999865322111 111233578999999999999999999999999999998 99998743 3345
Q ss_pred chhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 564 MLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 564 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+..+-+.++- +.+ +.++.++.+|+..||+..|++
T Consensus 714 VIe~i~~g~lL-~~P---e~CP~~vY~LM~~CW~~~P~~ 748 (774)
T KOG1026|consen 714 VIECIRAGQLL-SCP---ENCPTEVYSLMLECWNENPKR 748 (774)
T ss_pred HHHHHHcCCcc-cCC---CCCCHHHHHHHHHHhhcCccc
Confidence 55555555552 222 237788999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=270.91 Aligned_cols=178 Identities=28% Similarity=0.393 Sum_probs=145.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
++|+..+.||+|+||+||+|+.. +++.||+|++.+...........+.+|+.++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999764 6889999999765443334455677787766
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 55666666666653 234889999999999999999999 889999999999999999999999999998754321
Q ss_pred CC-----------------------------------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCC
Q 047576 503 SS-----------------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH 547 (602)
Q Consensus 503 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 547 (602)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 0112469999999999999999999999999999999999999
Q ss_pred CCCCC
Q 047576 548 PRDLH 552 (602)
Q Consensus 548 Pf~~~ 552 (602)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=274.71 Aligned_cols=177 Identities=27% Similarity=0.396 Sum_probs=142.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC--------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-------------------- 428 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-------------------- 428 (602)
+|+..+.||+|+||.||+|+.. +|+.||||++.............+.+|+.++..+.|.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6788899999999999999864 6899999999765433334456677888888555444
Q ss_pred -----ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 429 -----SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 429 -----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+|.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 82 YLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 44444432 234789999999999999999999 8899999999999999999999999999987543211
Q ss_pred C--------------------------------------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcC
Q 047576 504 S--------------------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMG 545 (602)
Q Consensus 504 ~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG 545 (602)
. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0 00123589999999999998999999999999999999999
Q ss_pred CCCCCCC
Q 047576 546 KHPRDLH 552 (602)
Q Consensus 546 ~~Pf~~~ 552 (602)
+.||...
T Consensus 236 ~~Pf~~~ 242 (364)
T cd05599 236 YPPFCSD 242 (364)
T ss_pred CCCCCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=269.81 Aligned_cols=179 Identities=28% Similarity=0.398 Sum_probs=143.8
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
++|...+.||+|+||.||+++.. +++.||+|++.+...........+.+|..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999864 6789999998754333233344566676655
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 566777777777542 234788899999999999999999 889999999999999999999999999999776443
Q ss_pred CCC-cccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSN-QTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 322 223569999999999875 45788999999999999999999999743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=268.76 Aligned_cols=219 Identities=23% Similarity=0.336 Sum_probs=157.1
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|+..+.||+|+||.||+|+. .++..||+|+++..... .....+.+|+.++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4688899999999999999863 23467999999754332 1234566777766
Q ss_pred ------HhhhcCcccccccccc----------------------------------------------------------
Q 047576 423 ------SQMERGSLFRILHNDA---------------------------------------------------------- 438 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~---------------------------------------------------------- 438 (602)
||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 4455555555543211
Q ss_pred ---------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC--cc
Q 047576 439 ---------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--QT 507 (602)
Q Consensus 439 ---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~--~~ 507 (602)
...++++.++.+|+.||+.||+||| +++|+||||||+||++++++.+||+|||+++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0124788899999999999999999 889999999999999999999999999999765432211 11
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......++........... ...
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~ 342 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPDF---APP 342 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCCC---CCH
Confidence 2234567999999998899999999999999999997 9999974321 1112222222222111111 123
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+||+.||++
T Consensus 343 ~l~~li~~cl~~dp~~ 358 (374)
T cd05106 343 EIYSIMKMCWNLEPTE 358 (374)
T ss_pred HHHHHHHHHcCCChhh
Confidence 4889999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=269.98 Aligned_cols=209 Identities=25% Similarity=0.353 Sum_probs=150.0
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH----------------------------Hhhhc
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------------SQMER 427 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------------~~l~~ 427 (602)
||+|+||.||+|+.. +++.||+|++.............+..|..++ ||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 6899999998654332222223333344433 44555
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|...+.. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 555555442 234889999999999999999999 88999999999999999999999999999876433333333
Q ss_pred ccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 508 LLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...||+.|+|||++.+. .++.++||||+||++|||+||+.||..... ......+.......+.. . ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~-~---~~~ 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVRFPKN-V---LSD 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCCCCCc-c---CCH
Confidence 45799999999998765 478999999999999999999999974321 11112222222221111 0 122
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+|++.||++
T Consensus 224 ~~~~li~~~L~~~P~~ 239 (330)
T cd05586 224 EGRQFVKGLLNRNPQH 239 (330)
T ss_pred HHHHHHHHHcCCCHHH
Confidence 3678899999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=272.31 Aligned_cols=217 Identities=25% Similarity=0.323 Sum_probs=159.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999864 6889999998654332223344566788777
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.+.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 44455555554432 23677888899999999999999 88999999999999999999999999999987643
Q ss_pred CCC-CccccccccccccccccccC----cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC--CC
Q 047576 502 DSS-NQTLLAGSYGYIAPELAYTM----VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR--LP 574 (602)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~--l~ 574 (602)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+++.. +.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCcCC
Confidence 322 22335799999999988653 378899999999999999999999975322 11223333322 11
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.+.... ....+.+++..|++.+|+
T Consensus 268 ~~~~~~---~s~~~~~li~~~L~~~p~ 291 (370)
T cd05596 268 FPDDIE---ISKQAKDLICAFLTDREV 291 (370)
T ss_pred CCCcCC---CCHHHHHHHHHHccChhh
Confidence 111111 223477888899988875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=260.59 Aligned_cols=219 Identities=22% Similarity=0.267 Sum_probs=159.9
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh------------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM------------------------ 425 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l------------------------ 425 (602)
|+....||+|+||.||++... +++.||+|++.............+.+|+.++..+
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 677789999999999999864 6899999998765443333345567788877444
Q ss_pred -hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 426 -ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 426 -~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
++|+|.+.+... ....+++.++..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 444444443321 1234889999999999999999999 78999999999999999999999999999877543222
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+...+.... ..+... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~-~~~~~~---~ 228 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERRVKEDQ-EEYSEK---F 228 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHHhhhcc-cccCcc---c
Confidence 22346899999999999888999999999999999999999999753211 00011111121111 111111 2
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+|++.||++
T Consensus 229 ~~~~~~li~~~l~~~P~~ 246 (285)
T cd05605 229 SEAARSICRQLLTKDPGF 246 (285)
T ss_pred CHHHHHHHHHHccCCHHH
Confidence 234789999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=268.85 Aligned_cols=215 Identities=23% Similarity=0.312 Sum_probs=163.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
...|.....||.|+.|.|-.|++ .+|+.+|||++.+...-.......+.+|+.||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 34678889999999999999986 57999999999876332222345677888877
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|.|++++-. .+++++.++.+++.||+.|+.||| ..+|+|||+||+|+|+|..+.+||+|||+|..-..
T Consensus 91 lEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 55555556555543 455899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCccccccccccccccccccCcCC-ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMT-EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
+. --...+|++.|.|||++.+.+|+ .++||||.|||||.|+||+.||+...- +.-+..+-...+..|..
T Consensus 165 gk-lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f~MPs~-- 234 (786)
T KOG0588|consen 165 GK-LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVFEMPSN-- 234 (786)
T ss_pred Cc-cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcccCCCc--
Confidence 43 33446899999999999999975 789999999999999999999984211 11112222222222211
Q ss_pred hHHHHHHHHHHHhhccCcCCC
Q 047576 581 VIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
-..+..+++.+.+..||+
T Consensus 235 ---Is~eaQdLLr~ml~VDp~ 252 (786)
T KOG0588|consen 235 ---ISSEAQDLLRRMLDVDPS 252 (786)
T ss_pred ---CCHHHHHHHHHHhccCcc
Confidence 122356777788888886
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=257.78 Aligned_cols=214 Identities=21% Similarity=0.304 Sum_probs=153.6
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------------------
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------------------- 432 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------------------- 432 (602)
||+|+||.||+++.. +|+.||+|++.............+..|+++++.+.|+++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986543332222344556888875555544443
Q ss_pred --ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 433 --ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 433 --~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
.+... ....+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 33221 1223788889999999999999999 8899999999999999999999999999987764322 223346
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..........+......+.. .....+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTLEDEVKFEHQ----NFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch---hhHHHHHHHhhccccccccc----cCCHHHHH
Confidence 889999999999888999999999999999999999999643210 01111112222222221110 12234789
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++.+|+++||++
T Consensus 229 li~~~L~~~P~~ 240 (277)
T cd05607 229 ICRLFLAKKPED 240 (277)
T ss_pred HHHHHhccCHhh
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=273.20 Aligned_cols=177 Identities=25% Similarity=0.369 Sum_probs=141.1
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
+|...+.||+|+||.||+|+. .+++.||||++...........+.+.+|++++..+.|
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577889999999999999975 4789999999875543333455678888888754444
Q ss_pred ----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 428 ----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 428 ----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 444444432 234788889999999999999999 8899999999999999999999999999986321100
Q ss_pred C-----------------------------------------------CccccccccccccccccccCcCCccchhHHHH
Q 047576 504 S-----------------------------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536 (602)
Q Consensus 504 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 536 (602)
. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 00124689999999999988899999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 047576 537 VVTLEVLMGKHPRDLH 552 (602)
Q Consensus 537 vil~elltG~~Pf~~~ 552 (602)
|++|||+||+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (377)
T cd05629 236 AIMFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhhhcCCCCCCCC
Confidence 9999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=242.75 Aligned_cols=219 Identities=26% Similarity=0.400 Sum_probs=167.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHh------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQ------------------ 424 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~------------------ 424 (602)
.+|...+.+|.|..+.|-++..+ +|.++|+|++..... ...+..+.-++|+.|+.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46788899999999999999764 688999998753221 123345566788888844
Q ss_pred --------hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 425 --------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 425 --------l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
|+.|.|++++.+ ...+++.+.++|++|+..|++||| .++||||||||+|||+|++..+||+|||++
T Consensus 97 F~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence 344555555543 344889999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccC------cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTM------VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
..+..+. .-...+|||+|.|||.+... .|+..+|+|+.||+||.++.|.+||..... ..++..++.
T Consensus 171 ~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~Ime 242 (411)
T KOG0599|consen 171 CQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIME 242 (411)
T ss_pred eccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHh
Confidence 9886543 34557999999999987643 377889999999999999999999974321 222334444
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...... ++++.+..+...+++.+|++.||.+
T Consensus 243 GkyqF~-speWadis~~~KdLIsrlLqVdp~~ 273 (411)
T KOG0599|consen 243 GKYQFR-SPEWADISATVKDLISRLLQVDPTK 273 (411)
T ss_pred cccccC-CcchhhccccHHHHHHHHHeeCchh
Confidence 444322 1233445566899999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.40 Aligned_cols=222 Identities=25% Similarity=0.389 Sum_probs=159.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
..+|...+.||+|+||.||+|+.. +++.||||++...... .....+.+|++++..+.|.++..+.....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 356777889999999999999864 6899999998654322 24467889999998888877766543210
Q ss_pred ----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 439 ----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 439 ----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 151 LEFMDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred EecCCCCcccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence 0122456778889999999999999 889999999999999999999999999999876543333334
Q ss_pred ccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 509 LAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
..|+..|+|||++.. ...+.++|||||||++|||++|+.||...... .+ ......+... ....... .
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~--~~~~~~~~~~-~~~~~~~---~ 299 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DW--ASLMCAICMS-QPPEAPA---T 299 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cH--HHHHHHHhcc-CCCCCCC---c
Confidence 578999999998743 23456899999999999999999999732110 00 0000111111 1111111 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 300 ~~~~l~~li~~~l~~~P~~ 318 (353)
T PLN00034 300 ASREFRHFISCCLQREPAK 318 (353)
T ss_pred cCHHHHHHHHHHccCChhh
Confidence 2334889999999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=259.33 Aligned_cols=179 Identities=28% Similarity=0.370 Sum_probs=139.4
Q ss_pred ccccCcccccccccccceeeecC--CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCccccccccc------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGSLFRILHND------ 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gsL~~~l~~~------ 437 (602)
++|.....||+|+||.||+|+.. +++.||+|+++...... .....+.+|+.++..+ .|+++..+....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 36888899999999999999862 46889999886443221 1123445566666544 466655543210
Q ss_pred ----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 438 ----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 438 ----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 80 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 01123688899999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 9866433 2233456899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=299.31 Aligned_cols=287 Identities=38% Similarity=0.667 Sum_probs=224.4
Q ss_pred HHHHHHHhcc-------CCCCCCCCCCCCCCCCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhcc
Q 047576 66 QLETKALLNT-------GWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILA 138 (602)
Q Consensus 66 ~~~~~al~~~-------~~~~~~w~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~ 138 (602)
+.|+.||++. +.+..+|+ .+.+||.|.||+|+..++|+.|+++..++ .|.++ ..+..+++|+.|++.
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~~~w~--~~~~~c~w~gv~c~~~~~v~~L~L~~~~i--~~~~~-~~~~~l~~L~~L~Ls- 101 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYLSNWN--SSADVCLWQGITCNNSSRVVSIDLSGKNI--SGKIS-SAIFRLPYIQTINLS- 101 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccCCCCC--CCCCCCcCcceecCCCCcEEEEEecCCCc--cccCC-hHHhCCCCCCEEECC-
Confidence 3677777651 22345675 35689999999998778999999976543 34443 357788888888887
Q ss_pred ccCCccccCCccCC-CCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCC
Q 047576 139 YYDGFTGSIPSEIS-ALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212 (602)
Q Consensus 139 ~~~~~~~~ip~~l~-~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 212 (602)
.+++.+.+|..+. ++++|++|+|++|++.+ .+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+
T Consensus 102 -~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 102 -NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred -CCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 6778888988755 89999999999998874 4778888888888888888888888888888888888888888
Q ss_pred cccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCC
Q 047576 213 PLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291 (602)
Q Consensus 213 p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 291 (602)
|..++++++|++|+|++|++++ +|..++++++|+.|+|++|++++.+|..++++++|++|++++|.+++.+|..+++++
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 8888888888888888888887 777888888888888888888888888788888888888888888777777777777
Q ss_pred CCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 292 QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 292 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
+|+.|+|++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.++|.+|..+
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~ 328 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence 77777777777777777777777777777777777777777777777777777777777776666544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=261.63 Aligned_cols=218 Identities=24% Similarity=0.356 Sum_probs=158.9
Q ss_pred ccccCcccccccccccceeeecC-CCc----EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.+|+..+.||+|+||.||+|+.. ++. .||+|+++..... ...+.+.+|+.++..+.|+++..++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCce
Confidence 46889999999999999999753 333 4899998644322 2345677888888666665555444211
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 01223778889999999999999999 88999999999999999999999999999987654
Q ss_pred CCCCc--cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 502 DSSNQ--TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 502 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
..... ....++..|+|||++.+..++.++||||||+++|||++ |+.||+.... ..+..++......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLPQP 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCCCCCC
Confidence 32221 11234568999999999999999999999999999998 9999975321 1122222222221211
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. +...+.+++..||+.||++
T Consensus 234 ~~---~~~~~~~li~~cl~~~p~~ 254 (316)
T cd05108 234 PI---CTIDVYMIMVKCWMIDADS 254 (316)
T ss_pred CC---CCHHHHHHHHHHccCChhh
Confidence 11 2344788999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=266.98 Aligned_cols=178 Identities=30% Similarity=0.396 Sum_probs=143.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
+|.....||+|+||.||+++.. +++.||+|++.+...........+.+|+.++ |
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5778899999999999999865 5788999998654433333344566677665 6
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 66777777777542 234788999999999999999999 8899999999999999999999999999987653332
Q ss_pred CC-ccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SN-QTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 22 22356999999999986 345788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=271.19 Aligned_cols=177 Identities=23% Similarity=0.336 Sum_probs=141.5
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------------ 424 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~------------------------ 424 (602)
.|.....||+|+||+||+|+. .+++.||+|++...........+.+.+|+.++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477788999999999999975 4688999999976554434455678888888744
Q ss_pred -hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 425 -MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 425 -l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 445555544432 234788889999999999999999 8899999999999999999999999999875331100
Q ss_pred -----------------------------------------------CCccccccccccccccccccCcCCccchhHHHH
Q 047576 504 -----------------------------------------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536 (602)
Q Consensus 504 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 536 (602)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001124699999999999988899999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 047576 537 VVTLEVLMGKHPRDLH 552 (602)
Q Consensus 537 vil~elltG~~Pf~~~ 552 (602)
|++|||+||+.||...
T Consensus 236 ~il~elltG~~Pf~~~ 251 (381)
T cd05626 236 VILFEMLVGQPPFLAP 251 (381)
T ss_pred hHHHHHHhCCCCCcCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-31 Score=268.58 Aligned_cols=213 Identities=27% Similarity=0.444 Sum_probs=164.4
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHH---------------HHHHhhhcCccccccc
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEA---------------QVLSQMERGSLFRILH 435 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~---------------~il~~l~~gsL~~~l~ 435 (602)
+...+.||.|+.|.||+|++ .++.||||+++.-...+....+.+.++- .||||+.+|.|..+|+
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk 204 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK 204 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh
Confidence 34456799999999999999 4688999998654433332333332221 1558999999999987
Q ss_pred cccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcccccccccc
Q 047576 436 NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515 (602)
Q Consensus 436 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y 515 (602)
. +..++....+.|.++||.|+.||| .+.|||||||+-||||+.+..+||+|||-++..... ...-.+.||..|
T Consensus 205 a---~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaW 277 (904)
T KOG4721|consen 205 A---GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAW 277 (904)
T ss_pred c---cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhh
Confidence 6 345778888999999999999999 789999999999999999999999999999877544 333447899999
Q ss_pred ccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhc
Q 047576 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFAC 595 (602)
Q Consensus 516 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~C 595 (602)
||||++...+.++|+||||||||||||+||..||...+..+.-|.... ..+. ++.| ..+.+-+.=++..|
T Consensus 278 MAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs---NsL~--LpvP-----stcP~GfklL~Kqc 347 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS---NSLH--LPVP-----STCPDGFKLLLKQC 347 (904)
T ss_pred hCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC---Cccc--ccCc-----ccCchHHHHHHHHH
Confidence 999999999999999999999999999999999987655443333221 1111 2222 12555677888899
Q ss_pred cCcCCC
Q 047576 596 LQSNPK 601 (602)
Q Consensus 596 l~~dP~ 601 (602)
|+.-|.
T Consensus 348 w~sKpR 353 (904)
T KOG4721|consen 348 WNSKPR 353 (904)
T ss_pred HhcCCC
Confidence 998774
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.30 Aligned_cols=219 Identities=24% Similarity=0.349 Sum_probs=156.5
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------- 425 (602)
++|...+.||+|+||.||+|+.. +++.||+|+++..... ...+.+.+|++++..+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 57889999999999999999642 3578999998754322 1234455666666444
Q ss_pred ----------hcCccccccccccc--------------------------------------------------------
Q 047576 426 ----------ERGSLFRILHNDAE-------------------------------------------------------- 439 (602)
Q Consensus 426 ----------~~gsL~~~l~~~~~-------------------------------------------------------- 439 (602)
++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 44444444322100
Q ss_pred --hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC--cccccccccc
Q 047576 440 --AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGY 515 (602)
Q Consensus 440 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y 515 (602)
...++|..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..+...... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125789999999999999999999 889999999999999999999999999999876432211 2223456789
Q ss_pred ccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhh
Q 047576 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFA 594 (602)
Q Consensus 516 ~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~ 594 (602)
+|||++.+..++.++|||||||++|||++ |+.||..... ...+...+........+. .....+.+++.+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~ 311 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFCRRLKEGTRMRAPE---YATPEIYSIMLD 311 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHHHHHhccCCCCCCc---cCCHHHHHHHHH
Confidence 99999999999999999999999999998 9999974221 111112222211111111 123458899999
Q ss_pred ccCcCCCC
Q 047576 595 CLQSNPKS 602 (602)
Q Consensus 595 Cl~~dP~e 602 (602)
||+.+|++
T Consensus 312 cl~~~p~~ 319 (337)
T cd05054 312 CWHNNPED 319 (337)
T ss_pred HccCChhh
Confidence 99999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=265.54 Aligned_cols=179 Identities=28% Similarity=0.359 Sum_probs=143.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....||+|+||.||+|+.. +|+.||||++...... ......+.+|+.++..+.|+++..+.+..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4777889999999999999864 6899999998643221 12235678899999888888776543210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 01224788999999999999999999 889999999999999999999999999999765332
Q ss_pred CC---Ccccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SS---NQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 21 1123468999999999876 57889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=286.68 Aligned_cols=222 Identities=26% Similarity=0.363 Sum_probs=159.9
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---------------------- 425 (602)
++|+..+.||+|+||.||+|+.. +|+.||+|++...........+++.+|++++..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999864 6899999998754433334456788899887444
Q ss_pred ---hcCcccccccccc--------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 426 ---ERGSLFRILHNDA--------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 426 ---~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
++|+|.+++.... ....+++..++.++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 4455544443210 0123556778899999999999999 7899999999999999999999999999
Q ss_pred ccccccCCC------------------CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc
Q 047576 495 TARLLHADS------------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS 556 (602)
Q Consensus 495 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 556 (602)
+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662110 01122468999999999999999999999999999999999999997522110
Q ss_pred cCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 557 SSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 557 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ..+.++.-..+. .+....+.+++.+|++.||++
T Consensus 239 i~~~-----~~i~~P~~~~p~----~~iP~~L~~LI~rcL~~DP~k 275 (932)
T PRK13184 239 ISYR-----DVILSPIEVAPY----REIPPFLSQIAMKALAVDPAE 275 (932)
T ss_pred hhhh-----hhccChhhcccc----ccCCHHHHHHHHHHccCChhh
Confidence 0000 111111100110 112334788999999999974
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.04 Aligned_cols=180 Identities=22% Similarity=0.298 Sum_probs=143.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.++..+.|+++..+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 467999999999999999999875 6889999998754322 1223566789988887777765543210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 01133778889999999999999999 88999999999999999999999999999876543332
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......+++.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33335688999999988754 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.84 Aligned_cols=219 Identities=23% Similarity=0.336 Sum_probs=157.1
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------- 423 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------- 423 (602)
++|+..+.||+|+||.||+|+. .++..||||+++..... ...+.+.+|+.++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4788899999999999999962 34668999998754322 22355677777764
Q ss_pred -------hhhcCcccccccccc----------------------------------------------------------
Q 047576 424 -------QMERGSLFRILHNDA---------------------------------------------------------- 438 (602)
Q Consensus 424 -------~l~~gsL~~~l~~~~---------------------------------------------------------- 438 (602)
|+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 444555554443211
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
....+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 0124788999999999999999999 88999999999999999999999999999986643221
Q ss_pred C--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 N--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+...+...........
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~- 341 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPEC- 341 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCCC-
Confidence 1 112234567999999999999999999999999999998 8999864321 1112222222221111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...++.+++..||+.||++
T Consensus 342 --~~~~l~~li~~cl~~dP~~ 360 (375)
T cd05104 342 --APSEMYDIMKSCWDADPLK 360 (375)
T ss_pred --CCHHHHHHHHHHccCChhH
Confidence 2234889999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=270.30 Aligned_cols=178 Identities=26% Similarity=0.368 Sum_probs=141.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~----------------------- 423 (602)
.++|+....||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++.
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999875 58899999986543332233455677887774
Q ss_pred --hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 424 --QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 424 --~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 4445555554432 23678889999999999999999 88999999999999999999999999999987643
Q ss_pred CCC-CccccccccccccccccccCc----CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSS-NQTLLAGSYGYIAPELAYTMV----MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 222 123457999999999987543 778999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=282.74 Aligned_cols=178 Identities=30% Similarity=0.400 Sum_probs=153.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|.+...||+|+||.|..++.+ ++++||+|++.+...-.......|..|..||
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 568999999999999999999975 6889999999875543233334566666655
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+||+||+|..++.... ++++..++.|+.+|.-||.-+| +.|+|||||||+|||+|..|++||+|||.+..+..
T Consensus 154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 8999999999998643 5889999999999999999999 89999999999999999999999999999998876
Q ss_pred CCCC-ccccccccccccccccc----c-CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DSSN-QTLLAGSYGYIAPELAY----T-MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
++.. ....+|||.|++||+++ + +.|++.+|+||+||++|||+.|..||..
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 6554 44568999999999986 2 4688999999999999999999999974
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=271.08 Aligned_cols=177 Identities=27% Similarity=0.391 Sum_probs=143.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
+|+..+.||+|+||.||+|+.. +++.||+|++.............+.+|+.++ |
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778899999999999999864 6889999998755433334456677788776 4
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 4555666555543 234788999999999999999999 8899999999999999999999999999987542210
Q ss_pred C-----------------------------------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCC
Q 047576 504 S-----------------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548 (602)
Q Consensus 504 ~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 548 (602)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 01124689999999999999999999999999999999999999
Q ss_pred CCCC
Q 047576 549 RDLH 552 (602)
Q Consensus 549 f~~~ 552 (602)
|...
T Consensus 236 f~~~ 239 (360)
T cd05627 236 FCSE 239 (360)
T ss_pred CCCC
Confidence 9753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.94 Aligned_cols=219 Identities=22% Similarity=0.272 Sum_probs=157.8
Q ss_pred ccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc----------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER---------------------- 427 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~---------------------- 427 (602)
|...+.||+|+||+||+|.. .+++.||+|.+.............+.+|++++..+.|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999999999986 4788999999876544333334556778888855444
Q ss_pred ---CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 428 ---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 428 ---gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+++...+... ....+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 4443333221 1224889999999999999999999 8899999999999999999999999999987653322
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......|+..|+|||++.+..++.++|+||+|+++|||++|+.||........ .......+.+... ..... .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~--~~~~~---~ 228 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE--VYSAK---F 228 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc--ccCcc---C
Confidence 22234689999999999988899999999999999999999999974321100 0000111111111 11111 2
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 229 ~~~~~~li~~~l~~~P~~ 246 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQ 246 (285)
T ss_pred CHHHHHHHHHHccCCHhH
Confidence 234778999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=270.76 Aligned_cols=177 Identities=23% Similarity=0.331 Sum_probs=141.6
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------- 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------- 423 (602)
.|...+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477888999999999999986 468899999987654433445567888888874
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 4455555555433 234788889999999999999999 8899999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCccccccccccccccccccCcCCccchhHHHH
Q 047576 504 -----------------------------------------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536 (602)
Q Consensus 504 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 536 (602)
.......||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 047576 537 VVTLEVLMGKHPRDLH 552 (602)
Q Consensus 537 vil~elltG~~Pf~~~ 552 (602)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.33 Aligned_cols=222 Identities=21% Similarity=0.245 Sum_probs=154.2
Q ss_pred ccccCcccccccccccceeeecC-----------------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC---
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-----------------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG--- 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g--- 428 (602)
++|...+.||+|+||.||+|+.. ++..||+|.+...... .....+.+|+.++..+.|+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCee
Confidence 46888899999999999999743 2347999998764332 2346788898888555444
Q ss_pred ----------------------cccccccccc----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 047576 429 ----------------------SLFRILHNDA----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470 (602)
Q Consensus 429 ----------------------sL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 470 (602)
+|.+++.... ....++|.++..++.||+.||+||| +.+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 4444332210 0123678889999999999999999 7899
Q ss_pred EEeCCCCCCeeeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc--CC
Q 047576 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM--GK 546 (602)
Q Consensus 471 vH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~ 546 (602)
+||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999976543221 1122345778999999988889999999999999999987 56
Q ss_pred CCCCCCcccccCCCcccchhhhhccCC---CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 547 HPRDLHSTLSSSYDPKIMLIDVLDQRL---PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 547 ~Pf~~~~~~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.||........ .....+...... ...... .....+.+++.+||+.||++
T Consensus 240 ~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 240 QPYGELTDEQV----IENAGEFFRDQGRQVYLFRPP---PCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred CCCCcCCHHHH----HHHHHHHhhhccccccccCCC---CCCHHHHHHHHHHccCCchh
Confidence 67764321100 000011111110 000000 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=267.84 Aligned_cols=178 Identities=26% Similarity=0.396 Sum_probs=143.5
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
+|.....||+|+||.||+|+.. +|+.||+|+++..........+.+.+|+.++ |
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788899999999999999864 6889999999765443333455677787776 4
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 82 YQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 45555555555432 235888999999999999999999 8899999999999999999999999999998765433
Q ss_pred CC-ccccccccccccccccc------cCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SN-QTLLAGSYGYIAPELAY------TMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 22 22346899999999986 455788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=265.61 Aligned_cols=171 Identities=21% Similarity=0.250 Sum_probs=141.8
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.+|...+.||+|+||.||+|.. .+++.||+|.... +.+.+|++++..+.|+++.++....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 5699999999999999999986 4688999997532 3456899999999998887764311
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC-CCC
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD-SSN 505 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~-~~~ 505 (602)
.....+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 163 e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 163 PRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 01234788899999999999999999 789999999999999999999999999999754321 122
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||-.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 2335799999999999998999999999999999999999988743
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=249.42 Aligned_cols=182 Identities=25% Similarity=0.351 Sum_probs=145.9
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-cc---ccccccc-----
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-LF---RILHNDA----- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-L~---~~l~~~~----- 438 (602)
..|...+.+|+|+||+||+|+. .+|+.||+|++...... ...-....+|+.+++.+.|.+ +. ++++...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4577778899999999999986 47899999998765432 112234567999998888777 33 2222110
Q ss_pred ------------------c--h---hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 439 ------------------E--A---VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 439 ------------------~--~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
+ . ..++...++.++.|+++|++||| +++|+||||||.||+++..|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 0 0 12555679999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
|+...-+....+..++|..|+|||++.+. .|+...||||+||+++||++++.-|....+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 99876555555567789999999999887 589999999999999999999999976543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=265.61 Aligned_cols=212 Identities=23% Similarity=0.322 Sum_probs=156.5
Q ss_pred ccccccccccceeeec----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 375 YCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
+.||+|+||.||+++. .+|+.||+|++...... ......+..|++++..+.|+++..+....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4689999999999874 36889999998754332 12234566788888666665554432210
Q ss_pred ---------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 438 ---------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 438 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 01234789999999999999999999 889999999999999999999999999998865443333334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......+.. ....+
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~~~~p~~-----~~~~~ 225 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAKLGMPQF-----LSPEA 225 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCCCCCCCC-----CCHHH
Confidence 5789999999999988899999999999999999999999975321 11222233222221111 11236
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++..|+++||++
T Consensus 226 ~~li~~~l~~~P~~ 239 (318)
T cd05582 226 QSLLRALFKRNPAN 239 (318)
T ss_pred HHHHHHHhhcCHhH
Confidence 78999999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=263.65 Aligned_cols=178 Identities=30% Similarity=0.407 Sum_probs=142.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
++|...+.||+|+||.||+++.. +++.||+|++.+.........+.+.+|+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 35788899999999999999864 6899999998754333333445677777766
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||+++|+|.+++... ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 555666666666431 234788899999999999999999 889999999999999999999999999998765433
Q ss_pred CCC-cccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 503 SSN-QTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 222 223468999999999863 4478899999999999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=271.28 Aligned_cols=177 Identities=23% Similarity=0.330 Sum_probs=141.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
+|.....||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++ |
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999864 6899999998765443333455677888877 4
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 4455555555543 234778888999999999999999 8899999999999999999999999999975321000
Q ss_pred -------------------------------------------CCccccccccccccccccccCcCCccchhHHHHHHHH
Q 047576 504 -------------------------------------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTL 540 (602)
Q Consensus 504 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 540 (602)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0011246899999999999999999999999999999
Q ss_pred HHHcCCCCCCCC
Q 047576 541 EVLMGKHPRDLH 552 (602)
Q Consensus 541 elltG~~Pf~~~ 552 (602)
||++|+.||...
T Consensus 236 ell~G~~Pf~~~ 247 (376)
T cd05598 236 EMLVGQPPFLAD 247 (376)
T ss_pred ehhhCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=262.96 Aligned_cols=180 Identities=26% Similarity=0.306 Sum_probs=147.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~------- 439 (602)
.++|.....||+|+||.||+|+.. +|+.||+|++...... ......+.+|+.++..+.|+++..++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 568999999999999999999864 6889999998654322 2234567789999998888887765532100
Q ss_pred ------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 440 ------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 440 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 123577888899999999999999 88999999999999999999999999999976533
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. ......||+.|+|||++.+..++.++||||+||++|+|+||+.||...
T Consensus 176 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 NF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred Cc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 22 223356889999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=244.64 Aligned_cols=183 Identities=24% Similarity=0.281 Sum_probs=152.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|...+.|++|+||.||+|+.+ +++.||+|+++..... ..+--...+|+.++..+.|+++.++-.-.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 457888899999999999999975 6899999999865422 22333456899999888887776542100
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.-..+|...+++.++.|+++|++||| ...|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 11345888999999999999999999 889999999999999999999999999999999877
Q ss_pred CCCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
....+..+-|..|+|||.+.+.. |+.+.|+||+|||+.||+++++-|.+.+.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 66666678899999999998865 89999999999999999999999976543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=253.44 Aligned_cols=218 Identities=26% Similarity=0.410 Sum_probs=159.6
Q ss_pred ccccCcccccccccccceeeecCC------CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------- 425 (602)
.+|+..+.||+|+||.||+|.... ...||+|.++..... .....+.+|+.++..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468888999999999999997532 357999998754332 2345678888877444
Q ss_pred --------hcCccccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 426 --------ERGSLFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 426 --------~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
++++|.+++..... ...+++.++..++.|++.||+||| +.+++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcC
Confidence 44555554432211 134788889999999999999999 789999999999999999
Q ss_pred CCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------- 232 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999976533221 1223456788999999998889999999999999999998 9999974321
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .+...+......+... .....+.+++..||+.||++
T Consensus 233 ~-~~~~~i~~~~~~~~~~---~~~~~~~~l~~~c~~~~p~~ 269 (283)
T cd05048 233 Q-EVIEMIRSRQLLPCPE---DCPARVYALMIECWNEIPAR 269 (283)
T ss_pred H-HHHHHHHcCCcCCCcc---cCCHHHHHHHHHHccCChhh
Confidence 1 1122222222212111 23455889999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=245.03 Aligned_cols=178 Identities=24% Similarity=0.327 Sum_probs=149.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
-++|+....||+|.||.|.+++-+ .|+.+|+|++++.-.-....+..-..|-.++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367999999999999999999864 7899999999876443222333334444444
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|..+|.|+-.+.. ...+++...+.+..+|+.||.||| +++||+||+|.+|.|+|.+|++||.|||+++.--.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 66777777766654 345888999999999999999999 89999999999999999999999999999987555
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.+......+|||.|.|||++....|+.++|+|.+||+||||++|+.||..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 55566678999999999999999999999999999999999999999974
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=256.42 Aligned_cols=180 Identities=19% Similarity=0.260 Sum_probs=143.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||.|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..+.|+++..+....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 356888899999999999999864 6889999998644321 1234567899999888887766543211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 01123678889999999999999999 88999999999999999999999999999976543332
Q ss_pred Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2333568899999998875 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=258.46 Aligned_cols=178 Identities=25% Similarity=0.328 Sum_probs=141.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+....||+|+||.||+++.. +|..||+|.+...... ...+.+.+|++++..+.|+++..++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 357888999999999999999865 6888999988654221 2346788899888555555544433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.|+.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 012337888899999999999999993 2369999999999999999999999999987654322
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2335689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=266.90 Aligned_cols=178 Identities=25% Similarity=0.350 Sum_probs=141.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 6889999998654333233345567787777444
Q ss_pred ----hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 426 ----ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 426 ----~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++|+|.+++.. ..++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 122 MEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 44455444432 23678888899999999999999 88999999999999999999999999999987643
Q ss_pred CCC-CccccccccccccccccccCc----CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSS-NQTLLAGSYGYIAPELAYTMV----MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 322 223457999999999987543 788999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=263.21 Aligned_cols=218 Identities=23% Similarity=0.355 Sum_probs=170.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
++|...+.+|+|+||.++.++.+ ++..+|+|.+.-...... ..+...+|+.++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 56888899999999999999875 678999999875543322 223556677766
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|+++|++.+.+.+.. +..+++.++.+|+.|++.|+.||| +..|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 5556666666655432 456899999999999999999999 88999999999999999999999999999999987
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
+.......+||+.|++||.+.+.+|..|+||||+||++|||++-+++|+..+.. .-...++.... .|.+.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------~Li~ki~~~~~-~Plp~-- 228 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------ELILKINRGLY-SPLPS-- 228 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-------HHHHHHhhccC-CCCCc--
Confidence 765666789999999999999999999999999999999999999999853221 11122222221 12221
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+..++..|++.+|+.
T Consensus 229 -~ys~el~~lv~~~l~~~P~~ 248 (426)
T KOG0589|consen 229 -MYSSELRSLVKSMLRKNPEH 248 (426)
T ss_pred -cccHHHHHHHHHHhhcCCcc
Confidence 23444788889999999963
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=252.56 Aligned_cols=217 Identities=25% Similarity=0.385 Sum_probs=157.6
Q ss_pred CccccCcccccccccccceeeec-CCCc----EEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------- 425 (602)
.++|...+.||+|+||.||+|+. .+|+ .||+|+++..... ...+.+.+|+.++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLTSTV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCc
Confidence 46788889999999999999974 3444 4899998654332 2345667777766444
Q ss_pred -------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 426 -------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 426 -------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++|++.+++... ...+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 445555444431 234889999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
....... .....++..|+|||+..+..++.++|||||||++|||++ |..||+.... ..+...+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~ 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGERL 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcC
Confidence 6433221 111234678999999998889999999999999999998 9999874321 1122222222111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+... .....+.+++..||+.||++
T Consensus 231 ~~~~---~~~~~~~~li~~~l~~dp~~ 254 (279)
T cd05109 231 PQPP---ICTIDVYMIMVKCWMIDSEC 254 (279)
T ss_pred CCCc---cCCHHHHHHHHHHcCCChhh
Confidence 1111 12345789999999999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=250.27 Aligned_cols=216 Identities=25% Similarity=0.383 Sum_probs=159.9
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
.++|+..+.+|+|++|.||+|...+++.||+|.+...... .+.+.+|+.++..+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 4578889999999999999999888889999988654332 356777888775444
Q ss_pred ----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 427 ----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 427 ----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++|.++++.. ....+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 44444444321 1234788899999999999999999 789999999999999999999999999999876432
Q ss_pred CCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
... .....++..|+|||+..+..++.++|||||||++|+|+| |+.||..... ...... +....+.+....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~~ 228 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-------SDVMSA-LQRGYRMPRMEN 228 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-------HHHHHH-HHcCCCCCCCCC
Confidence 211 122345678999999988889999999999999999999 9999964221 111111 111112111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 229 ---~~~~~~~li~~~l~~~p~~ 247 (261)
T cd05072 229 ---CPDELYDIMKTCWKEKAEE 247 (261)
T ss_pred ---CCHHHHHHHHHHccCCccc
Confidence 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=253.44 Aligned_cols=179 Identities=23% Similarity=0.306 Sum_probs=144.8
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++..+.|+++..+....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 5788899999999999999875 6889999998754322 12345677899988777777665543211
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-C
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-N 505 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~-~ 505 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 01124788889999999999999999 88999999999999999999999999999987643221 2
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 22356899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=251.16 Aligned_cols=223 Identities=20% Similarity=0.271 Sum_probs=163.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------------ 435 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------------ 435 (602)
++|.....+|+|+||.||+|+.. +++.||||.+.............+.+|++++..+.|+++..+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999864 78999999876433333334567788998886666655444332
Q ss_pred -------------ccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 436 -------------NDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 436 -------------~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 111 1223677888999999999999999 88999999999999999999999999999887654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........|++.|+|||++.+..++.++|+||+|+++|||++|+.||..... . .......+.....++...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~-~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----N-LFSLCQKIEQCDYPPLPT-- 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----c-HHHHHHHHhcCCCCCCCh--
Confidence 33222335688899999999888899999999999999999999999863211 0 111122222211111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.||++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~ 251 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQ 251 (267)
T ss_pred hhcCHHHHHHHHHHCCCCccc
Confidence 123355889999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=249.67 Aligned_cols=223 Identities=22% Similarity=0.306 Sum_probs=163.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
++|+..+.+|+|++|.||+|... +|+.||+|.++..........+.+.+|++++..+.|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 789999998864333323345677788887754444
Q ss_pred -----Ccccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 428 -----GSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 428 -----gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++|.+++.... ....+++.++..++.+++.|+.||| +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 44444443211 1234788999999999999999999 88999999999999999999999999999876644
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........++..|+|||++.+..++.++|||||||++|+|++|+.||..... .... ..+.+.....++...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~~~~~~~~-- 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYS-LCKKIEKCDYPPLPA-- 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHH-HHhhhhcCCCCCCCh--
Confidence 33333335688899999999988899999999999999999999999864221 0000 111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.+|++
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~ 251 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEK 251 (267)
T ss_pred hhcCHHHHHHHHHHcCCCccc
Confidence 123345889999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=250.09 Aligned_cols=178 Identities=25% Similarity=0.392 Sum_probs=156.4
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.+|...+.||+|.||.|-+|.. ..|+.||||.+++......+..-.+++|++||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5788999999999999999975 68999999999988877777777899999988
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||..+|.|.+++.+ .+.+++.+++.+++||..|+.|+| ..+++|||||.+|||+|+++.+||+|||++-.+..+
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 55566667666654 445999999999999999999999 889999999999999999999999999999888665
Q ss_pred CCCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
..- ..++|++-|.+||...+.+| ++.+|-||+||+||.++.|..||++.+
T Consensus 207 kfL-qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 207 KFL-QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred cHH-HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 543 44799999999999999987 478999999999999999999999643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=281.52 Aligned_cols=216 Identities=27% Similarity=0.424 Sum_probs=170.6
Q ss_pred cccCcccccccccccceeeecC--CCc----EEeeeccCCchhHHHHHhhhhHhHHHHH---------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP--NGR----VFALKKLNSPETEELAFIRSFRNEAQVL--------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~--~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------- 422 (602)
+......||+|+||.||+|.+. +|. .||+|.+++.... +.+..|.+|..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556678999999999999864 343 4999998766433 4567899998877
Q ss_pred ----HhhhcCcccccccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 423 ----SQMERGSLFRILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 423 ----~~l~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
|||++|+|..++++.. ....++....+.++.|||+|+.||+ ++++|||||-++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999998742 1345888999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCCCc-ccc-ccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh-hhhc
Q 047576 495 TARLLHADSSNQ-TLL-AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI-DVLD 570 (602)
Q Consensus 495 ~a~~~~~~~~~~-~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~d 570 (602)
+|+.+-...... ... .-...|||||.+.++.++.|+|||||||++||++| |..||...+.. +.+. -.-+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------~v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------EVLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------HHHHHHHhC
Confidence 999543322211 111 22368999999999999999999999999999999 89999754321 1222 2233
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+|++|.. +.+.+.+++..||+.+|++
T Consensus 921 gRL~~P~~-----CP~~ly~lM~~CW~~~pe~ 947 (1025)
T KOG1095|consen 921 GRLDPPSY-----CPEKLYQLMLQCWKHDPED 947 (1025)
T ss_pred CccCCCCC-----CChHHHHHHHHHccCChhh
Confidence 46665532 7778999999999999975
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=251.50 Aligned_cols=219 Identities=27% Similarity=0.390 Sum_probs=161.0
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------------- 424 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~----------------- 424 (602)
.++|...+.+|+|+||.||+|+.. +++.||+|.+...... ...+.+.+|+++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 356888899999999999999763 3578999998755432 234678888887744
Q ss_pred --------hhcCcccccccccc-----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 425 --------MERGSLFRILHNDA-----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 425 --------l~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
+++++|.++++... ....+++.++..++.|++.|++|+| +.+++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCC
Confidence 44555555554321 1234788999999999999999999 8899999999999999999
Q ss_pred CcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcc
Q 047576 486 LEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPK 562 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 562 (602)
+.+||+|||.+........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-------~ 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-------E 231 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-------H
Confidence 9999999999876533221 1122345678999999999999999999999999999998 9999864321 1
Q ss_pred cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.......+. . .....+.+++.+||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~ 267 (280)
T cd05049 232 EVIECITQGRLLQRP-R---TCPSEVYDIMLGCWKRDPQQ 267 (280)
T ss_pred HHHHHHHcCCcCCCC-C---CCCHHHHHHHHHHcCCCccc
Confidence 111222222222111 1 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=255.38 Aligned_cols=216 Identities=21% Similarity=0.292 Sum_probs=157.8
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh-------------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------------- 424 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~------------------------- 424 (602)
|+....||+|+||.||+|... +++.||+|.+.............+.+|+.++..
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999999999999864 688999999865543333334556678887744
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+++++|.+++... ....+++.++..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 4445554444321 1234788999999999999999999 88999999999999999999999999999876543222
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc---cCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD---QRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d---~~l~~~~~~~~ 581 (602)
.....|+..|+|||++.+..++.++||||+|+++|+|++|+.||...... ........+++ ...+...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~---- 228 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVQEEYSEKF---- 228 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHHHhhhhhhhhhcCccC----
Confidence 22346899999999999988999999999999999999999999743210 00011111111 1111122
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 229 ---~~~~~~li~~~l~~~p~~ 246 (285)
T cd05630 229 ---SPDARSLCKMLLCKDPKE 246 (285)
T ss_pred ---CHHHHHHHHHHhhcCHHH
Confidence 223778999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=247.63 Aligned_cols=216 Identities=25% Similarity=0.408 Sum_probs=159.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---------------------- 425 (602)
.++|...+.+|+|++|.||+|...+++.||+|.++..... .+.+.+|+.++..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3568888999999999999999878889999998754332 34566777776444
Q ss_pred ---hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 426 ---ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 426 ---~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++++|.+++.... ...+++.++..++.|++.|+.||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 4455555543321 235789999999999999999999 789999999999999999999999999999876532
Q ss_pred CCCc-cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSNQ-TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.... .....+..|+|||+..+..++.++||||||+++|||+| |+.||..... .. ....++.....+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~- 227 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AE-VLQQVDQGYRMPCPP- 227 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HH-HHHHHHcCCCCCCCC-
Confidence 2111 11123457999999998889999999999999999999 9999974321 11 111222222211111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.||++
T Consensus 228 --~~~~~~~~li~~~l~~~P~~ 247 (261)
T cd05068 228 --GCPKELYDIMLDCWKEDPDD 247 (261)
T ss_pred --cCCHHHHHHHHHHhhcCccc
Confidence 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=249.98 Aligned_cols=216 Identities=23% Similarity=0.324 Sum_probs=156.9
Q ss_pred ccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER----------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~----------------- 427 (602)
.+|...+.||+|+||.||+|... .+..||+|.++..... .....+.+|+.++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 46788899999999999999753 4678999998765432 234567888888754444
Q ss_pred --------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 428 --------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 428 --------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
|+|.+++... ...+++.+++.++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 4444444321 235789999999999999999999 889999999999999999999999999987654
Q ss_pred cCCCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 500 HADSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... ......+.+. ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~ 229 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDG-FRLPA 229 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCC-CCCCC
Confidence 322111 111234578999999999999999999999999999775 9999974321 1111222221 11111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. .....+.+++..||+++|++
T Consensus 230 ~~---~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 230 PR---NCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred CC---CCCHHHHHHHHHHcCCCchh
Confidence 11 13445889999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=248.62 Aligned_cols=215 Identities=25% Similarity=0.391 Sum_probs=160.6
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------------- 425 (602)
++|...+.||+|+||.||+|..++++.||+|.+...... ...+.+|+.++..+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY 81 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence 568888999999999999999989999999998755432 24567788877444
Q ss_pred -hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 426 -ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 426 -~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.+++|.+++... ....+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 444554444321 1235788999999999999999999 88999999999999999999999999999977653222
Q ss_pred -CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 -NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .. ....+......+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~-- 227 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------PE-VIQNLERGYRMPRPDN-- 227 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-------HH-HHHHHHcCCCCCCCCC--
Confidence 1222345678999999988889999999999999999999 9999974321 11 1111222221111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
...++.+++.+|++.||++
T Consensus 228 -~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05067 228 -CPEELYELMRLCWKEKPEE 246 (260)
T ss_pred -CCHHHHHHHHHHccCChhh
Confidence 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=248.52 Aligned_cols=216 Identities=28% Similarity=0.413 Sum_probs=162.9
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
.+|...+.+|.|++|.||+|...+++.+|+|.+...... ....+.+|+.++ |
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 468888999999999999999888999999998765442 234566777766 4
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++++|.+++... ....+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+.....+.
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 44555555555432 2345789999999999999999999 7899999999999999999999999999998765433
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.......++..|+|||+..+..++.++||||||+++|+|++ |+.||.... ....+..+. .....+...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~~--- 227 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQIT-AGYRMPCPA--- 227 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHH-hCCcCCCCC---
Confidence 32333345678999999988889999999999999999998 899997432 111112222 222211111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.||++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~ 247 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPED 247 (261)
T ss_pred CCCHHHHHHHHHHcCCCchh
Confidence 13345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=248.04 Aligned_cols=215 Identities=26% Similarity=0.393 Sum_probs=159.0
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
.+|.....||+|+||.||+|+..++..||+|++...... .+.+.+|++++..+.|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEc
Confidence 568888999999999999998877778999998754332 2456778887755544
Q ss_pred ---CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 428 ---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 428 ---gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
|++.+++... ....+++..+..++.|++.||+|+| +.+|+||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 4444444321 1234788999999999999999999 88999999999999999999999999999976643322
Q ss_pred C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. .....++..|+|||+..+..++.++||||||+++|||+| |+.||..... ......+ ....+.+.. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~---~ 226 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQV-ERGYRMPCP---P 226 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------HHHHHHH-hcCCCCCCc---c
Confidence 1 122346678999999988889999999999999999999 8889864321 1111111 111111111 1
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
+....+.+++.+|+++||++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~ 246 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEE 246 (262)
T ss_pred ccCHHHHHHHHHHccCCccc
Confidence 23455889999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=259.79 Aligned_cols=180 Identities=25% Similarity=0.293 Sum_probs=147.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|...+.||+|+||.||+|... .++.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 578999999999999999999864 6889999998754322 123456678999998888888766543210
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
-...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 0123677888899999999999999 88999999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 172 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 172 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223356899999999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.69 Aligned_cols=216 Identities=22% Similarity=0.298 Sum_probs=155.2
Q ss_pred ccccCcccccccccccceeeecC-CCc----EEeeeccCCchhHHHHHhhhhHhHHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGR----VFALKKLNSPETEELAFIRSFRNEAQVLS-------------------- 423 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~-------------------- 423 (602)
.+|...+.||+|+||.||+|+.. +++ .+++|.+...... .....+..|+.++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHHHHHHhcCCCCCcceEEEEECCCccE
Confidence 46788899999999999999863 444 4788887543221 23345666665553
Q ss_pred ----hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 424 ----QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 424 ----~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
|+++|+|.+++... ...+++..+..++.||+.||+|+| +++++||||||+||++++++.+||+|||.++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 44455555555431 234789999999999999999999 789999999999999999999999999999865
Q ss_pred cCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 500 HADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
..... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... ....+++......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~ 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERLA 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcCC
Confidence 43221 1223456778999999998899999999999999999998 9999975321 11122222211111
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... +...+.+++.+||+.||++
T Consensus 232 ~~~~---~~~~~~~li~~c~~~~p~~ 254 (279)
T cd05111 232 QPQI---CTIDVYMVMVKCWMIDENV 254 (279)
T ss_pred CCCC---CCHHHHHHHHHHcCCCccc
Confidence 1111 2234678899999999974
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=247.98 Aligned_cols=223 Identities=19% Similarity=0.255 Sum_probs=163.4
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc--------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI-------------- 433 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~-------------- 433 (602)
++|.....||+|++|.||+|+. .+++.+|||.+...........+.+.+|+.++..+.|+++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 5789999998865443333445677888888866655544433
Q ss_pred -----------cccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 434 -----------LHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 434 -----------l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+... .....+++.++..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 3211 11234788999999999999999999 88999999999999999999999999999877654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........|+..|+|||+..+..++.++|+||||+++|+|++|..||...... .......+.....++....
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~-- 231 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYPPLPSD-- 231 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhhcCCCCCCCcc--
Confidence 333233356888999999998888999999999999999999999998632110 0011111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+||+.||++
T Consensus 232 -~~~~~~~~li~~~l~~~p~~ 251 (267)
T cd08229 232 -HYSEELRQLVNMCINPDPEK 251 (267)
T ss_pred -cccHHHHHHHHHhcCCCccc
Confidence 13345889999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=249.51 Aligned_cols=196 Identities=23% Similarity=0.361 Sum_probs=158.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH--------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ-------------------------- 420 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~-------------------------- 420 (602)
..+|.....||+|+||.|.+|..+ +.+.+|||++++.-.-....++.-..|-.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888889999999999999765 56789999998653221111111111222
Q ss_pred HHHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 421 VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 421 il~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+|||+.+|+|.-.+... ..+.++.++.+|.+||-||-||| ++|||+||||.+|||+|.+|++||.|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 34899999998777653 34788999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
.+.......+|||.|+|||.+...+|+..+|+|||||+||||+.|++||++. ++++.+..+.+.....|
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-------DE~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-------DEDELFQAIMEHNVSYP 570 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHHccCcCc
Confidence 5555666789999999999999999999999999999999999999999853 34556677777776544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=248.85 Aligned_cols=213 Identities=23% Similarity=0.339 Sum_probs=157.3
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------- 429 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------- 429 (602)
.+|+....||+|+||.||+|+..++..+|+|.+...... ...+.+|+.++..+.|++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 457778899999999999999888889999988654332 245677888775555444
Q ss_pred ------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 430 ------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 430 ------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 44444321 124789999999999999999999 7899999999999999999999999999987653322
Q ss_pred CC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccC-CCCCCChh
Q 047576 504 SN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQR-LPPPVDRK 580 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~ 580 (602)
.. .....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+.+.. ...+. .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~~~~~--~ 225 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRLYRPK--L 225 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCCCCCC--C
Confidence 11 112235568999999988889999999999999999999 9999974321 11112222111 11111 1
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 226 ---~~~~~~~li~~c~~~~p~~ 244 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEG 244 (256)
T ss_pred ---CCHHHHHHHHHHccCCccc
Confidence 2235889999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=258.28 Aligned_cols=217 Identities=26% Similarity=0.399 Sum_probs=161.7
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-------------------- 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-------------------- 428 (602)
+.|...+.||+||.+.||++...+.+.||+|++.....+ .+....|.+|+..++.+.+.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457778899999999999999988899999887644332 34678899999999665542
Q ss_pred -----ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 429 -----SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 429 -----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+|.++|.... ....+| .++.|..|++.|+.++| ..||||.||||+|+|+= .|.+||+|||+|..+..+.
T Consensus 440 E~Gd~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecccccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 1222222211 111234 67889999999999999 78999999999999984 4689999999999887665
Q ss_pred CC--ccccccccccccccccccCc-----------CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 504 SN--QTLLAGSYGYIAPELAYTMV-----------MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 504 ~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
.. ...-+||+.||+||.+.... .+.++||||+|||+|+|+.|+.||..... .-.++..+.|
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aKl~aI~~ 587 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAKLHAITD 587 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHHHHhhcC
Confidence 43 23357999999999875432 56789999999999999999999975421 2334567777
Q ss_pred cCC--CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRL--PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l--~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.- ..|.-. .-.++++++..|+++||++
T Consensus 588 P~~~Iefp~~~----~~~~li~~mK~CL~rdPkk 617 (677)
T KOG0596|consen 588 PNHEIEFPDIP----ENDELIDVMKCCLARDPKK 617 (677)
T ss_pred CCccccccCCC----CchHHHHHHHHHHhcCccc
Confidence 743 222211 2223899999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=271.61 Aligned_cols=217 Identities=21% Similarity=0.208 Sum_probs=159.6
Q ss_pred ccccCcccccccccccceeeecC-C-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-N-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
..|.....+|+|++|.||+|... + ++.||+|........ ....+.+|+.++..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER---QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 45888999999999999999753 3 678888876544332 234567788887444
Q ss_pred ----hcCccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 426 ----ERGSLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 426 ----~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++|+|.+.+... ....++++.++..++.|++.||+|+| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 455554444321 11234788899999999999999999 8899999999999999999999999999998764
Q ss_pred CCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 501 ADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+..+......+. .
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~~-~ 292 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDPF-P 292 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCC-C
Confidence 3221 12335699999999999999999999999999999999999999974221 111222222222211 1
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++.+||+.||++
T Consensus 293 ~~---~s~~~~~li~~~L~~dP~~ 313 (478)
T PTZ00267 293 CP---VSSGMKALLDPLLSKNPAL 313 (478)
T ss_pred cc---CCHHHHHHHHHHhccChhh
Confidence 11 2234788999999999974
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=247.14 Aligned_cols=217 Identities=25% Similarity=0.371 Sum_probs=159.0
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc-------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL------------- 430 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL------------- 430 (602)
+++|+..+.||+|+||.||+|+.. +...||+|.++..... .....|.+|+.++..+.|+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 467889999999999999999864 2457999988754332 234567788888755555444
Q ss_pred ------------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 431 ------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 431 ------------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.+++... ...+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 4333321 225789999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+.+. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~-~~~ 227 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDG-YRL 227 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcC-CCC
Confidence 7522111 112234578999999998889999999999999999998 999986321 11111222221 111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+... .....+.+++.+|++.||++
T Consensus 228 ~~~~---~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 228 PPPM---DCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCccc
Confidence 1111 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=271.65 Aligned_cols=213 Identities=30% Similarity=0.467 Sum_probs=175.1
Q ss_pred cccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
...+.+.||.|.||+||+|+++ .-..||||.++..-.+ .+...|..|+.||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456788999999999999874 2357999999876544 3567899999988
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
|||++|+|..+|+.+. ..|++.+.+.+.++||.|++||- ++++|||||-++|||++.+...|++|||+++.+.
T Consensus 708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999998743 45999999999999999999999 8999999999999999999999999999999886
Q ss_pred CCCCCccccc-c--ccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhh-hccCCCC
Q 047576 501 ADSSNQTLLA-G--SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDV-LDQRLPP 575 (602)
Q Consensus 501 ~~~~~~~~~~-g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~-~d~~l~~ 575 (602)
++........ | ...|.|||.+..++++.++|||||||+|||.++ |.+||.. +...+.+.++ -+.+||+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd-------mSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------MSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc-------cchHHHHHHHHhccCCCC
Confidence 6553322222 2 368999999999999999999999999999776 9999753 2223334444 3457787
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
|.+ ++..+.++++.|||+|-.
T Consensus 856 PmD-----CP~aL~qLMldCWqkdR~ 876 (996)
T KOG0196|consen 856 PMD-----CPAALYQLMLDCWQKDRN 876 (996)
T ss_pred CCC-----CcHHHHHHHHHHHHHHhh
Confidence 765 888899999999999843
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=258.90 Aligned_cols=180 Identities=25% Similarity=0.298 Sum_probs=146.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|... .++.||||++...... ....+.+.+|+.+++.+.|+++..++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 568999999999999999999864 6889999998754322 123456778999998888887766543110
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
-...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 0123578888899999999999999 88999999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 179 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 179 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 22 223356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=252.16 Aligned_cols=171 Identities=25% Similarity=0.396 Sum_probs=135.9
Q ss_pred cccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 374 KYCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
...||+|+||.||+|+.. +++.||+|.+...... ..+.+|+.++..+.|+++.++....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999854 5678999998654322 3456799999888888876653311
Q ss_pred -------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee----CCCCcceeeccc
Q 047576 438 -------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL----NSKLEAFVADFG 494 (602)
Q Consensus 438 -------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFG 494 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+|||+ +..+.+||+|||
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 00123778889999999999999999 8899999999999999 456789999999
Q ss_pred ccccccCCCC---CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSS---NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9987643221 12235689999999998774 5889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.26 Aligned_cols=215 Identities=25% Similarity=0.429 Sum_probs=160.3
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
++|+..+.+|+|++|.||+|..+++..+|+|.+...... .+.+.+|+.++..+.|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEe
Confidence 568888999999999999999888889999998764432 2457788887755444
Q ss_pred ---CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 428 ---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 428 ---gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
++|.++++.. ....+++.++..++.|++.|++||| +.+|+||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 4444444321 1234789999999999999999999 78999999999999999999999999999987643221
Q ss_pred C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. .....++..|+|||+..+..++.++|+||||+++|+|++ |+.||..... .. ..+.+....+.+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~--- 226 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------RE-VLEQVERGYRMPCPQ--- 226 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HH-HHHHHHcCCCCCCCC---
Confidence 1 112235567999999988889999999999999999999 8999964221 11 122222222222221
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|+++||++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEE 246 (260)
T ss_pred cCCHHHHHHHHHHcccCccc
Confidence 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=247.94 Aligned_cols=221 Identities=26% Similarity=0.418 Sum_probs=166.3
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.++....+.+|+|.||+||+|++ .|+.||||++...+. +.+.+|.+|+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45678889999999999999999 589999999976543 3344566655
Q ss_pred ------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 423 ------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
+|-++|+|+++|.. ..++....++++..+|.||+|||.. .++.|.|||||+.|||+..++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 77889999999975 3488899999999999999999953 46789999999999999999999999
Q ss_pred cccccccccCCCC----CccccccccccccccccccCc------CCccchhHHHHHHHHHHHcC----------CCCCCC
Q 047576 492 DFGTARLLHADSS----NQTLLAGSYGYIAPELAYTMV------MTEKYDVYSFGVVTLEVLMG----------KHPRDL 551 (602)
Q Consensus 492 DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG----------~~Pf~~ 551 (602)
|+|+|.....+.. .....+||..|||||++.... .-..+||||||.|+||+..+ +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999987655422 233458999999999987542 12458999999999999753 457764
Q ss_pred CcccccCCCcccchhhhhccCCCCCCCh--hhHHHHHHHHHHHhhccCcCCC
Q 047576 552 HSTLSSSYDPKIMLIDVLDQRLPPPVDR--KVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.-+.....++. ..-+-.++++|..+. ...+++..+.+++..||..+|+
T Consensus 439 ~Vp~DPs~eeM--rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 439 VVPSDPSFEEM--RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred CCCCCCCHHHH--hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 33322232222 122223334333321 2245777899999999999996
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=269.09 Aligned_cols=173 Identities=20% Similarity=0.329 Sum_probs=133.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS----------------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs----------------- 429 (602)
.++|...+.||+|+||.||+|... .++.||||+++.... ....+..|+++++.+.+.+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 467999999999999999999864 678999999864321 1223444555554443322
Q ss_pred --------------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCC--------
Q 047576 430 --------------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKL-------- 486 (602)
Q Consensus 430 --------------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~-------- 486 (602)
+.+++. ....+++.++..|+.||+.||+||| + .+||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CceEEEEEeccCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 111111 1234788999999999999999999 5 5999999999999998765
Q ss_pred --------cceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 487 --------EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 487 --------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 489999998754322 2234679999999999999999999999999999999999999997543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.45 Aligned_cols=219 Identities=26% Similarity=0.323 Sum_probs=158.0
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
.++|+....+|+|+||.||+|... ++..||+|++...... .....+.+|+.++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 467889999999999999998642 3568999988644322 2234577788776
Q ss_pred ------HhhhcCccccccccccc-------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcce
Q 047576 423 ------SQMERGSLFRILHNDAE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~k 489 (602)
+|+++++|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 44455555555433111 123578889999999999999999 78999999999999999999999
Q ss_pred eecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Confidence 9999998765332211 111245678999999998889999999999999999999 788986432 111222
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+...+... . .....+.+++.+|++.||++
T Consensus 233 ~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05062 233 FVMEGGLLDKP-D---NCPDMLFELMRMCWQYNPKM 264 (277)
T ss_pred HHHcCCcCCCC-C---CCCHHHHHHHHHHcCCChhh
Confidence 22232222111 1 13345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=245.39 Aligned_cols=217 Identities=26% Similarity=0.423 Sum_probs=161.8
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------- 429 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------- 429 (602)
+|...+.+|+|++|.||+|+.. +++.|++|.+...... ....+.+.+|++++..+.|++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 3667788999999999999864 6889999988643322 223456778888775555444
Q ss_pred ------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 430 ------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 430 ------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|.++++.. ....+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 44444321 1235788899999999999999999 7899999999999999999999999999988765443
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.......|++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ......+.....++. .. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~---~ 224 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPPV-SQ---M 224 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC-cc---c
Confidence 333345688999999999998899999999999999999999999974321 111222222222211 11 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQ 243 (256)
T ss_pred cCHHHHHHHHHHccCCccc
Confidence 2345889999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=266.08 Aligned_cols=174 Identities=24% Similarity=0.307 Sum_probs=138.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN---------- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~---------- 436 (602)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.++..+.|.++..+...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999864 68899999885432 123468888888888776543210
Q ss_pred ----------c-------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeec
Q 047576 437 ----------D-------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVAD 492 (602)
Q Consensus 437 ----------~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~D 492 (602)
. .....+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence 0 01234678889999999999999999 88999999999999999665 699999
Q ss_pred ccccccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
||+++....... .....||+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 215 FGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987643322 2235689999999998764 6899999999999999999999999754
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=250.57 Aligned_cols=218 Identities=23% Similarity=0.328 Sum_probs=159.0
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc-------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------- 435 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------- 435 (602)
.+|...+.||+|+||.||+|+.. +++.||+|+++..... ...+.+.+|+.++..+.|.++.+++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 35777889999999999999753 3578999999754432 23456778888876666555543321
Q ss_pred ------------------cc-------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 436 ------------------ND-------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 436 ------------------~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
.. .....+++..+..++.|++.||+|+| +++|+||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence 10 01124788889999999999999999 889999999999999999
Q ss_pred CCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||+++....... ......+++.|+|||++.++.++.++||||||+++|||++ |..||.... .
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~ 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------N 232 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------H
Confidence 99999999999876533221 1122345678999999988889999999999999999998 888886421 1
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+.... +... .....+.+++..||++||++
T Consensus 233 ~~~~~~i~~~~~~-~~~~---~~~~~~~~li~~cl~~~p~~ 269 (283)
T cd05091 233 QDVIEMIRNRQVL-PCPD---DCPAWVYTLMLECWNEFPSR 269 (283)
T ss_pred HHHHHHHHcCCcC-CCCC---CCCHHHHHHHHHHhCCCccc
Confidence 2222333333322 1111 13445889999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=248.87 Aligned_cols=218 Identities=22% Similarity=0.356 Sum_probs=158.4
Q ss_pred ccccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------- 432 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------- 432 (602)
..|+....||+|+||.||+|+. .++..||+|.+...... .....+.+|++++..+.|+++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4577788999999999999973 35678999998754332 23456788888886655555443
Q ss_pred --------------cccccc--------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 433 --------------ILHNDA--------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 433 --------------~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
++.... ....+++.+...++.|++.||+||| +++|+||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence 332100 0123678888999999999999999 789999999999999999
Q ss_pred CCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------- 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------- 232 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999976543221 1222345678999999988889999999999999999999 9999864321
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.++.....+.... ....+.+++..||+.||++
T Consensus 233 -~~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~ 269 (283)
T cd05090 233 -QEVIEMVRKRQLLPCSED---CPPRMYSLMTECWQEGPSR 269 (283)
T ss_pred -HHHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcccCccc
Confidence 112233332222111111 2345888999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=257.13 Aligned_cols=178 Identities=28% Similarity=0.398 Sum_probs=145.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.+.|.++..++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 46788899999999999999985 46889999998754332 22345567899999888887766544210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 01134788999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 170 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred CC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 32 223468999999999877 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=247.61 Aligned_cols=223 Identities=23% Similarity=0.307 Sum_probs=163.5
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA---------- 438 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---------- 438 (602)
+|...+.||+|+||.||+|+. .+++.||+|.+...... ...+.+.+|+.++..+.|+++..++....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 567778999999999999985 47889999988654222 23456888999998888887776553210
Q ss_pred --c------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 439 --E------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 439 --~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
+ ...+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.+||+|||++...... ......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (279)
T cd06619 80 FMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYV 154 (279)
T ss_pred cCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCC
Confidence 0 123678888999999999999999 889999999999999999999999999999765432 223357
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
|+..|+|||++.+..++.++||||||+++|+|++|+.||..................+.+...+..... .....+.+
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG---QFSEKFVH 231 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC---cCCHHHHH
Confidence 889999999999888999999999999999999999999753221111111111122222211111000 12234789
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++.+|+++||++
T Consensus 232 li~~~l~~~P~~ 243 (279)
T cd06619 232 FITQCMRKQPKE 243 (279)
T ss_pred HHHHHhhCChhh
Confidence 999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=249.65 Aligned_cols=217 Identities=26% Similarity=0.396 Sum_probs=157.9
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------- 425 (602)
++|...+.+|+|+||.||++.. .++..+|+|.+...... ..+.+.+|++++..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5688889999999999999973 23567899988754322 345677888877444
Q ss_pred --------hcCcccccccccc----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc
Q 047576 426 --------ERGSLFRILHNDA----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE 487 (602)
Q Consensus 426 --------~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~ 487 (602)
++++|.+++.... ....+++.++..++.|++.||+||| +++++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 4455544443211 1124899999999999999999999 889999999999999999999
Q ss_pred ceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccc
Q 047576 488 AFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIM 564 (602)
Q Consensus 488 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 564 (602)
+||+|||.+......... .....++..|+|||++.+..++.++|||||||++|+|+| |+.||..... ...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~ 231 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV 231 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 999999999765432211 122345678999999998889999999999999999998 9999864321 111
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+........ .+. ....+.+++.+||+.||.+
T Consensus 232 ~~~i~~~~~~~~-~~~---~~~~l~~li~~~l~~~p~~ 265 (288)
T cd05093 232 IECITQGRVLQR-PRT---CPKEVYDLMLGCWQREPHM 265 (288)
T ss_pred HHHHHcCCcCCC-CCC---CCHHHHHHHHHHccCChhh
Confidence 122222221111 111 2234889999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=248.05 Aligned_cols=218 Identities=24% Similarity=0.334 Sum_probs=156.3
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
.+|.....+|+|+||.||+|+. .+++.||+|++...... ....+.+|+.++..+.|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 4688899999999999999986 47889999998644322 12346677777754444
Q ss_pred -----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 428 -----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 428 -----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++|.++++. ...+++..+..++.|++.|++||| +.+|+|||+||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 444444432 234788899999999999999999 789999999999999999999999999999866433
Q ss_pred CCCccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 503 SSNQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
........|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.... ..+....+.++...
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~ 232 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSNFQPPKLK 232 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCCCCCCCCc
Confidence 22223346888999999874 344778999999999999999999998643221111 11111111111100
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++.+||+.||++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~ 255 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKK 255 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhh
Confidence 00112345889999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=244.91 Aligned_cols=215 Identities=24% Similarity=0.404 Sum_probs=159.0
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------------- 425 (602)
++|.....||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEc
Confidence 46888899999999999999987777899998765432 224567788877444
Q ss_pred -hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 426 -ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 426 -~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.+++|.++++.. ....+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 445555555432 1234788999999999999999999 78999999999999999999999999999976643221
Q ss_pred C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. .....++..|+|||+..+..++.++||||||+++|||+| |+.||..... ...... +......+...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~--- 226 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-------REVLEQ-VERGYRMPCPQ--- 226 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCc---
Confidence 1 122345678999999988889999999999999999999 9999974321 111111 11122212111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+||++||++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~ 246 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDE 246 (260)
T ss_pred ccCHHHHHHHHHHccCCccc
Confidence 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=244.08 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=154.9
Q ss_pred cccccccccceeeec---CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------------
Q 047576 376 CIGTGAYGSVYKAQL---PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------------- 437 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------------- 437 (602)
.||+|+||.||+|.. .++..+|+|+++..... ....+.+.+|+.++..+.|+++..++...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCC
Confidence 589999999999964 36789999998644322 23456788888888666665554433210
Q ss_pred ------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC---ccc
Q 047576 438 ------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---QTL 508 (602)
Q Consensus 438 ------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~---~~~ 508 (602)
.....+++..+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||.+......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 01234788999999999999999999 889999999999999999999999999999876443221 111
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
..++..|+|||.+....++.++|+||||+++|||++ |+.||..... ....+.++....++.... ....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~---~~~~ 226 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIESGERMECPQR---CPPE 226 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCC---CCHH
Confidence 234578999999988888999999999999999998 9999974321 112223333222221111 2344
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..||+.||++
T Consensus 227 l~~li~~~~~~~p~~ 241 (257)
T cd05116 227 MYDLMKLCWTYGVDE 241 (257)
T ss_pred HHHHHHHHhccCchh
Confidence 789999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=245.44 Aligned_cols=215 Identities=26% Similarity=0.361 Sum_probs=157.6
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
.+|...+.+|+|++|.||+|... .++.||+|.+...... ...+.+|++++..+.|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 45778889999999999999864 5889999998754322 3456778877744444
Q ss_pred -----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 428 -----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 428 -----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++|.+++.... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 44444443211 234788999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCc-cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSNQ-TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.... ....++..|+|||+..+..++.++|||||||++|||++ |..||..... ......+......+....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKGYRMERPEG 229 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCC
Confidence 2211 11224567999999998899999999999999999998 9999864221 111122222222221111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 230 ---~~~~~~~li~~cl~~~p~~ 248 (263)
T cd05052 230 ---CPPKVYELMRACWQWNPSD 248 (263)
T ss_pred ---CCHHHHHHHHHHccCCccc
Confidence 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=257.94 Aligned_cols=180 Identities=27% Similarity=0.352 Sum_probs=144.0
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|+..+.||+|+||.||+|+. .+|+.||+|++...... ....+.+.+|++++..+.|+++..++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 367788999999999999986 47899999998654322 12345678899999888887776544211
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 01234788999999999999999999 889999999999999999999999999999865432
Q ss_pred CC-CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 503 SS-NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.. ......+++.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 21 22234678899999998875 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=247.93 Aligned_cols=223 Identities=26% Similarity=0.438 Sum_probs=162.9
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.......+++|+|.||.||+|++ +++.||||++.... .+.|++|..|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34566678999999999999999 45999999996432 45677777766
Q ss_pred ------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhc------CCCCeEEeCCCCCCeeeCCCCccee
Q 047576 423 ------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD------CSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
+|-+.|+|.++|.. ..++|.+..+++..+++||+|||+. ++++|+|||||+.|||+..|+...|
T Consensus 282 eywLVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 33345555555543 2379999999999999999999964 4678999999999999999999999
Q ss_pred ecccccccccCCCCC--ccccccccccccccccccCc-C-----CccchhHHHHHHHHHHHcCCCCCC--CCcccccCCC
Q 047576 491 ADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMV-M-----TEKYDVYSFGVVTLEVLMGKHPRD--LHSTLSSSYD 560 (602)
Q Consensus 491 ~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGvil~elltG~~Pf~--~~~~~~~~~~ 560 (602)
+|||+|..+...... ....+||..|||||++.+.. . -.+.||||+|.+||||+++-..++ ...++...++
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988654332 22257999999999987653 1 135899999999999999765543 1111111111
Q ss_pred --------cccchhhhhccCCCCCCChh--hHHHHHHHHHHHhhccCcCCC
Q 047576 561 --------PKIMLIDVLDQRLPPPVDRK--VIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 561 --------~~~~~~~~~d~~l~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
-+++..-++..+.+|..... ....+..+.+.+..||+.||+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae 488 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE 488 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence 12333445555555444321 124667799999999999986
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=253.85 Aligned_cols=174 Identities=26% Similarity=0.380 Sum_probs=140.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
++|+....||+|+||.||+|+.. ++..+|+|.+...... .....+.+|++++..+.
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 57889999999999999999875 6888999987654221 23456778888875444
Q ss_pred ----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 427 ----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 427 ----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++|.+++.. ...+++..+..++.|++.|+.|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 4444444432 2247788889999999999999993 247999999999999999999999999998765332
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred c--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 2234688999999999988899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=233.07 Aligned_cols=221 Identities=22% Similarity=0.302 Sum_probs=156.5
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND--------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~--------- 437 (602)
++......+|.|+.|.||++++. .|...|||.+.+....+ ..+++...+.++-... -+-+...+...
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 34555677999999999999875 58899999998765442 2355555666552111 11111111100
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
....++++...-++...+++||.||.+ .++|+|||+||+|||+|+.|.+|+||||++..+.....
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 113346777777888999999999987 67999999999999999999999999999988765444
Q ss_pred Ccccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
+ +...|.+.|||||.+.- ..|+.++||||||++++|+.||+.||..... +-+.+..+++.+.+ ..+..
T Consensus 248 h-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t------dFe~ltkvln~ePP-~L~~~- 318 (391)
T KOG0983|consen 248 H-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT------DFEVLTKVLNEEPP-LLPGH- 318 (391)
T ss_pred c-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc------cHHHHHHHHhcCCC-CCCcc-
Confidence 3 33578999999998864 3588999999999999999999999986432 22334445553322 11110
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..-...+.+++..|+++|+.+
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred cCcCHHHHHHHHHHhhcCccc
Confidence 112334888999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=232.95 Aligned_cols=221 Identities=24% Similarity=0.322 Sum_probs=167.8
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
.++.|+..+.||+|.|+.||++.. ++|+.+|+|.+........ ..+.+.+|+.|-..+.|+++.++.+...
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 467889999999999999999965 6799999999875544322 4577889999998888888776543211
Q ss_pred ---------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeeccccccccc
Q 047576 439 ---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG~a~~~~ 500 (602)
.+..+++..+-.+++||+.||.|+| ..+|||||+||+|+++- ..--+||+|||+|....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 1223567777889999999999999 88999999999999993 34568999999999887
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC--CCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL--PPPVD 578 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l--~~~~~ 578 (602)
++......+|||+|||||++...+|+..+|||+.||+||-++.|..||...+. ..-++.+..... ++++-
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhccccCCCCccc
Confidence 55555667899999999999999999999999999999999999999975221 111222322222 22211
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. -.+.-.+++.+.+..||++
T Consensus 237 ~~---is~~Ak~LvrrML~~dP~k 257 (355)
T KOG0033|consen 237 DT---VTPEAKSLIRRMLTVNPKK 257 (355)
T ss_pred Cc---CCHHHHHHHHHHhccChhh
Confidence 11 2223567788888888874
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=244.05 Aligned_cols=208 Identities=21% Similarity=0.328 Sum_probs=151.5
Q ss_pred ccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------------
Q 047576 377 IGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------------- 432 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------------- 432 (602)
||+|+||.||+|... .+..||+|++...... ...+.+.+|+.+++.+.|+++..
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCC
Confidence 799999999999653 4567999998755322 23466888888886665555443
Q ss_pred ---ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc---
Q 047576 433 ---ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ--- 506 (602)
Q Consensus 433 ---~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~--- 506 (602)
++.. ....+++.++.+++.|++.|++||| +++++||||||+||+++.++.+||+|||++.....+....
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 3322 1234788999999999999999999 7899999999999999999999999999998654332211
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ......+....+.+.+.. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~---~~ 224 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPAE---CP 224 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCCC---CC
Confidence 11223568999999988889999999999999999996 9999974321 111222222222221111 23
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++..||+.||++
T Consensus 225 ~~l~~li~~c~~~~~~~ 241 (257)
T cd05115 225 PEMYALMKDCWIYKWED 241 (257)
T ss_pred HHHHHHHHHHcCCChhh
Confidence 45789999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=242.66 Aligned_cols=182 Identities=27% Similarity=0.360 Sum_probs=148.3
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
..|...+.+|+|+||.|..|.. .+|+.||||++........ ..++..+|+.++++++|.++..+.+-..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4565578899999999999986 4789999999975554433 4566778999999999988766543210
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
....++...+..++.|+++||.|+| +.+|+|||+||+|++++.+..+||+|||+|+....
T Consensus 101 vYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccc
Confidence 1222677778889999999999999 99999999999999999999999999999998854
Q ss_pred C--CCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 502 D--SSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 502 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
. ....+..+.|..|+|||.+.. ..|+.+.||||.|||+.||++|++-|.+.+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 2 222355678999999998764 5699999999999999999999999987554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.92 Aligned_cols=214 Identities=23% Similarity=0.327 Sum_probs=156.2
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------- 429 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------- 429 (602)
.+|+..+.+|+|++|.||+|+.+++..+|+|.+...... ...+.+|++++..+.|++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 457888999999999999999877788999998654332 234667888775555444
Q ss_pred ------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 430 ------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 430 ------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|.+++... ...+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 44433321 124789999999999999999999 8899999999999999999999999999987654322
Q ss_pred CCc-cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 SNQ-TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
... ....++..|+|||++.+..++.++||||||+++|||++ |+.||+...+. . ..+.+....+.+....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~~- 225 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------E-VVESVSAGYRLYRPKL- 225 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------H-HHHHHHcCCcCCCCCC-
Confidence 111 11223457999999998899999999999999999999 89999743221 1 1111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 226 --~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05059 226 --APTEVYTIMYSCWHEKPED 244 (256)
T ss_pred --CCHHHHHHHHHHhcCChhh
Confidence 3345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=260.27 Aligned_cols=148 Identities=23% Similarity=0.334 Sum_probs=111.5
Q ss_pred hhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC--Ccccccccccccccc
Q 047576 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPE 519 (602)
Q Consensus 442 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE 519 (602)
.+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ......++..|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 3778888999999999999999 88999999999999999999999999999986543221 122234677899999
Q ss_pred ccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCc
Q 047576 520 LAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQS 598 (602)
Q Consensus 520 ~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~ 598 (602)
++.+..++.++|||||||++|||++ |..||..... ...+...+......+... .....+.+++..||+.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~ 379 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-------DSTFYNKIKSGYRMAKPD---HATQEVYDIMVKCWNS 379 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-------hHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHHCcc
Confidence 9998889999999999999999997 9999874211 111111122211111111 1334588999999999
Q ss_pred CCCC
Q 047576 599 NPKS 602 (602)
Q Consensus 599 dP~e 602 (602)
||++
T Consensus 380 dP~~ 383 (400)
T cd05105 380 EPEK 383 (400)
T ss_pred CHhH
Confidence 9974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=249.99 Aligned_cols=217 Identities=28% Similarity=0.406 Sum_probs=159.4
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|.....||+|+||.||+|+. .++..+++|.+...... ..+.+.+|++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 4577888999999999999974 24567999998655432 335677788877
Q ss_pred -----HhhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 423 -----SQMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
+|+++++|.+++.... ....+++.++..++.|++.|++||| +++|+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence 4555566665554321 1234789999999999999999999 889999999999999999
Q ss_pred CCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||.+........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------- 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------- 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999976543221 1222446788999999998889999999999999999999 9999864321
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+......... . .....+.+++.+||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~P~~ 268 (291)
T cd05094 232 TEVIECITQGRVLERP-R---VCPKEVYDIMLGCWQREPQQ 268 (291)
T ss_pred HHHHHHHhCCCCCCCC-c---cCCHHHHHHHHHHcccChhh
Confidence 1111222222221111 1 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=244.45 Aligned_cols=214 Identities=21% Similarity=0.315 Sum_probs=158.3
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------------- 433 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------------- 433 (602)
++|.....+|+|++|.||+|+..++..+|+|.+...... ...+.+|+.+++.+.|+++.++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 467788899999999999998877778999988754332 2457788888866665554443
Q ss_pred ----------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 434 ----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 434 ----------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+... ...+++.++..++.||+.|++||| +.+++|+||||+||+++.++.+||+|||.++....+.
T Consensus 80 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 3221 124789999999999999999999 8899999999999999999999999999987654332
Q ss_pred CC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 SN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. .....++..|+|||+..+..++.++||||||+++|+|++ |+.||..... ......+.+.... +....
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~- 225 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRL-YRPHL- 225 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCC-CCCCC-
Confidence 21 111235567999999988889999999999999999999 9999974321 1111122222111 11111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 226 --~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05113 226 --ASEKVYAIMYSCWHEKAEE 244 (256)
T ss_pred --CCHHHHHHHHHHcCCCccc
Confidence 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=244.83 Aligned_cols=216 Identities=23% Similarity=0.307 Sum_probs=154.9
Q ss_pred cCcccccccccccceeeecCC-Cc--EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc------------
Q 047576 372 DSKYCIGTGAYGSVYKAQLPN-GR--VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN------------ 436 (602)
Q Consensus 372 ~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~------------ 436 (602)
.....||+|+||.||+|+..+ +. .||+|.++..... ....+.+.+|++++..+.|+++.+++..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999998754 32 5899988654322 1234667788888876666665554321
Q ss_pred -------------------c---cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 437 -------------------D---AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 437 -------------------~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
. .....+++.....++.|++.||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 0 01123678899999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhcc
Q 047576 495 TARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 495 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
+++........ .....+++.|+|||+..+..++.++||||||+++|||++ |+.||..... ......+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence 99876432211 112245678999999999889999999999999999999 8899964321 1111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... +... .....+.+++.+||+.||++
T Consensus 231 ~~~-~~~~---~~~~~~~~li~~~l~~~p~~ 257 (272)
T cd05075 231 NRL-KQPP---DCLDGLYSLMSSCWLLNPKD 257 (272)
T ss_pred CCC-CCCC---CCCHHHHHHHHHHcCCCccc
Confidence 111 1111 12344789999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=251.28 Aligned_cols=219 Identities=23% Similarity=0.355 Sum_probs=164.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
+|...+.+|+|++|.||+|... +++.||+|.+...........+.+..|++++..+.+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999999999999875 589999999976654433455677888887754444
Q ss_pred ----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 428 ----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 428 ----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 4444444321 1245788999999999999999999 8899999999999999999999999999987553211
Q ss_pred C-----------------------------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 504 S-----------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 504 ~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 01123578899999999988899999999999999999999999974321
Q ss_pred cccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+..+.+.....+.... ....+.+++..|++.||++
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~ 275 (316)
T cd05574 238 -------DETFSNILKKEVTFPGSPP---VSSSARDLIRKLLVKDPSK 275 (316)
T ss_pred -------HHHHHHHhcCCccCCCccc---cCHHHHHHHHHHccCCHhH
Confidence 2223444444433222211 3455889999999999974
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=246.87 Aligned_cols=217 Identities=22% Similarity=0.342 Sum_probs=154.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcC-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERG----------------- 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~g----------------- 428 (602)
...|+..+.+|+|+||.||+|+.. +++.||+|++...... ...+..|+.++..+ .|.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456888899999999999999864 6889999998654322 23445566655444 233
Q ss_pred --------------ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 429 --------------SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 429 --------------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
++.+++... ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 333333321 1234788999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
++..............|+..|+|||++. +..++.++||||+||++|||++|+.||......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------~~~~ 229 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIP 229 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHHh
Confidence 9986543333333456889999999986 335788999999999999999999999643221111 1111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+..... .....+.+++.+||+.||++
T Consensus 230 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 259 (272)
T cd06637 230 RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQ 259 (272)
T ss_pred cCCCCCCCCC---CcCHHHHHHHHHHcCCChhh
Confidence 1111111111 12234789999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=253.20 Aligned_cols=220 Identities=23% Similarity=0.304 Sum_probs=155.1
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
.++|...+.||+|+||.||+|+. .+++.||||+++..... .....+.+|+.++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35799999999999999999963 35789999998754322 1234555666665
Q ss_pred --------HhhhcCcccccccccc--------------------------------------------------------
Q 047576 423 --------SQMERGSLFRILHNDA-------------------------------------------------------- 438 (602)
Q Consensus 423 --------~~l~~gsL~~~l~~~~-------------------------------------------------------- 438 (602)
||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4445555555443210
Q ss_pred --------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC--Cccc
Q 047576 439 --------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTL 508 (602)
Q Consensus 439 --------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~ 508 (602)
....+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 0123688889999999999999999 88999999999999999999999999999876533221 1112
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
..++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..+...+......+.... ....
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~ 310 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDY---TTPE 310 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCCCC---CCHH
Confidence 335677999999988889999999999999999997 99998643211 111111211111111110 1234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..||+.||++
T Consensus 311 ~~~~~~~cl~~~p~~ 325 (343)
T cd05103 311 MYQTMLDCWHGEPSQ 325 (343)
T ss_pred HHHHHHHHccCChhh
Confidence 789999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=252.82 Aligned_cols=179 Identities=20% Similarity=0.272 Sum_probs=142.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|...+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..+.|.++..+.....
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56888899999999999999865 6788999998644322 12335667999988887777665543210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.........
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 1123678889999999999999999 889999999999999999999999999999765433333
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 333467899999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=242.54 Aligned_cols=221 Identities=22% Similarity=0.291 Sum_probs=161.6
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchh--HHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPET--EELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
++|...+.+|+|++|.||+|.. .+++.||+|.+..... ......+.+.+|++++..+.|+++..+....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999986 4689999998864422 1222346788899988777776665443210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||.++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 01223677888999999999999999 8899999999999999999999999999987654321
Q ss_pred CCc---cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 504 SNQ---TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 504 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
... ....++..|+|||+..+..++.++||||+|+++|||++|+.||...... ..................
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~ 231 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLPSH 231 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCCCcc
Confidence 111 2345788999999999988999999999999999999999999643221 111111112111111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 232 ---~~~~~~~li~~~l~~~p~~ 250 (263)
T cd06625 232 ---VSPDARNFLRRTFVENAKK 250 (263)
T ss_pred ---CCHHHHHHHHHHhhcCccc
Confidence 2234788999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=246.35 Aligned_cols=219 Identities=17% Similarity=0.252 Sum_probs=160.4
Q ss_pred CccccCcccccccccccceeeecCC-----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR---------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~---------- 432 (602)
.++|...+.+|+|+||.||+|...+ +..|++|++...... ...+.+.+|+.++..+.|.++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678888999999999999998755 788999988644322 23466778888886555554443
Q ss_pred ----------------ccccccch-----hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 433 ----------------ILHNDAEA-----VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 433 ----------------~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
++...... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 33221111 35789999999999999999999 7899999999999999999999999
Q ss_pred cccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhh
Q 047576 492 DFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 492 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
|||+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAAY 231 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHHH
Confidence 99999865432211 112345678999999988889999999999999999999 99999753221 11122
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+....+.+... .....+.+++.+||+.||++
T Consensus 232 ~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 262 (280)
T cd05043 232 LKDGYRLAQPI---NCPDELFAVMACCWALDPEE 262 (280)
T ss_pred HHcCCCCCCCC---cCCHHHHHHHHHHcCCChhh
Confidence 22222211111 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=261.66 Aligned_cols=218 Identities=27% Similarity=0.387 Sum_probs=163.2
Q ss_pred cccCcccccccccccceeeecC--CC---cEEeeeccCCchhHHHHHhhhhHhHHHHH----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP--NG---RVFALKKLNSPETEELAFIRSFRNEAQVL---------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~--~g---~~vavK~l~~~~~~~~~~~~~~~~E~~il---------------------- 422 (602)
+......||+|+||+||+|++. ++ ..||||..+..........+.|.+|+++|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3445589999999999999864 22 23899998864434445678899999988
Q ss_pred ---HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 423 ---SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 423 ---~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
|.+.+|+|.++|..... .++..++..++.++|.||+||| +++++||||-++|+|++.++.+||+|||+++..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 45556666666665332 4899999999999999999999 999999999999999999999999999998764
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
...........-...|+|||.+..+.++.++|||||||++||+.+ |..||..... ......++....+.+.+
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHhcCccCCCC
Confidence 311111111123478999999999999999999999999999999 8999975332 22223332333332222
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+..++..||+.||++
T Consensus 386 ~~---~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 386 SK---TPKELAKVMKQCWKKDPED 406 (474)
T ss_pred CC---CHHHHHHHHHHhccCChhh
Confidence 22 4455778888999999974
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=258.99 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=142.2
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-c--------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-R-------------------- 427 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~-------------------- 427 (602)
+|.+.+.||+|+||.|-+|.. ++++.||||+++.... +..+-..|+.+++.+. +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 788899999999999999975 5799999999986653 4566677899997776 1
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC--Ccceeeccccc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK--LEAFVADFGTA 496 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFG~a 496 (602)
-+|.++++.+. ...++...++.++.||+.||.+|| +.+|||+||||+|||+-+- ..+||+|||+|
T Consensus 263 lciVfELL~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhhhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 23334444332 233889999999999999999999 8899999999999999543 37999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
........ ....+..|+|||++.|.+|+.+.||||||||+.||.+|.+-|.+.+
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 87644322 4678899999999999999999999999999999999988886543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=247.37 Aligned_cols=217 Identities=26% Similarity=0.376 Sum_probs=156.7
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC--------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-------------- 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-------------- 428 (602)
++|+....+|+|+||.||+|+. .++..+|+|.+...... ..+.+.+|++++..+.|+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4677889999999999999963 24668999988754432 345778888887554444
Q ss_pred -----------ccccccccccc------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 429 -----------SLFRILHNDAE------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 429 -----------sL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
+|.+++..... ...+++.++..++.|++.|++||| +.+++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCC
Confidence 44444332111 124788999999999999999999 8899999999999999999
Q ss_pred CcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcc
Q 047576 486 LEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPK 562 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 562 (602)
+.+||+|||++........ ......+++.|+|||+..+..++.++|||||||++|||++ |+.||..... .
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~ 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------T 231 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------H
Confidence 9999999999876533221 1122335678999999999899999999999999999998 9999864221 1
Q ss_pred cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+...... .... .....+.+++..||+.||++
T Consensus 232 ~~~~~~~~~~~~-~~~~---~~~~~~~~li~~cl~~~P~~ 267 (280)
T cd05092 232 EAIECITQGREL-ERPR---TCPPEVYAIMQGCWQREPQQ 267 (280)
T ss_pred HHHHHHHcCccC-CCCC---CCCHHHHHHHHHHccCChhh
Confidence 111222222111 1111 12344789999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=257.21 Aligned_cols=211 Identities=24% Similarity=0.389 Sum_probs=155.6
Q ss_pred ccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------HhhhcC
Q 047576 375 YCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQMERG 428 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~l~~g 428 (602)
-.||+|.||+||-|+..+ ...+|||.+...+.. ..+-+..|+.+- |++++|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 358999999999999765 457899998766544 334455555543 455666
Q ss_pred ccccccccccchhhh--cHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-CCCcceeecccccccccCCCCC
Q 047576 429 SLFRILHNDAEAVEL--DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 429 sL~~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
+|.++++.. =+++ .+.+.-.+.+||++||.||| +..|||||||-+|||++ -.|.+||+|||-++.+..-...
T Consensus 658 SLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 666666542 1224 67788889999999999999 78999999999999996 4689999999999887654445
Q ss_pred ccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 506 QTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
...+.||..|||||++..++ |+.++|||||||++.||.||++||........+... .-+... .++.+ .+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk----VGmyKv--HP~iP---ee 803 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK----VGMYKV--HPPIP---EE 803 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh----hcceec--CCCCc---HH
Confidence 56678999999999998765 889999999999999999999999754322111111 011111 12222 22
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
-.++...++++|..+||.+
T Consensus 804 lsaeak~FilrcFepd~~~ 822 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCD 822 (1226)
T ss_pred HHHHHHHHHHHHcCCCccc
Confidence 4455788999999999963
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=247.59 Aligned_cols=177 Identities=27% Similarity=0.403 Sum_probs=136.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGSLFRILHND-------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gsL~~~l~~~-------- 437 (602)
+|.....||+|+||.||+|+.. +++.||+|.++...... .....+.+|+.+++.+ .|+++..++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4677889999999999999865 68899999886432211 1122344566665444 455554433210
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+|+| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 01123788999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
...... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 764322 22234688999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=240.85 Aligned_cols=210 Identities=23% Similarity=0.339 Sum_probs=152.8
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc--------------------
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI-------------------- 433 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~-------------------- 433 (602)
+.||+|+||.||+|+.. +++.||+|.+...... .....+.+|++++..+.|+++..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999864 7899999987644322 234567888888866655554443
Q ss_pred -----cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc--
Q 047576 434 -----LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-- 506 (602)
Q Consensus 434 -----l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~-- 506 (602)
+.. ....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+..........
T Consensus 79 ~L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 322 1224789999999999999999999 8899999999999999999999999999987654321111
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
....++..|+|||.+.++.++.++||||||+++|||++ |..||..... ......++...+.+.... ..
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~---~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCPEL---CP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCccc---CC
Confidence 11123457999999998889999999999999999998 8999864221 111222222222222111 23
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 223 ~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 223 DAVYRLMERCWEYDPGQ 239 (252)
T ss_pred HHHHHHHHHHcCCChhh
Confidence 45889999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=240.83 Aligned_cols=217 Identities=25% Similarity=0.375 Sum_probs=159.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR---------------- 432 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~---------------- 432 (602)
.|...+.+|+|++|.||+++.. +++.||+|++...... ....+.+.+|++++..+.|.++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 3677889999999999999864 5788999998643322 123445677777775554444333
Q ss_pred ----------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 433 ----------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 433 ----------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++... ....+++.++..++.|++.|++|+| +.+++||||||+||+++.++.++|+|||.+......
T Consensus 80 e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 33221 1234788999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........+++.|+|||+..+..++.++||||+|+++|+|++|+.||+.... ......+....++.. ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~-~~--- 224 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIEGKLPPM-PK--- 224 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCC-cc---
Confidence 3333445688999999999998899999999999999999999999974321 111122222222211 11
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.||++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd08223 225 DYSPELGELIATMLSKRPEK 244 (257)
T ss_pred ccCHHHHHHHHHHhccCccc
Confidence 12345889999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=245.38 Aligned_cols=222 Identities=22% Similarity=0.307 Sum_probs=157.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+. .+++.||+|.++..... ....+.+|+.++..+.|+++..+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 35788889999999999999986 46889999998654322 234566788777555555443332210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||.+........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 01234788999999999999999999 78999999999999999999999999999876543332
Q ss_pred Cccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
......|+..|+|||++. ...++.++||||+||++|+|++|+.||....+.. ...........++.....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHhhhccCCCCCccccc
Confidence 233457899999999874 4558889999999999999999999986432211 001111111111100000
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~ 255 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKK 255 (267)
T ss_pred CCCCHHHHHHHHHHccCCchh
Confidence 011234788999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=247.61 Aligned_cols=219 Identities=23% Similarity=0.341 Sum_probs=159.2
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.+|.....+|+|++|.||+|+. .+++.||+|.+...... ..+.+.+|+.++..+.|.++..++...
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 5788889999999999999985 47889999988754433 235567788877555554444333210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+..........
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 01123688899999999999999999 8899999999999999999999999999987654433223
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||......... .....+.....+... ....
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~~~~---~~~~ 244 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPELQNPE---KLSA 244 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCCCCCCCcc---ccCH
Confidence 3346889999999999888899999999999999999999999753221100 011111111111111 1224
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+|+++||++
T Consensus 245 ~l~~li~~~l~~~p~~ 260 (296)
T cd06654 245 IFRDFLNRCLDMDVEK 260 (296)
T ss_pred HHHHHHHHHCcCCccc
Confidence 4788999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=239.04 Aligned_cols=209 Identities=22% Similarity=0.321 Sum_probs=152.6
Q ss_pred cccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc----------------------
Q 047576 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI---------------------- 433 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~---------------------- 433 (602)
.||+|+||.||+|...+++.+|+|.+...... .....+.+|++++..+.|+++..+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 68999999999999888999999998754322 233467788888765555554433
Q ss_pred ---cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc-ccc
Q 047576 434 ---LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-TLL 509 (602)
Q Consensus 434 ---l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~-~~~ 509 (602)
+... ...+++.++..++.|++.|+.|+| +++++||||||+||+++.++.+||+|||++.......... ...
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 3221 224789999999999999999999 8899999999999999999999999999987543322111 112
Q ss_pred ccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
.++..|+|||++.+..++.++||||||+++|++++ |..||...... .. ...+........... ....+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~-~~~~~~~~~~~~~~~---~~~~~ 223 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QA-REQVEKGYRMSCPQK---CPDDV 223 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HH-HHHHHcCCCCCCCCC---CCHHH
Confidence 34567999999998889999999999999999998 99999643211 00 111111111111111 23458
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|++.+|++
T Consensus 224 ~~li~~~l~~~p~~ 237 (250)
T cd05085 224 YKVMQRCWDYKPEN 237 (250)
T ss_pred HHHHHHHcccCccc
Confidence 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=248.89 Aligned_cols=225 Identities=15% Similarity=0.163 Sum_probs=146.8
Q ss_pred ccccCcccccccccccceeeecCC----CcEEeeeccCCchhHH---HHHhh-----hhHhHHHHHHhhhcCcccccccc
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN----GRVFALKKLNSPETEE---LAFIR-----SFRNEAQVLSQMERGSLFRILHN 436 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~---~~~~~-----~~~~E~~il~~l~~gsL~~~l~~ 436 (602)
.+|...+.||+|+||.||+|+..+ +..+|+|+........ ..... ....+...+..+.|.++..+...
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999998654 4566777543221110 00000 11111222223333333221110
Q ss_pred --------------------c-----cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 437 --------------------D-----AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 437 --------------------~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
. ......++..+..|+.|++.|++||| +++|+||||||+|||++.++.++|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEE
Confidence 0 00112467778899999999999999 8899999999999999999999999
Q ss_pred cccccccccCCC-------CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCC--cc
Q 047576 492 DFGTARLLHADS-------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYD--PK 562 (602)
Q Consensus 492 DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~ 562 (602)
|||+++...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||........... ..
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999998663221 112234699999999999999999999999999999999999999975421111000 00
Q ss_pred cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+..+.......+ .....+.+++..|++.+|++
T Consensus 249 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 282 (294)
T PHA02882 249 DFIKRLHEGKIKIK------NANKFIYDFIECVTKLSYEE 282 (294)
T ss_pred HHHHHhhhhhhccC------CCCHHHHHHHHHHHhCCCCC
Confidence 01111222211111 12345889999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=253.59 Aligned_cols=223 Identities=22% Similarity=0.309 Sum_probs=171.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~-------- 437 (602)
...|.....||+|.||.||+++.+ +|+.+|+|.+.+.............+|+.+|+.+. |+++..+....
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999876 49999999998776544334567889999997776 65554433211
Q ss_pred -------cc-----hh-hhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC----Ccceeeccccccccc
Q 047576 438 -------AE-----AV-ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK----LEAFVADFGTARLLH 500 (602)
Q Consensus 438 -------~~-----~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~----~~~kL~DFG~a~~~~ 500 (602)
++ .. .+++..+..++.|++.|+.||| +.||+|||+||+|+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 00 01 2889999999999999999999 8999999999999999533 579999999999887
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..... ......+....+..+.+.
T Consensus 191 ~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~~~~i~~~~~~f~~~~- 261 (382)
T KOG0032|consen 191 P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEIFLAILRGDFDFTSEP- 261 (382)
T ss_pred C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHHHHHHHcCCCCCCCCC-
Confidence 6 4455667999999999999999999999999999999999999999985432 222334544444322111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+..-.....+++..++..||..
T Consensus 262 w~~is~~akd~i~~ll~~dp~~ 283 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRK 283 (382)
T ss_pred ccccCHHHHHHHHHhcccCccc
Confidence 1122344778888999999963
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=247.32 Aligned_cols=215 Identities=22% Similarity=0.297 Sum_probs=163.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|...+.||+|++|.||+|... +++.||+|++...........+.+.+|++++..+.|+++..++...
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5778899999999999999864 6899999998755443334556788899888666666554443210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~ 155 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---T 155 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---C
Confidence 01234788999999999999999999 789999999999999999999999999999876443 2
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ......+.+...+.+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~-----~~~ 223 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKVRFPSF-----FSP 223 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCccCCcc-----CCH
Confidence 234688999999999888889999999999999999999999974321 11222333332221111 123
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+||+.||++
T Consensus 224 ~l~~li~~~l~~~p~~ 239 (290)
T cd05580 224 DAKDLIRNLLQVDLTK 239 (290)
T ss_pred HHHHHHHHHccCCHHH
Confidence 4778999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=246.58 Aligned_cols=223 Identities=28% Similarity=0.425 Sum_probs=162.0
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|+..+.||+|+||.||+++.. +++.||+|++......... .....+|+.+++.+.|+++..++...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 456789999999999999875 5678999999877655332 22334588888777776665543211
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|+++||++|| +.+|+||||||+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence 02345789999999999999999999 78999999999999999999999999999976433333344
Q ss_pred ccccccccccccccc-cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 508 LLAGSYGYIAPELAY-TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...++..|+|||+.. +..++.++||||+|+++|+|++|+.||...... .....+.............. ......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD----DQLEIIEKILKRPLPSSSQQ-SREKSE 231 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH----HHHHHHHHHHHTHHHHHTTS-HTTSHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccch----hhhhhhhhcccccccccccc-cchhHH
Confidence 467889999999998 788999999999999999999999999853100 11111111111111100000 000125
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..|++.||++
T Consensus 232 ~l~~li~~~l~~~p~~ 247 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQ 247 (260)
T ss_dssp HHHHHHHHHSSSSGGG
T ss_pred HHHHHHHHHccCChhH
Confidence 6899999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=246.90 Aligned_cols=217 Identities=26% Similarity=0.349 Sum_probs=152.3
Q ss_pred ccccCcccccccccccceeeecCC-Cc--EEeeeccCCchhHHHHHhhhhHhHHHHHHhh--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN-GR--VFALKKLNSPETEELAFIRSFRNEAQVLSQM-------------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-------------------- 425 (602)
++|.....||+|+||.||+|+..+ +. .+++|.++..... ...+.+.+|++++..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 568888999999999999998653 33 4688887643221 2235567777776444
Q ss_pred ------hcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC
Q 047576 426 ------ERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486 (602)
Q Consensus 426 ------~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~ 486 (602)
++++|.+++.... ....+++..+..++.|++.|++||| +++|+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence 3445555543311 1124788899999999999999999 78999999999999999999
Q ss_pred cceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccch
Q 047576 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIML 565 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~ 565 (602)
.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |+.||..... ...
T Consensus 157 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~- 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AEL- 227 (297)
T ss_pred eEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH-
Confidence 99999999986432111 1111223457999999988889999999999999999997 9999964321 111
Q ss_pred hhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 566 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+......+.... ....+.+++.+||+.||.+
T Consensus 228 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~ 261 (297)
T cd05089 228 YEKLPQGYRMEKPRN---CDDEVYELMRQCWRDRPYE 261 (297)
T ss_pred HHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhh
Confidence 111222221111111 2234789999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=241.76 Aligned_cols=215 Identities=25% Similarity=0.415 Sum_probs=158.7
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------------ 424 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~------------------------ 424 (602)
++|...+.+|+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++..
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 81 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence 56888999999999999999987788899998875432 23567778887744
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
++++++.+++... ....+++.+++.++.|++.||.|+| +.+++||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 4445555555432 1234788899999999999999999 78999999999999999999999999999876543221
Q ss_pred C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. .....++..|+|||++....++.++|+|||||++|+++| |+.||...... .....+......+...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--- 226 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPRPE--- 226 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCCCCCcc---
Confidence 1 122345677999999998889999999999999999999 99999743211 1111111211111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|+++||++
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~ 246 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEE 246 (260)
T ss_pred cCCHHHHHHHHHHcccCccc
Confidence 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=244.00 Aligned_cols=224 Identities=20% Similarity=0.278 Sum_probs=160.0
Q ss_pred ccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
|.....||+|+||.||++.. .+++.||+|.++..... .....+.+|++++..+.|+++..+....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37778999999999988642 36789999998754322 2345677899988777776655544310
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 01124789999999999999999999 789999999999999999999999999999876432
Q ss_pred CCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccccc-------CCCcccchhhhhccC
Q 047576 503 SSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS-------SYDPKIMLIDVLDQR 572 (602)
Q Consensus 503 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~~~~d~~ 572 (602)
... .....++..|+|||+..+..++.++||||||+++|||+||+.||........ .......+.+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 1112355679999999888899999999999999999999999864321100 000111122223332
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.... ....+.+++..||+.||++
T Consensus 241 ~~~~~~~~---~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 241 MRLPCPKN---CPQEVYILMKNCWETEAKF 267 (283)
T ss_pred CCCCCCCC---CCHHHHHHHHHHhccChhh
Confidence 22222111 3345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=244.19 Aligned_cols=219 Identities=26% Similarity=0.306 Sum_probs=156.9
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------ 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------ 423 (602)
.++|...+.||+|++|.||+|... .+..||+|........ .....+.+|+.++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 467888899999999999999864 3568999987644322 12355777877774
Q ss_pred -------hhhcCccccccccccc----hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cce
Q 047576 424 -------QMERGSLFRILHNDAE----AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAF 489 (602)
Q Consensus 424 -------~l~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~k 489 (602)
|+++++|.++++.... ...+++.++.+++.||+.|++||| +++++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence 4445555555543221 124889999999999999999999 78999999999999998654 589
Q ss_pred eecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~ 231 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVM 231 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 9999999876322111 111223567999999998899999999999999999997 9999974321 1122
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+........... ....+.+++.+|++.||++
T Consensus 232 ~~~~~~~~~~~~~~---~~~~~~~~i~~cl~~~p~~ 264 (277)
T cd05036 232 EFVTGGGRLDPPKG---CPGPVYRIMTDCWQHTPED 264 (277)
T ss_pred HHHHcCCcCCCCCC---CCHHHHHHHHHHcCCCccc
Confidence 22322222111111 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=244.19 Aligned_cols=223 Identities=25% Similarity=0.362 Sum_probs=158.2
Q ss_pred ccccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI---------- 433 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~---------- 433 (602)
.+|.....+|+|+||.||+|+. .++..||+|++...... ..+.+.+|++++..+.|+++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4677888999999999999974 35789999998755432 34677888888866666554443
Q ss_pred -----------------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 434 -----------------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 434 -----------------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
+.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 221 1123788999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccc-ccCCCc-------ccch
Q 047576 497 RLLHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL-SSSYDP-------KIML 565 (602)
Q Consensus 497 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~~-------~~~~ 565 (602)
......... .....++..|+|||+..+..++.++||||||+++|||++|..|+...... ...... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 876433221 11112345699999999888999999999999999999998876432111 000000 0112
Q ss_pred hhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 566 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.++.....+.... ....+.+++.+||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 236 IELLKNNGRLPAPPG---CPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHHhcCCcCCCCCC---CCHHHHHHHHHHccCChhh
Confidence 222222222121111 2345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.81 Aligned_cols=217 Identities=20% Similarity=0.323 Sum_probs=157.2
Q ss_pred cccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccc---------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL--------- 434 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l--------- 434 (602)
+|.....+|+|+||.||+|+.. ....+++|.+...... ...+.+.+|+.++..+.|+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4677889999999999999742 2357899988654332 2346688888888655555544432
Q ss_pred ----------------ccc---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCC
Q 047576 435 ----------------HND---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISS 477 (602)
Q Consensus 435 ----------------~~~---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp 477 (602)
... .....+++.++..++.|++.||+||| +.+|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence 211 01134788999999999999999999 78999999999
Q ss_pred CCeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcc
Q 047576 478 NNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHST 554 (602)
Q Consensus 478 ~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~ 554 (602)
+||++++++.+||+|||+++........ .....++..|+|||+..+..++.++||||||+++|||+| |+.||....+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998765332211 122345678999999988889999999999999999999 9999974321
Q ss_pred cccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+.++.....+.... ....+.+++..|++.||++
T Consensus 236 --------~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~cl~~~P~~ 272 (290)
T cd05045 236 --------ERLFNLLKTGYRMERPEN---CSEEMYNLMLTCWKQEPDK 272 (290)
T ss_pred --------HHHHHHHhCCCCCCCCCC---CCHHHHHHHHHHccCCccc
Confidence 122233333222221111 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.72 Aligned_cols=217 Identities=20% Similarity=0.327 Sum_probs=157.3
Q ss_pred ccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc-----------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH----------- 435 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~----------- 435 (602)
|...+.+|+|+||.||+|... .+..||+|+++..... ......+.+|++++..+.|+++..+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 456688999999999999753 2467999998754322 223456788888886666665544332
Q ss_pred --------------------cc---cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 436 --------------------ND---AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 436 --------------------~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
.. .....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 10 01124788899999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhh
Q 047576 493 FGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 493 FG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||..... ......+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~ 229 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLR 229 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 9999876433221 111234678999999988889999999999999999999 8999864321 11122222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.... .... .....+.+++.+||+.||++
T Consensus 230 ~~~~~-~~~~---~~~~~~~~li~~~l~~~p~~ 258 (273)
T cd05035 230 HGNRL-KQPE---DCLDELYDLMYSCWRADPKD 258 (273)
T ss_pred cCCCC-CCCc---CCCHHHHHHHHHHcCCChhh
Confidence 22211 1111 13445889999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=240.81 Aligned_cols=210 Identities=21% Similarity=0.321 Sum_probs=153.9
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL------------------ 430 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL------------------ 430 (602)
++|.....+|+|++|.||+|.. .|..||+|..+.... .+.+.+|+.++..+.|+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4678889999999999999987 478899998864432 3457778887755554444
Q ss_pred --------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 431 --------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 431 --------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.+++.... ...+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 33333211 123788899999999999999999 889999999999999999999999999998765332
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. ....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+....++....
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 222 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPD-- 222 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCCC--
Confidence 2 12334568999999988889999999999999999997 9999864211 01111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.||++
T Consensus 223 -~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05082 223 -GCPPVVYDVMKQCWHLDAAT 242 (256)
T ss_pred -CCCHHHHHHHHHHhcCChhh
Confidence 12345789999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=244.98 Aligned_cols=218 Identities=28% Similarity=0.408 Sum_probs=161.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....+|.|++|.||+|+.. +++.||+|.+...... .....+.+|++++..+.|+++..+....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 5777889999999999999864 6889999998654322 2345677888888666665554433210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.|+.|+| +.+++||||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 01125789999999999999999999 88999999999999999999999999999987765433334
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...++..|+|||++.+..++.++||||||+++|+|+||+.||...... ..... +.....+..... .....
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~-~~~~~~~~~~~~--~~~~~ 226 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFL-IPKNNPPSLEGN--KFSKP 226 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHH-hhhcCCCCCccc--ccCHH
Confidence 456888999999999888999999999999999999999999753311 11111 111111111100 02234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|++.||++
T Consensus 227 ~~~~l~~~l~~~p~~ 241 (274)
T cd06609 227 FKDFVSLCLNKDPKE 241 (274)
T ss_pred HHHHHHHHhhCChhh
Confidence 788999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=239.87 Aligned_cols=212 Identities=26% Similarity=0.361 Sum_probs=153.0
Q ss_pred ccccccccccceeeecC--C--CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 375 YCIGTGAYGSVYKAQLP--N--GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
+.||+|+||.||+|... + +..+|+|.+...... ...+.+.+|+.+++.+.|+++..++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCC
Confidence 36899999999999753 2 368999998765543 3446778888888666555544433210
Q ss_pred --------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc--
Q 047576 438 --------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT-- 507 (602)
Q Consensus 438 --------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~-- 507 (602)
.....+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++..........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 01124789999999999999999999 78999999999999999999999999999987644332211
Q ss_pred -ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 508 -LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 508 -~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
...++..|+|||...+..++.++||||||+++|||++ |+.||..... ..+...+....+.+... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~ 224 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESGERLPRPE---ECP 224 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCcCCCCC---CCC
Confidence 1123467999999998889999999999999999998 9999974321 11111222211111111 123
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 225 ~~l~~li~~cl~~~p~~ 241 (257)
T cd05060 225 QEIYSIMLSCWKYRPED 241 (257)
T ss_pred HHHHHHHHHHhcCChhh
Confidence 45889999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=243.33 Aligned_cols=216 Identities=23% Similarity=0.372 Sum_probs=159.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------------- 433 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------------- 433 (602)
+|+..+.+|+|+||.||+++.. +++.+|+|.++..... ...+.+.+|+.++..+.|+++..+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4677889999999999999864 6889999988543322 234567778887766655554433
Q ss_pred ----------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 434 ----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 434 ----------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+... ....+++.....++.|++.|+.||| +.+|+|+||||+||+++.++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 2211 1234678889999999999999999 8899999999999999999999999999997765433
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.......|++.|+|||+..+..++.++|+||||+++|+|++|+.||...... .....+......+ ....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~--- 223 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-------NLILKVCQGSYKP-LPSH--- 223 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-------HHHHHHhcCCCCC-CCcc---
Confidence 3333456888999999999888999999999999999999999999743211 1111121121211 1111
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 224 ~~~~~~~li~~~l~~~P~~ 242 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRS 242 (255)
T ss_pred cCHHHHHHHHHHHhCCccc
Confidence 2234778999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.58 Aligned_cols=218 Identities=26% Similarity=0.321 Sum_probs=158.2
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------- 425 (602)
++|.....+|+|+||.||+|... .+..||+|.+...... .....+.+|+.++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 56888899999999999999753 3468999998654322 2235677788877444
Q ss_pred --------hcCccccccccccc-------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCccee
Q 047576 426 --------ERGSLFRILHNDAE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 426 --------~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
++++|.+++..... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 44555555433211 123678899999999999999999 889999999999999999999999
Q ss_pred ecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhh
Q 047576 491 ADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLID 567 (602)
Q Consensus 491 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 567 (602)
+|||.++....... ......++..|+|||++.+..++.++|||||||++||++| |+.||..... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKF 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-------HHHHHH
Confidence 99999876543221 1222346788999999988889999999999999999998 9999864221 111122
Q ss_pred hhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+.... +.... ....+.+++.+||+.+|++
T Consensus 234 ~~~~~~~-~~~~~---~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05032 234 VIDGGHL-DLPEN---CPDKLLELMRMCWQYNPKM 264 (277)
T ss_pred HhcCCCC-CCCCC---CCHHHHHHHHHHcCCChhh
Confidence 2222111 11111 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=246.17 Aligned_cols=179 Identities=23% Similarity=0.293 Sum_probs=140.8
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN------------ 436 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~------------ 436 (602)
+|...+.||+|++|.||+|+.. +++.||+|++...... ......+.+|+.++..+.|+++..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 3667788999999999999864 6899999988644321 1123556778888877776665554321
Q ss_pred ------------ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 437 ------------DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 437 ------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 111245788999999999999999999 88999999999999999999999999999876543332
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......+++.|+|||++.+. .++.++||||||+++|+|+||+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22334568899999988764 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=241.16 Aligned_cols=216 Identities=24% Similarity=0.332 Sum_probs=158.7
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchh---HHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPET---EELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+|.....+|.|+||.||+|...+++.+|+|.+..... ......+.+.+|+++++.+.|.++..+....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667788999999999999988899999998864321 2223446688898888655555444332210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC-
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS- 503 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~- 503 (602)
.....+++..+..++.|++.|++|+| +.+|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 01134788889999999999999999 7899999999999999999999999999987653211
Q ss_pred -----CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh-----ccCC
Q 047576 504 -----SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL-----DQRL 573 (602)
Q Consensus 504 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----d~~l 573 (602)
.......|+..|+|||+..+..++.++||||||+++|+|++|+.||...+... ....+. .+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------AMFYIGAHRGLMPRL 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------HHHHhhhccCCCCCC
Confidence 11223468889999999998889999999999999999999999997432111 011111 1122
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.. ....+.+++.+||+.||++
T Consensus 231 ~~~-------~~~~~~~~i~~~l~~~p~~ 252 (265)
T cd06631 231 PDS-------FSAAAIDFVTSCLTRDQHE 252 (265)
T ss_pred CCC-------CCHHHHHHHHHHhcCCccc
Confidence 222 2234788999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=245.99 Aligned_cols=207 Identities=24% Similarity=0.313 Sum_probs=148.0
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH----------------------------Hhhh
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------------SQME 426 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------------~~l~ 426 (602)
.||+|+||.||++... +++.+|+|.+.............+.+|..++ ||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4799999999999864 6889999988654322111112222232221 5566
Q ss_pred cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 427 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
+++|.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 6666665543 234899999999999999999999 8899999999999999999999999999987553322 2
Q ss_pred ccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh---hccCCCCCCChhhH
Q 047576 507 TLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV---LDQRLPPPVDRKVI 582 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~d~~l~~~~~~~~~ 582 (602)
....|+..|+|||+..+ ..++.++||||+||++|||++|+.||...... ........ .+..++...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~----- 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTVNVELPDSF----- 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHHHHHHhhcCCcCCcccc-----
Confidence 23468999999998864 55889999999999999999999999743211 01111111 112222222
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 223 --~~~~~~li~~~l~~~p~~ 240 (279)
T cd05633 223 --SPELKSLLEGLLQRDVSK 240 (279)
T ss_pred --CHHHHHHHHHHhcCCHHH
Confidence 234778899999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=245.10 Aligned_cols=215 Identities=20% Similarity=0.312 Sum_probs=168.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc--------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI-------------- 433 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~-------------- 433 (602)
.-|+..+.||+|.|+.|-+|++- +|..||||++.+....+. ....+.+|+..|+.+.|+++..+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34888999999999999999863 799999999987765533 23455678888866666655543
Q ss_pred -----------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee-CCCCcceeecccccccccC
Q 047576 434 -----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL-NSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 434 -----------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFG~a~~~~~ 501 (602)
+-.+ ...+.+.-+.+|+.||+.|+.|+| ...||||||||+||++ ..-|-|||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 3222 123778889999999999999999 7789999999999876 5668999999999977654
Q ss_pred CCCCccccccccccccccccccCcCC-ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMT-EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. .-+..+|+..|.|||.+.+..|+ +++||||+|||||.+++|+.||+... +.+.+.-++|=....|..
T Consensus 172 G~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------DSETLTmImDCKYtvPsh-- 241 (864)
T KOG4717|consen 172 GK-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------DSETLTMIMDCKYTVPSH-- 241 (864)
T ss_pred cc-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------chhhhhhhhcccccCchh--
Confidence 43 33457899999999999999887 57899999999999999999998532 234456667766654421
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
-..++.+++...+++||++
T Consensus 242 ---vS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 242 ---VSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred ---hhHHHHHHHHHHHhcCchh
Confidence 3344889999999999974
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=246.22 Aligned_cols=170 Identities=24% Similarity=0.390 Sum_probs=134.3
Q ss_pred ccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------------
Q 047576 375 YCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------------- 437 (602)
..||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++..+.|+++..+....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999864 457899998865432 23466799999888887766543211
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee----CCCCcceeecccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL----NSKLEAFVADFGT 495 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFG~ 495 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 00123678889999999999999999 8899999999999999 5667899999999
Q ss_pred cccccCCCC---CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 496 ARLLHADSS---NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 496 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
++....... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 987643221 12234688999999998764 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=240.91 Aligned_cols=217 Identities=29% Similarity=0.445 Sum_probs=157.1
Q ss_pred CccccCcccccccccccceeeecC-CC---cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NG---RVFALKKLNSPETEELAFIRSFRNEAQVLSQMER---------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~---------------- 427 (602)
+++|+..+.+|+|++|.||+|+.. ++ ..+|+|.+...... ...+.+.+|++++..+.|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 457888999999999999999864 23 37999988654322 234567788887754444
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++|.+++.. ....+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 444444432 1234789999999999999999999 78999999999999999999999999999876
Q ss_pred ccCCCCCc---cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 499 LHADSSNQ---TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 499 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .. ....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~-~~~~i~~~~~ 228 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE-VMKAINDGFR 228 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH-HHHHHhcCCC
Confidence 64322111 11123457999999988889999999999999999997 9999964321 11 1222222222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+... .....+.+++.+||+.||++
T Consensus 229 ~~~~~---~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 229 LPAPM---DCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred CCCCC---CCCHHHHHHHHHHcCCCccc
Confidence 22211 13455889999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=239.02 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=163.6
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|.....+|.|++|.||+|+.. +++.+++|.+...... ..+.+.+|++++..+.|+++..+....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 56888899999999999999864 5788999998755433 346778899888777776655543210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 01135788899999999999999999 78999999999999999999999999999876654322
Q ss_pred CccccccccccccccccccC---cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAYTM---VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
......++..|+|||...+. .++.++|+||||+++|||+||+.||....... ....+....+.++.....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLISKSNFPPPKLKDK 229 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCCCccccch
Confidence 23335678899999998776 78899999999999999999999997533211 111111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.||++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~ 250 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKK 250 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhh
Confidence 223455889999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=238.87 Aligned_cols=217 Identities=26% Similarity=0.395 Sum_probs=161.5
Q ss_pred ccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+....+|+|++|.||+|+..+ ++.+++|.+..... .+.+.+|++++..+.|.++..++...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578889999999999999998764 78999999865432 46788888888666655554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||.+........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 01234789999999999999999999 78999999999999999999999999999987654432
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......... .. +.....+... .....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~-~~~~~~~~~~-~~~~~ 225 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FM-IPNKPPPTLS-DPEKW 225 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hh-hccCCCCCCC-chhhc
Confidence 333455788999999999888999999999999999999999999753221110 00 1111111100 00112
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+||+.||++
T Consensus 226 ~~~~~~~i~~~l~~~P~~ 243 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEE 243 (256)
T ss_pred CHHHHHHHHHHHhcChhh
Confidence 234788999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=246.09 Aligned_cols=219 Identities=21% Similarity=0.322 Sum_probs=159.0
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLF--------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~--------- 431 (602)
.++|...+.||+|+||.||+|.. .++..||+|.++..... ...+.+.+|+.++..+ .|+++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 35788899999999999999963 24568999988754322 2345677888887555 444444
Q ss_pred ----------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 432 ----------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 432 ----------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
+++.... ...+++.++..++.|++.|++||| +.+|+|+||||+||+++.++.+|++|||.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 3332211 122789999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccC
Q 047576 496 ARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 496 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
++....... ......++..|+|||++.+..++.++||||+||++|||++ |+.||..... ...+...++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIKEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHHcC
Confidence 986543221 1112345678999999999889999999999999999998 9999864321 11222333332
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+...... ....+.+++.+|++++|++
T Consensus 261 ~~~~~~~~---~~~~~~~li~~cl~~~p~~ 287 (302)
T cd05055 261 YRMAQPEH---APAEIYDIMKTCWDADPLK 287 (302)
T ss_pred CcCCCCCC---CCHHHHHHHHHHcCCCchh
Confidence 22211111 2235889999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=238.74 Aligned_cols=212 Identities=25% Similarity=0.373 Sum_probs=155.5
Q ss_pred ccccccccccceeeecCC--C--cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc------------------
Q 047576 375 YCIGTGAYGSVYKAQLPN--G--RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR------------------ 432 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~------------------ 432 (602)
+.+|+|++|.||+|...+ + ..||+|.+...... ...+.+.+|+.++..+.|+++..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecC
Confidence 368999999999998643 3 36899999776553 45678888999886666555444
Q ss_pred ------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC-
Q 047576 433 ------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN- 505 (602)
Q Consensus 433 ------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~- 505 (602)
.+..... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 3322111 35789999999999999999999 889999999999999999999999999999876542211
Q ss_pred --ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 506 --QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 506 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.......+...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~--- 224 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEGERLERPE--- 224 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCcCCCCc---
Confidence 112346788999999998889999999999999999999 99999643211 11111111111111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.+|++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred cCCHHHHHHHHHHCCCCccc
Confidence 12345889999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=242.90 Aligned_cols=219 Identities=22% Similarity=0.320 Sum_probs=160.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
+.|.....+|.|+||.||+|+.. +++.|++|.+...... ..+.+.+|+.++..+.|+++..+....
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 56888899999999999999875 5889999998755432 356677888888777666655543210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 01234788999999999999999999 88999999999999999999999999998876433322
Q ss_pred Cccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 505 NQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
......++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....+.....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLSQP 238 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCCccCCCC
Confidence 233456888999999885 344678999999999999999999999643211 11112221111100000
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.||++
T Consensus 239 --~~~~~~~~~li~~~l~~~p~~ 259 (292)
T cd06644 239 --SKWSMEFRDFLKTALDKHPET 259 (292)
T ss_pred --cccCHHHHHHHHHHhcCCccc
Confidence 112234788999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=239.47 Aligned_cols=220 Identities=21% Similarity=0.353 Sum_probs=156.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+++++....+|+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+.++..+.|.++.+++...
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 566777789999999999999854 6788999988755433 345678888888666665555443210
Q ss_pred --------------cchhhh--cHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeeccccccccc
Q 047576 438 --------------AEAVEL--DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLLH 500 (602)
Q Consensus 438 --------------~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~a~~~~ 500 (602)
.....+ ++..+..++.|++.|++||| +++|+||||||+||+++. ++.+||+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 001223 67788889999999999999 889999999999999976 6799999999987664
Q ss_pred CCCCCccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
..........|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.............. ..-..+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 236 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--MFKIHPEIPES-- 236 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--hhccCCCCCcc--
Confidence 3332233346789999999987644 78899999999999999999999964321100000000 00011112211
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 237 -----~~~~~~~li~~~l~~~p~~ 255 (268)
T cd06624 237 -----LSAEAKNFILRCFEPDPDK 255 (268)
T ss_pred -----cCHHHHHHHHHHcCCCchh
Confidence 2234788999999999974
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=254.66 Aligned_cols=219 Identities=21% Similarity=0.317 Sum_probs=159.4
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|...+.||+|+||.||+|+.. .+..||+|+++...... ..+.+.+|+.++
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 46777899999999999999742 35689999997543321 234577788877
Q ss_pred ------HhhhcCccccccccccc---------------------------------------------------------
Q 047576 423 ------SQMERGSLFRILHNDAE--------------------------------------------------------- 439 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~--------------------------------------------------------- 439 (602)
||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 45566666666643210
Q ss_pred --------------------------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCee
Q 047576 440 --------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNIL 481 (602)
Q Consensus 440 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 481 (602)
...+++.....|+.|++.||+||| +++|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence 123677888999999999999999 889999999999999
Q ss_pred eCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccC
Q 047576 482 LNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSS 558 (602)
Q Consensus 482 ld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 558 (602)
+++++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~---- 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM---- 347 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc----
Confidence 99999999999999986532211 1122356788999999998889999999999999999998 8999864321
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+....+.+.... ....+.+++.+||+.||++
T Consensus 348 ---~~~~~~~~~~~~~~~~p~~---~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 348 ---NEQFYNAIKRGYRMAKPAH---ASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred ---hHHHHHHHHcCCCCCCCCC---CCHHHHHHHHHHcCCChhH
Confidence 1112233333222211111 2345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=247.38 Aligned_cols=219 Identities=24% Similarity=0.337 Sum_probs=157.6
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---------------- 425 (602)
.++|+....+|+|+||.||+|... ....+|+|.+...... .....+.+|++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 457888899999999999999753 3468999988754332 2235577788777444
Q ss_pred ----------hcCccccccccc-------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee
Q 047576 426 ----------ERGSLFRILHND-------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482 (602)
Q Consensus 426 ----------~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 482 (602)
++|+|.++++.. .....+++..++.++.|++.|++||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 344444444321 12345889999999999999999999 8899999999999999
Q ss_pred CCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCC
Q 047576 483 NSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSY 559 (602)
Q Consensus 483 d~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~ 559 (602)
++++.+||+|||.++........ .....++..|+|||+..+..++.++|||||||++||+++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----
Confidence 99999999999999876432211 111234567999999988889999999999999999998 9999864321
Q ss_pred CcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 560 DPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 560 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+......+... .....+.+++.+|++.||++
T Consensus 241 --~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 277 (293)
T cd05053 241 --EE-LFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQ 277 (293)
T ss_pred --HH-HHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCccc
Confidence 11 111121211111111 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=242.70 Aligned_cols=216 Identities=23% Similarity=0.328 Sum_probs=157.2
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|+....||+|+||.||+|+.. ++..+++|.+...... ..+.+.+|++++..+.|+++..+....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 566778999999999999875 5778899988654432 345678888888666666655443210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 01234789999999999999999999 8899999999999999999999999999987654332223
Q ss_pred cccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC-CCCChh
Q 047576 507 TLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPVDRK 580 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~ 580 (602)
....++..|+|||++. +..++.++|||||||++|||++|+.||...... .....+.....+ ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLAQPSR 233 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhcCCCCCCCccc
Confidence 3356889999999874 345778999999999999999999999753221 111111111111 011111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 234 ---~~~~~~~li~~~l~~~p~~ 252 (282)
T cd06643 234 ---WSSEFKDFLKKCLEKNVDA 252 (282)
T ss_pred ---cCHHHHHHHHHHccCChhh
Confidence 2234789999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=245.84 Aligned_cols=219 Identities=25% Similarity=0.353 Sum_probs=160.3
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.+|...+.||+|++|.||+|.. .+++.||+|.+...... ..+.+.+|+.++..+.|+++..++...
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 5788899999999999999985 57899999998654432 234567788877555555554433210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||.+..........
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 01123678899999999999999999 7899999999999999999999999999987765443333
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
....+++.|+|||+..+..++.++|+|||||++|++++|+.||............ ...-.+....+ .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~ 243 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNGTPELQNP-----ERLSA 243 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee----ccCCCCCCCCc-----cccCH
Confidence 3456888999999999888999999999999999999999999753321111000 00000111111 11223
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+||+.||++
T Consensus 244 ~~~~li~~~l~~~p~~ 259 (297)
T cd06656 244 VFRDFLNRCLEMDVDR 259 (297)
T ss_pred HHHHHHHHHccCChhh
Confidence 4778999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=243.26 Aligned_cols=217 Identities=27% Similarity=0.400 Sum_probs=158.3
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
.|+..+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|++++..+.|+++..+....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4667788999999999999754 6789999988644322 2345677888877555554444332210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++..+..++.|+++|+.||| +.+++|+||+|+||+++.++.++++|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 83 YLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred ccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 01234788999999999999999999 78999999999999999999999999999876654332233
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...++..|+|||++.+..++.++||||||+++|||+||+.||....... .... +....++.... .....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~~~~~~---~~~~~ 228 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFL-IPKNSPPTLEG---QYSKP 228 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhh-hhcCCCCCCCc---ccCHH
Confidence 3467889999999998889999999999999999999999986432211 0111 11111111111 12344
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+||+.+|++
T Consensus 229 ~~~li~~~l~~~p~~ 243 (277)
T cd06642 229 FKEFVEACLNKDPRF 243 (277)
T ss_pred HHHHHHHHccCCccc
Confidence 789999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=245.83 Aligned_cols=219 Identities=25% Similarity=0.312 Sum_probs=157.4
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
+++|.....||+|+||.||+|..+ .+..||+|.+...... .....+.+|+.++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 567889999999999999999643 3558999988644322 1234566777766
Q ss_pred ------HhhhcCccccccccccc-------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcce
Q 047576 423 ------SQMERGSLFRILHNDAE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~k 489 (602)
||+++|+|.+++..... ....++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 55556666666643211 123466778899999999999999 88999999999999999999999
Q ss_pred eecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence 9999998765332211 111234678999999998889999999999999999999 7889864221 11222
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+...... .. .....+.+++..|++.||++
T Consensus 233 ~~~~~~~~~~-~~---~~~~~~~~li~~~l~~~p~~ 264 (288)
T cd05061 233 FVMDGGYLDQ-PD---NCPERVTDLMRMCWQFNPKM 264 (288)
T ss_pred HHHcCCCCCC-CC---CCCHHHHHHHHHHcCCChhH
Confidence 2333322211 11 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=246.33 Aligned_cols=213 Identities=29% Similarity=0.439 Sum_probs=153.8
Q ss_pred CcccccccccccceeeecC-----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 373 SKYCIGTGAYGSVYKAQLP-----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
..+.||.|.||.||+|.+. .+..|+||.++..... ...+.+.+|++++..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE--EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH--HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc--ccceeeeecccccccccccccccccccccccccccccc
Confidence 3568999999999999865 3678999999653322 235778889988854444
Q ss_pred -----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 428 -----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 428 -----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
|+|.++++.. ....+++.++..|+.||++||+||| +.+++||||+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 4455444432 1345899999999999999999999 779999999999999999999999999999876322
Q ss_pred CCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 503 SSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 503 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
... .....+...|+|||.+.+..++.++||||||+++||++| |+.||.... .......+.+... .+...
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~-~~~~~ 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQR-LPIPD 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEE-TTSBT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccc-ceecc
Confidence 111 122346678999999999999999999999999999999 789986431 1111222222221 11111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++..||+.||++
T Consensus 229 ~---~~~~~~~li~~C~~~~p~~ 248 (259)
T PF07714_consen 229 N---CPKDIYSLIQQCWSHDPEK 248 (259)
T ss_dssp T---SBHHHHHHHHHHT-SSGGG
T ss_pred c---hhHHHHHHHHHHcCCChhh
Confidence 1 2344789999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=239.98 Aligned_cols=215 Identities=27% Similarity=0.421 Sum_probs=159.2
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---------------------- 426 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~---------------------- 426 (602)
++|.....+|+|++|.||+|..++++.||||.+...... .+.+.+|+.+++.+.
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 568888999999999999999888889999998754432 245677887774444
Q ss_pred ---cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 427 ---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 427 ---~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+++|.+++... ....+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 44444444331 1234789999999999999999999 7899999999999999999999999999987664321
Q ss_pred CC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 SN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. .....++..|+|||...+..++.++|+||+|+++|+++| |+.||.... ....+..+. .....+....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~~~- 228 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQVE-RGYRMPRPPN- 228 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH-cCCCCCCCCC-
Confidence 11 112234568999999998889999999999999999999 999996422 111222222 2121111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.+|++
T Consensus 229 --~~~~~~~~i~~~l~~~p~~ 247 (261)
T cd05034 229 --CPEELYDLMLQCWDKDPEE 247 (261)
T ss_pred --CCHHHHHHHHHHcccCccc
Confidence 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=239.30 Aligned_cols=212 Identities=28% Similarity=0.398 Sum_probs=157.9
Q ss_pred ccccccccccceeeecCC----CcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------------hh
Q 047576 375 YCIGTGAYGSVYKAQLPN----GRVFALKKLNSPETEELAFIRSFRNEAQVLS-------------------------QM 425 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~-------------------------~l 425 (602)
+.||+|+||.||+|.... +..|++|.+....... ..+.+.+|+.++. |+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 368999999999998753 7889999987655432 3466777887774 44
Q ss_pred hcCccccccccccc------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 426 ERGSLFRILHNDAE------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 426 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
++++|.+++..... ...+++.++..++.|+++|++||| +++++||||||+||+++.++.+||+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 45555555544211 255899999999999999999999 889999999999999999999999999999877
Q ss_pred cCCC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 500 HADS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 500 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
.... .......++..|+|||...+..++.++||||+|+++|||++ |+.||..... ......+.+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~ 227 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGY-RLP 227 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-CCC
Confidence 5432 11223457889999999988889999999999999999999 6999975421 11112222211 111
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... .....+.+++.+|++.||++
T Consensus 228 ~~~---~~~~~~~~li~~~l~~~p~~ 250 (262)
T cd00192 228 KPE---YCPDELYELMLSCWQLDPED 250 (262)
T ss_pred CCc---cCChHHHHHHHHHccCCccc
Confidence 111 12345889999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.24 Aligned_cols=222 Identities=21% Similarity=0.318 Sum_probs=154.5
Q ss_pred ccccCcccccccccccceeeecC-----------------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc----
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-----------------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER---- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~---- 427 (602)
++|...+.||+|+||.||+++.. ++..||+|++...... .....+.+|+.++..+.|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence 46888999999999999998532 2447899998754322 234577888888755444
Q ss_pred ---------------------Ccccccccccc--------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCC
Q 047576 428 ---------------------GSLFRILHNDA--------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSN 478 (602)
Q Consensus 428 ---------------------gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~ 478 (602)
++|.+++.... ....+++.++..++.|++.|++||| +.+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence 44444443211 1123677889999999999999999 789999999999
Q ss_pred CeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc--CCCCCCCCcc
Q 047576 479 NILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM--GKHPRDLHST 554 (602)
Q Consensus 479 NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~ 554 (602)
||+++.++.++|+|||+++........ .....++..|+|||+..++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999998765332211 112234578999999888889999999999999999998 7788864322
Q ss_pred cccCCCcccchhhhhcc---CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLDQ---RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d~---~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... .. ...+.... ....+... .+...+.+++..||+.||++
T Consensus 240 ~~~-~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~ 283 (296)
T cd05095 240 EQV-IE---NTGEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKE 283 (296)
T ss_pred HHH-HH---HHHHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCccc
Confidence 110 00 00111111 00001001 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=242.15 Aligned_cols=219 Identities=25% Similarity=0.344 Sum_probs=156.1
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------- 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------- 423 (602)
+|+....||+|+||.||+|+.. +++.||+|.+...... .....+.+|++++.
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5777889999999999999875 7899999988643221 12356667777664
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|++++++..++........+++..+..++.|++.|+.|||+ +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 44445554444332112358999999999999999999994 3599999999999999999999999999987653322
Q ss_pred CCccccccccccccccccccCc------CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMV------MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.....++..|+|||++.+.. ++.++|+||+||++|+|++|+.||...... .....+..+.+...+ ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~-~~ 230 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSAIVDGDPP-TL 230 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHHHhhcCCC-CC
Confidence 22245788999999986543 478999999999999999999999642110 001112222322211 11
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. .....+.+++..|++.+|++
T Consensus 231 ~~---~~~~~~~~li~~~l~~~p~~ 252 (286)
T cd06622 231 PS---GYSDDAQDFVAKCLNKIPNR 252 (286)
T ss_pred Cc---ccCHHHHHHHHHHcccCccc
Confidence 11 13344788999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=233.19 Aligned_cols=224 Identities=20% Similarity=0.331 Sum_probs=174.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|+....||+|+|+.|-.++++ +.+.+|+|++++.-..+.+.+.+.+.|..+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 578999999999999999999875 5788999999866444333445555555544
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+.+|+|.-.+.. ...++++.++.+..+|..||.||| ++|||+||+|.+|||+|.+|++||.|||+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 66667776544433 445899999999999999999999 8999999999999999999999999999998766
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCc-ccchhhhhccCCCCCCCh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP-KIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~ 579 (602)
.+....+.++|||.|+|||.+++..|...+|+|++||+|+||+.|+.||+........... +--+.-+++..++-|.+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs- 481 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS- 481 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce-
Confidence 6666677789999999999999999999999999999999999999999865432222222 22234456666655532
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
-..+...+...-+.+||+|
T Consensus 482 ----lsvkas~vlkgflnkdp~e 500 (593)
T KOG0695|consen 482 ----LSVKASHVLKGFLNKDPKE 500 (593)
T ss_pred ----eehhhHHHHHHhhcCCcHH
Confidence 2223445666778888875
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=239.60 Aligned_cols=220 Identities=26% Similarity=0.390 Sum_probs=161.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------------- 431 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------------- 431 (602)
++|+..+.+|.|++|.||+|... ++..+|+|++....... ..+.+.+|++++..+.|.++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 35788899999999999999854 68899999986544322 346678888877555554444
Q ss_pred ---------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 432 ---------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 432 ---------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++........+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 33332111234788999999999999999999 889999999999999999999999999998876543
Q ss_pred CCC----ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC---CC
Q 047576 503 SSN----QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR---LP 574 (602)
Q Consensus 503 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~---l~ 574 (602)
... .....|+..|+|||++... .++.++|+|||||++|+|++|+.||....... .+.+.+... +.
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~ 228 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPSLE 228 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCCCCCcC
Confidence 322 1234688999999998877 78899999999999999999999997543211 111111111 11
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... .......+.+++.+|++.||++
T Consensus 229 ~~~~--~~~~~~~~~~li~~~l~~~p~~ 254 (267)
T cd06610 229 TGAD--YKKYSKSFRKMISLCLQKDPSK 254 (267)
T ss_pred Cccc--cccccHHHHHHHHHHcCCChhh
Confidence 1100 0112345789999999999974
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=249.00 Aligned_cols=218 Identities=25% Similarity=0.330 Sum_probs=152.7
Q ss_pred CccccCcccccccccccceeeecC-CCc--EEeeeccCCchhHHHHHhhhhHhHHHHHHhh-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGR--VFALKKLNSPETEELAFIRSFRNEAQVLSQM------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~~E~~il~~l------------------- 425 (602)
.++|+....||+|+||.||+|+.. ++. .+|+|.++..... .....+.+|++++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 457888899999999999999864 444 4678776543222 2345677788877444
Q ss_pred -------hcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 426 -------ERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 426 -------~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
++++|.++++... ....+++.+++.++.|++.|++||| +++|+||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCC
Confidence 3444444443221 1124788999999999999999999 8899999999999999999
Q ss_pred CcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccc
Q 047576 486 LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIM 564 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 564 (602)
+.+||+|||++....... ......++..|+|||+..+..++.++|||||||++|||+| |..||..... ...
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~ 232 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AEL 232 (303)
T ss_pred CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HHH
Confidence 999999999986432111 1111234567999999988889999999999999999998 9999964321 111
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... +......+... .....+.+++.+||+.||++
T Consensus 233 ~~~-~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 266 (303)
T cd05088 233 YEK-LPQGYRLEKPL---NCDDEVYDLMRQCWREKPYE 266 (303)
T ss_pred HHH-HhcCCcCCCCC---CCCHHHHHHHHHHcCCChhh
Confidence 111 11111111110 12234789999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.07 Aligned_cols=219 Identities=21% Similarity=0.322 Sum_probs=157.5
Q ss_pred ccccCcccccccccccceeeecCC-----------------CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN-----------------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF 431 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~ 431 (602)
.+|+....||+|+||.||+|+..+ +..||+|.+...... ...+.+.+|++++..+.|+++.
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCEe
Confidence 578889999999999999987542 346899998755433 3456788899888666665554
Q ss_pred cc-------------------------ccccc--------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCC
Q 047576 432 RI-------------------------LHNDA--------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSN 478 (602)
Q Consensus 432 ~~-------------------------l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~ 478 (602)
.+ +.... ....+++..+..++.|++.||+||| +.+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchh
Confidence 43 22211 0114789999999999999999999 789999999999
Q ss_pred CeeeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc--CCCCCCCCcc
Q 047576 479 NILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM--GKHPRDLHST 554 (602)
Q Consensus 479 NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~ 554 (602)
||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876533221 1222345678999999988889999999999999999998 6778764321
Q ss_pred cccCCCcccchhhhhc------cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLD------QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d------~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+..... .....+.. ......+.+++.+|++.||++
T Consensus 240 -------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~ 283 (296)
T cd05051 240 -------QQVIENAGHFFRDDGRQIYLPRP---PNCPKDIYELMLECWRRDEED 283 (296)
T ss_pred -------HHHHHHHHhccccccccccCCCc---cCCCHHHHHHHHHHhccChhc
Confidence 111111110 01101111 112245899999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.65 Aligned_cols=219 Identities=23% Similarity=0.317 Sum_probs=156.3
Q ss_pred CccccCcccccccccccceeeec--------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS---------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~---------------- 423 (602)
.++|.....||+|+||.||+|+. .++..||+|.+...... ...+.+.+|+.++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45788889999999999999963 23557999988654221 23455667777664
Q ss_pred ----------hhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 424 ----------QMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 424 ----------~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
|+++|+|.+++.... ....+++.++..++.||+.||+||| +.+|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 444555555554321 1234788899999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
++++++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 9999999999999999876432211 112345678999999998889999999999999999998 8888864321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. +.+.+.......... .....+.+++.+||+.+|++
T Consensus 246 ----~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~ 282 (304)
T cd05101 246 ----EE-LFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSH 282 (304)
T ss_pred ----HH-HHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhh
Confidence 11 111111111111111 13345888999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=243.64 Aligned_cols=218 Identities=26% Similarity=0.363 Sum_probs=155.4
Q ss_pred ccccCcccccccccccceeeecC-CCc----EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.+|...+.||+|+||.||+|+.. +|. .||+|.+...... .....+.+|+.++..+.|+++..++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCce
Confidence 46778889999999999999753 443 5789988654332 2234577788877666555554433210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 01224688899999999999999999 88999999999999999999999999999987643
Q ss_pred CCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 502 DSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 502 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+++......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGERLPQP 233 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCC
Confidence 3221 112345678999999998889999999999999999997 9999964211 1112222221111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++..||..||++
T Consensus 234 ~~---~~~~~~~li~~c~~~~p~~ 254 (303)
T cd05110 234 PI---CTIDVYMVMVKCWMIDADS 254 (303)
T ss_pred CC---CCHHHHHHHHHHcCCChhh
Confidence 11 2234788999999999974
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=244.77 Aligned_cols=218 Identities=24% Similarity=0.303 Sum_probs=158.1
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---------------------- 426 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~---------------------- 426 (602)
+|...+.+|+|+||.||+++.. +++.||+|.+...........+.+.+|++++..+.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 57899999987654433334566778888774444
Q ss_pred ---cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 427 ---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 427 ---~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+++|.+++.. ...+++..+..++.|++.|++|+| +.+++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 4444444432 234788899999999999999999 7899999999999999999999999999886421100
Q ss_pred ---------------CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh
Q 047576 504 ---------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 504 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
.......++..|+|||++.+..++.++|+||||+++|||++|+.||..... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 001123577889999999888899999999999999999999999964221 1112222
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+.... .....+.+++.+|++.||++
T Consensus 229 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 229 ISDDIEWPEGDE--ALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HhcccCCCCccc--cCCHHHHHHHHHHhccChhh
Confidence 222211111100 12334789999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=254.49 Aligned_cols=170 Identities=23% Similarity=0.341 Sum_probs=140.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
...|.....||+|+||.||+|+.. .++.||||... ...+.+|++++..+.|.++..++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 456888999999999999999875 57889999642 23456799999999888877665321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....++|.++..|+.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 01224889999999999999999999 88999999999999999999999999999986543221
Q ss_pred C--ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCC
Q 047576 505 N--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549 (602)
Q Consensus 505 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 549 (602)
. .....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 22356999999999999999999999999999999999988764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=238.10 Aligned_cols=217 Identities=21% Similarity=0.306 Sum_probs=162.0
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----------------- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----------------- 431 (602)
+|+..+.+|.|+||.||.++. .+++.+++|.+....... ...+.+.+|+++++.+.|.++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 477788999999999999975 468899999876543222 2345677898888555554444
Q ss_pred --------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 432 --------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 432 --------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+++.... ...+++.++..++.|++.|+.||| +.+++||||||+||++++++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 4333211 234788999999999999999999 7899999999999999999999999999998765443
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||+.... ......+.....++.. . .
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~-~---~ 224 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGNYTPVV-S---V 224 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCc-c---c
Confidence 233345688999999999888889999999999999999999999974321 1122233323222211 1 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08221 225 YSSELISLVHSLLQQDPEK 243 (256)
T ss_pred cCHHHHHHHHHHcccCccc
Confidence 2345788999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=247.57 Aligned_cols=216 Identities=25% Similarity=0.326 Sum_probs=167.7
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
-|...+-||.|+||.||-|+. .+.+.||||++.-.........+.+.+|+..+..+.|++..++-...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466778899999999999986 46789999999765544444557788999999888888876653211
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
...+++.+.++..|..+++.||+||| +.+.||||||+.|||+++.|.|||+|||.|..+.+ .
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----A 179 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----A 179 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc----h
Confidence 12345788889999999999999999 88999999999999999999999999999987653 3
Q ss_pred cccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 507 TLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
..++|||+|||||++. .+.|+-|+||||+|++..|+...++|.=. ......+.-|....-|.-... +
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-------MNAMSALYHIAQNesPtLqs~---e 249 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNESPTLQSN---E 249 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-------chHHHHHHHHHhcCCCCCCCc---h
Confidence 4478999999999864 57799999999999999999999999521 222223333333332222222 3
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+..++-.|+++-|.|
T Consensus 250 WS~~F~~Fvd~CLqKipqe 268 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQE 268 (948)
T ss_pred hHHHHHHHHHHHHhhCccc
Confidence 5566888888999998875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=239.30 Aligned_cols=215 Identities=25% Similarity=0.411 Sum_probs=159.5
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhH------HHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETE------ELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
|.....+|+|++|.||+|... +++.||+|.+...... .....+.+.+|+.++..+.|+++..+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556778999999999999864 6889999988644321 223446788899988777766655443210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 01234788889999999999999999 78999999999999999999999999999887653
Q ss_pred CCC------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh---hccC
Q 047576 502 DSS------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV---LDQR 572 (602)
Q Consensus 502 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~d~~ 572 (602)
... ......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... .....+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 231 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGENASPE 231 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhccCCCc
Confidence 211 111235788999999999888999999999999999999999999753221 111111 1122
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++.. ....+.+++.+||+.||++
T Consensus 232 ~~~~-------~~~~~~~li~~~l~~~p~~ 254 (267)
T cd06628 232 IPSN-------ISSEAIDFLEKTFEIDHNK 254 (267)
T ss_pred CCcc-------cCHHHHHHHHHHccCCchh
Confidence 2222 2344788999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=236.76 Aligned_cols=221 Identities=20% Similarity=0.320 Sum_probs=162.8
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------------- 433 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------------- 433 (602)
+|+....+|.|++|.||+|.. .+++.||+|++...... ....+.+.+|++++..+.|+++.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 367778899999999999975 47889999988654332 2234567778888766655555443
Q ss_pred ------------cccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcC--CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 434 ------------LHND-AEAVELDWAKRVNIVKAMAHALAYLHHDC--SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 434 ------------l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
+... .....+++.++..++.|++.|++|+|..+ +.+++|+||||+||+++.++.+||+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 2211 01234788899999999999999999543 67899999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
............+++.|+|||+..+..++.++|+||||+++|+|++|+.||+.... ......+.+...+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~ 231 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFR-RIP 231 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCC-CCc
Confidence 75544323345688999999999988899999999999999999999999975321 1111122222111 111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .....+.+++.+|++.+|++
T Consensus 232 ~---~~~~~~~~l~~~~l~~~p~~ 252 (265)
T cd08217 232 Y---RYSSELNEVIKSMLNVDPDK 252 (265)
T ss_pred c---ccCHHHHHHHHHHccCCccc
Confidence 1 13345889999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=244.94 Aligned_cols=222 Identities=21% Similarity=0.264 Sum_probs=154.1
Q ss_pred ccccCcccccccccccceeeecCC---------------CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc----
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN---------------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---- 429 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs---- 429 (602)
++|...+.||+|+||.||+++.+. ...||+|.+...... .....+.+|++++..+.|++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCcCeE
Confidence 468888999999999999997642 235899998754322 23456888998885555444
Q ss_pred ---------------------ccccccccc---------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCC
Q 047576 430 ---------------------LFRILHNDA---------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNN 479 (602)
Q Consensus 430 ---------------------L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~N 479 (602)
|.+++.... ....+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence 444432211 0113678889999999999999999 8899999999999
Q ss_pred eeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc--CCCCCCCCccc
Q 047576 480 ILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM--GKHPRDLHSTL 555 (602)
Q Consensus 480 ILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~ 555 (602)
|+++.++.+||+|||++......... .....++..|+|||+..+..++.++|||||||++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765332211 122345678999999988889999999999999999998 66787643211
Q ss_pred ccCCCcccchhhhhcc---CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 556 SSSYDPKIMLIDVLDQ---RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 556 ~~~~~~~~~~~~~~d~---~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. .....+..+. ........ .....+.+++.+||+.||++
T Consensus 240 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~ 282 (295)
T cd05097 240 QV----IENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKD 282 (295)
T ss_pred HH----HHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchh
Confidence 00 0000111111 00000000 02245899999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=245.07 Aligned_cols=219 Identities=23% Similarity=0.311 Sum_probs=156.2
Q ss_pred CccccCcccccccccccceeeecC--------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVLS---------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~---------------- 423 (602)
.++|...+.||+|+||.||+|+.. ++..+|+|.+...... .....+..|+.++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467888999999999999999742 2457999998754322 12345666777664
Q ss_pred ----------hhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 424 ----------QMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 424 ----------~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
|+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence 444555655554321 1134889999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||.+......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--- 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence 9999999999999998765432111 111224468999999998889999999999999999998 8899864221
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+...+......+... .....+.+++.+|++.+|++
T Consensus 249 -----~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 285 (307)
T cd05098 249 -----EELFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQ 285 (307)
T ss_pred -----HHHHHHHHcCCCCCCCC---cCCHHHHHHHHHHcccChhh
Confidence 11111222221111111 12345788999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.76 Aligned_cols=225 Identities=23% Similarity=0.295 Sum_probs=160.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+..+.||+|+||+||+|+.. +|+.||+|++..... ....+.+.+|++++..++|+++..+....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 46778889999999999999864 688999998764432 22356778888888655555444332110
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.+++.|+.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 012347889999999999999999994 3589999999999999999999999999986543222
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccc----hhhhhccCCCCCCChhh
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM----LIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~d~~l~~~~~~~~ 581 (602)
.....|+..|+|||++.+..++.++|||||||++|+++||+.||+.............. ...++....+....
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS--- 235 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc---
Confidence 12346889999999998888999999999999999999999999753321111011111 11222221111101
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|+++||++
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~ 256 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTE 256 (284)
T ss_pred hhcCHHHHHHHHHHhcCCccc
Confidence 113345889999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=237.40 Aligned_cols=180 Identities=24% Similarity=0.334 Sum_probs=143.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchh--HHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPET--EELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
.+|.....+|+|+||.||+|... ++..||+|++..... ......+.+.+|+.++..++|+++..+....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 688999998764321 2223456788899998777776665433210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 01123678888999999999999999 88999999999999999999999999999876532
Q ss_pred CC---CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DS---SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.. .......++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 11 112224578899999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=236.83 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=154.8
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--------------------- 427 (602)
.+|.....+|+|+||.||++.. +++.||+|....... .+.+.+|+.++..+.|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEEC
Confidence 4688889999999999999976 678899999865432 2467778887754444
Q ss_pred ---CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 428 ---GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 428 ---gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+++.+++.... ...+++.++..++.|++.|+.|+| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 80 MSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 44444443221 224788999999999999999999 7899999999999999999999999999987643221
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.....+..|+|||++.+..++.++|+||||+++|||++ |+.||...... ...+.+......+... .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~ 221 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECVEKGYRMEPPE---G 221 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhCCCCCCCCC---c
Confidence 12234568999999988889999999999999999998 99999743211 1111222222111111 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 222 ~~~~~~~li~~~l~~~p~~ 240 (254)
T cd05083 222 CPADVYVLMTSCWETEPKK 240 (254)
T ss_pred CCHHHHHHHHHHcCCChhh
Confidence 2345789999999999964
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=255.21 Aligned_cols=174 Identities=22% Similarity=0.327 Sum_probs=142.9
Q ss_pred CccccCcccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
..+|.....||+|+||.||++... .+..||+|.+.... ...+|+.++..+.|+++..+++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 346888999999999999999643 46789999886432 235688999888888777654311
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.+++.|+.|++.||+||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 163 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 11234789999999999999999999 7899999999999999999999999999997654332
Q ss_pred CC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 21 22357999999999999999999999999999999999999999653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=244.56 Aligned_cols=217 Identities=24% Similarity=0.376 Sum_probs=161.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|+....+|.|++|.||+|.. .+++.||+|.+...... ..+.+.+|+.++..+.|+++..+....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 35688899999999999999975 57899999988654322 235667788887666665554443210
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 01234789999999999999999999 889999999999999999999999999998766543333
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc---CCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ---RLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~---~l~~~~~~~~~ 582 (602)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+... .+..+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~----- 239 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPELQNPE----- 239 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCcccCCcc-----
Confidence 333468889999999998889999999999999999999999997543211 11111111 111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+||+.||++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~ 259 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEK 259 (296)
T ss_pred cCCHHHHHHHHHHhhcChhh
Confidence 12234778999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=237.84 Aligned_cols=211 Identities=23% Similarity=0.340 Sum_probs=158.3
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc-------------------------
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL------------------------- 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL------------------------- 430 (602)
||.|++|.||+|+.. +++.||+|++...........+.+.+|+.++..+.|+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 488999999876554433445678888888755555444
Q ss_pred ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 431 FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 431 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
.+++.. ...+++..+..++.|+++||+|+| +.+++|+||||+||+++.++.+||+|||.+....... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 443332 224788899999999999999999 8899999999999999999999999999998765432 222346
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
++..|+|||++.+..++.++|+||+|+++|+|++|+.||..... ........+.+.......+.. ....+.+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 225 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNY---IDKAAKD 225 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCcc---cCHHHHH
Confidence 78899999999888899999999999999999999999975321 112222333322222222211 1345889
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++..||++||++
T Consensus 226 ~i~~~l~~~p~~ 237 (262)
T cd05572 226 LIKQLLRRNPEE 237 (262)
T ss_pred HHHHHccCChhh
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=237.27 Aligned_cols=216 Identities=24% Similarity=0.339 Sum_probs=156.6
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
.+|+..+.+|+|+||.||+|...+++.+|+|.+...... ...+.+|++++..+.|+++..++...
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 467788999999999999998877889999988754432 24577788888666555544432210
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 01234788999999999999999999 789999999999999999999999999998765432211
Q ss_pred -ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 506 -QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+ .........+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~~~--- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETI-NAGFRLYKPRL--- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHH-hCCCCCCCCCC---
Confidence 112234568999999998889999999999999999998 9999974221 1111111 11111000011
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 226 ~~~~~~~l~~~~l~~~p~~ 244 (256)
T cd05112 226 ASQSVYELMQHCWKERPED 244 (256)
T ss_pred CCHHHHHHHHHHcccChhh
Confidence 2245889999999999975
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=243.87 Aligned_cols=219 Identities=21% Similarity=0.305 Sum_probs=156.1
Q ss_pred CccccCcccccccccccceeeecC--------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------- 422 (602)
.++|.....+|+|+||.||+|+.. ....+|+|.++..... .....+.+|+.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 457888999999999999999641 3557999988754322 2345566777766
Q ss_pred ---------HhhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 423 ---------SQMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 423 ---------~~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
+|+++|+|.+++.... ....+++.+++.++.|++.||+|+| +++|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence 3445555555554321 1234889999999999999999999 88999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999866432111 111234467999999998889999999999999999999 8999864321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+... ....... .....+.+++.+|++.||++
T Consensus 243 ----~~~~~~~~~~-~~~~~~~---~~~~~l~~li~~cl~~~p~~ 279 (314)
T cd05099 243 ----EELFKLLREG-HRMDKPS---NCTHELYMLMRECWHAVPTQ 279 (314)
T ss_pred ----HHHHHHHHcC-CCCCCCC---CCCHHHHHHHHHHcCCCccc
Confidence 1111111111 1111111 12334778999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=240.85 Aligned_cols=210 Identities=23% Similarity=0.293 Sum_probs=148.1
Q ss_pred cccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHH----------------------------HHhhh
Q 047576 376 CIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQV----------------------------LSQME 426 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~i----------------------------l~~l~ 426 (602)
.||+|+||.||+|+.. +++.||+|.+.............+..|..+ +||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999864 588999998865432211111122222221 15566
Q ss_pred cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 427 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
+++|.+++.. ...+++.+++.++.|+++|++||| +.+|+||||||+||+++.++.+||+|||.+....... .
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 6666665543 235899999999999999999999 7899999999999999999999999999987553322 2
Q ss_pred cccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 507 TLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||......... .........+..++... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~-------s 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSF-------S 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhccCCCCCCcC-------C
Confidence 234689999999998754 5889999999999999999999999753211100 00000111122222221 2
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 224 ~~~~~li~~~l~~~p~~ 240 (278)
T cd05606 224 PELRSLLEGLLQRDVNR 240 (278)
T ss_pred HHHHHHHHHHhhcCHHh
Confidence 34788899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=238.76 Aligned_cols=213 Identities=27% Similarity=0.413 Sum_probs=160.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM----------------------- 425 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l----------------------- 425 (602)
.|+....||.|+||.||+|... +++.||+|.+...... ...+.+.+|+.++..+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4677788999999999999864 6889999988654322 2346778888877444
Q ss_pred --hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 426 --ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 426 --~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
++++|.+++.. ..+++.+...++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 44455444432 24788889999999999999999 8899999999999999999999999999997765433
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.......++..|+|||++.+..++.++|+||||+++|||+||+.||....+.. ....+....++... ..
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~---~~ 224 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNNPPTLT---GE 224 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCCCCCCc---hh
Confidence 33333567889999999998889999999999999999999999997432211 01111111122211 12
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 225 ~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSF 243 (277)
T ss_pred hhHHHHHHHHHHcccCccc
Confidence 4455889999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=243.00 Aligned_cols=180 Identities=25% Similarity=0.357 Sum_probs=143.8
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+....+|+|++|.||+|+.. +|+.||+|++...... ....+.+.+|+.++..+.|.++..++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 35778889999999999999875 6899999988644321 12234577899999888777766554321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 01224789999999999999999999 789999999999999999999999999999876543322
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 233457889999999876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=243.56 Aligned_cols=215 Identities=24% Similarity=0.344 Sum_probs=156.7
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------------------- 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g------------------- 428 (602)
+.|+....||+|+||.||++... ++..||||.+...... ..+.+.+|+.++..+.|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44566678999999999999864 6889999988654322 234566777766444444
Q ss_pred ------ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 429 ------SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 429 ------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++.+++. ...+++.++..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 99 EFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred eCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 4444332 224788999999999999999999 789999999999999999999999999998765433
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........|+..|+|||+..+..++.++||||||+++|||++|+.||....... ....+...+.+..+...
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~----- 242 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRRIRDNLPPRVKDSH----- 242 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCcccccc-----
Confidence 333334568899999999988889999999999999999999999997432210 00011111222222111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++..|++.||++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred ccCHHHHHHHHHHccCChhH
Confidence 12234778899999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=241.51 Aligned_cols=219 Identities=23% Similarity=0.301 Sum_probs=155.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
+++|.....+|+|+||.||+|.. .+++.+|+|++...... ...+.+|+.++..+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 67899999999999999999986 46889999998654321 12344555555433
Q ss_pred ----------hcCccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 426 ----------ERGSLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 426 ----------~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
++++|.++++.. .....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 344444433321 11235788999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCc-----CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMV-----MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
.+..............|+..|+|||++.... ++.++|||||||++|||++|+.||....+. ..+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~~~~ 246 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFKIP 246 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHHHHh
Confidence 9887654332233356888999999876543 678999999999999999999999643211 1111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+..... .+....+.+++.+|++.||++
T Consensus 247 ~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~ 277 (291)
T cd06639 247 RNPPPTLLHP--EKWCRSFNHFISQCLIKDFEA 277 (291)
T ss_pred cCCCCCCCcc--cccCHHHHHHHHHHhhcChhh
Confidence 1111100000 112345889999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=234.99 Aligned_cols=212 Identities=23% Similarity=0.321 Sum_probs=154.5
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------------
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------------- 437 (602)
+.||+|++|.||+|...+++.||+|.+...... .....+.+|+++++.+.|+++..+....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999877999999988765433 2446788898888666665554432210
Q ss_pred ------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc--ccc
Q 047576 438 ------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ--TLL 509 (602)
Q Consensus 438 ------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~--~~~ 509 (602)
.....+++..+..++.+++.|++||| +.+++||||||+||+++.++.+||+|||.+.......... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 01224688889999999999999999 7899999999999999999999999999987654222111 112
Q ss_pred ccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
.++..|+|||++.+..++.++|+||||+++|||+| |..||..... ......+......+... .....+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~ 224 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQ---LCPEEI 224 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCc---cCCHHH
Confidence 23567999999988889999999999999999999 8889864321 11122222222211111 133458
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|++.+|++
T Consensus 225 ~~li~~~l~~~p~~ 238 (251)
T cd05041 225 YRLMLQCWAYDPEN 238 (251)
T ss_pred HHHHHHHhccChhh
Confidence 89999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=239.41 Aligned_cols=219 Identities=22% Similarity=0.326 Sum_probs=160.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR---------------- 432 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~---------------- 432 (602)
+|+..+.||.|++|.||+|... +++.||+|.+...... ...+.+.+|++++..+.|+++..
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5777889999999999999875 6889999988765332 23456778888776555555443
Q ss_pred ---------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 433 ---------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 433 ---------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++... ...+++..+..++.|++.|++|+| + .+++||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 33221 145788888999999999999999 7 89999999999999999999999999998766432
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.... ..++..|+|||+..+..++.++||||||+++|+|++|+.||........ ........+.+...+.. ...
T Consensus 155 ~~~~--~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~-- 227 (265)
T cd06605 155 LAKT--FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQYIVNEPPPRL-PSG-- 227 (265)
T ss_pred Hhhc--ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHHHhcCCCCCC-Chh--
Confidence 2211 5688899999999998999999999999999999999999974321000 00111122222211111 110
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++..||+.||++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~ 247 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRE 247 (265)
T ss_pred hcCHHHHHHHHHHcCCCchh
Confidence 02344889999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=236.69 Aligned_cols=180 Identities=24% Similarity=0.329 Sum_probs=140.6
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCch--hHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPE--TEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
.+|...+.+|+|+||.||+|+.. ++..||+|.+.... .......+.+.+|+.++..+.|+++..+....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 56888999999999999999864 58899999875322 11123456778888888666665544432210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+.+++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||.+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 01123677888999999999999999 78999999999999999999999999999876532
Q ss_pred CC---CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DS---SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 11 112234588899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=238.10 Aligned_cols=216 Identities=29% Similarity=0.448 Sum_probs=154.9
Q ss_pred ccccCcccccccccccceeeecC-CC---cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NG---RVFALKKLNSPETEELAFIRSFRNEAQVLSQMER----------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~----------------- 427 (602)
..|+..+.+|+|+||.||+|+.. ++ ..||+|.+...... ...+.|..|+.++..+.|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35778899999999999999864 23 36999998754322 234678888888754444
Q ss_pred --------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 428 --------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 428 --------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 4444444321 234788999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCCc---cccc--cccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCC
Q 047576 500 HADSSNQ---TLLA--GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573 (602)
Q Consensus 500 ~~~~~~~---~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l 573 (602)
....... .... .+..|+|||++.+..++.++||||||+++||+++ |..||...... .. .+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~-~~~i~~~~ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DV-INAIEQDY 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HH-HHHHHcCC
Confidence 4322111 1111 1357999999999899999999999999999886 99999643211 11 11111111
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+... +....+.+++..||+++|++
T Consensus 229 ~~~~~~---~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 229 RLPPPM---DCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred cCCCcc---cCCHHHHHHHHHHcCCChhh
Confidence 111111 13344789999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=241.57 Aligned_cols=173 Identities=25% Similarity=0.347 Sum_probs=138.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----------------- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----------------- 431 (602)
+|+..+.||+|+||.||+|+.. ++..+|+|.+...... ....++.+|++++..+.|+++.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 5888899999999999999864 6788999988644222 2345677888888655555444
Q ss_pred --------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 432 --------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 432 --------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
++++. ...+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||.+.......
T Consensus 80 y~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 80 HMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 33332 2347888899999999999999993 2589999999999999999999999999987653321
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2335688999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=236.27 Aligned_cols=221 Identities=27% Similarity=0.369 Sum_probs=160.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|...+.||+|++|.||+|... +++.|++|.++..... ....+.+.+|++++..+.|.++.+++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4677889999999999999864 7899999998765443 33567788899988666665554443210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|+++|++||| +.+|+|+||||+||+++.++.+||+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 01223788899999999999999999 8899999999999999999999999999988765432221
Q ss_pred c----ccccccccccccccccCc---CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 507 T----LLAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 507 ~----~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
. ...++..|+|||++.+.. .+.++||||||+++|++++|+.||...... ............+.++..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~--- 230 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGAGHKPPIPDS--- 230 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHhcCCCCCCCcc---
Confidence 1 245788999999988766 789999999999999999999999743210 000000011111112111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 231 --~~~~~~~~~li~~~l~~~p~~ 251 (264)
T cd06626 231 --LQLSPEGKDFLDRCLESDPKK 251 (264)
T ss_pred --cccCHHHHHHHHHHccCCccc
Confidence 112344778999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=237.58 Aligned_cols=212 Identities=25% Similarity=0.311 Sum_probs=147.2
Q ss_pred ccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 375 YCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.++..+.|+++..++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999753 346799998854322 12345677788877666655554433210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC--
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-- 504 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~-- 504 (602)
......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||.++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 00122467778899999999999999 78999999999999999999999999999876533211
Q ss_pred --CccccccccccccccccccCcCCccchhHHHHHHHHHHHcC-CCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 --NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMG-KHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
......++..|+|||++.+..++.++||||||+++|||++| ..||..... ......+..... .+..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~- 226 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRR-LLQPEY- 226 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhcCCC-CCCCCc-
Confidence 11123456789999999888899999999999999999995 556653211 111111222111 111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 227 --~~~~~~~li~~cl~~~p~~ 245 (262)
T cd05058 227 --CPDPLYEVMLSCWHPKPEM 245 (262)
T ss_pred --CCHHHHHHHHHHcCCChhh
Confidence 2235889999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=240.30 Aligned_cols=218 Identities=24% Similarity=0.358 Sum_probs=154.3
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh--------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-------------------- 425 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-------------------- 425 (602)
....|+....+|.|+||.||+|+. .+++.+|+|++...... ...+..|+.++..+
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 356788889999999999999986 46889999987654322 23345555555433
Q ss_pred ------------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 426 ------------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 426 ------------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
.+|++.+++... ....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 333444333221 1223677888899999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
|.+..............|+..|+|||++. +..++.++|||||||++|||++|+.||....+... ...+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~~~~ 238 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LFLI 238 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------hhhH
Confidence 99876543222233456889999999876 34578899999999999999999999964322111 1111
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+ .... ......+.+++.+||+.||++
T Consensus 239 ~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~ 269 (282)
T cd06636 239 PRNPPP-KLKS--KKWSKKFIDFIEGCLVKNYLS 269 (282)
T ss_pred hhCCCC-CCcc--cccCHHHHHHHHHHhCCChhh
Confidence 111111 1100 112345889999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=239.74 Aligned_cols=219 Identities=23% Similarity=0.366 Sum_probs=157.5
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL----------- 430 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL----------- 430 (602)
.++|+....||+|+||.||+|+.. ++..||+|.+...... ...+.+.+|+.++..+.|+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357888899999999999999753 5678999998754332 234568888888755555444
Q ss_pred --------------cccccccc-------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCC
Q 047576 431 --------------FRILHNDA-------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISS 477 (602)
Q Consensus 431 --------------~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp 477 (602)
.+++.... ....+++.++..++.|++.||+|+| +.+++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence 33332110 0123678888999999999999999 78999999999
Q ss_pred CCeeeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcc
Q 047576 478 NNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHST 554 (602)
Q Consensus 478 ~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~ 554 (602)
+||++++++.+||+|||.+........ ......++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875533211 1112234567999999998889999999999999999998 8889853211
Q ss_pred cccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+....+.. . .....+.+++.+|++.||++
T Consensus 239 -------~~~~~~~~~~~~~~~~-~---~~~~~l~~li~~~l~~~p~~ 275 (288)
T cd05050 239 -------EEVIYYVRDGNVLSCP-D---NCPLELYNLMRLCWSKLPSD 275 (288)
T ss_pred -------HHHHHHHhcCCCCCCC-C---CCCHHHHHHHHHHcccCccc
Confidence 1112222222222111 1 12345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=238.72 Aligned_cols=217 Identities=26% Similarity=0.378 Sum_probs=156.7
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF------------ 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~------------ 431 (602)
..+|+..+.+|+|+||.||+|+.. .+..+|+|.++..... ...+.+.+|+.++..+.|+++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 356888899999999999999753 2347999988654322 2345778888887555554444
Q ss_pred -------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 432 -------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 432 -------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 333321 234788999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCCc---cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 499 LHADSSNQ---TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 499 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
........ ....++..|+|||++.+..++.++|+||||+++||+++ |+.||...... .....+.+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~-~~ 227 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEG-YR 227 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCC-Cc
Confidence 65432211 11123467999999998889999999999999999886 99999643211 111122211 11
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+... .....+.+++.+|++++|++
T Consensus 228 ~~~~~---~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 228 LPAPM---DCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred CCCCC---CCCHHHHHHHHHHcccCchh
Confidence 11111 12344789999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=237.36 Aligned_cols=220 Identities=25% Similarity=0.364 Sum_probs=158.2
Q ss_pred cccCcccccccccccceeeecCC--CcEEeeeccCCchh-------HHHHHhhhhHhHHHHH------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPN--GRVFALKKLNSPET-------EELAFIRSFRNEAQVL------------------ 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~-------~~~~~~~~~~~E~~il------------------ 422 (602)
.|+....||+|+||.||+|.... ++.+|+|.+..... ........+.+|+.++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998754 68899998753221 1112334555676655
Q ss_pred --------HhhhcCccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 423 --------SQMERGSLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 423 --------~~l~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
||++++++.+++... .....+++..+..++.|++.|+.|||+ ..+++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 444455555544321 122347888999999999999999993 268999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l 573 (602)
|.+....... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||..... ......+.+...
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhccC
Confidence 9998765432 22345688999999999988899999999999999999999999964321 111122233322
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+..... ....+.+++.+||+.||++
T Consensus 231 ~~~~~~~---~~~~l~~li~~cl~~~p~~ 256 (269)
T cd08528 231 EPLPEGM---YSEDVTDVITSCLTPDAEA 256 (269)
T ss_pred CcCCccc---CCHHHHHHHHHHCCCCCcc
Confidence 2211111 2244889999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=235.15 Aligned_cols=212 Identities=22% Similarity=0.344 Sum_probs=157.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------------- 431 (602)
.++|.....+|.|++|.||+|... |+.||+|.+..... ..+++.+|+.++..+.|.++.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 356888899999999999999874 78999999876543 346678888888555554443
Q ss_pred ---------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 432 ---------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 432 ---------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++.... ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 3332211 124789999999999999999999 889999999999999999999999999999876332
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ....+..|+|||++.+..++.++||||||+++||+++ |+.||...... .+.+.+....+.....
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 222 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKGYRMEAPE-- 222 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCCCcc--
Confidence 21 2234567999999998889999999999999999997 99998643211 1111111111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.+|++
T Consensus 223 -~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05039 223 -GCPPEVYKVMKDCWELDPAK 242 (256)
T ss_pred -CCCHHHHHHHHHHhccChhh
Confidence 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=237.21 Aligned_cols=219 Identities=26% Similarity=0.358 Sum_probs=163.3
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|...+.+|.|+||.||+|+.. +++.||+|.+...........+.+.+|+++++.+.|+++..+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999875 5899999998765443334557788888888666666555432110
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 01235888999999999999999999 7899999999999999999999999999987664332 22
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc-cCCCCCCChhhHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD-QRLPPPVDRKVIQDI 585 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~~ 585 (602)
....|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... ....+..... .....+ .. ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~--~~---~~ 226 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETADVLYP--AT---WS 226 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccccccCc--cc---Cc
Confidence 3356888999999998888999999999999999999999999754321 1111111222 111111 11 22
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+||+.||++
T Consensus 227 ~~~~~~i~~~l~~~p~~ 243 (258)
T cd05578 227 TEAIDAINKLLERDPQK 243 (258)
T ss_pred HHHHHHHHHHccCChhH
Confidence 45889999999999974
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=238.18 Aligned_cols=217 Identities=22% Similarity=0.355 Sum_probs=159.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------------- 433 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------------- 433 (602)
+|+..+.+|+|+||.||+++.. +|+.||+|.+....... ...+.+.+|+.+++.+.|+++..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4777889999999999999864 68899999886432221 233567788888766555554443
Q ss_pred ----------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 434 ----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 434 ----------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+... ....+++.++..++.|++.|+.|+| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 3221 1123678889999999999999999 7899999999999999999999999999998764433
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.......|++.|+|||+..+..++.++|+|||||++|+|++|+.||..... ......++....++.. . .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~-~---~ 224 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSYPPVS-S---H 224 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCCCCCc-c---c
Confidence 223334688899999999988899999999999999999999999964211 1112222322222111 1 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.+|++
T Consensus 225 ~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRD 243 (256)
T ss_pred CCHHHHHHHHHHhhCChhh
Confidence 2344889999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=240.12 Aligned_cols=219 Identities=24% Similarity=0.338 Sum_probs=159.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....+|.|++|.||+|+.. ++..||+|.+...... ..+.+.+|++++..+.|+++..++...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 356888999999999999999864 6889999998654332 346677888888665555544433210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.|++.|+.||| +.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 01234889999999999999999999 8899999999999999999999999999887654433
Q ss_pred CCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-CC
Q 047576 504 SNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-PV 577 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~~ 577 (602)
.......+++.|+|||++. +..++.++|+||||+++|||++|+.||...... .....+.....+. ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEPPTLDQ 230 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCCCCcCC
Confidence 3333456889999999875 344678999999999999999999999753211 1111222111110 00
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. .....+.+++..||+.||++
T Consensus 231 ~~---~~~~~~~~li~~~l~~~p~~ 252 (280)
T cd06611 231 PS---KWSSSFNDFLKSCLVKDPDD 252 (280)
T ss_pred cc---cCCHHHHHHHHHHhccChhh
Confidence 01 12234778999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=239.49 Aligned_cols=179 Identities=25% Similarity=0.345 Sum_probs=141.8
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|...+.||+|++|.||+|..+ +++.||+|++....... ...+.+.+|++++..+.|+++..+....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5778899999999999999875 58899999886543322 2345677888888776666655433211
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..++.|+++|++||| +.+++||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 01123789999999999999999999 7899999999999999999999999999988765433333
Q ss_pred cccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....++..|+|||+..+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 335678899999988754 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=239.83 Aligned_cols=177 Identities=24% Similarity=0.333 Sum_probs=139.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....||+|++|.||+|+.. +|+.||+|+++..... ......+.+|+.++..+.|+++..+....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 3667788999999999999864 6899999998654321 12334567788888777776655432210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.||++||.||| +++|+||||||+||+++.++.+||+|||.+..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 01234789999999999999999999 7899999999999999999999999999998664433323
Q ss_pred cccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
....++..|+|||++.+.. ++.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 3345788999999887654 6899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=238.49 Aligned_cols=211 Identities=25% Similarity=0.344 Sum_probs=146.3
Q ss_pred ccccccccccceeeecCC-Cc--EEeeeccCCchhHHHHHhhhhHhHHHHHHhh--------------------------
Q 047576 375 YCIGTGAYGSVYKAQLPN-GR--VFALKKLNSPETEELAFIRSFRNEAQVLSQM-------------------------- 425 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-------------------------- 425 (602)
+.+|+|+||.||+|+..+ +. .+++|.++..... ...+.+.+|++++..+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999998753 43 4688888643221 2334566777776444
Q ss_pred hcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 426 ERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 426 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
++|+|.+++.... ....+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECC
Confidence 4455555443221 1124788999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhcc
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||..... ... ...+..
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~-~~~~~~ 226 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AEL-YEKLPQ 226 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHH-HHHHhC
Confidence 99985322111 1111223567999999988889999999999999999997 9999964221 111 111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+... .....+.+++.+||+.||.+
T Consensus 227 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 254 (270)
T cd05047 227 GYRLEKPL---NCDDEVYDLMRQCWREKPYE 254 (270)
T ss_pred CCCCCCCC---cCCHHHHHHHHHHcccChhh
Confidence 11111111 12234789999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=240.79 Aligned_cols=220 Identities=23% Similarity=0.277 Sum_probs=159.3
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND--------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~--------- 437 (602)
++|.....||+|+||.||+++.. +++.||+|.+...... .....+.+|+.++..+. |+++.+++...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35666788999999999999864 6899999998754332 23456788888887775 66665533210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.|++|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 012347788899999999999999993 3599999999999999999999999999987654
Q ss_pred CCCCCccccccccccccccccccC---cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc---cCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTM---VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD---QRLP 574 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d---~~l~ 574 (602)
.... .....|+..|+|||++.+. .++.++||||+||++|||++|+.||...... ...+.++.. +.+.
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------FDQLTQVVKGDPPILS 232 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH------HHHHhhhcCCCCCcCC
Confidence 3221 2224578899999998876 6889999999999999999999999743210 011112211 1121
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ......+.+++.+|++.||++
T Consensus 233 ~~~~---~~~~~~l~~li~~~l~~~p~~ 257 (288)
T cd06616 233 NSEE---REFSPSFVNFINLCLIKDESK 257 (288)
T ss_pred CcCC---CccCHHHHHHHHHHccCChhh
Confidence 1111 113345889999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=239.48 Aligned_cols=213 Identities=23% Similarity=0.287 Sum_probs=153.1
Q ss_pred ccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------------------
Q 047576 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------------------- 432 (602)
Q Consensus 377 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------------------- 432 (602)
||+|+||+||+|.. .+|+.||+|.+...........+.+.+|++++..+.++++..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 468899999987544333334456677888886555554443
Q ss_pred --ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 433 --ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 433 --~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
++.... ...+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+....... ......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRA 155 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-cccccc
Confidence 332211 125788999999999999999999 8899999999999999999999999999987654322 222346
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
++..|+|||++.+..++.++||||+|+++|+|++|+.||....... ....+....... +...... ....+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~-~~~~~~~---~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEM-AVEYPDK---FSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhccccc-cccCCcc---CCHHHHH
Confidence 7889999999988889999999999999999999999997533210 011111111110 1111111 1234789
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++.+||+.||++
T Consensus 228 li~~~l~~~p~~ 239 (277)
T cd05577 228 LCEALLQKDPEK 239 (277)
T ss_pred HHHHHccCChhH
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=243.23 Aligned_cols=181 Identities=22% Similarity=0.363 Sum_probs=151.8
Q ss_pred ccccCcccccccccccceeeecCCCc-EEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGR-VFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.++...-.||-|+||.|-+++.+... .+|+|.+++....+....+....|..||
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666678999999999999875433 4899999887665555556666666655
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
|.+-+|.+..+++. +..|+..+.+.|+..+.+|++||| +++||+|||||+|.++|.+|.+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 44456777777765 445889999999999999999999 899999999999999999999999999999998765
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS 556 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 556 (602)
.. +..++|||.|.|||.+.....+.++|.||+|+++||++||.+||...+++.
T Consensus 574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 44 344799999999999999999999999999999999999999999766543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=240.69 Aligned_cols=223 Identities=21% Similarity=0.320 Sum_probs=156.1
Q ss_pred cccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF------------- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~------------- 431 (602)
-|...+.||+|+||.||++++ .++..||+|.++..... .....+.+|+++++.+.|+++.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 467778899999999999973 35789999998754322 2345688888888555554443
Q ss_pred --------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 432 --------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 432 --------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
+++... ...+++.++..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 333221 124789999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc-c---CCCccc---chhh
Q 047576 498 LLHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS-S---SYDPKI---MLID 567 (602)
Q Consensus 498 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~---~~~~~~---~~~~ 567 (602)
........ .....++..|+|||+..+..++.++||||||+++|||+|++.|+....... . ...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433211 122346678999999988889999999999999999999887753211100 0 000000 0111
Q ss_pred hhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+......+... .....+.+++..|++.||++
T Consensus 238 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~ 269 (284)
T cd05079 238 VLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSK 269 (284)
T ss_pred HHHcCccCCCCC---CCCHHHHHHHHHHccCCccc
Confidence 111111111111 13345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=237.37 Aligned_cols=218 Identities=28% Similarity=0.444 Sum_probs=155.3
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---cCccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---RGSLFRILHND-------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~---~gsL~~~l~~~-------- 437 (602)
.|+..+.+|+|+||.||+|.. .+++.||+|.+...... .....+.+|+.++..+. |+++..+....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 467778899999999999985 57899999988654222 12345667777664443 44333322100
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 01125789999999999999999999 88999999999999999999999999999987654433
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......|+..|+|||++.++ .++.++|+||||+++|+|++|+.||......... .. +....++..... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~-~~~~~~~~~~~~--~ 226 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------ML-IPKSKPPRLEDN--G 226 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hc-cccCCCCCCCcc--c
Confidence 33345688899999988754 4688999999999999999999999753221110 00 111111111100 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 227 ~~~~~~~~i~~~l~~~p~~ 245 (277)
T cd06917 227 YSKLLREFVAACLDEEPKE 245 (277)
T ss_pred CCHHHHHHHHHHcCCCccc
Confidence 2345889999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=235.30 Aligned_cols=218 Identities=26% Similarity=0.413 Sum_probs=163.4
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----------------- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----------------- 431 (602)
+|...+.||+|++|.||+|+.. +++.|++|++...... ...+.+.+|+.++..+.|+++.
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5778899999999999999876 5899999998765432 2346678888877555444444
Q ss_pred --------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 432 --------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 432 --------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++.. ...+++..+..++.|+++|++|+| + .+++||||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 80 YMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 43332 144788999999999999999999 7 89999999999999999999999999999877554
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........++..|+|||...+..++.++|+||||+++|+|+||+.||..... .........+.+...+.. ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~-~~~-- 226 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPPSL-PAE-- 226 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCCCCCC-Ccc--
Confidence 4333345678899999999988899999999999999999999999975432 011111222222222211 110
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++..|++.+|++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~ 246 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKK 246 (264)
T ss_pred cCCHHHHHHHHHHccCChhh
Confidence 02345889999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=236.99 Aligned_cols=217 Identities=24% Similarity=0.381 Sum_probs=157.2
Q ss_pred CccccCcccccccccccceeeecC-CCc----EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------- 433 (602)
..+|...+.||+|+||.||+|... +|. .+|+|....... ......+.+|+.++..+.|+++..+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLSSQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCce
Confidence 356888899999999999999854 233 589998865543 2234667788888866665554443
Q ss_pred ---------------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 434 ---------------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 434 ---------------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
+... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 3221 224789999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCCcc--ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSSNQT--LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
......... ...++..|+|||......++.++|+||||+++||+++ |+.||+.... ..+...+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCCC
Confidence 643222111 1123567999999988889999999999999999999 9999975321 1112222211111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+.. +...+.+++..||..||++
T Consensus 231 ~~~~~---~~~~~~~~~~~~l~~~p~~ 254 (279)
T cd05057 231 PQPPI---CTIDVYMVLVKCWMIDAES 254 (279)
T ss_pred CCCCC---CCHHHHHHHHHHcCCChhh
Confidence 11111 2234778999999999964
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=235.10 Aligned_cols=210 Identities=22% Similarity=0.305 Sum_probs=151.9
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhhc
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQMER 427 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~~ 427 (602)
..+|+|++|.||+|... +|+.||+|++.............+..|..++ ||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999864 6889999998754432222233334443332 55566
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
++|.+++... ..+++..+..++.|++.||.|+| +.+++||||+|+||+++.++.+||+|||.+..... ..
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 6666666432 34788999999999999999999 78999999999999999999999999998875432 22
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+.......+.. ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRINWPEE-VKEFCSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccCCCCc-ccccCCHH
Confidence 34678899999999888889999999999999999999999974321 11112222211111110 00112345
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+|++.||++
T Consensus 224 ~~~~i~~~l~~~p~~ 238 (260)
T cd05611 224 AVDLINRLLCMDPAK 238 (260)
T ss_pred HHHHHHHHccCCHHH
Confidence 889999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=235.17 Aligned_cols=223 Identities=23% Similarity=0.417 Sum_probs=159.5
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchh---HHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPET---EELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
+|+....+|+|++|.||+|+. .+++.||+|++..... ......+.+.+|+.++..+.|+++..++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367778999999999999985 5789999998864331 1223456788899888666665554443211
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHAD 502 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~ 502 (602)
....++++..+..++.|++.|+.||| +.+++||||||+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 01234788999999999999999999 88999999999999998776 5899999998776543
Q ss_pred CC----CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 503 SS----NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 503 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.. ......++..|+|||+..+..++.++||||+|+++|+|++|+.||...... .......+.......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHHHHHhccCCCCCCc
Confidence 11 112345788999999998888999999999999999999999999643211 0011111111111111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .....+.+++..|++.||++
T Consensus 234 ~---~~~~~~~~~i~~~l~~~p~~ 254 (268)
T cd06630 234 E---HLSPGLRDVTLRCLELQPED 254 (268)
T ss_pred h---hhCHHHHHHHHHHcCCCccc
Confidence 1 12344788999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=237.98 Aligned_cols=224 Identities=22% Similarity=0.323 Sum_probs=160.9
Q ss_pred ccccCcccccccccccceeeecC-----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI---------- 433 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~---------- 433 (602)
+.|.....+|+|+||.||+|+.. ++..||+|++...... ...+.+.+|++++..+.|.++..+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 45667788999999999999853 4789999998765443 345678888888866655554443
Q ss_pred -----------------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 434 -----------------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 434 -----------------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
+... ...+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 2211 113788999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccC-------CCcccchh
Q 047576 497 RLLHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS-------YDPKIMLI 566 (602)
Q Consensus 497 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-------~~~~~~~~ 566 (602)
......... .....++..|+|||+..+..++.++||||||+++|||+||+.||......... ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876532221 11123456799999998888999999999999999999999998642211100 00011122
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+......+... ....++.+++.+||+.+|++
T Consensus 237 ~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05038 237 ELLKEGERLPRPP---SCPDEVYDLMKLCWEAEPQD 269 (284)
T ss_pred HHHHcCCcCCCCc---cCCHHHHHHHHHHhccChhh
Confidence 3333322222111 13356889999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=239.43 Aligned_cols=179 Identities=20% Similarity=0.273 Sum_probs=141.6
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|.....||+|+||.||+|+.. +++.||+|.+...... .....+.+|+.++..+.|.++..+.....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 56888899999999999999864 6889999988644322 12234567888887777777655433210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 1223678889999999999999999 889999999999999999999999999999765433322
Q ss_pred ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....+++.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3334578899999988754 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=267.36 Aligned_cols=218 Identities=26% Similarity=0.367 Sum_probs=156.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-------------------- 426 (602)
+-++.....+|.|.||.||.|.. .+|...|+|.++..... ........+|..++|-+.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44667788999999999999986 46888999988755444 334455666777665544
Q ss_pred -----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 427 -----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 427 -----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|+|.+.+.. +...++.....+..|++.|+.||| +.|||||||||+||+++.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 4555444432 222566667789999999999999 78999999999999999999999999999988765
Q ss_pred CCCC----ccccccccccccccccccCc---CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 502 DSSN----QTLLAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 502 ~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
.... .....||+.|||||++.+.. ...++||||+|||+.||+||+.||...+. .|...-+....=.|.+|
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhccCCCCCc
Confidence 4211 22357999999999987654 55789999999999999999999975432 11111111111112222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+. -..+=.+++..|++.||+.
T Consensus 1464 ----~~---ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1464 ----ER---LSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred ----hh---hhHhHHHHHHHHHhcCchh
Confidence 21 2222457788999999973
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=242.47 Aligned_cols=219 Identities=22% Similarity=0.362 Sum_probs=158.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|+....+|+|+||.||+|... +++.||+|++...... ..+.+.+|+.++..+.|+++..+....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 44666678999999999999864 7899999998644322 234566788877666655554433210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..........
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 01234788999999999999999999 8899999999999999999999999999987654433333
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ...+........ ........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~~~~~~-~~~~~~~~ 245 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------A-MKRLRDSPPPKL-KNAHKISP 245 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------H-HHHHhccCCCCc-cccCCCCH
Confidence 34568899999999998889999999999999999999999996432110 0 011111111000 00001223
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..|++.||++
T Consensus 246 ~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 246 VLRDFLERMLTREPQE 261 (297)
T ss_pred HHHHHHHHHhcCCccc
Confidence 4778999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=233.09 Aligned_cols=204 Identities=19% Similarity=0.247 Sum_probs=144.8
Q ss_pred cccccccccceeeecCC-------------CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 376 CIGTGAYGSVYKAQLPN-------------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.||+|+||.||+|+..+ ...|++|.+...... ....+.+|+.++..+.|+++..++...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD---ISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 58999999999997531 235889987654322 345677788877666666655543210
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-------ceeec
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE-------AFVAD 492 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~-------~kL~D 492 (602)
.....+++..+..++.||++|++||| +++|+||||||+||+++.++. +|++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 01234788999999999999999999 889999999999999987654 89999
Q ss_pred ccccccccCCCCCccccccccccccccccc-cCcCCccchhHHHHHHHHHHH-cCCCCCCCCcccccCCCcccchhhhhc
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAY-TMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
||.+...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||..... .+ ......
T Consensus 156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~---~~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AE---KERFYE 223 (262)
T ss_pred CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hH---HHHHHh
Confidence 9998655322 2245778999999887 456889999999999999998 58888864211 00 111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........ ....+.+++.+||+.||++
T Consensus 224 ~~~~~~~~-----~~~~~~~li~~cl~~dp~~ 250 (262)
T cd05077 224 GQCMLVTP-----SCKELADLMTHCMNYDPNQ 250 (262)
T ss_pred cCccCCCC-----ChHHHHHHHHHHcCCChhh
Confidence 11111110 1234789999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=237.44 Aligned_cols=219 Identities=26% Similarity=0.381 Sum_probs=151.3
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHH-HHhhhcC------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQV-LSQMERG------------------ 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~i-l~~l~~g------------------ 428 (602)
++|+....+|+|+||.||+|+.. +|+.||+|+++....... ...+..|+.+ ++...|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 35778889999999999999865 689999999875432211 1233334443 2223333
Q ss_pred ------ccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 429 ------SLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 429 ------sL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++.+++... .....+++.++..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 333333221 12235789999999999999999999 65 99999999999999999999999999987654
Q ss_pred CCCCCcccccccccccccccccc----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
... ..+...++..|+|||++.+ ..++.++|+||||+++|+|++|+.||..... ....+..+++...+..
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 228 (283)
T cd06617 156 DSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEEPSPQL 228 (283)
T ss_pred ccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhcCCCCC
Confidence 322 1222467889999998865 3468899999999999999999999963211 0111222222211110
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ....+.+++..|++.||++
T Consensus 229 ~~~~---~~~~l~~li~~~l~~~p~~ 251 (283)
T cd06617 229 PAEK---FSPEFQDFVNKCLKKNYKE 251 (283)
T ss_pred Cccc---cCHHHHHHHHHHccCChhh
Confidence 0001 2234789999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=252.40 Aligned_cols=177 Identities=29% Similarity=0.421 Sum_probs=145.6
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
.+...+.||+|+||.||+|+. +.|+.||||.++..... ...+...+|++++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 356678999999999999995 57999999999764322 2234455666665
Q ss_pred -----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC--CCC--cceeecc
Q 047576 423 -----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN--SKL--EAFVADF 493 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld--~~~--~~kL~DF 493 (602)
||+.+|+|...+........+++.+.+.+..++..||.||| +.+|+||||||.||++- .+| .-||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 66777777777776555566999999999999999999999 78999999999999983 333 3599999
Q ss_pred cccccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
|.|+.++.+. .....+||..|.+||.+.. ..|+..+|.|||||++|+.+||..||...
T Consensus 169 G~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 169 GAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999987655 5556789999999999984 78899999999999999999999999653
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=238.05 Aligned_cols=220 Identities=21% Similarity=0.290 Sum_probs=154.5
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh--------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-------------------- 425 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-------------------- 425 (602)
..++|.....||+|+||.||+|+.. +++.+|+|++...... ...+.+|+.++..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3678999999999999999999764 6889999987643221 13344566555444
Q ss_pred -----------hcCccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 426 -----------ERGSLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 426 -----------~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
++++|.++++.. .....+++..+..++.|+++|+.||| +.+|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccC
Confidence 334443333211 11234778888899999999999999 889999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
|.+..............|++.|+|||++.. ..++.++||||+||++|||++|+.||........... ....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~----~~~~ 244 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK----IPRN 244 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh----cccc
Confidence 998876443333333468899999998753 3478899999999999999999999975332111100 0000
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+..+. .....+.+++.+|++.||++
T Consensus 245 ~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 245 PPPTLHQPE-----LWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred CCCcccCCC-----CcCHHHHHHHHHHccCCccc
Confidence 001111110 01234889999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=240.78 Aligned_cols=178 Identities=26% Similarity=0.354 Sum_probs=138.3
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhH--HHHHhhhhHhHHHHHHhhh--------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETE--ELAFIRSFRNEAQVLSQME-------------------- 426 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~~~~E~~il~~l~-------------------- 426 (602)
+|+....||+|++|.||+|... +|+.||+|.+...... .......+..|++++..+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999864 6899999998755432 1123345566777664444
Q ss_pred ----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 427 ----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 427 ----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++|.+++.... ..+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFMETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EcccCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 444444443321 25899999999999999999999 889999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
........++..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 333333456788999998865 45788999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=242.72 Aligned_cols=218 Identities=22% Similarity=0.313 Sum_probs=154.3
Q ss_pred ccccCcccccccccccceeeecC--------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------- 425 (602)
.+|.....||+|+||.||+|+.. .+..||+|.++..... ...+.+.+|++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 35788899999999999999642 2346899988743222 2345667777776444
Q ss_pred -----------hcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCee
Q 047576 426 -----------ERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNIL 481 (602)
Q Consensus 426 -----------~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 481 (602)
++|+|.+++.... ....+++.+++.++.|++.||+||| +++|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence 4455555543211 1234788999999999999999999 889999999999999
Q ss_pred eCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccC
Q 047576 482 LNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSS 558 (602)
Q Consensus 482 ld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 558 (602)
++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999765432211 111234567999999999899999999999999999998 8899864321
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+. ...+... .....+.+++.+|++.+|++
T Consensus 243 ---~~~~~~~~~~-~~~~~~~---~~~~~l~~li~~cl~~~p~~ 279 (334)
T cd05100 243 ---EELFKLLKEG-HRMDKPA---NCTHELYMIMRECWHAVPSQ 279 (334)
T ss_pred ---HHHHHHHHcC-CCCCCCC---CCCHHHHHHHHHHcccChhh
Confidence 1111111111 1111111 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=249.15 Aligned_cols=218 Identities=22% Similarity=0.369 Sum_probs=162.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchh-HHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPET-EELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
.+-......||+|+|-+||+|-+. +|..||--.++..+. ......++|..|+.+++-+.|.++.+++....
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 334466789999999999999764 577787544432222 22345688999999999999988887765431
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccccccccc
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLH 500 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a~~~~ 500 (602)
..+.++....+.|++||++||.|||.+ .++|||||||-+||+|+++ |.|||+|.|+|..+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 123467788999999999999999987 8999999999999999876 899999999999875
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ....+.|||.|||||++. ..|++.+||||||++|+||+|+.+||......++ .+..+.-...|..+..-
T Consensus 198 ~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 198 KS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPAALSKV 268 (632)
T ss_pred cc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHHHhhcc
Confidence 43 334478999999999776 7899999999999999999999999986543222 22233333333222211
Q ss_pred hHHHHHHHHHHHhhccCc
Q 047576 581 VIQDILLVSTISFACLQS 598 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~ 598 (602)
...++.+++.+|+..
T Consensus 269 ---~dPevr~fIekCl~~ 283 (632)
T KOG0584|consen 269 ---KDPEVREFIEKCLAT 283 (632)
T ss_pred ---CCHHHHHHHHHHhcC
Confidence 112367788888876
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=265.86 Aligned_cols=222 Identities=23% Similarity=0.326 Sum_probs=158.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|.....||.|+||.||+|+.. ++..||+|.+....... .....+..|+.++..+.|+++..++...
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 467999999999999999999864 57789999886543221 2346678899988777776665543210
Q ss_pred ------------------c-chhhhcHHHHHHHHHHHHHHHHHhhhcC----CCCeEEeCCCCCCeeeCC----------
Q 047576 438 ------------------A-EAVELDWAKRVNIVKAMAHALAYLHHDC----SPSVVHRDISSNNILLNS---------- 484 (602)
Q Consensus 438 ------------------~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~DLkp~NILld~---------- 484 (602)
. ....+++..+..|+.||+.||+|||... .++||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 0 0134788999999999999999999431 146999999999999964
Q ss_pred -------CCcceeecccccccccCCCCCcccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCCccc
Q 047576 485 -------KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL 555 (602)
Q Consensus 485 -------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 555 (602)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999998764332 2233578999999999864 44789999999999999999999999743221
Q ss_pred ccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 556 SSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 556 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .+...+......+.. .....+.+++..||+.||++
T Consensus 250 ~-------qli~~lk~~p~lpi~----~~S~eL~dLI~~~L~~dPee 285 (1021)
T PTZ00266 250 S-------QLISELKRGPDLPIK----GKSKELNILIKNLLNLSAKE 285 (1021)
T ss_pred H-------HHHHHHhcCCCCCcC----CCCHHHHHHHHHHhcCChhH
Confidence 1 111112111111111 12234789999999999974
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=236.65 Aligned_cols=218 Identities=25% Similarity=0.334 Sum_probs=162.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
...|+....+|+|++|.||+|+.. +++.||+|++...........+.+.+|++++..+.|+++..+....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999864 6899999988654433333456788899999888887766553210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 01234788999999999999999999 789999999999999999999999999998765332
Q ss_pred Cccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
....++..|+|||++. ...++.++||||||+++|||+||+.||....... ....+.....+ ....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~~-~~~~-- 236 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNDSP-TLSS-- 236 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHHhcCCCC-CCCc--
Confidence 2246788999999874 3568889999999999999999999986432111 01111111111 1100
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.||++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~ 257 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQD 257 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhh
Confidence 123345889999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=243.15 Aligned_cols=180 Identities=24% Similarity=0.321 Sum_probs=145.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|+....||+|+||.||+|+.. +|+.||+|.+...... ......+.+|+.++..+.|+++..++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 467999999999999999999864 7899999998654322 123355667999998888888766543110
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
-...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 0112678888899999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 171 SFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 222 22345788999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=246.96 Aligned_cols=218 Identities=22% Similarity=0.328 Sum_probs=164.2
Q ss_pred ccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
+-|.+..-||.|+||.||+|..++ +-..|-|++...... ....|..|++|+..++|+.+..++...
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseE---ELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEE---ELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchh---HHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 345666778999999999998865 445567777544433 457788899999888887776654321
Q ss_pred ---c----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 ---A----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 ---~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+ -+..+++.++.-+++|++.||.||| +.+|||||||+.|||++-+|.++|+|||.+........
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 1 1234788999999999999999999 89999999999999999999999999999876543322
Q ss_pred Cccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 505 NQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
....+.|||+|||||++. +.+|++++||||||++|.||..+.+|.....+++- +..+.....|.-..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-------llKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------LLKIAKSEPPTLLQP 258 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-------HHHHhhcCCCcccCc
Confidence 334578999999999875 45799999999999999999999999876555432 222222222211110
Q ss_pred hhHHHHHHHHHHHhhccCcCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
......+.++..+|+.+||.
T Consensus 259 --S~Ws~~F~DfLk~cL~Knp~ 278 (1187)
T KOG0579|consen 259 --SHWSRSFSDFLKRCLVKNPR 278 (1187)
T ss_pred --chhhhHHHHHHHHHHhcCCc
Confidence 12445588999999999996
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=235.16 Aligned_cols=219 Identities=22% Similarity=0.317 Sum_probs=158.1
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC--------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-------------- 428 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-------------- 428 (602)
++|+....+|+|+||.||+|+.+ +.+.|++|.+...... ...+.+.+|+.+++.+.|+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 56888889999999999999853 3567999988654322 2346678888888555554
Q ss_pred -----------ccccccccccch------hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 429 -----------SLFRILHNDAEA------VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 429 -----------sL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
+|.+++...... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence 444444322211 15889999999999999999999 8899999999999999999999999
Q ss_pred cccccccccCCCC-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhh
Q 047576 492 DFGTARLLHADSS-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 492 DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~ 232 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ 232 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH
Confidence 9999875432211 1222346678999999988888999999999999999999 8889864221 11122222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.... ....+.+++.+|++.||++
T Consensus 233 ~~~~~~~~~~~---~~~~l~~~i~~~l~~~p~~ 262 (275)
T cd05046 233 AGKLELPVPEG---CPSRLYKLMTRCWAVNPKD 262 (275)
T ss_pred cCCcCCCCCCC---CCHHHHHHHHHHcCCCccc
Confidence 22222111111 2345889999999999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.70 Aligned_cols=210 Identities=25% Similarity=0.385 Sum_probs=156.2
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc-------------------------
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL------------------------- 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL------------------------- 430 (602)
+|.|+||.||+|+.. +|+.+++|++...........+.+.+|++++..+.|.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999876 489999999876554333455677778777755554444
Q ss_pred ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC------
Q 047576 431 FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS------ 504 (602)
Q Consensus 431 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~------ 504 (602)
.+++.. ...+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 333332 124789999999999999999999 78999999999999999999999999999876533211
Q ss_pred --CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 --NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......++..|+|||+..+...+.++||||||+++|++++|+.||..... ......+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~-- 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILNGKIEWPEDVE-- 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcCCCcccc--
Confidence 22234578899999999888889999999999999999999999974321 1122223322232221110
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..|++.+|++
T Consensus 226 -~~~~~~~~i~~~l~~~p~~ 244 (265)
T cd05579 226 -VSDEAIDLISKLLVPDPEK 244 (265)
T ss_pred -CCHHHHHHHHHHhcCCHhh
Confidence 1345789999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=232.59 Aligned_cols=218 Identities=24% Similarity=0.370 Sum_probs=157.1
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchh--HHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPET--EELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+|.....||+|++|.||+|... +++.|++|.+..... ......+.+.+|++++..+.|.++.++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999999999875 789999998764332 1123446778888887555554444332110
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 01123788999999999999999999 7899999999999999999999999999987764332
Q ss_pred CccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc-cCCCCCCChhhH
Q 047576 505 NQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD-QRLPPPVDRKVI 582 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~ 582 (602)
......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...... .....+.. ...+ .....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~-~~~~~-- 226 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELP-PIPDH-- 226 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCC-CcCCC--
Confidence 223356888999999987766 899999999999999999999999753311 11111111 1111 11111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 227 -~~~~~~~li~~~l~~~p~~ 245 (258)
T cd06632 227 -LSDEAKDFILKCLQRDPSL 245 (258)
T ss_pred -cCHHHHHHHHHHhhcCccc
Confidence 1233778999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=231.34 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=146.1
Q ss_pred ccccccccccceeeecCCCc-----------EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------
Q 047576 375 YCIGTGAYGSVYKAQLPNGR-----------VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------- 432 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------- 432 (602)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++..++|+++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVRDENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEecCCcE
Confidence 36899999999999875432 5788877644322 466777888775555555444
Q ss_pred -------------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-------cceeec
Q 047576 433 -------------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-------EAFVAD 492 (602)
Q Consensus 433 -------------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-------~~kL~D 492 (602)
++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 33321 114788999999999999999999 88999999999999999887 799999
Q ss_pred ccccccccCCCCCccccccccccccccccccC--cCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhh
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... ....... .
T Consensus 152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~~~~-~ 221 (259)
T cd05037 152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKERFYQ-D 221 (259)
T ss_pred CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHHHHh-c
Confidence 999986543 1224567789999998877 78899999999999999999 57787643211 0000000 1
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+. ...+.+++..||+.+|++
T Consensus 222 ~~~~~~~~-------~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 222 QHRLPMPD-------CAELANLINQCWTYDPTK 247 (259)
T ss_pred CCCCCCCC-------chHHHHHHHHHhccChhh
Confidence 11122221 145889999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=244.33 Aligned_cols=223 Identities=24% Similarity=0.282 Sum_probs=165.8
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hh
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQ 424 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~ 424 (602)
.....+.||+|-||+|.++....+..||||.++..... .....|.+|+++| ||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34566789999999999999987899999999877654 3467899999987 77
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
|++|+|.+++.++.... ..-...+.|+.|||.|++||. +.++||||+.+.|+|+|+++.+||+|||+++-+-....
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 77777777776543222 345566779999999999999 88999999999999999999999999999985532221
Q ss_pred --CccccccccccccccccccCcCCccchhHHHHHHHHHHHc--CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 505 --NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM--GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.....+-...|||||.+.-++++.++|||+||+++||+++ ...||....+.. . -+...++++..-+..+...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-v---ven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-V---VENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-H---HHhhhhhcCCCCcceeccC
Confidence 1222345678999999999999999999999999999875 788987533211 0 1112233333222111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..-+...+.+++++||.+|.++
T Consensus 769 P~~cp~~lyelml~Cw~~es~~ 790 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQ 790 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhc
Confidence 1236667889999999998653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=234.62 Aligned_cols=216 Identities=24% Similarity=0.358 Sum_probs=155.8
Q ss_pred ccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
|...+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.+.|+++..+....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 456678999999999999753 46889999987543322 2346678899988777776654443210
Q ss_pred -------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 438 -------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 438 -------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
.....+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 00113677888999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhh
Q 047576 493 FGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 493 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
||.++....... ......+++.|++||......++.++||||||+++|||++ |+.||..... ......+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~ 229 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLI 229 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHH
Confidence 999886543221 1112345678999999988889999999999999999999 8899864321 01111111
Q ss_pred ccC-CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQR-LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~-l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... +..+. .....+.+++..|++.+|++
T Consensus 230 ~~~~~~~~~-----~~~~~~~~l~~~~l~~~p~~ 258 (273)
T cd05074 230 KGNRLKQPP-----DCLEDVYELMCQCWSPEPKC 258 (273)
T ss_pred cCCcCCCCC-----CCCHHHHHHHHHHcCCChhh
Confidence 111 11111 12345889999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.06 Aligned_cols=171 Identities=25% Similarity=0.301 Sum_probs=128.5
Q ss_pred cccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-------------------------hhhc
Q 047576 376 CIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLS-------------------------QMER 427 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~-------------------------~l~~ 427 (602)
.||+|+||.||+|+.. .+..+|+|.++..... .....+.+|+.++. |+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999999999753 3467999988755432 22346777888774 4445
Q ss_pred Ccccccccccc--chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 428 GSLFRILHNDA--EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 428 gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
|+|.+++.... .....++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 55555543221 1123567778889999999999999 88999999999999999999999999999875433221
Q ss_pred -CccccccccccccccccccC-------cCCccchhHHHHHHHHHHHc-CCCCCCC
Q 047576 505 -NQTLLAGSYGYIAPELAYTM-------VMTEKYDVYSFGVVTLEVLM-GKHPRDL 551 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~Pf~~ 551 (602)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 11224567889999987642 35789999999999999996 9999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.31 Aligned_cols=217 Identities=28% Similarity=0.398 Sum_probs=161.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
++.|.....+|+|++|.||+|... +++.|++|++..... ..+.+.+|++++..+.|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 567888899999999999999876 688999999875443 24567778887755544
Q ss_pred ------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 428 ------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 428 ------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 44444443321 25899999999999999999999 88999999999999999999999999999876544
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........++..|+|||++.+..++.++|+||||+++|+|++|+.||...... .....+.....+.....
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~-- 239 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTKGIPPLKNP-- 239 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCcch--
Confidence 322223345788999999998888999999999999999999999998743221 11111111111111000
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred hhCCHHHHHHHHHHhccChhh
Confidence 112344788999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=225.50 Aligned_cols=221 Identities=22% Similarity=0.284 Sum_probs=165.4
Q ss_pred CCCCccccCc-ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH----------------------
Q 047576 365 MPTPRKIDSK-YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ---------------------- 420 (602)
Q Consensus 365 lp~t~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~---------------------- 420 (602)
-+.+++|... ..||-|-.|.|-.+..+ +|+.+|+|++...... ++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA--------RrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA--------RREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHH--------HhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3456777654 67999999999998764 7889999999754322 22322
Q ss_pred --------HHHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcce
Q 047576 421 --------VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAF 489 (602)
Q Consensus 421 --------il~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~k 489 (602)
++|.|++|.|++.+.+.+ ...+++.++-.|+.||..|+.||| +.+|.||||||+|+|.+. +-.+|
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceE
Confidence 348899999999998754 456999999999999999999999 899999999999999964 45689
Q ss_pred eecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 490 VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
|+|||+|+....... ....+-|++|.|||++-...|+...|+||+||+||-|++|.+||....-. ... ..+...+.
T Consensus 205 LtDfGFAK~t~~~~~-L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--ais-pgMk~rI~ 280 (400)
T KOG0604|consen 205 LTDFGFAKETQEPGD-LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AIS-PGMKRRIR 280 (400)
T ss_pred ecccccccccCCCcc-ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCC-hhHHhHhh
Confidence 999999987653222 23357899999999999999999999999999999999999999753221 111 12223333
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......|.. ++..-.+...+++..-+..+|.|
T Consensus 281 ~gqy~FP~p-EWs~VSe~aKdlIR~LLkt~Pte 312 (400)
T KOG0604|consen 281 TGQYEFPEP-EWSCVSEAAKDLIRKLLKTEPTE 312 (400)
T ss_pred ccCccCCCh-hHhHHHHHHHHHHHHHhcCCchh
Confidence 333333332 22333445677887888888865
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=237.57 Aligned_cols=219 Identities=23% Similarity=0.334 Sum_probs=158.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....+|+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.++..+.|+++..+....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 35788889999999999999975 46889999998643322 235567787777555444433322110
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+.........
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 01123688899999999999999999 889999999999999999999999999988765443333
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh-ccCCCCCCChhhHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL-DQRLPPPVDRKVIQD 584 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~ 584 (602)
.....+++.|+|||++.+..++.++||||||+++|++++|+.||......... ..+. .+....... ...
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~---~~~ 241 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGTPELQNP---EKL 241 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcCCCCCCCCc---ccc
Confidence 33456888999999998888899999999999999999999999753321110 0111 111111111 112
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..||+.||++
T Consensus 242 ~~~l~~li~~~l~~~p~~ 259 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEK 259 (293)
T ss_pred CHHHHHHHHHHccCChhh
Confidence 234788999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=244.00 Aligned_cols=179 Identities=27% Similarity=0.408 Sum_probs=143.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|++|.||+|+. .+|+.||+|++...... .....+.+|+.++..+.|+++..+....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46799999999999999999975 47899999998643221 2345677899999888887766654210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 01234788899999999999999999 88999999999999999999999999999876543
Q ss_pred CCCC---cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DSSN---QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.... .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2211 122467889999998765 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=238.76 Aligned_cols=179 Identities=27% Similarity=0.351 Sum_probs=145.5
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA---------- 438 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---------- 438 (602)
+|+....+|+|++|.||+|... +++.||+|+++..... ....+.+.+|++++..+.|+++..+++...
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5788899999999999999875 5889999998654322 223467888999998877777665543210
Q ss_pred ------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-C
Q 047576 439 ------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-N 505 (602)
Q Consensus 439 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~-~ 505 (602)
....+++.++..++.|++.|++||| ..+++||||||+||++++++.+||+|||.+........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 1123778899999999999999999 78999999999999999999999999999887654432 2
Q ss_pred ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2335678899999999888 7889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.30 Aligned_cols=179 Identities=22% Similarity=0.299 Sum_probs=139.7
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|.....+|+|++|.||+|+.+ +++.||+|.+...... .....+.+|++++..+.|.++..+....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57888899999999999999865 6899999998654322 1123456788888777666655443210
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 01124788899999999999999999 889999999999999999999999999998754332222
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222346788999998876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.31 Aligned_cols=180 Identities=22% Similarity=0.280 Sum_probs=140.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+.+|...+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|+.++..+.|.++..+....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 56788999999999999999975 46889999998654322 1123456788888777777655433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 82 FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 00123567888899999999999999 78999999999999999999999999999876543322
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......++..|+|||++.+. .++.++||||||+++|||++|+.||+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 22334578899999998764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=233.15 Aligned_cols=215 Identities=27% Similarity=0.383 Sum_probs=155.7
Q ss_pred ccccCcccccccccccceeeecCC----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR------------ 432 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~------------ 432 (602)
.+|.....+|+|+||.||+|...+ ...||+|........ ...+.+.+|+.++..+.|+++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEE
Confidence 457778899999999999998643 346899988654422 23457788888886555544444
Q ss_pred ------------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 433 ------------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 433 ------------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++... ...+++.++..++.|++.|++|+| +.+++||||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 33221 224789999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhcc-CCCCCC
Q 047576 501 ADSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-RLPPPV 577 (602)
Q Consensus 501 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~-~l~~~~ 577 (602)
..... .....++..|+|||++....++.++||||||+++||+++ |+.||...... .....+... .++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~- 230 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGERLPMP- 230 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCcCCCC-
Confidence 43221 112234568999999988889999999999999999986 99999743211 111111111 11111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .....+.+++.+|+..+|++
T Consensus 231 -~---~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 231 -P---NCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred -C---CCCHHHHHHHHHHcCCChhh
Confidence 1 12345888999999999974
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.28 Aligned_cols=218 Identities=22% Similarity=0.360 Sum_probs=158.1
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
.|+....||+|++|.||+|.. .+++.+++|++...... ..+.+.+|+.++..+.|+++..+....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 566678999999999999985 47889999988644322 234577788887666665554443210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.|++|+| +.+++||||||+||+++.++.++|+|||.+...........
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 00134788899999999999999999 88999999999999999999999999998876544333333
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...|++.|+|||+..+..++.++||||||+++|||++|+.||...... .....+. ...++.. .........
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~-~~~~~~~-~~~~~~~~~ 244 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIR-DNLPPKL-KNLHKVSPR 244 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHH-hcCCCCC-cccccCCHH
Confidence 356889999999998888999999999999999999999999643211 0011111 1111110 000112245
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..||++||++
T Consensus 245 l~~li~~~l~~~p~~ 259 (285)
T cd06648 245 LRSFLDRMLVRDPAQ 259 (285)
T ss_pred HHHHHHHHcccChhh
Confidence 889999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.98 Aligned_cols=169 Identities=24% Similarity=0.300 Sum_probs=135.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|.....||+|+||.||+|+.. +++.||+|+..... ...|+.++..+.|+++.+++...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 456889999999999999999865 57789999754322 23577777777777666554211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..|+.||+.||.||| +++|+||||||+||+++.++.+||+|||.++......
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 11234789999999999999999999 7899999999999999999999999999987543221
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 549 (602)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 222356899999999999999999999999999999999865554
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=228.97 Aligned_cols=215 Identities=25% Similarity=0.364 Sum_probs=155.6
Q ss_pred cCcccccccccccceeeecCC-----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 372 DSKYCIGTGAYGSVYKAQLPN-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 372 ~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.....+|.|+||.||+++..+ +..||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 456789999999999998753 488999999755432 1346778888888666555544433210
Q ss_pred -------------cchhh--hcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 -------------AEAVE--LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 -------------~~~~~--l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
..... +++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 00111 789999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCcc-ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSNQT-LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..... ...+++.|+|||...+..++.++||||+|+++|+|++ |+.||..... ......+...... +....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~ 228 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRL-PKPEN 228 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCC-CCCCc
Confidence 22111 2236788999999988889999999999999999998 8888864211 1111112111111 11111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 229 ---~~~~~~~~i~~~l~~~p~~ 247 (258)
T smart00219 229 ---CPPEIYKLMLQCWAEDPED 247 (258)
T ss_pred ---CCHHHHHHHHHHCcCChhh
Confidence 3345888999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=233.17 Aligned_cols=220 Identities=24% Similarity=0.417 Sum_probs=155.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchh-------HHHHHhhhhHhHHHHHHhhhcCcc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPET-------EELAFIRSFRNEAQVLSQMERGSL----------- 430 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~~~~E~~il~~l~~gsL----------- 430 (602)
+|...+.||.|++|.||+|... +|+.||+|.++.... ......+.+.+|+.++..+.|+++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667788999999999999754 689999998754221 112234567788887755555444
Q ss_pred --------------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 431 --------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 431 --------------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
.+++... ..+++..+..++.|++.|+.|+| +.+++||||||+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 3333321 34788999999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCC--CccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 497 RLLHADSS--NQTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 497 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
........ ......|+..|+|||+..... ++.++|+||+|+++|++++|+.||...... ....++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence 76543211 122345788999999987654 789999999999999999999999632211 0111111111
Q ss_pred CCCCCChh-hHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRK-VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........ ..+....+.+++..|+++||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDN 259 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhh
Confidence 11111100 0112345888999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=237.48 Aligned_cols=216 Identities=24% Similarity=0.320 Sum_probs=161.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
.|+....||+|+||.||+|+.. ++..||+|++.............+.+|++++..+.|+++..+....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4788889999999999999864 6889999998654333333456788899999877777665544311
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 01234788999999999999999999 789999999999999999999999999988754322
Q ss_pred cccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 507 TLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||.... .......+.....+..... .
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---~ 248 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTLQSN---E 248 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCCCCCCc---c
Confidence 2346888999999874 4568899999999999999999999986421 1111222222222211111 1
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 249 ~~~~l~~li~~~l~~~p~~ 267 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQD 267 (317)
T ss_pred ccHHHHHHHHHHccCCccc
Confidence 3345889999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=223.02 Aligned_cols=218 Identities=22% Similarity=0.337 Sum_probs=158.1
Q ss_pred cccccccccccceeee-cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhh
Q 047576 374 KYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQME 426 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~ 426 (602)
.+.||+|+|+.|--+. +.+|.+||||++.+.... ...+..+|++++ |.|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4679999999999886 568999999999766432 345556677755 5566
Q ss_pred cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceeecccccccccCCC
Q 047576 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVADFGTARLLHADS 503 (602)
Q Consensus 427 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFG~a~~~~~~~ 503 (602)
+|+|...+++ .+.|++.++.++.++|+.||.||| .+||.|||+||+|||...-. -+|||||.++.-+....
T Consensus 160 GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 160 GGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred CchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 7777776664 456999999999999999999999 89999999999999996543 47999998775443211
Q ss_pred -------CCccccccccccccccccc---c--CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccc-------
Q 047576 504 -------SNQTLLAGSYGYIAPELAY---T--MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM------- 564 (602)
Q Consensus 504 -------~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------- 564 (602)
..-...+|+..|||||+.. + ..|+.+.|.||+|||+|-|+.|.+||.+.-....+|...+.
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 1122357999999999753 2 34889999999999999999999999765544455554322
Q ss_pred -hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCC
Q 047576 565 -LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 565 -~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
+..|-+.....| +.++..-..+-.+++..-+.+||.
T Consensus 314 LFesIQEGkYeFP-dkdWahIS~eakdlisnLlvrda~ 350 (463)
T KOG0607|consen 314 LFESIQEGKYEFP-DKDWAHISSEAKDLISNLLVRDAK 350 (463)
T ss_pred HHHHHhccCCcCC-hhhhHHhhHHHHHHHHHHHhccHH
Confidence 334444444433 233344444556676666666654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.87 Aligned_cols=219 Identities=26% Similarity=0.381 Sum_probs=154.0
Q ss_pred cccCcccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhh-------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQM------------------- 425 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l------------------- 425 (602)
+|+....+|+|+||.||+|+. .+|+.||+|++...... .....+.+.+|+.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999975 47899999998654322 112334566777776444
Q ss_pred -------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 426 -------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 426 -------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++++|.+++.. ...+++.++..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 34444444332 234788888999999999999999 88999999999999999999999999999876
Q ss_pred ccCCCC-CccccccccccccccccccC--cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSS-NQTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
...... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... .........+.....+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~- 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP- 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccCCC-
Confidence 543221 12234688899999998753 4678999999999999999999999642211 0001111111111111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ....+.+++.+|++.||++
T Consensus 231 -~~~~---~~~~~~~ll~~~l~~~p~~ 253 (290)
T cd05613 231 -YPQE---MSALAKDIIQRLLMKDPKK 253 (290)
T ss_pred -CCcc---CCHHHHHHHHHHhcCCHHH
Confidence 1111 2234789999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=231.44 Aligned_cols=180 Identities=23% Similarity=0.319 Sum_probs=143.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCch--hHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPE--TEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
.+|...+.+|+|++|.||+|+.. ++..||+|.+.... .........+.+|+++++.+.|+++..++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 68899999875321 11223456788899999777776655443210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 00123678888999999999999999 88999999999999999999999999999976532
Q ss_pred C---CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 502 D---SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
. ........++..|+|||++.+..++.++|+|||||++|++++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 1 1112234688899999999988889999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=233.21 Aligned_cols=212 Identities=23% Similarity=0.327 Sum_probs=150.0
Q ss_pred ccccccccccceeeecCC-------CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc------------------
Q 047576 375 YCIGTGAYGSVYKAQLPN-------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------ 429 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------ 429 (602)
+.+|+|+||.||+|+..+ +..+|+|.+...... .....+.+|+.++..+.|++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999998642 357999988654321 22456777888775555444
Q ss_pred -------ccccccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-----cceeecc
Q 047576 430 -------LFRILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-----EAFVADF 493 (602)
Q Consensus 430 -------L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-----~~kL~DF 493 (602)
|.+++.... ....+++.++..++.|++.|++|+| +.+++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 444443211 1123678899999999999999999 78999999999999999877 8999999
Q ss_pred cccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhc
Q 047576 494 GTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 494 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
|++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....++
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence 99876533211 1112345678999999999999999999999999999998 99999743211 1111222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......... ....+.+++.+||+.+|++
T Consensus 228 ~~~~~~~~~~---~~~~~~~li~~~l~~~p~~ 256 (269)
T cd05044 228 AGGRLQKPEN---CPDKIYQLMTNCWAQDPSE 256 (269)
T ss_pred cCCccCCccc---chHHHHHHHHHHcCCCccc
Confidence 1111111111 2345789999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=233.58 Aligned_cols=219 Identities=25% Similarity=0.359 Sum_probs=158.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCcccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHN--------- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~--------- 436 (602)
+++|.....+|+|++|.||+|+.. +++.+++|++...... .+.+.+|+.++..+ .|+++.+++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 578999999999999999999874 6789999998655432 34567787777655 45554333211
Q ss_pred ----------------------cc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 437 ----------------------DA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 437 ----------------------~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
.. ....+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 00 0235788889999999999999999 889999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
|.+..............|+..|+|||++.. ..++.++||||||+++|+|++|+.||...... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~ 230 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKI 230 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHh
Confidence 998766443333334568899999998754 23678899999999999999999999643211 111222
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+ ... ........+.+++.+|++.||++
T Consensus 231 ~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 231 PRNPPP-TLK-SPENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred hccCCC-CCC-chhhcCHHHHHHHHHHhhcChhh
Confidence 211111 100 00113345889999999999974
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=235.46 Aligned_cols=216 Identities=27% Similarity=0.410 Sum_probs=158.5
Q ss_pred ccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|+....||.|+||.||+|.. .+++.||+|........ ...+.+.+|+.++..+.|+++..+....
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 66778899999999999975 46889999987644322 2346788888888666666555432110
Q ss_pred ---------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 438 ---------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 438 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||.+............
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 01234789999999999999999999 889999999999999999999999999998765443222233
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..++..|+|||++.+..++.++|+|||||++|+|++|+.||...... ..... +.....+..... ....+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~~~~---~~~~~ 229 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFL-IPKNNPPTLEGN---YSKPL 229 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHH-HhcCCCCCCCcc---cCHHH
Confidence 46788999999998888899999999999999999999999643211 11111 111111111111 22347
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|++.||++
T Consensus 230 ~~~i~~~l~~~p~~ 243 (277)
T cd06641 230 KEFVEACLNKEPSF 243 (277)
T ss_pred HHHHHHHccCChhh
Confidence 88999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=232.40 Aligned_cols=203 Identities=19% Similarity=0.326 Sum_probs=144.4
Q ss_pred ccccccccccceeeecCC--------CcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 375 YCIGTGAYGSVYKAQLPN--------GRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+.++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 358999999999997532 23488888754432 2344566677666
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc--------ceeecc
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE--------AFVADF 493 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~--------~kL~DF 493 (602)
||+++|+|.++++... ..+++..++.++.||+.|++||| +++|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 4555666666655422 24789999999999999999999 889999999999999987765 589999
Q ss_pred cccccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCC-CCCCCCcccccCCCcccchhhhhcc
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGK-HPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
|.+..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||...... ....+...
T Consensus 153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~ 220 (258)
T cd05078 153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFYED 220 (258)
T ss_pred ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHHHc
Confidence 98865432 1224678899999999874 4789999999999999999995 565532211 01112222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.. ....+.+++..||+.||++
T Consensus 221 ~~~~~~~-----~~~~~~~li~~~l~~~p~~ 246 (258)
T cd05078 221 RHQLPAP-----KWTELANLINQCMDYEPDF 246 (258)
T ss_pred cccCCCC-----CcHHHHHHHHHHhccChhh
Confidence 2221111 1234789999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=234.46 Aligned_cols=180 Identities=24% Similarity=0.306 Sum_probs=143.9
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|...+.||.|++|.||+|+.+ +++.+|+|.++..... ......+.+|+.++..+.|+++..+.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46888899999999999999875 6889999998754332 223345667888888887777665432110
Q ss_pred ---------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 439 ---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 439 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
....+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 0123789999999999999999999 7899999999999999999999999999998765443
Q ss_pred CCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.......+++.|+|||++.+.. ++.++|+||+|+++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3333345788999999887654 688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=228.51 Aligned_cols=214 Identities=27% Similarity=0.407 Sum_probs=159.3
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF------------------ 431 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~------------------ 431 (602)
|+....+|+|++|.||+|... ++..+++|++..... ...+.+.+|++++..+.+.++.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 667788999999999999875 688999999876554 2346777888877555544443
Q ss_pred -------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 432 -------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 432 -------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+++... ...+++..+..++.|++.|+.||| ..+++||||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 79 CSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 333221 135799999999999999999999 78999999999999999999999999999987654332
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........ ...+..... ...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~~-~~~ 223 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIAT-NGPPGLRNP-EKW 223 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHh-cCCCCcCcc-ccc
Confidence 23456889999999998888899999999999999999999999753211 11111111 111111000 101
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 224 ~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred CHHHHHHHHHHccCChhh
Confidence 345889999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=229.91 Aligned_cols=216 Identities=20% Similarity=0.343 Sum_probs=157.7
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-----------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----------------- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----------------- 431 (602)
+|.....+|+|++|.||+|.. .+++.+|+|.+...... ....+.+.+|+++++.+.|+++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 477788999999999999976 46889999998654322 12346778888887655555443
Q ss_pred --------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-CcceeecccccccccCC
Q 047576 432 --------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHAD 502 (602)
Q Consensus 432 --------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a~~~~~~ 502 (602)
+++... ....+++..+..++.|++.|++|+| +.+++||||||+||+++.+ +.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 333221 1233788999999999999999999 7899999999999999855 46899999999876543
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ......+......+. ...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~-- 224 (256)
T cd08220 156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMSGTFAPI-SDR-- 224 (256)
T ss_pred cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHhcCCCCC-CCC--
Confidence 22 2234678899999999988889999999999999999999999975321 111122222211111 111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 225 -~~~~l~~li~~~l~~~p~~ 243 (256)
T cd08220 225 -YSPDLRQLILSMLNLDPSK 243 (256)
T ss_pred -cCHHHHHHHHHHccCChhh
Confidence 2234789999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=238.85 Aligned_cols=173 Identities=17% Similarity=0.267 Sum_probs=132.6
Q ss_pred ccccccc--ccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccc----------------
Q 047576 374 KYCIGTG--AYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL---------------- 434 (602)
Q Consensus 374 ~~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l---------------- 434 (602)
..+||+| +|++||+++. ++|+.||+|++...... ....+.+.+|++++..+.|+++.++.
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 4678999 6789999976 57899999998754332 12345677788888666666555433
Q ss_pred ---------ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 435 ---------HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 435 ---------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
... ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 211 1223788999999999999999999 78999999999999999999999999986544321110
Q ss_pred ------Ccccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 505 ------NQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 505 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1112346778999999876 3588999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=232.62 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=142.5
Q ss_pred cccccccccceeeecC-------------------------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------
Q 047576 376 CIGTGAYGSVYKAQLP-------------------------NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------- 422 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~-------------------------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------- 422 (602)
.||+|+||.||+|... ....||+|++..... .....+.+|+.++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 5899999999999641 123588998864432 2335566677666
Q ss_pred -----------------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 423 -----------------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 423 -----------------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
||+++|+|..++.. ....+++..+..++.|+++||+||| +++|+||||||+||+++..
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 45555555555533 1234788999999999999999999 8899999999999999765
Q ss_pred C-------cceeecccccccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHH-HcCCCCCCCCcccc
Q 047576 486 L-------EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEV-LMGKHPRDLHSTLS 556 (602)
Q Consensus 486 ~-------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~el-ltG~~Pf~~~~~~~ 556 (602)
+ .+|++|||.+...... ....++..|+|||++.+ ..++.++||||||+++||+ ++|+.||......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 3 3799999987654221 12356788999998876 5588999999999999999 4799998743211
Q ss_pred cCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 557 SSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 557 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....++.....+.. ....+.+++.+||+.+|++
T Consensus 229 -------~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 229 -------EKERFYEKKHRLPEP-----SCKELATLISQCLTYEPTQ 262 (274)
T ss_pred -------HHHHHHHhccCCCCC-----CChHHHHHHHHHcccChhh
Confidence 111222222221111 1124789999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=236.76 Aligned_cols=180 Identities=26% Similarity=0.384 Sum_probs=140.8
Q ss_pred cccCcccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
+|+....||+|++|.||+|... +++.||+|.+...........+.+.+|+.++..+.|+++..+.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677788999999999999864 47899999987643222223455677888887777776555433110
Q ss_pred --------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC----CCcceeeccc
Q 047576 439 --------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS----KLEAFVADFG 494 (602)
Q Consensus 439 --------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFG 494 (602)
....+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 0124677888999999999999999 889999999999999999 8999999999
Q ss_pred ccccccCCCC---CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSS---NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
++........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9987643322 12234678899999988764 4789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=239.61 Aligned_cols=181 Identities=27% Similarity=0.376 Sum_probs=143.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|++|.||+|+.. +++.||+|++....... .....+.+|++++..+.|+++..+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 578999999999999999999864 68899999886443221 1123456789999888887776654210
Q ss_pred ---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 438 ---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 438 ---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
.....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 01235889999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCCC-----------ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADSSN-----------QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......... .+...+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 765432211 1123567889999987654 4789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=230.82 Aligned_cols=176 Identities=30% Similarity=0.416 Sum_probs=136.4
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCcccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGSLFRIL------------ 434 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gsL~~~l------------ 434 (602)
|+....+|+|++|.||+|+.. +++.||+|+++...... .....+.+|+.++..+ .|+++..+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 456788999999999999976 48999999987443221 1234455676666444 244433322
Q ss_pred -----------------ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 435 -----------------HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 435 -----------------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
... ....+++..+..++.|+++||.||| +.+++|+||||+||+++.++.+||+|||.+.
T Consensus 80 ~~~l~~e~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcccCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 111 1124789999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
........ ....++..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 156 IYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred eccCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 76443221 2235788999999999988999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=235.25 Aligned_cols=178 Identities=22% Similarity=0.341 Sum_probs=141.3
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN------------ 436 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~------------ 436 (602)
+|+..+.||.|++|.||+|+.. +|+.||+|+++..... .....+.+|+.++..+.|+++..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4777889999999999999875 6889999998754322 123456678888877777665554331
Q ss_pred ------------ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 437 ------------DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 437 ------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+........
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 111234789999999999999999999 78999999999999999999999999999976544322
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22334578899999988664 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=232.47 Aligned_cols=171 Identities=23% Similarity=0.303 Sum_probs=125.9
Q ss_pred cccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------------
Q 047576 376 CIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------------- 427 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------------- 427 (602)
.||+|+||.||+|+.. ....+|+|.+...... .....+.+|+.++..+.|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 5899999999999643 3457888987644322 234567778887754444
Q ss_pred Cccccccccccc--hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 428 GSLFRILHNDAE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 428 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
|+|.+++..... ....++.....++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 444444433211 122467778899999999999999 88999999999999999999999999999865432211
Q ss_pred -Ccccccccccccccccccc-------CcCCccchhHHHHHHHHHHHc-CCCCCCC
Q 047576 505 -NQTLLAGSYGYIAPELAYT-------MVMTEKYDVYSFGVVTLEVLM-GKHPRDL 551 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~ 551 (602)
......++..|+|||+... ..++.++|||||||++|||++ |..||..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 1122345677999998743 346789999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=233.65 Aligned_cols=179 Identities=25% Similarity=0.335 Sum_probs=142.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|+....||.|++|.||+|+.. +|+.||||++...... ....+.+.+|++++..+.|+++.++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4777889999999999999864 6899999988644322 12335677899999888777766554321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 01234788999999999999999999 789999999999999999999999999998766443322
Q ss_pred ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||+..+.. ++.++||||||+++|||+||+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 33345678999999887654 588999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=236.33 Aligned_cols=179 Identities=23% Similarity=0.281 Sum_probs=136.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-Cccccccc------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-GSLFRILH------------ 435 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-gsL~~~l~------------ 435 (602)
+|+....||+|+||.||+|+.. +++.||+|+....... ......+.+|+.++..+.+ +++..+..
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5788899999999999999864 6899999987644221 1123456678777765533 33332221
Q ss_pred -----------------cccc--hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecccc
Q 047576 436 -----------------NDAE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGT 495 (602)
Q Consensus 436 -----------------~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~ 495 (602)
.... ...+++..+..++.||+.||+||| +++|+||||||+||+++. ++.+||+|||.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 1000 134688999999999999999999 889999999999999998 89999999999
Q ss_pred cccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+..............+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 8765433222233456788999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=230.27 Aligned_cols=217 Identities=20% Similarity=0.320 Sum_probs=158.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccc--------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL-------------- 434 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l-------------- 434 (602)
+|...+.+|+|+||.||+|... +|..||+|.+....... ...+.+.+|++++..+.|.++..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4677788999999999999875 58899999886542211 1235667788877655555444433
Q ss_pred -----------ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCC
Q 047576 435 -----------HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHAD 502 (602)
Q Consensus 435 -----------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~ 502 (602)
... ....+++..+..++.|++.|+.||| +.+++|+||||+||++++++ .+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 221 1123689999999999999999999 78999999999999999885 4699999998876543
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........|++.|+|||+..+..++.++|+||||+++|||++|+.||..... .............+... .
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~-~-- 225 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFAPISP-N-- 225 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCCCCCC-C--
Confidence 3333334688999999999888899999999999999999999999974321 11122223222221111 1
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.+|++
T Consensus 226 -~~~~~~~~i~~~l~~~p~~ 244 (257)
T cd08225 226 -FSRDLRSLISQLFKVSPRD 244 (257)
T ss_pred -CCHHHHHHHHHHhccChhh
Confidence 1234788999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=240.12 Aligned_cols=180 Identities=26% Similarity=0.301 Sum_probs=143.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+. .+++.||||.+....... .....+.+|+.++..+.|.++..+....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45788889999999999999986 468999999986542221 1234566788888888777776543210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 01234788999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
..........++..|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 43222333467889999998765 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=231.66 Aligned_cols=215 Identities=24% Similarity=0.372 Sum_probs=159.1
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---------------------- 426 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~---------------------- 426 (602)
+|.....+|+|++|.||+|+.. +|+.||+|++...........+.+.+|++++..+.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5777889999999999999864 78999999987643322223355666666664444
Q ss_pred ----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 427 ----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 427 ----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+......
T Consensus 82 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 82 EYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 4444444432 225899999999999999999999 789999999999999999999999999998866432
Q ss_pred CC--------------------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcc
Q 047576 503 SS--------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPK 562 (602)
Q Consensus 503 ~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 562 (602)
.. ......++..|+|||+..+..++.++|+||+|++++++++|+.||..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~ 228 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------Y 228 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------H
Confidence 21 11224578899999999888899999999999999999999999985431 1
Q ss_pred cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+..+.+.....+. . ....+.+++.+|++.||++
T Consensus 229 ~~~~~~~~~~~~~~~--~---~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 229 LTFQKILKLEYSFPP--N---FPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred HHHHHHHhcCCCCCC--c---cCHHHHHHHHHHhcCCHhh
Confidence 112223222222111 1 1334889999999999974
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=239.88 Aligned_cols=212 Identities=26% Similarity=0.363 Sum_probs=166.8
Q ss_pred cccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------H
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------S 423 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~ 423 (602)
++...+.||-|-||.||.|.++. .-.||||.++.+... +++|.+|+.+| |
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45567889999999999998753 567999999765543 56788888877 5
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
||..|+|.++|+++. ...++....+.+|.||+.|++||. .+++|||||-+.|.|+.++..+|++|||+++++..+.
T Consensus 344 fM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 566666666666543 334566677889999999999999 8999999999999999999999999999999998765
Q ss_pred CCcccccc---ccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 504 SNQTLLAG---SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 504 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
... +.| ..-|.|||.+....++.|+|||+|||+|||+.| |..||.+.+ .....++++...+....
T Consensus 420 YTA--HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEkgyRM~~P- 488 (1157)
T KOG4278|consen 420 YTA--HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEKGYRMDGP- 488 (1157)
T ss_pred eec--ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhccccccCC-
Confidence 432 333 467999999999999999999999999999998 888987542 11223444444433322
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+|...+.+++..||+..|.+
T Consensus 489 --eGCPpkVYeLMraCW~WsPsD 509 (1157)
T KOG4278|consen 489 --EGCPPKVYELMRACWNWSPSD 509 (1157)
T ss_pred --CCCCHHHHHHHHHHhcCCccc
Confidence 347888999999999999974
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=239.51 Aligned_cols=178 Identities=26% Similarity=0.388 Sum_probs=144.0
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
.+++|.....||+|+||.||+|.. .+++.||+|++....... ...+.+.+|+.++..+.|.++..+....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 357899999999999999999975 578999999987543322 2345677899999888887766543210
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....+++..+..++.|+++|++||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 00124788999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 223467889999998876 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-27 Score=226.10 Aligned_cols=221 Identities=24% Similarity=0.343 Sum_probs=153.6
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCcccccc-------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRIL------------- 434 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l------------- 434 (602)
+.+....+|.|+||+|++..+ +.|+..|||+++..... ...+++..|.++...-+ .+.+.++.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 445556799999999999986 47999999999866553 23467777777552211 12222221
Q ss_pred -----------cc--ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 435 -----------HN--DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 435 -----------~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.. .....++++...-.|+.....||.||.+ ...|||||+||+|||+|..|.+||||||.+..+..
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 11 0123446777777788888999999986 57899999999999999999999999999876643
Q ss_pred CCCCcccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-CCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-PVD 578 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~ 578 (602)
+...+...|..+|||||.+.. ..|+.++||||+|++|||+.||+.|+..-.+. -+.+..++....+. ..+
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------feql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FEQLCQVVIGDPPILLFD 293 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HHHHHHHHcCCCCeecCc
Confidence 233445678999999998763 34899999999999999999999998642211 11223333332220 011
Q ss_pred hhhHHHHHHHHHHHhhccCcCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.+..+-...+++++..|+.+|-+
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~ 316 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRS 316 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccc
Confidence 11123344588899999988753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=233.07 Aligned_cols=178 Identities=25% Similarity=0.338 Sum_probs=138.9
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|+..+.+|.|++|.||+|... +|..||+|++...... ......+.+|++++..+.|+++.++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 456788999999999999864 7999999988654322 11234567788888777666655433210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|+++||+||| +++++||||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 01124789999999999999999999 7899999999999999999999999999997654332222
Q ss_pred cccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233568899999988764 4688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=232.54 Aligned_cols=223 Identities=25% Similarity=0.324 Sum_probs=161.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|+..+.+|.|++|.||+|... +++.+|+|.+...... .....+.+|++++..+.|+++..++...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5777889999999999999874 6889999998754332 2346788899999877777766543210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 01123567778899999999999999 7899999999999999999999999999987654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC---CCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR---LPPPV 577 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~---l~~~~ 577 (602)
.... ....++..|+|||...+..++.++||||+|+++|+|++|+.||+..... ..........+.+.. ++...
T Consensus 157 ~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 157 NSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCchhhccCC
Confidence 3221 2345778999999999888999999999999999999999999754220 001111111112111 11111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ........+.+++..||++||++
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 233 G-NGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred C-CCCchHHHHHHHHHHHcCCCccc
Confidence 0 00112345889999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=239.69 Aligned_cols=178 Identities=30% Similarity=0.411 Sum_probs=143.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
..+|.....||+|+||.||+|+. .+|+.||+|++...... ......+.+|+.++..+.|.++..+.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 35788889999999999999986 46899999998754322 123356778999998888887765443110
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 0124788899999999999999999 78999999999999999999999999999876532
Q ss_pred CCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 123457889999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=232.61 Aligned_cols=179 Identities=26% Similarity=0.331 Sum_probs=140.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....+|+|++|.||+|+.. +|+.||+|++...... ......+.+|+.+++.+.|+++..++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 3667788999999999999864 6899999998754422 12345677888888666666655443210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-C
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS-N 505 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~-~ 505 (602)
.....+++.++..++.||++||+||| +.+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 01234788999999999999999999 78999999999999999999999999999987654321 1
Q ss_pred ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+.. ++.++||||+|+++|||+||+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 22346888999999886544 688999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=251.97 Aligned_cols=179 Identities=20% Similarity=0.258 Sum_probs=133.9
Q ss_pred CccccCcccccccccccceeeecC--CCcEEeeecc--------------CCchhHHHHHhhhhHhHHHHHHhhhcCccc
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKL--------------NSPETEELAFIRSFRNEAQVLSQMERGSLF 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l--------------~~~~~~~~~~~~~~~~E~~il~~l~~gsL~ 431 (602)
..+|.....||+|+||+||++... ++..++.|.+ .+...........+.+|+.++..+.|+++.
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999998643 2222222211 111111122345688999999999998887
Q ss_pred cccccccc--------------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 432 RILHNDAE--------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 432 ~~l~~~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
.++..... .......++..|+.|++.||+||| +++|+||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 76431100 011224556789999999999999 8899999999999999999
Q ss_pred CcceeecccccccccCCCC-CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCC
Q 047576 486 LEAFVADFGTARLLHADSS-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 549 (602)
+.+||+|||+++.+..... ......|+..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999987654322 222357999999999999999999999999999999999988643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=226.87 Aligned_cols=220 Identities=25% Similarity=0.370 Sum_probs=164.6
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA---------- 438 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---------- 438 (602)
+|+..+.+|+|++|.||+|... +++.|++|++...... ....+.+.+|++++..+.|+++..++....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3667788999999999999875 7899999998765432 234577888999887777766655432110
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
....+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 0114788999999999999999999 78999999999999999999999999999987755432
Q ss_pred --CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 --NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......++..|+|||...+...+.++||||||+++|+|++|+.||..... .......+............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~-- 228 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGSSGEPPEIPEH-- 228 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccccCCCcCCCcc--
Confidence 12335688999999999888899999999999999999999999975431 11111111111111111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 229 -~~~~l~~~i~~~l~~~p~~ 247 (260)
T cd06606 229 -LSEEAKDFLRKCLRRDPKK 247 (260)
T ss_pred -cCHHHHHHHHHhCcCChhh
Confidence 2345889999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=237.03 Aligned_cols=179 Identities=28% Similarity=0.363 Sum_probs=143.4
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....||.|++|.||+|+.. +++.||+|++...... ....+.+.+|+.++..+.|.++..+....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4777889999999999999875 5889999998754321 22346677888888777666554433210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||.+......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 01124788899999999999999999 889999999999999999999999999999877554
Q ss_pred C---CCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 S---SNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 3 122334678899999999887 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=238.94 Aligned_cols=181 Identities=31% Similarity=0.364 Sum_probs=144.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~~------- 438 (602)
.++|.....+|+|+||.||+|... +++.+|+|++....... .....+.+|+.++..+ .|+++..++....
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 567889999999999999999865 68899999886432211 1234566799999888 8887766554210
Q ss_pred ---------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 439 ---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 439 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 0124788889999999999999999 7899999999999999999999999999998664332
Q ss_pred C-----Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 S-----NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. ......|+..|+|||++.+ ..++.++||||||+++|+|+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223468889999998765 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=233.27 Aligned_cols=217 Identities=22% Similarity=0.367 Sum_probs=156.2
Q ss_pred ccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|+....||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++..+.|+++.......
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44446799999999999976 47899999987543322 345677888877666555544433210
Q ss_pred ---------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 438 ---------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 438 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....+++.....++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+............
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 01124788899999999999999999 789999999999999999999999999988765443322334
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
..|++.|+|||+..+..++.++|+||+|+++|+|++|+.||...... .....+...++..... .......+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~l 246 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPKLKN-LHKVSPSL 246 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhhCCcccCC-cccCCHHH
Confidence 56889999999998888899999999999999999999999743211 0111222222211100 01122347
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++.+|++.||.+
T Consensus 247 ~~li~~~l~~~P~~ 260 (292)
T cd06657 247 KGFLDRLLVRDPAQ 260 (292)
T ss_pred HHHHHHHHhCCccc
Confidence 78899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=232.42 Aligned_cols=221 Identities=23% Similarity=0.320 Sum_probs=154.9
Q ss_pred CccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~-------- 437 (602)
.++|+....+|+|++|.||+|+..+ ++.||||.++...... ....+..|+.++... .|+++..++...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3578889999999999999999764 8999999987543221 123344455544332 244433332210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++..+..++.|++.|++|||. ..+|+||||+|+||+++.++.+||+|||.+.......
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 002347889999999999999999993 2599999999999999999999999999987664322
Q ss_pred CCccccccccccccccccccCc----CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-CCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMV----MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-PVD 578 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~ 578 (602)
.. ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..+.+..+++...+. +..
T Consensus 170 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 170 AK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCCCCCC
Confidence 22 2245778999999987653 78899999999999999999999974211 111222333332221 111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .....+.+++.+|++.||++
T Consensus 243 ~---~~~~~l~~li~~~l~~~p~~ 263 (296)
T cd06618 243 E---GFSPDFCSFVDLCLTKDHRK 263 (296)
T ss_pred C---CCCHHHHHHHHHHccCChhh
Confidence 1 12345889999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=225.12 Aligned_cols=208 Identities=25% Similarity=0.367 Sum_probs=156.6
Q ss_pred ccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------------c
Q 047576 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-------------------------L 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-------------------------L 430 (602)
+|.|++|.||++... +++.+|+|.+.............+..|+++++.+.|.+ |
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999865 58999999987665443334566777877775554444 3
Q ss_pred ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccc
Q 047576 431 FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510 (602)
Q Consensus 431 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~ 510 (602)
.+++.. ...+++.....++.|++.|+.|+| +.+++|+||||+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 333332 224789999999999999999999 78999999999999999999999999999987654322233456
Q ss_pred cccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHH
Q 047576 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590 (602)
Q Consensus 511 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 590 (602)
++..|+|||...+...+.++|+||||+++|++++|+.||..... ......+....++.+.. ....+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~-----~~~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLRFPEF-----LSPEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCCCCCC-----CCHHHHH
Confidence 78899999999888889999999999999999999999974321 12222333333322211 1344789
Q ss_pred HHhhccCcCCCC
Q 047576 591 ISFACLQSNPKS 602 (602)
Q Consensus 591 l~~~Cl~~dP~e 602 (602)
++.+|+..||++
T Consensus 223 ~i~~~l~~~p~~ 234 (250)
T cd05123 223 LISGLLQKDPTK 234 (250)
T ss_pred HHHHHhcCCHhh
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=226.62 Aligned_cols=216 Identities=23% Similarity=0.318 Sum_probs=159.2
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh----------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---------------------- 426 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~---------------------- 426 (602)
+|+..+.+|+|++|.||+++. .+++.+|+|.+....... .....+.+|++++..+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 367788999999999999975 478899999987543322 22345666777664444
Q ss_pred ---cCcccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 427 ---RGSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 427 ---~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++++.+++.... ....+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 444444433211 1234788899999999999999999 889999999999999999999999999999877544
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||...... .....+.....+ +...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~--- 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYP-PIPP--- 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCC-CCch---
Confidence 222345788999999999888999999999999999999999999753211 111111222222 2111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKL 243 (256)
T ss_pred hhCHHHHHHHHHHcCCCccc
Confidence 24455899999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=228.48 Aligned_cols=218 Identities=24% Similarity=0.369 Sum_probs=162.2
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
+|.....+|+|++|.||+|+.. +++.|++|.+...... ....+.+.+|++++..+.+.++..+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 3677889999999999999764 6789999998766532 22456788899988766665554433210
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++..+..++.|++.|+.|+| +.+|+||||||+||+++.++.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 01134789999999999999999999 8899999999999999999999999999998775543333
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
....++..|+|||+..+..++.++||||+|+++|+|++|+.||....... ..........+ ..... ...
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~~~---~~~ 225 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-------ALFRIVQDDHP-PLPEG---ISP 225 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHhccCCC-CCCCC---CCH
Confidence 34568889999999988888999999999999999999999997533211 11111111111 11111 223
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+|++.+|++
T Consensus 226 ~~~~~i~~~l~~~p~~ 241 (254)
T cd06627 226 ELKDFLMQCFQKDPNL 241 (254)
T ss_pred HHHHHHHHHHhCChhh
Confidence 4789999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=238.40 Aligned_cols=180 Identities=26% Similarity=0.341 Sum_probs=143.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|.....||+|++|.||+|... +|+.||+|++...... ....+.+.+|+.++..+.|+++..+....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 67888899999999999999864 6899999998754321 12345667789888888777765433210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 01234789999999999999999999 789999999999999999999999999999765432
Q ss_pred CCC----cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSN----QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... .....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 211 123468889999998765 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=230.15 Aligned_cols=178 Identities=29% Similarity=0.399 Sum_probs=140.2
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-----------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA----------- 438 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~----------- 438 (602)
|.....+|.|++|.||+|+.. +++.+|+|++.... ......+.+.+|++++..+.|+++..+.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 456678999999999999865 58899999997653 11223456778888887777766554432211
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
....+++.++..++.|+++|++||| +.+++|+||||+||++++++.+||+|||.+........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 1135888999999999999999999 78999999999999999999999999999987654321
Q ss_pred Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1222356788999998765 35789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=238.47 Aligned_cols=174 Identities=26% Similarity=0.408 Sum_probs=145.4
Q ss_pred cccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc----------------c
Q 047576 374 KYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH----------------N 436 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~----------------~ 436 (602)
.+.||.|-||+||-|+. ++|+.||||++.+...... ....+++|+.|++.+.|+.+..+-. .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 46799999999999985 5899999999976654432 3478899999998888776654311 0
Q ss_pred -------ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeecccccccccCCCCCc
Q 047576 437 -------DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 437 -------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
..+..++++...+....||+.||.||| -++|+|+||||+|||+.. --++||||||+|+.++.... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-R 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-R 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-h
Confidence 023456888888999999999999999 789999999999999953 35799999999999876544 3
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
..++||+.|.|||+++...|...-|+||.||++|--+.|..||...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 4478999999999999999999999999999999999999999753
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=237.11 Aligned_cols=181 Identities=25% Similarity=0.327 Sum_probs=142.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+..+.||+|+||.||+|... +|+.||+|++....... .....+.+|+.++..+.|+++..+....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 467889999999999999999864 68999999886433211 1223456789998888877765543210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 00134788999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222223345788999999876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=230.24 Aligned_cols=179 Identities=25% Similarity=0.319 Sum_probs=140.8
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|.....||.|++|.||+|... +++.+++|++...... ......+.+|++++..+.++++..+....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 455678999999999999864 6889999998755432 12345677788887666665554433210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.|+.||| +.+|+|+||||+||+++.++.+||+|||.+...........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 01135789999999999999999999 78999999999999999999999999999987754432222
Q ss_pred ccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 508 LLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
...++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 34577889999998876 68899999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=241.04 Aligned_cols=215 Identities=26% Similarity=0.396 Sum_probs=165.1
Q ss_pred ccccCcccccccccccceeeecC--CC--cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-----------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP--NG--RVFALKKLNSPETEELAFIRSFRNEAQVLSQMER----------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~----------------- 427 (602)
+++...++||+|.||.|++|.+. .| ..||||.++..... .....|.+|+.+|-.|+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeeccchhhH
Confidence 45667789999999999999874 34 36899999765443 246789999998855555
Q ss_pred -------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 428 -------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 428 -------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
|+|.+.|+. .....|-......|+.|||.|+.||. +++.|||||-..|+++-....+||+|||+.+.++
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 555555554 23344667778899999999999999 8999999999999999888899999999999887
Q ss_pred CCCCCcc---ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhc--cCCC
Q 047576 501 ADSSNQT---LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLD--QRLP 574 (602)
Q Consensus 501 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d--~~l~ 574 (602)
....... ...-...|+|||.+....++.++|||+|||++|||+| |+.||.+.... .+.+.+| .+++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGERLP 335 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccccCC
Confidence 6443321 1123468999999999999999999999999999998 88999764321 1222333 2344
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+. .|.+.+.+++..||...|++
T Consensus 336 RPk-----~csedIY~imk~cWah~paD 358 (1039)
T KOG0199|consen 336 RPK-----YCSEDIYQIMKNCWAHNPAD 358 (1039)
T ss_pred CCC-----CChHHHHHHHHHhccCCccc
Confidence 332 26777999999999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=230.67 Aligned_cols=216 Identities=21% Similarity=0.366 Sum_probs=153.1
Q ss_pred ccccCccc--ccccccccceeeec-CCCcEEeeeccCCchhHHHHH-hhhhHh-H----------------HHHHHhhhc
Q 047576 369 RKIDSKYC--IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAF-IRSFRN-E----------------AQVLSQMER 427 (602)
Q Consensus 369 ~~f~~~~~--LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~-~~~~~~-E----------------~~il~~l~~ 427 (602)
++|+..+. +|+|+||.||+++. .++..+|+|.+.......... ...... . ..++||+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 93 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence 34455455 49999999999986 468889999886543221100 000000 0 002277788
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCCCCCc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~~~~~ 506 (602)
++|.+++... ..+++.++..++.|+++|++|+| +.+++||||||+||+++.++ .++|+|||.+.......
T Consensus 94 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--- 164 (267)
T PHA03390 94 GDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--- 164 (267)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---
Confidence 8888887653 26899999999999999999999 88999999999999999998 99999999987664322
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...++..|+|||++.+..++.++||||+|+++|||++|+.||...... ... ...+........+.+ + ....
T Consensus 165 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~~~~~~~--~---~~~~ 235 (267)
T PHA03390 165 -CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELD-LESLLKRQQKKLPFI--K---NVSK 235 (267)
T ss_pred -cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhh-HHHHHHhhcccCCcc--c---ccCH
Confidence 245788999999999988999999999999999999999999732211 000 011111111111111 1 1334
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..|++.||++
T Consensus 236 ~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 236 NANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHHHHHhccChhh
Confidence 4788999999999964
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=228.06 Aligned_cols=214 Identities=18% Similarity=0.231 Sum_probs=142.2
Q ss_pred cccccccccceeeecCCC---cEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hhhhc
Q 047576 376 CIGTGAYGSVYKAQLPNG---RVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQMER 427 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~l~~ 427 (602)
.||+|+||.||+|+..++ ..+++|.+...... ...+.+.+|+.++ ||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999975433 35667766543322 2245667776655 55566
Q ss_pred Cccccccccccc-hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC--C
Q 047576 428 GSLFRILHNDAE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS--S 504 (602)
Q Consensus 428 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~--~ 504 (602)
|+|.+++..... ....++.....++.|+++||+||| +.+++||||||+||+++.++.+||+|||.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 666666654221 223566777889999999999999 7899999999999999999999999999886432211 1
Q ss_pred Ccccccccccccccccccc-------CcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCC-cccchhhhhccCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-------MVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYD-PKIMLIDVLDQRLPP 575 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~-~~~~~~~~~d~~l~~ 575 (602)
......++..|+|||++.. ..++.++||||||+++|||++ |..||........... .........++.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1223457889999998753 235788999999999999997 5678864322100000 001112223333333
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+++ ..+.+++..|| .+|++
T Consensus 237 ~~~-------~~~~~l~~~c~-~~P~~ 255 (268)
T cd05086 237 PYS-------ERWYEVLQFCW-LSPEK 255 (268)
T ss_pred CCc-------HHHHHHHHHHh-hCccc
Confidence 332 23667888999 56864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=227.31 Aligned_cols=218 Identities=24% Similarity=0.405 Sum_probs=161.9
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc---------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI--------------- 433 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~--------------- 433 (602)
+|+....+|.|++|.||++... ++..||+|++...... ....+.+.+|++++..+.++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4677889999999999999864 6889999998754332 2234567778887766555544433
Q ss_pred ----------ccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 434 ----------LHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 434 ----------l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+.... ....+++.++..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 32211 1245889999999999999999999 789999999999999999999999999999876554
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
........|++.|+|||...+..++.++|+||+|+++|+|++|+.||+.... ............+ +....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~-- 226 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQYP-PIPSQ-- 226 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCCCC-CCCCC--
Confidence 3233345688899999999888899999999999999999999999974321 1111222222221 11111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..|++.+|++
T Consensus 227 -~~~~~~~~i~~~l~~~p~~ 245 (258)
T cd08215 227 -YSSELRNLVSSLLQKDPEE 245 (258)
T ss_pred -CCHHHHHHHHHHcCCChhh
Confidence 2344789999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=230.94 Aligned_cols=180 Identities=24% Similarity=0.312 Sum_probs=139.9
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|.....||+|++|.||+|+.. +|+.||+|.+...... ......+.+|++++..+.|+++..+.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46788899999999999999865 6889999988644321 123356778999998888777665543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecccccccccCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLLHADS 503 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~a~~~~~~~ 503 (602)
....+++..+..++.||+.||+||| +++++||||||+||+++. ++.+||+|||.+.......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 1112467778889999999999999 789999999999999985 5679999999997654332
Q ss_pred CCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222334578899999988764 5788999999999999999999999643
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=230.03 Aligned_cols=218 Identities=26% Similarity=0.382 Sum_probs=154.1
Q ss_pred ccCcccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhh--------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQM-------------------- 425 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l-------------------- 425 (602)
|...+.||+|++|.||+++. .+++.||||.++..... .....+.+.+|++++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66778899999999999974 35788999998754322 222345667788777554
Q ss_pred ------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 426 ------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 426 ------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
+++++.+.+.. ...+++.++..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 33333333322 234788899999999999999999 789999999999999999999999999998765
Q ss_pred cCCCC-CccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 500 HADSS-NQTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
..... ......|+..|+|||...+.. .+.++||||||+++|||++|+.||....... ........+.....+.+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 232 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSKPPFP 232 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHccCCCCC
Confidence 43221 122345788999999987765 7889999999999999999999996422111 01111122222222211
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. . ....+.+++.+|++.||++
T Consensus 233 ~--~---~~~~l~~li~~~l~~~p~~ 253 (288)
T cd05583 233 K--T---MSAEARDFIQKLLEKDPKK 253 (288)
T ss_pred c--c---cCHHHHHHHHHHhcCCHhh
Confidence 1 1 1233778999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.47 Aligned_cols=215 Identities=25% Similarity=0.310 Sum_probs=156.5
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|.....+|+|+||.||+|+.. +++.|++|++...........+.+.+|++++..+.|+++..+....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455567999999999999864 6889999998654333333446678899999888777665543210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+..... ..
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 01234788999999999999999999 78999999999999999999999999998864322 22
Q ss_pred ccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 508 LLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
...|+..|+|||++. ...++.++|||||||++|+|++|+.||...... .....+.....+...... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~---~ 245 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNE---W 245 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccc---c
Confidence 356888999999974 456888999999999999999999998643211 101111111111111111 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+|++++|++
T Consensus 246 ~~~l~~li~~~l~~~P~~ 263 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQE 263 (313)
T ss_pred CHHHHHHHHHHccCChhh
Confidence 234778999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.53 Aligned_cols=217 Identities=23% Similarity=0.326 Sum_probs=158.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|+....+|+|++|.||+|+.. ++..+|+|.+...........+.+.+|++++..+.|.++..+....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999864 6788999988643222223345677899988777776655443210
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 01234788899999999999999999 789999999999999999999999999998765432
Q ss_pred ccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
....++..|+|||++. ...++.++|||||||++|+|++|+.||..... ......+.....+.....
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--- 237 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSG--- 237 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhhcCCCCcCcc---
Confidence 2346788999999875 34578899999999999999999999864211 111111222221111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+||+++|++
T Consensus 238 ~~~~~~~~li~~cl~~~P~~ 257 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQD 257 (308)
T ss_pred cccHHHHHHHHHHhhCCccc
Confidence 13344788999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.24 Aligned_cols=175 Identities=23% Similarity=0.257 Sum_probs=132.4
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc-----------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND----------- 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~----------- 437 (602)
|.....+|+|+||.||+|+.. +++.||+|+++....... . ....+|+.++..+. |+++..+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 455678999999999999864 689999999875432211 1 22335666665543 55444332210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+++||||||+||+++. +.+||+|||.+........
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 01134789999999999999999999 789999999999999999 9999999999987643322
Q ss_pred Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 123457889999997654 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=234.48 Aligned_cols=179 Identities=25% Similarity=0.339 Sum_probs=139.2
Q ss_pred cccCcccccccccccceeeecC-C--CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-N--GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHND-------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~-------- 437 (602)
+|.....||+|+||.||+|+.. + +..||+|++...... ....+.+.+|+.++..+ .|+++..++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 3677788999999999999864 3 778999988643221 12345667788888776 366555544210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++...
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 01234788999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCC----Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSS----NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.... ......|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 3211 1223468899999998766 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=228.62 Aligned_cols=181 Identities=23% Similarity=0.332 Sum_probs=141.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||||.+....... .....+.+|+.++..+.|+++..++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 456888999999999999999864 68999999886433221 1223456788888888777765543210
Q ss_pred ---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 438 ---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 438 ---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
.....+++.++..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.+
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 00124788999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCC----ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADSSN----QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......... .....++..|+|||++.+.. ++.++||||||+++|||+||+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 866432211 12245678899999887654 688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=206.83 Aligned_cols=177 Identities=25% Similarity=0.402 Sum_probs=134.0
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH--------------hhhcCccc---
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS--------------QMERGSLF--- 431 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~--------------~l~~gsL~--- 431 (602)
.......||+|++|.|-+.++ .+|+..|+|.+...-.. +..++...|+.+.. +.+.|++.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344556799999999988875 47999999998754332 23456667777651 12222222
Q ss_pred --------cccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 432 --------RILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 432 --------~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.+..+. ..+..+++...-+||..+.+||.|||+ ...|+|||+||+|||++.+|++|+||||.+..+.++
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 111110 123457788888999999999999996 579999999999999999999999999999876543
Q ss_pred CCCcccccccccccccccccc----CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYT----MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
-..+...|...|||||.+.. ..|+.|+||||+|+++.||.+++.||+.
T Consensus 203 -iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 203 -IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred -hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 22334568899999998753 3589999999999999999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=226.05 Aligned_cols=176 Identities=27% Similarity=0.359 Sum_probs=137.8
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------------- 432 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------------- 432 (602)
|+....+|+|++|.||+|+.. +++.||+|.+...... ....+.+..|+.++..+.|.++..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 455678999999999999875 5899999998765421 223355667777775555444433
Q ss_pred -------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 433 -------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 433 -------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
++... ...+++.++..++.|+++||+||| +.+|+||||+|+||++++++.+||+|||.+.........
T Consensus 80 ~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 80 CDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 33221 135889999999999999999999 789999999999999999999999999999876543322
Q ss_pred ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2234467789999998776 7889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=234.67 Aligned_cols=178 Identities=28% Similarity=0.412 Sum_probs=141.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.++..+.|.++..+....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 567889999999999999999875 68899999986543221 2335566788888777766654433210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.++..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||.+....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 01134789999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||...
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 223467889999998865 35788999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=233.41 Aligned_cols=178 Identities=29% Similarity=0.413 Sum_probs=144.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|+....||+|+||.||+|.. .+|..||||++...... ....+.+.+|+.++..+.|+++..+.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46788899999999999999975 47899999998654322 223456778999999888887765432110
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||.+....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 1135789999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... ....+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||...
T Consensus 170 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 SEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 22457889999998876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=225.56 Aligned_cols=175 Identities=22% Similarity=0.319 Sum_probs=132.4
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-----------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME----------------------- 426 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~----------------------- 426 (602)
|...+.||+|++|.||+|+.. +++.|++|++........ .....+|+..+..+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 456788999999999999975 578899998865432110 111223444443333
Q ss_pred --cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 427 --RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 427 --~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
+|++.+.+.... ...+++.++..++.|++.+|.||| +.+++|+||||+||++++++.++|+|||.+........
T Consensus 79 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YMEGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 444444443321 235799999999999999999999 78999999999999999999999999999987643322
Q ss_pred Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+ ..++.++|+||||+++|||++|+.||...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 223467889999998754 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=228.98 Aligned_cols=181 Identities=30% Similarity=0.369 Sum_probs=141.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+....+|+|++|.||+|... +|+.||+|+++..... ......+.+|++++..+.|+++..+....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 467888999999999999999875 6889999998654321 11234566788888877777666533210
Q ss_pred -------------c----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 438 -------------A----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 438 -------------~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
. ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 0 0124789999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCC-CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSS-NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.+........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987654332 11223467789999988654 4788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=249.25 Aligned_cols=143 Identities=27% Similarity=0.456 Sum_probs=105.6
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc---C---------------CCCCccc
Q 047576 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH---A---------------DSSNQTL 508 (602)
Q Consensus 447 ~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~---~---------------~~~~~~~ 508 (602)
...+++++|++||.|+| ++|||||||||.||++|.+..|||+|||+|.... . +....+.
T Consensus 698 ~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 698 EAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred HHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 45578999999999999 8899999999999999999999999999998721 0 1112344
Q ss_pred cccccccccccccccCc---CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 509 LAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
.+||.-|+|||++.+.. |+.|+|+||+|||++||+. ||.. ..+....+..+-++.++.+.+ -.....
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T------sMERa~iL~~LR~g~iP~~~~-f~~~~~ 844 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT------SMERASILTNLRKGSIPEPAD-FFDPEH 844 (1351)
T ss_pred ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc------hHHHHHHHHhcccCCCCCCcc-cccccc
Confidence 68999999999987655 9999999999999999985 4653 223333344445556665510 011223
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..=+.++.+-++.||.+
T Consensus 845 ~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hHHHHHHHHHhcCCCcc
Confidence 33456777888889875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=230.02 Aligned_cols=214 Identities=27% Similarity=0.361 Sum_probs=164.8
Q ss_pred cCcccccccccccceeeecCC---C--cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 372 DSKYCIGTGAYGSVYKAQLPN---G--RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 372 ~~~~~LG~G~~g~Vy~~~~~~---g--~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
...++||.|-||.||+|.+.+ | -.||||..+.....+ ..+.|..|..+|+.++|+.+.+++.-.
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 345789999999999998643 2 358999988755432 357899999999888888877765422
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....++..+...++.||..||+||| ++..|||||-.+|||+.....+||+|||+++.+..+..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 11234777888899999999999999 99999999999999999999999999999999876543
Q ss_pred Cc-cccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhh-ccCCCCCCChhh
Q 047576 505 NQ-TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVL-DQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~~~ 581 (602)
.. +...-..-|||||.+.-++++.++|||-|||+|||++. |..||..... ...+..+- ..++|-|.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-------sDVI~~iEnGeRlP~P~---- 615 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-------SDVIGHIENGERLPCPP---- 615 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-------cceEEEecCCCCCCCCC----
Confidence 32 22233567999999999999999999999999999987 9999975321 11111111 12344332
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.|+..+..++.+||++||.+
T Consensus 616 -nCPp~LYslmskcWayeP~k 635 (974)
T KOG4257|consen 616 -NCPPALYSLMSKCWAYEPSK 635 (974)
T ss_pred -CCChHHHHHHHHHhccCccc
Confidence 26667889999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=233.16 Aligned_cols=178 Identities=23% Similarity=0.339 Sum_probs=143.9
Q ss_pred ccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hh
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQ 424 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~ 424 (602)
|....-||-|+||+|.+++- ++...||+|.+++.+.-....+.....|..|| +|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 44456699999999999974 45678999999888766555666667777766 67
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC---
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA--- 501 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~--- 501 (602)
+++|++..+|-. ..-|++.-++.|+.++..|+++.| ..|+|||||||+|||||.+|++||.|||++.-+..
T Consensus 711 IPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred cCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 777777776643 234788889999999999999999 89999999999999999999999999999753310
Q ss_pred ------CCC---------------------------------CccccccccccccccccccCcCCccchhHHHHHHHHHH
Q 047576 502 ------DSS---------------------------------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEV 542 (602)
Q Consensus 502 ------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el 542 (602)
..+ .....+||+.|+|||++....++.-+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000 01124699999999999999999999999999999999
Q ss_pred HcCCCCCCCCcc
Q 047576 543 LMGKHPRDLHST 554 (602)
Q Consensus 543 ltG~~Pf~~~~~ 554 (602)
+.|+.||....+
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999975433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=233.73 Aligned_cols=179 Identities=21% Similarity=0.302 Sum_probs=140.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|...+.||.|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++..+.|+++..+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 36788899999999999999986 46889999988654432 345677889888888877766543210
Q ss_pred -------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceee
Q 047576 438 -------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVA 491 (602)
Q Consensus 438 -------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~ 491 (602)
.....+++..+..++.||+.|++||| +.+|+||||||+||+++. ++.+|++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 01124788899999999999999999 789999999999999974 5678999
Q ss_pred cccccccccCCCC---Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 492 DFGTARLLHADSS---NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 492 DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
|||.+........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999976533211 1122357889999998654 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=249.39 Aligned_cols=180 Identities=24% Similarity=0.313 Sum_probs=127.9
Q ss_pred CccccCcccccccccccceeeecC-C----CcEEeeeccCCchhHHHHHhhhhHh---------------HH--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-N----GRVFALKKLNSPETEELAFIRSFRN---------------EA-------- 419 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~~~~---------------E~-------- 419 (602)
.++|...+.||+|+||.||+|+.. + +..||+|++......+........+ +.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence 568999999999999999999875 4 6899999876433221111111110 00
Q ss_pred -HHHHhhhcCccccccccccc-----------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCee
Q 047576 420 -QVLSQMERGSLFRILHNDAE-----------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNIL 481 (602)
Q Consensus 420 -~il~~l~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 481 (602)
.+++|+.+++|.+++..... ........+..++.|++.||+||| +++|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence 02256677777777653211 011223446679999999999999 789999999999999
Q ss_pred eCC-CCcceeecccccccccCCC-CCccccccccccccccccccC----------------------cCCccchhHHHHH
Q 047576 482 LNS-KLEAFVADFGTARLLHADS-SNQTLLAGSYGYIAPELAYTM----------------------VMTEKYDVYSFGV 537 (602)
Q Consensus 482 ld~-~~~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwSlGv 537 (602)
++. ++.+||+|||+++.+.... .......+++.|+|||.+... .++.++||||+||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 5799999999998654322 223446789999999965322 1334679999999
Q ss_pred HHHHHHcCCCCCC
Q 047576 538 VTLEVLMGKHPRD 550 (602)
Q Consensus 538 il~elltG~~Pf~ 550 (602)
++|||+++..|++
T Consensus 368 iL~el~~~~~~~~ 380 (566)
T PLN03225 368 IFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHhCcCCCc
Confidence 9999999887765
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=229.62 Aligned_cols=174 Identities=21% Similarity=0.284 Sum_probs=130.5
Q ss_pred cccccc--ccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------------
Q 047576 375 YCIGTG--AYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------------- 437 (602)
Q Consensus 375 ~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------------- 437 (602)
..||+| +||+||+|+. .+|+.||+|++....... ...+.+.+|+.+++.+.|+++..+....
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345666 8999999986 479999999987543322 2346788888888767666665432211
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC--
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-- 505 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~-- 505 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 00123778888899999999999999 889999999999999999999999999865433221111
Q ss_pred -----ccccccccccccccccccC--cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 -----QTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1112345679999998764 4788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=251.01 Aligned_cols=124 Identities=24% Similarity=0.402 Sum_probs=99.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
.++|.....||+|+||.||+|+.. +++.||||+++............+..|+.++..+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467888999999999999999875 6899999998765433333456677777776444
Q ss_pred ----hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 426 ----ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 426 ----~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.+++|.+++.. ...+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 44455444432 123678889999999999999999 7899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=229.82 Aligned_cols=179 Identities=25% Similarity=0.342 Sum_probs=143.3
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
.+++|.....||.|+||.||+|+.. +++.||+|++...... ....+.+.+|++++..+.|+++..+.....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999854 7899999987643221 123456778999998888877766543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
....+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 87 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 87 FVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 0123677778889999999999999 889999999999999999999999999998754322
Q ss_pred Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++..|+|||++.+ ..++.++||||||+++|+|+||+.||...
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122457889999998766 56889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=229.84 Aligned_cols=181 Identities=25% Similarity=0.301 Sum_probs=138.3
Q ss_pred cccc-CcccccccccccceeeecC-CCcEEeeeccCCchhHHH-----------HHhhhhHhHHHHHHhhhcCccccccc
Q 047576 369 RKID-SKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL-----------AFIRSFRNEAQVLSQMERGSLFRILH 435 (602)
Q Consensus 369 ~~f~-~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-----------~~~~~~~~E~~il~~l~~gsL~~~l~ 435 (602)
++|. ....||.|+||.||+|+.. +++.||+|++........ .....+.+|++++..+.|.++..++.
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4577999999999999864 689999998865432210 01124668899888887776655443
Q ss_pred cc---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 436 ND---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 436 ~~---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
.. .....+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcc
Confidence 20 01234788889999999999999999 8899999999999999999999999999
Q ss_pred ccccccCC--------------CCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHAD--------------SSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.+.....+ ........++..|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98766411 1111223467889999998764 4688999999999999999999999754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=225.45 Aligned_cols=171 Identities=19% Similarity=0.266 Sum_probs=126.7
Q ss_pred cccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc-----------------------
Q 047576 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR----------------------- 432 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~----------------------- 432 (602)
.+|.|+++.||+++. +++.||||++...... ....+.+.+|++++..+.|+++..
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 334445555555544 6899999998754222 224567888888886555554443
Q ss_pred --ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC------
Q 047576 433 --ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS------ 504 (602)
Q Consensus 433 --~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~------ 504 (602)
++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.+........
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 333211 123678889999999999999999 78999999999999999999999999998875532211
Q ss_pred -CccccccccccccccccccC--cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 -NQTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
......++..|+|||++.+. .++.++|+|||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223567789999998764 4788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=220.96 Aligned_cols=218 Identities=21% Similarity=0.261 Sum_probs=150.0
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhH--HHHHhhhhHhHHHHH------------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETE--ELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~~~~E~~il------------------------ 422 (602)
+|...+.||+|+||.||+++.. .+..+++|.++..... .......+..|+.++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677789999999999999764 3344555554432111 001122344455555
Q ss_pred -HhhhcCccccccccc-cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 -SQMERGSLFRILHND-AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+|++++++..++... .....+++.+++.++.|++.|+.||| +.+++|+||||+||+++. +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 344455554444321 12345889999999999999999999 889999999999999976 569999999988765
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........|+..|+|||+..+..++.++|+||||+++|+|++|+.||..... ......+.+...+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~- 227 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIVEGPTPS-LPE- 227 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCCCCC-Ccc-
Confidence 433333345678899999999888889999999999999999999999964221 11112222222211 111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+++.+|++.||++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~ 247 (260)
T cd08222 228 --TYSRQLNSIMQSMLNKDPSL 247 (260)
T ss_pred --hhcHHHHHHHHHHhcCChhh
Confidence 13345788999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=216.77 Aligned_cols=197 Identities=23% Similarity=0.223 Sum_probs=143.5
Q ss_pred cccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhH-----HH-------------HHHhhhcCccccccccccch
Q 047576 380 GAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNE-----AQ-------------VLSQMERGSLFRILHNDAEA 440 (602)
Q Consensus 380 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E-----~~-------------il~~l~~gsL~~~l~~~~~~ 440 (602)
|.+|.||+++.. +++.||+|++......... ....... +. ++||+++|+|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhH-HHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh---
Confidence 899999999864 6889999998764321111 0000000 00 22777888888877542
Q ss_pred hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccccccccccccc
Q 047576 441 VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520 (602)
Q Consensus 441 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~ 520 (602)
..+++..+..++.|++.||+|+| +++|+||||||+||+++.++.++++|||.+....... ....++..|+|||+
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~ 153 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEV 153 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcc
Confidence 34899999999999999999999 8899999999999999999999999999876554321 12345678999999
Q ss_pred cccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCC
Q 047576 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNP 600 (602)
Q Consensus 521 ~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP 600 (602)
..+..++.++||||+|+++|||++|+.||+..... . .......++...+ ..+.+++.+|++.||
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~------~~~~~~~~~~~~~-------~~~~~li~~~l~~dp 217 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG---I------NTHTTLNIPEWVS-------EEARSLLQQLLQFNP 217 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c------ccccccCCcccCC-------HHHHHHHHHHccCCH
Confidence 98888899999999999999999999998643211 0 0001111222222 237789999999999
Q ss_pred CC
Q 047576 601 KS 602 (602)
Q Consensus 601 ~e 602 (602)
++
T Consensus 218 ~~ 219 (237)
T cd05576 218 TE 219 (237)
T ss_pred HH
Confidence 74
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=232.07 Aligned_cols=208 Identities=23% Similarity=0.304 Sum_probs=152.2
Q ss_pred CCCCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHH----------------------
Q 047576 365 MPTPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQV---------------------- 421 (602)
Q Consensus 365 lp~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~i---------------------- 421 (602)
.+.++.|.....+|.|+|+.|-++.. .+++..++|++.+.... -.+|+.+
T Consensus 318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred CCcchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCce
Confidence 45577888888899999999988875 46888999998766221 1123322
Q ss_pred ----HHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee-CCCCcceeeccccc
Q 047576 422 ----LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL-NSKLEAFVADFGTA 496 (602)
Q Consensus 422 ----l~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFG~a 496 (602)
++.+.++-+.+.+.... ....++..|+.+|+.|+.||| ++||||||+||+|||+ +..+.++|+|||.+
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred eeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechh
Confidence 24444444443333211 222677789999999999999 8899999999999999 58899999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
+....+ ....+-|..|.|||++....+++++||||||++||+|++|+.||.....- .++......++
T Consensus 464 ~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------~ei~~~i~~~~ 530 (612)
T KOG0603|consen 464 SELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------IEIHTRIQMPK 530 (612)
T ss_pred hhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------HHHHHhhcCCc
Confidence 876544 11234578899999999999999999999999999999999999754221 23333333344
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++.. -.....+++..|+|.||.+
T Consensus 531 ~s~~---vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 531 FSEC---VSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred cccc---cCHHHHHHHHHhccCChhh
Confidence 3322 2233678999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=230.85 Aligned_cols=180 Identities=22% Similarity=0.339 Sum_probs=148.6
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
....|+....||+|.|+.|.+|+.. ++..||+|.+.+....... .+.+.+|+++|.-+.|+++.+++..-
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4567889999999999999999864 6899999998877655433 34478899999777777665443211
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
....++...++..++.|+.+|++||| ++.|||||||++|||++.++.+||+|||++.++...
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 01223556888899999999999999 899999999999999999999999999999988743
Q ss_pred CCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
......+|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 33445789999999999999876 5789999999999999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-25 Score=243.45 Aligned_cols=218 Identities=26% Similarity=0.363 Sum_probs=164.4
Q ss_pred cccCcccccccccccceeeecC--------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
+....+.+|+|.||.|++|... ....||||.++..... ...+.+..|++++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3445569999999999999742 1457999999866544 3457788888877
Q ss_pred -------HhhhcCcccccccccc-----c------h--hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee
Q 047576 423 -------SQMERGSLFRILHNDA-----E------A--VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 482 (602)
||+++|+|.++++... . . ..++......++.|||.|++||+ +.++|||||-++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 7888899998887654 0 0 23888899999999999999999 8899999999999999
Q ss_pred CCCCcceeecccccccccCCCCCc-ccccc--ccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccC
Q 047576 483 NSKLEAFVADFGTARLLHADSSNQ-TLLAG--SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSS 558 (602)
Q Consensus 483 d~~~~~kL~DFG~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 558 (602)
+++..+||+|||+|+......... ....| ...|||||.+....++.++|||||||+|||+.| |..||...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~------ 525 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI------ 525 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC------
Confidence 999999999999998654433222 22222 234999999999999999999999999999999 88998742
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+.+..-.+.+.+ ..+..++.+++..||+.+|++
T Consensus 526 -~~~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 526 -PPTEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred -CcHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCccc
Confidence 1111122233332221211 225666889999999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=223.89 Aligned_cols=179 Identities=27% Similarity=0.374 Sum_probs=139.5
Q ss_pred ccccCcccccccccccceeee-cCCCcEEeeeccCCchhH----HHHHhhhhHhHHHHH---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE----ELAFIRSFRNEAQVL--------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----~~~~~~~~~~E~~il--------------------- 422 (602)
++|-..++||+|||++||+|- +...+.||||+-.-...+ ...+.+...+|..|-
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456677889999999999996 457889999986543322 223444555666655
Q ss_pred -----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeeccc
Q 047576 423 -----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFG 494 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG 494 (602)
||+++.+|.-++.. .+.+++.+++.|+.||+.||.||.+. +++|||-||||.|||+- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 44444444444433 34488999999999999999999976 89999999999999993 45889999999
Q ss_pred ccccccCCCCC-------ccccccccccccccccccC----cCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 495 TARLLHADSSN-------QTLLAGSYGYIAPELAYTM----VMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 495 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
+++.++.+... .+...||..|.+||.+.-+ ..+.|+||||.||++|..+.|+.||..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 99999765432 3446799999999987543 368899999999999999999999974
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-26 Score=235.03 Aligned_cols=244 Identities=27% Similarity=0.326 Sum_probs=217.5
Q ss_pred cccccCCCCCCCCCccchhccccCCccccCCc-cCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCc
Q 047576 118 GRLSHLNFSCFPNLESLRILAYYDGFTGSIPS-EISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLP 189 (602)
Q Consensus 118 ~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~-~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p 189 (602)
++|+.+..++|.+|.+|-.+.+..|-...+|. .|.+|++|+.|+|..|+|. ..|++|+.|.|..|.|+..-.
T Consensus 183 N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D 262 (873)
T KOG4194|consen 183 NRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD 262 (873)
T ss_pred ccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC
Confidence 56777777777777766666667777777875 5777999999999999987 358999999999999999999
Q ss_pred hhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCC
Q 047576 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSD 268 (602)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 268 (602)
..|..|.++++|+|+.|+++..--.++.+|++|+.|+||+|.|..| ++++.-.++|+.|+|++|+|+...+.+|..+..
T Consensus 263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~ 342 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ 342 (873)
T ss_pred cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence 9999999999999999999988888999999999999999999995 778888899999999999999988999999999
Q ss_pred CccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCc---ccCCCCCCCEEeCCCCCCCCCCCccccccccccccc
Q 047576 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS---QIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLN 345 (602)
Q Consensus 269 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 345 (602)
|++|.|++|.++..-...|..+++|+.|||++|.|++.+-+ .|.+++.|+.|+|.+|+|+...-.+|.+++.|+.|+
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 99999999999988888899999999999999999876643 578899999999999999977778999999999999
Q ss_pred ccCCcCCCccCCCCCc
Q 047576 346 LSGNKLSGRVPYSNKH 361 (602)
Q Consensus 346 l~~N~l~g~~p~~~~~ 361 (602)
|.+|.+...-|..|..
T Consensus 423 L~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 423 LGDNAIASIQPNAFEP 438 (873)
T ss_pred CCCCcceeeccccccc
Confidence 9999998887777643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=219.16 Aligned_cols=175 Identities=22% Similarity=0.357 Sum_probs=141.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-------------------- 426 (602)
+.+|.....+|+|.||.|-.+... .+..||||+++.... +.++.+-|+++++.+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 568889999999999999999753 578999999975432 3445556777775442
Q ss_pred ----------cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC------------
Q 047576 427 ----------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS------------ 484 (602)
Q Consensus 427 ----------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~------------ 484 (602)
+.++++++..+ ...+++...+..++.|++++++||| +.+++|-||||+|||+-.
T Consensus 164 ghiCivfellG~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEeccChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 12455555543 3456889999999999999999999 889999999999999921
Q ss_pred --------CCcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 485 --------KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 485 --------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
+..+||+|||.|..-.... +..+.|..|+|||++.+-.++.++||||+||||+|+.||..-|...+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2457899999998754332 44678999999999999999999999999999999999999997655
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=195.66 Aligned_cols=179 Identities=26% Similarity=0.369 Sum_probs=144.7
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccc---cccc-------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL---HNDA------- 438 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l---~~~~------- 438 (602)
+|+..+.||+|.||+||+|+.. +++.||+|+++..+..+ ..-....+|+.+++.++|.++..+. |...
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 5677789999999999999865 58899999987554432 1234567899999999998876543 3211
Q ss_pred ------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 439 ------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 439 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
-...++.+.++.++.|+++|+.|+| ++++.|||+||.|.+|+.+|+.|++|||+++..+-+..-.
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 0223778889999999999999999 8899999999999999999999999999999876654444
Q ss_pred cccccccccccccccccCc-CCccchhHHHHHHHHHHHc-CCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLM-GKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt-G~~Pf~~~ 552 (602)
+..+-|..|++|.++.+.. |+...|+||.||++.|+.. |++-|.+.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 4556789999999998876 8899999999999999987 55556543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=211.01 Aligned_cols=181 Identities=25% Similarity=0.327 Sum_probs=141.9
Q ss_pred CCccccCcccccccccccceeeecC---C--CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP---N--GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------ 435 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------ 435 (602)
....|+....||+|.||.||+|... + ...+|+|+++..... ........+|+.+++.+.|+++..+..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3567888899999999999999543 3 337999999765321 123345567888887777777655432
Q ss_pred -------------------c--ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC----Cccee
Q 047576 436 -------------------N--DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK----LEAFV 490 (602)
Q Consensus 436 -------------------~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~----~~~kL 490 (602)
. ......++...++.|..||+.|+.||| +.=|+||||||+|||+..+ |+|||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 1 122345788899999999999999999 7889999999999999887 89999
Q ss_pred ecccccccccCCCCC---ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 491 ADFGTARLLHADSSN---QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 491 ~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
+|||+++.+...-.. ...++-|..|+|||.+.+.. |+.+.||||.||+..||+|-++-|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999987653221 22356789999999999876 88999999999999999999888864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=208.70 Aligned_cols=183 Identities=28% Similarity=0.362 Sum_probs=146.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+....+-||-|+||.||.+..+ +|+.||+|++..-... ....+++.+|+.++-+.+|.++.+.++--
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 345677788999999999999875 8999999998654332 33456677889888888777665544311
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++..-++-+..||++||.||| +.+|.||||||.|.|++.+...||||||+++..+
T Consensus 131 EiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence 11334666677788999999999999 8999999999999999999999999999999876
Q ss_pred CCC-CCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCcc
Q 047576 501 ADS-SNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHST 554 (602)
Q Consensus 501 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~ 554 (602)
.+. .+.+..+-|.+|+|||.+.+.. |+.+.||||.||++.|++-.+.-|....+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 543 3445567789999999998865 89999999999999999999998875443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=232.25 Aligned_cols=216 Identities=25% Similarity=0.386 Sum_probs=172.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
++.|...+.+|.|.+|.||+++. ++++.+|+|+.......+ ++...|..++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 56788999999999999999985 578899999886554331 2333344443
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
|++.+|++.+++.... +.++.|..+..|.+++++|+.+|| ...++|||||-.|||++.++.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence 8888999999888765 677999999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCc-----CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMV-----MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
+...+..........||+.|||||++...+ |+.++|+||+|++..||--|.+|+..-.+++.-. .-
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---------~I 240 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LI 240 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---------cC
Confidence 988876555556678999999999987543 6788999999999999999999986443332211 11
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNP 600 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP 600 (602)
++=|+|.........+++-+++..|+.+|-
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~ 270 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDY 270 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhcc
Confidence 233344444446677889999999998874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=228.54 Aligned_cols=248 Identities=29% Similarity=0.308 Sum_probs=168.7
Q ss_pred CcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCc
Q 047576 117 NGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLP 189 (602)
Q Consensus 117 ~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p 189 (602)
+++++++++.-|-+|..|+..++..|....||...+...+|+.|+|.+|.|+. .++.|+.||||.|.|+.+.-
T Consensus 87 nNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~ 166 (873)
T KOG4194|consen 87 NNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPK 166 (873)
T ss_pred ccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccC
Confidence 45777777777777777776666888888999888888889999999998873 25556666666666665555
Q ss_pred hhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCC-------------
Q 047576 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDI------------- 255 (602)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l------------- 255 (602)
+.|..=.++++|+|++|+|+...-..|.++.+|.+|.|++|+++.+|. .|.+|+.|+.|+|..|+|
T Consensus 167 ~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~S 246 (873)
T KOG4194|consen 167 PSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPS 246 (873)
T ss_pred CCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchh
Confidence 555555556666666666655555555556666666666666666543 344455555555555554
Q ss_pred -----------CCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCC
Q 047576 256 -----------IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324 (602)
Q Consensus 256 -----------~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 324 (602)
+..-...|..+.++++|+|+.|+++..-..++.+++.|+.|+||+|.|....++.+.-.++|++|+|++
T Consensus 247 l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~ 326 (873)
T KOG4194|consen 247 LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSS 326 (873)
T ss_pred hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccc
Confidence 444444555666777777777777766666777778888888888887777777777777888888888
Q ss_pred CCCCCCCCcccccccccccccccCCcCCCccCCCCCcCCC
Q 047576 325 NNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364 (602)
Q Consensus 325 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 364 (602)
|+|+...+++|..+..|+.|+|++|.++-.-...+..+++
T Consensus 327 N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lss 366 (873)
T KOG4194|consen 327 NRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSS 366 (873)
T ss_pred cccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhh
Confidence 8888777777888888888888888776554444443333
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-25 Score=204.51 Aligned_cols=180 Identities=22% Similarity=0.335 Sum_probs=138.9
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|.....+|+|.||+||+|+.+ .|+.||+|+.--.... ..+-....+|+.+++.++|.+..++++-.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 35666778999999999999875 5777888865322111 11223345688888888777766654311
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
....+++..++.++++++..||.|+| +..|+|||+||+|+||+.++.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 01244788999999999999999999 8899999999999999999999999999997
Q ss_pred cccCCCC----CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 498 LLHADSS----NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 498 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....... ..+..+-|..|++||.+.+. .++++.|||+.||+|.||.||.+-+.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 6643221 12233558999999998875 5899999999999999999999988653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=227.27 Aligned_cols=211 Identities=26% Similarity=0.405 Sum_probs=159.7
Q ss_pred ccCcccccccccccceeeec-CCCc----EEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGR----VFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
......||+|+||+||+|.+ +.|+ .||+|++...... ..-+++.+|+-+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHH
Confidence 34456799999999999964 4443 6899988654432 2234555565544
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++|++|.|.++++.+ +..+-....+.|..|||+|+.||| .+.++||||-++|||+..-..+|+.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 777888888888764 334667788899999999999999 88999999999999999999999999999999877
Q ss_pred CCCCccccc--cccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhcc--CCCCC
Q 047576 502 DSSNQTLLA--GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPP 576 (602)
Q Consensus 502 ~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~--~l~~~ 576 (602)
+........ -.+.|||-|.+....++.++|||||||++||++| |..|++.... . .+.+.+.. +++.|
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----~---eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----E---EIPDLLEKGERLSQP 922 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----H---HhhHHHhccccCCCC
Confidence 655433332 3567999999999999999999999999999999 9999985421 1 12222222 24322
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
. -+...+..++.+||..|++
T Consensus 923 p-----iCtiDVy~~mvkCwmid~~ 942 (1177)
T KOG1025|consen 923 P-----ICTIDVYMVMVKCWMIDAD 942 (1177)
T ss_pred C-----CccHHHHHHHHHHhccCcc
Confidence 1 1555588899999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=226.95 Aligned_cols=181 Identities=20% Similarity=0.232 Sum_probs=129.0
Q ss_pred CccccCcccccccccccceeeec-----------------CCCcEEeeeccCCchhHHH-HH----------hhhhHhHH
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-----------------PNGRVFALKKLNSPETEEL-AF----------IRSFRNEA 419 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~-~~----------~~~~~~E~ 419 (602)
.++|+..+.||+|+||.||+|.. .+++.||||++........ .+ .+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999953 2457899999864322100 00 00011111
Q ss_pred H--------------------------------------HHHhhhcCcccccccccc---------------------ch
Q 047576 420 Q--------------------------------------VLSQMERGSLFRILHNDA---------------------EA 440 (602)
Q Consensus 420 ~--------------------------------------il~~l~~gsL~~~l~~~~---------------------~~ 440 (602)
. ++||+++++|.++++... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 1 236677788877775321 01
Q ss_pred hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC-cccccccccccccc
Q 047576 441 VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-QTLLAGSYGYIAPE 519 (602)
Q Consensus 441 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE 519 (602)
..++|..+..++.|++.||.|+| +.+|+||||||+||+++.++.+||+|||++......... .....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23577889999999999999999 789999999999999999999999999999765432211 11123478999999
Q ss_pred ccccCcC----------------------CccchhHHHHHHHHHHHcCCC-CCCC
Q 047576 520 LAYTMVM----------------------TEKYDVYSFGVVTLEVLMGKH-PRDL 551 (602)
Q Consensus 520 ~~~~~~~----------------------~~~~DvwSlGvil~elltG~~-Pf~~ 551 (602)
.+..... ..+.||||+||++|+|++|.. ||..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 8754321 124699999999999999986 7753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=211.89 Aligned_cols=238 Identities=19% Similarity=0.268 Sum_probs=171.4
Q ss_pred cCCcCCCccCCCCCc-CCCCCC-CccccCcccccccccccceeee------cCCCcEEeeeccCCchhHHHHHhhhhHhH
Q 047576 347 SGNKLSGRVPYSNKH-LSSMPT-PRKIDSKYCIGTGAYGSVYKAQ------LPNGRVFALKKLNSPETEELAFIRSFRNE 418 (602)
Q Consensus 347 ~~N~l~g~~p~~~~~-l~~lp~-t~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~~~~E 418 (602)
+.|.+-..-|.++.. ..++.. ..+++...++-+|.||.||+|. +.+.+.|-+|.++..... -++..+..|
T Consensus 260 ~~ns~~~~~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~e 337 (563)
T KOG1024|consen 260 SPNSEYEHEPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQE 337 (563)
T ss_pred CCCccccCChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHH
Confidence 566665555555422 233321 3457888889999999999994 345667888888655443 234566677
Q ss_pred HHHHH--------------------------hhhcCcccccccc-----ccchhhhcHHHHHHHHHHHHHHHHHhhhcCC
Q 047576 419 AQVLS--------------------------QMERGSLFRILHN-----DAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467 (602)
Q Consensus 419 ~~il~--------------------------~l~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 467 (602)
...+- ++.-|+|..++.. ....+.++-.+.+.++.|++.|++||| +
T Consensus 338 s~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~ 414 (563)
T KOG1024|consen 338 SMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---N 414 (563)
T ss_pred HHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---h
Confidence 66653 3334555555542 122344677788899999999999999 8
Q ss_pred CCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-
Q 047576 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM- 544 (602)
Q Consensus 468 ~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt- 544 (602)
++|||.||-++|.+||+..++||+|=.+++.+-+...+ -........||+||.+....++.++|||||||+||||+|
T Consensus 415 ~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 415 HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 89999999999999999999999999998866443222 111234578999999999999999999999999999998
Q ss_pred CCCCCCCCcccccCCCcccchhhhhc--cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 545 GKHPRDLHSTLSSSYDPKIMLIDVLD--QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 545 G~~Pf~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
|+.|+...++.. +..++. .++..|. .+++++-.++..||+.+|+|
T Consensus 495 g~~PyaeIDPfE--------m~~ylkdGyRlaQP~-----NCPDeLf~vMacCWallpee 541 (563)
T KOG1024|consen 495 GKLPYAEIDPFE--------MEHYLKDGYRLAQPF-----NCPDELFTVMACCWALLPEE 541 (563)
T ss_pred CCCCccccCHHH--------HHHHHhccceecCCC-----CCcHHHHHHHHHHHhcCccc
Confidence 999998655431 111221 2344443 37788999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=202.46 Aligned_cols=205 Identities=26% Similarity=0.396 Sum_probs=148.3
Q ss_pred ccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------------ccccc
Q 047576 381 AYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-------------------------LFRIL 434 (602)
Q Consensus 381 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-------------------------L~~~l 434 (602)
+||.||+|+.. +|+.+|+|++........ .+.+.+|++.+..+.+.+ |.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999875 589999999876544321 466777877765544443 43333
Q ss_pred ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccccccc
Q 047576 435 HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG 514 (602)
Q Consensus 435 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~ 514 (602)
... ..+++..+..++.++++++.||| ..+++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 79 ~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKR---GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred Hhc---cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 221 11788899999999999999999 7899999999999999999999999999998765432 2233567889
Q ss_pred cccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhh
Q 047576 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFA 594 (602)
Q Consensus 515 y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~ 594 (602)
|+|||...+..++.++||||+|+++|++++|..||+... ......+.+........... ......+.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFPPPE-WKISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCcccc-ccCCHHHHHHHHH
Confidence 999999988888999999999999999999999997421 11111222221111110000 0022458899999
Q ss_pred ccCcCCCC
Q 047576 595 CLQSNPKS 602 (602)
Q Consensus 595 Cl~~dP~e 602 (602)
|+..||++
T Consensus 224 ~l~~~p~~ 231 (244)
T smart00220 224 LLVKDPEK 231 (244)
T ss_pred HccCCchh
Confidence 99999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-25 Score=228.26 Aligned_cols=203 Identities=32% Similarity=0.467 Sum_probs=116.7
Q ss_pred cCCccCCCCCCCCEEECcCCcCccc------CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCc
Q 047576 146 SIPSEISALSKLQLLDLSSNRLRGR------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRL 219 (602)
Q Consensus 146 ~ip~~l~~L~~L~~L~Ls~N~i~~~------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 219 (602)
-||+.|..|..|+.||||.|++... -+++-.|+||+|+|..+..+.|-+|+.|-+||||+|++. .+|+.+..|
T Consensus 94 GiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL 172 (1255)
T KOG0444|consen 94 GIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRL 172 (1255)
T ss_pred CCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHH
Confidence 3566666666666666666666532 345556666666666555555666666666666666665 455556666
Q ss_pred CCCceeecccccCCCC-cccccCCCCCcEEEccCCCCC-CCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEe
Q 047576 220 TSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDII-GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297 (602)
Q Consensus 220 ~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 297 (602)
.+|++|.|++|.+.-. -..+..+++|+.|.+++.+=+ ..+|.++..+.+|..+|+|.|++. .+|..+-++.+|+.|+
T Consensus 173 ~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLN 251 (1255)
T KOG0444|consen 173 SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLN 251 (1255)
T ss_pred hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheec
Confidence 6666666666654321 011222333444444332211 245666666666666677766665 5666666666666666
Q ss_pred ccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCC
Q 047576 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
||+|+|+. +........+|+.|+||+|+++ .+|+.++++++|+.|++.+|+++
T Consensus 252 LS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 252 LSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred cCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 66666652 3334444555666666666665 45555666666666665555553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=191.80 Aligned_cols=173 Identities=19% Similarity=0.327 Sum_probs=140.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-Cccccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-GSLFRILHNDAE------ 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-gsL~~~l~~~~~------ 439 (602)
.++|+..+.+|+|.|++||.|.. .+.+.++||++++.. .+.+.+|+.|++.+.+ +++..++.-..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 56788999999999999999974 578899999997543 3567899999999984 455544432111
Q ss_pred ---------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-CcceeecccccccccCCC
Q 047576 440 ---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADS 503 (602)
Q Consensus 440 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a~~~~~~~ 503 (602)
...++-..++.++.+++.||.||| ++||+|||+||.|||||.. -..+|+|+|+|.+..+..
T Consensus 111 aLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 112555677889999999999999 9999999999999999965 468999999999987654
Q ss_pred CCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
. ....+.+..|.-||.+..-+ ++..-|+|||||++..|+..+.||=
T Consensus 188 e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 188 E-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred e-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 3 33346778899999987654 8889999999999999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=211.97 Aligned_cols=175 Identities=23% Similarity=0.291 Sum_probs=141.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
..|.+....|+|-|++|.+|... .|+.||||++...+. +.+.-.+|++||+.+.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 35677777899999999999864 588999999987664 3456667888874432
Q ss_pred ---------cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccccc
Q 047576 427 ---------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTA 496 (602)
Q Consensus 427 ---------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a 496 (602)
+-+|.++|...+....|....+..|+.|+.-||..|. ..+|+|.||||+|||+++. ..+||||||.|
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 2344455555555555788889999999999999999 7899999999999999865 56899999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
........ +.+.-+..|.|||.+.|.+|+...|+||.||+|||+.||+.-|.+.
T Consensus 585 ~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 585 SFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 87754332 2345667899999999999999999999999999999999988653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=198.81 Aligned_cols=180 Identities=26% Similarity=0.426 Sum_probs=137.7
Q ss_pred CCCCCCCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHh---------HHH-----------
Q 047576 362 LSSMPTPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRN---------EAQ----------- 420 (602)
Q Consensus 362 l~~lp~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~---------E~~----------- 420 (602)
+..+...+.|++...+|+|.||.+-+++++ ..+.+|+|.+.+.......+.++|.- -+.
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 334455678999999999999999999875 67889999998776654333333310 011
Q ss_pred ---HHHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee-C-CCCcceeecccc
Q 047576 421 ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL-N-SKLEAFVADFGT 495 (602)
Q Consensus 421 ---il~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-d-~~~~~kL~DFG~ 495 (602)
+.||.+.|+|.+-+...+ +.+...++++.|++.|++|+| ++++||||||.+|||| + +..++||||||.
T Consensus 97 YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccc
Confidence 117888899888776533 677888999999999999999 9999999999999999 3 345899999999
Q ss_pred cccccCCCCCccccccccccccccccccC-----cCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTM-----VMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
....+.- .....-+..|.+||..... ...+.+|+|.||+++|..+||+.||..
T Consensus 170 t~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 170 TRKVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ccccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 8754321 1112345678999976533 256789999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=214.77 Aligned_cols=176 Identities=21% Similarity=0.332 Sum_probs=141.1
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHh-----hhhHhHHHHHHhhh---cCccccccccc---
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFI-----RSFRNEAQVLSQME---RGSLFRILHND--- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~-----~~~~~E~~il~~l~---~gsL~~~l~~~--- 437 (602)
+|.....+|+|+||.|+.|.++ +...|+||.+.+...-...++ -....|++||..++ |.++.+++.-.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4777788999999999999876 456899998876643221122 23456888886665 66665554321
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.+++-|++||+-|+++|| +.+|||||||-+||.+|.+|-+||+|||.+.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchh
Confidence 01334889999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
....+ +...++||.+|.|||++.+.+| +...|||++|+++|.++....||.
T Consensus 719 ~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 76543 3345789999999999999886 456899999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-23 Score=221.22 Aligned_cols=171 Identities=30% Similarity=0.457 Sum_probs=129.3
Q ss_pred ccCccccccccccc-ceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccc-----------------
Q 047576 371 IDSKYCIGTGAYGS-VYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLF----------------- 431 (602)
Q Consensus 371 f~~~~~LG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~----------------- 431 (602)
|...+++|.|+.|+ ||+|.+ +|+.||||++-... ....++|+..+..- +|+++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 56678899999885 699999 68999999985443 33456788877322 334433
Q ss_pred -------cccccccchhhhcH-HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---C--Ccceeeccccccc
Q 047576 432 -------RILHNDAEAVELDW-AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---K--LEAFVADFGTARL 498 (602)
Q Consensus 432 -------~~l~~~~~~~~l~~-~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~--~~~kL~DFG~a~~ 498 (602)
++++.......... ...+.+..|++.||++|| +.+||||||||.||||+. + .+++|+|||+++.
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 33333111111111 234667899999999999 889999999999999965 3 5789999999998
Q ss_pred ccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcC-CCCCCC
Q 047576 499 LHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMG-KHPRDL 551 (602)
Q Consensus 499 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~ 551 (602)
+..+... .....||.+|+|||++....-+.++||||+||++|+.++| .+||..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 8765433 3345799999999999998888899999999999999996 999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=188.13 Aligned_cols=151 Identities=23% Similarity=0.216 Sum_probs=111.1
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|.++++.. ...++|.++..|+.|+++||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence 5677777642 335899999999999999999999 444 999999999999999 99998764322
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-C---CChhhHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-P---VDRKVIQ 583 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~---~~~~~~~ 583 (602)
..|++.|+|||++.+..++.++|||||||++|||+||+.||...... ...+..++...... + .......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRDRSNLESVS 136 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccccccHHHHH
Confidence 25889999999999999999999999999999999999999643221 11112222111111 0 0111111
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
+...+.+++.+|++.||++
T Consensus 137 ~~~~~~~~i~~cl~~~p~~ 155 (176)
T smart00750 137 AARSFADFMRVCASRLPQR 155 (176)
T ss_pred hhhhHHHHHHHHHhccccc
Confidence 1125899999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=189.73 Aligned_cols=173 Identities=32% Similarity=0.466 Sum_probs=136.9
Q ss_pred ccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc--------------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-------------------- 429 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-------------------- 429 (602)
|+....+|.|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+..+.+.+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 4566789999999999998764 889999998765433 23456777887775554444
Q ss_pred -----cccccccccchhh-hcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 430 -----LFRILHNDAEAVE-LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 430 -----L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|.+++... .. +++.....++.+++.++.++| ..+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 79 CEGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 33333321 12 788889999999999999999 7799999999999999999999999999998775432
Q ss_pred -CCcccccccccccccccc-ccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 504 -SNQTLLAGSYGYIAPELA-YTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.......++..|++||.. ....++.++|+|+||+++++|++|+.||+.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112234577889999998 666678899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-23 Score=217.47 Aligned_cols=229 Identities=28% Similarity=0.419 Sum_probs=178.5
Q ss_pred cccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCC-CCCc
Q 047576 118 GRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLG-GLLP 189 (602)
Q Consensus 118 ~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~-~~~p 189 (602)
+.|..+.-.-|-+|+.|-.+++++|-...+|+.+..|.+|++|+||+|.+. -.+++|+.|.+++.+-+ ..+|
T Consensus 136 N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 136 NNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred CccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCC
Confidence 345555556667777777777788899999999999999999999999875 13556777777776543 4577
Q ss_pred hhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCC
Q 047576 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269 (602)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 269 (602)
.++..|.+|..+|||.|++. .+|..+.++++|+.|+||+|+++.+.-..+...+|+.|+||.|+++ .+|..+..++.|
T Consensus 216 tsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL 293 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL 293 (1255)
T ss_pred CchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence 88888888888888888876 6788888888888888888888876655666677888888888887 678888888888
Q ss_pred ccccCCCCcCCC-CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccC
Q 047576 270 SYLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348 (602)
Q Consensus 270 ~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 348 (602)
+.|.+.+|+++- -+|+.++.+.+|+.+..++|.+. .+|+.++.+.+|+.|.|++|++. .+|..+.-++.|+.||+..
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 888888887653 36777888888888888888876 67888888888888888888877 6788888888888888887
Q ss_pred Cc
Q 047576 349 NK 350 (602)
Q Consensus 349 N~ 350 (602)
|+
T Consensus 372 Np 373 (1255)
T KOG0444|consen 372 NP 373 (1255)
T ss_pred Cc
Confidence 75
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=224.94 Aligned_cols=165 Identities=19% Similarity=0.243 Sum_probs=115.8
Q ss_pred HHHHHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC--------------
Q 047576 419 AQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-------------- 484 (602)
Q Consensus 419 ~~il~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-------------- 484 (602)
+.++|++ +++|.++++.. ...+++.+++.|+.||++||+||| +++|+||||||+|||++.
T Consensus 56 ~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 56 VRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred hhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCc
Confidence 3445655 56898888642 345899999999999999999999 889999999999999954
Q ss_pred -----CCcceeecccccccccCCC----------------CCccccccccccccccccccCcCCccchhHHHHHHHHHHH
Q 047576 485 -----KLEAFVADFGTARLLHADS----------------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543 (602)
Q Consensus 485 -----~~~~kL~DFG~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 543 (602)
++.+|++|||+++...... .......||+.|||||++.+..++.++|||||||++|||+
T Consensus 130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl 209 (793)
T PLN00181 130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF 209 (793)
T ss_pred ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence 4556777777765421100 0001135788899999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 544 MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 544 tG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+|..|+..... .+..+....+++.. ........+++..||++||++
T Consensus 210 ~~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 210 CPVSSREEKSR---------TMSSLRHRVLPPQI----LLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred hCCCchhhHHH---------HHHHHHHhhcChhh----hhcCHHHHHHHHHhCCCChhh
Confidence 99998753211 11111111122111 112233567888999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=179.69 Aligned_cols=159 Identities=30% Similarity=0.558 Sum_probs=125.6
Q ss_pred ccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-------------------------c
Q 047576 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-------------------------L 430 (602)
Q Consensus 377 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-------------------------L 430 (602)
||+|++|.||+++..+ ++.+++|++....... ..+.+.+|+++++.+.+.. +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998754 8999999997665431 3456778888775555433 3
Q ss_pred ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecccccccccCCCCCcccc
Q 047576 431 FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLLHADSSNQTLL 509 (602)
Q Consensus 431 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~a~~~~~~~~~~~~~ 509 (602)
.+++.... ..+++..+..++.+++++++++| +.+++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 33332210 24788899999999999999999 789999999999999999 8999999999998765432122334
Q ss_pred ccccccccccccccC-cCCccchhHHHHHHHHHH
Q 047576 510 AGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEV 542 (602)
Q Consensus 510 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~el 542 (602)
.+...|++||..... ..+.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 577899999998877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=188.06 Aligned_cols=109 Identities=24% Similarity=0.390 Sum_probs=85.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc--------cccccccc-
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS--------LFRILHND- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs--------L~~~l~~~- 437 (602)
..+|-+.+.||-|.|++||++.. .+.+.||+|+.+.... +.+....|++++..+..++ +.++++..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 46788899999999999999976 4678999999876543 4566778999997776555 22222211
Q ss_pred --------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee
Q 047576 438 --------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482 (602)
Q Consensus 438 --------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 482 (602)
...+-++...+++|++||+.||.|||+ +.+|||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 112337889999999999999999998 4599999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=182.84 Aligned_cols=177 Identities=27% Similarity=0.326 Sum_probs=133.8
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE-------- 439 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~-------- 439 (602)
.+|....-+|.|.- .|-.|-. -.++.||+|++...... ....++..+|..++..+.|.++.+.+.....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 34555556677766 4444432 25788999988766332 2223455667777766666655554432110
Q ss_pred -----------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 440 -----------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 440 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.-.++-.+...|..|++.|++|+| +.+|+||||||+||++..+..+||.|||+|+....+
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 112455677889999999999999 899999999999999999999999999999876554
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
...+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 345557889999999999998999999999999999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-21 Score=199.09 Aligned_cols=172 Identities=27% Similarity=0.417 Sum_probs=140.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|.....+|.|.||.||+|+.. .+...|+|+++...... ++-.++|+.++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457999999999999999999874 68899999987554331 23334444433
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+.+|++.+..+. ..++++.++....++.++|++|+| +.+-+|||||-.||++++.|.+|+.|||.+..+..
T Consensus 91 MEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence 67777888877765 345888899999999999999999 88999999999999999999999999999887754
Q ss_pred CCCCcccccccccccccccc---ccCcCCccchhHHHHHHHHHHHcCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELA---YTMVMTEKYDVYSFGVVTLEVLMGKHP 548 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~P 548 (602)
.-.......||++|||||+. +.+.|...+|||+.|++..|+-.-+.|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 43344557899999999975 356689999999999999999888887
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=187.70 Aligned_cols=169 Identities=29% Similarity=0.410 Sum_probs=129.3
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------- 424 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~------------------- 424 (602)
...|...+.+|+|.|++||++... ..+.||+|.+...... .+..+|++++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 356888999999999999999743 4678999998765433 446677776633
Q ss_pred -------hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccccc
Q 047576 425 -------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTA 496 (602)
Q Consensus 425 -------l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a 496 (602)
++|....+++. .++..++..++..+..||+++| ..|||||||||+|++.+.. ++-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence 33333333332 2678899999999999999999 8999999999999999865 45689999999
Q ss_pred ccccCCC--------------C----------------C--------------ccccccccccccccccccCc-CCccch
Q 047576 497 RLLHADS--------------S----------------N--------------QTLLAGSYGYIAPELAYTMV-MTEKYD 531 (602)
Q Consensus 497 ~~~~~~~--------------~----------------~--------------~~~~~gt~~y~aPE~~~~~~-~~~~~D 531 (602)
...+... . . .....||++|+|||++...+ .++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 0 0 00135999999999987654 788999
Q ss_pred hHHHHHHHHHHHcCCCCCC
Q 047576 532 VYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 532 vwSlGvil~elltG~~Pf~ 550 (602)
|||.||+++-+++++.||-
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999983
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-22 Score=200.45 Aligned_cols=202 Identities=37% Similarity=0.521 Sum_probs=123.4
Q ss_pred CccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCccc
Q 047576 142 GFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215 (602)
Q Consensus 142 ~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 215 (602)
+-...+|++++.+.+|..|++++|.+. +.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++....|..
T Consensus 101 n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~ 179 (565)
T KOG0472|consen 101 NKLSELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENH 179 (565)
T ss_pred chHhhccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHH
Confidence 344455555555555556665555554 23555666666666665 44555566666666666666665444433
Q ss_pred ccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhh-CCCCCC
Q 047576 216 LSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT-RLTQLF 294 (602)
Q Consensus 216 l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~ 294 (602)
+. ++.|++||...|-++.+|+.++.+.+|.-|+|.+|++. ..| .|..++.|.+|+++.|++. .+|.+.+ .++++.
T Consensus 180 i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~ 255 (565)
T KOG0472|consen 180 IA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLL 255 (565)
T ss_pred HH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccce
Confidence 33 66666666666666666666666666666666666665 444 5666666666666666665 4444443 566666
Q ss_pred EEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcC
Q 047576 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351 (602)
Q Consensus 295 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 351 (602)
.|||.+|++. ..|+.+.-+.+|+.||+|+|.|+ ..|.+++++ .|+.|.+.+|++
T Consensus 256 vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 256 VLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred eeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCch
Confidence 6666666666 45666666666666666666666 345566666 666666666665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=203.31 Aligned_cols=206 Identities=30% Similarity=0.346 Sum_probs=126.2
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecC
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 205 (602)
++|++|++. +|....+|.. .++|+.|+|++|.|+. .+++|+.|+|++|+|+.. |. .+++|+.|+|++
T Consensus 242 ~~Lk~LdLs---~N~LtsLP~l---p~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~ 311 (788)
T PRK15387 242 PELRTLEVS---GNQLTSLPVL---PPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSD 311 (788)
T ss_pred CCCcEEEec---CCccCcccCc---ccccceeeccCCchhhhhhchhhcCEEECcCCccccc-cc---cccccceeECCC
Confidence 455555553 2333345532 2455556666655542 234555666666666532 32 235677777777
Q ss_pred CCCCCCCcccccC-----------------cCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCC
Q 047576 206 NSLIGPIPLTLSR-----------------LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSD 268 (602)
Q Consensus 206 N~l~~~~p~~l~~-----------------l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 268 (602)
|+|++ +|..... ..+|+.|+|++|+|+++|... ++|+.|++++|+|++ +|.. .++
T Consensus 312 N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 312 NQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred Ccccc-CCCCcccccccccccCccccccccccccceEecCCCccCCCCCCC---cccceehhhcccccc-Cccc---ccc
Confidence 77664 2321110 124555555555555555421 345555566665553 4432 246
Q ss_pred CccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccC
Q 047576 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348 (602)
Q Consensus 269 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 348 (602)
|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 7778888888874 4432 3568888888888874 5643 346788999999998 6888999999999999999
Q ss_pred CcCCCccCCCCCc
Q 047576 349 NKLSGRVPYSNKH 361 (602)
Q Consensus 349 N~l~g~~p~~~~~ 361 (602)
|+|+|.+|..+..
T Consensus 455 N~Ls~~~~~~L~~ 467 (788)
T PRK15387 455 NPLSERTLQALRE 467 (788)
T ss_pred CCCCchHHHHHHH
Confidence 9999988876533
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6e-22 Score=196.86 Aligned_cols=222 Identities=33% Similarity=0.505 Sum_probs=197.8
Q ss_pred CCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEe
Q 047576 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 203 (602)
+|..|..+....+...++|++++.+..++.|+.+.|+++ +.+.+|+.|+.++|.+. .+|+.++.+..|+.|+.
T Consensus 66 nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 344444444467778889999999999999999999997 56889999999999999 66788999999999999
Q ss_pred cCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCC
Q 047576 204 GDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283 (602)
Q Consensus 204 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 283 (602)
.+|+++ ..|+.++++.+|..|++.+|.+..+|+..-+++.|+.||...|-+. .+|..++.+.+|.-|+|..|.+. ..
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 999998 6788899999999999999999998887777999999999999886 88999999999999999999998 56
Q ss_pred chhhhCCCCCCEEeccCCCCCCCCCccc-CCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 284 PNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 284 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
| +|.++..|.+|+++.|+|. .+|... ..++.|..|||..|+++ ..|..++.+.+|.+||+|+|.+++- |.+.
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sL 294 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSL 294 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-Cccc
Confidence 6 8999999999999999998 566655 58999999999999999 7899999999999999999999884 4444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=195.27 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=156.1
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEec
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 204 (602)
++++.|++. +|....+|..+. ++|++|+|++|+|++ ...+|+.|+|++|+++ .+|..+. ++|+.|+|+
T Consensus 199 ~~L~~L~Ls---~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILD---NNELKSLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred cCCcEEEec---CCCCCcCChhhc--cCCCEEECCCCccccCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 356666554 445557887664 589999999999874 2457999999999998 5676664 589999999
Q ss_pred CCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCc
Q 047576 205 DNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284 (602)
Q Consensus 205 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 284 (602)
+|+|+ .+|..+. ++|+.|++++|+|+++|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++ +|
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP 341 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LP 341 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CC
Confidence 99998 4676664 589999999999999887654 578899999999985 55543 3688999999999985 66
Q ss_pred hhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 285 NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
..+. ++|+.|+|++|+|+ .+|..+ .++|+.|+|++|+|+ .+|..+. ..|+.|++++|+++ .+|..+
T Consensus 342 ~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl 407 (754)
T PRK15370 342 ASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESL 407 (754)
T ss_pred hhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhH
Confidence 6553 68999999999988 467655 368999999999998 4565553 36888999999987 455443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=166.37 Aligned_cols=196 Identities=20% Similarity=0.304 Sum_probs=147.3
Q ss_pred CCccccCcccccccccccceeee-cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-----------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG----------------- 428 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g----------------- 428 (602)
...+|...+.||.|+||.+|.|. ..+|..||||+-..... ..++..|..+++.+.+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 35679999999999999999997 46899999997654432 23455677777555443
Q ss_pred --------ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC---Ccceeecccccc
Q 047576 429 --------SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK---LEAFVADFGTAR 497 (602)
Q Consensus 429 --------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFG~a~ 497 (602)
+|.++..- ....++..+++..|-|++.-++|+| .++.|||||||+|+|..-+ ..+.++|||+|+
T Consensus 88 lVMdLLGPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeccCccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 33333322 2345888999999999999999999 8899999999999999543 467899999999
Q ss_pred cccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 498 LLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 498 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
.+.+..+ ......||..|.+-....+...+.+.|+-|+|.++.+.--|..||..... ....++.+.+.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka----~tk~QKyEkI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA----ATKKQKYEKISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch----hhHHHHHHHHHH
Confidence 7754221 23346799999998888888888999999999999999999999986432 222334445555
Q ss_pred cCCCCC
Q 047576 571 QRLPPP 576 (602)
Q Consensus 571 ~~l~~~ 576 (602)
..+..+
T Consensus 239 kK~s~~ 244 (341)
T KOG1163|consen 239 KKMSTP 244 (341)
T ss_pred hhcCCC
Confidence 555444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.3e-21 Score=168.61 Aligned_cols=179 Identities=28% Similarity=0.501 Sum_probs=151.7
Q ss_pred CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEcc
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVG 251 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~ 251 (602)
.+.+.|.||+|+++ .+|+.++.|.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++..+|.+|+.++.|+.|||.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcc
Confidence 44566777888887 66788999999999999999987 68889999999999999999999999999999999999999
Q ss_pred CCCCCC-CCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 252 NNDIIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 252 ~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
.|++.. .+|..|..++.|+.|+|+.|.|. .+|+.++++++|+.|.+..|.+- ..|..++.++.|++|++.+|+++ .
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-v 187 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-V 187 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-e
Confidence 999976 47888999999999999999997 78889999999999999999987 68999999999999999999998 5
Q ss_pred CCccccccccc---ccccccCCcCCCcc
Q 047576 331 IPGEITKLSRL---DYLNLSGNKLSGRV 355 (602)
Q Consensus 331 ~p~~~~~l~~L---~~L~l~~N~l~g~~ 355 (602)
+|..++++..+ +.+.+.+|++-..|
T Consensus 188 lppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 188 LPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred cChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 66666655322 33445566554433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=195.43 Aligned_cols=211 Identities=27% Similarity=0.418 Sum_probs=165.8
Q ss_pred cccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCccc----CCCcCEEECcCCcCCCCCchhhhCC
Q 047576 120 LSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR----LTNLNYMSLSRNMLGGLLPQEIGNL 195 (602)
Q Consensus 120 l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~~----l~~L~~L~L~~N~l~~~~p~~~~~l 195 (602)
++.+....+++|+.|.+. +|+ ...+|..+. ++|+.|+|++|++... .++|++|+|++|+|+. +|..+.
T Consensus 211 LtsLP~~l~~nL~~L~Ls--~N~-LtsLP~~l~--~~L~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L~~-LP~~l~-- 282 (754)
T PRK15370 211 LKSLPENLQGNIKTLYAN--SNQ-LTSIPATLP--DTIQEMELSINRITELPERLPSALQSLDLFHNKISC-LPENLP-- 282 (754)
T ss_pred CCcCChhhccCCCEEECC--CCc-cccCChhhh--ccccEEECcCCccCcCChhHhCCCCEEECcCCccCc-cccccC--
Confidence 333433445678888775 444 446787654 4799999999998832 3589999999999994 676654
Q ss_pred CCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCC
Q 047576 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275 (602)
Q Consensus 196 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 275 (602)
++|+.|+|++|+|++ +|..+. ++|+.|++++|+++.+|..+. ++|+.|++++|.+++ +|..+. ++|+.|+++
T Consensus 283 ~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls 354 (754)
T PRK15370 283 EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVS 354 (754)
T ss_pred CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECC
Confidence 589999999999985 565543 579999999999999987654 789999999999986 676553 799999999
Q ss_pred CCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCccc----ccccccccccccCCcC
Q 047576 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI----TKLSRLDYLNLSGNKL 351 (602)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~l~~N~l 351 (602)
+|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|++.+|++
T Consensus 355 ~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 355 KNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence 99998 4676653 689999999999994 666654 36999999999998 455544 4457889999999998
Q ss_pred CC
Q 047576 352 SG 353 (602)
Q Consensus 352 ~g 353 (602)
+.
T Consensus 428 s~ 429 (754)
T PRK15370 428 SE 429 (754)
T ss_pred cH
Confidence 74
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.6e-20 Score=182.75 Aligned_cols=203 Identities=26% Similarity=0.298 Sum_probs=117.4
Q ss_pred cCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcC-CcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCC
Q 047576 150 EISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSR-NMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTS 221 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 221 (602)
+|+.+++|+.||||+|+|+. .+++|..|-+.+ |+|+......|++|..|+.|.+.-|++.-.....|..|++
T Consensus 86 aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~ 165 (498)
T KOG4237|consen 86 AFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPS 165 (498)
T ss_pred hccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhh
Confidence 45555555555555555551 234443333333 5555555555555555555555555555545555555555
Q ss_pred CceeecccccCCCCcc-cccCCCCCcEEEccCCCC---------------------------------------------
Q 047576 222 LKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDI--------------------------------------------- 255 (602)
Q Consensus 222 L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l--------------------------------------------- 255 (602)
|..|.+..|.+..|+. .+..+.+++.+.+..|.+
T Consensus 166 l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~ 245 (498)
T KOG4237|consen 166 LSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFL 245 (498)
T ss_pred cchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhh
Confidence 5555555555555544 445555555555555542
Q ss_pred ----------------CCCCC-CccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCC
Q 047576 256 ----------------IGPIP-STLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318 (602)
Q Consensus 256 ----------------~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 318 (602)
.+..| ..|..+++|+.|+|++|.++++-+.+|..+..++.|.|..|+|...-...|.++..|+
T Consensus 246 c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~ 325 (498)
T KOG4237|consen 246 CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLK 325 (498)
T ss_pred hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccce
Confidence 11112 1245666666777777777666666666666667777777766654445566666666
Q ss_pred EEeCCCCCCCCCCCcccccccccccccccCCcCC
Q 047576 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 319 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
.|+|.+|+|+...|..|..+.+|..|+|-.|++.
T Consensus 326 tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 326 TLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred eeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 7777777776666666666666666666666654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=163.37 Aligned_cols=175 Identities=19% Similarity=0.261 Sum_probs=138.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------------------- 424 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~---------------------- 424 (602)
--.|.+...||+|+||+.+.|+. -+++.||||.-...... -+++.|...++.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 34799999999999999999984 47899999964433221 223334433322
Q ss_pred ---hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-----Ccceeeccccc
Q 047576 425 ---MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-----LEAFVADFGTA 496 (602)
Q Consensus 425 ---l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-----~~~kL~DFG~a 496 (602)
+=+++|.++.+.++ ..|+..++..+|.|++.-++|+| ++..|+|||||+|+||..- ..+.++|||+|
T Consensus 102 VidLLGPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhCcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 23577777776643 45889999999999999999999 8899999999999999543 45789999999
Q ss_pred ccccCCCCC-------ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADSSN-------QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+.+.+..+. .....||..||+-.-..+...+.+.|+-|+|-|+.+.+-|..||.+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 988654332 22357999999999999999999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-18 Score=177.04 Aligned_cols=176 Identities=24% Similarity=0.334 Sum_probs=133.7
Q ss_pred cccCcccccccccccceeeecCCC--cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNG--RVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
+|.....||+|+||.||.|..... ..+|+|........ ....+..|..++..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999986543 57888876543221 01145566666655541
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-----Ccceeecc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-----LEAFVADF 493 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-----~~~kL~DF 493 (602)
.+|.++..... ...++..++..|+.|++.+|+++| +.|++||||||+|+++... ..++|.||
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEeccCccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 22222221111 356899999999999999999999 8899999999999999765 35899999
Q ss_pred ccccccc--CCC----C---C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 494 GTARLLH--ADS----S---N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 494 G~a~~~~--~~~----~---~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
|+++... ... . . .....||..|+++....+...+.+.|+||++.++.|+..|..||...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 9998322 111 1 1 22356999999999999999999999999999999999999999653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-18 Score=176.80 Aligned_cols=154 Identities=18% Similarity=0.173 Sum_probs=111.5
Q ss_pred CccccCcccccccccccceeeecC--CCcEEeeeccCCchh--HHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKLNSPET--EELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~--~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
..+|.....||+|+||+||+|+.. +++.||||+...... ......+.+.+|++++..+.|.++...+...
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LV 96 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLV 96 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEE
Confidence 567999999999999999999764 578889998653311 1122356789999999888776654311111
Q ss_pred ---cchhhhcH---HHHHHHHHHHHHHHHHhhhcCCCCeEEeCC-CCCCeeeCCCCcceeecccccccccCCCCCc----
Q 047576 438 ---AEAVELDW---AKRVNIVKAMAHALAYLHHDCSPSVVHRDI-SSNNILLNSKLEAFVADFGTARLLHADSSNQ---- 506 (602)
Q Consensus 438 ---~~~~~l~~---~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFG~a~~~~~~~~~~---- 506 (602)
..+..+.. .....++.++++||+||| +++|+|||| ||+|||++.++.+||+|||+|+.........
T Consensus 97 mE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~ 173 (365)
T PRK09188 97 RGWTEGVPLHLARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAA 173 (365)
T ss_pred EEccCCCCHHHhCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhh
Confidence 01111211 112568899999999999 889999999 9999999999999999999999775433211
Q ss_pred ----cccccccccccccccccC
Q 047576 507 ----TLLAGSYGYIAPELAYTM 524 (602)
Q Consensus 507 ----~~~~gt~~y~aPE~~~~~ 524 (602)
+...+++.|+|||++...
T Consensus 174 ~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 174 YEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhccCccCCcccCChh
Confidence 234578889999987644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-19 Score=160.82 Aligned_cols=162 Identities=33% Similarity=0.576 Sum_probs=149.6
Q ss_pred hhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCc
Q 047576 191 EIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270 (602)
Q Consensus 191 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 270 (602)
.+.++++.+.|.|++|+++ .+|+.+..+.+|+.|++++|+++.+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 3456788899999999998 6777899999999999999999999999999999999999999998 7899999999999
Q ss_pred cccCCCCcCCC-CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 271 YLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 271 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
.|||.+|++.. ..|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.+++|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999975 57888999999999999999998 78999999999999999999998 78999999999999999999
Q ss_pred cCCCccC
Q 047576 350 KLSGRVP 356 (602)
Q Consensus 350 ~l~g~~p 356 (602)
+++-..|
T Consensus 184 rl~vlpp 190 (264)
T KOG0617|consen 184 RLTVLPP 190 (264)
T ss_pred eeeecCh
Confidence 9976444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-18 Score=171.22 Aligned_cols=212 Identities=23% Similarity=0.307 Sum_probs=131.8
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------Hhh---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------SQM--------- 425 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------~~l--------- 425 (602)
+.+.....||.|+++.||.+++. +|+.+|||++...........+++++|.... .++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 45667788999999999999875 5899999987644433223344444443211 010
Q ss_pred ------------h-----------------cCcccccccc---cc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 047576 426 ------------E-----------------RGSLFRILHN---DA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472 (602)
Q Consensus 426 ------------~-----------------~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 472 (602)
. .++|.+++.. .. ....+....++.+..|+++.++++| ..|++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 0 0111111110 00 0123455667788899999999999 789999
Q ss_pred eCCCCCCeeeCCCCcceeecccccccccCCCCCccccccccccccccccccC--------cCCccchhHHHHHHHHHHHc
Q 047576 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM--------VMTEKYDVYSFGVVTLEVLM 544 (602)
Q Consensus 473 ~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGvil~ellt 544 (602)
+||||+|++++.+|.++|+||+.....+.... ....+..|.|||..... .++.+.|.|++|+++|.|.+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765432111 12345779999976442 47889999999999999999
Q ss_pred CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 545 GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 545 G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
|+.||+...+.... .. .+.... +..+.+.+++..-+++||.+
T Consensus 246 ~~lPf~~~~~~~~~---~~------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 246 GRLPFGLSSPEADP---EW------------DFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp SS-STCCCGGGSTS---GG------------GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred ccCCCCCCCccccc---cc------------cchhcC-CcCHHHHHHHHHHccCCccc
Confidence 99999854321111 10 111111 34555888888999998863
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=181.20 Aligned_cols=185 Identities=31% Similarity=0.357 Sum_probs=105.4
Q ss_pred CCCCCEEECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccc
Q 047576 154 LSKLQLLDLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 230 (602)
+++|++|+|++|+|+. ..++|+.|+|++|.|+. +|.. .++|+.|+|++|+++. +|.. +++|+.|+|++|
T Consensus 241 p~~Lk~LdLs~N~LtsLP~lp~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N 312 (788)
T PRK15387 241 PPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 312 (788)
T ss_pred CCCCcEEEecCCccCcccCcccccceeeccCCchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCC
Confidence 3566666666666653 24566666666666653 2322 2456677777777763 4432 467888888888
Q ss_pred cCCCCcccccCC-----------------CCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCC
Q 047576 231 QLSGLPQEIGNL-----------------KNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL 293 (602)
Q Consensus 231 ~l~~ip~~~~~l-----------------~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 293 (602)
+++++|.....+ .+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|.. .++|
T Consensus 313 ~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L 384 (788)
T PRK15387 313 QLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGL 384 (788)
T ss_pred ccccCCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---cccc
Confidence 888876422110 134444444444442 2321 1234444455555442 3322 2356
Q ss_pred CEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcCC
Q 047576 294 FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLS 363 (602)
Q Consensus 294 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 363 (602)
+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+++ .+|..+..+.
T Consensus 385 ~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~ 445 (788)
T PRK15387 385 KELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLS 445 (788)
T ss_pred ceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhcc
Confidence 777777777764 4432 3567777888888774 5543 235677888888886 5676554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=164.69 Aligned_cols=177 Identities=28% Similarity=0.426 Sum_probs=138.9
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-cccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-LFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-L~~~l~~~------------ 437 (602)
|.....+|.|+||.||++... ..+++|.+.............+.+|+.++..+.+.. +..+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678899999999999886 778999887665543334667888888877666552 33322110
Q ss_pred ----------cch---hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCCC
Q 047576 438 ----------AEA---VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADS 503 (602)
Q Consensus 438 ----------~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~~ 503 (602)
... ..++......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 001 14777888999999999999999 78999999999999999988 79999999998654432
Q ss_pred C------Ccccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 S------NQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. ......|+..|+|||...+ ..++...|+||+|++++++++|..||...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2345679999999999987 57888999999999999999999997654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-18 Score=179.88 Aligned_cols=208 Identities=28% Similarity=0.324 Sum_probs=118.5
Q ss_pred CCccCCCCCCCCEEECcCCcCcc-------------cCCCcCEEECcCCcCCCCCchhhhCCCC---CCEEEecCCCCCC
Q 047576 147 IPSEISALSKLQLLDLSSNRLRG-------------RLTNLNYMSLSRNMLGGLLPQEIGNLKN---LIELDVGDNSLIG 210 (602)
Q Consensus 147 ip~~l~~L~~L~~L~Ls~N~i~~-------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~ 210 (602)
++..+...++|++|++++|.+.+ .+++|++|+|++|.+.+..+..+..+.+ |++|++++|++++
T Consensus 43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~ 122 (319)
T cd00116 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD 122 (319)
T ss_pred HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence 44455566666666666665551 2446666666666666555555555554 7777777766653
Q ss_pred ----CCcccccCc-CCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCC
Q 047576 211 ----PIPLTLSRL-TSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSC 276 (602)
Q Consensus 211 ----~~p~~l~~l-~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~ 276 (602)
.+...+..+ ++|+.|++++|.+++ ++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++
T Consensus 123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 202 (319)
T cd00116 123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202 (319)
T ss_pred HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence 222334445 666777777776663 233455556677777777766642 222334445677777777
Q ss_pred CcCCCCC----chhhhCCCCCCEEeccCCCCCCCCCcccC-----CCCCCCEEeCCCCCCCC----CCCccccccccccc
Q 047576 277 NQFNSSI----PNELTRLTQLFHLDLSSNKLSGKIPSQIA-----SMEDLTWLDLSNNNIKG----SIPGEITKLSRLDY 343 (602)
Q Consensus 277 N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~ 343 (602)
|.+++.. +..+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|++
T Consensus 203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 7665432 23344556677777777766642222221 13567777777776652 22334445566677
Q ss_pred ccccCCcCCCc
Q 047576 344 LNLSGNKLSGR 354 (602)
Q Consensus 344 L~l~~N~l~g~ 354 (602)
+++++|+++..
T Consensus 283 l~l~~N~l~~~ 293 (319)
T cd00116 283 LDLRGNKFGEE 293 (319)
T ss_pred EECCCCCCcHH
Confidence 77777766543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.2e-16 Score=186.50 Aligned_cols=200 Identities=28% Similarity=0.354 Sum_probs=102.4
Q ss_pred CccccCCccCCCCCCCCEEECcCCc-Cc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCccc
Q 047576 142 GFTGSIPSEISALSKLQLLDLSSNR-LR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215 (602)
Q Consensus 142 ~~~~~ip~~l~~L~~L~~L~Ls~N~-i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 215 (602)
+....+|..+..+++|+.|+|++|. +. +.+++|++|+|++|.....+|..++++++|+.|++++|...+.+|..
T Consensus 621 s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 621 SKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred ccccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 3344455555555666666665543 21 23455666666665544555666666666666666654433444443
Q ss_pred ccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCcc------------------------------C
Q 047576 216 LSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTL------------------------------G 264 (602)
Q Consensus 216 l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l------------------------------~ 264 (602)
+ ++++|+.|++++|...+ +|.. .++|+.|++++|.++ .+|..+ .
T Consensus 701 i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~ 775 (1153)
T PLN03210 701 I-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTM 775 (1153)
T ss_pred C-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhh
Confidence 3 34444444444442221 2221 123444444444433 222211 1
Q ss_pred CCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCC---------------------CCCEEeCC
Q 047576 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME---------------------DLTWLDLS 323 (602)
Q Consensus 265 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---------------------~L~~L~L~ 323 (602)
..++|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|..+ .++ +|+.|+|+
T Consensus 776 ~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls 854 (1153)
T PLN03210 776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLS 854 (1153)
T ss_pred ccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECC
Confidence 12356666666666666666667777777777776654333444433 333 45555555
Q ss_pred CCCCCCCCCcccccccccccccccC
Q 047576 324 NNNIKGSIPGEITKLSRLDYLNLSG 348 (602)
Q Consensus 324 ~N~l~~~~p~~~~~l~~L~~L~l~~ 348 (602)
+|.++ .+|..+..+++|+.|++++
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCC
Confidence 55555 4555666666666666666
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.8e-16 Score=185.29 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=152.1
Q ss_pred CccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCccc
Q 047576 142 GFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215 (602)
Q Consensus 142 ~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 215 (602)
+....+|..+ .+.+|+.|+|++|++. ..+++|++|+|++|.....+| .++.+++|++|+|++|.....+|..
T Consensus 599 ~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~s 676 (1153)
T PLN03210 599 YPLRCMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSS 676 (1153)
T ss_pred CCCCCCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchh
Confidence 3445556555 4577888888888775 247788888888776555555 4777888888888887766778888
Q ss_pred ccCcCCCceeecccc-cCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhh-------
Q 047576 216 LSRLTSLKILILAQN-QLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL------- 287 (602)
Q Consensus 216 l~~l~~L~~L~L~~N-~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~------- 287 (602)
++++++|+.|++++| .++.+|..+ ++++|+.|++++|...+.+|.. .++|++|++++|.++ .+|..+
T Consensus 677 i~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~ 751 (1153)
T PLN03210 677 IQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDE 751 (1153)
T ss_pred hhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccccccccccccc
Confidence 888888888888875 555577765 6788888888888766666643 357888888888876 344321
Q ss_pred -----------------------hCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccc
Q 047576 288 -----------------------TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344 (602)
Q Consensus 288 -----------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 344 (602)
...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|
T Consensus 752 L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L 830 (1153)
T PLN03210 752 LILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESL 830 (1153)
T ss_pred ccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEE
Confidence 112478889999998888899999999999999999986555777665 67778888
Q ss_pred cccCCcCCCccC
Q 047576 345 NLSGNKLSGRVP 356 (602)
Q Consensus 345 ~l~~N~l~g~~p 356 (602)
++++|..-..+|
T Consensus 831 ~Ls~c~~L~~~p 842 (1153)
T PLN03210 831 DLSGCSRLRTFP 842 (1153)
T ss_pred ECCCCCcccccc
Confidence 887765444444
|
syringae 6; Provisional |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-17 Score=177.92 Aligned_cols=175 Identities=23% Similarity=0.262 Sum_probs=123.0
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchhH-HHHHhhhhHhHHHHH------------------------Hh
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETE-ELAFIRSFRNEAQVL------------------------SQ 424 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il------------------------~~ 424 (602)
.+...+-||.+.|=+|.+|+.+.|. |+||++-+.+.. ......+...|++.. +|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778889999999999999998887 889988655421 111112222222211 22
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc--cCC
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL--HAD 502 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~--~~~ 502 (602)
.. .+|++.+.- +.-+...+.+.|+.|++.|+.-+| ..||+|||||.+||||+.=.-+.|+||..-+.. ..+
T Consensus 103 vk-hnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 22 245544432 223677888999999999999999 889999999999999999999999999876533 111
Q ss_pred CCC-ccc----cccccccccccccccC----------c-CCccchhHHHHHHHHHHHc-CCCCCCCC
Q 047576 503 SSN-QTL----LAGSYGYIAPELAYTM----------V-MTEKYDVYSFGVVTLEVLM-GKHPRDLH 552 (602)
Q Consensus 503 ~~~-~~~----~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-G~~Pf~~~ 552 (602)
... .+. ...-.+|.|||.+... . .+++-||||+||++.|+++ |++||+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 111 111 1233589999976541 1 4677899999999999998 68889754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.7e-17 Score=154.50 Aligned_cols=123 Identities=20% Similarity=0.260 Sum_probs=86.5
Q ss_pred cccccccccccceeeecCCCcEEeeeccCCchhHHH---HH---hhh-----------------hHhHHHHHHhhhcCcc
Q 047576 374 KYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEEL---AF---IRS-----------------FRNEAQVLSQMERGSL 430 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~---~~---~~~-----------------~~~E~~il~~l~~gsL 430 (602)
...||+|++|.||+|..++|+.||||+++....... .. ..+ ...|..++..+.+..+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988999999999875421100 00 111 2347776644432111
Q ss_pred --------------ccccccc------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCccee
Q 047576 431 --------------FRILHND------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 431 --------------~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
.+++... .....+++.+...++.|++.+|+|+|| +.+|+||||||+||+++ ++.++|
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCcEEE
Confidence 0111100 112357888999999999999999932 67999999999999998 478999
Q ss_pred ecccccccc
Q 047576 491 ADFGTARLL 499 (602)
Q Consensus 491 ~DFG~a~~~ 499 (602)
+|||+|...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.1e-17 Score=182.33 Aligned_cols=175 Identities=23% Similarity=0.309 Sum_probs=140.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHH----HHHhhhhHhH-------HH-----------HHHhh
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEE----LAFIRSFRNE-------AQ-----------VLSQM 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~~~~E-------~~-----------il~~l 425 (602)
...|.+...+|+|+||.||+|...+|+.||+|+=+....++ .+...++.-+ +. +.+|.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 45688889999999999999998889999999876654432 1222222200 00 11777
Q ss_pred hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-------CCCcceeeccccccc
Q 047576 426 ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-------SKLEAFVADFGTARL 498 (602)
Q Consensus 426 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-------~~~~~kL~DFG~a~~ 498 (602)
+.|+|.+++. ..+.++|.-++.++.|+++.+++|| ..+||||||||+|+||. +..-++|+|||.+..
T Consensus 777 ~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 777 PYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred ccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 8899999887 3455999999999999999999999 88999999999999993 234579999999976
Q ss_pred ccC--CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCC
Q 047576 499 LHA--DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548 (602)
Q Consensus 499 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 548 (602)
+.- ++.......+|-.+-++|...++++++++|.|.++.+++-|+.|++-
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 643 33344556788999999999999999999999999999999999875
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.2e-18 Score=174.40 Aligned_cols=223 Identities=28% Similarity=0.359 Sum_probs=167.7
Q ss_pred CCCCCccchhccccCCcc------ccCCccCCCCCCCCEEECcCCcCcc-------cCC---CcCEEECcCCcCCC----
Q 047576 127 CFPNLESLRILAYYDGFT------GSIPSEISALSKLQLLDLSSNRLRG-------RLT---NLNYMSLSRNMLGG---- 186 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~------~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~---~L~~L~L~~N~l~~---- 186 (602)
.+++++.|.+. .+... ..++..+..+++|+.|+|++|.+.+ .+. +|++|++++|++++
T Consensus 49 ~~~~l~~l~l~--~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~ 126 (319)
T cd00116 49 PQPSLKELCLS--LNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR 126 (319)
T ss_pred hCCCceEEecc--ccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH
Confidence 44556666554 22222 3345678889999999999999863 233 49999999999984
Q ss_pred CCchhhhCC-CCCCEEEecCCCCCCC----CcccccCcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCC
Q 047576 187 LLPQEIGNL-KNLIELDVGDNSLIGP----IPLTLSRLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 187 ~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
.+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|++++|.+++ ++..+..+++|+.|++++|.++
T Consensus 127 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 344566777 9999999999999854 33456677899999999999994 3455667789999999999997
Q ss_pred CC----CCCccCCCCCCccccCCCCcCCCCCchhhhC-----CCCCCEEeccCCCCCC----CCCcccCCCCCCCEEeCC
Q 047576 257 GP----IPSTLGLFSDLSYLDLSCNQFNSSIPNELTR-----LTQLFHLDLSSNKLSG----KIPSQIASMEDLTWLDLS 323 (602)
Q Consensus 257 ~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~ 323 (602)
+. ++..+..+++|++|++++|.+++.....+.. .+.|++|++++|.++. .+...+..+++|+.++++
T Consensus 207 ~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~ 286 (319)
T cd00116 207 DEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLR 286 (319)
T ss_pred hHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECC
Confidence 54 3345677899999999999998643333332 3799999999999973 234456677899999999
Q ss_pred CCCCCCC----CCcccccc-cccccccccCCcC
Q 047576 324 NNNIKGS----IPGEITKL-SRLDYLNLSGNKL 351 (602)
Q Consensus 324 ~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l 351 (602)
+|.++.. ....+... +.|+.+++.+|++
T Consensus 287 ~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 287 GNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 9999965 33334344 6889999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-17 Score=153.11 Aligned_cols=211 Identities=20% Similarity=0.347 Sum_probs=149.8
Q ss_pred CcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------Hhhhc
Q 047576 373 SKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------SQMER 427 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------~~l~~ 427 (602)
..-.+.+...|+.|+|++. |..+++|++.-.+.. ....+.|..|.-.+ .||+.
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3345678888999999994 566777877644332 22234455443211 78889
Q ss_pred CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 428 GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 428 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
|+|+.++|+. .....+-.++++++.+||+|++|||.. ++-|.---+.+..|++|++..++|+ .+-+++.-.. .
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfqe----~ 344 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----V 344 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeeec----c
Confidence 9999999874 345578889999999999999999965 4555556799999999999988874 1222221111 1
Q ss_pred ccccccccccccccccCcCC---ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMT---EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
...-.+.||+||.++..+.+ .++|+|||++++||+.|...||...+++..+... -.+-+...+++...+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---aleglrv~ippgis~h---- 417 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---ALEGLRVHIPPGISRH---- 417 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---hhccccccCCCCccHH----
Confidence 11235789999999887754 4689999999999999999999877665444332 2344556666665443
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
+.+++.-|...||.+
T Consensus 418 ---m~klm~icmnedpgk 432 (448)
T KOG0195|consen 418 ---MNKLMNICMNEDPGK 432 (448)
T ss_pred ---HHHHHHHHhcCCCCc
Confidence 788999999999964
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.2e-18 Score=185.33 Aligned_cols=213 Identities=32% Similarity=0.439 Sum_probs=159.6
Q ss_pred CCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEe
Q 047576 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 203 (602)
+|+++++ +.+....+|..++.+.+|+.|+..+|+|.. ..++|++|...+|.++ -+|+....++.|++|||
T Consensus 242 nl~~~di---s~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 242 NLQYLDI---SHNNLSNLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred cceeeec---chhhhhcchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 4455544 445556678889999999999999999873 2567777888888877 45666777788888888
Q ss_pred cCCCCCCCCcccc--------------------------cCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCC
Q 047576 204 GDNSLIGPIPLTL--------------------------SRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 204 ~~N~l~~~~p~~l--------------------------~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
..|+|.. .|+.+ ..++.|+.|++.+|.|+. .-+.+.+...|+.|+|++|+|.
T Consensus 318 ~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 8887753 33221 123557788888888888 3345777888999999999887
Q ss_pred CCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccc
Q 047576 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEIT 336 (602)
Q Consensus 257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 336 (602)
......+.++..|++|+||+|.++ .+|..+.+++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-..-.
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 544456788888899999999987 67788888888999988888887 567 788899999999999998853322223
Q ss_pred cccccccccccCCc
Q 047576 337 KLSRLDYLNLSGNK 350 (602)
Q Consensus 337 ~l~~L~~L~l~~N~ 350 (602)
..++|++||+++|.
T Consensus 474 p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGNT 487 (1081)
T ss_pred CCcccceeeccCCc
Confidence 33789999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=174.64 Aligned_cols=123 Identities=24% Similarity=0.408 Sum_probs=105.4
Q ss_pred HHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 422 LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 422 l~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|||++. +|+.++... ..++..++..+++|++.|++|+| +.||.|||+|++|++++.++.+||+|||.+.....
T Consensus 400 mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 477777 777777653 24777888999999999999999 88999999999999999999999999999887644
Q ss_pred CC----CCccccccccccccccccccCcCCcc-chhHHHHHHHHHHHcCCCCCCC
Q 047576 502 DS----SNQTLLAGSYGYIAPELAYTMVMTEK-YDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 502 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~ 551 (602)
+. .......|+.+|+|||++.+..|++. .||||.|+++..|++|+.||..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 32 23445689999999999999998865 7999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-16 Score=167.97 Aligned_cols=162 Identities=28% Similarity=0.406 Sum_probs=125.5
Q ss_pred ccccccccceeeec----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------Hhhh
Q 047576 377 IGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------------SQME 426 (602)
Q Consensus 377 LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------------~~l~ 426 (602)
+|+|.||.|++++- ..|..+|+|++++........ .....|..++ ++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 68999999998852 357789999887653321110 1222333333 5556
Q ss_pred cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 427 RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 427 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
+|.++..+.. ...+++.....+...++-+++++| +.+|+|||+|++||+++.+|++++.|||.++..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 6666655543 334677788888999999999999 88999999999999999999999999999987643322
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.+||..|||||+.. ....++|+||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28899999999988 566789999999999999999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-16 Score=173.66 Aligned_cols=164 Identities=28% Similarity=0.412 Sum_probs=120.6
Q ss_pred CCCCCccccCcccccccccccceeeecCC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----ccccccc
Q 047576 364 SMPTPRKIDSKYCIGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----RILHNDA 438 (602)
Q Consensus 364 ~lp~t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----~~l~~~~ 438 (602)
..|...+|+..+++..|+||.||.++++. .+.+|+|+ ++...- .+ + ++.+..++..+ ..+..
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lR---n---ilt~a~npfvvgDc~tllk~-- 144 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LR---N---ILTFAGNPFVVGDCATLLKN-- 144 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hh---c---cccccCCcceechhhhhccc--
Confidence 34567789999999999999999998863 56788843 333211 01 1 33333333221 11111
Q ss_pred chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC---------------C
Q 047576 439 EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD---------------S 503 (602)
Q Consensus 439 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~---------------~ 503 (602)
..+++- +++.+++|+| +.+|+|||+||+|.+|+.-|++|+.|||+++..... .
T Consensus 145 -~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~E 212 (1205)
T KOG0606|consen 145 -IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHE 212 (1205)
T ss_pred -CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHH
Confidence 111221 2278899999 889999999999999999999999999998754210 1
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....++||+.|+|||++....|+..+|+|++|+++||.+.|..||...
T Consensus 213 f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 213 FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 1234468999999999999999999999999999999999999999753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=145.97 Aligned_cols=124 Identities=21% Similarity=0.303 Sum_probs=87.6
Q ss_pred cccccccccccceeeecCCCcEEeeeccCCchhHH---H--------------------HHhhhhHhHHHHHHhhhcCcc
Q 047576 374 KYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEE---L--------------------AFIRSFRNEAQVLSQMERGSL 430 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~--------------------~~~~~~~~E~~il~~l~~gsL 430 (602)
...||+|++|.||+|+..+|+.||||+++...... . .....+..|...+..+.+..+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35789999999999998789999999987542110 0 001123456665544332221
Q ss_pred --------------ccccccc------cchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcce
Q 047576 431 --------------FRILHND------AEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 431 --------------~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~k 489 (602)
.+++... .....++..+...++.|++.++.++| . .||+||||||+||+++ ++.++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCEE
Confidence 1111110 01234667788999999999999999 6 8999999999999999 78999
Q ss_pred eecccccccccC
Q 047576 490 VADFGTARLLHA 501 (602)
Q Consensus 490 L~DFG~a~~~~~ 501 (602)
|+|||++.....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=142.89 Aligned_cols=176 Identities=16% Similarity=0.071 Sum_probs=120.6
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHH-HHhhhhHhHHHHHHhhhc-Cccccccccc--------cch
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEEL-AFIRSFRNEAQVLSQMER-GSLFRILHND--------AEA 440 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~~~~E~~il~~l~~-gsL~~~l~~~--------~~~ 440 (602)
+.....|++|+||+||.+.. +++.++.+.+........ .....+.+|+++++.+.+ +.+..++... ..+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G 82 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG 82 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence 44567899999999998877 677888777765544211 122357899999988854 3333333211 011
Q ss_pred hhhc---HHHHHHHHHHHHHHHHHhhhcCCCCeEEeCC-CCCCeeeCCCCcceeecccccccccCCCCC----c-c----
Q 047576 441 VELD---WAKRVNIVKAMAHALAYLHHDCSPSVVHRDI-SSNNILLNSKLEAFVADFGTARLLHADSSN----Q-T---- 507 (602)
Q Consensus 441 ~~l~---~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFG~a~~~~~~~~~----~-~---- 507 (602)
..+. ......++.|++++++++| +.||+|||| ||+|||++.++.++|+|||++......... . .
T Consensus 83 ~~L~~~~~~~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ 159 (218)
T PRK12274 83 AAMYQRPPRGDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH 159 (218)
T ss_pred ccHHhhhhhhhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence 1111 0123467889999999999 889999999 799999999999999999999865432210 0 0
Q ss_pred ----cccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCC
Q 047576 508 ----LLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 508 ----~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
....++.|++|+...- ..--.+.++++-|..+|.++||+.|+.
T Consensus 160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0124667777764322 222256799999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.4e-18 Score=183.91 Aligned_cols=199 Identities=36% Similarity=0.469 Sum_probs=174.0
Q ss_pred CCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeec
Q 047576 154 LSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILIL 227 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 227 (602)
-.+|+++|++.|+++ +.+.+|+.|+..+|+|+ .+|..+..+++|+.|++.+|.+. -+|....+++.|++|+|
T Consensus 240 p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred cccceeeecchhhhhcchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 468999999999998 46899999999999995 78899999999999999999998 67878899999999999
Q ss_pred ccccCCCCccccc--------------------------CCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCC
Q 047576 228 AQNQLSGLPQEIG--------------------------NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281 (602)
Q Consensus 228 ~~N~l~~ip~~~~--------------------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 281 (602)
..|+|..+|+.+- .++.|+.|++.+|.|+...-..+.++.+|+.|+|++|++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 9999998775321 12467889999999998777778899999999999999986
Q ss_pred CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC-ccCC
Q 047576 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG-RVPY 357 (602)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~ 357 (602)
.....+.++..|+.|+||+|+|+ .+|.+++.++.|+.|...+|++. ..| .+..++.|+.+|+|.|+++- .+|.
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~ 471 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPE 471 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhh
Confidence 66667889999999999999998 68899999999999999999998 667 88999999999999999874 3443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-17 Score=163.64 Aligned_cols=205 Identities=24% Similarity=0.314 Sum_probs=163.4
Q ss_pred CCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecC-CCCCCCCcccccCcCCCceeec
Q 047576 156 KLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD-NSLIGPIPLTLSRLTSLKILIL 227 (602)
Q Consensus 156 ~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L 227 (602)
.-..++|..|+|+ +.+++|+.||||+|+|+.+.|++|.+|.+|.+|-+.+ |+|+...-..|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 3467888999988 3588999999999999999999999999988877766 8888766678999999999999
Q ss_pred ccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCC--------------------------
Q 047576 228 AQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN-------------------------- 280 (602)
Q Consensus 228 ~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-------------------------- 280 (602)
.-|++.-+ .+.|..+++|..|.+.+|.+...--.+|..+..++.+.+..|.+-
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 99999985 457889999999999999998433347888888898888888731
Q ss_pred -----------------------------------CCCc-hhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCC
Q 047576 281 -----------------------------------SSIP-NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324 (602)
Q Consensus 281 -----------------------------------~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 324 (602)
++-| ..|..+++|+.|+|++|+|+++-+.+|.++..++.|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 0011 1356677888888888888877777888888888888888
Q ss_pred CCCCCCCCcccccccccccccccCCcCCCccCCCCC
Q 047576 325 NNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 325 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
|+|...-...|.++..|+.|+|.+|+|+...|..+.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 888766666777888888888888888777776653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-16 Score=151.58 Aligned_cols=159 Identities=14% Similarity=0.116 Sum_probs=110.3
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhh------hHhHHHHHHhhhcCcccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRS------FRNEAQVLSQMERGSLFRILHN----- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~------~~~E~~il~~l~~gsL~~~l~~----- 436 (602)
..+|...+.+|.|+||.||++.. ++..+|+|.+.+.........+. +.+|+..+..+.+..+......
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 45788899999999999999766 57789999998665444444444 5788887766665544332211
Q ss_pred ---------------ccchhhhcH-H-HHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 437 ---------------DAEAVELDW-A-KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 437 ---------------~~~~~~l~~-~-~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
..++..+.. . .......+++.++..+| +.|++|||+||+||++++++ ++++|||.....
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 001111100 0 00234679999999999 88999999999999999988 999999988655
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHH
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 543 (602)
..+... ..+.....+..++|+||||+++....
T Consensus 185 ~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 185 AQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 322211 11344555678999999999876654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-14 Score=161.16 Aligned_cols=90 Identities=33% Similarity=0.692 Sum_probs=66.2
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCC
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N 253 (602)
+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++ +|..++++++|+.|+|++|
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 345666777777778888888888888888888887777777777777777777777776 6777777777777777777
Q ss_pred CCCCCCCCccC
Q 047576 254 DIIGPIPSTLG 264 (602)
Q Consensus 254 ~l~~~~p~~l~ 264 (602)
+++|.+|..+.
T Consensus 501 ~l~g~iP~~l~ 511 (623)
T PLN03150 501 SLSGRVPAALG 511 (623)
T ss_pred cccccCChHHh
Confidence 77766666554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.4e-14 Score=139.35 Aligned_cols=124 Identities=21% Similarity=0.183 Sum_probs=89.8
Q ss_pred cccCcccccccccccceeee--cCCCcEEeeeccCCchhHH---------------------HHHhhhhHhHHHHHHhhh
Q 047576 370 KIDSKYCIGTGAYGSVYKAQ--LPNGRVFALKKLNSPETEE---------------------LAFIRSFRNEAQVLSQME 426 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~~---------------------~~~~~~~~~E~~il~~l~ 426 (602)
-|.....||+|++|.||+|. ..+|+.||+|+++...... ......+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777899999999999998 5689999999887542100 001123556777775554
Q ss_pred c-----------------------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC-eEEeCCCCCCeee
Q 047576 427 R-----------------------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS-VVHRDISSNNILL 482 (602)
Q Consensus 427 ~-----------------------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~DLkp~NILl 482 (602)
+ +++..... ....++..+...++.|++.+++++| ..+ |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEE
Confidence 2 22221111 1122455567789999999999999 788 9999999999999
Q ss_pred CCCCcceeeccccccccc
Q 047576 483 NSKLEAFVADFGTARLLH 500 (602)
Q Consensus 483 d~~~~~kL~DFG~a~~~~ 500 (602)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-14 Score=151.48 Aligned_cols=195 Identities=43% Similarity=0.598 Sum_probs=161.6
Q ss_pred CEEECcCCcCcc------cCCCcCEEECcCCcCCCCCchhhhCCC-CCCEEEecCCCCCCCCcccccCcCCCceeecccc
Q 047576 158 QLLDLSSNRLRG------RLTNLNYMSLSRNMLGGLLPQEIGNLK-NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230 (602)
Q Consensus 158 ~~L~Ls~N~i~~------~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 230 (602)
..|+++.|.+.. .++.++.|++.+|.++ .+|+..+.++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 96 ~~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 96 PSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred ceeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 468888888742 3567899999999998 5566777774 9999999999987 56667889999999999999
Q ss_pred cCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcc
Q 047576 231 QLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQ 310 (602)
Q Consensus 231 ~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 310 (602)
+++.+|...+.+++|+.|++++|+++ .+|........|++|.+++|.+. .++..+.++.++..+.+++|++.. .+..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~ 250 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPES 250 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccch
Confidence 99999887778899999999999998 66776666777999999999643 456678889999999999999874 4678
Q ss_pred cCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 311 IASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 311 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
++.+++++.|++++|+++. ++. ++.+.+|+.|++++|.++...|...
T Consensus 251 ~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 251 IGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhh
Confidence 8889999999999999984 444 8899999999999999988777654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.6e-15 Score=156.00 Aligned_cols=178 Identities=38% Similarity=0.592 Sum_probs=118.8
Q ss_pred CCCCCCEEECcCCcCcc------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 153 ALSKLQLLDLSSNRLRG------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~~------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
.|+.-...||+.|++.. .+..|+.+.|++|.+. .+|..+.+|..|.+|||+.|+++ ..|..+..|+ |+.|-
T Consensus 73 ~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred cccchhhhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 45555667777777763 2455666677777776 56667777777777777777766 4555555543 67777
Q ss_pred cccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 306 (602)
+++|+++.+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..++.| .|..||+|.|+++ .
T Consensus 150 ~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 150 VSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred EecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 777777777777776677777777777765 55666677777777777777775 455566644 4667777777776 5
Q ss_pred CCcccCCCCCCCEEeCCCCCCCCCCCcccccc
Q 047576 307 IPSQIASMEDLTWLDLSNNNIKGSIPGEITKL 338 (602)
Q Consensus 307 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 338 (602)
+|..|..|+.|++|-|.+|.|. ..|..++..
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 6777777777777777777776 455555443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.8e-13 Score=131.60 Aligned_cols=127 Identities=18% Similarity=0.195 Sum_probs=87.2
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHH-------------------HHhhhhHhHHHHHHhhhcCc--
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEEL-------------------AFIRSFRNEAQVLSQMERGS-- 429 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-------------------~~~~~~~~E~~il~~l~~gs-- 429 (602)
|...+.||+|+||.||+|..++|+.||||++........ .....+..|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 566788999999999999988899999998654321000 00112455666665554431
Q ss_pred cccccc--------cccchhh---hcH-HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 430 LFRILH--------NDAEAVE---LDW-AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 430 L~~~l~--------~~~~~~~---l~~-~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
+...+. +...+.. +.. .....++.+++.++.++| ..+|+||||||+||++++++.++|+|||.+.
T Consensus 97 v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 97 VPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred CCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCccc
Confidence 111111 0001111 111 345578899999999999 7899999999999999999999999999986
Q ss_pred ccc
Q 047576 498 LLH 500 (602)
Q Consensus 498 ~~~ 500 (602)
...
T Consensus 174 ~~~ 176 (198)
T cd05144 174 STD 176 (198)
T ss_pred cCC
Confidence 544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.4e-15 Score=153.09 Aligned_cols=172 Identities=35% Similarity=0.537 Sum_probs=90.2
Q ss_pred CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccC
Q 047576 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGN 252 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~ 252 (602)
.-...||+.|++. .+|..+..+..|+.|.|+.|.+. .+|..+.++..|++|+|+.|+++.+|..++.|+ |+.|-+++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEec
Confidence 3344555555555 44555555555555555555544 455555555555555555555555555555442 55555555
Q ss_pred CCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 253 NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 253 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
|+++ .+|..++.+.+|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|..+..+ .|..||+|.|+++ .+|
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecc
Confidence 5554 44555555555555555555554 34445555555555555555554 244444432 3455555555555 455
Q ss_pred cccccccccccccccCCcCC
Q 047576 333 GEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 333 ~~~~~l~~L~~L~l~~N~l~ 352 (602)
-.|.+|+.|++|-|.+|+++
T Consensus 228 v~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhhhheeeeeccCCCC
Confidence 55555555555555555554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=5e-13 Score=127.13 Aligned_cols=123 Identities=20% Similarity=0.237 Sum_probs=80.9
Q ss_pred cccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhh---------------------hHhHHHHHHhhhcCc---
Q 047576 374 KYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRS---------------------FRNEAQVLSQMERGS--- 429 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~---------------------~~~E~~il~~l~~gs--- 429 (602)
...||+|+||.||+|...+|+.||||++............. ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35789999999999998889999999876543211111100 123333332221110
Q ss_pred -----------cccccccc----cchhhhcH-HHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcceeec
Q 047576 430 -----------LFRILHND----AEAVELDW-AKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 430 -----------L~~~l~~~----~~~~~l~~-~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
+.+++... ..-..... .+...++.+++.++.++| . .+|+||||||+||+++ ++.++++|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEE
Confidence 11111110 00000111 567789999999999999 6 8999999999999999 88999999
Q ss_pred cccccccc
Q 047576 493 FGTARLLH 500 (602)
Q Consensus 493 FG~a~~~~ 500 (602)
||.+....
T Consensus 158 fg~a~~~~ 165 (187)
T cd05119 158 VPQAVEID 165 (187)
T ss_pred Cccccccc
Confidence 99997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-13 Score=143.65 Aligned_cols=183 Identities=39% Similarity=0.523 Sum_probs=154.4
Q ss_pred CccCCCCCCCCEEECcCCcCcc------cCC-CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcC
Q 047576 148 PSEISALSKLQLLDLSSNRLRG------RLT-NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLT 220 (602)
Q Consensus 148 p~~l~~L~~L~~L~Ls~N~i~~------~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 220 (602)
+..+..++.++.|++.+|.+.. .+. +|+.|++++|.+. .+|..++.+++|+.|++++|+++ .+|...+.++
T Consensus 109 ~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~ 186 (394)
T COG4886 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLS 186 (394)
T ss_pred chhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhh
Confidence 4456667889999999998873 353 8999999999998 45578999999999999999998 5666666899
Q ss_pred CCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccC
Q 047576 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300 (602)
Q Consensus 221 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 300 (602)
+|+.|++++|+++.+|.....+..|++|.+++|.+. .++..+.++.++..+.+.+|++.. .+..++.+++++.|++++
T Consensus 187 ~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~ 264 (394)
T COG4886 187 NLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSN 264 (394)
T ss_pred hhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccc
Confidence 999999999999999988777778999999999644 466778899999999999999874 366788999999999999
Q ss_pred CCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccc
Q 047576 301 NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEIT 336 (602)
Q Consensus 301 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 336 (602)
|+++.. +. ++.+.+++.|++++|.++...|....
T Consensus 265 n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 265 NQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred cccccc-cc-ccccCccCEEeccCccccccchhhhc
Confidence 999854 43 89999999999999999977665543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.5e-13 Score=142.76 Aligned_cols=172 Identities=27% Similarity=0.456 Sum_probs=119.9
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
+|+..|+|.+.+.. ....++|-=...+.++|+.|++|+|+ ++...|+.+++.|.++|..+.+|+.|||+.......
T Consensus 27 ~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~ 102 (484)
T KOG1023|consen 27 EYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET 102 (484)
T ss_pred eeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--CcceeeeeeccccceeeeeEEEEechhhhccccccc
Confidence 67777888888775 34558888888899999999999994 333399999999999999999999999998876421
Q ss_pred --CCCccccccccccccccccccCc-------CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc-cC
Q 047576 503 --SSNQTLLAGSYGYIAPELAYTMV-------MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD-QR 572 (602)
Q Consensus 503 --~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d-~~ 572 (602)
........-..-|.|||.+.... .+.++||||||++++|+++.+.||+........ .+....+-+ ..
T Consensus 103 ~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~---~eii~~~~~~~~ 179 (484)
T KOG1023|consen 103 AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP---DEIILRVKKGGS 179 (484)
T ss_pred ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh---HHHHHHHHhcCC
Confidence 11111122446799999887642 356799999999999999999999864321111 111111222 11
Q ss_pred --CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 --LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 --l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++|..... .+...++..++..||..+|++
T Consensus 180 ~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 180 NPFRPSIELL-NELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred CCcCcchhhh-hhcchHHHHHHHHhcccChhh
Confidence 12221111 133346899999999999974
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-13 Score=142.94 Aligned_cols=123 Identities=24% Similarity=0.405 Sum_probs=102.6
Q ss_pred HHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 422 LSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 422 l~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
|..++-.+|.+++.........++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+......
T Consensus 335 Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~ 408 (516)
T KOG1033|consen 335 MNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK 408 (516)
T ss_pred hhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhheeeccc
Confidence 3556677888888755555567889999999999999999 4899999999999999999999999999887655
Q ss_pred CCC------CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCC
Q 047576 502 DSS------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRD 550 (602)
Q Consensus 502 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~ 550 (602)
... ..+...||.-||+||.+.+..|+.|+||||+|++++|+++ -..+|+
T Consensus 409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 409 DETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred CCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 441 1233579999999999999999999999999999999998 445544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-12 Score=125.60 Aligned_cols=119 Identities=21% Similarity=0.322 Sum_probs=82.0
Q ss_pred cccccccccceeeecCCCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHhhhcCccc--ccc----------cccc
Q 047576 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQMERGSLF--RIL----------HNDA 438 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~l~~gsL~--~~l----------~~~~ 438 (602)
+||+|++|.||+|.. +|..|++|+...... .......++.+|++++..+.+..+. ..+ .+..
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999985 678899998553221 1112235677888888766543321 100 0001
Q ss_pred chhhhcHHHHH---HHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 439 EAVELDWAKRV---NIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 439 ~~~~l~~~~~~---~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
++..+...... .++.+++.++.++| +.+++|||+||.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 11112111111 78999999999999 88999999999999999 789999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=125.60 Aligned_cols=118 Identities=20% Similarity=0.331 Sum_probs=82.0
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHhhhcCcccc--cc----------ccc
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQMERGSLFR--IL----------HND 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~l~~gsL~~--~l----------~~~ 437 (602)
..||+|++|.||+|+. +|..|++|+...... ........+.+|+.++..+.+..+.. .+ .+.
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 677889997653321 11112345677888775554432211 00 000
Q ss_pred cchhhh-------cHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 438 AEAVEL-------DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 438 ~~~~~l-------~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.++..+ .+ ++..++.+++.++.++| ..+++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 001111 12 56789999999999999 88999999999999999 78899999998865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.7e-12 Score=122.06 Aligned_cols=116 Identities=16% Similarity=0.215 Sum_probs=77.5
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-----cCcccccc-----------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-----RGSLFRIL----------- 434 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-----~gsL~~~l----------- 434 (602)
++....||+|++|.||. ...++.. +||+....... ..+.+.+|+.++..+. ++++..+.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 45568899999999996 3334444 68987654322 2356788999887773 34443332
Q ss_pred -----ccc-c-ch---------hhhcHHHHHHHHHHHHHHH-HHhhhcCCCCeEEeCCCCCCeeeCC----CCcceeecc
Q 047576 435 -----HND-A-EA---------VELDWAKRVNIVKAMAHAL-AYLHHDCSPSVVHRDISSNNILLNS----KLEAFVADF 493 (602)
Q Consensus 435 -----~~~-~-~~---------~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~DLkp~NILld~----~~~~kL~DF 493 (602)
.+. + .. ..+++. ..++.+++.++ +||| +.+|+||||||+|||++. ++.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 111 0 01 112333 35678888888 9999 889999999999999974 347999995
Q ss_pred ccc
Q 047576 494 GTA 496 (602)
Q Consensus 494 G~a 496 (602)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.2e-12 Score=142.44 Aligned_cols=109 Identities=28% Similarity=0.432 Sum_probs=80.2
Q ss_pred CcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCC
Q 047576 245 LMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324 (602)
Q Consensus 245 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 324 (602)
++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCCCCCCcccccc-cccccccccCCcCCC
Q 047576 325 NNIKGSIPGEITKL-SRLDYLNLSGNKLSG 353 (602)
Q Consensus 325 N~l~~~~p~~~~~l-~~L~~L~l~~N~l~g 353 (602)
|+++|.+|..+..+ .++..+++.+|+..+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcccc
Confidence 77777777776553 345566777775433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.4e-12 Score=124.68 Aligned_cols=147 Identities=25% Similarity=0.357 Sum_probs=97.7
Q ss_pred hcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee--CCCC--cceeecccccccccCCC------CCccccccc
Q 047576 443 LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL--NSKL--EAFVADFGTARLLHADS------SNQTLLAGS 512 (602)
Q Consensus 443 l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl--d~~~--~~kL~DFG~a~~~~~~~------~~~~~~~gt 512 (602)
.+...+.-+..|+++|+.||| .+||.|||+|++|||+ |+|+ ...|+|||++-.-+..+ ...-..-|.
T Consensus 338 ~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN 414 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN 414 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence 455667778899999999999 8899999999999999 4444 45789999875322211 011113467
Q ss_pred cccccccccccCc------CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 513 YGYIAPELAYTMV------MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 513 ~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
..-||||+....+ -..|+|.|+.|.+.||+++...||.....+.- +. ...-+..++.-.++ ..-
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L---~~---r~Yqe~qLPalp~~----vpp 484 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL---DT---RTYQESQLPALPSR----VPP 484 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee---ch---hhhhhhhCCCCccc----CCh
Confidence 7889999876443 12589999999999999999999986332210 00 11122223211111 222
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..-+++||++
T Consensus 485 ~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSK 500 (598)
T ss_pred HHHHHHHHHhcCCccc
Confidence 3667777888888875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=139.86 Aligned_cols=127 Identities=21% Similarity=0.307 Sum_probs=87.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeec-cCCc----hhHHHHHhhhhHhHHHHHHhhhcCcccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKK-LNSP----ETEELAFIRSFRNEAQVLSQMERGSLFRIL-------- 434 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~-l~~~----~~~~~~~~~~~~~E~~il~~l~~gsL~~~l-------- 434 (602)
...|...+.||+|+||.||+|.+.... +++|+ ..+. ........+++.+|++++..+.+..+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999875443 33333 2211 111122345688899999887765543211
Q ss_pred ----ccccchhhhcH--HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 435 ----HNDAEAVELDW--AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 435 ----~~~~~~~~l~~--~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.+..+...+.. .....++.++++++.|+| +.+++|||+||+||++ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 11111222221 246779999999999999 8899999999999999 5779999999999764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-12 Score=132.83 Aligned_cols=204 Identities=27% Similarity=0.315 Sum_probs=145.8
Q ss_pred CCCCCCCEEECcCCcCc--c------cCCCcCEEECcCCcCCCC--CchhhhCCCCCCEEEecCCCCCCCCccc-ccCcC
Q 047576 152 SALSKLQLLDLSSNRLR--G------RLTNLNYMSLSRNMLGGL--LPQEIGNLKNLIELDVGDNSLIGPIPLT-LSRLT 220 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N~i~--~------~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~ 220 (602)
+++++|+...|.+..+. | .+++++.||||+|-+... +......|++|+.|+|+.|++.-..... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 56788888888887765 2 378888889988888743 3345667889999999999886433322 23578
Q ss_pred CCceeecccccCCC--CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCC-chhhhCCCCCCEEe
Q 047576 221 SLKILILAQNQLSG--LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI-PNELTRLTQLFHLD 297 (602)
Q Consensus 221 ~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 297 (602)
.|+.|.|++|.|+. +-..+..+|+|+.|+|..|..-+.-......+..|++|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 89999999999985 4444567789999999998633333344456778999999999876432 24577888888888
Q ss_pred ccCCCCCCC-CCcc-----cCCCCCCCEEeCCCCCCCCC-CCcccccccccccccccCCcCCCcc
Q 047576 298 LSSNKLSGK-IPSQ-----IASMEDLTWLDLSNNNIKGS-IPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 298 Ls~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
++.+.+... .|+. ...+++|++|+++.|++..- --..+..+++|+.|....|.++.+-
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~ 342 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKET 342 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccccc
Confidence 888887643 2333 35678899999999998521 1234566777788888888876543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.9e-12 Score=115.74 Aligned_cols=101 Identities=30% Similarity=0.324 Sum_probs=32.0
Q ss_pred CCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccc-cCCCCCcEEEccCCCCCCCCC-CccCCCCCCccc
Q 047576 195 LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIP-STLGLFSDLSYL 272 (602)
Q Consensus 195 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~-~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L 272 (602)
+.+|+.|+|++|.|+.. + .+..+++|++|++++|+++.+++.+ ..+++|+.|+|++|+|...-- ..++.+++|+.|
T Consensus 41 l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred hcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 44555555555555432 1 3444555555555555555554333 235555555555555543211 234445555566
Q ss_pred cCCCCcCCCCC---chhhhCCCCCCEEe
Q 047576 273 DLSCNQFNSSI---PNELTRLTQLFHLD 297 (602)
Q Consensus 273 ~L~~N~l~~~~---p~~~~~l~~L~~L~ 297 (602)
+|.+|.++... ...+..+++|+.||
T Consensus 119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 119 SLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred eccCCcccchhhHHHHHHHHcChhheeC
Confidence 66666554321 11345566676665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-12 Score=116.79 Aligned_cols=121 Identities=34% Similarity=0.373 Sum_probs=31.9
Q ss_pred CCceeecccccCCCCccccc-CCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhh-hCCCCCCEEec
Q 047576 221 SLKILILAQNQLSGLPQEIG-NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDL 298 (602)
Q Consensus 221 ~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L 298 (602)
++++|+|.+|+|+.|. .++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+++.. +..+ ..+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYL 95 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-
T ss_pred cccccccccccccccc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEEC
Confidence 3444444444444432 222 234444444444444422 1 233444555555555555432 2222 23555555555
Q ss_pred cCCCCCCCC-CcccCCCCCCCEEeCCCCCCCCCC---Cccccccccccccc
Q 047576 299 SSNKLSGKI-PSQIASMEDLTWLDLSNNNIKGSI---PGEITKLSRLDYLN 345 (602)
Q Consensus 299 s~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~ 345 (602)
++|+|...- -..++.+++|+.|+|.+|.++... ...+..+|+|+.||
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 555554321 123455666666666666665321 11345667777665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-11 Score=125.37 Aligned_cols=201 Identities=24% Similarity=0.286 Sum_probs=147.9
Q ss_pred CCCccchhccccCCccccCC--ccCCCCCCCCEEECcCCcCc---------ccCCCcCEEECcCCcCCCCCchhh-hCCC
Q 047576 129 PNLESLRILAYYDGFTGSIP--SEISALSKLQLLDLSSNRLR---------GRLTNLNYMSLSRNMLGGLLPQEI-GNLK 196 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip--~~l~~L~~L~~L~Ls~N~i~---------~~l~~L~~L~L~~N~l~~~~p~~~-~~l~ 196 (602)
.+++.|+...+.+.-.+..+ .....|++++.||||.|-|. ..|++|+.|+|+.|++........ ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 35566665555665555555 35778999999999999876 469999999999999985443332 3578
Q ss_pred CCCEEEecCCCCCCC-CcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCC-CCccCCCCCCcccc
Q 047576 197 NLIELDVGDNSLIGP-IPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPI-PSTLGLFSDLSYLD 273 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~ 273 (602)
+|+.|.|+.+.|+-. +-..+..+|+|+.|+|..|..-. -......+..|+.|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 999999999998732 22234567999999999996222 2223455678999999999986432 14568899999999
Q ss_pred CCCCcCCCC-Cchh-----hhCCCCCCEEeccCCCCCCC-CCcccCCCCCCCEEeCCCCCCCC
Q 047576 274 LSCNQFNSS-IPNE-----LTRLTQLFHLDLSSNKLSGK-IPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 274 L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
++.+.++.. .|+. ...+++|++|+++.|+|... .-..+..+++|+.|....|.++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 999999764 2332 35688999999999999632 11245567788888888888874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.9e-12 Score=120.22 Aligned_cols=145 Identities=28% Similarity=0.314 Sum_probs=116.2
Q ss_pred CCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhh
Q 047576 209 IGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288 (602)
Q Consensus 209 ~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 288 (602)
+|..-..+.....|++|||++|.++.|.++..-++.++.|++|.|.++.. ..+..+++|+.||||+|.++. +..+-.
T Consensus 273 ~G~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~ 349 (490)
T KOG1259|consen 273 NGSALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHL 349 (490)
T ss_pred CCceEEecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHh
Confidence 44444455566789999999999999988888889999999999999743 337889999999999999984 344556
Q ss_pred CCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC-CCcccccccccccccccCCcCCCccCCC
Q 047576 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS-IPGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 289 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
.+.+++.|.|++|.|... ..+..+-+|..||+++|+|... --..++++|-|+.+.|.+|++.+.+...
T Consensus 350 KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdYR 418 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDYR 418 (490)
T ss_pred hhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchHH
Confidence 788899999999998632 3567778899999999999742 2346899999999999999998876544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-10 Score=103.49 Aligned_cols=119 Identities=21% Similarity=0.214 Sum_probs=88.4
Q ss_pred cccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC--ccccccccc------------cc
Q 047576 374 KYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG--SLFRILHND------------AE 439 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g--sL~~~l~~~------------~~ 439 (602)
...+|+|.++.||++...+ ..+++|....... ...+.+|..+++.+.+. .+..++... ..
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4678999999999999854 7899998865543 24577788888777552 333322211 01
Q ss_pred hhh---hcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 440 AVE---LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 440 ~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
... ++......++.+++++++++|.....+++|+|+||+||++++.+.++++|||.+..
T Consensus 77 g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 111 24467788999999999999955446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.4e-12 Score=121.51 Aligned_cols=204 Identities=24% Similarity=0.293 Sum_probs=127.2
Q ss_pred cccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCccc---CCCcCEEECcC---CcCCCCCchhhh
Q 047576 120 LSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR---LTNLNYMSLSR---NMLGGLLPQEIG 193 (602)
Q Consensus 120 l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~~---l~~L~~L~L~~---N~l~~~~p~~~~ 193 (602)
.-+++++.|.+|..+.++.+.. ..|-.-...-+.|+++...+..++.. ++.=..-|... .-.+|..-..+.
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~---~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~d 281 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALST---ENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSAD 281 (490)
T ss_pred ccccchHHhhhhheeeeeccch---hheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecc
Confidence 3345677788888877764332 11222122235567777666555421 11111112211 112233333344
Q ss_pred CCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCcccc
Q 047576 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLD 273 (602)
Q Consensus 194 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 273 (602)
....|++||||+|.|+ .+..+..-++.++.|++++|.++.+-. +..+++|+.||||+|.++. +-..-..+-+.+.|.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLK 358 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeeee
Confidence 4466788888888876 566667777888888888888877644 7777888888888888773 334444566777888
Q ss_pred CCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCC-CcccCCCCCCCEEeCCCCCCCCCC
Q 047576 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI-PSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 274 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
|+.|.+... ..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+|.+.+.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 888877532 35666777888888888876321 235788888999999999888653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.7e-11 Score=115.79 Aligned_cols=122 Identities=23% Similarity=0.291 Sum_probs=82.0
Q ss_pred ccccc-ccccccceeeecCCCcEEeeeccCCchh-----H-----HHHHhhhhHhHHHHHHhhhcCcc--cc--------
Q 047576 374 KYCIG-TGAYGSVYKAQLPNGRVFALKKLNSPET-----E-----ELAFIRSFRNEAQVLSQMERGSL--FR-------- 432 (602)
Q Consensus 374 ~~~LG-~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~-----~~~~~~~~~~E~~il~~l~~gsL--~~-------- 432 (602)
...+| .|+.|+||.++.. +..++||.+..... . ......++.+|+.++..+.+..+ ..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46787 8999999999884 67889998864321 0 01123456778888877754332 00
Q ss_pred --------ccccccch-hhhcH-----HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 433 --------ILHNDAEA-VELDW-----AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 433 --------~l~~~~~~-~~l~~-----~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++-+..++ ..+.. ......+.+++.++.++| +.||+||||||+|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 11110010 11100 001234678999999999 88999999999999999989999999998865
Q ss_pred c
Q 047576 499 L 499 (602)
Q Consensus 499 ~ 499 (602)
.
T Consensus 192 ~ 192 (239)
T PRK01723 192 R 192 (239)
T ss_pred C
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-11 Score=122.44 Aligned_cols=181 Identities=23% Similarity=0.269 Sum_probs=117.2
Q ss_pred CCCcCEEECcCCcCCCCCchhh----hCCCCCCEEEecCCCCCCCC-------------cccccCcCCCceeecccccCC
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEI----GNLKNLIELDVGDNSLIGPI-------------PLTLSRLTSLKILILAQNQLS 233 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~-------------p~~l~~l~~L~~L~L~~N~l~ 233 (602)
.++|++||||.|.|.-..+..| .+++.|++|.|.+|.+.-.. ..-.+.-++|+++..++|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 4578888888888775555443 34577888888887764111 112334567888888888776
Q ss_pred CCc-----ccccCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCCCcCCCCC----chhhhCCCCCCEEeccC
Q 047576 234 GLP-----QEIGNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSCNQFNSSI----PNELTRLTQLFHLDLSS 300 (602)
Q Consensus 234 ~ip-----~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~ 300 (602)
.-+ ..+...+.|+.+.++.|.+... +...|..+++|+.|||..|.|+... ...+..+++|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 533 3455567788888888876422 1234567778888888888876432 34466677788888888
Q ss_pred CCCCCCCCccc-----CCCCCCCEEeCCCCCCCCC----CCcccccccccccccccCCcC
Q 047576 301 NKLSGKIPSQI-----ASMEDLTWLDLSNNNIKGS----IPGEITKLSRLDYLNLSGNKL 351 (602)
Q Consensus 301 N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l 351 (602)
+.+.......+ ...++|+.|.+.+|.++.. +...+...+.|..|+|++|.+
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 87765433222 3467788888888887632 223345567788888888877
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.6e-10 Score=122.53 Aligned_cols=51 Identities=22% Similarity=0.319 Sum_probs=42.4
Q ss_pred HHHHHHHHHH-HHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 448 RVNIVKAMAH-ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 448 ~~~i~~~ia~-~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+.+++..++. .+..+| ..|++|+|+||.||+++.+++++++|||++..++.
T Consensus 258 ~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 258 RKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 3456666665 467788 78999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3e-11 Score=129.57 Aligned_cols=202 Identities=32% Similarity=0.428 Sum_probs=136.6
Q ss_pred cCCccccCCccCCCCCCCCEEECcCCcCcc------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc
Q 047576 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRG------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP 213 (602)
Q Consensus 140 ~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 213 (602)
..+..+.+-..+..+++|+.|++.+|+|.. .+++|++|+|++|.|+.+ ..+..++.|+.|++++|.|+..
T Consensus 80 ~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~-- 155 (414)
T KOG0531|consen 80 RQNLIAKILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI-- 155 (414)
T ss_pred chhhhhhhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--
Confidence 445555555567788888888888888762 377888888888888866 3466677788888888888743
Q ss_pred ccccCcCCCceeecccccCCCCccc-ccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCC
Q 047576 214 LTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ 292 (602)
Q Consensus 214 ~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 292 (602)
..+..+++|+.+++++|+++.+... ...+.+|+.+++++|.+... ..+..+..+..+++..|.++-.-+ +..+..
T Consensus 156 ~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~ 231 (414)
T KOG0531|consen 156 SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVM 231 (414)
T ss_pred cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchh
Confidence 3456688888888888888886553 46777888888888887632 233444555566777777764322 222222
Q ss_pred --CCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCC
Q 047576 293 --LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 293 --L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
|+.+++++|++. .++..+..+.++..|++++|++... ..+...+.+..+.+..|++.
T Consensus 232 ~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 232 LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred HHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 677788888776 3335566677777888887777643 23445555666666777665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-11 Score=129.89 Aligned_cols=194 Identities=31% Similarity=0.357 Sum_probs=152.7
Q ss_pred CCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 152 SALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
..+..++.+++..|.|. +.+++|+.|++.+|+|..+.. .+..+++|++|+|++|.|+...+ +..++.|+.|
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhh
Confidence 45677888889999887 347899999999999996632 37889999999999999986543 6678889999
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCC-CccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIP-STLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLS 304 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 304 (602)
++++|.++.+.. +..+++|+.+++++|+++..-+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++
T Consensus 146 ~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 146 NLSGNLISDISG-LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eeccCcchhccC-CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 999999999854 5668999999999999986544 2 57788999999999998743 33455556666789999987
Q ss_pred CCCCcccCCCCC--CCEEeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 305 GKIPSQIASMED--LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 305 ~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
-.- .+..+.. |+.+++++|.+. .++..+..+..+..|++.+|++.+.-
T Consensus 222 ~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~ 271 (414)
T KOG0531|consen 222 KLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE 271 (414)
T ss_pred ecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc
Confidence 432 2233333 899999999998 44467788889999999999987644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.8e-10 Score=127.82 Aligned_cols=180 Identities=28% Similarity=0.347 Sum_probs=128.7
Q ss_pred ccccCcccccccccccceeeecC--CCcEEeeeccCCchhHHHHHhhhhHhHHH--------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKLNSPETEELAFIRSFRNEAQ-------------------------- 420 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~-------------------------- 420 (602)
..|....-+|+|+|+.|-..... ....+|+|.+...... .........|..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~-~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS-EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc-cchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35666777999999999888753 3345666655433211 111122222222
Q ss_pred HHHhhhcCcccccc-ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeeccccccc
Q 047576 421 VLSQMERGSLFRIL-HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARL 498 (602)
Q Consensus 421 il~~l~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~ 498 (602)
..++..++++++.+ +.. ....+......++.|+..++.|+|. ..++.|||+||+|.+++..+ ..++.|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 12555666666666 321 1135566777899999999999994 45899999999999999999 999999999987
Q ss_pred ccC-CCCC--cccccc-ccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 499 LHA-DSSN--QTLLAG-SYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 499 ~~~-~~~~--~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
... .+.. .....| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 765 3322 223467 9999999998885 45678999999999999999999997543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-10 Score=115.10 Aligned_cols=227 Identities=21% Similarity=0.249 Sum_probs=159.1
Q ss_pred CCEEEEEecCCCCCCCc-ccccCCCCCCCCCccchhccccC-CccccCCc-------cCCCCCCCCEEECcCCcCcc---
Q 047576 102 GSIIGLHLSKDNVNFNG-RLSHLNFSCFPNLESLRILAYYD-GFTGSIPS-------EISALSKLQLLDLSSNRLRG--- 169 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~-~l~~~~~~~l~~L~~L~l~~~~~-~~~~~ip~-------~l~~L~~L~~L~Ls~N~i~~--- 169 (602)
..++.|+++++.+...- +.-.-.+...++|+..+++++.. .....+|+ ++-..++|++||||.|.|.-
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 45677777655432100 00000122333444444433222 22334554 35566799999999999872
Q ss_pred --------cCCCcCEEECcCCcCCCCCchh-------------hhCCCCCCEEEecCCCCCCCC----cccccCcCCCce
Q 047576 170 --------RLTNLNYMSLSRNMLGGLLPQE-------------IGNLKNLIELDVGDNSLIGPI----PLTLSRLTSLKI 224 (602)
Q Consensus 170 --------~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~ 224 (602)
.+..|++|+|.+|.+.-.--.. .++-++|+++..++|++.... ...|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 3789999999999997332222 334578999999999986432 234667799999
Q ss_pred eecccccCCC--C---cccccCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCCCcCCCCCchhhh-----CC
Q 047576 225 LILAQNQLSG--L---PQEIGNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSCNQFNSSIPNELT-----RL 290 (602)
Q Consensus 225 L~L~~N~l~~--i---p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l 290 (602)
+.++.|.+.. + -..+..+++|+.|||.+|-|+.. +...+..+++|++|+++++.++..-..+|. ..
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~ 269 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESA 269 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccC
Confidence 9999999874 3 34678899999999999999853 345577889999999999999876554442 36
Q ss_pred CCCCEEeccCCCCCCC----CCcccCCCCCCCEEeCCCCCCC
Q 047576 291 TQLFHLDLSSNKLSGK----IPSQIASMEDLTWLDLSNNNIK 328 (602)
Q Consensus 291 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 328 (602)
++|+.|.|.+|.|+.. +...+...+.|..|+|++|.+.
T Consensus 270 p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 270 PSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 8999999999998743 2334567899999999999994
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.9e-09 Score=115.91 Aligned_cols=35 Identities=23% Similarity=0.376 Sum_probs=31.4
Q ss_pred CCCeEEeCCCCCCeeeCCCC----cceeecccccccccC
Q 047576 467 SPSVVHRDISSNNILLNSKL----EAFVADFGTARLLHA 501 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~----~~kL~DFG~a~~~~~ 501 (602)
..|++|+|+||.||+++.++ +++++|||++..++.
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 56999999999999999888 999999999987743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-09 Score=83.29 Aligned_cols=61 Identities=38% Similarity=0.518 Sum_probs=38.6
Q ss_pred CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccC
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 232 (602)
++|++|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666655556666666666666666666655555666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.2e-09 Score=81.09 Aligned_cols=59 Identities=37% Similarity=0.510 Sum_probs=25.2
Q ss_pred CCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCC
Q 047576 244 NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNK 302 (602)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 302 (602)
+|++|++++|+++...+..|..+++|++|++++|.++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333344444444444444444443333444444444444444443
|
... |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-08 Score=94.05 Aligned_cols=115 Identities=17% Similarity=0.226 Sum_probs=77.0
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-ccc----------ccccchhhh
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF-RIL----------HNDAEAVEL 443 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~-~~l----------~~~~~~~~l 443 (602)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+.+++.+....+. ..+ .+..++..+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcc
Confidence 45788999999999874 77899998765432 123456777777665432211 111 111111122
Q ss_pred cH--HHHHHHHHHHHHHHHHhhhcCCCC-----eEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 444 DW--AKRVNIVKAMAHALAYLHHDCSPS-----VVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 444 ~~--~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.. .....++.+++++++.|| ..+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTEDFSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 21 123456789999999999 555 59999999999999 66899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.3e-08 Score=92.39 Aligned_cols=122 Identities=18% Similarity=0.215 Sum_probs=78.4
Q ss_pred ccccccccccceeeecCC-------CcEEeeeccCCchh------H----H-------------HHHhhhhHhHHHHHHh
Q 047576 375 YCIGTGAYGSVYKAQLPN-------GRVFALKKLNSPET------E----E-------------LAFIRSFRNEAQVLSQ 424 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~------~----~-------------~~~~~~~~~E~~il~~ 424 (602)
..+|.|.-+.||.|...+ +..+|||+.+.... . + .....+..+|...|..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47999998763211 0 0 0011122367776643
Q ss_pred hhcCc--------------cccccccc------cchhhhcHHHHHHHHHHHHHHHHHh-hhcCCCCeEEeCCCCCCeeeC
Q 047576 425 MERGS--------------LFRILHND------AEAVELDWAKRVNIVKAMAHALAYL-HHDCSPSVVHRDISSNNILLN 483 (602)
Q Consensus 425 l~~gs--------------L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~DLkp~NILld 483 (602)
+..-. +.+++... .....++..+...+..+++.++..+ | ..++||||+++.||+++
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~ 159 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWH 159 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEE
Confidence 32110 11111110 0011234455667889999999999 7 77999999999999997
Q ss_pred CCCcceeeccccccccc
Q 047576 484 SKLEAFVADFGTARLLH 500 (602)
Q Consensus 484 ~~~~~kL~DFG~a~~~~ 500 (602)
+ +.++++|||.+...+
T Consensus 160 ~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 160 D-GKVWFIDVSQSVEPT 175 (197)
T ss_pred C-CcEEEEECCCceeCC
Confidence 4 679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-07 Score=93.88 Aligned_cols=124 Identities=22% Similarity=0.331 Sum_probs=94.3
Q ss_pred HhhhcCcccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 SQMERGSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+||+.|++..+|++.. ....+......+|..||..||.|||.+ ++.|+|+++.-+-|++..++-+|+.--. -.....
T Consensus 152 eymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~ 229 (458)
T KOG1266|consen 152 EYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHP 229 (458)
T ss_pred ecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccC-ccccch
Confidence 7889999999987643 245577777889999999999999965 9999999999999999999888763211 111110
Q ss_pred -----CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCC
Q 047576 502 -----DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548 (602)
Q Consensus 502 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 548 (602)
.........+-++|.+||+=.....+.++|||+||...+||..|..-
T Consensus 230 s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 230 SVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred hhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 11112223466899999987777778899999999999999887653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-09 Score=117.21 Aligned_cols=126 Identities=31% Similarity=0.308 Sum_probs=74.9
Q ss_pred CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCccc-ccCCCCCcEEEcc
Q 047576 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVG 251 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~ 251 (602)
.|.+.+.++|++. ....++.-++.|+.|||++|+++.. ..+..+++|++|||+.|.++.+|.- ...+ .|+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 3555666666665 3445566666777777777776643 2566677777777777777766642 1222 26777777
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCC-chhhhCCCCCCEEeccCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI-PNELTRLTQLFHLDLSSNKLS 304 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 304 (602)
+|-++.. ..+.++.+|+.||+++|-|.+.- -.-+..+..|+.|.|.+|.+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7766532 23456666667777777665421 112344556666666666664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.5e-08 Score=105.18 Aligned_cols=172 Identities=25% Similarity=0.231 Sum_probs=119.8
Q ss_pred CccccCcccccccccccceeeec--CCCcEEeeeccCCchhHHHHHhhhh---HhHHHHH--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--PNGRVFALKKLNSPETEELAFIRSF---RNEAQVL-------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~---~~E~~il-------------------- 422 (602)
+.+|.....+|.|.|+.|+.... .++..|++|.+..........+..+ .-|+.+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45788889999999999999864 4678899998875543322211111 1122211
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeecccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLL 499 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a~~~ 499 (602)
||+++++..... .-...++...++++..|++.++-++| ++.++|+|+||+||++..+ +.-++.|||++..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 344444443332 12334677888999999999999999 9999999999999999876 78899999998753
Q ss_pred cCCCCCcccccccccc-ccccccccCcCCccchhHHHHHHHHHHHcCCC
Q 047576 500 HADSSNQTLLAGSYGY-IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH 547 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 547 (602)
..... .....+..| .+|+......+..++|+||||..+.+.++|..
T Consensus 418 ~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 418 AFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ceecc--cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 22111 111233334 35555666778899999999999999999875
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.5e-09 Score=90.46 Aligned_cols=132 Identities=20% Similarity=0.290 Sum_probs=76.0
Q ss_pred cCEEECcCCcCCCCCchhhh---CCCCCCEEEecCCCCCCCCcccc-cCcCCCceeecccccCCCCcccccCCCCCcEEE
Q 047576 174 LNYMSLSRNMLGGLLPQEIG---NLKNLIELDVGDNSLIGPIPLTL-SRLTSLKILILAQNQLSGLPQEIGNLKNLMLLD 249 (602)
Q Consensus 174 L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~ 249 (602)
+..++|++++|. .+++... ....|+..+|++|.+.. .|..| ...+.++.|+|++|.++.+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcc
Confidence 344555555554 2333333 33445555777777764 33333 334567777777777777777777777777777
Q ss_pred ccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCc
Q 047576 250 VGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS 309 (602)
Q Consensus 250 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 309 (602)
++.|.|. ..|..+..+.+|-.|+..+|.+. ++|-.+..-+..-..++.++.+.+..+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 7777776 44555555677777777777665 4443332222333334455555554443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.9e-09 Score=90.27 Aligned_cols=136 Identities=22% Similarity=0.234 Sum_probs=91.1
Q ss_pred CCceeecccccCCCCcccc---cCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEe
Q 047576 221 SLKILILAQNQLSGLPQEI---GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297 (602)
Q Consensus 221 ~L~~L~L~~N~l~~ip~~~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 297 (602)
.+..++|+++++-.+++.. .....|+..+|++|.|....+..-..++.++.|+|++|.++ .+|..+..++.|+.|+
T Consensus 28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 3556777777776665543 34445666677777777433333344567788888888887 5677788888888888
Q ss_pred ccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
++.|.|. ..|..+..+.+|..|+..+|.+. .+|..+..-......++.++++.+.-+...
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 8888887 46666767888888888888776 455444333444555667777777666544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.9e-08 Score=113.28 Aligned_cols=197 Identities=23% Similarity=0.348 Sum_probs=129.1
Q ss_pred CCCCCCEEECcCCcCc-----ccCCCcCEEECcCCc--CCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 153 ALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNM--LGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+....+...+-+|.+. -..++|++|-+..|. +....+..|..++.|++|||++|.=-+.+|..++.|-+|++|
T Consensus 521 ~~~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred chhheeEEEEeccchhhccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 3356677777777664 235578888888886 555556668889999999999887667889999999999999
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcC--CCCCchhhhCCCCCCEEeccCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF--NSSIPNELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l--~~~~p~~~~~l~~L~~L~Ls~N~l 303 (602)
+|++..++.+|.++++|+.|.+|++..+.-...+|.....+++|++|.+..-.. +...-..+.++.+|+.+.......
T Consensus 601 ~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 601 DLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred cccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 999999999999999999999999998886666677777788999888866542 222223344444444444422221
Q ss_pred CCCCCcccCCCCCCC----EEeCCCCCCCCCCCcccccccccccccccCCcCC
Q 047576 304 SGKIPSQIASMEDLT----WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 304 ~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
.+-..+..+.+|. .+.+.++... ..+..+..+.+|+.|.+.+...+
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence 1111222222222 2222222222 33455666666777766665553
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.6e-09 Score=112.06 Aligned_cols=127 Identities=28% Similarity=0.298 Sum_probs=87.4
Q ss_pred CCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCch-hhhCCCCCCEEec
Q 047576 220 TSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN-ELTRLTQLFHLDL 298 (602)
Q Consensus 220 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L 298 (602)
..|.+.+.+.|.+.-+-.++.-++.|+.|+|++|+++..- .+..++.|+.|||++|.++. +|. ....+ .|..|.|
T Consensus 164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc-ccccchhhh-hheeeee
Confidence 3566777777777777677777778888888888887543 66777888888888888873 332 22223 3788888
Q ss_pred cCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC-CcccccccccccccccCCcCC
Q 047576 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI-PGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 299 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~ 352 (602)
.+|.++.. ..+.++.+|..|||++|-|.+.- -.-++.+..|..|+|.+|++.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88887632 34667778888888888777531 123456667778888888775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-07 Score=106.53 Aligned_cols=124 Identities=26% Similarity=0.337 Sum_probs=96.3
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc--
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH-- 500 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~-- 500 (602)
+++.++++...++..+ ..+......+...+..+.+||| ...+.|+|++|.|.++..++..++.|||......
T Consensus 884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5666677777777543 2444555667778889999999 7779999999999999999999999998322110
Q ss_pred -------------------CCC----------CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 501 -------------------ADS----------SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 501 -------------------~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
... .......||+.|.+||...+......+|+|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000 001224689999999999999999999999999999999999999975
Q ss_pred C
Q 047576 552 H 552 (602)
Q Consensus 552 ~ 552 (602)
.
T Consensus 1038 ~ 1038 (1205)
T KOG0606|consen 1038 E 1038 (1205)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-07 Score=99.95 Aligned_cols=176 Identities=26% Similarity=0.319 Sum_probs=118.1
Q ss_pred ccccCcccccc--cccccceeeec---CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH---------------------
Q 047576 369 RKIDSKYCIGT--GAYGSVYKAQL---PNGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------- 422 (602)
..|....-+|. |.+|.||.++. .++..+|+|+-+......... ..-.+|...-
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCcccccCCc
Confidence 34566777899 99999999976 468889998744332210000 0001111100
Q ss_pred ----HhhhcCccccccccccchhhhcHHHHHHHHHHHHH----HHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeecc
Q 047576 423 ----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAH----ALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADF 493 (602)
Q Consensus 423 ----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DF 493 (602)
..+.+.++..+.+.. ...++......+..+..+ |+.++| ..+++|-|+||+||+...+ ...++.||
T Consensus 193 lfiqtE~~~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccccchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 111223333333321 112444555556666666 999999 8999999999999999999 88899999
Q ss_pred cccccccCCCCCccc-----cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 494 GTARLLHADSSNQTL-----LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 494 G~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
|....+......... ..|..-|++||...+ .++.++|+|++|.+..+..+|..++..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 999888665433222 257788999997655 457889999999999999999887653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.4e-08 Score=95.31 Aligned_cols=183 Identities=23% Similarity=0.231 Sum_probs=92.8
Q ss_pred CCCCCEEECcCCcCc---------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCC-CcccccCcCCCc
Q 047576 154 LSKLQLLDLSSNRLR---------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGP-IPLTLSRLTSLK 223 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~---------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~ 223 (602)
.+.++.|||.+|.|+ ..+|.|++|+|++|+++..+-..-..+.+|++|-|.+..+.-. .-..+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 456677777777766 2366666666666666643322223445666666665554321 122344555556
Q ss_pred eeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCC--ccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCC
Q 047576 224 ILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS--TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301 (602)
Q Consensus 224 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 301 (602)
.|+++.|++.. +++..|-+...-|. .+...+.+..+.++-|++.. .++++..+-+..|
T Consensus 150 elHmS~N~~rq-------------~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~ 209 (418)
T KOG2982|consen 150 ELHMSDNSLRQ-------------LNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEG 209 (418)
T ss_pred hhhhccchhhh-------------hccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecC
Confidence 66665554332 11111111111110 12223334444444444432 2345666666666
Q ss_pred CCCCCC-CcccCCCCCCCEEeCCCCCCCCC-CCcccccccccccccccCCcCCCccC
Q 047576 302 KLSGKI-PSQIASMEDLTWLDLSNNNIKGS-IPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 302 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
.|...- -..+..++.+.-|+|+.|+|..- --..+.+++.|..|.+++|++...+-
T Consensus 210 PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~ 266 (418)
T KOG2982|consen 210 PLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLR 266 (418)
T ss_pred cccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccccc
Confidence 654321 12344556666777777777531 12346667777777777777755443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.5e-08 Score=93.71 Aligned_cols=182 Identities=24% Similarity=0.300 Sum_probs=109.9
Q ss_pred cCCCCCCCCEEECcCCcCc---------ccCCCcCEEECcCCcCCC--CCchhhhCCCCCCEEEecCCCCCCCCcccccC
Q 047576 150 EISALSKLQLLDLSSNRLR---------GRLTNLNYMSLSRNMLGG--LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~---------~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 218 (602)
.++.+..++.|-+.+..|. ...+.++.|||..|.|+. .+...+.+|+.|++|+|+.|++...|-..-..
T Consensus 40 ~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p 119 (418)
T KOG2982|consen 40 GVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLP 119 (418)
T ss_pred eeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCccc
Confidence 3444445556666666664 236778888888888873 34445667788888888888877544332245
Q ss_pred cCCCceeecccccCCC--CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCch--hhhCCCCCC
Q 047576 219 LTSLKILILAQNQLSG--LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN--ELTRLTQLF 294 (602)
Q Consensus 219 l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~ 294 (602)
+.+|++|-|.+..++- .-..+..++.++.|.+|.|++. .+.+..|-....-|. .+..++.+.
T Consensus 120 ~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~ 185 (418)
T KOG2982|consen 120 LKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLE 185 (418)
T ss_pred ccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHH
Confidence 6677777777766653 3444566677777777776443 233333433321111 122333444
Q ss_pred EEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC-CCcccccccccccccccCCcCC
Q 047576 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS-IPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 295 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
.+.++-|++... ++++..+-+..|.+... .-.....++.+..|+|+.|++.
T Consensus 186 ~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~id 237 (418)
T KOG2982|consen 186 QLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNID 237 (418)
T ss_pred HHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccc
Confidence 445555565533 46778888888877643 2234556777888999999884
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=6e-07 Score=82.66 Aligned_cols=108 Identities=23% Similarity=0.359 Sum_probs=71.8
Q ss_pred cccccccccceeeecCCCcEEeeeccCCchhHHHH-----HhhhhHhHHHHHHhh-------------------------
Q 047576 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELA-----FIRSFRNEAQVLSQM------------------------- 425 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-----~~~~~~~E~~il~~l------------------------- 425 (602)
.+++|+-+.+|.+.+. |..+++|.-.++....+. -..+-.+|+.++..+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5688999999999774 444666654333222111 223455677776332
Q ss_pred hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 426 ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 426 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++..+.+.+. .....++..+-.-+.-|| ..+|+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~----------~~~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALE----------EARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHH----------hcchHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 2222222222 113457777888888899 88999999999999998765 89999999975
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=92.65 Aligned_cols=150 Identities=13% Similarity=0.135 Sum_probs=103.9
Q ss_pred ecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccchh----------h-------hcHHHHHHH
Q 047576 389 QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAEAV----------E-------LDWAKRVNI 451 (602)
Q Consensus 389 ~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~~~----------~-------l~~~~~~~i 451 (602)
+..++..|.|...+.... .......+-++-++-++|+++..+++...... + +........
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~G 109 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLG 109 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHH
Confidence 345788888887765543 22344556677788899999998887543211 1 223345567
Q ss_pred HHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccccccccccccccccccCcCCccch
Q 047576 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531 (602)
Q Consensus 452 ~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 531 (602)
+.||+.||.|||+ +.+++|++|.-+.|+++..|+-||++|..+.....-........--..|..|+.+.... ...|
T Consensus 110 l~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 110 LFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 8899999999996 67999999999999999999999999998765433221111111122355565433322 3469
Q ss_pred hHHHHHHHHHHHcC
Q 047576 532 VYSFGVVTLEVLMG 545 (602)
Q Consensus 532 vwSlGvil~elltG 545 (602)
.|.||++++|++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-06 Score=80.38 Aligned_cols=121 Identities=20% Similarity=0.311 Sum_probs=77.5
Q ss_pred CcccccccccccceeeecCCCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHh-----------------------
Q 047576 373 SKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQ----------------------- 424 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~----------------------- 424 (602)
...++-+|+-+.|+++.+ .|+.+.||.--.... +..-..++..+|+..+..
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456788999999999988 678777774332221 212223455677776622
Q ss_pred --hhc-CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceeeccccccc
Q 047576 425 --MER-GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVADFGTARL 498 (602)
Q Consensus 425 --l~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFG~a~~ 498 (602)
+++ .++.+++....... .+-......+..|-+.+.-|| +.+|+||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 222 12333332211111 111222567888889999999 88999999999999996554 347999999864
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.7e-07 Score=88.84 Aligned_cols=205 Identities=20% Similarity=0.188 Sum_probs=126.4
Q ss_pred CCCCCCCCEEECcCCcCcc-----------cCCCcCEEECcCCcCCC---CC-------chhhhCCCCCCEEEecCCCCC
Q 047576 151 ISALSKLQLLDLSSNRLRG-----------RLTNLNYMSLSRNMLGG---LL-------PQEIGNLKNLIELDVGDNSLI 209 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~~-----------~l~~L~~L~L~~N~l~~---~~-------p~~~~~l~~L~~L~L~~N~l~ 209 (602)
+.-+..++.+|||+|-|.. .-.+|+..+++.--... .+ -+.+.++++|+..+||+|.|.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 4446778888899888862 24566666665533221 11 234556778888888888876
Q ss_pred CCCccc----ccCcCCCceeecccccCCCCc-----cc---------ccCCCCCcEEEccCCCCCCCCCC-----ccCCC
Q 047576 210 GPIPLT----LSRLTSLKILILAQNQLSGLP-----QE---------IGNLKNLMLLDVGNNDIIGPIPS-----TLGLF 266 (602)
Q Consensus 210 ~~~p~~----l~~l~~L~~L~L~~N~l~~ip-----~~---------~~~l~~L~~L~L~~N~l~~~~p~-----~l~~l 266 (602)
...|.. +++-+.|++|.|++|.+.-+. .+ ..+-|.|+......|++.. .|. .+..-
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~a~~l~sh 184 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELSAALLESH 184 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhcc-CcHHHHHHHHHhh
Confidence 666654 345577888888888765432 11 1234678888888888752 221 12222
Q ss_pred CCCccccCCCCcCCCCCc-----hhhhCCCCCCEEeccCCCCCCCC----CcccCCCCCCCEEeCCCCCCCCCCCccc--
Q 047576 267 SDLSYLDLSCNQFNSSIP-----NELTRLTQLFHLDLSSNKLSGKI----PSQIASMEDLTWLDLSNNNIKGSIPGEI-- 335 (602)
Q Consensus 267 ~~L~~L~L~~N~l~~~~p-----~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-- 335 (602)
.+|+++.+..|.|.-..- ..+..+.+|+.|||.+|-++-.. ...+..++.|+.|.+..+-++.....++
T Consensus 185 ~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~ 264 (388)
T COG5238 185 ENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLR 264 (388)
T ss_pred cCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHH
Confidence 467788888887753211 12345677888888888876332 2334566778888888887775443332
Q ss_pred ----ccccccccccccCCcCCCccC
Q 047576 336 ----TKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 336 ----~~l~~L~~L~l~~N~l~g~~p 356 (602)
...++|..|-..+|...|.+-
T Consensus 265 ~f~e~~~p~l~~L~~~Yne~~~~~i 289 (388)
T COG5238 265 RFNEKFVPNLMPLPGDYNERRGGII 289 (388)
T ss_pred HhhhhcCCCccccccchhhhcCcee
Confidence 134677788888887766543
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.9e-08 Score=96.54 Aligned_cols=148 Identities=24% Similarity=0.239 Sum_probs=75.5
Q ss_pred CCCCEEECcCCcCcc--------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCC-CCCCC-cccccCcCCCce
Q 047576 155 SKLQLLDLSSNRLRG--------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-LIGPI-PLTLSRLTSLKI 224 (602)
Q Consensus 155 ~~L~~L~Ls~N~i~~--------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~-p~~l~~l~~L~~ 224 (602)
+.|++||||+-.|+. .+.+|+.|.|.++++...+...++.-.+|+.|+|+... |+... ---+.+++.|..
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 357778887777762 35667777777777777777777777777777776643 22110 112455666666
Q ss_pred eecccccCCC-C-cccccC-CCCCcEEEccCCCC---CCCCCCccCCCCCCccccCCCCc-CCCCCchhhhCCCCCCEEe
Q 047576 225 LILAQNQLSG-L-PQEIGN-LKNLMLLDVGNNDI---IGPIPSTLGLFSDLSYLDLSCNQ-FNSSIPNELTRLTQLFHLD 297 (602)
Q Consensus 225 L~L~~N~l~~-i-p~~~~~-l~~L~~L~L~~N~l---~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ 297 (602)
|+|+.+.++. . -..+.. -++|+.|+|++.+= ..-+..-....++|..||||.|. ++...-..|..++.|++|.
T Consensus 265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS 344 (419)
T ss_pred cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence 6666666554 1 111111 14555555555321 10111111234455555555443 2222223344455555555
Q ss_pred ccCCC
Q 047576 298 LSSNK 302 (602)
Q Consensus 298 Ls~N~ 302 (602)
|+.+.
T Consensus 345 lsRCY 349 (419)
T KOG2120|consen 345 LSRCY 349 (419)
T ss_pred hhhhc
Confidence 54443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.4e-06 Score=83.08 Aligned_cols=122 Identities=22% Similarity=0.283 Sum_probs=84.2
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-----ccccccc------------c
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS-----LFRILHN------------D 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs-----L~~~l~~------------~ 437 (602)
..++.|..+.||++...+|+.+++|........ .....+..|.++++++.... +..+... .
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 457899999999999877788999987654321 12346677888886664311 1111110 0
Q ss_pred cch---------hhhcHHHHHHHHHHHHHHHHHhhhcC------------------------------------------
Q 047576 438 AEA---------VELDWAKRVNIVKAMAHALAYLHHDC------------------------------------------ 466 (602)
Q Consensus 438 ~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 466 (602)
.++ ..++..+...++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 000 12456677888999999999998421
Q ss_pred -----------CCCeEEeCCCCCCeeeCC--CCcceeeccccccc
Q 047576 467 -----------SPSVVHRDISSNNILLNS--KLEAFVADFGTARL 498 (602)
Q Consensus 467 -----------~~~ivH~DLkp~NILld~--~~~~kL~DFG~a~~ 498 (602)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.6e-06 Score=80.58 Aligned_cols=113 Identities=23% Similarity=0.363 Sum_probs=66.5
Q ss_pred cceeeecCCCcEEeeeccCCchh-----------------------HHHHHhhhhHhHHHHHHhhhcCc-----------
Q 047576 384 SVYKAQLPNGRVFALKKLNSPET-----------------------EELAFIRSFRNEAQVLSQMERGS----------- 429 (602)
Q Consensus 384 ~Vy~~~~~~g~~vavK~l~~~~~-----------------------~~~~~~~~~~~E~~il~~l~~gs----------- 429 (602)
.||.|..++|..+|||+.+.... .......+.++|...|..+..-.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 38999988999999998763211 00111234556777774432211
Q ss_pred ---ccccccccc------chhhhcHHHHHHHHHHHHHHHHH-hhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 430 ---LFRILHNDA------EAVELDWAKRVNIVKAMAHALAY-LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 430 ---L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
+.+++...+ ....++......++.+++..+.. +| ..||+|||+.+.||+++++ .+.++|||.+...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 111222000 00111234456678888886666 46 7899999999999999988 9999999988654
Q ss_pred c
Q 047576 500 H 500 (602)
Q Consensus 500 ~ 500 (602)
.
T Consensus 157 ~ 157 (188)
T PF01163_consen 157 S 157 (188)
T ss_dssp T
T ss_pred C
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-08 Score=98.20 Aligned_cols=174 Identities=22% Similarity=0.236 Sum_probs=118.2
Q ss_pred CcCEEECcCCcCCC-CCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccc-cCCC--CcccccCCCCCcEE
Q 047576 173 NLNYMSLSRNMLGG-LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN-QLSG--LPQEIGNLKNLMLL 248 (602)
Q Consensus 173 ~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~--ip~~~~~l~~L~~L 248 (602)
.|++||||+..|+. ..-..+..+.+|+.|.|.++++...+-..+..-.+|+.|+|+.+ .|+. +---+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 58888888888873 23345667788888888888888888888888888888888875 4554 22345778888888
Q ss_pred EccCCCCCCCCCC-ccCC-CCCCccccCCCCc---CCCCCchhhhCCCCCCEEeccCCC-CCCCCCcccCCCCCCCEEeC
Q 047576 249 DVGNNDIIGPIPS-TLGL-FSDLSYLDLSCNQ---FNSSIPNELTRLTQLFHLDLSSNK-LSGKIPSQIASMEDLTWLDL 322 (602)
Q Consensus 249 ~L~~N~l~~~~p~-~l~~-l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L 322 (602)
+|+.+.++...-. .+.. -++|+.|+|++.. ....+..-..+.++|.+||||+|. |+...-..|..++.|++|.|
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSl 345 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSL 345 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeeh
Confidence 8888887654321 1111 2467777887653 222233334567888888888876 55444456677888888888
Q ss_pred CCCCCCCCCCcc---cccccccccccccC
Q 047576 323 SNNNIKGSIPGE---ITKLSRLDYLNLSG 348 (602)
Q Consensus 323 ~~N~l~~~~p~~---~~~l~~L~~L~l~~ 348 (602)
+.+.. .+|.. +...|.|.+|++.+
T Consensus 346 sRCY~--i~p~~~~~l~s~psl~yLdv~g 372 (419)
T KOG2120|consen 346 SRCYD--IIPETLLELNSKPSLVYLDVFG 372 (419)
T ss_pred hhhcC--CChHHeeeeccCcceEEEEecc
Confidence 77653 45553 45667778887543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-06 Score=100.29 Aligned_cols=221 Identities=28% Similarity=0.344 Sum_probs=136.0
Q ss_pred CCccchhccccCC-ccccCCcc-CCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCE
Q 047576 130 NLESLRILAYYDG-FTGSIPSE-ISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200 (602)
Q Consensus 130 ~L~~L~l~~~~~~-~~~~ip~~-l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 200 (602)
+|++|-+. .+. ....++.. |..++.|++|||++|.=- |.|-+|++|+|++..++ .+|..+++|+.|.+
T Consensus 546 ~L~tLll~--~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQ--RNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEe--ecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 56665554 332 24555554 677899999999976432 45778999999999988 77889999999999
Q ss_pred EEecCCCCCCCCcccccCcCCCceeecccccCCC---CcccccCCCCCcEEEccCCCC----------------------
Q 047576 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG---LPQEIGNLKNLMLLDVGNNDI---------------------- 255 (602)
Q Consensus 201 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---ip~~~~~l~~L~~L~L~~N~l---------------------- 255 (602)
|++.++.-...+|.....|++|++|.+..-.... .-..+.++.+|+.|.......
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhc
Confidence 9999887666667777778999998887654332 223345555555554433222
Q ss_pred ---CCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCC------CCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCC
Q 047576 256 ---IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT------QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNN 326 (602)
Q Consensus 256 ---~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 326 (602)
.-..+.++..+.+|+.|.+.++.++........... ++..+...+... -..+....-.++|+.|.+....
T Consensus 703 ~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~-~r~l~~~~f~~~L~~l~l~~~~ 781 (889)
T KOG4658|consen 703 GCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHM-LRDLTWLLFAPHLTSLSLVSCR 781 (889)
T ss_pred ccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcccc-ccccchhhccCcccEEEEeccc
Confidence 012345567788899999988887643222211111 111111111110 0122333456788888888776
Q ss_pred CCCCCCcccccccccccccccCCcCCCc
Q 047576 327 IKGSIPGEITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 327 l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 354 (602)
....+.+....+..+..+.+..+.+.|.
T Consensus 782 ~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 782 LLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccccCCCHHHHhhhcccEEecccccccc
Confidence 6655555555565566556666666654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=9.9e-07 Score=95.58 Aligned_cols=97 Identities=28% Similarity=0.382 Sum_probs=77.2
Q ss_pred HHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC---------Cccccccccccccccccc
Q 047576 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS---------NQTLLAGSYGYIAPELAY 522 (602)
Q Consensus 452 ~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~ 522 (602)
+.+++.|+.|+|. +.++||++|.|++|.+++.+..|++.|+++........ ......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999996 68999999999999999999999999998876544211 111123456899999999
Q ss_pred cCcCCccchhHHHHHHHHHHH-cCCCCCC
Q 047576 523 TMVMTEKYDVYSFGVVTLEVL-MGKHPRD 550 (602)
Q Consensus 523 ~~~~~~~~DvwSlGvil~ell-tG~~Pf~ 550 (602)
....+.++|+||+|+.+|.+. .|+.-+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 988889999999999999999 4555444
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.8e-06 Score=85.97 Aligned_cols=107 Identities=21% Similarity=0.356 Sum_probs=86.3
Q ss_pred hhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcccccccccccccccc
Q 047576 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521 (602)
Q Consensus 442 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 521 (602)
..+|.-.++.++.+|.+.+.+| ..|.+-||++++|+|+++++.+.|+|=..-.... ........+|...|.+||.-
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~-ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA-NGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeecc-CCceEecccCccccCCHHHh
Confidence 3789999999999999999999 7799999999999999999999999855433322 22223345788999999964
Q ss_pred c-----cCcCCccchhHHHHHHHHHHHcC-CCCCCCC
Q 047576 522 Y-----TMVMTEKYDVYSFGVVTLEVLMG-KHPRDLH 552 (602)
Q Consensus 522 ~-----~~~~~~~~DvwSlGvil~elltG-~~Pf~~~ 552 (602)
. +-.-+...|-|.+|+++++++.| ++||.+.
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 3 23346778999999999999987 9999764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.8e-06 Score=81.22 Aligned_cols=52 Identities=25% Similarity=0.329 Sum_probs=45.0
Q ss_pred cHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-------CCcceeeccccccc
Q 047576 444 DWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-------KLEAFVADFGTARL 498 (602)
Q Consensus 444 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-------~~~~kL~DFG~a~~ 498 (602)
+...+..++.+++..+.-|| ..||+|+|+++.|||++. ++.+.++||+.+..
T Consensus 136 ~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 136 DPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 34466789999999999999 889999999999999975 46789999998754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 602 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-26 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 5e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 6e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 5e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 9e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 2e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 4e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 6e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 8e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 8e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 7e-75
Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 26/281 (9%)
Query: 81 SWTMDYDSDHCEWIGITCNSAG---SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL 137
SW D + W+G+ C++ + L LS N+ + + + P L L +
Sbjct: 26 SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL-YI 83
Query: 138 AYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKN 197
+ G IP I+ L++L L ++ + G + P + +K
Sbjct: 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI-----------------PDFLSQIKT 126
Query: 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLM-LLDVGNNDI 255
L+ LD N+L G +P ++S L +L + N++SG +P G+ L + + N +
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 256 IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME 315
G IP T + L+++DLS N + L+ N L+ + + +
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK 244
Query: 316 DLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
+L LDL NN I G++P +T+L L LN+S N L G +P
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-51
Identities = 52/186 (27%), Positives = 79/186 (42%), Gaps = 6/186 (3%)
Query: 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG--PIPLTLSRLTSLKILILA-QNQLSG 234
G+L + LD+ +L PIP +L+ L L L + N L G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 235 -LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL 293
+P I L L L + + ++ G IP L L LD S N + ++P ++ L L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 294 FHLDLSSNKLSGKIPSQIASMEDL-TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ N++SG IP S L T + +S N + G IP L+ L +++LS N L
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210
Query: 353 GRVPYS 358
G
Sbjct: 211 GDASVL 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 188 LPQEIGNLKNL----IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG---LPQEIG 240
+ +++GN L D + + +G + T ++ + L L+ L +P +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 241 NLKNLMLLDVGN-NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLS 299
NL L L +G N+++GPIP + + L YL ++ + +IP+ L+++ L LD S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 300 SNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD-YLNLSGNKLSGRVPYS 358
N LSG +P I+S+ +L + N I G+IP S+L + +S N+L+G++P +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 8e-34
Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 3/136 (2%)
Query: 235 LPQEIGNLKNLMLLDVGNNDIIG--PIPSTLGLFSDLSYLDLS-CNQFNSSIPNELTRLT 291
L + LD+ ++ PIPS+L L++L + N IP + +LT
Sbjct: 42 LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT 101
Query: 292 QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
QL +L ++ +SG IP ++ ++ L LD S N + G++P I+ L L + GN++
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 352 SGRVPYSNKHLSSMPT 367
SG +P S S + T
Sbjct: 162 SGAIPDSYGSFSKLFT 177
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 130 NLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSR 181
+ ++ + + + + + L LDL +NR+ G +L L+ +++S
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 182 NMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL 214
N L G +PQ GNL+ +N + PL
Sbjct: 278 NNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-68
Identities = 89/271 (32%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L L+ +N F G + L L + + F G++P + S L+ L LSSN
Sbjct: 274 LSLA-EN-KFTGEIPDFLSGACDTLTGLDL--SGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 167 LRG--------RLTNLNYMSLSRNMLGGLLPQEIGNLK-NLIELDVGDNSLIGPIPLTLS 217
G ++ L + LS N G LP+ + NL +L+ LD+ N+ GPI L
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 218 R--LTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274
+ +L+ L L N +G +P + N L+ L + N + G IPS+LG S L L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGE 334
N IP EL + L L L N L+G+IPS +++ +L W+ LSNN + G IP
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 335 ITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
I +L L L LS N SG +P S+
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSL 540
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-67
Identities = 82/324 (25%), Positives = 134/324 (41%), Gaps = 48/324 (14%)
Query: 78 WNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNG-----------RLSHLNFS 126
W+++ + C + G+TC + + LS +N L L S
Sbjct: 33 WSSN------KNPCTFDGVTCRD-DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85
Query: 127 C---------FPNLESLRILA-YYDGFTGSIPS--EISALSKLQLLDLSSNRLRG----- 169
F SL L + +G + + + + S L+ L++SSN L
Sbjct: 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145
Query: 170 ---RLTNLNYMSLSRNMLGGLLPQEI---GNLKNLIELDVGDNSLIGPIPLTLSRLTSLK 223
+L +L + LS N + G L L + N + G + + SR +L+
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLE 203
Query: 224 ILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283
L ++ N S +G+ L LD+ N + G + ++L L++S NQF I
Sbjct: 204 FLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 284 PNELTRLTQLFHLDLSSNKLSGKIPSQIA-SMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
P L L +L L+ NK +G+IP ++ + + LT LDLS N+ G++P S L+
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 343 YLNLSGNKLSGRVPYSNKHLSSMP 366
L LS N SG +P L M
Sbjct: 322 SLALSSNNFSGELPMD--TLLKMR 343
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-64
Identities = 84/262 (32%), Positives = 126/262 (48%), Gaps = 17/262 (6%)
Query: 115 NFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALS-KLQLLDLSSNRLRGR--- 170
NF+G L L+ L + ++ F+G +P ++ LS L LDLSSN G
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDL--SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 171 ------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
L + L N G +P + N L+ L + N L G IP +L L+ L+
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 225 LILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283
L L N L G +PQE+ +K L L + ND+ G IPS L ++L+++ LS N+ I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 284 PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDY 343
P + RL L L LS+N SG IP+++ L WLDL+ N G+IP + K S
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS---- 562
Query: 344 LNLSGNKLSGRVPYSNKHLSSM 365
++ N ++G+ K+
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMK 584
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-62
Identities = 81/249 (32%), Positives = 121/249 (48%), Gaps = 13/249 (5%)
Query: 130 NLESLRILA-YYDGFTGSIPSE-ISALSKLQLLDLSSNRLRGRL--------TNLNYMSL 179
+ L LA + F+G +P + + + L++LDLS N G L +L + L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 180 SRNMLGGLLPQEIGN--LKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LP 236
S N G + + L EL + +N G IP TLS + L L L+ N LSG +P
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296
+G+L L L + N + G IP L L L L N IP+ L+ T L +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 297 DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
LS+N+L+G+IP I +E+L L LSNN+ G+IP E+ L +L+L+ N +G +P
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 357 YSNKHLSSM 365
+ S
Sbjct: 556 AAMFKQSGK 564
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 6e-60
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 20/275 (7%)
Query: 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI--SALSKLQLL 160
+ L LS N F+G L + +L +L + + F+G I + + + LQ L
Sbjct: 344 GLKVLDLS-FN-EFSGELPESLTNLSASLLTLDL--SSNNFSGPILPNLCQNPKNTLQEL 399
Query: 161 DLSSNRLRGR-------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP 213
L +N G+ + L + LS N L G +P +G+L L +L + N L G IP
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 214 LTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL 272
L + +L+ LIL N L+G +P + N NL + + NN + G IP +G +L+ L
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519
Query: 273 DLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332
LS N F+ +IP EL L LDL++N +G IP+ + ++ N I G
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRY 575
Query: 333 GEITKLSRLDYLNLSGN--KLSGRVPYSNKHLSSM 365
I + +GN + G LS+
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-58
Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 21/264 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSN 165
L L N + G + S N +L + + TG IP I L L +L LS+N
Sbjct: 471 LILD-FN-DLTGEIP----SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 166 RLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
G +L ++ L+ N+ G +P + I N + G + +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKRYVYIKN 580
Query: 219 LTSLKILILAQN--QLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
K A N + G +++ L ++ + G T + +LD+S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
N + IP E+ + LF L+L N +SG IP ++ + L LDLS+N + G IP +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 336 TKLSRLDYLNLSGNKLSGRVPYSN 359
+ L+ L ++LS N LSG +P
Sbjct: 701 SALTMLTEIDLSNNNLSGPIPEMG 724
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-57
Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 48/270 (17%)
Query: 372 DSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+K +G G +G VYK +L +G + A+K+L T+ F+ E +++S
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLL 90
Query: 425 ------------------MERGSLFRILHNDAEAVE-LDWAKRVNIVKAMAHALAYLHHD 465
M GS+ L E+ LDW KR I A LAYLH
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-QTLLAGSYGYIAPELAYTM 524
C P ++HRD+ + NILL+ + EA V DFG A+L+ ++ T + G+ G+IAPE T
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID-------------VLDQ 571
+EK DV+ +GV+ LE++ G+ DL + D +ML+D ++D
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLAN---DDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 572 RLPPPVDRKVIQDILLVSTISFACLQSNPK 601
L + ++ ++ V + C QS+P
Sbjct: 268 DLQGNYKDEEVEQLIQV---ALLCTQSSPM 294
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-50
Identities = 51/263 (19%), Positives = 103/263 (39%), Gaps = 22/263 (8%)
Query: 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD-GFTGSIPSEISALSKLQLL 160
I +N + + + + NL+ L + Y+ +P+ + AL ++QL+
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLK-WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 161 DLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLI-GPIPLTLSRL 219
+++ NR S + + + + + +G N+L P+ +L ++
Sbjct: 279 NVACNRGI---------SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 220 TSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF 279
L +L NQL G G+ L L++ N I + G + L + N+
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389
Query: 280 NSSIPN--ELTRLTQLFHLDLSSNKLSG-------KIPSQIASMEDLTWLDLSNNNIKGS 330
IPN + ++ + +D S N++ + +++ ++LSNN I
Sbjct: 390 -KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448
Query: 331 IPGEITKLSRLDYLNLSGNKLSG 353
+ S L +NL GN L+
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-48
Identities = 43/273 (15%), Positives = 105/273 (38%), Gaps = 18/273 (6%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L KD +N + + + S L+ +I + T + + L+KL+ + ++
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSP 217
Query: 167 LRGR--LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
+ + NLK+L +++V + + +P L L +++
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 225 LILAQNQLSGLPQ---------EIGNLKNLMLLDVGNNDII-GPIPSTLGLFSDLSYLDL 274
+ +A N+ Q + + + ++ +G N++ P+ ++L L L+
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG-SIPG 333
NQ +P +L L+L+ N+++ + E + L ++N +K
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIF 396
Query: 334 EITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMP 366
+ +S + ++ S N++ K+ +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGS---VDGKNFDPLD 426
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-46
Identities = 47/272 (17%), Positives = 91/272 (33%), Gaps = 34/272 (12%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGF-TGSIPSEISALSKLQLLDLSSNRLRG------R 170
+ + P E ++I+ Y+ T + + + + KL +L+ N+L G
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS 351
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQ 229
L ++L+ N + + G + + L N L P ++ + + +
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411
Query: 230 NQLSG--------LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281
N++ L N+ +++ NN I S LS ++L N
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 282 -------SIPNELTRLTQLFHLDLSSNKLSGKIPSQIA--SMEDLTWLDLSNNNIKGSIP 332
L +DL NKL+ + ++ L +DLS N+ P
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FP 529
Query: 333 GEITKLSRL------DYLNLSGNKLSGRVPYS 358
+ S L + + GN+ P
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-44
Identities = 47/329 (14%), Positives = 104/329 (31%), Gaps = 63/329 (19%)
Query: 70 KALLNTGWWNNSWTMDYDSDHCEW-IGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCF 128
AL W + W + G+ G+ L+ NGR++ L+ F
Sbjct: 40 DALNGKNWSQQGFG---TQPGANWNFNKELDMWGAQPGVSLNS-----NGRVTGLSLEGF 91
Query: 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-----------RLTNLNYM 177
G +G +P I L++L++L L S+ + +
Sbjct: 92 -------------GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 178 SLSRNMLGGLLPQEIGNLK--NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL 235
R +LI+ + + I + + N ++ +
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFV 198
Query: 236 PQEIGNLKNLMLLDVGNNDIIGPIPSTLGL-------------------FSDLSYLDLSC 276
+ + L L +GN+ + DL+ +++
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 277 NQFNSSIPNELTRLTQLFHLDLSSNKL--------SGKIPSQIASMEDLTWLDLSNNNIK 328
+ +P L L ++ ++++ N+ + + E + + + NN+K
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 329 -GSIPGEITKLSRLDYLNLSGNKLSGRVP 356
+ + K+ +L L N+L G++P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-43
Identities = 44/256 (17%), Positives = 89/256 (34%), Gaps = 37/256 (14%)
Query: 130 NLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLS 180
+ L L Y+ T + +++ L + N+L+ ++ ++ + S
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 181 RNMLGGL-------LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLS 233
N +G + L N+ +++ +N + S + L + L N L+
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 234 GLP--------QEIGNLKNLMLLDVGNNDIIGPIPSTLGL--FSDLSYLDLSCNQFNSSI 283
+P + N L +D+ N + + L +DLS N F S
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKF 528
Query: 284 PNELTRLTQLFHL------DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITK 337
P + + L D N+ + P I LT L + +N+I+ + +I
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI-- 585
Query: 338 LSRLDYLNLSGNKLSG 353
+ L++ N
Sbjct: 586 TPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 43/272 (15%), Positives = 92/272 (33%), Gaps = 38/272 (13%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRIL-AYYDGFTGSIPS--EISALSKLQLLDLSSNRLRG 169
N+ +N +++ + + E + L ++ IP+ + ++S + +D S N +
Sbjct: 359 NLAYN-QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 170 --------------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL------- 208
+ N++ ++LS N + + L +++ N L
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 209 IGPIPLTLSRLTSLKILILAQNQLSGLPQEI--GNLKNLMLLDVGNNDIIGPIPSTLGLF 266
+ L + L N+L+ L + L L+ +D+ N P+
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 267 SDLSYL------DLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWL 320
S L D N+ P +T L L + SN + + +I +++ L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVL 592
Query: 321 DLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
D+ +N + L +K
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 20/115 (17%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------------GRLTNLNYMSLSRNMLGGLLPQEI 192
P++ S L+ + + R +L + + N + + ++I
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV-NEKI 585
Query: 193 GNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLML 247
N+ LD+ DN I + + +L ++ Q+I L +
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK----TQDIRGCDALDI 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-47
Identities = 66/262 (25%), Positives = 106/262 (40%), Gaps = 16/262 (6%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------R 170
+L L + F L L ++ + P L L++L+L N L
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
TNL + L N + + KNLI LD+ N L T +L +L+ L+L+ N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 231 QLSGLPQE---IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL 287
++ L E I +L L++ +N I P L L L+ Q S+ +L
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 288 T---RLTQLFHLDLSSNKLSGKIPSQIASMED--LTWLDLSNNNIKGSIPGEITKLSRLD 342
T + +L LS+++LS + ++ LT LDLS NN+ L +L+
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 343 YLNLSGNKLSGRVPYSNKHLSS 364
Y L N + +S L +
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFN 297
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-42
Identities = 54/270 (20%), Positives = 100/270 (37%), Gaps = 24/270 (8%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLRGR------- 170
L ++ F L+ L L + G + + L L+ L LS++ R
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 171 ----LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKIL 225
+ L+ ++L++N + + L +L LD+G N + + L ++ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 226 ILAQNQLSGLPQE-IGNLKNLMLLDVGNNDI--IGPIPSTLGLFSDLSYLDLSCNQFNSS 282
L+ N+ L + + +L L + + + PS +L+ LDLS N +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 283 IPNELTRLTQLFHLDLSSNKLS--------GKIPSQIASMEDLTWLDLSNNNIKGSIPGE 334
+ L L +L LDL N L+ G + + L L+L +N
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 335 ITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
L L ++L N L+ + S
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-42
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 15/233 (6%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+P ++ + + +L+L+ N+LR R + L + + N + L P+ L L
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIG 257
L++ N L T + T+L L L N + + KNL+ LD+ +N +
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 258 PIPSTLGLFSDLSYLDLSCNQFNSSIPNELT--RLTQLFHLDLSSNKLSGKIPSQIASME 315
T +L L LS N+ + EL + L L+LSSN++ P ++
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 316 DLTWLDLSNNNIKGSIPGEIT---KLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
L L L+N + S+ ++ + + L+LS ++LS + L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-42
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 24/259 (9%)
Query: 119 RLSHLNFSCFPNLESLRI--LAYYDGFTGSIPSEI---SALSKLQLLDLSSNRLRG---- 169
+ + + F L +L+ L+ ++ +E A S L +L+L+ N++
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 170 ---RLTNLNYMSLSRNMLGGLLP-QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225
L +L + L N +G L QE L+N+ E+ + N + + + + SL+ L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 226 ILAQNQLSGL---PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS- 281
+L + L + P L+NL +LD+ NN+I L L LDL N
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 282 -------SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGE 334
L L+ L L+L SN + +L +DL NN+
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 335 ITKLSRLDYLNLSGNKLSG 353
L LNL N ++
Sbjct: 580 FNNQVSLKSLNLQKNLITS 598
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-41
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 7/207 (3%)
Query: 157 LQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212
++ D S +L TN+ ++L+ N L L L LDVG N++
Sbjct: 6 HEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 213 PLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSY 271
P +L LK+L L N+LS L + NL L + +N I + +L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 272 LDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED--LTWLDLSNNNIKG 329
LDLS N +S+ +L L L LS+NK+ ++ + L L+LS+N IK
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 330 SIPGEITKLSRLDYLNLSGNKLSGRVP 356
PG + RL L L+ +L +
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLT 212
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-40
Identities = 59/268 (22%), Positives = 98/268 (36%), Gaps = 23/268 (8%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSN 165
L LS ++ L++ F + L IL + + S L L++LDL N
Sbjct: 358 LSLS-NSFTSLRTLTNETFVSLAHS-PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 166 RLRG--------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLT 215
+ L N+ + LS N L + +L L + +L + P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 216 LSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDI--------IGPIPSTLGLF 266
L +L IL L+ N ++ + + + L+ L +LD+ +N++ G L
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 267 SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNN 326
S L L+L N F+ L +L +DL N L+ S + L L+L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 327 IKGSIPGEI-TKLSRLDYLNLSGNKLSG 353
I L L++ N
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 16/257 (6%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------R 170
+S L L L++L ++ + + + L L L SN ++ +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLTLSRLTSLKILILA 228
NL + LS N L L+NL EL + +N + + L + +SLK L L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 229 QNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF---SDLSYLDLSCNQFNSSIP 284
NQ+ P + L L + N + + L L + + L LS +Q +++
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 285 NELT--RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
+ T L LDLS N L+ A + L + L NNI+ + L +
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 343 YLNLSGNKLSGRVPYSN 359
YLNL + + ++
Sbjct: 300 YLNLKRSFTKQSISLAS 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 60/274 (21%), Positives = 99/274 (36%), Gaps = 27/274 (9%)
Query: 119 RLSHLNFSCFPNLE--SLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG------ 169
+LS + + F L+ +L +L Y+ + L +L+ L N ++
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 170 -RLTNLNYMSLSRNM---------LGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRL 219
L N+ Y++L R+ L + LK L L++ DN + G + L
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 220 TSLKILILAQNQLSGLPQEIGNLKNLML-----LDVGNNDIIGPIPSTLGLFSDLSYLDL 274
+LK L L+ + S +L L++ N I L LDL
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 275 SCNQFNSSIP-NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG--SI 331
N+ + E L +F + LS NK + A + L L L +K S
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472
Query: 332 PGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
P L L L+LS N ++ + L +
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-40
Identities = 55/266 (20%), Positives = 99/266 (37%), Gaps = 25/266 (9%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------- 169
+ + + F ++L L ++G + + L LQ L LS+N+++
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 170 -RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLS---RLTSLKIL 225
++L + LS N + P + L L + + L + L TS++ L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 226 ILAQNQLSGLPQEIG---NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282
L+ +QLS NL +LD+ N++ + L Y L N
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 283 IPNELTRLTQLFHLDLSSN---------KLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
+ L L + +L+L + L ++ L L++ +N+I G
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 334 EITKLSRLDYLNLSGNKLSGRVPYSN 359
T L L YL+LS + S R +
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNE 373
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 26/257 (10%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIP-SEISALSKLQLLDLSSNRLRG------- 169
++S + F L L +L + + E L + + LS N+
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 170 RLTNLNYMSLSRNMLGGL--LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILIL 227
+ +L + L R L + P L+NL LD+ +N++ L L L+IL L
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 228 AQNQLSGL---------PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278
N L+ L + L +L +L++ +N +L +DL N
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571
Query: 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA-SMEDLTWLDLSNNNIKGSIPG---- 333
N+ + L L+L N ++ + +LT LD+ N +
Sbjct: 572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631
Query: 334 -EITKLSRLDYLNLSGN 349
+ + LS +
Sbjct: 632 VNWINETHTNIPELSSH 648
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-31
Identities = 53/247 (21%), Positives = 87/247 (35%), Gaps = 26/247 (10%)
Query: 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLD 161
G + L L N L+ + N+ + + Y+ + + + + LQ L
Sbjct: 405 GHLEVLDLG-LN-EIGQELTGQEWRGLENIFEIYL--SYNKYLQLTRNSFALVPSLQRLM 460
Query: 162 LSSNRLRG---------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL---- 208
L L+ L NL + LS N + + + L+ L LD+ N+L
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520
Query: 209 ----IGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGPIPSTL 263
G L L+ L IL L N +P E +L L ++D+G N++ S
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
Query: 264 GLFSDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDL 322
L L+L N S L LD+ N S + W++
Sbjct: 581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF---VNWINE 637
Query: 323 SNNNIKG 329
++ NI
Sbjct: 638 THTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 43/170 (25%), Positives = 62/170 (36%), Gaps = 4/170 (2%)
Query: 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDI 255
+ D L +P L T++ +L L NQL L L LDVG N I
Sbjct: 5 SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 256 IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME 315
P L L+L N+ + T L L L SN + + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 316 DLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
+L LDLS+N + + G +L L L LS NK+ ++
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 67/207 (32%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 372 DSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
D K+ IG G +G VYK L +G ALK+ E I F E + LS
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPHLV 98
Query: 425 ------------------MERGSLFRILH-NDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
ME G+L R L+ +D + + W +R+ I A L YLH
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ--TLLAGSYGYIAPELAYT 523
++HRD+ S NILL+ + DFG ++ T++ G+ GYI PE
Sbjct: 159 A---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHPRD 550
+TEK DVYSFGVV EVL +
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIV 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-46
Identities = 63/290 (21%), Positives = 99/290 (34%), Gaps = 32/290 (11%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRI----LAYYDGFTGSIPSEISALSKLQLLDL 162
L G L + S L +L I LAY D + I + L+ + L
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 163 SSNRLRG-----RLTNLNYMSLSRNMLGGLLPQE-------------------IGNLKNL 198
S + ++ L G + +L +L
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
Query: 199 IELDVGDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDII 256
LD+ N L G + TSLK L L+ N + + L+ L LD ++++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 409
Query: 257 GPIP-STLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASM 314
S +L YLD+S + L+ L L ++ N I +
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 315 EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
+LT+LDLS ++ P LS L LN+S N + K L+S
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-43
Identities = 56/248 (22%), Positives = 85/248 (34%), Gaps = 18/248 (7%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---------G 169
+ +L+ L G L L+ LDLS N L
Sbjct: 315 KFGQFPTLKLKSLKRLTFT----SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILILA 228
T+L Y+ LS N + + L+ L LD ++L L +L L ++
Sbjct: 371 GTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 229 QNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPI-PSTLGLFSDLSYLDLSCNQFNSSIPNE 286
L +L +L + N P +L++LDLS Q P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKL-SRLDYLN 345
L+ L L++S N + L LD S N+I S E+ S L +LN
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 346 LSGNKLSG 353
L+ N +
Sbjct: 550 LTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 57/256 (22%), Positives = 93/256 (36%), Gaps = 12/256 (4%)
Query: 120 LSHLNFSC---FPNLESLRILAYYD-GFTGSIPSEISALSKLQLLDLSSNRLR--GRLTN 173
L + F + L + F ++ +L +L L +
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
Query: 174 LNYMSLSRNMLG--GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
L ++ LSRN L G Q +L LD+ N +I + L L+ L +
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407
Query: 232 LSGL--PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI-PNELT 288
L + +L+NL+ LD+ + S L L ++ N F + P+ T
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L L LDLS +L P+ S+ L L++S+NN L+ L L+ S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 349 NKLSGRVPYSNKHLSS 364
N + +H S
Sbjct: 528 NHIMTSKKQELQHFPS 543
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 17/284 (5%)
Query: 99 NSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD---GFTGSIPSEISALS 155
G L L N +L SL L F G +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 156 KLQLLDLSSNRLRGR------LTNLNYMSLSRNMLGGLLPQEI-GNLKNLIELDVGDNSL 208
L+ LDLS N + L L ++ + L + + +L+NLI LD+
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 209 IGPIPLTLSRLTSLKILILAQNQLSG--LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF 266
+ L+SL++L +A N LP L+NL LD+ + P+
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 267 SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED-LTWLDLSNN 325
S L L++S N F S L L LD S N + ++ L +L+L+ N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 326 NIKGSIPGE--ITKLSRLDYLNLSGNKLSGRVP--YSNKHLSSM 365
+ + + + + L + ++ P + S+
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-39
Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 18/241 (7%)
Query: 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSL 179
C + ++ F IP + + LDLS N LR L + L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 180 SRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQE 238
SR + + +L +L L + N + S L+SL+ L+ + L+ L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 239 IGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL---- 293
IG+LK L L+V +N I +P ++L +LDLS N+ S +L L Q+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 294 FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGE-ITKLSRLDYLNLSGNKLS 352
LDLS N ++ P + L L L NN ++ I L+ L+ L +
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 353 G 353
Sbjct: 239 N 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-38
Identities = 52/265 (19%), Positives = 94/265 (35%), Gaps = 25/265 (9%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------R 170
L HL F + L++L +LS L L L+ N ++
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQ 229
L++L + L L IG+LK L EL+V N + +P S LT+L+ L L+
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 230 NQLSGL-PQEIGNLKNL----MLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
N++ + ++ L + + LD+ N + P L L L N + ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVM 217
Query: 285 NE-LTRLTQLFHLDLSSNKLSGKI---PSQIASMEDLTWLDLSNNNIK------GSIPGE 334
+ L L L + + +++E L L + + I
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 335 ITKLSRLDYLNLSGNKLSGRVPYSN 359
L+ + +L + +S
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSY 302
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 27/281 (9%)
Query: 96 ITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL----AYYDGFTGSIPSEI 151
+ G+ + L K + N ++ +C L L + + +
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 152 SALSKLQLLDLSSNRLR-------------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
SAL L L + RL LTN++ SL + +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGW 306
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--I 256
L++ + L L L L N+ E+ +L +L LD+ N +
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGNAFSEV-DLPSLEFLDLSRNGLSFK 362
Query: 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASME 315
G + + L YLDLS N ++ + L QL HLD + L + S+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 316 DLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
+L +LD+S+ + + + G LS L+ L ++GN
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 41/199 (20%), Positives = 80/199 (40%), Gaps = 10/199 (5%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
+ N+ Y + N +P + + LD+ N L + L++L L++
Sbjct: 7 VPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 231 QLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
++ + +L +L L + N I S L L S +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 290 LTQLFHLDLSSNKL-SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDY----L 344
L L L+++ N + S K+P +++ +L LDLS+N I+ ++ L ++ L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 345 NLSGNKLSGRVPYSNKHLS 363
+LS N ++ P + K +
Sbjct: 183 DLSLNPMNFIQPGAFKEIR 201
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 50/289 (17%), Positives = 84/289 (29%), Gaps = 45/289 (15%)
Query: 119 RLSHLNFSCFPNLESLRILAYY----DGFTGSIPSEISALSKLQLLDLSSNRLRG----- 169
++ + + L + +L I +L L L +N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 170 ---RLTNLNYMSLSRNMLGG---LLPQEIGNLKNLIELDVGDNSL------IGPIPLTLS 217
L L L L + L+ L L + + L + I +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 218 RLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN-------------------DIIGP 258
LT++ L + + + L++ N G
Sbjct: 280 CLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 259 IPSTLGLFSDLSYLDLSCNQFN--SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED 316
+ L +LDLS N + T L +LDLS N + + S +E
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ 397
Query: 317 LTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
L LD ++N+K + L L YL++S LSS
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 4/158 (2%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
IP L S K L L+ N L L + L +LD+ +I S LS
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG- 329
L L+ N S + L+ L L L+ I ++ L L++++N I+
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 330 SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPT 367
+P + L+ L++L+LS NK+ + L MP
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 16/213 (7%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLRG-------RLTNLN 175
NF LE L + + +L L LD+S R L++L
Sbjct: 391 NFLGLEQLEHLDF--QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 176 YMSLSRNML-GGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234
+ ++ N LP L+NL LD+ L P + L+SL++L ++ N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 235 L-PQEIGNLKNLMLLDVGNNDIIGPIPSTLG-LFSDLSYLDLSCNQFNSSIPNE--LTRL 290
L L +L +LD N I+ L S L++L+L+ N F + ++ L +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568
Query: 291 TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLS 323
L + ++ PS M + L+++
Sbjct: 569 KDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 7e-45
Identities = 49/263 (18%), Positives = 97/263 (36%), Gaps = 21/263 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L +D +N N + + +L+ +I + T I I L+KLQ++ +++
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSP 459
Query: 167 LRG--RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
+ + NLK+L ++++ + + +P L L L+
Sbjct: 460 FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 225 LILAQNQLSG----------LPQEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLD 273
L +A N+ L + + + +G N++ P ++L L LD
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIP 332
N+ +L L L N++ IP A + + L S+N +K IP
Sbjct: 580 CVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIP 635
Query: 333 --GEITKLSRLDYLNLSGNKLSG 353
+ + ++ S NK+
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGS 658
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-40
Identities = 50/285 (17%), Positives = 94/285 (32%), Gaps = 37/285 (12%)
Query: 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLL 160
I + N ++ + + S + NL+ L + Y +P + L +LQ L
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELS-WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
Query: 161 DLSSNRLR----------------GRLTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDV 203
+++ NR + + N L + + L LD
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580
Query: 204 GDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIG-NLKNLMLLDVGNNDIIGPIPST 262
N + + L L L NQ+ +P++ + L +N + IP+
Sbjct: 581 VHNKVRH-LE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 263 LGLFS--DLSYLDLSCNQFNSSIPN-----ELTRLTQLFHLDLSSNKLSGKIPSQIASME 315
S + +D S N+ S N + + + LS N++ A+
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 316 DLTWLDLSNNNIK-------GSIPGEITKLSRLDYLNLSGNKLSG 353
++ + LSNN + G L ++L NKL+
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-38
Identities = 47/264 (17%), Positives = 97/264 (36%), Gaps = 37/264 (14%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISA-LSKLQLLDLSSNRLR-------- 168
++ HL F L L Y+ IP + A +++ L S N+L+
Sbjct: 584 KVRHL--EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA 640
Query: 169 GRLTNLNYMSLSRNMLGGLLPQ-----EIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLK 223
+ + + S N +G + N + + N + + + +
Sbjct: 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700
Query: 224 ILILAQNQLSGLPQE--------IGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDL 274
+IL+ N ++ +P+ N L +D+ N + LS +D+
Sbjct: 701 TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDV 760
Query: 275 SCNQFNSSIPNELTRLTQLFHLDL------SSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328
S N F SS P + +QL + N++ + P+ I + L L + +N+I+
Sbjct: 761 SYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 329 GSIPGEITKLSRLDYLNLSGNKLS 352
+ ++ +L L+++ N
Sbjct: 820 -KVDEKL--TPQLYILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 40/237 (16%), Positives = 78/237 (32%), Gaps = 31/237 (13%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQ-EIGNLKN 197
KL L L N++ + + S N L + ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV 645
Query: 198 LIELDVGDNSLIG-----PIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVG 251
+ +D N + + + + + L+ N++ P E+ + + +
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705
Query: 252 NNDI-------IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL--TRLTQLFHLDLSSNK 302
NN + + P L+ +DL N+ +S+ ++ T L L ++D+S N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNC 764
Query: 303 LSGKIPSQIASMEDLTWLDL------SNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
S P+Q + L + N I P IT L L + N +
Sbjct: 765 FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-36
Identities = 39/264 (14%), Positives = 84/264 (31%), Gaps = 35/264 (13%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPS--EISALSKLQLLDLSSNRLRG------ 169
++ + + + L ++ IP+ ++ + +D S N++
Sbjct: 606 QIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
Query: 170 ------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL-------IGPIPLTL 216
+ N + ++LS N + + + + + +N + + P
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 217 SRLTSLKILILAQNQLSGLPQEI--GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274
L + L N+L+ L + L L +DV N P+ S L +
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783
Query: 275 ------SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328
N+ P +T L L + SN + K+ ++ L LD+++N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNI 840
Query: 329 GSIPGEITKLSRLDYLNLSGNKLS 352
+ L +K
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 50/299 (16%), Positives = 97/299 (32%), Gaps = 38/299 (12%)
Query: 70 KALLNTGWWNNSWTMDYDSDHCEW-IGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCF 128
+AL W S T++ W + G G+ L NGR++ L+ + F
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-----NGRVTGLSLAGF 333
Query: 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLL 188
G G +P I L++L++L ++ L
Sbjct: 334 -------------GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG--------DEELT 372
Query: 189 PQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIG-NLKNLML 247
P K+ I + L L LS L I ++ + ++ +LK+ +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQI 430
Query: 248 LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307
++ N I I + + L + + + F + K
Sbjct: 431 GNLTNR--ITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENE 483
Query: 308 PSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMP 366
++++DLT ++L N +P + L L LN++ N+ + +
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRLA 541
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 14/155 (9%), Positives = 41/155 (26%), Gaps = 1/155 (0%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPI 259
+ + I + + L + + +
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315
Query: 260 PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW 319
L ++ L L+ +P+ + +LT+L L ++ +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 320 LDLSNNNIKGSIPGE-ITKLSRLDYLNLSGNKLSG 353
+ + I+ + RL+ +L + ++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
++ K IG G++G+V++A+ +G A+K L + + F E ++ +
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRH 93
Query: 425 ----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
+ RGSL+R+LH +LD +R+++ +A + YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL-- 520
H+ +P +VHR++ S N+L++ K V DFG +RL + + AG+ ++APE+
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 521 --AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
EK DVYSFGV+ E+ + P
Sbjct: 213 DEPS----NEKSDVYSFGVILWELATLQQP 238
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 53/271 (19%), Positives = 87/271 (32%), Gaps = 18/271 (6%)
Query: 98 CNSAGSIIGLHLSKDNVNFNGRLSHL-NFSCFPNLESLRILAYYDGFTGSIPSEISALSK 156
+SA + + L + L P + LS
Sbjct: 46 WHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSH 105
Query: 157 LQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG 210
LQ + + + L + L ++L+RN L L P I +L L EL + +
Sbjct: 106 LQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELT 164
Query: 211 PIP---------LTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
+P L +L+ L L + LP I NL+NL L + N+ + +
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGP 223
Query: 262 TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD 321
+ L LDL + P L L L +P I + L LD
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 322 LSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L +P I +L + + + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 40/232 (17%), Positives = 81/232 (34%), Gaps = 17/232 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGL--LPQEIGNLK--NLIEL 201
+S + D + R N N + L + + + L
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVAL 86
Query: 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
++ L P RL+ L+ + + L LP + L L + N + +P+
Sbjct: 87 ELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 262 TLGLFSDLSYLDLS-CNQF--------NSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312
++ + L L + C + ++ E L L L L + +P+ IA
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 313 SMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
++++L L + N+ + ++ I L +L+ L+L G P +
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP 254
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 28/175 (16%), Positives = 55/175 (31%), Gaps = 9/175 (5%)
Query: 186 GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNL 245
G + L ++ + P LS+ N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNAD---RNRWHSAWRQANSNNP 58
Query: 246 MLLDVGNNDIIGPIPSTLGLFSD--LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303
+ + L + L+L P++ RL+ L H+ + + L
Sbjct: 59 QIETRTGRALKA-TADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGL 116
Query: 304 SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358
++P + L L L+ N ++ ++P I L+RL L++ +P
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 20/142 (14%), Positives = 40/142 (28%), Gaps = 23/142 (16%)
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF------------ 279
+ + L + + P L + D +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 280 -------NSSIPNELTRLTQ--LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330
+ + L TQ L+L S L + P Q + L + + +
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 331 IPGEITKLSRLDYLNLSGNKLS 352
+P + + + L+ L L+ N L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR 140
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 59/264 (22%), Positives = 104/264 (39%), Gaps = 54/264 (20%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
++I+ + +G GA+G V KA+ + A+K++ S + +F E + LS+
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK-----AFIVELRQLSRVNH 60
Query: 425 --------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
E GSL+ +LH A ++ + +AYLH
Sbjct: 61 PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 465 DCSPSVVHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
+++HRD+ N+LL + + DFGTA + +N GS ++APE+
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEG 177
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP-RDLHSTLSSSYDPKIMLIDVLDQRLP-----PPV 577
+EK DV+S+G++ EV+ + P ++ IM R P P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNGTRPPLIKNLPKP 232
Query: 578 DRKVIQDILLVSTISFACLQSNPK 601
++ C +P
Sbjct: 233 IESLMTR----------CWSKDPS 246
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 50/264 (18%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEE-LAFIRSFRNEAQVLSQ----------- 424
+G G +G VYK + N A+KKL + + F E +V+++
Sbjct: 39 MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M GSL L L W R I + A+ + +LH +
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---H 154
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHAD--SSNQTLLAGSYGYIAPELAYTMVMTE 528
+HRDI S NILL+ A ++DFG AR + + + G+ Y+APE A +T
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITP 213
Query: 529 KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID----VL--DQRLPPPVDRKV- 581
K D+YSFGVV LE++ G D H +L+D + ++ + +D+K+
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEH-------REPQLLLDIKEEIEDEEKTIEDYIDKKMN 266
Query: 582 ---IQDILLVSTISFACLQSNPKS 602
+ + +++ CL
Sbjct: 267 DADSTSVEAMYSVASQCLHEKKNK 290
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 67/269 (24%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQ------- 424
IG G +G V+K + + + V A+K L ETE + + F+ E ++S
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 425 ----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
+ G L+ L + +A + W+ ++ ++ +A + Y+ + +P
Sbjct: 87 KLYGLMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 469 SVVHRDISSNNILLNSKLEAF-----VADFGTARLLHADSSNQTLLAGSYGYIAPEL--- 520
+VHRD+ S NI L S E VADFG ++ S G++ ++APE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNFQWMAPETIGA 200
Query: 521 ---AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577
+Y TEK D YSF ++ +L G+ P S I +I R P
Sbjct: 201 EEESY----TEKADTYSFAMILYTILTGEGP---FDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 578 D-----RKVIQDILLVSTISFACLQSNPK 601
D R VI+ C +PK
Sbjct: 254 DCPPRLRNVIEL----------CWSGDPK 272
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 57/283 (20%), Positives = 98/283 (34%), Gaps = 55/283 (19%)
Query: 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAF----------------- 411
+ G +G V+KAQ A+K + +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQ 82
Query: 412 -----IRSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
R + + + E+GSL L + + W + +I + MA LAYLH
Sbjct: 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLH 138
Query: 464 HD-------CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYG 514
D P++ HRDI S N+LL + L A +ADFG A A S + G+
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 515 YIAPELA-----YTMVMTEKYDVYSFGVVTLEVLMGKHPRD---------LHSTLSSSYD 560
Y+APE+ + + D+Y+ G+V E+ D +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 561 PKIMLIDVLDQRLPPPVDRKVIQDILL--VSTISFACLQSNPK 601
+ M V+ ++ P + + + + C + +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELA-FIRSFRNEAQVLSQ-- 424
++ + IG G +G VY+A G A+K E+++ I + R EA++ +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 425 -----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAY 461
G L R+L + VN +A + Y
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNY 120
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAF--------VADFGTARLLHADSSNQTLLAGSY 513
LH + ++HRD+ S+NIL+ K+E + DFG AR H + AG+Y
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAY 178
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
++APE+ + ++ DV+S+GV+ E+L G+ P
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMS 178
+ S NL + L S S +S ++ L L ++ ++++ LT+L +S
Sbjct: 124 DISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLS 183
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE 238
L+ N + + P + +L +L N + P+ + +T L L + N+++ L
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDLS-P 238
Query: 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL 298
+ NL L L++G N I + + + L L++ NQ S I L L+QL L L
Sbjct: 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI-SDISV-LNNLSQLNSLFL 294
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
++N+L + I + +LT L LS N+I P + LS++D + + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 21/236 (8%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYM 177
NL L + D + P ++ L+K+ L+L +N +T LNY+
Sbjct: 105 ALQNLTNLRELYL--NEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL 160
Query: 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ 237
+++ + + + P I NL +L L + N + PL + LTSL NQ++ +
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDIT- 215
Query: 238 EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297
+ N+ L L +GNN I P L S L++L++ NQ + N + LT+L L+
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
+ SN++S S + ++ L L L+NN + I L+ L L LS N ++
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 17/224 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200
+ S + L+ L+ L L+ + + LT + ++L N + N+ L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNY 159
Query: 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIP 260
L V ++ + P+ + LT L L L NQ+ + + +L +L N I P
Sbjct: 160 LTVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITP 216
Query: 261 STLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWL 320
+ + L+ L + N+ P L L+QL L++ +N++S + + + L L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 321 DLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
++ +N I + LS+L+ L L+ N+L L++
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 57/251 (22%), Positives = 102/251 (40%), Gaps = 21/251 (8%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL 167
+ + + ++ L + + SI I L+ L+ L+L+ N++
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVV--AGEKVA-SIQ-GIEYLTNLEYLNLNGNQI 78
Query: 168 R-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSL 222
L L + + N + + + NL NL EL + ++++ P L+ LT +
Sbjct: 79 TDISPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKM 134
Query: 223 KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282
L L N + N+ L L V + + P + +DL L L+ NQ
Sbjct: 135 YSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192
Query: 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
P L LT L + N+++ P +A+M L L + NN I P + LS+L
Sbjct: 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT 246
Query: 343 YLNLSGNKLSG 353
+L + N++S
Sbjct: 247 WLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 149 SEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203
+ L++ L + L ++ + ++ + + Q I L NL L++
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNL 73
Query: 204 GDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTL 263
N + P LS L L L + N+++ + + NL NL L + ++I P L
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISDISP--L 128
Query: 264 GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLS 323
+ + L+L N N S + L+ +T L +L ++ +K+ P IA++ DL L L+
Sbjct: 129 ANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN 185
Query: 324 NNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
N I+ P + L+ L Y N+++
Sbjct: 186 YNQIEDISP--LASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 37/183 (20%), Positives = 76/183 (41%), Gaps = 15/183 (8%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L + + P +L I + S+ + L S+ L++A
Sbjct: 2 AATLA---TLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGE 54
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL 290
+++ + I L NL L++ N I P L L+ L + N+ + + L L
Sbjct: 55 KVASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNL 109
Query: 291 TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK 350
T L L L+ + +S P +A++ + L+L N+ + ++ ++ L+YL ++ +K
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166
Query: 351 LSG 353
+
Sbjct: 167 VKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328
+ L N P L + L ++ + +E +T L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 329 GSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359
SI G I L+ L+YLNL+GN+++ P SN
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISPLSN 86
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 20/244 (8%)
Query: 117 NGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GR 170
+ L S + +++ L + + ++++ +KL+LL+LSSN L
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLES 78
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L+ L + L+ N + QE+ ++ L +N++ ++ SR K + LA N
Sbjct: 79 LSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANN 130
Query: 231 QLSGLP-QEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
+++ L + G + LD+ N+I L +L+L N + ++
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV 189
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
+L LDLSSNKL+ + + S +TW+ L NN + I + L++ +L G
Sbjct: 190 -FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 349 NKLS 352
N
Sbjct: 247 NGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 22/246 (8%)
Query: 128 FPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR-------GRLTNLNYMSL 179
N +I D + + + ++ LDLS N L T L ++L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 180 SRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI 239
S N+L ++ +L L LD+ +N + L S++ L A N +S +
Sbjct: 66 SSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSR 118
Query: 240 GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS-SIPNELTRLTQLFHLDL 298
+ + + NN I G S + YLDL N+ ++ + L HL+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358
N + + Q+ L LDLS+N + + E + + +++L NKL + +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 359 NKHLSS 364
+ +
Sbjct: 233 LRFSQN 238
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 45/224 (20%), Positives = 87/224 (38%), Gaps = 37/224 (16%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
+I ++ ++ ++ + L+ L + N+ ELD+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-----------------ALASLRQSAWNVKELDLSG 43
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--IGPIPS-- 261
N L L+ T L++L L+ N L ++ +L L LD+ NN + + PS
Sbjct: 44 NPLSQISAADLAPFTKLELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLVGPSIE 102
Query: 262 ------------TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG-KIP 308
+ + L+ N+ + +++ +LDL N++
Sbjct: 103 TLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 309 SQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
AS + L L+L N I + G++ ++L L+LS NKL+
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 28/187 (14%), Positives = 63/187 (33%), Gaps = 14/187 (7%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR--------GR 170
+S ++ S +++ + + T + S++Q LDL N +
Sbjct: 110 NISRVSCSRGQGKKNIYL--ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L +++L N + + ++ L LD+ N L + + + L N
Sbjct: 168 SDTLEHLNLQYNFIYDV-KGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNN 224
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDI-IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
+L + + + +NL D+ N G + + + + + E
Sbjct: 225 KLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 290 LTQLFHL 296
+ L H
Sbjct: 285 VPTLGHY 291
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-39
Identities = 52/262 (19%), Positives = 95/262 (36%), Gaps = 16/262 (6%)
Query: 119 RLSHLNFSCFPNLE---SLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GR 170
L+ ++ ++ + L+ P+ L L+ L L+ N+
Sbjct: 291 SLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPT--LDLPFLKSLTLTMNKGSISFKKVA 348
Query: 171 LTNLNYMSLSRNMLGGLLPQ--EIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228
L +L+Y+ LSRN L +L LD+ N I + L L+ L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQ 407
Query: 229 QNQLSGLPQE--IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP-N 285
+ L + + +L+ L+ LD+ + + L+ L ++ N F + N
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLN 345
T L LDLS +L ++ L L++S+NN+ +L L L+
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527
Query: 346 LSGNKLSGRVPYSNKHLSSMPT 367
S N++ S+
Sbjct: 528 CSFNRIETSKGILQHFPKSLAF 549
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 59/246 (23%), Positives = 89/246 (36%), Gaps = 17/246 (6%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG--------- 169
+L P L+SL + GSI + AL L LDLS N L
Sbjct: 318 QLKQFPTLDLPFLKSLTL----TMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILILA 228
+L ++ LS N ++ L+ L LD ++L L L L ++
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 229 QNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPS-TLGLFSDLSYLDLSCNQFNSSIPNE 286
I L +L L + N S ++L++LDLS Q
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNL 346
L +L L++S N L S + L+ LD S N I+ S L + NL
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552
Query: 347 SGNKLS 352
+ N ++
Sbjct: 553 TNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-33
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 17/222 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+P +I S + +DLS N L+ + L ++ LSR + + + L +L
Sbjct: 25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIG 257
L + N + P + S LTSL+ L+ + +L+ L IG L L L+V +N I
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 258 -PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL----FHLDLSSNKLSGKIPSQIA 312
+P+ ++L ++DLS N + N+L L + LD+S N + I Q
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 313 SMEDLTWLDLSNNNIKGSIPGE-ITKLSRLDYLNLSGNKLSG 353
L L L N +I + L+ L L +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 61/280 (21%), Positives = 99/280 (35%), Gaps = 26/280 (9%)
Query: 96 ITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDG-------FTGSIP 148
I + G+ L + + N S++ +C NL L + G P
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252
Query: 149 SEISALSKLQLLDLSSNRLR---------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
S + L + + + L N++ MSL+ + L +++
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQ 310
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--IG 257
L + L L LK L L N+ S + L +L LD+ N + G
Sbjct: 311 SLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSG 366
Query: 258 PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-SQIASMED 316
+ + L +LDLS N + L +L HLD + L S S+E
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 317 LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
L +LD+S N K G L+ L+ L ++GN
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 53/257 (20%), Positives = 87/257 (33%), Gaps = 24/257 (9%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------R 170
L L F N L+ L L L L L+ N ++
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQ 229
LT+L + L L IG L L +L+V N + +P S LT+L + L+
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 230 NQLSGLPQEI-----GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
N + + N + + LD+ N I L L L N +S+I
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIM 221
Query: 285 NELTR-LTQLFHLDLSSNKLSGKI------PSQIASMEDLTW--LDLSNNNIKGSIPGEI 335
+ L L L + + PS + + D+T L+ N +
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 336 TKLSRLDYLNLSGNKLS 352
L+ + ++L+G +
Sbjct: 282 HCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 49/268 (18%), Positives = 91/268 (33%), Gaps = 31/268 (11%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTG-SIPSEISALSKLQLLDLSSNRLRG------- 169
+L+ L L +L+ L ++ +P+ S L+ L +DLS N ++
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 170 RLTNLNYM----SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKI 224
L + +S N + + + L EL + N I L L L +
Sbjct: 175 FLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 225 LILAQNQLSGL-------PQEIGNLKNLML--LDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
L + P + L ++ + + + +++S + L+
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
++ + + L + +L P+ + L L L+ N SI +
Sbjct: 294 GVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKG--SISFKK 346
Query: 336 TKLSRLDYLNLSGNKLSGRVPYSNKHLS 363
L L YL+LS N LS S L
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLG 374
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 45/262 (17%), Positives = 74/262 (28%), Gaps = 29/262 (11%)
Query: 119 RLSHLNFSCFPNLESLRILAYY----DGFTGSIPSEISALSKLQLLDLSSNRLRG----- 169
+ + + L + I + KL L L N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT 223
Query: 170 ---RLTNLNYMSLSRNMLGG------LLPQEIGNLKNL--IELDVGDNSLIGPIPLTLSR 218
L L+ L P + L ++ E + + +
Sbjct: 224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC 283
Query: 219 LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278
L ++ + LA + L ++ L + + L L L L+ N+
Sbjct: 284 LANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNK 339
Query: 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPS--QIASMEDLTWLDLSNNNIKGSIPGEIT 336
SI + L L +LDLS N LS L LDLS N +
Sbjct: 340 G--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFM 396
Query: 337 KLSRLDYLNLSGNKLSGRVPYS 358
L L +L+ + L +S
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 38/157 (24%), Positives = 62/157 (39%), Gaps = 4/157 (2%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
+P + +S K + L+ N L L N L LD+ +I LS
Sbjct: 26 VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG- 329
L L+ N S P + LT L +L KL+ I + L L++++N I
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 330 SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMP 366
+P + L+ L +++LS N + + L P
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 38/169 (22%), Positives = 57/169 (33%), Gaps = 12/169 (7%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIP-SEISALSKLQLLDLSSNRLRG-------RLTNLN 175
NF L+ L + S +L KL LD+S + LT+LN
Sbjct: 394 NFMGLEELQHLDF--QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451
Query: 176 YMSLSRNML-GGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234
+ ++ N L N NL LD+ L L L++L ++ N L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 235 LPQE-IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282
L L +L LD N I L++ +L+ N
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 2/124 (1%)
Query: 230 NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
+LS +P +I + + +D+ N + + FS+L +LDLS + +
Sbjct: 21 QKLSKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG 78
Query: 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
L L +L L+ N + P + + L L + I +L L LN++ N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 350 KLSG 353
+
Sbjct: 139 FIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 4/132 (3%)
Query: 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ 292
L I + N+ + + +P + S +DLS N + ++
Sbjct: 2 GSLNPCIEVVPNITYQCMDQK--LSKVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 293 LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L LDLS ++ + L+ L L+ N I+ PG + L+ L+ L KL+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 353 GRVPYSNKHLSS 364
+ L +
Sbjct: 118 SLESFPIGQLIT 129
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 32/166 (19%), Positives = 55/166 (33%), Gaps = 9/166 (5%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEI-SALSKLQLLDLSSNRLRG------- 169
F L SL L + F + S + + + L LDLS +L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ 229
L L +++S N L L L +L LD N + + SL L
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 230 NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
N ++ + + L+ + ++ +T + LD +
Sbjct: 555 NSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFN 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-38
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 19/261 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L LS N L ++ S FP+L L + + L L+ LDLS +
Sbjct: 306 LVLSA---NKFENLCQISASNFPSLTHLS-IKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 167 LRG---------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT-L 216
+ L++L ++LS N L + L LD+ L +
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 217 SRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS---YL 272
L LK+L L+ + L +++ L L L++ N L L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 273 DLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332
LS +S + T L + H+DLS N+L+ ++ ++ + L+L++N+I +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 333 GEITKLSRLDYLNLSGNKLSG 353
+ LS+ +NL N L
Sbjct: 541 SLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-38
Identities = 64/276 (23%), Positives = 105/276 (38%), Gaps = 19/276 (6%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNR 166
L + ++ LS L S L +L+ L + F S L L + N
Sbjct: 279 GLQELDLTAT-HLSELP-SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 167 LRGR--------LTNLNYMSLSRNMLG--GLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216
R L NL + LS + + ++ NL +L L++ N +
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 217 SRLTSLKILILAQNQLSGLPQE--IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274
L++L LA +L + NL L +L++ ++ + L +L+L
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 275 SCNQFNSSI---PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331
N F N L L +L L LS LS S++ + +DLS+N + S
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 332 PGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPT 367
++ L + YLNL+ N +S +P LS T
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRT 551
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-37
Identities = 59/278 (21%), Positives = 94/278 (33%), Gaps = 14/278 (5%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L+ N L S +L D E ++ ++L +
Sbjct: 207 LNFG-GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 167 LRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRL 219
+ L + L+ L L P + L L +L + N ++ S
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 220 TSLKILILAQNQLSGL--PQEIGNLKNLMLLDVGNNDI--IGPIPSTLGLFSDLSYLDLS 275
SL L + N + NL+NL LD+ ++DI L S L L+LS
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-SQIASMEDLTWLDLSNNNIKGSIPGE 334
N+ S QL LDL+ +L K S ++ L L+LS++ + S
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 335 ITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKID 372
L L +LNL GN L ++ +
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-36
Identities = 47/280 (16%), Positives = 89/280 (31%), Gaps = 18/280 (6%)
Query: 96 ITCNSAGSIIGL-HLSKDNVNFNGRLSHLNFSCFPNLESLRI--LAYYDGFTGSIPSEIS 152
I+ L + N + +L+ +L+ L I
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNN-AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199
Query: 153 ALSKLQLLDLSSNRLRG---------RLTNLNYMSLSRNMLGGLLPQEIGNLK--NLIEL 201
+ Q L+ + + +L + + P L ++ +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
++ + T + L+ L L LS LP + L L L + N
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 262 TLGLFSDLSYLDLSCNQFNSSI-PNELTRLTQLFHLDLSSNKL--SGKIPSQIASMEDLT 318
+ F L++L + N + L L L LDLS + + S Q+ ++ L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358
L+LS N + +L+ L+L+ +L + S
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 45/261 (17%), Positives = 85/261 (32%), Gaps = 17/261 (6%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------R 170
L + + F L +L L + +L L L++N L
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L ++ + + + + N K L L +G N + LK+L N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 231 QLSGL-PQEIGNLKNLML--LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL 287
+ L +++ +L+ L++ NDI G I + L+ Q I L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 288 --TRLTQLFHLDLSSNKLSGKIPSQIASMED--LTWLDLSNNNIKGSIPGEITKLSRLDY 343
+ + L+ P+ + + + ++L + S L
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 344 LNLSGNKLSGRVPYSNKHLSS 364
L+L+ LS +P LS+
Sbjct: 283 LDLTATHLS-ELPSGLVGLST 302
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 52/269 (19%), Positives = 102/269 (37%), Gaps = 19/269 (7%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQL--LDLSSNRLRG 169
+ N +S + E L++L + ++S+L + L+L+ N + G
Sbjct: 135 YLGSN-HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 170 ------RLTNLNYMSLSRNMLGGLLPQEIGN--LKNLIELDVGDNSLIGPIPLTLSRL-- 219
++ ++ + + N +++L D P L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278
S++ + L ++ + L LD+ + +PS L S L L LS N+
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312
Query: 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQ-IASMEDLTWLDLSNNNIKGS--IPGEI 335
F + + L HL + N ++ + + ++E+L LDLS+++I+ S ++
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 336 TKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
LS L LNLS N+ + K
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 41/262 (15%), Positives = 83/262 (31%), Gaps = 17/262 (6%)
Query: 117 NGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG------- 169
N L+ + + + E L ++ + S L L LDL+ ++
Sbjct: 21 NLGLNEIPGTLPNSTECLEF--SFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ 229
L+ + L+ N L + + K L L + + L +L+ L L
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 230 NQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS--YLDLSCNQFNSSIPNE 286
N +S + + + L +LD NN I + + L+L+ N + I
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPG 197
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIA--SMEDLTWLDLSNNNIKGSIPGEITKLSRLD-- 342
L+ + I + +++ L + + + P L +
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257
Query: 343 YLNLSGNKLSGRVPYSNKHLSS 364
+NL + + S
Sbjct: 258 SINLQKHYFFNISSNTFHCFSG 279
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 50/264 (18%), Positives = 97/264 (36%), Gaps = 19/264 (7%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GR 170
+S ++F N ++L L + + + KL++LD +N +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 171 LTNLN--YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP--LTLSRLTSLKILI 226
L ++L+ N + G + + L+ G + I L S + SL +
Sbjct: 176 LQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 227 LAQNQLSGLPQEI---GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283
+ + ++ +++ + +T FS L LDL+ S +
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SEL 293
Query: 284 PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI-PGEITKLSRLD 342
P+ L L+ L L LS+NK ++ LT L + N + + G + L L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 343 YLNLSGNKLSGRVPYSNKHLSSMP 366
L+LS + + N L ++
Sbjct: 354 ELDLSHDDIET-SDCCNLQLRNLS 376
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 40/201 (19%), Positives = 62/201 (30%), Gaps = 31/201 (15%)
Query: 160 LDLSSNRL----RGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215
+ + L + + S N+L + L NL LD+ + T
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 216 LSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274
L L+L N L + + K L +L
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKAL------------------------KHLFF 112
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGE 334
+S L L L L SN +S + E L LD NN I +
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 335 ITKLSRLD--YLNLSGNKLSG 353
++ L + LNL+GN ++G
Sbjct: 173 MSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 33/155 (21%), Positives = 51/155 (32%), Gaps = 4/155 (2%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGP 258
+ + L IP TL S + L + N L + L NL LD+ I
Sbjct: 16 TYNCENLGLNE-IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318
T L L L+ N L+ L HL +S + + + L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
L L +N+I + +L L+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 24/142 (16%), Positives = 46/142 (32%), Gaps = 2/142 (1%)
Query: 223 KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282
K L+ +P + + L+ N + +T +L++LDL+ Q
Sbjct: 15 KTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
+ +L L L++N L + ++ + L L I + L+
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 343 YLNLSGNKLSGRVPYSNKHLSS 364
L L N +S
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEK 154
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 42/222 (18%), Positives = 76/222 (34%), Gaps = 18/222 (8%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIP-SEISALSKLQLLDLSSNRLRG------- 169
L F L +L + S L L++L+LS + L
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIG---NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226
L L +++L N Q+ L L L + L + L + +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 227 LAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN 285
L+ N+L+ E +LK + L ++ +N I +PS L + S ++L N + +
Sbjct: 507 LSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-- 563
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327
L + KL + + L + LS+ +
Sbjct: 564 SNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 34/202 (16%), Positives = 67/202 (33%), Gaps = 39/202 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+ G ++K + G +K L + R F E L
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
M GSL+ +LH +D ++ V MA +A+LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL---AYTMVM 526
+ ++S +++++ + A ++ + ++APE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTN 188
Query: 527 TEKYDVYSFGVVTLEVLMGKHP 548
D++SF V+ E++ + P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-37
Identities = 66/336 (19%), Positives = 128/336 (38%), Gaps = 20/336 (5%)
Query: 117 NGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GR 170
+ L S + +++ L + + ++++ +KL+LL+LSSN L
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLES 78
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L+ L + L+ N + QE+ ++ L +N++ ++ SR K + LA N
Sbjct: 79 LSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANN 130
Query: 231 QLSGLP-QEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
+++ L + G + LD+ N+I L +L+L N + ++
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV 189
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
+L LDLSSNKL+ + + S +TW+ L NN + I + L++ +L G
Sbjct: 190 -FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 349 NKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEE 408
N + + + L + + + L +P +
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 409 LAFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELD 444
L ++ + E L N A E+D
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREID 342
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 20/199 (10%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
++ + L L + N+ ELD+ N L L+ T L++L L+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDI--IGPIPS--------------TLGLFSDLSYLDL 274
L ++ +L L LD+ NN + + PS + + L
Sbjct: 69 VLYETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYL 127
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSG-KIPSQIASMEDLTWLDLSNNNIKGSIPG 333
+ N+ + +++ +LDL N++ AS + L L+L N I + G
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 334 EITKLSRLDYLNLSGNKLS 352
++ ++L L+LS NKL+
Sbjct: 187 QVV-FAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 32/267 (11%), Positives = 70/267 (26%), Gaps = 36/267 (13%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR--------LRGR 170
+S ++ S +++ + + T + S++Q LDL N L
Sbjct: 110 NISRVSCSRGQGKKNIYL--ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 171 LTNLNYMSLSRNMLGGL---------------------LPQEIGNLKNLIELDVGDNSLI 209
L +++L N + + + E + + + + +N L+
Sbjct: 168 SDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 210 GPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269
I L +L+ L N KN + V + +
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 270 SYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG----KIPSQIASMEDLTWLDLSNN 325
+ RL L + + G ++ + + +D
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 326 NIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ I + L L
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 7/119 (5%)
Query: 234 GLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL 293
+ + N + V ++ + + S ++ LDLS N + +L T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 294 FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L+LSSN L + S+ L LDL+NN ++ E+ ++ L+ + N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 28/258 (10%), Positives = 65/258 (25%), Gaps = 22/258 (8%)
Query: 116 FNGRLSHLNFS---------CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
+L L+ S F + + ++ + I + L+ DL N
Sbjct: 189 VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNG 248
Query: 167 LR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLT 220
N ++++ + L Q G RL
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 221 SL-----KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
+L +L ++ L E N +D I L+
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD-LSNNNIKGSIPGE 334
+ + N +L + ++ L L + + + +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQ 427
Query: 335 ITKLSRLDYLNLSGNKLS 352
+ + + ++ +K +
Sbjct: 428 SVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 16/72 (22%), Positives = 30/72 (41%)
Query: 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
+I + ++ + L + S S ++ LDLS N + ++ ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 342 DYLNLSGNKLSG 353
+ LNLS N L
Sbjct: 61 ELLNLSSNVLYE 72
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 37/201 (18%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG+G++G+VYK + +G V A+K LN +++F+NE VL +
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 425 ------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
E SL+ LH + + K ++I + A + YLH + S++H
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLH--ADSSNQTLLAGSYGYIAPEL---AYTMVMT 527
RD+ SNNI L+ + DFG A + S L+GS ++APE+ + +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 528 EKYDVYSFGVVTLEVLMGKHP 548
+ DVY+FG+V E++ G+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 61/291 (20%), Positives = 103/291 (35%), Gaps = 69/291 (23%)
Query: 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---- 424
R I C+G G YG V++ G A+K +S + +S+ E ++ +
Sbjct: 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLR 60
Query: 425 ---------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAH 457
E GSL+ L LD + IV ++A
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIAS 116
Query: 458 ALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NQTL 508
LA+LH + P++ HRD+ S NIL+ + +AD G A + ++
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 509 LAGSYGYIAPEL------AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY--- 559
G+ Y+APE+ ++ D+++FG+V EV + +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 560 ---DPKI--MLIDVLDQRLPPPVDRKVIQDI---LLVSTISFACLQSNPKS 602
DP M V + P + + D L + C NP +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK-ECWYQNPSA 286
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 66/252 (26%), Positives = 115/252 (45%), Gaps = 22/252 (8%)
Query: 117 NGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRL 171
N + LE L I + + S ++ L+ L+ L ++N++ G L
Sbjct: 165 NQVTDLKPLANLTTLERLDI--SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGIL 220
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
TNL+ +SL+ N L + + +L NL +LD+ +N + PL S LT L L L NQ
Sbjct: 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQ 276
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291
+S + + L L L++ N + P + +L+YL L N + P ++ LT
Sbjct: 277 ISNIS-PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 292 QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
+L L +NK+S S +A++ ++ WL +N I P + L+R+ L L+
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 352 SGRVPYSNKHLS 363
+ ++S
Sbjct: 388 TNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 74/253 (29%), Positives = 123/253 (48%), Gaps = 25/253 (9%)
Query: 113 NVNFNGRLSHL-NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR--- 168
+N N +++ + + NL L + + + T P + L+ L L+LSSN +
Sbjct: 96 LMNNN-QIADITPLANLTNLTGLTL--FNNQITDIDP--LKNLTNLNRLELSSNTISDIS 150
Query: 169 --GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226
LT+L +S + + + NL L LD+ N + L ++LT+L+ LI
Sbjct: 151 ALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLI 205
Query: 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNE 286
NQ+S + +G L NL L + N + TL ++L+ LDL+ NQ ++ P
Sbjct: 206 ATNNQISDIT-PLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-- 260
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNL 346
L+ LT+L L L +N++S P +A + LT L+L+ N ++ P I+ L L YL L
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316
Query: 347 SGNKLSGRVPYSN 359
N +S P S+
Sbjct: 317 YFNNISDISPVSS 329
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-32
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 20/235 (8%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMS 178
L S + L ++ L ++ L NL ++
Sbjct: 16 QIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQIN 74
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE 238
S N L + P + NL L+++ + +N + P L+ LT+L L L NQ++ +
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID-P 129
Query: 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL 298
+ NL NL L++ +N I L + L L + L LT L LD+
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLK---PLANLTTLERLDI 184
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
SSNK+S S +A + +L L +NN I P + L+ LD L+L+GN+L
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 22/253 (8%)
Query: 113 NVNFNGRLSHL-NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR--- 168
+++ N ++S + + NLESL + + P + L+ L L L+ N+L+
Sbjct: 183 DISSN-KVSDISVLAKLTNLESLIA--TNNQISDITP--LGILTNLDELSLNGNQLKDIG 237
Query: 169 --GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226
LTNL + L+ N + L P + L L EL +G N + PL + LT+L L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTNLE 293
Query: 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNE 286
L +NQL + I NLKNL L + N+I P + + L L N+ + +
Sbjct: 294 LNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSS 348
Query: 287 LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNL 346
L LT + L N++S P +A++ +T L L++ + +S + +
Sbjct: 349 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN 406
Query: 347 SGNKLSGRVPYSN 359
L S+
Sbjct: 407 VTGALIAPATISD 419
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 22/129 (17%), Positives = 49/129 (37%), Gaps = 9/129 (6%)
Query: 225 LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
I ++ + L M +G ++ + ++ L S
Sbjct: 7 TITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--I 61
Query: 285 NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344
+ + L L ++ S+N+L+ P + ++ L + ++NN I P + L+ L L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 345 NLSGNKLSG 353
L N+++
Sbjct: 118 TLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 12/167 (7%)
Query: 124 NFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYM 177
+ S NL++L L Y++ + P +S+L+KLQ L +N++ LTN+N++
Sbjct: 301 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWL 358
Query: 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ 237
S N + L P + NL + +L + D + P+ S+ + P
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPA 415
Query: 238 EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
I + + D+ N + FS + F+ ++
Sbjct: 416 TISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
N T L + L ++ + ++ +T L IK SI G
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG 63
Query: 334 EITKLSRLDYLNLSGNKLSGRVPYSN 359
+ L+ L +N S N+L+ P N
Sbjct: 64 -VEYLNNLTQINFSNNQLTDITPLKN 88
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 59/285 (20%), Positives = 98/285 (34%), Gaps = 57/285 (20%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEE------------------L 409
++I IG G YG V+ + G A+K + E L
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 410 AFI----RSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
FI + + Q + E GSL+ L + LD + + + L +L
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHL 150
Query: 463 H-----HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLL----AGSY 513
H P++ HRD+ S NIL+ +AD G A +D++ + G+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 514 GYIAPE-LAYTMVM-----TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI---- 563
Y+ PE L ++ D+YSFG++ EV + Y +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 564 ----MLIDVLDQRLPPPVDRKVIQDIL---LVSTISFACLQSNPK 601
M V ++L P + D + ++ C NP
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT-ECWAHNPA 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 67/279 (24%), Positives = 109/279 (39%), Gaps = 43/279 (15%)
Query: 105 IGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSS 164
+ H++ + N L+ L + P L +L + + T S+P L +L +
Sbjct: 59 LPAHITTLVIPDN-NLTSLP-ALPPELRTLEV--SGNQLT-SLPVLPPGLLELSIFSNPL 113
Query: 165 NRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
L + L + + N L L P L+ EL V DN L +P S L L
Sbjct: 114 THLPALPSGLCKLWIFGNQLTSL-PVLPPGLQ---ELSVSDNQLAS-LPALPSELCKLWA 168
Query: 225 -----------------LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFS 267
L ++ NQL+ LP L L NN + +P+
Sbjct: 169 YNNQLTSLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAY---NNRLT-SLPALPS--- 221
Query: 268 DLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327
L L +S N+ +S+P + L L +S N+L+ +P + L L + N +
Sbjct: 222 GLKELIVSGNRL-TSLPVLPSELK---ELMVSGNRLT-SLPMLPSG---LLSLSVYRNQL 273
Query: 328 KGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMP 366
+P + LS +NL GN LS R + + ++S P
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 35/265 (13%)
Query: 120 LSHLNFSCFPN-LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMS 178
+S + P L L+ + +P+ S L KL + L L +S
Sbjct: 88 VSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELS 147
Query: 179 LSRNMLGGLLPQEIGNLK-----------------NLIELDVGDNSLIGPIPLTLSRLTS 221
+S N L L P L L EL V DN L +P S L
Sbjct: 148 VSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYK 205
Query: 222 LKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281
L N+L+ LP LK L V N + +P +L L +S N+ +
Sbjct: 206 LWAY---NNRLTSLPALPSGLKEL---IVSGNRLTS-LPVLPS---ELKELMVSGNRL-T 254
Query: 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
S+P + L L + N+L+ ++P + + T ++L N + + +++
Sbjct: 255 SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 342 DYLNLSGNKLSGRVPYSNKHLSSMP 366
+ + + + ++
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALH 335
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 55/244 (22%), Positives = 86/244 (35%), Gaps = 26/244 (10%)
Query: 120 LSHLNFSCFPN-LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMS 178
+ + P L+ L+ D S+P+ S L KL + L + L +S
Sbjct: 128 IFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELS 187
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE 238
+S N L L P L L + SL + + LK LI++ N+L+ LP
Sbjct: 188 VSDNQLASL-PTLPSELYKLWAYNNRLTSL-------PALPSGLKELIVSGNRLTSLPVL 239
Query: 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL 298
LK L V N + +P L L + NQ + +P L L+ ++L
Sbjct: 240 PSELKEL---MVSGNRLTS-LPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNL 291
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNI------KGSIPGEITKLSRLDYLNLSGNKLS 352
N LS + + ++T + I S P E L L +
Sbjct: 292 EGNPLSERTLQA---LREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
Query: 353 GRVP 356
P
Sbjct: 349 EPAP 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 26/183 (14%)
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ 229
+++ + L L P + ++ L + DN+L +P + L+ L ++
Sbjct: 38 LNNGNAVLNVGESGLTTL-PDCLP--AHITTLVIPDNNLTS-LP---ALPPELRTLEVSG 90
Query: 230 NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
NQL+ LP L L + + L S L L + NQ +S+P
Sbjct: 91 NQLTSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQL-TSLPVLPPG 142
Query: 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
L + L +S N+L+ +P+ + L L NN + S+P + L L++S N
Sbjct: 143 LQE---LSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQE---LSVSDN 191
Query: 350 KLS 352
+L+
Sbjct: 192 QLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 15/211 (7%)
Query: 119 RLSHLNFSCFPN-LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYM 177
+ + P L+ L+ D S+P+ S L KL + L + L +
Sbjct: 167 WAYNNQLTSLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKEL 226
Query: 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ 237
+S N L L P LK L V N L +P+ S L SL + +NQL+ LP+
Sbjct: 227 IVSGNRLTSL-PVLPSELKEL---MVSGNRLTS-LPMLPSGLLSL---SVYRNQLTRLPE 278
Query: 238 EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS--SIPNELTRLTQLFH 295
+ +L + +++ N + +++ R T+ H
Sbjct: 279 SLIHLSSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPIIRFDMAGASAPRETRALH 335
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNN 326
L +++ L + A + +N
Sbjct: 336 L-AAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 29/153 (18%), Positives = 61/153 (39%), Gaps = 26/153 (16%)
Query: 214 LTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLD 273
+ +L + ++ L+ LP + ++ L + +N++ +P+ +L L+
Sbjct: 34 MRACLNNGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTS-LPALPP---ELRTLE 87
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI--------------ASMEDLTW 319
+S NQ +S+P L +L L +PS + L
Sbjct: 88 VSGNQL-TSLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQE 145
Query: 320 LDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L +S+N + S+P ++L +L N+L+
Sbjct: 146 LSVSDNQLA-SLPALPSELCKLW---AYNNQLT 174
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 37/211 (17%), Positives = 83/211 (39%), Gaps = 48/211 (22%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG G +G VY + +G V A++ ++ E +++F+ E Q
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
+ +L+ ++ + + LD K I + + + YLH + ++
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-----TLLAGSYGYIAPEL------ 520
H+D+ S N+ ++ + + DFG + + + + G ++APE+
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 521 ---AYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ ++ DV++ G + E+ + P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 58/271 (21%), Positives = 103/271 (38%), Gaps = 67/271 (24%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G K G V +K+L + E R+F E +V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
++ G+L I+ + + W++RV+ K +A +AYLH S ++
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLL--------------HADSSNQTLLAGSYGYI 516
+HRD++S+N L+ VADFG ARL+ D + + G+ ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
APE+ EK DV+SFG+V E++ + + + + L P
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----GLNVRGFLDRYCP 245
Query: 577 VD-----RKVIQDILLVSTISFACLQSNPKS 602
+ + C +P+
Sbjct: 246 PNCPPSFFPITVR----------CCDLDPEK 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/291 (21%), Positives = 106/291 (36%), Gaps = 69/291 (23%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
R I + IG G +G V++ + G A+K +S E RS+ EA++
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVML 93
Query: 425 ----------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMA 456
E GSLF L+ + + + + A
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTA 149
Query: 457 HALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLL-- 509
LA+LH + P++ HRD+ S NIL+ +AD G A + + +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 510 --AGSYGYIAPE-LAYTMVM-----TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY-- 559
G+ Y+APE L ++ M ++ D+Y+ G+V E+ +H Y
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 560 ----DPKI--MLIDVLDQRLPPPVDRKVIQDIL---LVSTISFACLQSNPK 601
DP + M V +Q+L P + + + + C +N
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGA 319
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 16/255 (6%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL 167
++S ++ +FS + L ++ + G P+ L L+ L +SN+
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELV---NCKFGQFPT--LKLKSLKRLTFTSNKG 337
Query: 168 RG-----RLTNLNYMSLSRNMLG--GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLT 220
L +L ++ LSRN L G Q +L LD+ N +I + L
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLE 396
Query: 221 SLKILILAQNQLSGLPQEI--GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278
L+ L + L + + +L+NL+ LD+ + S L L ++ N
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 279 FNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITK 337
F + + T L L LDLS +L P+ S+ L L++++N +K G +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 338 LSRLDYLNLSGNKLS 352
L+ L + L N
Sbjct: 517 LTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 18/241 (7%)
Query: 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSL 179
C + ++ F IP + + LDLS N LR L + L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 180 SRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE- 238
SR + + +L +L L + N + S L+SL+ L+ + L+ L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 239 IGNLKNLMLLDVGNNDI-IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL---- 293
IG+LK L L+V +N I +P ++L +LDLS N+ S +L L Q+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 294 FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLS 352
LDLS N ++ I L L L NN ++ I L+ L+ L +
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 353 G 353
Sbjct: 239 N 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 60/282 (21%), Positives = 105/282 (37%), Gaps = 29/282 (10%)
Query: 96 ITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPS----EI 151
+ G+ + L K + N ++ +C L L + G + + +
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 152 SALSKLQLLDLSSNRLRG-------------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
SAL L L + RL LTN++ SL + +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGW 306
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--I 256
L++ + +L SLK L N+ E+ +L +L LD+ N +
Sbjct: 307 QHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSFK 362
Query: 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA--SM 314
G + + L YLDLS N ++ + L QL HLD + L ++ S+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 420
Query: 315 EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
+L +LD+S+ + + + G LS L+ L ++GN
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 23/253 (9%)
Query: 119 RLSHLNFSCFP--NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------- 168
L + F FP L+SL+ L + G+ SE+ L L+ LDLS N L
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQS 368
Query: 169 -GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILI 226
T+L Y+ LS N + + L+ L LD ++L L +L L
Sbjct: 369 DFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 227 LAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS---YLDLSCNQFNSS 282
++ I L +L +L + N +F++L +LDLS Q
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--DIFTELRNLTFLDLSQCQLEQL 485
Query: 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342
P L+ L L+++SN+L + L + L N S P I LSR
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-IDYLSR-- 542
Query: 343 YLNLSGNKLSGRV 355
+LN + K G
Sbjct: 543 WLNKNSQKEQGSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 49/206 (23%), Positives = 71/206 (34%), Gaps = 11/206 (5%)
Query: 161 DLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216
+ + LS N L L + L LD+ +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 217 SRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
L+ L LIL N + L L +L L ++ +G L L+++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 276 CNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW----LDLSNNNIKGS 330
N S +P + LT L HLDLSSNK+ + + + + LDLS N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 331 IPGEITKLSRLDYLNLSGNKLSGRVP 356
I K RL L L N S V
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVM 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 4/157 (2%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
IP L S K L L+ N L L + L +LD+ +I S LS
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK-G 329
L L+ N S + L+ L L L+ I ++ L L++++N I+
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 330 SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMP 366
+P + L+ L++L+LS NK+ + L MP
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 78/302 (25%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
+ IG G YG+VYK L + R A+K + ++F NE +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLM 64
Query: 425 -----------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
GSL + L DW + ++
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSV 120
Query: 456 AHALAYLHHD------CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA-------- 501
LAYLH + P++ HRD++S N+L+ + ++DFG + L
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 502 DSSNQTLLAGSYGYIAPELAYTMV-------MTEKYDVYSFGVVTLEVLMGKHPRDLHST 554
+ + G+ Y+APE+ V ++ D+Y+ G++ E+ M +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 555 LSS---------SYDPKI--MLIDVLDQRLPPPVDRKVIQDILLVSTIS---FACLQSNP 600
+ P M + V ++ P ++ L V ++ C +
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 601 KS 602
++
Sbjct: 301 EA 302
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 55/248 (22%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR--- 168
+ FN + +L F N+ L +L S+P I KL L +S+N L
Sbjct: 99 YMGFN-AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157
Query: 169 ----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
T+L + LS N L + ++ + +L +V N L TL+ +++
Sbjct: 158 DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEE 209
Query: 225 LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
L + N ++ + + L +L + +N++ L L +DLS N+ +
Sbjct: 210 LDASHNSINVVRGPV--NVELTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELEKIMY 265
Query: 285 NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344
+ ++ +L L +S+N+L + + L LDLS+N++ + + RL+ L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 345 NLSGNKLS 352
L N +
Sbjct: 324 YLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 55/262 (20%), Positives = 95/262 (36%), Gaps = 33/262 (12%)
Query: 117 NGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR------- 168
N + L + + + +L D I + + +Q L + N +R
Sbjct: 54 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 113
Query: 169 GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228
+ L + L RN L L N L L + +N+L T TSL+ L L+
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 173
Query: 229 QNQLSGLPQEIGNLKNLMLLDVGNNDI------------------IGPIPSTLGLFSDLS 270
N+L+ + + + +L +V N + I + + +L+
Sbjct: 174 SNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRG--PVNVELT 229
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330
L L N + L L +DLS N+L + M+ L L +SNN + +
Sbjct: 230 ILKLQHNNL-TDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 331 IPGEITKLSRLDYLNLSGNKLS 352
+ + L L+LS N L
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 42/246 (17%), Positives = 83/246 (33%), Gaps = 17/246 (6%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR--GRLTNLNY 176
L + F SL+ L + +S + L ++S N L +
Sbjct: 152 NLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEE 209
Query: 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP 236
+ S N + + L L + N+L L L + L+ N+L +
Sbjct: 210 LDASHNSINVV---RGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIM 264
Query: 237 QEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFH 295
++ L L + NN ++ + L LDLS N + + +L +
Sbjct: 265 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLEN 322
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355
L L N + + +++ L L LS+N+ + + + + ++
Sbjct: 323 LYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKI 377
Query: 356 PYSNKH 361
Y +H
Sbjct: 378 DYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 34/197 (17%), Positives = 77/197 (39%), Gaps = 9/197 (4%)
Query: 157 LQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216
+Q D+ L N ++ + + L + + + + L++ D +
Sbjct: 30 MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF 89
Query: 217 SRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
+ +++ L + N + LP + N+ L +L + ND+ L+ L +S
Sbjct: 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
N + T L +L LSSN+L+ + ++ + L ++S N + +
Sbjct: 150 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TL 201
Query: 336 TKLSRLDYLNLSGNKLS 352
++ L+ S N ++
Sbjct: 202 AIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 18/112 (16%), Positives = 37/112 (33%), Gaps = 5/112 (4%)
Query: 242 LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301
++ + + G TL ++ + + L Q+ L+L+
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITL---NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 79
Query: 302 KLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
++ A + L + N I+ +P + + L L L N LS
Sbjct: 80 QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 12/95 (12%), Positives = 29/95 (30%), Gaps = 2/95 (2%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318
I S L + + + E L + ++ + + + S +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 319 WLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
L+L++ I+ I + L + N +
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 6/72 (8%), Positives = 25/72 (34%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
I + L + + + + ++ + + N+ ++ + +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 341 LDYLNLSGNKLS 352
++ LNL+ ++
Sbjct: 71 VELLNLNDLQIE 82
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 11/244 (4%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR-------GR 170
R+ LN F + L L + ++ + L L+ L L SNRL+
Sbjct: 43 RIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTG 102
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L+NL + +S N + LL +L NL L+VGDN L+ S L SL+ L L +
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 231 QLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
L+ +P E +L L++L + + +I + L L++S + ++
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 290 LTQLFHLDLSSNKLSGKIPSQ-IASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L L ++ L+ +P + + L +L+LS N I + +L RL + L G
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 349 NKLS 352
+L+
Sbjct: 282 GQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 19/257 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSN 165
L L+ +S + F NL +LR L IP + + LS L LD+S N
Sbjct: 61 LELN------ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 166 RLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
++ L NL + + N L + + L +L +L + +L LS
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174
Query: 219 LTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277
L L +L L ++ + L L +L++ + + + +L+ L ++
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 278 QFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEI 335
+++P + L L L+LS N +S I + + L + L + P
Sbjct: 235 NL-TAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 336 TKLSRLDYLNLSGNKLS 352
L+ L LN+SGN+L+
Sbjct: 293 RGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 49/257 (19%), Positives = 99/257 (38%), Gaps = 19/257 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSN 165
L L + RL + F L +L L + + + L L+ L++ N
Sbjct: 85 LGLR------SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 166 RLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
L L +L ++L + L + + + +L LI L + ++ + R
Sbjct: 139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 219 LTSLKILILAQ-NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277
L LK+L ++ L + NL L + + ++ + L +L+LS N
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEI- 335
++ + L L +L + L +L+ + + L L++S N + ++ +
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVF 316
Query: 336 TKLSRLDYLNLSGNKLS 352
+ L+ L L N L+
Sbjct: 317 HSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 47/206 (22%), Positives = 81/206 (39%), Gaps = 9/206 (4%)
Query: 158 QLLDLSSNRL----RGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP 213
+ + R G T + L +N + L E + +L EL++ +N + P
Sbjct: 14 RAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73
Query: 214 LTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL 272
+ L +L+ L L N+L +P + L NL LD+ N I+ + +L L
Sbjct: 74 GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 273 DLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGS 330
++ N I + + L L L L L+ IP++ + + L L L + NI
Sbjct: 134 EVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 331 IPGEITKLSRLDYLNLSGNKLSGRVP 356
+L RL L +S +
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMT 217
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 37/160 (23%), Positives = 71/160 (44%), Gaps = 15/160 (9%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
+P + T ++L L +N++ L Q+ + +L L++ N + + G F++L
Sbjct: 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEP--GAFNNLF 80
Query: 271 ---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNN 325
L L N+ IP T L+ L LD+S NK+ + + + +L L++ +N
Sbjct: 81 NLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN 138
Query: 326 NIKGSIP-GEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
++ I + L+ L+ L L L+ + HL
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHG 177
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 58/250 (23%), Positives = 93/250 (37%), Gaps = 30/250 (12%)
Query: 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL----RGRLTNLNYMSLS 180
FS + E + S+ E +++ L L+ L + + ++
Sbjct: 30 FSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLPPQITVLEIT 88
Query: 181 RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIG 240
+N L L P+ +L+ LD DN L +P SLK L + NQL+ LP+
Sbjct: 89 QNALISL-PELPASLE---YLDACDNRLST-LP---ELPASLKHLDVDNNQLTMLPELPA 140
Query: 241 NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300
L+ + + NN + +P L L + NQ +P L LD+S+
Sbjct: 141 LLEYI---NADNNQLTM-LPELPT---SLEVLSVRNNQLTF-LPELPESLE---ALDVST 189
Query: 301 NKLSGKIPSQIASM----EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
N L +P+ E + N I IP I L + L N LS R+
Sbjct: 190 NLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 357 YSNKHLSSMP 366
S ++ P
Sbjct: 248 ESLSQQTAQP 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 1e-25
Identities = 54/261 (20%), Positives = 96/261 (36%), Gaps = 29/261 (11%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL 167
+ N N +S L L++ + S+P + ++ +L+++ N L
Sbjct: 38 KQALPGENRNEAVSLLKECLINQFSELQL--NRLNLS-SLPDNL--PPQITVLEITQNAL 92
Query: 168 R---GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
+L Y+ N L L P+ +LK LDV +N L +P L+
Sbjct: 93 ISLPELPASLEYLDACDNRLSTL-PELPASLK---HLDVDNNQLTM-LP---ELPALLEY 144
Query: 225 LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
+ NQL+ LP+ +L+ L V NN + +P L LD+S N S+P
Sbjct: 145 INADNNQLTMLPELPTSLEVL---SVRNNQLTF-LPELPE---SLEALDVSTNLL-ESLP 196
Query: 285 NELTRLTQL----FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
R N+++ IP I S++ + L +N + I +++ +
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 341 LDYLNLSGNKLSGRVPYSNKH 361
+ S N
Sbjct: 256 QPDYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 52/238 (21%), Positives = 89/238 (37%), Gaps = 39/238 (16%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLP 189
N SL ++Y+ +G+ SA K + L +RN LL
Sbjct: 9 NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGE--------------NRNEAVSLLK 54
Query: 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLD 249
+ + EL + +L +P L + +L + QN L LP+ +L+ LD
Sbjct: 55 E--CLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALISLPELPASLEY---LD 106
Query: 250 VGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS 309
+N + +P L +LD+ NQ + +P L +++ +N+L+ +P
Sbjct: 107 ACDNRLST-LPELPA---SLKHLDVDNNQL-TMLPELPALLE---YINADNNQLT-MLPE 157
Query: 310 QIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPT 367
S L L + NN + +P L LD +S N L +P
Sbjct: 158 LPTS---LEVLSVRNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEE 207
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 42/238 (17%), Positives = 79/238 (33%), Gaps = 28/238 (11%)
Query: 120 LSHLNFSCFPN-LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---RLTNLN 175
S P SL+ L + +P + L+ ++ +N+L T+L
Sbjct: 107 ACDNRLSTLPELPASLKHLDVDNNQLTMLPELPA---LLEYINADNNQLTMLPELPTSLE 163
Query: 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLK----ILILAQNQ 231
+S+ N L L P+ +L+ LDV N L +P R + +N+
Sbjct: 164 VLSVRNNQLTFL-PELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291
++ +P+ I +L + + +N + I +L + F+ S + T
Sbjct: 219 ITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHR 278
Query: 292 QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
L + P S W T + LD L+ + +
Sbjct: 279 PLADAVTAW------FPENKQSDVSQIWHAF------EHEEHANTFSAFLDRLSDTVS 324
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 55/248 (22%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR--- 168
+ FN + +L F N+ L +L S+P I KL L +S+N L
Sbjct: 105 YMGFN-AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 163
Query: 169 ----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
T+L + LS N L + ++ + +L +V N L TL+ +++
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEE 215
Query: 225 LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
L + N ++ + + L +L + +N++ L L +DLS N+ +
Sbjct: 216 LDASHNSINVVRGPV--NVELTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELEKIMY 271
Query: 285 NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344
+ ++ +L L +S+N+L + + L LDLS+N++ + + RL+ L
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329
Query: 345 NLSGNKLS 352
L N +
Sbjct: 330 YLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-21
Identities = 41/247 (16%), Positives = 89/247 (36%), Gaps = 43/247 (17%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR----GRLTNL 174
RL+H++ S P+L + + ++ S ++ ++ LD S N + L
Sbjct: 182 RLTHVDLSLIPSLFHANV-------SYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL 234
Query: 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234
+ L N L + N L+E+D+ N L + ++ L+ L ++ N+L
Sbjct: 235 TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 292
Query: 235 LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294
L + L +LD+ +N + + + +L
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHL-------------------------LHVERNQPQFDRLE 327
Query: 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGR 354
+L L N + + +++ L L LS+N+ + + + + +
Sbjct: 328 NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCK 382
Query: 355 VPYSNKH 361
+ Y +H
Sbjct: 383 IDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-21
Identities = 34/197 (17%), Positives = 77/197 (39%), Gaps = 9/197 (4%)
Query: 157 LQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216
+Q D+ L N ++ + + L + + + + L++ D +
Sbjct: 36 MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF 95
Query: 217 SRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
+ +++ L + N + LP + N+ L +L + ND+ L+ L +S
Sbjct: 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
N + T L +L LSSN+L+ + ++ + L ++S N + +
Sbjct: 156 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TL 207
Query: 336 TKLSRLDYLNLSGNKLS 352
++ L+ S N ++
Sbjct: 208 AIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 35/184 (19%), Positives = 69/184 (37%), Gaps = 9/184 (4%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
+++ ++++ G E L N + ++++ L +++L L
Sbjct: 29 FYDVHIDMQTQDVYFGF---EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85
Query: 231 QLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
Q+ + + L +G N I P L+ L L N +S
Sbjct: 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145
Query: 290 LTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
+L L +S+N L +I + L L LS+N + + ++ + L + N+S
Sbjct: 146 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSY 201
Query: 349 NKLS 352
N LS
Sbjct: 202 NLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 2e-17
Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 5/183 (2%)
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
Y R + + ++ + + L + KI+ + +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 233 SGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291
LP + + + + LL++ + I + L + N P+ +
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 292 QLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
L L L N LS +P I + LT L +SNNN++ I + + L L LS N
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN 181
Query: 350 KLS 352
+L+
Sbjct: 182 RLT 184
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-30
Identities = 65/281 (23%), Positives = 103/281 (36%), Gaps = 30/281 (10%)
Query: 85 DYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSC---------FPNLESLR 135
+Y + EW G + +S+ + + L + P+LESL
Sbjct: 38 EYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLV 97
Query: 136 ILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNL 195
+ T +P +L L + + + L L Y+ +S N L L E+ N
Sbjct: 98 A--SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL--PELQNS 152
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI 255
L +DV +NSL +P SL+ + NQL LP E+ NL L + NN +
Sbjct: 153 SFLKIIDVDNNSLKK-LP---DLPPSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSL 207
Query: 256 IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME 315
+P L + N EL L L + +N L +P S
Sbjct: 208 KK-LPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS-- 258
Query: 316 DLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
L L++ +N + +P L+ LD + LS P
Sbjct: 259 -LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 46/220 (20%), Positives = 82/220 (37%), Gaps = 31/220 (14%)
Query: 148 PSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201
P +S + LQ S+ L + + + + P G + +
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 202 DVGDNSLIGPIPLTLSR---------LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGN 252
+ D L L+ L+ L+ + N L+ LP+ +LK+L++ +
Sbjct: 64 RLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 123
Query: 253 NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312
+ P L YL +S NQ +P EL + L +D+ +N L K+P
Sbjct: 124 KALSDLPPL-------LEYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 313 SMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
S L ++ NN ++ +P E+ L L + N L
Sbjct: 174 S---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 52/270 (19%)
Query: 119 RLSHLNFSCFPNL-ESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---GRLTNL 174
+ + N +L L L + +P E+ S L+++D+ +N L+ +L
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSL 175
Query: 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL------------------TL 216
+++ N L L E+ NL L + +NSL L L
Sbjct: 176 EFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 233
Query: 217 SRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTL------------- 263
L L + N L LP +L+ L + D D+ +P +L
Sbjct: 234 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLP-ELPQSLTFLDVSENIFSGL 292
Query: 264 -GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDL 322
L +L YL+ S N+ S+ + L L++S+NKL ++P+ L L
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELPALPPR---LERLIA 344
Query: 323 SNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
S N++ +P L +L + N L
Sbjct: 345 SFNHLA-EVPELPQNLKQLH---VEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 52/267 (19%), Positives = 90/267 (33%), Gaps = 39/267 (14%)
Query: 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLD 161
+ ++ + + L+ + N++S + + + P ++ +
Sbjct: 6 RNVSNTFLQEPLRHSSNLTEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 162 LSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTS 221
L R + + L+ L LP+ +L+ L NSL +P L S
Sbjct: 65 LRDCLDR----QAHELELNNLGLSS-LPELPPHLE---SLVASCNSLT-ELPELPQSLKS 115
Query: 222 LKILILAQNQLSGLPQ----------------EIGNLKNLMLLDVGNNDIIGPIPSTLGL 265
L + LS LP E+ N L ++DV NN + +P
Sbjct: 116 LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPP- 173
Query: 266 FSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
L ++ NQ +P EL L L + +N L K+P S L + NN
Sbjct: 174 --SLEFIAAGNNQL-EELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNN 225
Query: 326 NIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ E+ L L + N L
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 47/234 (20%), Positives = 83/234 (35%), Gaps = 25/234 (10%)
Query: 120 LSHLNFSCFPN-LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMS 178
+ P+ SL L D + +P +L+ L + + + L NL Y++
Sbjct: 244 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 303
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE 238
S N + L +L EL+V +N LI +P + L+ LI + N L+ +P+
Sbjct: 304 ASSNEIRSL----CDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLAEVPEL 355
Query: 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL 298
NLK L V N + P DL + +P L L +
Sbjct: 356 PQNLKQ---LHVEYNPLRE-FPDIPESVEDLR----MNSHLA-EVPELPQNLK---QLHV 403
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+N L + P S + L +++ + +L+ +
Sbjct: 404 ETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 42/238 (17%), Positives = 81/238 (34%), Gaps = 43/238 (18%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR---GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202
E+ L L + +N L+ +L +++ N L L P+ +L L +
Sbjct: 228 EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDL-PELPQSLTFLDVSE 286
Query: 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPST 262
+ L +L L + N++ L +L+ L +V NN +I +P+
Sbjct: 287 NIFSGLS-------ELPPNLYYLNASSNEIRSLCDLPPSLEEL---NVSNNKLIE-LPAL 335
Query: 263 LGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED------ 316
L L S N + +P L L + N L + P S+ED
Sbjct: 336 PP---RLERLIASFNHL-AEVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLRMNSH 387
Query: 317 ----------LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364
L L + N ++ P + L ++ ++ ++++
Sbjct: 388 LAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDK 441
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 31/172 (18%), Positives = 57/172 (33%), Gaps = 34/172 (19%)
Query: 219 LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLG-------------L 265
T L+ + + L+ +P E N+K+ ++ P G L
Sbjct: 10 NTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 266 FSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
L+L+ SS+P L L S N L+ ++P S++ L + +
Sbjct: 70 DRQAHELELNNLGL-SSLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 326 NIKGSIPG---------------EITKLSRLDYLNLSGNKLSGRVPYSNKHL 362
+ P E+ S L +++ N L ++P L
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 23/223 (10%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNML--GGLLPQEIGNLK 196
S+P+ I S L+L SN+L+ +LT L +SLS N L G Q
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE--IGNLKNLMLLDVGNND 254
+L LD+ N +I + L L+ L + L + + +L+NL+ LD+ +
Sbjct: 79 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 255 IIGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQ 310
+ G+F+ LS L ++ N F + + T L L LDLS +L ++
Sbjct: 138 TRV-AFN--GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 311 I-ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
S+ L L++S+NN L+ L L+ S N +
Sbjct: 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 22/222 (9%)
Query: 148 PSEISALSKLQLLDLSSNRLRGR---------LTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
L++L L LSSN L + T+L Y+ LS N + + L+ L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQL 103
Query: 199 IELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDII 256
LD ++L L +L L ++ I L +L +L + N
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 257 GPIPSTLGLFSDLS---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQIA 312
+F++L +LDLS Q + L+ L L++S N
Sbjct: 164 ENFLP--DIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 313 SMEDLTWLDLSNNNIKGSIPGEITK--LSRLDYLNLSGNKLS 352
+ L LD S N+I + + + S L +LNL+ N +
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 14/204 (6%)
Query: 160 LDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIP 213
+ +S L G ++ + L N L L L L +L + N L G
Sbjct: 12 IRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 214 LTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS--- 270
+ TSLK L L+ N + + L+ L LD ++++ + +F L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ-MSEF-SVFLSLRNLI 129
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKG 329
YLD+S + L+ L L ++ N I + +LT+LDLS ++
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188
Query: 330 SIPGEI-TKLSRLDYLNLSGNKLS 352
+ LS L LN+S N
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 9/150 (6%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
+P + +S L L N+L LP + L L L + +N + +
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL-SFKGCCSQSDFGTT 78
Query: 271 ---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNN 326
YLDLS N ++ + L QL HLD + L + S+ +L +LD+S+ +
Sbjct: 79 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 327 IKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
+ + G LS L+ L ++GN
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 31/153 (20%), Positives = 51/153 (33%), Gaps = 27/153 (17%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD-GFTGSIPSEI-SALSKLQLLDLSS 164
L +S + F L SL +L F + +I + L L LDLS
Sbjct: 131 LDIS------HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 165 NRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
+L LS L +L L++ N+ L SL++
Sbjct: 185 CQLE---------QLSPTAFNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 225 LILAQNQLSGLPQEI--GNLKNLMLLDVGNNDI 255
L + N + ++ +L L++ ND
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 49/310 (15%), Positives = 102/310 (32%), Gaps = 27/310 (8%)
Query: 60 SALSPIQLETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGR 119
+ L + + + + + + +N G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 120 LSHLNFSCFPNLESLRILA------YYDGFTGSIPSEISALSKLQLLDLSSNRLRG---- 169
+ L + + + + S L K++ + + ++++
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 170 ---RLTNLNYMSLSRNMLGGLLPQE---IGNLKNLIELDVGDNSL--IGPIPLTLSRLTS 221
L +L ++ LS N++ + G +L L + N L + L L +
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 222 LKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281
L L +++N +P + + L++ + I + + + L LD+S N
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTG-IRVVKT--CIPQTLEVLDVSNNNL-D 444
Query: 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
S L RL L +S NKL +P + L + +S N +K G +L+ L
Sbjct: 445 SFSLFLPRLQ---ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
Query: 342 DYLNLSGNKL 351
+ L N
Sbjct: 500 QKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 48/294 (16%), Positives = 95/294 (32%), Gaps = 39/294 (13%)
Query: 92 EWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI 151
++ + + L D V+ + S + +L E
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 152 SALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
+ L D + + + + + + L L L+ + + V
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQNQLSGL----PQEIGNLKNLMLLDVGNNDIIGPIP 260
++ + L SL+ L L++N + G +L L + N + +
Sbjct: 319 NSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQ 377
Query: 261 STLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDL 317
T + L LD+S N F +P+ ++ L+LSS + + + I + L
Sbjct: 378 KTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTL 433
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLD-------------------YLNLSGNKLS 352
LD+SNNN+ S + +L L + +S N+L
Sbjct: 434 EVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 47/284 (16%), Positives = 104/284 (36%), Gaps = 31/284 (10%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTG-SIPSEISALSKLQLLDLSSNRLRGR------ 170
LS L+ S F L SL+ L + + + S L+ LQ L + +
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 171 --LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228
LT+LN + + L Q + +++++ L + + + + L+S++ L L
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 229 QNQLSGLPQEIG------------NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276
L+ + +L D N+++ + L L S++ + D +
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL-SEVEFDDCTL 263
Query: 277 NQFNSSIPNELT--------RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328
N P+E + L + L + + + +E + + + N+ +
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 329 GSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKID 372
L L++L+LS N + ++ + P+ + +
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 43/245 (17%), Positives = 79/245 (32%), Gaps = 10/245 (4%)
Query: 115 NFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTN 173
+ + L + ++ L + F S S ++ L + L +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE--S 239
Query: 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLS 233
N + + L E + D + L +++ L + Q L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 234 GLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI---PNELTR 289
+ L+ + + V N+ + S L +LDLS N
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 290 LTQLFHLDLSSNKLS--GKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347
L L LS N L K + ++++LT LD+S N +P ++ +LNLS
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 348 GNKLS 352
+
Sbjct: 419 STGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 43/244 (17%), Positives = 91/244 (37%), Gaps = 12/244 (4%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRL 171
+ + ++SL + ++ T ++ A + LQ+L L S+R+ L
Sbjct: 16 SFTSIPSGLTAAMKSLDL--SFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL 73
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILA-Q 229
+L ++ LS N L L G L +L L++ N + LT+L+ L +
Sbjct: 74 GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
Query: 230 NQLSGLPQE-IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
S + + L +L L++ + +L D+ +L L ++ +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L+ + +L+L L+ S + E + + +L +L L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 349 NKLS 352
+++
Sbjct: 254 SEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 36/183 (19%), Positives = 65/183 (35%), Gaps = 20/183 (10%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISA---LSKLQLLDLS 163
L LS+ N N +C SL+ L S+ L L LD+S
Sbjct: 339 LDLSE---NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395
Query: 164 SNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLS 217
N + +++LS + + + L LDV +N+L
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKT---CIPQTLEVLDVSNNNLDS-FS---L 448
Query: 218 RLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277
L L+ L +++N+L LP + L+++ + N + + L + L N
Sbjct: 449 FLPRLQELYISRNKLKTLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 278 QFN 280
++
Sbjct: 508 PWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 28/137 (20%), Positives = 50/137 (36%), Gaps = 3/137 (2%)
Query: 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280
+ + + +P + + LD+ N I L ++L L L ++ N
Sbjct: 6 ASGVCDGRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG-SIPGEITKLS 339
+ + L L HLDLS N LS S + L +L+L N + + L+
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 340 RLDYLNLSGNKLSGRVP 356
L L + + +
Sbjct: 124 NLQTLRIGNVETFSEIR 140
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 10/132 (7%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSNRLR---GRLTNL 174
+ SC E +R L G + + I L++LD+S+N L L L
Sbjct: 398 TFHPMPDSCQ-WPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFSLFLPRL 453
Query: 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234
+ +SRN L L + L+ + + N L RLTSL+ + L N
Sbjct: 454 QELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511
Query: 235 LPQEIGNLKNLM 246
I L +
Sbjct: 512 SCPRIDYLSRWL 523
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 17/218 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+P I + + L+L N ++ L +L + L RN + + L +L
Sbjct: 68 EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIG 257
L++ DN L L+ L+ L L N + +P + +LM LD+G +
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 258 PIPSTLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM 314
I G F L YL+L +P LT L L L++S N P +
Sbjct: 186 YISE--GAFEGLFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 315 EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L L + N+ + L+ L LNL+ N LS
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 152 SALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
L L++L L N +R L +LN + L N L + L L EL +
Sbjct: 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQ-NQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPST 262
+N + +R+ SL L L + +L + + L NL L++G +I +P+
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNL 214
Query: 263 LGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDL 322
L L L++S N F P L+ L L + ++++S + + L L+L
Sbjct: 215 TPLVG-LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 323 SNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
++NN+ S+P ++ T L L L+L N
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 45/221 (20%), Positives = 73/221 (33%), Gaps = 50/221 (22%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L L DN L+ + F L L+ L L +N
Sbjct: 128 LELF-DN-----WLTVIPSGAFEYLSK-----------------------LRELWLRNNP 158
Query: 167 LRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKIL 225
+ S+ + +L+ LD+G+ + I L +LK L
Sbjct: 159 IE---------SIPSYAFNR--------VPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201
Query: 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN 285
L + +P + L L L++ N P + S L L + +Q + N
Sbjct: 202 NLGMCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNN 325
L L L+L+ N LS +P + + L L L +N
Sbjct: 261 AFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 24/132 (18%), Positives = 44/132 (33%), Gaps = 35/132 (26%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD-------GFTG-------------- 145
L L + +L +++ F L +L+ L T
Sbjct: 176 LDLGELK-----KLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHF 230
Query: 146 -SIPSE-ISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLK 196
I LS L+ L + ++++ L +L ++L+ N L L L+
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 197 NLIELDVGDNSL 208
L+EL + N
Sbjct: 291 YLVELHLHHNPW 302
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+P IS +LL+L N+++ L +L + LSRN + + L NL
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIG 257
L++ DN L L+ LK L L N + +P + +L LD+G +
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 258 PIPSTLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-AS 313
I G F LS YL+L+ IP LT L +L LDLS N LS I
Sbjct: 175 YISE--GAFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ L L + + I+ L L +NL+ N L+
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 152 SALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
L L++L LS N +R L NLN + L N L + L L EL +
Sbjct: 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQ-NQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPST 262
+N + +R+ SL+ L L + +LS + + L NL L++ ++ IP+
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNL 203
Query: 263 LGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDL 322
L L LDLS N ++ P L L L + +++ + +++ L ++L
Sbjct: 204 TPLIK-LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 323 SNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
++NN+ +P ++ T L L+ ++L N
Sbjct: 263 AHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 43/220 (19%), Positives = 71/220 (32%), Gaps = 48/220 (21%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L L DN RL+ + F L L+ L L +N
Sbjct: 117 LELF-DN-----RLTTIPNGAFVYLSK-----------------------LKELWLRNNP 147
Query: 167 LRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKIL 225
+ S+ + +L LD+G+ + I L++L+ L
Sbjct: 148 IE---------SIPSYAFNR--------IPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN 285
LA L +P + L L LD+ N + P + L L + +Q N
Sbjct: 191 NLAMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
L L ++L+ N L+ + L + L +N
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 25/132 (18%), Positives = 43/132 (32%), Gaps = 35/132 (26%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRIL-------AYYDGFTG-------------- 145
L L + RLS+++ F L +LR L T
Sbjct: 165 LDLGELK-----RLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHL 219
Query: 146 -SIPSEI-SALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLK 196
+I L LQ L + ++++ L +L ++L+ N L L L
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 197 NLIELDVGDNSL 208
+L + + N
Sbjct: 280 HLERIHLHHNPW 291
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 16/247 (6%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR----GRLTN 173
+++ + F NL++L L + I + L KL+ L LS N+L+
Sbjct: 63 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 122
Query: 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL-IGPIP-LTLSRLTSLKILILAQNQ 231
L + + N + + L +I +++G N L I + L + +A
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291
++ +PQ G +L L + N I ++L ++L+ L LS N ++ L
Sbjct: 183 ITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240
Query: 292 QLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG------SIPGEITKLSRLDYLN 345
L L L++NKL K+P +A + + + L NNNI PG TK + ++
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 299
Query: 346 LSGNKLS 352
L N +
Sbjct: 300 LFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 157 LQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212
L+++ S L + + L N + + + NLKNL L + +N +
Sbjct: 33 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 213 PLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS-- 270
P + L L+ L L++NQL LP+++ K L L V N+I + +F+ L+
Sbjct: 93 PGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENEITK-VRK--SVFNGLNQM 147
Query: 271 -YLDLSCNQFNSSI--PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327
++L N SS + +L ++ ++ ++ IP + LT L L N I
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 204
Query: 328 KGSIPGEI-TKLSRLDYLNLSGNKLS 352
+ L+ L L LS N +S
Sbjct: 205 T-KVDAASLKGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 33/209 (15%)
Query: 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDL 162
+I + L N + + + F L +RI T +IP L L L
Sbjct: 146 QMIVVELG-TNPLKSSGIENGAFQGMKKLSYIRI--ADTNIT-TIPQ--GLPPSLTELHL 199
Query: 163 SSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215
N++ L NL + LS N + + + N +L EL + +N L+ +P
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGG 258
Query: 216 LSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
L+ ++++ L N +S + ++ P + S + L
Sbjct: 259 LADHKYIQVVYLHNNNISAIG----------------SNDFCPPGYNTKK-ASYSGVSLF 301
Query: 276 CNQFNSSI--PNELTRLTQLFHLDLSSNK 302
N P+ + + L + K
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 268 DLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327
L + S +P +L T LDL +NK++ ++++L L L NN I
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 328 KGSIPGEITKLSRLDYLNLSGNKLS 352
PG L +L+ L LS N+L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK 113
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
++P I A Q + L NR+ NL + L N+L + L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 199 IELDVGDNSLIGPIPL-TLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDII 256
+LD+ DN+ + + T L L L L + L L + L L L + +N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL- 141
Query: 257 GPIPSTLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-A 312
+P F DL +L L N+ +S L L L L N+++ +
Sbjct: 142 QALPD--DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 313 SMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
+ L L L NN+ ++P E L L YL L+ N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 37/171 (21%), Positives = 57/171 (33%), Gaps = 12/171 (7%)
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLM 246
+P I + + N + + +L IL L N L+ + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 247 LLDVGNNDIIGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNK 302
LD+ +N + + F L L L + L L +L L N
Sbjct: 84 QLDLSDNAQLRSVDP--ATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNA 140
Query: 303 LSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L +P + +LT L L N I L LD L L N+++
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 44/184 (23%), Positives = 67/184 (36%), Gaps = 16/184 (8%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEI-SALSKLQLLDLSS 164
L L N L+ ++ + F L L L + S+ L +L L L
Sbjct: 61 LWLH-SN-----VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 165 NRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLS 217
L+ L L Y+ L N L L +L NL L + N +
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 218 RLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276
L SL L+L QN+++ + +L LM L + N++ L L YL L+
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 277 NQFN 280
N +
Sbjct: 235 NPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
++P + +Q + L N++S + + +LT L L +N + T L+
Sbjct: 24 QAVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 341 LDYLNLSGNKLSGRVP 356
L+ L+LS N V
Sbjct: 82 LEQLDLSDNAQLRSVD 97
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 70/312 (22%), Positives = 124/312 (39%), Gaps = 45/312 (14%)
Query: 79 NNSWTMDYDSDHCEWIGITCNSAGSIIGLH-LSKDNVNFNGRLSHLNFSCFPNLE--SLR 135
N WT+D + I+ + A S+I H + F+ + + + F L S+R
Sbjct: 213 GNGWTVDITGNFSN--AISKSQAFSLILAHHIMGAGFGFH-NIKDPDQNTFAGLARSSVR 269
Query: 136 ILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGL 187
L GF S+ S + L L++L+L+ N++ L NL ++LS N+LG L
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLML 247
L + +D+ N + T L L+ L L N L+ I + ++
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPD 385
Query: 248 LDVGNNDIIG---------------------PIPSTLGLFSDLSYLDLSCNQFNSSIPNE 286
+ + N ++ I L L L L+ N+F+S ++
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 287 L-TRLTQLFHLDLSSNKLSGKIPSQI-----ASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
+ L L L N L +++ + L L L++N + PG + L+
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 341 LDYLNLSGNKLS 352
L L+L+ N+L+
Sbjct: 506 LRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 55/269 (20%), Positives = 105/269 (39%), Gaps = 28/269 (10%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR--- 168
N+ +N +++ + F L++L++L G + S L K+ +DL N +
Sbjct: 296 NLAYN-KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354
Query: 169 ----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
L L + L N L I + ++ ++ + N L+ + L+ +
Sbjct: 355 DQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLT----ANL 405
Query: 225 LILAQNQLSGLPQE--IGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDLSCNQFNS 281
+ L++N+L L + + +L +L + N T L L L N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 282 SIPNELTR-----LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEIT 336
+ EL L+ L L L+ N L+ P + + L L L++N + +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHN-D 523
Query: 337 KLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
+ L+ L++S N+L P LS +
Sbjct: 524 LPANLEILDISRNQLLAPNPDVFVSLSVL 552
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 36/275 (13%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEI-SALSKLQLLDLSSNRLR-- 168
++FN + + S FP LE L++L +I E L L++LDL S+++
Sbjct: 30 LLSFN-YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL 88
Query: 169 -----GRLTNLNYMSLSRNML--GGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLT 220
L +L + L L L NLK L LD+ N + + + +L
Sbjct: 89 HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148
Query: 221 SLKILILAQNQLSGLPQEIGN---LKNLMLLDVGNNDIIGPIPSTLGLFSD------LSY 271
SLK + + NQ+ + + K L + N + + G + L
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208
Query: 272 LDLSCNQFNSSIPN------------ELTRLTQLFHLDLSSNKLSGKIPSQIASMED--L 317
LD+S N + I L + + + + A + +
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
LDLS+ + L L LNL+ NK++
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 34/281 (12%)
Query: 119 RLSHLNFSCFPNLESLRIL-AYYDGFTGSI--PSEISALSKLQLLDLSSNRLR------- 168
++ L+ F L L L Y+ G + ++ L L LDLS N++R
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143
Query: 169 -GRLTNLNYMSLSRNMLGGLLPQEIGNL--KNLIELDVGDNSLIGPIPLTLS------RL 219
G+L +L + S N + + E+ L K L + NSL + + R
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203
Query: 220 TSLKILILAQNQLSGLP-------------QEIGNLKNLMLLDVGNNDIIGPIPSTL-GL 265
L+IL ++ N + + ++M G ++I P +T GL
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263
Query: 266 F-SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
S + +LDLS S L L L+L+ NK++ +++L L+LS
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 325 NNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
N + L ++ Y++L N ++ + K L +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 55/276 (19%), Positives = 90/276 (32%), Gaps = 32/276 (11%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
L L + L F L L L+ + + L+ L+ +D SSN+
Sbjct: 102 LRLY-FCGLSDAVLKDGYFRNLKALTRLD-LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 167 LRG---------RLTNLNYMSLSRNMLGGLLPQEIGNLKN------LIELDVGDNSLIGP 211
+ + L++ SL+ N L + + G N L LDV N
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219
Query: 212 IP------------LTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLML--LDVGNNDII 256
I +L + + + Q L + LD+ + +
Sbjct: 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
Query: 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED 316
DL L+L+ N+ N L L L+LS N L S +
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339
Query: 317 LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ ++DL N+I L +L L+L N L+
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 53/239 (22%), Positives = 80/239 (33%), Gaps = 35/239 (14%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEI-GNLKN 197
+P L+ + L LS N +R L L + L + +E NL N
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE---IGNLKNLMLLDVGNND 254
L LD+G + + P L L L L LS + NLK L LD+ N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 255 IIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ--LFHLDLSSNKLSGKIPSQI 311
I + + G + L +D S NQ +EL L L L++N L ++
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 312 ASMED------LTWLDLSNNNIKGSIPG------------EITKLSRLDYLNLSGNKLS 352
+ L LD+S N I G + + + +
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 41/238 (17%), Positives = 87/238 (36%), Gaps = 27/238 (11%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR----GRLTNL 174
L+ ++ S L L +++ ++L LD S N++ + L
Sbjct: 138 TLTEIDVSHNTQLTEL----DCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLL 193
Query: 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234
N ++ N + L ++ L LD N L + ++ LT L + N L+
Sbjct: 194 NRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTE 247
Query: 235 LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294
L + L L L D+ + L + + ++T TQL+
Sbjct: 248 LD--VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLY 300
Query: 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
LD + ++ ++ ++ L +L L+N + + ++ ++L L+ +
Sbjct: 301 LLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 149 SEISALSKLQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
+ I L+ L L +SN + + TNL Y++ N L L ++ L L L+
Sbjct: 58 TGIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCD 114
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
N L L +S+ L L A+N L+ + + + L LD N I + +
Sbjct: 115 TNKL---TKLDVSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKKITKLD--VT 167
Query: 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
+ L+ LD S N+ ++++ L L+ +N ++ K+ + LT+LD S+
Sbjct: 168 PQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSS 221
Query: 325 NNIKGSIPGEITKLSRLDYLNLSGNKLS 352
N + I +T L++L Y + S N L+
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 60/256 (23%), Positives = 113/256 (44%), Gaps = 29/256 (11%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL 167
L+K N ++ L+ S NL L + T ++ ++ L+KL L+ +N+L
Sbjct: 65 GLTKLICTSN-NITTLDLSQNTNLTYLAC--DSNKLT-NLD--VTPLTKLTYLNCDTNKL 118
Query: 168 R----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLK 223
+ L Y++ +RN L + ++ + L ELD N I + + + T L
Sbjct: 119 TKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDV--TPQTQLT 173
Query: 224 ILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283
L + N+++ L + K L L+ N+I L L++LD S N+ + I
Sbjct: 174 TLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL-TEI 227
Query: 284 PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDY 343
+T LTQL + D S N L+ ++ ++++ LT L ++ I +T ++L Y
Sbjct: 228 D--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIY 279
Query: 344 LNLSGNKLSGRVPYSN 359
G + + ++
Sbjct: 280 FQAEGCRKIKELDVTH 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 47/273 (17%), Positives = 91/273 (33%), Gaps = 48/273 (17%)
Query: 109 LSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR 168
L++ + + N +++ L+ + L +L F ++S L L+ +N +
Sbjct: 150 LTELDCHLNKKITKLDVTPQTQLTTLDC-----SFNKITELDVSQNKLLNRLNCDTNNIT 204
Query: 169 ----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224
+ L ++ S N L + ++ L L D N L L +S L+ L
Sbjct: 205 KLDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTT 258
Query: 225 LILAQNQLSGLP--------------------QEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
L Q L + ++ + L LLD I + L
Sbjct: 259 LHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LS 315
Query: 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
L YL L+ + + + ++ T+L L + + S + + L +
Sbjct: 316 QNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAE 370
Query: 325 NNIKGSIPGEITKLS-----RLDYLNLSGNKLS 352
+T S D L+ GN ++
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 15/180 (8%)
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
N + + L L LD ++S+ + +LT L LI N +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNI 76
Query: 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ 292
+ L + NL L +N + + + + L+YL+ N+ ++ LT
Sbjct: 77 TTLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLT- 130
Query: 293 LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+L+ + N L+ +I ++ LT LD N + +T ++L L+ S NK++
Sbjct: 131 --YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 33/166 (19%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
N + + + ++ +L +L L + ++ + I L L L +N
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSN 74
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313
+I S ++L+YL N+ +++ +T LT+L +L+ +NKL+ K+ ++
Sbjct: 75 NITTLDLSQN---TNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLD--VSQ 125
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359
LT+L+ + N + I ++ ++L L+ NK ++ +
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTP 168
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 26/177 (14%), Positives = 61/177 (34%), Gaps = 17/177 (9%)
Query: 117 NGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR----GRLT 172
L ++ + L +G +++ ++L LLD + + +
Sbjct: 263 QTDLLEIDLTHNTQLIYF----QAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNP 318
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
L Y+ L+ L L ++ + L L + + ++ ++ +L A+ Q
Sbjct: 319 KLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQT 373
Query: 233 SGLPQEIGNLKNLMLLDVGNN-DIIG---PIPSTLGLFSDLSYLDLSCNQFNSSIPN 285
+P+E +L + + D G I G D + ++ ++ P
Sbjct: 374 ITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 25/124 (20%), Positives = 52/124 (41%), Gaps = 11/124 (8%)
Query: 241 NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300
N + + + + L+ LD + + + + +LT L L +S
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTS 73
Query: 301 NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360
N ++ + ++ +LT+L +N + ++ +T L++L YLN NKL+ N
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNP 127
Query: 361 HLSS 364
L+
Sbjct: 128 LLTY 131
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 22/220 (10%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
IP + + LDLS N LR L + LSR + + +L +L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIG 257
L + N + S L+SL+ L+ + L+ L G+LK L L+V +N I
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 258 PIPSTLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQL----FHLDLSSNKLSGKIPSQ 310
FS+L+ +LDLS N+ S +L L Q+ LDLS N ++ I
Sbjct: 139 -FKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195
Query: 311 IASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
L L L N +K S+P I +L+ L + L N
Sbjct: 196 AFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 18/143 (12%)
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTL--GLFSDLS---YLD 273
S K L L+ N L L + L +LD+ +I T+ G + LS L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-----QTIEDGAYQSLSHLSTLI 82
Query: 274 LSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIAS-MEDLTWLDLSNNNIKGSI 331
L+ N S+ + L+ L L L+ + + ++ L L++++N I+ S
Sbjct: 83 LTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SF 139
Query: 332 P--GEITKLSRLDYLNLSGNKLS 352
+ L+ L++L+LS NK+
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 26/96 (27%), Positives = 36/96 (37%), Gaps = 6/96 (6%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
IP L LDLS N +L LDLS ++ I S+ L
Sbjct: 22 IPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 318 TWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
+ L L+ N I+ S+ + LS L L L+
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 17/247 (6%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR----GRLTN 173
+S L F L+ L L + I + S L KLQ L +S N L ++
Sbjct: 65 DISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS 124
Query: 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL-IGPIPLTLSRLTSLKILILAQNQL 232
L + + N + + L+N+ +++G N L L L +++ +L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ 292
+G+P+ + L L + +N I L +S L L L NQ L+ L
Sbjct: 185 TGIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242
Query: 293 LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP-------GEITKLSRLDYLN 345
L L L +NKLS ++P+ + ++ L + L NNI + G K + + ++
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
Query: 346 LSGNKLS 352
L N +
Sbjct: 301 LFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 35/201 (17%), Positives = 69/201 (34%), Gaps = 34/201 (16%)
Query: 157 LQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212
L+++ S L+ + + L N + L + L++L L + +N +
Sbjct: 35 LRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 213 PLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL 272
S L L+ L +++N L +P L S L L
Sbjct: 95 EKAFSPLRKLQKLYISKNHLVEIPP--------------------------NLPSSLVEL 128
Query: 273 DLSCNQFNSSIPNELTRLTQLFHLDLSSNKL-SGKIPSQIASMEDLTWLDLSNNNIKGSI 331
+ N+ + L + +++ N L + L +L +S + I
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 332 PGEITKLSRLDYLNLSGNKLS 352
P ++ L+ L+L NK+
Sbjct: 188 PKDL--PETLNELHLDHNKIQ 206
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 37/199 (18%), Positives = 71/199 (35%), Gaps = 16/199 (8%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDG---FTGSIPSEISALSKLQLLDLSSNRLR----GRL 171
R+ + F L ++ + G KL L +S +L
Sbjct: 134 RIRKVPKGVFSGLRNMNCI-EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP 192
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
LN + L N + + +++ L L +G N + +LS L +L+ L L N+
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDI--IGP----IPSTLGLFSDLSYLDLSCNQF-NSSIP 284
LS +P + +LK L ++ + N+I +G + + + L N +
Sbjct: 253 LSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 285 NEL-TRLTQLFHLDLSSNK 302
+T + + K
Sbjct: 313 PATFRCVTDRLAIQFGNYK 331
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 149 SEISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203
AL+ + + + L + +S + + + + L NLI L++
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 204 GDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTL 263
DN + P L LT + L L+ N L + I L+++ LD+ + I P L
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 264 GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLS 323
S+L L L NQ ++I L LT L +L + + ++S + +A++ LT L
Sbjct: 126 AGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKAD 181
Query: 324 NNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+N I I + L L ++L N++S
Sbjct: 182 DNKIS-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 18/233 (7%)
Query: 148 PSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202
+ L + L + L NL + L N + L P + NL + EL+
Sbjct: 34 TVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91
Query: 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPST 262
+ N L + + L S+K L L Q++ + + L NL +L + N I P
Sbjct: 92 LSGNPLKNVSAI--AGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNISP-- 146
Query: 263 LGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDL 322
L ++L YL + Q S + L L++L L NK+S I +AS+ +L + L
Sbjct: 147 LAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHL 202
Query: 323 SNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKY 375
NN I + + S L + L+ ++ + + N +L +
Sbjct: 203 KNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 18/233 (7%)
Query: 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLS 180
+L+ + L+ + +I + L+ L L+L N++ LT + + LS
Sbjct: 35 VTQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 181 RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIG 240
N L + I L+++ LD+ + PL + L++L++L L NQ++ + +
Sbjct: 94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPL--AGLSNLQVLYLDLNQITNIS-PLA 148
Query: 241 NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300
L NL L +GN + P L S L+ L N+ S I L L L + L +
Sbjct: 149 GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI-SDISP-LASLPNLIEVHLKN 204
Query: 301 NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL-NLSGNKLS 352
N++S P +A+ +L + L+N I L + + SG ++
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 52/271 (19%), Positives = 97/271 (35%), Gaps = 56/271 (20%)
Query: 366 PTPRKIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
R + IG G++ +VYK A +L + + + + F+ EA++L
Sbjct: 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 81
Query: 425 -----------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
M G+L L + + +
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQI 138
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADSSNQTLLAGSYG 514
L +LH +P ++HRD+ +NI + + D G A L A + + G+
Sbjct: 139 LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPE 195
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP-RDLHSTLSSSYDPKIMLIDVLDQRL 573
++APE+ Y E DVY+FG+ LE+ ++P + + +I V
Sbjct: 196 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRR-VTSGVK 247
Query: 574 PPPVDR---KVIQDILLVSTISFACLQSNPK 601
P D+ +++I+ C++ N
Sbjct: 248 PASFDKVAIPEVKEIIE------GCIRQNKD 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 33/199 (16%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G G VY+A+ R+ ALK ++ + + F + EA+ +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 425 -----------ME--RG-SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M G L +L L + V IV+ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT-LLAGSYGYIAPELAYTMVMTEK 529
HRD+ NIL+++ A++ DFG A + Q G+ Y+APE T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 530 YDVYSFGVVTLEVLMGKHP 548
D+Y+ V E L G P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 53/269 (19%)
Query: 345 NLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNS 403
++ G ++ R Y KI K +G G +VY A+ A+K +
Sbjct: 3 HMIGKIINER--Y------------KIVDK--LGGGGMSTVYLAEDTILNIKVAIKAIFI 46
Query: 404 PETEELAFIRSFRNEAQVLSQ----------------------ME--RG-SLFRILHNDA 438
P E+ ++ F E SQ ME G +L + +
Sbjct: 47 PPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG 106
Query: 439 EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498
L +N + + + H +VHRDI NIL++S + DFG A+
Sbjct: 107 P---LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160
Query: 499 LHADSSNQT-LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS 557
L S QT + G+ Y +PE A E D+YS G+V E+L+G+ P + + +S
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
Query: 558 SY----DPKIMLIDVLDQRLPPPVDRKVI 582
+ D + + + +P + ++
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/253 (20%), Positives = 103/253 (40%), Gaps = 22/253 (8%)
Query: 119 RLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLRG-------R 170
R+++++ S +L+ L +I + S+L L+ LDLS N L
Sbjct: 63 RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKP 122
Query: 171 LTNLNYMSLSRNMLGGLLPQEI-GNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILILA 228
L++L +++L N L + +L L L VG+ I + LT L+ L +
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 229 QNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL 287
+ L + +++N+ L + I + + + S + L+L ++ +EL
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 288 --------TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI-TKL 338
+ ++ ++ L ++ + + L L+ S N +K S+P I +L
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRL 300
Query: 339 SRLDYLNLSGNKL 351
+ L + L N
Sbjct: 301 TSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 7/208 (3%)
Query: 153 ALSKLQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL 208
+ + + SS L G + + LS N + + ++ NL L + N +
Sbjct: 29 SCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 209 IGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIG-PIPSTLGLF 266
+ S L SL+ L L+ N LS L L +L L++ N S
Sbjct: 89 NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 267 SDLSYLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
+ L L + + I + LT L L++ ++ L P + S+++++ L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 326 NIKGSIPGEITKLSRLDYLNLSGNKLSG 353
+ + S ++ L L L
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDT 236
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 23/260 (8%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILA---YYDGFTGSIPSEISALSKLQLLDLS 163
L L+ +N + L + I ++L L + +
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 164 SNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216
S+ +N+N + + + + + + LD +N L +
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 217 SRLTSLKILILAQNQLSGLPQEIG---NLKNLMLLDVGNNDIIGPIPSTLGLFS---DLS 270
LT L+ LIL NQL L + +K+L LD+ N + G S L
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK--GDCSWTKSLL 402
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330
L++S N +I L ++ LDL SNK+ IP Q+ +E L L++++N +K S
Sbjct: 403 SLNMSSNILTDTIFRCLPPRIKV--LDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-S 458
Query: 331 IPGEI-TKLSRLDYLNLSGN 349
+P I +L+ L + L N
Sbjct: 459 VPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 16/233 (6%)
Query: 107 LHLSKDNVNFNGRLSHLNFSC-FPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSS 164
+ S NV G+L +F +L++L I G S I S + + + +
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 165 NRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLT 215
+ R +++ ++ S N+L + + G+L L L + N L + I
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 216 LSRLTSLKILILAQNQLSGLPQEIG--NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLD 273
+++ SL+ L ++QN +S ++ K+L+ L++ +N + I L + LD
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLD 427
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNN 326
L N+ SIP ++ +L L L+++SN+L + L + L N
Sbjct: 428 LHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 44/217 (20%), Positives = 74/217 (34%), Gaps = 10/217 (4%)
Query: 159 LLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL 214
L+D S N L +++S+N + L +I +L L L + N +
Sbjct: 4 LVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 215 TLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLD 273
L+ L L+ N+L + NL LD+ N PI G S L +L
Sbjct: 64 VFKFNQELEYLDLSHNKLVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS---QIASMEDLTWLDLSNNNIKGS 330
LS S + L L + K Q + E L + +N
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 331 IPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPT 367
+ + ++ L+ N+ + Y L+ + T
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQT 218
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 41/227 (18%), Positives = 74/227 (32%), Gaps = 16/227 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+P ++S K +L++S N + L+ L + +S N + L + L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ--EIGNLKNLMLLDVGNNDII 256
LD+ N L+ ++ +LK L L+ N LP E GN+ L L + +
Sbjct: 72 EYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED 316
+ + L + + L L + K I +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGE--TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 317 LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLS 363
T +L +NIK + L N + +N +
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 47/258 (18%), Positives = 96/258 (37%), Gaps = 12/258 (4%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGF-TGSIPSEISALSKLQLLDLSSNR 166
HL+ V ++ L+ + + F T I +S + +L +
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 167 LRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226
++ + N S ++L L + L ++ NS I L L T++
Sbjct: 197 IK-CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFS 253
Query: 227 LAQNQLSGLPQEIG------NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280
++ +L G +LK L + V ++ P +FS+++ + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK--GSIPGEITKL 338
++++ HLD S+N L+ + + +L L L N +K I T++
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 339 SRLDYLNLSGNKLSGRVP 356
L L++S N +S
Sbjct: 374 KSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 48/239 (20%), Positives = 89/239 (37%), Gaps = 28/239 (11%)
Query: 148 PSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200
S+I +LSKL++L +S NR++ L Y+ LS N L + NL
Sbjct: 38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKH 94
Query: 201 LDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGP 258
LD+ N+ PI ++ LK L L+ L I +L +L V
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG-----------KI 307
D + L + + + ++ +L + + I
Sbjct: 155 ED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 308 PSQIASMEDLTWLDLSNNNIKGSIPGEITKL---SRLDYLNLSGNKLSGRVPYSNKHLS 363
+++ + L+ L L+N + I +L + + Y ++S KL G++ + + S
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 33/184 (17%), Positives = 76/184 (41%), Gaps = 14/184 (7%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNR 166
+++ N + ++ C + L + T ++ L++L+ L L N+
Sbjct: 301 NMNIKNFTVS-GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 167 LR---------GRLTNLNYMSLSRNMLGGLLPQEI-GNLKNLIELDVGDNSLIGPIPLTL 216
L+ ++ +L + +S+N + + K+L+ L++ N L I L
Sbjct: 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 217 SRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276
+K+L L N++ +P+++ L+ L L+V +N + + L + L
Sbjct: 420 --PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
Query: 277 NQFN 280
N ++
Sbjct: 478 NPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 43/266 (16%), Positives = 87/266 (32%), Gaps = 29/266 (10%)
Query: 113 NVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---- 168
++ N R+ +L+ S F + L L I L+ LDLS N
Sbjct: 51 IISHN-RIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPI 107
Query: 169 ----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP---LTLSRLTS 221
G ++ L ++ LS L I +L L V + L S
Sbjct: 108 CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
Query: 222 LKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPS---------TLGLFSDLSY 271
L I+ + + + + NL L ++ T S+L+
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227
Query: 272 LDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA-----SMEDLTWLDLSNNN 326
++ + +L T +++ +S+ KL G++ + S++ L+ + ++
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 327 IKGSIPGEITKLSRLDYLNLSGNKLS 352
S ++ N + +
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTR 313
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 363 SSMPTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRN 417
S M TP + +Y +G G V+ A+ L + R A+K L + + +F FR
Sbjct: 2 SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 418 EAQVLSQ--------------------------ME--RG-SLFRILHNDAEAVELDWAKR 448
EAQ + ME G +L I+H + + +
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRA 118
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT- 507
+ ++ AL + H + ++HRD+ NI++++ V DFG AR + ++ T
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 508 --LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ G+ Y++PE A + + DVYS G V EVL G+ P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 50/217 (23%)
Query: 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
K +G GA G++ + + R A+K++ E Q+L +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL------PECFSFADREVQLLRESDEHP 78
Query: 425 ------------------MER--GSLF-RILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+E +L + D + L+ + +++ LA+LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 464 HDCSPSVVHRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNQTLL---AGSYGY 515
S ++VHRD+ +NIL+ + K++A ++DFG + L + + G+ G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 516 IAPEL---AYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
IAPE+ T D++S G V V+ G HP
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 54/258 (20%), Positives = 97/258 (37%), Gaps = 21/258 (8%)
Query: 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLS 180
+ + L+ + + +++ ++ L N+ + L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLN 73
Query: 181 RNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQE 238
N L + P + NLKNL L + +N + + L L LK L L N +S +
Sbjct: 74 GNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS----LKDLKKLKSLSLEHNGISDI-NG 126
Query: 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDL 298
+ +L L L +GNN I + L + L L L NQ S I L LT+L +L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYL 182
Query: 299 SSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358
S N +S +A +++L L+L + + L + + + L S
Sbjct: 183 SKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 359 NKHLSSMPTPRKIDSKYC 376
+ P + ++
Sbjct: 241 DDGDYEKPNVKWHLPEFT 258
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 4e-20
Identities = 57/290 (19%), Positives = 103/290 (35%), Gaps = 28/290 (9%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL 167
KDN+ ++ L S+ + + S+ I L + L L+ N+L
Sbjct: 22 ETIKDNLKKK-SVTDA--VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKL 77
Query: 168 R-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLTLSRLT 220
L NL ++ L N + L + +LK L L + N + I L L
Sbjct: 78 TDIKPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGISDING----LVHLP 131
Query: 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--IGPIPSTLGLFSDLSYLDLSCNQ 278
L+ L L N+++ + + L L L + +N I I P+ + L L LS N
Sbjct: 132 QLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVPLAG----LTKLQNLYLSKNH 186
Query: 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKL 338
S + L L L L+L S + K + +++ + ++ ++ P I+
Sbjct: 187 I-SDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDD 242
Query: 339 SRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKA 388
+ N+ + S + + + T VY
Sbjct: 243 GDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTV 292
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 49/265 (18%), Positives = 88/265 (33%), Gaps = 45/265 (16%)
Query: 108 HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD-GFTGSIPSEISALSKLQL--LDLSS 164
L+ R+ + L+ L + TG+ P + + L L+L +
Sbjct: 72 RLTVRAARIPSRIL-FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 165 NRLRGR-----------LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP 213
R L +S+++ +++ L LD+ DN +G
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 214 LTLS----RLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269
L + + +L++L L + G + L
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPS--------------------GVCSALAAARVQL 230
Query: 270 SYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328
LDLS N + +QL L+LS L ++P + + L+ LDLS N +
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK--LSVLDLSYNRLD 287
Query: 329 GSIPGEITKLSRLDYLNLSGNKLSG 353
P +L ++ L+L GN
Sbjct: 288 -RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 42/198 (21%), Positives = 69/198 (34%), Gaps = 15/198 (7%)
Query: 170 RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLT--SLKILIL 227
L L + + + L EL + + + G P L T L IL L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 228 AQNQLSGLPQEIGNLKNLML-----LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF--- 279
+ + L+ + L + + + +F LS LDLS N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 280 ----NSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
++ P + L L + SG + A+ L LDLS+N+++ +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 336 -TKLSRLDYLNLSGNKLS 352
S+L+ LNLS L
Sbjct: 249 CDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 46/229 (20%), Positives = 73/229 (31%), Gaps = 21/229 (9%)
Query: 143 FTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLP-QEIGNLKNLIEL 201
F+ P SA L + L G +L Y+ + L +I +L L
Sbjct: 17 FSDPKPDWSSAF---NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 202 DVGDNSLIGPIPLTLSRL---TSLKILILAQNQLSGL-PQEIGNLKNLML--LDVGNNDI 255
V + I R+ + L+ L L +++G P + L L++ N
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 256 IGPIPSTLGLFS----DLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311
L L L ++ + ++ L LDLS N G+
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 312 ASMED----LTWLDLSNNNIK---GSIPGEITKLSRLDYLNLSGNKLSG 353
A L L L N ++ G +L L+LS N L
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 31/150 (20%), Positives = 50/150 (33%), Gaps = 11/150 (7%)
Query: 221 SLKILILAQNQLSGLPQEIGNLKNLML--LDVGNNDIIGPIPSTLGLF---SDLSYLDLS 275
SL+ L+ + + L Q +K+L L L V I I S L L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 276 CNQFNSSIPNELTRLT--QLFHLDLSSNKLSGKIPS----QIASMEDLTWLDLSNNNIKG 329
+ + P L T L L+L + + + Q L L ++ +
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 330 SIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359
++ L L+LS N G +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLIS 193
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 31/136 (22%), Positives = 48/136 (35%), Gaps = 33/136 (24%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYD----GFTGSIPSEISALSKLQLLDL 162
L LS DN G ++ C +L++LA + +G + +A +LQ LDL
Sbjct: 178 LDLS-DN-PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 163 SSNRLRG--------RLTNLNYMSLSRNMLGGL---LPQ----------------EIGNL 195
S N LR + LN ++LS L + LP L
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPDEL 295
Query: 196 KNLIELDVGDNSLIGP 211
+ L + N +
Sbjct: 296 PQVGNLSLKGNPFLDS 311
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 28/165 (16%), Positives = 64/165 (38%), Gaps = 10/165 (6%)
Query: 191 EIGNLKNLIELDVGDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLL 248
+ +L + + + ++ + + ++K L + + I L NL L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG----IEYAHNIKDLTINNIHATNY-NPISGLSNLERL 93
Query: 249 DVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP 308
+ D+ L + L+ LD+S + + SI ++ L ++ +DLS N I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152
Query: 309 SQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
+ ++ +L L++ + + I +L+ L + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 7/159 (4%)
Query: 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
K + +G +S +T +++ SL + LA ++ L I N+ L + N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNI 76
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313
+ + S+L L + S L+ LT L LD+S + I ++I +
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ + +DLS N I + L L LN+ + +
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 33/181 (18%), Positives = 69/181 (38%), Gaps = 12/181 (6%)
Query: 152 SALSKLQLLDLSSNRL----RGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS 207
S L + ++ +L Y++L+ + L I N+ +L + +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 208 LIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF 266
P+ S L++L+ L + ++ + L +L LLD+ ++ I + +
Sbjct: 78 ATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 267 SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNN 326
++ +DLS N + I L L +L L++ + + I L L +
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 327 I 327
I
Sbjct: 193 I 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 21/157 (13%), Positives = 52/157 (33%), Gaps = 8/157 (5%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNML 184
+ SL + + + + I ++ L +++ L+NL + + +
Sbjct: 42 QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDV 100
Query: 185 GGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKN 244
+ L +L LD+ ++ I ++ L + + L+ N + L
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPE 160
Query: 245 LMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281
L L++ + + + F L+ L
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 14/124 (11%), Positives = 45/124 (36%), Gaps = 7/124 (5%)
Query: 241 NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300
K + +G + + + + L+Y+ L+ + + + + L +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINV-TDLTG-IEYAHNIKDLTINN 75
Query: 301 NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360
+ + I+ + +L L + ++ ++ L+ L L++S + +
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 361 HLSS 364
L
Sbjct: 134 TLPK 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 12/119 (10%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR-------LTNLNY 176
S NLE LRI T +S L+ L LLD+S + L +N
Sbjct: 83 PISGLSNLERLRI--MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL 235
+ LS N + + L L L++ + + + L L + G
Sbjct: 141 IDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGI--EDFPKLNQLYAFSQTIGGK 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 17/205 (8%)
Query: 154 LSKLQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLI 209
++ ++ L + + LS N+L + L +L++ L
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL- 67
Query: 210 GPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269
+ L L L L+ NQL LP L L +LDV N + +P G L
Sbjct: 68 TKLQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPL--GALRGL 123
Query: 270 S---YLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSN 324
L L N+ ++P L T +L L L++N L+ ++P+ + +E+L L L
Sbjct: 124 GELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 325 NNIKGSIPGEITKLSRLDYLNLSGN 349
N++ +IP L + L GN
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 10/188 (5%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
+ + ++ + L L P ++ K+ L + +N L TL T L L L +
Sbjct: 9 VASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL 290
+L+ L G L L LD+ +N + +P L+ LD+S N+ S L L
Sbjct: 66 ELTKLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 291 TQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSG 348
+L L L N+L +P + L L L+NNN+ +P + L LD L L
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 349 NKLSGRVP 356
N L +P
Sbjct: 182 NSLY-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 45/163 (27%), Positives = 61/163 (37%), Gaps = 14/163 (8%)
Query: 148 PSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202
+ + ++L L+L L G L L + LS N L L P L L LD
Sbjct: 48 LATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLD 106
Query: 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPS 261
V N L L L L+ L L N+L LP + L L + NN++ +P+
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPA 165
Query: 262 TLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301
GL + L L L N +IP L L N
Sbjct: 166 --GLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 11/166 (6%)
Query: 96 ITCNSAGSIIGL-HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISAL 154
+ S +++ L++ N++ L+ L L L L S+P L
Sbjct: 43 LYTFSLATLMPYTRLTQLNLDRA-ELTKL--QVDGTLPVLGTLDLSHNQLQSLPLLGQTL 99
Query: 155 SKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS 207
L +LD+S NRL L L + L N L L P + L +L + +N+
Sbjct: 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159
Query: 208 LIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
L L+ L +L L+L +N L +P+ L + N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 62/290 (21%), Positives = 100/290 (34%), Gaps = 59/290 (20%)
Query: 345 NLSGNKLSGRVPYSNKHLSSMPTPRKIDSKY--------CIGTGAYGSVYKAQ-LPNGRV 395
L ++S R S S P + +S + +G G+YG V+K + +GR+
Sbjct: 25 QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL 84
Query: 396 FALKKLNSP------------ETEELA----------FIRSFRNEAQVLSQME--RGSLF 431
+A+K+ SP E +++ + Q E SL
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQ 144
Query: 432 RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491
+ ++ ++ ALA+LH S +VH D+ NI L + +
Sbjct: 145 QHCEAWGASLPEAQVW--GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199
Query: 492 DFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKH 547
DFG L + + G Y+APE ++ Y DV+S G+ LEV
Sbjct: 200 DFGLLVELGTAGAGEVQE-GDPRYMAPE-----LLQGSYGTAADVFSLGLTILEVACNME 253
Query: 548 P----RDLHSTLSSSYDPKI------MLIDVLDQRLPP-PVDRKVIQDIL 586
P+ L VL L P P R + +L
Sbjct: 254 LPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 22/234 (9%)
Query: 149 SEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203
A ++ +L + L +++ + + + + + Q I L N+ +L +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 204 GDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
N L I P L+ L +L L L +N++ L + +LK L L + +N I +
Sbjct: 76 NGNKLTDIKP----LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS--DIN 128
Query: 262 TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD 321
L L L L N+ + I L+RLT+L L L N++S I +A + L L
Sbjct: 129 GLVHLPQLESLYLGNNKI-TDITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 184
Query: 322 LSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKY 375
LS N+I + + L LD L L + + +L T + D
Sbjct: 185 LSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 23/250 (9%)
Query: 109 LSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR 168
L + + + + + L+ + + +++ ++
Sbjct: 3 LGSETITVPTPIKQI--FSDDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIK 59
Query: 169 -----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL--IGPIPLTLSRLTS 221
L N+ + L+ N L + P + NLKNL L + +N + + L L
Sbjct: 60 SVQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS----LKDLKK 113
Query: 222 LKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281
LK L L N +S + + +L L L +GNN I + L + L L L NQ S
Sbjct: 114 LKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI-S 169
Query: 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
I L LT+L +L LS N +S + +A +++L L+L + + L
Sbjct: 170 DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 342 DYLNLSGNKL 351
+ + + L
Sbjct: 227 NTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 149 SEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203
S + L KL+ L L N + L L + L N + + + L L L +
Sbjct: 106 SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSL 163
Query: 204 GDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
DN + I P L+ LT L+ L L++N +S L + + LKNL +L++ + + + +
Sbjct: 164 EDNQISDIVP----LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPIN 218
Query: 262 TLGLFSDLSYLDLSCNQFNS----SIPNELTRLTQLFHLDLSSNKLS 304
+ + + + S + + +HL +N++S
Sbjct: 219 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 52/302 (17%), Positives = 102/302 (33%), Gaps = 20/302 (6%)
Query: 63 SPIQLETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSH 122
+ + AL + N + + +++ + L + +
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDE-NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269
Query: 123 LNFSCFPNLESLRILA---YYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLT 172
F +E L I +AL L + + +
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
+N LS + + + + L+ N + S L L+ LIL +N L
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 233 SGLPQEIGNLKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
+ KN+ L+ + + T + L+LS N S+ L
Sbjct: 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLS 347
++ LDL +N++ IP + ++ L L++++N +K S+P G +L+ L Y+ L
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 348 GN 349
N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 45/234 (19%), Positives = 94/234 (40%), Gaps = 20/234 (8%)
Query: 108 HLSKDNVNFNGRLSHLNFS-CFPNLESLRIL-AYYDGFTGSIPSEISALSKLQLLDLSSN 165
+L+ N+ R+ F+ L+SL I F S + S +++ + LS +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 166 RLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
++ +++ ++N+ + Q LK L L + N L
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALM 398
Query: 219 LTSLKILILAQNQLSGLP-----QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLD 273
++ L L+ L + +++++L++ +N + L + LD
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML--TGSVFRCLPPKVKVLD 456
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNN 326
L N+ SIP ++T L L L+++SN+L +P + + L ++ L +N
Sbjct: 457 LHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 41/267 (15%), Positives = 93/267 (34%), Gaps = 23/267 (8%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLE--SLRILAYYDGFTGSIPSEISALSKLQLLDLSS 164
LHL + +++ + +L+ ++++ + SE++ L + L
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258
Query: 165 NRLRGR----------LTNLNYMSLSRNMLGGLLPQEIGN-----LKNLIELDVGDNSLI 209
+ + Y+++ + + +E LK+L+ V + +
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318
Query: 210 GPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSD 268
S + I +L+ + + + + L+ N +
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378
Query: 269 LSYLDLSCNQFNS--SIPNELTRLTQLFHLDLSSNKL-SGKIPSQIASMEDLTWLDLSNN 325
L L L N + + ++ L LD+S N L S A E + L+LS+N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 326 NIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ GS+ + ++ L+L N++
Sbjct: 439 MLTGSVFRCLP--PKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 9/216 (4%)
Query: 160 LDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT 215
+D S+ L +SLS+N + L +I L L L + N +
Sbjct: 36 VDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV 95
Query: 216 LSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDL 274
L+ L ++ N+L + + +L LD+ ND P+ G + L++L L
Sbjct: 96 FLFNQDLEYLDVSHNRLQNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153
Query: 275 SCNQFNSSIPNELTRL-TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
S +F + L LDL S + G ++ + + T L L +
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG-GETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 334 EITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPR 369
++ L +L LS KL+ S T
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 37/203 (18%), Positives = 72/203 (35%), Gaps = 9/203 (4%)
Query: 162 LSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-----TL 216
LS L N+ + + + + + L++ + ++ I +
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301
Query: 217 SRLTSLKILILAQNQLSGLPQEIGN-LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
+ L SL I + + + + + + + +D S ++L+ +
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLS--GKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
N F S+ + L +L L L N L K+ +M L LD+S N++
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 334 EITKL-SRLDYLNLSGNKLSGRV 355
+ LNLS N L+G V
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSV 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 34/183 (18%), Positives = 73/183 (39%), Gaps = 14/183 (7%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
+++ +++ + + + L + FT S+ S L +LQ L L N
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNF--TQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 167 LR------GRLTNLNYMSLSRNMLGGLLPQEIGNL----KNLIELDVGDNSLIGPIPLTL 216
L+ N++ + L L ++++ L++ N L G + L
Sbjct: 389 LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 217 SRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276
+K+L L N++ +P+++ +L+ L L+V +N + + L Y+ L
Sbjct: 449 P--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506
Query: 277 NQF 279
N +
Sbjct: 507 NPW 509
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/288 (19%), Positives = 101/288 (35%), Gaps = 46/288 (15%)
Query: 347 SGNKLSGRVPYSNKHLSSMPTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKL 401
G + + + + + IG G + VY+A L +G ALKK+
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 402 NSPETEELAFIRSFRNEAQVLSQM-------------------------ERGSLFRILHN 436
+ + E +L Q+ + G L R++ +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 437 DAEAVELDWAKRV-NIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495
+ L + V + AL ++H S V+HRDI N+ + + + D G
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 182
Query: 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL 555
R + ++ L G+ Y++PE + K D++S G + E+ + P
Sbjct: 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242
Query: 556 SSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL--LVSTISFACLQSNPK 601
S KI Q PP+ + L LV+ C+ +P+
Sbjct: 243 LYSLCKKIE------QCDYPPLPSDHYSEELRQLVN----MCINPDPE 280
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 40/207 (19%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQM------ 425
IGTG+YG K + +G++ K+L+ + +++ +E +L ++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML-----VSEVNLLRELKHPNIV 68
Query: 426 ---------------------ERGSLFRILHNDAEAVE-LDWAKRVNIVKAMAHALAYLH 463
E G L ++ + + LD + ++ + AL H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 464 --HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
D +V+HRD+ N+ L+ K + DFG AR+L+ D+S G+ Y++PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 522 YTMVMTEKYDVYSFGVVTLEVLMGKHP 548
M EK D++S G + E+ P
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 68/276 (24%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------- 423
C+G G +G V++A+ + +A+K++ P E E + L+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYF 69
Query: 424 -----------------------QME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAH 457
QM+ + +L ++ E + + ++I +A
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA------- 510
A+ +LH S ++HRD+ +NI V DFG + D QT+L
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 511 -----GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIML 565
G+ Y++PE + + K D++S G++ E+L +P S+ + L
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP------FSTQMERVRTL 237
Query: 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
DV + + PP +K + ++V L +P
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQ----DMLSPSPM 269
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/261 (22%), Positives = 96/261 (36%), Gaps = 66/261 (25%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQM----- 425
IG G++G + +GR + +K++N S + E + R E VL+ M
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-----RREVAVLANMKHPNI 85
Query: 426 --------------------ERGSLFRILHNDA-----EAVELDWAKRVNIVKAMAHALA 460
E G LF+ ++ E LDW + + AL
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLALK 139
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
++H ++HRDI S NI L + DFG AR+L++ G+ Y++PE+
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 521 AYTMVMTEKYDVYSFGVVTLEVLMGKHP--------------RDLHSTLSSSYDPKIMLI 566
K D+++ G V E+ KH +S Y L
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD--LR 254
Query: 567 DVLDQRLPP-PVDRKVIQDIL 586
++ Q P DR + IL
Sbjct: 255 SLVSQLFKRNPRDRPSVNSIL 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 56/267 (20%), Positives = 88/267 (32%), Gaps = 67/267 (25%)
Query: 354 RVPYSNKHLSSMPTPRKIDSKY----CIGTGAYGSVYKA--QLPNGRVFALKKLNSPETE 407
PYS L + + +Y CI G G +Y A + NGR LK L
Sbjct: 63 GSPYS--FLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA 120
Query: 408 ELAFIRSFRNEAQVLSQ---------------------------MER---GSLFRILHND 437
E E Q L++ ME SL R
Sbjct: 121 E--AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ- 177
Query: 438 AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFG 494
+L A+ + + + AL+YLH S +V+ D+ NI+L K + D G
Sbjct: 178 ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLK----LIDLG 226
Query: 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHST 554
+++ L G+ G+ APE+ T T D+Y+ G + + R+
Sbjct: 227 AVSRINSFGY----LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN---- 277
Query: 555 LSSSYDPKIMLIDVLDQRLPPPVDRKV 581
+ D + R +
Sbjct: 278 ---GRYVDGLPEDDPVLKTYDSYGRLL 301
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 66/263 (25%), Positives = 96/263 (36%), Gaps = 55/263 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK--LNSPETE------ELAFIR-------------S 414
IG GAYGSV K P+G++ A+K+ E E +L + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 415 FRNEAQVLSQME--RGSLFRILHNDAEAVELDWAKRVN------IVKAMAHALAYLHHDC 466
E ME S + V + I A AL +L +
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKY----VYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
++HRDI +NILL+ + DFG + L DS +T AG Y+APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 527 TEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDRK 580
+ Y DV+S G+ E+ G+ P Y + D L Q + PP
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFP----------YPKWNSVFDQLTQVVKGDPPQLSN 252
Query: 581 VIQDILLVSTISF--ACLQSNPK 601
+ S I+F CL +
Sbjct: 253 SEEREFSPSFINFVNLCLTKDES 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 62/268 (23%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG+G V++ +++A+K +N E + + S+RNE L++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 425 -------------ME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
ME L L ++++ K K M A+ +H
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTIH---QHG 147
Query: 470 VVHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPEL---- 520
+VH D+ N L+ KL DFG A + D+++ G+ Y+ PE
Sbjct: 148 IVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 521 -------AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573
++ K DV+S G + + GK P + L ++D
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIIDPNH 257
Query: 574 PPPVDRKVIQDILLVSTISFACLQSNPK 601
+D L + CL+ +PK
Sbjct: 258 EIEFPDIPEKD--LQDVLK-CCLKRDPK 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 62/268 (23%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG+G V++ +++A+K +N E + + S+RNE L++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 425 -------------ME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
ME L L ++++ K K M A+ +H
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTIH---QHG 128
Query: 470 VVHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPEL---- 520
+VH D+ N L+ KL DFG A + D+++ G+ Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 521 -------AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573
++ K DV+S G + + GK P + L ++D
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIIDPNH 238
Query: 574 PPPVDRKVIQDILLVSTISFACLQSNPK 601
+D L + CL+ +PK
Sbjct: 239 EIEFPDIPEKD--LQDVLK-CCLKRDPK 263
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 51/238 (21%), Positives = 83/238 (34%), Gaps = 60/238 (25%)
Query: 377 IGTGAYGSVYKAQL--PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG G +G V+ +L N V A+K +L F EA++L Q
Sbjct: 122 IGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLI 178
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
++ G L + + + + +V A + YL S
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE---SKC 233
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAYTM 524
+HRD+++ N L+ K ++DFG +R +G + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAPEALNYG 290
Query: 525 VMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
+ + DV+SFG++ E G P Y P + + RLP P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP----------Y-PNLSNQQTREFVEKGGRLPCP 337
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 376 CIGTGAYGSVYKAQL-PNGRVFALKK--LNSPETE------ELAFIR------------S 414
+G G G V+K P+G V A K L EL + +
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 415 FRNEAQVLSQME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
F ++ ++ ME GSL ++L E K + A+ L YL ++
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLREKHK--IM 154
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
HRD+ +NIL+NS+ E + DFG + L DS + G+ Y++PE + + D
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSPERLQGTHYSVQSD 212
Query: 532 VYSFGVVTLEVLMGKHP 548
++S G+ +E+ +G++P
Sbjct: 213 IWSMGLSLVEMAVGRYP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 28/285 (9%), Positives = 57/285 (20%), Gaps = 72/285 (25%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPET----------EELAFIRSFR--NEAQVLS 423
+ G V+ + FALK E + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 424 Q------------------------------------MER--GSLFRILHNDAEAVE--- 442
+ M L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 443 -LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
+ + A L S +VH + +N+ + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---K 243
Query: 502 DSSNQTLLAGSYGYIAPEL--AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY 559
+ + Y E A T T + + G+ V P L +
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 560 DPKIMLIDVLDQRLPPPVDRKV---IQDILLVSTISFACLQSNPK 601
+ L L + ++ ++ L + +
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRR 342
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 44/269 (16%), Positives = 98/269 (36%), Gaps = 72/269 (26%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------- 425
IG+G +G V+KA+ +G+ + +K++ E+ E + L+++
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKY-NNEKA------EREVKALAKLDHVNIVHYN 70
Query: 426 --------------------------------ERGSLFRILHNDAEAVELDWAKRVNIVK 453
++G+L + + +LD + + +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE 129
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY 513
+ + Y+H S +++RD+ +NI L + + DFG L D G+
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTL 185
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572
Y++PE + ++ D+Y+ G++ E+L + + + D+ D
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT----------DLRDGI 235
Query: 573 LPPPVDRKVIQDILLVSTISFACLQSNPK 601
+ D+K + + L P+
Sbjct: 236 ISDIFDKK------EKTLLQ-KLLSKKPE 257
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 59/263 (22%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE--------ELAFIR-------------S 414
+G GAYG V K + +P+G++ A+K++ + +L +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 415 FRNEAQVLSQME--RGSLFRILHNDAEAVELDWAKRVN------IVKAMAHALAYLHHDC 466
E V ME SL + +D + + I ++ AL +LH
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQ-----VIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
S V+HRD+ +N+L+N+ + + DFG + L D + + AG Y+APE +
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPELN 186
Query: 527 TEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDRK 580
+ Y D++S G+ +E+ + + P YD L Q P P +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFP----------YDSWGTPFQQLKQVVEEPSP---Q 233
Query: 581 VIQDILLVSTISF--ACLQSNPK 601
+ D + F CL+ N K
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSK 256
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 64/265 (24%)
Query: 376 CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
+G G YG VY L N A+K++ ++ + E +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYL 85
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+ GSL +L + ++ + K + L YLH
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 470 VVHRDISSNNILLNS-----KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPEL---- 520
+VHRDI +N+L+N+ K+ +DFGT++ L + G+ Y+APE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 521 --AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578
Y D++S G +E+ GK P L + + + P
Sbjct: 199 PRGYGK----AADIWSLGCTIIEMATGKPP---FYELGEPQ-AAMFKVGMFKV--HPE-- 246
Query: 579 RKVIQDILLVSTISF--ACLQSNPK 601
I + + +F C + +P
Sbjct: 247 ---IPESMSAEAKAFILKCFEPDPD 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-22
Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 62/268 (23%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG+G V++ +++A+K +N E + + S+RNE L++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 425 -------------ME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
ME L L ++++ K K M A+ +H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTIH---QHG 175
Query: 470 VVHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPEL---- 520
+VH D+ N L+ KL DFG A + D+++ G+ Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 521 -------AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573
++ K DV+S G + + GK P + L ++D
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIIDPNH 285
Query: 574 PPPVDRKVIQDILLVSTISFACLQSNPK 601
+D L + CL+ +PK
Sbjct: 286 EIEFPDIPEKD--LQDVLK-CCLKRDPK 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 45/269 (16%), Positives = 92/269 (34%), Gaps = 60/269 (22%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G + V + L +G +ALK++ E ++ + EA +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---READMHRLFNHPNILRLVA 93
Query: 425 ---------------ME---RGSLFRIL-HNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
+ RG+L+ + + L + + ++ + L +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA---------GSYGYI 516
+ HRD+ NILL + + + D G+ + Y
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 517 APEL----AYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572
APEL ++ ++ E+ DV+S G V ++ G+ P D+ S + +
Sbjct: 211 APELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ------NQ 263
Query: 573 LPPPVDRKVIQDILLVSTISFACLQSNPK 601
L P + L ++ + + +P
Sbjct: 264 LSIPQSPRHSSA--LWQLLN-SMMTVDPH 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 57/265 (21%), Positives = 96/265 (36%), Gaps = 64/265 (24%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKK--LNSPETE------ELAFIR-------------S 414
+G+G G V+K + G V A+K+ + + E +L + +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 415 FRNEAQVLSQME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
F V ME ++ + + + A+ AL YL V+H
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEK--HGVIH 148
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKY- 530
RD+ +NILL+ + + + DFG + L D + AG Y+APE + Y
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 531 ---DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDRKVIQDI 585
DV+S G+ +E+ G+ P Y +VL + + PP
Sbjct: 208 IRADVWSLGISLVELATGQFP----------YKNCKTDFEVLTKVLQEEPP--------- 248
Query: 586 LLVSTISF---------ACLQSNPK 601
LL + F CL + +
Sbjct: 249 LLPGHMGFSGDFQSFVKDCLTKDHR 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 44/222 (19%)
Query: 358 SNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQ-LPNGRVFALKK--LNSPETEELAFIR- 413
+ + +G G++G V++ + G A+KK L EEL
Sbjct: 47 KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG 106
Query: 414 -----------SFRNEAQ---VLSQMERGSLFRILHND---AEAVELDWAKRVNIVKAMA 456
+ R + +E GSL +++ E L +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL------YYLGQAL 160
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTL-----LA 510
L YLH + ++H D+ ++N+LL+S A + DFG A L D ++L +
Sbjct: 161 EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 511 GSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
G+ ++APE +VM + D++S + L +L G HP
Sbjct: 218 GTETHMAPE----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 42/239 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G+VY A+ + + ALK L + E+ R E ++ S
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 425 -----------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+E G+++R L ++ E + +A+AL+Y H S V
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT--YITELANALSYCH---SKRV 130
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRDI N+LL S E +ADFG + +HA SS +T L G+ Y+ PE+ + EK
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD---RKVIQDIL 586
D++S GV+ E L+GK P + +T +Y +I ++ P V R +I +L
Sbjct: 189 DLWSLGVLCYEFLVGKPPFE-ANTYQETYK-RISRVEF---TFPDFVTEGARDLISRLL 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 7e-21
Identities = 38/283 (13%), Positives = 79/283 (27%), Gaps = 75/283 (26%)
Query: 368 PRKIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSP-------------ETEELAFIR 413
PR + +G + +A G F + E L +R
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 414 SFRNEAQVLS-----------------------------------------QMERGSLFR 432
+N+ Q Q +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 433 ILHNDAEAVE-LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVA 491
+L + + + L R+ + + LA LH +VH + +I+L+ + F+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 492 DFGTARLLHADSSNQTLLAGSYG---YIAPELAY-----TMVMTEKYDVYSFGVVTLEVL 543
F +S + + + A + +MT +D ++ G+ +
Sbjct: 254 GFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 544 MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
P + + I + +P PV R +++ L
Sbjct: 312 CADLP-NTDDAALGGSE----WIFRSCKNIPQPV-RALLEGFL 348
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 44/239 (18%), Positives = 90/239 (37%), Gaps = 67/239 (28%)
Query: 368 PRKIDSKYC----IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS 423
+ + + +G G+ G+V GR A+K++ + F E ++L+
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLT 63
Query: 424 Q-----------------------MER--GSLF-RILHNDA---EAVELDWAKRVNIVKA 454
+ +E +L + + +++++
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF-------------VADFGTARLLHA 501
+A +A+LH S ++HRD+ NIL+++ ++DFG + L +
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 502 DSSNQTL----LAGSYGYIAPEL---AYTMVMTEKY----DVYSFGVVTLEVL-MGKHP 548
S+ +G+ G+ APEL + + + D++S G V +L GKHP
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
L N +L + + L+ Q+ L + + ++++ + T+LK L L+ N
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAGM--QFFTNLKELHLSHN 73
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDI--IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
Q+S L + +L L L V N + + IPS LS L L N+ + L
Sbjct: 74 QISDLSP-LKDLTKLEELSVNRNRLKNLNGIPSAC-----LSRLFLDNNEL-RDTDS-LI 125
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L L L + +NKL I + + L LDL N I + G +T+L ++++++L+G
Sbjct: 126 HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTG 181
Query: 349 NKLSGRVPYSNKHLSSMPTPRKIDSK 374
K L T + D +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 24/128 (18%), Positives = 49/128 (38%), Gaps = 10/128 (7%)
Query: 225 LILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP 284
I ++ + L N + ++G + + S + + + S+
Sbjct: 2 SIQRPTPINQV-FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNI-QSLA 57
Query: 285 NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344
+ T L L LS N++S + S + + L L ++ N +K ++ G + L L
Sbjct: 58 G-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRL 111
Query: 345 NLSGNKLS 352
L N+L
Sbjct: 112 FLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 18/112 (16%), Positives = 37/112 (33%), Gaps = 8/112 (7%)
Query: 149 SEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203
+ L L++L + +N+L+ G L+ L + L N + + LK + +D+
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 204 GDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI 255
+ L + + P I N + + V
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS-PYYISNGGSYVDGCVLWELP 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 56/248 (22%), Positives = 90/248 (36%), Gaps = 73/248 (29%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF---ALKKL--NSPETEELAFIRSFRNEAQVLSQ----- 424
+G+GA+G+VYK +V A+K+L + + EA V++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPH 78
Query: 425 -------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAY 461
M G L + + + L+W V I K M Y
Sbjct: 79 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----Y 132
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI----- 516
L +VHRD+++ N+L+ + + DFG A+LL A+ G +
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKVPIKWM 186
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ---- 571
A E + T + DV+S+GV E++ G P Y I ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------Y-DGIPASEISSILEKG 235
Query: 572 -RLPPPVD 578
RLP P
Sbjct: 236 ERLPQPPI 243
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 92.9 bits (230), Expect = 6e-20
Identities = 52/300 (17%), Positives = 98/300 (32%), Gaps = 20/300 (6%)
Query: 84 MDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGF 143
+D EW + S + L + H + +S +
Sbjct: 278 VDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDR 337
Query: 144 TGSIPSEISALSKLQLLDLSSNRL---RGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200
+ + +L +LS + + L + + L I ++ L
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDP 397
Query: 201 LDVGDNSLIGPIPLTLSRLTSLKILILA------QNQLSGLPQEIGNLKNLMLLDVGNND 254
L +L S L ++ + A L ++ +L + + D
Sbjct: 398 LLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 255 IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM 314
+ + L +++LDLS N+ ++P L L L L S N L + +A++
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-NVDG-VANL 507
Query: 315 EDLTWLDLSNNNIKG-SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDS 373
L L L NN ++ + + RL LNL GN L + +P+ I +
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 2e-13
Identities = 41/273 (15%), Positives = 83/273 (30%), Gaps = 39/273 (14%)
Query: 77 WWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRI 136
+ WT C + + S + S + + L+
Sbjct: 317 TFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQE 376
Query: 137 LAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG--RLTNLN-----YMSLSRNMLGGLLP 189
L + + + + I + L L L+ L ++ Y+ R+
Sbjct: 377 LEPENKWC--LLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENS 434
Query: 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLD 249
++ L + L L +L + L L+ N+L LP + L+ L +L
Sbjct: 435 VLKMEYADVRVLHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ 492
Query: 250 VGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG-KIP 308
+N + ++ + L +L L L +N+L
Sbjct: 493 ASDNAL-------------------------ENVDG-VANLPRLQELLLCNNRLQQSAAI 526
Query: 309 SQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
+ S L L+L N++ G +L+ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 49/244 (20%), Positives = 84/244 (34%), Gaps = 62/244 (25%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
+G G++G V + + P+G+ A+K L + + F E +
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 425 ----------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLHH 464
GSL L +A V + + M YL
Sbjct: 86 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMG----YLE- 138
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS---YGYIAPELA 521
S +HRD+++ N+LL ++ + DFG R L + + + + + APE
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 522 YTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ------RLP 574
T + D + FGV E+ G+ P + + +L + RLP
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP----------W-IGLNGSQILHKIDKEGERLP 245
Query: 575 PPVD 578
P D
Sbjct: 246 RPED 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 57/280 (20%), Positives = 106/280 (37%), Gaps = 73/280 (26%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------- 423
+G GA+G V KA+ + R +A+KK+ E + + + +E +L+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQYVVRYY 68
Query: 424 ------------------------QME---RGSLFRILHNDAEAVELDWAKRVNIVKAMA 456
QME G+L+ ++H++ + D R + + +
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--LFRQIL 126
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA------ 510
AL+Y+H S ++HRD+ NI ++ + DFG A+ +H L +
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 511 --------GSYGYIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP 561
G+ Y+A E L T EK D+YS G++ E++ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK---- 239
Query: 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
K+ + + PP D ++ I + +P
Sbjct: 240 KLRSVSI---EFPPDFDDNKMKV--EKKIIR-LLIDHDPN 273
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 65/216 (30%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
+IPS I A + LDL SN+L RLT L + L+ N L L LKNL
Sbjct: 30 AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP 258
L V DN L +L +L L L +NQL LP
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPP--------------------- 126
Query: 259 IPSTLGLFSDLS---YLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-AS 313
+F L+ YL L N+ S+P + +LT L L L +N+L ++P
Sbjct: 127 -----RVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDK 179
Query: 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
+ +L L L NN +K G L +L L L N
Sbjct: 180 LTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 55/163 (33%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDI 255
+ +LD+ N L RLT L++L L N+L LP I LKNL L V +N +
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 256 IGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI 311
+P G+F L L L NQ S+P + LT+L +L L N+L +P +
Sbjct: 98 QA-LPI--GVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 312 -ASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLS 352
+ L L L NN +K +P G KL+ L L L N+L
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 8/73 (10%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI-TKLS 339
S+IP + +L DL SNKLS + L L L++N ++ ++P I +L
Sbjct: 33 SNIPADTKKL------DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 340 RLDYLNLSGNKLS 352
L+ L ++ NKL
Sbjct: 86 NLETLWVTDNKLQ 98
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 73/285 (25%), Positives = 112/285 (39%), Gaps = 67/285 (23%)
Query: 343 YLNLSGNKLSGRVPYSNKHLSSMPT------PRKIDSKY-----CIGTGAYGSVYKAQL- 390
+ KL G + + H PT +++D+ +G G +G V +L
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 391 -PNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQ----------------------- 424
P+ + A+K L TE+ R F EA ++ Q
Sbjct: 68 LPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 425 --MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482
ME GSL L + + V +++ +A + YL VHRD+++ NIL+
Sbjct: 126 EYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILI 180
Query: 483 NSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---APELAYTMVMTEKYDVYSFGVVT 539
NS L V+DFG R+L D G I +PE T DV+S+G+V
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 540 LEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
EV+ G+ P Y ++ DV+ RLPPP+D
Sbjct: 241 WEVMSYGERP----------Y-WEMSNQDVIKAVDEGYRLPPPMD 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 62/245 (25%)
Query: 374 KYCIGTGAYGSVYKAQL--PNGRVF-ALKKL--NSPETEELAFIRSFRNEAQVLSQ---- 424
+G G +GSV + ++ A+K L + + + +R EAQ++ Q
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNP 70
Query: 425 --------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
G L + L E E+ + ++ ++ + YL
Sbjct: 71 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL-- 126
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APE 519
+ VHRD+++ N+LL ++ A ++DFG ++ L AD S T + G APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA--GKWPLKWYAPE 183
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RL 573
+ + DV+S+GV E L G+ P Y K+ +V+ R+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP----------Y-KKMKGPEVMAFIEQGKRM 232
Query: 574 PPPVD 578
P +
Sbjct: 233 ECPPE 237
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 35/225 (15%)
Query: 154 LSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL----- 201
LS + L D++ L + T++ + LS N + + + ++
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 202 --------DVGDNSLIGPIPLTLSRL--TSLKILILAQNQLSGLPQEI-GNLKNLMLLDV 250
G + P T L + +K L+++++ L + + + +L L +
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 251 GNNDIIGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGK 306
N+I I F L+ L+LS N SI + + L +L LDLS N +
Sbjct: 307 AQNEI-NKIDD--NAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA- 361
Query: 307 IPSQI-ASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGN 349
+ Q + +L L L N +K S+P I +L+ L + L N
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 51/276 (18%), Positives = 99/276 (35%), Gaps = 43/276 (15%)
Query: 117 NGRLSHLNFSCFPNLESLRILA-YYDGFTGS-IPSEI-SALSKLQLLDLSSNRLR----- 168
+ L F L +L +L G+ + L+ L++L L N ++
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 169 ---GRLTNLNYMSLSRNMLGGLLPQEIGNL--KNLIELDVGDNSLIGPIPLTLS------ 217
+ + + L+ N + + +++ N K+ L + +L L
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 218 --RLTSLKILILAQNQLSGLPQEI--------------GNLKNLMLLDVGNNDIIGPIPS 261
+ TS+ L L+ N + + M G+ + P
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 262 TLG--LFSDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
T S + DLS ++ ++ + + T L L L+ N+++ KI + L
Sbjct: 268 TFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHL 325
Query: 318 TWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
L+LS N + SI + L +L+ L+LS N +
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 49/199 (24%), Positives = 74/199 (37%), Gaps = 21/199 (10%)
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILILAQN 230
++NY+ LS N + L L++L L V + I T L+SL IL L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 231 QLSGLPQEI-GNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLS---YLDLSCNQFNSSIPN 285
Q L L NL +L + ++ G + F L+ L L N P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 286 EL-TRLTQLFHLDLSSNKLSGKIPSQI---ASMEDLTWLDLSNNNI--------KGSIPG 333
+ + LDL+ NK+ I + + T L LS+ + G
Sbjct: 148 SFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 334 EITKLSRLDYLNLSGNKLS 352
K + + L+LSGN
Sbjct: 207 NPFKNTSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 47/242 (19%), Positives = 76/242 (31%), Gaps = 37/242 (15%)
Query: 148 PSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
+ S L LQ L + L++L + L N L L NL
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 200 ELDVGDNSLIGPI--PLTLSRLTSLKILILAQNQLSGLPQEI--GNLKNLMLLDVGNNDI 255
L + +L G + LTSL++L+L N + + N++ +LD+ N +
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 256 IGPIPSTLGLF--SDLSYLDLSCNQFNSSIPNELT--------RLTQLFHLDLSSNKLSG 305
L F + L LS L + T + LDLS N
Sbjct: 167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 306 KIPSQIASMEDLTWL-------------DLSNNNIKGSIPGEITKL--SRLDYLNLSGNK 350
+ + T + + N K L S + +LS +K
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286
Query: 351 LS 352
+
Sbjct: 287 IF 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 22/221 (9%)
Query: 117 NGRLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEIS---ALSKLQLLDLSSNRLRGR-L 171
L S+ L +GF S+ A +K+Q L LS++ G
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
+ N+ GL + D+ + + + S T L+ L LAQN+
Sbjct: 257 GHTNFKDPDNFTFKGLEAS------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE 310
Query: 232 LSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNEL 287
++ + L +L+ L++ N + G I S +F +L LDLS N ++ ++
Sbjct: 311 INKIDDNAFWGLTHLLKLNLSQNFL-GSIDS--RMFENLDKLEVLDLSYNHI-RALGDQS 366
Query: 288 -TRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNN 326
L L L L +N+L +P I + L + L N
Sbjct: 367 FLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P L + ++Y+DLS N +RL L L + I + + L
Sbjct: 25 VPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 318 TWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLSGRV 355
L L N + L+ L+ L L+ L G V
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 36/134 (26%), Positives = 46/134 (34%), Gaps = 14/134 (10%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSN 165
LS ++ L S F + L L I L+ L L+LS N
Sbjct: 280 CDLS------KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333
Query: 166 RLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
L L L + LS N + L Q L NL EL + N L R
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393
Query: 219 LTSLKILILAQNQL 232
LTSL+ + L N
Sbjct: 394 LTSLQKIWLHTNPW 407
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 36/204 (17%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG G++G V+K +V A+K ++ E E+ I + E VLSQ
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYY 86
Query: 425 ------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
ME GS +L LD + I++ + L YLH S
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEK 139
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
+HRDI + N+LL+ E +ADFG A L + G+ ++APE+ K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 530 YDVYSFGVVTLEVLMGKHPR-DLH 552
D++S G+ +E+ G+ P +LH
Sbjct: 200 ADIWSLGITAIELARGEPPHSELH 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 54/262 (20%)
Query: 362 LSSMPTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFR 416
L+ MP + + +G G +G+VY A+ N + ALK L + E+ R
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 417 NEAQVLSQ----------------------ME---RGSLFRILHNDAEAVELDWAKRVNI 451
E ++ S +E RG L++ L E +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSAT--F 119
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
++ +A AL Y H V+HRDI N+L+ K E +ADFG + +HA S + + G
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCG 174
Query: 512 SYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567
+ Y+ PE M+ + + D++ GV+ E L+G P D + + ++ +I+ +D
Sbjct: 175 TLDYLPPE----MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHR-RIVNVD 228
Query: 568 VLDQRLPPPVD---RKVIQDIL 586
+ + PP + + +I +L
Sbjct: 229 L---KFPPFLSDGSKDLISKLL 247
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 56/246 (22%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVF-ALKKLNSPETEELAFIRSFRNEAQVLSQ-- 424
I K+ +G G YG VY+ + A+K L E F++ EA V+ +
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIK 274
Query: 425 -----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAY 461
M G+L L E+ + + ++ A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEY 333
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAP 518
L + +HR++++ N L+ VADFG +RL+ D + + AP
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAP 388
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----R 572
E + K DV++FGV+ E+ G P Y P I L V + R
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----------Y-PGIDLSQVYELLEKDYR 437
Query: 573 LPPPVD 578
+ P
Sbjct: 438 MERPEG 443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 58/241 (24%), Positives = 83/241 (34%), Gaps = 70/241 (29%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG+G +G V+ N A+K + E FI EA+V+ +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 71
Query: 425 -------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLHHDCS 467
ME G L L L V +AYL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV------CEGMAYL---EE 122
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYI---APELA 521
V+HRD+++ N L+ V+DFG R + D SS T + +PE+
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWASPEVF 177
Query: 522 YTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPP 575
+ K DV+SFGV+ EV GK P Y +V++ RL
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP----------Y-ENRSNSEVVEDISTGFRLYK 226
Query: 576 P 576
P
Sbjct: 227 P 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 3e-19
Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF-ALKKL--NSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +GSV + ++ A+K L + + + +R EAQ++ Q
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPYIV 399
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
G L + L E E+ + ++ ++ + YL
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL---EE 454
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---APELAYTM 524
+ VHR++++ N+LL ++ A ++DFG ++ L AD S T + + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 525 VMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ + DV+S+GV E L G+ P Y K+ +V+ R+ P +
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP----------Y-KKMKGPEVMAFIEQGKRMECPPE 563
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 60/237 (25%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V+ A+K L AF+ EA ++ Q
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA 75
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME GSL L ++L K +++ +A +A++ + +
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYI---APELAYTMV 525
HRD+ + NIL++ L +ADFG ARL+ + + I APE
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTAPEAINYGT 186
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
T K DV+SFG++ E++ G+ P Y P + +V+ R+ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP----------Y-PGMTNPEVIQNLERGYRMVRP 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 62/239 (25%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G+G +G V + A+K + E F + EAQ + +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGV 71
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
+ G L L + + L+ ++ + + + +A+L S +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYI---APELAYTMV 525
HRD+++ N L++ L V+DFG R + D SS T + APE+ +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-----VKWSAPEVFHYFK 181
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ K DV++FG++ EV GK P Y +V+ + RL P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP----------Y-DLYTNSEVVLKVSQGHRLYRPHL 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 36/228 (15%), Positives = 74/228 (32%), Gaps = 38/228 (16%)
Query: 155 SKLQLLDLSSNRLR---GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGP 211
+ + ++ ++ + + L L + NL N+ + V + +
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 212 IP------------LTLSR--------------LTSLKILILAQNQLSGLPQE--IGNLK 243
+ + + L LK L + L P + +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTD 130
Query: 244 NLMLLDVGNNDIIGPIPSTL--GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301
+L++ +N + IP GL ++ L L N F +S+ T+L + L+ N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKN 189
Query: 302 KLSGKIPSQIAS--MEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNL 346
K I + LD+S ++ ++P + L L N
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 37/198 (18%), Positives = 71/198 (35%), Gaps = 18/198 (9%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEI-SALSKLQLLDLSSNR-LR------- 168
L + F NL ++ + D + S LSK+ +++ + R L
Sbjct: 42 HLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101
Query: 169 GRLTNLNYMSLSRNMLGGLLPQE-IGNLKNLIELDVGDNSLIGPIPL-TLSRLTS-LKIL 225
L L ++ + L + + L++ DN + IP+ L + L
Sbjct: 102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTL--GLFSDLSYLDLSCNQFNSSI 283
L N + + N L + + N + I G++S S LD+S +++
Sbjct: 162 KLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TAL 220
Query: 284 PNELTRLTQLFHLDLSSN 301
P++ L L L +
Sbjct: 221 PSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 13/91 (14%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 264 GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDL 322
L L L + + + L + + +S + ++ S ++ +T +++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 323 SNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
N I + +L L +L + L
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 41/239 (17%), Positives = 84/239 (35%), Gaps = 58/239 (24%)
Query: 362 LSSMPTPRKI-DSKYCIGTGA--YGSVYKAQ-LPNGRVFALKKLN--SPETEELAFIRSF 415
+SS + IG G +V A+ P G ++++N + E + F++
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ-- 74
Query: 416 RNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVN 450
E V M GS ++ ++
Sbjct: 75 -GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAY 132
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG-TARLLHADSSNQTLL 509
I++ + AL Y+HH VHR + +++IL++ + +++ ++ + +
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 510 AGSYGYI------APELAYTMVMTE-------KYDVYSFGVVTLEVLMGKHPR-DLHST 554
+ +PE V+ + K D+YS G+ E+ G P D+ +T
Sbjct: 190 DFPKYSVKVLPWLSPE-----VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 67/282 (23%), Positives = 105/282 (37%), Gaps = 82/282 (29%)
Query: 376 CIGTGAYGSVYKA-QLPNGRVFALKKLN----SPETEELAFIRSFRNEAQVLSQ------ 424
IG+GA V A P A+K++N +EL E Q +SQ
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL------LKEIQAMSQCHHPNI 75
Query: 425 -------------------MERGSLFRIL-----HNDAEAVELDWAKRVNIVKAMAHALA 460
+ GS+ I+ + ++ LD + I++ + L
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA------GSYG 514
YLH +HRD+ + NILL +ADFG + L A + T G+
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL-ATGGDITRNKVRKTFVGTPC 191
Query: 515 YIAPELAYTMVMTE------KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP--KIMLI 566
++APE VM + K D++SFG+ +E+ G P Y P +ML
Sbjct: 192 WMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPY-------HKYPPMKVLMLT 239
Query: 567 DVLDQRLPPPVDRKVIQDILLVSTIS--F-----ACLQSNPK 601
+ PP +QD ++ F CLQ +P+
Sbjct: 240 ----LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 54/236 (22%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V+ A+K L AF++ EAQV+ +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYA 246
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M +GSL L + L + V++ +A +AY+ + V
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTE 528
HRD+ + NIL+ L VADFG ARL+ + + + APE A T
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 360
Query: 529 KYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
K DV+SFG++ E+ G+ P Y P ++ +VLDQ R+P P +
Sbjct: 361 KSDVWSFGILLTELTTKGRVP----------Y-PGMVNREVLDQVERGYRMPCPPE 405
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 56/237 (23%), Positives = 87/237 (36%), Gaps = 60/237 (25%)
Query: 377 IGTGAYGSVYKAQLPNGRVF-ALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G YG VY+ + A+K L E F++ EA V+ +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M G+L L E+ + + ++ A+ YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAYTMV 525
+HRD+++ N L+ VADFG +RL+ D T A + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 188
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
+ K DV++FGV+ E+ G P Y P I L V + R+ P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP----------Y-PGIDLSQVYELLEKDYRMERP 234
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 58/240 (24%)
Query: 377 IGTGAYGSVYKAQLPNGRVF---ALKKLNSPETEELAFIRSFRNEAQVLSQ--------- 424
+G+G +G+V K +V A+K L E + A EA V+ Q
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
E G L + L + + + +V ++ + YL +
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESN 137
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAYTM 524
VHRD+++ N+LL ++ A ++DFG ++ L AD + A ++G APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 195
Query: 525 VMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ K DV+SFGV+ E G+ P Y + +V R+ P
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP----------Y-RGMKGSEVTAMLEKGERMGCPAG 244
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 7e-19
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 54/236 (22%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V+ A+K L AF++ EAQV+ +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYA 329
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M +GSL L + L + V++ +A +AY+ + V
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYIAPELAYTMVMTE 528
HRD+ + NIL+ L VADFG ARL+ + + + APE A T
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 443
Query: 529 KYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
K DV+SFG++ E+ G+ P Y P ++ +VLDQ R+P P +
Sbjct: 444 KSDVWSFGILLTELTTKGRVP----------Y-PGMVNREVLDQVERGYRMPCPPE 488
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 69/243 (28%), Positives = 104/243 (42%), Gaps = 61/243 (25%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF---ALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
IG G +G VYK L +G+ A+K L + TE+ F EA ++ Q
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSHHNII 109
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
ME G+L + L E + V +++ +A + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELA 521
+ + VHRD+++ NIL+NS L V+DFG +R+L D +G G I APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--GKIPIRWTAPEAI 222
Query: 522 YTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPP 575
T DV+SFG+V EV+ G+ P Y ++ +V+ RLP
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP----------Y-WELSNHEVMKAINDGFRLPT 271
Query: 576 PVD 578
P+D
Sbjct: 272 PMD 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 66/242 (27%), Positives = 95/242 (39%), Gaps = 60/242 (24%)
Query: 377 IGTGAYGSVYKAQL---PNGRVF-ALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG+G G V +L V A+K L + TE R F +EA ++ Q
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDHPNIIR 114
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
ME GSL L + + V +++ + + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAY 522
VHRD+++ N+L++S L V+DFG +R+L D G G I APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--GKIPIRWTAPEAIA 227
Query: 523 TMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
+ DV+SFGVV EVL G+ P Y + DV+ RLP P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP----------Y-WNMTNRDVISSVEEGYRLPAP 276
Query: 577 VD 578
+
Sbjct: 277 MG 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 51/239 (21%), Positives = 84/239 (35%), Gaps = 62/239 (25%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+GTG +G V + A+K + E FI EA+V+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M G L L + + + K + A+ YL S +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYI---APELAYTMV 525
HRD+++ N L+N + V+DFG +R + D SS + + PE+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPPEVLMYSK 197
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ K D+++FGV+ E+ GK P Y + + + RL P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP----------Y-ERFTNSETAEHIAQGLRLYRPHL 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 1e-18
Identities = 55/277 (19%), Positives = 95/277 (34%), Gaps = 63/277 (22%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTG +G V + G A+K+ + + + E Q++ +
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79
Query: 425 -----------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
ME G L + L+ L ++ ++ AL YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 465 DCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
++HRD+ NI+L + + D G A+ L + G+ Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQYLAPE-- 193
Query: 522 YTMVMTEKY----DVYSFGVVTLEVLMGK-------HPRDLHSTLSSSYDPKIMLIDVLD 570
++ +KY D +SFG + E + G P H + + I++ D L
Sbjct: 194 --LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 571 QR------LPPPVDRKVIQDILLVSTISFACLQSNPK 601
LP P I L + L + +
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCM-LMWHQR 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 57/217 (26%)
Query: 368 PRKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRN 417
P+ + +Y + G+GA G V A + + A+K K E +
Sbjct: 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 418 EAQVLSQ------------------------MERGSLF-RILHND----AEAVELDWAKR 448
E ++L + ME G LF +++ N A
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------- 117
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSN 505
M A+ YLH ++HRD+ N+LL+S+ E + DFG +++L S
Sbjct: 118 -LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 506 QTLLAGSYGYIAPE-LAYTMVM--TEKYDVYSFGVVT 539
+T L G+ Y+APE L D +S GV+
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 54/236 (22%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V+ A A+K + AF+ EA V+
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLHA 250
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M +GSL L +D E + K ++ +A +A++ + +
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---APELAYTMVMTE 528
HRD+ + NIL+++ L +ADFG AR++ + T G+ I APE T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 529 KYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
K DV+SFG++ +E++ G+ P Y P + +V+ R+P P +
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP----------Y-PGMSNPEVIRALERGYRMPRPEN 409
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 55/215 (25%), Positives = 83/215 (38%), Gaps = 66/215 (30%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G+GAYG V A+K +++ +L E VL
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL------LEEVAVLKLLDHPNI 98
Query: 425 ----------------MER---GSLF-RILH----NDAEAVELDWAKRVNIVKAMAHALA 460
ME G LF I+H N+ +A I+K + +
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQVLSGVT 150
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIA 517
YLH ++VHRD+ N+LL SK + + DFG + + + G+ YIA
Sbjct: 151 YLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIA 206
Query: 518 PELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
PE V+ +KY DV+S GV+ +L G P
Sbjct: 207 PE-----VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 46/212 (21%), Positives = 82/212 (38%), Gaps = 46/212 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G GA +V++ + G +FA+K N+ + E +VL +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 425 -------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
ME GSL+ +L + A L ++ + +++ + + +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 469 SVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAGSYGYIAPEL---- 520
+VHR+I NI+ + + DFG AR L D +L G+ Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERA 190
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+KY D++S GV G P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 70/220 (31%)
Query: 367 TPRKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFR 416
+Y I G G++G V K + +A+K + +T +
Sbjct: 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI------L 69
Query: 417 NEAQVLSQ----------------------MER---GSLF-RILH----NDAEAVELDWA 446
E ++L + E G LF I+ ++ +A
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---- 125
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADS 503
I+K + + Y+H ++VHRD+ NILL SK + + DFG + ++
Sbjct: 126 ----IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVT 539
+ G+ YIAPE V+ Y DV+S GV+
Sbjct: 179 KMKD-RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVIL 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 51/222 (22%), Positives = 82/222 (36%), Gaps = 59/222 (26%)
Query: 369 RKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS 423
+Y G G++G V G+ A+K ++ + ++ S E Q+L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 424 Q----------------------MER---GSLF-RIL----HNDAEAVELDWAKRVNIVK 453
Q E G LF I+ ++ +A I++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--------IIR 133
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLA 510
+ + Y+H +VHRD+ N+LL SK + + DFG + S
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKI 189
Query: 511 GSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
G+ YIAPE V+ Y DV+S GV+ +L G P
Sbjct: 190 GTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 55/248 (22%), Positives = 85/248 (34%), Gaps = 73/248 (29%)
Query: 377 IGTGAYGSVYKAQL----PNGRVF-ALK--KLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G+G +G+V+K + ++ +K + S A +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD----HMLAIGSLDHAH 76
Query: 425 -------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAY 461
+ GSL + A+ L+W V I K M Y
Sbjct: 77 IVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----Y 130
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI----- 516
L +VHR++++ N+LL S + VADFG A LL D S
Sbjct: 131 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAKTPIKWM 184
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ---- 571
A E + T + DV+S+GV E++ G P Y + L +V D
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP----------Y-AGLRLAEVPDLLEKG 233
Query: 572 -RLPPPVD 578
RL P
Sbjct: 234 ERLAQPQI 241
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 32/257 (12%), Positives = 66/257 (25%), Gaps = 52/257 (20%)
Query: 341 LDYLNLSGNKLSGRVPYSNK--HLSSMPTPRKIDSKYCI----GTGAYGSVYKAQ----- 389
L L+ + + K + + + G GA+ VY+A
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 390 -LPNGRVFALKKLNSPETEELAFIRSFRNEAQ----------------------VLSQME 426
N + F LK E + V
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 427 RGSLFRILHNDAEAVE--LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484
G+L ++ E + ++ M + + +H ++H DI +N +L +
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGN 207
Query: 485 KLEAF-----------VADFGTARLLHADSSNQTL--LAGSYGYIAPELAYTMVMTEKYD 531
+ D G + + + G+ E+ + D
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267
Query: 532 VYSFGVVTLEVLMGKHP 548
+ +L G +
Sbjct: 268 YFGVAATVYCMLFGTYM 284
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 56/248 (22%), Positives = 90/248 (36%), Gaps = 73/248 (29%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF---ALKKL--NSPETEELAFIRSFRNEAQVLSQ----- 424
+G+GA+G+VYK +V A+K+L + + EA V++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPH 78
Query: 425 -------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAY 461
M G L + + + L+W V I K M Y
Sbjct: 79 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----Y 132
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI----- 516
L +VHRD+++ N+L+ + + DFG A+LL A+ G +
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKVPIKWM 186
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ---- 571
A E + T + DV+S+GV E++ G P Y I ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------Y-DGIPASEISSILEKG 235
Query: 572 -RLPPPVD 578
RLP P
Sbjct: 236 ERLPQPPI 243
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 57/217 (26%)
Query: 368 PRKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRN 417
P+ + +Y + G+GA G V A + + A++ K E +
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 418 EAQVLSQ------------------------MERGSLF-RILHND----AEAVELDWAKR 448
E ++L + ME G LF +++ N A
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------- 242
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSN 505
M A+ YLH ++HRD+ N+LL+S+ E + DFG +++L S
Sbjct: 243 -LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 506 QTLLAGSYGYIAPE-LAYTMVM--TEKYDVYSFGVVT 539
+T L G+ Y+APE L D +S GV+
Sbjct: 299 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 49/254 (19%), Positives = 83/254 (32%), Gaps = 67/254 (26%)
Query: 377 IGTGAYGSVYKAQLP-----NGRVFALKKL--NSPETEELAFIRSFRNEAQVLSQ----- 424
+G G +G V + G A+K L S + E ++L
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK----EIEILRNLYHEN 84
Query: 425 ----------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHA 458
+ GSL L + + L +A ++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI------CKG 138
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-- 516
+ YL S VHRD+++ N+L+ S+ + + DFG + + D T
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPV 193
Query: 517 ---APELAYTMVMTEKYDVYSFGVVTLEVL----MGKHPRDLHSTLSSSYDPKIMLIDVL 569
APE DV+SFGV E+L P L + ++ + ++
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 570 DQ-----RLPPPVD 578
+ RLP P +
Sbjct: 254 NTLKEGKRLPCPPN 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 66/237 (27%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG G +G V +V A+K + + T + +F EA V++Q
Sbjct: 29 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 82
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M +GSL L + + L + + A+ YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAYTMV 525
VHRD+++ N+L++ A V+DFG + + G + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTAPEALREKK 190
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
+ K DV+SFG++ E+ G+ P Y P+I L DV+ + ++ P
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVP----------Y-PRIPLKDVVPRVEKGYKMDAP 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 61/276 (22%), Positives = 95/276 (34%), Gaps = 67/276 (24%)
Query: 356 PYSNKHLSSMPT---PRKIDSKYCIGTGAYGSVYKAQLP-----NGRVFALKKLNSPETE 407
++ + PT R + +G G +GSV + G + A+K+L +
Sbjct: 7 HHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 408 ELAFIRSFRNEAQVLSQ---------------------------MERGSLFRILHNDAEA 440
+ R F+ E Q+L + G L L
Sbjct: 67 QQ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 441 VE----LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496
++ L ++ I K M YL S VHRD+++ NIL+ S+ +ADFG A
Sbjct: 124 LDASRLLLYS--SQICKGME----YLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174
Query: 497 RLLHADSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHP-- 548
+LL D G APE + + + DV+SFGVV E+
Sbjct: 175 KLLPLDKDYYV--VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232
Query: 549 -RDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ L +L+ RLP P
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 58/262 (22%), Positives = 112/262 (42%), Gaps = 54/262 (20%)
Query: 364 SMPT--PRKIDSKYCI----GTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFR 416
S+ T KI+ + + G G++ VY+A+ + G A+K ++ + ++ +
Sbjct: 1 SLATCIGEKIE-DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ 59
Query: 417 NEAQVLSQ----------------------ME---RGSLFRILHNDAEAVELDWAKRVNI 451
NE ++ Q +E G + R L N + + A+
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--F 117
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
+ + + YLH S ++HRD++ +N+LL + +ADFG A L L G
Sbjct: 118 MHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 512 SYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567
+ YI+PE + + DV+S G + +L+G+ P D T+ ++ + K++L D
Sbjct: 175 TPNYISPE----IATRSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLN-KVVLAD 228
Query: 568 VLDQRLPPPVD---RKVIQDIL 586
+P + + +I +L
Sbjct: 229 Y---EMPSFLSIEAKDLIHQLL 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG G+ G V A+ +GR A+K ++ + + + NE ++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQHFNVVEMY 108
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
++ G+L I+ V L+ + + +A+ ALAYLH +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
V+HRDI S++ILL ++DFG + D + L G+ ++APE+ + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 530 YDVYSFGVVTLEVLMGKHPR-DLH 552
D++S G++ +E++ G+ P
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 376 CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG GA G+VY A + G+ A++++N + + I NE V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYL 83
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+ GSL ++ +D + + + AL +LH S
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
V+HRDI S+NILL + DFG + + S ++ + G+ ++APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 530 YDVYSFGVVTLEVLMGKHPR-DLH 552
D++S G++ +E++ G+ P + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 53/197 (26%), Positives = 77/197 (39%), Gaps = 46/197 (23%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKN 197
++P + + LLDLS N L RLTNL+ + LS N L + + + N
Sbjct: 32 NVPQSLPSY--TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG 257
L LD+ N L S L +L++L+L N + + +
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR-------------------- 129
Query: 258 PIPSTLGLFSDLS---YLDLSCNQFNSSIPNE----LTRLTQLFHLDLSSNKLSGKIPSQ 310
F D++ L LS NQ S P E +L +L LDLSSNKL +
Sbjct: 130 ------NAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 311 IASMEDLTW--LDLSNN 325
+ + L L NN
Sbjct: 183 LQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 48/167 (28%), Positives = 67/167 (40%), Gaps = 19/167 (11%)
Query: 212 IPLTLSRLTSLKILILAQNQLSGLPQEI--GNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269
+P +L T +L L+ N LS L E L NL L + +N + I S F +
Sbjct: 33 VPQSLPSYT--ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISS--EAFVPV 87
Query: 270 S---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSN 324
YLDLS N ++ + L L L L +N + + M L L LS
Sbjct: 88 PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 325 NNIKGSIPGEI----TKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPT 367
N I P E+ KL +L L+LS NKL + L +
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 53/228 (23%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+ G + VY+AQ + +GR +ALK+L S E E+ R+ E + +
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 425 --------------------ME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
E +G L L L + I A+ ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA------------ 510
H P ++HRD+ N+LL+++ + DFG+A +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 511 GSYGYIAPELAYTM---VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL 555
+ Y PE+ + EK D+++ G + + +HP + + L
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 66/215 (30%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G G++G V K + +A+K + +T + E ++L +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI------LREVELLKKLDHPNI 83
Query: 425 ----------------MER---GSLF-RILHND----AEAVELDWAKRVNIVKAMAHALA 460
E G LF I+ +A I+K + +
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--------IIKQVFSGIT 135
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIA 517
Y+H ++VHRD+ NILL SK + + DFG + ++ + G+ YIA
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIA 191
Query: 518 PELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
PE V+ Y DV+S GV+ +L G P
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 49/240 (20%), Positives = 89/240 (37%), Gaps = 46/240 (19%)
Query: 352 SGRVPYSNKHLSSMPTPRKI-DSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEEL 409
S LS++ P I + +G G YG VYK + + G++ A+K ++ E
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-- 63
Query: 410 AFIRSFRNEAQVLSQMER--------GSLFRILHNDAEA-----------------VELD 444
+ E +L + G+ + + ++
Sbjct: 64 --EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 445 WAKRVN------IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498
+ I + + L++LH V+HRDI N+LL E + DFG +
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTE-----KYDVYSFGVVTLEVLMGKHPR-DLH 552
L + G+ ++APE+ + K D++S G+ +E+ G P D+H
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 47/221 (21%), Positives = 89/221 (40%), Gaps = 70/221 (31%)
Query: 367 TPRKIDSKYC----IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFR 416
T + +Y +G GA+ V + ++ G+ +A KL++ + ++L
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------E 58
Query: 417 NEAQVLSQ-------------------------MERGSLF-RILH----NDAEAVELDWA 446
EA++ + G LF I+ ++A+A
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---- 114
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADS 503
++ + A+ + H VVHR++ N+LL SKL+ +ADFG A + +
Sbjct: 115 ----CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 504 SNQTLLAGSYGYIAPELAYTMVMTEK-Y----DVYSFGVVT 539
AG+ GY++PE V+ + Y D+++ GV+
Sbjct: 168 QAWFGFAGTPGYLSPE-----VLRKDPYGKPVDLWACGVIL 203
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 61/329 (18%), Positives = 113/329 (34%), Gaps = 60/329 (18%)
Query: 291 TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK 350
+S +P ++ + ++ + ++ E + +++ +
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70
Query: 351 LSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQL--PNGRVF--ALKKLNSPET 406
L+ + + +H+ P+ + IG G +G VY L +G+ A+K LN
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130
Query: 407 EELAFIRSFRNEAQVLSQ--------------------------MERGSLFRILHNDAEA 440
+ F E ++ M+ G L + N+
Sbjct: 131 IGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH- 187
Query: 441 VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500
+ +A + +L S VHRD+++ N +L+ K VADFG AR ++
Sbjct: 188 -NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 501 ADSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHST 554
+ + + A E T T K DV+SFGV+ E++ G P
Sbjct: 244 DKEFDSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------ 296
Query: 555 LSSSYDPKIMLIDVLDQ-----RLPPPVD 578
Y P + D+ RL P
Sbjct: 297 ----Y-PDVNTFDITVYLLQGRRLLQPEY 320
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 47/226 (20%), Positives = 93/226 (41%), Gaps = 41/226 (18%)
Query: 360 KHLSSMPTPRKI-DSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRN 417
+H+ P ++ + +G GA+G VYKA+ G + A K + + EEL
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---V 65
Query: 418 EAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNIV 452
E ++L+ G++ I+ + + +
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VC 123
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS 512
+ M AL +LH S ++HRD+ + N+L+ + + +ADFG + + G+
Sbjct: 124 RQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 513 YGYIAPELAYTMVMTE-----KYDVYSFGVVTLEVLMGKHPR-DLH 552
++APE+ M + K D++S G+ +E+ + P +L+
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 39/198 (19%), Positives = 66/198 (33%), Gaps = 41/198 (20%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQ------ 424
IG G + V + G+ FA+K K S + EA +
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHPHI 88
Query: 425 -------------------MERGSLF-RILHNDAEAVELDWAKRVNIVKAMAHALAYLHH 464
M+ L I+ A + ++ + AL Y H
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147
Query: 465 DCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPELA 521
+++HRD+ + +LL SK + + FG A L G+ ++APE+
Sbjct: 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 522 YTMVMTEKYDVYSFGVVT 539
+ DV+ GV+
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 43/220 (19%), Positives = 77/220 (35%), Gaps = 17/220 (7%)
Query: 119 RLSHLNFSCFPNLESLRILA-YYDGFTGSIPSEI-SALSKLQLLDLS-SNRLR------- 168
+L + F L + + I +++ S L KL + + +N L
Sbjct: 41 KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 100
Query: 169 GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTS-LKILI 226
L NL Y+ +S + L + + LD+ DN I I + L+ IL
Sbjct: 101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160
Query: 227 LAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN 285
L +N + + + L NN++ S LD+S + +S
Sbjct: 161 LNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
L L +L + K K+P+ + + L L+
Sbjct: 221 GLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 44/220 (20%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEI-GNLKN 197
IPS++ L +LR +L + +S+N + ++ ++ NL
Sbjct: 23 EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 198 LIELDVGDNSLIGPIPL-TLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDI 255
L E+ + + + I L +L+ L+++ + LP + +LLD+ +N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 256 IGPIPSTL--GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313
I I GL + L L+ N I N TQL L+L
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNL--------------- 184
Query: 314 MEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
NNN++ +P ++ S L++S ++
Sbjct: 185 --------SDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/235 (22%), Positives = 91/235 (38%), Gaps = 56/235 (23%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G +G V +V A+K + + T + +F EA V++Q
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLG 253
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
M +GSL L + + L + + A+ YL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
VHRD+++ N+L++ A V+DFG + + L + APE + K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTK 366
Query: 530 YDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
DV+SFG++ E+ G+ P Y P+I L DV+ + ++ P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP----------Y-PRIPLKDVVPRVEKGYKMDAPDG 410
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 39/221 (17%), Positives = 72/221 (32%), Gaps = 56/221 (25%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------- 423
IG+G +GSV+K +G ++A+K+ P ++ E +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRY 76
Query: 424 ------------QME---RGSLFRIL-HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
Q E GSL + N A+ +++ + L Y+H S
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 468 PSVVHRDISSNNILLNSKLEAFV-------------------ADFGTARLLHADSSNQTL 508
S+VH DI +NI ++ D G + S+ +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SSPQV 189
Query: 509 LAGSYGYIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
G ++A E L K D+++ + + +
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 56/231 (24%), Positives = 82/231 (35%), Gaps = 69/231 (29%)
Query: 370 KIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRS----- 414
KI Y G+GAYG V + A+K + + +
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 415 FRNEAQVLSQ----------------------MER---GSLF-RILHND----AEAVELD 444
NE +L E G LF +I++ +A
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN-- 150
Query: 445 WAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHA 501
I+K + + YLH ++VHRDI NILL +K + DFG +
Sbjct: 151 ------IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
D + G+ YIAPE V+ +KY DV+S GV+ +L G P
Sbjct: 202 DYKLRD-RLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 49/204 (24%), Positives = 76/204 (37%), Gaps = 44/204 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALK-----KLNSPETEE-----------------LAFIR 413
+G G + ++ VFA K L P E + F
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 414 SFRNEAQVLSQME---RGSLFRILHNDAEAVELDWAKRVN------IVKAMAHALAYLHH 464
F + V +E R SL + K + ++ + YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYLH- 158
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
V+HRD+ N+ LN LE + DFG A + D + +L G+ YIAPE+
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHP 548
+ + DV+S G + +L+GK P
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 51/203 (25%), Positives = 78/203 (38%), Gaps = 42/203 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALK-----KLNSPETEE-----------------LAFIR 413
+G G + ++ VFA K L P E + F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 414 SFRNEAQVLSQME---RGSLFRILH-----NDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
F + V +E R SL + + EA R ++ + YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVLGCQYLH-- 132
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
V+HRD+ N+ LN LE + DFG A + D + +L G+ YIAPE+
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 526 MTEKYDVYSFGVVTLEVLMGKHP 548
+ + DV+S G + +L+GK P
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 38/206 (18%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IG G++G+VY A+ + N V A+KK++ + + E + L +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 425 ------------ME--RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
ME GS +L + ++ + LAYLH S ++
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLH---SHNM 175
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE-- 528
+HRD+ + NILL+ + DFG+A + + G+ ++APE+ M +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVILAMDEGQYD 231
Query: 529 -KYDVYSFGVVTLEVLMGKHPR-DLH 552
K DV+S G+ +E+ K P +++
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMN 257
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 40/277 (14%), Positives = 78/277 (28%), Gaps = 80/277 (28%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSP-------------ETEELAFIRSFRNEAQVL 422
+G + +A G F + E L +R +N+ Q
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 423 S-----------------------------------------QMERGSLFRILHNDAEAV 441
Q + +L + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 442 E-LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500
+ L R+ + + LA LH +VH + +I+L+ + F+ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 501 ADSSNQTLLAGSYGYIAPEL-----------AYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549
+ + + S G+ PEL +MT +D ++ G+V + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 550 DLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
+ I + +P PV R +++ L
Sbjct: 314 T-KDAALGGSE-WIF---RSCKNIPQPV-RALLEGFL 344
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 49/208 (23%)
Query: 370 KIDSKYC----IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
ID + +G+GA+G V+ + +G +K +N ++ + E +VL
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKS 76
Query: 425 ----------------------MER---GSLF-RILHNDAEAVELDWAKRVNIVKAMAHA 458
ME G L RI+ A L ++K M +A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGY 515
LAY H S VVH+D+ NIL + DFG A L +D + AG+ Y
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTALY 192
Query: 516 IAPELAYTMVMTEKY----DVYSFGVVT 539
+APE V D++S GVV
Sbjct: 193 MAPE-----VFKRDVTFKCDIWSAGVVM 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 46/212 (21%), Positives = 82/212 (38%), Gaps = 46/212 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G GA +V++ + G +FA+K N+ + E +VL +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 425 -------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
ME GSL+ +L + A L ++ + +++ + + +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 469 SVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAGSYGYIAPEL---- 520
+VHR+I NI+ + + DFG AR L D +L G+ Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERA 190
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+KY D++S GV G P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 48/294 (16%), Positives = 106/294 (36%), Gaps = 36/294 (12%)
Query: 323 SNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAY 382
+ + + E+ L++L++ + + K M D +
Sbjct: 43 NRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP 102
Query: 383 GSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME---RGSLFRILHNDAE 439
+ + R + ++ T ++ + + QM+ + +L ++
Sbjct: 103 SPMDAPSVKIRR---MDPFSTKNTVG--QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 440 AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499
+ + ++I +A A+ +LH S ++HRD+ +NI V DFG +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 500 HADSSNQTLLA------------GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH 547
D QT+L G+ Y++PE + + K D++S G++ E+L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 548 PRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
+ + + DV + + P +K Q+ ++V L +P
Sbjct: 275 TQMERVRI---------ITDVRNLKFPLLFTQKYPQEHMMVQ----DMLSPSPT 315
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 65/243 (26%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF--ALK--KLNSPETEELAFIRSFRNEAQVLSQ------ 424
IG G +G V++ P A+K K + ++ F++ EA + Q
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ----EALTMRQFDHPHI 78
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
G L L LD A + ++ ALAYL
Sbjct: 79 VKLIGVITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLE--- 133
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELA 521
S VHRDI++ N+L++S + DFG +R + + S G + APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWMAPESI 189
Query: 522 YTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPP 575
T DV+ FGV E+LM G P + + DV+ + RLP
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP----------F-QGVKNNDVIGRIENGERLPM 238
Query: 576 PVD 578
P +
Sbjct: 239 PPN 241
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 47/229 (20%), Positives = 77/229 (33%), Gaps = 66/229 (28%)
Query: 363 SSMPTPRKIDSKY-----CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFR 416
S+ + + Y +G GA+ V L + +A+K + +
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE---KQPGHIRSRVF 58
Query: 417 NEAQVLSQ--------------------------MERGSLF-RILH----NDAEAVELDW 445
E ++L Q M GS+ I N+ EA
Sbjct: 59 REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV--- 115
Query: 446 AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLH-- 500
+V+ +A AL +LH + + HRD+ NIL + + DF +
Sbjct: 116 -----VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 501 ---ADSSNQTLL--AGSYGYIAPE-LAYTMVMTEKY----DVYSFGVVT 539
+ S LL GS Y+APE + Y D++S GV+
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 54/248 (21%), Positives = 88/248 (35%), Gaps = 75/248 (30%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF--ALK--KLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G G +G VY+ G A+K K + + F+ EA ++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----EAVIMKNLDHPHI 75
Query: 425 ------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYL 462
G L L + +++ + ++ ++ A+AYL
Sbjct: 76 VKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAMAYL 129
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNQTLLAGSYGYI--- 516
S + VHRDI+ NIL+ S + DFG +R + + ++ T L I
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-----IKWM 181
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ---- 571
+PE T DV+ F V E+L GK P + + DV+
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP----------F-FWLENKDVIGVLEKG 230
Query: 572 -RLPPPVD 578
RLP P
Sbjct: 231 DRLPKPDL 238
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 62/212 (29%)
Query: 370 KIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
I+ Y + G G++G V A Q A KK+ + + F+ E +++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIMKS 62
Query: 425 ----------------------MER---GSLF-RILH----NDAEAVELDWAKRVNIVKA 454
ME G LF R++H +++A I+K
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--------IMKD 114
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAG 511
+ A+AY H +V HRD+ N L + + DFG A +T G
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVG 170
Query: 512 SYGYIAPELAYTMVMTEKY----DVYSFGVVT 539
+ Y++P+ V+ Y D +S GV+
Sbjct: 171 TPYYVSPQ-----VLEGLYGPECDEWSAGVMM 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 360 KHLSSMPTPRKI-DSKYCIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRN 417
S P ++ D +G G+YGSVYKA G++ A+K++ +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIK 73
Query: 418 EAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNIV 452
E ++ Q GS+ I+ + + D I+
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--IL 131
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS 512
++ L YLH +HRDI + NILLN++ A +ADFG A L + + + G+
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 188
Query: 513 YGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR-DLH 552
++APE+ + D++S G+ +E+ GK P D+H
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 51/254 (20%), Positives = 95/254 (37%), Gaps = 55/254 (21%)
Query: 324 NNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCI----GT 379
+++ + L +++ + G + + + + G
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 380 GAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------------- 424
GA VY+ Q + +ALK L ++ R E VL +
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 425 --------MER---GSLF-RILH----NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
+E G LF RI+ ++ +A + VK + A+AYLH
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAA--------DAVKQILEAVAYLH---EN 167
Query: 469 SVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
+VHRD+ N+L + +ADFG ++++ +T + G+ GY APE+
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAPEILRGCA 226
Query: 526 MTEKYDVYSFGVVT 539
+ D++S G++T
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200
P + A + +L + L +++ + + + + + I L N+
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRY 67
Query: 201 LDVGDNSL--IGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIG 257
L +G N L I L LT+L LIL NQL LP + L NL L + N +
Sbjct: 68 LALGGNKLHDIS----ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-- 121
Query: 258 PIPSTL--GLF---SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI- 311
+L G+F ++L+YL+L+ NQ S +LT L LDLS N+L +P +
Sbjct: 122 ---QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
Query: 312 ASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGN 349
+ L L L N +K S+P G +L+ L Y+ L N
Sbjct: 178 DKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 218 RLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF---SDLSYLDL 274
L S+ +I + + + I L N+ L +G N + + ++L+YL L
Sbjct: 39 ELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLIL 92
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPG 333
+ NQ S +LT L L L N+L +P + + +LT+L+L++N ++ G
Sbjct: 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKG 151
Query: 334 EITKLSRLDYLNLSGNKL 351
KL+ L L+LS N+L
Sbjct: 152 VFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 17/94 (18%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318
P F++ +L ++ L + + +++ + + I + ++
Sbjct: 13 FPD--DAFAETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVR 66
Query: 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+L L N + I + +L+ L YL L+GN+L
Sbjct: 67 YLALGGNKLH-DI-SALKELTNLTYLILTGNQLQ 98
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 44/200 (22%), Positives = 77/200 (38%), Gaps = 41/200 (20%)
Query: 370 KIDSKYCIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---- 424
+ +G G +G V+K + G A K + + ++ +NE V++Q
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146
Query: 425 ------------------MER---GSLF-RILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
ME G LF RI+ ELD +K + + ++
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---LFMKQICEGIRHM 203
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYIAPE- 519
H ++H D+ NIL ++ + DFG AR + G+ ++APE
Sbjct: 204 H---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEV 259
Query: 520 LAYTMVMTEKYDVYSFGVVT 539
+ Y V + D++S GV+
Sbjct: 260 VNYDFV-SFPTDMWSVGVIA 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 63/228 (27%)
Query: 363 SSMPTPRK---IDSKY----CIGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEEL 409
+++P Y +G G V + P + +A+K S EE+
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 410 AFIR-SFRNEAQVLSQ--------------------------MERGSLF-RILH----ND 437
+R + E +L + M++G LF + ++
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 438 AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497
E + I++A+ + LH ++VHRD+ NILL+ + + DFG +
Sbjct: 124 KETRK--------IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 498 LLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEK-Y----DVYSFGVVT 539
L + + G+ Y+APE + +M Y D++S GV+
Sbjct: 173 QLDPGEKLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 69/220 (31%)
Query: 367 TPRKIDSKY----CIGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFR 416
K Y +G GA+ V + G FA K KL++ + ++L
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------E 76
Query: 417 NEAQVLSQ-------------------------MERGSLF-RILH----NDAEAVELDWA 446
EA++ + + G LF I+ ++A+A
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---- 132
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADS 503
++ + ++AY H S +VHR++ N+LL SK + +ADFG A ++
Sbjct: 133 ----CIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 504 SNQTLLAGSYGYIAPEL----AYTMVMTEKYDVYSFGVVT 539
+ AG+ GY++PE+ Y ++ D+++ GV+
Sbjct: 186 AWHG-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 65/206 (31%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G GA+ V + G FA K KL++ + ++L EA++ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------EREARICRKLQHPNI 67
Query: 425 ----------------ME---RGSLF-RILH----NDAEAVELDWAKRVNIVKAMAHALA 460
+ G LF I+ ++A+A ++ + ++A
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------CIQQILESIA 119
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIA 517
Y H S +VHR++ N+LL SK + +ADFG A ++ + AG+ GY++
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLS 175
Query: 518 PEL----AYTMVMTEKYDVYSFGVVT 539
PE+ Y ++ D+++ GV+
Sbjct: 176 PEVLKKDPY----SKPVDIWACGVIL 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 51/240 (21%), Positives = 88/240 (36%), Gaps = 59/240 (24%)
Query: 347 SGNKLSGRVPYSNKHLSSMPTPRKIDSKY----CIGTGAYGSVYKA-QLPNGRVFALK-- 399
L + L ++ KY IG G V + G FA+K
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 400 ---KLNSPETEELAFIRSFRNEAQVLSQ--------------------------MERGSL 430
+ + R E +L Q M +G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 431 F-RILH----NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485
F + ++ E I++++ A+++LH + ++VHRD+ NILL+
Sbjct: 188 FDYLTEKVALSEKETRS--------IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236
Query: 486 LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEK-Y----DVYSFGVVT 539
++ ++DFG + L + L G+ GY+APE L +M T Y D+++ GV+
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 45/213 (21%)
Query: 370 KIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
+ Y I G+GA+G V++ + GRVF K +N+P + + +NE +++Q
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQ 104
Query: 425 ----------------------MER---GSLF-RILHNDAEAVELDWAKRVNIVKAMAHA 458
+E G LF RI D + E + N ++
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI---NYMRQACEG 161
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYI 516
L ++H S+VH DI NI+ +K + V DFG A L+ + + +
Sbjct: 162 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFA 217
Query: 517 APE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
APE + V D+++ GV+ +L G P
Sbjct: 218 APEIVDREPV-GFYTDMWAIGVLGYVLLSGLSP 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 48/248 (19%), Positives = 84/248 (33%), Gaps = 61/248 (24%)
Query: 377 IGTGAYGSVYKAQLPN-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +G V G + A+K L + + ++ E +L
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILRTLYHEHII 96
Query: 425 --------------------MERGSLFRILHNDAEAVE--LDWAKRVNIVKAMAHALAYL 462
+ GSL L + + L +A I + MA YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMA----YL 150
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----A 517
H + +HRD+++ N+LL++ + DFG A+ + G A
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYA 205
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYD---PKIMLIDVLD--- 570
PE DV+SFGV E+L + + ++ ++ + +
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 571 --QRLPPP 576
+RLP P
Sbjct: 266 RGERLPRP 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 45/233 (19%)
Query: 350 KLSGRVPYSNKHLSSMPTPRKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLNSP 404
+ + Y I GTGA+G V++ + G FA K + +P
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 405 ETEELAFIRSFRNEAQVLSQ----------------------MER---GSLF-RILHNDA 438
+ + R E Q +S E G LF ++
Sbjct: 194 HESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 439 EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV--ADFGTA 496
+ E + ++ + L ++H + VH D+ NI+ +K + DFG
Sbjct: 251 KMSEDEAV---EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 497 RLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
L S + G+ + APE V D++S GV++ +L G P
Sbjct: 305 AHLDPKQSVKVTT-GTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSP 355
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 72/334 (21%), Positives = 114/334 (34%), Gaps = 82/334 (24%)
Query: 293 LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L + + P + + L+NN +G ++ DY
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE------- 369
Query: 353 GRVPYSNKHLSSMPTPRK--IDSKY-----CIGTGAYGSVYKAQL--PNGRVF--ALK-- 399
+ +MP+ R I + CIG G +G V++ P A+K
Sbjct: 370 ---IIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 400 KLNSPETEELAFIRSFRNEAQVLSQ------------------------MERGSLFRILH 435
K + ++ F++ EA + Q G L L
Sbjct: 427 KNCTSDSVREKFLQ----EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQ 482
Query: 436 NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495
LD A + ++ ALAYL S VHRDI++ N+L++S + DFG
Sbjct: 483 VRKF--SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 537
Query: 496 ARLLHADSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPR 549
+R + + S G + APE T DV+ FGV E+LM G P
Sbjct: 538 SRYMEDSTYY----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP- 592
Query: 550 DLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
+ + DV+ + RLP P +
Sbjct: 593 ---------F-QGVKNNDVIGRIENGERLPMPPN 616
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 56/243 (23%), Positives = 84/243 (34%), Gaps = 60/243 (24%)
Query: 377 IGTGAYGSVYKAQL--PNGRVF--ALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G VY L +G+ A+K LN + F E ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 90
Query: 425 ------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC 466
M+ G L + N+ + +A + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELA 521
S VHRD+++ N +L+ K VADFG AR ++ + + A E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV-HNKTGAKLPVKWMALESL 204
Query: 522 YTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPP 575
T T K DV+SFGV+ E++ G P Y P + D+ RL
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP----------Y-PDVNTFDITVYLLQGRRLLQ 253
Query: 576 PVD 578
P
Sbjct: 254 PEY 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 39/253 (15%), Positives = 77/253 (30%), Gaps = 81/253 (32%)
Query: 377 IGTGAYGSVYKAQLPNGRVF--------ALKKLNSPETEELAFIRSFRNEAQVLSQ---- 424
+G G + ++K + LK L+ SF A ++S+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMSKLSHK 72
Query: 425 ---------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
++ GSL L + + + W ++ + K +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE 130
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAF--------VADFGTARLLHADSSNQTLLAGSYGY 515
+++H ++ + NILL + + ++D G + +
Sbjct: 131 ---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---------DILQ 178
Query: 516 I-----APE-LAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDV 568
PE + + D +SFG E+ G P +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP----------L-SALDSQRK 227
Query: 569 LDQ-----RLPPP 576
L +LP P
Sbjct: 228 LQFYEDRHQLPAP 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 55/214 (25%)
Query: 364 SMPTPRKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNE 418
SM T I + G+GA+ V+ Q G++FALK + S NE
Sbjct: 1 SMQTTN-IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK---KSPAFRDSSLENE 56
Query: 419 AQVLSQ----------------------MER---GSLF-RILH----NDAEAVELDWAKR 448
VL + M+ G LF RIL + +A
Sbjct: 57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------ 110
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSN 505
+++ + A+ YLH +VHRD+ N+L + E + DFG +++ +
Sbjct: 111 --VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGI 163
Query: 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVT 539
+ G+ GY+APE+ ++ D +S GV+T
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 65/253 (25%)
Query: 377 IGTGAYGSVYKAQLP-----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +GSV + G V A+KKL TEE +R F E ++L
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEH--LRDFEREIEILKSLQHDNIV 74
Query: 425 --------------------MERGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALA 460
+ GSL L E ++ L + I K M
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME---- 128
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI---- 516
YL + +HRD+++ NIL+ ++ + DFG ++L D G
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKEPGESPIFW 183
Query: 517 -APELAYTMVMTEKYDVYSFGVV-----TLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570
APE + DV+SFGVV T P + + + ++++ +++
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 571 Q-----RLPPPVD 578
RLP P
Sbjct: 244 LLKNNGRLPRPDG 256
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 63/289 (21%), Positives = 101/289 (34%), Gaps = 68/289 (23%)
Query: 342 DYLNLSGNKLSGRVPYSNKHLSSMPT---PRKIDSKYCIGTGAYGSVYKAQLP-----NG 393
DY + L + + PT R + +G G +GSV + G
Sbjct: 11 DYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG 70
Query: 394 RVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------------------------ME 426
V A+KKL TEE +R F E ++L +
Sbjct: 71 EVVAVKKLQ-HSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 427 RGSLFRILHNDAEAVE----LDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482
GSL L E ++ L + I K M YL + +HRD+++ NIL+
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----YLG---TKRYIHRDLATRNILV 178
Query: 483 NSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGV 537
++ + DFG ++L D G APE + DV+SFGV
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 538 V-----TLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPP 576
V T P + + + ++++ +++ RLP P
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEE------------LAFIRSFRNE 418
+G G++ K + + FA+K + + E + F ++
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 419 AQVLSQMER---GSLF-RILH----NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
ME G LF RI ++ EA I++ + A++++H V
Sbjct: 79 LHTFLVMELLNGGELFERIKKKKHFSETEASY--------IMRKLVSAVSHMH---DVGV 127
Query: 471 VHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
VHRD+ N+L + + + DFG ARL D+ + Y APEL +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL----LNQ 183
Query: 528 EKY----DVYSFGVVT 539
Y D++S GV+
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 54/268 (20%), Positives = 86/268 (32%), Gaps = 65/268 (24%)
Query: 356 PYSNKHLSSMPTPR---KIDSKYCIGTGAYGSVYKAQLPNG-----RVFALKKLNSPETE 407
+ + P S IG G +G VY + + + A+K L+
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEM 63
Query: 408 ELAFIRSFRNEAQVLSQ--------------------------MERGSLFRILHNDAEAV 441
+ + +F E ++ M G L + + +
Sbjct: 64 QQ--VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-- 119
Query: 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
++ +A + YL VHRD+++ N +L+ VADFG AR +
Sbjct: 120 NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 502 DSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTL 555
+ + A E T T K DV+SFGV+ E+L G P
Sbjct: 177 REYYSV-QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP------- 228
Query: 556 SSSYDPKIMLIDVLDQ-----RLPPPVD 578
Y I D+ RLP P
Sbjct: 229 ---Y-RHIDPFDLTHFLAQGRRLPQPEY 252
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 48/215 (22%)
Query: 369 RKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALKKLN-SPETEELAFIRSFRNEAQVL 422
+++ KY I G G +G V++ + + + + K + + + E +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISIL 55
Query: 423 SQ----------------------MER---GSLF-RILHNDAEAVELDWAKRVNIVKAMA 456
+ E +F RI + E E + + V +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---SYVHQVC 112
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYG 514
AL +LH S ++ H DI NI+ ++ + + +FG AR L + + L +
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPE 168
Query: 515 YIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
Y APE + +V + D++S G + +L G +P
Sbjct: 169 YYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK---KLNSPETEELAFIR-------------SFRNEA 419
IG G+Y + FA+K K TEE+ + + +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK 89
Query: 420 QVLSQMER---GSLF-RILH----NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
V E G L +IL ++ EA ++ + + YLH + VV
Sbjct: 90 YVYVVTELMKGGELLDKILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVV 138
Query: 472 HRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
HRD+ +NIL + + DFG A+ L A++ + ++APE ++
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE----VLER 194
Query: 528 EKY----DVYSFGVVT 539
+ Y D++S GV+
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 52/201 (25%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G G + V + G+ +A K + E+ +E VL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI------LHEIAVLELAKSCPR 90
Query: 425 -----------------MER---GSLF-RILHNDAEAV-ELDWAKRVNIVKAMAHALAYL 462
+E G +F L AE V E D ++K + + YL
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI---RLIKQILEGVYYL 147
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPE 519
H ++VH D+ NILL+S + DFG +R + + ++ G+ Y+APE
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-GTPEYLAPE 203
Query: 520 -LAYTMVMTEKYDVYSFGVVT 539
L Y + T D+++ G++
Sbjct: 204 ILNYDPI-TTATDMWNIGIIA 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 64/256 (25%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG GA+ V ++ G+V+A+K +N + + + FR E VL +R
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 428 -----------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSPS 469
G L +L E + + A+ A + A+ +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR---FYLAEIVMAIDSVH---RLG 182
Query: 470 VVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPELAYTM 524
VHRDI +NILL+ +L ADFG+ L AD + ++L+A G+ Y++PE+ +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRL----ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 525 VMTEKYDVY-------SFGVVTLEVLMGKHP---RDLHSTLSSSYDPKIMLIDVLDQRLP 574
Y + GV E+ G+ P T Y KI+ L
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----YG-KIVHYKE---HLS 290
Query: 575 PPVDRKVI----QDIL 586
P+ + + +D +
Sbjct: 291 LPLVDEGVPEEARDFI 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 43/202 (21%), Positives = 75/202 (37%), Gaps = 52/202 (25%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK---KLNSPETEELAFIRSFRNEAQVLSQ-------- 424
+G+G + V K Q G+ +A K K + E +L +
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 425 --------------MER---GSLF-RILHND----AEAVELDWAKRVNIVKAMAHALAYL 462
+E G LF + + EA + +K + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------LKQILDGVHYL 124
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAGSYGYIAP 518
H S + H D+ NI+L K + DFG A + A + + + G+ ++AP
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAP 180
Query: 519 E-LAYTMVMTEKYDVYSFGVVT 539
E + Y + + D++S GV+T
Sbjct: 181 EIVNYEPL-GLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 58/220 (26%)
Query: 365 MPTPRK--IDSKYCI----GTGAYGSVYKA-QLPNGRVFALK---KLNSPETEELAFIRS 414
M T ++ ++ Y I G+G + V K + G +A K K S +
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 415 FRNEAQVLSQ----------------------MER---GSLF-RILHND----AEAVELD 444
E +L Q +E G LF + + EA
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF- 120
Query: 445 WAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLLH 500
+K + + YLH + + H D+ NI+L K + DFG A +
Sbjct: 121 -------IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 501 ADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYDVYSFGVVT 539
+ + G+ ++APE + Y + + D++S GV+T
Sbjct: 171 DGVEFKN-IFGTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 43/213 (20%), Positives = 77/213 (36%), Gaps = 56/213 (26%)
Query: 370 KIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK---KLNSPETEELAFIRSFRNEAQV 421
+D Y G+G + V K + G +A K K + + E +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 422 LSQ----------------------MER---GSLF-RILHND----AEAVELDWAKRVNI 451
L + +E G LF + + EA E
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-------- 119
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQT 507
+K + + + YLH S + H D+ NI+L + + DFG A + + +
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 508 LLAGSYGYIAPE-LAYTMVMTEKYDVYSFGVVT 539
+ G+ ++APE + Y + + D++S GV+T
Sbjct: 177 -IFGTPEFVAPEIVNYEPL-GLEADMWSIGVIT 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 42/202 (20%), Positives = 72/202 (35%), Gaps = 52/202 (25%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALK---KLNSPETEELAFIRSFRNEAQVLSQ-------- 424
+G+G + V K + G +A K K S + E +L Q
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 425 --------------MER---GSLF-RILHND----AEAVELDWAKRVNIVKAMAHALAYL 462
+E G LF + + EA +K + + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQILDGVNYL 131
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNQTLLAGSYGYIAP 518
H + + H D+ NI+L K + DFG A + + + G+ ++AP
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAP 187
Query: 519 E-LAYTMVMTEKYDVYSFGVVT 539
E + Y + + D++S GV+T
Sbjct: 188 EIVNYEPL-GLEADMWSIGVIT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 33/271 (12%), Positives = 66/271 (24%), Gaps = 76/271 (28%)
Query: 363 SSMPTPRKIDSKY----CIGTGAYGSVYKA---QLPNGRVFALKKLNSPETEELAFIRSF 415
+P R + +Y G ++A L R AL ++ ++
Sbjct: 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQET 78
Query: 416 RNEAQVLSQ----------------------ME--RG-SLFRILHNDAEAVELDWAKRVN 450
+ LS+ E RG SL + +
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIR 133
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
++++A A H V + + V+ G L
Sbjct: 134 AMQSLAAAADAAHRA---GVALSIDHPSRVR--------VSIDGDVVL------------ 170
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570
+ D+ G +L+ + P S
Sbjct: 171 AYPATMPDANPQD-------DIRGIGASLYALLVNRWPLPEAGVRS----GLAPAERDTA 219
Query: 571 QRLPPPVDRKVIQDI-LLVSTISFACLQSNP 600
+ P + +DI +S ++ +Q +
Sbjct: 220 GQPIEP--ADIDRDIPFQISAVAARSVQGDG 248
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 15/138 (10%)
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTL--GLFSDLS---YLD 273
++ + L QN + +P K L +D+ NN I S L F L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-----SELAPDAFQGLRSLNSLV 86
Query: 274 LSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSI 331
L N+ + +P L L L L L++NK++ + + +L L L +N ++
Sbjct: 87 LYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 332 PGEITKLSRLDYLNLSGN 349
G + L + ++L+ N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 32/160 (20%), Positives = 58/160 (36%), Gaps = 26/160 (16%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
IP+ + + + L N ++ + K L +D+ +
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIK---------VIPPGAFSPY--------KKLRRIDLSN 65
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLG 264
N + P L SL L+L N+++ LP+ + L +L LL + N I +
Sbjct: 66 NQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK-INCLRV--D 122
Query: 265 LFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301
F DL L L N+ + + L + + L+ N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 31/131 (23%), Positives = 54/131 (41%), Gaps = 9/131 (6%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGP 258
E+ + N++ P S L+ + L+ NQ+S L + L++L L + N I
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TE 94
Query: 259 IPSTLGLFSDLS---YLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIASM 314
+P LF L L L+ N+ + + + L L L L NKL + +
Sbjct: 95 LPK--SLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 315 EDLTWLDLSNN 325
+ + L+ N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
IP+ L ++ + L N P + +L +DLS+N++S ++ + L
Sbjct: 26 IPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 318 TWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
L L N I +P + L L L L+ NK++
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 28/124 (22%), Positives = 47/124 (37%), Gaps = 9/124 (7%)
Query: 115 NFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SALSKLQLLDLSSNRLR----- 168
N + + F + LR + + + + L L L L N++
Sbjct: 40 EQN-TIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKS 98
Query: 169 --GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226
L +L + L+ N + L +L NL L + DN L T S L +++ +
Sbjct: 99 LFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH 158
Query: 227 LAQN 230
LAQN
Sbjct: 159 LAQN 162
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 57/253 (22%), Positives = 90/253 (35%), Gaps = 72/253 (28%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G GA+G VY+ Q+ +V A+K L +E+ F EA ++S+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQD--ELDFLMEALIISKFNHQN 94
Query: 425 --------------------MERGSLFRIL----HNDAEAVELDWAKRVNIVKAMAHALA 460
M G L L ++ L +++ + +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFV---ADFGTARLLHADSSNQTLLAGSYGYI- 516
YL +HRDI++ N LL V DFG AR ++ G +
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY---RASYYRKGGCAMLP 208
Query: 517 ----APE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLD 570
PE + T K D +SFGV+ E+ +G P Y P +VL+
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP----------Y-PSKSNQEVLE 256
Query: 571 Q-----RLPPPVD 578
R+ PP +
Sbjct: 257 FVTSGGRMDPPKN 269
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGP 258
+LD+ L T LT L L L NQL L + +L L L + NN +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-AS 97
Query: 259 IPSTLGLF---SDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-AS 313
+P G+F + L L L NQ S+P+ + RLT+L L L++N+L IP+
Sbjct: 98 LPL--GVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 314 MEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGN 349
+ +L L LS N ++ S+P G +L +L + L GN
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 43/138 (31%), Positives = 63/138 (45%), Gaps = 11/138 (7%)
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS---YLDLS 275
+ L L L+ L L L L++ N + + + G+F DL+ L L+
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSA--GVFDDLTELGTLGLA 91
Query: 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIP-G 333
NQ S LTQL L L N+L +PS + + L L L+ N ++ SIP G
Sbjct: 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 334 EITKLSRLDYLNLSGNKL 351
KL+ L L+LS N+L
Sbjct: 150 AFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 46/191 (24%), Positives = 63/191 (32%), Gaps = 48/191 (25%)
Query: 139 YYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
G + L+KL L+L N+L+ +LS + L L
Sbjct: 43 QSTGLATLSDATFRGLTKLTWLNLDYNQLQ---------TLSAGVFDD--------LTEL 85
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP 258
L + +N L LT L L L NQL LP
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS--------------------- 124
Query: 259 IPSTLGLF---SDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIASM 314
G+F + L L L+ NQ SIP +LT L L LS+N+L +
Sbjct: 125 -----GVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL 178
Query: 315 EDLTWLDLSNN 325
L + L N
Sbjct: 179 GKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 31/111 (27%), Positives = 56/111 (50%), Gaps = 5/111 (4%)
Query: 248 LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307
LD+ + + +T + L++L+L NQ + LT+L L L++N+L+ +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 308 PSQI-ASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLSGRVP 356
P + + L L L N +K S+P G +L++L L L+ N+L +P
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+PS G+ +D LDL + LT+L L+L N+L + + + + +L
Sbjct: 29 VPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
L L+NN + G L++LD L L GN+L
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 2/72 (2%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
S+P+ + T+ LDL S L+ + + LTWL+L N ++ G L+
Sbjct: 27 DSVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84
Query: 341 LDYLNLSGNKLS 352
L L L+ N+L+
Sbjct: 85 LGTLGLANNQLA 96
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 96 ITCNSAGSIIGL-HLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEI-SA 153
+ S + GL L+ N+++N +L L+ F +L L L + S+P +
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYN-QLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDH 105
Query: 154 LSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDN 206
L++L L L N+L+ RLT L + L+ N L + L NL L + N
Sbjct: 106 LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165
Query: 207 SLIGPIPLTLSRLTSLKILILAQNQ 231
L RL L+ + L NQ
Sbjct: 166 QLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 48/262 (18%), Positives = 89/262 (33%), Gaps = 90/262 (34%)
Query: 369 RKIDSKYCI----GTGAYGSVYKA-QLPNGRVFALK-----KLNSPETEELAFIRSFRNE 418
++ KY + G G+YG V A + + A+K K+ ++ + + E
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTE 78
Query: 419 AQVLSQ-------------------------MERGSLF-RILHNDAEAVELDWAKRV--- 449
+++ + G L ++ ++ V
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 450 ---------------------------------NIVKAMAHALAYLHHDCSPSVVHRDIS 476
NI++ + AL YLH + + HRDI
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIK 195
Query: 477 SNNILLNSKLEAFV--ADFGTARLLHADSSNQ----TLLAGSYGYIAPELAYTMVMTEKY 530
N L ++ + DFG ++ + ++ + T AG+ ++APE+ T E Y
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT--TNESY 253
Query: 531 ----DVYSFGVVTLEVLMGKHP 548
D +S GV+ +LMG P
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVP 275
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/233 (23%), Positives = 83/233 (35%), Gaps = 64/233 (27%)
Query: 352 SGRVPYSNKHLSSMPTPRKIDSKY-----CIGTGAYGSVYKA-QLPNGRVFALKKLNSPE 405
+ P + I Y +G G G V + FALK L
Sbjct: 40 PQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-- 97
Query: 406 TEELAFIRSFRNEAQVLSQ---------------------------MER---GSLF-RIL 434
R E ++ + ME G LF RI
Sbjct: 98 ------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151
Query: 435 HNDAEA-VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---V 490
+A E + + I+K++ A+ YLH S ++ HRD+ N+L SK +
Sbjct: 152 DRGDQAFTEREAS---EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 205
Query: 491 ADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVT 539
DFG A+ + +S T + Y+APE+ + EKY D++S GV+
Sbjct: 206 TDFGFAKETTSHNSLTT-PCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIM 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 52/253 (20%), Positives = 85/253 (33%), Gaps = 72/253 (28%)
Query: 377 IGTGAYGSVYKAQLPNGR-------VFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G G +GSV + L V +K NS + E F+ EA +
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS----EAACMKDFSHPN 97
Query: 425 -------------------------MERGSL---FRILHNDAEAVELDWAKRVNIVKAMA 456
M+ G L + + + + +A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI 516
+ YL + + +HRD+++ N +L + VADFG ++ ++ S G +
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY---SGDYYRQGRIAKM 211
Query: 517 -----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLD 570
A E V T K DV++FGV E+ G P Y P + ++ D
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----------Y-PGVQNHEMYD 260
Query: 571 Q-----RLPPPVD 578
RL P D
Sbjct: 261 YLLHGHRLKQPED 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 49/225 (21%)
Query: 364 SMPTPRKIDSKY---------CIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIR 413
SMP + IG G++G V Q +++A+K +N + E +R
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 414 SFRNEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKR 448
+ E Q++ + G L L + E +
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE----ET 116
Query: 449 VNIVKA-MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
V + + AL YL + ++HRD+ +NILL+ + DF A +L ++ T
Sbjct: 117 VKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
Query: 508 LLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+AG+ Y+APE+ ++ Y D +S GV E+L G+ P
Sbjct: 174 -MAGTKPYMAPEM-FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 57/253 (22%), Positives = 90/253 (35%), Gaps = 72/253 (28%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G GA+G VY+ Q+ +V A+K L +E+ F EA ++S+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQD--ELDFLMEALIISKFNHQN 135
Query: 425 --------------------MERGSLFRIL----HNDAEAVELDWAKRVNIVKAMAHALA 460
M G L L ++ L +++ + +A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 461 YLHHDCSPSVVHRDISSNNILLNSKLEAFV---ADFGTARLLHADSSNQTLLAGSYGYI- 516
YL +HRDI++ N LL V DFG AR ++ G +
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY---RAGYYRKGGCAMLP 249
Query: 517 ----APE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLD 570
PE + T K D +SFGV+ E+ +G P Y P +VL+
Sbjct: 250 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP----------Y-PSKSNQEVLE 297
Query: 571 Q-----RLPPPVD 578
R+ PP +
Sbjct: 298 FVTSGGRMDPPKN 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 54/250 (21%), Positives = 86/250 (34%), Gaps = 69/250 (27%)
Query: 377 IGTGAYGSVYKAQLPNG-----RVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G G +GSV +AQL +V A+K L + I F EA + +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASSD-IEEFLREAACMKEFDHPHVA 88
Query: 425 ------------------------MERGSL---FRILHNDAEAVELDWAKRVNIVKAMAH 457
M+ G L L V + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI- 516
+ YL S + +HRD+++ N +L + VADFG +R ++ S G +
Sbjct: 149 GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY---SGDYYRQGCASKLP 202
Query: 517 ----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ 571
A E + T DV++FGV E++ G+ P Y I ++ +
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----------Y-AGIENAEIYNY 251
Query: 572 -----RLPPP 576
RL P
Sbjct: 252 LIGGNRLKQP 261
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 38/238 (15%), Positives = 84/238 (35%), Gaps = 60/238 (25%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKL--------------NSPETEELAFIRSFRNEAQVL 422
+ G + + + + + +ALKK N+ + + F+NE Q++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 423 SQ-------------------------MERGSLFRILH-----NDAEAVELDWAKRVNIV 452
+ ME S+ + + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS 512
K++ ++ +Y+H+ ++ HRD+ +NIL++ ++DFG + + G+
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGSRGT 213
Query: 513 YGYIAPELAYTMVMTEKY------DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM 564
Y ++ PE E D++S G+ + P L +L ++ I
Sbjct: 214 YEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN-NIR 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 47/209 (22%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG GA+G V +L +VFA+K LN E + A FR E VL +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 428 -----------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSPS 469
G L +L + + + A+ A M A+ +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR---FYLAEMVIAIDSVH---QLH 195
Query: 470 VVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTLLA-GSYGYIAPE-LAYT 523
VHRDI +NIL++ +L ADFG+ L D + Q+ +A G+ YI+PE L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRL----ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 524 MVMTEKY----DVYSFGVVTLEVLMGKHP 548
+Y D +S GV E+L G+ P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 69/222 (31%)
Query: 365 MPTPRKIDSKY-----CIGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNE 418
P + Y +G G G V + G+ ALK L R E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQE 71
Query: 419 AQVLSQ---------------------------MER---GSLF-RILHNDAEA-VELDWA 446
Q ME G LF RI +A E + A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADS 503
+ I++ + A+ +LH S ++ HRD+ N+L SK + + DFG A+
Sbjct: 132 E---IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--- 182
Query: 504 SNQTL--LAGSYGYIAPELAYTMVMTEKY----DVYSFGVVT 539
L + Y+APE ++ EKY D++S GV+
Sbjct: 183 -QNALQTPCYTPYYVAPE----VLGPEKYDKSCDMWSLGVIM 219
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 61/299 (20%), Positives = 98/299 (32%), Gaps = 89/299 (29%)
Query: 347 SGNKLSGRVPYSNKHLSSMPT----------PR-KIDSKYCIGTGAYGSVYKAQLPNG-- 393
S + G+ H+ P R I K+ +G GA+G V+ A+ N
Sbjct: 8 SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP 67
Query: 394 -----RVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------------------ 424
V A+K L + F+ EA++L+
Sbjct: 68 EQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123
Query: 425 -MERGSL------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
M G L D L + + + +A + YL V
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFV 180
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-----APE-LAYTMV 525
HRD+++ N L+ L + DFG +R ++ S G + PE + Y
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIY---STDYYRVGGRTMLPIRWMPPESILYR-K 236
Query: 526 MTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQ-----RLPPPVD 578
T + DV+SFGVV E+ GK P + ++ + +D L P
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQP----------W-YQLSNTEAIDCITQGRELERPRA 284
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 54/258 (20%), Positives = 85/258 (32%), Gaps = 76/258 (29%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G +G VYK L V A+K L L FR+EA + ++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPL--REEFRHEAMLRARLQHPN 73
Query: 425 --------------------MERGSL-------------FRILHNDAEAVELDWAKRVNI 451
G L + L+ V++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
V +A + YL S VVH+D+++ N+L+ KL ++D G R ++ +
Sbjct: 134 VAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY---AADYYKLL 187
Query: 512 SYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIML 565
+ APE + D++S+GVV EV G P Y
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----------Y-CGYSN 236
Query: 566 IDVLDQ-----RLPPPVD 578
DV++ LP P D
Sbjct: 237 QDVVEMIRNRQVLPCPDD 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 40/204 (19%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG GA+G V + +V+A+K L+ E + + F E +++
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 428 -----------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSPS 469
G L ++ N V WA+ A + AL +H S
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWAR---FYTAEVVLALDAIH---SMG 188
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT-LLAGSYGYIAPELAYTMVMTE 528
+HRD+ +N+LL+ +ADFGT ++ + + G+ YI+PE+ +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 529 KY----DVYSFGVVTLEVLMGKHP 548
Y D +S GV E+L+G P
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 55/221 (24%)
Query: 367 TPRKIDSKYC----IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQV 421
R + Y IG G++G VY+A+L +G + A+KK+ + + R E Q+
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQI 100
Query: 422 LSQMERGSLFRILHNDAEAVELDWAKRVNIV---------KAMAH--------------- 457
+ +++ ++ R+ + + E +N+V + H
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 458 -------ALAYLHHDCSPSVVHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLL 509
+LAY+H S + HRDI N+LL+ + DFG+A+ L N + +
Sbjct: 161 YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 510 AGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
Y Y APEL + Y DV+S G V E+L+G+
Sbjct: 218 CSRY-YRAPEL---IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 62/224 (27%)
Query: 367 TPRKIDSKYC----IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL 422
T + + Y IG G++G V++A+L A+KK+ + + R E Q++
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------R-ELQIM 86
Query: 423 SQMERGSLFRILHNDAEAVELDWAKRVNIV---------KAMAH---------------- 457
++ ++ + + +N+V +A H
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 458 ------ALAYLHHDCSPSVVHRDISSNNILLNS-----KLEAFVADFGTARLLHADSSNQ 506
+LAY+H S + HRDI N+LL+ KL DFG+A++L A N
Sbjct: 147 MYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIAGEPNV 199
Query: 507 TLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
+ + Y Y APEL + Y D++S G V E++ G+
Sbjct: 200 SYICSRY-YRAPEL---IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 18/140 (12%)
Query: 220 TSLKILILAQNQLSGLPQEIG--NLKNLMLLDVGNNDIIGPIPSTL--GLFSDLS---YL 272
L L N+ + L L L ++ NN I + + G F S +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-----TDIEEGAFEGASGVNEI 86
Query: 273 DLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGS 330
L+ N+ ++ +++ L L L L SN+++ + + + + L L +N I +
Sbjct: 87 LLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-T 143
Query: 331 IP-GEITKLSRLDYLNLSGN 349
+ G L L LNL N
Sbjct: 144 VAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 32/168 (19%), Positives = 52/168 (30%), Gaps = 41/168 (24%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKN 197
IP I L L++N +L L ++ S N + +
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG 257
+ E+ + N L L SLK L+L N+++ +
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGN-------------------- 122
Query: 258 PIPSTLGLFSDLS---YLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSN 301
F LS L L NQ +++ L L L+L +N
Sbjct: 123 ------DSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 25/114 (21%), Positives = 50/114 (43%), Gaps = 10/114 (8%)
Query: 248 LDVGNNDIIGPIPSTLGLFSDLS---YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLS 304
L + NN+ + +T G+F L ++ S N+ + + + L+SN+L
Sbjct: 37 LRLNNNEF-TVLEAT-GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 305 GKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLSGRVP 356
+ ++ +E L L L +N I + + LS + L+L N+++ V
Sbjct: 95 N-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 20/97 (20%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPN-ELTRLTQLFHLDLSSNKLSGKIPSQI-ASMED 316
IP + + L L+ N+F +L QL ++ S+NK++ I
Sbjct: 26 IPE--HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 317 LTWLDLSNNNIKGSIPGEI-TKLSRLDYLNLSGNKLS 352
+ + L++N ++ ++ ++ L L L L N+++
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT 118
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 56/250 (22%), Positives = 87/250 (34%), Gaps = 70/250 (28%)
Query: 377 IGTGAYGSVYKAQL-------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G G++G VY+ P RV A+K +N + F NEA V+ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRE--RIEFLNEASVMKEFNCHH 89
Query: 425 --------------------MERGSLFRIL-------HNDAEAVELDWAKRVNIVKAMAH 457
M RG L L N+ +K + + +A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI- 516
+AYL+ + VHRD+++ N ++ + DFG R ++ G G +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLP 203
Query: 517 ----APELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQ 571
+PE V T DV+SFGVV E+ + P Y + VL
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------Y-QGLSNEQVLRF 252
Query: 572 -----RLPPP 576
L P
Sbjct: 253 VMEGGLLDKP 262
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 33/141 (23%), Positives = 60/141 (42%), Gaps = 9/141 (6%)
Query: 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296
+ ++ L+L + +N G I F +L +L L S+ N L +L +L L
Sbjct: 21 RTPAAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKL 76
Query: 297 DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR---LDYLNLSGNKLSG 353
+LS N++ G + + +LT L+LS N +K + L + L L+L +++
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTN 134
Query: 354 RVPYSNKHLSSMPTPRKIDSK 374
Y +P +D
Sbjct: 135 LNDYRESVFKLLPQLTYLDGY 155
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 26/113 (23%), Positives = 53/113 (46%), Gaps = 9/113 (7%)
Query: 150 EISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
+A+ +L L + SN + NL ++SL L + + L L +L++
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQNQLSGLP--QEIGNLKNLMLLDVGNNDI 255
+N + G + + +L +L L L+ N+L + + + L+ L LD+ N ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 58/223 (26%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
I S + +G GAYG V A P G + A+KK+ + A +R+ R E ++L
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKHF 66
Query: 426 ERGSLFRILH----------ND----AEAVELDWAKRVNIVKA--------------MAH 457
+ ++ I + N+ E ++ D + ++
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR---VISTQMLSDDHIQYFIYQTLR 123
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG--- 514
A+ LH +V+HRD+ +N+L+NS + V DFG AR++ +++ + G
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 515 -------YIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
Y APE+ M+ + KY DV+S G + E+ + +
Sbjct: 181 EFVATRWYRAPEV---MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 40/217 (18%)
Query: 367 TPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQV 421
+ +I +Y IGTG+YG V +A RV A+KK+ + + R R E +
Sbjct: 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAI 105
Query: 422 LSQMERG---SLFRILHNDA-----------EAVELDWAK--RVNIVKAMAH-------- 457
L+++ + I+ E + D+ K R + H
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 458 --ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
+ Y+H S ++HRD+ N L+N V DFG AR + + + L S
Sbjct: 166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTL-----EVLMGKH 547
L + VVT E+++ +
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 40/200 (20%), Positives = 80/200 (40%), Gaps = 41/200 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG----SLF 431
+G G Y V++A + N +K L P ++ + R E ++L + G +L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-PVKKK----KIKR-EIKILENLRGGPNIITLA 97
Query: 432 RILHNDAEAV------ELDWAKRVNIVKAMAH------------ALAYLHHDCSPSVVHR 473
I+ + ++ + + + AL Y H S ++HR
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHR 154
Query: 474 DISSNNILLNSKL-EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY-- 530
D+ +N++++ + + + D+G A H +A Y + PEL +V + Y
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-FKGPEL---LVDYQMYDY 210
Query: 531 --DVYSFGVVTLEVLMGKHP 548
D++S G + ++ K P
Sbjct: 211 SLDMWSLGCMLASMIFRKEP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 51/236 (21%), Positives = 87/236 (36%), Gaps = 51/236 (21%)
Query: 353 GRVPYSNKHLSSMPTPRKIDSKYC----IGTGAYGSVYKAQL-PNGRVFALKK-LNSP-- 404
G + N ++ RK ++ G G +G+V + G A+KK + P
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 405 ---ETEELAFIRSFRNE------AQVLSQMERGSLFRILHNDAEAVELD------WAKRV 449
E + + + + + + ER L+ E V R
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 450 NIVKAMAH----------ALAYLHHDCSPSVVHRDISSNNILLNS-----KLEAFVADFG 494
+ ++ LH S +V HRDI +N+L+N KL DFG
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL----CDFG 177
Query: 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
+A+ L N + Y Y APEL + + Y D++S G + E+++G+
Sbjct: 178 SAKKLSPSEPNVAYICSRY-YRAPEL---IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 51/258 (19%), Positives = 96/258 (37%), Gaps = 81/258 (31%)
Query: 377 IGTGAYGSVYKAQLPNGRVF---ALKKL--NSPETEELAFIRSFRNEAQVLSQ------- 424
IG G +G V KA++ + A+K++ + + + F E +VL +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLCKLGHHPNI 88
Query: 425 -------------------MERGSL-------------FRILHNDAEAVELDWAKRVNIV 452
G+L ++ A L + ++
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGS 512
+A + YL +HRD+++ NIL+ A +ADFG +R + + +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKT 199
Query: 513 YGYI-----APE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIML 565
G + A E L Y+ V T DV+S+GV+ E++ +G P Y +
Sbjct: 200 MGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP----------Y-CGMTC 247
Query: 566 IDVLDQ-----RLPPPVD 578
++ ++ RL P++
Sbjct: 248 AELYEKLPQGYRLEKPLN 265
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 57/257 (22%), Positives = 96/257 (37%), Gaps = 79/257 (30%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKLNSPETEELAFIRSFRNEAQVLSQ----- 424
+G GA+G V+ A+ N V A+K L P F+ EA++L+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAARK---DFQREAELLTNLQHEH 78
Query: 425 --------------------MERGSLFRIL-------------HNDAEAVELDWAKRVNI 451
M+ G L + L EL ++ ++I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
+A + YL S VHRD+++ N L+ + L + DFG +R ++ S G
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY---STDYYRVG 192
Query: 512 SYGYI-----APE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIM 564
+ + PE + Y T + DV+SFGV+ E+ GK P + ++
Sbjct: 193 GHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP----------W-FQLS 240
Query: 565 LIDVLDQ-----RLPPP 576
+V++ L P
Sbjct: 241 NTEVIECITQGRVLERP 257
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 53/212 (25%), Positives = 74/212 (34%), Gaps = 78/212 (36%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAF------IRSFRNEAQVLSQMERG- 428
IG GAYG+VYKA+ +G ALK + P +R E +L ++E
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----EVALLRRLEAFE 72
Query: 429 -----SLFRILHNDA-----------EAVELDWAK----------RVNIVKAMAH----A 458
L + E V+ D +K +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
L +LH +C +VHRD+ NIL+ S +ADFG AR Y
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--------------IYS---Y 172
Query: 519 ELAYTMVMTEKYDVYSFGVVTL-----EVLMG 545
++A T V VVTL EVL+
Sbjct: 173 QMALTPV-----------VVTLWYRAPEVLLQ 193
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P G+ D++ L L NQF + +P EL+ L +DLS+N++S + +Q ++M L
Sbjct: 25 LPK--GIPRDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 318 TWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLSGRVP 356
L LS N ++ IP L L L+L GN +S VP
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 248 LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307
L + N +P L + L+ +DLS N+ ++ + +TQL L LS N+L I
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-I 93
Query: 308 PSQI-ASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGN 349
P + ++ L L L N+I +P G LS L +L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 47/158 (29%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
+P I + L L N+ L+P+E+ N K+L +D+ +
Sbjct: 24 VLPKGIPR--DVTELYLDGNQFT------------------LVPKELSNYKHLTLIDLSN 63
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTLG 264
N + + S +T L LIL+ N+L +P LK+L LL + NDI
Sbjct: 64 NRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI--------- 114
Query: 265 LFSDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSN 301
S +P L+ L HL + +N
Sbjct: 115 ----------------SVVPEGAFNDLSALSHLAIGAN 136
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ +Y IG+GA G V A R A+KKL+ P + + A R++R E ++
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-KRAYR-ELVLMKC 80
Query: 425 MERGSLFRILHNDAEAVELDWAKRV------------NIVKA-------------MAHAL 459
+ ++ +L+ L+ + V +++ M +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
+LH S ++HRD+ +NI++ S + DFG AR S T + Y APE
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPE 196
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLMGK 546
+ M E D++S G + E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 62/240 (25%)
Query: 357 YSNKHLSSMPTPRK---------IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLN 402
+ + H+++ + +Y IG GAYG V A N A+KK++
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 403 SPETEELAFIRSFRNEAQVLSQMERGSLFRILH----------ND----AEAVELDWAKR 448
E + R+ R E ++L + ++ I D + +E D K
Sbjct: 62 PFEHQTYC-QRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK- 118
Query: 449 VNIVKA--------------MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494
++K + L Y+H S +V+HRD+ +N+LLN+ + + DFG
Sbjct: 119 --LLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 495 TARLLHADSSNQTLLAGSY----GYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
AR+ D + L Y Y APE+ M+ ++ Y D++S G + E+L +
Sbjct: 174 LARVADPDHDHTGFLTE-YVATRWYRAPEI---MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 53/253 (20%), Positives = 100/253 (39%), Gaps = 54/253 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALK-----KLNSPETEELAFIRSFRNEAQVLSQME---- 426
+G+GA+G V+ A + +K K+ E + E +LS++E
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 427 ---------RGSLFRILHNDAEAVEL------------DWAKRVNIVKAMAHALAYLHHD 465
+G ++ ++L A I + + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY--IFRQLVSAVGYLR-- 147
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
++HRDI NI++ + DFG+A L T G+ Y APE ++
Sbjct: 148 -LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPE----VL 201
Query: 526 MTEKY-----DVYSFGVVTLEVLM-GKHP-RDLHSTLSSSYD-PKIM---LIDVLDQRLP 574
M Y +++S GV L L+ ++P +L T+ ++ P ++ L+ ++ L
Sbjct: 202 MGNPYRGPELEMWSLGVT-LYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQ 260
Query: 575 P-PVDRKVIQDIL 586
P P R ++ ++
Sbjct: 261 PVPERRTTLEKLV 273
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/266 (20%), Positives = 91/266 (34%), Gaps = 50/266 (18%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLP 189
+ + L I + D FTG + EI +L L L +L + LS N G
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP---KLHTVR---LSDNAFGPTAQ 111
Query: 190 QEIGNL----KNLIELDVGDNSLIGP--------------IPLTLSRLTSLKILILAQNQ 231
+ + + L L + +N +GP + L+ +I +N+
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNG-LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 232 L-----SGLPQEIGNLKNLMLLDVGNNDI-----IGPIPSTLGLFSDLSYLDLSCNQFN- 280
L + + + L + + N I + L +L LDL N F
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 281 ---SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM------EDLTWLDLSNNNIKGSI 331
S++ L L L L+ LS + + + L L L N I+
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290
Query: 332 PGEI-----TKLSRLDYLNLSGNKLS 352
+ K+ L +L L+GN+ S
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 35/252 (13%), Positives = 69/252 (27%), Gaps = 56/252 (22%)
Query: 157 LQLLDLSSNRLRGR-----------LTNLNYMSLSRNMLGG----LLPQEIGNLKNLIEL 201
++ L + + ++ + LS N +G L + I + K+L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 202 DVGDNSLIGPIPLT----------LSRLTSLKILILAQNQL-----SGLPQEIGNLKNLM 246
+ D L + L + L+ N L + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 247 LLDVGNNDI-------------IGPIPSTLGLFSDLSYLDLSCNQFN----SSIPNELTR 289
L + NN + + L + N+
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 290 LTQLFHLDLSSNKLSGK-----IPSQIASMEDLTWLDLSNNNI--KG--SIPGEITKLSR 340
L + + N + + + +A ++L LDL +N G ++ +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 341 LDYLNLSGNKLS 352
L L L+ LS
Sbjct: 246 LRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 21/168 (12%), Positives = 47/168 (27%), Gaps = 38/168 (22%)
Query: 221 SLKILILAQNQLS-----GLPQEIGNLKNLMLLDVGNNDIIGP-----IPSTLGLFSDLS 270
S++ L + ++ + + ++ + + N I G + + DL
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLE 63
Query: 271 YLDLSCNQFN----------SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM----ED 316
+ S + L + +L + LS N +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 317 LTWLDLSNNNI-------------KGSIPGEITKLSRLDYLNLSGNKL 351
L L L NN + + ++ + L + N+L
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 52/198 (26%), Positives = 78/198 (39%), Gaps = 60/198 (30%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
IG G YG VYKA+ G V ALKK+ E + R E +L ++ L
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 433 ILHNDA------EAVELDWAK----------RVNIVKAMAH----ALAYLHHDCSPSVVH 472
++H + E + D K + ++K+ LA+ H V+H
Sbjct: 70 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 126
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDV 532
RD+ N+L+N++ +ADFG AR ++G P YT
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLAR--------------AFG--VPVRTYTHE------- 163
Query: 533 YSFGVVTL-----EVLMG 545
VVTL E+L+G
Sbjct: 164 ----VVTLWYRAPEILLG 177
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 41/130 (31%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGP 258
L + DN + P L +LK L L NQL LP + +L L +LD+G N +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL-TV 102
Query: 259 IPSTLGLF---SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME 315
+PS +F L L + CN+ + +P + RLT L HL L N+L +
Sbjct: 103 LPS--AVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 316 DLTWLDLSNN 325
LT L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTL--GLF---SDLSYLD 273
T+ +IL L NQ++ L + +L NL L +G+N + L G+F + L+ LD
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----GALPVGVFDSLTQLTVLD 94
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
L NQ RL L L + NKL+ ++P I + LT L L N +K G
Sbjct: 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153
Query: 334 EITKLSRLDYLNLSGN 349
+LS L + L GN
Sbjct: 154 AFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 37/123 (30%), Positives = 50/123 (40%), Gaps = 9/123 (7%)
Query: 139 YYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQE 191
+ + T P +L L+ L L SN+L LT L + L N L L
Sbjct: 48 HDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAV 107
Query: 192 IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDV 250
L +L EL + N L +P + RLT L L L QNQL +P L +L +
Sbjct: 108 FDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166
Query: 251 GNN 253
N
Sbjct: 167 FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
S+P+ I + Q+L L N++ L NL + L N LG L +L L
Sbjct: 33 SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
LD+G N L RL LK L + N+L+ LP+ I L +L L + N
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 28/94 (29%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P+ G+ ++ L L NQ P L L L L SN+L +P + S+ L
Sbjct: 34 VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
T LDL N + +L L L + NKL
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 248 LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307
L + +N I P +L L L NQ + LTQL LDL +N+L+ +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 308 PSQI-ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
PS + + L L + N + +P I +L+ L +L L N+L +P
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
+S+P + Q L L N+++ P S+ +L L L +N + G L++
Sbjct: 32 ASVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89
Query: 341 LDYLNLSGNKLS 352
L L+L N+L+
Sbjct: 90 LTVLDLGTNQLT 101
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 57/208 (27%), Positives = 75/208 (36%), Gaps = 70/208 (33%)
Query: 377 IGTGAYGSVYKAQ--LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------ 428
IG GAYG V+KA+ GR ALK++ EE + + R E VL +E
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 429 SLFRILHNDA-----------EAVELDWAK----------RVNIVKAMAH----ALAYLH 463
LF + E V+ D +K M L +LH
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
VVHRD+ NIL+ S + +ADFG AR Y ++A T
Sbjct: 138 SHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--------------IYS---FQMALT 177
Query: 524 MVMTEKYDVYSFGVVTL-----EVLMGK 546
V VVTL EVL+
Sbjct: 178 SV-----------VVTLWYRAPEVLLQS 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 58/223 (26%)
Query: 371 IDSKY----CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFI---------RSFRN 417
+ S Y I +G+YG+V G A+K++ + ++ R R
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR- 78
Query: 418 EAQVLSQMERGSLFRILH----------ND----AEAVELDWAKRVNIVKA--------- 454
E ++L+ ++ + + E + D A+ ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ---VIHDQRIVISPQH 135
Query: 455 -------MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
+ L LH VVHRD+ NILL + + DF AR AD++
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 508 LLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
+ + Y APEL ++ + + D++S G V E+ K
Sbjct: 193 YVTHRW-YRAPEL---VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 47/220 (21%), Positives = 81/220 (36%), Gaps = 73/220 (33%)
Query: 364 SMPTPRKIDSKYC----IGTGAYGSVYKAQ-LPNGRVFALKK--LNSPETEELAF----I 412
++ + +Y +G G + +VYKA+ ++ A+KK L + +
Sbjct: 2 ALDVKSRAK-RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 413 RSFRNEAQVLSQMERG---SLFRILHNDA------EAVELDWAK---------RVNIVKA 454
R E ++L ++ L + + + +E D + +KA
Sbjct: 61 R----EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA 116
Query: 455 MAH----ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
L YLH ++HRD+ NN+LL+ +ADFG A+
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK------------- 160
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTL-----EVLMG 545
S+G +P AYT + VVT E+L G
Sbjct: 161 -SFG--SPNRAYT---HQ--------VVTRWYRAPELLFG 186
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 39/208 (18%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETE--------ELAFIRSFR 416
+ +Y IG+GA G V A R A+KKL+ P + + EL ++
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 417 NE-----AQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAH----------ALAY 461
++ V + + F+ ++ E ++ + + + + + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 462 LHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG---YIAP 518
LH S ++HRD+ +NI++ S + DFG AR ++ Y AP
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAP 232
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGK 546
E+ M E D++S G + E++ K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 54/196 (27%), Positives = 79/196 (40%), Gaps = 58/196 (29%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFRI 433
IG G YG VYKAQ G FALKK+ + +E + R E +L +++ L+ +
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 434 LHNDA------EAVELDWAK---------RVNIVKAMAH----ALAYLHHDCSPSVVHRD 474
+H E ++ D K K+ +AY H V+HRD
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYS 534
+ N+L+N + E +ADFG AR ++G P YT
Sbjct: 126 LKPQNLLINREGELKIADFGLAR--------------AFG--IPVRKYTHE--------- 160
Query: 535 FGVVTL-----EVLMG 545
+VTL +VLMG
Sbjct: 161 --IVTLWYRAPDVLMG 174
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 54/222 (24%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETE--------ELAFIRSFRN 417
+ S+Y +G G G V+ A + A+KK+ E+ IR +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKIIRRLDH 67
Query: 418 E-------------AQVLSQMERGSLFRI-----------LHNDAEAVELDWAKRVNIVK 453
+ +Q+ + + L N E L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLAGS 512
+ L Y+H S +V+HRD+ N+ +N++ L + DFG AR++ S++ L+
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE- 183
Query: 513 Y----GYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
Y +P L ++ Y D+++ G + E+L GK
Sbjct: 184 GLVTKWYRSPRL---LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 58/196 (29%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFRI 433
+G G YG VYKA+ GR+ ALK++ +E + R E +L ++ SL +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 434 LHNDA------EAVELDWAK---------RVNIVKAMAH----ALAYLHHDCSPSVVHRD 474
+H++ E +E D K + + +K + +A+ H ++HRD
Sbjct: 88 IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRD 144
Query: 475 ISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYS 534
+ N+L+NS +ADFG AR ++G P +YT
Sbjct: 145 LKPQNLLINSDGALKLADFGLAR--------------AFG--IPVRSYTHE--------- 179
Query: 535 FGVVTL-----EVLMG 545
VVTL +VLMG
Sbjct: 180 --VVTLWYRAPDVLMG 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 49/227 (21%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKL--NSPETEELAFIRSFRNEAQVLSQ--- 424
+G GA+G V +A V A+K L + +E A + E ++L
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMS----ELKILIHIGH 89
Query: 425 ------------------------MERGSL-------------FRILHNDAEAVELDWAK 447
+ G+L +++ D L
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 448 RVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
+ +A + +L S +HRD+++ NILL+ K + DFG AR ++ D
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205
Query: 508 LLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ APE + V T + DV+SFGV+ E+ +G P
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ Y +G+GAYGSV A +G A+KKL+ P ++E A R++R E +L
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA-KRAYR-ELLLLKH 79
Query: 425 MERGSLFRILHNDAEAVELDWAKRV------------NIVKA-------------MAHAL 459
M+ ++ +L A L I+ M L
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
Y+H S VVHRD+ N+ +N E + DFG AR HAD+ + + Y APE
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRW-YRAPE 193
Query: 520 LAYT-MVMTEKYDVYSFGVVTLEVLMGK 546
+ + M + D++S G + E+L GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 50/260 (19%), Positives = 92/260 (35%), Gaps = 81/260 (31%)
Query: 377 IGTGAYGSVYKAQLPNGRVF--------ALKKL--NSPETEELAFIRSFRNEAQVLSQ-- 424
+G GA+G V A+ A+K L ++ E + + E +++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIG 98
Query: 425 ------------------------MERGSL-------------FRILHNDAEAVELDWAK 447
+G+L + N ++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 448 RVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
V+ +A + YL S +HRD+++ N+L+ +ADFG AR ++ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214
Query: 508 LLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDP 561
+ G + APE + V T + DV+SFGV+ E+ +G P Y P
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----------Y-P 261
Query: 562 KIMLIDVLDQ-----RLPPP 576
I + ++ R+ P
Sbjct: 262 GIPVEELFKLLKEGHRMDKP 281
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 65/202 (32%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
+G G Y +VYK G ALK++ ++EE + R E ++ +++ L+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-EISLMKELKHENIVRLYD 70
Query: 433 ILHNDA------EAVELDWAK--------------RVNIVKAMAH----ALAYLHHDCSP 468
++H + E ++ D K +N+VK LA+ H +
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--- 127
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
++HRD+ N+L+N + + + DFG LA ++G P ++ +E
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFG--------------LARAFG--IPVNTFS---SE 168
Query: 529 KYDVYSFGVVTL-----EVLMG 545
VVTL +VLMG
Sbjct: 169 --------VVTLWYRAPDVLMG 182
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 59/197 (29%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
IG G YG+V+KA+ + ALK++ + +E + R E +L +++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 433 ILHNDA------EAVELDWAK---------RVNIVKAMAH----ALAYLHHDCSPSVVHR 473
+LH+D E + D K IVK+ L + H V+HR
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHR 125
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVY 533
D+ N+L+N E +A+FG AR ++G P Y+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR--------------AFG--IPVRCYSAE-------- 161
Query: 534 SFGVVTL-----EVLMG 545
VVTL +VL G
Sbjct: 162 ---VVTLWYRPPDVLFG 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 63/201 (31%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
+G G YG VYKA A+K++ EE + R E +L +++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 433 ILHNDA------EAVELDWAK--------RVNIVKAMAH----ALAYLHHDCSPSVVHRD 474
++H++ E E D K + ++K+ + + + H S +HRD
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRD 157
Query: 475 ISSNNILLNSKLEAF-----VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
+ N+LL+ + + DFG AR ++G P +T
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLAR--------------AFG--IPIRQFTHE---- 197
Query: 530 YDVYSFGVVTL-----EVLMG 545
++TL E+L+G
Sbjct: 198 -------IITLWYRPPEILLG 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 54/290 (18%), Positives = 104/290 (35%), Gaps = 64/290 (22%)
Query: 347 SGNKLSGRVPYSNKHLSSMPTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKL 401
G+ ++ L+ ++S+Y +G+G +GSVY + + A+K +
Sbjct: 17 RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76
Query: 402 NSPETEELAFIRSFRN---EAQVLSQ------------------------MER----GSL 430
+ + + E +L + +ER L
Sbjct: 77 EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136
Query: 431 F-RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEA 488
F I A ++ + A+ + A+ + H + V+HRDI NIL++ + E
Sbjct: 137 FDFITERGA--LQEELARS--FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL 189
Query: 489 FVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY-----DVYSFGVVTLEVL 543
+ DFG+ LL D+ G+ Y PE + +Y V+S G++ L +
Sbjct: 190 KLIDFGSGALLK-DTVYTD-FDGTRVYSPPE----WIRYHRYHGRSAAVWSLGIL-LYDM 242
Query: 544 M-GKHP-RDLHSTLSSSYD-PKIM---LIDVLDQRLPP-PVDRKVIQDIL 586
+ G P + + + ++ L P DR ++I
Sbjct: 243 VCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 49/260 (18%), Positives = 91/260 (35%), Gaps = 81/260 (31%)
Query: 377 IGTGAYGSVYKAQLPNGRVF--------ALKKL--NSPETEELAFIRSFRNEAQVLSQ-- 424
+G G +G V A+ A+K L ++ E + + E +++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIG 144
Query: 425 ------------------------MERGSL-------------FRILHNDAEAVELDWAK 447
+G+L + N ++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 448 RVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
V+ +A + YL S +HRD+++ N+L+ +ADFG AR ++ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 508 LLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDP 561
+ G + APE + V T + DV+SFGV+ E+ +G P Y P
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----------Y-P 307
Query: 562 KIMLIDVLDQ-----RLPPP 576
I + ++ R+ P
Sbjct: 308 GIPVEELFKLLKEGHRMDKP 327
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 50/260 (19%), Positives = 90/260 (34%), Gaps = 81/260 (31%)
Query: 377 IGTGAYGSVYKAQLPNGRVF--------ALKKL--NSPETEELAFIRSFRNEAQVLSQ-- 424
+G GA+G V A+ A+K L ++ E + I E +++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----EMEMMKMIG 132
Query: 425 ------------------------MERGSL-------------FRILHNDAEAVELDWAK 447
+G+L + + +L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 448 RVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
V+ +A + YL S +HRD+++ N+L+ +ADFG AR +H
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH---HIDY 246
Query: 508 LLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDP 561
+ G + APE + + T + DV+SFGV+ E+ +G P Y P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----------Y-P 295
Query: 562 KIMLIDVLDQ-----RLPPP 576
+ + ++ R+ P
Sbjct: 296 GVPVEELFKLLKEGHRMDKP 315
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 70/234 (29%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ KY +G GAYG V+K+ G V A+KK+ + A R+FR E +L++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFR-EIMILTE 64
Query: 425 MERG-----SLFRILHNDA--------EAVELDWAKRVNIVKA--------------MAH 457
+ G +L +L D + +E D +++A +
Sbjct: 65 L-SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHA---VIRANILEPVHKQYVVYQLIK 120
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYG--- 514
+ YLH S ++HRD+ +NILLN++ VADFG +R + S
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 515 ------------------YIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGK 546
Y APE+ ++ + KY D++S G + E+L GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEI---LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
+G G Y +VYK + + ALK++ E EE A + R E +L ++ +L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 433 ILHNDA------EAVELDWAK---------RVNIVKAMAH----ALAYLHHDCSPSVVHR 473
I+H + E ++ D + ++ VK LAY H V+HR
Sbjct: 68 IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 474 DISSNNILLNSKLEAFVADFGTAR 497
D+ N+L+N + E +ADFG AR
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR 148
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 53/215 (24%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ +Y +G+GAYGSV A G A+KKL+ P ++ A R++R E ++L
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYR-ELRLLKH 84
Query: 425 MERGSLFRILHNDAEAVELDWAKRV------------NIVKAM----AH----------A 458
M+ ++ +L A L+ V NIVK H
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-- 516
L Y+H S ++HRD+ +N+ +N E + DFG AR + T GY+
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMT------GYVAT 192
Query: 517 ----APELAYT-MVMTEKYDVYSFGVVTLEVLMGK 546
APE+ M + D++S G + E+L G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 63/224 (28%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKL--NSPETEELAFIRSFRNEAQVLSQ--- 424
+G GA+G V +A +V A+K L + E+ A + E +++S
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMS----ELKIMSHLGQ 108
Query: 425 -----------------------MERGSLFRILHNDAEAVELDWAKR-----------VN 450
G L L + +E D A ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA 510
+A +A+L S + +HRD+++ N+LL + A + DFG AR + DS+
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---V 222
Query: 511 GSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ APE + V T + DV+S+G++ E+ +G +P
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 49/234 (20%), Positives = 92/234 (39%), Gaps = 59/234 (25%)
Query: 358 SNKHLSSMPTPRKI-----DSKYCIGTGAYGSVYKAQL-PNGRVFALKKLN--------- 402
S +H P PRK +G G++ +V A+ R +A+K L
Sbjct: 14 SLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK 73
Query: 403 ----SPETEELAFIR---------SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWA 446
+ E + ++ + +F+++ + LS + G L + +
Sbjct: 74 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------I 124
Query: 447 KRVNIVKA------MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500
+ + AL YLH ++HRD+ NILLN + + DFGTA++L
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 501 ADSSNQTL--LAGSYGYIAPELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+S G+ Y++PEL + + D+++ G + +++ G P
Sbjct: 182 PESKQARANSFVGTAQYVSPEL----LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 44/203 (21%), Positives = 72/203 (35%), Gaps = 46/203 (22%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ Y IG G+YG VY A + A+KK+N E R R E +L++
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC-KRILR-EITILNR 81
Query: 425 MERGSLFRILH----------ND----AEAVELDWAK--RVNIVKAMAH----------A 458
++ + R+ ++ E + D K + I H
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH--ADSSNQTLLAGSYGYI 516
++H ++HRD+ N LLN V DFG AR ++ D++ L +
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 517 APELAYTMVMTEKYDVYSFGVVT 539
+T + VVT
Sbjct: 199 PHNKNLKKQLTS-H------VVT 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 44/202 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
+G G+YG V K + GR+ A+KK + +++ + R E ++L Q+ +L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 433 ILHNDA------EAVELDWAK---------RVNIVKAMAH----ALAYLHHDCSPSVVHR 473
+ E V+ +V+ + + H S +++HR
Sbjct: 92 VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHR 148
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADS---SNQ--TLLAGSYGYIAPELAYTMVMTE 528
DI NIL++ + DFG AR L A ++ T Y APEL +V
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-----YRAPEL---LVGDV 200
Query: 529 KY----DVYSFGVVTLEVLMGK 546
KY DV++ G + E+ MG+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 81/247 (32%)
Query: 370 KIDSKYC----IGTGAYGSVYKAQ-LPNGRVFA-----------------LKKLNSPETE 407
KY +GTG++G V + + +G+ FA +K L+
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNII 63
Query: 408 EL-AFIRSFRNEAQVLSQMERGSLFRILHNDAEAVELDWA-------KRVNIV------- 452
+L + + +E Q N+ K +N++
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 453 --KAMAH----------------------ALAYLHHDCSPSVVHRDISSNNILLNS---- 484
K + A+ ++H S + HRDI N+L+NS
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 485 -KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY----DVYSFGVVT 539
KL DFG+A+ L + + + Y APEL M+ +Y D++S G V
Sbjct: 181 LKL----CDFGSAKKLIPSEPSVAYICSRF-YRAPEL---MLGATEYTPSIDLWSIGCVF 232
Query: 540 LEVLMGK 546
E+++GK
Sbjct: 233 GELILGK 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 49/227 (21%), Positives = 78/227 (34%), Gaps = 65/227 (28%)
Query: 377 IGTGAYGSVYKAQLPNGRVF------ALKKL--NSPETEELAFIRSFRNEAQVLSQ---- 424
+G GA+G V +A A+K L ++ TE A + E +VLS
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS----ELKVLSYLGNH 86
Query: 425 ----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM------- 455
G L L ++ +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 456 --------AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507
A +A+L S + +HRD+++ NILL + DFG AR + DS
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---N 200
Query: 508 LLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ + APE + V T + DV+S+G+ E+ +G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 43/197 (21%), Positives = 73/197 (37%), Gaps = 59/197 (29%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---SLFR 432
IG G+YG V+K + G++ A+KK E + + + R E ++L Q++ +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 433 ILHNDA------EAVELDWAKRV---------NIVKAMAH----ALAYLHHDCSPSVVHR 473
+ E + + ++VK++ A+ + H + +HR
Sbjct: 70 VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVY 533
D+ NIL+ + DFG ARLL T D Y
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLL---------------------------TGPSDYY 159
Query: 534 SFGVVTL-----EVLMG 545
V T E+L+G
Sbjct: 160 DDEVATRWYRSPELLVG 176
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 69/208 (33%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLN-SPETE--------ELAFIRSFRNE-------- 418
IG G +G V+KA+ G+ ALKK+ E E E+ ++ ++E
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 419 ---AQVLSQMERGSLFRILHNDAEAVELDWAK---------RVNIVKAMAH----ALAYL 462
+GS++ + + E D A ++ +K + L Y+
Sbjct: 85 CRTKASPYNRCKGSIYLVF----DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY 522
H + ++HRD+ + N+L+ +ADFG AR A+
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR-----------------------AF 174
Query: 523 TMVMTEKYDVYSFGVVTL-----EVLMG 545
++ + + Y+ VVTL E+L+G
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG 202
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 46/206 (22%), Positives = 75/206 (36%), Gaps = 46/206 (22%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G +G VY + G+++A+K L+ + NE +LS
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDC 466
M G L L E + A + L ++H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMH--- 309
Query: 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
+ VV+RD+ NILL+ ++D G A + G++GY+APE+ +
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEV---LQK 364
Query: 527 TEKY----DVYSFGVVTLEVLMGKHP 548
Y D +S G + ++L G P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 44/231 (19%), Positives = 82/231 (35%), Gaps = 68/231 (29%)
Query: 354 RVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQ---LPNGRVFALKKLNS---PETE 407
+V S++ K +G G YG VYKA+ + + +ALK++ +
Sbjct: 8 KVKLSSERERVEDLFEYEGCK--VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 408 --ELAFIRSFRNE-----AQVLSQMERGSLF-----------RILHNDAEAVELDWAKRV 449
E+A +R ++ +V ++ I+ + ++
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 450 N--IVKAMAH----ALAYLHHDCSPSVVHRDISSNNILLNSKLEAF----VADFGTARLL 499
+VK++ + + YLH + V+HRD+ NIL+ + +AD G ARL
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTL-----EVLMG 545
+ +P + VVT E+L+G
Sbjct: 182 ---------------FNSPLKPLADLDPV--------VVTFWYRAPELLLG 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 42/205 (20%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL------------------------NSPETEELAF 411
+G G +G V+ Q+ G+++A KKL +S LA+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 412 IRSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCS 467
+F + V++ M G + ++N E R A + L +LH
Sbjct: 253 --AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMT 527
++++RD+ N+LL+ ++D G A L A + AG+ G++APE +++
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE----LLLG 363
Query: 528 EKY----DVYSFGVVTLEVLMGKHP 548
E+Y D ++ GV E++ + P
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 49/207 (23%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL------------------------NSPETEELAF 411
+G G +G V Q+ G+++A KKL NS LA+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 412 IRSFRNEAQ---VLSQMERGSLFRILHNDAEAV--ELDWAKRVNIVKA-MAHALAYLHHD 465
++ + VL+ M G L +++ +A E R A + L LH
Sbjct: 252 --AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCGLEDLH-- 303
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV 525
+V+RD+ NILL+ ++D G A + + + G+ GY+APE +V
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPE----VV 357
Query: 526 MTEKY----DVYSFGVVTLEVLMGKHP 548
E+Y D ++ G + E++ G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 29/141 (20%), Positives = 57/141 (40%), Gaps = 8/141 (5%)
Query: 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296
+ N LD+ I I + +D S N+ + L +L L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKTL 69
Query: 297 DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLS---RLDYLNLSGNKLSG 353
+++N++ ++ DLT L L+NN++ G++ L+ L YL + N ++
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRNPVTN 127
Query: 354 RVPYSNKHLSSMPTPRKIDSK 374
+ Y + +P R +D +
Sbjct: 128 KKHYRLYVIYKVPQVRVLDFQ 148
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 5/126 (3%)
Query: 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP 236
+ L+ ++ + N ELD+ I I + L + + N++ L
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS-SIPNELTRLTQLFH 295
L+ L L V NN I DL+ L L+ N + L L L +
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 296 LDLSSN 301
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 29/132 (21%), Positives = 52/132 (39%), Gaps = 10/132 (7%)
Query: 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRN 182
+ N R L I + + L + +D S N +R L L + ++ N
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNN 74
Query: 183 MLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT-LSRLTSLKILILAQNQLSGLPQ---- 237
+ + L +L EL + +NSL+ L L+ L SL L + +N ++
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 134
Query: 238 EIGNLKNLMLLD 249
I + + +LD
Sbjct: 135 VIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 26/115 (22%), Positives = 43/115 (37%), Gaps = 10/115 (8%)
Query: 149 SEISALSKLQLLDLSSNR------LRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202
++ + + + LDL + L L + + S N + L L+ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70
Query: 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP--QEIGNLKNLMLLDVGNNDI 255
V +N + L L LIL N L L + +LK+L L + N +
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 50/249 (20%), Positives = 83/249 (33%), Gaps = 50/249 (20%)
Query: 151 ISALSKLQLLDLSSNRLRGR-----------LTNLNYMSLSRNMLGGLLPQEIGN-LKN- 197
+ L + Q++ L L L ++L N LG + + L+
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 198 ---LIELDVGDNSL----IGPIPLTLSRLTSLKILILAQNQLS---------GLPQEIGN 241
+ +L + + L G + TL L +L+ L L+ N L GL
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 242 LKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL-----TQ 292
L+ L L + P+ S L D L +S N N + L + Q
Sbjct: 144 LEKLQL---EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 293 LFHLDLSSNKLSGKIPSQIASM----EDLTWLDLSNNNIKGS-----IPGEITKLSRLDY 343
L L L S ++ + + L L L +N + PG + SRL
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 344 LNLSGNKLS 352
L + ++
Sbjct: 261 LWIWECGIT 269
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 47/281 (16%), Positives = 82/281 (29%), Gaps = 55/281 (19%)
Query: 117 NGRLSHLNFS-CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR--------- 166
+ ++ L+ C +L+ S + L LQ L LS N
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLS----------STLRTLPTLQELHLSDNLLGDAGLQLL 133
Query: 167 ---LRGRLTNLNYMSLSRNMLG----GLLPQEIGNLKNLIELDVGDNSLIGP----IPLT 215
L L + L L L + + EL V +N + +
Sbjct: 134 CEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQG 193
Query: 216 LSRLT-SLKILILAQNQLS-----GLPQEIGNLKNLMLLDVGNNDI-----IGPIPSTLG 264
L L+ L L ++ L + + +L L +G+N + P L
Sbjct: 194 LKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH 253
Query: 265 LFSDLSYLDLSCNQFN----SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM-----E 315
S L L + + L L L L+ N+L + +
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC 313
Query: 316 DLTWLDLSNNNIKG----SIPGEITKLSRLDYLNLSGNKLS 352
L L + + + + + L L +S N+L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 43/242 (17%), Positives = 75/242 (30%), Gaps = 44/242 (18%)
Query: 155 SKLQLLDLSSNRLR-----------GRLTNLNYMSLSRNMLGG-----LLPQEIGNLKNL 198
+L+ L L L + +++S N + L + L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 199 IELDVGDNSL----IGPIPLTLSRLTSLKILILAQNQLSG------LPQEIGNLKNLMLL 248
L + + + ++ SL+ L L N+L P + L L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 249 DVGNNDI----IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL-----TQLFHLDLS 299
+ I G + L L L L+ N+ L QL L +
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321
Query: 300 SNKLSGKIPSQIASM----EDLTWLDLSNNNIKGSIPGEITKL-----SRLDYLNLSGNK 350
S + S +S+ L L +SNN ++ + E+ + S L L L+
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 351 LS 352
+S
Sbjct: 382 VS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 53/241 (21%), Positives = 81/241 (33%), Gaps = 44/241 (18%)
Query: 156 KLQLLDLSSNRLRGR-----------LTNLNYMSLSRNMLGG-----LLPQEIGNLKNLI 199
+L+ L L S + +L ++L N LG L P + L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 200 ELDVGDNSL----IGPIPLTLSRLTSLKILILAQNQL--SGLPQEIGNLKN----LMLLD 249
L + + + G + L SLK L LA N+L G L L L
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 250 VGNNDI----IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL-----TQLFHLDLSS 300
V + S L L L +S N+ + EL + + L L L+
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 301 NKLSGKIPSQIASM----EDLTWLDLSNNNIKGSIPGEITKL-----SRLDYLNLSGNKL 351
+S S +A+ L LDLSNN + + ++ + L+ L L
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
Query: 352 S 352
S
Sbjct: 440 S 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 42/219 (19%), Positives = 71/219 (32%), Gaps = 40/219 (18%)
Query: 149 SEISALSKLQLLDLSSNRL------------RGRLTNLNYMSLSRNMLG----GLLPQEI 192
+++ + L+ L L SN+L + L + + + G L + +
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 193 GNLKNLIELDVGDNSL--IGPIPLT---LSRLTSLKILILAQNQLS-----GLPQEIGNL 242
++L EL + N L G L L L+ L + + +
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 243 KNLMLLDVGNNDIIGPIPSTLGLF-----SDLSYLDLSCNQFN----SSIPNELTRLTQL 293
+ L+ L + NN + L S L L L+ + SS+ L L
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400
Query: 294 FHLDLSSNKLSGKIPSQIASM-----EDLTWLDLSNNNI 327
LDLS+N L Q+ L L L +
Sbjct: 401 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 18/96 (18%), Positives = 35/96 (36%), Gaps = 10/96 (10%)
Query: 267 SDLSYLDLSCNQFN-SSIPNELTRLTQLFHLDLSSNKLSGK----IPSQIASMEDLTWLD 321
D+ LD+ C + + + L L Q + L L+ I S + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 322 LSNNNIKGSIPGEITKL-----SRLDYLNLSGNKLS 352
L +N + + + ++ L+L L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 53/215 (24%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSP-ETEELAFIRSFRNEAQVLSQ 424
+ + Y +G+GAYG+V A G A+KKL P ++E A R++R E ++L
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYR-ELRLLKH 80
Query: 425 MERGSLFRILHNDAEAVELDWAKRV------------NIVKA--------------MAHA 458
M ++ +L LD ++K M
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYI-- 516
L Y+H + ++HRD+ N+ +N E + DFG AR S T GY+
Sbjct: 141 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMT------GYVVT 188
Query: 517 ----APELAYT-MVMTEKYDVYSFGVVTLEVLMGK 546
APE+ M T+ D++S G + E++ GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 266 FSDLSYLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324
SD+ L L ++ N + +L L + L+ I + + + L L+LS+
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 325 NNIKGSIPGEITKLSRLDYLNLSGNKLS 352
N + G + K L +LNLSGNK+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 26/115 (22%), Positives = 42/115 (36%), Gaps = 10/115 (8%)
Query: 145 GSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
G + +L+ L + L +L L + LS N + G L NL
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91
Query: 200 ELDVGDNSLIGPIPLT-LSRLTSLKILILAQNQLSGLP----QEIGNLKNLMLLD 249
L++ N + + L +L +LK L L +++ L L L LD
Sbjct: 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-07
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 218 RLTSLKILILAQNQLSGLPQE--IGNLKNLMLLDVGNNDI--IGPIPSTLGLFSDLSYLD 273
+ +K L+L ++ + E + L L N + I +P + L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLE 70
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG-KIPSQIASMEDLTWLDLSNNNI 327
LS N+ + + + L HL+LS NK+ + +E+L LDL N +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 28/101 (27%), Positives = 40/101 (39%), Gaps = 8/101 (7%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-ASMED 316
IP + + L L+ N+ + L RL L L+L N+L+ I
Sbjct: 23 IPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79
Query: 317 LTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLSGRVP 356
+ L L N IK I L +L LNL N++S V
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 146 SIPSEISA------LSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
IP +I L+ +L +SS+ L GRL +L + L RN L G+ P ++
Sbjct: 22 EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81
Query: 200 ELDVGDNSLIGPIPL-TLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNN 253
EL +G+N + I L LK L L NQ+S + +L +L L++ +N
Sbjct: 82 ELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 30/132 (22%), Positives = 48/132 (36%), Gaps = 26/132 (19%)
Query: 220 TSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF 279
L+L N+L + + G L L L+L NQ
Sbjct: 29 LHTTELLLNDNELGRISSD-GLFGRL---------------------PHLVKLELKRNQL 66
Query: 280 NSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIP-GEITK 337
PN + + L L NK+ +I +++ + L L+L +N I + G
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEH 124
Query: 338 LSRLDYLNLSGN 349
L+ L LNL+ N
Sbjct: 125 LNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 20/74 (27%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA--SMEDLTWLDLSNNNIKGSIPGEITKL 338
IP ++ T L L+ N+L +I S + L L+L N + G P
Sbjct: 21 KEIPRDIPLHTT--ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77
Query: 339 SRLDYLNLSGNKLS 352
S + L L NK+
Sbjct: 78 SHIQELQLGENKIK 91
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 11/132 (8%)
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGN-LKNLMLLDVGNNDIIGP 258
LD+ NSL LTSL L L N+L LP + N L +L L++ N +
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-QS 90
Query: 259 IPSTLGLF---SDLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQI-AS 313
+P+ G+F + L L L+ NQ S+P+ + +LTQL L L N+L +P +
Sbjct: 91 LPN--GVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR 146
Query: 314 MEDLTWLDLSNN 325
+ L ++ L +N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 220 TSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPSTL--GLF---SDLSYLD 273
L L N L LP + L +L L +G N + +L G+F + L+YL+
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----QSLPNGVFNKLTSLTYLN 82
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIP 332
LS NQ S +LTQL L L++N+L +P + + L L L N +K S+P
Sbjct: 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
Query: 333 -GEITKLSRLDYLNLSGN 349
G +L+ L Y+ L N
Sbjct: 141 DGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P+ G+ + +YLDL N S LT L L L NKL +P+ + + L
Sbjct: 22 VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
T+L+LS N ++ G KL++L L L+ N+L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 248 LDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307
LD+ N + + L+ L L N+ S +LT L +L+LS+N+L +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 308 PSQI-ASMEDLTWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLSGRVP 356
P+ + + L L L+ N ++ S+P G KL++L L L N+L VP
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 47/167 (28%), Positives = 64/167 (38%), Gaps = 40/167 (23%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
S+P+ I A + LDL +N L+ LT+L + L N L L L +L
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP 258
L++ N L +LT LK L L NQL LP
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPD--------------------- 117
Query: 259 IPSTLGLF---SDLSYLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSN 301
G+F + L L L NQ S+P+ RLT L ++ L N
Sbjct: 118 -----GVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 10/124 (8%)
Query: 139 YYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQE 191
+ L+ L L L N+L+ +LT+L Y++LS N L L
Sbjct: 36 ETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGV 95
Query: 192 IGNLKNLIELDVGDNSLIGPIPL-TLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLD 249
L L EL + N L +P +LT LK L L QNQL +P + L +L +
Sbjct: 96 FDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 250 VGNN 253
+ +N
Sbjct: 155 LHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 2/71 (2%)
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
+S+P + T +LDL +N L + LT L L N ++ G KL+
Sbjct: 20 TSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS 77
Query: 341 LDYLNLSGNKL 351
L YLNLS N+L
Sbjct: 78 LTYLNLSTNQL 88
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 47/232 (20%), Positives = 82/232 (35%), Gaps = 70/232 (30%)
Query: 377 IGTGAYGSVYKAQLPNGRVF------ALKKL--NSPETEELAFIRSFRNEAQVLSQ---- 424
+G+GA+G V A A+K L + +E A + E ++++Q
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSH 108
Query: 425 ----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM------- 455
G L L + E D + N +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 456 -------------AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502
A + +L S VHRD+++ N+L+ + DFG AR + +D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 503 SSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
S+ + APE + + T K DV+S+G++ E+ +G +P
Sbjct: 226 SNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 55/260 (21%), Positives = 91/260 (35%), Gaps = 66/260 (25%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRN---EAQVLSQ-------- 424
+G G +G+V+ L + A+K + + + E +L +
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 425 ------------------MER----GSLF-RILHNDA--EAVELDWAKRVNIVKAMAHAL 459
+ER LF I E ++ + A+
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----SRC--FFGQVVAAI 152
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
+ H S VVHRDI NIL++ + A + DFG+ LLH D G+ Y P
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYSPP 207
Query: 519 ELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHP-RDLHSTLSSSYD-PKIMLIDVLD 570
E + +Y V+S G++ L ++ G P L + P + D
Sbjct: 208 E----WISRHQYHALPATVWSLGIL-LYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262
Query: 571 --QRL--PPPVDRKVIQDIL 586
+R P P R +++IL
Sbjct: 263 LIRRCLAPKPSSRPSLEEIL 282
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 51/231 (22%), Positives = 82/231 (35%), Gaps = 68/231 (29%)
Query: 377 IGTGAYGSVYKAQLPNGRVF------ALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
IG GA+G V++A+ P + A+K L + ++ F+ EA ++++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112
Query: 425 -------------------MERGSLFRIL-----HNDAEAVELDWAKRVNIVKAMAHAL- 459
M G L L H D + R + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 460 ---------------AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504
AYL VHRD+++ N L+ + +ADFG +R ++ S
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY---S 226
Query: 505 NQTLLAGSYGYI-----APE-LAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
A I PE + Y T + DV+++GVV E+ G P
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 12/99 (12%)
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
A + +L S +HRD+++ NILL+ K + DFG AR ++ D
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDAR 256
Query: 516 I-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ APE + V T + DV+SFGV+ E+ +G P
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 45/206 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G + V A+ + GR A+K ++ + + + FR E +++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 425 -----------ME---RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
ME G +F L E A+ + + A+ Y H +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS--KFRQIVSAVQYCHQKR---I 135
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
VHRD+ + N+LL++ + +ADFG + G+ Y APE + +KY
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPE----LFQGKKY 190
Query: 531 -----DVYSFGVVTLEVLM-GKHPRD 550
DV+S GV+ L L+ G P D
Sbjct: 191 DGPEVDVWSLGVI-LYTLVSGSLPFD 215
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 72/233 (30%)
Query: 377 IGTGAYGSVYKAQLPNG-------RVFALKKL--NSPETEELAFIRSFRNEAQVLSQ--- 424
+G G +G V KA + V A+K L N+ +E + E VL Q
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLS----EFNVLKQVNH 85
Query: 425 ----------------------MERGSL---------------------FRILHNDAEAV 441
+ GSL + +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 442 ELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501
L ++ ++ + YL +VHRD+++ NIL+ + ++DFG +R ++
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 502 DSSNQTLLAGSYGYI-----APELAYTMVMTEKYDVYSFGVVTLEVL-MGKHP 548
+ S S G I A E + + T + DV+SFGV+ E++ +G +P
Sbjct: 203 EDSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 25/121 (20%), Positives = 43/121 (35%), Gaps = 4/121 (3%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNE-LTRLTQLFHLDLSSNKLSGKIPSQIASMEDL 317
L +L+ L + Q + L L +L +L + + L P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 318 TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL--SGRVPYSNKHLSSMPTPRKIDSKY 375
+ L+LS N ++ S+ + + L L LSGN L S + + +
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141
Query: 376 C 376
C
Sbjct: 142 C 142
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 8e-09
Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 273 DLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQ-IASMEDLTWLDLSNNNIKGS 330
L C + + + L L L + + + + + + + +L L + + ++
Sbjct: 12 GLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-F 70
Query: 331 IPGEI-TKLSRLDYLNLSGNKLS 352
+ + RL LNLS N L
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 17/101 (16%), Positives = 32/101 (31%), Gaps = 8/101 (7%)
Query: 229 QNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL---DLSCNQFNSSIPN 285
++ + +NL L + N + + L L + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLEL--RDLRGLGELRNLTIVKSGL-RFVAP 73
Query: 286 E-LTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
+ +L L+LS N L + + L L LS N
Sbjct: 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 4e-07
Identities = 18/108 (16%), Positives = 30/108 (27%), Gaps = 16/108 (14%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
+ L L + + L L +++ L L L +
Sbjct: 22 DSLHHLPGAENLTELYIENQ----------------QHLQHLELRDLRGLGELRNLTIVK 65
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
+ L P L L L+ N L L + +L L + N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 46/203 (22%), Positives = 66/203 (32%), Gaps = 80/203 (39%)
Query: 377 IGTGAYGSVYKA-QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G G V + FALK L R E ++ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 77
Query: 425 ----------------MER---GSLF-RILHNDAEA-VELDWAKRVNIVKAMAHALAYLH 463
ME G LF RI +A E + + I+K++ A+ YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 134
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPEL 520
S ++ HRD+ N+L SK + DFG A E
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKE- 169
Query: 521 AYTMVMTEKY----DVYSFGVVT 539
EKY D++S GV+
Sbjct: 170 ----TTGEKYDKSCDMWSLGVIM 188
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 57/206 (27%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V + G A+K LN + L + + E Q L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 425 -----------ME---RGSLF-RILHNDAEAVELDWAKRVNIVKA------MAHALAYLH 463
ME G LF I + RV ++A + A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH----------GRVEEMEARRLFQQILSAVDYCH 128
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
VVHRD+ N+LL++ + A +ADFG + ++ +T GS Y APE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE---- 180
Query: 524 MVMTEKY-----DVYSFGVVTLEVLM 544
++ Y D++S GV+ L L+
Sbjct: 181 VISGRLYAGPEVDIWSCGVI-LYALL 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 49/204 (24%), Positives = 76/204 (37%), Gaps = 41/204 (20%)
Query: 376 CIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
+G G +G V + GR +A+K L + E +VL
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 425 ------------ME---RGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
ME G LF L + E R A + AL YLH + +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSEKN- 269
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
VV+RD+ N++L+ + DFG + D + G+ Y+APE ++
Sbjct: 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE----VLEDN 324
Query: 529 KY----DVYSFGVVTLEVLMGKHP 548
Y D + GVV E++ G+ P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P+ G+ S + L+L N+ S +LTQL L LS N++ +P + + L
Sbjct: 22 VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 318 TWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGNKLSGRVP 356
T L L N ++ S+P G KL++L L L N+L VP
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 36/117 (30%), Positives = 54/117 (46%), Gaps = 12/117 (10%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
S+P+ I + L+L SN+L+ +LT L +SLS+N + L L L
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 199 IELDVGDNSLIGPIPL-TLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNN 253
L + +N L +P +LT LK L L NQL +P I L +L + + N
Sbjct: 79 TILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 37/135 (27%), Positives = 53/135 (39%), Gaps = 33/135 (24%)
Query: 220 TSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF---SDLSYLDLSC 276
+S L L N+L LP G+F + L+ L LS
Sbjct: 28 SSATRLELESNKLQSLPH--------------------------GVFDKLTQLTKLSLSQ 61
Query: 277 NQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIP-GE 334
NQ S +LT+L L L NKL +P+ + + L L L N +K S+P G
Sbjct: 62 NQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGI 119
Query: 335 ITKLSRLDYLNLSGN 349
+L+ L + L N
Sbjct: 120 FDRLTSLQKIWLHTN 134
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 44/168 (26%)
Query: 147 IPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201
+ + +S L + L LS+N + + NL +SL RN++ ++I NL +
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLI-----KKIENLDAV--- 91
Query: 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI--IGPI 259
+L+ L ++ NQ++ L I L NL +L + NN I G I
Sbjct: 92 -----------------ADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITNWGEI 133
Query: 260 PSTLGLFSDLSYLDLSCNQFNSSIPNE----------LTRLTQLFHLD 297
L L L L+ N + + RL L LD
Sbjct: 134 -DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 33/148 (22%), Positives = 58/148 (39%), Gaps = 21/148 (14%)
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLML 247
+ + LK L + N I I +LS + +L+IL L +N + + L
Sbjct: 40 MDATLSTLKACKHLALSTN-NIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEE 97
Query: 248 LDVGNNDIIGPIPSTL-GL--FSDLSYLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKL 303
L + N I ++L G+ +L L +S N+ + ++L L +L L L+ N L
Sbjct: 98 LWISYNQI-----ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 304 SGKIPSQ----------IASMEDLTWLD 321
+ + +L LD
Sbjct: 153 YNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 14/92 (15%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
A+ Y H +VHRD+ N+LL+ L +ADFG + ++ + +T GS Y A
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 175
Query: 518 PELAYTMVMTEKY-----DVYSFGVVTLEVLM 544
PE ++ + Y DV+S G+V L V++
Sbjct: 176 PE----VINGKLYAGPEVDVWSCGIV-LYVML 202
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 5e-08
Identities = 21/161 (13%), Positives = 50/161 (31%), Gaps = 20/161 (12%)
Query: 210 GPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLG--LFS 267
+ L + L L + + ++ NL L++ + + + +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKK--PRPNLKSLEIISGGLPDSVVEDILGSDLP 219
Query: 268 DLSYLDLSCNQFNSSIPNEL---------TRLTQLFHLDLSSNKLSGKIPSQIAS---ME 315
+L L L + ++ R L L + + + +
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 316 DLTWLDLSNNNIKGS----IPGEITKLSRLDYLNLSGNKLS 352
L +D+S + + + K+ L ++N+ N LS
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 6e-08
Identities = 29/189 (15%), Positives = 68/189 (35%), Gaps = 18/189 (9%)
Query: 142 GFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNL--I 199
F G I E +S ++ +DLS + + LN + + + + NLK+L I
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLS--PVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEII 201
Query: 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-------GNLKNLMLLDVGN 252
+ D+ + + L L L + + ++ + NL L + +
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 253 NDIIGPIPSTLG---LFSDLSYLDLSCNQFNSS----IPNELTRLTQLFHLDLSSNKLSG 305
+ + + L +D+S + + + ++ L +++ N LS
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
Query: 306 KIPSQIASM 314
++ ++
Sbjct: 322 EMKKELQKS 330
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 15/101 (14%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYGY 515
L YLH S +VH+DI N+LL + ++ G A LH +++ T GS +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 516 IAPELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHPRD 550
PE+A + + D++S GV L + G +P +
Sbjct: 178 QPPEIANG---LDTFSGFKVDIWSAGVT-LYNITTGLYPFE 214
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 6e-08
Identities = 86/533 (16%), Positives = 153/533 (28%), Gaps = 163/533 (30%)
Query: 1 LKCLYKLRKSLLNPIAQSTEKLII-SMDPA--SSIFRLAALV---------------WVA 42
L+ KLR++LL + + ++I + + + +A V W+
Sbjct: 134 LQPYLKLRQALLE--LRPAKNVLIDGVLGSGKTW---VALDVCLSYKVQCKMDFKIFWLN 188
Query: 43 IFTCDNVAVRTGTIVTASALSPIQLETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAG 102
+ C+ T++ L+ W + SDH I + +S
Sbjct: 189 LKNCN----SPETVL-------EMLQKLLYQIDPNWTSR------SDHSSNIKLRIHSIQ 231
Query: 103 SIIGLHLSK----------DNVNFNGRLSHLNFSC------------------------- 127
+ + L NV + N SC
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 128 ------FPNLESLRILA-YYDGFTGSIPSEISALSKLQLLDLSSNRLR---GRLTN---L 174
E +L Y D +P E+ + L + + +R N +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR-RLSIIAESIRDGLATWDNWKHV 350
Query: 175 NYMSLSRNM---LGGLLPQEIGNL-KNL--IELDVGDNSLIGPIPL-TLSRLTSLKILIL 227
N L+ + L L P E + L IP LS ++
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-------HIPTILLS--------LI 395
Query: 228 AQNQLSGLPQEIGN-LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN-----QFNS 281
+ + + N L L++ + ST+ + + YL+L +
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKE------STISIP-SI-YLELKVKLENEYALHR 447
Query: 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341
SI + DL L S I +++K E L R+
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------------HHLKNIEHPERMTLFRM 495
Query: 342 DYLNLS--GNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALK 399
+L+ K+ N S + T K+ YK + +
Sbjct: 496 VFLDFRFLEQKIRHDSTAWNASGSILNT--LQQLKF----------YKPYICD------- 536
Query: 400 KLNSPETEEL--AFIRSFRNEAQVLSQMERGSLFRI-LHNDAEAVELDWAKRV 449
N P+ E L A + + L + L RI L + EA+ + K+V
Sbjct: 537 --NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 96/644 (14%), Positives = 187/644 (29%), Gaps = 203/644 (31%)
Query: 11 LLNPIAQSTE--KLIISMDPASSIFRLAALVWVAIFTCDNVAVRTGTIVTASALSPIQLE 68
+ I E +I+S D S RL W + + + + L
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRL---FWTLLSKQEEMVQK----FVEEVLRI---- 89
Query: 69 TKALLNTGWWNNSW-------TMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLS 121
N + + +M + E N +K NV+ RL
Sbjct: 90 -----NYKFLMSPIKTEQRQPSMMTRM-YIEQRDRLYNDNQV-----FAKYNVS---RLQ 135
Query: 122 HLNF--SCFPNLESLRILAYYDGFTGSIPSEISALSK--LQLLDLSSNRLRGRLTN-LNY 176
L + + G GS K + L S +++ ++ + +
Sbjct: 136 PYLKLRQALLELRPAKNVLID-GVLGS--------GKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTS-LKILILAQNQLSG 234
++L + + + L I+ + S I L + + + L+ L+ ++ +
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 235 LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL--TRLTQ 292
L L+LL+V N + +LSC I L TR Q
Sbjct: 247 L---------LVLLNVQNAKAW-------------NAFNLSC-----KI---LLTTRFKQ 276
Query: 293 LFHLDLSSNKLSGKIPSQIASMED----LT----------WLDLSNNNIKGSIPGEITKL 338
+ + LS + I S++ LT +LD +P E+
Sbjct: 277 VT------DFLSAATTTHI-SLDHHSMTLTPDEVKSLLLKYLDCR----PQDLPREVLTT 325
Query: 339 SRLDYLNLSGNKLSGRVPYSN--KHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVF 396
+ L++ + + + KH++ I+S
Sbjct: 326 NPR-RLSIIAESIRDGLATWDNWKHVNCDKLTTIIES----------------------- 361
Query: 397 ALKKLNSPET----EELAFIRSFRNEA----QVLS----QMERGSLFRI---LHNDAEAV 441
+L L E + L+ + F A +LS + + + + LH + V
Sbjct: 362 SLNVLEPAEYRKMFDRLS-V--FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS-LV 417
Query: 442 ELDWAK-RVNIVKAMAHALAYLHHDCSPS---VVHRD-ISSNNILLNSKLEAFVADFGTA 496
E + ++I ++ YL +HR + NI + +
Sbjct: 418 EKQPKESTISI-----PSI-YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP---- 467
Query: 497 RLLHADSSNQTLLAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGK------- 546
+ D Y + + + E+ ++ + L K
Sbjct: 468 ---YLD-----------QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA 513
Query: 547 --HPRDLHSTLS--SSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
+ +TL Y P I D P +++ IL
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDND--------PKYERLVNAIL 549
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 12/97 (12%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
+ YLH ++HRDI +N+L+ +ADFG + + + G+ ++A
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMA 205
Query: 518 PELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHP 548
PE + + DV++ G VTL + G+ P
Sbjct: 206 PES--LSETRKIFSGKALDVWAMG-VTLYCFVFGQCP 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 67/214 (31%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTG++G V + +G +A+K L+ + +L I NE ++L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 425 -----------MER---GSLFRILHND------------AEAVELDWAKRVNIVKAMAHA 458
ME G +F L A+ V
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------------T 153
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
YLH S +++RD+ N+L++ + V DFG A+ + T L G+ +AP
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWT-LCGTPEALAP 207
Query: 519 ELAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
E +++++ Y D ++ GV+ E+ G P
Sbjct: 208 E----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 18/111 (16%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA---GSYG 514
+ YLH + HRDI N+LL+ + ++DFG A + ++ + LL G+
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLP 172
Query: 515 YIAPELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHPRDLHSTLSSSY 559
Y+APE ++ ++ DV+S G+V L ++ G+ P D S Y
Sbjct: 173 YVAPE----LLKRREFHAEPVDVWSCGIV-LTAMLAGELPWDQPSDSCQEY 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIA 517
+ Y H VVHRD+ N+LL++ + A +ADFG + ++ +T GS Y A
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAA 183
Query: 518 PELAYTMVMTEKY-----DVYSFGVVTLEVLM 544
PE ++ Y D++S GV+ L L+
Sbjct: 184 PE----VISGRLYAGPEVDIWSSGVI-LYALL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 18/115 (15%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA---GSYG 514
+ YLH + HRDI N+LL+ + ++DFG A + ++ + LL G+
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLP 172
Query: 515 YIAPELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKI 563
Y+APE ++ ++ DV+S G+V L ++ G+ P D S Y
Sbjct: 173 YVAPE----LLKRREFHAEPVDVWSCGIV-LTAMLAGELPWDQPSDSCQEYSDWK 222
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P+ G+ + L L NQ P RLTQL LDL +N+L+ +P+ + + L
Sbjct: 24 VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 318 TWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGN 349
T L L++N +K SIP G L L ++ L N
Sbjct: 81 TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 32/116 (27%), Positives = 44/116 (37%), Gaps = 34/116 (29%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
S+P+ I Q+L L N++ RLT L + L N L L
Sbjct: 23 SVPTGIPT--TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPA--------- 71
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNN 253
V D +LT L L L NQL +P+ NLK+L + + NN
Sbjct: 72 ---GVFD------------KLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 59/254 (23%)
Query: 151 ISALSKLQLLDLSSNR------------LRGRLTNLNYMSLSRNMLGGLLPQEIG----- 193
S + LDLS N ++ ++LS N LG E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 194 NLKNLIELDVGDNSL----IGPIPLTLSRL-TSLKILILAQNQLS-----GLPQEIGNL- 242
N+ L++ N L + TL+ + ++ +L L N S Q NL
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 243 KNLMLLDVGNNDI-----------IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL- 290
++ L++ ND+ + IP+ ++ L+L N S EL +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPAN------VNSLNLRGNNLASKNCAELAKFL 191
Query: 291 ----TQLFHLDLSSNKLSGKIPSQIASM-----EDLTWLDLSNNNIKGS----IPGEITK 337
+ LDLS+N L K +++A + + L+L N + G +
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 338 LSRLDYLNLSGNKL 351
L L + L + +
Sbjct: 252 LKHLQTVYLDYDIV 265
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 45/256 (17%), Positives = 84/256 (32%), Gaps = 67/256 (26%)
Query: 155 SKLQLLDLSSNR------------LRGRLTNLNYMSLSRNMLGGLLPQEIGNL-----KN 197
+ + L+LS N L N+ ++LS N L E+
Sbjct: 51 ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 198 LIELDVGDNSL----IGPIPLTLSRL-TSLKILILAQNQL---------SGLPQEIGNLK 243
+ LD+G N S L S+ L L N L L N+
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVN 170
Query: 244 NLMLLDVGNNDI-----------IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRL-- 290
+ L++ N++ + IP++ ++ LDLS N EL +
Sbjct: 171 S---LNLRGNNLASKNCAELAKFLASIPAS------VTSLDLSANLLGLKSYAELAYIFS 221
Query: 291 ---TQLFHLDLSSNKLSGKIPSQIASMED----LTWLDLSNNNIKGSIPGE-------IT 336
+ L+L N L G + ++D L + L + +K +
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 337 KLSRLDYLNLSGNKLS 352
+ ++ ++ +G ++
Sbjct: 282 NIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 28/192 (14%), Positives = 60/192 (31%), Gaps = 47/192 (24%)
Query: 155 SKLQLLDLSSNR------------LRGRLTNLNYMSLSRNMLGGLLPQEIG-----NLKN 197
+ + L+L N L ++ + LS N+LG E+ +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226
Query: 198 LIELDVGDNSL----IGPIPLTLSRLTSLKILILAQNQLSGLPQE--------IGNLKNL 245
++ L++ N L + + L L L+ + L + + + +E N++ +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 246 MLLDVGNNDI--------------IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLT 291
+L+D +I + L + + +Q N N L
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSL-LNQCLIFAQKHQTNIEDLNIPDELR 345
Query: 292 QLFHLDLSSNKL 303
+ L
Sbjct: 346 ---ESIQTCKPL 354
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 42/261 (16%), Positives = 87/261 (33%), Gaps = 71/261 (27%)
Query: 371 IDSKYCI----GTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
D++Y + G G + +V+ A+ + N A+K + + + + +E ++L ++
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRV 72
Query: 426 ERGSLFRILHNDAEAV---------------------EL------DWAKR-------VNI 451
+ A + E+ K+ +
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 452 VKAMAH----ALAYLHHDCSPSVVHRDISSNNILLNSKLEAF------VADFGTARLLHA 501
VK ++ L Y+H C ++H DI N+L+ +AD G A
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 502 DSSNQTLLAGSYGYIAPE----LAYTMVMTEKYDVYSFGVVTLEVLMGKH--PRDLHSTL 555
+N + Y +PE + D++S + E++ G D +
Sbjct: 191 HYTN---SIQTREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 556 SSSYDPKIMLIDVLDQRLPPP 576
+ D +I++L P
Sbjct: 244 TKDDDHIAQIIELLG---ELP 261
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI-ASMEDL 317
+P+ G+ +D L L+ NQ P L L L +SNKL+ IP+ + + L
Sbjct: 27 VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 318 TWLDLSNNNIKGSIP-GEITKLSRLDYLNLSGN 349
T LDL++N++K SIP G L L ++ L N
Sbjct: 84 TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 28/116 (24%), Positives = 43/116 (37%), Gaps = 34/116 (29%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198
S+P+ I Q L L++N++ L NL + + N L +
Sbjct: 26 SVPAGIPT--DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPT--------- 74
Query: 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNN 253
V D +LT L L L N L +P+ NLK+L + + NN
Sbjct: 75 ---GVFD------------KLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 52/203 (25%), Positives = 80/203 (39%), Gaps = 42/203 (20%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL-----------NSPETEE--LAFIR--------- 413
+G G +G V + GR +A+K L TE L R
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 414 SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSPS 469
+F+ + V+ G LF L + E +R A + AL YLH S
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLH---SRD 125
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
VV+RDI N++L+ + DFG + +D + G+ Y+APE ++
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE----VLEDND 181
Query: 530 Y----DVYSFGVVTLEVLMGKHP 548
Y D + GVV E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 59/224 (26%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFA---LKKLNSPETEELAFIRSFRNEAQVLSQMER----- 427
IG G+Y V +L R++A +KK + E++ ++++ E V Q
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLV 73
Query: 428 ---------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHD 465
G L + + E + A ++ AL YLH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALNYLH-- 127
Query: 466 CSPSVVHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPEL 520
+++RD+ +N+LL+S KL D+G + L + T G+ YIAPE
Sbjct: 128 -ERGIIYRDLKLDNVLLDSEGHIKL----TDYGMCKEGLRPGDTTST-FCGTPNYIAPE- 180
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYD 560
++ E Y D ++ GV+ E++ G+ P D+ + +
Sbjct: 181 ---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 458 ALAYLHHDCSPSVVHRDISSNNILLNSKLEAF--VADFGTARLLHADSSNQTLLAGSYGY 515
++Y H S + HRD+ N LL+ + DFG ++ S ++ + G+ Y
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAY 183
Query: 516 IAPELAYTMVMTEKY-----DVYSFGVVTLEVLM-GKHP 548
IAPE +++ ++Y DV+S GV L V++ G +P
Sbjct: 184 IAPE----VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 51/307 (16%), Positives = 102/307 (33%), Gaps = 36/307 (11%)
Query: 79 NNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILA 138
N + WI +S + + L + V + L + F N + L L+
Sbjct: 82 FNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVT-DDCLELI-AKSFKNFKVLV-LS 138
Query: 139 YYDGFTGSIPSEISA-LSKLQLLDLSSNRLR--------------GRLTNLNYMSLSRNM 183
+GF+ + I+A L+ LDL + + L +LN L+ +
Sbjct: 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEV 198
Query: 184 LGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ-------NQLSGLP 236
L + + NL L + + + L R L+ L + SGL
Sbjct: 199 SFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS 258
Query: 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS-CNQFNSSIPNELTRLTQLFH 295
+ K L L + + +P+ + S L+ L+LS + + L + +L
Sbjct: 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQR 318
Query: 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSN-NNIKGSIPGEIT---------KLSRLDYLN 345
L + + ++ +DL L + +T +L+ +
Sbjct: 319 LWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVL 378
Query: 346 LSGNKLS 352
+++
Sbjct: 379 YFCRQMT 385
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 42/280 (15%), Positives = 82/280 (29%), Gaps = 34/280 (12%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFT-GSIPSEISALSKLQLLDLSSN 165
L + + LR L+ + +P+ S S+L L+LS
Sbjct: 240 LGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYA 299
Query: 166 RLR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLT-- 215
++ + L + + + L K+L EL V + P
Sbjct: 300 TVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359
Query: 216 --------LSRLTSLKILILAQNQLS--GLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGL 265
L+ ++ Q++ L N N+ + + P TL
Sbjct: 360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP 419
Query: 266 -----------FSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA-S 313
DL L LS + T ++ L ++ S +
Sbjct: 420 LDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG 479
Query: 314 MEDLTWLDLSN-NNIKGSIPGEITKLSRLDYLNLSGNKLS 352
+ L L++ + ++ +KL + L +S +S
Sbjct: 480 CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 54/211 (25%)
Query: 376 CIGTGAYGSVY----KAQLPNGRVFALKKLN-----SPETEE-------LAFIR------ 413
+G G++G V+ + +++A+K L + L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 414 ---SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDC 466
+F+ E + +L + G LF L + E + V A +A AL +LH
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE----EDVKFYLAELALALDHLH--- 143
Query: 467 SPSVVHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPELA 521
S +++RD+ NILL+ KL DFG ++ + + + G+ Y+APE
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKL----TDFGLSKESIDHEKKAYSFC-GTVEYMAPE-- 196
Query: 522 YTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
+V + D +SFGV+ E+L G P
Sbjct: 197 --VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 59/224 (26%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFA---LKKLNSPETEELAFIRSFRNEAQVLSQMER----- 427
IG G+Y V +L R++A +KK + E++ ++++ E V Q
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLV 116
Query: 428 ---------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHD 465
G L + + E + A ++ AL YLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALNYLH-- 170
Query: 466 CSPSVVHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPEL 520
+++RD+ +N+LL+S KL D+G + L + T G+ YIAPE+
Sbjct: 171 -ERGIIYRDLKLDNVLLDSEGHIKL----TDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 224
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGKHPRDLHSTLSSSYD 560
+ E Y D ++ GV+ E++ G+ P D+ + +
Sbjct: 225 ----LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 56/213 (26%)
Query: 376 CIGTGAYGSVYKAQLPN----GRVFALKKL-------NSPETE----E---LAFIR---- 413
+G G YG V++ + G++FA+K L N+ +T E L ++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 414 -----SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHH 464
+F+ + +L + G LF L + +E A ++ AL +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME----DTACFYLAEISMALGHLH- 138
Query: 465 DCSPSVVHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPE 519
+++RD+ NI+LN KL DFG + +H + T G+ Y+APE
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKL----TDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191
Query: 520 LAYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
++M + D +S G + ++L G P
Sbjct: 192 ----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 47/206 (22%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
+G G++G V ++ ++A+K L + + E +VL+ +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 428 ------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
G L + E A +A L +L S
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQ---SK 461
Query: 469 SVVHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
+++RD+ +N++L+S E + ADFG + D G+ YIAPE+ +
Sbjct: 462 GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI----IA 515
Query: 527 TEKY----DVYSFGVVTLEVLMGKHP 548
+ Y D ++FGV+ E+L G+ P
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 58/216 (26%)
Query: 376 CIGTGAYGSVYKAQLP----NGRVFALKKLNSPE-TEELAFIRSFRNEAQVLSQMER--- 427
+GTGAYG V+ + G+++A+K L ++ R E QVL + +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 428 -----------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLH 463
G LF L E V I + AL +LH
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLALEHLH 176
Query: 464 HDCSPSVVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAP 518
+++RDI NILL+S L DFG ++ AD + + G+ Y+AP
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGHVVL----TDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 519 ELAYTMVMTEKY------DVYSFGVVTLEVLMGKHP 548
+ +V D +S GV+ E+L G P
Sbjct: 230 D----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 52/208 (25%), Positives = 80/208 (38%), Gaps = 51/208 (24%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------- 427
IG G++G V A+ +A+K L + + +E VL + +
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 428 ------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
G LF L + +E R A +A AL YLH S
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASALGYLH---SL 158
Query: 469 SVVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
++V+RD+ NILL+S L DFG + +S + G+ Y+APE +
Sbjct: 159 NIVYRDLKPENILLDSQGHIVL----TDFGLCKENIEHNSTTSTFCGTPEYLAPE----V 210
Query: 525 VMTEKY----DVYSFGVVTLEVLMGKHP 548
+ + Y D + G V E+L G P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 45/205 (21%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL-----------NSPETEE--LAFIR--------- 413
+G G++G V A++ G ++A+K L TE+ L+ R
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 414 -SFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
F+ + V+ + G L + E R A + AL +LH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISALMFLH---DK 143
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPELAYTMVMT 527
+++RD+ +N+LL+ + +ADFG + + + T G+ YIAPE+ +
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEI----LQE 198
Query: 528 EKY----DVYSFGVVTLEVLMGKHP 548
Y D ++ GV+ E+L G P
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 55/208 (26%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTG++G V+ + NGR +A+K L L + +E +LS
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 425 -----------MER---GSLFRILHNDAEAVELDWAKRVNIVKA------MAHALAYLHH 464
M+ G LF +L ++R A + AL YLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEVCLALEYLH- 123
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
S +++RD+ NILL+ + DFG A+ + T L G+ YIAPE+
Sbjct: 124 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYT-LCGTPDYIAPEV---- 174
Query: 525 VMTEKY----DVYSFGVVTLEVLMGKHP 548
V T+ Y D +SFG++ E+L G P
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 49/207 (23%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKL-----------NSPETE----ELA----FI---- 412
+G G++G V+ A+ + FA+K L E LA F+
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 413 RSFRNEAQ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 468
+F+ + V+ + G L + + + R A + L +LH S
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEIILGLQFLH---SK 137
Query: 469 SVVHRDISSNNILLNSKLEAFV--ADFGTARL-LHADSSNQTLLAGSYGYIAPELAYTMV 525
+V+RD+ +NILL+ + + ADFG + + D+ T G+ YIAPE+ +
Sbjct: 138 GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEI----L 190
Query: 526 MTEKY----DVYSFGVVTLEVLMGKHP 548
+ +KY D +SFGV+ E+L+G+ P
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 59/212 (27%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFA---LKKLNSPETEELAFIRSFRNEAQVLSQMER----- 427
+G G++G V ++ ++A LKK + +++ E +VL+ +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLALPGKPPFLT 84
Query: 428 ---------------------GSLFRILHNDAEAVELDWAKRVNIVKA-MAHALAYLHHD 465
G L + E A +A L +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQ-- 138
Query: 466 CSPSVVHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNQTLLAGSYGYIAPEL 520
S +++RD+ +N++L+S K+ ADFG + + + +T G+ YIAPE
Sbjct: 139 -SKGIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENIWDGVTTKT-FCGTPDYIAPE- 191
Query: 521 AYTMVMTEKY----DVYSFGVVTLEVLMGKHP 548
++ + Y D ++FGV+ E+L G+ P
Sbjct: 192 ---IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 35/217 (16%), Positives = 68/217 (31%), Gaps = 39/217 (17%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIG-----NLKNLIELDVGDNSL--IGPIPLTLSRLTSLK 223
L++L ++L+ + + + L E+++ L G L L +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPVFLRAR 129
Query: 224 ILILAQNQL---------SGLPQEIGNLKNLMLLDVGNNDI----IGPIPSTLGLFSDLS 270
L L N L L + + L + NN + + + L + ++
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLH---DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186
Query: 271 YLDLSCNQFN----SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM----EDLTWLDL 322
+L L + +L R QL L+++ N +A L L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246
Query: 323 SNNNIK-------GSIPGEITKLSRLDYLNLSGNKLS 352
N + + G +R+ G +S
Sbjct: 247 YFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 32/229 (13%), Positives = 66/229 (28%), Gaps = 53/229 (23%)
Query: 151 ISALSKLQLLDLSSNR------------LRGRLTNLNYMSLSRNMLGG----LLPQEIGN 194
+ + + L L N L + + LS N L +L + +
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181
Query: 195 LKNLIELDVGDNSLIGP-----IPLTLSRLTSLKILILAQNQLSG-----LPQEIGNLKN 244
++ L + +G + L R L+ L +A N L + +
Sbjct: 182 NTSVTHLSLLHTG-LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPS 240
Query: 245 LMLLDVGNNDI----IGPIPSTLGLFSDLSYLDL---SCNQF---------------NSS 282
L LL + N++ + G + + + NS
Sbjct: 241 LELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSW 300
Query: 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASM----EDLTWLDLSNNNI 327
+ R +L DL ++ + P + A + ++ L +
Sbjct: 301 DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 47/303 (15%), Positives = 94/303 (31%), Gaps = 111/303 (36%)
Query: 371 IDSKYCI----GTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
+ +Y + G G + +V+ + + + A+K + S E + + +E ++L +
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSV 90
Query: 426 ERG------------------------------------SLFRILH-NDAEAVELDWAKR 448
L + + ++ + + L K+
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 449 VNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN------------------------- 483
I++ + L YLH C ++H DI NILL+
Sbjct: 151 --IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 484 ------------------------SKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIA 517
KL+ +AD G A +H + QT Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR-----QYRS 261
Query: 518 PELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI--MLIDVLDQRLPP 575
E+ D++S + E+ G + + HS + D ++I++L
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG---KV 318
Query: 576 PVD 578
P
Sbjct: 319 PRK 321
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/282 (13%), Positives = 82/282 (29%), Gaps = 39/282 (13%)
Query: 107 LHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166
N + ++N L L + +P ++++ LDL
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN---EMPILFPFAAQIRKLDLLYAL 304
Query: 167 LR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218
L + NL + + L K L L + + +
Sbjct: 305 LETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGL 364
Query: 219 LT------------SLKILILAQNQ-----LSGLPQEIGNLKNLMLLDVGNNDIIGPIPS 261
++ L+ + + + L + + NL + L+ + + I +P
Sbjct: 365 VSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPL 424
Query: 262 TLGL------FSDLSYLDLS--CNQFNSSIPNELTRL-TQLFHLDLSSNKLSGKIPSQIA 312
G+ L + + + + + L S + + +
Sbjct: 425 DNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFS 484
Query: 313 -SMEDLTWLDLSNNNI-KGSIPGEITKLSRLDYLNLSGNKLS 352
+L L++ + +I +TKL L YL + G + S
Sbjct: 485 RGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 43/260 (16%), Positives = 84/260 (32%), Gaps = 37/260 (14%)
Query: 125 FSCFPNLESLRI------------LAYYDGFTGSIPSEISA-LSKLQLLDLSSNRL---- 167
FPNL SL++ + G+ +EIS L +L+ + +
Sbjct: 69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLD 128
Query: 168 -----RGRLTNLNYMSLS--RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRL- 219
+ R +L + L L + + + + L + ++S L L
Sbjct: 129 LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188
Query: 220 ---TSLKILILAQNQLS-----GLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSY 271
TSL++L + + L N ++L+ + VG+ +I+ + ++L
Sbjct: 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAAANLEE 247
Query: 272 LDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK--IPSQIASMEDLTWLDLSNNNIKG 329
+ +P + L L G +P + LDL ++
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLET 307
Query: 330 SIPGE-ITKLSRLDYLNLSG 348
I K L+ L
Sbjct: 308 EDHCTLIQKCPNLEVLETRN 327
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 41/259 (15%), Positives = 80/259 (30%), Gaps = 42/259 (16%)
Query: 98 CNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKL 157
N + G LS+ + F S ++ + R+ LS
Sbjct: 57 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQH-------------MDLSNS 103
Query: 158 QLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLS 217
+ + + + + + L +SL L + + NL+ L++ S
Sbjct: 104 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG----------CS 153
Query: 218 RLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDII---GPIPSTLGLFSDLSYLDL 274
+ + L + L L++ + + ++ L+L
Sbjct: 154 GFSEFALQTLLS-----------SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202
Query: 275 S-CNQF--NSSIPNELTRLTQLFHLDLSS-NKLSGKIPSQIASMEDLTWLDLSN-NNIKG 329
S + S + + R L HLDLS L + + L L LS +I
Sbjct: 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 262
Query: 330 SIPGEITKLSRLDYLNLSG 348
E+ ++ L L + G
Sbjct: 263 ETLLELGEIPTLKTLQVFG 281
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 70/224 (31%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
+ +Y IG G++G V KA + ALK + + + F R E ++L +
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHL 150
Query: 426 E-------------------RG-----------SLFRIL-HNDAEAVELDWAKRVNIVKA 454
R +L+ ++ N + L ++ +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHS 208
Query: 455 MAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF--VADFGTARLLHADSSNQTLLAGS 512
+ L LH ++H D+ NILL + + V DFG++ H Q +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-----QRV---- 256
Query: 513 YGYI------APE----LAYTMVMTEKYDVYSFGVVTLEVLMGK 546
Y YI APE Y M + D++S G + E+L G
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPI----DMWSLGCILAELLTGY 296
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 602 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.98 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.98 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.98 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.98 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.98 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.98 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.98 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.86 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.66 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.53 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.48 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.44 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.42 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.59 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.3 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.15 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.63 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.54 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.47 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.4 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.36 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.01 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 89.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 86.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 86.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 83.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 82.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 81.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 81.84 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=346.52 Aligned_cols=217 Identities=22% Similarity=0.379 Sum_probs=172.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
.++|+..+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|++++..+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999986 47999999999765544444556788999998444
Q ss_pred ----hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 426 ----ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 426 ----~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++|+|.+++.. ...+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 45555555432 345899999999999999999999 88999999999999999999999999999998754
Q ss_pred CC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 502 DS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
+. ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+ ....+..+....+..+.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~~p~-- 255 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFAKIIKLEYDFPE-- 255 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCT--
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCc--
Confidence 32 23345689999999999999999999999999999999999999997432 12233444444433221
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+|+++||++
T Consensus 256 ~---~s~~~~dli~~lL~~dp~~ 275 (311)
T 4aw0_A 256 K---FFPKARDLVEKLLVLDATK 275 (311)
T ss_dssp T---CCHHHHHHHHHHSCSSGGG
T ss_pred c---cCHHHHHHHHHHccCCHhH
Confidence 1 1123788999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=344.65 Aligned_cols=219 Identities=26% Similarity=0.425 Sum_probs=161.8
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------Hh
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------SQ 424 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------~~ 424 (602)
+++...+.||+|+||+||+|++.+ .||||+++..... ....+.|.+|+.++ ||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 467778899999999999998753 5899998754332 23457899999988 66
Q ss_pred hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC-
Q 047576 425 MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS- 503 (602)
Q Consensus 425 l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~- 503 (602)
+++|+|.++++.. ...++|.++..|+.|||+||+||| +++||||||||+|||+|+++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 6667776666542 235899999999999999999999 7899999999999999999999999999998764322
Q ss_pred -CCcccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC-CCCC
Q 047576 504 -SNQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPVD 578 (602)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~ 578 (602)
.......||+.|||||++.+ +.++.++|||||||++|||+||+.||..... ...+..++..... +...
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------RDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHTTCCCCCST
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCCcc
Confidence 22344689999999999864 4589999999999999999999999975322 1112222222211 1111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+...+.+++.+||+.||++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~ 284 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEE 284 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTT
T ss_pred cccccchHHHHHHHHHHcCCCHhH
Confidence 111123455889999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.65 Aligned_cols=219 Identities=24% Similarity=0.369 Sum_probs=165.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 36899999999999999999986 479999999987654332 2356788999988
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.+++... ....+++.+++.|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 555566666655432 1234688999999999999999999 88999999999999999999999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.....+..+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ....+..++....++.. ..
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~~~-~~- 248 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPPVS-LH- 248 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCC-TT-
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCC-cc-
Confidence 3222344679999999999999999999999999999999999999997532 12233444444443221 11
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 249 --~s~~~~~li~~~L~~dP~~ 267 (350)
T 4b9d_A 249 --YSYDLRSLVSQLFKRNPRD 267 (350)
T ss_dssp --SCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHccCChhH
Confidence 2234789999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.75 Aligned_cols=217 Identities=26% Similarity=0.385 Sum_probs=167.8
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|...+.||+|+||+||+|++. +++.||||+++..... ..+.|.+|++++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH---HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56888899999999999999753 5789999999765432 457899999988
Q ss_pred -----HhhhcCcccccccccc----------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc
Q 047576 423 -----SQMERGSLFRILHNDA----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE 487 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~ 487 (602)
||+++|+|.++++... ....++|.+++.|+.|||+||+||| +++||||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCc
Confidence 6677777777776432 1235899999999999999999999 789999999999999999999
Q ss_pred ceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccc
Q 047576 488 AFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIM 564 (602)
Q Consensus 488 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 564 (602)
+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~ 239 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV 239 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 999999999876443221 223468999999999999999999999999999999999 9999975321 222
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+..+.+.... +.++. ....+.+++.+||+.||++
T Consensus 240 ~~~i~~~~~~-~~p~~---~~~~~~~li~~cl~~dP~~ 273 (299)
T 4asz_A 240 IECITQGRVL-QRPRT---CPQEVYELMLGCWQREPHM 273 (299)
T ss_dssp HHHHHHTCCC-CCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHcCCCC-CCCcc---chHHHHHHHHHHcCCChhH
Confidence 3333333222 11111 3445889999999999974
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.97 Aligned_cols=282 Identities=27% Similarity=0.472 Sum_probs=235.0
Q ss_pred CCHHHHHHHhc------cCCCCCCCCCCCCCCCCC--CCCceeCCC---CCEEEEEecCCCCCCCc--ccccCCCCCCCC
Q 047576 64 PIQLETKALLN------TGWWNNSWTMDYDSDHCE--WIGITCNSA---GSIIGLHLSKDNVNFNG--RLSHLNFSCFPN 130 (602)
Q Consensus 64 ~~~~~~~al~~------~~~~~~~w~~~~~~~~C~--w~gv~C~~~---~~v~~l~l~~~~~~~~~--~l~~~~~~~l~~ 130 (602)
|.+.|++||++ ...+.++|.. +.+||. |.||+|+.. ++|+.|++++.++. | .++. .++.+++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~--~~~~~~~-~l~~l~~ 77 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP--KPYPIPS-SLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCS--SCEECCG-GGGGCTT
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCcc--CCcccCh-hHhCCCC
Confidence 45677777765 1123356753 468998 999999864 79999999766543 4 4443 5677778
Q ss_pred CccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEe
Q 047576 131 LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDV 203 (602)
Q Consensus 131 L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 203 (602)
|+.|++.. .+++.+.+|..|+++++|++|+|++|+|++ .+++|++|+|++|.+++.+|..|+++++|++|+|
T Consensus 78 L~~L~L~~-~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 78 LNFLYIGG-INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp CSEEEEEE-ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCeeeCCC-CCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 88777751 277888899999999999999999998873 4788999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCcC-CCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCC
Q 047576 204 GDNSLIGPIPLTLSRLT-SLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281 (602)
Q Consensus 204 ~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 281 (602)
++|++++.+|..++.++ +|++|++++|++++ +|..+..++ |+.|++++|++++.+|..+..+++|+.|+|++|.+++
T Consensus 157 ~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceee
Confidence 99999888999998888 89999999999987 888888887 9999999999998888889999999999999999987
Q ss_pred CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCc-CCCc
Q 047576 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK-LSGR 354 (602)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~ 354 (602)
.+|. +..+++|++|+|++|+|++.+|..+..+++|+.|+|++|+++|.+|.. ..+++|+.+++++|+ ++|.
T Consensus 236 ~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp BGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred ecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 7765 788889999999999999889999999999999999999999888876 888899999999997 6764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=344.06 Aligned_cols=218 Identities=24% Similarity=0.338 Sum_probs=167.6
Q ss_pred ccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
.+++..+.||+|+||+||+|++ .+++.||||+++..... ...+.|.+|+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3566678899999999999985 25789999999754322 2346789999988
Q ss_pred -----HhhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 423 -----SQMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
||+++|+|.+++.... ....++|.++..|+.|||+||+||| +++||||||||+|||+|+
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence 6777777777775321 1235899999999999999999999 789999999999999999
Q ss_pred CCcceeecccccccccCCC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||+++...... ...+...||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence 9999999999998764322 22334579999999999999999999999999999999999 8999975321
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+..+.+... .+.+.. +...+.+++..||+.||++
T Consensus 254 ~~~~~~i~~~~~-~~~p~~---~~~~~~~li~~C~~~dP~~ 290 (308)
T 4gt4_A 254 QDVVEMIRNRQV-LPCPDD---CPAWVYALMIECWNEFPSR 290 (308)
T ss_dssp HHHHHHHHTTCC-CCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHcCCC-CCCccc---chHHHHHHHHHHcCCChhH
Confidence 222223333222 222222 4455889999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=345.24 Aligned_cols=219 Identities=22% Similarity=0.343 Sum_probs=168.7
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++..+.|+++.+++...
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45888889999999999999864 7999999998654332 346688999999665555555443211
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....+....
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 01234899999999999999999999 7899999999999999999999999999999876655555
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ...+..+.+. .++.... ......
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~-~~~~~~~-~~~~s~ 298 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDN-LPPRLKN-LHKVSP 298 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS-SCCCCSC-GGGSCH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcC-CCCCCCc-cccCCH
Confidence 567899999999999999999999999999999999999999975322 1122222222 1111110 011223
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++.+||++||++
T Consensus 299 ~~~dli~~~L~~dP~~ 314 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQ 314 (346)
T ss_dssp HHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHcCCChhH
Confidence 4789999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=344.89 Aligned_cols=216 Identities=27% Similarity=0.395 Sum_probs=162.2
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|...+.||+|+||+||+|++. +++.||||+++..... ..+.|.+|++++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 56777889999999999999753 5789999999765432 457899999988
Q ss_pred -----HhhhcCccccccccccc------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 423 -----SQMERGSLFRILHNDAE------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
||+++|+|.++++.... ..+++|.+++.|+.|||+||+||| +++||||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCC
Confidence 66777777777654321 235899999999999999999999 7899999999999999999
Q ss_pred CcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcc
Q 047576 486 LEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPK 562 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 562 (602)
+.+||+|||+|+....... ..+...||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~ 267 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------T 267 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------H
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------H
Confidence 9999999999987644322 2234579999999999999999999999999999999999 9999975322 1
Q ss_pred cchhhhhcc-CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 IMLIDVLDQ-RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ~~~~~~~d~-~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+..+.+. +++.| +. ....+.+++.+||+.||++
T Consensus 268 ~~~~~i~~g~~~~~p--~~---~~~~~~~li~~cl~~dP~~ 303 (329)
T 4aoj_A 268 EAIDCITQGRELERP--RA---CPPEVYAIMRGCWQREPQQ 303 (329)
T ss_dssp HHHHHHHHTCCCCCC--TT---CCHHHHHHHHHHCCSSTTT
T ss_pred HHHHHHHcCCCCCCc--cc---ccHHHHHHHHHHcCcChhH
Confidence 222233322 12222 11 3345889999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.33 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=163.8
Q ss_pred CccccCcccccccccccceeeec----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------- 422 (602)
+++|+..+.||+|+||+||+|+. ..++.||||++++...... ....+.+|++++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 46899999999999999999974 2578999999875532211 123566787766
Q ss_pred ----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 423 ----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 423 ----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
||+++|+|.+++.. ...+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 66777777777654 345899999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
...........+||+.|||||++.+..++.++||||+||++|||+||+.||...+ ....+..+....++.|.
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~p~- 247 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-------RKETMTMILKAKLGMPQ- 247 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCT-
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-------HHHHHHHHHcCCCCCCC-
Confidence 6544444455789999999999999999999999999999999999999997532 12233444444443321
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+||++||++
T Consensus 248 -~---~s~~~~~li~~~L~~dP~~ 267 (304)
T 3ubd_A 248 -F---LSPEAQSLLRMLFKRNPAN 267 (304)
T ss_dssp -T---SCHHHHHHHHHHTCSSGGG
T ss_pred -c---CCHHHHHHHHHHcccCHHH
Confidence 1 1234788999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=327.92 Aligned_cols=218 Identities=21% Similarity=0.296 Sum_probs=156.6
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|...+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|+.++..+.|+++.++....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999986 47999999999766554444567789999999888887776654321
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~ 168 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FL 168 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-cc
Confidence 11235899999999999999999999 7899999999999999999999999999998765433 23
Q ss_pred cccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 507 TLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
....||+.|||||++.+..+ +.++||||+||++|||+||+.||+.... ...+..+.+...+.+. . ..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~~~~p~--~---~s 236 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGVYTLPK--F---LS 236 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCT--T---SC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCC--C---CC
Confidence 34689999999999998876 5799999999999999999999974321 1222333333333221 1 12
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|+++||++
T Consensus 237 ~~~~~li~~~L~~dP~~ 253 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLN 253 (275)
T ss_dssp HHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHHHccCChhH
Confidence 33778999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=330.72 Aligned_cols=215 Identities=22% Similarity=0.341 Sum_probs=160.6
Q ss_pred cCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 372 DSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 372 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
.....||+|+||+||+|+.. +++.||+|++....... ...+.|.+|+.++..+.|+++..++...
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 55678999999999999864 68899999987544322 2356799999999777777766654310
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCC-CCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNS-KLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~-~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..|+.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 01234889999999999999999999 666 999999999999985 79999999999986432
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
......+||+.|||||++.+ .++.++|||||||++|||+||+.||...... ......+.....+...+..
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~~- 254 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKV- 254 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGGC-
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCCcc-
Confidence 23445689999999998865 6999999999999999999999999743211 1111122222222111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 255 --~~~~~~~li~~~L~~dP~~ 273 (290)
T 3fpq_A 255 --AIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp --CCHHHHHHHHHHSCSSGGG
T ss_pred --CCHHHHHHHHHHccCChhH
Confidence 2234789999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.06 Aligned_cols=216 Identities=23% Similarity=0.335 Sum_probs=168.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
..|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++..+.|+++.+++....
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 46888899999999999999864 7999999998654332 3456889999995555555554432110
Q ss_pred ------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 439 ------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 439 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
....+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+.......
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 1234899999999999999999999 8899999999999999999999999999999876655555
Q ss_pred cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc---CCCCCCChhhHH
Q 047576 507 TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ---RLPPPVDRKVIQ 583 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~---~l~~~~~~~~~~ 583 (602)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..+..+.+. .+... ..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~~~~~~--~~--- 372 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPRLKNL--HK--- 372 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSCT--TS---
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCCCCccc--cc---
Confidence 5678999999999999999999999999999999999999999753221 112222222 22111 11
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 373 ~s~~~~dli~~~L~~dP~~ 391 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQ 391 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTT
T ss_pred CCHHHHHHHHHHcCCChhH
Confidence 2234789999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.99 Aligned_cols=225 Identities=25% Similarity=0.368 Sum_probs=160.8
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
++|...+.||+|+||+||+|++ +|+.||||++....... ..+..|+..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4577788999999999999998 68999999997544321 1122344332
Q ss_pred ---HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 423 ---SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 423 ---~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
||+++|+|.++++. ..++|.++.+++.|+++||+|||+. +.++||||||||+|||+|.++.+||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 55666666666643 3489999999999999999999943 13499999999999999999999999999
Q ss_pred ccccccCCCCC----ccccccccccccccccccC------cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCC----
Q 047576 495 TARLLHADSSN----QTLLAGSYGYIAPELAYTM------VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYD---- 560 (602)
Q Consensus 495 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~---- 560 (602)
+|+........ .....||+.|||||++.+. .++.++|||||||++|||+||+.||.........+.
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99877543321 2235799999999998764 467899999999999999999998864332221111
Q ss_pred c----ccchhhhhccCCCCCCCh--hhHHHHHHHHHHHhhccCcCCCC
Q 047576 561 P----KIMLIDVLDQRLPPPVDR--KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 561 ~----~~~~~~~~d~~l~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ......+.+..++++.+. ...+....+.+++.+||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~ 281 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence 0 111222344444333222 11245667899999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.46 Aligned_cols=210 Identities=22% Similarity=0.293 Sum_probs=159.3
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
+.|...+.||+|+||.||+|+. .+|+.||||+++... ...+|+.++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4677778899999999999986 469999999986432 224577765
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHA 501 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.++++. ...+++.++..|+.||+.||+||| +++||||||||+|||++.++ ++||+|||+|+....
T Consensus 130 Ey~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 66677777776653 345899999999999999999999 88999999999999999987 699999999988754
Q ss_pred CCCC-----ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-
Q 047576 502 DSSN-----QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP- 575 (602)
Q Consensus 502 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~- 575 (602)
+... ....+||+.|||||++.+..++.++||||+||++|||+||+.||..... ...+..+.....+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-------GPLCLKIASEPPPIR 276 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-------SCCHHHHHHSCCGGG
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHcCCCCch
Confidence 3221 2235799999999999999999999999999999999999999975322 11222333322110
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..... ....+.+++.+||++||++
T Consensus 277 ~~~~~---~s~~~~~li~~~L~~dP~~ 300 (336)
T 4g3f_A 277 EIPPS---CAPLTAQAIQEGLRKEPVH 300 (336)
T ss_dssp GSCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred hcCcc---CCHHHHHHHHHHccCCHhH
Confidence 01111 2234788999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.32 Aligned_cols=220 Identities=24% Similarity=0.305 Sum_probs=167.8
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
.++|...+.||+|+||+||+|+.. .++.||||+++..... ...+.|.+|+.++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 357888899999999999999742 3468999999765433 2346788899887
Q ss_pred --------HhhhcCccccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCee
Q 047576 423 --------SQMERGSLFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNIL 481 (602)
Q Consensus 423 --------~~l~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 481 (602)
||+++|+|.++++.... ...++|.+++.|+.|||+||+||| +++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 55666666666653221 234899999999999999999999 789999999999999
Q ss_pred eCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccC
Q 047576 482 LNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSS 558 (602)
Q Consensus 482 ld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 558 (602)
+++++.+||+|||+|+....+... .+...||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---- 293 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 293 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999999876544322 234578999999999999999999999999999999998 9999975321
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+...+....+++.+.. ...++.+++..||+.||++
T Consensus 294 ---~~~~~~~i~~g~~~~~p~~---~~~~~~~li~~c~~~dP~~ 331 (353)
T 4ase_A 294 ---DEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQ 331 (353)
T ss_dssp ---SHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred ---HHHHHHHHHcCCCCCCCcc---CCHHHHHHHHHHcCcChhH
Confidence 1122233322222121111 2345889999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.61 Aligned_cols=216 Identities=23% Similarity=0.395 Sum_probs=153.5
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------------ 435 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------------ 435 (602)
.+|+..+.||+|+||+||+|+. .+|+.||||+++..... ...+.+.+|+.++..+.|+++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 4688889999999999999986 47999999998654332 23467889999997777777665442
Q ss_pred -------------------------cccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCccee
Q 047576 436 -------------------------NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 436 -------------------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
........++..++.|+.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 1111223456778899999999999999 789999999999999999999999
Q ss_pred ecccccccccCCCCC------------ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccC
Q 047576 491 ADFGTARLLHADSSN------------QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS 558 (602)
Q Consensus 491 ~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 558 (602)
+|||+|+....+... .+..+||+.|||||++.+..++.++||||+||++|||++ ||.....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---- 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---- 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence 999999877543211 123479999999999999999999999999999999996 7753211
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+..+.+...+ +...+......+++.+||++||++
T Consensus 233 --~~~~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~ 270 (299)
T 4g31_A 233 --RVRTLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPME 270 (299)
T ss_dssp --HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGG
T ss_pred --HHHHHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhH
Confidence 11112223332222 122223344678999999999974
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.29 Aligned_cols=287 Identities=23% Similarity=0.362 Sum_probs=252.4
Q ss_pred CCCCHHHHHHHhc------cCCCC---------CCCCCCCCCCCCCC---CCceeCCCCCEEEEEecCCCCCCCcccccC
Q 047576 62 LSPIQLETKALLN------TGWWN---------NSWTMDYDSDHCEW---IGITCNSAGSIIGLHLSKDNVNFNGRLSHL 123 (602)
Q Consensus 62 ~~~~~~~~~al~~------~~~~~---------~~w~~~~~~~~C~w---~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~ 123 (602)
......|+.||.+ ...|. .+|+ .+.+||.| .||+|+..++|++|++++.+ +.|.++.
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~--~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~--l~g~lp~- 99 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWN--FNKELDMWGAQPGVSLNSNGRVTGLSLEGFG--ASGRVPD- 99 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCC--CSSCGGGTTCCTTEEECTTCCEEEEECTTSC--CEEEECG-
T ss_pred hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCC--CCCCcccccCCCCeEEcCCCCEEEEEecCcc--cCCcCCh-
Confidence 3445678888877 12243 1565 35899999 99999988999999997654 4577774
Q ss_pred CCCCCCCCccchhccc----------------------------------------------------------------
Q 047576 124 NFSCFPNLESLRILAY---------------------------------------------------------------- 139 (602)
Q Consensus 124 ~~~~l~~L~~L~l~~~---------------------------------------------------------------- 139 (602)
.++.+++|+.|++...
T Consensus 100 ~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~ 179 (636)
T 4eco_A 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179 (636)
T ss_dssp GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCC
T ss_pred HHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccc
Confidence 6889999999888643
Q ss_pred ------------cCCccccCCccCCCCCCCCEEECcCCcCcc--------------------------cCCCcCEEECcC
Q 047576 140 ------------YDGFTGSIPSEISALSKLQLLDLSSNRLRG--------------------------RLTNLNYMSLSR 181 (602)
Q Consensus 140 ------------~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~--------------------------~l~~L~~L~L~~ 181 (602)
.+++.| ||++|+++++|++|+|++|+|++ .+++|++|+|++
T Consensus 180 ~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~ 258 (636)
T 4eco_A 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258 (636)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEEC
T ss_pred ccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecC
Confidence 124556 89999999999999999999998 688999999999
Q ss_pred CcCCCCCchhhhCCCCCCEEEecCCC-CCC-CCcccccCc------CCCceeecccccCCCCcc--cccCCCCCcEEEcc
Q 047576 182 NMLGGLLPQEIGNLKNLIELDVGDNS-LIG-PIPLTLSRL------TSLKILILAQNQLSGLPQ--EIGNLKNLMLLDVG 251 (602)
Q Consensus 182 N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~ 251 (602)
|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|++++|+++.+|. .++++++|++|+++
T Consensus 259 n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp CTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECC
T ss_pred CcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCc
Confidence 99999999999999999999999998 998 899999887 999999999999999999 89999999999999
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCC-CCEEeccCCCCCCCCCcccCCCC--CCCEEeCCCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ-LFHLDLSSNKLSGKIPSQIASME--DLTWLDLSNNNIK 328 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~ 328 (602)
+|+++|.+| .++.+++|++|++++|+++ .+|..++.+++ |++|+|++|+++ .+|..+..++ +|+.|++++|+++
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~ 415 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC
Confidence 999999999 8999999999999999999 78888999999 999999999999 7888887765 8999999999999
Q ss_pred CCCCcccc-------cccccccccccCCcCCCccCCC
Q 047576 329 GSIPGEIT-------KLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 329 ~~~p~~~~-------~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
+.+|..+. .+++|+.|++++|+++ .+|..
T Consensus 416 ~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~ 451 (636)
T 4eco_A 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKE 451 (636)
T ss_dssp TTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTH
T ss_pred CcchhhhcccccccccCCCCCEEECcCCccC-cCCHH
Confidence 99999888 8889999999999998 45543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=352.73 Aligned_cols=280 Identities=29% Similarity=0.492 Sum_probs=174.1
Q ss_pred CHHHHHHHhcc--CC----CCCCCCCCCCCCCCCCCCceeCCCCCEEEEEecCCCCCCCcc---ccc-------------
Q 047576 65 IQLETKALLNT--GW----WNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGR---LSH------------- 122 (602)
Q Consensus 65 ~~~~~~al~~~--~~----~~~~w~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~---l~~------------- 122 (602)
...|++||++. +. ..++|. .+.|||.|.||+|+ .++|++|+++..++ .|. +++
T Consensus 10 ~~~~~~all~~k~~~~~~~~l~~W~--~~~~~C~w~gv~C~-~~~v~~L~L~~~~l--~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 10 LYREIHQLISFKDVLPDKNLLPDWS--SNKNPCTFDGVTCR-DDKVTSIDLSSKPL--NVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp HHHHHHHHHHHHTTCSCTTSSTTCC--TTSCGGGSTTEEEE-TTEEEEEECTTSCC--CEEHHHHHHHTTTCTTCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcccccCCC--CCCCCcCCcceEEC-CCcEEEEECCCCCc--CCccCccChhHhccCcccccCC
Confidence 56889999862 11 235786 35799999999998 79999999976543 333 221
Q ss_pred ---------CCCCCCCCCccchhccccCCccccCCc--cCCCCCCCCEEECcCCcCc--------ccCCCcCEEECcCCc
Q 047576 123 ---------LNFSCFPNLESLRILAYYDGFTGSIPS--EISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNM 183 (602)
Q Consensus 123 ---------~~~~~l~~L~~L~l~~~~~~~~~~ip~--~l~~L~~L~~L~Ls~N~i~--------~~l~~L~~L~L~~N~ 183 (602)
-.++.+++|++|++. ++.+.|.+|. .++++++|++|+|++|.+. +.+++|++|+|++|+
T Consensus 85 ~~~~~~~l~~~~~~l~~L~~L~Ls--~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 85 SNSHINGSVSGFKCSASLTSLDLS--RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp TTSCEEECCCCCCCCTTCCEEECC--SSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred cCCCcCCCchhhccCCCCCEEECC--CCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 246677777777777 6778888888 8889999999999988876 346788888888888
Q ss_pred CCCCCchh---hhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCC
Q 047576 184 LGGLLPQE---IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPI 259 (602)
Q Consensus 184 l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~ 259 (602)
+++..|.. ++++++|++|+|++|.+++.+|. ..+++|++|+|++|++++ +|. ++++++|++|++++|++++.+
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 88877766 56666666666666665554442 455555555555555555 333 555555555555555555555
Q ss_pred CCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCC-CCCCEEeCCCCCCCCCCCcccccc
Q 047576 260 PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASM-EDLTWLDLSNNNIKGSIPGEITKL 338 (602)
Q Consensus 260 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l 338 (602)
|..++.+++|++|++++|.+++.+|.. .+++|++|+|++|+++|.+|..+... ++|++|+|++|++++.+|..++.+
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l 317 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred cHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence 555555555555555555555544432 44444444444444444444444332 444444444444444444444444
Q ss_pred cccccccccCCcCCCccC
Q 047576 339 SRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 339 ~~L~~L~l~~N~l~g~~p 356 (602)
++|+.|++++|+++|.+|
T Consensus 318 ~~L~~L~L~~n~l~~~ip 335 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELP 335 (768)
T ss_dssp TTCCEEECCSSEEEEECC
T ss_pred CCccEEECCCCcccCcCC
Confidence 444444444444444444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.69 Aligned_cols=218 Identities=22% Similarity=0.274 Sum_probs=165.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhH---HHHH---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNE---AQVL--------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E---~~il--------------------- 422 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++.+.............+| +.++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999864 699999999975543322222223333 3333
Q ss_pred ----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 423 ----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 423 ----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
||+++|+|..++.. ...+++..++.|+.||+.||+||| +++||||||||+|||+|.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 67777888877764 345899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
..... ....+||+.|||||++.+ ..|+.++||||+||++|||+||+.||...... ........+.......+.
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~----~~~~i~~~i~~~~~~~p~ 415 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLTMAVELPD 415 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC----CHHHHHHHHHHCCCCCCT
T ss_pred cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhhcCCCCCCCc
Confidence 75433 234689999999999975 57999999999999999999999999743211 111112233333333221
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+|+++||++
T Consensus 416 --~---~S~~a~dLI~~lL~~dP~~ 435 (689)
T 3v5w_A 416 --S---FSPELRSLLEGLLQRDVNR 435 (689)
T ss_dssp --T---SCHHHHHHHHHHTCSCGGG
T ss_pred --c---CCHHHHHHHHHHccCCHhH
Confidence 1 1223789999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.48 Aligned_cols=182 Identities=25% Similarity=0.340 Sum_probs=150.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|++++..+.|+++..+++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 35799999999999999999986 47999999999755432 22346788999999999998887665310
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 01345899999999999999999999 889999999999999999999999999999876
Q ss_pred cCC----CCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 500 HAD----SSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 500 ~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 432 1223446899999999998875 46899999999999999999999997643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.80 Aligned_cols=170 Identities=29% Similarity=0.387 Sum_probs=136.4
Q ss_pred CccccCcccccccccccceeeec----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLS-------------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~-------------------- 423 (602)
.+.|+..+.||+|+||+||+|+. .+++.||+|++...... .++.+|++++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 46799999999999999999974 25789999988655432 34667888774
Q ss_pred ------hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccccc
Q 047576 424 ------QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTA 496 (602)
Q Consensus 424 ------~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a 496 (602)
|+++|+|.+++. .+++.+++.|+.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 444444444442 3889999999999999999999 8899999999999999877 79999999999
Q ss_pred ccccCCCC----------------------------CccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCC
Q 047576 497 RLLHADSS----------------------------NQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKH 547 (602)
Q Consensus 497 ~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~ 547 (602)
+....... ..+..+||+.|+|||++.+.. ++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76533211 112347999999999998764 8999999999999999999999
Q ss_pred CCCC
Q 047576 548 PRDL 551 (602)
Q Consensus 548 Pf~~ 551 (602)
||..
T Consensus 246 Pf~~ 249 (361)
T 4f9c_A 246 PFYK 249 (361)
T ss_dssp SSSC
T ss_pred CCCC
Confidence 9954
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=335.77 Aligned_cols=286 Identities=23% Similarity=0.321 Sum_probs=237.3
Q ss_pred CCCHHHHHHHhcc--CCCCCCCCCCC---CCCC--CCC------------CCceeCCCCCEEEEEecCCCCCCCcccccC
Q 047576 63 SPIQLETKALLNT--GWWNNSWTMDY---DSDH--CEW------------IGITCNSAGSIIGLHLSKDNVNFNGRLSHL 123 (602)
Q Consensus 63 ~~~~~~~~al~~~--~~~~~~w~~~~---~~~~--C~w------------~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~ 123 (602)
.....|+.||++. ++-..+|+... ..+| |+| .||+|+..++|++|+|++.+ +.|.+++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~--L~G~ip~- 341 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFG--AKGRVPD- 341 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTC--CEEEECG-
T ss_pred ccchHHHHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCC--CCCcCch-
Confidence 3456788898872 11112454332 2344 999 99999988999999997654 4577774
Q ss_pred CCCCCCCCccchh-ccc---------------------------------------------------------------
Q 047576 124 NFSCFPNLESLRI-LAY--------------------------------------------------------------- 139 (602)
Q Consensus 124 ~~~~l~~L~~L~l-~~~--------------------------------------------------------------- 139 (602)
.++.+++|+.|++ ...
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 6888888888888 210
Q ss_pred ------------cCCccccCCccCCCCCCCCEEECcCCcCcc--------------------------cCCCcCEEECcC
Q 047576 140 ------------YDGFTGSIPSEISALSKLQLLDLSSNRLRG--------------------------RLTNLNYMSLSR 181 (602)
Q Consensus 140 ------------~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~--------------------------~l~~L~~L~L~~ 181 (602)
.|++.+ ||..|+++++|++|+|++|+|++ .+++|++|+|++
T Consensus 422 ~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred ccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 123333 89999999999999999999998 688999999999
Q ss_pred CcCCCCCchhhhCCCCCCEEEecCCC-CCC-CCcccccCcC-------CCceeecccccCCCCcc--cccCCCCCcEEEc
Q 047576 182 NMLGGLLPQEIGNLKNLIELDVGDNS-LIG-PIPLTLSRLT-------SLKILILAQNQLSGLPQ--EIGNLKNLMLLDV 250 (602)
Q Consensus 182 N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L 250 (602)
|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.++ +|+.|+|++|+++.+|. .++++++|+.|+|
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~L 580 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEEC
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEEC
Confidence 99999999999999999999999998 998 8998777776 99999999999999998 8999999999999
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCC-CCEEeccCCCCCCCCCcccCCCCC--CCEEeCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ-LFHLDLSSNKLSGKIPSQIASMED--LTWLDLSNNNI 327 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l 327 (602)
++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|++
T Consensus 581 s~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l 656 (876)
T 4ecn_A 581 VHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656 (876)
T ss_dssp TTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred CCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcC
Confidence 999999 888 8999999999999999999 88888999999 999999999999 78888877654 99999999999
Q ss_pred CCCCCccc---c--cccccccccccCCcCCCccCC
Q 047576 328 KGSIPGEI---T--KLSRLDYLNLSGNKLSGRVPY 357 (602)
Q Consensus 328 ~~~~p~~~---~--~l~~L~~L~l~~N~l~g~~p~ 357 (602)
+|.+|... . .+++|+.|++++|+++ .+|.
T Consensus 657 ~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~ 690 (876)
T 4ecn_A 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPT 690 (876)
T ss_dssp TTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCH
T ss_pred CCccccchhhhccccCCCcCEEEccCCcCC-ccCH
Confidence 98776432 2 3447888999999888 4554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.47 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=219.0
Q ss_pred CHHHHHHHhc--------cCCCCCCCC--CCCCCCCCCCCCceeCC---------CCCEEEEEecCCCCCCCcccccCCC
Q 047576 65 IQLETKALLN--------TGWWNNSWT--MDYDSDHCEWIGITCNS---------AGSIIGLHLSKDNVNFNGRLSHLNF 125 (602)
Q Consensus 65 ~~~~~~al~~--------~~~~~~~w~--~~~~~~~C~w~gv~C~~---------~~~v~~l~l~~~~~~~~~~l~~~~~ 125 (602)
...|++||++ ...|.++|. .+.+.++|.|.|++|+. ..+|+.|+++
T Consensus 25 ~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~--------------- 89 (328)
T 4fcg_A 25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELR--------------- 89 (328)
T ss_dssp CCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEE---------------
T ss_pred CchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEcc---------------
Confidence 4467777765 123445663 12357899999999952 2456666663
Q ss_pred CCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCC
Q 047576 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199 (602)
Q Consensus 126 ~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 199 (602)
+++ ...+|+.++++++|++|+|++|.|+ +.+++|++|+|++|.++ .+|..++++++|+
T Consensus 90 --------------~n~-l~~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~ 153 (328)
T 4fcg_A 90 --------------SVP-LPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153 (328)
T ss_dssp --------------SSC-CSSCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCC
T ss_pred --------------CCC-chhcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCC
Confidence 233 3378888999999999999999887 34788999999999999 7788999999999
Q ss_pred EEEecCCCCCCCCcccccC---------cCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCc
Q 047576 200 ELDVGDNSLIGPIPLTLSR---------LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270 (602)
Q Consensus 200 ~L~L~~N~l~~~~p~~l~~---------l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 270 (602)
+|+|++|++.+.+|..++. +++|++|+|++|+++.+|..++++++|++|+|++|++++ +|..+..+++|+
T Consensus 154 ~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~ 232 (328)
T 4fcg_A 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232 (328)
T ss_dssp EEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCC
T ss_pred EEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCC
Confidence 9999999999999987765 999999999999999999999999999999999999996 666789999999
Q ss_pred cccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCc
Q 047576 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK 350 (602)
Q Consensus 271 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 350 (602)
+|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998876
Q ss_pred CCC
Q 047576 351 LSG 353 (602)
Q Consensus 351 l~g 353 (602)
+..
T Consensus 313 ~~~ 315 (328)
T 4fcg_A 313 QAQ 315 (328)
T ss_dssp SCC
T ss_pred HHH
Confidence 643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.82 Aligned_cols=218 Identities=23% Similarity=0.289 Sum_probs=166.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-------------------- 426 (602)
.++|+..+.||+|+||.||+|+. .+|+.||+|++...... ..+.+.+|+.++..+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999986 47999999998765433 2356788999885544
Q ss_pred -----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC--Ccceeecccccccc
Q 047576 427 -----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK--LEAFVADFGTARLL 499 (602)
Q Consensus 427 -----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFG~a~~~ 499 (602)
+|+|.+++.. ....+++.++..|+.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 4555544432 2235899999999999999999999 8899999999999999854 89999999999987
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ...+..+.......+..
T Consensus 308 ~~~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~- 378 (573)
T 3uto_A 308 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDS- 378 (573)
T ss_dssp CTTS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCSG-
T ss_pred cCCC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHhCCCCCCcc-
Confidence 5433 23446899999999999999999999999999999999999999975322 22223333322221110
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++.+||++||++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~ 401 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNT 401 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGG
T ss_pred cccCCCHHHHHHHHHHccCChhH
Confidence 00112234778999999999974
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=325.84 Aligned_cols=233 Identities=36% Similarity=0.599 Sum_probs=197.1
Q ss_pred CCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCC
Q 047576 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLK 196 (602)
Q Consensus 124 ~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~ 196 (602)
.++.+++|+.|++. .+.+.+.+|..++++++|++|+|++|++.+ .+++|++|+|++|++++.+|..+++++
T Consensus 413 ~l~~l~~L~~L~Ls--~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 490 (768)
T 3rgz_A 413 TLSNCSELVSLHLS--FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490 (768)
T ss_dssp GGGGCTTCCEEECC--SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred HHhcCCCCCEEECc--CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC
Confidence 46667777777776 667777888888888888888888888874 367888888888888888888888888
Q ss_pred CCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCcc------------
Q 047576 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTL------------ 263 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l------------ 263 (602)
+|++|+|++|++++.+|..++.+++|++|+|++|++++ +|..++++++|+.|++++|.++|.+|..+
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~ 570 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTT
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcc
Confidence 88888888888888888888888888888888888887 88888888888888888888887776533
Q ss_pred ----------------------------------------------------------CCCCCCccccCCCCcCCCCCch
Q 047576 264 ----------------------------------------------------------GLFSDLSYLDLSCNQFNSSIPN 285 (602)
Q Consensus 264 ----------------------------------------------------------~~l~~L~~L~L~~N~l~~~~p~ 285 (602)
..+++|++|||++|+++|.+|.
T Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~ 650 (768)
T 3rgz_A 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650 (768)
T ss_dssp CSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCG
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCH
Confidence 3356788888888888888888
Q ss_pred hhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCC
Q 047576 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 286 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
.++++++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|++|++++|+++|.+|..
T Consensus 651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 8888888999999999998888888888888999999999998888888888888889999999998888865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.71 Aligned_cols=220 Identities=22% Similarity=0.266 Sum_probs=168.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+..+.||+|+||.||+|+.. +|+.||+|++++...........+.+|+.++..+.|+.+..+....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999865 6899999999755433333445677899888655555544432210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 01234789999999999999999999 78999999999999999999999999999986544444
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. . .
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~---~ 228 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIRFPR--T---L 228 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCT--T---S
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCC--C---C
Confidence 44556899999999999999999999999999999999999999974321 1222333333333221 1 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+|+++||++
T Consensus 229 s~~~~~li~~lL~~dP~~ 246 (337)
T 1o6l_A 229 SPEAKSLLAGLLKKDPKQ 246 (337)
T ss_dssp CHHHHHHHHHHTCSSTTT
T ss_pred CHHHHHHHHHHhhcCHHH
Confidence 233788999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.96 Aligned_cols=224 Identities=21% Similarity=0.347 Sum_probs=167.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------------------- 424 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~---------------------- 424 (602)
.++|+..+.||+|+||.||+|+.. +++.||+|++++.........+.+.+|..++..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999865 688999999976654434445567778877743
Q ss_pred ----hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 425 ----MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 425 ----l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+++|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 344444444432 245899999999999999999999 7899999999999999999999999999998644
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccC--CCcccchhhhhccCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS--YDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~d~~l~~~~~ 578 (602)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||+........ .........+....+..+..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 4444455578999999999999999999999999999999999999999753221111 11112233344444432221
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 285 -----~s~~~~~li~~lL~~dP~~ 303 (396)
T 4dc2_A 285 -----LSVKAASVLKSFLNKDPKE 303 (396)
T ss_dssp -----SCHHHHHHHHHHTCSCTTT
T ss_pred -----CCHHHHHHHHHHhcCCHhH
Confidence 1234789999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.91 Aligned_cols=217 Identities=22% Similarity=0.336 Sum_probs=163.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++++.........+.+.+|..++..+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999864 6899999999765443333455677788877443
Q ss_pred -----hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 426 -----ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 426 -----~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++|+|..++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 34444444432 245899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....+..+.......+..
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-- 246 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDEVVYPTW-- 246 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--
Confidence 44444445689999999999999899999999999999999999999997532 223344455554433321
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 247 ---~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 247 ---LHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp ---SCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHhhhCHHH
Confidence 1223778999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.19 Aligned_cols=217 Identities=20% Similarity=0.310 Sum_probs=169.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|.....||+|+||.||+|+.. +|+.||+|++++.........+.+..|..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999875 5889999999765433233345667777777
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 44555566655543 235899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....+..+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-- 243 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS-- 243 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhCCCCCCCC--
Confidence 44444455689999999999999999999999999999999999999997432 122334444444432211
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 244 ---~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 244 ---MSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp ---SCHHHHHHHHHHTCSCTTS
T ss_pred ---CCHHHHHHHHHHhhcCHHH
Confidence 1234788999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.08 Aligned_cols=227 Identities=31% Similarity=0.494 Sum_probs=174.2
Q ss_pred CCccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-----------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------------------- 423 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~----------------------- 423 (602)
.+++|+....||+|+||.||+|+..+|+.||||++...... ..+.+.+|+.++.
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46789999999999999999999888999999988765432 2456778888774
Q ss_pred --hhhcCcccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 424 --QMERGSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 424 --~l~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
|+++|+|.+++.... ....+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 445556655554322 1234899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCC--------Ccccchhhhhc
Q 047576 501 ADS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY--------DPKIMLIDVLD 570 (602)
Q Consensus 501 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~--------~~~~~~~~~~d 570 (602)
... .......||+.|+|||++.+..++.++||||||+++|||+||+.||....+..... .....+..+++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 321 12233568999999999999999999999999999999999999997543221100 00112334455
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+..... .+....+.+++.+||+.||++
T Consensus 271 ~~~~~~~~---~~~~~~l~~li~~~l~~dP~~ 299 (321)
T 2qkw_B 271 PNLADKIR---PESLRKFGDTAVKCLALSSED 299 (321)
T ss_dssp SSCTTCSC---HHHHHHHHHHHHHHTCSSGGG
T ss_pred hhhccccC---HHHHHHHHHHHHHHcCCCccc
Confidence 55544443 346677999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.83 Aligned_cols=227 Identities=21% Similarity=0.315 Sum_probs=168.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~-------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|..++..+ .|+++..++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999865 6899999999765443334456677888887554 455544432210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 01234889999999999999999999 7899999999999999999999999999998654333
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccC--CCcccchhhhhccCCCCCCChhh
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS--YDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .........+.......+..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~--- 241 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--- 241 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT---
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC---
Confidence 3445568999999999999999999999999999999999999999743211111 11111223333433332211
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 242 --~s~~~~~li~~lL~~dP~~ 260 (345)
T 3a8x_A 242 --LSVKAASVLKSFLNKDPKE 260 (345)
T ss_dssp --SCHHHHHHHHHHTCSSTTT
T ss_pred --CCHHHHHHHHHHhcCCHhH
Confidence 1234788999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.60 Aligned_cols=220 Identities=28% Similarity=0.423 Sum_probs=156.6
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---------------------- 425 (602)
..+|+..+.||+|+||.||+|+. +|+.||||++...... ....+.+.+|+.++..+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 45788899999999999999987 6889999998765432 22356788899988544
Q ss_pred ---hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 426 ---ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 426 ---~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++|+|.+++........+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 44555555544333445899999999999999999999 778 9999999999999999999999999998655
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||||+++|||+||+.||..... ......+.......+....
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHHSCCCCCCCTT
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCCCcc
Confidence 443334446799999999999999999999999999999999999999975322 1111111111111111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 264 ---~~~~l~~li~~~l~~dP~~ 282 (309)
T 3p86_A 264 ---LNPQVAAIIEGCWTNEPWK 282 (309)
T ss_dssp ---SCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHccCChhh
Confidence 2234789999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.35 Aligned_cols=230 Identities=32% Similarity=0.554 Sum_probs=174.4
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
.++|...+.||+|+||.||+|+..+|+.||||++...... .....+.+|+.++..+.
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 5789999999999999999999888999999999765432 12346778888774444
Q ss_pred ----cCcccccccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 427 ----RGSLFRILHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 427 ----~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|+|.+++.... ....+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||++.....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 445554444322 123489999999999999999999954344999999999999999999999999999987654
Q ss_pred CCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccc----------ccCCCcccchhhhhc
Q 047576 502 DSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL----------SSSYDPKIMLIDVLD 570 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----------~~~~~~~~~~~~~~d 570 (602)
.... .....||+.|+|||++.+..++.++||||+|+++|+|+||+.||+..... ............+++
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 3322 33346999999999999989999999999999999999999999632110 011222333455666
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+...... +....+.+++..||+.||++
T Consensus 267 ~~~~~~~~~---~~~~~l~~li~~cl~~dP~~ 295 (326)
T 3uim_A 267 VDLQGNYKD---EEVEQLIQVALLCTQSSPME 295 (326)
T ss_dssp TTCTTSCCH---HHHHHHHHHHHHHTCSCGGG
T ss_pred hhhccccCH---HHHHHHHHHHHHHhCcCCcc
Confidence 666655543 46677999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.69 Aligned_cols=217 Identities=22% Similarity=0.316 Sum_probs=165.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++++.........+.+..|..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 568999999999999999999874 6899999999755332222334566677766
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 34445555555432 234889999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. .
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~ 240 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNPFYPR--W 240 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCT--T
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCCCCCc--c
Confidence 433344556899999999999999999999999999999999999999975321 1222233322222111 1
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 241 ---~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 241 ---LEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp ---SCHHHHHHHHHHSCSSGGG
T ss_pred ---cCHHHHHHHHHHhcCCHhH
Confidence 1234788999999999974
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.07 Aligned_cols=226 Identities=28% Similarity=0.483 Sum_probs=212.2
Q ss_pred CCCccchhccccCCccc--cCCccCCCCCCCCEEECcC-CcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCC
Q 047576 129 PNLESLRILAYYDGFTG--SIPSEISALSKLQLLDLSS-NRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~--~ip~~l~~L~~L~~L~Ls~-N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 198 (602)
.+++.|++. ++++.+ .+|+.|+++++|++|+|++ |++.+ .+++|++|+|++|++++.+|..|+++++|
T Consensus 50 ~~l~~L~L~--~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (313)
T 1ogq_A 50 YRVNNLDLS--GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CCEEEEEEE--CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred ceEEEEECC--CCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC
Confidence 356667766 677888 8999999999999999995 88874 47899999999999999999999999999
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCC-CCcEEEccCCCCCCCCCCccCCCCCCccccCCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLK-NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 276 (602)
++|+|++|++++.+|..+..+++|++|+|++|++++ +|..+++++ +|++|++++|++++.+|..+..++ |++|++++
T Consensus 128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~ 206 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR 206 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS
T ss_pred CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC
Confidence 999999999999999999999999999999999997 999999998 999999999999999999999997 99999999
Q ss_pred CcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 277 NQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 277 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
|.+++.+|..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|
T Consensus 207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 999999999999999999999999999987776 8889999999999999999999999999999999999999999999
Q ss_pred CC
Q 047576 357 YS 358 (602)
Q Consensus 357 ~~ 358 (602)
..
T Consensus 286 ~~ 287 (313)
T 1ogq_A 286 QG 287 (313)
T ss_dssp CS
T ss_pred CC
Confidence 76
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-33 Score=287.11 Aligned_cols=214 Identities=25% Similarity=0.319 Sum_probs=167.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR-------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~-------------- 432 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++++.........+.+.+|+.++..+.|+++..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999864 78999999997654333334456778888885555555444
Q ss_pred -----------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 433 -----------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 433 -----------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 3332 234788999999999999999999 88999999999999999999999999999987543
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......++...+..+..
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~--- 225 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNAELRFPPF--- 225 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC---
Confidence 2 233579999999999999999999999999999999999999997432 122334444444432211
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 226 --~~~~~~~li~~lL~~dp~~ 244 (318)
T 1fot_A 226 --FNEDVKDLLSRLITRDLSQ 244 (318)
T ss_dssp --SCHHHHHHHHHHTCSCTTT
T ss_pred --CCHHHHHHHHHHhccCHHH
Confidence 1233788999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-33 Score=284.05 Aligned_cols=219 Identities=24% Similarity=0.344 Sum_probs=166.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
..+|...+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++..+.|+++..++....
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 46799999999999999999985 57899999998644332 2345778888886666666555433110
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 1223788999999999999999999 789999999999999999999999999999877655555
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC-CCCCChhhHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL-PPPVDRKVIQD 584 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~ 584 (602)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+..... ....... .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~---~ 242 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQNPEK---L 242 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCCSCGGG---S
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCccc---c
Confidence 55568999999999999999999999999999999999999999753221 11111111111 1111111 2
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+||+.||++
T Consensus 243 ~~~~~~li~~~l~~dp~~ 260 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEK 260 (297)
T ss_dssp CHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHccCChhH
Confidence 334789999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=314.15 Aligned_cols=217 Identities=20% Similarity=0.310 Sum_probs=172.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
..+|.....||+|+||.||+|+.. +++.||||++++.........+.+..|..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 457888999999999999999864 6889999998755433333345566677766
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+++|+|..++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 56666777766654 245899999999999999999999 7899999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+..++...+..+..
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-- 564 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS-- 564 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHSSCCCCCTT--
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhCCCCCCcc--
Confidence 44444555789999999999999999999999999999999999999997532 233345555555443321
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..|+++||++
T Consensus 565 ---~s~~~~~li~~lL~~dP~~ 583 (674)
T 3pfq_A 565 ---MSKEAVAICKGLMTKHPGK 583 (674)
T ss_dssp ---SCHHHHHHHHHHSCSSSTT
T ss_pred ---CCHHHHHHHHHHccCCHHH
Confidence 2234789999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=282.39 Aligned_cols=220 Identities=27% Similarity=0.458 Sum_probs=166.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++..+.|+++..++...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 568899999999999999999864 6899999988654332 456788999998666555554433210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 01245889999999999999999999 7899999999999999999999999999998764332
Q ss_pred CCc--------------cccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 504 SNQ--------------TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 504 ~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
... ....||+.|+|||++.+..++.++||||||+++|||++|..||........ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~ 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--DFGLNVRGFL 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--TSSBCHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--HHhhhhhccc
Confidence 211 135699999999999999999999999999999999999999875432211 1122233444
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+...+...++ .+.+++.+||+.||++
T Consensus 241 ~~~~~~~~~~-------~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 241 DRYCPPNCPP-------SFFPITVRCCDLDPEK 266 (310)
T ss_dssp HHTCCTTCCT-------THHHHHHHHTCSSGGG
T ss_pred cccCCCCCCH-------HHHHHHHHHccCChhh
Confidence 4444433332 2778999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=295.54 Aligned_cols=217 Identities=25% Similarity=0.315 Sum_probs=161.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++++...........+.+|..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999875 6889999998765433223334455555542
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 55666666666543 334788999999999999999999 7899999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++...+..+..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~-- 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPLQLKPN-- 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHSCCCCCSS--
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcccCCCCC--
Confidence 444444556899999999999999999999999999999999999999974321 22334444444332211
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 262 ---~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 262 ---ITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp ---SCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHcccCHHh
Confidence 1223778999999999974
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-31 Score=287.67 Aligned_cols=234 Identities=25% Similarity=0.309 Sum_probs=149.8
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---------cCCCcCEEECcCCcCCCCCchh-hhC
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---------RLTNLNYMSLSRNMLGGLLPQE-IGN 194 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---------~l~~L~~L~L~~N~l~~~~p~~-~~~ 194 (602)
|+.+++|+.|++. ++.+.+..|..|+++++|++|+|++|++++ .+++|++|+|++|++++..|.. +++
T Consensus 75 ~~~l~~L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 152 (455)
T 3v47_A 75 FRGLSSLIILKLD--YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152 (455)
T ss_dssp TTTCTTCCEEECT--TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGG
T ss_pred ccccccCCEEeCC--CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCC
Confidence 3444444444444 344444555566666666666666666542 2556666666666666665554 566
Q ss_pred CCCCCEEEecCCCCCCCCcccccCc----------------------------------CCCceeecccccCCC-Ccccc
Q 047576 195 LKNLIELDVGDNSLIGPIPLTLSRL----------------------------------TSLKILILAQNQLSG-LPQEI 239 (602)
Q Consensus 195 l~~L~~L~L~~N~l~~~~p~~l~~l----------------------------------~~L~~L~L~~N~l~~-ip~~~ 239 (602)
+++|++|+|++|++++..|..+..+ ++|++|++++|++++ +|..+
T Consensus 153 l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp CTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred CCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhh
Confidence 6666666666666666555544333 345555555554443 22211
Q ss_pred cC---------------------------------------CCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCC
Q 047576 240 GN---------------------------------------LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280 (602)
Q Consensus 240 ~~---------------------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 280 (602)
.. .++|+.|++++|++++.+|..++.+++|++|+|++|+++
T Consensus 233 ~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 312 (455)
T 3v47_A 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN 312 (455)
T ss_dssp HHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred hccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc
Confidence 11 145666666666776667777777778888888888887
Q ss_pred CCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCC
Q 047576 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 281 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
+..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++..+..+.
T Consensus 313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 392 (455)
T 3v47_A 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392 (455)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence 77777777777888888888887776677777777888888888887777777777777788888888877765554433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=290.57 Aligned_cols=214 Identities=21% Similarity=0.283 Sum_probs=167.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc---------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF--------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~--------------- 431 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.++..+.|+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 568999999999999999999864 6899999998765443333456778899988555554444
Q ss_pred ----------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 432 ----------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 432 ----------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 43332 234789999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....+..+..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--- 260 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPSH--- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC---
Confidence 2 233579999999999999999999999999999999999999997432 122233444444332211
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 261 --~~~~~~~li~~lL~~dp~~ 279 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTT
T ss_pred --CCHHHHHHHHHHhhcCHHh
Confidence 1234789999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=286.41 Aligned_cols=225 Identities=22% Similarity=0.321 Sum_probs=161.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999985 46899999988654433344567888999988666665554433211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 01234789999999999999999999 78999999999999999999999999999987654322
Q ss_pred -CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 -NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......||+.|+|||++.+..++.++||||+|+++|+|+||+.||...... ......+....+.........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCCCCHHHHSCTT
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccCCCcchhcccC
Confidence 223356999999999999999999999999999999999999999753321 111112222211110000001
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 240 ~~~~l~~li~~~l~~dp~~ 258 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKAN 258 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGG
T ss_pred CCHHHHHHHHHHhcCCHhH
Confidence 2234788999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=291.73 Aligned_cols=222 Identities=23% Similarity=0.353 Sum_probs=167.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999864 6889999998765444334456788899999777776665543211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 01234889999999999999999999 7899999999999999999999999999998765432
Q ss_pred Ccccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 505 NQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .........+.......+. .
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~p~--~- 242 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHTFETTVVTYPS--A- 242 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHHHHHCCCCCCT--T-
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhhcccCCCC--c-
Confidence 3344679999999999874 4588999999999999999999999974321 1111112222222222221 1
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 243 --~s~~~~~li~~lL~~dP~~ 261 (384)
T 4fr4_A 243 --WSQEMVSLLKKLLEPNPDQ 261 (384)
T ss_dssp --SCHHHHHHHHHHSCSSGGG
T ss_pred --CCHHHHHHHHHHhcCCHhH
Confidence 2234789999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=287.01 Aligned_cols=219 Identities=21% Similarity=0.299 Sum_probs=168.5
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
...+|...+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 456899999999999999999986 57999999998655432 22456788899999776666655543211
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 01234788999999999999999999 7899999999999999999999999999998765432
Q ss_pred CCccccccccccccccccccCcCC-ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMT-EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......||+.|+|||++.+..++ .++||||+||++|+|+||+.||+.... ......+.......+..
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~p~~---- 236 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRGKYRIPFY---- 236 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCTT----
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCC----
Confidence 23446799999999999888765 789999999999999999999975321 22223333333332221
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 237 -~s~~~~~li~~~L~~dP~~ 255 (328)
T 3fe3_A 237 -MSTDCENLLKRFLVLNPIK 255 (328)
T ss_dssp -SCHHHHHHHHHHCCSSTTT
T ss_pred -CCHHHHHHHHHHCCCChhH
Confidence 1233778999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=303.20 Aligned_cols=218 Identities=27% Similarity=0.330 Sum_probs=165.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.++
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 578999999999999999999875 5889999999754433333344577888877
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 153 ~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp ECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 556667777766542 345899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC-ccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc----
Q 047576 502 DSSN-QTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ---- 571 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~---- 571 (602)
+... .....||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+++.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERF 300 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTHHHHC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-------hHHHHhhhhccccc
Confidence 3322 23357999999999987 45689999999999999999999999975321 1222233221
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.++... .. ....+.+++.+|+..+|+
T Consensus 301 ~~p~~~-~~---~s~~~~dLi~~lL~~~~~ 326 (437)
T 4aw2_A 301 QFPTQV-TD---VSENAKDLIRRLICSREH 326 (437)
T ss_dssp CCCSSC-CC---SCHHHHHHHHTTSSCGGG
T ss_pred cCCccc-cc---CCHHHHHHHHHHhccccc
Confidence 122110 01 122377888898877664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=299.48 Aligned_cols=218 Identities=25% Similarity=0.336 Sum_probs=164.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++++.........+.+.+|..++
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 578999999999999999999874 7999999999765443333456688888877
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 140 mE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 455566666666432 235899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC-ccccccccccccccccc-------cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc--
Q 047576 502 DSSN-QTLLAGSYGYIAPELAY-------TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ-- 571 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~-- 571 (602)
.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......++..
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~ 287 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-------AETYGKIVHYKE 287 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTHHH
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccc
Confidence 4332 22357999999999987 35689999999999999999999999975321 1222233321
Q ss_pred CCCCC-CChhhHHHHHHHHHHHhhccCcCCC
Q 047576 572 RLPPP-VDRKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 572 ~l~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.+..+ .... ....+.+++.+|++ +|+
T Consensus 288 ~~~~p~~~~~---~s~~~~dli~~lL~-~p~ 314 (412)
T 2vd5_A 288 HLSLPLVDEG---VPEEARDFIQRLLC-PPE 314 (412)
T ss_dssp HCCCC----C---CCHHHHHHHHTTSS-CGG
T ss_pred CcCCCccccC---CCHHHHHHHHHHcC-Chh
Confidence 11111 0111 22347889999998 875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=303.66 Aligned_cols=224 Identities=23% Similarity=0.325 Sum_probs=171.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH-----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS----------------------- 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~----------------------- 423 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++.+.........+.+.+|+.++.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999874 69999999997654443334566788888884
Q ss_pred --hhhcCccccccccccc-hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 424 --QMERGSLFRILHNDAE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 424 --~l~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
|+++|+|..++..... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 4455555555443221 235899999999999999999999 7899999999999999999999999999998776
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ..........+.+.....+. .
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p~--~ 415 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYPD--K 415 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCCT--T
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCCc--c
Confidence 544444446899999999999999999999999999999999999999975321 11112222334444333221 1
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 416 ---~s~~~~~li~~lL~~dP~~ 434 (543)
T 3c4z_A 416 ---FSPASKDFCEALLQKDPEK 434 (543)
T ss_dssp ---SCHHHHHHHHHHSCSSGGG
T ss_pred ---cCHHHHHHHHHhccCCHhH
Confidence 1234778999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=280.00 Aligned_cols=221 Identities=26% Similarity=0.402 Sum_probs=157.2
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh--hhcC-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--MERG----------------- 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~--l~~g----------------- 428 (602)
.++|...+.||+|+||.||+|+. +++.||||++..... ..+..|.+++.. +.|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 56899999999999999999988 789999999865432 233445554433 3444
Q ss_pred ------------ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEeCCCCCCeeeCCCCcceee
Q 047576 429 ------------SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 429 ------------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~ 491 (602)
+|.++++ ...+++..+..++.|++.||+|||.. ++++|+||||||+||+++.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 4444442 23488999999999999999999932 15699999999999999999999999
Q ss_pred cccccccccCCCCC----ccccccccccccccccccC------cCCccchhHHHHHHHHHHHcC----------CCCCCC
Q 047576 492 DFGTARLLHADSSN----QTLLAGSYGYIAPELAYTM------VMTEKYDVYSFGVVTLEVLMG----------KHPRDL 551 (602)
Q Consensus 492 DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~Pf~~ 551 (602)
|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876543322 1224799999999998876 456799999999999999999 777754
Q ss_pred CcccccCCCcccchhhhhc-cCCCCCCC--hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 552 HSTLSSSYDPKIMLIDVLD-QRLPPPVD--RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~d-~~l~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....... .......+. ....+... .........+.+++..||+.||++
T Consensus 236 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 286 (301)
T 3q4u_A 236 VVPNDPS---FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286 (301)
T ss_dssp TSCSSCC---HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGG
T ss_pred cCCCCcc---hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhh
Confidence 3211111 111111111 11111111 111235567999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=277.85 Aligned_cols=222 Identities=20% Similarity=0.273 Sum_probs=163.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH-----------------------HHHhhhhHhHHHHHH
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE-----------------------LAFIRSFRNEAQVLS 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----------------------~~~~~~~~~E~~il~ 423 (602)
.++|...+.||+|+||.||+|+. .+++.||||++....... ....+.+.+|++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999986 468999999986543211 112456889999998
Q ss_pred hhhcCccccccccc-----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 424 QMERGSLFRILHND-----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 424 ~l~~gsL~~~l~~~-----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
.+.|+++..++... .....+++.++..++.|++.||+||| +.+|+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence 88877766554321 01234889999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCCccccccccccccccccccCc---CCccchhHHHHHHHHHHHcCCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||++..............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence 999999999999999987755443344467999999999988765 47889999999999999999999974321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.......+.... ....+.+++.+||+.||++
T Consensus 246 ----~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 283 (298)
T 2zv2_A 246 ----MCLHSKIKSQALEFPDQPD---IAEDLKDLITRMLDKNPES 283 (298)
T ss_dssp ----HHHHHHHHHCCCCCCSSSC---CCHHHHHHHHHHTCSCTTT
T ss_pred ----HHHHHHHhcccCCCCCccc---cCHHHHHHHHHHhhcChhh
Confidence 1111222222222221111 2234789999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=301.10 Aligned_cols=217 Identities=23% Similarity=0.296 Sum_probs=156.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l--------------------- 425 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++.............+.+|+.++..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999985 47899999998754333333445667788776444
Q ss_pred ----hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 426 ----ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 426 ----~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
++|+|..++.. ...+++..+..++.|++.||+||| + ++|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 44444444432 234789999999999999999999 6 799999999999999999999999999998654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~p~~-- 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPRT-- 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCTT--
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCCCCCcc--
Confidence 444444556899999999999999999999999999999999999999974321 22223333333332211
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 372 ---~~~~~~~li~~~L~~dP~~ 390 (446)
T 4ejn_A 372 ---LGPEAKSLLSGLLKKDPKQ 390 (446)
T ss_dssp ---SCHHHHHHHHHHTCSSTTT
T ss_pred ---CCHHHHHHHHHHcccCHHH
Confidence 1234789999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=287.69 Aligned_cols=219 Identities=22% Similarity=0.319 Sum_probs=162.4
Q ss_pred CccccCcccccccccccceeeec--------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGS--------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gs--------- 429 (602)
.++|...+.||+|+||.||+|+. .++..||||+++..... ...+.+.+|+.++..+ .|++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 46788899999999999999974 24668999999765332 3456788899988555 4444
Q ss_pred ----------------cccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 430 ----------------LFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 430 ----------------L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
|.+++..... ...+++.++..++.||+.||+||| +++|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence 4444432210 123788999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
|++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--- 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999999986654322 1223457789999999999999999999999999999999 9999975321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. +...+......+.... ....+.+++..||+.||++
T Consensus 312 ----~~-~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 312 ----EE-LFKLLKEGHRMDKPAN---CTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp ----GG-HHHHHHTTCCCCCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred ----HH-HHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhh
Confidence 11 1122222211111111 2344889999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=277.91 Aligned_cols=181 Identities=23% Similarity=0.316 Sum_probs=148.3
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
.++|...+.||+|+||.||+|+..+|+.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4689999999999999999999988999999998754332 223467788999999888888776654210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 1223789999999999999999999 789999999999999999999999999999877554444
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 445678999999999876 45899999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=284.74 Aligned_cols=220 Identities=20% Similarity=0.298 Sum_probs=158.7
Q ss_pred CccccCcccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhhhcCcccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQMERGSLFRILHNDA---- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---- 438 (602)
.++|...+.||+|+||.||+|+. .+|+.||+|+++..... .......+.+|+.+++.+.|+++..++....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 56899999999999999999986 47899999999765422 1223456788999997777777666543210
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 1234788899999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~p~~-- 243 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKCKLNLPPY-- 243 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCCTT--
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCCC--
Confidence 433334446799999999999998999999999999999999999999975321 22233344433332211
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 244 ---~~~~~~~li~~~L~~dp~~ 262 (327)
T 3a62_A 244 ---LTQEARDLLKKLLKRNAAS 262 (327)
T ss_dssp ---SCHHHHHHHHHHSCSCGGG
T ss_pred ---CCHHHHHHHHHHHhcCHhh
Confidence 1234788999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=282.25 Aligned_cols=227 Identities=23% Similarity=0.335 Sum_probs=161.9
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
.++|...+.||+|+||.||+|+.. ++.||||++...... ...+..|+.++..+.|+++..++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 467999999999999999999874 799999998654432 233445777665555555444332100
Q ss_pred ----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCC----------CeEEeCCCCCCeeeCCCCcceeec
Q 047576 439 ----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSP----------SVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 439 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~ivH~DLkp~NILld~~~~~kL~D 492 (602)
....+++.++..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 1233789999999999999999999 77 999999999999999999999999
Q ss_pred ccccccccCCCCC--cccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccC-------
Q 047576 493 FGTARLLHADSSN--QTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSS------- 558 (602)
Q Consensus 493 FG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------- 558 (602)
||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543222 233578999999999886 35677899999999999999999999753321110
Q ss_pred -CCcccchhh-hhccCCCCCCCh--hhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 -YDPKIMLID-VLDQRLPPPVDR--KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 -~~~~~~~~~-~~d~~l~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+ +......+.... ........+.+++.+||+.||++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence 001111111 222222222111 11235566999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=281.11 Aligned_cols=221 Identities=22% Similarity=0.304 Sum_probs=162.6
Q ss_pred CCCCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc-------------
Q 047576 365 MPTPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL------------- 430 (602)
Q Consensus 365 lp~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL------------- 430 (602)
.+..++|...+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|+.++..+.|+++
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 345678999999999999999999865 7899999998654332 234677889988855555444
Q ss_pred ------------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 431 ------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 431 ------------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 444432 234899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCC--CCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADS--SNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+..... ..............
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~ 228 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYL 228 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHHTTCTTS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhcccccC
Confidence 64322 22234579999999999987775 77899999999999999999999753221 11112222222211
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.... ....+.+++.+|++.||++
T Consensus 229 ~~~~~---~~~~~~~li~~~L~~dP~~ 252 (323)
T 3tki_A 229 NPWKK---IDSAPLALLHKILVENPSA 252 (323)
T ss_dssp TTGGG---SCHHHHHHHHHHSCSSTTT
T ss_pred Ccccc---CCHHHHHHHHHHccCChhh
Confidence 11111 2234778999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=280.62 Aligned_cols=218 Identities=24% Similarity=0.349 Sum_probs=163.5
Q ss_pred cccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
.|+....||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3666778999999999999875 7999999998654322 235677899988666555554433210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...........
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 01224889999999999999999999 78999999999999999999999999999987765444444
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.+...+.... .......
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~--~~~~~~~ 270 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPPPKLKN--SHKVSPV 270 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSSCCCCTT--GGGSCHH
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCcCc--cccCCHH
Confidence 567999999999999999999999999999999999999999753221 1112222221111000 0112234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+||+.||++
T Consensus 271 l~~li~~~l~~dp~~ 285 (321)
T 2c30_A 271 LRDFLERMLVRDPQE 285 (321)
T ss_dssp HHHHHHHHSCSSTTT
T ss_pred HHHHHHHHccCChhh
Confidence 788999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=285.59 Aligned_cols=220 Identities=14% Similarity=0.147 Sum_probs=162.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccc------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRI------------ 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~------------ 433 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++..+ .|+++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 46799999999999999999985 5789999999865432 24677888888666 55544433
Q ss_pred ------------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-----ceeeccccc
Q 047576 434 ------------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE-----AFVADFGTA 496 (602)
Q Consensus 434 ------------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DFG~a 496 (602)
+... ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 83 v~e~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELLGPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECCCCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEeCCCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 3221 245899999999999999999999 789999999999999999887 999999999
Q ss_pred ccccCCCCC-------ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 497 RLLHADSSN-------QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 497 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~ 233 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKIG 233 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHHH
Confidence 876443221 2346799999999999999999999999999999999999999975321 11111122222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+...+.+......... .+.+++..||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~ 265 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFE 265 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTC
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCC
Confidence 2222111110000012 6889999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-33 Score=294.51 Aligned_cols=221 Identities=21% Similarity=0.264 Sum_probs=162.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++..+.|+++..++....
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999875 68899999987544333333456778888885555554444322100
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp ECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 1224788999999999999999999 78999999999999999999999999999987654322
Q ss_pred CccccccccccccccccccCc----CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC--CCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTMV----MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR--LPPPVD 578 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~--l~~~~~ 578 (602)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.||..... ......++... +..+..
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTHHHHCCCCTT
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-------hhHHHHHHhccccccCCCc
Confidence 123467999999999987655 78999999999999999999999974321 22223333221 111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPK 601 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~ 601 (602)
.. ....+.+++.+|++.+|+
T Consensus 298 ~~---~s~~~~~li~~lL~~~~~ 317 (410)
T 3v8s_A 298 ND---ISKEAKNLICAFLTDREV 317 (410)
T ss_dssp CC---CCHHHHHHHHHHSSCGGG
T ss_pred cc---ccHHHHHHHHHHccChhh
Confidence 11 123377889999997764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=286.17 Aligned_cols=175 Identities=17% Similarity=0.226 Sum_probs=143.3
Q ss_pred CccccCcccccccccccceeee------cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQ------LPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------- 422 (602)
.++|...+.||+|+||.||+|. ..+++.||||++...... .+..|++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW------EFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH------HHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh------HHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4678899999999999999994 446889999999765432 233344333
Q ss_pred ---------HhhhcCcccccccccc--chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-------
Q 047576 423 ---------SQMERGSLFRILHNDA--EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS------- 484 (602)
Q Consensus 423 ---------~~l~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~------- 484 (602)
||+++|+|.+++.... ....+++.++..|+.||+.||+||| +.+|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 6777888888876422 2345999999999999999999999 889999999999999998
Q ss_pred ----CCcceeecccccccccCC--CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 485 ----KLEAFVADFGTARLLHAD--SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 485 ----~~~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
++.+||+|||+++.+... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765422 2223345799999999999999999999999999999999999999953
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=279.52 Aligned_cols=222 Identities=17% Similarity=0.253 Sum_probs=160.3
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc------------------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------ 427 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------ 427 (602)
..++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++..+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 357899999999999999999985 5789999998654332 2456777777754443
Q ss_pred -------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeecccccc
Q 047576 428 -------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTAR 497 (602)
Q Consensus 428 -------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~ 497 (602)
++|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 82 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECCCCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEccCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 444444432 1234899999999999999999999 7899999999999999 788999999999998
Q ss_pred cccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 498 LLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 498 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~ 232 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISE 232 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh----hhhhhhhhhhc
Confidence 7654322 123457899999999999999999999999999999999999999753321 11112222222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+...........+.+++..||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCC
Confidence 22222210000011245889999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=279.84 Aligned_cols=221 Identities=17% Similarity=0.187 Sum_probs=162.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-h-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-E------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~------------------- 426 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++..+ .
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 35799999999999999999985 5799999998864432 24566777776444 2
Q ss_pred -----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-----ceeeccccc
Q 047576 427 -----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE-----AFVADFGTA 496 (602)
Q Consensus 427 -----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DFG~a 496 (602)
+++|.+++... ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 84 v~e~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECCCCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEecCCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 44455544431 234899999999999999999999 889999999999999987776 999999999
Q ss_pred ccccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 497 RLLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 497 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~~ 234 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIG 234 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc----ccHHHHHHHH
Confidence 87754322 123457999999999999999999999999999999999999999753211 1111122222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+...........+.+++..||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 267 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDA 267 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTC
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCccc
Confidence 211111110000012345889999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=283.38 Aligned_cols=218 Identities=20% Similarity=0.257 Sum_probs=139.4
Q ss_pred ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc---------------
Q 047576 375 YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND--------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~--------------- 437 (602)
+.||+|+||.||+|+.. +++.||||++.... ...+.+|+.++..+. |+++..++...
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 67999999999999864 68999999986432 234566777775554 44444432210
Q ss_pred -------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceeecccccccccCCCCCcc
Q 047576 438 -------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 438 -------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++..........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 01234889999999999999999999 78999999999999997665 899999999987655444444
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
...||+.|+|||++.+..++.++||||+||++|+|++|+.||...............+..+.......+. .........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~ 246 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG-EAWKNVSQE 246 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-HHHHTSCHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-ccccCCCHH
Confidence 5678999999999999999999999999999999999999997543221111222222333333332221 111223455
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++..|++.||++
T Consensus 247 ~~~li~~~L~~dP~~ 261 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNK 261 (325)
T ss_dssp HHHHHHHHHCCCTTT
T ss_pred HHHHHHHHCCCChhH
Confidence 889999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=285.49 Aligned_cols=224 Identities=22% Similarity=0.350 Sum_probs=161.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||||++.............+.+|+.++..+.|+++..++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999985 57899999999876544445567788899888666666655543210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 01234789999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 501 ADSS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 501 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.... ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ......+.....++.
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPPS 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCcc
Confidence 4322 122356899999999999999999999999999999999999999753221 111222222211110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.........+.+++.+||+.||++
T Consensus 241 -~~~~~~~~~l~~li~~~l~~dP~~ 264 (311)
T 3ork_A 241 -ARHEGLSADLDAVVLKALAKNPEN 264 (311)
T ss_dssp -HHSTTCCHHHHHHHHHHTCSSGGG
T ss_pred -cccCCCCHHHHHHHHHHHhcCHhh
Confidence 000112234788999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=281.12 Aligned_cols=217 Identities=20% Similarity=0.285 Sum_probs=166.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|...+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35789999999999999999986 57899999998755443333445788999999888887776654321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 01234789999999999999999999 77999999999999999999999999999987654332
Q ss_pred ccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc--CCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~--~l~~~~~~~~~ 582 (602)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+....... ...+... .++...+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~~~p~~~s---- 232 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------FKKVNSCVYVMPDFLS---- 232 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------BCCCCSSCCCCCTTSC----
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHcCCCCCcccCC----
Confidence 234579999999999988776 6899999999999999999999975321100 0111111 1122222
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 233 ---~~~~~li~~~L~~dP~~ 249 (336)
T 3h4j_B 233 ---PGAQSLIRRMIVADPMQ 249 (336)
T ss_dssp ---HHHHHHHHTTSCSSGGG
T ss_pred ---HHHHHHHHHHcCCChhH
Confidence 23778999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=287.20 Aligned_cols=226 Identities=12% Similarity=0.044 Sum_probs=156.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--cCcccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--RGSLFRILHN-------- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--~gsL~~~l~~-------- 436 (602)
..+|...+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.+. |+++..++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456889999999999999999854 78999999998765544445667788866665554 6664331100
Q ss_pred ----------------------------c--c--------chhhhcHHHH------HHHHHHHHHHHHHhhhcCCCCeEE
Q 047576 437 ----------------------------D--A--------EAVELDWAKR------VNIVKAMAHALAYLHHDCSPSVVH 472 (602)
Q Consensus 437 ----------------------------~--~--------~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ivH 472 (602)
. + ....+++..+ ..++.||+.||+||| +++|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence 0 0 0112344445 677899999999999 789999
Q ss_pred eCCCCCCeeeCCCCcceeecccccccccCCCCCcccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCC
Q 047576 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 473 ~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999865421 213467799999999987 679999999999999999999999998
Q ss_pred CCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 551 LHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.........................+.... ....+.+++.+||+.||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~ 343 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTP---LPDFVKTLIGRFLNFDRRR 343 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSC---CCHHHHHHHHHHTCSSTTT
T ss_pred CcCcccccchhhhhhhhccccccchhhccC---CCHHHHHHHHHHcCCChhh
Confidence 643221111111111111112222111111 2334889999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=278.85 Aligned_cols=221 Identities=17% Similarity=0.254 Sum_probs=163.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++..+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 57899999999999999999985 5799999998765432 2456678777755444
Q ss_pred ------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeeccccccc
Q 047576 428 ------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTARL 498 (602)
Q Consensus 428 ------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~~ 498 (602)
++|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++..
T Consensus 83 v~e~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 83 VMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECCCCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEecCCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 444444432 1235899999999999999999999 7899999999999999 4888999999999987
Q ss_pred ccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 499 LHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 499 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~ 233 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEK 233 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch----hhhhhhhhhccc
Confidence 654332 123457999999999999999999999999999999999999999753221 111122222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+...........+.+++..||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 264 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCc
Confidence 2221110000012234889999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=282.45 Aligned_cols=221 Identities=22% Similarity=0.337 Sum_probs=163.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--Cccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--GSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--gsL~~~l~~~-------- 437 (602)
.++|...+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++..+.+ +++..++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4679999999999999999999988999999998654332 2345678899999988765 5555443321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 01234788999999999999999999 78999999999999997 57899999999987654322
Q ss_pred --Ccccccccccccccccccc-----------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 505 --NQTLLAGSYGYIAPELAYT-----------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+..++++
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~ 236 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDP 236 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHCT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHhcC
Confidence 1234579999999999865 668899999999999999999999997421 122234455554
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......... ....+.+++..||+.||++
T Consensus 237 ~~~~~~~~~---~~~~l~~li~~~L~~dp~~ 264 (343)
T 3dbq_A 237 NHEIEFPDI---PEKDLQDVLKCCLKRDPKQ 264 (343)
T ss_dssp TSCCCCCCC---SCHHHHHHHHHHTCSSTTT
T ss_pred CcccCCccc---CCHHHHHHHHHHcCCChhH
Confidence 443222221 1234789999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=291.22 Aligned_cols=223 Identities=18% Similarity=0.223 Sum_probs=168.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|...+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++..+.|+++..++....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 46789999999999999999975 478999999987654332 23567889999997777777665543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeecccccccccC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG~a~~~~~ 501 (602)
....+++.++..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 1234789999999999999999999 78999999999999998 457899999999987765
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.......+... .
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-~ 237 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAYDFPSPE-W 237 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCTTT-T
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCCCccc-c
Confidence 4444445679999999999999999999999999999999999999997432 1222233333332211110 0
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~ 258 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSK 258 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTT
T ss_pred ccCCHHHHHHHHHHcCCChhH
Confidence 112334789999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.78 Aligned_cols=181 Identities=25% Similarity=0.293 Sum_probs=146.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~------- 439 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 46799999999999999999975 46899999999765322 2345678899999999999888776542100
Q ss_pred ------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 440 ------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 440 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
...+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 123788999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 217 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 217 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2344679999999999999999999999999999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=278.18 Aligned_cols=225 Identities=19% Similarity=0.286 Sum_probs=164.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR-------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~-------------- 432 (602)
.++|...+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++..+.|+++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 467999999999999999999875 5899999998754332 12355678888885555554444
Q ss_pred -------------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee----CCCCcceeecccc
Q 047576 433 -------------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL----NSKLEAFVADFGT 495 (602)
Q Consensus 433 -------------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFG~ 495 (602)
++........+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 3333222223899999999999999999999 7899999999999999 8888999999999
Q ss_pred cccccCCCCCccccccccccccccccc--------cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhh
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAY--------TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 567 (602)
++....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||........ ....+..
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYK 238 (319)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHH
T ss_pred ceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHH
Confidence 987754432 23356999999999886 46789999999999999999999999964321110 0111111
Q ss_pred hhcc---------------------CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQ---------------------RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~---------------------~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++.. .++... .........+.+++.+|++.||++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ll~~~L~~dP~~ 293 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEK 293 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCccc-ccchhHHHHhHHHHHHhccCChhh
Confidence 1111 112111 111335556889999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=276.08 Aligned_cols=180 Identities=21% Similarity=0.306 Sum_probs=134.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|+++..... ...+.+.+|+.++..+.|+++..++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999864 6899999998654321 12356778999998888877766543210
Q ss_pred -------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 439 -------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 439 -------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 0123788899999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
...........||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5443334445789999999998764 5899999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=282.45 Aligned_cols=219 Identities=23% Similarity=0.351 Sum_probs=159.7
Q ss_pred CccccCcccccccccccceeeecC-CCcE----EeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRV----FALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.++|...+.||+|+||.||+|+.. +++. ||+|.+..... ....+.+.+|+.++..+.|+++..++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 567999999999999999999853 4443 58888754332 23456788999999777776666544311
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..|+.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 01234789999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 501 ADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.... ..+...+......+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLPQ 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCCCC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HHHHHHHHcCCCCCC
Confidence 43322 223456789999999999999999999999999999999 9999975321 122333333322222
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++.+||+.||++
T Consensus 241 ~~~---~~~~~~~li~~~l~~~p~~ 262 (327)
T 3poz_A 241 PPI---CTIDVYMIMVKCWMIDADS 262 (327)
T ss_dssp CTT---BCHHHHHHHHHHTCSCGGG
T ss_pred Ccc---CCHHHHHHHHHHcCCChhh
Confidence 222 3345889999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=280.64 Aligned_cols=219 Identities=21% Similarity=0.276 Sum_probs=166.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ...+.+|+.++..+.|+++..++...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 467889999999999999999864 6889999998755432 34577899988666655554433210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC--CCcceeecccccccccC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS--KLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 01234889999999999999999999 789999999999999987 78999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ....+..+.+.....+. ...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~-~~~ 227 (321)
T 1tki_A 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFDE-EAF 227 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCH-HHH
T ss_pred CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHcCCCCCCh-hhh
Confidence 32 2344679999999999999889999999999999999999999997432 12233444444433221 111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~ 248 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCCHHHHHHHHHHcCCChhH
Confidence 112345889999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=284.88 Aligned_cols=220 Identities=23% Similarity=0.311 Sum_probs=162.0
Q ss_pred CccccCcccccccccccceeee------cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCcccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQ------LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFR-------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~-------- 432 (602)
.++|...+.||+|+||.||+|+ ..+++.||||+++..... ...+.+.+|++++..+ .|+++..
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 5689999999999999999996 245789999999765432 2346788899888555 3444443
Q ss_pred ------------------ccccccc-------------------------------------------------------
Q 047576 433 ------------------ILHNDAE------------------------------------------------------- 439 (602)
Q Consensus 433 ------------------~l~~~~~------------------------------------------------------- 439 (602)
++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3322110
Q ss_pred --------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC--Ccccc
Q 047576 440 --------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NQTLL 509 (602)
Q Consensus 440 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~ 509 (602)
...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 111889999999999999999999 78999999999999999999999999999987644322 22335
Q ss_pred ccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHH
Q 047576 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588 (602)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 588 (602)
.||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .......+......+.... ....+
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~l 325 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDY---TTPEM 325 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-------SHHHHHHHHHTCCCCCCTT---CCHHH
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-------hHHHHHHHHcCCCCCCCCC---CCHHH
Confidence 68889999999999999999999999999999999 9999975321 1111222222211111111 22347
Q ss_pred HHHHhhccCcCCCC
Q 047576 589 STISFACLQSNPKS 602 (602)
Q Consensus 589 ~~l~~~Cl~~dP~e 602 (602)
.+++..||+.||++
T Consensus 326 ~~li~~~l~~dP~~ 339 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQ 339 (359)
T ss_dssp HHHHHHHTCSSGGG
T ss_pred HHHHHHHccCChhh
Confidence 89999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=279.60 Aligned_cols=217 Identities=27% Similarity=0.381 Sum_probs=160.2
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER---------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~---------------- 427 (602)
..+|...+.||+|+||.||+|+.. .+..||||+++..... ...+.+.+|+.++..+.|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 457888999999999999999864 4556999999765332 234678889998855544
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
|+|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 444444432 1235889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 499 LHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 499 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+. ....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~-~~~~ 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVE-EGYR 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHH-TTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHH-cCCC
Confidence 6543222 112345778999999998899999999999999999999 9999974321 11112222 2222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.... ....+.+++..||+.||++
T Consensus 273 ~~~~~~---~~~~l~~li~~~l~~dp~~ 297 (325)
T 3kul_A 273 LPAPMG---CPHALHQLMLDCWHKDRAQ 297 (325)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCC---cCHHHHHHHHHHccCChhh
Confidence 222111 2345889999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=286.45 Aligned_cols=217 Identities=23% Similarity=0.304 Sum_probs=163.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR-------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~-------------- 432 (602)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ...+.|.+|+.++..+.|+++..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 457888899999999999999875 7899999998754322 34567889999986555555444
Q ss_pred -----------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 433 -----------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 433 -----------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
++.. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 3332 1234889999999999999999999 78999999999999999999999999999986533
Q ss_pred CCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 502 DSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 502 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... ....+.+......+..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPCP 337 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCCC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence 2111 111235678999999998899999999999999999998 9999975321 1122233322222222
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++..||+.||++
T Consensus 338 ~~---~~~~l~~li~~cl~~dP~~ 358 (377)
T 3cbl_A 338 EL---CPDAVFRLMEQCWAYEPGQ 358 (377)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGG
T ss_pred CC---CCHHHHHHHHHHcCCCchh
Confidence 21 2345889999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=275.89 Aligned_cols=180 Identities=26% Similarity=0.350 Sum_probs=145.2
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA---------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---------- 438 (602)
++|...+.||+|+||.||+|+..+|+.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 468888999999999999999888999999998755432 123356778999998888888776654210
Q ss_pred ------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 439 ------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 439 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 1234788999999999999999999 7899999999999999999999999999998765433333
Q ss_pred cccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 445789999999998764 5899999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=283.54 Aligned_cols=224 Identities=19% Similarity=0.242 Sum_probs=165.7
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHH---HHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL---AFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
..+.|...+.||+|+||.||+|+.. +|+.||+|+++....... ...+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999865 689999999875433210 1235678899988555555544432210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC----cceeeccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL----EAFVADFGTA 496 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG~a 496 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 01234899999999999999999999 78999999999999998776 7999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ....+..+.......+
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITAVSYDFD 238 (361)
T ss_dssp EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCC
T ss_pred eEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCC
Confidence 8765432 2334579999999999999899999999999999999999999997532 1222233333322211
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. +........+.+++..|+++||++
T Consensus 239 ~-~~~~~~s~~~~~li~~~L~~dP~~ 263 (361)
T 2yab_A 239 E-EFFSQTSELAKDFIRKLLVKETRK 263 (361)
T ss_dssp H-HHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred c-hhccCCCHHHHHHHHHHCCCChhH
Confidence 1 000112234789999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=291.44 Aligned_cols=212 Identities=17% Similarity=0.181 Sum_probs=155.9
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
++.|...+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+.++..+.+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 45688889999999999999984 5799999999884443333345567777776655543
Q ss_pred --------------------------------Ccccccccc----ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 047576 428 --------------------------------GSLFRILHN----DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471 (602)
Q Consensus 428 --------------------------------gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 471 (602)
++|.+++.. ......+++..+..++.|+++||+||| +++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 222222211 011345888999999999999999999 78999
Q ss_pred EeCCCCCCeeeCCCCcceeecccccccccCCCCCcccccccccccccccc----------ccCcCCccchhHHHHHHHHH
Q 047576 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA----------YTMVMTEKYDVYSFGVVTLE 541 (602)
Q Consensus 472 H~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil~e 541 (602)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998865433 233467 999999998 55568899999999999999
Q ss_pred HHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 542 VLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 542 lltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
|+||+.||...... .....++.... ..+ ..+.+++.+||+.||++
T Consensus 310 lltg~~Pf~~~~~~-------~~~~~~~~~~~--~~~-------~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 310 IWCADLPNTDDAAL-------GGSEWIFRSCK--NIP-------QPVRALLEGFLRYPKED 354 (413)
T ss_dssp HHHSSCCCCTTGGG-------SCSGGGGSSCC--CCC-------HHHHHHHHHHTCSSGGG
T ss_pred HHHCCCCCCCcchh-------hhHHHHHhhcc--cCC-------HHHHHHHHHHccCChhh
Confidence 99999999753321 11122222111 111 33788999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=272.47 Aligned_cols=218 Identities=22% Similarity=0.405 Sum_probs=145.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999986 57899999998655433333456788899998777766665543211
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 01134789999999999999999999 7899999999999999999999999999998765433
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc--CCCCCCChhh
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDRKV 581 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~--~l~~~~~~~~ 581 (602)
.......|++.|+|||++.+..++.++||||+|+++|||++|+.||....... .+..+... ..+...+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~--- 236 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TLNKVVLADYEMPSFLS--- 236 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCCCCCTTSC---
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HHHHHhhcccCCccccC---
Confidence 33334578999999999998889999999999999999999999997532211 11111111 1222222
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 237 ----~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 237 ----IEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp ----HHHHHHHHHHSCSSGGG
T ss_pred ----HHHHHHHHHHcccCHhh
Confidence 24779999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=284.69 Aligned_cols=220 Identities=22% Similarity=0.340 Sum_probs=164.0
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--Cccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--GSLFRILHND--------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--gsL~~~l~~~--------- 437 (602)
+.|...+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++..+.+ +++..++...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 468999999999999999999888999999998654332 2345778899999988764 5565544211
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC-
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 504 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~- 504 (602)
.....+++.++..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 01224688899999999999999999 88999999999999996 57899999999987654322
Q ss_pred -Ccccccccccccccccccc-----------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 505 -NQTLLAGSYGYIAPELAYT-----------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+..++++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPN 284 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHCTT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhCcc
Confidence 1234579999999999865 368899999999999999999999997421 1123345555554
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.... ....+.+++.+||+.||++
T Consensus 285 ~~~~~~~~---~~~~~~~li~~~L~~dP~~ 311 (390)
T 2zmd_A 285 HEIEFPDI---PEKDLQDVLKCCLKRDPKQ 311 (390)
T ss_dssp SCCCCCCC---SCHHHHHHHHHHTCSSTTT
T ss_pred ccCCCCcc---chHHHHHHHHHHcccChhh
Confidence 43322221 1234789999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=286.20 Aligned_cols=217 Identities=27% Similarity=0.401 Sum_probs=152.1
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER---------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~---------------- 427 (602)
..+|...+.||+|+||.||+|+.. ++..||||+++..... ...+.|.+|+.++..+.|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 467999999999999999999864 5778999999754322 235678899998855544
Q ss_pred ---------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 428 ---------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 428 ---------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
|+|.++++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 4444444321 235899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 499 LHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 499 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......++....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEGYR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTTEE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 6543221 112235678999999999999999999999999999998 9999974321 112222222222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.... ....+.+++..||+.||++
T Consensus 269 ~~~~~~---~~~~l~~li~~cl~~dp~~ 293 (373)
T 2qol_A 269 LPPPMD---CPAALYQLMLDCWQKDRNN 293 (373)
T ss_dssp CCCCTT---CBHHHHHHHHHHTCSSGGG
T ss_pred CCCCcc---ccHHHHHHHHHHhCcChhh
Confidence 111111 3345889999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=284.66 Aligned_cols=223 Identities=19% Similarity=0.246 Sum_probs=166.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHH--HHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEEL--AFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
.+.|...+.||+|+||.||+|+. .+|+.||||++........ ...+.+.+|+.++..+.|+++..++...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46789999999999999999986 4789999999854322110 1235688899999777776666544311
Q ss_pred ------------------c-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc---ceeecccc
Q 047576 438 ------------------A-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE---AFVADFGT 495 (602)
Q Consensus 438 ------------------~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFG~ 495 (602)
. ....+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 0 0113788899999999999999999 789999999999999987654 99999999
Q ss_pred cccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
+..............||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ......+.......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKM 251 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCC
Confidence 9877654443445679999999999999999999999999999999999999997521 12223333333322
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+. +........+.+++.+|++.||++
T Consensus 252 ~~-~~~~~~s~~~~~li~~~L~~dP~~ 277 (351)
T 3c0i_A 252 NP-RQWSHISESAKDLVRRMLMLDPAE 277 (351)
T ss_dssp CH-HHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred Cc-cccccCCHHHHHHHHHHCCCChhH
Confidence 11 100112345789999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.53 Aligned_cols=219 Identities=23% Similarity=0.329 Sum_probs=167.7
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|.....||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++..+.|+++..++...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457889999999999999999865 7999999999755443333456788999998666555554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 01234889999999999999999999 8899999999999999999999999999998765432
Q ss_pred CccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+.... ......+.+.....+..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~p~~----- 238 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICDGIFYTPQY----- 238 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHTTCCCCCTT-----
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCcCCCcc-----
Confidence 2334579999999999988765 6899999999999999999999974321 12233344443332211
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 239 ~s~~~~~Li~~~L~~dP~~ 257 (476)
T 2y94_A 239 LNPSVISLLKHMLQVDPMK 257 (476)
T ss_dssp CCHHHHHHHHHHTCSSTTT
T ss_pred CCHHHHHHHHHHcCCCchh
Confidence 1123788999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=277.56 Aligned_cols=226 Identities=22% Similarity=0.325 Sum_probs=161.6
Q ss_pred CccccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.++|...+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46799999999999999999973 36899999998765433 346788899988666666555443210
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 01234889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc-----cCCCcc---cchh
Q 047576 498 LLHADSS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS-----SSYDPK---IMLI 566 (602)
Q Consensus 498 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-----~~~~~~---~~~~ 566 (602)
....... ......++..|+|||++.+..++.++||||||+++|||+||..||....... ...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654322 1222356778999999999999999999999999999999999987432110 000000 0112
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+......+.... ....+.+++..||+.||++
T Consensus 243 ~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 275 (295)
T 3ugc_A 243 ELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQ 275 (295)
T ss_dssp HHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGG
T ss_pred HHHhccCcCCCCcC---cCHHHHHHHHHHcCCChhh
Confidence 22222222222221 3345889999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=297.98 Aligned_cols=220 Identities=21% Similarity=0.273 Sum_probs=166.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-------------------- 426 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++.............+.+|+.++..+.
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 79999999997654433334456778998885444
Q ss_pred -----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 427 -----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 427 -----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
+|+|.+++.... ...+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 445544443321 223889999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc--CCCCCCCh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--RLPPPVDR 579 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~--~l~~~~~~ 579 (602)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........+... .++...+
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~---~~~~~i~~~i~~~~~~~p~~~s- 413 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEVERLVKEVPEEYSERFS- 413 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC---CCHHHHHHHHHHCCCCCCTTSC-
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc---hhHHHHHHHhhcccccCCccCC-
Confidence 33 233457999999999999989999999999999999999999999753211 1111111112211 1222222
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|+++||++
T Consensus 414 ------~~~~dLI~~lL~~dP~~ 430 (576)
T 2acx_A 414 ------PQARSLCSQLLCKDPAE 430 (576)
T ss_dssp ------HHHHHHHHHHTCSSGGG
T ss_pred ------HHHHHHHHHhccCCHHH
Confidence 34788999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=271.21 Aligned_cols=221 Identities=28% Similarity=0.463 Sum_probs=163.9
Q ss_pred CcccccccccccceeeecCCCcEEeeeccCCchh-HHHHHhhhhHhHHHHHHhhhcCccccc------------------
Q 047576 373 SKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPET-EELAFIRSFRNEAQVLSQMERGSLFRI------------------ 433 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~~~~E~~il~~l~~gsL~~~------------------ 433 (602)
..+.||+|+||.||+|+. +++.||||++..... ......+.+.+|+.++..+.|+++..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp TCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred cCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 348899999999999987 688999998865321 112235678889998866655555443
Q ss_pred -------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC-
Q 047576 434 -------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN- 505 (602)
Q Consensus 434 -------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~- 505 (602)
+........+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 332222334889999999999999999999 789999999999999999999999999999876543221
Q ss_pred -ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCC-------CcccchhhhhccCCCCCC
Q 047576 506 -QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY-------DPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-------~~~~~~~~~~d~~l~~~~ 577 (602)
.....|++.|+|||++.+ .++.++||||||+++|+|++|+.||+......... .....+.+.+++.+....
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 223468999999998765 47899999999999999999999997543221100 111223444555444322
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++..||+.||++
T Consensus 270 ----~~~~~~l~~li~~cl~~~p~~ 290 (307)
T 2nru_A 270 ----STSVEAMYSVASQCLHEKKNK 290 (307)
T ss_dssp ----HHHHHHHHHHHHHHTCSSTTT
T ss_pred ----hHHHHHHHHHHHHHcCCCccc
Confidence 335667899999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.54 Aligned_cols=215 Identities=24% Similarity=0.294 Sum_probs=154.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHND--------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~--------- 437 (602)
++|+....||+|+||+||+|+.. +|+.||||++......... ...+..|+..+... .|+++..++...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57888999999999999999875 7999999988654333222 23334444444322 555555443211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....++|.++..|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 01234899999999999999999999 7899999999999999999999999999988764432
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......||+.|+|||++.+ .++.++|||||||++|||++|..||..... ...+.+...++.... ..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~~~~---~~ 277 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTA---GL 277 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHHHHT---TS
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCccccc---CC
Confidence 2334569999999998876 789999999999999999999877653221 122222222211111 12
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+|++.||++
T Consensus 278 ~~~l~~li~~~L~~dP~~ 295 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKL 295 (311)
T ss_dssp CHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHcCCChhh
Confidence 244889999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=269.80 Aligned_cols=221 Identities=26% Similarity=0.416 Sum_probs=162.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHH----HHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEEL----AFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~----~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++........ ...+.+.+|+.++..+.|+++..++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 46799999999999999999986 4789999999865433211 1225788899998666665555443210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCCCCc-----ceeeccc
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNSKLE-----AFVADFG 494 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~~~~-----~kL~DFG 494 (602)
.....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 01234889999999999999999999 778 999999999999988776 9999999
Q ss_pred ccccccCCCCCccccccccccccccccc--cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAY--TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
+++.... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||..... ........+....
T Consensus 175 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 175 LSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----GKIKFINMIREEG 246 (287)
T ss_dssp TCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-----CHHHHHHHHHHSC
T ss_pred ccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-----cHHHHHHHHhccC
Confidence 9975432 233457899999999984 45578999999999999999999999974321 1111122222222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+..... ....+.+++..||+.||++
T Consensus 247 ~~~~~~~~---~~~~l~~li~~~l~~dp~~ 273 (287)
T 4f0f_A 247 LRPTIPED---CPPRLRNVIELCWSGDPKK 273 (287)
T ss_dssp CCCCCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCcc---cCHHHHHHHHHHhcCChhh
Confidence 32222222 2344889999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=282.18 Aligned_cols=222 Identities=22% Similarity=0.305 Sum_probs=166.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|+.++..+.|+++..++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457899999999999999999864 68999999987554322 2346788999999777776665543311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 01234789999999999999999999 78999999999999998654 599999999987653
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.......+... .
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~-~ 254 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPE-W 254 (362)
T ss_dssp CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTG-G
T ss_pred Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCccc-c
Confidence 32 23346799999999999998999999999999999999999999974321 122223333332222110 0
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~ 275 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKK 275 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGG
T ss_pred cCCCHHHHHHHHHHcCCChhh
Confidence 112344789999999999974
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=268.03 Aligned_cols=247 Identities=25% Similarity=0.313 Sum_probs=212.9
Q ss_pred CCCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCc-cCCCCCCCCEEECcCCcC
Q 047576 89 DHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPS-EISALSKLQLLDLSSNRL 167 (602)
Q Consensus 89 ~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~-~l~~L~~L~~L~Ls~N~i 167 (602)
..|.|.+|.|+..+ ++.+..+..++++.|++. ++++. .+|. .|+++++|++|+|++|++
T Consensus 5 C~C~~~~l~c~~~~-----------------l~~ip~~~~~~l~~L~L~--~n~l~-~i~~~~~~~l~~L~~L~L~~n~l 64 (306)
T 2z66_A 5 CSCSGTEIRCNSKG-----------------LTSVPTGIPSSATRLELE--SNKLQ-SLPHGVFDKLTQLTKLSLSSNGL 64 (306)
T ss_dssp CEEETTEEECCSSC-----------------CSSCCSCCCTTCCEEECC--SSCCC-CCCTTTTTTCTTCSEEECCSSCC
T ss_pred CeeCCCEEEcCCCC-----------------cccCCCCCCCCCCEEECC--CCccC-ccCHhHhhccccCCEEECCCCcc
Confidence 45899999997532 122223334677777775 44444 6665 479999999999999998
Q ss_pred cc---------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecccccCCC-Cc
Q 047576 168 RG---------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQNQLSG-LP 236 (602)
Q Consensus 168 ~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-ip 236 (602)
+. .+++|++|+|++|.++. +|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|++++ .|
T Consensus 65 ~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 143 (306)
T 2z66_A 65 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143 (306)
T ss_dssp CEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECST
T ss_pred CcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccch
Confidence 72 37999999999999984 67779999999999999999987665 679999999999999999998 56
Q ss_pred ccccCCCCCcEEEccCCCCCC-CCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCC
Q 047576 237 QEIGNLKNLMLLDVGNNDIIG-PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME 315 (602)
Q Consensus 237 ~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 315 (602)
..+.++++|++|++++|.+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|+|++|++++..+..+..++
T Consensus 144 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred hhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 778999999999999999987 6789999999999999999999998899999999999999999999988777899999
Q ss_pred CCCEEeCCCCCCCCCCCccccccc-ccccccccCCcCCCccC
Q 047576 316 DLTWLDLSNNNIKGSIPGEITKLS-RLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 316 ~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p 356 (602)
+|+.|+|++|++++..|..+..++ +|+.|++++|++++.-+
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred cCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 999999999999999999999985 99999999999988643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=268.83 Aligned_cols=217 Identities=22% Similarity=0.314 Sum_probs=162.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|.....||+|+||.||+|+..++..||+|++...... .+.+.+|+.++..+.|+++..++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4678899999999999999999988889999999765433 24577888888666655554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 01234899999999999999999999 78999999999999999999999999999987654322
Q ss_pred C-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 N-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. .....+++.|+|||++.+..++.++||||+|+++|+|+| |+.||+.... ......+...... .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~-- 229 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHRL-YRPHL-- 229 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCC-CCCTT--
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCCC-CCCCc--
Confidence 1 122346678999999998889999999999999999999 9999975322 1111122211111 11111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 230 -~~~~l~~li~~~l~~~p~~ 248 (268)
T 3sxs_A 230 -ASDTIYQIMYSCWHELPEK 248 (268)
T ss_dssp -SCHHHHHHHHHTTCSSGGG
T ss_pred -ChHHHHHHHHHHcCCChhh
Confidence 1234788999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=292.55 Aligned_cols=216 Identities=24% Similarity=0.404 Sum_probs=163.9
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
.++|...+.||+|+||.||+|+..+++.||||+++.... ..+.|.+|+.++..+.|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 467888999999999999999998889999999976443 24678889998855554
Q ss_pred ----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 428 ----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 428 ----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+|.++++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 4444444321 1235788899999999999999999 7899999999999999999999999999998764321
Q ss_pred C-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 S-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. ......++..|+|||++.+..++.++|||||||++|||+| |+.||..... ...... +......+....
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~-i~~~~~~~~~~~- 409 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRA-LERGYRMPRPEN- 409 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH-HHHTCCCCCCTT-
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCCC-
Confidence 1 1122346788999999998899999999999999999999 9999974321 111122 222222121111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 410 --~~~~l~~li~~cl~~dp~~ 428 (454)
T 1qcf_A 410 --CPEELYNIMMRCWKNRPEE 428 (454)
T ss_dssp --SCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHccCChhH
Confidence 3345889999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=270.72 Aligned_cols=217 Identities=24% Similarity=0.323 Sum_probs=163.2
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|...+.||+|+||.||+|+..+++.||+|++...... .+.+.+|+.++..+.|+++..++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 4678999999999999999999888999999999765433 24578899988666655554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC-
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS- 503 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~- 503 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 01234789999999999999999999 7899999999999999999999999999998664321
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ......+... ........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~~~~-- 231 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTG-FRLYKPRL-- 231 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT-CCCCCCTT--
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcC-ccCCCCCc--
Confidence 11222456788999999998999999999999999999999 9999975321 1112222222 11111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 232 -~~~~~~~li~~~l~~~p~~ 250 (269)
T 4hcu_A 232 -ASTHVYQIMNHCWRERPED 250 (269)
T ss_dssp -SCHHHHHHHHHHTCSSGGG
T ss_pred -CCHHHHHHHHHHccCCccc
Confidence 2234788999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=293.57 Aligned_cols=221 Identities=18% Similarity=0.258 Sum_probs=163.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|++++..+.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 46799999999999999999985 5789999998764432 2456778877755443
Q ss_pred ------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeeccccccc
Q 047576 428 ------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTARL 498 (602)
Q Consensus 428 ------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~~ 498 (602)
++|.+++... ...+++.+++.|+.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 vme~~g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEECCCCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEECCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 4444444321 335899999999999999999999 7899999999999999 6889999999999987
Q ss_pred ccCCCCC-------ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 499 LHADSSN-------QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 499 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~ 231 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEK 231 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch----hHHHHHHHHhhc
Confidence 6543321 22457999999999999999999999999999999999999999753221 111112222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.............++.+++..||+.||++
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~ 262 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDD 262 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTC
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhh
Confidence 2211111000112345889999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.68 Aligned_cols=217 Identities=23% Similarity=0.330 Sum_probs=166.8
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..|...+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+.++..+.|+++..++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999985 57999999998755433344557788999999888888877655321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 01234789999999999999999999 789999999999999999999999999999865432
Q ss_pred ccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..+..+.....+......
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~-- 277 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGH-- 277 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCCCTT--
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCCCC--
Confidence 2357999999999884 567899999999999999999999999753221 112222222222111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 278 -~~~~l~~li~~~l~~dP~~ 296 (348)
T 1u5q_A 278 -WSEYFRNFVDSCLQKIPQD 296 (348)
T ss_dssp -SCHHHHHHHHHHTCSSGGG
T ss_pred -CCHHHHHHHHHHcccChhh
Confidence 2234778999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=278.80 Aligned_cols=220 Identities=20% Similarity=0.308 Sum_probs=161.7
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGS----------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gs----------- 429 (602)
.++|...+.||+|+||.||+|+. .++..||||++...... ...+.+.+|+.++..+ .|++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 46788999999999999999985 35678999999754322 2346788898888555 4444
Q ss_pred --------------cccccccccc--------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCC
Q 047576 430 --------------LFRILHNDAE--------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDI 475 (602)
Q Consensus 430 --------------L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 475 (602)
|.+++..... ...+++.++..++.|++.||+||| +.+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 4444432211 123789999999999999999999 789999999
Q ss_pred CCCCeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 047576 476 SSNNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLH 552 (602)
Q Consensus 476 kp~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~ 552 (602)
||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876543322 223457889999999999999999999999999999998 99999753
Q ss_pred cccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 553 STLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 553 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ...+...+......+.... ....+.+++..||+.||++
T Consensus 279 ~~-------~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 318 (344)
T 1rjb_A 279 PV-------DANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRK 318 (344)
T ss_dssp CC-------SHHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred Cc-------HHHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCCchh
Confidence 21 1122333333322222211 2344888999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=270.91 Aligned_cols=178 Identities=23% Similarity=0.321 Sum_probs=148.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|...+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 46888999999999999999864 6899999998754332 123456788999999988888777654210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 1235889999999999999999999 789999999999999999999999999999877654444
Q ss_pred ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
.....||+.|+|||++.+.. ++.++||||+||++|||+||..||.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 45567899999999998766 7999999999999999999998863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.71 Aligned_cols=216 Identities=22% Similarity=0.382 Sum_probs=161.9
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc-----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN----------- 436 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~----------- 436 (602)
++|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+.++..+.|+++..++..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57888999999999999999875 7999999998654322 234678889999988888877765431
Q ss_pred -----------------------------------------------------------------------ccchhhhcH
Q 047576 437 -----------------------------------------------------------------------DAEAVELDW 445 (602)
Q Consensus 437 -----------------------------------------------------------------------~~~~~~l~~ 445 (602)
.......++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 111123456
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC------------Ccccccccc
Q 047576 446 AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS------------NQTLLAGSY 513 (602)
Q Consensus 446 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~------------~~~~~~gt~ 513 (602)
..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 678899999999999999 78999999999999999999999999999987754321 122346999
Q ss_pred ccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHh
Q 047576 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISF 593 (602)
Q Consensus 514 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~ 593 (602)
.|+|||++.+..++.++||||+|+++|||++|..|+... ......+.....+ .........+.+++.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~~----~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKFP----LLFTQKYPQEHMMVQ 307 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCCC----HHHHHHCHHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCCC----cccccCChhHHHHHH
Confidence 999999999999999999999999999999998875321 1111122222221 222334455789999
Q ss_pred hccCcCCCC
Q 047576 594 ACLQSNPKS 602 (602)
Q Consensus 594 ~Cl~~dP~e 602 (602)
.||+.||++
T Consensus 308 ~~l~~~p~~ 316 (332)
T 3qd2_B 308 DMLSPSPTE 316 (332)
T ss_dssp HHHCSSGGG
T ss_pred HHccCCCCc
Confidence 999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=280.86 Aligned_cols=216 Identities=19% Similarity=0.251 Sum_probs=157.5
Q ss_pred cCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 372 DSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 372 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
...+.||+|+||.||+|+. .+|+.||+|+++..... ..+.+.+|+.++..+.|+++..++...
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3456899999999999986 47899999998765433 346788999999666665555443210
Q ss_pred ----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee--CCCCcceeecccccccccCCCCC
Q 047576 438 ----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL--NSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl--d~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++.......
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 01234889999999999999999999 7899999999999999 6678999999999987654322
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..++......+.. ......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~-~~~~~~ 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLNNILACRWDLEDE-EFQDIS 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCSCSG-GGTTSC
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCChh-hhccCC
Confidence 2335699999999999988999999999999999999999999975321 22233444433322111 001123
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|++.||++
T Consensus 317 ~~~~~li~~~L~~dp~~ 333 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSW 333 (373)
T ss_dssp HHHHHHHHTTSCSSGGG
T ss_pred HHHHHHHHHHcCCChhh
Confidence 45889999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=286.42 Aligned_cols=224 Identities=15% Similarity=0.199 Sum_probs=158.4
Q ss_pred CccccCcccccccccccceeeecCC------CcEEeeeccCCchhHHH---HHhh-----hhHhHHHHHHhhhcCccc--
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEEL---AFIR-----SFRNEAQVLSQMERGSLF-- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~---~~~~-----~~~~E~~il~~l~~gsL~-- 431 (602)
.++|...+.||+|+||.||+|+... ++.||||++........ ...+ .+..|+..+..+.|.++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998754 47899999875542211 1111 122333334334444443
Q ss_pred --------------------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC--
Q 047576 432 --------------------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-- 483 (602)
Q Consensus 432 --------------------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-- 483 (602)
+++.. ....+++.++..|+.||+.||+||| +.+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 33322 1245899999999999999999999 78999999999999999
Q ss_pred CCCcceeecccccccccCCCCC-------ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc
Q 047576 484 SKLEAFVADFGTARLLHADSSN-------QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS 556 (602)
Q Consensus 484 ~~~~~kL~DFG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 556 (602)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876432211 123459999999999999999999999999999999999999997422110
Q ss_pred cCC-----CcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 557 SSY-----DPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 557 ~~~-----~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... .....+.+++++.++... ....+.+++..||+.||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~ 313 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAAN------APGEIAKYMETVKLLDYTE 313 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTC------CCHHHHHHHHHHHTCCTTC
T ss_pred HHHHHHHHHhhhhHHHHHHHhccccc------CHHHHHHHHHHHhcCCCCC
Confidence 000 001223444555443221 1234788999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.39 Aligned_cols=219 Identities=25% Similarity=0.345 Sum_probs=160.2
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------- 432 (602)
.++|...+.||+|+||.||+|+. .+++.||||+++..... .....+.+|+.++..+.|+++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46788999999999999999984 25778999999754332 23456778998886655555544
Q ss_pred ----------------cccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cce
Q 047576 433 ----------------ILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAF 489 (602)
Q Consensus 433 ----------------~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~k 489 (602)
++.... ....+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEE
Confidence 333211 1134888999999999999999999 78999999999999999554 599
Q ss_pred eecccccccccCCC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .. +.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~-~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QE-VL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HH-HH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HH
Confidence 99999998653321 22233567899999999999999999999999999999998 9999975321 11 12
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+......+.... ....+.+++..||+.||++
T Consensus 297 ~~i~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~ 329 (367)
T 3l9p_A 297 EFVTSGGRMDPPKN---CPGPVYRIMTQCWQHQPED 329 (367)
T ss_dssp HHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHcCCCCCCCcc---CCHHHHHHHHHHcCCCHhH
Confidence 22222111111111 2334889999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.39 Aligned_cols=217 Identities=25% Similarity=0.381 Sum_probs=153.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------------- 431 (602)
.++|...+.||+|+||.||+|+. .++.||+|++..... .+.+.+|+.++..+.|+++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTH-----HHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhH-----HHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEc
Confidence 45788899999999999999987 478899999975432 35678888888555555444
Q ss_pred -------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-ceeecccccccccCCC
Q 047576 432 -------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE-AFVADFGTARLLHADS 503 (602)
Q Consensus 432 -------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~-~kL~DFG~a~~~~~~~ 503 (602)
+++........+++..+..++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 44433222223678899999999999999999433389999999999999988876 799999999765432
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||+..... .......+... ..++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~~--- 228 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNG-TRPPLIKN--- 228 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTT-CCCCCBTT---
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcC-CCCCcccc---
Confidence 22346899999999999999999999999999999999999999743211 00011111111 11111111
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 229 ~~~~l~~li~~~l~~dp~~ 247 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQ 247 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGG
T ss_pred cCHHHHHHHHHHhcCChhh
Confidence 2234788999999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=270.44 Aligned_cols=215 Identities=22% Similarity=0.325 Sum_probs=159.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------- 432 (602)
.++|...+.||+|+||.||+|+..+++.||+|++...... .+.+.+|++++..+.|.++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 5678899999999999999999988889999999765433 245778998886555555443
Q ss_pred ----------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 433 ----------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 433 ----------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
++.. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 3332 1245899999999999999999999 789999999999999999999999999999866432
Q ss_pred CC-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SS-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ......+++.|+|||++.+..++.++||||+|+++|+|+| |+.||..... ......+.+ .........
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~~ 245 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQ-GLRLYRPHL 245 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHT-TCCCCCCTT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhc-ccCCCCCCc
Confidence 11 1122346788999999998899999999999999999999 9999975321 111122222 111111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 246 ---~~~~l~~li~~~l~~~p~~ 264 (283)
T 3gen_A 246 ---ASEKVYTIMYSCWHEKADE 264 (283)
T ss_dssp ---CCHHHHHHHHHTTCSSGGG
T ss_pred ---CCHHHHHHHHHHccCChhH
Confidence 1234789999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.92 Aligned_cols=219 Identities=24% Similarity=0.362 Sum_probs=163.3
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------------- 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g------------- 428 (602)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ...+.+.+|+.++..+.|+
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 467889999999999999999863 4589999999765432 2456788999988555544
Q ss_pred ------------ccccccccccc---------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCC
Q 047576 429 ------------SLFRILHNDAE---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDI 475 (602)
Q Consensus 429 ------------sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 475 (602)
+|.+++..... ...+++.++..++.||++||+||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 44444432110 145889999999999999999999 789999999
Q ss_pred CCCCeeeCCCCcceeecccccccccCCC--CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 047576 476 SSNNILLNSKLEAFVADFGTARLLHADS--SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLH 552 (602)
Q Consensus 476 kp~NILld~~~~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~ 552 (602)
||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999998664322 12233467889999999999899999999999999999999 99999743
Q ss_pred cccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 553 STLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 553 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ......+.+...... ... ....+.+++..||+.||++
T Consensus 281 ~~-------~~~~~~~~~~~~~~~-~~~---~~~~l~~li~~~l~~~p~~ 319 (343)
T 1luf_A 281 AH-------EEVIYYVRDGNILAC-PEN---CPLELYNLMRLCWSKLPAD 319 (343)
T ss_dssp CH-------HHHHHHHHTTCCCCC-CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred Ch-------HHHHHHHhCCCcCCC-CCC---CCHHHHHHHHHHcccCccc
Confidence 21 122223333322211 111 2234889999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=270.59 Aligned_cols=220 Identities=21% Similarity=0.301 Sum_probs=170.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|.++..++...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999875 5889999998655433334456788899999777777766554321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 01234789999999999999999999 78999999999999999999999999999987754444
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+. . .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--~---~ 238 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEYSIPK--H---I 238 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCT--T---S
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhccCCCcc--c---c
Confidence 44456799999999999998899999999999999999999999975321 1112222222222111 1 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 239 ~~~~~~li~~~l~~~p~~ 256 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTA 256 (294)
T ss_dssp CHHHHHHHHHHTCSSGGG
T ss_pred CHHHHHHHHHHcccChhh
Confidence 234778999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.54 Aligned_cols=223 Identities=21% Similarity=0.269 Sum_probs=164.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHH---HHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL---AFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.+.|...+.||+|+||.||+|+.. +|+.||+|++........ ...+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457889999999999999999864 689999998865432110 1235678899988666665554443210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC----cceeecccccc
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL----EAFVADFGTAR 497 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 01234889999999999999999999 78999999999999999887 79999999998
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ...+..+.......+.
T Consensus 167 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~ 238 (326)
T 2y0a_A 167 KIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFED 238 (326)
T ss_dssp ECCTTSC-CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHTCCCCCH
T ss_pred ECCCCCc-cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHhcCCCcCc
Confidence 7654322 2335799999999999988999999999999999999999999974321 1112222222221110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.........+.+++.+|++.||++
T Consensus 239 -~~~~~~~~~~~~li~~~L~~dP~~ 262 (326)
T 2y0a_A 239 -EYFSNTSALAKDFIRRLLVKDPKK 262 (326)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSGGG
T ss_pred -cccccCCHHHHHHHHHHccCChhh
Confidence 000112244789999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.38 Aligned_cols=181 Identities=27% Similarity=0.368 Sum_probs=143.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhH--HHHHhhhhHhHHHHHHhhh---cCccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETE--ELAFIRSFRNEAQVLSQME---RGSLFRILHND---- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~~~~E~~il~~l~---~gsL~~~l~~~---- 437 (602)
.++|.....||+|+||.||+|+. .+++.||||++...... .......+.+|+.+++.+. |+++..++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999986 47899999998633211 0111234556777665554 76665544311
Q ss_pred ------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecc
Q 047576 438 ------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 438 ------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 493 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 01122889999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 165 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 165 GLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred ccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998765433 234467899999999999999999999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=274.53 Aligned_cols=218 Identities=24% Similarity=0.386 Sum_probs=154.0
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.++|...+.||+|+||.||+|+.. ++.||||++...... .+..|.+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 467999999999999999999885 899999998644322 222333333
Q ss_pred ------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCC--------CeEEeCCCCCCeeeCCCCcc
Q 047576 423 ------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP--------SVVHRDISSNNILLNSKLEA 488 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~ivH~DLkp~NILld~~~~~ 488 (602)
||+++|+|.++++. ..+++.++..++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 44455555555532 24889999999999999999999 66 99999999999999999999
Q ss_pred eeecccccccccCCCCC----ccccccccccccccccccCcCCcc------chhHHHHHHHHHHHcC----------CCC
Q 047576 489 FVADFGTARLLHADSSN----QTLLAGSYGYIAPELAYTMVMTEK------YDVYSFGVVTLEVLMG----------KHP 548 (602)
Q Consensus 489 kL~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG----------~~P 548 (602)
||+|||++......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999766443221 123579999999999987766654 9999999999999999 445
Q ss_pred CCCCcccccCCCcccchhhhh-ccCCCCCCCh--hhHHHHHHHHHHHhhccCcCCCC
Q 047576 549 RDLHSTLSSSYDPKIMLIDVL-DQRLPPPVDR--KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 549 f~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
|....... .......+.+ .....+.... ...+....+.+++..||+.||++
T Consensus 262 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 315 (337)
T 3mdy_A 262 YHDLVPSD---PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315 (337)
T ss_dssp TTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred HhhhcCCC---CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhh
Confidence 44221110 1111111211 1222222211 11246677999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=268.23 Aligned_cols=218 Identities=26% Similarity=0.380 Sum_probs=164.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++.............+.+|+.++..+.|+++..++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 578999999999999999999764 6779999998665544444456788899999777777766554321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 01234788999999999999999999 8899999999999999999999999999986554322
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+. . .
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--~---~ 230 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFTFPD--F---V 230 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCT--T---S
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCCCCCCC--c---C
Confidence 2345789999999999999999999999999999999999999974321 1112222222222111 1 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+|++.||++
T Consensus 231 ~~~~~~li~~~l~~~p~~ 248 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQ 248 (279)
T ss_dssp CHHHHHHHHHHCCSSGGG
T ss_pred CHHHHHHHHHHhccChhh
Confidence 233778999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=281.34 Aligned_cols=218 Identities=23% Similarity=0.285 Sum_probs=163.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS----------------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs----------------- 429 (602)
.+.|...+.||+|+||.||+|+.. +|+.||+|++...... ....+.+|+.++..+.|++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 467899999999999999999864 6899999998765432 2346788999885555544
Q ss_pred --------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC--CCcceeecccccccc
Q 047576 430 --------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS--KLEAFVADFGTARLL 499 (602)
Q Consensus 430 --------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFG~a~~~ 499 (602)
|.+++.. ....+++.++..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||++...
T Consensus 127 ~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 4444432 1235899999999999999999999 789999999999999974 478999999999876
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+...
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSST
T ss_pred CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccc
Confidence 5433 23345799999999999999999999999999999999999999975322 111222222211111000
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+.+++..||+.||++
T Consensus 274 -~~~~s~~~~~li~~~L~~dP~~ 295 (387)
T 1kob_A 274 -FSSVSPEAKDFIKNLLQKEPRK 295 (387)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGG
T ss_pred -cccCCHHHHHHHHHHcCCChhH
Confidence 0012234789999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.44 Aligned_cols=217 Identities=20% Similarity=0.280 Sum_probs=157.1
Q ss_pred CccccCcccccccccccceeeecC-CCcE----EeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRV----FALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF----------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~----------- 431 (602)
.++|.....||+|+||.||+|+.. +++. ||+|.+...... ...+.+.+|+.++..+.|+++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcc
Confidence 467899999999999999999853 4444 777876543221 2345677788877555554444
Q ss_pred -------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 432 -------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 432 -------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 444321 345889999999999999999999 78999999999999999999999999999988
Q ss_pred ccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
...... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||..... ....+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AEVPDLLEKGERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------THHHHHHHTTCBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCC
Confidence 754322 2234567889999999999999999999999999999999 9999975321 1112222221111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..... ....+.+++.+||+.||++
T Consensus 237 ~~~~~---~~~~~~~li~~~l~~dp~~ 260 (325)
T 3kex_A 237 AQPQI---CTIDVYMVMVKCWMIDENI 260 (325)
T ss_dssp CCCTT---BCTTTTHHHHHHTCSCTTT
T ss_pred CCCCc---CcHHHHHHHHHHcCCChhh
Confidence 11111 1223778999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=281.37 Aligned_cols=219 Identities=24% Similarity=0.319 Sum_probs=162.6
Q ss_pred CccccCcccccccccccceeeec--------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ER----------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~----------- 427 (602)
.++|...+.||+|+||.||+|+. .++..||||+++..... ...+.+.+|++++..+ .|
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--HHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 46788999999999999999974 23468999999765432 2346778888888555 44
Q ss_pred --------------Cccccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 428 --------------GSLFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 428 --------------gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
|+|.+++..... ...+++.++..|+.|++.||+||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 444444433211 134899999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987654321 2233457889999999999999999999999999999999 9999974321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .+.+.+........... ....+.+++..||+.||++
T Consensus 300 ----~-~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~ 336 (382)
T 3tt0_A 300 ----E-ELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQ 336 (382)
T ss_dssp ----H-HHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGG
T ss_pred ----H-HHHHHHHcCCCCCCCcc---CCHHHHHHHHHHcCCChhh
Confidence 1 11222222211111111 2334888999999999974
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=261.24 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=201.3
Q ss_pred CCCCCCCceeCCC----------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCC
Q 047576 89 DHCEWIGITCNSA----------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQ 158 (602)
Q Consensus 89 ~~C~w~gv~C~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~ 158 (602)
+.|.|..+.|... .+++.|+++...+. .+..-.|+.+++|+.|++. .+.+.+..|..|+++++|+
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~---~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~ 105 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS---ELRKDDFKGLQHLYALVLV--NNKISKIHEKAFSPLRKLQ 105 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC---EECTTTTTTCTTCCEEECC--SSCCCEECGGGSTTCTTCC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCC---ccCHhHhhCCCCCcEEECC--CCccCccCHhHhhCcCCCC
Confidence 3478999999632 24566777554332 3333356777777777776 5666666688888888999
Q ss_pred EEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCC--CCCcccccCcCCCceeecccccC
Q 047576 159 LLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLI--GPIPLTLSRLTSLKILILAQNQL 232 (602)
Q Consensus 159 ~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 232 (602)
+|+|++|++.. ..++|++|++++|++++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|++
T Consensus 106 ~L~L~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 106 KLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp EEECCSSCCCSCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred EEECCCCcCCccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 99998888873 2468889999999888877778888888999999988885 4677778777 888899999988
Q ss_pred CCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccC
Q 047576 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312 (602)
Q Consensus 233 ~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (602)
+++|..+. ++|++|++++|.+++..|..+..+++|++|++++|++++..+..+..+++|+.|+|++|+++ .+|..+.
T Consensus 185 ~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 185 TGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp SSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred CccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 88887665 68888889999888888888888888999999999888887778888888999999998888 6788888
Q ss_pred CCCCCCEEeCCCCCCCCCCCcccccc------cccccccccCCcCC
Q 047576 313 SMEDLTWLDLSNNNIKGSIPGEITKL------SRLDYLNLSGNKLS 352 (602)
Q Consensus 313 ~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~ 352 (602)
.+++|+.|++++|++++..+..+... +.|+.|++++|++.
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 88889999999888887766666543 56788888888886
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=278.06 Aligned_cols=222 Identities=19% Similarity=0.238 Sum_probs=155.4
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
..++|...+.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.++..+.|+++..++...
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3578999999999999999999875 7899999998754332 24567888888666666655443211
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc--ceeecccccccccC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE--AFVADFGTARLLHA 501 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 01234889999999999999999999 789999999999999987765 99999999975432
Q ss_pred CCCCccccccccccccccccccCcCCcc-chhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEK-YDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...... ......+..+.......+....
T Consensus 171 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 171 HS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTCCCCCTTSC
T ss_pred cC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCCCCCCCcCC
Confidence 22 2233579999999999988887655 89999999999999999999753221 1112222333333333222111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 247 ---~s~~~~~li~~~L~~dP~~ 265 (361)
T 3uc3_A 247 ---ISPECCHLISRIFVADPAT 265 (361)
T ss_dssp ---CCHHHHHHHHHHSCSCTTT
T ss_pred ---CCHHHHHHHHHHccCChhH
Confidence 2234789999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=283.26 Aligned_cols=221 Identities=21% Similarity=0.256 Sum_probs=153.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHhhhcCccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQMERGSLF---------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~l~~gsL~---------- 431 (602)
.++|...+.||+|+||.||+|.. .+++.||||++..... ........+.+|+.++..+.|+++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 46788999999999999999976 4689999999865432 1122345688899988655555544
Q ss_pred --------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceeeccc
Q 047576 432 --------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVADFG 494 (602)
Q Consensus 432 --------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFG 494 (602)
+++.. ...+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 214 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred eEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 33332 234899999999999999999999 78999999999999997544 59999999
Q ss_pred ccccccCCCCCcccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|+||+.||...... ......+...
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~------~~~~~~i~~~ 360 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSG 360 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS------CCHHHHHHTT
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch------HHHHHHHhcC
Confidence 998765432 2334679999999999863 56788999999999999999999999743211 1111122222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..... .+........+.+++.+|++.||++
T Consensus 361 ~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~ 390 (419)
T 3i6u_A 361 KYNFI-PEVWAEVSEKALDLVKKLLVVDPKA 390 (419)
T ss_dssp CCCCC-HHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred CCCCC-chhhcccCHHHHHHHHHHccCChhH
Confidence 22111 1111112345889999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.91 Aligned_cols=175 Identities=23% Similarity=0.319 Sum_probs=142.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-----cCccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-----RGSLFRILHND---- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-----~gsL~~~l~~~---- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..+.+..|+.+++.+. |+++..++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH----HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh----hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 56899999999999999999986 4788999999975432 2345666888776664 54544433210
Q ss_pred -------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC--------------
Q 047576 438 -------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-------------- 484 (602)
Q Consensus 438 -------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-------------- 484 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+|||++.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccc
Confidence 01123788999999999999999999 789999999999999975
Q ss_pred -----------CCcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 485 -----------KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 485 -----------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|+|+||+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999865432 23357899999999999999999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=275.43 Aligned_cols=218 Identities=21% Similarity=0.325 Sum_probs=169.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|.++..++...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999875 5789999998755433334456788899999777777766554311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 01234789999999999999999999 78999999999999999999999999999987754444
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC--CCCCChhhH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL--PPPVDRKVI 582 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~ 582 (602)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+..... +...+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~---- 265 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEYSIPKHIN---- 265 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCTTSC----
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCCCCCCccCC----
Confidence 44456799999999999998899999999999999999999999975321 111222222222 22222
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+||+.||++
T Consensus 266 ---~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 266 ---PVAASLIQKMLQTDPTA 282 (335)
T ss_dssp ---HHHHHHHHHHTCSSGGG
T ss_pred ---HHHHHHHHHHccCChhH
Confidence 23778999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.14 Aligned_cols=219 Identities=21% Similarity=0.326 Sum_probs=163.1
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------- 432 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+.++..+.|+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 46788999999999999999974 34688999999755432 34567888999886555555444
Q ss_pred ----------------ccccccc---------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCC
Q 047576 433 ----------------ILHNDAE---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDI 475 (602)
Q Consensus 433 ----------------~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 475 (602)
++..... ...+++.++..++.|++.||+||| +.+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 3332111 123789999999999999999999 789999999
Q ss_pred CCCCeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 047576 476 SSNNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLH 552 (602)
Q Consensus 476 kp~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~ 552 (602)
||+||+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||+|+++|||+| |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876443221 223456788999999999889999999999999999999 99999753
Q ss_pred cccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 553 STLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 553 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ..+.+.+......+.... ....+.+++..||+.||++
T Consensus 257 ~~--------~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~ 295 (314)
T 2ivs_A 257 PP--------ERLFNLLKTGHRMERPDN---CSEEMYRLMLQCWKQEPDK 295 (314)
T ss_dssp CG--------GGHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CH--------HHHHHHhhcCCcCCCCcc---CCHHHHHHHHHHccCChhh
Confidence 21 111222222221111111 2334889999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.50 Aligned_cols=220 Identities=21% Similarity=0.325 Sum_probs=151.4
Q ss_pred CccccCcccccccccccceeeecCCC----cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNG----RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|...+.||+|+||.||+|+.... ..||||+++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 56799999999999999999987543 279999987543221 2356788999999777776665543210
Q ss_pred -------------------------c---chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcce
Q 047576 438 -------------------------A---EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 438 -------------------------~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~k 489 (602)
. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 0 0013788999999999999999999 78999999999999999999999
Q ss_pred eecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-------AEIYN 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-------HHHHH
Confidence 999999987644322 1223456788999999999999999999999999999999 9999975322 11222
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+........ ... ....+.+++..||+.||++
T Consensus 251 ~~~~~~~~~~-~~~---~~~~l~~li~~~l~~dp~~ 282 (323)
T 3qup_A 251 YLIGGNRLKQ-PPE---CMEEVYDLMYQCWSADPKQ 282 (323)
T ss_dssp HHHTTCCCCC-CTT---CCHHHHHHHHHTTCSSGGG
T ss_pred HHhcCCCCCC-CCc---cCHHHHHHHHHHccCChhh
Confidence 2222221111 111 2344889999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.92 Aligned_cols=222 Identities=26% Similarity=0.426 Sum_probs=153.6
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|...+.||+|+||.||+|+... .||+|+++..... ....+.+.+|+.++..+.|.++..++...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEE
Confidence 4578999999999999999998743 5999988754332 23456788999999777666655443210
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC--C
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD--S 503 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~--~ 503 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 11344889999999999999999999 789999999999999999999999999999765432 1
Q ss_pred CCccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh-ccCCCCCCCh
Q 047576 504 SNQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL-DQRLPPPVDR 579 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~ 579 (602)
.......||+.|+|||++. +..++.++||||+|+++|+|++|+.||..... ...+.+.+ .....+....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCCCCTTS
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccCcchhh
Confidence 2223356899999999986 56688899999999999999999999975322 11112222 1222211111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++..||+.||++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~ 272 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDE 272 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGG
T ss_pred ccccCCHHHHHHHHHHccCChhh
Confidence 11113345889999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.74 Aligned_cols=219 Identities=22% Similarity=0.307 Sum_probs=148.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|.....||+|+||.||+|+.. +++.||||++..... .+.+.+|+.++..+.|+++..++...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467899999999999999999875 588999999875432 35677888888666555554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 01233789999999999999999999 789999999999999975 88999999999987643
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+.+.....+.. ..
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~i~~~~~~~~~~-~~ 275 (349)
T 2w4o_A 204 QV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG------DQFMFRRILNCEYYFISP-WW 275 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC------HHHHHHHHHTTCCCCCTT-TT
T ss_pred cc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc------cHHHHHHHHhCCCccCCc-hh
Confidence 32 22345789999999999999999999999999999999999999964321 111223333333221110 00
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+....+.+++.+|++.||++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~ 296 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKK 296 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGG
T ss_pred hhCCHHHHHHHHHHccCChhh
Confidence 112334789999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.51 Aligned_cols=218 Identities=23% Similarity=0.282 Sum_probs=151.6
Q ss_pred CccccCc-ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 368 PRKIDSK-YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 368 t~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
.++|... +.||+|+||.||+|+.. +|+.||||++.... .+.+|++++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3456655 68999999999999864 68899999986432 223344433
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeec
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVAD 492 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~D 492 (602)
||+++|+|.+++.... ...+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence 4555666666665422 234899999999999999999999 789999999999999987 78999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+....
T Consensus 208 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~i~~~~ 283 (400)
T 1nxk_A 208 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ 283 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---CSHHHHHHHTC
T ss_pred cccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---HHHHHHHHcCc
Confidence 99998764322 223457899999999999999999999999999999999999999754321110 11112222222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+... .......+.+++.+||+.||++
T Consensus 284 ~~~~~~~-~~~~s~~~~~li~~~L~~dP~~ 312 (400)
T 1nxk_A 284 YEFPNPE-WSEVSEEVKMLIRNLLKTEPTQ 312 (400)
T ss_dssp CCCCTTT-TTTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCCCcc-cccCCHHHHHHHHHHCCCChhH
Confidence 2111100 0112234789999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.79 Aligned_cols=216 Identities=25% Similarity=0.381 Sum_probs=158.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------------------- 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g------------------- 428 (602)
.++|.....||+|+||.||+|+..++..||||+++..... .+.|.+|+.++..+.|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEeh
Confidence 4578889999999999999999988888999999765432 35678899988555554
Q ss_pred -----ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 429 -----SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 429 -----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+|.+++... ....+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 444444321 1234889999999999999999999 7899999999999999999999999999998765332
Q ss_pred CC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 SN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. .....++..|+|||++.+..++.++||||||+++|||+| |+.||..... ...... +......+....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~-i~~~~~~~~~~~- 405 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQ-VERGYRMPCPPE- 405 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHH-HHTTCCCCCCTT-
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCCC-
Confidence 21 223456788999999999999999999999999999999 9999974321 111122 222222121111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 406 --~~~~l~~li~~cl~~dP~~ 424 (452)
T 1fmk_A 406 --CPESLHDLMCQCWRKEPEE 424 (452)
T ss_dssp --SCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHccCChhh
Confidence 3345889999999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=267.06 Aligned_cols=219 Identities=25% Similarity=0.385 Sum_probs=154.6
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHH-HHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEE-LAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .++.||||++....... ....+.+.+|++++..+.|+++..++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788999999999999999997 48899999987554322 23346788899998777776665543311
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC---eEEeCCCCCCeeeCC--------CCcceeeccc
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS---VVHRDISSNNILLNS--------KLEAFVADFG 494 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---ivH~DLkp~NILld~--------~~~~kL~DFG 494 (602)
.....+++..+..++.|++.||+||| +.+ |+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 01234789999999999999999999 556 999999999999986 6789999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
.+........ ....|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+......
T Consensus 162 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 162 LAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAMNKLA 232 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHTSCCC
T ss_pred cccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhcCCCC
Confidence 9986644322 235689999999999998999999999999999999999999975322 1111222222222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.... ....+.+++..||+.||++
T Consensus 233 ~~~~~~---~~~~~~~li~~~l~~~p~~ 257 (271)
T 3dtc_A 233 LPIPST---CPEPFAKLMEDCWNPDPHS 257 (271)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CCCCcc---cCHHHHHHHHHHhcCCccc
Confidence 222211 2344889999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.10 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=159.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+|++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 567899999999999999999864 689999999865432 234466655
Q ss_pred --HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC----Ccceeeccccc
Q 047576 423 --SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK----LEAFVADFGTA 496 (602)
Q Consensus 423 --~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~----~~~kL~DFG~a 496 (602)
||+++|+|.+.+.. ...+++.++..++.||+.||+||| +.+|+||||||+||++..+ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 44445555554433 234899999999999999999999 7899999999999998433 35999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
+.............||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..+.......+
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTPEEILARIGSGKFSLS 243 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCHHHHHHHHHHCCCCCC
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCHHHHHHHHccCCcccC
Confidence 8776544444456789999999999888899999999999999999999999974211 111122223333332211
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ........+.+++.+|++.||++
T Consensus 244 ~~-~~~~~s~~~~~li~~~L~~dP~~ 268 (342)
T 2qr7_A 244 GG-YWNSVSDTAKDLVSKMLHVDPHQ 268 (342)
T ss_dssp ST-TTTTSCHHHHHHHHHHTCSSTTT
T ss_pred cc-ccccCCHHHHHHHHHHCCCChhH
Confidence 10 00012234789999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=290.13 Aligned_cols=216 Identities=25% Similarity=0.344 Sum_probs=164.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL---------------- 430 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL---------------- 430 (602)
..+|...+.||+|+||.||+|+.. ++..||||+++..... .+.|.+|+.++..+.|+++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 456888899999999999999875 4889999999765432 4568889998855555444
Q ss_pred ---------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 431 ---------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 431 ---------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.+++... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 4444321 1234789999999999999999999 78999999999999999999999999999987644
Q ss_pred CCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 502 DSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
+... .....++..|+|||++.+..++.++|||||||++|||+| |+.||..... ....+.+......+...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 442 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKDYRMERPE 442 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHHHTTCCCCCCT
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence 3211 122346778999999999999999999999999999999 9999975321 11223333333222222
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++..||+.||++
T Consensus 443 ~---~~~~l~~li~~cl~~dP~~ 462 (495)
T 1opk_A 443 G---CPEKVYELMRACWQWNPSD 462 (495)
T ss_dssp T---CCHHHHHHHHHHTCSSGGG
T ss_pred C---CCHHHHHHHHHHcCcChhH
Confidence 1 3345889999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=284.47 Aligned_cols=175 Identities=28% Similarity=0.372 Sum_probs=132.6
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
..++|...+.||+|+||.||+|+.. +++.||||++...... ....+++.+|+.++..+.|+++..++....
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3578999999999999999999864 7899999998654322 234567889999999999988877654210
Q ss_pred -------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 439 -------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 439 -------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 1123789999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCC---------------------------Ccccccccccccccccc-ccCcCCccchhHHHHHHHHHHHcC
Q 047576 500 HADSS---------------------------NQTLLAGSYGYIAPELA-YTMVMTEKYDVYSFGVVTLEVLMG 545 (602)
Q Consensus 500 ~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG 545 (602)
..... ......||+.|+|||++ .+..++.++||||+||++|||+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43211 12335689999999976 456699999999999999999994
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=274.61 Aligned_cols=224 Identities=24% Similarity=0.270 Sum_probs=161.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhH--HHHHhhhhHhHHHHHHhhhcCcccc------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETE--ELAFIRSFRNEAQVLSQMERGSLFR------------ 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~~~~E~~il~~l~~gsL~~------------ 432 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++...... .....+.+.+|+.++..+.|+++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46799999999999999999986 46889999998654321 1223467888999885555555444
Q ss_pred -------------cccccc-------------------------------------chhhhcHHHHHHHHHHHHHHHHHh
Q 047576 433 -------------ILHNDA-------------------------------------EAVELDWAKRVNIVKAMAHALAYL 462 (602)
Q Consensus 433 -------------~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~L~~L 462 (602)
++.... ....+++..+..++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 332100 022346788889999999999999
Q ss_pred hhcCCCCeEEeCCCCCCeeeCCCC--cceeecccccccccCCCC----Ccccccccccccccccccc--CcCCccchhHH
Q 047576 463 HHDCSPSVVHRDISSNNILLNSKL--EAFVADFGTARLLHADSS----NQTLLAGSYGYIAPELAYT--MVMTEKYDVYS 534 (602)
Q Consensus 463 H~~~~~~ivH~DLkp~NILld~~~--~~kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS 534 (602)
| +.+|+||||||+||+++.++ .+||+|||++........ ......||+.|+|||++.+ ..++.++||||
T Consensus 185 H---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 H---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp H---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred H---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9 78999999999999998776 899999999986643211 1234579999999999875 56889999999
Q ss_pred HHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 535 FGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 535 lGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
||+++|||++|+.||.... .......+++.....+... .......+.+++..|++.||++
T Consensus 262 lG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVN-------DADTISQVLNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCTTSGG-GGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcccccCCcc-cccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999997532 2223344444443322111 0112344789999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=274.16 Aligned_cols=213 Identities=21% Similarity=0.326 Sum_probs=164.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH-----HHHhhhhHhHHHHHHhhhcCccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE-----LAFIRSFRNEAQVLSQMERGSLFRILHND---- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----~~~~~~~~~E~~il~~l~~gsL~~~l~~~---- 437 (602)
.++|.....||+|+||.||+|+. .+++.||||++....... ....+.+.+|+.++..+.|+++..++...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46788999999999999999985 578999999987653211 11345678899999888777776654311
Q ss_pred -------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 438 -------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 438 -------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 01224789999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .+......+.
T Consensus 180 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~~~~~~ 245 (335)
T 3dls_A 180 LERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEAAIHPPY 245 (335)
T ss_dssp CCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTTCCCCSS
T ss_pred CCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhhccCCCc
Confidence 654332 334579999999999988876 7899999999999999999999974221 1222222221
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++..|+++||++
T Consensus 246 ~-----~~~~l~~li~~~L~~dP~~ 265 (335)
T 3dls_A 246 L-----VSKELMSLVSGLLQPVPER 265 (335)
T ss_dssp C-----CCHHHHHHHHHHTCSSGGG
T ss_pred c-----cCHHHHHHHHHHccCChhh
Confidence 1 1223788999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=271.76 Aligned_cols=220 Identities=22% Similarity=0.339 Sum_probs=164.7
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILH----- 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~----- 435 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+.++..+ .|+++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 45788899999999999999973 35789999999755432 2346788899988776 5655554432
Q ss_pred --------------------cccc---------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 436 --------------------NDAE---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 436 --------------------~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
.... ...+++.++..++.|++.||+||| +.+|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 2110 113789999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 253 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---
Confidence 9999999999999999876544322 223457788999999999999999999999999999999 9999975321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+........... ....+.+++.+|++.||++
T Consensus 254 ----~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 291 (313)
T 1t46_A 254 ----DSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLK 291 (313)
T ss_dssp ----SHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred ----hhHHHHHhccCCCCCCccc---CCHHHHHHHHHHcCCCchh
Confidence 1122233333222221111 2234889999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.43 Aligned_cols=183 Identities=25% Similarity=0.331 Sum_probs=145.9
Q ss_pred CCCCCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc----
Q 047576 364 SMPTPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA---- 438 (602)
Q Consensus 364 ~lp~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~---- 438 (602)
.....++|...+.||+|+||.||+|+.. +++.||||++...... ....+++.+|+.++..+.|+++..++....
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 3444678999999999999999999864 6889999999754332 234567889999999998888776553210
Q ss_pred ----------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 439 ----------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 439 ----------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
....+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 100 LKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 1123789999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCC----------------------Ccccccccccccccccc-ccCcCCccchhHHHHHHHHHHHcCCCCCC
Q 047576 497 RLLHADSS----------------------NQTLLAGSYGYIAPELA-YTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 497 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
+....... ..+...||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 12446789999999986 55669999999999999999999766664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=281.69 Aligned_cols=225 Identities=19% Similarity=0.286 Sum_probs=163.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR-------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~-------------- 432 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++..+.|+++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 467999999999999999999875 5899999998754322 12355678888886555555444
Q ss_pred -------------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee----CCCCcceeecccc
Q 047576 433 -------------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL----NSKLEAFVADFGT 495 (602)
Q Consensus 433 -------------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFG~ 495 (602)
++........+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 3333222223899999999999999999999 7899999999999999 8888899999999
Q ss_pred cccccCCCCCcccccccccccccccccc--------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhh
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYT--------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 567 (602)
++....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .....+..
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYK 238 (396)
T ss_dssp CEECCCGGG-SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---TCHHHHHH
T ss_pred ceEccCCCc-cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---chHHHHHH
Confidence 987654322 223569999999998865 567889999999999999999999996432110 11111111
Q ss_pred hhcc---------------------CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQ---------------------RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~---------------------~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
++.. .++... .........+.+++.+|++.||++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~ll~~~L~~dP~~ 293 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEK 293 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HhcCCCcccchhheeccCCCcccCccCCccc-ccchHHHhhchHHHHHhhccChhh
Confidence 2111 111111 111335566889999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.35 Aligned_cols=229 Identities=24% Similarity=0.328 Sum_probs=168.5
Q ss_pred CCCCccccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--
Q 047576 365 MPTPRKIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-- 437 (602)
Q Consensus 365 lp~t~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-- 437 (602)
+-..++|...+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++..+.|+++..++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH---HHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 33457899999999999999999983 46889999999765433 346788999998666665555432210
Q ss_pred -----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 438 -----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 438 -----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccc
Confidence 01234899999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc-------cCCCcccc
Q 047576 495 TARLLHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS-------SSYDPKIM 564 (602)
Q Consensus 495 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~~ 564 (602)
++......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 99876543321 222457888999999999889999999999999999999999986432210 00111112
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+......+.... ....+.+++..||+.||++
T Consensus 253 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~ 287 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPA---CPAEVHELMKLCWAPSPQD 287 (327)
T ss_dssp HHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhhcccCCCCCCc---ccHHHHHHHHHHcCCChhh
Confidence 2233333333222222 3344889999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=267.15 Aligned_cols=219 Identities=23% Similarity=0.336 Sum_probs=153.9
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|...+.||+|+||.||+|+.. .+..||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEccCccE
Confidence 467889999999999999999864 3567999998754332 3456788999999777776665543211
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 01224889999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 502 DSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.+.... +...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-------~~~~~~i~~~~~~-~~~~ 240 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERL-PMPP 240 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCCC-CCCT
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-------HHHHHHHHcCCCC-CCCC
Confidence 3221 223456788999999998899999999999999999997 9999975321 1112222222111 1111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++..||+.||++
T Consensus 241 ~---~~~~l~~li~~~l~~~p~~ 260 (281)
T 1mp8_A 241 N---CPPTLYSLMTKCWAYDPSR 260 (281)
T ss_dssp T---CCHHHHHHHHHHTCSSGGG
T ss_pred C---CCHHHHHHHHHHccCChhh
Confidence 1 2334789999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.34 Aligned_cols=221 Identities=26% Similarity=0.377 Sum_probs=159.0
Q ss_pred CccccCcccccccccccceeeec----CCCcEEeeeccCCchhH-HHHHhhhhHhHHHHHHhh-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPETE-ELAFIRSFRNEAQVLSQM----------------- 425 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~~~~~~E~~il~~l----------------- 425 (602)
.++|...+.||+|+||.||+|+. .+++.||||+++..... .....+.+.+|++++..+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999986 47899999998754321 111234566777777544
Q ss_pred ---------hcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 426 ---------ERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 426 ---------~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
++++|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 34444444432 234889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCC-CCccccccccccccccccccC--cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC
Q 047576 497 RLLHADS-SNQTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573 (602)
Q Consensus 497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l 573 (602)
+...... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .........+.....
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEP 283 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc---chHHHHHHHHhccCC
Confidence 8654322 122335799999999999863 4788999999999999999999999743211 011111122222222
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+ .. ....+.+++.+||+.||++
T Consensus 284 ~~~--~~---~~~~~~~li~~~L~~dP~~ 307 (355)
T 1vzo_A 284 PYP--QE---MSALAKDLIQRLLMKDPKK 307 (355)
T ss_dssp CCC--TT---SCHHHHHHHHHHTCSSGGG
T ss_pred CCC--cc---cCHHHHHHHHHHhhhCHHH
Confidence 211 11 2234788999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=279.75 Aligned_cols=182 Identities=29% Similarity=0.355 Sum_probs=137.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~~------- 438 (602)
.++|.....||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+. |+++..++....
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35788999999999999999985 47899999998654322 223456778999998886 877766544210
Q ss_pred ---------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC-
Q 047576 439 ---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD- 502 (602)
Q Consensus 439 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~- 502 (602)
....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 1234788889999999999999999 789999999999999999999999999999865321
Q ss_pred --------------------CCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 503 --------------------SSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 503 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
....+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111233579999999999887 568999999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=273.67 Aligned_cols=220 Identities=22% Similarity=0.365 Sum_probs=153.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.++|...+.||+|+||.||+|+. +++.||||++...... .+..|.++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ------NFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh------hHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46799999999999999999987 6899999998644322 222233332
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCC---------CeEEeCCCCCCeeeCCCC
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP---------SVVHRDISSNNILLNSKL 486 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~ivH~DLkp~NILld~~~ 486 (602)
||+++|+|.+++.. ...++..+..++.|++.||+||| +. +|+||||||+|||++.++
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 44445555555532 23578899999999999999999 67 999999999999999999
Q ss_pred cceeecccccccccCCCC--------Ccccccccccccccccccc-------CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 487 EAFVADFGTARLLHADSS--------NQTLLAGSYGYIAPELAYT-------MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999987643221 1223469999999999887 4567889999999999999999887643
Q ss_pred CcccccCCC----------cccchhhhh-----ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 552 HSTLSSSYD----------PKIMLIDVL-----DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 552 ~~~~~~~~~----------~~~~~~~~~-----d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......... ........+ .+.++..... .......+.+++..||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~ 302 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEA 302 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGG
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhh
Confidence 322111000 000001111 1112211111 1224556899999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=284.71 Aligned_cols=211 Identities=22% Similarity=0.314 Sum_probs=159.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccc-------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL------------- 434 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l------------- 434 (602)
.++|...+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|+.++..+.|+++..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 457888899999999999999884 7899999997654 246788899998666665555443
Q ss_pred -------------ccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 435 -------------HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 435 -------------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 221 1122688999999999999999999 78999999999999999999999999999986432
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+ ....+.+....
T Consensus 342 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i-~~~~~~~~p~~ 410 (450)
T 1k9a_A 342 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRV-EKGYKMDAPDG 410 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-------TTHHHHH-HTTCCCCCCTT
T ss_pred cc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHH-HcCCCCCCCCc
Confidence 21 22357889999999999999999999999999999998 9999975321 1111222 22111111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 411 ---~~~~l~~li~~cl~~dp~~ 429 (450)
T 1k9a_A 411 ---CPPAVYDVMKNCWHLDAAT 429 (450)
T ss_dssp ---CCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHcCCChhH
Confidence 3345889999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=276.88 Aligned_cols=183 Identities=16% Similarity=0.237 Sum_probs=147.8
Q ss_pred CCCccccCccccccc--ccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 366 PTPRKIDSKYCIGTG--AYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 366 p~t~~f~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
+...+|...+.||+| +||.||+|+.. +|+.||||++...... ....+.+.+|+.++..+.|+++..++...
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 99999999875 7999999998755432 23456788899999776666665543210
Q ss_pred -------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 438 -------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 438 -------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 01134789999999999999999999 78999999999999999999999999998865
Q ss_pred ccCCC-------CCcccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 499 LHADS-------SNQTLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 499 ~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 43211 11223468999999999987 57899999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=271.29 Aligned_cols=181 Identities=26% Similarity=0.319 Sum_probs=143.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|...+.||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 56888999999999999999875 5899999988655432 234567888999998888888776543210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 1233788999999999999999999 789999999999999999999999999999877644444
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.....||+.|+|||++.+ ..++.++||||+|+++|+|+||+.||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 445678999999999876 568999999999999999999999997543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=265.66 Aligned_cols=216 Identities=22% Similarity=0.349 Sum_probs=162.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------- 432 (602)
.++|...+.||+|+||.||+|+..+++.||+|++...... .+.+.+|++++..+.|+++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 4678889999999999999999888889999998755432 356788999886655555443
Q ss_pred ---------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 433 ---------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 433 ---------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
++... ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 33321 1235889999999999999999999 7899999999999999999999999999998765432
Q ss_pred CC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 SN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+. ..........
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~-~~~~~~~~~~- 234 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLE-RGYRMVRPDN- 234 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHH-TTCCCCCCTT-
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHh-cccCCCCccc-
Confidence 11 222456788999999998889999999999999999999 9999975321 11111111 1111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..|++.||++
T Consensus 235 --~~~~l~~li~~~l~~~p~~ 253 (279)
T 1qpc_A 235 --CPEELYQLMRLCWKERPED 253 (279)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --ccHHHHHHHHHHhccChhh
Confidence 2234889999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=274.82 Aligned_cols=179 Identities=20% Similarity=0.274 Sum_probs=139.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.++..+.|+++..++....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 46888899999999999999875 7899999998754432 23346678999998888877766543210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 1233788999999999999999999 789999999999999999999999999999876544444
Q ss_pred cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 444578999999999876 56899999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.32 Aligned_cols=212 Identities=17% Similarity=0.170 Sum_probs=152.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGS-------------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gs-------------- 429 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+.+++.+ .|++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999996 46999999998643222222345667777443222 3333
Q ss_pred ----------------------------------ccccccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 047576 430 ----------------------------------LFRILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471 (602)
Q Consensus 430 ----------------------------------L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 471 (602)
|.+++.... ....+++..+..|+.||+.||+||| +.+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 333332211 0123456888899999999999999 78999
Q ss_pred EeCCCCCCeeeCCCCcceeecccccccccCCCCCccccccccccccccccccC-----------cCCccchhHHHHHHHH
Q 047576 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM-----------VMTEKYDVYSFGVVTL 540 (602)
Q Consensus 472 H~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~ 540 (602)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999999986432 2333567 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 541 EVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 541 elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
||+||+.||...... .....+... . ...+ ..+.+++.+||+.||++
T Consensus 305 elltg~~Pf~~~~~~-------~~~~~~~~~-~-~~~~-------~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 305 WIWCADLPITKDAAL-------GGSEWIFRS-C-KNIP-------QPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHSSCCC-------------CCSGGGGSS-C-CCCC-------HHHHHHHHHHTCSSGGG
T ss_pred HHHHCCCCCcccccc-------cchhhhhhh-c-cCCC-------HHHHHHHHHHcCCCchh
Confidence 999999999743221 111112211 1 1222 23788999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=270.91 Aligned_cols=224 Identities=19% Similarity=0.251 Sum_probs=153.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH----------- 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~----------- 435 (602)
..+|...+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.++..+.|+++..++.
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46789999999999999999985 578999999987543333345567888999987666666554432
Q ss_pred --------------ccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 436 --------------NDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 436 --------------~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
... ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 110 1233788899999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
..........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........+.....+......
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCSCCCCTTT
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccCCCCcccc
Confidence 443333445789999999999999999999999999999999999999964321 111111112222222111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 263 ---~~~~l~~li~~~l~~dp~~ 281 (310)
T 2wqm_A 263 ---YSEELRQLVNMCINPDPEK 281 (310)
T ss_dssp ---SCHHHHHHHHHHTCSSGGG
T ss_pred ---cCHHHHHHHHHHcCCChhh
Confidence 2234889999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=265.99 Aligned_cols=218 Identities=25% Similarity=0.341 Sum_probs=166.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...........+.+.+|++++..+.|+++..++...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999865 6889999998655433333346788899999777777666543311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 01234788999999999999999999 889999999999999999999999999998765432
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||+.... ......+.......+. . .
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~--~---~ 235 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIVNVDLKFPP--F---L 235 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCT--T---S
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHhccccCCCC--c---C
Confidence 22345789999999999999999999999999999999999999975321 1112233333222111 1 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|++.||++
T Consensus 236 ~~~~~~li~~~l~~~p~~ 253 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQ 253 (284)
T ss_dssp CHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHhhcCHhh
Confidence 233788999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.81 Aligned_cols=181 Identities=25% Similarity=0.296 Sum_probs=141.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~------- 439 (602)
.++|.....||+|+||.||+|+. .+++.||||++...... ....+.+.+|+.++..+.|+++..++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 46799999999999999999975 46899999998754322 2245678899999999999888766542100
Q ss_pred ------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 440 ------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 440 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 123688899999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 180 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 180 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2233578999999999999999999999999999999999999997543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-29 Score=258.28 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=201.6
Q ss_pred CCCCCCCceeCCC----------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCC
Q 047576 89 DHCEWIGITCNSA----------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQ 158 (602)
Q Consensus 89 ~~C~w~gv~C~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~ 158 (602)
+.|+|..+.|... ..++.++++...+. .+..-.|+.+++|+.|++. .+.+.+..|..|+++++|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~---~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT---EIKDGDFKNLKNLHTLILI--NNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC---CBCTTTTTTCTTCCEEECC--SSCCCCBCTTTTTTCTTCC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCC---EeChhhhccCCCCCEEECC--CCcCCeeCHHHhcCCCCCC
Confidence 4578999999632 24556676544332 2333346667777777776 5566666688888888899
Q ss_pred EEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCC--CCcccccCcCCCceeecccccC
Q 047576 159 LLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG--PIPLTLSRLTSLKILILAQNQL 232 (602)
Q Consensus 159 ~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l 232 (602)
+|+|++|+|+. ..++|++|++++|.+++..+..|.++++|++|++++|.++. ..+..+.++++|++|++++|++
T Consensus 104 ~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 104 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp EEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred EEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 99998888873 24688889998888888888888888889999998888853 6677888888889999988888
Q ss_pred CCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccC
Q 047576 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312 (602)
Q Consensus 233 ~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (602)
+.+|..+. ++|+.|++++|++++..|..+..+++|++|++++|.+++..+..+..+++|++|+|++|+++ .+|..+.
T Consensus 184 ~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 184 TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp CSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred ccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 88887665 78888899888888887888888888888999888888877778888888889999988888 6788888
Q ss_pred CCCCCCEEeCCCCCCCCCCCcccccc------cccccccccCCcCC
Q 047576 313 SMEDLTWLDLSNNNIKGSIPGEITKL------SRLDYLNLSGNKLS 352 (602)
Q Consensus 313 ~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~ 352 (602)
.+++|+.|++++|++++..+..|... +.|+.|++++|++.
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 88888899998888887766666543 66788888888875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=264.50 Aligned_cols=222 Identities=22% Similarity=0.305 Sum_probs=166.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|...+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 578999999999999999999864 6899999998654432 223467888999998777777665543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc---ceeecccccccccC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE---AFVADFGTARLLHA 501 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFG~a~~~~~ 501 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||.+.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 1233788999999999999999999 789999999999999987655 99999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+... .
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~-~ 231 (284)
T 3kk8_A 161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPE-W 231 (284)
T ss_dssp SC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTT-T
T ss_pred Cc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhccccCCchh-h
Confidence 32 22335789999999999999999999999999999999999999964321 111222222222211100 0
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++..|++.||++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~ 252 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKK 252 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTT
T ss_pred cccCHHHHHHHHHHcccChhh
Confidence 112234789999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=271.11 Aligned_cols=223 Identities=22% Similarity=0.311 Sum_probs=157.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++..+.|+++..++...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999864 7899999999766544445567888999999777776665543311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 01234789999999999999999999 78999999999999999999999999999977644321
Q ss_pred -CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 -NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+....+.+. .....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~-~~~~~ 260 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIPRPS-TVRPG 260 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCCCGG-GTSTT
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCCCcc-ccCCC
Confidence 223356899999999999989999999999999999999999999753221 11122222211110 00001
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 261 ~~~~l~~li~~~l~~dP~~ 279 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPED 279 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGG
T ss_pred CCHHHHHHHHHhccCCHHH
Confidence 1233778999999999974
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-30 Score=276.57 Aligned_cols=267 Identities=26% Similarity=0.336 Sum_probs=213.5
Q ss_pred CCCCceeCCC----------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEE
Q 047576 92 EWIGITCNSA----------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLD 161 (602)
Q Consensus 92 ~w~gv~C~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~ 161 (602)
.|..|.|... ..++.|+++...+. .+..-.|..+++|+.|++. .+.+.+..|..|+++++|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~ 86 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK---TLNQDEFASFPHLEELELN--ENIVSAVEPGAFNNLFNLRTLG 86 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCC---EECTTTTTTCTTCCEEECT--TSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccc---eECHhHccCCCCCCEEECC--CCccCEeChhhhhCCccCCEEE
Confidence 4778888632 25667777654432 3334457778888888876 5677777789999999999999
Q ss_pred CcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC
Q 047576 162 LSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG 234 (602)
Q Consensus 162 Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 234 (602)
|++|+|++ .+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++
T Consensus 87 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 166 (477)
T 2id5_A 87 LRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166 (477)
T ss_dssp CCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred CCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence 99999873 47899999999999999999999999999999999999999889999999999999999999999
Q ss_pred Ccc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCC
Q 047576 235 LPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313 (602)
Q Consensus 235 ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 313 (602)
+|. .+.++++|+.|+|++|.+++..+..|..+++|++|++++|.+.+.+|.......+|+.|+|++|++++..+..+..
T Consensus 167 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 246 (477)
T 2id5_A 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246 (477)
T ss_dssp CCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTT
T ss_pred cChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcC
Confidence 764 5889999999999999999888888888888888888888777776666666667777777777777544456777
Q ss_pred CCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcCC
Q 047576 314 MEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLS 363 (602)
Q Consensus 314 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 363 (602)
+++|+.|+|++|++++..+..+..+++|+.|++++|++++..|..+..+.
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 296 (477)
T 2id5_A 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296 (477)
T ss_dssp CTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCT
T ss_pred ccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcc
Confidence 77777777777777766666777777777777777777776666654433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=275.85 Aligned_cols=222 Identities=24% Similarity=0.378 Sum_probs=163.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCch-----hHHHHHhhhhHhHHHHHHhh-hcCccccccccc----
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPE-----TEELAFIRSFRNEAQVLSQM-ERGSLFRILHND---- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~---- 437 (602)
++|.....||+|+||.||+|+.. +|+.||||++.... .......+.+.+|+.++..+ .|+++..++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56888899999999999999875 79999999886432 12233456788899888665 455554433210
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 01234789999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccC------cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTM------VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l 573 (602)
.... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||..... ...+..+.....
T Consensus 251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~ 322 (365)
T 2y7j_A 251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRMIMEGQY 322 (365)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC
T ss_pred CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC
Confidence 5433 23346799999999988643 578899999999999999999999974321 112222333322
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+. .........+.+++.+|++.||++
T Consensus 323 ~~~~-~~~~~~~~~~~~li~~~L~~dP~~ 350 (365)
T 2y7j_A 323 QFSS-PEWDDRSSTVKDLISRLLQVDPEA 350 (365)
T ss_dssp CCCH-HHHSSSCHHHHHHHHHHSCSSTTT
T ss_pred CCCC-cccccCCHHHHHHHHHHcCCChhH
Confidence 2211 000112344889999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=270.45 Aligned_cols=220 Identities=23% Similarity=0.314 Sum_probs=161.5
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRI------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~------- 433 (602)
.++|...+.||+|+||.||+|+. .+++.||||++...... ...+.+.+|+.++..+ .|+++..+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 46789999999999999999963 46789999999765432 2345678898888665 34444433
Q ss_pred -------------------cccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCee
Q 047576 434 -------------------LHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNIL 481 (602)
Q Consensus 434 -------------------l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NIL 481 (602)
+..... ...+++.++..++.|++.||.||| +.+|+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEE
Confidence 322111 112789999999999999999999 789999999999999
Q ss_pred eCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccC
Q 047576 482 LNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSS 558 (602)
Q Consensus 482 ld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 558 (602)
++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---- 256 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 256 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch----
Confidence 999999999999999876443322 223457889999999999999999999999999999998 9999975321
Q ss_pred CCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 559 YDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 559 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+...+......+.... ....+.+++..||+.||++
T Consensus 257 ---~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 257 ---DEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp ---SHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred ---hHHHHHHhccCccCCCCCC---CCHHHHHHHHHHcCCChhh
Confidence 1111112211111111111 2234788999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=271.74 Aligned_cols=182 Identities=19% Similarity=0.257 Sum_probs=138.8
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
..++|...+.||+|+||.||+|+. .+++.||||+++..... ....+.+.+|+.++..+.|+++..++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 357899999999999999999975 47899999999755432 234467788999998888887776543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee-----CCCCcceeecccccccc
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL-----NSKLEAFVADFGTARLL 499 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl-----d~~~~~kL~DFG~a~~~ 499 (602)
....+++.++..|+.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++...
T Consensus 111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 1224789999999999999999999 7899999999999999 45556999999999877
Q ss_pred cCCCCCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
...........||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 54444444467899999999998754 899999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=268.15 Aligned_cols=181 Identities=22% Similarity=0.310 Sum_probs=147.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
..+|...+.||+|+||.||+|+. .+|+.||+|++...... ......+.+|+.++..+.|+++..++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 46799999999999999999986 57899999988654332 112345678999999888888776543110
Q ss_pred ----------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 439 ----------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 439 ----------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 1134789999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCC----CCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADS----SNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+...... .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 8764321 12233568999999999876 45799999999999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=266.49 Aligned_cols=222 Identities=19% Similarity=0.302 Sum_probs=155.9
Q ss_pred CccccCcccccccccccceeeecC--CC--cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--NG--RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|...+.||+|+||.||+|++. ++ ..||||+++..........+.+.+|+.++..+.|+++..++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 568999999999999999999752 33 36899999765443344567888999999777776665543311
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 01244889999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 502 DSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 502 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+.......+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERLPR 246 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCCCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCCCCCC
Confidence 3221 222457788999999998889999999999999999999 9999975321 1222222222222221
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..||+.||++
T Consensus 247 ~~~---~~~~l~~li~~~l~~~p~~ 268 (291)
T 1u46_A 247 PED---CPQDIYNVMVQCWAHKPED 268 (291)
T ss_dssp CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CcC---cCHHHHHHHHHHccCCccc
Confidence 111 2344889999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.68 Aligned_cols=219 Identities=23% Similarity=0.322 Sum_probs=159.3
Q ss_pred CccccCcccccccccccceeeec--------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcC----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERG---------- 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~g---------- 428 (602)
.++|...+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+.++..+ .|+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 46788999999999999999975 35778999999755432 2356778888888555 444
Q ss_pred ---------------ccccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 429 ---------------SLFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 429 ---------------sL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
+|.+++..... ...+++.++..++.|++.||+||| +.+|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 44444433211 123789999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
+++.++.+||+|||++........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999999987654321 1222356788999999998889999999999999999999 9999975321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. +...+......+.... ....+.+++..||+.||++
T Consensus 266 ----~~-~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 302 (334)
T 2pvf_A 266 ----EE-LFKLLKEGHRMDKPAN---CTNELYMMMRDCWHAVPSQ 302 (334)
T ss_dssp ----HH-HHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred ----HH-HHHHHhcCCCCCCCcc---CCHHHHHHHHHHccCChhh
Confidence 11 1111111111111111 2234788999999999964
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-31 Score=273.80 Aligned_cols=219 Identities=23% Similarity=0.349 Sum_probs=156.8
Q ss_pred CccccCcccccccccccceeeecC-CCcE----EeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRV----FALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.++|...+.||+|+||.||+|+.. +++. ||+|.+...... ...+.+.+|+.++..+.|+++..++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCc
Confidence 567999999999999999999853 4554 477766543221 2346788899999777777666544311
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 01234789999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 501 ADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+...+......+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLPQ 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 43221 223456788999999999999999999999999999999 9999975321 122333333322222
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..||+.||++
T Consensus 241 ~~~---~~~~l~~li~~~l~~dp~~ 262 (327)
T 3lzb_A 241 PPI---CTIDVYMIMRKCWMIDADS 262 (327)
T ss_dssp CTT---BCHHHHHHHHHHTCSSGGG
T ss_pred Ccc---CCHHHHHHHHHHcCCChhH
Confidence 221 2334788999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-31 Score=271.31 Aligned_cols=220 Identities=21% Similarity=0.306 Sum_probs=163.4
Q ss_pred CccccCcccccccccccceeeecC-C-----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCcccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-N-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHN---- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~---- 436 (602)
.++|...+.||+|+||.||+|+.. + +..||+|++...... ...+.+.+|+.++..+ .|+++..++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 467888999999999999999853 2 347999998765432 2346788899998777 66666554431
Q ss_pred ---------------------ccc-----------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 437 ---------------------DAE-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 437 ---------------------~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECC
Confidence 100 123588899999999999999999 789999999999999999
Q ss_pred CCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCc
Q 047576 485 KLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 561 (602)
++.+||+|||++......... .....+++.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------- 272 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV------- 272 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-------
Confidence 999999999999876543322 223456789999999999899999999999999999999 9999974321
Q ss_pred ccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+..++......+.... ....+.+++..||+.||++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~ 310 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAF---APKNIYSIMQACWALEPTH 310 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHhccChhh
Confidence 1122233333222221111 2234788999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=259.79 Aligned_cols=218 Identities=22% Similarity=0.297 Sum_probs=161.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL---------------- 430 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL---------------- 430 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|+.++..+.|+++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 467889999999999999999865 7899999998644322 234567888888855555444
Q ss_pred ---------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 431 ---------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 431 ---------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 84 LEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 443332 234889999999999999999999 78999999999999999999999999999986543
Q ss_pred CC--CCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 502 DS--SNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.. .......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||+..... ..............+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 231 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYLNPW 231 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHHTTCTTSTTG
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhhhcccccCch
Confidence 22 12234568999999999987765 77899999999999999999999753221 11112222211111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++..|++.||++
T Consensus 232 ~~---~~~~~~~li~~~l~~~p~~ 252 (276)
T 2yex_A 232 KK---IDSAPLALLHKILVENPSA 252 (276)
T ss_dssp GG---SCHHHHHHHHHHSCSSTTT
T ss_pred hh---cCHHHHHHHHHHCCCCchh
Confidence 11 2234778999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-31 Score=269.77 Aligned_cols=228 Identities=18% Similarity=0.252 Sum_probs=155.4
Q ss_pred CccccC-cccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh-hhcCccccccccc-------
Q 047576 368 PRKIDS-KYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-MERGSLFRILHND------- 437 (602)
Q Consensus 368 t~~f~~-~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~-l~~gsL~~~l~~~------- 437 (602)
.+.|.. .+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++.. ..|+++..++...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 345666 47899999999999986 47899999998654322 23567788887754 2354444433210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc---ceeecccccccc
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE---AFVADFGTARLL 499 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFG~a~~~ 499 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++...
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 01234789999999999999999999 789999999999999988776 999999998765
Q ss_pred cCCCC-------Ccccccccccccccccccc-----CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcc-----
Q 047576 500 HADSS-------NQTLLAGSYGYIAPELAYT-----MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPK----- 562 (602)
Q Consensus 500 ~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----- 562 (602)
..... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 1122458999999999875 558899999999999999999999997643322222111
Q ss_pred ---cchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 563 ---IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 563 ---~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.+.....+. .........+.+++.+|++.||++
T Consensus 245 ~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~ 286 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQ 286 (316)
T ss_dssp HHHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhh
Confidence 112223333332221 100112345889999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=271.69 Aligned_cols=179 Identities=27% Similarity=0.372 Sum_probs=143.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 46789999999999999999986 47999999998654332 234567889999999998888776543210
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 1234788899999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 233578999999999887 678999999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=265.48 Aligned_cols=218 Identities=20% Similarity=0.356 Sum_probs=156.2
Q ss_pred cccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc-------------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------------- 435 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------------- 435 (602)
.|.....||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.++..+.|+++..++.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 445556899999999999985 46889999998755432 3466888999987777666655432
Q ss_pred ------------cccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecccccccccCC
Q 047576 436 ------------NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADFGTARLLHAD 502 (602)
Q Consensus 436 ------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG~a~~~~~~ 502 (602)
.......+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||.+......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 1111223568888999999999999999 789999999999999987 899999999999876543
Q ss_pred CCCccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........... ........+.++...
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~--- 251 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMFKVHPEIPESM--- 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHHCCCCCCCTTS---
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccccccccccccC---
Confidence 33334457899999999987654 78999999999999999999999964221100000 000001112222222
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+||+.||++
T Consensus 252 ----~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 252 ----SAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp ----CHHHHHHHHHTTCSSTTT
T ss_pred ----CHHHHHHHHHHccCChhh
Confidence 234788999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=270.72 Aligned_cols=223 Identities=19% Similarity=0.239 Sum_probs=164.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHH---HHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL---AFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.+.|...+.||+|+||.||+|+.. +|+.||+|++........ ...+.+.+|+.++..+.|+++..++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999865 689999999865432210 1235678899988666665554433210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC----cceeecccccc
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL----EAFVADFGTAR 497 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG~a~ 497 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 01234789999999999999999999 78999999999999999887 79999999998
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ...+..+.......+.
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 168 EIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVSYDFDE 239 (321)
T ss_dssp ECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCH
T ss_pred ecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccccCh
Confidence 765432 22345699999999999999999999999999999999999999974321 1122222222221110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.........+.+++..|++.||++
T Consensus 240 -~~~~~~~~~~~~li~~~l~~dp~~ 263 (321)
T 2a2a_A 240 -EFFSHTSELAKDFIRKLLVKETRK 263 (321)
T ss_dssp -HHHTTCCHHHHHHHHTTSCSSTTT
T ss_pred -hhhcccCHHHHHHHHHHcCCChhh
Confidence 000112234789999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-31 Score=263.88 Aligned_cols=219 Identities=20% Similarity=0.283 Sum_probs=165.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|++++..+.|+++..++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 457889999999999999999865 5778999998654332 245688899999777777766544311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 01233789999999999999999999 7899999999999999 7889999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+. ++.++||||+|+++|+|++|+.||.... .......+.......+. ...
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-~~~ 231 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-------DSEVMLKIREGTFTFPE-KDW 231 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCH-HHH
T ss_pred cc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCc-hhh
Confidence 33 23345799999999988654 8999999999999999999999997532 12222333333333221 110
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++..|++.||++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~ 252 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQ 252 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTT
T ss_pred hcCCHHHHHHHHHHccCChhh
Confidence 112345889999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-31 Score=270.50 Aligned_cols=224 Identities=19% Similarity=0.259 Sum_probs=163.5
Q ss_pred ccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
|...+.||+|+||.||++++ .+++.||||++...... ...+.+.+|++++..+.|+++..++....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48889999999999988753 26889999999765322 34567889999997776666555432110
Q ss_pred ----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 439 ----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 439 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 1123789999999999999999999 789999999999999999999999999999877543
Q ss_pred CC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc---cCCC----cccchhhhhccC
Q 047576 503 SS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS---SSYD----PKIMLIDVLDQR 572 (602)
Q Consensus 503 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~----~~~~~~~~~d~~ 572 (602)
.. ......++..|+|||++.+..++.++||||+|+++|+|+||+.||....... .... ....+.+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 32 1223457888999999999899999999999999999999999986432110 0000 011123333333
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.... ....+.+++..||+.||++
T Consensus 268 ~~~~~~~~---~~~~l~~li~~~l~~dP~~ 294 (318)
T 3lxp_A 268 ERLPRPDK---CPAEVYHLMKNCWETEASF 294 (318)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred cCCCCCcc---ccHHHHHHHHHHcCCCccc
Confidence 33222222 3345889999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-31 Score=272.65 Aligned_cols=182 Identities=23% Similarity=0.328 Sum_probs=143.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHH--HHHhhhhHhHHHHHHhhhcCcccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEE--LAFIRSFRNEAQVLSQMERGSLFRILHNDA------ 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------ 438 (602)
.++|.....||+|+||.||+|+.. +|+.||||++....... ....+.+.+|+.++..+.|+++..++....
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999875 68999999987543221 123456788999998888888776654210
Q ss_pred ----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 439 ----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 439 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 1123778899999999999999999 789999999999999999999999999999877554
Q ss_pred CCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
........||+.|+|||++.+. .++.++||||+||++|||++|..||...
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 4444456789999999998764 4889999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=277.28 Aligned_cols=174 Identities=28% Similarity=0.376 Sum_probs=143.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|...+.||+|+||.||+|+.. +|+.||||++.... ....+|++++..+.|.++..++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 457899999999999999999874 68999999986432 2345799999999998887653211
Q ss_pred ----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccc
Q 047576 438 ----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFG 494 (602)
Q Consensus 438 ----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG 494 (602)
.....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence 01234788889999999999999999 8899999999999999965 578999999
Q ss_pred ccccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9987644322 2335789999999998765 6899999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-31 Score=265.01 Aligned_cols=217 Identities=25% Similarity=0.344 Sum_probs=165.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. ++..||+|++...... .+.+.+|+.++..+.|+++..++...
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 567889999999999999999875 4889999998765432 45678899988776666655443210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 01234889999999999999999999 779999999999999999999999999999876543
Q ss_pred CCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ....+.+......+....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKDYRMERPEG 236 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHHHTTCCCCCCTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhccCCCCCCCC
Confidence 322 222456788999999999999999999999999999999 9999975321 112222322222222111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..|++.||++
T Consensus 237 ---~~~~l~~li~~~l~~dp~~ 255 (288)
T 3kfa_A 237 ---CPEKVYELMRACWQWNPSD 255 (288)
T ss_dssp ---CCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHhCCChhh
Confidence 2344889999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=263.81 Aligned_cols=218 Identities=21% Similarity=0.291 Sum_probs=161.7
Q ss_pred ccccCcc-cccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 369 RKIDSKY-CIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 369 ~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
++|.... .||+|+||.||+|... +++.||+|+++..... ...+.+.+|+.++..+.|+++..++...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence 4565555 8999999999999753 6788999999765322 3456788999998776666655443210
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 01234889999999999999999999 789999999999999999999999999999876543
Q ss_pred CCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 503 SSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 503 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||..... .. ....+......+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~-~~~~i~~~~~~~~~ 235 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PE-VMAFIEQGKRMECP 235 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HH-HHHHHHTTCCCCCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HH-HHHHHhcCCcCCCC
Confidence 221 122346789999999988889999999999999999999 9999975321 11 11122111111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++..||+.||++
T Consensus 236 ~~---~~~~l~~li~~~l~~~p~~ 256 (287)
T 1u59_A 236 PE---CPPELYALMSDCWIYKWED 256 (287)
T ss_dssp TT---CCHHHHHHHHHTTCSSGGG
T ss_pred CC---cCHHHHHHHHHHcCCChhh
Confidence 11 2334889999999999974
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-31 Score=269.61 Aligned_cols=227 Identities=19% Similarity=0.272 Sum_probs=161.9
Q ss_pred CccccCcccccccccccceeee-----cCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQ-----LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.+.|...+.||+|+||.||+|+ ..+++.||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3468888999999999999998 346899999998754322 2346678899988666665554433210
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 01234789999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccc----ccCCCc---ccchhh
Q 047576 498 LLHADSS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL----SSSYDP---KIMLID 567 (602)
Q Consensus 498 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----~~~~~~---~~~~~~ 567 (602)
....... ......||..|+|||++.+..++.++||||+|+++|+|+||+.|+...... ...... ......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7754432 122346788899999999999999999999999999999999997532110 000111 111122
Q ss_pred hhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+......+.... ....+.+++.+||+.||++
T Consensus 255 ~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 286 (302)
T 4e5w_A 255 TLKEGKRLPCPPN---CPDEVYQLMRKCWEFQPSN 286 (302)
T ss_dssp HHHTTCCCCCCTT---CCHHHHHHHHHTTCSSGGG
T ss_pred HHhccCCCCCCCC---CCHHHHHHHHHHcCCCCCC
Confidence 2222222211111 2344889999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-31 Score=271.16 Aligned_cols=219 Identities=20% Similarity=0.279 Sum_probs=157.0
Q ss_pred cccCc-ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 370 KIDSK-YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 370 ~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
.|... +.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.++
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 44444 78999999999999865 68999999987543321 1234566777776
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeeccccccc
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFGTARL 498 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFG~a~~ 498 (602)
||+++|+|.+++... ....+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 444555666555432 1345899999999999999999999 789999999999999988 78999999999987
Q ss_pred ccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+..
T Consensus 184 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 184 IGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-------QETYLNISQVNVDYSEE 255 (327)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTT
T ss_pred cCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHhcccccCch
Confidence 654322 2335799999999999999999999999999999999999999975322 11112222222111110
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++..|++.||++
T Consensus 256 -~~~~~~~~~~~li~~~L~~dP~~ 278 (327)
T 3lm5_A 256 -TFSSVSQLATDFIQSLLVKNPEK 278 (327)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSGGG
T ss_pred -hhcccCHHHHHHHHHHcCCChhh
Confidence 00112334789999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=263.48 Aligned_cols=219 Identities=23% Similarity=0.303 Sum_probs=160.5
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|...+.||+|+||.||+|+.. ++..||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCE
Confidence 568999999999999999999753 2446999998765322 2356788999999777776665543311
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 01234788999999999999999999 78999999999999999999999999999987654
Q ss_pred CCC-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 502 DSS-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||..... ... ...+......+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-------~~~-~~~~~~~~~~~~~~ 237 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-------KDV-IGVLEKGDRLPKPD 237 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-------GGH-HHHHHHTCCCCCCT
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-------HHH-HHHHhcCCCCCCCC
Confidence 322 1233457789999999998899999999999999999998 9999974321 111 11111111111111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+||+.||++
T Consensus 238 ~---~~~~l~~li~~~l~~~p~~ 257 (281)
T 3cc6_A 238 L---CPPVLYTLMTRCWDYDPSD 257 (281)
T ss_dssp T---CCHHHHHHHHHHTCSSGGG
T ss_pred C---CCHHHHHHHHHHccCCchh
Confidence 1 2234889999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=271.94 Aligned_cols=176 Identities=23% Similarity=0.328 Sum_probs=140.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
.++|.....||+|+||.||+|+.. +++.||||+++.... ....+..|+.+++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 568999999999999999999864 688999999975432 23456667776655432
Q ss_pred -----------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC--CCCcceeeccc
Q 047576 428 -----------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN--SKLEAFVADFG 494 (602)
Q Consensus 428 -----------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFG 494 (602)
++|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCCCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 2233333221 113478999999999999999999943 57999999999999994 57889999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876432 23357899999999999999999999999999999999999999854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-31 Score=262.43 Aligned_cols=217 Identities=24% Similarity=0.323 Sum_probs=162.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|...+.||+|+||.||+|+..+++.||+|++...... .+.+.+|++++..+.|+++..++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 4678889999999999999999888899999999765433 24678899988666655554433210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC-
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS- 503 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~- 503 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 01234789999999999999999999 7899999999999999999999999999998654321
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
.......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ......+... ........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~-~~~~~~~~-- 229 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTG-FRLYKPRL-- 229 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT-CCCCCCTT--
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcC-CcCCCCcc--
Confidence 11122456788999999998889999999999999999999 8999975321 1111222211 11111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 230 -~~~~l~~li~~~l~~~p~~ 248 (267)
T 3t9t_A 230 -ASTHVYQIMNHCWRERPED 248 (267)
T ss_dssp -SCHHHHHHHHHHTCSSGGG
T ss_pred -CcHHHHHHHHHHccCChhh
Confidence 2234788999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=265.60 Aligned_cols=216 Identities=26% Similarity=0.380 Sum_probs=165.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|...+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45688899999999999999975 47899999998654322 2346788899988766666655443211
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 01234789999999999999999999 789999999999999999999999999999877554434
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc---cCCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD---QRLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d---~~l~~~~~~~~~ 582 (602)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.. +.++...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~----- 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTLEGNY----- 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCCSSC-----
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhcCCCCCCcccc-----
Confidence 44567899999999999999999999999999999999999999753221 11111111 1122222
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..||+.||++
T Consensus 244 --~~~l~~li~~~l~~dp~~ 261 (303)
T 3a7i_A 244 --SKPLKEFVEACLNKEPSF 261 (303)
T ss_dssp --CHHHHHHHHHHCCSSGGG
T ss_pred --CHHHHHHHHHHcCCChhh
Confidence 233789999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=273.22 Aligned_cols=179 Identities=26% Similarity=0.396 Sum_probs=135.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 46789999999999999999985 57899999998754322 224567889999999998888776553210
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 1234789999999999999999999 7899999999999999999999999999998754
Q ss_pred CCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
.. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 233578999999999887 678999999999999999999999997643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=269.13 Aligned_cols=182 Identities=26% Similarity=0.346 Sum_probs=144.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 467899999999999999999875 5899999988654332 223466788999998888888777654210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 1234788999999999999999999 78999999999999999999999999999987655444
Q ss_pred CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 505 NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
......|++.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 44446789999999998875 68999999999999999999999997543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-31 Score=266.44 Aligned_cols=220 Identities=24% Similarity=0.338 Sum_probs=163.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++..+.|+++..++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 468999999999999999999864 7899999998754332 12356788999999777777766654311
Q ss_pred ------------------c-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCC-----eEEeCCCCCCeeeCCCCcceeecc
Q 047576 438 ------------------A-EAVELDWAKRVNIVKAMAHALAYLHHDCSPS-----VVHRDISSNNILLNSKLEAFVADF 493 (602)
Q Consensus 438 ------------------~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~DLkp~NILld~~~~~kL~DF 493 (602)
. ....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 0 0112789999999999999999999 556 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l 573 (602)
|.+..............|++.|+|||++.+..++.++||||||+++|+|+||+.||..... ......+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~ 233 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKF 233 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhccc
Confidence 9998765433223345689999999999998899999999999999999999999975321 111122222222
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+ ..... ....+.+++.+||+.||++
T Consensus 234 ~-~~~~~---~~~~l~~li~~~l~~~p~~ 258 (279)
T 2w5a_A 234 R-RIPYR---YSDELNEIITRMLNLKDYH 258 (279)
T ss_dssp C-CCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred c-cCCcc---cCHHHHHHHHHHcCCCccc
Confidence 1 11111 2234789999999999974
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=268.57 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=191.3
Q ss_pred CCCCCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCc
Q 047576 87 DSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166 (602)
Q Consensus 87 ~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~ 166 (602)
...+|.|.|+ |+..+ +.++.+..+..++|+.|++. ++++.+..+..|.++++|++|+|++|+
T Consensus 26 ~~~~C~~~~~-c~~~~---------------~~l~~iP~~~~~~L~~L~l~--~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 26 ASLSCDRNGI-CKGSS---------------GSLNSIPSGLTEAVKSLDLS--NNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -CCEECTTSE-EECCS---------------TTCSSCCTTCCTTCCEEECT--TSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred cCCCCCCCeE-eeCCC---------------CCcccccccccccCcEEECC--CCcCcccCHHHhccCCCCCEEECCCCc
Confidence 3578999998 86321 12333333444677777776 455555445578888888888888888
Q ss_pred Ccc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecccc-cCCCC-c
Q 047576 167 LRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQN-QLSGL-P 236 (602)
Q Consensus 167 i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~i-p 236 (602)
|++ .+++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..+.++++|++|++++| .++++ |
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 873 36788888888888887766678888888888888888885444 47888888888888888 46664 5
Q ss_pred ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC----------
Q 047576 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK---------- 306 (602)
Q Consensus 237 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---------- 306 (602)
..++++++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|+|++|++++.
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~ 247 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence 6788888888888888888888888888888888888888888644444455678888888888888764
Q ss_pred ---------------------CCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 307 ---------------------IPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 307 ---------------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+|..+..+++|+.|++++|+++...+..+..+++|+.|++++|++++..|
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 34456678899999999999984433345889999999999999988766
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-31 Score=270.73 Aligned_cols=219 Identities=24% Similarity=0.312 Sum_probs=161.7
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------- 431 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.++..+.|+++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 467999999999999999999753 4788999999755432 2345688899988555554444
Q ss_pred ---------------cccccccch-------hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcce
Q 047576 432 ---------------RILHNDAEA-------VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 432 ---------------~~l~~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~k 489 (602)
+++...... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEE
Confidence 433321110 23588899999999999999999 78999999999999999999999
Q ss_pred eecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||++......... .....+++.|+|||++.+..++.++||||+|+++|+|+| |+.||..... .....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~ 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLR 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HHHHH
Confidence 9999999866433221 122356889999999999899999999999999999999 8999974321 12222
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+....... .. ....+.+++.+||+.||++
T Consensus 252 ~~~~~~~~~~~-~~---~~~~l~~li~~~l~~dp~~ 283 (322)
T 1p4o_A 252 FVMEGGLLDKP-DN---CPDMLFELMRMCWQYNPKM 283 (322)
T ss_dssp HHHTTCCCCCC-TT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCcCCCC-CC---CCHHHHHHHHHHcCCCccc
Confidence 23332222111 11 2334788999999999974
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=270.71 Aligned_cols=274 Identities=22% Similarity=0.275 Sum_probs=222.7
Q ss_pred CCCCCCCCC--ceeCCC---------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCC-ccCCCC
Q 047576 87 DSDHCEWIG--ITCNSA---------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIP-SEISAL 154 (602)
Q Consensus 87 ~~~~C~w~g--v~C~~~---------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip-~~l~~L 154 (602)
....|.|.+ |.|+.. .+++.|+++...+. .+..-.++.+++|+.|++. .+.+.+.++ ..|.++
T Consensus 4 ~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~L~--~n~~~~~i~~~~~~~l 78 (455)
T 3v47_A 4 GTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIA---ELNETSFSRLQDLQFLKVE--QQTPGLVIRNNTFRGL 78 (455)
T ss_dssp ---CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCC---EECTTTTSSCTTCCEEECC--CCSTTCEECTTTTTTC
T ss_pred ccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccC---cCChhHhccCccccEEECc--CCcccceECccccccc
Confidence 345566655 778632 35788888755432 3334457778888888876 556666664 579999
Q ss_pred CCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchh--hhCCCCCCEEEecCCCCCCCCccc-ccCcCCCce
Q 047576 155 SKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQE--IGNLKNLIELDVGDNSLIGPIPLT-LSRLTSLKI 224 (602)
Q Consensus 155 ~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~ 224 (602)
++|++|+|++|++.+ .+++|++|+|++|++++..|.. |+++++|++|+|++|++++..|.. +.++++|++
T Consensus 79 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 158 (455)
T 3v47_A 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158 (455)
T ss_dssp TTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCE
T ss_pred ccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccE
Confidence 999999999999873 4789999999999999866665 999999999999999999888876 889999999
Q ss_pred eecccccCCC-CcccccCC----------------------------------CCCcEEEccCCCCCCCCCCccC-----
Q 047576 225 LILAQNQLSG-LPQEIGNL----------------------------------KNLMLLDVGNNDIIGPIPSTLG----- 264 (602)
Q Consensus 225 L~L~~N~l~~-ip~~~~~l----------------------------------~~L~~L~L~~N~l~~~~p~~l~----- 264 (602)
|++++|++++ .|..+.++ ++|+.|++++|++++.+|..+.
T Consensus 159 L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred EeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 9999999998 45555443 6788888888888764443221
Q ss_pred ----------------------------------CCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcc
Q 047576 265 ----------------------------------LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQ 310 (602)
Q Consensus 265 ----------------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 310 (602)
..++|++|++++|.+++.+|..++.+++|++|+|++|++++..|..
T Consensus 239 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 318 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318 (455)
T ss_dssp CCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred cceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence 1258999999999999999999999999999999999999988999
Q ss_pred cCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcCCCC
Q 047576 311 IASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365 (602)
Q Consensus 311 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~l 365 (602)
+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..+..+
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 373 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccc
Confidence 9999999999999999998889999999999999999999999988877555444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=261.59 Aligned_cols=214 Identities=19% Similarity=0.274 Sum_probs=158.3
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
.++|.....||+|+||.||+|+. +++.||||++....... ...+.+.+|+.++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 46788999999999999999998 48899999987654322 23456888888774444
Q ss_pred ------cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 427 ------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 427 ------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
+|+|.+++.... ...+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 444444444321 224799999999999999999999 677 99999999999999999999999988765
Q ss_pred ccCCCCCccccccccccccccccccCcCCc---cchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTE---KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
... ....||+.|+|||++.+..++. ++||||||+++|||+||+.||..... ......+......+
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRP 230 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCCC
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCCC
Confidence 322 2246889999999998766544 79999999999999999999975322 11122222222222
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..... ....+.+++..||+.||++
T Consensus 231 ~~~~~---~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 231 TIPPG---ISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp CCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CCCCC---CCHHHHHHHHHHcCCChhh
Confidence 22111 2234889999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=263.49 Aligned_cols=218 Identities=23% Similarity=0.300 Sum_probs=158.0
Q ss_pred cccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
.|...+.||+|+||.||+|+.. ++..||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4666789999999999999753 2337999998754332 3456788999999776666655543211
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 01234788999999999999999999 78999999999999999999999999999976533
Q ss_pred CC----CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 502 DS----SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 502 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.. .......+++.|+|||.+.+..++.++||||||+++|+|+||..|+.... . .......+......+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~------~-~~~~~~~~~~~~~~~~ 249 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI------D-PFDLTHFLAQGRRLPQ 249 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------C-GGGHHHHHHTTCCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC------C-HHHHHHHhhcCCCCCC
Confidence 21 12233467889999999999999999999999999999999666643211 1 1111222222222111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..|++.||++
T Consensus 250 ~~~---~~~~l~~li~~~l~~~p~~ 271 (298)
T 3pls_A 250 PEY---CPDSLYQVMQQCWEADPAV 271 (298)
T ss_dssp CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred Ccc---chHHHHHHHHHHccCChhh
Confidence 111 2234889999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=275.97 Aligned_cols=175 Identities=23% Similarity=0.307 Sum_probs=140.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC------ccccccccc---
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------SLFRILHND--- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g------sL~~~l~~~--- 437 (602)
..+|...+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.+++.+.+. ++..++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 457999999999999999999764 689999999976532 235566788877665332 333322110
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc--ceeecccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE--AFVADFGT 495 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFG~ 495 (602)
.....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 01123889999999999999999999 779999999999999999887 99999999
Q ss_pred cccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 249 a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9765432 22357899999999999999999999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=269.79 Aligned_cols=175 Identities=21% Similarity=0.304 Sum_probs=142.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh--------cCccccccccc-
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------RGSLFRILHND- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------~gsL~~~l~~~- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.++..+. +.++..++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 36799999999999999999975 4689999999975532 3456778998887775 33344333210
Q ss_pred --------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCC----
Q 047576 438 --------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKL---- 486 (602)
Q Consensus 438 --------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~---- 486 (602)
.....+++.++..|+.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 01134889999999999999999999 66 999999999999999775
Q ss_pred ---------------------------------------------cceeecccccccccCCCCCcccccccccccccccc
Q 047576 487 ---------------------------------------------EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELA 521 (602)
Q Consensus 487 ---------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 521 (602)
.+||+|||.+...... .....||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 7999999999876433 2335789999999999
Q ss_pred ccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 522 YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 522 ~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.+..++.++|||||||++|||+||+.||...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=275.65 Aligned_cols=218 Identities=24% Similarity=0.296 Sum_probs=148.8
Q ss_pred ccccCcccccccccccceeeecC--C--CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP--N--GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
..|...+.||+|+||.||+|+.. + +..||+|.++..... ...+.+.+|+.++..+.|+++..++...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45777889999999999999853 2 246899998654322 2356788888887555555554443210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 01233788999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCC----CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 501 ADSS----NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 501 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
.... ......+++.|+|||++.+..++.++||||||+++|||+| |..||...... .....+.......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-------~~~~~~~~~~~~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-------CHHHHHHTTCCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-------HHHHHHHcCCCCC
Confidence 3221 1223457788999999999999999999999999999999 67787643211 1111222221111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ... ....+.+++..||+.||++
T Consensus 317 ~-p~~---~~~~l~~li~~cl~~dp~~ 339 (373)
T 3c1x_A 317 Q-PEY---CPDPLYEVMLKCWHPKAEM 339 (373)
T ss_dssp C-CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred C-CCC---CCHHHHHHHHHHcCCChhh
Confidence 1 111 2334889999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=265.12 Aligned_cols=220 Identities=21% Similarity=0.315 Sum_probs=154.8
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHN------- 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~------- 436 (602)
.++|...+.||+|+||.||+|+.. .++.||+|++...... ....+.+.+|+.++..+.|+++..++..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 567889999999999999999753 3558999998754332 2234678889998876666665544321
Q ss_pred -----------------------c---cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCccee
Q 047576 437 -----------------------D---AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 437 -----------------------~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
. .....+++.++..++.|+++||.||| +.+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 0 01234789999999999999999999 889999999999999999999999
Q ss_pred ecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhh
Q 047576 491 ADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLID 567 (602)
Q Consensus 491 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 567 (602)
+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ......
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------HEMYDY 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------GGHHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHH
Confidence 99999987643321 1223457889999999999999999999999999999999 8999975321 111222
Q ss_pred hhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 568 ~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+...... +.... ....+.+++..||+.||++
T Consensus 262 ~~~~~~~-~~~~~---~~~~l~~li~~~l~~dp~~ 292 (313)
T 3brb_A 262 LLHGHRL-KQPED---CLDELYEIMYSCWRTDPLD 292 (313)
T ss_dssp HHTTCCC-CCBTT---CCHHHHHHHHHTTCSSGGG
T ss_pred HHcCCCC-CCCcc---ccHHHHHHHHHHcCCChhh
Confidence 2222111 11111 2234889999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-31 Score=289.77 Aligned_cols=216 Identities=25% Similarity=0.383 Sum_probs=162.7
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------------- 432 (602)
.++|...+.||+|+||.||+|+..++..||||+++..... .+.|.+|+.++..+.|.++..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeee
Confidence 4568888999999999999999988889999999765432 356888999886665555444
Q ss_pred ---------ccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 433 ---------ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 433 ---------~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
++... ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 33321 1234889999999999999999999 7899999999999999999999999999998764321
Q ss_pred C-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 504 S-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. ......++..|+|||++.+..++.++|||||||++|||+| |+.||..... ... .+.+......+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~-~~~i~~~~~~~~~~~- 488 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REV-LDQVERGYRMPCPPE- 488 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHH-HHHHHTTCCCCCCTT-
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHH-HHHHHcCCCCCCCCC-
Confidence 1 1122346788999999999999999999999999999999 9999974321 111 112222222121111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 489 --~~~~l~~li~~cl~~dP~~ 507 (535)
T 2h8h_A 489 --CPESLHDLMCQCWRKEPEE 507 (535)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHcCCChhH
Confidence 3345889999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-31 Score=286.87 Aligned_cols=222 Identities=21% Similarity=0.300 Sum_probs=167.4
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++..+.|+++..++...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999865 7899999998654332222346788899999777777766554311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 01234789999999999999999999 7899999999999999 5678999999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...+..+.......+.+. .
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~-~ 251 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTFELPQ-W 251 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGG-G
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCCcc-c
Confidence 33 2334579999999998876 689999999999999999999999975322 222233333333222111 1
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|+++||++
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~ 272 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSM 272 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGG
T ss_pred ccCCHHHHHHHHHHCCCChhH
Confidence 112344789999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=261.47 Aligned_cols=212 Identities=22% Similarity=0.302 Sum_probs=155.0
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|...+.||+|+||.||+|+. .|+.||||+++.... .+.+.+|+.++..+.|+++..++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 46789999999999999999987 488999999976542 35678899998777776665544310
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 01122688889999999999999999 789999999999999999999999999998765432
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. ....+++.|+|||++.+..++.++||||||+++|||+| |+.||..... ... ...+......+....
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~-~~~~~~~~~~~~~~~- 238 (278)
T 1byg_A 171 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDV-VPRVEKGYKMDAPDG- 238 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-------GGH-HHHHTTTCCCCCCTT-
T ss_pred c---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHH-HHHHhcCCCCCCccc-
Confidence 2 22357889999999998899999999999999999998 9999975321 111 111211111111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 239 --~~~~l~~li~~~l~~~p~~ 257 (278)
T 1byg_A 239 --CPPAVYEVMKNCWHLDAAM 257 (278)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHhcCChhh
Confidence 2334888999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=289.66 Aligned_cols=209 Identities=22% Similarity=0.330 Sum_probs=153.3
Q ss_pred cccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc------------------------C
Q 047576 376 CIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------------G 428 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------------g 428 (602)
.||+|+||.||+|.+. ++..||||+++..... ...+.+.+|+.++..+.| |
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCC
Confidence 7999999999999753 5678999999765322 234678889998855544 4
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC---
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--- 505 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~--- 505 (602)
+|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 421 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 421 PLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp BHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 44444432 2345899999999999999999999 789999999999999999999999999999876433221
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... .. ..+.+......+.... .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~-~~~~i~~~~~~~~p~~---~ 564 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PE-VMAFIEQGKRMECPPE---C 564 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-------HH-HHHHHHTTCCCCCCTT---C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HH-HHHHHHcCCCCCCCCc---C
Confidence 112345688999999999999999999999999999998 9999975321 11 1222222222111111 3
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..||+.||++
T Consensus 565 ~~~l~~li~~cl~~dP~~ 582 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWED 582 (613)
T ss_dssp CHHHHHHHHHTTCSSTTT
T ss_pred CHHHHHHHHHHcCCChhH
Confidence 345889999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=260.23 Aligned_cols=219 Identities=22% Similarity=0.331 Sum_probs=161.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|.....||+|+||.||+|.. .++..||+|++...... ....+.+.+|+.++..+.|+++..++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34577788999999999999986 46889999998654332 22356788999999887777776554310
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeC-CCCcceeecccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLN-SKLEAFVADFGTAR 497 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld-~~~~~kL~DFG~a~ 497 (602)
.....+++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 01134788999999999999999999 677 99999999999998 78999999999997
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
..... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||...... ......+.....+...
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF 251 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCcccc
Confidence 65332 2334579999999998764 5899999999999999999999999753221 1111112221111111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..||+.||++
T Consensus 252 ~~~---~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 252 DKV---AIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp GGC---CCHHHHHHHHHHSCSSGGG
T ss_pred CCC---CCHHHHHHHHHHccCChhh
Confidence 111 1234889999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=262.25 Aligned_cols=219 Identities=22% Similarity=0.326 Sum_probs=157.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357889999999999999999875 7899999998655433333456788899998777666665543311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 01234788999999999999999999 7799999999999999999999999999998765432
Q ss_pred CccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||+.... ......+.......+. .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--~--- 233 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVFYIPE--Y--- 233 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCT--T---
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCcccCch--h---
Confidence 2233568999999999988765 6899999999999999999999974321 1111222222221111 0
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|++.||++
T Consensus 234 ~~~~l~~li~~~l~~~p~~ 252 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLK 252 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGG
T ss_pred cCHHHHHHHHHHccCChhh
Confidence 1233788999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=266.19 Aligned_cols=180 Identities=26% Similarity=0.355 Sum_probs=148.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|.....||+|+||.||+|+.. +++.||||++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 467999999999999999999854 7889999998754322 2456788999999999888877654311
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 01234788999999999999999999 78999999999999999999999999999987653
Q ss_pred CCCC---ccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSN---QTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 3221 2335799999999987654 4899999999999999999999999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=267.49 Aligned_cols=215 Identities=21% Similarity=0.352 Sum_probs=145.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~-------- 437 (602)
..+|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++..+. |+++..++...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34788999999999999999986 47899999988554332 3456788999998885 87776653211
Q ss_pred ------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeCCCCcceee
Q 047576 438 ------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLNSKLEAFVA 491 (602)
Q Consensus 438 ------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld~~~~~kL~ 491 (602)
.....+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence 01234889999999999999999999 777 9999999999999999999999
Q ss_pred cccccccccCCCCC------------cccccccccccccccc---ccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccc
Q 047576 492 DFGTARLLHADSSN------------QTLLAGSYGYIAPELA---YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLS 556 (602)
Q Consensus 492 DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 556 (602)
|||++......... .....||+.|+|||++ .+..++.++||||||+++|+|+||+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 99999876543211 1124589999999998 5667889999999999999999999999743221
Q ss_pred cCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 557 SSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 557 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+++.....+.... ....+.+++..||+.||++
T Consensus 260 ----------~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 260 ----------RIVNGKYSIPPHDT---QYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp ----------------CCCCTTCC---SSGGGHHHHHHHSCSSGGG
T ss_pred ----------HhhcCcccCCcccc---cchHHHHHHHHHccCChhh
Confidence 11111111111110 1122678889999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=270.37 Aligned_cols=229 Identities=16% Similarity=0.160 Sum_probs=153.3
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHH---HH-----HhhhhHhHHHHHHhhhcCccccccc
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEE---LA-----FIRSFRNEAQVLSQMERGSLFRILH 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~---~~-----~~~~~~~E~~il~~l~~gsL~~~l~ 435 (602)
.++|...+.||+|+||.||+|+.. ++..||+|+........ .. ....+.+|+.++..+.|+++..++.
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 57889999987553211 11 1123556777776666655544332
Q ss_pred cc-------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC--cc
Q 047576 436 ND-------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL--EA 488 (602)
Q Consensus 436 ~~-------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~--~~ 488 (602)
.. .....+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence 10 01225899999999999999999999 78999999999999998887 99
Q ss_pred eeecccccccccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCc
Q 047576 489 FVADFGTARLLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP 561 (602)
Q Consensus 489 kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 561 (602)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--- 269 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--- 269 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH---
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH---
Confidence 9999999987643211 123457999999999999999999999999999999999999999632110000
Q ss_pred ccchhhhhccCCCCCCChhh--HHHHHHHHHHHhhccCcCCCC
Q 047576 562 KIMLIDVLDQRLPPPVDRKV--IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 ~~~~~~~~d~~l~~~~~~~~--~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...........++....... ......+.+++..||+.||++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 312 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDE 312 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCccc
Confidence 00001111111111000000 012235889999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=267.23 Aligned_cols=223 Identities=23% Similarity=0.265 Sum_probs=158.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhH-----HHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETE-----ELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
++|.....||+|+||.||+|+.. +++.||||++...... .......+.+|++++..+.|+++..++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 57888999999999999999864 6889999998754321 122345688899999777776665543210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc---ceeeccccccc
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE---AFVADFGTARL 498 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFG~a~~ 498 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 01234788999999999999999999 789999999999999987654 99999999987
Q ss_pred ccCCCCCccccccccccccccccc---cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
..... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||...... ......+.+.....
T Consensus 167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 167 LGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNF 239 (322)
T ss_dssp CCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS------SCHHHHHHHTCCCC
T ss_pred ccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH------HHHHHHHHhCcccc
Confidence 64321 123356899999999874 456889999999999999999999999743211 01111122221111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ..........+.+++.+|++.||++
T Consensus 240 ~-~~~~~~~~~~~~~li~~~l~~dP~~ 265 (322)
T 2ycf_A 240 I-PEVWAEVSEKALDLVKKLLVVDPKA 265 (322)
T ss_dssp C-HHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred C-chhhhhcCHHHHHHHHHHcccCHhh
Confidence 1 0100112345889999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=263.45 Aligned_cols=217 Identities=24% Similarity=0.347 Sum_probs=159.9
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|+....||+|+||.||+|+.. +|+.||+|++..... .+.+.+|+.++..+.|+++..++...
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 457889999999999999999865 589999999865432 35677899988777766665544311
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 01234789999999999999999999 7899999999999999999999999999998765443
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC-CCCChhhH
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPVDRKVI 582 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~ 582 (602)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.....+ ......
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~-- 250 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNPPPTFRKPEL-- 250 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCCSSGGG--
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCCcccCCccc--
Confidence 33444578999999999999899999999999999999999999997533211 11111111100 000111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 251 -~~~~l~~li~~~l~~dp~~ 269 (314)
T 3com_A 251 -WSDNFTDFVKQCLVKSPEQ 269 (314)
T ss_dssp -SCHHHHHHHHHHTCSCTTT
T ss_pred -CCHHHHHHHHHHccCChhh
Confidence 2234889999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=261.60 Aligned_cols=219 Identities=24% Similarity=0.295 Sum_probs=157.2
Q ss_pred CccccCcccccccccccceeeecCC----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
...|...+.||+|+||.||+|+..+ ...||+|.+...... ...+.+.+|+.++..+.|+++..++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH--HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3568888999999999999998532 336899998754332 3456788899988666666555543310
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 01233788999999999999999999 789999999999999999999999999999866
Q ss_pred cCCC----CCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 500 HADS----SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 500 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
.... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||..... ......+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLLQGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-------TTHHHHHHTTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhcCCCC
Confidence 4321 11233457789999999999999999999999999999999 5556653221 1111122222111
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ... ....+.+++..||+.||++
T Consensus 252 ~~-~~~---~~~~l~~li~~~l~~~p~~ 275 (298)
T 3f66_A 252 LQ-PEY---CPDPLYEVMLKCWHPKAEM 275 (298)
T ss_dssp CC-CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred CC-Ccc---CCHHHHHHHHHHcCCChhh
Confidence 11 111 2234888999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=267.68 Aligned_cols=219 Identities=27% Similarity=0.385 Sum_probs=155.9
Q ss_pred CccccCcccccccccccceeeecCC-----CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN-----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
..+|...+.||+|+||.||+|+... +..||||+++..... .....+.+|+.++..+.|+++..++...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 4568888999999999999997542 346999998754332 2345788899998766666655443210
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 01234889999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 500 HADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 500 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.+. ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~-~~~ 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDG-FRL 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT-CCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCC-CcC
Confidence 543211 122345778999999998899999999999999999999 9999964321 1112222222 111
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.... ....+.+++..||+.||++
T Consensus 270 ~~~~~---~~~~l~~li~~~l~~~p~~ 293 (333)
T 1mqb_A 270 PTPMD---CPSAIYQLMMQCWQQERAR 293 (333)
T ss_dssp CCCTT---CBHHHHHHHHHHTCSSTTT
T ss_pred CCccc---CCHHHHHHHHHHcCCChhh
Confidence 11111 2344889999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=260.77 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=149.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+. .+|+.||+|++....... ...+.+.++...+..+.|+++..++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46799999999999999999986 578999999987553322 1223344444445555565555443210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 01235889999999999999999999 66 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccc----ccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELA----YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
.... .....||+.|+|||++ .+..++.++||||+|+++|+|+||+.||+.... ....+...++...+..
T Consensus 162 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 162 DDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCCCC
T ss_pred cccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCCCc
Confidence 4322 2334689999999996 556789999999999999999999999974211 1122233333332221
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ....+.+++.+|++.||++
T Consensus 235 ~~~~---~~~~~~~li~~~l~~~p~~ 257 (290)
T 3fme_A 235 PADK---FSAEFVDFTSQCLKKNSKE 257 (290)
T ss_dssp CTTT---SCHHHHHHHHHHTCSSGGG
T ss_pred cccc---CCHHHHHHHHHHhhcChhh
Confidence 1111 2234789999999999974
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=258.64 Aligned_cols=209 Identities=23% Similarity=0.308 Sum_probs=194.0
Q ss_pred CCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 153 ALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
..++++.|+|++|+++ +.+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+
T Consensus 79 ~~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 79 TQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TSTTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 3578999999999987 34889999999999999 88999999999999999999999 7899999999999999
Q ss_pred cccccCCC-CcccccC---------CCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEE
Q 047576 227 LAQNQLSG-LPQEIGN---------LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296 (602)
Q Consensus 227 L~~N~l~~-ip~~~~~---------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 296 (602)
+++|++.+ +|..++. +++|++|+|++|+++ .+|..++.+++|++|+|++|.+++ +|..++.+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 99988877 8887664 999999999999999 889999999999999999999996 56689999999999
Q ss_pred eccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcCCCC
Q 047576 297 DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365 (602)
Q Consensus 297 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~l 365 (602)
+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|++++|++.|.+|..+..+..+
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L 303 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTT
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCc
Confidence 999999999999999999999999999999999999999999999999999999999999887665543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=263.40 Aligned_cols=221 Identities=22% Similarity=0.337 Sum_probs=160.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--Cccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER--GSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~--gsL~~~l~~~-------- 437 (602)
.++|.....||+|+||.||+|+..+++.||||++...... ....+.+.+|+.++..+.+ +++..++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4679999999999999999999888999999998654322 2245678899999987764 5555443211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|+++||.||| +.+|+||||||+||++++ +.+||+|||++........
T Consensus 106 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 106 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 01234788899999999999999999 789999999999999965 8899999999987654322
Q ss_pred --Ccccccccccccccccccc-----------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 505 --NQTLLAGSYGYIAPELAYT-----------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... .....+..++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~ 255 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDP 255 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHCT
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------HHHHHHHHHHhc
Confidence 1223468999999999875 467889999999999999999999997432 112223444444
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......... ....+.+++..||+.||++
T Consensus 256 ~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 283 (313)
T 3cek_A 256 NHEIEFPDI---PEKDLQDVLKCCLKRDPKQ 283 (313)
T ss_dssp TSCCCCCCC---SCHHHHHHHHHHTCSSTTT
T ss_pred ccccCCccc---chHHHHHHHHHHccCCccc
Confidence 433222211 1234788999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=263.52 Aligned_cols=174 Identities=22% Similarity=0.400 Sum_probs=140.6
Q ss_pred CccccCcccccccccccceeeec--CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS---------------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs---------------- 429 (602)
.++|...+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.+++.+.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 45799999999999999999975 3689999999975432 3456777888876655433
Q ss_pred --------------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-----------
Q 047576 430 --------------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS----------- 484 (602)
Q Consensus 430 --------------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~----------- 484 (602)
+.+++... ....+++.++..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCCCCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 22222211 1124789999999999999999999 789999999999999987
Q ss_pred --------CCcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 485 --------KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 485 --------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999865432 23357899999999999999999999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=265.35 Aligned_cols=182 Identities=24% Similarity=0.383 Sum_probs=147.7
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
..++|.....||+|+||.||+|+.. +|+.||||++...... .....+.+|+.++..+.|+++..++....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 3578999999999999999999864 6899999998654322 24467788999999999988876653210
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 1234788999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC----------cccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 501 ADSSN----------QTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 501 ~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111 122468999999998765 678999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=272.73 Aligned_cols=175 Identities=26% Similarity=0.327 Sum_probs=143.9
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
..+|...+.||+|+||.||+|+...+..||+|++.... ....+|++++..+.|+++..+....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 35789999999999999999998777779999875432 2334799999999998887654211
Q ss_pred ---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-CCCcceeecccc
Q 047576 438 ---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVADFGT 495 (602)
Q Consensus 438 ---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG~ 495 (602)
.....+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 00234788889999999999999999 78999999999999999 789999999999
Q ss_pred cccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 987644332 2335789999999998765 48999999999999999999999997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=269.67 Aligned_cols=174 Identities=25% Similarity=0.352 Sum_probs=142.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+|++++..+.|+++..++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 46799999999999999999975 579999999886442 2345789999888888776654311
Q ss_pred ------------------------------------------------------cchhhhcHHHHHHHHHHHHHHHHHhh
Q 047576 438 ------------------------------------------------------AEAVELDWAKRVNIVKAMAHALAYLH 463 (602)
Q Consensus 438 ------------------------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH 463 (602)
.....+++..+..++.|+++||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 01234788899999999999999999
Q ss_pred hcCCCCeEEeCCCCCCeeeC-CCCcceeecccccccccCCCCCccccccccccccccccccCc-CCccchhHHHHHHHHH
Q 047576 464 HDCSPSVVHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLE 541 (602)
Q Consensus 464 ~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~e 541 (602)
+.+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||+||++||
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 88999999999999997 688999999999987644332 23357899999999988754 8999999999999999
Q ss_pred HHcCCCCCCCC
Q 047576 542 VLMGKHPRDLH 552 (602)
Q Consensus 542 lltG~~Pf~~~ 552 (602)
|++|+.||...
T Consensus 235 ll~g~~pf~~~ 245 (383)
T 3eb0_A 235 LILGKPLFSGE 245 (383)
T ss_dssp HHHSSCSSCCS
T ss_pred HHhCCCCCCCC
Confidence 99999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=269.97 Aligned_cols=178 Identities=31% Similarity=0.425 Sum_probs=145.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 46788899999999999999985 46899999998764332 234567889999999998888776554211
Q ss_pred -----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 439 -----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 439 -----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 0123789999999999999999999 78999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 233578999999999887 67899999999999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=259.96 Aligned_cols=206 Identities=21% Similarity=0.382 Sum_probs=160.8
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH------------ 435 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~------------ 435 (602)
.+|...+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++..+.|+++..++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57888999999999999999875 79999999986543 34667888887666666554322
Q ss_pred -----------------------------cccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC
Q 047576 436 -----------------------------NDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486 (602)
Q Consensus 436 -----------------------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~ 486 (602)
.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence 11 1234789999999999999999999 78999999999999999999
Q ss_pred cceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchh
Q 047576 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHH
T ss_pred CEEECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHH
Confidence 999999999987654332 233568999999999999899999999999999999999999975211 1122
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+..++...+. .+.+++..||+.||++
T Consensus 230 ~~~~~~~~~~~~~-------~~~~li~~~l~~dp~~ 258 (284)
T 2a19_B 230 DLRDGIISDIFDK-------KEKTLLQKLLSKKPED 258 (284)
T ss_dssp HHHTTCCCTTSCH-------HHHHHHHHHTCSSGGG
T ss_pred HhhcccccccCCH-------HHHHHHHHHccCChhh
Confidence 2333333333332 2678999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=263.73 Aligned_cols=217 Identities=21% Similarity=0.328 Sum_probs=161.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 357888999999999999999864 7899999998754332 235677899998777766665543210
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 01234788999999999999999999 7899999999999999 7889999999999876432
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC--CCCCh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP--PPVDR 579 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~ 579 (602)
. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.+.... .+...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~ 232 (304)
T 2jam_A 162 G--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGYYEFESPFWD 232 (304)
T ss_dssp B--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCCCCCCTTTTT
T ss_pred C--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCccccc
Confidence 2 22335689999999999999999999999999999999999999975321 1112222222221 11111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+|++.||++
T Consensus 233 ~---~~~~~~~li~~~l~~dp~~ 252 (304)
T 2jam_A 233 D---ISESAKDFICHLLEKDPNE 252 (304)
T ss_dssp T---SCHHHHHHHHHHHCSSTTT
T ss_pred c---CCHHHHHHHHHHcCCChhH
Confidence 1 2234889999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=274.71 Aligned_cols=176 Identities=24% Similarity=0.380 Sum_probs=131.4
Q ss_pred ccccC-cccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc------
Q 047576 369 RKIDS-KYCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------ 438 (602)
Q Consensus 369 ~~f~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------ 438 (602)
+.|.. .+.||+|+||.||+|+.. +++.||||++...... ..+.+|+.++..+.|+++..++....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34554 457999999999999854 5789999999765432 45778999999999988876543210
Q ss_pred --------------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee----CCCCcc
Q 047576 439 --------------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL----NSKLEA 488 (602)
Q Consensus 439 --------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl----d~~~~~ 488 (602)
....+++.++..|+.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 0013788899999999999999999 7899999999999999 677899
Q ss_pred eeecccccccccCCC---CCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 489 FVADFGTARLLHADS---SNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 489 kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999998765322 122335789999999998874 4899999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=268.27 Aligned_cols=226 Identities=22% Similarity=0.324 Sum_probs=164.3
Q ss_pred CccccCcccccccccccceeeec-----CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-----PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
.++|...+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH---HHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 45788899999999999999973 46899999998765432 346788899988666665554432210
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 01234789999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCccc-c---cCCCc----ccchh
Q 047576 498 LLHADSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL-S---SSYDP----KIMLI 566 (602)
Q Consensus 498 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~---~~~~~----~~~~~ 566 (602)
........ .....++..|+|||++.+..++.++||||||+++|||+||+.||...... . ..... ...+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543321 12235677899999999888999999999999999999999998642110 0 00000 01122
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.+......+.... ....+.+++..||+.||++
T Consensus 274 ~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~ 306 (326)
T 2w1i_A 274 ELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQ 306 (326)
T ss_dssp HHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGG
T ss_pred HHhhcCCCCCCCCc---ccHHHHHHHHHHcCCChhh
Confidence 33332222222111 3345889999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=281.79 Aligned_cols=221 Identities=20% Similarity=0.300 Sum_probs=164.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||||++...... ......+.+|+.++..+.|+++..++...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 467999999999999999999864 7899999998643221 11235678899999888877776654321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 01234789999999999999999999 78999999999999995 456799999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...+..+.......+.+. .
T Consensus 177 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~-~ 246 (486)
T 3mwu_A 177 NT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQ-W 246 (486)
T ss_dssp C-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCSGG-G
T ss_pred CC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCcc-c
Confidence 32 2334579999999999876 589999999999999999999999975321 122233333333222111 1
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+||+.||++
T Consensus 247 ~~~s~~~~~li~~~L~~dp~~ 267 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPSL 267 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTTT
T ss_pred CCCCHHHHHHHHHHcCCChhh
Confidence 112344789999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=266.43 Aligned_cols=218 Identities=22% Similarity=0.323 Sum_probs=153.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~-------- 437 (602)
.++|...+.||+|+||.||+|+. .+|+.||||++...... .+.+.+|+.++..+ .|+++..++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 57899999999999999999986 47899999998654322 34567788877665 455554432210
Q ss_pred ----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 438 ----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 438 ----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 01234788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
+..............|++.|+|||++. +..++.++||||||+++|+|+||+.||...... .....+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~ 248 (326)
T 2x7f_A 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPR 248 (326)
T ss_dssp TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH
T ss_pred ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhc
Confidence 987654333334457899999999987 556889999999999999999999999753321 11112222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+...... ....+.+++..||+.||++
T Consensus 249 ~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 277 (326)
T 2x7f_A 249 NPAPRLKSKK---WSKKFQSFIESCLVKNHSQ 277 (326)
T ss_dssp SCCCCCSCSC---SCHHHHHHHHHHCCSSGGG
T ss_pred CccccCCccc---cCHHHHHHHHHHhccChhh
Confidence 1111111111 1234788999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=263.41 Aligned_cols=174 Identities=19% Similarity=0.297 Sum_probs=143.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~~------- 438 (602)
.++|...+.||+|+||.||+|+. .+++.||||++..... +.+.+|+.+++.+. |+++..+.....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 46799999999999999999975 5789999999875432 45778999998886 666655433110
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADS 503 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~~ 503 (602)
....+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++......
T Consensus 109 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 0123788999999999999999999 78999999999999999776 89999999998765433
Q ss_pred CCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
. .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 186 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 186 E-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred c-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 334578999999999887 6689999999999999999999999953
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=260.05 Aligned_cols=223 Identities=20% Similarity=0.287 Sum_probs=164.8
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCch------hHHHHHhhhhHhHHHHHHhhh-cCccccccccc--
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPE------TEELAFIRSFRNEAQVLSQME-RGSLFRILHND-- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~-- 437 (602)
.++|.....||+|+||.||+|+.. +|+.||||++.... .......+.+.+|+.++..+. |+++..++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999874 68999999986442 122234567888999886664 65555443211
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 01234789999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccc------cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAY------TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
...... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||..... ......+...
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~ 244 (298)
T 1phk_A 173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMSG 244 (298)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHT
T ss_pred hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhcC
Confidence 765432 233457899999999875 44578899999999999999999999974321 1112223332
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+... .......+.+++.+|++.||++
T Consensus 245 ~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~ 274 (298)
T 1phk_A 245 NYQFGSPE-WDDYSDTVKDLVSRFLVVQPQK 274 (298)
T ss_dssp CCCCCTTT-GGGSCHHHHHHHHHHCCSSGGG
T ss_pred CcccCccc-ccccCHHHHHHHHHHccCCccc
Confidence 22211110 0112345889999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=261.51 Aligned_cols=222 Identities=20% Similarity=0.271 Sum_probs=161.2
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHH---HHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEEL---AFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
++|...+.||+|+||.||+|+.. +|+.||+|+++....... ...+.+.+|+.++..+.|+++..++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999875 689999998865432110 1235688899999777766665543311
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC----cceeeccccccc
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL----EAFVADFGTARL 498 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG~a~~ 498 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 01234789999999999999999999 78999999999999998877 899999999987
Q ss_pred ccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 499 LHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
...... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.......+.
T Consensus 162 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 162 IEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNYDFDE- 232 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCH-
T ss_pred ccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcccCCcc-
Confidence 644322 2335689999999999988999999999999999999999999975321 1111222222111110
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.........+.+++.+|++.||++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~ 256 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKR 256 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGG
T ss_pred hhcccCCHHHHHHHHHHccCCHhH
Confidence 000112344789999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=258.61 Aligned_cols=219 Identities=21% Similarity=0.233 Sum_probs=166.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHH-HHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEE-LAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
++|...+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+.++..+.|+++..++...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57999999999999999999874 68899999987554321 22356788999999888888877655421
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 01234788999999999999999999 78999999999999999999999999999987643
Q ss_pred CC--CCccccccccccccccccccCc--CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 502 DS--SNQTLLAGSYGYIAPELAYTMV--MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.. .......|++.|+|||++.+.. ++.++||||+|+++|||++|+.||..... ......+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~~~~ 234 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGSYAIPG 234 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCCCS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCCCCCCC
Confidence 22 1223356899999999987644 47899999999999999999999975321 1112222222222111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++.+|++.||++
T Consensus 235 ~-----~~~~l~~li~~~l~~dp~~ 254 (305)
T 2wtk_C 235 D-----CGPPLSDLLKGMLEYEPAK 254 (305)
T ss_dssp S-----SCHHHHHHHHHHTCSSTTT
T ss_pred c-----cCHHHHHHHHHHccCChhh
Confidence 1 2234778999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=271.90 Aligned_cols=220 Identities=18% Similarity=0.186 Sum_probs=154.1
Q ss_pred CccccCcccccccccccceeeecC---------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP---------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME------------ 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~------------ 426 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++... +.+.+|+.++..+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 368999999999999999999875 3789999998654 22334444443333
Q ss_pred ----------------------------cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCC
Q 047576 427 ----------------------------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSN 478 (602)
Q Consensus 427 ----------------------------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~ 478 (602)
+++|.+++... ....+++.++..++.||+.||+||| +.+|+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 44555554432 1355899999999999999999999 789999999999
Q ss_pred CeeeCCCC--cceeecccccccccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCC
Q 047576 479 NILLNSKL--EAFVADFGTARLLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549 (602)
Q Consensus 479 NILld~~~--~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 549 (602)
||+++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999987643221 112347999999999999989999999999999999999999999
Q ss_pred CCCcccccCCCcccchhhhhccCCC--CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 550 DLHSTLSSSYDPKIMLIDVLDQRLP--PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......... ......+...... ..... .......+.+++..||+.||++
T Consensus 269 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 269 TNCLPNTEDI--MKQKQKFVDKPGPFVGPCGH-WIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp GGGTTCHHHH--HHHHHHHHHSCCCEECTTSC-EECCCHHHHHHHHHHHTCCTTC
T ss_pred ccCCcCHHHH--HHHHHhccCChhhhhhhccc-cCCCcHHHHHHHHHHHhCChhh
Confidence 7532110000 0000111111110 00000 0001234888999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=267.82 Aligned_cols=178 Identities=21% Similarity=0.389 Sum_probs=145.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHH--------------hhhhHhHHHHH-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAF--------------IRSFRNEAQVL----------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~--------------~~~~~~E~~il----------- 422 (602)
.++|.....||+|+||.||+|+. +|+.||||++.......... .+.+.+|+.++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 89999999986443221101 16678888887
Q ss_pred --------------HhhhcCccccc------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCC-CCeEEeCCCCCCee
Q 047576 423 --------------SQMERGSLFRI------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSVVHRDISSNNIL 481 (602)
Q Consensus 423 --------------~~l~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~DLkp~NIL 481 (602)
||+++++|.++ +... ....+++..+..++.|++.||+||| + .+|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 45556666666 3321 1345899999999999999999999 6 89999999999999
Q ss_pred eCCCCcceeecccccccccCCCCCccccccccccccccccccC-cCCc-cchhHHHHHHHHHHHcCCCCCCCC
Q 047576 482 LNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTE-KYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 482 ld~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999876433 23345789999999999887 5665 999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=261.75 Aligned_cols=220 Identities=22% Similarity=0.304 Sum_probs=160.5
Q ss_pred CccccCcc-cccccccccceeeec---CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKY-CIGTGAYGSVYKAQL---PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
..+|.... .||+|+||.||+|.. .+++.||||+++..... ....+.+.+|+.++..+.|+++..++...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 45677777 999999999999953 35788999998755322 23456788999999777776665544321
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 01234789999999999999999999 789999999999999999999999999999876543
Q ss_pred CCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 503 SSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 503 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
... .....+++.|+|||++.+..++.++||||||+++|+|+| |+.||..... ....+.+......+..
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP 242 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence 321 112346688999999998889999999999999999999 9999975321 1112222221111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++..||+.||++
T Consensus 243 ~~---~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 243 AG---CPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp TT---CCHHHHHHHHHHTCSSTTT
T ss_pred CC---CCHHHHHHHHHHcCCChhh
Confidence 11 2334889999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=290.32 Aligned_cols=213 Identities=23% Similarity=0.317 Sum_probs=156.6
Q ss_pred ccccccccccceeeec---CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------------
Q 047576 375 YCIGTGAYGSVYKAQL---PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------------- 437 (602)
+.||+|+||.||+|.+ ..++.||||+++..... ....+.+.+|++++..+.|+++..++...
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCC
Confidence 4699999999999954 35688999998754332 22356788999999777666665544311
Q ss_pred -------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC---Ccc
Q 047576 438 -------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS---NQT 507 (602)
Q Consensus 438 -------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~---~~~ 507 (602)
.....+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....+.. ...
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 01234889999999999999999999 78999999999999999999999999999987654322 122
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...+++.|+|||++.+..++.++|||||||++|||+| |+.||..... . ...+.+......+.... ...
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~-~~~~~i~~~~~~~~p~~---~~~ 599 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------S-EVTAMLEKGERMGCPAG---CPR 599 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------H-HHHHHHHTTCCCCCCTT---CCH
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHcCCCCCCCCC---CCH
Confidence 2346788999999999999999999999999999998 9999975321 1 12222222222222211 334
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..||+.||++
T Consensus 600 ~l~~li~~cl~~dP~~ 615 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVEN 615 (635)
T ss_dssp HHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHcCCCHhH
Confidence 5889999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=259.69 Aligned_cols=213 Identities=18% Similarity=0.264 Sum_probs=155.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh----------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------------------- 424 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~---------------------- 424 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++........ ....+.+|+.++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 467888999999999999999875 799999999875433211 23456677776644
Q ss_pred ----hhcCccccccccccc-hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC--------------
Q 047576 425 ----MERGSLFRILHNDAE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-------------- 485 (602)
Q Consensus 425 ----l~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-------------- 485 (602)
+++++|.+++..... ...+++.++..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 444455555443211 134789999999999999999999 7899999999999999844
Q ss_pred -----CcceeecccccccccCCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCC
Q 047576 486 -----LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY 559 (602)
Q Consensus 486 -----~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 559 (602)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|+|++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 478999999998765432 24589999999998876 56689999999999999999998865321
Q ss_pred CcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 560 DPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 560 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.....+... .. ....+.+++.+||+.||++
T Consensus 236 ----~~~~~~~~~~~~~~-~~---~~~~~~~li~~~l~~dp~~ 270 (289)
T 1x8b_A 236 ----QWHEIRQGRLPRIP-QV---LSQEFTELLKVMIHPDPER 270 (289)
T ss_dssp ----HHHHHHTTCCCCCS-SC---CCHHHHHHHHHHTCSSGGG
T ss_pred ----HHHHHHcCCCCCCC-cc---cCHHHHHHHHHHhCCCccc
Confidence 11222222222111 11 1234788999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=263.12 Aligned_cols=220 Identities=21% Similarity=0.324 Sum_probs=160.2
Q ss_pred CCccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------- 437 (602)
..++|.....||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 3567999999999999999999875 5899999998654322 346788899999777777766654311
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 01234789999999999999999999 789999999999999999999999999987644322
Q ss_pred CCCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-C
Q 047576 503 SSNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-P 576 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~ 576 (602)
........|++.|+|||++. +..++.++||||||+++|+|++|+.||...... .....+.....+. .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCS
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCcccC
Confidence 11222356899999999883 566889999999999999999999999754321 1112222221111 1
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.... ....+.+++..||+.||++
T Consensus 244 ~~~~---~~~~l~~li~~~l~~dp~~ 266 (302)
T 2j7t_A 244 TPSK---WSVEFRDFLKIALDKNPET 266 (302)
T ss_dssp SGGG---SCHHHHHHHHHHSCSCTTT
T ss_pred Cccc---cCHHHHHHHHHHcccChhh
Confidence 1111 2234789999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=262.01 Aligned_cols=208 Identities=18% Similarity=0.346 Sum_probs=154.0
Q ss_pred CccccCcccccccccccceeeecCC-C-------cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPN-G-------RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF-------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~-------- 431 (602)
.++|...+.||+|+||.||+|+... + ..||+|++...... ..+.+.+|+.++..+.|+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4678899999999999999997642 3 47999998654332 346788899988555555444
Q ss_pred -----------------cccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-------
Q 047576 432 -----------------RILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE------- 487 (602)
Q Consensus 432 -----------------~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~------- 487 (602)
+++.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence 44432 1233889999999999999999999 789999999999999998877
Q ss_pred -ceeecccccccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCC-CCCCcccccCCCcccc
Q 047576 488 -AFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHP-RDLHSTLSSSYDPKIM 564 (602)
Q Consensus 488 -~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~ 564 (602)
+||+|||.+..... .....|++.|+|||++.+ ..++.++||||||+++|||++|..| |..... . .
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~-~ 226 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------Q-R 226 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------H-H
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------H-H
Confidence 99999999865432 233568899999999987 6789999999999999999996554 432211 1 1
Q ss_pred hhhhhc--cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLD--QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d--~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...... ..++.+.+ ..+.+++..||+.||++
T Consensus 227 ~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~ 259 (289)
T 4fvq_A 227 KLQFYEDRHQLPAPKA-------AELANLINNCMDYEPDH 259 (289)
T ss_dssp HHHHHHTTCCCCCCSS-------CTTHHHHHHHSCSSGGG
T ss_pred HHHHhhccCCCCCCCC-------HHHHHHHHHHcCCChhH
Confidence 111111 22222222 23778999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=261.50 Aligned_cols=219 Identities=25% Similarity=0.324 Sum_probs=155.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccc-----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH----------- 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~----------- 435 (602)
.++|...+.||+|+||.||+|+. .++..||+|++...... ...+.+.+|++++..+.|+++..++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 36789999999999999999986 46889999998654322 12456788999987666666555432
Q ss_pred --------------ccc-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee---CCCCcceeecccccc
Q 047576 436 --------------NDA-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL---NSKLEAFVADFGTAR 497 (602)
Q Consensus 436 --------------~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFG~a~ 497 (602)
... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 110 1234888999999999999999999 7899999999999999 456789999999998
Q ss_pred cccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
...... ......|++.|+|||++. ..++.++||||+|+++|||++|+.||........ ........+......
T Consensus 176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKEPNYAVEC 248 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCCCCCC--
T ss_pred ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----HhhhccCCccccccc
Confidence 765432 233457899999999875 4678999999999999999999999975321100 000011111111110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++.+|++.||++
T Consensus 249 ~~----~~~~~~~li~~~L~~dP~~ 269 (285)
T 3is5_A 249 RP----LTPQAVDLLKQMLTKDPER 269 (285)
T ss_dssp CC----CCHHHHHHHHHHTCSCTTT
T ss_pred Cc----CCHHHHHHHHHHccCChhh
Confidence 00 1234778999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=270.40 Aligned_cols=178 Identities=24% Similarity=0.324 Sum_probs=143.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...... ...+.+.+|+.++..+.|+++..++...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 467999999999999999999865 7899999998755322 2346788899888666555554443211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++.......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 01234788999999999999999999 54 89999999999999999999999999987654322
Q ss_pred CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.....||+.|+|||++.+..++.++||||||+++|+|+||+.||...
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22357899999999999999999999999999999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=266.02 Aligned_cols=220 Identities=18% Similarity=0.258 Sum_probs=158.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH---HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 45799999999999999999986 57899999988654322 346788899999777776665543211
Q ss_pred --------------------c-chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 438 --------------------A-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 438 --------------------~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 0 1234789999999999999999999 789999999999999999999999999988
Q ss_pred ccccCCCCC---------ccccccccccccccccccCc---CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccc
Q 047576 497 RLLHADSSN---------QTLLAGSYGYIAPELAYTMV---MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIM 564 (602)
Q Consensus 497 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 564 (602)
......... .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||+..... ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~ 255 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDS 255 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------TSC
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------cch
Confidence 765321111 11235789999999987543 688999999999999999999999632110 001
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+......+.... ....+.+++.+||+.||++
T Consensus 256 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 256 VALAVQNQLSIPQSPR---HSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp HHHHHHCC--CCCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred hhHHhhccCCCCcccc---CCHHHHHHHHHHhhcChhh
Confidence 1111222222111111 2234889999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=264.05 Aligned_cols=219 Identities=26% Similarity=0.338 Sum_probs=156.0
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFR--------- 432 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~--------- 432 (602)
.++|...+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.++..+.|+++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 46799999999999999999984 35778999999754332 23456788998886555555444
Q ss_pred ----------------cccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcce
Q 047576 433 ----------------ILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAF 489 (602)
Q Consensus 433 ----------------~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~k 489 (602)
++.... ....+++.++..++.|++.||.||| +.+|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 333211 1134788999999999999999999 789999999999999984 44699
Q ss_pred eecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|+| |+.||..... .....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHH
Confidence 999999986543321 1223467889999999998899999999999999999998 9999974321 11111
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+...... ..... ....+.+++..||+.||++
T Consensus 257 ~~~~~~~~-~~~~~---~~~~l~~li~~~l~~dp~~ 288 (327)
T 2yfx_A 257 FVTSGGRM-DPPKN---CPGPVYRIMTQCWQHQPED 288 (327)
T ss_dssp HHHTTCCC-CCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHhcCCCC-CCCCC---CCHHHHHHHHHHhcCChhh
Confidence 22221111 11111 2234788999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=261.31 Aligned_cols=223 Identities=23% Similarity=0.347 Sum_probs=142.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG------------------ 428 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g------------------ 428 (602)
.++|...+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|+.++..+.|+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 467999999999999999999864 6889999998654322 2345677888877444444
Q ss_pred -------ccccccccc-----cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 429 -------SLFRILHND-----AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 429 -------sL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
+|.+++... .....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 444444321 01234889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCC-----Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCC---Cc--ccch
Q 047576 497 RLLHADSS-----NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY---DP--KIML 565 (602)
Q Consensus 497 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~~--~~~~ 565 (602)
........ ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .. ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 87643221 1223568999999999876 568999999999999999999999997543221100 00 0000
Q ss_pred hhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 566 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....++...... ...+.+++.+||+.||++
T Consensus 249 ~~~~~~~~~~~~-------~~~~~~li~~~l~~dp~~ 278 (303)
T 2vwi_A 249 TGVQDKEMLKKY-------GKSFRKMISLCLQKDPEK 278 (303)
T ss_dssp C-----CCCCCC-------CHHHHHHHHHHCCSSGGG
T ss_pred cccccchhhhhh-------hHHHHHHHHHHccCChhh
Confidence 001111111121 234788999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=264.81 Aligned_cols=226 Identities=23% Similarity=0.373 Sum_probs=160.0
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHh--hhcCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--MERGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~--l~~gsL~~~l~~~~------- 438 (602)
.++|...+.||+|+||.||+|+. +|+.||||++..... +.+.+|.+++.. +.|+++..++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 35789999999999999999998 589999999865432 345567776644 44544443322100
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
....+++.++..++.|++.||+|||.. ++.+|+||||||+||+++.++.+||+|||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 122478999999999999999999932 146999999999999999999999999999
Q ss_pred cccccCCCCC----ccccccccccccccccccC------cCCccchhHHHHHHHHHHHcC----------CCCCCCCccc
Q 047576 496 ARLLHADSSN----QTLLAGSYGYIAPELAYTM------VMTEKYDVYSFGVVTLEVLMG----------KHPRDLHSTL 555 (602)
Q Consensus 496 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~Pf~~~~~~ 555 (602)
+......... .....||+.|+|||++.+. .++.++||||||+++|||+|| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876543321 2335789999999998776 334789999999999999999 6777543211
Q ss_pred ccCCCcccchhhhhccCCCCCCChh--hHHHHHHHHHHHhhccCcCCCC
Q 047576 556 SSSYDPKIMLIDVLDQRLPPPVDRK--VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 556 ~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ........+....+.+..... ..+....+.+++..||+.||++
T Consensus 274 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (342)
T 1b6c_B 274 DP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320 (342)
T ss_dssp SC--CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGG
T ss_pred cc--cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhh
Confidence 00 011111222333333322221 1246667999999999999974
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=263.71 Aligned_cols=224 Identities=24% Similarity=0.266 Sum_probs=203.5
Q ss_pred CCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCC
Q 047576 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 199 (602)
-.++++.|++. ++++.+..|..|+++++|++|+|++|+|++ .+++|++|+|++|+|++..+..|.++++|+
T Consensus 73 ~~~~l~~L~L~--~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 150 (452)
T 3zyi_A 73 IPSNTRYLNLM--ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLR 150 (452)
T ss_dssp CCTTCSEEECC--SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCC
T ss_pred CCCCccEEECc--CCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCC
Confidence 34678888887 677888888999999999999999999873 478999999999999998888899999999
Q ss_pred EEEecCCCCCCCCcccccCcCCCceeeccc-ccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQ-NQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 200 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
+|+|++|++++..+..|.++++|+.|++++ |.++.+|. .+.++++|++|+|++|++++. | .+..+++|++|+|++|
T Consensus 151 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N 228 (452)
T 3zyi_A 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGN 228 (452)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTS
T ss_pred EEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCC
Confidence 999999999987777899999999999999 45555665 688999999999999999964 4 4789999999999999
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCc
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 354 (602)
.+++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++...
T Consensus 229 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 99999999999999999999999999998899999999999999999999988888899999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.44 Aligned_cols=178 Identities=31% Similarity=0.424 Sum_probs=145.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~------- 439 (602)
.++|.....||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++..+.|+++..++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 46788899999999999999986 46899999998754332 2345678899999999888887765432110
Q ss_pred ------------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 440 ------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 440 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 124789999999999999999999 78999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 233578999999999877 67899999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=263.85 Aligned_cols=174 Identities=24% Similarity=0.385 Sum_probs=139.6
Q ss_pred CccccCcccccccccccceeeecC-CC-cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc------c---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NG-RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------L--------- 430 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------L--------- 430 (602)
.++|.....||+|+||.||+|+.. ++ +.||+|+++.... ..+.+.+|+.++..+.+.+ +
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 467999999999999999999864 34 7899999975432 2356677888776655432 1
Q ss_pred ---------------ccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee-------------
Q 047576 431 ---------------FRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL------------- 482 (602)
Q Consensus 431 ---------------~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl------------- 482 (602)
.+.+... ....+++.++..++.||+.||+||| +.+|+||||||+||++
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEeccCCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 1111110 1134889999999999999999999 8899999999999999
Q ss_pred ------CCCCcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 483 ------NSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 483 ------d~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999865432 23357899999999999999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=280.14 Aligned_cols=222 Identities=23% Similarity=0.295 Sum_probs=162.6
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHH----------HHHhhhhHhHHHHHHhhhcCcccccccc
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEE----------LAFIRSFRNEAQVLSQMERGSLFRILHN 436 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~----------~~~~~~~~~E~~il~~l~~gsL~~~l~~ 436 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++....... ....+.+.+|+.++..+.|+++..++..
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999865 68899999987543221 1234568889999977777766654431
Q ss_pred c----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---cceee
Q 047576 437 D----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL---EAFVA 491 (602)
Q Consensus 437 ~----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~---~~kL~ 491 (602)
. .....+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 1 01234789999999999999999999 78999999999999998775 69999
Q ss_pred cccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc
Q 047576 492 DFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571 (602)
Q Consensus 492 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~ 571 (602)
|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ...+..+...
T Consensus 192 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~ 262 (504)
T 3q5i_A 192 DFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEKG 262 (504)
T ss_dssp CCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC
T ss_pred ECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC
Confidence 999998765432 233457999999999876 4689999999999999999999999975321 2223333333
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.. ........+.+++..|+++||++
T Consensus 263 ~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~ 292 (504)
T 3q5i_A 263 KYYFDFN-DWKNISDEAKELIKLMLTYDYNK 292 (504)
T ss_dssp CCCCCHH-HHTTSCHHHHHHHHHHTCSSTTT
T ss_pred CCCCCcc-ccCCCCHHHHHHHHHHcCCChhH
Confidence 3322211 10112345889999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=264.22 Aligned_cols=218 Identities=24% Similarity=0.327 Sum_probs=155.7
Q ss_pred CccccCcccccccccccceeeecC-CCcE--EeeeccCCchhHHHHHhhhhHhHHHHHHhh-hc----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRV--FALKKLNSPETEELAFIRSFRNEAQVLSQM-ER---------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~--vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~---------------- 427 (602)
.++|.....||+|+||.||+|+.. ++.. ||+|.+...... ...+.+.+|+.++..+ .|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 467999999999999999999864 5554 499988643322 2346688899888555 44
Q ss_pred ---------Ccccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC
Q 047576 428 ---------GSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485 (602)
Q Consensus 428 ---------gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~ 485 (602)
++|.+++.... ....+++.++..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCC
Confidence 44444443321 1125889999999999999999999 7899999999999999999
Q ss_pred CcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccc
Q 047576 486 LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIM 564 (602)
Q Consensus 486 ~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 564 (602)
+.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||..... ...
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~ 250 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AEL 250 (327)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHH
T ss_pred CeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHH
Confidence 999999999987543221 1222456789999999998889999999999999999998 9999975321 111
Q ss_pred hhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 565 LIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 565 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+. .....+.... ....+.+++.+||+.||++
T Consensus 251 ~~~~~-~~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 284 (327)
T 1fvr_A 251 YEKLP-QGYRLEKPLN---CDDEVYDLMRQCWREKPYE 284 (327)
T ss_dssp HHHGG-GTCCCCCCTT---BCHHHHHHHHHHTCSSGGG
T ss_pred HHHhh-cCCCCCCCCC---CCHHHHHHHHHHccCChhh
Confidence 11111 1111111111 2234889999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=279.08 Aligned_cols=221 Identities=22% Similarity=0.284 Sum_probs=160.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|...+.||+|+||.||+|+.. ++..||+|++....... .....+.+|+.++..+.|+++..++...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357899999999999999999865 68899999987554321 1245678899999777777766654321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC---CcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK---LEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.||+.||+||| +.+|+||||||+||+++.. +.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 01234788999999999999999999 7899999999999999764 4599999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.. ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ...+..+.......+.. ..
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~-~~ 261 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYTFDSP-EW 261 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCSG-GG
T ss_pred Cc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCch-hc
Confidence 32 233457999999999876 4689999999999999999999999975321 12223333333221111 11
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++.+|++.||++
T Consensus 262 ~~~s~~~~~li~~~L~~dp~~ 282 (494)
T 3lij_A 262 KNVSEGAKDLIKQMLQFDSQR 282 (494)
T ss_dssp TTSCHHHHHHHHHHTCSSTTT
T ss_pred ccCCHHHHHHHHHHCCCChhh
Confidence 112344789999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=264.76 Aligned_cols=179 Identities=22% Similarity=0.275 Sum_probs=132.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ....+.+|+..+..+.|+++..++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 457999999999999999999864 689999998854432 123455667667777777776643211
Q ss_pred -----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-CCcceeecc
Q 047576 438 -----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-KLEAFVADF 493 (602)
Q Consensus 438 -----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-~~~~kL~DF 493 (602)
.....+++..+..++.|++.|+.|||.+ +.+|+||||||+||+++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 0122367788899999999999999944 679999999999999996 899999999
Q ss_pred cccccccCCCCCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 494 GTARLLHADSSNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 494 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
|++........ .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||...
T Consensus 177 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 177 GSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp TTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99987654332 23356899999999987654 899999999999999999999999754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=286.00 Aligned_cols=224 Identities=23% Similarity=0.388 Sum_probs=194.8
Q ss_pred CccchhccccCCccccCCccCCCCCCCCEEECcCCcC-------------------------------------------
Q 047576 131 LESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL------------------------------------------- 167 (602)
Q Consensus 131 L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i------------------------------------------- 167 (602)
++.|++. ++++.|.+|++|++|++|++|+|++|.+
T Consensus 83 V~~L~L~--~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 83 VTGLSLE--GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp EEEEECT--TSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred EEEEEec--CcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 3444554 6788999999999999999999999955
Q ss_pred -----------------------------------c------ccCCCcCEEECcCCcCCCC-----------------Cc
Q 047576 168 -----------------------------------R------GRLTNLNYMSLSRNMLGGL-----------------LP 189 (602)
Q Consensus 168 -----------------------------------~------~~l~~L~~L~L~~N~l~~~-----------------~p 189 (602)
+ +.+++|++|+|++|.+++. +|
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip 240 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCc
Confidence 1 2477899999999999986 88
Q ss_pred hhhh--CCCCCCEEEecCCCCCCCCcccccCcCCCceeeccccc-CCC--CcccccCC------CCCcEEEccCCCCCCC
Q 047576 190 QEIG--NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ-LSG--LPQEIGNL------KNLMLLDVGNNDIIGP 258 (602)
Q Consensus 190 ~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~--ip~~~~~l------~~L~~L~L~~N~l~~~ 258 (602)
..++ ++++|++|+|++|++.|.+|..++++++|++|++++|+ +++ +|..++++ ++|++|++++|+++ .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 8888 99999999999999999999999999999999999998 887 88888776 89999999999998 7
Q ss_pred CCC--ccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCC-CCEEeCCCCCCCCCCCccc
Q 047576 259 IPS--TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED-LTWLDLSNNNIKGSIPGEI 335 (602)
Q Consensus 259 ~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~ 335 (602)
+|. .++.+++|++|++++|+++|.+| .++.+++|++|+|++|+++ .+|..+..+++ |+.|++++|+++ .+|..+
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 888 88999999999999999998888 8888999999999999998 78888888988 999999999998 778877
Q ss_pred cccc--ccccccccCCcCCCccCCCCC
Q 047576 336 TKLS--RLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 336 ~~l~--~L~~L~l~~N~l~g~~p~~~~ 360 (602)
..++ +|+.|++++|+++|.+|..+.
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 423 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGSVDGKNFD 423 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTTTTTCSSC
T ss_pred hhcccCccCEEECcCCcCCCcchhhhc
Confidence 7655 899999999999998887654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=275.92 Aligned_cols=232 Identities=22% Similarity=0.245 Sum_probs=179.0
Q ss_pred cccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhh
Q 047576 120 LSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEI 192 (602)
Q Consensus 120 l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~ 192 (602)
++...++.+++|+.|++. ++.+.+..|..|+.+++|++|+|++|.|++ .+++|++|+|++|.|++..+..|
T Consensus 66 lp~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~ 143 (597)
T 3oja_B 66 LPAALLDSFRQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143 (597)
T ss_dssp ECTHHHHHCCCCSEEECT--TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred cCHHHHccCCCCcEEECC--CCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHh
Confidence 333335667788888876 566777777789999999999999998873 47889999999999997777778
Q ss_pred hCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCC-----------------------------
Q 047576 193 GNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLK----------------------------- 243 (602)
Q Consensus 193 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~----------------------------- 243 (602)
+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++++. +.++
T Consensus 144 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n 221 (597)
T 3oja_B 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221 (597)
T ss_dssp TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSCCSEEECCTTCSEEECCSS
T ss_pred ccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCccccccCCchhheeeccCC
Confidence 999999999999999998888889999999999999999888642 2222
Q ss_pred -----------CCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccC
Q 047576 244 -----------NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312 (602)
Q Consensus 244 -----------~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (602)
+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|+.+++|+.|+|++|++++ +|..+.
T Consensus 222 ~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 298 (597)
T 3oja_B 222 SINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 298 (597)
T ss_dssp CCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSS
T ss_pred cccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccc
Confidence 34555555555554 2456777888888888888888778888888888888888888875 566667
Q ss_pred CCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 313 SMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 313 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
.+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..+..+
T Consensus 299 ~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 344 (597)
T 3oja_B 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH 344 (597)
T ss_dssp CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTT
T ss_pred cCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhc
Confidence 7888888888888887 567777788888888888888876543333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=264.13 Aligned_cols=181 Identities=23% Similarity=0.282 Sum_probs=142.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchh--------HHHHHhhhhHhHHHHHHhhhcCccccccccc--
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPET--------EELAFIRSFRNEAQVLSQMERGSLFRILHND-- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-- 437 (602)
.++|...+.||+|+||.||+|+..+|+.||||++..... ......+.+.+|+.++..+.|+++..++...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 568999999999999999999988899999998864321 1223446788999999999888877654321
Q ss_pred -------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 438 -------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 438 -------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEe
Confidence 01124789999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 178 fg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 178 FNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 99997654332 2233578999999999877 66899999999999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=261.60 Aligned_cols=175 Identities=19% Similarity=0.278 Sum_probs=137.4
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-----------cCccccccc
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-----------RGSLFRILH 435 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-----------~gsL~~~l~ 435 (602)
..+|...+.||+|+||.||+|+. .+++.||||++...... .+.+.+|+.++..+. |.++..++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 45799999999999999999985 57899999999754432 345667777775554 333333221
Q ss_pred cc---------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeC----
Q 047576 436 ND---------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLN---- 483 (602)
Q Consensus 436 ~~---------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld---- 483 (602)
.. .....+++..+..++.||+.||+||| ++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 10 01233788999999999999999999 66 999999999999994
Q ss_pred --CCCcceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 484 --SKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 484 --~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcCcceEEEcccccccccCCCC---CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 44589999999998765432 2347899999999999999999999999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=265.23 Aligned_cols=223 Identities=22% Similarity=0.280 Sum_probs=138.5
Q ss_pred CCCccccCc-ccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH-----------------------
Q 047576 366 PTPRKIDSK-YCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ----------------------- 420 (602)
Q Consensus 366 p~t~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~----------------------- 420 (602)
...++|... +.||+|+||.||+|+.. +|+.||||++...... .+.+..+..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 346778884 57999999999999875 6899999998654322 122222222
Q ss_pred ---HHHhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeeccc
Q 047576 421 ---VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVADFG 494 (602)
Q Consensus 421 ---il~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFG 494 (602)
++||+++|+|.+++.... ...+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 226667777777776532 235899999999999999999999 789999999999999976 4559999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ........+
T Consensus 177 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 253 (336)
T 3fhr_A 177 FAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-IRLGQYGFP 253 (336)
T ss_dssp TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCC
T ss_pred cceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-hhccccccC
Confidence 998664322 23356899999999998888999999999999999999999999753321110000000 000111111
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.... ....+.+++.+|++.||++
T Consensus 254 ~~~~~~---~~~~~~~li~~~L~~dP~~ 278 (336)
T 3fhr_A 254 NPEWSE---VSEDAKQLIRLLLKTDPTE 278 (336)
T ss_dssp TTTSTT---CCHHHHHHHHHHSCSSGGG
T ss_pred chhhcc---CCHHHHHHHHHHCCCChhH
Confidence 111111 2334789999999999974
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=243.58 Aligned_cols=183 Identities=26% Similarity=0.343 Sum_probs=150.2
Q ss_pred CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEcc
Q 047576 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVG 251 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~ 251 (602)
+|++|+|++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|++++|+++++|. .+.++++|++|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45556666666666666788888888888888888886666667888888888888888888654 56788888888998
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
+|++++..|..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 88888887788888888999999999888777767888888999999999888777777888889999999999988777
Q ss_pred CcccccccccccccccCCcCCCcc
Q 047576 332 PGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 332 p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
+..+..+++|+.|++++|++...-
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HHHhccccCCCEEEecCCCeeCCC
Confidence 777888888999999999887654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=259.33 Aligned_cols=180 Identities=21% Similarity=0.293 Sum_probs=140.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++..+.|+++..++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 467889999999999999999875 589999999865543 2456788999999999988887764210
Q ss_pred -------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-CCCcceee
Q 047576 438 -------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVA 491 (602)
Q Consensus 438 -------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~ 491 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 01234788999999999999999999 78999999999999997 56799999
Q ss_pred cccccccccCCC---CCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 492 DFGTARLLHADS---SNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 492 DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
|||+++...... .......++..|+|||++.+ ..++.++||||||+++|||+||+.||....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999998764321 11223457899999998865 678999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=258.96 Aligned_cols=180 Identities=28% Similarity=0.369 Sum_probs=144.3
Q ss_pred CccccCcccccccccccceeeec--CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL--PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gsL~~~l~~~----- 437 (602)
.++|.....||+|+||.||+|+. .+|+.||+|++....... .....+.+|+.++..+ .|+++..++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 46799999999999999999986 468899999986443211 1223566777777655 577666554211
Q ss_pred -----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 438 -----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 438 -----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 00123789999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 166 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 997654322 223356899999999999999999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=264.10 Aligned_cols=210 Identities=21% Similarity=0.306 Sum_probs=159.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH---HHHhhhhHhHHHHHHhhhc--Cccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE---LAFIRSFRNEAQVLSQMER--GSLFRILHND---- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~~E~~il~~l~~--gsL~~~l~~~---- 437 (602)
.++|.....||+|+||.||+|+. .+++.||||++....... ....+.+.+|+.++..+.+ .++..++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 56799999999999999999975 578999999986543221 0123567789998877753 4444433210
Q ss_pred -------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-CCCcceeecccccc
Q 047576 438 -------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVADFGTAR 497 (602)
Q Consensus 438 -------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG~a~ 497 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||++.
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 01234788999999999999999999 78999999999999999 78999999999998
Q ss_pred cccCCCCCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC--C
Q 047576 498 LLHADSSNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL--P 574 (602)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l--~ 574 (602)
..... ......||+.|+|||++.+..+ +.++||||||+++|||+||+.||..... +..... +
T Consensus 199 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~~~~~ 263 (320)
T 3a99_A 199 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQVFFR 263 (320)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCCCCS
T ss_pred ccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhccccccc
Confidence 76533 2233568999999999887765 6889999999999999999999974321 111111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+ ..+.+++.+||+.||++
T Consensus 264 ~~~~-------~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 264 QRVS-------SECQHLIRWCLALRPSD 284 (320)
T ss_dssp SCCC-------HHHHHHHHHHTCSSGGG
T ss_pred ccCC-------HHHHHHHHHHccCChhh
Confidence 2222 23788999999999974
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=245.89 Aligned_cols=228 Identities=23% Similarity=0.239 Sum_probs=110.8
Q ss_pred CCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCc-CCCCCchhhhCCCCCC
Q 047576 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNM-LGGLLPQEIGNLKNLI 199 (602)
Q Consensus 128 l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~ 199 (602)
.++++.|++. ++++.+..+..|+++++|++|+|++|++.+ .+++|++|+|++|. ++...|..|..+++|+
T Consensus 31 ~~~l~~L~l~--~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~ 108 (285)
T 1ozn_A 31 PAASQRIFLH--GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108 (285)
T ss_dssp CTTCSEEECT--TSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCC
T ss_pred CCCceEEEee--CCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCC
Confidence 3455555544 334444333455555555555555555542 24455555555554 4444444555555555
Q ss_pred EEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCc
Q 047576 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278 (602)
Q Consensus 200 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 278 (602)
+|+|++|++++..|..+.++++|++|++++|+++++|. .++++++|+.|+|++|++++..+..+..+++|++|++++|.
T Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence 55555555554444445555555555555555555332 24445555555555555554444445555555555555555
Q ss_pred CCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCC
Q 047576 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|.++...+.. .-...++.+..+.|.+.+..|..
T Consensus 189 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred ccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence 55544555555555555555555555444444555555555555555554332211 11122333444444444444443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=263.56 Aligned_cols=254 Identities=21% Similarity=0.203 Sum_probs=212.5
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCc
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNL 174 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L 174 (602)
.++..|+++...+. .+..-.|+.+++|+.|++. .+.+.+..+..|+++++|++|+|++|++.+ .+++|
T Consensus 56 ~~L~~L~L~~n~i~---~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 130 (477)
T 2id5_A 56 PHLEELELNENIVS---AVEPGAFNNLFNLRTLGLR--SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130 (477)
T ss_dssp TTCCEEECTTSCCC---EECTTTTTTCTTCCEEECC--SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCEEECCCCccC---EeChhhhhCCccCCEEECC--CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccC
Confidence 45778888654332 2333356667777777765 444444334568999999999999999873 47899
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCC
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N 253 (602)
++|+|++|.+++..+..|.++++|++|+|++|++++..+..+.++++|+.|+|++|.++++ +..+.++++|+.|++++|
T Consensus 131 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~ 210 (477)
T 2id5_A 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210 (477)
T ss_dssp CEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC
T ss_pred CEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC
Confidence 9999999999999999999999999999999999987777899999999999999999995 557899999999999999
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
.+.+.+|.......+|++|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus 211 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 290 (477)
T 2id5_A 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290 (477)
T ss_dssp TTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred ccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence 98888888777777999999999999876667889999999999999999988888899999999999999999988899
Q ss_pred ccccccccccccccCCcCCCccCCCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
.+..+++|+.|++++|++++..+..+.
T Consensus 291 ~~~~l~~L~~L~L~~N~l~~~~~~~~~ 317 (477)
T 2id5_A 291 AFRGLNYLRVLNVSGNQLTTLEESVFH 317 (477)
T ss_dssp TBTTCTTCCEEECCSSCCSCCCGGGBS
T ss_pred HhcCcccCCEEECCCCcCceeCHhHcC
Confidence 999999999999999999886665443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=275.37 Aligned_cols=178 Identities=24% Similarity=0.353 Sum_probs=143.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc-------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI------------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~------------- 433 (602)
..+|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+.++..+.|+++..+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 367999999999999999999874 6899999998764322 345678889999877666665443
Q ss_pred ------------------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc---ceeec
Q 047576 434 ------------------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE---AFVAD 492 (602)
Q Consensus 434 ------------------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~---~kL~D 492 (602)
+........+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 222122224788899999999999999999 789999999999999987664 89999
Q ss_pred ccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
||.+........ .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 168 FG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 168 LGYAKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCCBTTSCCC-CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccc-cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999987654332 3345799999999999999999999999999999999999999965
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-28 Score=259.16 Aligned_cols=225 Identities=24% Similarity=0.268 Sum_probs=202.6
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCC
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKN 197 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 197 (602)
.+-.++++.|++. .+++.+..+..|.++++|++|+|++|+|++ .+++|++|+|++|+|++..+..|..+++
T Consensus 60 ~~~~~~l~~L~L~--~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 137 (440)
T 3zyj_A 60 DGISTNTRLLNLH--ENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSK 137 (440)
T ss_dssp SCCCTTCSEEECC--SCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSS
T ss_pred CCCCCCCcEEEcc--CCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhcccc
Confidence 3445678888876 667777777899999999999999999873 4899999999999999888889999999
Q ss_pred CCEEEecCCCCCCCCcccccCcCCCceeecccc-cCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCC
Q 047576 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQN-QLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275 (602)
Q Consensus 198 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 275 (602)
|++|+|++|++++..+..|.++++|++|+|++| .++.+|. .+.++++|++|+|++|+++ .+| .+..+++|++|+|+
T Consensus 138 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls 215 (440)
T 3zyj_A 138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215 (440)
T ss_dssp CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECT
T ss_pred CceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECC
Confidence 999999999999888889999999999999995 5555654 6899999999999999998 455 47899999999999
Q ss_pred CCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
+|.+++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++..
T Consensus 216 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 999999999999999999999999999999889999999999999999999998888889999999999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=256.93 Aligned_cols=221 Identities=24% Similarity=0.245 Sum_probs=143.6
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCC
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKN 197 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 197 (602)
+..+++|+.|++. ++.+.+..+..|+.+++|++|+|++|++.+ .+++|++|+|++|.++...+..|+++++
T Consensus 65 ~~~l~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~ 142 (390)
T 3o6n_A 65 LDSFRQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142 (390)
T ss_dssp HHHCCCCSEEECT--TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hcccccCcEEECC--CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCC
Confidence 5666777777775 455555555678888888888888888763 4677888888888888666666788888
Q ss_pred CCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCC-CCCcc-------------
Q 047576 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP-IPSTL------------- 263 (602)
Q Consensus 198 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~-~p~~l------------- 263 (602)
|++|+|++|++++..|..+.++++|++|++++|++++++ +..+++|+.|++++|.+++. .|..+
T Consensus 143 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~ 220 (390)
T 3o6n_A 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV 220 (390)
T ss_dssp CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEE
T ss_pred CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccCCCCcceEEECCCCeeeec
Confidence 888888888888777777888888888888888888764 23333333333333333220 00000
Q ss_pred --CCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCccccccccc
Q 047576 264 --GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341 (602)
Q Consensus 264 --~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 341 (602)
...++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|
T Consensus 221 ~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L 297 (390)
T 3o6n_A 221 RGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL 297 (390)
T ss_dssp ECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTC
T ss_pred cccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCC
Confidence 1124566666666666543 355666666666666666666556666666666666666666653 34445556666
Q ss_pred ccccccCCcCC
Q 047576 342 DYLNLSGNKLS 352 (602)
Q Consensus 342 ~~L~l~~N~l~ 352 (602)
+.|++++|+++
T Consensus 298 ~~L~L~~n~l~ 308 (390)
T 3o6n_A 298 KVLDLSHNHLL 308 (390)
T ss_dssp CEEECCSSCCC
T ss_pred CEEECCCCcce
Confidence 66666666665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=269.21 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=204.0
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcC
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLN 175 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~ 175 (602)
.+..++++...+. .+....|+.+++|+.|++. ++....+|..++++++|++|+|++|++.+ .+++|+
T Consensus 255 ~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~l~---~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 328 (606)
T 3t6q_A 255 SVESINLQKHYFF---NISSNTFHCFSGLQELDLT---ATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328 (606)
T ss_dssp EEEEEECTTCCCS---SCCTTTTTTCTTCSEEECT---TSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred ceeEEEeecCccC---ccCHHHhccccCCCEEecc---CCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence 4667777544332 2333346666666666664 44455888889999999999999998873 478899
Q ss_pred EEECcCCcCCCCCch-hhhCCCCCCEEEecCCCCCCCC--cccccCcCCCceeecccccCCC-CcccccCCCCCcEEEcc
Q 047576 176 YMSLSRNMLGGLLPQ-EIGNLKNLIELDVGDNSLIGPI--PLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVG 251 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~ 251 (602)
+|++++|.+.+.+|. .++++++|++|++++|++++.. |..+.++++|++|++++|++++ .|..+.++++|+.|+++
T Consensus 329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 408 (606)
T 3t6q_A 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408 (606)
T ss_dssp EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred EEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence 999999988876655 4888999999999999988765 6778889999999999999888 57778888999999999
Q ss_pred CCCCCCCCCCc-cCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC---CCcccCCCCCCCEEeCCCCCC
Q 047576 252 NNDIIGPIPST-LGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK---IPSQIASMEDLTWLDLSNNNI 327 (602)
Q Consensus 252 ~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l 327 (602)
+|++++..|.. +..+++|++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+.|++++|++
T Consensus 409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l 488 (606)
T 3t6q_A 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488 (606)
T ss_dssp TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence 99988876654 88888999999999999888888888899999999999988762 335688888999999999999
Q ss_pred CCCCCcccccccccccccccCCcCCCccCCCCCcCCC
Q 047576 328 KGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364 (602)
Q Consensus 328 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 364 (602)
++..|..+..+++|+.|++++|++++..|..+..+..
T Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred CccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 8888888888999999999999998888776654433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=243.57 Aligned_cols=210 Identities=26% Similarity=0.275 Sum_probs=192.6
Q ss_pred ccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCC-CCCCCcccc
Q 047576 145 GSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-LIGPIPLTL 216 (602)
Q Consensus 145 ~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l 216 (602)
..+|..+ .++|++|+|++|+|++ .+++|++|+|++|.+++..|..|+++++|++|+|++|. +++..|..+
T Consensus 24 ~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~ 101 (285)
T 1ozn_A 24 QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101 (285)
T ss_dssp SSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTT
T ss_pred ccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHh
Confidence 3455543 4699999999999973 47899999999999999999999999999999999998 877778899
Q ss_pred cCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCE
Q 047576 217 SRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFH 295 (602)
Q Consensus 217 ~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 295 (602)
..+++|++|++++|+++++ |..+.++++|++|++++|++++..+..++.+++|++|++++|++++..+..+..+++|+.
T Consensus 102 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 181 (285)
T 1ozn_A 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (285)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred cCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCE
Confidence 9999999999999999995 677899999999999999999888888999999999999999999887778999999999
Q ss_pred EeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 296 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..+
T Consensus 182 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred EECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 9999999999889999999999999999999998877889999999999999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=260.34 Aligned_cols=220 Identities=24% Similarity=0.294 Sum_probs=140.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHH-HHHhhhcCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQ-VLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~-il~~l~~gsL~~~l~~~~------- 438 (602)
.++|.....||+|+||.||+|+.. +|+.||||++....... ....+..|+. ++..+.|+++..++....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 467888999999999999999874 78999999987553321 2234445555 555566666665543110
Q ss_pred -------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 439 -------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 439 -------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++..
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 1234788999999999999999999 66 999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccccc----ccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhcc---
Q 047576 499 LHADSSNQTLLAGSYGYIAPELA----YTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ--- 571 (602)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~--- 571 (602)
..... ......|++.|+|||++ .+..++.++||||||+++|+|++|+.||......... +..++..
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~ 248 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDPP 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCCC
Confidence 64332 22234689999999998 4566899999999999999999999999753221111 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 572 RLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 572 ~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.++...... ....+.+++..||+.||++
T Consensus 249 ~~~~~~~~~---~~~~l~~li~~~l~~dp~~ 276 (327)
T 3aln_A 249 QLSNSEERE---FSPSFINFVNLCLTKDESK 276 (327)
T ss_dssp CCCCCSSCC---CCHHHHHHHHHHTCSSGGG
T ss_pred CCCCccccc---CCHHHHHHHHHHhhCChhh
Confidence 111111111 2234889999999999974
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=278.81 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=175.1
Q ss_pred CCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccC-CccCCCCCCCCEEECcCCcCc
Q 047576 90 HCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSI-PSEISALSKLQLLDLSSNRLR 168 (602)
Q Consensus 90 ~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~i-p~~l~~L~~L~~L~Ls~N~i~ 168 (602)
.|+|..|.+ -..+++.|+++...+. .+..-.|+.+++|+.|++. .++..+.+ |.+|+++++|++|+|++|+|+
T Consensus 13 ~~~L~~vP~-lp~~l~~LdLs~N~i~---~i~~~~~~~l~~L~~LdLs--~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~ 86 (844)
T 3j0a_A 13 FCNLTQVPQ-VLNTTERLLLSFNYIR---TVTASSFPFLEQLQLLELG--SQYTPLTIDKEAFRNLPNLRILDLGSSKIY 86 (844)
T ss_dssp CCCSSCCCS-SCTTCCEEEEESCCCC---EECSSSCSSCCSCSEEEEC--TTCCCCEECTTTTSSCTTCCEEECTTCCCC
T ss_pred CCCCCCCCC-CCCCcCEEECCCCcCC---ccChhHCcccccCeEEeCC--CCCCccccCHHHhcCCCCCCEEECCCCcCc
Confidence 467888888 5578899999765432 3333456666666666665 44466666 567888888888888888876
Q ss_pred c-------cCCCcCEEECcCCcCCCCCchh--hhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecccccCCC-Ccc
Q 047576 169 G-------RLTNLNYMSLSRNMLGGLLPQE--IGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQNQLSG-LPQ 237 (602)
Q Consensus 169 ~-------~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-ip~ 237 (602)
+ .+++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..| ..|+++++|++|+|++|.+++ .|.
T Consensus 87 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~ 166 (844)
T 3j0a_A 87 FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166 (844)
T ss_dssp EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSG
T ss_pred ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHH
Confidence 3 4778888888888888766655 8888888888888888877655 467888888888888888877 455
Q ss_pred cccCC--CCCcEEEccCCCCCCCCCCccCCC-------------------------------------------------
Q 047576 238 EIGNL--KNLMLLDVGNNDIIGPIPSTLGLF------------------------------------------------- 266 (602)
Q Consensus 238 ~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l------------------------------------------------- 266 (602)
.+..+ ++|+.|++++|.+++..|..++.+
T Consensus 167 ~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~ 246 (844)
T 3j0a_A 167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246 (844)
T ss_dssp GGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCS
T ss_pred HcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccc
Confidence 55554 555555555555555444433333
Q ss_pred -------------------CCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCC
Q 047576 267 -------------------SDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNI 327 (602)
Q Consensus 267 -------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 327 (602)
++|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++
T Consensus 247 ~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l 326 (844)
T 3j0a_A 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326 (844)
T ss_dssp SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCC
T ss_pred ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCC
Confidence 3455555555555555555556666666666666666655556666666666666666666
Q ss_pred CCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 328 KGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 328 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
++..|..+..+++|+.|++++|++++..+..+
T Consensus 327 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 358 (844)
T 3j0a_A 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF 358 (844)
T ss_dssp SCCCSCSCSSCTTCCEEECCSCCCCCCCSSCS
T ss_pred CccCHHHhcCCCCCCEEECCCCCCCccChhhh
Confidence 66556666666666666666666655555444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=255.76 Aligned_cols=216 Identities=24% Similarity=0.409 Sum_probs=153.5
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+....||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++..+.|+++..++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 35788899999999999999986 478999999986433 2346788899998777777665543210
Q ss_pred ---------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCccee
Q 047576 438 ---------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFV 490 (602)
Q Consensus 438 ---------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL 490 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEE
Confidence 01234678889999999999999999 789999999999999999999999
Q ss_pred ecccccccccCCC--------------CCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCCccc
Q 047576 491 ADFGTARLLHADS--------------SNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTL 555 (602)
Q Consensus 491 ~DFG~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 555 (602)
+|||.+....... .......|++.|+|||++.+. .++.++||||+|+++|||++ ||.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~- 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME- 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence 9999998654221 112234689999999998764 68999999999999999998 5542111
Q ss_pred ccCCCcccchhhhhc--cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 556 SSSYDPKIMLIDVLD--QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 556 ~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+.+ ..+++..... ....+.+++..|++.||++
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 234 -----RVNILKKLRSVSIEFPPDFDDN---KMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp -----HHHHHHHHHSTTCCCCTTCCTT---TSHHHHHHHHHHTCSSGGG
T ss_pred -----HHHHHHhccccccccCcccccc---chHHHHHHHHHHHhcCccc
Confidence 0111111111 1222222221 3344789999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-29 Score=280.71 Aligned_cols=219 Identities=23% Similarity=0.339 Sum_probs=159.3
Q ss_pred CccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|...+.||+|+||.||+|+.. .+..||+|+++..... ...+.+.+|+.++..+.|+++..++...
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 356888899999999999999763 3567999998754332 2456788899988666665554433210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 01234789999999999999999999 78999999999999999999999999999987644
Q ss_pred CCCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 502 DSSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 502 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.+.... +...
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~ 615 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERL-PMPP 615 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTCCC-CCCT
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCC-CCCc
Confidence 3221 223456789999999998899999999999999999997 9999975321 1112222222111 1111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ....+.+++..||+.||++
T Consensus 616 ~---~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 616 N---CPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp T---CCHHHHHHHHHHTCSSGGG
T ss_pred c---ccHHHHHHHHHHcCCChhH
Confidence 1 2334789999999999974
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=264.98 Aligned_cols=259 Identities=23% Similarity=0.233 Sum_probs=201.7
Q ss_pred CCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc----
Q 047576 93 WIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---- 168 (602)
Q Consensus 93 w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~---- 168 (602)
+.+|..+-..+++.|+++...+. .+..-.|+.+++|+.|++. ++.+.+..|..|+++++|++|+|++|+|+
T Consensus 43 L~~ip~~~~~~L~~L~Ls~N~i~---~~~~~~~~~l~~L~~L~Ls--~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~ 117 (562)
T 3a79_B 43 LTHVPKDLPPRTKALSLSQNSIS---ELRMPDISFLSELRVLRLS--HNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISC 117 (562)
T ss_dssp CCSCCTTSCTTCCEEECCSSCCC---CCCGGGTTTCTTCCEEECC--SCCCCEECTTTTTTCTTCCEEECTTSCCCEECS
T ss_pred CccCCCCCCCCcCEEECCCCCcc---ccChhhhccCCCccEEECC--CCCCCcCCHHHhCCCCCCCEEECCCCcCCccCc
Confidence 44443332357888888765443 3334457788888888887 67777777889999999999999999997
Q ss_pred ccCCCcCEEECcCCcCCCC-CchhhhCCCCCCEEEecCCCCCCCCcccccCcCCC--ceeecccccC--CC-CcccccCC
Q 047576 169 GRLTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSL--KILILAQNQL--SG-LPQEIGNL 242 (602)
Q Consensus 169 ~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~-ip~~~~~l 242 (602)
+.+++|++|+|++|++++. +|..|+++++|++|+|++|++++. .+..+++| +.|++++|++ ++ .|..+..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l 194 (562)
T 3a79_B 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194 (562)
T ss_dssp CCCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred cccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCccccccc
Confidence 3578999999999999984 578999999999999999999863 45555555 9999999988 55 45555443
Q ss_pred C-------------------------------------------------------------------------------
Q 047576 243 K------------------------------------------------------------------------------- 243 (602)
Q Consensus 243 ~------------------------------------------------------------------------------- 243 (602)
+
T Consensus 195 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~ 274 (562)
T 3a79_B 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274 (562)
T ss_dssp CEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT
T ss_pred CcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh
Confidence 2
Q ss_pred --CCcEEEccCCCCCCCCCCcc-----------------------------------------------------CCCCC
Q 047576 244 --NLMLLDVGNNDIIGPIPSTL-----------------------------------------------------GLFSD 268 (602)
Q Consensus 244 --~L~~L~L~~N~l~~~~p~~l-----------------------------------------------------~~l~~ 268 (602)
+|++|++++|+++|.+|..+ ..+++
T Consensus 275 ~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~ 354 (562)
T 3a79_B 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354 (562)
T ss_dssp TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCC
Confidence 67788888888888777765 56778
Q ss_pred CccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC--CCcccCCCCCCCEEeCCCCCCCCCCCc-cccccccccccc
Q 047576 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK--IPSQIASMEDLTWLDLSNNNIKGSIPG-EITKLSRLDYLN 345 (602)
Q Consensus 269 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ 345 (602)
|++|++++|.+++.+|..++++++|+.|+|++|++++. +|..+..+++|+.|++++|++++.+|. .+..+++|+.|+
T Consensus 355 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~ 434 (562)
T 3a79_B 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434 (562)
T ss_dssp CCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEE
T ss_pred ceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEE
Confidence 88888888888888888888888888888888888863 356678888888888888888874554 477788888888
Q ss_pred ccCCcCCCccCCCC
Q 047576 346 LSGNKLSGRVPYSN 359 (602)
Q Consensus 346 l~~N~l~g~~p~~~ 359 (602)
+++|++++.+|..+
T Consensus 435 l~~n~l~~~~~~~l 448 (562)
T 3a79_B 435 LSSNMLTGSVFRCL 448 (562)
T ss_dssp CCSSCCCGGGGSSC
T ss_pred CCCCCCCcchhhhh
Confidence 88888888777655
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=265.36 Aligned_cols=251 Identities=21% Similarity=0.219 Sum_probs=206.1
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-------ccCCCc
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNL 174 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L 174 (602)
..++.|+++...+. .+.+-.|+.+++|+.|++. ++.+.+..|.+|+++++|++|+|++|++. +.+++|
T Consensus 33 ~~l~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~Ls--~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 107 (606)
T 3t6q_A 33 NSTECLEFSFNVLP---TIQNTTFSRLINLTFLDLT--RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107 (606)
T ss_dssp TTCCEEECTTCCCS---EECTTTSTTCTTCSEEECT--TCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTC
T ss_pred CcCcEEEccCCccC---cCChhHhccCccceEEECC--CCccceeChhhccCccccCeeeCCCCcccccChhhhcccccc
Confidence 35778888765443 3444467888888888887 66778888899999999999999999987 348899
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCc--EEEcc
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLM--LLDVG 251 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~--~L~L~ 251 (602)
++|+|++|.+++..|..++++++|++|+|++|++++..+..+..+++|++|++++|+++++ |..++.+++|+ .|+++
T Consensus 108 ~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~ 187 (606)
T 3t6q_A 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187 (606)
T ss_dssp CEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECT
T ss_pred cEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecC
Confidence 9999999999988888899999999999999999985545566699999999999999994 67788999998 89999
Q ss_pred CCCCCCCCCCccCCC---------------------------------------------------CCCccccCCCCcCC
Q 047576 252 NNDIIGPIPSTLGLF---------------------------------------------------SDLSYLDLSCNQFN 280 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l---------------------------------------------------~~L~~L~L~~N~l~ 280 (602)
+|.+++..|..+... .+|+.|++++|.++
T Consensus 188 ~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~ 267 (606)
T 3t6q_A 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267 (606)
T ss_dssp TCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred CCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC
Confidence 999988777655321 15777888888888
Q ss_pred CCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCC
Q 047576 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 281 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
+..+..|+.+++|++|+|++|+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+.+|..
T Consensus 268 ~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (606)
T 3t6q_A 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344 (606)
T ss_dssp SCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS
T ss_pred ccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh
Confidence 777777888888888888888887 67778888888888888888888777778888888888888888888777654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=259.04 Aligned_cols=216 Identities=18% Similarity=0.338 Sum_probs=150.4
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------ 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------ 429 (602)
.++|...+.||+|+||.||+|+... .||+|+++..... ....+.+.+|+.++..+.|++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4678899999999999999998753 4899988754321 112356777887775555444
Q ss_pred -------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 430 -------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 430 -------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
|.+++... ...+++.++..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 44444321 234889999999999999999999 78999999999999998 679999999998765321
Q ss_pred -----CCCcccccccccccccccccc---------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhh
Q 047576 503 -----SSNQTLLAGSYGYIAPELAYT---------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568 (602)
Q Consensus 503 -----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 568 (602)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIWQM 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHh
Confidence 112233468999999999874 3478899999999999999999999975321 1111111
Q ss_pred hccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 569 ~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+...... ....+.+++..||+.||++
T Consensus 256 ~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~ 286 (319)
T 2y4i_B 256 GTGMKPNLSQIG---MGKEISDILLFCWAFEQEE 286 (319)
T ss_dssp HTTCCCCCCCSS---CCTTHHHHHHHHHCSSTTT
T ss_pred ccCCCCCCCcCC---CCHHHHHHHHHHhcCChhh
Confidence 111111110000 1123788999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=252.96 Aligned_cols=212 Identities=23% Similarity=0.312 Sum_probs=157.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH---HHHhhhhHhHHHHHHhh----hcCccccccccc--
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE---LAFIRSFRNEAQVLSQM----ERGSLFRILHND-- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~~E~~il~~l----~~gsL~~~l~~~-- 437 (602)
.++|...+.||+|+||.||+|+. .+++.||||++....... ......+.+|+.++..+ .|.++..++...
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 46799999999999999999976 478899999997554321 12335667788888776 566666544311
Q ss_pred ---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC-CCCcceeecccc
Q 047576 438 ---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVADFGT 495 (602)
Q Consensus 438 ---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFG~ 495 (602)
.....+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 01234789999999999999999999 77999999999999999 889999999999
Q ss_pred cccccCCCCCccccccccccccccccccCcCC-ccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYTMVMT-EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
+....... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||.... ++.+....
T Consensus 187 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~~~~~~~ 251 (312)
T 2iwi_A 187 GALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------EILEAELH 251 (312)
T ss_dssp CEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHTCCC
T ss_pred hhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------HHhhhccC
Confidence 98765432 2345689999999998877654 58999999999999999999997421 12222222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+. . ....+.+++.+||+.||++
T Consensus 252 ~~~--~---~~~~~~~li~~~l~~~p~~ 274 (312)
T 2iwi_A 252 FPA--H---VSPDCCALIRRCLAPKPSS 274 (312)
T ss_dssp CCT--T---SCHHHHHHHHHHTCSSTTT
T ss_pred Ccc--c---CCHHHHHHHHHHccCChhh
Confidence 111 0 1223778999999999975
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=266.15 Aligned_cols=125 Identities=18% Similarity=0.222 Sum_probs=96.9
Q ss_pred cCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCc-hhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCC
Q 047576 240 GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP-NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318 (602)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 318 (602)
..+++|++|++++|.+++ +|..+..+++|+.|++++|.+++..| ..+..+++|++|++++|++++..|..+..+++|+
T Consensus 373 ~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 451 (606)
T 3vq2_A 373 LGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451 (606)
T ss_dssp HCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred ccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence 334444444444444443 44667788888899999999888877 6788889999999999999888888888889999
Q ss_pred EEeCCCCCCCC-CCCcccccccccccccccCCcCCCccCCCCCcCCCC
Q 047576 319 WLDLSNNNIKG-SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365 (602)
Q Consensus 319 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~l 365 (602)
.|++++|++++ .+|..+..+++|+.|++++|++++..|..+..+..+
T Consensus 452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 499 (606)
T 3vq2_A 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499 (606)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC
Confidence 99999998887 478888888999999999999988888766544443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=253.69 Aligned_cols=221 Identities=21% Similarity=0.305 Sum_probs=162.3
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|.....||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++..+.|+++..++...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 357889999999999999999875 7899999998644322 11245678899999777777766554311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC---CcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK---LEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 01234789999999999999999999 7899999999999999754 4699999999987654
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
... .....|++.|+|||++.+. ++.++||||||+++|+|++|+.||..... ......+.......+... .
T Consensus 177 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-~ 246 (287)
T 2wei_A 177 NTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQ-W 246 (287)
T ss_dssp CSS-CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGG-G
T ss_pred CCc-cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCchh-h
Confidence 322 2234688999999988764 88999999999999999999999975321 111222222222211110 0
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+++..|++.||++
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~ 267 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSL 267 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGG
T ss_pred hhcCHHHHHHHHHHcccChhh
Confidence 112334789999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=251.96 Aligned_cols=221 Identities=24% Similarity=0.311 Sum_probs=146.1
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA-------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~-------- 438 (602)
.++|.....||+|+||.||+|+.. +|+.||||++....... ...+.+.++..++..+.|+++..++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 467888899999999999999875 78999999987554322 12234444555667777777766543210
Q ss_pred --------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCC-CeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 439 --------------EAVELDWAKRVNIVKAMAHALAYLHHDCSP-SVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 439 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
....+++..+..++.|++.||+||| ++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 1234788999999999999999999 64 99999999999999999999999999997664432
Q ss_pred CCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC-CCC
Q 047576 504 SNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPV 577 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~-~~~ 577 (602)
......|++.|+|||++. ...++.++||||||+++|||++|+.||..... ....+..+.....+ .+.
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCCCCCCS
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCCCCCCc
Confidence 223356899999999984 45688999999999999999999999974221 11122222222211 110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..||+.||++
T Consensus 253 ~~~---~~~~l~~li~~~l~~dp~~ 274 (318)
T 2dyl_A 253 HMG---FSGDFQSFVKDCLTKDHRK 274 (318)
T ss_dssp SSC---CCHHHHHHHHHHTCSCTTT
T ss_pred cCC---CCHHHHHHHHHHccCChhH
Confidence 001 2234788999999999975
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=269.94 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=169.9
Q ss_pred CCCCCCceeCCC------------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCC
Q 047576 90 HCEWIGITCNSA------------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKL 157 (602)
Q Consensus 90 ~C~w~gv~C~~~------------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L 157 (602)
.|.|.|| |+.. .+++.|+++...+. .+..-.|+.+++|+.|++. .+.+.+..|.+|+++++|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls--~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKIT---YIGHGDLRACANLQVLILK--SSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCC---EECSSTTSSCTTCCEEECT--TSCCCEECTTTTTTCTTC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccC---ccChhhhhcCCcccEEECC--CCCcCccChhhccccccC
Confidence 5899998 8632 25667777654332 2333356777777777776 566666667788888888
Q ss_pred CEEECcCCcCcc-------cCCCcCEEECcCCcCCCC-CchhhhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecc
Q 047576 158 QLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILA 228 (602)
Q Consensus 158 ~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~ 228 (602)
++|+|++|++++ .+++|++|+|++|.+++. .|..++++++|++|++++|++.+.+| ..+.++++|++|+++
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence 888888888773 477888888888888763 56678888888888888887555554 567888888888888
Q ss_pred cccCCC-CcccccC------------------------CCCCcEEEccCCCCCCCC--CCcc-CC---------------
Q 047576 229 QNQLSG-LPQEIGN------------------------LKNLMLLDVGNNDIIGPI--PSTL-GL--------------- 265 (602)
Q Consensus 229 ~N~l~~-ip~~~~~------------------------l~~L~~L~L~~N~l~~~~--p~~l-~~--------------- 265 (602)
+|++++ +|..+++ +++|++|++++|++++.. |..+ ..
T Consensus 157 ~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 236 (549)
T 2z81_A 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236 (549)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEE
T ss_pred CCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccc
Confidence 888877 5655543 456666666677666531 0000 00
Q ss_pred ------------------------------------------------------------------------CCCCcccc
Q 047576 266 ------------------------------------------------------------------------FSDLSYLD 273 (602)
Q Consensus 266 ------------------------------------------------------------------------l~~L~~L~ 273 (602)
.++|+.|+
T Consensus 237 ~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~ 316 (549)
T 2z81_A 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316 (549)
T ss_dssp HHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEE
T ss_pred hhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEE
Confidence 12344444
Q ss_pred CCCCcCCCCCchhh-hCCCCCCEEeccCCCCCCCCC---cccCCCCCCCEEeCCCCCCCCCCC--ccccccccccccccc
Q 047576 274 LSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIP---SQIASMEDLTWLDLSNNNIKGSIP--GEITKLSRLDYLNLS 347 (602)
Q Consensus 274 L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~ 347 (602)
+++|.++ .+|..+ ..+++|++|+|++|++++.+| ..++.+++|+.|+|++|++++..+ ..+..+++|+.|+++
T Consensus 317 l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls 395 (549)
T 2z81_A 317 VENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395 (549)
T ss_dssp EESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECT
T ss_pred eccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECC
Confidence 4444443 344443 356777777777777776553 235667777777777777765432 346667777777777
Q ss_pred CCcCCCccCCCC
Q 047576 348 GNKLSGRVPYSN 359 (602)
Q Consensus 348 ~N~l~g~~p~~~ 359 (602)
+|+++ .+|..+
T Consensus 396 ~N~l~-~lp~~~ 406 (549)
T 2z81_A 396 RNTFH-PMPDSC 406 (549)
T ss_dssp TCCCC-CCCSCC
T ss_pred CCCCc-cCChhh
Confidence 77776 455443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=245.76 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=216.9
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCcc--ccCCccCCCCCCCCEEECcCCcCc------ccCCC
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFT--GSIPSEISALSKLQLLDLSSNRLR------GRLTN 173 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~--~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~ 173 (602)
.+++.|+++...+. .++.-.|+.+++|+.|++. .+.+. +.+|..+..+++|++|+|++|.+. +.+++
T Consensus 28 ~~l~~L~L~~n~l~---~i~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~~~~~~l~~ 102 (306)
T 2z66_A 28 SSATRLELESNKLQ---SLPHGVFDKLTQLTKLSLS--SNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 102 (306)
T ss_dssp TTCCEEECCSSCCC---CCCTTTTTTCTTCSEEECC--SSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEEEEEETCTT
T ss_pred CCCCEEECCCCccC---ccCHhHhhccccCCEEECC--CCccCcccCcccccccccccCEEECCCCccccChhhcCCCCC
Confidence 46888999765443 3444446777888888776 44443 444778888999999999999987 35899
Q ss_pred cCEEECcCCcCCCCCc-hhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC--CcccccCCCCCcEEEc
Q 047576 174 LNYMSLSRNMLGGLLP-QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG--LPQEIGNLKNLMLLDV 250 (602)
Q Consensus 174 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L 250 (602)
|++|+|++|++++..+ ..+..+++|++|++++|.+++..|..+.++++|++|++++|.+++ +|..+..+++|++|++
T Consensus 103 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L 182 (306)
T 2z66_A 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182 (306)
T ss_dssp CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEEC
Confidence 9999999999998766 689999999999999999999999999999999999999999997 7889999999999999
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCC-CCCEEeCCCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASME-DLTWLDLSNNNIKG 329 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 329 (602)
++|++++..|..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|.+++
T Consensus 183 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 99999998899999999999999999999998888899999999999999999999999999985 99999999999997
Q ss_pred CCC--cccccccccccccccCCcCCCccCCCCC
Q 047576 330 SIP--GEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 330 ~~p--~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
..+ .....+...+.+.+..+.+....|....
T Consensus 263 ~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 263 TCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp SGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred ccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 533 1233445566777788888888887754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=263.41 Aligned_cols=217 Identities=23% Similarity=0.317 Sum_probs=149.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHNDAE------- 439 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~~~------- 439 (602)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+.++..+ .|+++..++.....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34688899999999999665555589999999986543 24467899999877 68887776542111
Q ss_pred ---------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-----CCcceeecccccccc
Q 047576 440 ---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-----KLEAFVADFGTARLL 499 (602)
Q Consensus 440 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFG~a~~~ 499 (602)
...+.+.++..++.||+.||+||| +.+|+||||||+||+++. ...+||+|||+++..
T Consensus 97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 111334456789999999999999 789999999999999943 345789999999876
Q ss_pred cCCC---CCccccccccccccccccc---cCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccC
Q 047576 500 HADS---SNQTLLAGSYGYIAPELAY---TMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 500 ~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
.... .......||+.|+|||++. ...++.++||||+||++|||+| |+.||...... ....+....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhccC
Confidence 5432 1223457999999999987 4567889999999999999999 99999532110 011111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........ ......+.+++.+||+.||++
T Consensus 246 ~~~~~~~~-~~~~~~~~~li~~~L~~dP~~ 274 (432)
T 3p23_A 246 SLDCLHPE-KHEDVIARELIEKMIAMDPQK 274 (432)
T ss_dssp CCTTSCTT-CHHHHHHHHHHHHHSCSSGGG
T ss_pred CccccCcc-ccccHHHHHHHHHHHhCCHhh
Confidence 11000000 123344789999999999974
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=261.76 Aligned_cols=245 Identities=21% Similarity=0.273 Sum_probs=164.3
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc----cCCCcCEE
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG----RLTNLNYM 177 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~----~l~~L~~L 177 (602)
.+++.|+++...+. .+..-.|..+++|+.|++. ++.+.+..|..|+++++|++|+|++|+|++ .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYIS---ELWTSDILSLSKLRILIIS--HNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCC---CCCHHHHTTCTTCCEEECC--SSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECCCCCCCSEE
T ss_pred ccccEEECCCCccc---ccChhhccccccccEEecC--CCccCCcChHHhhcccCCCEEecCCCceeecCccccCCccEE
Confidence 57888888765432 2222347788888888887 677777778999999999999999999973 57899999
Q ss_pred ECcCCcCCC-CCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCC--ceeecccccC--CC-CcccccCCC--------
Q 047576 178 SLSRNMLGG-LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSL--KILILAQNQL--SG-LPQEIGNLK-------- 243 (602)
Q Consensus 178 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~-ip~~~~~l~-------- 243 (602)
+|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++|++ ++ +|..+..++
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence 999999998 578999999999999999999876 356666777 8888888877 44 454444322
Q ss_pred ---------------------------------------------------------------------------CCcEE
Q 047576 244 ---------------------------------------------------------------------------NLMLL 248 (602)
Q Consensus 244 ---------------------------------------------------------------------------~L~~L 248 (602)
+|++|
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 67777
Q ss_pred EccCCCCCCCCCCcc-----CCCCCCccccCCCCcCCCCCc-hh-------------------------hhCCCCCCEEe
Q 047576 249 DVGNNDIIGPIPSTL-----GLFSDLSYLDLSCNQFNSSIP-NE-------------------------LTRLTQLFHLD 297 (602)
Q Consensus 249 ~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~p-~~-------------------------~~~l~~L~~L~ 297 (602)
++++|+++|.+|..+ +.+++|+.+++++|.+ .+| .. +..+++|++|+
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~ 330 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEE
T ss_pred EeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEE
Confidence 777777777777766 4444444444444433 122 00 13445555555
Q ss_pred ccCCCCCCCCCcccCCCCCCCEEeCCCCCCCC--CCCcccccccccccccccCCcCCCccC
Q 047576 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG--SIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
|++|++++.+|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++|++++.+|
T Consensus 331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ 391 (520)
T 2z7x_B 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391 (520)
T ss_dssp CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGG
T ss_pred eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccc
Confidence 55555555555555555555555555555554 334445555555555555555555444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=268.61 Aligned_cols=241 Identities=27% Similarity=0.343 Sum_probs=174.3
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCc
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNL 174 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L 174 (602)
.+++.|+++...+. .+....|+.+++|+.|++. .+.+.+..|..|+++++|++|+|++|++++ .+++|
T Consensus 25 ~~l~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 99 (680)
T 1ziw_A 25 TNITVLNLTHNQLR---RLPAANFTRYSQLTSLDVG--FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99 (680)
T ss_dssp TTCSEEECCSSCCC---CCCGGGGGGGTTCSEEECC--SSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCcEEECCCCCCC---CcCHHHHhCCCcCcEEECC--CCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCC
Confidence 46788888765432 2344457777888888876 567777778889999999999999998873 47889
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCc-ccc--cCCCCCcEEEcc
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP-QEI--GNLKNLMLLDVG 251 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip-~~~--~~l~~L~~L~L~ 251 (602)
++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|++++++ ..+ ..+++|+.|+++
T Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~ 179 (680)
T 1ziw_A 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179 (680)
T ss_dssp SEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECT
T ss_pred CEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECC
Confidence 99999999999888889999999999999999999888888999999999999999998854 333 345788888888
Q ss_pred CCCCCCCCCCccCCC---------------------------CCCccccCCCCcCCCCCchhhhCCCC--CCEEeccCCC
Q 047576 252 NNDIIGPIPSTLGLF---------------------------SDLSYLDLSCNQFNSSIPNELTRLTQ--LFHLDLSSNK 302 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~ 302 (602)
+|++++..|..+..+ ++|+.|++++|.+++..|..|..++. |+.|+|++|+
T Consensus 180 ~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~ 259 (680)
T 1ziw_A 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259 (680)
T ss_dssp TCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSC
T ss_pred CCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCC
Confidence 888887777655433 34555666666666666656655533 6666666666
Q ss_pred CCCCCCcccCCCCCCCEEeCCCCCCCCCCCccccccccccccccc
Q 047576 303 LSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347 (602)
Q Consensus 303 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 347 (602)
+++..|..++.+++|+.|++++|++++..|..+..+++|+.|+++
T Consensus 260 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (680)
T 1ziw_A 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECT
T ss_pred cCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEecc
Confidence 666555666666666666666666665555444444333333333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=261.39 Aligned_cols=216 Identities=22% Similarity=0.309 Sum_probs=147.2
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRILHNDAE-------- 439 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~l~~~~~-------- 439 (602)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++..+ .|+++..++.....
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 3455678899999999987766689999999986432 23456788888654 67766655432100
Q ss_pred ----------------h----hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-------------C
Q 047576 440 ----------------A----VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-------------L 486 (602)
Q Consensus 440 ----------------~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-------------~ 486 (602)
. ...++..+..++.||+.||+||| +.+|+||||||+||+++.+ +
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 0 00122345679999999999999 7899999999999999754 4
Q ss_pred cceeecccccccccCCCCC----cccccccccccccccccc-------CcCCccchhHHHHHHHHHHHc-CCCCCCCCcc
Q 047576 487 EAFVADFGTARLLHADSSN----QTLLAGSYGYIAPELAYT-------MVMTEKYDVYSFGVVTLEVLM-GKHPRDLHST 554 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~ 554 (602)
.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999877543221 223579999999999876 568999999999999999999 9999974321
Q ss_pred cccCCCcccchhhhhccCCCCC--CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 555 LSSSYDPKIMLIDVLDQRLPPP--VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 555 ~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. . ..++......+ ...........+.+++..|++.||++
T Consensus 246 ~------~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 286 (434)
T 2rio_A 246 R------E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286 (434)
T ss_dssp H------H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGG
T ss_pred h------H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhh
Confidence 1 0 11222111100 00001224456889999999999974
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=269.49 Aligned_cols=308 Identities=19% Similarity=0.196 Sum_probs=169.0
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc--cCCCcCEEECc
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG--RLTNLNYMSLS 180 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~--~l~~L~~L~L~ 180 (602)
+++.|+++...+. .+.+-.|+.+++|+.|++. +|.+.+.+| ++.+++|++|+|++|.|++ ..++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls--~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLS---QISAADLAPFTKLELLNLS--SNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCC---CCCGGGGTTCTTCCEEECT--TSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECC
T ss_pred CccEEEeeCCcCC---CCCHHHHhCCCCCCEEEee--CCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECc
Confidence 4556666543322 1222235555555555554 444444443 6666666666666666653 24666666666
Q ss_pred CCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-Cccccc-CCCCCcEEEccCCCCCCC
Q 047576 181 RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIG-NLKNLMLLDVGNNDIIGP 258 (602)
Q Consensus 181 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~-~l~~L~~L~L~~N~l~~~ 258 (602)
+|.|++..+. .+++|++|+|++|.+++..|..++++++|++|+|++|.+++ +|..+. ++++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 6666655443 24566666666666666666666666666666666666666 444554 566666666666666654
Q ss_pred CCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCC-CCCCccccc
Q 047576 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK-GSIPGEITK 337 (602)
Q Consensus 259 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~ 337 (602)
.+ +..+++|++|+|++|.+++..| .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 22 2246666666666666665433 36666666666666666664 5555666666666666666665 455555666
Q ss_pred ccccccccccC-CcCCCccCCCCCcCCCCCCCccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhH
Q 047576 338 LSRLDYLNLSG-NKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFR 416 (602)
Q Consensus 338 l~~L~~L~l~~-N~l~g~~p~~~~~l~~lp~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~ 416 (602)
++.|+.++++. +.+.|..|..... +....+ ..++.+..+.+|..+. +++|+....... ....+.|.
T Consensus 261 l~~L~~l~~~~~~~~~~~~~~~c~~----~~~~~~---~~~~~~~~~~~~~~~l-----~~~~~~~~~~~~-~~g~~eF~ 327 (487)
T 3oja_A 261 NQRVQTVAKQTVKKLTGQNEEECTV----PTLGHY---GAYCCEDLPAPFADRL-----IALKRKEHALLS-GQGSETER 327 (487)
T ss_dssp CHHHHHHHHHHHHHHTSSSSCCCSS----TTCEEE---TTEEECCCSCHHHHHH-----HHHHHHHHCSCC------CHH
T ss_pred CCCCcEEeccccccccCCCcccccC----Cccccc---cccccccccchhhhHH-----HHHHHHhhhhcc-cccHHHHH
Confidence 66666666541 1222222222110 000000 0123334444444322 233322111100 12357899
Q ss_pred hHHHHHHhhhcCccccccccc
Q 047576 417 NEAQVLSQMERGSLFRILHND 437 (602)
Q Consensus 417 ~E~~il~~l~~gsL~~~l~~~ 437 (602)
.|++++..+.|.+|..++..+
T Consensus 328 ~Eve~L~~i~HrNLV~L~gyC 348 (487)
T 3oja_A 328 LECERENQARQREIDALKEQY 348 (487)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcccccchhhHHHHh
Confidence 999999999999999887654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=239.80 Aligned_cols=240 Identities=21% Similarity=0.303 Sum_probs=204.9
Q ss_pred EEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCE
Q 047576 104 IIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNY 176 (602)
Q Consensus 104 v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~ 176 (602)
+..++++..++ ..+....+++++.|++. ++++.+..|..|+++++|++|+|++|+|++ .+++|++
T Consensus 35 l~~l~~~~~~l------~~ip~~~~~~l~~L~l~--~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 106 (332)
T 2ft3_A 35 LRVVQCSDLGL------KAVPKEISPDTTLLDLQ--NNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK 106 (332)
T ss_dssp TTEEECCSSCC------SSCCSCCCTTCCEEECC--SSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCE
T ss_pred CCEEECCCCCc------cccCCCCCCCCeEEECC--CCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCE
Confidence 34567765433 33333445788888876 566666667789999999999999999873 4789999
Q ss_pred EECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC---CcccccCCCCCcEEEccCC
Q 047576 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG---LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 177 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---ip~~~~~l~~L~~L~L~~N 253 (602)
|+|++|+++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|.++. .|..+..+ +|+.|++++|
T Consensus 107 L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n 182 (332)
T 2ft3_A 107 LYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA 182 (332)
T ss_dssp EECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred EECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence 999999999 4555554 899999999999998777789999999999999999974 56677777 9999999999
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
++++ +|..+. ++|++|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|.
T Consensus 183 ~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 183 KLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp BCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred CCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 9996 666554 79999999999999988889999999999999999999988889999999999999999999 7888
Q ss_pred ccccccccccccccCCcCCCccCCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
.+..+++|+.|++++|++++..+..+
T Consensus 259 ~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 259 GLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp TGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred hhhcCccCCEEECCCCCCCccChhHc
Confidence 89999999999999999998766554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-26 Score=236.95 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=206.0
Q ss_pred EEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCE
Q 047576 104 IIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNY 176 (602)
Q Consensus 104 v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~ 176 (602)
+..+++++.++ ..+.....++++.|++. ++++.+..+..|+++++|++|+|++|++++ .+++|++
T Consensus 33 l~~l~~~~~~l------~~lp~~~~~~l~~L~L~--~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (330)
T 1xku_A 33 LRVVQCSDLGL------EKVPKDLPPDTALLDLQ--NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 104 (330)
T ss_dssp TTEEECTTSCC------CSCCCSCCTTCCEEECC--SSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CeEEEecCCCc------cccCccCCCCCeEEECC--CCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCE
Confidence 34567764433 33333345678888776 566666666689999999999999999874 4789999
Q ss_pred EECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC---CcccccCCCCCcEEEccCC
Q 047576 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG---LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 177 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---ip~~~~~l~~L~~L~L~~N 253 (602)
|+|++|+++. +|..+. ++|++|++++|++++..+..+.++++|++|++++|+++. .+..+.++++|++|++++|
T Consensus 105 L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 105 LYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp EECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred EECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 9999999994 455544 799999999999998888889999999999999999974 5678999999999999999
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
.++. +|..+. ++|++|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|.
T Consensus 182 ~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 182 NITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp CCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred cccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 9985 565543 89999999999999998999999999999999999999888888999999999999999999 7888
Q ss_pred ccccccccccccccCCcCCCccCCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
.+..+++|++|++++|++++..+..+
T Consensus 258 ~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 258 GLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred hhccCCCcCEEECCCCcCCccChhhc
Confidence 99999999999999999998766655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=266.81 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=182.7
Q ss_pred CCEEEEEecCCCCCCCc-----------------cccc-CCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECc
Q 047576 102 GSIIGLHLSKDNVNFNG-----------------RLSH-LNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLS 163 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~-----------------~l~~-~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls 163 (602)
.++..|+++...+ .| .++. +.|..+++|+.|++. .+++.+.+|..|+++++|++|+|+
T Consensus 448 ~~L~~L~Ls~N~L--sg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls--~N~l~~~iP~~l~~L~~L~~L~Ls 523 (876)
T 4ecn_A 448 TKLQIIYFANSPF--TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY--NCPNMTQLPDFLYDLPELQSLNIA 523 (876)
T ss_dssp TTCCEEEEESCCC--CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE--SCTTCCSCCGGGGGCSSCCEEECT
T ss_pred CCCCEEECcCCcC--CCCcccccccccccccccccCChhhhhccCCCCCEEECc--CCCCCccChHHHhCCCCCCEEECc
Confidence 4567788876543 34 2433 224488889998887 778899999999999999999999
Q ss_pred CCc-Ccc-c--------------CCCcCEEECcCCcCCCCCch--hhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 164 SNR-LRG-R--------------LTNLNYMSLSRNMLGGLLPQ--EIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 164 ~N~-i~~-~--------------l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+|+ ++| . +++|++|+|++|+++ .+|. .|+++++|++|+|++|+++ .+| .|+.+++|+.|
T Consensus 524 ~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp TCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred CCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 998 876 2 349999999999999 7888 9999999999999999998 888 89999999999
Q ss_pred ecccccCCCCcccccCCCC-CcEEEccCCCCCCCCCCccCCCCC--CccccCCCCcCCCCCchh---hh--CCCCCCEEe
Q 047576 226 ILAQNQLSGLPQEIGNLKN-LMLLDVGNNDIIGPIPSTLGLFSD--LSYLDLSCNQFNSSIPNE---LT--RLTQLFHLD 297 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~p~~---~~--~l~~L~~L~ 297 (602)
+|++|+++.+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++++.+|.. +. .+++|+.|+
T Consensus 601 ~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 601 KLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp ECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred ECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 9999999999999999998 999999999998 77877766654 778888888777765521 12 223566666
Q ss_pred ccCCCCCCCCCccc-CCCCCCCEEeCCCCCCCCCCCccccc--------ccccccccccCCcCCCccCCC
Q 047576 298 LSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPGEITK--------LSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 298 Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~l~~N~l~g~~p~~ 358 (602)
|++|+|+ .+|..+ ..+++|+.|+|++|+++ .+|..+.. +++|+.|+|++|+++ .+|..
T Consensus 680 Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~ 746 (876)
T 4ecn_A 680 LSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDD 746 (876)
T ss_dssp CCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGG
T ss_pred ccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHH
Confidence 6666666 334332 35566666666666665 33433322 125666666666665 44443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=262.80 Aligned_cols=246 Identities=22% Similarity=0.239 Sum_probs=202.5
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-----ccCCCcCEE
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYM 177 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L 177 (602)
.+..++++...+. .++ .+..+++|+.|++. .+.+ +.+| .+ .+++|++|++++|+.. +.+++|++|
T Consensus 286 ~L~~L~l~~~~~~---~l~--~l~~~~~L~~L~l~--~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L 355 (606)
T 3vq2_A 286 NVSAMSLAGVSIK---YLE--DVPKHFKWQSLSII--RCQL-KQFP-TL-DLPFLKSLTLTMNKGSISFKKVALPSLSYL 355 (606)
T ss_dssp TCSEEEEESCCCC---CCC--CCCTTCCCSEEEEE--SCCC-SSCC-CC-CCSSCCEEEEESCSSCEECCCCCCTTCCEE
T ss_pred CCCEEEecCccch---hhh--hccccccCCEEEcc--cccC-cccc-cC-CCCccceeeccCCcCccchhhccCCCCCEE
Confidence 4556666544332 222 35556666666665 3444 8888 55 8999999999999544 358899999
Q ss_pred ECcCCcCCCC--CchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-c-ccccCCCCCcEEEccCC
Q 047576 178 SLSRNMLGGL--LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-P-QEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 178 ~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p-~~~~~l~~L~~L~L~~N 253 (602)
+|++|++++. .|..+..+++|++|+|++|.+++ +|..+.++++|+.|++++|+++++ | ..+.++++|++|++++|
T Consensus 356 ~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n 434 (606)
T 3vq2_A 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434 (606)
T ss_dssp ECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTS
T ss_pred ECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCC
Confidence 9999999876 48889999999999999999875 567888999999999999999985 4 47888999999999999
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCC-CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
.+++..|..+..+++|++|++++|.+++ .+|..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|
T Consensus 435 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 514 (606)
T 3vq2_A 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514 (606)
T ss_dssp CCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEG
T ss_pred CCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCH
Confidence 9999889999999999999999999988 478888999999999999999998888889999999999999999998889
Q ss_pred cccccccccccccccCCcCCCccCCCCC
Q 047576 333 GEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 333 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
..+..+++|+.|++++|+++ .+|..+.
T Consensus 515 ~~~~~l~~L~~L~l~~N~l~-~~p~~~~ 541 (606)
T 3vq2_A 515 SHYNQLYSLSTLDCSFNRIE-TSKGILQ 541 (606)
T ss_dssp GGTTTCTTCCEEECTTSCCC-CEESCGG
T ss_pred HHccCCCcCCEEECCCCcCc-ccCHhHh
Confidence 99999999999999999998 5665543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-28 Score=248.84 Aligned_cols=195 Identities=24% Similarity=0.284 Sum_probs=107.5
Q ss_pred CCCCCCEEECcCCcCcc---------cCCCcCEEECcCCcCCCCCchhhhCC-----CCCCEEEecCCCCCCCCcccccC
Q 047576 153 ALSKLQLLDLSSNRLRG---------RLTNLNYMSLSRNMLGGLLPQEIGNL-----KNLIELDVGDNSLIGPIPLTLSR 218 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~ 218 (602)
++++|++|+|++|++++ .+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..+++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 55566666666665542 245566666666666555 5555555 56666666666665555555666
Q ss_pred cCCCceeecccccCCC---Ccccc--cCCCCCcEEEccCCCCCCC--CC-CccCCCCCCccccCCCCcCCCCCc-hhhhC
Q 047576 219 LTSLKILILAQNQLSG---LPQEI--GNLKNLMLLDVGNNDIIGP--IP-STLGLFSDLSYLDLSCNQFNSSIP-NELTR 289 (602)
Q Consensus 219 l~~L~~L~L~~N~l~~---ip~~~--~~l~~L~~L~L~~N~l~~~--~p-~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~ 289 (602)
+++|++|+|++|++++ +|..+ .++++|++|+|++|++++. ++ ..+..+++|++|+|++|++++.+| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 6666666666665554 23333 5555666666666665521 11 222345556666666666655543 23444
Q ss_pred CCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 290 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 555666666666665 4454444 5566666666666544 33 5555666666666665554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=258.12 Aligned_cols=127 Identities=29% Similarity=0.368 Sum_probs=103.7
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-------ccCCCcC
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLN 175 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~ 175 (602)
.++.|+|+.+.+. .++.-.|..+++|+.|++. ++.+.+..|.+|.+|++|++|+|++|+|+ +.+++|+
T Consensus 53 ~~~~LdLs~N~i~---~l~~~~f~~l~~L~~L~Ls--~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~ 127 (635)
T 4g8a_A 53 STKNLDLSFNPLR---HLGSYSFFSFPELQVLDLS--RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 127 (635)
T ss_dssp TCCEEECTTSCCC---EECTTTTTTCTTCCEEECT--TCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCC
T ss_pred CCCEEEeeCCCCC---CCCHHHHhCCCCCCEEECC--CCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCC
Confidence 5788888765443 4555567777888888776 55666666678999999999999999987 3488999
Q ss_pred EEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCC-CCcccccCcCCCceeecccccCCC
Q 047576 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSG 234 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~ 234 (602)
+|+|++|+|++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|++++
T Consensus 128 ~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 128 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred EEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence 99999999998888889999999999999999976 467888889999999999888765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-28 Score=251.61 Aligned_cols=221 Identities=24% Similarity=0.276 Sum_probs=188.7
Q ss_pred CCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---------------cCCCcCEEECcCCcCCCCCch
Q 047576 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---------------RLTNLNYMSLSRNMLGGLLPQ 190 (602)
Q Consensus 126 ~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---------------~l~~L~~L~L~~N~l~~~~p~ 190 (602)
+..++|+.|++. ++.+ .+|..+... |++|+|++|++.. .+++|++|+|++|++++.+|.
T Consensus 40 ~~~~~L~~l~l~--~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 40 GGGRSLEYLLKR--VDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEECTTHHHH--CCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred ccCCCceeEeec--cccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 334567777765 4555 788876655 9999999999952 489999999999999999999
Q ss_pred hh--hCCCCCCEEEecCCCCCCCCcccccCc-----CCCceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCC--CC
Q 047576 191 EI--GNLKNLIELDVGDNSLIGPIPLTLSRL-----TSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGP--IP 260 (602)
Q Consensus 191 ~~--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~--~p 260 (602)
.+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|+++++| ..++++++|++|+|++|+++|. .|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 87 9999999999999999987 8888888 99999999999999965 7899999999999999999875 33
Q ss_pred Ccc--CCCCCCccccCCCCcCCCC--Cc-hhhhCCCCCCEEeccCCCCCCCCC-cccCCCCCCCEEeCCCCCCCCCCCcc
Q 047576 261 STL--GLFSDLSYLDLSCNQFNSS--IP-NELTRLTQLFHLDLSSNKLSGKIP-SQIASMEDLTWLDLSNNNIKGSIPGE 334 (602)
Q Consensus 261 ~~l--~~l~~L~~L~L~~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~ 334 (602)
..+ ..+++|++|+|++|++++. ++ ..+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 344 8899999999999999842 23 345688999999999999998775 45677899999999999999 77887
Q ss_pred cccccccccccccCCcCCCccCC
Q 047576 335 ITKLSRLDYLNLSGNKLSGRVPY 357 (602)
Q Consensus 335 ~~~l~~L~~L~l~~N~l~g~~p~ 357 (602)
+. ++|+.|++++|++++. |.
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~ 291 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS 291 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC
T ss_pred cc--CCceEEECCCCCCCCC-hh
Confidence 76 8999999999999987 54
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=269.02 Aligned_cols=249 Identities=23% Similarity=0.261 Sum_probs=202.1
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---------cCC
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---------RLT 172 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---------~l~ 172 (602)
.+.+.|+++..+ ..+.+..-.|+.+++|+.|++. ++.+.+..|..|+++++|++|+|++|++++ .++
T Consensus 48 ~~L~~LdLs~n~--~~~~i~~~~f~~L~~L~~L~Ls--~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~ 123 (844)
T 3j0a_A 48 EQLQLLELGSQY--TPLTIDKEAFRNLPNLRILDLG--SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123 (844)
T ss_dssp CSCSEEEECTTC--CCCEECTTTTSSCTTCCEEECT--TCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCS
T ss_pred ccCeEEeCCCCC--CccccCHHHhcCCCCCCEEECC--CCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccC
Confidence 356677776542 2455656667788888888876 667777778888888889999998888864 367
Q ss_pred CcCEEECcCCcCCCCCc-hhhhCCCCCCEEEecCCCCCCCCcccccCc--CC----------------------------
Q 047576 173 NLNYMSLSRNMLGGLLP-QEIGNLKNLIELDVGDNSLIGPIPLTLSRL--TS---------------------------- 221 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~---------------------------- 221 (602)
+|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..+ ++
T Consensus 124 ~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~ 203 (844)
T 3j0a_A 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203 (844)
T ss_dssp SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTT
T ss_pred CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCcccc
Confidence 88888888888887755 578888888888888888887777666554 34
Q ss_pred --CceeecccccCCC-CcccccC--------------------------------------CCCCcEEEccCCCCCCCCC
Q 047576 222 --LKILILAQNQLSG-LPQEIGN--------------------------------------LKNLMLLDVGNNDIIGPIP 260 (602)
Q Consensus 222 --L~~L~L~~N~l~~-ip~~~~~--------------------------------------l~~L~~L~L~~N~l~~~~p 260 (602)
|+.|++++|++++ +|..+.. .++|+.|++++|.+++..|
T Consensus 204 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~ 283 (844)
T 3j0a_A 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283 (844)
T ss_dssp CCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS
T ss_pred CceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccCh
Confidence 5555555555544 3322211 2578888899998888888
Q ss_pred CccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccc
Q 047576 261 STLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340 (602)
Q Consensus 261 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 340 (602)
..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 89999999999999999999999999999999999999999999988999999999999999999999888889999999
Q ss_pred cccccccCCcCCCc
Q 047576 341 LDYLNLSGNKLSGR 354 (602)
Q Consensus 341 L~~L~l~~N~l~g~ 354 (602)
|+.|++++|.+++.
T Consensus 364 L~~L~Ls~N~l~~i 377 (844)
T 3j0a_A 364 LQTLDLRDNALTTI 377 (844)
T ss_dssp CCEEEEETCCSCCC
T ss_pred CCEEECCCCCCCcc
Confidence 99999999999863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=234.44 Aligned_cols=208 Identities=29% Similarity=0.344 Sum_probs=179.1
Q ss_pred cCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccC
Q 047576 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218 (602)
Q Consensus 146 ~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 218 (602)
.+|..+. ++|++|+|++|+|++ .+++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 4555443 478889999988872 4688999999999999888889999999999999999999888889999
Q ss_pred cCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCC-CCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCC--
Q 047576 219 LTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGP-IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF-- 294 (602)
Q Consensus 219 l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-- 294 (602)
+++|++|++++|++++++. .++++++|++|++++|++++. +|..+..+++|++|++++|++++..+..+..+++|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 9999999999999999654 689999999999999999874 688999999999999999999988887787777776
Q ss_pred --EEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 295 --HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 295 --~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
.|++++|++++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 899999999976555554 4589999999999998877778999999999999999998765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=230.85 Aligned_cols=204 Identities=27% Similarity=0.349 Sum_probs=185.1
Q ss_pred cCCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCce
Q 047576 150 EISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKI 224 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 224 (602)
.+..+++|+.|++++|.+. +.+++|++|+|++|.+++. +.++.+++|++|+|++|++++..+..+.++++|++
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccccceeeeeeCCCCcccccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 3567889999999999987 3589999999999999974 58999999999999999999888888999999999
Q ss_pred eecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCC
Q 047576 225 LILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 225 L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 303 (602)
|++++|+++++|. .++++++|++|++++|++++..+..+..+++|++|++++|++++..+..++.+++|+.|+|++|++
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 9999999999655 578999999999999999988888889999999999999999988888889999999999999999
Q ss_pred CCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcC
Q 047576 304 SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHL 362 (602)
Q Consensus 304 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 362 (602)
++..|..+..+++|+.|++++|.+.+. +++|+.|+++.|.++|.+|.....+
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 998888899999999999999999865 4478999999999999999886433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=233.48 Aligned_cols=202 Identities=24% Similarity=0.246 Sum_probs=183.0
Q ss_pred cCCCCCCCCEEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 150 EISALSKLQLLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
.++++++|+++++++|+++. ..++|++|+|++|.+++..+..|.++++|++|+|++|+|++..+ .+.+++|++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 82 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTL 82 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEE
T ss_pred cccccCCccEEECCCCCCCcCCCCCCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEE
Confidence 36778889999999998874 35689999999999999999999999999999999999986433 3789999999
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
+|++|+++.+|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++
T Consensus 83 ~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp ECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 99999999999999999999999999999998888899999999999999999998888888999999999999999997
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCc
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 354 (602)
..+..+..+++|+.|+|++|+++ .+|..+...++|+.|++++|++...
T Consensus 163 l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 77777899999999999999999 6788888889999999999998753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=273.37 Aligned_cols=206 Identities=24% Similarity=0.329 Sum_probs=159.1
Q ss_pred CccccCcccccccccccceeeecC--CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA------- 438 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~------- 438 (602)
.++|.....||+|+||.||+|+.. +|+.||||++...... .....+.+|+.++..+.|+++..++....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 367999999999999999999864 6899999988654322 24467788999888887777765543110
Q ss_pred ------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 439 ------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 439 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.+ .+||+|||+++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 0124789999999999999999999 7899999999999999986 89999999998764
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ....||+.|+|||++.+.. +.++|||||||++|+|++|..||..... . .++.. ..
T Consensus 233 ~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~--~--------------~~~~~--~~ 289 (681)
T 2pzi_A 233 SF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV--D--------------GLPED--DP 289 (681)
T ss_dssp CC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC--S--------------SCCTT--CH
T ss_pred cC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc--c--------------ccccc--cc
Confidence 33 3357999999999987654 8899999999999999999999864210 0 01111 01
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+.+++.+||++||++
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~ 311 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQ 311 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHHHHHHHhhhccCChhh
Confidence 1223345889999999999974
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=247.28 Aligned_cols=213 Identities=24% Similarity=0.294 Sum_probs=189.9
Q ss_pred ccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCccccc
Q 047576 145 GSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLS 217 (602)
Q Consensus 145 ~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 217 (602)
..+|..+. ++|++|+|++|+|++ .+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.
T Consensus 67 ~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 144 (452)
T 3zyi_A 67 SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFE 144 (452)
T ss_dssp SSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSS
T ss_pred CccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhc
Confidence 34565544 689999999999973 488999999999999999999999999999999999999988888899
Q ss_pred CcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCC-CCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCE
Q 047576 218 RLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNND-IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFH 295 (602)
Q Consensus 218 ~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 295 (602)
++++|++|+|++|+++++|. .+.++++|+.|++++|+ +....+..|..+++|++|+|++|++++. | .+..+++|+.
T Consensus 145 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~ 222 (452)
T 3zyi_A 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEE 222 (452)
T ss_dssp SCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCE
T ss_pred ccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccE
Confidence 99999999999999999654 78999999999999954 5444445799999999999999999864 4 5889999999
Q ss_pred EeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCc
Q 047576 296 LDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKH 361 (602)
Q Consensus 296 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 361 (602)
|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..
T Consensus 223 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp EECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred EECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 999999999999999999999999999999999999999999999999999999999766655443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=243.16 Aligned_cols=222 Identities=22% Similarity=0.264 Sum_probs=181.7
Q ss_pred CCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCchhhhCCC
Q 047576 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLK 196 (602)
Q Consensus 124 ~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 196 (602)
.|+.+++|+.|++. .+.+.+..|..|+++++|++|+|++|+|+ +.+++|++|+|++|.+++..|..|++++
T Consensus 88 ~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 165 (390)
T 3o6n_A 88 AFAYAHTIQKLYMG--FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165 (390)
T ss_dssp TTTTCTTCCEEECC--SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCT
T ss_pred hccCCCCcCEEECC--CCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCC
Confidence 45666777777765 55666666778999999999999999987 3478999999999999999999999999
Q ss_pred CCCEEEecCCCCCCCCcccccCcCCC-------------------ceeecccccCCCCcccccCCCCCcEEEccCCCCCC
Q 047576 197 NLIELDVGDNSLIGPIPLTLSRLTSL-------------------KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG 257 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~~l~~L-------------------~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~ 257 (602)
+|++|+|++|++++.. +..+++| +.|++++|+++.+|.. ..++|+.|++++|.+++
T Consensus 166 ~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~n~l~~ 240 (390)
T 3o6n_A 166 SLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTD 240 (390)
T ss_dssp TCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECC--CCSSCCEEECCSSCCCC
T ss_pred CCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCeeeecccc--ccccccEEECCCCCCcc
Confidence 9999999999998753 3334444 4455555555544432 23689999999999986
Q ss_pred CCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCccccc
Q 047576 258 PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITK 337 (602)
Q Consensus 258 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 337 (602)
. ..+..+++|++|++++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..
T Consensus 241 ~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~ 316 (390)
T 3o6n_A 241 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316 (390)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred c--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence 4 568889999999999999999889999999999999999999985 5667788999999999999998 56777888
Q ss_pred ccccccccccCCcCCCccC
Q 047576 338 LSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 338 l~~L~~L~l~~N~l~g~~p 356 (602)
+++|+.|++++|++++...
T Consensus 317 l~~L~~L~L~~N~i~~~~~ 335 (390)
T 3o6n_A 317 FDRLENLYLDHNSIVTLKL 335 (390)
T ss_dssp HTTCSEEECCSSCCCCCCC
T ss_pred cCcCCEEECCCCccceeCc
Confidence 9999999999999987543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=257.94 Aligned_cols=224 Identities=22% Similarity=0.228 Sum_probs=191.2
Q ss_pred CCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCC
Q 047576 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLK 196 (602)
Q Consensus 124 ~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~ 196 (602)
.|+.+++|+.|++. ++.+.+..|..|+++++|++|+|++|.|++ .+++|++|+|++|.+++..|..|++++
T Consensus 94 ~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 171 (597)
T 3oja_B 94 AFAYAHTIQKLYMG--FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171 (597)
T ss_dssp TTTTCTTCCEEECC--SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT
T ss_pred HhcCCCCCCEEECC--CCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCC
Confidence 56677777777776 566777667789999999999999999873 478999999999999999999999999
Q ss_pred CCCEEEecCCCCCCCCcccccCc-------------------------------------CCCceeecccccCCCCcccc
Q 047576 197 NLIELDVGDNSLIGPIPLTLSRL-------------------------------------TSLKILILAQNQLSGLPQEI 239 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~~l-------------------------------------~~L~~L~L~~N~l~~ip~~~ 239 (602)
+|++|+|++|.+++..+..+.++ ++|+.|+|++|.+++. ..+
T Consensus 172 ~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~-~~l 250 (597)
T 3oja_B 172 SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT-AWL 250 (597)
T ss_dssp TCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCC-GGG
T ss_pred cCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCC-hhh
Confidence 99999999999987543333322 2366666666666664 468
Q ss_pred cCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCE
Q 047576 240 GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW 319 (602)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 319 (602)
+++++|+.|+|++|.+++.+|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.
T Consensus 251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~ 328 (597)
T 3oja_B 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328 (597)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCE
Confidence 899999999999999999999999999999999999999997 5667788999999999999999 57888899999999
Q ss_pred EeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 320 LDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 320 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
|+|++|++++.. +..+++|+.|++++|++++..
T Consensus 329 L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 329 LYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp EECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHH
T ss_pred EECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChh
Confidence 999999999653 677889999999999998754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=252.11 Aligned_cols=121 Identities=23% Similarity=0.306 Sum_probs=88.1
Q ss_pred CCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCc-hhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEe
Q 047576 243 KNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIP-NELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD 321 (602)
Q Consensus 243 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 321 (602)
++|++|++++|.+++..+ .+..+++|++|++++|.+++..| ..+.++++|++|++++|++++..|..+..+++|+.|+
T Consensus 373 ~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp SCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 334444444444433222 25667788888888888877665 4677888888888888888888888888888888888
Q ss_pred CCCCCCC-CCCCcccccccccccccccCCcCCCccCCCCCcCCC
Q 047576 322 LSNNNIK-GSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364 (602)
Q Consensus 322 L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 364 (602)
+++|+++ +.+|..+..+++|+.|++++|++++..|..+..+..
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 495 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccC
Confidence 8888887 567888888888888888888888877776654433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-26 Score=244.06 Aligned_cols=215 Identities=28% Similarity=0.336 Sum_probs=191.6
Q ss_pred cccCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccc
Q 047576 144 TGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTL 216 (602)
Q Consensus 144 ~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 216 (602)
...+|..+. ++++.|+|++|+|+ +.+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|
T Consensus 55 l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 132 (440)
T 3zyj_A 55 LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAF 132 (440)
T ss_dssp CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTS
T ss_pred cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHh
Confidence 345676654 78999999999997 358899999999999999999999999999999999999998777789
Q ss_pred cCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCC-CCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCC
Q 047576 217 SRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNND-IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294 (602)
Q Consensus 217 ~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 294 (602)
.++++|++|+|++|+++.+|. .+.++++|+.|+|++|+ ++...+..|.++++|++|+|++|+++. +| .+..+++|+
T Consensus 133 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 210 (440)
T 3zyj_A 133 VYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLD 210 (440)
T ss_dssp CSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCC
T ss_pred hccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccC
Confidence 999999999999999999654 78999999999999955 444445579999999999999999984 55 588999999
Q ss_pred EEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcC
Q 047576 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHL 362 (602)
Q Consensus 295 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 362 (602)
.|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+
T Consensus 211 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred EEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 99999999999889999999999999999999999999999999999999999999998766555433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-26 Score=257.33 Aligned_cols=234 Identities=21% Similarity=0.230 Sum_probs=180.1
Q ss_pred CCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCccc-----------CCCcCEEECcCCcCCCCCchhh
Q 047576 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGR-----------LTNLNYMSLSRNMLGGLLPQEI 192 (602)
Q Consensus 124 ~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~~-----------l~~L~~L~L~~N~l~~~~p~~~ 192 (602)
.|+.+++|+.|++. .+.+.+..|..|.++++|++|+|++|.++.. .++|++|+|++|++++..|..|
T Consensus 324 ~~~~l~~L~~L~l~--~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~ 401 (680)
T 1ziw_A 324 SFQWLKCLEHLNME--DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401 (680)
T ss_dssp TTTTCTTCCEEECC--SCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred hcccCCCCCEEECC--CCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence 45566666666665 5566666677788888888888888875421 2578888888888888888888
Q ss_pred hCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCC--CCCCCccCCCCC
Q 047576 193 GNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDII--GPIPSTLGLFSD 268 (602)
Q Consensus 193 ~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~ 268 (602)
..+++|++|+|++|.+++.+| ..+.++++|++|++++|++++ .+..+..+++|+.|++++|.++ +.+|..+..+++
T Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~ 481 (680)
T 1ziw_A 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481 (680)
T ss_dssp TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence 888999999999998887666 578888888888888888887 4557777888888888888876 567778888888
Q ss_pred CccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC--------cccCCCCCCCEEeCCCCCCCCCCCcccccccc
Q 047576 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP--------SQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340 (602)
Q Consensus 269 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 340 (602)
|+.|++++|++++..|..|..+++|++|+|++|++++..+ ..+..+++|+.|+|++|+++...+..|..+++
T Consensus 482 L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 561 (680)
T 1ziw_A 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccC
Confidence 8888888888887777778888888888888888775321 23677788888888888888555556788888
Q ss_pred cccccccCCcCCCccCCCC
Q 047576 341 LDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 341 L~~L~l~~N~l~g~~p~~~ 359 (602)
|+.|++++|++++..+..+
T Consensus 562 L~~L~Ls~N~l~~l~~~~~ 580 (680)
T 1ziw_A 562 LKIIDLGLNNLNTLPASVF 580 (680)
T ss_dssp CCEEECCSSCCCCCCTTTT
T ss_pred cceeECCCCCCCcCCHhHh
Confidence 8888888888876554443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=253.49 Aligned_cols=229 Identities=23% Similarity=0.259 Sum_probs=187.3
Q ss_pred CCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCC
Q 047576 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 199 (602)
-.++|+.|++. ++.+.+..|..|.++++|++|+|++|+|++ .+++|++|+|++|+|+. +|.. .+++|+
T Consensus 19 ~~~~L~~L~Ls--~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~ 93 (520)
T 2z7x_B 19 LSQKTTILNIS--QNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLK 93 (520)
T ss_dssp CCTTCSEEECC--SSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCS
T ss_pred ccccccEEECC--CCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCcc
Confidence 34788888887 666777777899999999999999999973 48899999999999994 5655 899999
Q ss_pred EEEecCCCCCC-CCcccccCcCCCceeecccccCCCCcccccCCCCC--cEEEccCCCC--CCCCCCccCCCC-------
Q 047576 200 ELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNL--MLLDVGNNDI--IGPIPSTLGLFS------- 267 (602)
Q Consensus 200 ~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~------- 267 (602)
+|+|++|++++ .+|..++++++|++|++++|++++ ..+..+++| +.|++++|.+ ++..|..+..+.
T Consensus 94 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~ 171 (520)
T 2z7x_B 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171 (520)
T ss_dssp EEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEE
T ss_pred EEeccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccccccccccccccccccceEEEE
Confidence 99999999998 578999999999999999999987 356777888 9999999999 777777776633
Q ss_pred ----------------------------------------------------------------------------CCcc
Q 047576 268 ----------------------------------------------------------------------------DLSY 271 (602)
Q Consensus 268 ----------------------------------------------------------------------------~L~~ 271 (602)
+|++
T Consensus 172 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~ 251 (520)
T 2z7x_B 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251 (520)
T ss_dssp CCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSE
T ss_pred eccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccE
Confidence 6777
Q ss_pred ccCCCCcCCCCCchhh-----hCCCCCCEEeccCCCCCCCCCc-------------------------c-cCCCCCCCEE
Q 047576 272 LDLSCNQFNSSIPNEL-----TRLTQLFHLDLSSNKLSGKIPS-------------------------Q-IASMEDLTWL 320 (602)
Q Consensus 272 L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~-------------------------~-~~~l~~L~~L 320 (602)
|++++|.++|.+|..+ +.+++|+.+++++|.+ .+|. . +..+++|++|
T Consensus 252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L 329 (520)
T 2z7x_B 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329 (520)
T ss_dssp EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEE
T ss_pred EEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEE
Confidence 7777777877788777 6666666666666655 2331 0 2688999999
Q ss_pred eCCCCCCCCCCCcccccccccccccccCCcCCC--ccCCCCCcCCC
Q 047576 321 DLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG--RVPYSNKHLSS 364 (602)
Q Consensus 321 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~ 364 (602)
++++|++++.+|..+..+++|+.|++++|++++ .+|..+..+..
T Consensus 330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~ 375 (520)
T 2z7x_B 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375 (520)
T ss_dssp ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT
T ss_pred EeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC
Confidence 999999999999999999999999999999997 56654433333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=239.74 Aligned_cols=199 Identities=11% Similarity=0.033 Sum_probs=139.3
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccccc--------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDAE-------- 439 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~~-------- 439 (602)
++|...+.||+|+||.||+|+.. +++.||||++...........+.+.+|+.++..+.|+++..++.....
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999875 589999999986654434456778889988866655555443321100
Q ss_pred ------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcc
Q 047576 440 ------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT 507 (602)
Q Consensus 440 ------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~ 507 (602)
.......++.+|+.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 001244568889999999999999 7899999999999999999999997543
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILL 587 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 587 (602)
|++| ++.++|||||||++|||+||+.||............ ...+....+.+ ..........
T Consensus 175 -------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~ 235 (286)
T 3uqc_A 175 -------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDTAGQPIEP-ADIDRDIPFQ 235 (286)
T ss_dssp -------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CBCTTSCBCCH-HHHCTTSCHH
T ss_pred -------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HHHhccCCCCh-hhcccCCCHH
Confidence 3333 588999999999999999999999864332100000 00111111100 0000012234
Q ss_pred HHHHHhhccCcCCCC
Q 047576 588 VSTISFACLQSNPKS 602 (602)
Q Consensus 588 l~~l~~~Cl~~dP~e 602 (602)
+.+++.+||+.||++
T Consensus 236 l~~li~~~l~~dP~~ 250 (286)
T 3uqc_A 236 ISAVAARSVQGDGGI 250 (286)
T ss_dssp HHHHHHHHHCTTSSC
T ss_pred HHHHHHHHcccCCcc
Confidence 789999999999975
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=254.04 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=193.7
Q ss_pred EEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEE
Q 047576 105 IGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYM 177 (602)
Q Consensus 105 ~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L 177 (602)
..++++..++ +.+.....++++.|++. ++.+.+..|..|+++++|++|+|++|+|++ .+++|++|
T Consensus 34 ~~l~ls~~~L------~~ip~~~~~~L~~L~Ls--~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 34 SMVDYSNRNL------THVPKDLPPRTKALSLS--QNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp CEEECTTSCC------CSCCTTSCTTCCEEECC--SSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred cEEEcCCCCC------ccCCCCCCCCcCEEECC--CCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 4566654433 22333344788888887 667777667899999999999999999973 47899999
Q ss_pred ECcCCcCCCCCchhhhCCCCCCEEEecCCCCCC-CCcccccCcCCCceeecccccCCCCcccccCCCCC--cEEEccCCC
Q 047576 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNL--MLLDVGNND 254 (602)
Q Consensus 178 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L--~~L~L~~N~ 254 (602)
+|++|+|+. +|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++. .+..+++| +.|++++|+
T Consensus 106 ~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 106 DVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp ECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESS
T ss_pred ECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeeccc
Confidence 999999994 5555 89999999999999987 4578999999999999999999873 34555666 999999999
Q ss_pred C--CCCCCCccCCCC-----------------------------------------------------------------
Q 047576 255 I--IGPIPSTLGLFS----------------------------------------------------------------- 267 (602)
Q Consensus 255 l--~~~~p~~l~~l~----------------------------------------------------------------- 267 (602)
+ ++..|..+..++
T Consensus 181 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEE
T ss_pred ccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCc
Confidence 9 888777766543
Q ss_pred ----------------CCccccCCCCcCCCCCchhh--------------------------------------------
Q 047576 268 ----------------DLSYLDLSCNQFNSSIPNEL-------------------------------------------- 287 (602)
Q Consensus 268 ----------------~L~~L~L~~N~l~~~~p~~~-------------------------------------------- 287 (602)
+|++|++++|.++|.+|..+
T Consensus 261 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp ECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEES
T ss_pred CcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccC
Confidence 77888888888888887655
Q ss_pred ---------hCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC--CCcccccccccccccccCCcCCCccC
Q 047576 288 ---------TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS--IPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 288 ---------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++. +|..+..+++|+.|++++|++++.+|
T Consensus 341 n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 420 (562)
T 3a79_B 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420 (562)
T ss_dssp SCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCS
T ss_pred CCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccC
Confidence 5677888888888888888888888888888888888888863 35668888888888888888888776
Q ss_pred CC
Q 047576 357 YS 358 (602)
Q Consensus 357 ~~ 358 (602)
..
T Consensus 421 ~~ 422 (562)
T 3a79_B 421 DR 422 (562)
T ss_dssp SC
T ss_pred hh
Confidence 54
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=247.62 Aligned_cols=214 Identities=16% Similarity=0.147 Sum_probs=152.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhH-----HHHHhhhhHhHHHHHHhhh----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETE-----ELAFIRSFRNEAQVLSQME---------------- 426 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~il~~l~---------------- 426 (602)
.++|...+.||+|+||.||+|+. +|+.||||++...... .....+.+.+|+.+++.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 7899999998754211 1112245666766665554
Q ss_pred ------------------------------------------------cCccccccccccchhhhcHHHHHHHHHHHHHH
Q 047576 427 ------------------------------------------------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHA 458 (602)
Q Consensus 427 ------------------------------------------------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 458 (602)
+|++.+.+. ...+++.+++.|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 222222221 2347899999999999999
Q ss_pred HHHhhhcCCCCeEEeCCCCCCeeeCCCC--------------------cceeecccccccccCCCCCccccccccccccc
Q 047576 459 LAYLHHDCSPSVVHRDISSNNILLNSKL--------------------EAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518 (602)
Q Consensus 459 L~~LH~~~~~~ivH~DLkp~NILld~~~--------------------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aP 518 (602)
|+|||+ +++|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 999992 35899999999999999887 8999999999876532 34799999999
Q ss_pred cccccCcCCccchhHHHHHH-HHHHHcCCCCCCCCcccccCCCcccchhhhhccC-CC-CCCChhhHHHHHHHHHHHhhc
Q 047576 519 ELAYTMVMTEKYDVYSFGVV-TLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR-LP-PPVDRKVIQDILLVSTISFAC 595 (602)
Q Consensus 519 E~~~~~~~~~~~DvwSlGvi-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~-l~-~~~~~~~~~~~~~l~~l~~~C 595 (602)
|++.+.. +.++||||+|++ .+++++|..||....+. ......+++.. .. .+...........+.+++.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL------HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH------HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh------hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 9998776 889999998777 78899999998532110 00011122111 11 111122234556799999999
Q ss_pred cCcCC
Q 047576 596 LQSNP 600 (602)
Q Consensus 596 l~~dP 600 (602)
+++|+
T Consensus 320 L~~ds 324 (336)
T 2vuw_A 320 LNFSS 324 (336)
T ss_dssp GGSSS
T ss_pred hccCC
Confidence 99874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=236.96 Aligned_cols=197 Identities=22% Similarity=0.282 Sum_probs=137.2
Q ss_pred CccccCc-ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 368 PRKIDSK-YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 368 t~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
.++|... +.||+|+||.||+|+. .+++.||+|++.... .+.+|+.++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567666 7899999999999986 478999999986432 233444443
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeec
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVAD 492 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~D 492 (602)
||+++|+|.+++.... ...+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 4455566666655421 235899999999999999999999 789999999999999998 78899999
Q ss_pred ccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
||++.... +..++.++||||+||++|||+||+.||............ ...+....
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ 218 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CCSSCTTC
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HHHHhhcc
Confidence 99886532 134677999999999999999999999753321110000 01111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+. .........+.+++.+||+.||++
T Consensus 219 ~~~~~-~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 219 YEFPN-PEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp CSSCH-HHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred ccCCc-hhcccCCHHHHHHHHHHcccChhh
Confidence 11110 000112345889999999999975
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=253.10 Aligned_cols=227 Identities=24% Similarity=0.313 Sum_probs=124.2
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc----c----------------------cCCCcCEEE
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR----G----------------------RLTNLNYMS 178 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~----~----------------------~l~~L~~L~ 178 (602)
+..+++|+.|++. ++....+|..+..+ +|++|++++|.+. + .+++|++|+
T Consensus 278 ~~~l~~L~~L~l~---~~~l~~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~ 353 (570)
T 2z63_A 278 FNCLTNVSSFSLV---SVTIERVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353 (570)
T ss_dssp TGGGTTCSEEEEE---SCEECSCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEE
T ss_pred hcCcCcccEEEec---CccchhhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEe
Confidence 3444555555543 33344566666666 6666666666654 1 244555555
Q ss_pred CcCCcCCCCC--chhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-c-ccccCCCCCcEEEccCCC
Q 047576 179 LSRNMLGGLL--PQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-P-QEIGNLKNLMLLDVGNND 254 (602)
Q Consensus 179 L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p-~~~~~l~~L~~L~L~~N~ 254 (602)
|++|.+++.. |..+.++++|++|++++|.+++..+. +..+++|++|++++|+++++ | ..+.++++|++|++++|.
T Consensus 354 l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~ 432 (570)
T 2z63_A 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432 (570)
T ss_dssp CCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSC
T ss_pred CcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCc
Confidence 5555555433 44555555555555555555543322 55555555555555555553 2 244555555555555555
Q ss_pred CCCCCCCccCCCCCCccccCCCCcCC-CCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 255 IIGPIPSTLGLFSDLSYLDLSCNQFN-SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 255 l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
+++..|..+..+++|++|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|.
T Consensus 433 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 512 (570)
T 2z63_A 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512 (570)
T ss_dssp CEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHH
Confidence 55555555555555555555555554 34555555555555555555555555555555555555555555555555555
Q ss_pred ccccccccccccccCCcCCCccC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
.+..+++|+.|++++|++++..|
T Consensus 513 ~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 513 IFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTT
T ss_pred HhhcccCCcEEEecCCcccCCCc
Confidence 55555555555555555555544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=253.06 Aligned_cols=219 Identities=26% Similarity=0.276 Sum_probs=190.4
Q ss_pred CCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEE
Q 047576 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 201 (602)
.+++|+.|++. ++.+.+..|..|+.+++|++|+|++|.|+ +.+++|++|+|++|.|++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLS--GNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECC--SSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEee--CCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44578888887 67777777789999999999999999998 468999999999999986543 3899999
Q ss_pred EecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccC-CCCCCccccCCCCcC
Q 047576 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLG-LFSDLSYLDLSCNQF 279 (602)
Q Consensus 202 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l 279 (602)
+|++|.+++..+. .+++|+.|+|++|.++++ |..++++++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999987664 468899999999999994 67889999999999999999998888876 799999999999999
Q ss_pred CCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCC-CccCCC
Q 047576 280 NSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS-GRVPYS 358 (602)
Q Consensus 280 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~ 358 (602)
++..+ +..+++|+.|+|++|.|++. |..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|+++ +.+|..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 97733 44699999999999999975 4459999999999999999995 7888999999999999999998 566544
Q ss_pred C
Q 047576 359 N 359 (602)
Q Consensus 359 ~ 359 (602)
+
T Consensus 258 ~ 258 (487)
T 3oja_A 258 F 258 (487)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-25 Score=237.10 Aligned_cols=193 Identities=26% Similarity=0.316 Sum_probs=87.2
Q ss_pred CCCCCCCCEEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 151 ISALSKLQLLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
++++++|++|+|++|++++ .+++|++|++++|++++. .++.+++|++|++++|+..+.+ .++.+++|++|+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~l~~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCCCCTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred cCCCCcCCEEECCCCcCCeecCCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 4444444444444444432 234444444444444442 1444444444444444333333 244444455555
Q ss_pred cccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 306 (602)
+++|+++++| ++.+++|+.|++++|++++. .++.+++|++|++++|++++ +| ++.+++|+.|++++|++++.
T Consensus 177 ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 177 CSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 5555554444 44444555555555554443 24444455555555555544 23 44444555555555555443
Q ss_pred CCcccCCCC-------CCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCC
Q 047576 307 IPSQIASME-------DLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 307 ~p~~~~~l~-------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
.+..+..+. +|+.|++++|.+.|.+| ++.+++|+.|++++|+..|.+|..
T Consensus 249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~ 305 (457)
T 3bz5_A 249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ 305 (457)
T ss_dssp CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT
T ss_pred CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC
Confidence 333333222 33334444444444333 234445555555555555555443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=229.21 Aligned_cols=235 Identities=28% Similarity=0.418 Sum_probs=196.2
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc------ccCCCcC
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLN 175 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~ 175 (602)
.++..++++...+.. ++ .+..+++|+.|++. ++....+|. +..+++|++|++++|... +.+++|+
T Consensus 88 ~~L~~L~L~~n~i~~---~~--~~~~l~~L~~L~l~---~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~ 158 (347)
T 4fmz_A 88 VKLTNLYIGTNKITD---IS--ALQNLTNLRELYLN---EDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLN 158 (347)
T ss_dssp TTCCEEECCSSCCCC---CG--GGTTCTTCSEEECT---TSCCCCCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCC
T ss_pred CcCCEEEccCCcccC---ch--HHcCCCcCCEEECc---CCcccCchh-hccCCceeEEECCCCCCcccccchhhCCCCc
Confidence 467788886554331 22 36667777777765 344445555 899999999999999544 3578999
Q ss_pred EEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCC
Q 047576 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI 255 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l 255 (602)
+|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++++. +..+++|+.|++++|++
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCcc
Confidence 99999999987654 8999999999999999986443 8889999999999999999766 88899999999999999
Q ss_pred CCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCccc
Q 047576 256 IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335 (602)
Q Consensus 256 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 335 (602)
++..+ +..+++|++|++++|.+++. +.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+
T Consensus 234 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 234 TDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 87655 88999999999999999864 4688999999999999999864 468889999999999999999888999
Q ss_pred ccccccccccccCCcCCCccC
Q 047576 336 TKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 336 ~~l~~L~~L~l~~N~l~g~~p 356 (602)
..+++|+.|++++|++++..|
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG
T ss_pred hccccCCEEEccCCccccccC
Confidence 999999999999999998877
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=241.43 Aligned_cols=216 Identities=25% Similarity=0.287 Sum_probs=187.3
Q ss_pred cCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCC
Q 047576 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212 (602)
Q Consensus 140 ~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 212 (602)
.++....+|..+. ++|++|+|++|+|++ .+++|++|+|++|++++..|..|+++++|++|+|++|++++..
T Consensus 39 ~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 116 (353)
T 2z80_A 39 SSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116 (353)
T ss_dssp CSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCC
T ss_pred CCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCC
Confidence 4455667887665 599999999999873 4789999999999999999999999999999999999999766
Q ss_pred cccccCcCCCceeecccccCCCCcc--cccCCCCCcEEEccCC-CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhC
Q 047576 213 PLTLSRLTSLKILILAQNQLSGLPQ--EIGNLKNLMLLDVGNN-DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289 (602)
Q Consensus 213 p~~l~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 289 (602)
+..++++++|++|++++|+++++|. .+.++++|++|++++| .+++..|..+..+++|++|++++|++++..|..+..
T Consensus 117 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 196 (353)
T 2z80_A 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196 (353)
T ss_dssp HHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhc
Confidence 6669999999999999999999886 7899999999999999 577777888999999999999999999999999999
Q ss_pred CCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC-------------------------------Ccccccc
Q 047576 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI-------------------------------PGEITKL 338 (602)
Q Consensus 290 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-------------------------------p~~~~~l 338 (602)
+++|++|++++|+++...+..+..+++|+.|++++|++++.. |..+..+
T Consensus 197 l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l 276 (353)
T 2z80_A 197 IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQI 276 (353)
T ss_dssp CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTC
T ss_pred cccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcc
Confidence 999999999999997544334556899999999999999753 3345677
Q ss_pred cccccccccCCcCCCccCCC
Q 047576 339 SRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 339 ~~L~~L~l~~N~l~g~~p~~ 358 (602)
++|+.|++++|+++ .+|..
T Consensus 277 ~~L~~L~Ls~N~l~-~i~~~ 295 (353)
T 2z80_A 277 SGLLELEFSRNQLK-SVPDG 295 (353)
T ss_dssp TTCCEEECCSSCCC-CCCTT
T ss_pred cCCCEEECCCCCCC-ccCHH
Confidence 88889999999888 45544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=238.44 Aligned_cols=223 Identities=21% Similarity=0.249 Sum_probs=137.8
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc--cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEE
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG--RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 202 (602)
++.+++|+.|++. ++.+.+..| +..+++|++|+|++|+|++ ..++|++|++++|++++..+.. +++|++|+
T Consensus 54 ~~~l~~L~~L~Ls--~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~ 126 (317)
T 3o53_A 54 LAPFTKLELLNLS--SNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR---GQGKKNIY 126 (317)
T ss_dssp HTTCTTCCEEECT--TSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECC---CSSCEEEE
T ss_pred hhCCCcCCEEECC--CCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccc---cCCCCEEE
Confidence 4555566666554 344444333 6666667777777766663 3566677777777666554432 45667777
Q ss_pred ecCCCCCCCCcccccCcCCCceeecccccCCCC-cccc-cCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCC
Q 047576 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEI-GNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280 (602)
Q Consensus 203 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 280 (602)
|++|++++..|..++.+++|++|+|++|+++++ |..+ ..+++|++|+|++|.+++. |. ...+++|++|+|++|+++
T Consensus 127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC
Confidence 777776666666666667777777777776663 3444 3566677777777766644 22 223666777777777766
Q ss_pred CCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCC-CCCCccccccccccccccc-CCcCCCccCCC
Q 047576 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK-GSIPGEITKLSRLDYLNLS-GNKLSGRVPYS 358 (602)
Q Consensus 281 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~-~N~l~g~~p~~ 358 (602)
+..+ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 205 ~l~~-~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 205 FMGP-EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp EECG-GGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred cchh-hhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 4433 4666667777777777766 35666666667777777777766 5566666666666666666 33555555544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-25 Score=236.99 Aligned_cols=230 Identities=24% Similarity=0.275 Sum_probs=188.7
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc----cCCCcCEE
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG----RLTNLNYM 177 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~----~l~~L~~L 177 (602)
.+++.++++...+. + ++ .++.+++|+.|++. .+.+.+ +| ++.+++|++|+|++|+|++ .+++|++|
T Consensus 42 ~~L~~L~Ls~n~l~--~-~~--~l~~l~~L~~L~Ls--~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L 111 (457)
T 3bz5_A 42 ATLTSLDCHNSSIT--D-MT--GIEKLTGLTKLICT--SNNITT-LD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYL 111 (457)
T ss_dssp TTCCEEECCSSCCC--C-CT--TGGGCTTCSEEECC--SSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEE
T ss_pred CCCCEEEccCCCcc--c-Ch--hhcccCCCCEEEcc--CCcCCe-Ec--cccCCCCCEEECcCCCCceeecCCCCcCCEE
Confidence 46788888765443 2 22 46777888888776 455555 44 8999999999999999884 58899999
Q ss_pred ECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCC
Q 047576 178 SLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 178 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
+|++|++++. | ++.+++|++|++++|++++. + ++++++|++|++++|+..+ + .++.+++|+.|++++|+++
T Consensus 112 ~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 112 NCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp ECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence 9999999975 3 88999999999999999874 3 8889999999999995554 6 4788899999999999999
Q ss_pred CCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccc
Q 047576 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEIT 336 (602)
Q Consensus 257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 336 (602)
+ +| ++.+++|+.|++++|++++. .++.+++|+.|+|++|++++ +| +..+++|+.|++++|++++..+..+.
T Consensus 184 ~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~ 254 (457)
T 3bz5_A 184 E-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLS 254 (457)
T ss_dssp C-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCT
T ss_pred e-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCC
Confidence 7 45 78889999999999999875 38889999999999999997 56 88899999999999999987776666
Q ss_pred ccc-------ccccccccCCcCCCccCCC
Q 047576 337 KLS-------RLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 337 ~l~-------~L~~L~l~~N~l~g~~p~~ 358 (602)
.+. +|+.|++++|++.|.+|..
T Consensus 255 ~L~~L~l~~n~L~~L~l~~n~~~~~~~~~ 283 (457)
T 3bz5_A 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAE 283 (457)
T ss_dssp TCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred CCCEEeccCCCCCEEECCCCccCCccccc
Confidence 665 5678888888888888743
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-24 Score=226.09 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=201.9
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-----cCCCcCE
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-----RLTNLNY 176 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-----~l~~L~~ 176 (602)
.++..++++...+. .++. +..+++|+.|++. ++. ...+| .+.++++|++|+|++|++.+ .+++|++
T Consensus 66 ~~L~~L~l~~n~i~---~~~~--~~~l~~L~~L~L~--~n~-i~~~~-~~~~l~~L~~L~l~~n~i~~~~~~~~l~~L~~ 136 (347)
T 4fmz_A 66 TNLEYLNLNGNQIT---DISP--LSNLVKLTNLYIG--TNK-ITDIS-ALQNLTNLRELYLNEDNISDISPLANLTKMYS 136 (347)
T ss_dssp TTCCEEECCSSCCC---CCGG--GTTCTTCCEEECC--SSC-CCCCG-GGTTCTTCSEEECTTSCCCCCGGGTTCTTCCE
T ss_pred CCccEEEccCCccc---cchh--hhcCCcCCEEEcc--CCc-ccCch-HHcCCCcCCEEECcCCcccCchhhccCCceeE
Confidence 46788888765433 2222 6777788887775 344 44454 69999999999999999974 5899999
Q ss_pred EECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCC
Q 047576 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 177 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++++++. +..+++|+.|++++|.++
T Consensus 137 L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 212 (347)
T 4fmz_A 137 LNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQIT 212 (347)
T ss_dssp EECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCC
T ss_pred EECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc-ccCCCccceeecccCCCC
Confidence 9999997665554 49999999999999999986544 8899999999999999999876 889999999999999999
Q ss_pred CCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccc
Q 047576 257 GPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEIT 336 (602)
Q Consensus 257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 336 (602)
+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+.
T Consensus 213 ~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~ 284 (347)
T 4fmz_A 213 DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLN 284 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGG
T ss_pred CCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhc
Confidence 7655 7889999999999999986544 89999999999999999864 4689999999999999999975 4688
Q ss_pred cccccccccccCCcCCCccCCCCCcCC
Q 047576 337 KLSRLDYLNLSGNKLSGRVPYSNKHLS 363 (602)
Q Consensus 337 ~l~~L~~L~l~~N~l~g~~p~~~~~l~ 363 (602)
.+++|+.|++++|++++..|..+..+.
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~ 311 (347)
T 4fmz_A 285 NLSQLNSLFLNNNQLGNEDMEVIGGLT 311 (347)
T ss_dssp GCTTCSEEECCSSCCCGGGHHHHHTCT
T ss_pred CCCCCCEEECcCCcCCCcChhHhhccc
Confidence 999999999999999988876554333
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-25 Score=222.17 Aligned_cols=201 Identities=25% Similarity=0.306 Sum_probs=178.5
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEE
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 201 (602)
++++.|++. ++++.+..+..|+++++|++|+|++|++++ .+++|++|+|++|.+++..+..|.++++|++|
T Consensus 28 ~~l~~L~ls--~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (276)
T 2z62_A 28 FSTKNLDLS--FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (276)
T ss_dssp TTCCEEECT--TCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CCccEEECC--CCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEE
Confidence 467888776 566666666689999999999999999873 47899999999999999999999999999999
Q ss_pred EecCCCCCCCCcccccCcCCCceeecccccCCC--CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCc----cccCC
Q 047576 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG--LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS----YLDLS 275 (602)
Q Consensus 202 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~ 275 (602)
++++|++++..+..++++++|++|++++|++++ +|..++++++|+.|++++|++++..+..+..+++|+ .|+++
T Consensus 106 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls 185 (276)
T 2z62_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (276)
T ss_dssp ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECC
T ss_pred ECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecC
Confidence 999999998888789999999999999999998 689999999999999999999988888888777777 89999
Q ss_pred CCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
+|.+++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|++++|.+++..|
T Consensus 186 ~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 186 LNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp SSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 9999977665554 4589999999999998777778999999999999999997543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=224.64 Aligned_cols=203 Identities=27% Similarity=0.311 Sum_probs=177.8
Q ss_pred CCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEE
Q 047576 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202 (602)
Q Consensus 128 l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 202 (602)
+++|+.|.+. ++....++ .++.+++|++|+|++|++.+ .+++|++|+|++|.+++..+..|+++++|++|+
T Consensus 40 l~~L~~L~l~---~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 40 LNSIDQIIAN---NSDIKSVQ-GIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HTTCCEEECT---TSCCCCCT-TGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccceeeeeeC---CCCccccc-ccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 4444555443 33333343 58889999999999999974 588999999999999999888999999999999
Q ss_pred ecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCC
Q 047576 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281 (602)
Q Consensus 203 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 281 (602)
|++|++++..|..++++++|++|++++|+++++|. .++++++|+.|++++|++++..+..+..+++|++|++++|++++
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 99999998888889999999999999999999765 56899999999999999998888889999999999999999999
Q ss_pred CCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCccccccccc
Q 047576 282 SIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRL 341 (602)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 341 (602)
..|..+..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+|..++.++..
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred cCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 8888899999999999999998865 4578999999999999999998877653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=217.98 Aligned_cols=158 Identities=27% Similarity=0.289 Sum_probs=133.0
Q ss_pred CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCc-ccccCCCCCcEEEcc
Q 047576 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVG 251 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~ 251 (602)
+|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|+++++| ..+.++++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 4566666777777777888889999999999999998888888888999999999999998865 456888899999999
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+++.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9998877777788888888888888888877777788888888888888888877777888888888888888888865
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=243.51 Aligned_cols=128 Identities=25% Similarity=0.325 Sum_probs=114.8
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEE
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIEL 201 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 201 (602)
++++.|++. +|++.+..|..|.++++|++|||++|+|++ .+++|++|+|++|+|++..+..|.++++|++|
T Consensus 52 ~~~~~LdLs--~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L 129 (635)
T 4g8a_A 52 FSTKNLDLS--FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 129 (635)
T ss_dssp TTCCEEECT--TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEE
T ss_pred cCCCEEEee--CCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEE
Confidence 467888887 666666666789999999999999999973 48999999999999999988999999999999
Q ss_pred EecCCCCCCCCcccccCcCCCceeecccccCCC--CcccccCCCCCcEEEccCCCCCCC
Q 047576 202 DVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG--LPQEIGNLKNLMLLDVGNNDIIGP 258 (602)
Q Consensus 202 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~ 258 (602)
+|++|++++..+..|+++++|++|+|++|++++ +|..++++++|++|++++|++++.
T Consensus 130 ~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 130 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred ECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence 999999998888889999999999999999987 578889999999999999987643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=233.24 Aligned_cols=220 Identities=25% Similarity=0.280 Sum_probs=183.1
Q ss_pred CCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCE
Q 047576 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200 (602)
Q Consensus 126 ~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 200 (602)
..+++|+.|++. ++.+.+..|..|+++++|++|+|++|+++ +.+++|++|+|++|++++.. ..++|++
T Consensus 31 ~~~~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~ 103 (317)
T 3o53_A 31 QSAWNVKELDLS--GNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (317)
T ss_dssp TTGGGCSEEECT--TSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCCCEEECc--CCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence 345677777776 56667766778999999999999999997 45899999999999998543 3489999
Q ss_pred EEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCcc-CCCCCCccccCCCCc
Q 047576 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTL-GLFSDLSYLDLSCNQ 278 (602)
Q Consensus 201 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~ 278 (602)
|++++|++++..+.. +++|++|++++|+++++ |..++.+++|++|++++|.+++..|..+ ..+++|++|+|++|.
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 999999998765543 67899999999999996 4578889999999999999998777766 478999999999999
Q ss_pred CCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCC-CccCC
Q 047576 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS-GRVPY 357 (602)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-g~~p~ 357 (602)
+++. | ....+++|++|+|++|+|++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++ +.+|.
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred Cccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 9866 3 33458899999999999996 4556889999999999999999 57888999999999999999998 55554
Q ss_pred CC
Q 047576 358 SN 359 (602)
Q Consensus 358 ~~ 359 (602)
.+
T Consensus 257 ~~ 258 (317)
T 3o53_A 257 FF 258 (317)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=247.57 Aligned_cols=184 Identities=21% Similarity=0.229 Sum_probs=152.2
Q ss_pred cccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhh
Q 047576 120 LSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEI 192 (602)
Q Consensus 120 l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~ 192 (602)
++.+.-+.+++|+.|++. ++++.+..|..|+++++|++|+|++|+|++ .+++|++|+|++|++++..|..|
T Consensus 17 l~~ip~~~~~~L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 94 (549)
T 2z81_A 17 FTSIPSGLTAAMKSLDLS--FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWF 94 (549)
T ss_dssp CSSCCSCCCTTCCEEECC--SSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHH
T ss_pred cccccccCCCCccEEECc--CCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHh
Confidence 444444555788999887 677777788899999999999999999973 47899999999999999999899
Q ss_pred hCCCCCCEEEecCCCCCC-CCcccccCcCCCceeecccccC-CCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCC
Q 047576 193 GNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQL-SGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269 (602)
Q Consensus 193 ~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l-~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 269 (602)
+++++|++|+|++|++++ ..|..++++++|++|++++|++ +.+| ..+.++++|++|++++|++++.+|..++.+++|
T Consensus 95 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 174 (549)
T 2z81_A 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174 (549)
T ss_dssp TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred ccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccC
Confidence 999999999999999987 4678899999999999999994 4576 579999999999999999999999999887777
Q ss_pred ccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 270 SYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 270 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
+.|++++|.++...+..+..+++|++|++++|++++
T Consensus 175 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp EEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred ceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence 777777777653222223456677777777776665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=234.29 Aligned_cols=193 Identities=33% Similarity=0.485 Sum_probs=103.0
Q ss_pred CCCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 151 ISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
++++++|++|++++|++.+ .+++|++|++++|.+++..| ++.+++|++|++++|++++. ..+..+++|+.|
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 248 (466)
T 1o6v_A 173 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL 248 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred hccCCCCCEEECcCCcCCCChhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEE
Confidence 6666666666666666552 35566666666666655443 55555555555555555542 235555555555
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
++++|++++++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..| +..+++|+.|+|++|++++
T Consensus 249 ~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 249 DLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp ECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred ECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 555555555443 4555555555555555554333 4455555555555555554322 4455555555555555554
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|
T Consensus 324 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 324 ISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred chh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 433 44455555555555555543 234455555555555555555444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=233.72 Aligned_cols=190 Identities=31% Similarity=0.500 Sum_probs=87.4
Q ss_pred CCCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 151 ISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+..+++|++|++++|++.+ .+++|++|++++|++++. +.+..+++|++|++++|.+++..| +..+++|+.|
T Consensus 195 l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 270 (466)
T 1o6v_A 195 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270 (466)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred hccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEE
Confidence 4444444444444444432 244444444444444432 234444444444444444443332 4444444444
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
++++|+++++|. +..+++|+.|++++|++++..| +..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 271 ~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 271 KLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp ECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 444444444433 4444444444444444444322 3444444444444444444333 3444444444444444443
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 346 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 346 V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred c--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 2 234444444444444444444433 4444444444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-24 Score=219.78 Aligned_cols=194 Identities=21% Similarity=0.267 Sum_probs=133.9
Q ss_pred CCCEEECcCCcCcc----------cCCCcCEEECcCCcCCCCCchhh--hCCCCCCEEEecCCCCCCCCc----ccccCc
Q 047576 156 KLQLLDLSSNRLRG----------RLTNLNYMSLSRNMLGGLLPQEI--GNLKNLIELDVGDNSLIGPIP----LTLSRL 219 (602)
Q Consensus 156 ~L~~L~Ls~N~i~~----------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~l~~l 219 (602)
.++.|.+.++.+.. .+++|++|+|++|.+++..|..+ +.+++|++|+|++|++++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 46677777776652 14567777777777777777776 777777777777777776555 334567
Q ss_pred CCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCC--C--CCccCCCCCCccccCCCCcCCCCCch----hhhCC
Q 047576 220 TSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGP--I--PSTLGLFSDLSYLDLSCNQFNSSIPN----ELTRL 290 (602)
Q Consensus 220 ~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l 290 (602)
++|++|+|++|+++++ |..++++++|++|+|++|++.+. + +..+..+++|++|+|++|+++. +|. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 7777777777777774 45677777777777777776642 2 2234567777777777777763 222 24667
Q ss_pred CCCCEEeccCCCCCCCCCcccCCC---CCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 291 TQLFHLDLSSNKLSGKIPSQIASM---EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 291 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
++|++|+|++|+|++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|++++|++++
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR 286 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC
Confidence 777777777777777666666655 57777777777777 5566553 677777777777776
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=240.09 Aligned_cols=244 Identities=25% Similarity=0.270 Sum_probs=137.5
Q ss_pred CCCCCCCCCceeC-------CCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCE
Q 047576 87 DSDHCEWIGITCN-------SAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQL 159 (602)
Q Consensus 87 ~~~~C~w~gv~C~-------~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~ 159 (602)
+.+||.|.|..|. ....++.++++..++. .+ .-...++|+.|++. ++ ....+|. .+++|++
T Consensus 18 ~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~---~l---p~~l~~~L~~L~L~--~N-~l~~lp~---~l~~L~~ 85 (622)
T 3g06_A 18 AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT---TL---PDCLPAHITTLVIP--DN-NLTSLPA---LPPELRT 85 (622)
T ss_dssp TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS---CC---CSCCCTTCSEEEEC--SC-CCSCCCC---CCTTCCE
T ss_pred cCCcchhccccccCcccccccCCCCcEEEecCCCcC---cc---ChhhCCCCcEEEec--CC-CCCCCCC---cCCCCCE
Confidence 4578999764331 1134677788655443 22 11222445555443 22 2234444 3455555
Q ss_pred EECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCc
Q 047576 160 LDLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP 236 (602)
Q Consensus 160 L~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip 236 (602)
|+|++|+|++ .+++|++|+|++|.|++..+ .+++|+.|+|++|+|++ +|.. +++|++|+|++|+++++|
T Consensus 86 L~Ls~N~l~~lp~~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~ 157 (622)
T 3g06_A 86 LEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLP 157 (622)
T ss_dssp EEECSCCCSCCCCCCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCC
T ss_pred EEcCCCcCCcCCCCCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcC
Confidence 5555555542 34455555555555554221 23334444444444332 2221 133333333333333322
Q ss_pred ccc-----------------cCCCCCcEEEccCCCCCCCCCCccC-----------------CCCCCccccCCCCcCCCC
Q 047576 237 QEI-----------------GNLKNLMLLDVGNNDIIGPIPSTLG-----------------LFSDLSYLDLSCNQFNSS 282 (602)
Q Consensus 237 ~~~-----------------~~l~~L~~L~L~~N~l~~~~p~~l~-----------------~l~~L~~L~L~~N~l~~~ 282 (602)
..+ ..+++|+.|++++|++++ +|..+. .+++|++|+|++|+|++
T Consensus 158 ~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~- 235 (622)
T 3g06_A 158 ALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS- 235 (622)
T ss_dssp CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-
T ss_pred CccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-
Confidence 211 112455555555555553 221111 12678888888888875
Q ss_pred CchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCC
Q 047576 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
+| ..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++|.+|..+.
T Consensus 236 lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 236 LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 44 456788888999988884 555 5688999999999998 7788899999999999999999988876543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-24 Score=210.49 Aligned_cols=181 Identities=25% Similarity=0.298 Sum_probs=162.9
Q ss_pred CcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEcc
Q 047576 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVG 251 (602)
Q Consensus 173 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~ 251 (602)
+.++++++++.++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+++++ |..+.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3456777777777 4455444 6899999999999999999999999999999999999995 4568999999999999
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 99999888889999999999999999999888878899999999999999999887778999999999999999999888
Q ss_pred CcccccccccccccccCCcCCCccC
Q 047576 332 PGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 332 p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+..+..+++|+.|++++|++++...
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTST
T ss_pred HHHHhCCCCCCEEEeeCCceeCCcc
Confidence 8899999999999999999988643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=219.55 Aligned_cols=189 Identities=28% Similarity=0.422 Sum_probs=144.0
Q ss_pred CCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 152 SALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
..+++|++|++++|.+.. .+++|++|+|++|.+++..+ +..+++|++|+|++|++++. | .+..+++|++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~ 113 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLD 113 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEE
T ss_pred HHcCCcCEEEeeCCCccCchhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEE
Confidence 356677777777777662 46778888888888876544 78888888888888887753 3 577888888888
Q ss_pred cccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 306 (602)
+++|+++++|. +..+++|+.|++++|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++.
T Consensus 114 l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 114 LTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence 88888888765 7788888888888888876544 7778888888888888875433 77888888888888888764
Q ss_pred CCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 307 IPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 307 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
.+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 189 ~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred hh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 43 7778888888888888886543 7778888888888888876
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=212.92 Aligned_cols=189 Identities=21% Similarity=0.232 Sum_probs=146.8
Q ss_pred CCCEEECcCCcCcc-------cCCCcCEEECcCCc-CCCCCchhhhCCCCCCEEEecC-CCCCCCCcccccCcCCCceee
Q 047576 156 KLQLLDLSSNRLRG-------RLTNLNYMSLSRNM-LGGLLPQEIGNLKNLIELDVGD-NSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 156 ~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 226 (602)
+|++|+|++|+|++ .+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777762 36677777777776 7777777888888888888888 888877777888888888888
Q ss_pred cccccCCCCcccccCCCCCc---EEEccCC-CCCCCCCCccCCCCCCc-cccCCCCcCCCCCchhhhCCCCCCEEeccCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLM---LLDVGNN-DIIGPIPSTLGLFSDLS-YLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 301 (602)
+++|+++++|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++...+..+.. ++|+.|+|++|
T Consensus 112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 88888888886 77777887 8888888 88877777788888888 8888888888433334444 78888888888
Q ss_pred C-CCCCCCcccCCC-CCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 302 K-LSGKIPSQIASM-EDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 302 ~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 5 886666778888 8888888888888854333 5667777777765
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=225.80 Aligned_cols=212 Identities=30% Similarity=0.425 Sum_probs=140.4
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecC
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 205 (602)
++|+.|++. ++.+. .+| +++++++|++|++++|++++ ...+|++|++++|++++ +| .++++++|++|++++
T Consensus 131 ~~L~~L~L~--~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVS--NNQLE-KLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECC--SSCCS-SCC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEECc--CCCCC-CCc-ccCCCCCCCEEECCCCcCcccCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 466666665 44444 478 69999999999999999875 35688999999999887 45 588888888888888
Q ss_pred CCCCCCCcc-------------------cccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCC
Q 047576 206 NSLIGPIPL-------------------TLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF 266 (602)
Q Consensus 206 N~l~~~~p~-------------------~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 266 (602)
|++++ +|. .++.+++|++|++++|+++++|.. +++|+.|++++|++++ +|.. +
T Consensus 205 N~l~~-l~~~~~~L~~L~l~~n~l~~lp~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---~ 276 (454)
T 1jl5_A 205 NSLKK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---P 276 (454)
T ss_dssp SCCSS-CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---C
T ss_pred CcCCc-CCCCcCcccEEECcCCcCCcccccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---c
Confidence 87775 332 234444445555555544444432 1344444444444443 2322 2
Q ss_pred CCCccccCCCCcCCC--CCchhhh-------------CC-CCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 267 SDLSYLDLSCNQFNS--SIPNELT-------------RL-TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 267 ~~L~~L~L~~N~l~~--~~p~~~~-------------~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
++|++|++++|.+++ .+|..+. .+ ++|+.|++++|++++ +|.. +++|+.|++++|++++
T Consensus 277 ~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~- 351 (454)
T 1jl5_A 277 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE- 351 (454)
T ss_dssp TTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-
T ss_pred CcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-
Confidence 567777777777776 3333222 22 478888888888886 5543 5788888888888884
Q ss_pred CCcccccccccccccccCCcCCC--ccCCCCCcC
Q 047576 331 IPGEITKLSRLDYLNLSGNKLSG--RVPYSNKHL 362 (602)
Q Consensus 331 ~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l 362 (602)
+|. .+++|+.|++++|+++| .+|..+..+
T Consensus 352 lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 352 VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred ccc---hhhhccEEECCCCCCCcCCCChHHHHhh
Confidence 555 46788888888888888 777766443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=222.81 Aligned_cols=195 Identities=22% Similarity=0.191 Sum_probs=162.4
Q ss_pred CCCCCCEEECcCCcCc---------ccCCCcCEEECcCCcCCCCCc----hhhhCCCCCCEEEecCCCCCCCCcccccCc
Q 047576 153 ALSKLQLLDLSSNRLR---------GRLTNLNYMSLSRNMLGGLLP----QEIGNLKNLIELDVGDNSLIGPIPLTLSRL 219 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~---------~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 219 (602)
.+++|++|+|++|++. +.+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..++++
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 3567999999999887 336789999999999998665 455678999999999999998888899999
Q ss_pred CCCceeecccccCCC---Ccc--cccCCCCCcEEEccCCCCCCCCCC----ccCCCCCCccccCCCCcCCCCCchhhhCC
Q 047576 220 TSLKILILAQNQLSG---LPQ--EIGNLKNLMLLDVGNNDIIGPIPS----TLGLFSDLSYLDLSCNQFNSSIPNELTRL 290 (602)
Q Consensus 220 ~~L~~L~L~~N~l~~---ip~--~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 290 (602)
++|++|+|++|++.+ ++. .++++++|++|+|++|+++. +|. .++.+++|++|+|++|++++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999999876 433 34688999999999999973 232 24678999999999999998888777777
Q ss_pred ---CCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 291 ---TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 291 ---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|+++.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 6777664 7999999999999964 33 6788999999999999875
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-23 Score=211.87 Aligned_cols=196 Identities=26% Similarity=0.275 Sum_probs=167.4
Q ss_pred CCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCC
Q 047576 126 SCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198 (602)
Q Consensus 126 ~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 198 (602)
+.+++++.++.. ++-...+|..+. ++|++|+|++|+|++ .+++|++|+|++|.|++..+. +.+++|
T Consensus 7 ~~l~~l~~l~~~---~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 7 SKVASHLEVNCD---KRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp ECSTTCCEEECT---TSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccCCccEEECC---CCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 444555555443 344456777664 689999999999873 478999999999999876443 889999
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
++|+|++|+++ .+|..+.++++|++|+|++|+++++| ..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 67888999999999999999999976 57899999999999999999888888899999999999999
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+...
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 999877777889999999999999999 6788888889999999999999753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=228.49 Aligned_cols=225 Identities=23% Similarity=0.277 Sum_probs=150.7
Q ss_pred CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCC-------------CEEECcCCcCc
Q 047576 102 GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKL-------------QLLDLSSNRLR 168 (602)
Q Consensus 102 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L-------------~~L~Ls~N~i~ 168 (602)
.++..+.++..++ |.++. .++.+++|+.|++. .+.+.|.+|..++++++| ++|++++|+++
T Consensus 11 ~~L~~L~l~~n~l---~~iP~-~i~~L~~L~~L~l~--~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~ 84 (454)
T 1jl5_A 11 TFLQEPLRHSSNL---TEMPV-EAENVKSKTEYYNA--WSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84 (454)
T ss_dssp ---------------------------CCHHHHHHH--HHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS
T ss_pred ccchhhhcccCch---hhCCh-hHhcccchhhhhcc--CCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc
Confidence 3456666655433 56654 47888888888887 677889999999998875 99999999988
Q ss_pred c---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCC
Q 047576 169 G---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNL 245 (602)
Q Consensus 169 ~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L 245 (602)
+ ..++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+++++| .++++++|
T Consensus 85 ~lp~~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~lp-~~~~l~~L 155 (454)
T 1jl5_A 85 SLPELPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKLP-ELQNSSFL 155 (454)
T ss_dssp CCCSCCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSCC-CCTTCTTC
T ss_pred cCCCCcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCCCc-ccCCCCCC
Confidence 6 35789999999999987 5543 3778888888888775 2321 167888888888888877 47778888
Q ss_pred cEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCC
Q 047576 246 MLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325 (602)
Q Consensus 246 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 325 (602)
++|++++|++++ +|..+ ++|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|+.|++++|
T Consensus 156 ~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n 225 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNN 225 (454)
T ss_dssp CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSS
T ss_pred CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCC
Confidence 888888888775 55433 477788888888776 45 57777778888888887775 44322 46777777777
Q ss_pred CCCCCCCcccccccccccccccCCcCCC
Q 047576 326 NIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 326 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
+++ .+| .+..+++|+.|++++|++++
T Consensus 226 ~l~-~lp-~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 226 ILE-ELP-ELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CCS-SCC-CCTTCTTCCEEECCSSCCSS
T ss_pred cCC-ccc-ccCCCCCCCEEECCCCcCCc
Confidence 777 555 36777777777777777765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=206.32 Aligned_cols=184 Identities=29% Similarity=0.335 Sum_probs=162.6
Q ss_pred cCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCccc-ccCCCCCcEEEccC
Q 047576 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGN 252 (602)
Q Consensus 174 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~ 252 (602)
.+++++++|.++. +|..+. ++|++|+|++|++++..+..|.++++|++|++++|+++++|.. +.++++|++|++++
T Consensus 18 ~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 3456666666663 455443 6899999999999988888999999999999999999998765 58899999999999
Q ss_pred CCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 253 NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 253 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 99998888889999999999999999999888889999999999999999998777779999999999999999998888
Q ss_pred cccccccccccccccCCcCCCccCCCCC
Q 047576 333 GEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 333 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
..+..+++|+.|++++|++++..+..+.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 202 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFD 202 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhc
Confidence 8899999999999999999976554443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-26 Score=238.96 Aligned_cols=230 Identities=21% Similarity=0.257 Sum_probs=190.0
Q ss_pred CCCCCCCccchhccccCCcccc----CCccCCCCCCCCEEECcCCcCc-----------------ccCCCcCEEECcCCc
Q 047576 125 FSCFPNLESLRILAYYDGFTGS----IPSEISALSKLQLLDLSSNRLR-----------------GRLTNLNYMSLSRNM 183 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~----ip~~l~~L~~L~~L~Ls~N~i~-----------------~~l~~L~~L~L~~N~ 183 (602)
+..+++|+.|++. ++.+.+. ++..+..+++|++|+|++|.+. ..+++|++|+|++|.
T Consensus 28 l~~~~~L~~L~L~--~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 28 LLEDDSVKEIVLS--GNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHCSCCCEEECT--TSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HhcCCCccEEECC--CCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3445667777776 4555544 4456889999999999997543 357899999999999
Q ss_pred CCC----CCchhhhCCCCCCEEEecCCCCCCCCccccc----Cc---------CCCceeecccccCCC--Cc---ccccC
Q 047576 184 LGG----LLPQEIGNLKNLIELDVGDNSLIGPIPLTLS----RL---------TSLKILILAQNQLSG--LP---QEIGN 241 (602)
Q Consensus 184 l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~L~~N~l~~--ip---~~~~~ 241 (602)
+++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++. +| ..+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 998 5788999999999999999999755444443 34 899999999999983 66 56788
Q ss_pred CCCCcEEEccCCCCC--C---CCCCccCCCCCCccccCCCCcCC----CCCchhhhCCCCCCEEeccCCCCCCC----CC
Q 047576 242 LKNLMLLDVGNNDII--G---PIPSTLGLFSDLSYLDLSCNQFN----SSIPNELTRLTQLFHLDLSSNKLSGK----IP 308 (602)
Q Consensus 242 l~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 308 (602)
+++|+.|+|++|+++ | .+|..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|+|++. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 999999999999998 3 45557889999999999999997 66788899999999999999999876 55
Q ss_pred ccc--CCCCCCCEEeCCCCCCCC----CCCccc-ccccccccccccCCcCCCccC
Q 047576 309 SQI--ASMEDLTWLDLSNNNIKG----SIPGEI-TKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 309 ~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~g~~p 356 (602)
..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..|
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 666 448999999999999997 477777 668999999999999998765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-25 Score=231.25 Aligned_cols=257 Identities=16% Similarity=0.185 Sum_probs=205.3
Q ss_pred CCCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCC--CCCccchhccccCCccccCCccCCCCCCCCEEECcCCc
Q 047576 89 DHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCF--PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR 166 (602)
Q Consensus 89 ~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l--~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~ 166 (602)
-|..|.++.|++ ..++.++++...+. .-.+..+ ++++.|++. .+.+.+. ++.+.++++|++|+|++|.
T Consensus 35 vc~~W~~~~~~~-~~~~~l~l~~~~~~------~~~~~~~~~~~l~~L~l~--~n~l~~~-~~~~~~~~~L~~L~L~~~~ 104 (336)
T 2ast_B 35 VCKRWYRLASDE-SLWQTLDLTGKNLH------PDVTGRLLSQGVIAFRCP--RSFMDQP-LAEHFSPFRVQHMDLSNSV 104 (336)
T ss_dssp SCHHHHHHHTCS-TTSSEEECTTCBCC------HHHHHHHHHTTCSEEECT--TCEECSC-CCSCCCCBCCCEEECTTCE
T ss_pred HHHHHHHHhcCc-hhheeeccccccCC------HHHHHhhhhccceEEEcC--Ccccccc-chhhccCCCCCEEEccCCC
Confidence 344799988863 45677888654322 2223444 667777765 4444444 4457789999999999999
Q ss_pred Ccc--------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCC-CCCCC-CcccccCcCCCceeecccc-cCCC-
Q 047576 167 LRG--------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDN-SLIGP-IPLTLSRLTSLKILILAQN-QLSG- 234 (602)
Q Consensus 167 i~~--------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~- 234 (602)
+.+ .+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. +|..+.++++|++|++++| .+++
T Consensus 105 l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 105 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 184 (336)
T ss_dssp ECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred cCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence 873 4899999999999999999999999999999999999 67763 6777889999999999999 9997
Q ss_pred -CcccccCCC-CCcEEEccCC--CCC-CCCCCccCCCCCCccccCCCCc-CCCCCchhhhCCCCCCEEeccCCC-CCCCC
Q 047576 235 -LPQEIGNLK-NLMLLDVGNN--DII-GPIPSTLGLFSDLSYLDLSCNQ-FNSSIPNELTRLTQLFHLDLSSNK-LSGKI 307 (602)
Q Consensus 235 -ip~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~ 307 (602)
++..+..++ +|++|++++| .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|+|++|. +....
T Consensus 185 ~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~ 264 (336)
T 2ast_B 185 HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 264 (336)
T ss_dssp HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG
T ss_pred HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHH
Confidence 788889999 9999999999 566 4567778889999999999999 787888899999999999999996 33222
Q ss_pred CcccCCCCCCCEEeCCCCCCCCCCCccccccc-ccccccccCCcCCCccCCCC
Q 047576 308 PSQIASMEDLTWLDLSNNNIKGSIPGEITKLS-RLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 308 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~ 359 (602)
...++.+++|+.|++++| ++. ..+..+. .|..|++++|+++|..|...
T Consensus 265 ~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 265 LLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred HHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcc
Confidence 236888999999999999 443 2444443 47888899999999998765
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=212.88 Aligned_cols=188 Identities=26% Similarity=0.405 Sum_probs=158.7
Q ss_pred CCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEE
Q 047576 128 FPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202 (602)
Q Consensus 128 l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 202 (602)
+++|+.|++. ++....+| .+..+++|++|+|++|++. +.+++|++|+|++|++++. +.+..+++|++|+
T Consensus 40 l~~L~~L~l~---~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAF---GTGVTTIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECT---TSCCCCCT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEEee---CCCccCch-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence 4445555543 23333455 5888999999999999987 3578999999999999875 4799999999999
Q ss_pred ecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCC
Q 047576 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282 (602)
Q Consensus 203 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 282 (602)
|++|++++. |. +..+++|++|++++|++++++. ++.+++|+.|++++|++++..+ +..+++|+.|++++|.+++.
T Consensus 114 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 114 LTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp CTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence 999999874 43 8999999999999999999876 8899999999999999997544 88999999999999999865
Q ss_pred CchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
.+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++.
T Consensus 189 ~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred hh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 44 889999999999999999755 389999999999999999863
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=233.64 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=156.0
Q ss_pred CCCCC-----CCCCc-eeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEE
Q 047576 87 DSDHC-----EWIGI-TCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLL 160 (602)
Q Consensus 87 ~~~~C-----~w~gv-~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L 160 (602)
+.++| .|.|+ .|.. ++++.|+++ ++++.+ +|..+. ++|++|
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls-----------------------------~n~L~~-lp~~l~--~~L~~L 85 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLI-NQFSELQLN-----------------------------RLNLSS-LPDNLP--PQITVL 85 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHH-TTCSEEECC-----------------------------SSCCSC-CCSCCC--TTCSEE
T ss_pred cCCccccccchhhhcccccc-CCccEEEeC-----------------------------CCCCCc-cCHhHc--CCCCEE
Confidence 35677 69999 7863 467777774 233333 666553 789999
Q ss_pred ECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc
Q 047576 161 DLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ 237 (602)
Q Consensus 161 ~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~ 237 (602)
+|++|+|+. .+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|+++|.
T Consensus 86 ~Ls~N~l~~ip~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~ 157 (571)
T 3cvr_A 86 EITQNALISLPELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE 157 (571)
T ss_dssp ECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC
T ss_pred ECcCCCCcccccccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC
Confidence 999998873 46788899999999887 555 655 89999999999887 665 57889999999999998887
Q ss_pred cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCC-------CEEeccCCCCCCCCCcc
Q 047576 238 EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQL-------FHLDLSSNKLSGKIPSQ 310 (602)
Q Consensus 238 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~ 310 (602)
.+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..
T Consensus 158 ---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~ 225 (571)
T 3cvr_A 158 ---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPEN 225 (571)
T ss_dssp ---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGG
T ss_pred ---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHH
Confidence 56889999999999987 666 65 88999999999988 5565 544 66 88999999998 47887
Q ss_pred cCCCCCCCEEeCCCCCCCCCCCcccccccc
Q 047576 311 IASMEDLTWLDLSNNNIKGSIPGEITKLSR 340 (602)
Q Consensus 311 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 340 (602)
+..+++|+.|+|++|.+++.+|..+..++.
T Consensus 226 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 226 ILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp GGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred HhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 777899999999999998888887776543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=206.61 Aligned_cols=189 Identities=16% Similarity=0.161 Sum_probs=165.7
Q ss_pred CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCC-CCCCCcccccCcCCCceeeccc-ccCCCCc-ccccCCCCCcE
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-LIGPIPLTLSRLTSLKILILAQ-NQLSGLP-QEIGNLKNLML 247 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~ip-~~~~~l~~L~~ 247 (602)
.++|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|++++ |+++++| ..|.++++|++
T Consensus 30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 3589999999999999988899999999999999997 8877777899999999999999 9999975 57899999999
Q ss_pred EEccCCCCCCCCCCccCCCCCCc---cccCCCC-cCCCCCchhhhCCCCCC-EEeccCCCCCCCCCcccCCCCCCCEEeC
Q 047576 248 LDVGNNDIIGPIPSTLGLFSDLS---YLDLSCN-QFNSSIPNELTRLTQLF-HLDLSSNKLSGKIPSQIASMEDLTWLDL 322 (602)
Q Consensus 248 L~L~~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 322 (602)
|++++|++++ +|. +..+++|+ +|++++| .+++..+..|..+++|+ .|+|++|+++ .+|......++|+.|++
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L 186 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEEC
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEc
Confidence 9999999997 676 88888998 9999999 99988888899999999 9999999999 55554333489999999
Q ss_pred CCCC-CCCCCCcccccc-cccccccccCCcCCCccCCCCCcC
Q 047576 323 SNNN-IKGSIPGEITKL-SRLDYLNLSGNKLSGRVPYSNKHL 362 (602)
Q Consensus 323 ~~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l 362 (602)
++|+ +++..+..+..+ ++|+.|++++|++++..+..+..+
T Consensus 187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L 228 (239)
T 2xwt_C 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228 (239)
T ss_dssp TTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTC
T ss_pred CCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccC
Confidence 9995 997778889999 999999999999986544434333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=195.12 Aligned_cols=176 Identities=26% Similarity=0.269 Sum_probs=122.9
Q ss_pred EEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCC
Q 047576 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNND 254 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~ 254 (602)
.++.+++.++.. |..+ .++|++|+|++|++++..+..|.++++|++|++++|+++++|. .+.++++|++|+|++|+
T Consensus 11 ~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 344555555432 3222 3467777777777766555566677777777777777777544 35667777777777777
Q ss_pred CCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcc
Q 047576 255 IIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGE 334 (602)
Q Consensus 255 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 334 (602)
+++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 163 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 163 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC----
Confidence 7766666667777777777777777766666677778888888888888776666677788888888888877643
Q ss_pred cccccccccccccCCcCCCccCCCCCc
Q 047576 335 ITKLSRLDYLNLSGNKLSGRVPYSNKH 361 (602)
Q Consensus 335 ~~~l~~L~~L~l~~N~l~g~~p~~~~~ 361 (602)
+++|+.|+++.|+++|.+|..+..
T Consensus 164 ---~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 164 ---CPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp ---TTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred ---CCCHHHHHHHHHhCCceeeccCcc
Confidence 456788888888888888876543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=222.14 Aligned_cols=183 Identities=30% Similarity=0.369 Sum_probs=160.3
Q ss_pred CCCEEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeeccccc
Q 047576 156 KLQLLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231 (602)
Q Consensus 156 ~L~~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 231 (602)
+|+.|+|++|+|++ .+++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~ 131 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLPPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQ 131 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCCTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSC
T ss_pred CccEEEeCCCCCCccCHhHcCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCc
Confidence 89999999999985 3567999999999999 556 568999999999999998 777 665 99999999999
Q ss_pred CCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCccc
Q 047576 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311 (602)
Q Consensus 232 l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 311 (602)
|+++|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|.|++ +|. |. ++|+.|+|++|+|+ .+|. +
T Consensus 132 l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~ 198 (571)
T 3cvr_A 132 LTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-V 198 (571)
T ss_dssp CSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-C
T ss_pred CCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-H
Confidence 999998 68999999999999997 666 57899999999999997 666 65 89999999999999 6776 6
Q ss_pred CCCCCC-------CEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcC
Q 047576 312 ASMEDL-------TWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHL 362 (602)
Q Consensus 312 ~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 362 (602)
.. +| +.|+|++|+|+ .+|..+..+++|+.|++++|+++|.+|..+..+
T Consensus 199 ~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 199 PV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp C----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred HH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 54 77 99999999999 578888899999999999999999998776443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.1e-22 Score=190.02 Aligned_cols=176 Identities=24% Similarity=0.267 Sum_probs=158.8
Q ss_pred CEEECcCCcCc----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCC
Q 047576 158 QLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLS 233 (602)
Q Consensus 158 ~~L~Ls~N~i~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 233 (602)
+.++++++.+. +..++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 10 ~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 89 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89 (208)
T ss_dssp TEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC
Confidence 57888888876 34678999999999999888888999999999999999999877777899999999999999999
Q ss_pred CCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccC
Q 047576 234 GLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312 (602)
Q Consensus 234 ~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (602)
++|. .+.++++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|+|++|.+.+.
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------ 163 (208)
T 2o6s_A 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------ 163 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------
T ss_pred ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC------
Confidence 9765 478999999999999999988888899999999999999999988777799999999999999988754
Q ss_pred CCCCCCEEeCCCCCCCCCCCcccccccc
Q 047576 313 SMEDLTWLDLSNNNIKGSIPGEITKLSR 340 (602)
Q Consensus 313 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 340 (602)
+++|+.|+++.|+++|.+|..++.++.
T Consensus 164 -~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 -CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -CCCHHHHHHHHHhCCceeeccCccccC
Confidence 568999999999999999999887764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-23 Score=217.28 Aligned_cols=227 Identities=19% Similarity=0.219 Sum_probs=156.4
Q ss_pred CCCccchhccccCCccccCC----ccCCCCC-CCCEEECcCCcCccc------------CCCcCEEECcCCcCCCCCchh
Q 047576 129 PNLESLRILAYYDGFTGSIP----SEISALS-KLQLLDLSSNRLRGR------------LTNLNYMSLSRNMLGGLLPQE 191 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip----~~l~~L~-~L~~L~Ls~N~i~~~------------l~~L~~L~L~~N~l~~~~p~~ 191 (602)
++|+.|++. ++.+.+..+ ..+.+++ +|++|+|++|+|++. .++|++|+|++|.+++..+..
T Consensus 22 ~~L~~L~Ls--~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~ 99 (362)
T 3goz_A 22 HGVTSLDLS--LNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDE 99 (362)
T ss_dssp TTCCEEECT--TSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH
T ss_pred CCceEEEcc--CCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHH
Confidence 346666665 444444444 5677777 788888888888742 278888888888888777765
Q ss_pred hhCC-----CCCCEEEecCCCCCCCCcccccC-----cCCCceeecccccCCC-----CcccccCCC-CCcEEEccCCCC
Q 047576 192 IGNL-----KNLIELDVGDNSLIGPIPLTLSR-----LTSLKILILAQNQLSG-----LPQEIGNLK-NLMLLDVGNNDI 255 (602)
Q Consensus 192 ~~~l-----~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~-----ip~~~~~l~-~L~~L~L~~N~l 255 (602)
+... ++|++|+|++|++++..+..+.. .++|++|+|++|++++ ++..+..++ +|++|+|++|++
T Consensus 100 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 100 LVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 4443 78888888888887766655433 2588888888888874 344455555 888888888888
Q ss_pred CCCCCCccC----CC-CCCccccCCCCcCCCC----CchhhhC-CCCCCEEeccCCCCCCCCC----cccCCCCCCCEEe
Q 047576 256 IGPIPSTLG----LF-SDLSYLDLSCNQFNSS----IPNELTR-LTQLFHLDLSSNKLSGKIP----SQIASMEDLTWLD 321 (602)
Q Consensus 256 ~~~~p~~l~----~l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~ 321 (602)
++..+..+. .. ++|++|+|++|.+++. ++..+.. .++|++|+|++|+|++..+ ..+..+++|+.|+
T Consensus 180 ~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~ 259 (362)
T 3goz_A 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259 (362)
T ss_dssp GGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEE
T ss_pred chhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEE
Confidence 776664433 33 5888888888888763 3444554 3478888888888876544 3346677888888
Q ss_pred CCCCCCCCCC-------CcccccccccccccccCCcCCCccCC
Q 047576 322 LSNNNIKGSI-------PGEITKLSRLDYLNLSGNKLSGRVPY 357 (602)
Q Consensus 322 L~~N~l~~~~-------p~~~~~l~~L~~L~l~~N~l~g~~p~ 357 (602)
|++|.+++.. +..+..+++|+.|++++|++.+..+.
T Consensus 260 L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp EEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred eccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 8888855433 33566777788888888887766443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-21 Score=214.48 Aligned_cols=209 Identities=30% Similarity=0.349 Sum_probs=152.0
Q ss_pred CCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCC
Q 047576 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDN 206 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 206 (602)
+++.|++. ++....+|..+. ++|++|+|++|+|++ .+++|++|+|++|+|++ +|. .+++|++|+|++|
T Consensus 41 ~l~~L~ls---~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 111 (622)
T 3g06_A 41 GNAVLNVG---ESGLTTLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSN 111 (622)
T ss_dssp CCCEEECC---SSCCSCCCSCCC--TTCSEEEECSCCCSCCCCCCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSC
T ss_pred CCcEEEec---CCCcCccChhhC--CCCcEEEecCCCCCCCCCcCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCC
Confidence 35555554 444458888776 899999999999884 57899999999999996 444 7899999999999
Q ss_pred CCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCC--CCCccCCC--------------CCCc
Q 047576 207 SLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGP--IPSTLGLF--------------SDLS 270 (602)
Q Consensus 207 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l--------------~~L~ 270 (602)
++++ +|. .+++|+.|++++|+++++|.. +++|++|+|++|++++. .+..+..+ ++|+
T Consensus 112 ~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~ 184 (622)
T 3g06_A 112 PLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQ 184 (622)
T ss_dssp CCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCC
T ss_pred cCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCc
Confidence 9986 444 578999999999999999875 48899999999999862 22233333 7778
Q ss_pred cccCCCCcCCCCCchhhhC-----------------CCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 271 YLDLSCNQFNSSIPNELTR-----------------LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 271 ~L~L~~N~l~~~~p~~~~~-----------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
.|++++|.+++ +|..+.+ +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+. +|.
T Consensus 185 ~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~ 258 (622)
T 3g06_A 185 ELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM 258 (622)
T ss_dssp EEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC
T ss_pred EEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc
Confidence 88888888875 3322211 1456666666666664 44 345677777777777773 444
Q ss_pred ccccccccccccccCCcCCCccCCCCCcCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVPYSNKHLSS 364 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 364 (602)
.+++|+.|++++|+++ .+|..+..+..
T Consensus 259 ---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~ 285 (622)
T 3g06_A 259 ---LPSGLLSLSVYRNQLT-RLPESLIHLSS 285 (622)
T ss_dssp ---CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred ---ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence 4567788888888887 66665544433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.6e-24 Score=233.84 Aligned_cols=162 Identities=20% Similarity=0.120 Sum_probs=103.9
Q ss_pred ccccccccceeeec-CCCcEEeeeccCCch-------hHHHHHhhhhHhHHHHH--------------------------
Q 047576 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPE-------TEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 377 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-------~~~~~~~~~~~~E~~il-------------------------- 422 (602)
.+.|+.|.+..++. -.|+.||+|++.+.. .......++|.+|+++|
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 35566666665542 257889999886432 12233456799999988
Q ss_pred HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 423 SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 423 ~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
||++|++|.+.+... .+++.. +|+.||+.||+|+| ++|||||||||+|||++.++.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 667777777777653 235543 58999999999999 889999999999999999999999999999887665
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 548 (602)
.......+||+.|+|||++.+. +..++|+||+|++++++.+|..|
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 5555667899999999998764 56789999999998877666544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.7e-24 Score=223.72 Aligned_cols=218 Identities=19% Similarity=0.193 Sum_probs=182.4
Q ss_pred CccccCCccCCCCCCCCEEECcCCcCcc-----------cCCCcCEEECcCC---cCCCCCchhh-------hCCCCCCE
Q 047576 142 GFTGSIPSEISALSKLQLLDLSSNRLRG-----------RLTNLNYMSLSRN---MLGGLLPQEI-------GNLKNLIE 200 (602)
Q Consensus 142 ~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-----------~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~ 200 (602)
.-...++..+..+++|++|+|++|+|++ .+++|++|+|++| ++++.+|..+ ..+++|++
T Consensus 19 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~ 98 (386)
T 2ca6_A 19 EDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 98 (386)
T ss_dssp HHHHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCE
T ss_pred HHHHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccE
Confidence 3445677888899999999999999873 4889999999996 5556677666 78999999
Q ss_pred EEecCCCCCC----CCcccccCcCCCceeecccccCCC-----CcccccCC---------CCCcEEEccCCCCC-CCCC-
Q 047576 201 LDVGDNSLIG----PIPLTLSRLTSLKILILAQNQLSG-----LPQEIGNL---------KNLMLLDVGNNDII-GPIP- 260 (602)
Q Consensus 201 L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~-----ip~~~~~l---------~~L~~L~L~~N~l~-~~~p- 260 (602)
|+|++|.+++ .+|..+..+++|++|+|++|.++. ++..+..+ ++|++|+|++|+++ +.+|
T Consensus 99 L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 178 (386)
T 2ca6_A 99 VRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178 (386)
T ss_dssp EECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH
T ss_pred EECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH
Confidence 9999999998 477788999999999999999975 23334444 89999999999998 4455
Q ss_pred --CccCCCCCCccccCCCCcCCC-----CCchhhhCCCCCCEEeccCCCCC----CCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 261 --STLGLFSDLSYLDLSCNQFNS-----SIPNELTRLTQLFHLDLSSNKLS----GKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 261 --~~l~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
..+..+++|++|+|++|+++. ..|..+..+++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|++++
T Consensus 179 l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence 467788999999999999983 34447889999999999999996 5678889999999999999999987
Q ss_pred C----CCccc--ccccccccccccCCcCCC----ccCCCC
Q 047576 330 S----IPGEI--TKLSRLDYLNLSGNKLSG----RVPYSN 359 (602)
Q Consensus 330 ~----~p~~~--~~l~~L~~L~l~~N~l~g----~~p~~~ 359 (602)
. +|..+ +.+++|+.|++++|++++ .+|..+
T Consensus 259 ~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp HHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred hhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 6 56666 348999999999999998 466544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=217.13 Aligned_cols=225 Identities=24% Similarity=0.292 Sum_probs=158.7
Q ss_pred CCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 151 ISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+..|++|+.|+|++|.|. +.+++|++|+|++|+|++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 39 ~~~L~~L~~L~l~~n~i~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCCCTTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred hhcCCCCCEEECcCCCCCCChHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 456677777888887776 347788888888888887654 8888888888888888875 33 68888888888
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
+|++|+++++| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++
T Consensus 115 ~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 115 SLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp ECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred EecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 88888888875 478888888888888888865 567888888888888888887665 8888888888888888886
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCccccccccccc-------------ccccCCcCCCccCCCCCcCCCCCCCcccc
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDY-------------LNLSGNKLSGRVPYSNKHLSSMPTPRKID 372 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~-------------L~l~~N~l~g~~p~~~~~l~~lp~t~~f~ 372 (602)
. ..+..+++|+.|+|++|++++.....+..+..+.. +...++...|.++..+. .......|.
T Consensus 190 l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l~~l~g~~~~~~~i~~~g~~~~~~i~~~l~---~~~~~~~y~ 264 (605)
T 1m9s_A 190 L--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLP---EFTNEVSFI 264 (605)
T ss_dssp C--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCCBCSSSCBCCCSEESTTCEEETTEEECCCS---SCCSEEEEE
T ss_pred C--hHHccCCCCCEEEccCCcCcCCcccccccEEecccccccCCCCcCchhcccCCcccCCcceeccc---cccceeEEE
Confidence 4 35788888888888888888654443333332222 22334445555555432 222222344
Q ss_pred Ccccccccccccceeee
Q 047576 373 SKYCIGTGAYGSVYKAQ 389 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~ 389 (602)
..+-+..|.....|.|+
T Consensus 265 f~~~~~~g~~~~~F~G~ 281 (605)
T 1m9s_A 265 FYQPVTIGKAKARFHGR 281 (605)
T ss_dssp EEEEEEETTEEEEEEEE
T ss_pred EeEEeecccceeeeccc
Confidence 44445555555555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=196.80 Aligned_cols=170 Identities=29% Similarity=0.381 Sum_probs=105.8
Q ss_pred CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEc
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDV 250 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L 250 (602)
+++|++|++++|.++.. +.+..+++|++|+|++|++++..| +.++++|++|++++|+++++|. +.++++|+.|++
T Consensus 45 l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L 119 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSL 119 (291)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEEC
T ss_pred cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChh-hccCCCCCEEEC
Confidence 44555555555555543 236666666666666666665433 6666666666666666666543 666666666666
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|++++|++++.
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence 66666653 3455666666666666666654 356666667777777776665443 66666777777777766643
Q ss_pred CCcccccccccccccccCCcCCC
Q 047576 331 IPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 331 ~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
+ .+..+++|+.|++++|+++.
T Consensus 194 -~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 -R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -G-GGTTCTTCSEEEEEEEEEEC
T ss_pred -h-hhccCCCCCEEECcCCcccC
Confidence 3 36666667777777776655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-23 Score=212.51 Aligned_cols=202 Identities=21% Similarity=0.222 Sum_probs=177.2
Q ss_pred CccCCCC--CCCCEEECcCCcCccc------CCCcCEEECcCCcCCCC-CchhhhCCCCCCEEEecCCCCCCCCcccccC
Q 047576 148 PSEISAL--SKLQLLDLSSNRLRGR------LTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218 (602)
Q Consensus 148 p~~l~~L--~~L~~L~Ls~N~i~~~------l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 218 (602)
|..+..+ ++++.|++++|.+.+. +++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.
T Consensus 61 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~ 140 (336)
T 2ast_B 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140 (336)
T ss_dssp HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT
T ss_pred HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc
Confidence 5566677 8999999999998853 68999999999999876 8889999999999999999999888999999
Q ss_pred cCCCceeecccc-cCCC--CcccccCCCCCcEEEccCC-CCCCC-CCCccCCCC-CCccccCCCC--cCC-CCCchhhhC
Q 047576 219 LTSLKILILAQN-QLSG--LPQEIGNLKNLMLLDVGNN-DIIGP-IPSTLGLFS-DLSYLDLSCN--QFN-SSIPNELTR 289 (602)
Q Consensus 219 l~~L~~L~L~~N-~l~~--ip~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~L~~N--~l~-~~~p~~~~~ 289 (602)
+++|++|++++| .+++ +|..+.++++|++|++++| .+++. ++..+..++ +|++|++++| .++ +.+|..+..
T Consensus 141 ~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~ 220 (336)
T 2ast_B 141 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 220 (336)
T ss_dssp CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhh
Confidence 999999999999 7885 7877899999999999999 99865 577788899 9999999999 566 556778889
Q ss_pred CCCCCEEeccCCC-CCCCCCcccCCCCCCCEEeCCCCC-CCCCCCcccccccccccccccCC
Q 047576 290 LTQLFHLDLSSNK-LSGKIPSQIASMEDLTWLDLSNNN-IKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 290 l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
+++|++|+|++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++|
T Consensus 221 ~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 221 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 9999999999999 787888899999999999999995 33322336888999999999999
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.2e-23 Score=214.02 Aligned_cols=217 Identities=23% Similarity=0.208 Sum_probs=176.9
Q ss_pred cCCccccCCccCCCCCCCCEEECcCCcCccc-----------CC-CcCEEECcCCcCCCCCchhhhCC-----CCCCEEE
Q 047576 140 YDGFTGSIPSEISALSKLQLLDLSSNRLRGR-----------LT-NLNYMSLSRNMLGGLLPQEIGNL-----KNLIELD 202 (602)
Q Consensus 140 ~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~~-----------l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~ 202 (602)
.+++.|.+|..+...++|++|||++|+|++. ++ +|++|+|++|.+++..+..+..+ ++|++|+
T Consensus 7 ~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~ 86 (362)
T 3goz_A 7 LHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLN 86 (362)
T ss_dssp CCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred cccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEE
Confidence 5677888888888888899999999999842 55 89999999999999988888886 9999999
Q ss_pred ecCCCCCCCCcccccCc-----CCCceeecccccCCCCcc-c----ccC-CCCCcEEEccCCCCCCCCCC----ccCCCC
Q 047576 203 VGDNSLIGPIPLTLSRL-----TSLKILILAQNQLSGLPQ-E----IGN-LKNLMLLDVGNNDIIGPIPS----TLGLFS 267 (602)
Q Consensus 203 L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~ip~-~----~~~-l~~L~~L~L~~N~l~~~~p~----~l~~l~ 267 (602)
|++|++++..+..+... ++|++|+|++|++++.+. . +.. .++|++|+|++|.+++..+. .+..++
T Consensus 87 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 166 (362)
T 3goz_A 87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166 (362)
T ss_dssp CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred CcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCC
Confidence 99999998888765544 899999999999998543 3 334 36999999999999965443 334555
Q ss_pred -CCccccCCCCcCCCCCchhhh----CC-CCCCEEeccCCCCCCC----CCcccCC-CCCCCEEeCCCCCCCCCCC----
Q 047576 268 -DLSYLDLSCNQFNSSIPNELT----RL-TQLFHLDLSSNKLSGK----IPSQIAS-MEDLTWLDLSNNNIKGSIP---- 332 (602)
Q Consensus 268 -~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p---- 332 (602)
+|++|+|++|++++..+..+. .+ ++|++|+|++|+|++. ++..+.. .++|+.|+|++|.+++..+
T Consensus 167 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 246 (362)
T 3goz_A 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK 246 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHH
T ss_pred ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHH
Confidence 999999999999988876554 44 6999999999999864 3445555 4599999999999997655
Q ss_pred cccccccccccccccCCcCCCccC
Q 047576 333 GEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 333 ~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
..+..+++|+.|++++|.+++..+
T Consensus 247 ~~~~~l~~L~~L~L~~n~l~~i~~ 270 (362)
T 3goz_A 247 LLKDSLKHLQTVYLDYDIVKNMSK 270 (362)
T ss_dssp HTTTTTTTCSEEEEEHHHHTTCCH
T ss_pred HHHhcCCCccEEEeccCCccccCH
Confidence 345677899999999999765443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=184.70 Aligned_cols=136 Identities=30% Similarity=0.317 Sum_probs=108.7
Q ss_pred CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEc
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDV 250 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L 250 (602)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++++|. .+..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 345666666777777778888888888888888888876666677888888888888888888654 4678888888888
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP 308 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 308 (602)
++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+....+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 888888 677778888888888888888887777778888888888888888876554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=194.25 Aligned_cols=173 Identities=28% Similarity=0.380 Sum_probs=151.5
Q ss_pred CCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 151 ISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+..+++|++|++++|.+. +.+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hhhcCcccEEEccCCCcccChhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 456788999999999887 347899999999999998655 9999999999999999986 33 49999999999
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
++++|++++++ .+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|+|++|+|++
T Consensus 118 ~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 118 SLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp ECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 99999999985 688999999999999999976 578899999999999999997655 8999999999999999986
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCcc
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGE 334 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 334 (602)
+| .+..+++|+.|++++|+++......
T Consensus 193 -l~-~l~~l~~L~~L~l~~n~i~~~~~~~ 219 (291)
T 1h6t_A 193 -LR-ALAGLKNLDVLELFSQECLNKPINH 219 (291)
T ss_dssp -CG-GGTTCTTCSEEEEEEEEEECCCEEC
T ss_pred -Ch-hhccCCCCCEEECcCCcccCCcccc
Confidence 44 4899999999999999998644333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=8e-21 Score=184.57 Aligned_cols=153 Identities=22% Similarity=0.264 Sum_probs=80.2
Q ss_pred EEEecCCCCCCCCcccccCcCCCceeecccccCCCC-c-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-P-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 200 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
.+++++|.++. +|..+. +.+++|+|++|+++++ | ..+.++++|+.|+|++|++++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 44444444442 333332 2334555555555553 2 12445555555555555555544445555555555555555
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 555555555555555555555555555555555555555555555555555555555555555555555555555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-23 Score=223.78 Aligned_cols=199 Identities=21% Similarity=0.158 Sum_probs=84.7
Q ss_pred CCCCCEEECcCCcCcc-----------cCCCcCEEECcCCcCCCCCchhhhC-----CCCCCEEEecCCCCCCC----Cc
Q 047576 154 LSKLQLLDLSSNRLRG-----------RLTNLNYMSLSRNMLGGLLPQEIGN-----LKNLIELDVGDNSLIGP----IP 213 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~~-----------~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p 213 (602)
+++|++|+|++|++++ .+++|++|+|++|.++...+..+.. +++|++|+|++|.+++. ++
T Consensus 141 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 220 (461)
T 1z7x_W 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred CCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHH
Confidence 3445555555555442 1345555555555544333333321 34455555555554432 23
Q ss_pred ccccCcCCCceeecccccCCCC------cccccCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCCCcCCCCC
Q 047576 214 LTLSRLTSLKILILAQNQLSGL------PQEIGNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSCNQFNSSI 283 (602)
Q Consensus 214 ~~l~~l~~L~~L~L~~N~l~~i------p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~ 283 (602)
..+..+++|++|++++|++++. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++..
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 300 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH
Confidence 3444445555555555544431 11112344455555555544432 2333344444455555554444332
Q ss_pred chhhhC-----CCCCCEEeccCCCCCCC----CCcccCCCCCCCEEeCCCCCCCCCCCccccc-----ccccccccccCC
Q 047576 284 PNELTR-----LTQLFHLDLSSNKLSGK----IPSQIASMEDLTWLDLSNNNIKGSIPGEITK-----LSRLDYLNLSGN 349 (602)
Q Consensus 284 p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~l~~N 349 (602)
+..+.. .++|++|+|++|.+++. ++..+..+++|+.|++++|++++..+..+.. .++|+.|++++|
T Consensus 301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 222221 13444444444444432 2233334444444444444444333322221 334444444444
Q ss_pred cCC
Q 047576 350 KLS 352 (602)
Q Consensus 350 ~l~ 352 (602)
+++
T Consensus 381 ~i~ 383 (461)
T 1z7x_W 381 DVS 383 (461)
T ss_dssp CCC
T ss_pred CCC
Confidence 444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.2e-21 Score=211.22 Aligned_cols=188 Identities=27% Similarity=0.346 Sum_probs=166.0
Q ss_pred CCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccc
Q 047576 156 KLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230 (602)
Q Consensus 156 ~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 230 (602)
.+..+.|+.+.+.. .+++|++|+|++|.+... +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|
T Consensus 22 ~l~~l~l~~~~i~~~~~~~~L~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHHHTTCSCTTSEECHHHHTTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred HHHHHhccCCCcccccchhcCCCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence 34455666666653 588999999999999865 369999999999999999997655 999999999999999
Q ss_pred cCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcc
Q 047576 231 QLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQ 310 (602)
Q Consensus 231 ~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 310 (602)
+++++| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++..|
T Consensus 98 ~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 98 KIKDLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CCCCCT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CCCCCh-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 999987 689999999999999999974 4588999999999999999976 579999999999999999998766
Q ss_pred cCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 311 IASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 311 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++...
T Consensus 171 l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 99999999999999999974 468999999999999999988643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=195.25 Aligned_cols=172 Identities=19% Similarity=0.169 Sum_probs=75.9
Q ss_pred CCCccchhccccCCccccCC-ccCCCCCCCCEEECcCCcCcc--------cCCCcCE-EECcCCcCCCCCchhhhCCCCC
Q 047576 129 PNLESLRILAYYDGFTGSIP-SEISALSKLQLLDLSSNRLRG--------RLTNLNY-MSLSRNMLGGLLPQEIGNLKNL 198 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip-~~l~~L~~L~~L~Ls~N~i~~--------~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L 198 (602)
++++.|++. +|.+ ..|| .+|.++++|++|+|++|++.+ .+++|++ +.++.|+|+...|..|..+++|
T Consensus 30 ~~l~~L~Ls--~N~i-~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L 106 (350)
T 4ay9_X 30 RNAIELRFV--LTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106 (350)
T ss_dssp TTCSEEEEE--SCCC-SEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTC
T ss_pred CCCCEEEcc--CCcC-CCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccc
Confidence 345555543 2333 3343 345666666666666555432 1233332 3344455554444455555555
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeeccc-ccCCCCcc-cccCC-CCCcEEEccCCCCCCCCCCccCCCCCCccccCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQ-NQLSGLPQ-EIGNL-KNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~ip~-~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 275 (602)
++|++++|++++..+..+....++..|++.+ |+++.+|. .+..+ ..++.|+|++|+|+. +|.......+|++|+++
T Consensus 107 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~ 185 (350)
T 4ay9_X 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLS 185 (350)
T ss_dssp CEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECT
T ss_pred ccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhc
Confidence 5555555555444444444444444444433 34444332 23332 234445555555542 22222233344555544
Q ss_pred C-CcCCCCCchhhhCCCCCCEEeccCCCCC
Q 047576 276 C-NQFNSSIPNELTRLTQLFHLDLSSNKLS 304 (602)
Q Consensus 276 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 304 (602)
+ |.++...+..|..+++|+.|||++|+|+
T Consensus 186 ~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 186 DNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp TCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred cCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 3 3333222233444555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-21 Score=198.63 Aligned_cols=157 Identities=27% Similarity=0.246 Sum_probs=92.3
Q ss_pred CCCEEEecCCCCCCCCccccc-CcCCCceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccC
Q 047576 197 NLIELDVGDNSLIGPIPLTLS-RLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 274 (602)
.++.|+|++|+|++..+..+. ++++|++|+|++|+|++++ ..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 355666666666555555554 5666666666666666643 34556666666666666666555555666666666666
Q ss_pred CCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCccc---CCCCCCCEEeCCCCCCCCCCCcccccccc--cccccccCC
Q 047576 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI---ASMEDLTWLDLSNNNIKGSIPGEITKLSR--LDYLNLSGN 349 (602)
Q Consensus 275 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~N 349 (602)
++|+|++..|..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++|+|++..+..+..++. |+.|++++|
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N 199 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence 6666665556666666666666666666664333333 44666666666666666555555556655 356666666
Q ss_pred cCCC
Q 047576 350 KLSG 353 (602)
Q Consensus 350 ~l~g 353 (602)
++..
T Consensus 200 ~~~C 203 (361)
T 2xot_A 200 PLEC 203 (361)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=181.10 Aligned_cols=153 Identities=16% Similarity=0.211 Sum_probs=100.5
Q ss_pred EEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeecccccCCCCc-ccccCCCCCcEEEccCC
Q 047576 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N 253 (602)
++++++|.++. +|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|++++++ ..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45555555553 343332 345666666666665544 34566667777777777766643 35666677777777777
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 776666666667777777777777777666667777777777777777777766777777777777777777776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-22 Score=218.54 Aligned_cols=226 Identities=20% Similarity=0.164 Sum_probs=184.0
Q ss_pred CCccchhccccCCcc----ccCCccCCCCCCCCEEECcCCcCcc------------cCCCcCEEECcCCcCCCCC----c
Q 047576 130 NLESLRILAYYDGFT----GSIPSEISALSKLQLLDLSSNRLRG------------RLTNLNYMSLSRNMLGGLL----P 189 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~----~~ip~~l~~L~~L~~L~Ls~N~i~~------------~l~~L~~L~L~~N~l~~~~----p 189 (602)
+|++|++. ++.+. +.+|..+..+++|++|+|++|.+.+ ..++|++|+|++|++++.. +
T Consensus 86 ~L~~L~L~--~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 86 KIQKLSLQ--NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp CCCEEECT--TSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred ceeEEEcc--CCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 68888876 45555 3678899999999999999999873 1457999999999999754 6
Q ss_pred hhhhCCCCCCEEEecCCCCCCCCccccc-----CcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCCCCC
Q 047576 190 QEIGNLKNLIELDVGDNSLIGPIPLTLS-----RLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDIIGPI 259 (602)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~~ 259 (602)
..+..+++|++|+|++|.+++..+..+. ..++|++|++++|++++ ++..+..+++|+.|++++|.+++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 6778889999999999998765555443 36699999999999998 4777888999999999999987642
Q ss_pred -----CCccCCCCCCccccCCCCcCCCC----CchhhhCCCCCCEEeccCCCCCCCCCcccC-----CCCCCCEEeCCCC
Q 047576 260 -----PSTLGLFSDLSYLDLSCNQFNSS----IPNELTRLTQLFHLDLSSNKLSGKIPSQIA-----SMEDLTWLDLSNN 325 (602)
Q Consensus 260 -----p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N 325 (602)
+..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+. ..++|+.|++++|
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCC
Confidence 33344688999999999999875 577788899999999999999765444443 3379999999999
Q ss_pred CCCCC----CCcccccccccccccccCCcCCCccCC
Q 047576 326 NIKGS----IPGEITKLSRLDYLNLSGNKLSGRVPY 357 (602)
Q Consensus 326 ~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~~p~ 357 (602)
.+++. ++..+..+++|+.|++++|++++..+.
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 99976 566777889999999999999876443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4e-20 Score=179.61 Aligned_cols=133 Identities=23% Similarity=0.252 Sum_probs=70.5
Q ss_pred CCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccC
Q 047576 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274 (602)
Q Consensus 196 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 274 (602)
++|++|+|++|+|++..+..|.++++|+.|+|++|++++ .|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 345555555555554444455555555555555555555 2444555555555555555555443444455555555555
Q ss_pred CCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCC
Q 047576 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIK 328 (602)
Q Consensus 275 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 328 (602)
++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 555555555555555555555555555555544445555555555555555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-20 Score=179.53 Aligned_cols=153 Identities=22% Similarity=0.289 Sum_probs=141.1
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
+.+++++|.++ .+|..+. ++|+.|+|++|+++++|. .|.++++|+.|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 67899999987 4676654 789999999999999654 7899999999999999999999999999999999999999
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCc
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 354 (602)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99977777789999999999999999999999999999999999999999998888899999999999999999764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=197.72 Aligned_cols=173 Identities=27% Similarity=0.238 Sum_probs=140.1
Q ss_pred CEEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhh-CCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccC
Q 047576 158 QLLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIG-NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232 (602)
Q Consensus 158 ~~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 232 (602)
+.+++++|+++. ..+.+++|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 21 ~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l 100 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100 (361)
T ss_dssp TEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcC
Confidence 355666665552 234577888888888888788887 899999999999999888888899999999999999999
Q ss_pred CCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhh---hCCCCCCEEeccCCCCCCCCC
Q 047576 233 SGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL---TRLTQLFHLDLSSNKLSGKIP 308 (602)
Q Consensus 233 ~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p 308 (602)
+++| ..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+
T Consensus 101 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 180 (361)
T 2xot_A 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180 (361)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCH
T ss_pred CcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCH
Confidence 9864 468889999999999999998888889999999999999999987555555 568899999999999997666
Q ss_pred cccCCCCC--CCEEeCCCCCCCCC
Q 047576 309 SQIASMED--LTWLDLSNNNIKGS 330 (602)
Q Consensus 309 ~~~~~l~~--L~~L~L~~N~l~~~ 330 (602)
..+..++. ++.|+|++|.+...
T Consensus 181 ~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 181 TDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp HHHHHSCHHHHTTEECCSSCEECC
T ss_pred HHhhhccHhhcceEEecCCCccCC
Confidence 67777776 48899999998753
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-21 Score=221.63 Aligned_cols=236 Identities=17% Similarity=0.194 Sum_probs=90.5
Q ss_pred CCCCCCCCCceeCCCCCEEEEEecCCCCCCCcccccCCCCCCCCCccchhcc--ccCCccccCCccCCCCCCCCEEECcC
Q 047576 87 DSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILA--YYDGFTGSIPSEISALSKLQLLDLSS 164 (602)
Q Consensus 87 ~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~--~~~~~~~~ip~~l~~L~~L~~L~Ls~ 164 (602)
....+.|.+++++. .+++.+++...++.... ..+-....|..+.+.. ...+.....|..+..++
T Consensus 159 ~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~----~~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~--------- 224 (727)
T 4b8c_D 159 STPSGTATNSAVST-PLTPKIELFANGKDEAN----QALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQ--------- 224 (727)
T ss_dssp --------------------------------------------------------------------CCC---------
T ss_pred CCccccCCCceecC-CccceEEeeCCCCCcch----hhHhhcCccCcccccCccccccceecChhhhccCC---------
Confidence 44567899998875 67788887544332110 0000111112111110 01111112333444444
Q ss_pred CcCcccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCC
Q 047576 165 NRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKN 244 (602)
Q Consensus 165 N~i~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~ 244 (602)
+|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+.+|..++++++
T Consensus 225 --------~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~ 294 (727)
T 4b8c_D 225 --------LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQ 294 (727)
T ss_dssp --------CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTT
T ss_pred --------CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCC
Confidence 4555555555555 44555556777777777777766 5666667777777777777777777766777777
Q ss_pred CcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCC-CCEEeccCCCCCCCCCcccCCCCCCCEEeCC
Q 047576 245 LMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ-LFHLDLSSNKLSGKIPSQIASMEDLTWLDLS 323 (602)
Q Consensus 245 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 323 (602)
|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..++|++|.++|.+|.. |..|+++
T Consensus 295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~ 367 (727)
T 4b8c_D 295 LKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEIN 367 (727)
T ss_dssp CSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------
T ss_pred CCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEee
Confidence 777777777765 55666777777777777777777666666544321 123566777777666543 3344455
Q ss_pred CC--------CCCCCCCcccccccccccccccCCcCCC
Q 047576 324 NN--------NIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 324 ~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
+| .+.+..+..+..+..+....+++|-+++
T Consensus 368 ~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 368 TDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ----------------------------------CCCG
T ss_pred cccccccccCCccccccchhhcccccceeeeecccccc
Confidence 44 3444444455566666667777777654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-19 Score=176.90 Aligned_cols=153 Identities=27% Similarity=0.344 Sum_probs=119.7
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCC
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNN 253 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N 253 (602)
+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+++.+|. .+.++++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 45666666665 3444333 788888888888888888888888888888888888888764 4678888888888888
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+++..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 888777777788888888888888887 66777888888888888888888766667788888888888888887654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=176.95 Aligned_cols=155 Identities=18% Similarity=0.301 Sum_probs=121.1
Q ss_pred hhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCcc
Q 047576 192 IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSY 271 (602)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 271 (602)
.+.+++|++|++++|.++ .+| .+..+++|++|++++|.++.++ .+..+++|++|++++|++++..|..++.+++|++
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 366677888888888877 455 5777888888888888776665 5778888888888888888777888888888888
Q ss_pred ccCCCCcCCCCCchhhhCCCCCCEEeccCCC-CCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCc
Q 047576 272 LDLSCNQFNSSIPNELTRLTQLFHLDLSSNK-LSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK 350 (602)
Q Consensus 272 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 350 (602)
|++++|.+++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 8888888888778888888888888888887 55 455 678888888888888888863 3 67888888888888888
Q ss_pred CCC
Q 047576 351 LSG 353 (602)
Q Consensus 351 l~g 353 (602)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=6e-20 Score=191.26 Aligned_cols=199 Identities=22% Similarity=0.214 Sum_probs=158.0
Q ss_pred ccCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCc-hhhhCCCCCCE-EEecCCCCCCCCccc
Q 047576 145 GSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLP-QEIGNLKNLIE-LDVGDNSLIGPIPLT 215 (602)
Q Consensus 145 ~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~ 215 (602)
..||..+ .+++++|+|++|+|+ +.+++|++|+|++|++.+.+| ..|.++++|++ +.++.|++++..|..
T Consensus 22 t~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~ 99 (350)
T 4ay9_X 22 TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA 99 (350)
T ss_dssp CSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTS
T ss_pred CccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchh
Confidence 3567655 368999999999997 348899999999999877655 57889998875 667789999888899
Q ss_pred ccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccC-CCCCCCCCCccCCCC-CCccccCCCCcCCCCCchhhhCCCC
Q 047576 216 LSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGN-NDIIGPIPSTLGLFS-DLSYLDLSCNQFNSSIPNELTRLTQ 292 (602)
Q Consensus 216 l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~ 292 (602)
|.++++|++|++++|+++.+|+ .+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+.. |.......+
T Consensus 100 f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~ 178 (350)
T 4ay9_X 100 FQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQ 178 (350)
T ss_dssp BCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEE
T ss_pred hhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC-Chhhccccc
Confidence 9999999999999999999765 456667888899866 567765566676664 688999999999854 444445678
Q ss_pred CCEEeccC-CCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccc
Q 047576 293 LFHLDLSS-NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNL 346 (602)
Q Consensus 293 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 346 (602)
|+.|++++ |.++...+..|..+++|+.|+|++|+|+...+..+.++++|+.+++
T Consensus 179 L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp EEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred hhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC
Confidence 99999985 6676544567899999999999999999766666777776666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=185.45 Aligned_cols=166 Identities=22% Similarity=0.324 Sum_probs=96.9
Q ss_pred CCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeec
Q 047576 153 ALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILIL 227 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 227 (602)
.+.++..+++++|.+.+ .+++|++|++++|.++.. | .+..+++|++|+|++|++++..| +.++++|++|+|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEECHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHHHhcCCCcccccchhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 34455556666666653 356666666666666543 2 46666666666666666664333 666666666666
Q ss_pred ccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCC
Q 047576 228 AQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307 (602)
Q Consensus 228 ~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 307 (602)
++|+++++|.... ++|+.|+|++|++++. + .+..+++|+.|++++|++++. + .+..+++|+.|+|++|++++.
T Consensus 93 ~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 93 NRNRLKNLNGIPS--ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp CSSCCSCCTTCCC--SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCCccCCcCcccc--CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 6666666554222 5666666666666542 2 355666666666666666543 2 455666666666666666544
Q ss_pred CcccCCCCCCCEEeCCCCCCCCC
Q 047576 308 PSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 308 p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
..+..+++|+.|++++|.+++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 4455666666666666666544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-22 Score=219.36 Aligned_cols=181 Identities=25% Similarity=0.274 Sum_probs=123.9
Q ss_pred CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCC-------------CCCCCcccccCcCCCceee-cccccCCCCcc
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-------------LIGPIPLTLSRLTSLKILI-LAQNQLSGLPQ 237 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~ip~ 237 (602)
++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+..++.
T Consensus 349 ~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~ 427 (567)
T 1dce_A 349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427 (567)
T ss_dssp TTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHH
T ss_pred ccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhh
Confidence 34444444445544 445666666666666655443 4455555666666666666 44444333221
Q ss_pred ------cccC--CCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCc
Q 047576 238 ------EIGN--LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS 309 (602)
Q Consensus 238 ------~~~~--l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 309 (602)
.+.. ...|+.|+|++|+|++ +|. ++.+++|+.|+|++|.|+ .+|..++++++|+.|+|++|+|++ +|
T Consensus 428 l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp- 502 (567)
T 1dce_A 428 KFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD- 502 (567)
T ss_dssp HHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred hhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-
Confidence 0111 1257888888888886 565 788888888888888887 677788888888888888888886 56
Q ss_pred ccCCCCCCCEEeCCCCCCCCCC-CcccccccccccccccCCcCCCccCCC
Q 047576 310 QIASMEDLTWLDLSNNNIKGSI-PGEITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 310 ~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
.++.+++|+.|+|++|+|++.+ |..+..+++|+.|++++|++++..|..
T Consensus 503 ~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 7888888888888888888776 888888888888888888888876643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-20 Score=185.10 Aligned_cols=167 Identities=25% Similarity=0.368 Sum_probs=75.2
Q ss_pred cCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCC
Q 047576 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 174 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N 253 (602)
+..+++++|.+++.. .+..+++|++|++++|.++. +| .+..+++|+.|+|++|+++++|. +.++++|+.|+|++|
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCC
Confidence 344444444444332 34444444555555444442 22 34444445555555554444443 444444555555555
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
++++ +|.. .. ++|+.|+|++|++++. + .+..+++|+.|+|++|+|++. + .+..+++|+.|+|++|++++. .
T Consensus 96 ~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~ 166 (263)
T 1xeu_A 96 RLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G 166 (263)
T ss_dssp CCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred ccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence 4443 2221 11 4444445555544432 1 344444455555555544432 2 344444455555555544433 3
Q ss_pred ccccccccccccccCCcCCCc
Q 047576 334 EITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~ 354 (602)
.+..+++|+.|++++|++++.
T Consensus 167 ~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 167 GLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSTTCCCCCEEEEEEEEEECC
T ss_pred HhccCCCCCEEeCCCCcccCC
Confidence 344444444445544444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-21 Score=208.86 Aligned_cols=172 Identities=15% Similarity=0.175 Sum_probs=122.9
Q ss_pred CcccccccccccceeeecCCCcEEeeeccCCchh-----HHHHHhhhhHhHHHHHHhhhcCccc--cccccc--------
Q 047576 373 SKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPET-----EELAFIRSFRNEAQVLSQMERGSLF--RILHND-------- 437 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~~~~~~E~~il~~l~~gsL~--~~l~~~-------- 437 (602)
..+.||+|+||.||+|+. .++.+++|+...... ......+++.+|++++..+.|+++. ......
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999965 567788887543321 2222356789999999998888877 222111
Q ss_pred --cchhhhcH--HHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC-------c
Q 047576 438 --AEAVELDW--AKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-------Q 506 (602)
Q Consensus 438 --~~~~~l~~--~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~-------~ 506 (602)
.+...+.. ..+..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++........ .
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhh
Confidence 01111110 015689999999999999 789999999999999999 9999999999887542211 1
Q ss_pred ccccccccccccccccc--CcCCccchhHHHHHHHHHHHcCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYT--MVMTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
....||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 34579999999999987 567888999999999999998888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=6.5e-22 Score=218.70 Aligned_cols=191 Identities=18% Similarity=0.198 Sum_probs=162.8
Q ss_pred CCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCc-------------CCCCCchhhhCCCCCCEEE-ecCCCCCC
Q 047576 151 ISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNM-------------LGGLLPQEIGNLKNLIELD-VGDNSLIG 210 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 210 (602)
+..+++|+.|+|++|+++ +.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+..
T Consensus 345 ~~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 345 SATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp CSTTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred cccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 367899999999999987 458899999998876 6788899999999999999 66665431
Q ss_pred CCcc------cccC--cCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCC
Q 047576 211 PIPL------TLSR--LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS 282 (602)
Q Consensus 211 ~~p~------~l~~--l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 282 (602)
++. .+.. ...|+.|+|++|+|+++|. ++++++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++
T Consensus 425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~- 500 (567)
T 1dce_A 425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN- 500 (567)
T ss_dssp -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-
T ss_pred -hhhhhhhcccccccCccCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-
Confidence 111 1111 1368999999999999997 999999999999999999 889999999999999999999997
Q ss_pred CchhhhCCCCCCEEeccCCCCCCCC-CcccCCCCCCCEEeCCCCCCCCCCCcc---cccccccccccc
Q 047576 283 IPNELTRLTQLFHLDLSSNKLSGKI-PSQIASMEDLTWLDLSNNNIKGSIPGE---ITKLSRLDYLNL 346 (602)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~l 346 (602)
+| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++.+|.. +..+++|+.|++
T Consensus 501 lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 67 8999999999999999999887 999999999999999999999876543 334788888764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=171.90 Aligned_cols=152 Identities=20% Similarity=0.273 Sum_probs=111.4
Q ss_pred CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEE
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLD 249 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~ 249 (602)
+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++ .|..++.+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 455566666666666 334 5777888888888888654 23467778888888888888887 667778888888888
Q ss_pred ccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 250 VGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 250 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
+++|++++..|..++.+++|++|++++|.+.+.+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++.+
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 88888887777778888888888888887333455 67888888888888888875 33 67788888888888888764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-20 Score=209.81 Aligned_cols=176 Identities=23% Similarity=0.290 Sum_probs=124.6
Q ss_pred CCEEECcCCcCcccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCc
Q 047576 157 LQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP 236 (602)
Q Consensus 157 L~~L~Ls~N~i~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip 236 (602)
|+.++|+.|.|. .++++.|++. ..|..+..+++|+.|+|++|.+. .+|..++++++|++|+|++|.|+.+|
T Consensus 193 l~~l~Ls~~~i~-------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp 263 (727)
T 4b8c_D 193 LQHKKLSQYSID-------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELP 263 (727)
T ss_dssp -------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCC
T ss_pred hhcCccCccccc-------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccC
Confidence 455556665543 3456666666 66888999999999999999998 68888889999999999999999999
Q ss_pred ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCC
Q 047576 237 QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMED 316 (602)
Q Consensus 237 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 316 (602)
..++++++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|+.|+|++|.|++.+|..+..+..
T Consensus 264 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~ 341 (727)
T 4b8c_D 264 AEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV 341 (727)
T ss_dssp GGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH
T ss_pred hhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch
Confidence 99999999999999999999 78999999999999999999997 77888999999999999999999998888755432
Q ss_pred -CCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 317 -LTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 317 -L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
+..|+|++|.++|.+|..+ ..|+++.|
T Consensus 342 ~~~~l~l~~N~l~~~~p~~l------~~l~l~~n 369 (727)
T 4b8c_D 342 TGLIFYLRDNRPEIPLPHER------RFIEINTD 369 (727)
T ss_dssp HHHHHHHHHCCCCCCCCCC---------------
T ss_pred hhhHHhhccCcccCcCcccc------ceeEeecc
Confidence 2347899999999988754 45566666
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=164.57 Aligned_cols=131 Identities=24% Similarity=0.344 Sum_probs=87.4
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc--cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ--EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSC 276 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 276 (602)
+++++++|+++ .+|..+.. +|++|++++|+++++|. .++++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45666666663 45554432 66666666666666543 266667777777777777766666677777777777777
Q ss_pred CcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 277 NQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 277 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666666777777777777777776667777777777777777777776543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=164.79 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=124.2
Q ss_pred ceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCC-ccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCC
Q 047576 223 KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPS-TLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301 (602)
Q Consensus 223 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 301 (602)
+.+++++|+++.+|..+.. +|++|++++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 7899999999999987764 999999999999987765 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 302 KLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 302 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+|++..|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999888889999999999999999999999999999999999999999998766
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=5.4e-18 Score=157.01 Aligned_cols=130 Identities=24% Similarity=0.199 Sum_probs=60.5
Q ss_pred CCcCEEECcCCcCC-CCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEEE
Q 047576 172 TNLNYMSLSRNMLG-GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLD 249 (602)
Q Consensus 172 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~ 249 (602)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++ +|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 44444445555555555555555443 344445555555555555554 444444445555555
Q ss_pred ccCCCCCCCC-CCccCCCCCCccccCCCCcCCCCCc---hhhhCCCCCCEEeccCCCC
Q 047576 250 VGNNDIIGPI-PSTLGLFSDLSYLDLSCNQFNSSIP---NELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 250 L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l 303 (602)
+++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 5555544321 1334444444444444444443332 2344444444444444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=155.11 Aligned_cols=137 Identities=23% Similarity=0.263 Sum_probs=109.9
Q ss_pred CCCCCEEEecCCCCC-CCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCcccc
Q 047576 195 LKNLIELDVGDNSLI-GPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLD 273 (602)
Q Consensus 195 l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 273 (602)
.++|++|+|++|+++ +.+|..+..+++|++|++++|.++++ ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 377888888888887 77888888888888888888888888 6778888888888888888877777777788888888
Q ss_pred CCCCcCCCCC-chhhhCCCCCCEEeccCCCCCCCCC---cccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 274 LSCNQFNSSI-PNELTRLTQLFHLDLSSNKLSGKIP---SQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 274 L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
+++|.+++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 8888887643 2678888888888888888886554 47788888888888888876 3443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=175.71 Aligned_cols=136 Identities=17% Similarity=0.146 Sum_probs=96.9
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHH---------------HHhhhhHhHHHHHHhhhcCccccccc
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEEL---------------AFIRSFRNEAQVLSQMERGSLFRILH 435 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~---------------~~~~~~~~E~~il~~l~~gsL~~~l~ 435 (602)
|.....||+|+||.||+|+..+|+.||+|+++....... .....+.+|+.++..+.+..+...+.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~ 171 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEe
Confidence 334489999999999999987899999999864322110 13456788998886665322222221
Q ss_pred cc--------cch---hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 436 ND--------AEA---VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 436 ~~--------~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.. .++ ..+.......++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 172 ~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~----- 242 (282)
T 1zar_A 172 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV----- 242 (282)
T ss_dssp EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEET-----
T ss_pred ccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC-----
Confidence 10 000 01222445679999999999999 78999999999999999 999999999998643
Q ss_pred Ccccccccccccccccccc
Q 047576 505 NQTLLAGSYGYIAPELAYT 523 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~ 523 (602)
..++|||++.+
T Consensus 243 --------~~~~a~e~l~r 253 (282)
T 1zar_A 243 --------GEEGWREILER 253 (282)
T ss_dssp --------TSTTHHHHHHH
T ss_pred --------CCCCHHHHHHH
Confidence 34678888754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-17 Score=152.17 Aligned_cols=130 Identities=23% Similarity=0.254 Sum_probs=59.2
Q ss_pred eeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCC
Q 047576 224 ILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 224 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 303 (602)
.+++++|+++.+|..+. ++|+.|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+.|+|++|+|
T Consensus 11 ~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 11 EIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 34444444444443222 3444444444444443333444444444444444444443333344444444445544444
Q ss_pred CCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 304 SGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 304 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 89 QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 4444444444445555555555554433333444445555555555554433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.6e-17 Score=154.00 Aligned_cols=128 Identities=24% Similarity=0.324 Sum_probs=92.5
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCc
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 278 (602)
+++++++|+++ .+|..+. ++|++|+|++|+++.+|..+.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 46677777766 4555442 56777777777777777777777777777777777777666777777777777777777
Q ss_pred CCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 777777677777777777777777776555567777777777777777764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9e-18 Score=152.24 Aligned_cols=127 Identities=25% Similarity=0.227 Sum_probs=92.1
Q ss_pred CCCcCEEECcCCcCC-CCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCCcEE
Q 047576 171 LTNLNYMSLSRNMLG-GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLL 248 (602)
Q Consensus 171 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L 248 (602)
.++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|++++ +|..+.++++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 355666777777776 66777777888888888888887765 567777888888888888877 67666677778888
Q ss_pred EccCCCCCCC-CCCccCCCCCCccccCCCCcCCCCCc---hhhhCCCCCCEEecc
Q 047576 249 DVGNNDIIGP-IPSTLGLFSDLSYLDLSCNQFNSSIP---NELTRLTQLFHLDLS 299 (602)
Q Consensus 249 ~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls 299 (602)
++++|.+++. .|..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888877763 34666777777777777777776555 456677777777765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=155.04 Aligned_cols=130 Identities=26% Similarity=0.380 Sum_probs=121.1
Q ss_pred ceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCC
Q 047576 223 KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNK 302 (602)
Q Consensus 223 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 302 (602)
+.+++++|+++.+|..+. ++|+.|+|++|+|+ .+|..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 689999999999998765 69999999999998 778899999999999999999999888899999999999999999
Q ss_pred CCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 303 LSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 303 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++...-
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99988889999999999999999999877778999999999999999997643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=148.55 Aligned_cols=126 Identities=24% Similarity=0.295 Sum_probs=75.4
Q ss_pred CCCceeecccccCC--CCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEe
Q 047576 220 TSLKILILAQNQLS--GLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297 (602)
Q Consensus 220 ~~L~~L~L~~N~l~--~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 297 (602)
++|+.|++++|.++ .+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555555 2555555555555555555555544 4455566666666666666655665566666666666
Q ss_pred ccCCCCCCC-CCcccCCCCCCCEEeCCCCCCCCCCC---ccccccccccccccc
Q 047576 298 LSSNKLSGK-IPSQIASMEDLTWLDLSNNNIKGSIP---GEITKLSRLDYLNLS 347 (602)
Q Consensus 298 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~ 347 (602)
+++|++++. .+..+..+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666652 23556666667777777776665544 356666667666665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-18 Score=194.31 Aligned_cols=212 Identities=17% Similarity=0.144 Sum_probs=150.8
Q ss_pred CccccCCccCCCCCCCCEEECcCCcCc--------ccCCCcCEEECcCCcCC-CCCchhhhCCCCCCEEEec--------
Q 047576 142 GFTGSIPSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNMLG-GLLPQEIGNLKNLIELDVG-------- 204 (602)
Q Consensus 142 ~~~~~ip~~l~~L~~L~~L~Ls~N~i~--------~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~-------- 204 (602)
...+.+|..+..+++|++|+|++|.++ +.+++|++|+|+ |.++ +.++..+..+++|++|+|+
T Consensus 280 ~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~ 358 (592)
T 3ogk_B 280 MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGM 358 (592)
T ss_dssp CCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTT
T ss_pred cchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccccc
Confidence 345566777777888888888888765 347888888888 4443 3344445678888888888
Q ss_pred ---CCCCCCCCcc-cccCcCCCceeecccccCCC-CcccccC-CCCCcEEEcc----CCCCCCC-----CCCccCCCCCC
Q 047576 205 ---DNSLIGPIPL-TLSRLTSLKILILAQNQLSG-LPQEIGN-LKNLMLLDVG----NNDIIGP-----IPSTLGLFSDL 269 (602)
Q Consensus 205 ---~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~-ip~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~l~~l~~L 269 (602)
.|.+++.... ...++++|++|+++.|++++ .+..++. +++|+.|+++ .|.+++. ++..+..+++|
T Consensus 359 ~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L 438 (592)
T 3ogk_B 359 EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438 (592)
T ss_dssp SSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC
T ss_pred ccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC
Confidence 3566543222 24457888888888888887 4555554 7888888886 6777763 33345668888
Q ss_pred ccccCCCC--cCCCCCchhhhC-CCCCCEEeccCCCCCCC-CCcccCCCCCCCEEeCCCCCCCCC-CCcccccccccccc
Q 047576 270 SYLDLSCN--QFNSSIPNELTR-LTQLFHLDLSSNKLSGK-IPSQIASMEDLTWLDLSNNNIKGS-IPGEITKLSRLDYL 344 (602)
Q Consensus 270 ~~L~L~~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 344 (602)
++|++++| .+++..+..++. +++|+.|+|++|++++. ++..+..+++|+.|++++|.+++. ++..+..+++|+.|
T Consensus 439 ~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 518 (592)
T 3ogk_B 439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL 518 (592)
T ss_dssp CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEE
T ss_pred CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCee
Confidence 88888753 366655555543 78899999999988763 445567788999999999988754 34445678889999
Q ss_pred cccCCcCCCc
Q 047576 345 NLSGNKLSGR 354 (602)
Q Consensus 345 ~l~~N~l~g~ 354 (602)
++++|++++.
T Consensus 519 ~ls~n~it~~ 528 (592)
T 3ogk_B 519 WVQGYRASMT 528 (592)
T ss_dssp EEESCBCCTT
T ss_pred ECcCCcCCHH
Confidence 9999988765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.9e-16 Score=145.77 Aligned_cols=131 Identities=25% Similarity=0.308 Sum_probs=73.0
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
+.+++++|+++. +|..+ .++|+.|++++|+++++|. .++++++|++|++++|++++..+..+..+++|++|++++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 344445544442 33222 2455555555555555433 3455555555555555555444445555666666666666
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCC
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIP 332 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 332 (602)
++++..+..+..+++|++|+|++|+|++..+..+..+++|+.|++++|.+++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6665555555666666666666666665544455666667777777776665443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4.5e-19 Score=169.12 Aligned_cols=115 Identities=23% Similarity=0.270 Sum_probs=75.8
Q ss_pred hhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCC
Q 047576 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDL 269 (602)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 269 (602)
..+..+++|++|+|++|++++ +| .+.++++|++|++++|+++.+|..+..+++|+.|++++|++++ +| .+..+++|
T Consensus 42 ~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 377777777777777777776 55 6777777777777777777777666666777777777777765 33 45556666
Q ss_pred ccccCCCCcCCCCCc-hhhhCCCCCCEEeccCCCCCCCCC
Q 047576 270 SYLDLSCNQFNSSIP-NELTRLTQLFHLDLSSNKLSGKIP 308 (602)
Q Consensus 270 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 308 (602)
++|++++|++++..+ ..+..+++|++|++++|++++.+|
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 666666666654322 345566666666666666654444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.7e-19 Score=169.75 Aligned_cols=157 Identities=26% Similarity=0.343 Sum_probs=136.6
Q ss_pred hhhCCCCCCEEEecCCCCCCCCcc------cccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccC
Q 047576 191 EIGNLKNLIELDVGDNSLIGPIPL------TLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264 (602)
Q Consensus 191 ~~~~l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 264 (602)
.+....+++.++++.|.++|.+|. .+..+++|++|++++|+++++| .+.++++|+.|++++|+++ .+|..+.
T Consensus 13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 356677888888888888888776 8999999999999999999998 8999999999999999998 6788888
Q ss_pred CCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC-cccCCCCCCCEEeCCCCCCCCCCCcc---------
Q 047576 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-SQIASMEDLTWLDLSNNNIKGSIPGE--------- 334 (602)
Q Consensus 265 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~--------- 334 (602)
.+++|++|++++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 88999999999999987 45 68899999999999999986432 47899999999999999998876653
Q ss_pred -cccccccccccccCCcCCC
Q 047576 335 -ITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 335 -~~~l~~L~~L~l~~N~l~g 353 (602)
+..+++|+.|+ +|+++.
T Consensus 169 ~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHCSSCSEEC--CGGGTT
T ss_pred HHHhCCCcEEEC--CcccCH
Confidence 78899999886 676654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=4.9e-16 Score=145.02 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=84.3
Q ss_pred ccCcCCCceeecccccCCCCcccccCCC-CCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCC
Q 047576 216 LSRLTSLKILILAQNQLSGLPQEIGNLK-NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294 (602)
Q Consensus 216 l~~l~~L~~L~L~~N~l~~ip~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 294 (602)
+.++++|+.|++++|+++.+|. +..+. +|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..+..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 3445555556666665555543 33333 666666666666653 4566666677777777777655444456777777
Q ss_pred EEeccCCCCCCCCCc--ccCCCCCCCEEeCCCCCCCCCCCcc----cccccccccccccCCcCC
Q 047576 295 HLDLSSNKLSGKIPS--QIASMEDLTWLDLSNNNIKGSIPGE----ITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 295 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 352 (602)
+|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777775 3454 6677777777777777776 34443 777778888888777654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-17 Score=184.79 Aligned_cols=194 Identities=14% Similarity=0.054 Sum_probs=108.3
Q ss_pred CCCCCccchhccccCCccccCCccCCCC--CCCCEEECcCCc-Cc--------ccCCCcCEEECcCCcCCCC----Cchh
Q 047576 127 CFPNLESLRILAYYDGFTGSIPSEISAL--SKLQLLDLSSNR-LR--------GRLTNLNYMSLSRNMLGGL----LPQE 191 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~~~ip~~l~~L--~~L~~L~Ls~N~-i~--------~~l~~L~~L~L~~N~l~~~----~p~~ 191 (602)
.+++|+.|++. .+.+.+..+..++.+ ++|++|+|++|. +. ..+++|++|+|++|.+++. ++..
T Consensus 110 ~~~~L~~L~L~--~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~ 187 (592)
T 3ogk_B 110 NLRQLKSVHFR--RMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHEL 187 (592)
T ss_dssp HCTTCCEEEEE--SCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHH
T ss_pred hCCCCCeEEee--ccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHH
Confidence 45666666665 334444444444442 337777776665 22 1367777777777776655 3345
Q ss_pred hhCCCCCCEEEecCCCCCC----CCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCC---CCCCCccC
Q 047576 192 IGNLKNLIELDVGDNSLIG----PIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDII---GPIPSTLG 264 (602)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~---~~~p~~l~ 264 (602)
+.++++|++|+|++|.+++ .++..+.++++|+.|++++|.++++|..+.++++|+.|+++.+... +..+..+.
T Consensus 188 ~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 267 (592)
T 3ogk_B 188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267 (592)
T ss_dssp HHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred HhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence 5566777777777777763 2333445667777777777777777666667777777777643222 22233444
Q ss_pred CCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC-cccCCCCCCCEEeCC
Q 047576 265 LFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-SQIASMEDLTWLDLS 323 (602)
Q Consensus 265 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~ 323 (602)
.+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++
T Consensus 268 ~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 268 FPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp CCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred ccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 55555555555432 22344455555555666665555443222 223445555555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=142.79 Aligned_cols=103 Identities=22% Similarity=0.326 Sum_probs=52.0
Q ss_pred CCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccc-cCCCCCcEEEccCCCCCCCCCC--ccCCCCCCcccc
Q 047576 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEI-GNLKNLMLLDVGNNDIIGPIPS--TLGLFSDLSYLD 273 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~-~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~ 273 (602)
+|++|+|++|.+++. ..+..+++|++|+|++|+++++|+.+ ..+++|++|++++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 555555555555543 34555555555555555555544332 55555555555555553 2333 444455555555
Q ss_pred CCCCcCCCCCch----hhhCCCCCCEEeccCCCC
Q 047576 274 LSCNQFNSSIPN----ELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 274 L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l 303 (602)
+++|.++. +|. .+..+++|+.||+++|.+
T Consensus 120 l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 120 ILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred ecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 55555542 222 244455555555555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=155.77 Aligned_cols=201 Identities=15% Similarity=0.198 Sum_probs=121.9
Q ss_pred CCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhC--------CCCCCEEEecCCCCCCCCcccccCc
Q 047576 154 LSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGN--------LKNLIELDVGDNSLIGPIPLTLSRL 219 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~l~~l 219 (602)
+++|++|||++|+|. +.++.+..+.+..|.|. +..|.+ +++|+.|+|.+ +++...+.+|.++
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~ 123 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGC 123 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcC
Confidence 778888888888877 12333444555555322 344555 66666666666 5555555566666
Q ss_pred CCCceeecccccCCCCc-ccccCCCCCcEEEccCCCC----CCCCCCcc-------------------------------
Q 047576 220 TSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDI----IGPIPSTL------------------------------- 263 (602)
Q Consensus 220 ~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l----~~~~p~~l------------------------------- 263 (602)
++|+.|++++|.++.|+ ..|.++.++..+.+..+.. .......|
T Consensus 124 ~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~ 203 (329)
T 3sb4_A 124 DNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRD 203 (329)
T ss_dssp TTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGG
T ss_pred cccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccc
Confidence 66666666666665543 3445444444444433111 00000000
Q ss_pred -------------------CCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCC-EEeCC
Q 047576 264 -------------------GLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT-WLDLS 323 (602)
Q Consensus 264 -------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~ 323 (602)
..+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++...+..|.++++|+ .+++.
T Consensus 204 ~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~ 282 (329)
T 3sb4_A 204 INFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELP 282 (329)
T ss_dssp CSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEEC
T ss_pred cceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEc
Confidence 02567777777777777666667777777777777777 6655566677777777 77777
Q ss_pred CCCCCCCCCcccccccccccccccCCcCCCccCCCCC
Q 047576 324 NNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNK 360 (602)
Q Consensus 324 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 360 (602)
+ +++...+..|.++++|+.+++++|.++..-+..+.
T Consensus 283 ~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~ 318 (329)
T 3sb4_A 283 A-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG 318 (329)
T ss_dssp T-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred c-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence 6 66656667777777777777777777665555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=135.29 Aligned_cols=107 Identities=24% Similarity=0.279 Sum_probs=79.6
Q ss_pred CceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCC
Q 047576 222 LKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSN 301 (602)
Q Consensus 222 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 301 (602)
.+.+++++|+++.+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4567777777777776553 67777777777777777777777777777777777777666666777777777777777
Q ss_pred CCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 302 KLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 302 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
+|++..+..|..+++|+.|+|++|.+++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 77766666677777777777777777754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=156.86 Aligned_cols=222 Identities=15% Similarity=0.160 Sum_probs=145.1
Q ss_pred CCCCCEEECcCCcC-------cccCCCcCEEECcCCcCC--CCCchhhhCCCCCCEEEecCCCCCCCCcccccC------
Q 047576 154 LSKLQLLDLSSNRL-------RGRLTNLNYMSLSRNMLG--GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR------ 218 (602)
Q Consensus 154 L~~L~~L~Ls~N~i-------~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------ 218 (602)
+.+|+.|.++++-- ...+++|++|||++|+|. ...+..+ +.++.+.+..|.+ .+..|.+
T Consensus 24 ~~~l~~L~l~g~i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 24 ANSITHLTLTGKLNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVT 97 (329)
T ss_dssp HHHCSEEEEEEEECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEE
T ss_pred hCceeEEEEeccccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccc
Confidence 56788888876521 123788888888888887 2222222 2355666666643 2245566
Q ss_pred --cCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcC----CC----------
Q 047576 219 --LTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQF----NS---------- 281 (602)
Q Consensus 219 --l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~---------- 281 (602)
+++|+.|+|.+ +++.|++ +|.++++|+.|++++|.++...+..|....++..+.+..+.. ..
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 88999999988 8888654 688888999999999888877777888777777776655221 00
Q ss_pred ------------CCchh---------------------------h-hCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEe
Q 047576 282 ------------SIPNE---------------------------L-TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLD 321 (602)
Q Consensus 282 ------------~~p~~---------------------------~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 321 (602)
.++.. + ..+++|+.|+|++|+++...+..|.++++|+.|+
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 00000 0 1267888999998888866666788888999999
Q ss_pred CCCCCCCCCCCcccccccccc-cccccCCcCCCccCCCCCcCCCCCCCc-cccCccccccccccc
Q 047576 322 LSNNNIKGSIPGEITKLSRLD-YLNLSGNKLSGRVPYSNKHLSSMPTPR-KIDSKYCIGTGAYGS 384 (602)
Q Consensus 322 L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~lp~t~-~f~~~~~LG~G~~g~ 384 (602)
|.+| ++...+..|.++++|+ .+++.+ .++..-+..+.....+.... .-.....|+.++|..
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGN 319 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCT
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcC
Confidence 9887 7767777888888888 888887 56554455554333332111 012234566666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-14 Score=133.28 Aligned_cols=106 Identities=24% Similarity=0.294 Sum_probs=78.3
Q ss_pred ceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCC
Q 047576 223 KILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNK 302 (602)
Q Consensus 223 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 302 (602)
+.+++++|+++.+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 567777777777776654 677777777777777777777777777777777777776655566777778888888887
Q ss_pred CCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 303 LSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 303 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
|++..+..|..+++|+.|+|++|.+...
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred cceeCHHHhccccCCCEEEeCCCCcccc
Confidence 7765555677777777888877777743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=4.2e-15 Score=147.74 Aligned_cols=125 Identities=21% Similarity=0.262 Sum_probs=88.3
Q ss_pred ccCcccccccccccceeeec-CCCcE--EeeeccCCchhH---------------------HHHHhhhhHhHHHHHHhhh
Q 047576 371 IDSKYCIGTGAYGSVYKAQL-PNGRV--FALKKLNSPETE---------------------ELAFIRSFRNEAQVLSQME 426 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~---------------------~~~~~~~~~~E~~il~~l~ 426 (602)
|.....||+|+||.||+|+. .+|+. ||||+++..... .......+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45567899999999999987 68989 999987543211 0011235778888887665
Q ss_pred cCcc-----c---------ccccccc----c--h--hhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC
Q 047576 427 RGSL-----F---------RILHNDA----E--A--VELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS 484 (602)
Q Consensus 427 ~gsL-----~---------~~l~~~~----~--~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~ 484 (602)
+..+ . +++...+ . . ...++.++..++.|++.|+.|||. +.+|+||||||+|||++.
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~ 206 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID 206 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC
Confidence 4321 1 1121000 0 0 012244678899999999999994 459999999999999998
Q ss_pred CCcceeecccccccc
Q 047576 485 KLEAFVADFGTARLL 499 (602)
Q Consensus 485 ~~~~kL~DFG~a~~~ 499 (602)
.++|+|||+|...
T Consensus 207 --~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 --KVYFIDMGQAVTL 219 (258)
T ss_dssp --SEEECCCTTCEET
T ss_pred --cEEEEECcccccC
Confidence 9999999999765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-14 Score=131.84 Aligned_cols=110 Identities=25% Similarity=0.307 Sum_probs=100.5
Q ss_pred CCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCC
Q 047576 244 NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLS 323 (602)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 323 (602)
+.+.+++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 45789999999985 77665 3899999999999999999999999999999999999998888888999999999999
Q ss_pred CCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 324 NNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 324 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999998888889999999999999999988654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.53 E-value=8.6e-17 Score=178.98 Aligned_cols=207 Identities=17% Similarity=0.138 Sum_probs=149.6
Q ss_pred ccCCccCCCCCCCCEEECcCCcCcc--------cCCCcCEEECcCCcCCCC-CchhhhCCCCCCEEEec---------CC
Q 047576 145 GSIPSEISALSKLQLLDLSSNRLRG--------RLTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVG---------DN 206 (602)
Q Consensus 145 ~~ip~~l~~L~~L~~L~Ls~N~i~~--------~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~---------~N 206 (602)
+.+|..+..+++|++|+|++|.+++ .+++|++|+|++| ++.. ++.....+++|++|+|+ .|
T Consensus 279 ~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~ 357 (594)
T 2p1m_B 279 AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNV 357 (594)
T ss_dssp GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSS
T ss_pred hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCC
Confidence 3455555578899999999998763 5789999999988 4422 22333458999999983 35
Q ss_pred CCCCCCccccc-CcCCCceeecccccCCC-Cccccc-CCCCCcEEEcc--C----CCCCCC-----CCCccCCCCCCccc
Q 047576 207 SLIGPIPLTLS-RLTSLKILILAQNQLSG-LPQEIG-NLKNLMLLDVG--N----NDIIGP-----IPSTLGLFSDLSYL 272 (602)
Q Consensus 207 ~l~~~~p~~l~-~l~~L~~L~L~~N~l~~-ip~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~l~~l~~L~~L 272 (602)
.+++.....+. ++++|+.|.++.|++++ .+..+. ++++|+.|+++ + |.+++. ++..+..+++|+.|
T Consensus 358 ~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L 437 (594)
T 2p1m_B 358 ALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437 (594)
T ss_dssp CCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEE
T ss_pred CCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEE
Confidence 55543333333 47899999998899887 344444 58899999999 4 556532 11225667899999
Q ss_pred cCCCCcCCCCCchhhhC-CCCCCEEeccCCCCCCCCCccc-CCCCCCCEEeCCCCCCCCCCCc-ccccccccccccccCC
Q 047576 273 DLSCNQFNSSIPNELTR-LTQLFHLDLSSNKLSGKIPSQI-ASMEDLTWLDLSNNNIKGSIPG-EITKLSRLDYLNLSGN 349 (602)
Q Consensus 273 ~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N 349 (602)
++++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... .+..+++|+.|++++|
T Consensus 438 ~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 438 SLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp ECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred eecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 9977 777666666665 8899999999999876555444 6689999999999999654443 4456889999999999
Q ss_pred cCCC
Q 047576 350 KLSG 353 (602)
Q Consensus 350 ~l~g 353 (602)
+++.
T Consensus 517 ~~~~ 520 (594)
T 2p1m_B 517 SVSF 520 (594)
T ss_dssp CCBH
T ss_pred CCCH
Confidence 8854
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.2e-14 Score=129.38 Aligned_cols=108 Identities=26% Similarity=0.330 Sum_probs=98.1
Q ss_pred CcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCC
Q 047576 245 LMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSN 324 (602)
Q Consensus 245 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 324 (602)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 478999999996 6777664 8999999999999999999999999999999999999987777789999999999999
Q ss_pred CCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 325 NNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 325 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
|+|++..+..+..+++|+.|++++|++...-
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999877777999999999999999998654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-15 Score=169.88 Aligned_cols=123 Identities=20% Similarity=0.206 Sum_probs=67.0
Q ss_pred CCCCCccchhccccCCccccCCccCC-CCCCCCEEECcCC-cCcc--------cCCCcCEEECcCCcCCCCCchhhh---
Q 047576 127 CFPNLESLRILAYYDGFTGSIPSEIS-ALSKLQLLDLSSN-RLRG--------RLTNLNYMSLSRNMLGGLLPQEIG--- 193 (602)
Q Consensus 127 ~l~~L~~L~l~~~~~~~~~~ip~~l~-~L~~L~~L~Ls~N-~i~~--------~l~~L~~L~L~~N~l~~~~p~~~~--- 193 (602)
.+++|+.|++. .+.+.+..+..+. .+++|++|+|++| .++. .+++|++|+|++|.+++..+..+.
T Consensus 103 ~~~~L~~L~L~--~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 103 SYTWLEEIRLK--RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HCTTCCEEEEE--SCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred hCCCCCeEEee--CcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 45566666665 3344444444443 4667777777666 3332 366677777777766655444443
Q ss_pred -CCCCCCEEEecCCCCCCCCccc----ccCcCCCceeecccc-cCCCCcccccCCCCCcEEEccC
Q 047576 194 -NLKNLIELDVGDNSLIGPIPLT----LSRLTSLKILILAQN-QLSGLPQEIGNLKNLMLLDVGN 252 (602)
Q Consensus 194 -~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N-~l~~ip~~~~~l~~L~~L~L~~ 252 (602)
.+++|++|+|++|. ....+.. +.++++|++|++++| .++++|..+.++++|+.|+++.
T Consensus 181 ~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 181 DTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG 244 (594)
T ss_dssp TTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSB
T ss_pred hcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEccccc
Confidence 44567777776665 1111111 233466666766666 3333555555556666665443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.44 E-value=9.9e-13 Score=138.97 Aligned_cols=233 Identities=13% Similarity=0.116 Sum_probs=177.2
Q ss_pred CCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCC
Q 047576 116 FNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLL 188 (602)
Q Consensus 116 ~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~ 188 (602)
+...+..+.-..|.+. .|....+.+++...-..+|.+ .+|+.++|.+ .+. ..+++|+.++|++|+++.+.
T Consensus 120 ip~~i~~I~~~aF~~~-~L~~i~l~~~i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~ 196 (401)
T 4fdw_A 120 LPNSVKSIPKDAFRNS-QIAKVVLNEGLKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLP 196 (401)
T ss_dssp CCTTCCEECTTTTTTC-CCSEEECCTTCCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEEC
T ss_pred ECCccCEehHhhcccC-CccEEEeCCCccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEec
Confidence 3445555555555542 344444456655444567777 4799999986 443 24789999999999999877
Q ss_pred chhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcc-cccCCCCCcEEEccCCCCCCCCCCccCCCC
Q 047576 189 PQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQ-EIGNLKNLMLLDVGNNDIIGPIPSTLGLFS 267 (602)
Q Consensus 189 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 267 (602)
...|. .++|+.+.|..| ++.....+|.++++|+.+++.+| ++.|+. .|.+ .+|+.+.+. |.++...+..|.+++
T Consensus 197 ~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~ 271 (401)
T 4fdw_A 197 ASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCP 271 (401)
T ss_dssp TTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCT
T ss_pred hhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCC
Confidence 77777 589999999854 77667778999999999999875 666654 5555 789999994 557766678899999
Q ss_pred CCccccCCCCcCC-----CCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccc
Q 047576 268 DLSYLDLSCNQFN-----SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLD 342 (602)
Q Consensus 268 ~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 342 (602)
+|+.+++.+|.+. ...+..|.++++|+.++|. |.++......|.++++|+.++|.+| ++...+..|.++ +|+
T Consensus 272 ~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~ 348 (401)
T 4fdw_A 272 ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIK 348 (401)
T ss_dssp TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCC
T ss_pred CCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCC
Confidence 9999999988875 3556789999999999999 4577666778999999999999655 776667889998 999
Q ss_pred cccccCCcCCCccCCCC
Q 047576 343 YLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 343 ~L~l~~N~l~g~~p~~~ 359 (602)
.+++++|.+....+..+
T Consensus 349 ~l~l~~n~~~~l~~~~F 365 (401)
T 4fdw_A 349 EVKVEGTTPPQVFEKVW 365 (401)
T ss_dssp EEEECCSSCCBCCCSSC
T ss_pred EEEEcCCCCcccccccc
Confidence 99999997765444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.8e-12 Score=136.90 Aligned_cols=218 Identities=11% Similarity=0.099 Sum_probs=169.2
Q ss_pred CCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc----c--CCCcCEEECcCCcCCCCCchhhhCCCCCCEEE
Q 047576 129 PNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG----R--LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELD 202 (602)
Q Consensus 129 ~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~----~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 202 (602)
..++.+.+ .+++...-..+|.+. +|+.++|.+| +.. . -.+|+.+.|.+ .++.+.+.+|.++++|+.++
T Consensus 113 ~~l~~i~i---p~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIIL---PNSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEEC---CTTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEE---CCccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 44454443 455555445678875 7999999877 431 0 24799999986 78878888999999999999
Q ss_pred ecCCCCCCCCcccccCcCCCceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCC
Q 047576 203 VGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281 (602)
Q Consensus 203 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 281 (602)
|++|+++......|. .++|+.+.+.+| ++.|+ ..|.++++|+.+++.+| ++......|.+ .+|+.+.+ .|.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 999999865555666 689999999854 77764 47889999999999976 66556667777 78999999 566777
Q ss_pred CCchhhhCCCCCCEEeccCCCCC-----CCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 282 SIPNELTRLTQLFHLDLSSNKLS-----GKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
..+.+|.++++|+.+++.+|.+. ...+..|.++++|+.++|. |.++......|.++++|+.+.+..| ++..-+
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 77889999999999999998875 3456789999999999999 5587677788999999999999665 543333
Q ss_pred CCC
Q 047576 357 YSN 359 (602)
Q Consensus 357 ~~~ 359 (602)
..+
T Consensus 340 ~aF 342 (401)
T 4fdw_A 340 SAF 342 (401)
T ss_dssp TSS
T ss_pred HhC
Confidence 333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.4e-13 Score=139.71 Aligned_cols=103 Identities=21% Similarity=0.207 Sum_probs=54.4
Q ss_pred eecccc-cCCCCcccccCCCCCcEEEccC-CCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCC
Q 047576 225 LILAQN-QLSGLPQEIGNLKNLMLLDVGN-NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNK 302 (602)
Q Consensus 225 L~L~~N-~l~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 302 (602)
++++++ +|++||. ++.+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 13 v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp EECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 344444 5555555 55555555555553 55555444555555555555555555555555555555555555555555
Q ss_pred CCCCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 303 LSGKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 303 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
|++..+..+..++ |+.|+|++|.+..
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccC
Confidence 5544444444443 5555555555553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.8e-15 Score=158.50 Aligned_cols=164 Identities=16% Similarity=0.158 Sum_probs=82.6
Q ss_pred CCcCEEECcCCcCCCCCchhhhCC-----CCCCEEEecCCCCCCCCcccc-cCcCCCceeecccccCCCC-cccc-----
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNL-----KNLIELDVGDNSLIGPIPLTL-SRLTSLKILILAQNQLSGL-PQEI----- 239 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~i-p~~~----- 239 (602)
++|++|+|++|.|+......+... ++|++|+|++|.++......+ ..+++|+.|+|++|+++.. ...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 344444444555443333333222 456666666665543222222 2345566666666665541 1111
Q ss_pred cCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCCCcCCCC----CchhhhCCCCCCEEeccCCCCCCC----C
Q 047576 240 GNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSCNQFNSS----IPNELTRLTQLFHLDLSSNKLSGK----I 307 (602)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 307 (602)
...++|+.|+|++|.|+.. ++..+...++|++|+|++|.|++. ++..+...++|+.|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 1345566666666665431 222334455566666666666532 234455566677777777776542 2
Q ss_pred CcccCCCCCCCEEeCCCCCCCCCCCccc
Q 047576 308 PSQIASMEDLTWLDLSNNNIKGSIPGEI 335 (602)
Q Consensus 308 p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 335 (602)
+..+...++|+.|+|++|.|++.....+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 2233445667777777777665433333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.9e-15 Score=154.54 Aligned_cols=160 Identities=19% Similarity=0.158 Sum_probs=126.0
Q ss_pred CCCCCEEECcCCcCcc------------cCCCcCEEECcCCcCCCCCchhh-hCCCCCCEEEecCCCCCCCCcccc----
Q 047576 154 LSKLQLLDLSSNRLRG------------RLTNLNYMSLSRNMLGGLLPQEI-GNLKNLIELDVGDNSLIGPIPLTL---- 216 (602)
Q Consensus 154 L~~L~~L~Ls~N~i~~------------~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l---- 216 (602)
+++|++|+|++|.|+. ..++|++|+|++|.|+......+ ..+++|++|+|++|.|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4679999999999973 23699999999999986544443 346789999999999976544444
Q ss_pred -cCcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCCCC----CCCccCCCCCCccccCCCCcCCCC----
Q 047576 217 -SRLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDIIGP----IPSTLGLFSDLSYLDLSCNQFNSS---- 282 (602)
Q Consensus 217 -~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~---- 282 (602)
...++|++|+|++|.++. ++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 346889999999999976 455667889999999999999753 245567788999999999999864
Q ss_pred CchhhhCCCCCCEEeccCCCCCCCCCcccCC
Q 047576 283 IPNELTRLTQLFHLDLSSNKLSGKIPSQIAS 313 (602)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 313 (602)
++..+...++|++|+|++|.|++.....+..
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 3445666799999999999998655444433
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.38 E-value=2.3e-13 Score=141.36 Aligned_cols=117 Identities=12% Similarity=0.122 Sum_probs=81.5
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhH------------------HHH-HhhhhHhHHHHHHh-------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETE------------------ELA-FIRSFRNEAQVLSQ------- 424 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~-~~~~~~~E~~il~~------- 424 (602)
|.....||+|++|.||+|..++|+.||||+++..... ... ......+|...+..
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 6778899999999999999999999999987532110 000 00112334444422
Q ss_pred ----------------hhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCc-
Q 047576 425 ----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLE- 487 (602)
Q Consensus 425 ----------------l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~- 487 (602)
++++.+.++. +......++.|++.++.||| +.|||||||||.|||+++++.
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 2222222221 22334568899999999999 779999999999999988763
Q ss_pred ---------ceeecccccccc
Q 047576 488 ---------AFVADFGTARLL 499 (602)
Q Consensus 488 ---------~kL~DFG~a~~~ 499 (602)
+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 789999977654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.6e-12 Score=134.63 Aligned_cols=103 Identities=23% Similarity=0.202 Sum_probs=73.5
Q ss_pred EEECcCC-cCCCCCchhhhCCCCCCEEEecC-CCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccC
Q 047576 176 YMSLSRN-MLGGLLPQEIGNLKNLIELDVGD-NSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGN 252 (602)
Q Consensus 176 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~ 252 (602)
.++++++ +|++ +|. |..+++|++|+|++ |+|++..|..|++|++|+.|+|++|+|+++ |..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3456665 6664 555 77777788888875 777777777777778888888888887774 44667777777888877
Q ss_pred CCCCCCCCCccCCCCCCccccCCCCcCCC
Q 047576 253 NDIIGPIPSTLGLFSDLSYLDLSCNQFNS 281 (602)
Q Consensus 253 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 281 (602)
|+|++..+..+..++ |+.|+|.+|.|..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 777766555555555 7777777777764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=7.4e-11 Score=122.54 Aligned_cols=78 Identities=17% Similarity=0.112 Sum_probs=45.2
Q ss_pred CCCcCEEECcCCcCC---------CCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-Cccccc
Q 047576 171 LTNLNYMSLSRNMLG---------GLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIG 240 (602)
Q Consensus 171 l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~ 240 (602)
+++|+.|.+..+... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++. ....++
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 567777777654331 224455666777777777776311 1222 3 26777777777766654 222332
Q ss_pred --CCCCCcEEEcc
Q 047576 241 --NLKNLMLLDVG 251 (602)
Q Consensus 241 --~l~~L~~L~L~ 251 (602)
.+++|+.|+|+
T Consensus 215 ~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 215 GSDLPNLEKLVLY 227 (362)
T ss_dssp HSBCTTCCEEEEE
T ss_pred HccCCCCcEEEEe
Confidence 56777777764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-11 Score=122.44 Aligned_cols=18 Identities=6% Similarity=-0.285 Sum_probs=12.7
Q ss_pred CCCCCCceeCCCC-CEEEE
Q 047576 90 HCEWIGITCNSAG-SIIGL 107 (602)
Q Consensus 90 ~C~w~gv~C~~~~-~v~~l 107 (602)
.|+|.|+.|+..+ +|+.+
T Consensus 77 l~~~~g~i~~~~~~ki~~~ 95 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISII 95 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCE
T ss_pred HHhcCcEEECCCCCEEEEE
Confidence 5889999998654 44433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-10 Score=120.17 Aligned_cols=77 Identities=14% Similarity=0.121 Sum_probs=46.3
Q ss_pred ccCCCCCCCCEEECcCCcCc----------------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCC
Q 047576 149 SEISALSKLQLLDLSSNRLR----------------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212 (602)
Q Consensus 149 ~~l~~L~~L~~L~Ls~N~i~----------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 212 (602)
.++..+++|+.|.+..+... ..+++|+.|+|++|.-. .++. + .+++|+.|+|..+.++...
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHH
Confidence 34556677777777654321 13577888888776311 1222 3 3778888888877765433
Q ss_pred ccccc--CcCCCceeecc
Q 047576 213 PLTLS--RLTSLKILILA 228 (602)
Q Consensus 213 p~~l~--~l~~L~~L~L~ 228 (602)
...+. .+++|+.|+|+
T Consensus 210 l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHHHSBCTTCCEEEEE
T ss_pred HHHHHHccCCCCcEEEEe
Confidence 33333 67788888775
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.63 E-value=2.4e-07 Score=97.40 Aligned_cols=213 Identities=15% Similarity=0.067 Sum_probs=135.2
Q ss_pred CCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhhCCCCC
Q 047576 125 FSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNL 198 (602)
Q Consensus 125 ~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 198 (602)
|...++|+.+.+ .++....-..+|.++++|+.+++..|--. ..+..|+.+.+..+... +.......++|
T Consensus 158 F~~c~~L~~i~l---~~~~~~I~~~~F~~c~~L~~i~l~~~~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l 232 (394)
T 4fs7_A 158 FATCESLEYVSL---PDSMETLHNGLFSGCGKLKSIKLPRNLKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGV 232 (394)
T ss_dssp TTTCTTCCEEEC---CTTCCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCC
T ss_pred hcccCCCcEEec---CCccceeccccccCCCCceEEEcCCCceEeCchhhccccccceeecCCCceE--eehhhcccCCC
Confidence 444444444443 44544433456888888888888776211 23566777777665432 22334445678
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCc
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 278 (602)
+.+.+..+ ++......+.+..+|+.+.+..+..+--...+.++..++.+....+.+. ...|..+.+|+.+.+..+
T Consensus 233 ~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~- 307 (394)
T 4fs7_A 233 KNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS- 307 (394)
T ss_dssp CEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-
T ss_pred ceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccccc-
Confidence 88877643 3334445677778888888776644333445667777777777665432 235667777888777654
Q ss_pred CCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 279 FNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
++.....+|.++++|+.++|..+ ++.....+|.++.+|+.+++..| ++.....+|.++++|+.+++..|
T Consensus 308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 55555667777788888888644 55444567778888888888766 66555667778888888777654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=1.7e-08 Score=94.58 Aligned_cols=110 Identities=15% Similarity=0.128 Sum_probs=62.9
Q ss_pred cCCccCCCCCCCCEEECcCC-cCcc-----------cCCCcCEEECcCCcCCCC----CchhhhCCCCCCEEEecCCCCC
Q 047576 146 SIPSEISALSKLQLLDLSSN-RLRG-----------RLTNLNYMSLSRNMLGGL----LPQEIGNLKNLIELDVGDNSLI 209 (602)
Q Consensus 146 ~ip~~l~~L~~L~~L~Ls~N-~i~~-----------~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 209 (602)
.+...+...+.|++|+|++| .|.. ..++|++|+|++|.|+.. +...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34456777888888888888 7762 245677777777776542 2333444466666666666665
Q ss_pred CC----CcccccCcCCCceeec--ccccCCC-----CcccccCCCCCcEEEccCCCC
Q 047576 210 GP----IPLTLSRLTSLKILIL--AQNQLSG-----LPQEIGNLKNLMLLDVGNNDI 255 (602)
Q Consensus 210 ~~----~p~~l~~l~~L~~L~L--~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l 255 (602)
.. +...+...++|++|+| ++|.++. +...+...++|++|+|++|.+
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 32 2333444455666666 5555553 222333345555555555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.60 E-value=2.9e-07 Score=96.71 Aligned_cols=221 Identities=14% Similarity=0.088 Sum_probs=156.9
Q ss_pred cccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc------ccCCCcCEEECcCCcCCCCCchhhh
Q 047576 120 LSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIG 193 (602)
Q Consensus 120 l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~~p~~~~ 193 (602)
+..+....|.+...+... ...+....-..+|.++++|+.+.+.++-.. ..+.+|+.+++..| ++.+....|.
T Consensus 128 l~~i~~~aF~~~~~~~~~-~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~ 205 (394)
T 4fs7_A 128 LKSIGVEAFKGCDFKEIT-IPEGVTVIGDEAFATCESLEYVSLPDSMETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFA 205 (394)
T ss_dssp CCEECTTTTTTCCCSEEE-CCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTT
T ss_pred eeeecceeeecccccccc-cCccccccchhhhcccCCCcEEecCCccceeccccccCCCCceEEEcCCC-ceEeCchhhc
Confidence 333444455544433332 122222223457899999999999876432 24788999999876 6666678899
Q ss_pred CCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccc
Q 047576 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYL 272 (602)
Q Consensus 194 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 272 (602)
++..|+.+.+..+... +........+|+.+.+..+ ++.+ ...+.++.+|+.+.+..+..+ .....|.....++.+
T Consensus 206 ~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~ 281 (394)
T 4fs7_A 206 ECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKV 281 (394)
T ss_dssp TCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEE
T ss_pred cccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccccccee
Confidence 9999999998877533 3334455678888888643 4444 345778899999999887554 556678888899988
Q ss_pred cCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCC
Q 047576 273 DLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352 (602)
Q Consensus 273 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 352 (602)
....+.+. ...|..+.+|+.+.+..+ ++.....+|.++.+|+.+++.++ ++.....+|.++.+|+.+.+..| ++
T Consensus 282 ~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 282 IYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp EECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred ccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 88776542 346888899999999765 65555678999999999999754 77566788999999999998776 54
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.59 E-value=6.5e-09 Score=97.38 Aligned_cols=66 Identities=20% Similarity=0.159 Sum_probs=31.7
Q ss_pred hhhCCCCCCEEEecCC-CCCCC----CcccccCcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCC
Q 047576 191 EIGNLKNLIELDVGDN-SLIGP----IPLTLSRLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 191 ~~~~l~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
.+...++|++|+|++| .+... +...+...++|++|+|++|+++. +...+...++|++|+|++|.|+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 4444555666666655 54421 12233344555555555555543 2233334445555555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=9.4e-09 Score=101.56 Aligned_cols=63 Identities=27% Similarity=0.412 Sum_probs=28.1
Q ss_pred CCCCCCEEEecCCCCCC--CCcccccCcCCCceeecccccCCCCcccccCCC--CCcEEEccCCCCCC
Q 047576 194 NLKNLIELDVGDNSLIG--PIPLTLSRLTSLKILILAQNQLSGLPQEIGNLK--NLMLLDVGNNDIIG 257 (602)
Q Consensus 194 ~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~--~L~~L~L~~N~l~~ 257 (602)
++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|+++. .+..++ +|++|+|++|.+.+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~-~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER-ELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG-GGGGGTTSCCSEEECTTSTTGG
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch-hhhhcccCCcceEEccCCcCcc
Confidence 44555555555555554 22333444455555555555554431 122222 44444444444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.49 E-value=3.9e-06 Score=88.01 Aligned_cols=109 Identities=10% Similarity=0.164 Sum_probs=68.9
Q ss_pred ccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCC
Q 047576 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318 (602)
Q Consensus 239 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 318 (602)
|.++++|+.+.+.++..+ .....|.++++|+.+.+. +.++......|.++.+|+.++|..+ ++.....+|.++.+|+
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence 455666777776554332 444566667777777775 4455455556777777777777654 4434455677777777
Q ss_pred EEeCCCCCCCCCCCcccccccccccccccCCcC
Q 047576 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351 (602)
Q Consensus 319 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 351 (602)
.+.+..+ ++.....+|.++++|+.+++.+|..
T Consensus 338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred EEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 7777543 5545556777777777777766643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.7e-06 Score=90.78 Aligned_cols=131 Identities=14% Similarity=0.121 Sum_probs=93.3
Q ss_pred cccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCC
Q 047576 215 TLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLF 294 (602)
Q Consensus 215 ~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 294 (602)
+|.+.++|+.+.+.++..+--...|.++++|+.+.+. +.++......|.++++|+.+++..+ ++.....+|.++++|+
T Consensus 260 aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp TTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred eeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence 4667788888888655432223467889999999996 5566566678999999999999865 6666677899999999
Q ss_pred EEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcC
Q 047576 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351 (602)
Q Consensus 295 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 351 (602)
.+.|..+ ++.....+|.++++|+.+++.+|.... ..+.....|+.+.+..|.+
T Consensus 338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred EEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 9999755 665556789999999999999876532 3566777888888776654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=6.5e-07 Score=88.22 Aligned_cols=124 Identities=18% Similarity=0.160 Sum_probs=83.7
Q ss_pred cccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-ccccccc------------c
Q 047576 370 KIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-SLFRILH------------N 436 (602)
Q Consensus 370 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-sL~~~l~------------~ 436 (602)
.|......+.|+.+.||++... ++.+++|+....... ....+.+|+.+++++..+ ..-+.+. +
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 4656667788888999999864 678999998643211 124688899999887542 2222221 1
Q ss_pred ccchhhhc-----HHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 047576 437 DAEAVELD-----WAKRVNIVKAMAHALAYLHHDC--------------------------------------------- 466 (602)
Q Consensus 437 ~~~~~~l~-----~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------- 466 (602)
..++..+. ......++.++++++..||...
T Consensus 91 ~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 91 EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp CCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 11111121 1234578899999999999610
Q ss_pred -----------CCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 467 -----------SPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 467 -----------~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876666799998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.28 E-value=1.6e-05 Score=82.72 Aligned_cols=106 Identities=11% Similarity=0.065 Sum_probs=51.8
Q ss_pred ccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCC
Q 047576 239 IGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLT 318 (602)
Q Consensus 239 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 318 (602)
+.++.+|+.+.+..+ ++......|.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++......|.++.+|+
T Consensus 236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~ 313 (379)
T 4h09_A 236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS 313 (379)
T ss_dssp TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence 344445555555443 33333344455555555555432 3333334455555555555555555543444555555555
Q ss_pred EEeCCCCCCCCCCCccccccccccccccc
Q 047576 319 WLDLSNNNIKGSIPGEITKLSRLDYLNLS 347 (602)
Q Consensus 319 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 347 (602)
.+.|..+ ++.....+|.++.+|+.+.+.
T Consensus 314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 314 SVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred EEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 5555433 443334455555555555543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.27 E-value=7.8e-07 Score=87.16 Aligned_cols=122 Identities=20% Similarity=0.147 Sum_probs=79.7
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcc--ccccc------------c
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSL--FRILH------------N 436 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL--~~~l~------------~ 436 (602)
+....+.+.|..+.||++...+|+.+++|...... ...+.+|+.+++++.+..+ -..+. +
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 44333445666799999988778889999876531 2456778888877654322 11111 1
Q ss_pred ccchhhhcH--HHHHHHHHHHHHHHHHhhhcC------------------------------------------------
Q 047576 437 DAEAVELDW--AKRVNIVKAMAHALAYLHHDC------------------------------------------------ 466 (602)
Q Consensus 437 ~~~~~~l~~--~~~~~i~~~ia~~L~~LH~~~------------------------------------------------ 466 (602)
..++..++| .....++.++++.+..+|...
T Consensus 96 ~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 96 EVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp CCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 111222221 123367888999999999531
Q ss_pred -------CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 -------SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 -------~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.22 E-value=2.7e-07 Score=93.37 Aligned_cols=165 Identities=21% Similarity=0.244 Sum_probs=101.7
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-Ccc----------------ccc----
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-GSL----------------FRI---- 433 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-gsL----------------~~~---- 433 (602)
..++.|....||++. ..+++|+.... .....+.+|..+++++.. ..+ ..+
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 447899999999985 45888986543 123567888988876632 111 011
Q ss_pred -ccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcC------------------------------------------
Q 047576 434 -LHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDC------------------------------------------ 466 (602)
Q Consensus 434 -l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 466 (602)
+.... ....++..++..++.++++.+..||...
T Consensus 97 ~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 97 KIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred ccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 11100 0112455667788999999999999510
Q ss_pred -------------CCCeEEeCCCCCCeeeCC--CCcceeecccccccccCCCCCccc--------------ccccccccc
Q 047576 467 -------------SPSVVHRDISSNNILLNS--KLEAFVADFGTARLLHADSSNQTL--------------LAGSYGYIA 517 (602)
Q Consensus 467 -------------~~~ivH~DLkp~NILld~--~~~~kL~DFG~a~~~~~~~~~~~~--------------~~gt~~y~a 517 (602)
...++|+|++|.||++++ ...+.|+||+.+...+....-... .....++..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 135799999999999998 556789999988654321000000 000011111
Q ss_pred -ccccccCcCCccchhHHHHHHHHHHHcCCCCCC
Q 047576 518 -PELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 518 -PE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
|+.... .....+.|++|.++|.+.+|..+|-
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 222111 1223689999999999999998863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.15 E-value=3.6e-06 Score=87.05 Aligned_cols=122 Identities=16% Similarity=0.233 Sum_probs=80.7
Q ss_pred cccccccccccceeeecCCCcEEeeeccC--CchhHHHHHhhhhHhHHHHHHhhhcCcc---------------------
Q 047576 374 KYCIGTGAYGSVYKAQLPNGRVFALKKLN--SPETEELAFIRSFRNEAQVLSQMERGSL--------------------- 430 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~~~~E~~il~~l~~gsL--------------------- 430 (602)
...++.|.++.||+++..+ ..+++|+.. ..... .....+.+|..+++++....+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567899999999998754 578888876 33211 123467789988877653111
Q ss_pred cccccccc----chhhhcHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 047576 431 FRILHNDA----EAVELDWAKRVNIVKAMAHALAYLHHDC---------------------------------------- 466 (602)
Q Consensus 431 ~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 466 (602)
.+++.... ....++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 11111100 0112457788889999999999999621
Q ss_pred ---------------CCCeEEeCCCCCCeeeCCCCc--ceeeccccccc
Q 047576 467 ---------------SPSVVHRDISSNNILLNSKLE--AFVADFGTARL 498 (602)
Q Consensus 467 ---------------~~~ivH~DLkp~NILld~~~~--~kL~DFG~a~~ 498 (602)
...++|||++|.||+++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 58999998864
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.04 E-value=7.5e-05 Score=77.59 Aligned_cols=185 Identities=11% Similarity=0.062 Sum_probs=130.3
Q ss_pred CccCCCCCCCCEEECcCCcCcc-------------------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCC
Q 047576 148 PSEISALSKLQLLDLSSNRLRG-------------------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSL 208 (602)
Q Consensus 148 p~~l~~L~~L~~L~Ls~N~i~~-------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 208 (602)
...+....+|+.+.+..+.... ....+..+.+..+ ........+....+|+.+.+..+ +
T Consensus 151 ~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~ 228 (379)
T 4h09_A 151 DGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-V 228 (379)
T ss_dssp SCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-C
T ss_pred cchhcccccccccccccccceeecccceecccccceeccccccccccccccccc-eeEEeecccccccccceeeeccc-e
Confidence 3445666677776665543220 1233444444332 22344566777888999988765 4
Q ss_pred CCCCcccccCcCCCceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhh
Q 047576 209 IGPIPLTLSRLTSLKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNEL 287 (602)
Q Consensus 209 ~~~~p~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 287 (602)
.......+.+..+|+.+.+..+ ++.|. ..+.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++.....+|
T Consensus 229 ~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF 306 (379)
T 4h09_A 229 TTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVF 306 (379)
T ss_dssp CEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTT
T ss_pred eEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhh
Confidence 4455567888999999999776 66654 46788899999999754 554556688999999999999998987778899
Q ss_pred hCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccc
Q 047576 288 TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKL 338 (602)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 338 (602)
.++.+|+.+.|..+ ++.....+|.++++|+.+.+..+ ++..-..+|.+.
T Consensus 307 ~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 307 MDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 99999999999765 66455678999999999988654 553444555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.54 E-value=2e-05 Score=72.30 Aligned_cols=79 Identities=10% Similarity=0.135 Sum_probs=40.3
Q ss_pred cCEEECcCCcCCCCCchhhhCCCCCCEEEecCCC-CCCCCcccccCc----CCCceeecccc-cCCC--CcccccCCCCC
Q 047576 174 LNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-LIGPIPLTLSRL----TSLKILILAQN-QLSG--LPQEIGNLKNL 245 (602)
Q Consensus 174 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l----~~L~~L~L~~N-~l~~--ip~~~~~l~~L 245 (602)
|++|||+++.|+...-..+.++++|++|+|+++. ++...-..++.+ ++|++|+|++| ++|. + ..+.++++|
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl-~~L~~~~~L 141 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI-IALHHFRNL 141 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH-HHGGGCTTC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH-HHHhcCCCC
Confidence 3344444444443333445566666666666664 443322334433 24666666665 3554 2 234555666
Q ss_pred cEEEccCC
Q 047576 246 MLLDVGNN 253 (602)
Q Consensus 246 ~~L~L~~N 253 (602)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.47 E-value=1.7e-05 Score=72.79 Aligned_cols=82 Identities=13% Similarity=0.180 Sum_probs=39.7
Q ss_pred CCcEEEccCCCCCCCCCCccCCCCCCccccCCCCc-CCCCCchhhhCC----CCCCEEeccCCC-CCCCCCcccCCCCCC
Q 047576 244 NLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ-FNSSIPNELTRL----TQLFHLDLSSNK-LSGKIPSQIASMEDL 317 (602)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 317 (602)
+|+.||++++.++...-..+..+++|+.|+|+++. ++...-..++.+ ++|++|+|+++. |+...-..++.+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555443333334445555555555553 443222233332 246666666653 554333344555666
Q ss_pred CEEeCCCC
Q 047576 318 TWLDLSNN 325 (602)
Q Consensus 318 ~~L~L~~N 325 (602)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.40 E-value=9.4e-05 Score=69.08 Aligned_cols=81 Identities=15% Similarity=0.103 Sum_probs=42.1
Q ss_pred ccCCCCCCCCEEECcCC-cCcc-----------cCCCcCEEECcCCcCCCC----CchhhhCCCCCCEEEecCCCCCCCC
Q 047576 149 SEISALSKLQLLDLSSN-RLRG-----------RLTNLNYMSLSRNMLGGL----LPQEIGNLKNLIELDVGDNSLIGPI 212 (602)
Q Consensus 149 ~~l~~L~~L~~L~Ls~N-~i~~-----------~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 212 (602)
..+.+-+.|++|+|++| +|.. .-+.|+.|+|++|+|... +...+..-+.|++|+|++|.|....
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455567888888775 6652 134566666666666532 2233334455666666666654322
Q ss_pred c----ccccCcCCCceeeccc
Q 047576 213 P----LTLSRLTSLKILILAQ 229 (602)
Q Consensus 213 p----~~l~~l~~L~~L~L~~ 229 (602)
- ..+..-+.|+.|+|++
T Consensus 115 a~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCC
T ss_pred HHHHHHHHhhCCceeEEECCC
Confidence 1 1233334455555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.36 E-value=3.7e-05 Score=71.82 Aligned_cols=39 Identities=23% Similarity=0.260 Sum_probs=17.1
Q ss_pred CcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCC
Q 047576 218 RLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 218 ~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
.-+.|+.|+|++|+++. |...+..-+.|+.|+|++|.|+
T Consensus 68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33444445555544442 2222333344555555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00058 Score=59.44 Aligned_cols=34 Identities=26% Similarity=0.266 Sum_probs=13.6
Q ss_pred ccccCCCCcCCCCCchhhhCCCCCCEEeccCCCC
Q 047576 270 SYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKL 303 (602)
Q Consensus 270 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 303 (602)
++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 34 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 34 TELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp SEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 3333333333333333334444444444444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.002 Score=55.99 Aligned_cols=37 Identities=27% Similarity=0.274 Sum_probs=22.1
Q ss_pred CCCEEEecCCCCCCCCcccccCcCCCceeecccccCC
Q 047576 197 NLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLS 233 (602)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 233 (602)
+|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4666666666666555555566666666666666553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0024 Score=64.23 Aligned_cols=116 Identities=16% Similarity=0.187 Sum_probs=74.2
Q ss_pred ccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC-c--ccccc-------------cccc
Q 047576 375 YCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG-S--LFRIL-------------HNDA 438 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g-s--L~~~l-------------~~~~ 438 (602)
..++.|....||+. |+.+++|+.... .....+.+|..+++++.+. . +-+.+ .+..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 45678888899998 466888886432 1245788899999887542 1 11111 1001
Q ss_pred chh--------hhcHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 047576 439 EAV--------ELDWAKRVNIVKAMAHALAYLHHD--------------------------------------------- 465 (602)
Q Consensus 439 ~~~--------~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------------- 465 (602)
++. .++..++..++.++++.|..||..
T Consensus 96 ~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 96 QGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred CCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 111 123445566677777777777742
Q ss_pred ------------CCCCeEEeCCCCCCeeeCC---CCcc-eeecccccccc
Q 047576 466 ------------CSPSVVHRDISSNNILLNS---KLEA-FVADFGTARLL 499 (602)
Q Consensus 466 ------------~~~~ivH~DLkp~NILld~---~~~~-kL~DFG~a~~~ 499 (602)
....++|+|++|.||++++ ++.+ .|+||+.+..-
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 4554 79999987654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0014 Score=65.14 Aligned_cols=52 Identities=21% Similarity=0.253 Sum_probs=37.2
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l 425 (602)
+.....+|.|..+.||+.+..||+.|++|+....... ....|..|...|+.+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L 68 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA---LDGLFRAEALGLDWL 68 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHH
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHH
Confidence 3345667999999999999999999999986543321 123466777777444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0063 Score=62.24 Aligned_cols=32 Identities=22% Similarity=0.297 Sum_probs=26.6
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 35789999999999999654578999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.96 E-value=0.015 Score=57.90 Aligned_cols=115 Identities=16% Similarity=0.111 Sum_probs=68.5
Q ss_pred ccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcC---------------ccccccc
Q 047576 371 IDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERG---------------SLFRILH 435 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~g---------------sL~~~l~ 435 (602)
+.....++.|....+|++ +.+++|+...... ......+|..+++.+..- -+.+++.
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecC
Confidence 333567888999999999 4588888764321 112234577666544321 1222220
Q ss_pred cccchhhhcHHHH---HHHHHHHHHHHHHhhhcC----------------------------------------------
Q 047576 436 NDAEAVELDWAKR---VNIVKAMAHALAYLHHDC---------------------------------------------- 466 (602)
Q Consensus 436 ~~~~~~~l~~~~~---~~i~~~ia~~L~~LH~~~---------------------------------------------- 466 (602)
.+..++.... ..++.++++.|+-+|...
T Consensus 91 ---~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 91 ---GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp ---TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ---CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 1222333222 225666777777777431
Q ss_pred ----CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 ----SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ----~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|+|+.|.||+ ..++.+.++||..+..
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 123799999999999 5566789999987754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0071 Score=59.13 Aligned_cols=29 Identities=24% Similarity=0.352 Sum_probs=25.5
Q ss_pred eEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 470 VVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 470 ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++|+|+.+.||++++++.+-|+||+.+..
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 79999999999999887777999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.36 E-value=0.018 Score=59.82 Aligned_cols=31 Identities=23% Similarity=0.315 Sum_probs=26.2
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|||+.|.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4688999999999999876 489999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.037 Score=55.77 Aligned_cols=32 Identities=31% Similarity=0.567 Sum_probs=28.6
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998888899999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.1 Score=54.60 Aligned_cols=78 Identities=12% Similarity=0.044 Sum_probs=48.6
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCcccccc--ccccccccccccC---cCCccchhHHHHHHHHH
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG--SYGYIAPELAYTM---VMTEKYDVYSFGVVTLE 541 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGvil~e 541 (602)
...++|||++|.|||++.++ ++++||+.+..-....... .... ...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999998876 9999999886532110000 0010 1345666654321 11223456677888887
Q ss_pred HHcCC
Q 047576 542 VLMGK 546 (602)
Q Consensus 542 lltG~ 546 (602)
..+++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=89.20 E-value=0.3 Score=49.00 Aligned_cols=33 Identities=33% Similarity=0.397 Sum_probs=28.2
Q ss_pred CCCeEEeCCCCCCeeeCCC----Ccceeecccccccc
Q 047576 467 SPSVVHRDISSNNILLNSK----LEAFVADFGTARLL 499 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~----~~~kL~DFG~a~~~ 499 (602)
...++|||+.+.||+++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.88 E-value=0.14 Score=51.08 Aligned_cols=32 Identities=22% Similarity=0.240 Sum_probs=26.9
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
..+++|+|+++.||+++++..+.++||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 45799999999999999876668999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.08 E-value=0.46 Score=47.40 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=25.7
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|||+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45789999999999999 4 889999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=83.82 E-value=1.3 Score=41.50 Aligned_cols=103 Identities=18% Similarity=0.102 Sum_probs=61.9
Q ss_pred ccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 429 SLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 429 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
+|.++|.. ...++++.++-.++.|.+.+|.-.-.. +.+ ..+=+-|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 45555554 345699999999999999988776210 011 1223346788888888876653 1110
Q ss_pred cccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCC
Q 047576 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPR 549 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 549 (602)
.....+.|||... ...+.+.=|||+|+++|..+--..|=
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1123466888764 34567889999999999998755553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=82.58 E-value=0.76 Score=48.56 Aligned_cols=17 Identities=29% Similarity=0.374 Sum_probs=15.2
Q ss_pred CCCeEEeCCCCCCeeeC
Q 047576 467 SPSVVHRDISSNNILLN 483 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld 483 (602)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 45789999999999998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=81.93 E-value=0.8 Score=46.21 Aligned_cols=33 Identities=21% Similarity=0.430 Sum_probs=28.6
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
...++|+|+.+.||++++++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999877543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=81.84 E-value=0.76 Score=46.81 Aligned_cols=31 Identities=26% Similarity=0.371 Sum_probs=25.2
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
...++|+|+++.||+++++. +.++||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 45789999999999998654 89999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 602 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-12 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-40
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 45/255 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG+G++G+VYK + A+K LN +++F+NE VL +
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 425 ------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
E SL+ LH + + K ++I + A + YLH S++H
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPELAYTM---VMT 527
RD+ SNNI L+ L + DFG A + S + L+GS ++APE+ +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 528 EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL- 586
+ DVY+FG+V E++ G+ P + + + +I ++ + P KV +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYS-------NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 587 LVSTISFACLQSNPK 601
+ + CL+
Sbjct: 241 AMKRLMAECLKKKRD 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 47/259 (18%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
IGTG+YG K + +G++ K+L+ E A + +E +L +
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 425 -----------------MERGSLFRILHNDAEAVE-LDWAKRVNIVKAMAHALAYLH--H 464
E G L ++ + + LD + ++ + AL H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 465 DCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTM 524
D +V+HRD+ N+ L+ K + DFG AR+L+ D+S G+ Y++PE M
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 525 VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR--KVI 582
EK D++S G + E+ P ++ K + + + + R +
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 583 QDILLVSTISFACLQSNPK 601
+I+ L
Sbjct: 243 NEIIT------RMLNLKDY 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-39
Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 46/251 (18%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G+VY A+ + + ALK L + E+ R E ++ S
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
G+++R L ++ D + + +A+AL+Y H S V
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRV 127
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRDI N+LL S E +ADFG + HA SS +T L G+ Y+ PE+ + EK
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590
D++S GV+ E L+GK P + +++Y I ++ P V +D++
Sbjct: 186 DLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFTFPDFVTEGA-RDLIS--- 236
Query: 591 ISFACLQSNPK 601
L+ NP
Sbjct: 237 ---RLLKHNPS 244
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 53/250 (21%), Positives = 89/250 (35%), Gaps = 43/250 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G G +G V+ A+K L +F EA ++ Q
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 425 ------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
ME GSL L ++L K +++ +A +A++ +H
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSN-QTLLAGSYGYIAPELAYTMVMTEKYD 531
RD+ + NIL++ L +ADFG ARL+ + + + APE T K D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 532 VYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTI 591
V+SFG++ E++ T L P ++ Q + L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRPDNCPEELYQLMRL---- 245
Query: 592 SFACLQSNPK 601
C + P+
Sbjct: 246 ---CWKERPE 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 35/198 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G G V+K P+G V A K ++ E QVL +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 71
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M+ GSL ++L + + A+ L YL +
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRD+ +NIL+NS+ E + DFG + L +N G+ Y++PE + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQGTHYSVQS 184
Query: 531 DVYSFGVVTLEVLMGKHP 548
D++S G+ +E+ +G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 52/264 (19%)
Query: 370 KIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---- 424
K D + IG G++ +VYK A +L + + + + F+ EA++L
Sbjct: 12 KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHP 68
Query: 425 -------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHAL 459
M G+L L + + + + L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGL 125
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
+LH P ++HRD+ +NI + + D G A L A + + G+ ++AP
Sbjct: 126 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAP 182
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578
E+ Y E DVY+FG+ LE+ ++P S + + V P D
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFD 235
Query: 579 RKVIQDIL-LVSTISFACLQSNPK 601
+ I ++ ++ C++ N
Sbjct: 236 KVAIPEVKEIIE----GCIRQNKD 255
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 49/270 (18%)
Query: 362 LSSMPTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFR 416
L S+ + KY IG GA G+VY A + G+ A++++N ++
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELII 65
Query: 417 NEAQVLSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNI 451
NE V+ + + GSL ++ D + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAV 121
Query: 452 VKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAG 511
+ AL +LH S V+HRDI S+NILL + DFG + + S ++ + G
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 512 SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571
+ ++APE+ K D++S G++ +E++ G+ P + L + Y I +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIATNGTPEL 236
Query: 572 RLPPPVDRKVIQDILLVSTISFACLQSNPK 601
+ P + + +D L CL + +
Sbjct: 237 QNPEKLS-AIFRDFLN------RCLDMDVE 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-34
Identities = 53/250 (21%), Positives = 91/250 (36%), Gaps = 43/250 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
+G G +G V+ A+K L +F EAQV+ +
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 425 ------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
M +GSL L + + V++ +A +AY+ VH
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN---YVH 136
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHAD-SSNQTLLAGSYGYIAPELAYTMVMTEKYD 531
RD+ + NIL+ L VADFG ARL+ + + + + APE A T K D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 532 VYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTI 591
V+SFG++ E+ ++D +++ P + + + +
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH---DL 246
Query: 592 SFACLQSNPK 601
C + P+
Sbjct: 247 MCQCWRKEPE 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 7e-34
Identities = 52/257 (20%), Positives = 96/257 (37%), Gaps = 55/257 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G++G+VY A+ + N V A+KK++ + + E + L +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+ + + L + + LAYLH S ++
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM---T 527
+HRD+ + NILL+ + DFG+A ++ +S G+ ++APE+ M
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYD 192
Query: 528 EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV---IQD 584
K DV+S G+ +E+ K P + + L + P ++
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 585 ILLVSTISFACLQSNPK 601
+ +CLQ P+
Sbjct: 246 FVD------SCLQKIPQ 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-34
Identities = 52/251 (20%), Positives = 85/251 (33%), Gaps = 49/251 (19%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG G +G V G A+K + + T + +F EA V++Q
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 68
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M +GSL L + +V L + + A+ YL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
VHRD+++ N+L++ A V+DFG + SS Q + APE + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590
DV+SFG++ E+ L + P V + +
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEKGYKMDAPDGCPPAVYEVMK---- 234
Query: 591 ISFACLQSNPK 601
C +
Sbjct: 235 ---NCWHLDAA 242
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 9e-34
Identities = 54/255 (21%), Positives = 90/255 (35%), Gaps = 48/255 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G GAYG V A A+K ++ + + + E +
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 70
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
G LF + D + + + + YLH +
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH---GIGI 124
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPELAYTM-VMT 527
HRDI N+LL+ + ++DFG A + ++ + L + G+ Y+APEL
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 528 EKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL- 586
E DV+S G+V +L G+ P D S D D +++ +K+ L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 587 LVSTISFACLQSNPK 601
L+ L NP
Sbjct: 239 LLH----KILVENPS 249
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 50/258 (19%), Positives = 90/258 (34%), Gaps = 52/258 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G GA+G VYKAQ + A K +++ EE + + E +L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLD 76
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
G++ ++ L ++ + K AL YLH +
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM---- 526
+HRD+ + NIL + +ADFG + + G+ ++APE+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 527 -TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585
K DV+S G+ +E+ + P +P +L+ + P
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHH-------ELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 586 L--LVSTISFACLQSNPK 601
+ CL+ N
Sbjct: 245 FKDFLK----KCLEKNVD 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 51/257 (19%)
Query: 377 IGTGAYGSVYKAQL---PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--------- 424
+G G +GSV + A+K L + EAQ++ Q
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 74
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
G L + L E E+ + ++ ++ + YL +
Sbjct: 75 IGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---LAGSYGYIAPELAYTMVM 526
VHRD+++ N+LL ++ A ++DFG ++ L AD S T + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 527 TEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD-RKVIQD 584
+ + DV+S+GV E L G+ P P++M +R+ P + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMK------GPEVMAFIEQGKRMECPPECPPELYA 243
Query: 585 ILLVSTISFACLQSNPK 601
++ C +
Sbjct: 244 LMS------DCWIYKWE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 54/257 (21%), Positives = 98/257 (38%), Gaps = 51/257 (19%)
Query: 377 IGTGAYGSVYKAQLPN---GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--------- 424
+G+G +G+V K + A+K L E + A EA V+ Q
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
E G L + L + + + +V ++ + YL +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---QTLLAGSYGYIAPELAYTMVM 526
VHRD+++ N+LL ++ A ++DFG ++ L AD + QT + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 527 TEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD-RKVIQD 584
+ K DV+SFGV+ E G+ P ++ + +R+ P + + D
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEKGERMGCPAGCPREMYD 241
Query: 585 ILLVSTISFACLQSNPK 601
++ C + +
Sbjct: 242 LMN------LCWTYDVE 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 3e-33
Identities = 56/300 (18%), Positives = 106/300 (35%), Gaps = 74/300 (24%)
Query: 359 NKHLSSMPTPR-KIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAF 411
N L S+ PR I+ IG GA+G V++A+ P + A+K L + +
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--M 59
Query: 412 IRSFRNEAQVLSQ-------------------------MERGSLFRILHN---------- 436
F+ EA ++++ M G L L +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 437 -----------DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK 485
L A+++ I + +A +AYL VHRD+++ N L+
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 486 LEAFVADFGTARLLHADSSNQ--TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVL 543
+ +ADFG +R +++ + A ++ PE + T + DV+++GVV E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 544 MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR--KVIQDILLVSTISFACLQSNPK 601
+ ++ V D + + + +++ C P
Sbjct: 237 SYGLQPY------YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPA 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 54/276 (19%), Positives = 92/276 (33%), Gaps = 55/276 (19%)
Query: 376 CIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQ--------------- 420
IG G +G V++ + G A+K +S E
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 421 ----------VLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDC---- 466
V E GSLF L+ + + + + A LA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 467 -SPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL----LAGSYGYIAPELA 521
P++ HRD+ S NIL+ +AD G A + + + G+ Y+APE+
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 522 YTMVM------TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSY--------DPKIMLID 567
+ ++ D+Y+ G+V E+ +H Y + M
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 568 VLDQRLPPPVDRKVIQDILLVSTISFA--CLQSNPK 601
V +Q+L P + + L C +N
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-33
Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 53/268 (19%)
Query: 368 PRKID-SKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQV 421
PRK + +G G++ +V A+ L R +A+K L + + E V
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 422 LSQ-------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMA 456
+S+ + G L + + D +
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIV 118
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYG 514
AL YLH ++HRD+ NILLN + + DFGTA++L +S G+
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 515 YIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574
Y++PEL + D+++ G + +++ G P + + ++ ++
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYD 228
Query: 575 PPVD-RKVIQDILLVSTISFACLQSNPK 601
P +D++ L +
Sbjct: 229 FPEKFFPKARDLVE------KLLVLDAT 250
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 1e-32
Identities = 53/252 (21%), Positives = 91/252 (36%), Gaps = 45/252 (17%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G YG VY+ A+K L E+ + F EA V+ +
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M G+L L + E+ + + ++ A+ YL +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-TLLAGSYGYIAPELAYTMVMTEK 529
+HRD+++ N L+ VADFG +RL+ D+ + APE + K
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 530 YDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVS 589
DV++FGV+ E+ LS + ++L++ + +
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVY--- 246
Query: 590 TISFACLQSNPK 601
+ AC Q NP
Sbjct: 247 ELMRACWQWNPS 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 49/261 (18%), Positives = 91/261 (34%), Gaps = 47/261 (18%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ--- 424
P+ + +GTG +G V + A+K + E F EA+V+
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 425 ----------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYL 462
M G L L + + + K + A+ YL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYL 116
Query: 463 HHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPELA 521
+HRD+++ N L+N + V+DFG +R + D ++ + PE+
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 522 YTMVMTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580
+ K D+++FGV+ E+ +GK P + + + + Q L
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHL 225
Query: 581 VIQDILLVSTISFACLQSNPK 601
+ + TI ++C
Sbjct: 226 ASEKVY---TIMYSCWHEKAD 243
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 46/251 (18%), Positives = 82/251 (32%), Gaps = 45/251 (17%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG+G +G V+ N A+K + E F EA+V+ +
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
ME G L L + + + + + V+
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGM---AYLEEACVI 123
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL-LAGSYGYIAPELAYTMVMTEKY 530
HRD+++ N L+ V+DFG R + D + + +PE+ + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 531 DVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVST 590
DV+SFGV+ EV + + S + + RL +++
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN------- 236
Query: 591 ISFACLQSNPK 601
C + P+
Sbjct: 237 ---HCWKERPE 244
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 2e-31
Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 51/272 (18%)
Query: 367 TPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQV 421
TP + +Y +G G V+ A+ L R A+K L + + +F FR EAQ
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 422 LSQ-----------------------------MERGSLFRILHNDAEAVELDWAKRVNIV 452
+ ++ +L I+H + + + + ++
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 117
Query: 453 KAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---L 509
AL + ++HRD+ NI++++ V DFG AR + ++ T +
Sbjct: 118 ADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 510 AGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569
G+ Y++PE A + + DVYS G V EVL G+ P S +S +Y + + D +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVREDPI 232
Query: 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
+ ++L L NP+
Sbjct: 233 PPSARHEGLSADLDAVVL------KALAKNPE 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 51/274 (18%), Positives = 92/274 (33%), Gaps = 63/274 (22%)
Query: 377 IGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G GA+G V +A A+K L + L + +E +VLS
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLSYLGNHMN 88
Query: 425 --------------------MERGSLFRILHN---------------DAEAVELDWAKRV 449
G L L + + + LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 450 NIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--QT 507
+ +A +A+L S + +HRD+++ NILL + DFG AR + DS+ +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567
++APE + V T + DV+S+G+ E+ + S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFYK 259
Query: 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
++ + ++ I C ++P
Sbjct: 260 MIKEGFRMLSPEHAPAEMY---DIMKTCWDADPL 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 55/265 (20%), Positives = 93/265 (35%), Gaps = 46/265 (17%)
Query: 368 PRKIDSKYCIGTGAYGSVYKAQLPNG-----RVFALKKLNSPETEELAFIRSFRNEAQVL 422
P + + IG G +G VYK L A+K L + TE+ F EA ++
Sbjct: 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIM 63
Query: 423 SQ-------------MERGSLFRIL----------HNDAEAVELDWAKRVNIVKAMAHAL 459
Q + + I + E + V +++ +A +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 460 AYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA---GSYGYI 516
+ + + VHRD+++ NIL+NS L V+DFG +R+L D + +
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
APE T DV+SFG+V EV+ + ++ ++ P
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLP 233
Query: 577 VDRKVIQDILLVSTISFACLQSNPK 601
I + C Q
Sbjct: 234 TPMDCPSAIY---QLMMQCWQQERA 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 6e-31
Identities = 69/261 (26%), Positives = 106/261 (40%), Gaps = 55/261 (21%)
Query: 377 IGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G V L A+K L S TE+ R F +EA ++ Q
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIH 91
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
ME GSL L + + + V +++ +A + YL
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN- 148
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLA-----GSYGYIAPELAY 522
VHRD+++ NIL+NS L V+DFG +R L D+S+ T + + APE
Sbjct: 149 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206
Query: 523 TMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD-RK 580
T DV+S+G+V EV+ G+ P + ++ D RLPPP+D
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERP------YWDMTNQDVINAIEQDYRLPPPMDCPS 260
Query: 581 VIQDILLVSTISFACLQSNPK 601
+ ++L C Q +
Sbjct: 261 ALHQLML------DCWQKDRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 9e-31
Identities = 51/252 (20%), Positives = 91/252 (36%), Gaps = 45/252 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G++G V+ A+ + FA+K L + E +VLS
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+ G L + + + D ++ + L +L S
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL---HSKG 123
Query: 470 VVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEK 529
+V+RD+ +NILL+ +ADFG + + G+ YIAPE+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 530 YDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVS 589
D +SFGV+ E+L+G+ P + ++ +D P K +D+L+
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQD------EEELFHSIRMDNPFYPRWLEKEAKDLLV-- 235
Query: 590 TISFACLQSNPK 601
P+
Sbjct: 236 ----KLFVREPE 243
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 121 bits (304), Expect = 9e-31
Identities = 52/254 (20%), Positives = 95/254 (37%), Gaps = 47/254 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G+GA+G V++ GRVF K +N+P + + +NE +++Q
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 93
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+ G LF + E ++ A+ +N ++ L ++H S+
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 471 VHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
VH DI NI+ +K + V DFG A L+ D + + + APE+ +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPVGF 207
Query: 529 KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL-L 587
D+++ GV+ +L G P + + D V +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 588 VSTISFACLQSNPK 601
+ LQ P+
Sbjct: 263 IK----NLLQKEPR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (303), Expect = 1e-30
Identities = 52/253 (20%), Positives = 94/253 (37%), Gaps = 45/253 (17%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+GTGA+G V++ G FA K + +P + + R E Q +S
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHD 90
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
M G LF + + E ++ + V ++ + L ++H +
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 471 VHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
VH D+ NI+ +K + DFG L S + G+ + APE+A +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGY 204
Query: 529 KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588
D++S GV++ +L G P + D + + D + + +D
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSCDWNMDDSAFSGISED--GK 257
Query: 589 STISFACLQSNPK 601
I L ++P
Sbjct: 258 DFIR-KLLLADPN 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 2e-30
Identities = 52/247 (21%), Positives = 93/247 (37%), Gaps = 37/247 (14%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM--------- 425
+GTG++G V+ + NGR +A+K L L + +E +LS +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 426 ----ERGSLFRILHNDAEAVELDWAKR------VNIVKAMAHALAYLHHDCSPSVVHRDI 475
+ +F I+ ++ A L + S +++RD+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 130
Query: 476 SSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSF 535
NILL+ + DFG A+ + L G+ YIAPE+ T + D +SF
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187
Query: 536 GVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPVDRKVIQDILLVSTISFA 594
G++ E+L G P + +L+ L PP + ++D+L
Sbjct: 188 GILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFPPFFNEDVKDLLS------R 234
Query: 595 CLQSNPK 601
+ +
Sbjct: 235 LITRDLS 241
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 55/294 (18%)
Query: 343 YLNLSGNKLSGRVPYSNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPN----GRVFAL 398
+++LS L+ + + +H+ P+ + IG G +G VY L + A+
Sbjct: 3 HIDLSA--LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 399 KKLNSPETEELAFIRSFRNEAQVLSQ--------------------------MERGSLFR 432
K LN + F E ++ M+ G L
Sbjct: 61 KSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118
Query: 433 ILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVAD 492
+ N+ + + A + S VHRD+++ N +L+ K VAD
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 493 FGTARLLHADSSNQ----TLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
FG AR ++ + T ++A E T T K DV+SFGV+ E++ P
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
Query: 549 RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR-KVIQDILLVSTISFACLQSNPK 601
I + + +RL P + +++L C +
Sbjct: 234 PYPDVNT-----FDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAE 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-30
Identities = 53/268 (19%), Positives = 93/268 (34%), Gaps = 58/268 (21%)
Query: 376 CIGTGAYGSVYKAQLPNG---RVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
IG G +G V KA++ A+K++ +++ R F E +VL +
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNII 74
Query: 425 ------------------MERGSLFRILHN-------------DAEAVELDWAKRVNIVK 453
G+L L ++ A L + ++
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSY 513
+A + YL +HRD+++ NIL+ A +ADFG +R +T+
Sbjct: 135 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPV 190
Query: 514 GYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573
++A E V T DV+S+GV+ E++ T + Y+ L
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KLPQGYRLEK 247
Query: 574 PPPVDRKVIQDILLVSTISFACLQSNPK 601
P D +V + C + P
Sbjct: 248 PLNCDDEVYDLMRQ-------CWREKPY 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 44/279 (15%), Positives = 88/279 (31%), Gaps = 68/279 (24%)
Query: 377 IGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G+GA+G V A A+K L + +E ++++Q
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHEN 102
Query: 425 --------------------MERGSLFRILHN--------------------DAEAVELD 444
G L L + + + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 445 WAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504
+ + +A + +L S VHRD+++ N+L+ + DFG AR + +DS+
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 505 N--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPK 562
+ ++APE + + T K DV+S+G++ E+
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PYPGIPVD 273
Query: 563 IMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
++ ++I I +C + +
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSR 309
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 49/257 (19%), Positives = 82/257 (31%), Gaps = 47/257 (18%)
Query: 377 IGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-------- 424
+G G++G V + + A+K L + + F E +
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 425 ----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSP 468
GSL L L R +A + YL S
Sbjct: 76 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SK 130
Query: 469 SVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---QTLLAGSYGYIAPELAYTMV 525
+HRD+++ N+LL ++ + DFG R L + + Q + + APE T
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 526 MTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584
+ D + FGV E+ G+ P + +L + + P QD
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 585 ILLVSTISFACLQSNPK 601
I + C P+
Sbjct: 244 IY---NVMVQCWAHKPE 257
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-29
Identities = 44/253 (17%), Positives = 96/253 (37%), Gaps = 46/253 (18%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G +G V++ + + + K + T++ + E +L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHE 68
Query: 425 --------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+ +F ++ A EL+ + V+ V + AL +LH S ++
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 471 VHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTE 528
H DI NI+ ++ + + +FG AR L + + L + Y APE+ V++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-FTAPEYYAPEVHQHDVVST 182
Query: 529 KYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLV 588
D++S G + +L G +P + + ++ ++++ + I +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFL-------AETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 589 STISFACLQSNPK 601
+ L K
Sbjct: 236 DFVD-RLLVKERK 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 112 bits (280), Expect = 3e-28
Identities = 50/265 (18%), Positives = 93/265 (35%), Gaps = 56/265 (21%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELA------FIRSFRNEAQVLSQ----- 424
+G G V + P + +A+K ++ + + E +L +
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 425 ---------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
M++G LF L V L + I++A+ + LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALH 127
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
++VHRD+ NILL+ + + DFG + L + + G+ Y+APE+
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYLAPEIIEC 183
Query: 524 MVM------TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577
+ ++ D++S GV+ +L G P + +I + + P
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSGNYQFGSPE 238
Query: 578 DRKVIQDIL-LVSTISFACLQSNPK 601
+ LVS L P+
Sbjct: 239 WDDYSDTVKDLVS----RFLVVQPQ 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 56/257 (21%), Positives = 93/257 (36%), Gaps = 50/257 (19%)
Query: 376 CIGTGAYGSVYKAQLPN----GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
CIG G +G V++ + A+K + ++ F EA + Q
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIV 71
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
G L L + LD A + ++ ALAYL S
Sbjct: 72 KLIGVITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE---S 126
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ-TLLAGSYGYIAPELAYTMVM 526
VHRDI++ N+L++S + DFG +R + + + + ++APE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 527 TEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD-RKVIQD 584
T DV+ FGV E+LM G P + ++ +RLP P + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 585 ILLVSTISFACLQSNPK 601
++ C +P
Sbjct: 241 LMT------KCWAYDPS 251
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-27
Identities = 47/246 (19%), Positives = 86/246 (34%), Gaps = 34/246 (13%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+G G +G V + GR +A+K L + E++VL L + +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 436 NDAEAVELDWAKRVN-------------------IVKAMAHALAYLHHDCSPSVVHRDIS 476
L + A ++ L + S VV+RDI
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFG 536
N++L+ + DFG + +D + G+ Y+APE+ D + G
Sbjct: 133 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 537 VVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD-RKVIQDILLVSTISFAC 595
VV E++ G+ P + D + + +L + + P + +L
Sbjct: 193 VVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPEAKSLLA------GL 239
Query: 596 LQSNPK 601
L+ +PK
Sbjct: 240 LKKDPK 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 8e-27
Identities = 53/257 (20%), Positives = 96/257 (37%), Gaps = 50/257 (19%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVF----ALKKLNSPETEELAFIRSFRNEAQVLSQ------- 424
+G+GA+G+VYK +P G A+K+L + + + +EA V++
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVC 74
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
M G L + + + +N +A + YL
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED--- 129
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL--LAGSYGYIAPELAYTMV 525
+VHRD+++ N+L+ + + DFG A+LL A+ ++A E +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 526 MTEKYDVYSFGVVTLEVL-MGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584
T + DV+S+GV E++ G P D P + +L++ P D
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERLPQPPICTID 241
Query: 585 ILLVSTISFACLQSNPK 601
+ I C +
Sbjct: 242 VY---MIMVKCWMIDAD 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (273), Expect = 1e-26
Identities = 54/255 (21%), Positives = 88/255 (34%), Gaps = 47/255 (18%)
Query: 377 IGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
IG G +G VY + G+++A+K L+ + NE +LS
Sbjct: 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
M G L L E D + L ++H +
Sbjct: 72 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEHMH---N 125
Query: 468 PSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVM 526
VV+RD+ NILL+ ++D G A + + G++GY+APE L +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAY 183
Query: 527 TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586
D +S G + ++L G P H T ID + + + +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKT------KDKHEIDRMTLTMAVELPDSFSPE-- 235
Query: 587 LVSTISFACLQSNPK 601
L S + LQ +
Sbjct: 236 LRSLLE-GLLQRDVN 249
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 42/265 (15%), Positives = 87/265 (32%), Gaps = 46/265 (17%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLN---SPETEELAFIRSFRNEAQVL 422
+D Y +G+G + V K + G +A K + + + E +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 423 SQM-------------ERGSLFRIL------HNDAEAVELDWAKRVNIVKAMAHALAYLH 463
++ + + IL E + + + L ++
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 464 HDCSPSVVHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE 519
+ S + H D+ NI+L K + DFG A + + + G+ ++APE
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPE 186
Query: 520 LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579
+ + + D++S GV+T +L G P + + + ++
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEFEDEYFS 241
Query: 580 KV---IQDILLVSTISFACLQSNPK 601
+D + L +PK
Sbjct: 242 NTSALAKDFIR------RLLVKDPK 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 2e-26
Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 52/258 (20%)
Query: 376 CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---------- 424
+GTGA+ V A+ ++ A+K + E S NE VL +
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALD 73
Query: 425 ---------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 469
+ G LF + ++ + A+ YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 470 VVHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
+VHRD+ N+L S E ++DFG +++ S T G+ GY+APE+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQKPY 186
Query: 527 TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV---IQ 583
++ D +S GV+ +L G P + I + P + +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 584 DILLVSTISFACLQSNPK 601
D + ++ +P+
Sbjct: 242 DFIR------HLMEKDPE 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 49/267 (18%), Positives = 90/267 (33%), Gaps = 45/267 (16%)
Query: 377 IGTGAYGSVYKAQLPN-GRVFALKKLNSPETEEL--AFIRSFRNEAQVLSQ--------- 424
+G G + +VYKA+ N ++ A+KK+ E R+ E ++L +
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 425 -------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
+ + ++ L + + L YLH ++
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---IL 122
Query: 472 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM-TEKY 530
HRD+ NN+LL+ +ADFG A+ + + T + Y APEL + M
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 531 DVYSFGVVTLEVLMGKHP--------------RDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
D+++ G + E+L+ L + + L D + + P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 577 VDRKVIQDILLVSTISF--ACLQSNPK 601
+ I + NP
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPC 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 2e-26
Identities = 42/270 (15%), Positives = 84/270 (31%), Gaps = 50/270 (18%)
Query: 370 KIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
++ ++Y IG+G++G +Y + G A+K E+++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKM 58
Query: 425 MERGSLFRILH-----------------------NDAEAVELDWAKRVNIVKAMAHALAY 461
M+ G + + + + + + M + Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 462 LHHDCSPSVVHRDISSNNILLNSK---LEAFVADFGTARLLHADSSNQ-------TLLAG 511
+H S + +HRD+ +N L+ ++ DFG A+ ++Q L G
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 512 SYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQ 571
+ Y + + + + D+ S G V + +G P + K I
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERISEKKM 233
Query: 572 RLPPPVDRKVIQDILLVSTISFACLQSNPK 601
P V K +T C
Sbjct: 234 STPIEVLCKGYPSEF--ATYLNFCRSLRFD 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 29/197 (14%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---------- 425
IG G YG VYKA+ G V ALKK+ +TE + E +L ++
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 426 ---ERGSLFRI----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
L+ + + + + + + + LA+ H V+H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYD 531
RD+ N+L+N++ +ADFG AR T + Y APE L + D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 532 VYSFGVVTLEVLMGKHP 548
++S G + E++ +
Sbjct: 186 IWSLGCIFAEMVTRRAL 202
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 54/273 (19%), Positives = 94/273 (34%), Gaps = 62/273 (22%)
Query: 377 IGTGAYGSVYKA------QLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G GA+G V +A + R A+K L T R+ +E ++L
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLN 78
Query: 425 ---------------------MERGSLFRILHN-------------DAEAVELDWAKRVN 450
+ G+L L + D L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 451 IVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--QTL 508
+A + +L S +HRD+++ NILL+ K + DFG AR ++ D +
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 509 LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568
++APE + V T + DV+SFGV+ E+ + + ++ +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--EG 253
Query: 569 LDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
R P ++ Q +L C P
Sbjct: 254 TRMRAPDYTTPEMYQTMLD-------CWHGEPS 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (266), Expect = 2e-26
Identities = 50/197 (25%), Positives = 76/197 (38%), Gaps = 31/197 (15%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------------ 424
IG G YG VYKAQ G FALKK+ E E+ + E +L +
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 425 ------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVH 472
L ++L +E AK + L + + V+H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF-----LLQLLNGIAYCHDRRVLH 123
Query: 473 RDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPE-LAYTMVMTEKYD 531
RD+ N+L+N + E +ADFG AR T + Y AP+ L + + D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 532 VYSFGVVTLEVLMGKHP 548
++S G + E++ G
Sbjct: 184 IWSVGCIFAEMVNGTPL 200
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 54/267 (20%), Positives = 93/267 (34%), Gaps = 59/267 (22%)
Query: 377 IGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVLSQ------ 424
+G G++G VY+ A+K +N + F NEA V+ +
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHV 85
Query: 425 -------------------MERGSLFRILH-------NDAEAVELDWAKRVNIVKAMAHA 458
M RG L L N+ +K + + +A
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ--TLLAGSYGYI 516
+AYL + VHRD+++ N ++ + DFG R ++ + ++
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 517 APELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576
+PE V T DV+SFGVV E+ + +L V++ L
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLRFVMEGGLLDK 256
Query: 577 VDR--KVIQDILLVSTISFACLQSNPK 601
D ++ +++ C Q NPK
Sbjct: 257 PDNCPDMLFELMR------MCWQYNPK 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-26
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 53/260 (20%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G G V + FALK L R E ++ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 71
Query: 425 -------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
++ G LF + + + + I+K++ A+ YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 128
Query: 466 CSPSVVHRDISSNNILLNSKLE---AFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY 522
S ++ HRD+ N+L SK + DFG A+ + +S T + Y+APE+
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVLG 186
Query: 523 TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582
+ D++S GV+ +L G P + L+ S K I + P P +V
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYEFPNPEWSEVS 245
Query: 583 QDIL-LVSTISFACLQSNPK 601
+++ L+ L++ P
Sbjct: 246 EEVKMLIR----NLLKTEPT 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 105 bits (263), Expect = 6e-26
Identities = 40/271 (14%), Positives = 78/271 (28%), Gaps = 52/271 (19%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM 425
+ Y IG G++G +++ L N + A+K R+E + +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLL 57
Query: 426 ERGSLFRILH-----------------------NDAEAVELDWAKRVNIVKAMAHALAYL 462
+ ++ D + K M + +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 463 HHDCSPSVVHRDISSNNILLNSKLE-----AFVADFGTARLLHADSSNQTL-------LA 510
H S+V+RDI +N L+ +V DFG + + Q + L+
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 511 GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570
G+ Y++ + + D+ + G V + L G P +++ K I
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKK 232
Query: 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
Q P +
Sbjct: 233 QSTPLRELCAGFPEEF--YKYMHYARNLAFD 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 7e-26
Identities = 49/274 (17%), Positives = 89/274 (32%), Gaps = 64/274 (23%)
Query: 377 IGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ---- 424
+G GA+G V A+ A+K L S TE+ + +E +++
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 78
Query: 425 ----------------------MERGSLFRILHN-------------DAEAVELDWAKRV 449
+G+L L +L V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 450 NIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLL 509
+ +A + YL S +HRD+++ N+L+ +ADFG AR +H +
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 510 A--GSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLID 567
++APE + + T + DV+SFGV+ E+ + L
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFK 248
Query: 568 VLDQRLPPPVDRKVIQDILLVSTISFACLQSNPK 601
+L + ++ + C + P
Sbjct: 249 LLKEGHRMDKPSNCTNELY---MMMRDCWHAVPS 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 8e-26
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 47/216 (21%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ- 424
+ +Y IG GAYG V A N A+KK++ E + + + E ++L +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLRF 63
Query: 425 ----------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMA 456
+ L+++L L + +
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQIL 119
Query: 457 HALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL---LAGSY 513
L Y+H S +V+HRD+ +N+LLN+ + + DFG AR+ D + +
Sbjct: 120 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 514 GYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHP 548
Y APE+ T+ D++S G + E+L +
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 9e-26
Identities = 44/248 (17%), Positives = 85/248 (34%), Gaps = 41/248 (16%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
+GTG++G V + +G +A+K L+ + +L I NE ++L + L ++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 436 NDAEAVE----------------------LDWAKRVNIVKAMAHALAYLHHDCSPSVVHR 473
+ + + YLH S +++R
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 474 DISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVY 533
D+ N+L++ + V DFG A+ + L G+ +APE+ + + D +
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 534 SFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISF 593
+ GV+ E+ G P + I R P + +
Sbjct: 223 ALGVLIYEMAAGYPPFF-----ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR------- 270
Query: 594 ACLQSNPK 601
LQ +
Sbjct: 271 NLLQVDLT 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 50/268 (18%), Positives = 90/268 (33%), Gaps = 62/268 (23%)
Query: 371 IDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNS---PETEELAFIRSFRNEAQVL 422
++S+Y +G+G +GSVY + + A+K + + EL E +L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 423 SQ---------------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAM 455
+ E + A L + +
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 119
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNQTLLAGSYG 514
A+ + + V+HRDI NIL++ ++ E + DFG+ LL + T G+
Sbjct: 120 LEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRV 174
Query: 515 YIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL 573
Y PE + Y V+S G++ +++ G P + + I QR+
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQVFFRQRV 227
Query: 574 PPPVDRKVIQDILLVSTISFACLQSNPK 601
Q ++ CL P
Sbjct: 228 SSEC-----QHLIR------WCLALRPS 244
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 9e-25
Identities = 48/264 (18%), Positives = 96/264 (36%), Gaps = 40/264 (15%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILH 435
IG G YG+V+KA+ + ALK++ + +E S E +L +++ ++ R+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHD 68
Query: 436 NDAEAVELD-------------------WAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476
+L + + L L S +V+HRD+
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 477 SNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAY-TMVMTEKYDVYSF 535
N+L+N E +A+FG AR + + Y P++ + + + D++S
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 536 GVVTLEVLMGKHP-----------RDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584
G + E+ P + + L + + + + L P P+
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 585 ILLVSTISFA-------CLQSNPK 601
+ +V ++ L+ NP
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPV 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-24
Identities = 48/205 (23%), Positives = 75/205 (36%), Gaps = 38/205 (18%)
Query: 377 IGTGAYGSVYKAQ--LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI- 433
IG GAYG V+KA+ GR ALK++ EE S E VL +E +
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVV 73
Query: 434 ------------------------------LHNDAEAVELDWAKRVNIVKAMAHALAYLH 463
+ + +++ + L +LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 464 HDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYT 523
VVHRD+ NIL+ S + +ADFG AR+ + ++ + Y APE+
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQ 189
Query: 524 MVMTEKYDVYSFGVVTLEVLMGKHP 548
D++S G + E+ K
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 9e-24
Identities = 47/198 (23%), Positives = 76/198 (38%), Gaps = 29/198 (14%)
Query: 377 IGTGAYGSVYKAQL-PNGRVFALKKLNSPETE---ELAFIRSFRNE-------------- 418
IG G++G VY+A+L +G + A+KK+ + EL +R +
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 419 -------AQVLSQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVV 471
VL + H L + + +LAY+H S +
Sbjct: 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGIC 144
Query: 472 HRDISSNNILLNSKLEAF-VADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
HRDI N+LL+ + DFG+A+ L N + + Y + T
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204
Query: 531 DVYSFGVVTLEVLMGKHP 548
DV+S G V E+L+G+
Sbjct: 205 DVWSAGCVLAELLLGQPI 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-24
Identities = 56/262 (21%), Positives = 96/262 (36%), Gaps = 54/262 (20%)
Query: 377 IGTGAYGSVYKAQL----PNGRVFALKKLNSPE-TEELAFIRSFRNEAQVLSQ------- 424
+GTGAYG V+ + G+++A+K L ++ R E QVL
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 425 -------------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD 465
+ G LF L E + + + L H
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGEIVLALEHL 145
Query: 466 CSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQT-LLAGSYGYIAPELAYTM 524
+++RDI NILL+S + DFG ++ AD + + G+ Y+AP++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 525 VM--TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV- 581
+ D +S GV+ E+L G P + +S I + PP +++
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKSEPPYPQEMS 260
Query: 582 --IQDILLVSTISFACLQSNPK 601
+D++ L +PK
Sbjct: 261 ALAKDLIQ------RLLMKDPK 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 4e-23
Identities = 49/253 (19%), Positives = 90/253 (35%), Gaps = 44/253 (17%)
Query: 366 PTPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQ 420
P ++ KY IG G +G V+KA+ G+ ALKK+ E E+ F + E +
Sbjct: 4 PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIK 61
Query: 421 VLSQMERGSLFRILH--NDAEAVELDWAKRVNIV-------------------------K 453
+L ++ ++ ++ + + +V +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 454 AMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NQTLL 509
M L L++ ++HRD+ + N+L+ +ADFG AR + T
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 510 AGSYGYIAPE-LAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDV 568
+ Y PE L D++ G + E+ ++ ++ LI
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-----GNTEQHQLALISQ 236
Query: 569 LDQRLPPPVDRKV 581
L + P V V
Sbjct: 237 LCGSITPEVWPNV 249
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 9e-23
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 19/278 (6%)
Query: 77 WWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRI 136
+ + + ++ N+ I L + + NL +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL-TTLE 178
Query: 137 LAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQE 191
S S ++ L+ L+ L ++N++ LTNL+ +SL+ N L
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGT 236
Query: 192 IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVG 251
+ +L NL +LD+ +N + PL S LT L L L NQ+S + G L
Sbjct: 237 LASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQI 311
N S L +L+YL L N + P ++ LT+L L ++NK+S S +
Sbjct: 295 NQLEDISPISNL---KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347
Query: 312 ASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
A++ ++ WL +N I P + L+R+ L L+
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 1e-19
Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 13/191 (6%)
Query: 169 GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228
+LTNL + + N + + P I NL EL + N L TL+ LT+L L LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDIG--TLASLTNLTDLDLA 249
Query: 229 QNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
NQ+S L + L L L +G N I P L + +L N+ + ++
Sbjct: 250 NNQISNLA-PLSGLTKLTELKLGANQISNISP----LAGLTALTNLELNENQLEDISPIS 304
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L L +L L N +S P ++S+ L L +NN + + L+ +++L+
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 349 NKLSGRVPYSN 359
N++S P +N
Sbjct: 361 NQISDLTPLAN 371
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 51/251 (20%)
Query: 152 SALSKLQLLDLSSNRLRGR-----LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDN 206
+AL++ L + L + + R + + + L NL +++ +N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 207 SLIGPIPLTLSRLTSLKILILAQNQLSGLPQ----------------------------- 237
L P L LT L +++ NQ++ +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 238 --------EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT- 288
I ++ L L G + L ++L+ L+ N +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
+LT L L ++N++S P I + +L L L+ N +K G + L+ L L+L+
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 349 NKLSGRVPYSN 359
N++S P S
Sbjct: 251 NQISNLAPLSG 261
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 54/251 (21%), Positives = 96/251 (38%), Gaps = 30/251 (11%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNML 184
+L+ + L SI + L+ L ++ S+N+L LT L + ++ N +
Sbjct: 42 DLDQVTTLQADRLGIKSIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI 100
Query: 185 GGLLPQEIGNLKNLIELDVGDNSLIGP----------------IPLTLSRLTSLKILILA 228
+ P + L + I P I + + L+
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 229 QNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELT 288
+ + NL L LD+ +N + ++L L + NQ + P +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL 218
Query: 289 RLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
T L L L+ N+L +AS+ +LT LDL+NN I P ++ L++L L L
Sbjct: 219 --TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 349 NKLSGRVPYSN 359
N++S P +
Sbjct: 273 NQISNISPLAG 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.9 bits (237), Expect = 2e-22
Identities = 59/281 (20%), Positives = 111/281 (39%), Gaps = 22/281 (7%)
Query: 90 HCEWIGITCNSAG-----SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRIL-AYYDGF 143
C + C+ G + + ++ N +++ + F NL++L L +
Sbjct: 9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNN-KITEIKDGDFKNLKNLHTLILINNKI 67
Query: 144 TGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMS----LSRNMLGGLLPQEIGNLKNLI 199
+ P + L KL+ L LS N+L+ + + N + + L +I
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 200 ELDVGD--NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIG 257
+++G G + L + +A ++ +PQ G +L L + N I
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITK 185
Query: 258 PIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDL 317
++L ++L+ L LS N ++ L L L L++NKL K+P +A + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244
Query: 318 TWLDLSNNNIKG------SIPGEITKLSRLDYLNLSGNKLS 352
+ L NNNI PG TK + ++L N +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 4e-19
Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 7/199 (3%)
Query: 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
+ + L N + + + NLKNL L + +N + P + L L+ L L++NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 232 LSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSS--IPNELTR 289
L LP+++ L L V N+I S + + ++L N SS
Sbjct: 91 LKELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
+ +L ++ ++ ++ IP + LT L L N I + L+ L L LS N
Sbjct: 149 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 350 KLSGRVPYSNKHLSSMPTP 368
+S S + +
Sbjct: 206 SISAVDNGSLANTPHLREL 224
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.7 bits (156), Expect = 5e-12
Identities = 33/196 (16%), Positives = 71/196 (36%), Gaps = 12/196 (6%)
Query: 115 NFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR----GR 170
N ++ F+ + + + +G + KL + ++ + G
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 169
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
+L + L N + + + L NL +L + NS+ +L+ L+ L L N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 231 QLSGLPQEIGNLKNLMLLDVGNNDIIG------PIPSTLGLFSDLSYLDLSCN--QFNSS 282
+L +P + + K + ++ + NN+I P + S + L N Q+
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
Query: 283 IPNELTRLTQLFHLDL 298
P+ + + L
Sbjct: 290 QPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 6e-10
Identities = 27/145 (18%), Positives = 60/145 (41%), Gaps = 3/145 (2%)
Query: 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFN 280
L+++ + L +P+++ + LLD+ NN I +L L L N+ +
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 281 SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSR 340
P L +L L LS N+L ++++L + ++ S+ + ++
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 341 LDYLNLSGNKLSGRVPYSNKHLSSM 365
++ L + K SG + + + +
Sbjct: 129 VE-LGTNPLKSSGIENGAFQGMKKL 152
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 50/213 (23%), Positives = 82/213 (38%), Gaps = 37/213 (17%)
Query: 367 TPRKIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQV 421
T ++ + Y +G+GAYG+V A G A+KKL P EL F + E ++
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRL 70
Query: 422 LSQMERGSLFRILHNDAEAVE--------------------------LDWAKRVNIVKAM 455
L M ++ +L L + +V M
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 456 AHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGY 515
L Y+H + ++HRD+ N+ +N E + DFG AR ADS + +
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYR 185
Query: 516 IAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ M T+ D++S G + E++ GK
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 1e-20
Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 31/198 (15%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRIL- 434
IG+GA G V A R A+KKL+ P + + E ++ + ++ +L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 83
Query: 435 ------------------------HNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSV 470
+ELD + ++ M + +LH +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 140
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKY 530
+HRD+ +NI++ S + DFG AR S T + Y APE+ M E
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199
Query: 531 DVYSFGVVTLEVLMGKHP 548
D++S G + E++ K
Sbjct: 200 DIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 31/202 (15%), Positives = 66/202 (32%), Gaps = 45/202 (22%)
Query: 377 IGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ----------- 424
+G G Y V++A + N +K L + ++ + E ++L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGGPNIITLA 96
Query: 425 -----------------MERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCS 467
+ ++ L + + AL Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG- 149
Query: 468 PSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVM 526
++HRD+ +N++++ + + + D+G A H +A Y L +
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 527 TEKYDVYSFGVVTLEVLMGKHP 548
D++S G + ++ K P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 1e-18
Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 37/210 (17%)
Query: 370 KIDSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ 424
++ +Y +G+GAYGSV A G A+KKL+ + + + E ++L
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 73
Query: 425 MERGSLFRIL--------------------------HNDAEAVELDWAKRVNIVKAMAHA 458
M+ ++ +L +N + +L ++ +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 459 LAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTLLAGSYGYIAP 518
L Y+H S ++HRD+ +N+ +N E + DFG AR H D +A +
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPE 188
Query: 519 ELAYTMVMTEKYDVYSFGVVTLEVLMGKHP 548
+ M + D++S G + E+L G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (202), Expect = 2e-17
Identities = 39/253 (15%), Positives = 83/253 (32%), Gaps = 56/253 (22%)
Query: 372 DSKY----CIGTGAYGSVYKAQ-LPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQ-- 424
D++Y +G G + +V+ A+ + N A+K + + + + +E ++L +
Sbjct: 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVN 67
Query: 425 --------------------------------------MERGSLFRILHNDAEAVELDWA 446
+ L I + + L +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 447 KRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTARLLHADSSN 505
K+ I K + L Y+H C ++H DI N+L+ + A L +A +
Sbjct: 128 KQ--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 506 QTL--LAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKI 563
+ + Y +PE+ D++S + E++ G + S + D
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 564 MLIDVLDQRLPPP 576
+ + P
Sbjct: 244 IAQIIELLGELPS 256
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 2e-16
Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 34/299 (11%)
Query: 67 LETKALLNTGWWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFS 126
L+ K L +SW D + W+G+ C++ R+++L+ S
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-------------TYRVNNLDLS 58
Query: 127 CFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNR--------LRGRLTNLNYMS 178
NL IPS ++ L L L + +LT L+Y+
Sbjct: 59 GL-NLPK----------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQ 237
++ + G +P + +K L+ LD N+L G +P ++S L +L + N++SG +P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 238 EIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297
G+ L + + + +L+++DLS N +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356
L+ N L+ + S DL NN I G++P +T+L L LN+S N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGL-DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 7e-09
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI 255
KNL LD+ +N + G +P L++L L L ++ N L G + GNL+ + NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 256 I--GPIPS 261
+ P+P+
Sbjct: 304 LCGSPLPA 311
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 1e-14
Identities = 60/274 (21%), Positives = 94/274 (34%), Gaps = 17/274 (6%)
Query: 90 HCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPS 149
C G+ + I + ++ N R+SH+ + F +L IL + I +
Sbjct: 17 SCPQQGLQ--AVPVGIPAASQRIFLHGN-RISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 150 EISALSKLQ---------LLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIE 200
L L L L+ + L R L L P L L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-IGNLKNLMLLDVGNNDIIGPI 259
L + DN+L T L +L L L N++S +P+ L +L L + N +
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 260 PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW 319
P L L L N ++ L L L +L L+ N + L
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQK 252
Query: 320 LDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
S++ + S+P L+ D L+ N L G
Sbjct: 253 FRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 1e-13
Identities = 51/251 (20%), Positives = 77/251 (30%), Gaps = 36/251 (14%)
Query: 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNM--------------- 183
++P I A Q + L NR+ NL + L N+
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 184 ----------LGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLS 233
L + P L L L + L P L +L+ L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 234 GL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQ 292
L +L NL L + N I L L L N+ P+ L +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 293 LFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLS 352
L L L +N LS +A + L +L L++N + L S +++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261
Query: 353 GRVPYSNKHLS 363
+P
Sbjct: 262 CSLPQRLAGRD 272
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 38/180 (21%), Positives = 59/180 (32%), Gaps = 4/180 (2%)
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA-QNQLSGLPQEIGNLKNLM 246
+P I + + N + + +L IL L L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 247 LLDVGNNDIIGPI-PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305
LD+ +N + + P+T L L L P L L +L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSM 365
+ +LT L L N I L LD L L N+++ P++ + L +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 31/139 (22%), Positives = 48/139 (34%), Gaps = 3/139 (2%)
Query: 230 NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR 289
L +P I + + N I ++ +L+ L L N T
Sbjct: 21 QGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 290 LTQLFHLDLSSNKLSGKI-PSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSG 348
L L LDLS N + P+ + L L L ++ PG L+ L YL L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 349 NKLSGRVPYSNKHLSSMPT 367
N L + + L ++
Sbjct: 139 NALQALPDDTFRDLGNLTH 157
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 5e-14
Identities = 27/158 (17%), Positives = 59/158 (37%), Gaps = 30/158 (18%)
Query: 377 IGTGAYGSVYKAQLPNGRVFALK--KLNSPETEELAFIR-----SFRNEAQVLSQMERGS 429
+G G +V+ +K K+ +++ R F A ++ E +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 430 LFRILH----------NDAEAVELDWAKRVN---------IVKAMAHALAYLHHDCSPSV 470
L ++ +A +EL AK + ++ + +A +H +
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---I 124
Query: 471 VHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508
VH D+S N+L+ S+ ++ DF + + + + L
Sbjct: 125 VHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 1e-12
Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 7/206 (3%)
Query: 150 EISALSKLQLLDLSSNRLR----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205
E+S ++ ++ L + + LS N+L + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGL 265
L L L L L+ NQL LP L L +LDV N + L
Sbjct: 65 AELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 266 FSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
+L L L N+ + P LT +L L L++N L+ + +E+L L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 326 NIKGSIPGEITKLSRLDYLNLSGNKL 351
++ +IP L + L GN
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 2e-09
Identities = 28/125 (22%), Positives = 46/125 (36%), Gaps = 24/125 (19%)
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS--------------------- 309
L L+ ++ L +L + HLDLS N+L P+
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 310 QIASMEDLTWLDLSNNNIKG-SIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHLSSMPTP 368
+A++ L L L NN ++ + + RL LNL GN L + +P+
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 369 RKIDS 373
I +
Sbjct: 120 SSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 6e-09
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 5/107 (4%)
Query: 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIP 260
L + L L +L + L L+ N+L LP + L+ L +L +N +
Sbjct: 3 LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 261 STLGLFSDLSYLDLSCNQFNS-SIPNELTRLTQLFHLDLSSNKLSGK 306
L L L N+ + L +L L+L N L +
Sbjct: 61 VA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 2e-07
Identities = 26/108 (24%), Positives = 37/108 (34%), Gaps = 9/108 (8%)
Query: 146 SIPSEISALSKLQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199
++ + L + LDLS NRLR L L + S N L + L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLP--RLQ 68
Query: 200 ELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLM 246
EL + +N L L L +L L N L L ++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 4e-06
Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 10/122 (8%)
Query: 158 QLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI 212
++L L+ L +L + ++ LS N L L P + L+ L L DN+L
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 213 PLTLSRLTSLKILILAQNQLSGLP--QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLS 270
+ L L+ L+L N+L Q + + L+LL++ N + L L
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 271 YL 272
+
Sbjct: 118 SV 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 5e-09
Identities = 18/92 (19%), Positives = 34/92 (36%), Gaps = 10/92 (10%)
Query: 268 DLSYLDLSCNQFNSSIPNEL-TRLTQLFHLDLSSNKLSGKIPSQIASM----EDLTWLDL 322
D+ LD+ C + + + EL L Q + L L+ I+S L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 323 SNNNIKGSIPGEITKL-----SRLDYLNLSGN 349
+N + + + ++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 19/82 (23%), Positives = 27/82 (32%), Gaps = 9/82 (10%)
Query: 266 FSDLSYLDLSCNQFN----SSIPNELTRLTQLFHLDLSSNKLSGKIPSQIAS-----MED 316
S L L L+ + SS+ L L LDLS+N L Q+
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 317 LTWLDLSNNNIKGSIPGEITKL 338
L L L + + + L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 293 LFHLDLSSNKLSGKIPSQIAS-MEDLTWLDLSNNNIKG----SIPGEITKLSRLDYLNLS 347
+ LD+ +LS +++ ++ + L + + I + L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 348 GNKLSG 353
N+L
Sbjct: 64 SNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 16/93 (17%), Positives = 27/93 (29%), Gaps = 10/93 (10%)
Query: 244 NLMLLDVGNNDII-GPIPSTLGLFSDLSYLDLSCNQFN----SSIPNELTRLTQLFHLDL 298
++ LD+ ++ L L + L I + L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 299 SSNKLSGKIPSQIASM-----EDLTWLDLSNNN 326
SN+L + + L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 8e-06
Identities = 13/91 (14%), Positives = 33/91 (36%), Gaps = 6/91 (6%)
Query: 221 SLKILILAQNQLS--GLPQEIGNLKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDL 274
++ L + +LS + + L+ ++ + + + I S L + L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305
N+ + + + Q + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/75 (22%), Positives = 29/75 (38%), Gaps = 9/75 (12%)
Query: 291 TQLFHLDLSSNKLSGKIPSQIASM----EDLTWLDLSNNNIKGSIPGEITK-----LSRL 341
+ L L L+ +S S +A+ L LDLSNN + + ++ + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 342 DYLNLSGNKLSGRVP 356
+ L L S +
Sbjct: 429 EQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 2e-05
Identities = 17/84 (20%), Positives = 31/84 (36%), Gaps = 9/84 (10%)
Query: 241 NLKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTR-----LT 291
L +L + + D+ + +TL L LDLS N + +L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 292 QLFHLDLSSNKLSGKIPSQIASME 315
L L L S ++ ++ ++E
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 11/67 (16%), Positives = 22/67 (32%), Gaps = 5/67 (7%)
Query: 173 NLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVGDNSL----IGPIPLTLSRLTSLKILIL 227
++ + + L + + L+ + + D L I L +L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 228 AQNQLSG 234
N+L
Sbjct: 63 RSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 14/92 (15%), Positives = 25/92 (27%), Gaps = 17/92 (18%)
Query: 157 LQLLDLSSNRLR--------GRLTNLNYMSLSRNMLGG----LLPQEIGNLKNLIELDVG 204
+Q LD+ L L + L L + + L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 205 DNSLIGPIPLTLSRL-----TSLKILILAQNQ 231
N L + + ++ L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 7e-08
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
N ++ I + L L++S+NKL ++P+ L L S N++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 334 EITKLSRLDYLNLSGNKLSG 353
L +L + N L
Sbjct: 322 LPQNLKQLH---VEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 23/112 (20%), Positives = 34/112 (30%), Gaps = 32/112 (28%)
Query: 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGL 265
N+ I SL+ L ++ N+L LP L+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---------------------- 307
Query: 266 FSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDL 317
L S N + +P L L + N L + P S+EDL
Sbjct: 308 -----RLIASFNHL-AEVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 1e-06
Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGL 235
N + +L EL+V +N LI +P RL L I + N L+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEV 319
Query: 236 PQEIGNLKNLMLLDVGNNDI--IGPIPSTLG 264
P+ NLK L V N + IP ++
Sbjct: 320 PELPQNLKQ---LHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 8/77 (10%)
Query: 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQN 230
+L +++S N L L P L+ L N L +P +LK L + N
Sbjct: 283 PPSLEELNVSNNKLIEL-PALPPRLE---RLIASFNHL-AEVP---ELPQNLKQLHVEYN 334
Query: 231 QLSGLPQEIGNLKNLML 247
L P ++++L +
Sbjct: 335 PLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 21/125 (16%), Positives = 39/125 (31%), Gaps = 7/125 (5%)
Query: 77 WWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRI 136
+ + + + S GL N+ + S+ S SL
Sbjct: 229 LNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE 288
Query: 137 LAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---GRLTNLNYMSLSRNMLGGLLPQEIG 193
L + +P+ +L+ L S N L NL + + N L P
Sbjct: 289 LNVSNNKLIELPALPP---RLERLIASFNHLAEVPELPQNLKQLHVEYNPLRE-FPDIPE 344
Query: 194 NLKNL 198
++++L
Sbjct: 345 SVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 19/71 (26%), Positives = 28/71 (39%), Gaps = 5/71 (7%)
Query: 294 FHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
N S +I S L L++SNN + +P +L RL S N L+
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA- 317
Query: 354 RVPYSNKHLSS 364
VP ++L
Sbjct: 318 EVPELPQNLKQ 328
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 19/86 (22%), Positives = 28/86 (32%), Gaps = 5/86 (5%)
Query: 291 TQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK 350
Q L+L++ LS +P L L S N++ +P L L N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 351 LSGRVPYSNKHLSSMPTPRKIDSKYC 376
LS P S K+
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQN 118
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 14/66 (21%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 196 KNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI 255
+ EL++ + L +P L+ L+ + N L+ LP+ +LK+L++ + +
Sbjct: 38 RQAHELELNNLGL-SSLP---ELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 93
Query: 256 IGPIPS 261
P
Sbjct: 94 SDLPPL 99
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 1e-07
Identities = 41/215 (19%), Positives = 72/215 (33%), Gaps = 26/215 (12%)
Query: 153 ALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNS 207
AL+ + + + L + +S + + + + L NLI L++ DN
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 208 LIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGN--------------- 252
+ PL + L + + ++K L L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 253 NDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312
+ I + L + LS S L L++L L NK+S P +A
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 313 SMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347
S+ +L + L NN I P + S L + L+
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 6e-07
Identities = 32/204 (15%), Positives = 61/204 (29%), Gaps = 43/204 (21%)
Query: 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDV-GN 252
L N I++ G +++ + T + L + L ++ + + L NL+ L++ N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDN 73
Query: 253 NDIIGPIPSTLGLFSDLSYLDLSC------------------------------------ 276
L ++L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 277 -NQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEI 335
+ I N LS + +A++ LT L +N I P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 336 TKLSRLDYLNLSGNKLSGRVPYSN 359
L L ++L N++S P +N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLAN 215
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 7e-05
Identities = 18/61 (29%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 192 IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVG 251
+ NL L L DN + PL + L +L + L NQ+S + + N NL ++ +
Sbjct: 169 LANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225
Query: 252 N 252
N
Sbjct: 226 N 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 19/63 (30%), Positives = 32/63 (50%), Gaps = 4/63 (6%)
Query: 216 LSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275
L+ L+ L L N++S + + +L NL+ + + NN I P L S+L + L+
Sbjct: 169 LANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
Query: 276 CNQ 278
NQ
Sbjct: 226 -NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 14/87 (16%), Positives = 30/87 (34%), Gaps = 4/87 (4%)
Query: 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
L + + ++ + A ++ +T L + +I G + L+ L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 350 KLSGRVPYSNKHLSSMPTPRKIDSKYC 376
+++ P N + K
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNV 100
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 16/59 (27%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQ 231
L + N + + P + +L NLIE+ + +N + P L+ ++L I+ L NQ
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 19/134 (14%), Positives = 41/134 (30%), Gaps = 7/134 (5%)
Query: 77 WWNNSWTMDYDSDHCEWIGITCNSAGSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRI 136
+ + + + +T + L + L+ + +
Sbjct: 95 NPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQ 154
Query: 137 LAYYDGFTGSIPSEISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQE 191
S + ++ LSKL L N++ L NL + L N + + P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP-- 212
Query: 192 IGNLKNLIELDVGD 205
+ N NL + + +
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 38/243 (15%), Positives = 80/243 (32%), Gaps = 22/243 (9%)
Query: 133 SLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNML 184
+ F +E + ++Q +DLS++ + + + L +SL L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 185 GGLLPQEIGNLKNLIELDVGDNSLI--GPIPLTLSRLTSLKILI-------LAQNQLSGL 235
+ + NL+ L++ S + LS + L L ++ +
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 236 PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS-CNQFNSSIPNELTRLTQLF 294
+ L L N + + + +L +LDLS + E +L L
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 295 HLDLSS-NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
HL LS + + ++ + L L + G++ L L ++ + +
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTT 260
Query: 354 RVP 356
Sbjct: 261 IAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 2/98 (2%)
Query: 201 LDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI-IGPI 259
LD+ +L + L + ++ + E + + +D+ N+ I + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 260 PSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297
L S L L L + + I N L + + L L+
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 11/87 (12%), Positives = 31/87 (35%), Gaps = 4/87 (4%)
Query: 295 HLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGR 354
LDL+ L + ++ S + + + + + E R+ +++LS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 355 VPYSNKHLSSMPTPRKIDSKYCIGTGA 381
+ LS + + + +
Sbjct: 62 TL--HGILSQCSKLQNLSLEGLRLSDP 86
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 9/152 (5%)
Query: 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNE 286
L Q+ L + + + + L + L+ + +++
Sbjct: 4 LKPEQVEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRII 60
Query: 287 LTRLTQLFHLDLSSNKLSGK--IPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYL 344
+ +L L+LS+N+L + S + +L L+LS N +K + K +L+ L
Sbjct: 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 345 NLSGNKLSGRVP----YSNKHLSSMPTPRKID 372
L GN LS Y + P ++D
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 1e-04
Identities = 23/162 (14%), Positives = 57/162 (35%), Gaps = 13/162 (8%)
Query: 161 DLSSNRLR------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPL 214
+L ++ + + + +L L ++ + L+ + + + +
Sbjct: 3 ELKPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRI 59
Query: 215 TLSRLTSLKILILAQNQLS---GLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSY 271
+ L L L+ N+L + + NL +L++ N++ L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 272 LDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK-IPSQIA 312
L L N + + ++ T ++ + +L G +P IA
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 2e-06
Identities = 39/202 (19%), Positives = 63/202 (31%), Gaps = 24/202 (11%)
Query: 90 HCEWIGITCNSAG-----SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFT 144
HCE + C G I LH ++ +N N + F L L L
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 145 GSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG 204
I +++ + L N + + + L L L++
Sbjct: 67 TGIE----------------PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110
Query: 205 DNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLG 264
DN + +P + L SL L LA N + + L + PS +
Sbjct: 111 DNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV- 169
Query: 265 LFSDLSYLDLSCNQFNSSIPNE 286
D+ DL ++F S N
Sbjct: 170 --RDVQIKDLPHSEFKCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.5 bits (85), Expect = 0.002
Identities = 32/166 (19%), Positives = 56/166 (33%), Gaps = 8/166 (4%)
Query: 188 LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSL--KILILAQNQLSGLPQEIGNLKNL 245
+P++I + EL + DN L L K+ + P ++
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 246 MLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305
L +G N I L L+L NQ + +P L L L+L+SN +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
E L L+ + P +K+ + +L ++
Sbjct: 141 -NCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 38/195 (19%), Positives = 63/195 (32%), Gaps = 47/195 (24%)
Query: 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
I+ ++ S+ + T + L S+ +I + + + Q I L N+ L + N
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGN 78
Query: 254 DIIGPIPST----------------------------------------LGLFSDLSYLD 273
+ P GL
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 274 LSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333
L + L+RLT+L L L N++S +P +A + L L LS N+I +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR- 194
Query: 334 EITKLSRLDYLNLSG 348
+ L LD L L
Sbjct: 195 ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 35/205 (17%), Positives = 74/205 (36%), Gaps = 30/205 (14%)
Query: 146 SIPSEIS------ALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGN 194
++P+ I A ++ +L + L +++ + + + + + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQY 66
Query: 195 LKNLIELDVGDNSLIGPIPLTLSRLTSLKIL-------------ILAQNQLSGLPQEIGN 241
L N+ +L + N L PL + L + LS I +
Sbjct: 67 LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126
Query: 242 LKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPN--ELTRLTQLFHLDLS 299
+ L+ L + +G T + + ++ I + L LT+L +L LS
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 300 SNKLSGKIPSQIASMEDLTWLDLSN 324
N +S +A +++L L+L +
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 4/70 (5%)
Query: 290 LTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349
+ +L ++ + + + + +N++IK I L + L L+GN
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 350 KLSGRVPYSN 359
KL+ P +N
Sbjct: 79 KLTDIKPLAN 88
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 10/82 (12%), Positives = 27/82 (32%), Gaps = 10/82 (12%)
Query: 230 NQLSGLPQEIG------NLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283
++ +P I + ++ + + T + + + + + S
Sbjct: 5 SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ 62
Query: 284 PNELTRLTQLFHLDLSSNKLSG 305
+ L + L L+ NKL+
Sbjct: 63 G--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 5/171 (2%)
Query: 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRGRLTNLNYMSLSRNMLGGLLP 189
L S+ + + S+ I L + L L+ N+L N +L L
Sbjct: 44 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV 102
Query: 190 QEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLD 249
+++ +LK+L +L G + + N + L L L
Sbjct: 103 KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162
Query: 250 VGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300
+ +N I +P L + L L LS N S + L L L L+L S
Sbjct: 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHI-SDLR-ALAGLKNLDVLELFS 209
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 7e-06
Identities = 25/176 (14%), Positives = 61/176 (34%), Gaps = 21/176 (11%)
Query: 194 NLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN 253
L ++ +G ++ + + + L + L + + + + L NL ++ NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNN 72
Query: 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD---------------- 297
+ P ++ + + + N +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353
L + + S ++ + L L+ S+N + P + L+ L+ L++S NK+S
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 4/74 (5%)
Query: 288 TRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347
T L + L ++ + ++ +T L IK SI G + L+ L +N S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 70
Query: 348 GNKLSGRVPYSNKH 361
N+L+ P N
Sbjct: 71 NNQLTDITPLKNLT 84
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 5e-05
Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 16/131 (12%)
Query: 286 ELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLN 345
+ T + LDL K+ I + A+++ +D S+N I+ + G L RL L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 69
Query: 346 LSGNKLSGRVPY-------------SNKHLSSMPTPRKIDSKYCIGTGAYGSVYKAQLPN 392
++ N++ +N L + + S + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 393 GRVFALKKLNS 403
R++ + K+
Sbjct: 130 YRLYVIYKVPQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 6/133 (4%)
Query: 219 LTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278
+ L L ++ + L +D +N+I + L L L ++ N+
Sbjct: 17 AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRR-LKTLLVNNNR 74
Query: 279 FNSSIPNELTRLTQLFHLDLSSNKLSG-KIPSQIASMEDLTWLDLSNNN---IKGSIPGE 334
L L L L++N L +AS++ LT+L + N K
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 335 ITKLSRLDYLNLS 347
I K+ ++ L+
Sbjct: 135 IYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.001
Identities = 11/54 (20%), Positives = 21/54 (38%), Gaps = 3/54 (5%)
Query: 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKL 351
L++ + +Q + LDL I I L + D ++ S N++
Sbjct: 3 LTAELIEQ--AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (82), Expect = 0.004
Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 10/136 (7%)
Query: 124 NFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRL-----RGRLTNLNYMS 178
+ + N R L I + + L + +D S N + L L +
Sbjct: 10 QAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLL 69
Query: 179 LSRNMLGGLLPQEIGNLKNLIELDVGDNSLIG-PIPLTLSRLTSLKILILAQNQLSGLP- 236
++ N + + L +L EL + +NSL+ L+ L SL L + +N ++
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 237 ---QEIGNLKNLMLLD 249
I + + +LD
Sbjct: 130 YRLYVIYKVPQVRVLD 145
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 11/70 (15%)
Query: 294 FHLDLSSNKLSGKIPSQIASMED------LTWLDLSNNNIKGSIPGEI-----TKLSRLD 342
L L+ LS + + + L L L N I+ + K+ L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 343 YLNLSGNKLS 352
+L L+GN+ S
Sbjct: 306 FLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 15/103 (14%), Positives = 26/103 (25%), Gaps = 4/103 (3%)
Query: 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDI----IGPIPSTLGLFSDLSYLDLSC 276
SLK+ + + + ++ + + N I + + DL + S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 277 NQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTW 319
L L L KL S A
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.002
Identities = 12/56 (21%), Positives = 22/56 (39%), Gaps = 7/56 (12%)
Query: 290 LTQLFHLDLSSNKLSGKIPSQIAS-----MEDLTWLDLSNNNIK--GSIPGEITKL 338
L L L N++ + + M DL +L+L+ N + EI ++
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.004
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 11/83 (13%)
Query: 175 NYMSLSRNMLGGLLPQEIGN------LKNLIELDVGDNSLIGPIPLTL-----SRLTSLK 223
+ L+ +L + + L L + N + TL ++ L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 224 ILILAQNQLSGLPQEIGNLKNLM 246
L L N+ S + ++ +
Sbjct: 306 FLELNGNRFSEEDDVVDEIREVF 328
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 11/64 (17%), Positives = 15/64 (23%), Gaps = 2/64 (3%)
Query: 173 NLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQL 232
N L L + LD+ + L L L+ L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235
Query: 233 SGLP 236
LP
Sbjct: 236 KKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 4e-04
Identities = 12/80 (15%), Positives = 18/80 (22%)
Query: 271 YLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330
L L+ N +N L LD+S I
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 331 IPGEITKLSRLDYLNLSGNK 350
+ L +L + K
Sbjct: 217 PSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 6/57 (10%), Positives = 15/57 (26%)
Query: 269 LSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNN 325
N + + LD+S ++ + +++ L N
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 11/51 (21%), Positives = 18/51 (35%), Gaps = 3/51 (5%)
Query: 259 IPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS 309
S LD+S + +S L L +L + K K+P+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 602 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.98 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.98 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.87 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.14 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.69 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.84 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.19 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 88.21 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.8e-39 Score=329.92 Aligned_cols=286 Identities=27% Similarity=0.458 Sum_probs=247.7
Q ss_pred CCHHHHHHHhcc------CCCCCCCCCCCCCCCC--CCCCceeCCC---CCEEEEEecCCCCCCCcccccCCCCCCCCCc
Q 047576 64 PIQLETKALLNT------GWWNNSWTMDYDSDHC--EWIGITCNSA---GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLE 132 (602)
Q Consensus 64 ~~~~~~~al~~~------~~~~~~w~~~~~~~~C--~w~gv~C~~~---~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~ 132 (602)
|.+.|++||++. ....++|+ .++||| .|.||+|+.. +||++|+|++.++.-...++. .++.+++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~--~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCC--TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCC--CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccc
Confidence 568899999761 11225775 357999 4999999854 489999998765543334443 578888999
Q ss_pred cchhccccCCccccCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecC
Q 047576 133 SLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGD 205 (602)
Q Consensus 133 ~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 205 (602)
+|++.. .|++.|.+|++|++|++|++|+|++|+|.+ .+.+|+++++++|.+.+.+|..++++++|+++++++
T Consensus 80 ~L~Ls~-~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 80 FLYIGG-INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp EEEEEE-ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred cccccc-ccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence 888862 378899999999999999999999999985 378899999999999999999999999999999999
Q ss_pred CCCCCCCcccccCcCCC-ceeecccccCCC-CcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCC
Q 047576 206 NSLIGPIPLTLSRLTSL-KILILAQNQLSG-LPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSI 283 (602)
Q Consensus 206 N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 283 (602)
|.++|.+|..+..+.++ +.+++++|++++ .|..+.++.. ..+++++|.+.|.+|..+..+++|+.+++++|.+++.+
T Consensus 159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998886 899999999999 7778877654 57999999999999999999999999999999999876
Q ss_pred chhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCc-CCCc-cC
Q 047576 284 PNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNK-LSGR-VP 356 (602)
Q Consensus 284 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~-~p 356 (602)
| .++.+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ ++|. +|
T Consensus 238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred c-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence 6 688999999999999999999999999999999999999999999985 6889999999999997 6774 45
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=327.53 Aligned_cols=221 Identities=23% Similarity=0.309 Sum_probs=166.8
Q ss_pred CCCCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH---------------------
Q 047576 365 MPTPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL--------------------- 422 (602)
Q Consensus 365 lp~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il--------------------- 422 (602)
+|..++|+..+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|+.++
T Consensus 1 ~Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 1 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp CTTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 35678899999999999999999986 47899999998755432 2346788999988
Q ss_pred ----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 423 ----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 423 ----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence 55566666666643 345899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCC--CCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC
Q 047576 499 LHADS--SNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP 575 (602)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~ 575 (602)
..... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... ...............
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~~~~~~~~~~ 226 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYL 226 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST------TSHHHHHHHTTCTTS
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCCC
Confidence 65432 22344679999999999988776 5789999999999999999999975321 111122222222221
Q ss_pred CCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 576 PVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.... ....+.+++.+||++||++
T Consensus 227 ~~~~~---~s~~~~~li~~~L~~dP~~ 250 (271)
T d1nvra_ 227 NPWKK---IDSAPLALLHKILVENPSA 250 (271)
T ss_dssp TTGGG---SCHHHHHHHHHHSCSSTTT
T ss_pred Ccccc---CCHHHHHHHHHHcCCChhH
Confidence 11111 1234678999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=328.24 Aligned_cols=214 Identities=28% Similarity=0.423 Sum_probs=168.5
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------------- 427 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------------- 427 (602)
++|+..+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.++..+.|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999874 689999999876554444455678899998855544
Q ss_pred -----CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 428 -----GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 428 -----gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
|+|.+++.. ...+++.++..|+.||++||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 444444432 345899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......||+.|+|||++.+..++.++||||+||++|||+||+.||+.... ...+..+.......+. .
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~-- 226 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFTFPD--F-- 226 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCT--T--
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCc--c--
Confidence 23446799999999999999999999999999999999999999975321 2223333333333221 1
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 227 -~s~~~~~li~~~L~~dp~~ 245 (263)
T d2j4za1 227 -VTEGARDLISRLLKHNPSQ 245 (263)
T ss_dssp -SCHHHHHHHHHHTCSSGGG
T ss_pred -CCHHHHHHHHHHccCCHhH
Confidence 1234778999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=328.28 Aligned_cols=223 Identities=24% Similarity=0.344 Sum_probs=157.8
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc-------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI------------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~------------- 433 (602)
.++|+..+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|++++..+.|+++.++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 36799999999999999999986 478999999987654332 235678899998855555555443
Q ss_pred --------------ccccc-chhhhcHHHHHHHHHHHHHHHHHhhhcC--CCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 434 --------------LHNDA-EAVELDWAKRVNIVKAMAHALAYLHHDC--SPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 434 --------------l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
+.... ....+++.++..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 32211 1234889999999999999999999531 135999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
+....+........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.+...+..
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~~ 234 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRRI 234 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCC
Confidence 9876555445557899999999999999999999999999999999999999975321 122233333333211
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .. ...++.+++.+||+.||++
T Consensus 235 ~-~~---~s~~l~~li~~~L~~dp~~ 256 (269)
T d2java1 235 P-YR---YSDELNEIITRMLNLKDYH 256 (269)
T ss_dssp C-TT---SCHHHHHHHHHHTCSSGGG
T ss_pred C-cc---cCHHHHHHHHHHcCCChhH
Confidence 1 11 1234789999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=325.74 Aligned_cols=219 Identities=24% Similarity=0.344 Sum_probs=168.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++..+.|+++..++...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 35799999999999999999986 47999999998654332 235688999998666655555443211
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....+...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 01234889999999999999999999 789999999999999999999999999999987655555
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCC-CCCCChhhHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRL-PPPVDRKVIQD 584 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~ 584 (602)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+..+..... ..+.... .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~---~ 242 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQNPEK---L 242 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCCSSGGG---S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCccc---C
Confidence 55678999999999999999999999999999999999999999753221 11222222211 1111111 2
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++.+||++||++
T Consensus 243 s~~~~~li~~~L~~dP~~ 260 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEK 260 (293)
T ss_dssp CHHHHHHHHHHTCSSTTT
T ss_pred CHHHHHHHHHHccCChhH
Confidence 234789999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=328.70 Aligned_cols=220 Identities=20% Similarity=0.343 Sum_probs=167.9
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+++|+..+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|++++..+.|+++..+....
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999986 47899999998765443333456788999999666665555443211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 11345899999999999999999999 78999999999999999999999999999987754322
Q ss_pred --CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 --NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+. .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~-- 232 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYDFPE--K-- 232 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCCCCT--T--
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCCCCCCc--c--
Confidence 23345799999999999999999999999999999999999999975321 1222333333332221 1
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 233 -~s~~~~~li~~~L~~dP~~ 251 (288)
T d1uu3a_ 233 -FFPKARDLVEKLLVLDATK 251 (288)
T ss_dssp -CCHHHHHHHHTTSCSSGGG
T ss_pred -CCHHHHHHHHHHccCCHhH
Confidence 1223789999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-40 Score=326.86 Aligned_cols=220 Identities=28% Similarity=0.432 Sum_probs=159.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------ 423 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------ 423 (602)
.++|...+.||+|+||+||+|+.+ ..||||+++...... ...+.|.+|+.++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence 356888899999999999999874 359999987543221 24577899999984
Q ss_pred hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 424 QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 424 ~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
|+++|+|.+++... ...+++.++..|+.||++||+||| +++||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 44555555555432 234899999999999999999999 7899999999999999999999999999998765422
Q ss_pred C--Ccccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC-CCC
Q 047576 504 S--NQTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP-PPV 577 (602)
Q Consensus 504 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~-~~~ 577 (602)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+...+..... +..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSPDL 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCCCG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCCcc
Confidence 2 2334579999999999864 34789999999999999999999999753221 112222222211 111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+........+.+++.+||+.||++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~ 256 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDE 256 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hhccccchHHHHHHHHHHcCCCHhH
Confidence 1111113345889999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=331.79 Aligned_cols=220 Identities=22% Similarity=0.268 Sum_probs=171.6
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+..+.||+|+||.||+|+. .+|+.||||++++.........+.+.+|+.++..+.|+++..+....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 57999999999765544344556788999998555555544433211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 01344889999999999999999999 88999999999999999999999999999987655444
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+....+..|.. .
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~~~p~~-----~ 228 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIRFPRT-----L 228 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCTT-----S
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcCCCCCCcc-----C
Confidence 45557899999999999999999999999999999999999999975321 22223333333332211 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|+++||++
T Consensus 229 s~~~~dli~~~L~~dP~~ 246 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQ 246 (337)
T ss_dssp CHHHHHHHHHHTCSSTTT
T ss_pred CHHHHHHHHhhccCCchh
Confidence 223778999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=322.83 Aligned_cols=217 Identities=21% Similarity=0.315 Sum_probs=164.1
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRI-------------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~-------------- 433 (602)
.++|...+.||+|+||+||+|++++++.||||+++..... .+.|.+|++++..+.|+++.++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEE
Confidence 3578888999999999999999988899999999754432 3568899999855555554444
Q ss_pred ----------cccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 434 ----------LHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 434 ----------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
+... ....++|.+++.|+.||++||.||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 3321 2334899999999999999999999 7899999999999999999999999999998875432
Q ss_pred C-CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 504 S-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
. ......||+.|+|||++.+..++.++|||||||++|||+||..|+..... ....+..+.. ..+++.+..
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------~~~~~~~i~~-~~~~~~p~~-- 234 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLER-GYRMVRPDN-- 234 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHT-TCCCCCCTT--
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------HHHHHHHHHh-cCCCCCccc--
Confidence 2 23345688999999999999999999999999999999997666542211 1111222222 122111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 235 -~~~~l~~li~~cl~~~P~~ 253 (272)
T d1qpca_ 235 -CPEELYQLMRLCWKERPED 253 (272)
T ss_dssp -CCHHHHHHHHHHTCSSGGG
T ss_pred -ChHHHHHHHHHHcCCCHhH
Confidence 2334889999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=320.12 Aligned_cols=215 Identities=24% Similarity=0.316 Sum_probs=153.5
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCc------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGS------------------ 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gs------------------ 429 (602)
+++|...+.||+|+||+||+|++.+++.||||+++..... .+.|.+|++++..+.|++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 4578888999999999999999988999999999765433 356888999885555544
Q ss_pred -------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 430 -------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 430 -------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
|.+++.. ....++|..+..|+.|||+||+|+| +++|+||||||+|||+|.++.+||+|||+++.....
T Consensus 80 E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 4444432 2344789999999999999999999 789999999999999999999999999999876543
Q ss_pred CCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHcC-CCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMG-KHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
... .....||+.|+|||++.+..++.++|||||||++|||+|| ++||.... ....+..+ ....+.+.+..
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i-~~~~~~~~p~~ 226 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDI-STGFRLYKPRL 226 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHH-HHTCCCCCCTT
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHH-HhcCCCCCccc
Confidence 322 2335689999999999999999999999999999999995 44554221 11111222 22222111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+..++.+++..||+.||++
T Consensus 227 ---~~~~l~~li~~cl~~~p~~ 245 (263)
T d1sm2a_ 227 ---ASTHVYQIMNHCWKERPED 245 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGG
T ss_pred ---cCHHHHHHHHHHccCCHhH
Confidence 2345889999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=324.06 Aligned_cols=219 Identities=22% Similarity=0.306 Sum_probs=166.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.+.|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++..+.|+++.+++...
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 34578889999999999999986 47899999998755332 357889999999666666655543311
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCC
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADS 503 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 01234899999999999999999999 7899999999999999999999999999997654322
Q ss_pred CCccccccccccccccccc-----cCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCC-CC
Q 047576 504 SNQTLLAGSYGYIAPELAY-----TMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPP-PV 577 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~-~~ 577 (602)
.......||+.|+|||++. +..++.++||||+||++|||+||+.||..... ...+..+.....+. +.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------MRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GGHHHHHHHSCCCCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCCCc
Confidence 2233467999999999984 45588999999999999999999999975332 22233333332221 11
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++.+||++||++
T Consensus 238 ~~~---~s~~~~~li~~~L~~dp~~ 259 (288)
T d2jfla1 238 PSR---WSSNFKDFLKKCLEKNVDA 259 (288)
T ss_dssp GGG---SCHHHHHHHHHHSCSSTTT
T ss_pred ccc---CCHHHHHHHHHHccCChhH
Confidence 111 2344789999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-39 Score=323.01 Aligned_cols=218 Identities=24% Similarity=0.312 Sum_probs=167.2
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||+||+|++. +|+.||||+++..... .++|.+|+.++..+.|+++.+++...
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 357888899999999999999875 5889999998755432 35688999999666665555443211
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..+..|+.||++||+||| +++|+||||||+|||++.++.+||+|||+|+....+
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 11245899999999999999999999 789999999999999999999999999999887554
Q ss_pred CCC-ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 503 SSN-QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
... .....|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+.+.++...+++....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~~~~- 240 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERPEG- 240 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCCCTT-
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcCCCCCCCcc-
Confidence 332 2334588999999999999999999999999999999998777643211 1223344444443333222
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 241 --~~~~l~~li~~cl~~dP~~ 259 (287)
T d1opja_ 241 --CPEKVYELMRACWQWNPSD 259 (287)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --chHHHHHHHHHHcCCCHhH
Confidence 2345889999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-38 Score=322.40 Aligned_cols=216 Identities=25% Similarity=0.306 Sum_probs=170.9
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+..+.||+|+||+||+|+. .+|+.||||++++.........+.+.+|+.++..+.|+++.++....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5788999999999999999986 46999999999765544444567788999999877777776654321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 01233678888999999999999999 899999999999999999999999999999886543
Q ss_pred ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHH
Q 047576 506 QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDI 585 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 585 (602)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+.. ..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~~p~~-----~s 225 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELRFPPF-----FN 225 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCCCCTT-----SC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCCCCCCCC-----CC
Confidence 2346799999999999999999999999999999999999999975321 22233344443332211 11
Q ss_pred HHHHHHHhhccCcCCCC
Q 047576 586 LLVSTISFACLQSNPKS 602 (602)
Q Consensus 586 ~~l~~l~~~Cl~~dP~e 602 (602)
..+.+++.+|+++||++
T Consensus 226 ~~~~~li~~~L~~dp~~ 242 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQ 242 (316)
T ss_dssp HHHHHHHHHHTCSCTTT
T ss_pred HHHHHHHHHHhhhCHHh
Confidence 23778999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-38 Score=320.89 Aligned_cols=219 Identities=26% Similarity=0.385 Sum_probs=154.7
Q ss_pred CccccCcccccccccccceeeecC-CC---cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NG---RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
...|+..+.||+|+||+||+|+.. ++ ..||||++...... ...+.|.+|++++..+.|+++.+++...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356888899999999999999864 23 36899988755433 2356789999999666666655543311
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....++|.++..|+.|||+||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 11234899999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCC-----ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 501 ADSSN-----QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 501 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .. +...+.....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~-~~~~i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QD-VINAIEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcCCC
Confidence 43221 112357899999999999999999999999999999998 8999975321 11 1222222222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.... ....+.+++..||+.||++
T Consensus 252 ~~~~~~---~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 252 LPPPMD---CPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSTTT
T ss_pred CCCCcc---chHHHHHHHHHHcCCCHhH
Confidence 222222 3445889999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-38 Score=321.16 Aligned_cols=217 Identities=23% Similarity=0.325 Sum_probs=170.4
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
+.|+..+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.++..+.|+++.+++...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588889999999999999985 57899999998766544445667899999999888888887765421
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++.++..|+.||+.||.||| +++|+||||||+|||++.++.+||+|||+|......
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 11234899999999999999999999 789999999999999999999999999999875432
Q ss_pred cccccccccccccccccc---CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 506 QTLLAGSYGYIAPELAYT---MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+.....+......
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~-- 238 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGH-- 238 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSCTT--
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCCCCC--
Confidence 23579999999999864 4589999999999999999999999974321 2223333333333222211
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||++||++
T Consensus 239 -~s~~~~~li~~~L~~dP~~ 257 (309)
T d1u5ra_ 239 -WSEYFRNFVDSCLQKIPQD 257 (309)
T ss_dssp -SCHHHHHHHHHHTCSSGGG
T ss_pred -CCHHHHHHHHHHCcCChhH
Confidence 2234889999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-38 Score=327.67 Aligned_cols=217 Identities=20% Similarity=0.274 Sum_probs=172.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+..+.||+|+||.||+|+. .+|+.||||++.+.........+.+.+|+.++..+.|+++..+....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999986 47999999998765444444556788999999887777776554321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..|+.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 01234889999999999999999999 789999999999999999999999999999877543
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHH
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQD 584 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 584 (602)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.... ....+..+.......+.. .
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-----~ 261 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPSH-----F 261 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT-----C
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-------HHHHHHHHhcCCCCCCcc-----C
Confidence 233679999999999999999999999999999999999999997432 122233444443332211 1
Q ss_pred HHHHHHHHhhccCcCCCC
Q 047576 585 ILLVSTISFACLQSNPKS 602 (602)
Q Consensus 585 ~~~l~~l~~~Cl~~dP~e 602 (602)
...+.+++..|+++||++
T Consensus 262 s~~~~~li~~~L~~dP~k 279 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp CHHHHHHHHHHSCSCTTT
T ss_pred CHHHHHHHHHHhhhCHHh
Confidence 233789999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=317.78 Aligned_cols=216 Identities=22% Similarity=0.299 Sum_probs=162.2
Q ss_pred ccccCccc-ccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh------------------
Q 047576 369 RKIDSKYC-IGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME------------------ 426 (602)
Q Consensus 369 ~~f~~~~~-LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~------------------ 426 (602)
++|...+. ||+|+||+||+|.+. ++..||||+++..... ...+.|.+|++++..+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence 45666664 999999999999753 4568999998755432 24567899999985444
Q ss_pred ------cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 427 ------RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 427 ------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
+|+|.+++.. ....+++.++..|+.||++||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 4555444432 2345899999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 501 ADSS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 501 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+... .+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~-~~~~ 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQG-KRME 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTT-CCCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC-CCCC
Confidence 4322 1223468899999999999999999999999999999998 9999975321 1111222221 1111
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.. ....+.+++..||+.||++
T Consensus 233 ~p~~---~~~~l~~li~~cl~~~p~~ 255 (285)
T d1u59a_ 233 CPPE---CPPELYALMSDCWIYKWED 255 (285)
T ss_dssp CCTT---CCHHHHHHHHHTTCSSGGG
T ss_pred CCCc---CCHHHHHHHHHHcCCCHhH
Confidence 1111 2344789999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=316.10 Aligned_cols=220 Identities=25% Similarity=0.365 Sum_probs=162.0
Q ss_pred CccccCcccccccccccceeeecCCC-----cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNG-----RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
++.|+..++||+|+||+||+|++..+ ..||||++...... .....|.+|+.++..+.|+++..++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 35688899999999999999986432 47999998754433 2345788999999999998887765421
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....++|.++..++.||+.|++||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 01234899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCC---CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 500 HADSS---NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 500 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
..... ......||+.|+|||++.+..++.++|||||||++|||+||..||.... ... .+...++...+++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~-~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNH-EVMKAINDGFRLP 233 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHH-HHHHHHHTTCCCC
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC------CHH-HHHHHHhccCCCC
Confidence 54322 1223468999999999999999999999999999999999776654321 111 2223333333333
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.. ....+.+++.+||+.||++
T Consensus 234 ~~~~---~~~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 234 TPMD---CPSAIYQLMMQCWQQERAR 256 (283)
T ss_dssp CCTT---CBHHHHHHHHHHTCSSTTT
T ss_pred Cchh---hHHHHHHHHHHHCcCCHhH
Confidence 3322 3455889999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=313.39 Aligned_cols=216 Identities=22% Similarity=0.344 Sum_probs=160.4
Q ss_pred ccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------------
Q 047576 371 IDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------------ 437 (602)
Q Consensus 371 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------ 437 (602)
|.....||+|+||+||+|+.. +++.||+|++....... ...+.+.+|++++..+.|+++.+++...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 356678999999999999864 68899999987554322 2356789999999777777766654210
Q ss_pred --------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCC--eEEeCCCCCCeeeC-CCCcceeeccccccccc
Q 047576 438 --------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--VVHRDISSNNILLN-SKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 --------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~DLkp~NILld-~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.+++.++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 01234789999999999999999999 666 99999999999996 57899999999998653
Q ss_pred CCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
. .......||+.|+|||++.+ .++.++||||+||++|||+||+.||...... ......+.....+...+..
T Consensus 167 ~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 167 A--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp T--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGGC
T ss_pred C--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccCcc
Confidence 3 23345689999999998865 5899999999999999999999999743211 1111122222111111111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...++.+++.+||++||++
T Consensus 238 ---~~~~~~~li~~~l~~dp~~ 256 (270)
T d1t4ha_ 238 ---AIPEVKEIIEGCIRQNKDE 256 (270)
T ss_dssp ---CCHHHHHHHHHHSCSSGGG
T ss_pred ---CCHHHHHHHHHHccCCHhH
Confidence 2234789999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=311.39 Aligned_cols=217 Identities=21% Similarity=0.308 Sum_probs=169.6
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
+++|...+.||+|+||+||+|+.++++.||||+++..... .+.|.+|+.++..+.|+++..++...
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 4678899999999999999999988999999998765433 35688999999777777776654321
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++..+.+++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 11334788999999999999999999 78999999999999999999999999999987654332
Q ss_pred -CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhH
Q 047576 505 -NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVI 582 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 582 (602)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||+.... .+....+.+. .+.+.+..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~-~~~~~p~~-- 225 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQG-LRLYRPHL-- 225 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTT-CCCCCCTT--
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhC-CCCCCccc--
Confidence 2233568999999999999999999999999999999998 8999975321 1122222222 12111111
Q ss_pred HHHHHHHHHHhhccCcCCCC
Q 047576 583 QDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 583 ~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 226 -~~~~l~~li~~cl~~dP~~ 244 (258)
T d1k2pa_ 226 -ASEKVYTIMYSCWHEKADE 244 (258)
T ss_dssp -CCHHHHHHHHHTTCSSGGG
T ss_pred -ccHHHHHHHHHHccCCHhH
Confidence 3345889999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=323.28 Aligned_cols=219 Identities=20% Similarity=0.296 Sum_probs=164.7
Q ss_pred ccccCcccccccccccceeeecCC------CcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPN------GRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|...+.||+|+||+||+|+... ...||+|.+...... .....+.+|+.++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 578888999999999999997532 236999988654332 2345678888877
Q ss_pred ------HhhhcCcccccccccc--------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCC
Q 047576 423 ------SQMERGSLFRILHNDA--------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDIS 476 (602)
Q Consensus 423 ------~~l~~gsL~~~l~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLk 476 (602)
||+++|+|.++++... ....+++.+++.|+.||++||+||| +++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 5556666666665421 1234899999999999999999999 7899999999
Q ss_pred CCCeeeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCc
Q 047576 477 SNNILLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHS 553 (602)
Q Consensus 477 p~NILld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~ 553 (602)
|+||+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876554332 223568999999999999999999999999999999998 899997432
Q ss_pred ccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 554 TLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 554 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+..++....+.+.+.. ....+.+++.+||+.||++
T Consensus 272 -------~~~~~~~~~~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~ 310 (325)
T d1rjba_ 272 -------VDANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRK 310 (325)
T ss_dssp -------CSHHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred -------HHHHHHHHHhcCCCCCCCCc---CCHHHHHHHHHHcCCChhH
Confidence 12233445544443333222 2345889999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-38 Score=319.36 Aligned_cols=215 Identities=22% Similarity=0.321 Sum_probs=149.1
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHH------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLS------------------------ 423 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~------------------------ 423 (602)
+.|+..+.||+|+||+||+|+.. +|+.||||++....... ..+.+.+|+.++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 55889999999999999999864 68999999987554332 2356888999884
Q ss_pred -hhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeecccccccc
Q 047576 424 -QMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFGTARLL 499 (602)
Q Consensus 424 -~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG~a~~~ 499 (602)
|+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+||+++ +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 4455555555543 234899999999999999999999 78999999999999994 5789999999999876
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC--CCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP--PPV 577 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~--~~~ 577 (602)
..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+...... .+.
T Consensus 161 ~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 161 DPGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYEFDSPY 232 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCCCCTTT
T ss_pred cCCCe-eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCCCCCcc
Confidence 54332 2345799999999999999999999999999999999999999974321 1122333333322 111
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++.+|+++||++
T Consensus 233 ~~~---~s~~~~~li~~~L~~dP~~ 254 (307)
T d1a06a_ 233 WDD---ISDSAKDFIRHLMEKDPEK 254 (307)
T ss_dssp TTT---SCHHHHHHHHHHSCSSGGG
T ss_pred ccC---CCHHHHHHHHHHccCCHhH
Confidence 111 2234789999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=315.38 Aligned_cols=218 Identities=23% Similarity=0.328 Sum_probs=161.2
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|...+.||+|+||+||+|+..+++.||||+++..... .+.|.+|+.++..+.|+++.+++...
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence 3678899999999999999999988889999999755433 35688999998666666555543211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....++|.+++.|+.||+.||+||| +.+|+||||||+|||+|.++.+||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 11234899999999999999999999 78999999999999999999999999999987644322
Q ss_pred -CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHH
Q 047576 505 -NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQ 583 (602)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 583 (602)
......||+.|+|||++.++.++.++|||||||++|||+||..||.... .... +...+......+....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~------~~~~-~~~~i~~~~~~~~~~~--- 238 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNRE-VLDQVERGYRMPCPPE--- 238 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHH-HHHHHHTTCCCCCCTT---
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC------CHHH-HHHHHHhcCCCCCCcc---
Confidence 2333568999999999999999999999999999999999777654321 1111 1222222222222222
Q ss_pred HHHHHHHHHhhccCcCCCC
Q 047576 584 DILLVSTISFACLQSNPKS 602 (602)
Q Consensus 584 ~~~~l~~l~~~Cl~~dP~e 602 (602)
..+++.+++.+||+.||++
T Consensus 239 ~~~~l~~li~~cl~~dP~~ 257 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEE 257 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGG
T ss_pred cCHHHHHHHHHHcccCHhH
Confidence 3345889999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=323.23 Aligned_cols=179 Identities=24% Similarity=0.337 Sum_probs=145.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|+..+.||+|+||+||+|+. .+|+.||+|+++..... ...+.+.+|+.++..+.|+++.+++...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999986 47899999998654322 2346788899988666555555443211
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|+++||.|||+ ..+|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 012358999999999999999999993 1389999999999999999999999999998764332
Q ss_pred CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 505 NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....+||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 23468999999999999999999999999999999999999999653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-38 Score=320.10 Aligned_cols=216 Identities=22% Similarity=0.332 Sum_probs=168.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------- 422 (602)
++|...+.||+|+||+||+|+.. +|+.||||++++.........+.+..|..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999864 7999999999754433223344555666554
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 66666677666653 344889999999999999999999 78999999999999999999999999999987765
Q ss_pred CCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 502 DSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+ +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~~p--~~- 225 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNPFYP--RW- 225 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCC--TT-
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC--cc-
Confidence 55555557899999999999999999999999999999999999999975322 112222322222211 11
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+|+++||++
T Consensus 226 --~s~~~~dli~~~L~~dP~~ 244 (320)
T d1xjda_ 226 --LEKEAKDLLVKLFVREPEK 244 (320)
T ss_dssp --SCHHHHHHHHHHSCSSGGG
T ss_pred --CCHHHHHHHHHhcccCCCC
Confidence 1233789999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-38 Score=317.08 Aligned_cols=219 Identities=23% Similarity=0.293 Sum_probs=156.8
Q ss_pred ccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------- 422 (602)
++|...+.||+|+||.||+|+.. +++.||||+++..... ...+.+.+|..++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 57888999999999999999742 4578999998754332 2234555565544
Q ss_pred -------HhhhcCccccccccccc-------------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeee
Q 047576 423 -------SQMERGSLFRILHNDAE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILL 482 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILl 482 (602)
||+++|+|.++++.... ...+++.+++.|+.||++||+||| +++|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence 77788888888764321 234899999999999999999999 7899999999999999
Q ss_pred CCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCC-CCCCCCcccccCC
Q 047576 483 NSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK-HPRDLHSTLSSSY 559 (602)
Q Consensus 483 d~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~~~ 559 (602)
+.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||.....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~----- 242 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----- 242 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-----
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987654322 233457999999999999999999999999999999999975 57764321
Q ss_pred CcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 560 DPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 560 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+...+.....++.... ....+.+++.+||+.||++
T Consensus 243 --~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~ 280 (299)
T d1ywna1 243 --DEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQ 280 (299)
T ss_dssp --SHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred --HHHHHHHHhcCCCCCCCcc---CCHHHHHHHHHHcCCChhH
Confidence 1122233322222222111 2234789999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-37 Score=322.29 Aligned_cols=217 Identities=23% Similarity=0.283 Sum_probs=160.4
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhH---HHHH----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNE---AQVL---------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E---~~il---------------------- 422 (602)
++|+..+.||+|+||.||+|+.. +|+.||||++.+...........+.+| +.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999864 699999999865443322222333344 4444
Q ss_pred ---HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 423 ---SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 423 ---~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
||+++|+|.+++.. ...+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 55556666666543 344788999999999999999999 889999999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCC
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVD 578 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 578 (602)
.... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||...... ................+
T Consensus 158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~-- 229 (364)
T d1omwa3 158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLTMAVELP-- 229 (364)
T ss_dssp SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHHHHSSSCCCCCC--
T ss_pred CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcccCCCCCC--
Confidence 5432 334579999999999875 46899999999999999999999999753211 00011111111111111
Q ss_pred hhhHHHHHHHHHHHhhccCcCCCC
Q 047576 579 RKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 579 ~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ....+.+++.+||++||++
T Consensus 230 ~~---~s~~~~~li~~~L~~dP~~ 250 (364)
T d1omwa3 230 DS---FSPELRSLLEGLLQRDVNR 250 (364)
T ss_dssp SS---SCHHHHHHHHHHTCSSTTT
T ss_pred CC---CCHHHHHHHHHHcccCHHH
Confidence 11 1223789999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-38 Score=313.11 Aligned_cols=213 Identities=23% Similarity=0.316 Sum_probs=157.7
Q ss_pred ccccccccccceeeecC---CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc--------------
Q 047576 375 YCIGTGAYGSVYKAQLP---NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND-------------- 437 (602)
Q Consensus 375 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~-------------- 437 (602)
+.||+|+||+||+|.+. .++.||||+++.... .....+.|.+|+.++..+.|+++.+++...
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCC
Confidence 46999999999999753 357899999875433 233457899999999666665555443211
Q ss_pred -------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC---cc
Q 047576 438 -------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---QT 507 (602)
Q Consensus 438 -------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~---~~ 507 (602)
.....+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 01244899999999999999999999 789999999999999999999999999999876543222 22
Q ss_pred ccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhhHHHHH
Q 047576 508 LLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDIL 586 (602)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 586 (602)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||..... . .+...+....+++.+.. ...
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~-~~~~~i~~~~~~~~p~~---~~~ 237 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------S-EVTAMLEKGERMGCPAG---CPR 237 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------H-HHHHHHHTTCCCCCCTT---CCH
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------H-HHHHHHHcCCCCCCCcc---cCH
Confidence 3468999999999999999999999999999999998 8999975321 1 12223322222222222 334
Q ss_pred HHHHHHhhccCcCCCC
Q 047576 587 LVSTISFACLQSNPKS 602 (602)
Q Consensus 587 ~l~~l~~~Cl~~dP~e 602 (602)
.+.+++..||+.||++
T Consensus 238 ~~~~li~~cl~~dp~~ 253 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVEN 253 (277)
T ss_dssp HHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHcCCCHhH
Confidence 5889999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-37 Score=321.15 Aligned_cols=218 Identities=22% Similarity=0.279 Sum_probs=167.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
.++|+..+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999986 47999999999766543 246788899988
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC--CCCcceeecccccccc
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN--SKLEAFVADFGTARLL 499 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFG~a~~~ 499 (602)
||+++|+|.+++.. ....+++.++..|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+++..
T Consensus 102 mE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 45555555555533 2334899999999999999999999 78999999999999995 4678999999999877
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+..
T Consensus 177 ~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~- 247 (350)
T d1koaa2 177 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDS- 247 (350)
T ss_dssp CTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCCG-
T ss_pred cccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcc-
Confidence 5433 33446799999999999999999999999999999999999999974321 22233333333222111
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++.+|+++||++
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~ 270 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNT 270 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGG
T ss_pred cccCCCHHHHHHHHHHccCChhH
Confidence 00112234789999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-38 Score=313.41 Aligned_cols=224 Identities=22% Similarity=0.344 Sum_probs=164.9
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||.||+|+. .+|+.||||+++..........+.+.+|++++..+.|+++..++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999985 57999999999876554455667899999999887777776543311
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.++++|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 01234899999999999999999999 7899999999999999999999999999987654
Q ss_pred CCC---CCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 501 ADS---SNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 501 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+..++.....++.
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPPS 235 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCGG
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCCCc
Confidence 322 1233457999999999999999999999999999999999999999753321 112222222211110
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ........+.+++.+|+++||++
T Consensus 236 ~-~~~~~s~~l~~li~~~L~~dp~~ 259 (277)
T d1o6ya_ 236 A-RHEGLSADLDAVVLKALAKNPEN 259 (277)
T ss_dssp G-TSSSCCHHHHHHHHHHTCSSGGG
T ss_pred h-hccCCCHHHHHHHHHHccCCHhH
Confidence 0 00012234788999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-37 Score=319.55 Aligned_cols=218 Identities=24% Similarity=0.297 Sum_probs=166.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER------------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~------------------- 427 (602)
-+.|+..+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++..+.|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35688999999999999999986 47999999998765433 23567889999855544
Q ss_pred ------CccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC--CCCcceeecccccccc
Q 047576 428 ------GSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN--SKLEAFVADFGTARLL 499 (602)
Q Consensus 428 ------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFG~a~~~ 499 (602)
|+|.+.+.. ....+++.++..|+.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|+..
T Consensus 105 mE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 444443332 1234899999999999999999999 78999999999999998 5789999999999887
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+...
T Consensus 180 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 180 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDA 251 (352)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSST
T ss_pred CCCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccc
Confidence 6443 33446799999999999999999999999999999999999999975322 122233333222211100
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.......+.+++.+|+++||++
T Consensus 252 -~~~~s~~~~~li~~~L~~dp~~ 273 (352)
T d1koba_ 252 -FSSVSPEAKDFIKNLLQKEPRK 273 (352)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGG
T ss_pred -ccCCCHHHHHHHHHHccCChhH
Confidence 0012234789999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=309.62 Aligned_cols=222 Identities=19% Similarity=0.289 Sum_probs=160.9
Q ss_pred CccccCcccccccccccceeeecC--C--CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--N--GRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------ 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------ 437 (602)
.++|+..+.||+|+||+||+|++. + ...||||++++.........+.|.+|+.++..++|+++.++....
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~ 86 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence 467889999999999999999752 2 347899999876555455667899999999888887777654311
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..++.++.||+.||.||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 11345899999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCC---ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 502 DSSN---QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 502 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
.... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.... ....+..+......++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERLPR 236 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCCCC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHHHHHHHHhCCCCCCC
Confidence 3322 223457889999999999999999999999999999998 899997432 22223334333333222
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
... ....+.+++..||+.||++
T Consensus 237 ~~~---~~~~l~~li~~cl~~dp~~ 258 (273)
T d1u46a_ 237 PED---CPQDIYNVMVQCWAHKPED 258 (273)
T ss_dssp CTT---CCHHHHHHHHHHTCSSGGG
T ss_pred ccc---ccHHHHHHHHHHcCCChhH
Confidence 222 2234889999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-37 Score=312.22 Aligned_cols=219 Identities=24% Similarity=0.360 Sum_probs=163.9
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-------------- 427 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-------------- 427 (602)
.++|+..+.||+|+||+||+|+.+ +++.||||+++..... ...++|.+|++++..+.|
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 357999999999999999999752 4678999998755433 345788999999955554
Q ss_pred -----------Ccccccccccc---------------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCC
Q 047576 428 -----------GSLFRILHNDA---------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDI 475 (602)
Q Consensus 428 -----------gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DL 475 (602)
|+|.+++.... ....+++.++..|+.|++.||+||| +++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence 44444443211 0123789999999999999999999 789999999
Q ss_pred CCCCeeeCCCCcceeecccccccccCCCC--CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCC-CCCCCC
Q 047576 476 SSNNILLNSKLEAFVADFGTARLLHADSS--NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK-HPRDLH 552 (602)
Q Consensus 476 kp~NILld~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~Pf~~~ 552 (602)
||+|||+|.++.+||+|||+|+....... ..+...|++.|+|||++.+..++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999987644322 223456889999999999999999999999999999999996 567643
Q ss_pred cccccCCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 553 STLSSSYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 553 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. ..+....+.+...+ +.+.. ....+.+++.+||+.||++
T Consensus 247 ~-------~~e~~~~v~~~~~~-~~p~~---~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 247 A-------HEEVIYYVRDGNIL-ACPEN---CPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp C-------HHHHHHHHHTTCCC-CCCTT---CCHHHHHHHHHHTCSSGGG
T ss_pred C-------HHHHHHHHHcCCCC-CCCcc---chHHHHHHHHHHcCCChhH
Confidence 2 22223334443332 11211 2345889999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=313.72 Aligned_cols=219 Identities=23% Similarity=0.353 Sum_probs=163.9
Q ss_pred CccccCcccccccccccceeeecC-CCc----EEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGR----VFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----- 437 (602)
..+|+..+.||+|+||+||+|++. +|+ .||+|+++..... ...+.|.+|+.++..+.|+++..++...
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 356999999999999999999864 444 5888888654322 2456789999999888888887765421
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..++.|+.|||.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 11234889999999999999999999 7899999999999999999999999999999875
Q ss_pred CCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCC
Q 047576 501 ADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPV 577 (602)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 577 (602)
..... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+.... ..+...+....+.+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLPQ 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHHTCCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 43322 233468999999999999999999999999999999999 7889875321 112333333222222
Q ss_pred ChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 578 DRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 578 ~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+.. ....+.+++.+||+.||++
T Consensus 235 p~~---~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 235 PPI---CTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp CTT---BCHHHHHHHHHHTCSSGGG
T ss_pred Ccc---cCHHHHHHHHHhCCCChhh
Confidence 222 3345889999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-37 Score=309.64 Aligned_cols=220 Identities=21% Similarity=0.287 Sum_probs=165.2
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH---HHHhhhhHhHHHHHHhhhcCc--------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE---LAFIRSFRNEAQVLSQMERGS-------------- 429 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~~E~~il~~l~~gs-------------- 429 (602)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.+..... ....+.+.+|+.++..+.|++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46789999999999999999986 479999999986443221 112457889999885555544
Q ss_pred -----------cccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC----cceeeccc
Q 047576 430 -----------LFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL----EAFVADFG 494 (602)
Q Consensus 430 -----------L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 494 (602)
|.+++.. ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence 4444432 335899999999999999999999 78999999999999998776 48999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
++........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+......
T Consensus 163 ~a~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYE 234 (293)
T ss_dssp TCEECTTSCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC
T ss_pred hhhhcCCCcc-ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCC
Confidence 9987754332 3345789999999999999999999999999999999999999975321 2222333333222
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+. .........+.+++.+||+.||++
T Consensus 235 ~~~-~~~~~~s~~~~~li~~~L~~dP~~ 261 (293)
T d1jksa_ 235 FED-EYFSNTSALAKDFIRRLLVKDPKK 261 (293)
T ss_dssp CCH-HHHTTSCHHHHHHHHTTSCSSGGG
T ss_pred CCc-hhcCCCCHHHHHHHHHHccCChhH
Confidence 111 000112234789999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-36 Score=302.67 Aligned_cols=219 Identities=23% Similarity=0.334 Sum_probs=167.0
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchh------HHHHHhhhhHhHHHHH-------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPET------EELAFIRSFRNEAQVL------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~~~~E~~il------------------- 422 (602)
++|+..+.||+|+||+||+|+. .+|+.||||++..... ......+.+.+|+.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999986 4799999999865421 1233445688899888
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccc
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGT 495 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~ 495 (602)
||+++|+|.+++.. ...+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence 45555666665543 345899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccc------CcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhh
Q 047576 496 ARLLHADSSNQTLLAGSYGYIAPELAYT------MVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVL 569 (602)
Q Consensus 496 a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 569 (602)
++...... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..... ......+.
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i~ 228 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIM 228 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHHH
Confidence 98875533 3344679999999998864 2467899999999999999999999975321 22223344
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 570 DQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 570 d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+... ......++.+++.+|+++||++
T Consensus 229 ~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 229 SGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGG
T ss_pred hCCCCCCCcc-cccCCHHHHHHHHHHccCChhH
Confidence 3333211111 0112345889999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-36 Score=304.88 Aligned_cols=223 Identities=26% Similarity=0.410 Sum_probs=161.8
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHH--------------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVL-------------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il-------------------------- 422 (602)
++|...+.||+|+||.||+|++ +|+.||||+++..... .+..|.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4677788999999999999997 6899999998654322 223333333
Q ss_pred -----HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEeCCCCCCeeeCCCCcceeec
Q 047576 423 -----SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSVVHRDISSNNILLNSKLEAFVAD 492 (602)
Q Consensus 423 -----~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~DLkp~NILld~~~~~kL~D 492 (602)
||+++|+|.++++. ..++|.++.+++.|+|.||+|+|.. .+++|+||||||+|||+|+++.+||+|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 56666777776653 2489999999999999999999942 247999999999999999999999999
Q ss_pred ccccccccCCCC----CccccccccccccccccccCc------CCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCc-
Q 047576 493 FGTARLLHADSS----NQTLLAGSYGYIAPELAYTMV------MTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDP- 561 (602)
Q Consensus 493 FG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~- 561 (602)
||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||............
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 999987754332 223457999999999987642 677899999999999999999988643322211111
Q ss_pred -------ccchhhhhccCCCCCCCh--hhHHHHHHHHHHHhhccCcCCCC
Q 047576 562 -------KIMLIDVLDQRLPPPVDR--KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 562 -------~~~~~~~~d~~l~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
......+.+..++++... ...+....+.+++.+||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 281 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhH
Confidence 111223344444333221 12345667999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=299.95 Aligned_cols=212 Identities=22% Similarity=0.294 Sum_probs=155.3
Q ss_pred CccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
.++|+..+.||+|+||.||+|+. .|+.||||+++.... .+.|.+|++++..++|+++..++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 35688889999999999999998 578999999976543 35688999999666666655544311
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....++|..+++|+.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 11234899999999999999999999 789999999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
. ....++..|+|||++.+..++.++|||||||++|||+| |+.||+.... ......+. ....++....
T Consensus 157 ~---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-------~~~~~~i~-~~~~~~~~~~- 224 (262)
T d1byga_ 157 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVE-KGYKMDAPDG- 224 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-------GGHHHHHT-TTCCCCCCTT-
T ss_pred C---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHH-cCCCCCCCcc-
Confidence 2 23467899999999999999999999999999999998 6888764321 11112221 1122222222
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...++.+++.+||+.||++
T Consensus 225 --~~~~~~~li~~cl~~dP~~ 243 (262)
T d1byga_ 225 --CPPAVYEVMKNCWHLDAAM 243 (262)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --CCHHHHHHHHHHcccCHhH
Confidence 2234789999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-36 Score=308.34 Aligned_cols=218 Identities=23% Similarity=0.285 Sum_probs=160.9
Q ss_pred CccccCc-ccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 368 PRKIDSK-YCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 368 t~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
.++|... +.||+|+||.||+|+. .+++.||||+++... .+.+|++++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 4678775 4699999999999986 578999999986532 234455543
Q ss_pred -------HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC---CCcceeec
Q 047576 423 -------SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS---KLEAFVAD 492 (602)
Q Consensus 423 -------~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~---~~~~kL~D 492 (602)
||+++|+|.+++.... ...+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence 6666777777775432 235899999999999999999999 789999999999999975 46799999
Q ss_pred ccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC
Q 047576 493 FGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR 572 (602)
Q Consensus 493 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~ 572 (602)
||+|+....... .....||+.|+|||++.+..++.++||||+||++|+|+||+.||......... ......+....
T Consensus 158 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS
T ss_pred cceeeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCC
Confidence 999987754433 33467999999999999999999999999999999999999999743221110 00011111122
Q ss_pred CCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 573 LPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 573 l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
...+.. ........+.+++.+|+++||++
T Consensus 234 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~ 262 (335)
T d2ozaa1 234 YEFPNP-EWSEVSEEVKMLIRNLLKTEPTQ 262 (335)
T ss_dssp SSCCTT-HHHHSCHHHHHHHHHHSCSSTTT
T ss_pred CCCCCc-ccccCCHHHHHHHHHHccCChhH
Confidence 221211 11223345889999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-36 Score=302.41 Aligned_cols=180 Identities=26% Similarity=0.352 Sum_probs=148.9
Q ss_pred ccccCcccccccccccceeeecCCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND----------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~----------- 437 (602)
++|...+.||+|+||+||+|+.++|+.||||+++..... ....+++.+|+.+++.+.|+++..++...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 578889999999999999999989999999999765432 22456788999999999999888765421
Q ss_pred -----------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 438 -----------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 438 -----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
.....+++.++..|+.||+.||+||| +.+|+||||||+|||++.++.+|++|||.+..........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 12345899999999999999999999 7899999999999999999999999999998876554444
Q ss_pred cccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 507 TLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
....|++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 556789999999998765 4689999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=302.68 Aligned_cols=176 Identities=23% Similarity=0.323 Sum_probs=142.3
Q ss_pred cccccccccccceeeecC-CCcEEeeeccCCchhHH--HHHhhhhHhHHHHHHhhhcCccccccccc-------------
Q 047576 374 KYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEE--LAFIRSFRNEAQVLSQMERGSLFRILHND------------- 437 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~~~~E~~il~~l~~gsL~~~l~~~------------- 437 (602)
.++||+|+||+||+|+.. +|+.||||+++...... ....+.+.+|+.++..+.|+++.+++...
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 367999999999999874 68999999987554321 22346788999999999988887765421
Q ss_pred ---------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCccc
Q 047576 438 ---------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQTL 508 (602)
Q Consensus 438 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~~~ 508 (602)
.....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 11234788899999999999999999 889999999999999999999999999999877655444445
Q ss_pred cccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 509 LAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 509 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
..||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 6799999999998755 5799999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-36 Score=302.57 Aligned_cols=181 Identities=25% Similarity=0.335 Sum_probs=150.0
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|++++..+.|+++.++....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5788899999999999999986 5799999999965432 223456788999999999998887765421
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSS 504 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~ 504 (602)
.....+++.++..++.|++.||+||| +++||||||||+|||++.++.+||+|||.|+....+..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 11234899999999999999999999 78999999999999999999999999999988765544
Q ss_pred CccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCCc
Q 047576 505 NQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLHS 553 (602)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~ 553 (602)
......||+.|+|||+..... ++.++||||+||++|+|++|+.||+..+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 455568999999999877665 5789999999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-36 Score=298.01 Aligned_cols=218 Identities=23% Similarity=0.342 Sum_probs=157.1
Q ss_pred ccccCcccccccccccceeeecC----CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc-------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP----NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~------- 437 (602)
++|...+.||+|+||.||+|++. .+..||||+++..... ...+.|.+|+.++..+.|+++..++...
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence 57888999999999999999764 2457899988654432 3456789999999888888777665421
Q ss_pred ---------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 438 ---------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 438 ---------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
.....+++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 11234789999999999999999999 789999999999999999999999999999876543
Q ss_pred CC-CccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCcccccCCCcccchhhhhccCCCCCCChh
Q 047576 503 SS-NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRK 580 (602)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 580 (602)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+.+.... +....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-------~~~~~~i~~~~~~-~~~~~ 233 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERL-PMPPN 233 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCCC-CCCTT
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCC
Confidence 22 2334568899999999999999999999999999999998 8999975332 1222223322211 11111
Q ss_pred hHHHHHHHHHHHhhccCcCCCC
Q 047576 581 VIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 581 ~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++..||+.||++
T Consensus 234 ---~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 234 ---CPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp ---CCHHHHHHHHHHTCSSGGG
T ss_pred ---CCHHHHHHHHHHcCCCHhH
Confidence 2345889999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=305.75 Aligned_cols=217 Identities=22% Similarity=0.293 Sum_probs=166.5
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHH------------------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVL------------------------ 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il------------------------ 422 (602)
-++|...+.||+|+||+||+|+.. +|+.||||+++..... ...+.+|++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 367889999999999999999864 6889999999766543 24577899988
Q ss_pred -HhhhcCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC--Ccceeecccccccc
Q 047576 423 -SQMERGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK--LEAFVADFGTARLL 499 (602)
Q Consensus 423 -~~l~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFG~a~~~ 499 (602)
||+++|+|.+++... ...+++.++..|+.||+.||+||| +++|+||||||+|||++.+ ..+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 445555555555432 235899999999999999999999 7899999999999999854 57899999999876
Q ss_pred cCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCCh
Q 047576 500 HADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDR 579 (602)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 579 (602)
.... ......+|+.|+|||...+..++.++||||+||++|+|++|+.||.... ....+..+.......+..
T Consensus 155 ~~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~- 225 (321)
T d1tkia_ 155 KPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFDEE- 225 (321)
T ss_dssp CTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCHH-
T ss_pred ccCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCChh-
Confidence 4332 2334578999999999999999999999999999999999999997532 122334455444432211
Q ss_pred hhHHHHHHHHHHHhhccCcCCCC
Q 047576 580 KVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 580 ~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
........+.+++.+|+++||++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~ 248 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGG
T ss_pred hccCCCHHHHHHHHHHccCChhH
Confidence 00112234789999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=300.50 Aligned_cols=219 Identities=24% Similarity=0.309 Sum_probs=160.7
Q ss_pred CccccCcccccccccccceeeecC--------CCcEEeeeccCCchhHHHHHhhhhHhHHHHH-----------------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP--------NGRVFALKKLNSPETEELAFIRSFRNEAQVL----------------- 422 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il----------------- 422 (602)
.++|...+.||+|+||.||+|+.. ++..||||+++..... .....+.+|...+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 367888899999999999999752 2357999999765433 2235566676655
Q ss_pred ---------HhhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 423 ---------SQMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 423 ---------~~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
||+++|++.+++.... ....+++.+++.++.||+.||+||| +.+||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 6666777777765432 1234899999999999999999999 88999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHc-CCCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLM-GKHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 557 (602)
|++.++.+||+|||+++........ .....|++.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 9999999999999999877553322 233568999999999999999999999999999999998 6888864321
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
. .+.+.+.....++.+.. ....+.+++.+||++||++
T Consensus 244 ----~-~~~~~i~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~ 280 (299)
T d1fgka_ 244 ----E-ELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQ 280 (299)
T ss_dssp ----H-HHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGG
T ss_pred ----H-HHHHHHHcCCCCCCCcc---chHHHHHHHHHHccCCHhH
Confidence 1 12223333332222222 2234889999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=301.73 Aligned_cols=214 Identities=23% Similarity=0.292 Sum_probs=158.7
Q ss_pred cccccccccccceeeecCCC----cEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc-----------
Q 047576 374 KYCIGTGAYGSVYKAQLPNG----RVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA----------- 438 (602)
Q Consensus 374 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~----------- 438 (602)
.+.||+|+||+||+|++.++ ..||||+++.... ....++|.+|++++..+.|+++.+++....
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 57899999999999986432 3689999875432 234578999999997777777766653210
Q ss_pred -------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 439 -------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 439 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
....+++.++++++.|+++||.|+| +++|+||||||+|||+|+++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 1223678889999999999999999 789999999999999999999999999999876543221
Q ss_pred ----ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCCCChhh
Q 047576 506 ----QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPPVDRKV 581 (602)
Q Consensus 506 ----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 581 (602)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||..... .......+.+.. +++.+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------~~~~~~~i~~g~-~~~~p~~- 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGR-RLLQPEY- 258 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTC-CCCCCTT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcCC-CCCCccc-
Confidence 2235689999999999999999999999999999999998888764221 111122222221 1111111
Q ss_pred HHHHHHHHHHHhhccCcCCCC
Q 047576 582 IQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 582 ~~~~~~l~~l~~~Cl~~dP~e 602 (602)
....+.+++.+||+.||++
T Consensus 259 --~~~~l~~li~~cl~~dP~~ 277 (311)
T d1r0pa_ 259 --CPDPLYEVMLKCWHPKAEM 277 (311)
T ss_dssp --CCHHHHHHHHHHTCSSGGG
T ss_pred --CcHHHHHHHHHHcCCCHhH
Confidence 2345889999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-36 Score=299.35 Aligned_cols=211 Identities=21% Similarity=0.295 Sum_probs=161.7
Q ss_pred CCccccCcccccccccccceeeec-CCCcEEeeeccCCchhHH---HHHhhhhHhHHHHHHhhh--cCccccccccc---
Q 047576 367 TPRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEE---LAFIRSFRNEAQVLSQME--RGSLFRILHND--- 437 (602)
Q Consensus 367 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~~E~~il~~l~--~gsL~~~l~~~--- 437 (602)
..++|...+.||+|+||+||+|+. .+|+.||||++....... .....++.+|+.++..+. |+++..++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 346799999999999999999986 478999999986543211 112345778999998775 56666554311
Q ss_pred --------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCC-Ccceeeccccc
Q 047576 438 --------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSK-LEAFVADFGTA 496 (602)
Q Consensus 438 --------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFG~a 496 (602)
.....+++.++..++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 01234889999999999999999999 8899999999999999854 79999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcC-CccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccC--C
Q 047576 497 RLLHADSSNQTLLAGSYGYIAPELAYTMVM-TEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQR--L 573 (602)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~--l 573 (602)
+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ++.... +
T Consensus 159 ~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~~~ 223 (273)
T d1xwsa_ 159 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQVFF 223 (273)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCCCC
T ss_pred eecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcccCC
Confidence 875432 2334679999999999987765 577899999999999999999997532 122222 2
Q ss_pred CCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 574 PPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
+...+ ..+.+++.+|++.||++
T Consensus 224 ~~~~s-------~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 224 RQRVS-------SECQHLIRWCLALRPSD 245 (273)
T ss_dssp SSCCC-------HHHHHHHHHHTCSSGGG
T ss_pred CCCCC-------HHHHHHHHHHccCCHhH
Confidence 22222 23788999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=301.80 Aligned_cols=220 Identities=22% Similarity=0.321 Sum_probs=165.5
Q ss_pred CccccCcccccccccccceeeec------CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh-hcCccccc-------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL------PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQM-ERGSLFRI------- 433 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l-~~gsL~~~------- 433 (602)
.++|...+.||+|+||.||+|+. .+++.||||+++..... .....|.+|+.++..+ .|+++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 35788889999999999999964 35779999999765432 2345788898888555 35555443
Q ss_pred ------------------ccccc---------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCe
Q 047576 434 ------------------LHNDA---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNI 480 (602)
Q Consensus 434 ------------------l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NI 480 (602)
++... ....+++..+..++.||++|++||| +++|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 33211 1124789999999999999999999 78999999999999
Q ss_pred eeCCCCcceeecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHcC-CCCCCCCccccc
Q 047576 481 LLNSKLEAFVADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMG-KHPRDLHSTLSS 557 (602)
Q Consensus 481 Lld~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~ 557 (602)
+++.++.+|++|||.++........ .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||...
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~----- 251 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----- 251 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-----
Confidence 9999999999999999877543322 2335789999999999999999999999999999999995 4555432
Q ss_pred CCCcccchhhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 558 SYDPKIMLIDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 558 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+.++++...++..+.. ....+.+++.+||++||++
T Consensus 252 --~~~~~~~~~i~~~~~~~~~~~---~~~~l~~Li~~cl~~dP~~ 291 (311)
T d1t46a_ 252 --PVDSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLK 291 (311)
T ss_dssp --CSSHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGG
T ss_pred --CHHHHHHHHHhcCCCCCCccc---ccHHHHHHHHHHcCCChhH
Confidence 122334455555444333322 2345889999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-35 Score=298.86 Aligned_cols=180 Identities=29% Similarity=0.376 Sum_probs=145.3
Q ss_pred CccccCcccccccccccceeeec-CC-CcEEeeeccCCchhHHHHHhhhhHhHHHHHHhh---hcCccccccccc-----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PN-GRVFALKKLNSPETEELAFIRSFRNEAQVLSQM---ERGSLFRILHND----- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l---~~gsL~~~l~~~----- 437 (602)
.++|+..+.||+|+||+||+|+. .+ ++.||||+++...... .....+.+|+.+++.+ .|+++.+++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36799999999999999999986 34 6789999986543221 1234566788887665 577776654211
Q ss_pred -----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccc
Q 047576 438 -----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFG 494 (602)
Q Consensus 438 -----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 494 (602)
.....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 01223788899999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 162 ~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 162 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 987654322 233467999999999999999999999999999999999999999754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=300.06 Aligned_cols=219 Identities=23% Similarity=0.292 Sum_probs=164.6
Q ss_pred CccccCcccccccccccceeeecC------CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccc----------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP------NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLF---------- 431 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~---------- 431 (602)
.++|...+.||+|+||+||+|.+. +++.||||+++..... .....|.+|++++..+.|+++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 467888899999999999999763 3678999999754433 2346788999988555554444
Q ss_pred ---------------cccccccc-------hhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcce
Q 047576 432 ---------------RILHNDAE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAF 489 (602)
Q Consensus 432 ---------------~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~k 489 (602)
++++.... ...+++..+.+++.|+|+||.||| +++|+||||||+|||+|+++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence 44432111 112578899999999999999999 78999999999999999999999
Q ss_pred eecccccccccCCCCC--ccccccccccccccccccCcCCccchhHHHHHHHHHHHcCC-CCCCCCcccccCCCcccchh
Q 047576 490 VADFGTARLLHADSSN--QTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGK-HPRDLHSTLSSSYDPKIMLI 566 (602)
Q Consensus 490 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~ 566 (602)
|+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+||. .||... ...+.+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~ 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLR 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHH
Confidence 9999999876543322 22346899999999999999999999999999999999985 666532 2233344
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 567 DVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 567 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+.+....+.. .. ....+.+++.+||+.||++
T Consensus 247 ~i~~~~~~~~p-~~---~~~~l~~li~~cl~~~P~~ 278 (308)
T d1p4oa_ 247 FVMEGGLLDKP-DN---CPDMLFELMRMCWQYNPKM 278 (308)
T ss_dssp HHHTTCCCCCC-TT---CCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCCCCc-cc---chHHHHHHHHHHcCCChhH
Confidence 44444433221 11 2345889999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-35 Score=298.03 Aligned_cols=222 Identities=16% Similarity=0.245 Sum_probs=160.8
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|...+.||+|+||.||+|+. .+|+.||||++..... .+++..|++++..+.|.+....+...
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999986 5789999998765432 25677899999777665543322110
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeC---CCCcceeecccccccccC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLN---SKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++.++..++.|++.||+||| +++|+||||||+|||++ .+..+|++|||+|+....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 11345899999999999999999999 78999999999999875 455799999999998754
Q ss_pred CCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCC
Q 047576 502 DSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLP 574 (602)
Q Consensus 502 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~ 574 (602)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~----~~~~~~~~~~ 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----YERISEKKMS 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH----HHHhhcccCC
Confidence 322 12345799999999999999999999999999999999999999975432211111 1111111111
Q ss_pred CCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 575 PPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.+..........++.+++..||+.||++
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~ 262 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDD 262 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTC
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhH
Confidence 1110000112244888999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=297.61 Aligned_cols=217 Identities=24% Similarity=0.297 Sum_probs=157.4
Q ss_pred ccccCcccccccccccceeeecC-CCc--EEeeeccCCchhHHHHHhhhhHhHHHHH-----------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGR--VFALKKLNSPETEELAFIRSFRNEAQVL----------------------- 422 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~~E~~il----------------------- 422 (602)
++|+..+.||+|+||+||+|++. +|. .||||++...... ...+.|.+|++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57888899999999999999875 344 4788887544332 2356788999988
Q ss_pred ---HhhhcCcccccccccc-------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC
Q 047576 423 ---SQMERGSLFRILHNDA-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL 486 (602)
Q Consensus 423 ---~~l~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~ 486 (602)
||+++|+|.++++... ....+++..+..++.|||+|+.|+| +++|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence 4445556655554321 1245899999999999999999999 78999999999999999999
Q ss_pred cceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCC-CCCCCcccccCCCcccch
Q 047576 487 EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKH-PRDLHSTLSSSYDPKIML 565 (602)
Q Consensus 487 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~~~ 565 (602)
.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHH
T ss_pred ceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence 999999999986543222 223568999999999999999999999999999999999765 665322 11222
Q ss_pred hhhhccCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 566 IDVLDQRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 566 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
..+.+. .+++.... ...++.+++.+||+.||++
T Consensus 237 ~~i~~~-~~~~~~~~---~~~~~~~li~~cl~~dP~~ 269 (309)
T d1fvra_ 237 EKLPQG-YRLEKPLN---CDDEVYDLMRQCWREKPYE 269 (309)
T ss_dssp HHGGGT-CCCCCCTT---BCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhc-CCCCCCcc---CCHHHHHHHHHHcCCChhH
Confidence 222222 11121111 2345889999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=299.20 Aligned_cols=180 Identities=26% Similarity=0.345 Sum_probs=144.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+.+|.....||+|+||+||+|+. .+|+.||||++...... ...+.+.+|++++..+.|+++..+....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 46799999999999999999975 58999999999754432 3456788999999888777665433210
Q ss_pred ----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccC
Q 047576 438 ----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHA 501 (602)
Q Consensus 438 ----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~ 501 (602)
.....+++..++.++.|++.||+||| +++||||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 01235899999999999999999999 78999999999999999999999999999987644
Q ss_pred CCC---Ccccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 502 DSS---NQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 502 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 322 1233569999999999855 45789999999999999999999999754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-35 Score=294.82 Aligned_cols=220 Identities=17% Similarity=0.189 Sum_probs=156.5
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh---------------------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME--------------------- 426 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~--------------------- 426 (602)
.+|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++++..+.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 47888999999999999999864 789999998754432 234556666664443
Q ss_pred ----cCccccccccccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCC-----CCcceeecccccc
Q 047576 427 ----RGSLFRILHNDAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNS-----KLEAFVADFGTAR 497 (602)
Q Consensus 427 ----~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFG~a~ 497 (602)
++++.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus 80 me~~~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECCCCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEecCCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 3444444332 2335899999999999999999999 899999999999999974 5689999999998
Q ss_pred cccCCCC-------CccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhc
Q 047576 498 LLHADSS-------NQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLD 570 (602)
Q Consensus 498 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d 570 (602)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~~~~~i~~ 230 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGE 230 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch----hHHHHHHHHHh
Confidence 7653211 123357999999999999999999999999999999999999999753221 11111111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 571 QRLPPPVDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 571 ~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.....+..+.......++.+++..|++.+|++
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~ 262 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDA 262 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTC
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCccc
Confidence 11111100000012234778888999888864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-34 Score=291.50 Aligned_cols=181 Identities=22% Similarity=0.310 Sum_probs=145.7
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
-++|+..+.||+|+||+||+|+. .+|+.||||++...... ....+++.+|++++..+.|+++..++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 46899999999999999999986 57999999998654332 22446678999999999988876654321
Q ss_pred ---------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccc
Q 047576 438 ---------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTA 496 (602)
Q Consensus 438 ---------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a 496 (602)
.....++..+++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 01224678899999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCC----CccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 497 RLLHADSS----NQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 497 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 76643221 12234699999999998765 5899999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=291.01 Aligned_cols=178 Identities=26% Similarity=0.361 Sum_probs=144.1
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|++++..+.|+++.+++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46799999999999999999986 47999999999765432 23457788999999999998877654321
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++..++.++.||+.||+||| +++|+||||||+|||++.++.+|++|||.|+...
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccC
Confidence 01235899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccccccccC-cCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTM-VMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 43 2346799999999998764 4689999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-34 Score=293.25 Aligned_cols=224 Identities=24% Similarity=0.351 Sum_probs=160.8
Q ss_pred CccccCcccccccccccceeeec----CCCcEEeeeccCCchh-HHHHHhhhhHhHHHHHHhhhc-Cccccccccc----
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL----PNGRVFALKKLNSPET-EELAFIRSFRNEAQVLSQMER-GSLFRILHND---- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~-~~~~~~~~~~~E~~il~~l~~-gsL~~~l~~~---- 437 (602)
.++|+..+.||+|+||+||+|+. .+|+.||||++++... ......+.+.+|++++..+.| +++..+....
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 46799999999999999999974 2589999999875432 111234678889999866655 3444332110
Q ss_pred ------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccc
Q 047576 438 ------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLL 499 (602)
Q Consensus 438 ------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~ 499 (602)
.....++...+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 01233677888899999999999999 789999999999999999999999999999876
Q ss_pred cCCCC-CccccccccccccccccccC--cCCccchhHHHHHHHHHHHcCCCCCCCCcccccCCCcccchhhhhccCCCCC
Q 047576 500 HADSS-NQTLLAGSYGYIAPELAYTM--VMTEKYDVYSFGVVTLEVLMGKHPRDLHSTLSSSYDPKIMLIDVLDQRLPPP 576 (602)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~d~~l~~~ 576 (602)
..... ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||....... ..............+.+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHCCCCCC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccCCCCCc
Confidence 43222 23345799999999998765 36789999999999999999999997532211 10111122222222211
Q ss_pred CChhhHHHHHHHHHHHhhccCcCCCC
Q 047576 577 VDRKVIQDILLVSTISFACLQSNPKS 602 (602)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~Cl~~dP~e 602 (602)
.. ...++.+++.+|+++||++
T Consensus 257 --~~---~s~~~~~li~~~l~~dP~~ 277 (322)
T d1vzoa_ 257 --QE---MSALAKDLIQRLLMKDPKK 277 (322)
T ss_dssp --TT---SCHHHHHHHHHHTCSSGGG
T ss_pred --cc---CCHHHHHHHHHHcccCHHH
Confidence 11 2334888999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-33 Score=292.98 Aligned_cols=174 Identities=29% Similarity=0.382 Sum_probs=143.0
Q ss_pred CccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
..+|+..++||+|+||+||+|+.. +|+.||||++.... ....+|++++..+.|.++..++...
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 446888899999999999999874 69999999986543 2345799999888888776643210
Q ss_pred ----------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeeccc
Q 047576 438 ----------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFG 494 (602)
Q Consensus 438 ----------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG 494 (602)
.....+++.+++.|+.||+.||+||| +++|+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEeccc
Confidence 01223789999999999999999999 89999999999999999775 89999999
Q ss_pred ccccccCCCCCcccccccccccccccccc-CcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 495 TARLLHADSSNQTLLAGSYGYIAPELAYT-MVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 495 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
+++........ ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 169 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 169 SAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp TCEECCTTSCC-CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred chhhccCCccc-ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 99876543322 33579999999998775 46899999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.98 E-value=8.6e-33 Score=283.58 Aligned_cols=175 Identities=19% Similarity=0.285 Sum_probs=143.3
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhh-cCccccccccc--------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQME-RGSLFRILHND-------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~-~gsL~~~l~~~-------- 437 (602)
.++|...+.||+|+||+||+|+. .+|+.||||+++... .+++.+|++++..+. |+++..++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 35788899999999999999986 579999999987543 245778999997774 66666554311
Q ss_pred -------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC-cceeecccccccccCCC
Q 047576 438 -------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL-EAFVADFGTARLLHADS 503 (602)
Q Consensus 438 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFG~a~~~~~~~ 503 (602)
.....+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 00234889999999999999999999 88999999999999998655 68999999998765433
Q ss_pred CCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 504 SNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. .....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||...
T Consensus 185 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 185 E-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred c-ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 2 33457899999999987654 799999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.3e-33 Score=279.69 Aligned_cols=178 Identities=23% Similarity=0.326 Sum_probs=149.2
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc----------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND---------- 437 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~---------- 437 (602)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ....+++.+|+.++..+.|+++..+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5788999999999999999986 57899999998654322 23457888999999999988877654321
Q ss_pred ------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCC
Q 047576 438 ------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 505 (602)
Q Consensus 438 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~ 505 (602)
.....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 11334788999999999999999999 789999999999999999999999999999887655544
Q ss_pred ccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCC
Q 047576 506 QTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRD 550 (602)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~ 550 (602)
.....+++.|+|||++.+.. ++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 44556788999999887665 6899999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=281.77 Aligned_cols=179 Identities=25% Similarity=0.299 Sum_probs=141.0
Q ss_pred ccccCcccccccccccceeeecC-CCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCcccccccccc---------
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQLP-NGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHNDA--------- 438 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~~--------- 438 (602)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ....+++.+|+.+++.+.|+++..++....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 67999999999999999999864 7999999999755432 234567889999999999988877654210
Q ss_pred ----------------chhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCC
Q 047576 439 ----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHAD 502 (602)
Q Consensus 439 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~ 502 (602)
....+++.+++.++.||+.||+||| +.||+||||||+|||++.++.+|++|||.++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc
Confidence 0123789999999999999999999 789999999999999999999999999998876543
Q ss_pred CCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 503 SSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
. ......||+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus 173 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 173 F-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 2 334457999999999999999999999999999999999999999653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-33 Score=287.01 Aligned_cols=178 Identities=26% Similarity=0.395 Sum_probs=143.0
Q ss_pred CccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhcCccccccccc---------
Q 047576 368 PRKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMERGSLFRILHND--------- 437 (602)
Q Consensus 368 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~gsL~~~l~~~--------- 437 (602)
+++|+..+.||+|+||+||+|+. .+|+.||||++...... ....+++.+|++++..+.|+++..+....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 57899999999999999999985 57999999999765432 22346788999999888777765543210
Q ss_pred -----------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeeccccccccc
Q 047576 438 -----------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLH 500 (602)
Q Consensus 438 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~ 500 (602)
.....+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+|++|||.+....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC
Confidence 01234899999999999999999999 7899999999999999999999999999997654
Q ss_pred CCCCCccccccccccccccccccCc-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 047576 501 ADSSNQTLLAGSYGYIAPELAYTMV-MTEKYDVYSFGVVTLEVLMGKHPRDLH 552 (602)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~ 552 (602)
.. .....|++.|+|||+..+.. ++.++||||+||++|+|++|+.||...
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 32 23357899999999877654 688999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=6.7e-30 Score=265.36 Aligned_cols=174 Identities=19% Similarity=0.260 Sum_probs=138.0
Q ss_pred ccccCcccccccccccceeeec-CCCcEEeeeccCCchhHHHHHhhhhHhHHHHHHhhhc-----------Ccccccccc
Q 047576 369 RKIDSKYCIGTGAYGSVYKAQL-PNGRVFALKKLNSPETEELAFIRSFRNEAQVLSQMER-----------GSLFRILHN 436 (602)
Q Consensus 369 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~E~~il~~l~~-----------gsL~~~l~~ 436 (602)
.+|.....||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.+++.+.+ .++..++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3588999999999999999986 57999999999865432 3456778888766654 333333211
Q ss_pred c---------------------------cchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCC---
Q 047576 437 D---------------------------AEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKL--- 486 (602)
Q Consensus 437 ~---------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~--- 486 (602)
. .....+++..+..++.||++|++|||+ ..+|+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 0 112347788999999999999999994 37999999999999998665
Q ss_pred ---cceeecccccccccCCCCCccccccccccccccccccCcCCccchhHHHHHHHHHHHcCCCCCCC
Q 047576 487 ---EAFVADFGTARLLHADSSNQTLLAGSYGYIAPELAYTMVMTEKYDVYSFGVVTLEVLMGKHPRDL 551 (602)
Q Consensus 487 ---~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 551 (602)
.++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccceeeEeeccccccccccc---ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 38999999997654322 335799999999999999999999999999999999999999974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=9.8e-30 Score=258.71 Aligned_cols=225 Identities=28% Similarity=0.485 Sum_probs=205.7
Q ss_pred CCccchhccccCCccc--cCCccCCCCCCCCEEECcC-CcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCC
Q 047576 130 NLESLRILAYYDGFTG--SIPSEISALSKLQLLDLSS-NRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLI 199 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~~--~ip~~l~~L~~L~~L~Ls~-N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 199 (602)
.++.|++. ++++.| .+|++|++|++|++|+|++ |++.| .+++|++|+|++|++.+..+..+..+.+|+
T Consensus 51 ~v~~L~L~--~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 51 RVNNLDLS--GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CEEEEEEE--CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEECC--CCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 34556665 456666 6899999999999999997 88875 478999999999999999999999999999
Q ss_pred EEEecCCCCCCCCcccccCcCCCceeecccccCCC-CcccccCCCCC-cEEEccCCCCCCCCCCccCCCCCCccccCCCC
Q 047576 200 ELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNL-MLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCN 277 (602)
Q Consensus 200 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 277 (602)
++++++|++.+.+|..++++++|+.+++++|.+++ +|..+..+.++ +.+++++|+++|..|..+..+..+ .+++++|
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 99999999999999999999999999999999998 99999888886 899999999999999988887655 7999999
Q ss_pred cCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCC
Q 047576 278 QFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPY 357 (602)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 357 (602)
.+.+.+|..+..+++++.+++++|.+++.+| .+..+++|+.|+|++|+++|.+|..++++++|++|+|++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 9999999999999999999999999998765 688899999999999999999999999999999999999999999995
Q ss_pred C
Q 047576 358 S 358 (602)
Q Consensus 358 ~ 358 (602)
.
T Consensus 287 ~ 287 (313)
T d1ogqa_ 287 G 287 (313)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.6e-24 Score=218.98 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=202.4
Q ss_pred CCCCCCCceeCCC----------CCEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCC
Q 047576 89 DHCEWIGITCNSA----------GSIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQ 158 (602)
Q Consensus 89 ~~C~w~gv~C~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~ 158 (602)
+.|.|.+|.|+.. ..++.|+++...+. .++...|..+++|+.|++. ++.+....|..|.++++|+
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~---~l~~~~f~~l~~L~~L~l~--~n~~~~i~~~~f~~l~~L~ 82 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT---EIKDGDFKNLKNLHTLILI--NNKISKISPGAFAPLVKLE 82 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC---CBCTTTTTTCTTCCEEECC--SSCCCCBCTTTTTTCTTCC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC---CcChhHhhccccccccccc--cccccccchhhhhCCCccC
Confidence 4478999999742 34566777543221 3333346666667776665 4555655577889999999
Q ss_pred EEECcCCcCcc----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCC--CCCcccccCcCCCceeecccccC
Q 047576 159 LLDLSSNRLRG----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLI--GPIPLTLSRLTSLKILILAQNQL 232 (602)
Q Consensus 159 ~L~Ls~N~i~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 232 (602)
+|++++|+|+. ....|+.|++++|.+.+..+..+.....++.++...|... ...+..+..+++|+.+++++|.+
T Consensus 83 ~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l 162 (305)
T d1xkua_ 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162 (305)
T ss_dssp EEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred EecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence 99999998873 3567889999999999888888888888889988887643 34456788889999999999999
Q ss_pred CCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccC
Q 047576 233 SGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIA 312 (602)
Q Consensus 233 ~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 312 (602)
+.+|..+ +++|+.|++++|..++..+..+..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..+.
T Consensus 163 ~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~ 239 (305)
T d1xkua_ 163 TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239 (305)
T ss_dssp CSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred cccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccc
Confidence 8887654 578999999999999888888899999999999999999888888889999999999999998 5688889
Q ss_pred CCCCCCEEeCCCCCCCCCCCcc------cccccccccccccCCcCC-CccC
Q 047576 313 SMEDLTWLDLSNNNIKGSIPGE------ITKLSRLDYLNLSGNKLS-GRVP 356 (602)
Q Consensus 313 ~l~~L~~L~L~~N~l~~~~p~~------~~~l~~L~~L~l~~N~l~-g~~p 356 (602)
.+++|++|+|++|+|+...... ...+.+|+.|++++|+++ .+++
T Consensus 240 ~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred cccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 9999999999999998543333 345677888999999884 3443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.9e-25 Score=216.94 Aligned_cols=198 Identities=24% Similarity=0.264 Sum_probs=175.5
Q ss_pred CCCCCCEEECcCCcCcc---cC-CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecc
Q 047576 153 ALSKLQLLDLSSNRLRG---RL-TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILA 228 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~~---~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 228 (602)
+.+.+.+.|.++++++. .+ ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|+
T Consensus 8 ~~~~~~~v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp CSTTCCEEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECC
T ss_pred ccCCCeEEEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccc
Confidence 44556667777777663 22 578899999999998888899999999999999999984 44 46789999999999
Q ss_pred cccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC
Q 047576 229 QNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP 308 (602)
Q Consensus 229 ~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 308 (602)
+|+++.+|..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++++.|++++|+|++..+
T Consensus 86 ~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred cccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 99999998889999999999999999998888888999999999999999998888888899999999999999998888
Q ss_pred cccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCC
Q 047576 309 SQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 309 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 353 (602)
..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 88999999999999999999 788888899999999999999864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.3e-24 Score=217.33 Aligned_cols=180 Identities=27% Similarity=0.292 Sum_probs=88.3
Q ss_pred cCCCCCCCCEEECcCCcCcc-------cCCCcCEEECc-CCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCC
Q 047576 150 EISALSKLQLLDLSSNRLRG-------RLTNLNYMSLS-RNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTS 221 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 221 (602)
.|.++++|++|++++|+|.. .++.++.++.. .|.++...+..|.++++|++|++++|.+.+..+..+...++
T Consensus 51 ~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 130 (284)
T d1ozna_ 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred HhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcc
Confidence 45555555555555555441 23344444332 33444444444555555555555555544444444444555
Q ss_pred CceeecccccCCCCc-ccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccC
Q 047576 222 LKILILAQNQLSGLP-QEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSS 300 (602)
Q Consensus 222 L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 300 (602)
|+.+++++|+++++| ..+..+++|+.|++++|++++..+..|.++++|+++++++|++++..|..|..+++|++|++++
T Consensus 131 L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~ 210 (284)
T d1ozna_ 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210 (284)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence 555555555555543 2344444555555555555544444455555555555555555544455555555555555555
Q ss_pred CCCCCCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 301 NKLSGKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 301 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
|++.+..|..|..+++|++|++++|.+.+
T Consensus 211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 211 NNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp SCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cccccccccccccccccCEEEecCCCCCC
Confidence 55554444445555555555555555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.9e-24 Score=212.59 Aligned_cols=209 Identities=25% Similarity=0.270 Sum_probs=189.7
Q ss_pred cCCccCCCCCCCCEEECcCCcCcc-------cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEec-CCCCCCCCccccc
Q 047576 146 SIPSEISALSKLQLLDLSSNRLRG-------RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVG-DNSLIGPIPLTLS 217 (602)
Q Consensus 146 ~ip~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~l~ 217 (602)
++|..+. +.+++|+|++|+|++ .+++|++|++++|++....+..+..++.++.++.. .|.++...|..|.
T Consensus 25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 102 (284)
T d1ozna_ 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102 (284)
T ss_dssp SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 4455443 568999999999973 47899999999999999999999999999999875 6677777788999
Q ss_pred CcCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEE
Q 047576 218 RLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296 (602)
Q Consensus 218 ~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 296 (602)
++++|++|++++|.+..+ +..+..+++|+.+++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+.+
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 999999999999999985 4567788999999999999998888899999999999999999999889999999999999
Q ss_pred eccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 297 DLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 297 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
++++|++++..|..|..+++|++|++++|++++..+..|..+++|++|++++|++.+.-+
T Consensus 183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999999999999999999999999999999999999999999999999999987644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.5e-22 Score=200.30 Aligned_cols=178 Identities=28% Similarity=0.296 Sum_probs=154.3
Q ss_pred cCCccCCCCCCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccC
Q 047576 146 SIPSEISALSKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSR 218 (602)
Q Consensus 146 ~ip~~l~~L~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 218 (602)
.||+.+. ++|++|+|++|+|+ +.+++|++|+|++|+|+.. | .++.+++|++|+|++|++++ .+..+.+
T Consensus 24 ~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~ 98 (266)
T d1p9ag_ 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQT 98 (266)
T ss_dssp SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSS-CCCCTTT
T ss_pred eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccccccc-ccccccc
Confidence 4565553 57888888888886 2478889999999988854 3 46789999999999999985 5668899
Q ss_pred cCCCceeecccccCCCC-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEe
Q 047576 219 LTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLD 297 (602)
Q Consensus 219 l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 297 (602)
+++|+.|++++|.+.++ +..+..+.+++.|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|++|+
T Consensus 99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 99999999999999995 45678889999999999999988888888999999999999999998888899999999999
Q ss_pred ccCCCCCCCCCcccCCCCCCCEEeCCCCCCCC
Q 047576 298 LSSNKLSGKIPSQIASMEDLTWLDLSNNNIKG 329 (602)
Q Consensus 298 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 329 (602)
|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 9999999 788888899999999999999874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.9e-21 Score=201.73 Aligned_cols=172 Identities=31% Similarity=0.448 Sum_probs=116.8
Q ss_pred CCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEcc
Q 047576 172 TNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVG 251 (602)
Q Consensus 172 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~ 251 (602)
++++.+++++|.+++..| +...++|++|++++|+++.. +.+..+++|+.|++++|+++++++ ++.+++|+.|+++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~ 271 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLG 271 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc-ccccccCCEeecc
Confidence 445555555555554432 34455666666666665532 245566666666666666666543 5556666666666
Q ss_pred CCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 252 NNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
+|++++..+ +..++.++.++++.|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|++++|++++ +
T Consensus 272 ~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 272 ANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred CcccCCCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence 666664432 45566666666666666642 34777888999999999998753 37889999999999999985 4
Q ss_pred CcccccccccccccccCCcCCCccC
Q 047576 332 PGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 332 p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
+ .+..+++|++|++++|++++..|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred h-hHcCCCCCCEEECCCCcCCCChh
Confidence 4 58899999999999999998765
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.87 E-value=4.8e-21 Score=193.02 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=191.3
Q ss_pred EEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCC-ccCCCCCCCCEEECcCCcCcc-------cCCCcCE
Q 047576 105 IGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIP-SEISALSKLQLLDLSSNRLRG-------RLTNLNY 176 (602)
Q Consensus 105 ~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip-~~l~~L~~L~~L~Ls~N~i~~-------~l~~L~~ 176 (602)
..+++++.+ ++.+.-+-.++++.|++. ++....+| ..|.++++|++|++++|.+.. .+++|++
T Consensus 13 ~~~~C~~~~------L~~lP~~l~~~l~~L~Ls---~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~ 83 (305)
T d1xkua_ 13 RVVQCSDLG------LEKVPKDLPPDTALLDLQ---NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83 (305)
T ss_dssp TEEECTTSC------CCSCCCSCCTTCCEEECC---SSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CEEEecCCC------CCccCCCCCCCCCEEECc---CCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCE
Confidence 346775432 333333334667777664 44455565 478999999999999998873 4788999
Q ss_pred EECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCC---CcccccCCCCCcEEEccCC
Q 047576 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG---LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 177 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---ip~~~~~l~~L~~L~L~~N 253 (602)
|++++|+++.. |..+ ...|+.|++++|.+.+..+..+.....+..++...|.... .+..+..+++|+.+++++|
T Consensus 84 L~l~~n~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n 160 (305)
T d1xkua_ 84 LYLSKNQLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160 (305)
T ss_dssp EECCSSCCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred ecccCCccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence 99999999854 4332 3678899999999988777778888888899988886654 3557888999999999999
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
.++. +|..+ +++|+.|++++|..++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.
T Consensus 161 ~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~ 236 (305)
T d1xkua_ 161 NITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 236 (305)
T ss_dssp CCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred Cccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccc
Confidence 9984 55543 689999999999999999999999999999999999999888899999999999999999998 5688
Q ss_pred ccccccccccccccCCcCCCccCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSGRVPYS 358 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g~~p~~ 358 (602)
.+..+++|++|++++|+|+..-...
T Consensus 237 ~l~~l~~L~~L~Ls~N~i~~i~~~~ 261 (305)
T d1xkua_ 237 GLADHKYIQVVYLHNNNISAIGSND 261 (305)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred ccccccCCCEEECCCCccCccChhh
Confidence 9999999999999999998643333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.1e-20 Score=195.80 Aligned_cols=185 Identities=30% Similarity=0.497 Sum_probs=158.0
Q ss_pred CCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 152 SALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
..+++++.|++++|.+++ ..++|++|++++|+++.. +.+..+++|+.|++++|.+++..+ ++.+++|++|+
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 269 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 269 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred ccccccceeeccCCccCCCCcccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEee
Confidence 344555555555555543 368999999999999864 578999999999999999987544 88899999999
Q ss_pred cccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 306 (602)
+++|+++++++ +.+++.++.++++.|.+++. ..+..+++++.|++++|++++.. .+..+++|++|+|++|+|++
T Consensus 270 l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 270 LGANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred ccCcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-
Confidence 99999999875 77889999999999999863 34788899999999999999764 38899999999999999985
Q ss_pred CCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 307 IPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 307 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
++ .++.+++|++|++++|++++..| +.++++|+.|++++|
T Consensus 344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 44 68999999999999999997655 889999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=4.2e-19 Score=170.86 Aligned_cols=184 Identities=27% Similarity=0.389 Sum_probs=136.1
Q ss_pred CCCCCCCCEEECcCCcCc-----ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCcee
Q 047576 151 ISALSKLQLLDLSSNRLR-----GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 151 l~~L~~L~~L~Ls~N~i~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 225 (602)
+..|++|++|++++|+|+ +.+++|++|++++|++++..| +..+++|++|++++|.++. ++ .+.++++|+.+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l 112 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL 112 (227)
T ss_dssp HHHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred HHHcCCcCEEECCCCCCCcchhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccc
Confidence 355677888888888776 247788888888888876543 7888888888888888763 33 47778888888
Q ss_pred ecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCC
Q 047576 226 ILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSG 305 (602)
Q Consensus 226 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 305 (602)
++++|...+++. +...+.+..+.++++.+....+ +...++|+.|++++|.+++.. .++++++|+.|+|++|++++
T Consensus 113 ~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 113 DLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccch-hccccchhhhhchhhhhchhhh--hccccccccccccccccccch--hhcccccceecccCCCccCC
Confidence 888888777643 5566788888888887765433 566778888888888876432 37778888888888888875
Q ss_pred CCCcccCCCCCCCEEeCCCCCCCCCCCccccccccccccccc
Q 047576 306 KIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLS 347 (602)
Q Consensus 306 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 347 (602)
. + .++.+++|++|+|++|++++.. .+.++++|+.|+++
T Consensus 188 l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 188 I-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp C-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred C-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 3 3 3777888888888888887543 27788888888876
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=4.1e-19 Score=168.86 Aligned_cols=165 Identities=28% Similarity=0.369 Sum_probs=122.8
Q ss_pred CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEc
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDV 250 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L 250 (602)
+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|++++|+++++| .+.++++|+.|++
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-ccccccccccccc
Confidence 456666777777776542 3677888888888888887643 3677888888888888888876 4777888888888
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
++|.+.. + ..+..+++|+.+++++|.+++. ..+..+++|+.+++++|++++. + .++++++|+.|+|++|+++.
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc-c-cccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-
Confidence 8887763 2 3467778888888888888643 3567788888888888888753 2 37788888888888888874
Q ss_pred CCcccccccccccccccC
Q 047576 331 IPGEITKLSRLDYLNLSG 348 (602)
Q Consensus 331 ~p~~~~~l~~L~~L~l~~ 348 (602)
+| .+..+++|++|+|++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred Ch-hhcCCCCCCEEEccC
Confidence 44 578888888888764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.3e-19 Score=171.55 Aligned_cols=194 Identities=20% Similarity=0.193 Sum_probs=146.6
Q ss_pred CCCCEEECcCCcCc-------ccCCCcCEEECcCCcCCCCC-chhhhCCCCCCEEEec-CCCCCCCCcccccCcCCCcee
Q 047576 155 SKLQLLDLSSNRLR-------GRLTNLNYMSLSRNMLGGLL-PQEIGNLKNLIELDVG-DNSLIGPIPLTLSRLTSLKIL 225 (602)
Q Consensus 155 ~~L~~L~Ls~N~i~-------~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~-~N~l~~~~p~~l~~l~~L~~L 225 (602)
+++++|+|++|+|+ ..+++|++|+|++|.+...+ +..|.+++++++|++. .|++....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 46777777777775 23677777888888776543 4578889999999876 477877777888999999999
Q ss_pred ecccccCCCCcc--cccCCCCCcEEEccCCCCCCCCCCccCCCC-CCccccCCCCcCCCCCchhhhCCCCCCEE-eccCC
Q 047576 226 ILAQNQLSGLPQ--EIGNLKNLMLLDVGNNDIIGPIPSTLGLFS-DLSYLDLSCNQFNSSIPNELTRLTQLFHL-DLSSN 301 (602)
Q Consensus 226 ~L~~N~l~~ip~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~Ls~N 301 (602)
++++|+++.++. .+..++.+..+..+++.+....+..+..++ .++.|++++|+++...+..+ +.+++..+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 999999887543 345566777777788888766666666654 78889999999986555444 45555544 57888
Q ss_pred CCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 302 KLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 302 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
+|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+.
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence 898655667899999999999999999766777899999998887543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.9e-18 Score=162.78 Aligned_cols=161 Identities=30% Similarity=0.450 Sum_probs=120.2
Q ss_pred CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEc
Q 047576 171 LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDV 250 (602)
Q Consensus 171 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L 250 (602)
+.+|++|++++|.++.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.+..++. +.++++|+.|++
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTL 113 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEC
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccccc-cccccccccccc
Confidence 55666666666666643 347778888888888888876433 7888888888888888887764 778888888888
Q ss_pred cCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCC
Q 047576 251 GNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGS 330 (602)
Q Consensus 251 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 330 (602)
++|.+.... .+..+++|+.|++++|++.. ++ .+..+++|+.|++++|++++.. .++++++|+.|++++|++++
T Consensus 114 ~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~- 186 (199)
T d2omxa2 114 FNNQITDID--PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD- 186 (199)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-
T ss_pred ccccccccc--ccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-
Confidence 888877542 36678888888888888864 33 5778888888888888887642 47788888888888888875
Q ss_pred CCcccccccccccc
Q 047576 331 IPGEITKLSRLDYL 344 (602)
Q Consensus 331 ~p~~~~~l~~L~~L 344 (602)
++ .++.+++|+.|
T Consensus 187 i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 IS-VLAKLTNLESL 199 (199)
T ss_dssp CG-GGGGCTTCSEE
T ss_pred Cc-cccCCCCCCcC
Confidence 33 46777777654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.78 E-value=7.1e-20 Score=171.50 Aligned_cols=154 Identities=16% Similarity=0.167 Sum_probs=104.2
Q ss_pred CcccccccccccceeeecCCCcEEeeeccCCchhH---------------HHHHhhhhHhHHHHHHhhhcCcccccccc-
Q 047576 373 SKYCIGTGAYGSVYKAQLPNGRVFALKKLNSPETE---------------ELAFIRSFRNEAQVLSQMERGSLFRILHN- 436 (602)
Q Consensus 373 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------~~~~~~~~~~E~~il~~l~~gsL~~~l~~- 436 (602)
..+.||+|+||+||+|+..+|+.||||+++..... .........+|...+..+.+..+...+..
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999889999999987532111 01112334556777766655444332211
Q ss_pred ----------ccchhhhcHHHHHHHHHHHHHHHHHhhhcCCCCeEEeCCCCCCeeeCCCCcceeecccccccccCCCCCc
Q 047576 437 ----------DAEAVELDWAKRVNIVKAMAHALAYLHHDCSPSVVHRDISSNNILLNSKLEAFVADFGTARLLHADSSNQ 506 (602)
Q Consensus 437 ----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~~~~~~~~~ 506 (602)
......++......++.|++++++||| +++|+||||||+|||+++++ ++|+|||.|.....+...
T Consensus 84 ~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~- 158 (191)
T d1zara2 84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR- 158 (191)
T ss_dssp TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH-
T ss_pred CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH-
Confidence 112334666777889999999999999 78999999999999999764 899999999765432210
Q ss_pred ccccccccccc------ccccccCcCCccchhHHHHHHH
Q 047576 507 TLLAGSYGYIA------PELAYTMVMTEKYDVYSFGVVT 539 (602)
Q Consensus 507 ~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGvil 539 (602)
.|.. .+. ....++.++|+||..--+
T Consensus 159 -------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 -------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred -------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 1111 111 135678899999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=2.6e-19 Score=167.77 Aligned_cols=171 Identities=23% Similarity=0.250 Sum_probs=84.8
Q ss_pred EEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCC-cccccCcCCCceeecccccCCC-CcccccCCCCCcEEEccCC
Q 047576 176 YMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPI-PLTLSRLTSLKILILAQNQLSG-LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 176 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N 253 (602)
+++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++ .+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444444444 2333331 45555555555555433 3344555555555555555555 3344555555555555555
Q ss_pred CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCc
Q 047576 254 DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPG 333 (602)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 333 (602)
+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+... -...++.+.+..|.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCCh
Confidence 5555555555555555555555555555555555555555555555555543322111 011233344445555544443
Q ss_pred ccccccccccccccCCcCCC
Q 047576 334 EITKLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 334 ~~~~l~~L~~L~l~~N~l~g 353 (602)
.+ ..++.++++.|+++-
T Consensus 168 ~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp TT---TTSBGGGSCTTTCCC
T ss_pred hh---cCCEeeecCHhhCcC
Confidence 32 334455556665543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.5e-18 Score=164.86 Aligned_cols=161 Identities=29% Similarity=0.381 Sum_probs=140.1
Q ss_pred CCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeec
Q 047576 153 ALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILIL 227 (602)
Q Consensus 153 ~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 227 (602)
.+.+|++|++++|+|.. .+++|++|+|++|+|++.. .++.+++|++|++++|++++ +| .+.++++|+.|++
T Consensus 44 ~L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred HhcCccEEECcCCCCCCchhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 46789999999999863 4899999999999999754 47899999999999999985 44 5899999999999
Q ss_pred ccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCC
Q 047576 228 AQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKI 307 (602)
Q Consensus 228 ~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 307 (602)
++|.++.++ .+..+++|+.++++.|.+++. ..+..+++|+++++++|++++. + .+.++++|+.|+|++|+|+. +
T Consensus 120 ~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l 193 (210)
T d1h6ta2 120 EHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-L 193 (210)
T ss_dssp TTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-C
T ss_pred ccccccccc-ccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-C
Confidence 999998876 588899999999999999853 3567889999999999999864 3 48999999999999999985 5
Q ss_pred CcccCCCCCCCEEeCCC
Q 047576 308 PSQIASMEDLTWLDLSN 324 (602)
Q Consensus 308 p~~~~~l~~L~~L~L~~ 324 (602)
| .+.++++|++|+|++
T Consensus 194 ~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCSEEEEEE
T ss_pred h-hhcCCCCCCEEEccC
Confidence 5 599999999999864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=2e-18 Score=161.56 Aligned_cols=159 Identities=23% Similarity=0.262 Sum_probs=137.3
Q ss_pred CCEEEecCCCCCCCCcccccCcCCCceeecccccCCC-C-cccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCC
Q 047576 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSG-L-PQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLS 275 (602)
Q Consensus 198 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-i-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 275 (602)
.+++++++|+|+ .+|..+. +++++|+|++|+|++ + +..|.++++|+.|+|++|++++..+..+..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 468999999998 6777663 789999999999987 5 4567899999999999999999999999999999999999
Q ss_pred CCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCcc
Q 047576 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRV 355 (602)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 355 (602)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....... .-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence 99999988889999999999999999999888889999999999999999998654322 22234677788889888888
Q ss_pred CCCCC
Q 047576 356 PYSNK 360 (602)
Q Consensus 356 p~~~~ 360 (602)
|..++
T Consensus 166 p~~l~ 170 (192)
T d1w8aa_ 166 PSKVR 170 (192)
T ss_dssp STTTT
T ss_pred Chhhc
Confidence 87654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=6.2e-18 Score=162.49 Aligned_cols=189 Identities=25% Similarity=0.338 Sum_probs=159.6
Q ss_pred CCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeeccc
Q 047576 155 SKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ 229 (602)
Q Consensus 155 ~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 229 (602)
.++..++++.+++++ .+.+|++|++++|.|+.. +.+..+++|++|++++|++++..| +..+++|+++++++
T Consensus 19 ~~~~~~~l~~~~~~d~~~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHHHTTCSSTTSEECHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHHHhCCCCcCCcCCHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 334445677777764 478999999999999965 458999999999999999987544 89999999999999
Q ss_pred ccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCc
Q 047576 230 NQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS 309 (602)
Q Consensus 230 N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 309 (602)
|.++.++ .+.++++|+.+++++|...+.. .+...+.+..+.++++.+.... .+.+.++|+.|++++|.+++..
T Consensus 95 n~~~~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-- 167 (227)
T d1h6ua2 95 NPLKNVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-- 167 (227)
T ss_dssp CCCSCCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--
T ss_pred ccccccc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--
Confidence 9999886 4889999999999999987653 3567789999999999987543 4778899999999999998543
Q ss_pred ccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccC
Q 047576 310 QIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVP 356 (602)
Q Consensus 310 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 356 (602)
.++++++|+.|+|++|++++. + .++.+++|++|++++|++++..|
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG
T ss_pred hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc
Confidence 488999999999999999964 3 38899999999999999987544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=7.5e-18 Score=158.56 Aligned_cols=158 Identities=32% Similarity=0.469 Sum_probs=136.7
Q ss_pred CCCCCCCEEECcCCcCcc-----cCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceee
Q 047576 152 SALSKLQLLDLSSNRLRG-----RLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILI 226 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N~i~~-----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 226 (602)
..+.+|++|++++|+|.. .+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|+
T Consensus 37 ~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred HHhcCCCEEECCCCCCCCccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 457889999999999873 58999999999999997643 9999999999999999875 44 488999999999
Q ss_pred cccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEeccCCCCCCC
Q 047576 227 LAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLSSNKLSGK 306 (602)
Q Consensus 227 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 306 (602)
+++|.+..++ .+..+++|+.|++++|+++. ++ .+..+++|++|++++|++++. + .++++++|++|++++|++++
T Consensus 113 l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~- 186 (199)
T d2omxa2 113 LFNNQITDID-PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD- 186 (199)
T ss_dssp CCSSCCCCCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-
T ss_pred cccccccccc-ccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-
Confidence 9999998875 47889999999999999974 33 588899999999999999865 3 48999999999999999986
Q ss_pred CCcccCCCCCCCEE
Q 047576 307 IPSQIASMEDLTWL 320 (602)
Q Consensus 307 ~p~~~~~l~~L~~L 320 (602)
++ .++.+++|+.|
T Consensus 187 i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 IS-VLAKLTNLESL 199 (199)
T ss_dssp CG-GGGGCTTCSEE
T ss_pred Cc-cccCCCCCCcC
Confidence 43 58889998876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.9e-17 Score=160.40 Aligned_cols=204 Identities=16% Similarity=0.127 Sum_probs=157.8
Q ss_pred CEEECcCCcCcc---c-CCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc-ccccCcCCCceeeccc-cc
Q 047576 158 QLLDLSSNRLRG---R-LTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP-LTLSRLTSLKILILAQ-NQ 231 (602)
Q Consensus 158 ~~L~Ls~N~i~~---~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~-N~ 231 (602)
+.++.++++++. . .+++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|.+.. |+
T Consensus 11 ~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~ 90 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90 (242)
T ss_dssp SEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTT
T ss_pred CEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccc
Confidence 456666665552 2 3589999999999998877889999999999999999887554 4688999999999864 67
Q ss_pred CCC-CcccccCCCCCcEEEccCCCCCCCCC-CccCCCCCCccccCCCCcCCCCCchhhhCCC-CCCEEeccCCCCCCCCC
Q 047576 232 LSG-LPQEIGNLKNLMLLDVGNNDIIGPIP-STLGLFSDLSYLDLSCNQFNSSIPNELTRLT-QLFHLDLSSNKLSGKIP 308 (602)
Q Consensus 232 l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 308 (602)
+.. .+..+.++++|+.|++++|+++...+ ..+..+..+..+..+++.+....+..|..++ .++.|++++|+++...+
T Consensus 91 l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~ 170 (242)
T d1xwdc1 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 170 (242)
T ss_dssp CCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECT
T ss_pred ccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccc
Confidence 877 45678999999999999999985433 2345566777777888888877677777665 78899999999996444
Q ss_pred cccCCCCCCCE-EeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCCCcC
Q 047576 309 SQIASMEDLTW-LDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSNKHL 362 (602)
Q Consensus 309 ~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 362 (602)
..+ ...++.. +++++|+++...+..|.++++|+.|++++|+++...+..+..+
T Consensus 171 ~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 171 CAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 444 4455544 4678899996666678999999999999999985434344333
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.65 E-value=6.7e-15 Score=149.41 Aligned_cols=231 Identities=29% Similarity=0.311 Sum_probs=151.8
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCccccCCccCCCCCCCCEEECcCCcCcc---cCCCcCEEEC
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLRG---RLTNLNYMSL 179 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~~---~l~~L~~L~L 179 (602)
+++.|+|+..++. .++. ..++|++|++. .+ ....+|..+ .+|+.|++++|+++. -.+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~---~lp~----~~~~L~~L~Ls--~N-~l~~lp~~~---~~L~~L~l~~n~l~~l~~lp~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS---SLPE----LPPHLESLVAS--CN-SLTELPELP---QSLKSLLVDNNNLKALSDLPPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS---CCCS----CCTTCSEEECC--SS-CCSSCCCCC---TTCCEEECCSSCCSCCCSCCTTCCEEEC
T ss_pred CCCEEEeCCCCCC---CCCC----CCCCCCEEECC--CC-CCcccccch---hhhhhhhhhhcccchhhhhccccccccc
Confidence 4678888765442 3332 35678888775 34 445788654 578999999998873 2457999999
Q ss_pred cCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCc------------------ccccCcCCCceeecccccCCCCcc----
Q 047576 180 SRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIP------------------LTLSRLTSLKILILAQNQLSGLPQ---- 237 (602)
Q Consensus 180 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------~~l~~l~~L~~L~L~~N~l~~ip~---- 237 (602)
++|.++.. | .++.+++|++|++++|.+....+ ..+..++.++.|++++|.+..++.
T Consensus 106 ~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 106 SNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred cccccccc-c-chhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccc
Confidence 99999854 4 46889999999999998764322 235566778888888887665331
Q ss_pred ---------------cccCCCCCcEEEccCCCCCCCCCCccCC-----------------CCCCccccCCCCcCCCC---
Q 047576 238 ---------------EIGNLKNLMLLDVGNNDIIGPIPSTLGL-----------------FSDLSYLDLSCNQFNSS--- 282 (602)
Q Consensus 238 ---------------~~~~l~~L~~L~L~~N~l~~~~p~~l~~-----------------l~~L~~L~L~~N~l~~~--- 282 (602)
.+..++.|+.+++++|.... +|..... ..++...++..|.+.+.
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l 262 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCC
T ss_pred ccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccc
Confidence 23456788888888887653 3322111 11223333333322211
Q ss_pred -------------CchhhhCCCCCCEEeccCCCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCC
Q 047576 283 -------------IPNELTRLTQLFHLDLSSNKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 283 -------------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
++.....+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. +++|+.|++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N 334 (353)
T d1jl5a_ 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYN 334 (353)
T ss_dssp CTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred cchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCC
Confidence 1111122467899999999988 4664 3578889999999988 56643 457888999999
Q ss_pred cCCCccCCC
Q 047576 350 KLSGRVPYS 358 (602)
Q Consensus 350 ~l~g~~p~~ 358 (602)
+++ .+|..
T Consensus 335 ~L~-~lp~~ 342 (353)
T d1jl5a_ 335 PLR-EFPDI 342 (353)
T ss_dssp CCS-SCCCC
T ss_pred cCC-CCCcc
Confidence 887 45543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=2.5e-15 Score=129.61 Aligned_cols=102 Identities=25% Similarity=0.302 Sum_probs=57.4
Q ss_pred CEEECcCCcCCCCCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCC
Q 047576 175 NYMSLSRNMLGGLLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNND 254 (602)
Q Consensus 175 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~ 254 (602)
++|+|++|+|+.. + .++.+++|++|++++|+|+ .+|..++.+++|++|++++|+++++|. ++++++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccCc-cccccccCeEECCCCc
Confidence 3455666666533 2 3566666666666666665 345556666666666666666666643 5566666666666666
Q ss_pred CCCCC-CCccCCCCCCccccCCCCcCC
Q 047576 255 IIGPI-PSTLGLFSDLSYLDLSCNQFN 280 (602)
Q Consensus 255 l~~~~-p~~l~~l~~L~~L~L~~N~l~ 280 (602)
++... ...+..+++|+.|++++|.++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 65332 133445555555555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.59 E-value=2.4e-14 Score=145.23 Aligned_cols=211 Identities=28% Similarity=0.274 Sum_probs=142.3
Q ss_pred CCccchhccccCCccccCCccCCCCCCCCEEECcCCcCc---ccCCCcCEEECcCCcCCCCCchhhhCC-CCCCEEEecC
Q 047576 130 NLESLRILAYYDGFTGSIPSEISALSKLQLLDLSSNRLR---GRLTNLNYMSLSRNMLGGLLPQEIGNL-KNLIELDVGD 205 (602)
Q Consensus 130 ~L~~L~l~~~~~~~~~~ip~~l~~L~~L~~L~Ls~N~i~---~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~ 205 (602)
+++.|++. ++-.+.+|+. +++|++|+|++|+|+ +.+.+|+.|++++|+++.. + .+ +.|++|++++
T Consensus 39 ~l~~LdLs---~~~L~~lp~~---~~~L~~L~Ls~N~l~~lp~~~~~L~~L~l~~n~l~~l-~----~lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELN---NLGLSSLPEL---PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL-S----DLPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECT---TSCCSCCCSC---CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSCC-C----SCCTTCCEEECCS
T ss_pred CCCEEEeC---CCCCCCCCCC---CCCCCEEECCCCCCcccccchhhhhhhhhhhcccchh-h----hhccccccccccc
Confidence 56667665 3334578863 578999999999988 3468999999999999843 2 23 4699999999
Q ss_pred CCCCCCCcccccCcCCCceeecccccCCCCccc-------------------ccCCCCCcEEEccCCCCCCCC-------
Q 047576 206 NSLIGPIPLTLSRLTSLKILILAQNQLSGLPQE-------------------IGNLKNLMLLDVGNNDIIGPI------- 259 (602)
Q Consensus 206 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~-------------------~~~l~~L~~L~L~~N~l~~~~------- 259 (602)
|.++. +|. ++.+++|+.|++++|.++..|.. +..++.++.|++++|.+....
T Consensus 108 n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~ 185 (353)
T d1jl5a_ 108 NQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLE 185 (353)
T ss_dssp SCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred ccccc-ccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccc
Confidence 99984 564 68899999999999998764432 345677788888888765321
Q ss_pred -----------CCccCCCCCCccccCCCCcCCCCCchhhhC-----------------CCCCCEEeccCCCCCCC-----
Q 047576 260 -----------PSTLGLFSDLSYLDLSCNQFNSSIPNELTR-----------------LTQLFHLDLSSNKLSGK----- 306 (602)
Q Consensus 260 -----------p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-----------------l~~L~~L~Ls~N~l~~~----- 306 (602)
...+..++.|+.+++++|.... +|..... ...++..++..|.+.+.
T Consensus 186 ~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~ 264 (353)
T d1jl5a_ 186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264 (353)
T ss_dssp EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCT
T ss_pred ccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1123556788888888887653 2322111 11233333333332210
Q ss_pred -----------CCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 307 -----------IPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 307 -----------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
++.....+++|++|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~ 323 (353)
T d1jl5a_ 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP 323 (353)
T ss_dssp TCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCC
T ss_pred hhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccccc
Confidence 1111223578999999999998 56654 567889999999987 566543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.8e-15 Score=129.24 Aligned_cols=102 Identities=25% Similarity=0.309 Sum_probs=73.0
Q ss_pred CEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCc
Q 047576 199 IELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQ 278 (602)
Q Consensus 199 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 278 (602)
|+|+|++|+++. ++ .+.++++|++|++++|+++.+|+.++.+++|+.|++++|.|++. | .+..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 568888888873 34 47778888888888888888877777788888888888887743 3 36677777777777777
Q ss_pred CCCCC-chhhhCCCCCCEEeccCCCCC
Q 047576 279 FNSSI-PNELTRLTQLFHLDLSSNKLS 304 (602)
Q Consensus 279 l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 304 (602)
++... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 76443 245666677777777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.1e-15 Score=138.38 Aligned_cols=127 Identities=20% Similarity=0.174 Sum_probs=66.1
Q ss_pred cCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEE
Q 047576 217 SRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHL 296 (602)
Q Consensus 217 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 296 (602)
.+..+|++|+|++|+|+.+|..+..+++|+.|+|++|+|+. ++ .+..+++|++|++++|+++...+..+..+++|+.|
T Consensus 15 ~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp ECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34444555555555555554434445555555555555542 22 24455555555555555554444444556666666
Q ss_pred eccCCCCCCCCC-cccCCCCCCCEEeCCCCCCCCCC---Cccccccccccccc
Q 047576 297 DLSSNKLSGKIP-SQIASMEDLTWLDLSNNNIKGSI---PGEITKLSRLDYLN 345 (602)
Q Consensus 297 ~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~ 345 (602)
+|++|+|+.... ..+..+++|+.|++++|.++... +..+..+++|++||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666653211 24556666666666666665321 12355666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=5.9e-16 Score=140.27 Aligned_cols=127 Identities=22% Similarity=0.146 Sum_probs=73.3
Q ss_pred hhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCcc
Q 047576 192 IGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSY 271 (602)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 271 (602)
+.+..+|++|+|++|+|+. +|..+..+++|+.|+|++|+++.++ .+..+++|++|++++|+++...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 4455556666666666553 3444455566666666666666553 3555666666666666666444444455666666
Q ss_pred ccCCCCcCCCCCc-hhhhCCCCCCEEeccCCCCCCCCCc----ccCCCCCCCEEe
Q 047576 272 LDLSCNQFNSSIP-NELTRLTQLFHLDLSSNKLSGKIPS----QIASMEDLTWLD 321 (602)
Q Consensus 272 L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 321 (602)
|++++|+++.... ..+..+++|++|++++|+++. .|. .++.+++|++||
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 6666666653211 345666677777777776653 222 355667777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.3e-15 Score=151.27 Aligned_cols=207 Identities=17% Similarity=0.196 Sum_probs=151.6
Q ss_pred cCCCCCCCCEEECcCCcCc--------ccCCCcCEEECcCCcCCCCCchhhhCCCCCCEEEecCC-CCCCC-CcccccCc
Q 047576 150 EISALSKLQLLDLSSNRLR--------GRLTNLNYMSLSRNMLGGLLPQEIGNLKNLIELDVGDN-SLIGP-IPLTLSRL 219 (602)
Q Consensus 150 ~l~~L~~L~~L~Ls~N~i~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l 219 (602)
......+|++|||++|.+. ..+++|++|+|+++.+++..+..++.+++|++|+|+++ .++.. +.....++
T Consensus 41 ~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~ 120 (284)
T d2astb2 41 EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120 (284)
T ss_dssp SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHH
Confidence 3445678999999999886 34899999999999999888899999999999999995 55532 22234568
Q ss_pred CCCceeecccc-cCCC--CcccccC-CCCCcEEEccCC--CCCCC-CCCccCCCCCCccccCCCC-cCCCCCchhhhCCC
Q 047576 220 TSLKILILAQN-QLSG--LPQEIGN-LKNLMLLDVGNN--DIIGP-IPSTLGLFSDLSYLDLSCN-QFNSSIPNELTRLT 291 (602)
Q Consensus 220 ~~L~~L~L~~N-~l~~--ip~~~~~-l~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~ 291 (602)
++|++|+++++ .++. ++..+.. .++|+.|+++++ .++.. +...+..+++|++|++++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 99999999985 5554 4444444 478999999864 34432 2233456789999999986 57877778889999
Q ss_pred CCCEEeccC-CCCCCCCCcccCCCCCCCEEeCCCCCCCCCCCcccccccccccccccCCcCCCccCCCC
Q 047576 292 QLFHLDLSS-NKLSGKIPSQIASMEDLTWLDLSNNNIKGSIPGEITKLSRLDYLNLSGNKLSGRVPYSN 359 (602)
Q Consensus 292 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 359 (602)
+|++|+|++ +.+++.....++.+++|+.|+++++--.+.++.....++ .|.+..+++++..+...
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp---~L~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTI 266 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHST---TSEESCCCSCCTTCSSC
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCc---cccccCccCCCCCCCcc
Confidence 999999999 468877777788999999999988722222222223344 45567778877655544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=1.2e-15 Score=155.69 Aligned_cols=207 Identities=22% Similarity=0.247 Sum_probs=146.9
Q ss_pred CCccCCCCCCCCEEECcCCcCc-----------------ccCCCcCEEECcCCcCCCCC----chhhhCCCCCCEEEecC
Q 047576 147 IPSEISALSKLQLLDLSSNRLR-----------------GRLTNLNYMSLSRNMLGGLL----PQEIGNLKNLIELDVGD 205 (602)
Q Consensus 147 ip~~l~~L~~L~~L~Ls~N~i~-----------------~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~ 205 (602)
+...+...++|+.|+++++.+. ...++|++|+|++|.++... ...+...++|++|++++
T Consensus 51 l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~ 130 (344)
T d2ca6a1 51 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 130 (344)
T ss_dssp HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccc
Confidence 3456778888888888877543 12578999999999887653 34455678899999998
Q ss_pred CCCCCCCccc-------------ccCcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCCCC-----CCCc
Q 047576 206 NSLIGPIPLT-------------LSRLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDIIGP-----IPST 262 (602)
Q Consensus 206 N~l~~~~p~~-------------l~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~-----~p~~ 262 (602)
|.+....... ....+.|+.|++++|+++. +...+...++|+.|+|++|+++.. +...
T Consensus 131 n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~ 210 (344)
T d2ca6a1 131 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 210 (344)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhh
Confidence 8874221111 1345678899999988874 344566778899999999988642 3345
Q ss_pred cCCCCCCccccCCCCcCCCC----CchhhhCCCCCCEEeccCCCCCCCCCccc----C--CCCCCCEEeCCCCCCCCCC-
Q 047576 263 LGLFSDLSYLDLSCNQFNSS----IPNELTRLTQLFHLDLSSNKLSGKIPSQI----A--SMEDLTWLDLSNNNIKGSI- 331 (602)
Q Consensus 263 l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~~- 331 (602)
+...++|+.|+|++|.++.. +...+...++|++|+|++|.|++.....+ . ..+.|++|++++|+++...
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~ 290 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH
Confidence 67788899999999988643 34456788899999999999875422222 2 3467999999999987532
Q ss_pred ---Ccccc-cccccccccccCCcCCC
Q 047576 332 ---PGEIT-KLSRLDYLNLSGNKLSG 353 (602)
Q Consensus 332 ---p~~~~-~l~~L~~L~l~~N~l~g 353 (602)
...+. +.++|+.|++++|++..
T Consensus 291 ~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 291 RTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22332 56789999999998854
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=3.7e-15 Score=147.93 Aligned_cols=193 Identities=21% Similarity=0.216 Sum_probs=149.2
Q ss_pred CCEEECcCCcCc------ccCCCcCEEECcCCcCCCC-CchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeeccc
Q 047576 157 LQLLDLSSNRLR------GRLTNLNYMSLSRNMLGGL-LPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQ 229 (602)
Q Consensus 157 L~~L~Ls~N~i~------~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 229 (602)
+..+.++...+. ....+|++|||+++.++.. ++..+..+++|++|+|+++.+++..+..++.+++|++|++++
T Consensus 25 ~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 445556555433 2356899999999998854 355678899999999999999888888899999999999999
Q ss_pred c-cCCC--CcccccCCCCCcEEEccCC-CCCCC-CCCccC-CCCCCccccCCCC--cCCCC-CchhhhCCCCCCEEeccC
Q 047576 230 N-QLSG--LPQEIGNLKNLMLLDVGNN-DIIGP-IPSTLG-LFSDLSYLDLSCN--QFNSS-IPNELTRLTQLFHLDLSS 300 (602)
Q Consensus 230 N-~l~~--ip~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~-~l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~ 300 (602)
+ .++. +..-..++++|++|+++++ .++.. ++..+. ..++|+.|+++++ .++.. +...+.++++|++|+|++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 5 6764 4444567899999999985 45432 122232 2468999999864 34432 233346789999999998
Q ss_pred C-CCCCCCCcccCCCCCCCEEeCCC-CCCCCCCCcccccccccccccccCC
Q 047576 301 N-KLSGKIPSQIASMEDLTWLDLSN-NNIKGSIPGEITKLSRLDYLNLSGN 349 (602)
Q Consensus 301 N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N 349 (602)
| .+++..+..+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 6 48877788899999999999999 5788777778899999999999887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=2.3e-15 Score=153.56 Aligned_cols=211 Identities=19% Similarity=0.177 Sum_probs=157.5
Q ss_pred cccCCccCCCCCCCCEEECcCCcCcc-----------cCCCcCEEECcCCcCCCC----------CchhhhCCCCCCEEE
Q 047576 144 TGSIPSEISALSKLQLLDLSSNRLRG-----------RLTNLNYMSLSRNMLGGL----------LPQEIGNLKNLIELD 202 (602)
Q Consensus 144 ~~~ip~~l~~L~~L~~L~Ls~N~i~~-----------~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~ 202 (602)
...+...+.+.+.|+.|+|++|.|.. ..++|+.|+++++.+... +...+...++|++|+
T Consensus 20 ~~~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~ 99 (344)
T d2ca6a1 20 EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR 99 (344)
T ss_dssp HHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred HHHHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccc
Confidence 34555667788999999999999862 368999999998866532 223456679999999
Q ss_pred ecCCCCCCCCc----ccccCcCCCceeecccccCCC-----Cccc---------ccCCCCCcEEEccCCCCCCC----CC
Q 047576 203 VGDNSLIGPIP----LTLSRLTSLKILILAQNQLSG-----LPQE---------IGNLKNLMLLDVGNNDIIGP----IP 260 (602)
Q Consensus 203 L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~-----ip~~---------~~~l~~L~~L~L~~N~l~~~----~p 260 (602)
|++|.++.... ..+...++|+.|++++|.++. +... ....+.|+.|++++|+++.. +.
T Consensus 100 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~ 179 (344)
T d2ca6a1 100 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179 (344)
T ss_dssp CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred ccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccccc
Confidence 99999976533 345567999999999998753 1111 23567899999999998743 22
Q ss_pred CccCCCCCCccccCCCCcCCCC-----CchhhhCCCCCCEEeccCCCCCCC----CCcccCCCCCCCEEeCCCCCCCCCC
Q 047576 261 STLGLFSDLSYLDLSCNQFNSS-----IPNELTRLTQLFHLDLSSNKLSGK----IPSQIASMEDLTWLDLSNNNIKGSI 331 (602)
Q Consensus 261 ~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 331 (602)
..+...++|++|+|++|+++.. +...+...++|+.|+|++|.++.. +...+...++|++|+|++|.|++..
T Consensus 180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g 259 (344)
T d2ca6a1 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 259 (344)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh
Confidence 3345678999999999998743 233467789999999999998643 3345678899999999999998653
Q ss_pred Cccc----c--cccccccccccCCcCCCc
Q 047576 332 PGEI----T--KLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 332 p~~~----~--~l~~L~~L~l~~N~l~g~ 354 (602)
...+ . ..+.|+.|++++|+++..
T Consensus 260 ~~~l~~~l~~~~~~~L~~L~ls~N~i~~~ 288 (344)
T d2ca6a1 260 AAAVVDAFSKLENIGLQTLRLQYNEIELD 288 (344)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSCCBHH
T ss_pred hHHHHHHhhhccCCCCCEEECCCCcCChH
Confidence 3333 2 235799999999988653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=8.3e-16 Score=144.11 Aligned_cols=114 Identities=24% Similarity=0.259 Sum_probs=73.2
Q ss_pred CCchhhhCCCCCCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCC
Q 047576 187 LLPQEIGNLKNLIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLF 266 (602)
Q Consensus 187 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 266 (602)
.++..+..|++|++|+|++|+|+. ++ .+.++++|+.|+|++|+++.+|.....+++|+.|++++|+++.. + .+..+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l-~-~~~~l 114 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL-S-GIEKL 114 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccccccccccccccccccccccccccc-c-ccccc
Confidence 345677777778888887777764 33 47777777777777777777765555556677777777777642 2 24556
Q ss_pred CCCccccCCCCcCCCCCc-hhhhCCCCCCEEeccCCCCC
Q 047576 267 SDLSYLDLSCNQFNSSIP-NELTRLTQLFHLDLSSNKLS 304 (602)
Q Consensus 267 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 304 (602)
++|+.|++++|+++.... ..+..+++|+.|+|++|+++
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 666666666666653211 34556666666666666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.1e-15 Score=143.28 Aligned_cols=144 Identities=24% Similarity=0.320 Sum_probs=113.9
Q ss_pred CCCEEEecCC--CCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCCCCccCCCCCCccccC
Q 047576 197 NLIELDVGDN--SLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPIPSTLGLFSDLSYLDL 274 (602)
Q Consensus 197 ~L~~L~L~~N--~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 274 (602)
.++.++++++ .+ ..+|.++..+++|++|+|++|+++.++ .+.++++|+.|+|++|.++ .+|..+..+++|+.|++
T Consensus 24 ~~~~~~l~~~~~~i-~~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 24 EAEKVELHGMIPPI-EKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp TCSCEECCBCCTTC-CCCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred ccceeeeecccCch-hhhhhHHhcccccceeECcccCCCCcc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 4555666554 22 245678999999999999999999986 5889999999999999998 56666666778999999
Q ss_pred CCCcCCCCCchhhhCCCCCCEEeccCCCCCCCCC-cccCCCCCCCEEeCCCCCCCCCCCcc----------ccccccccc
Q 047576 275 SCNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIP-SQIASMEDLTWLDLSNNNIKGSIPGE----------ITKLSRLDY 343 (602)
Q Consensus 275 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~ 343 (602)
++|+++.. +.+..+++|+.|+|++|+|+.... ..+..+++|+.|+|++|.++...+.. +..+++|+.
T Consensus 101 ~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~ 178 (198)
T d1m9la_ 101 SYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178 (198)
T ss_dssp SEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCE
T ss_pred cccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCE
Confidence 99999853 358888999999999999985322 46889999999999999887544432 556788887
Q ss_pred cc
Q 047576 344 LN 345 (602)
Q Consensus 344 L~ 345 (602)
||
T Consensus 179 LD 180 (198)
T d1m9la_ 179 LD 180 (198)
T ss_dssp ES
T ss_pred eC
Confidence 75
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.2e-12 Score=117.35 Aligned_cols=107 Identities=19% Similarity=0.109 Sum_probs=73.6
Q ss_pred CCceeecccccCCCCcccccCCCCCcEEEccCC-CCCCCCCCccCCCCCCccccCCCCcCCCCCchhhhCCCCCCEEecc
Q 047576 221 SLKILILAQNQLSGLPQEIGNLKNLMLLDVGNN-DIIGPIPSTLGLFSDLSYLDLSCNQFNSSIPNELTRLTQLFHLDLS 299 (602)
Q Consensus 221 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 299 (602)
..+.++.+++++..+|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|+
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 345566777777777766777777777777655 3665555667777777777777777777667777777777777777
Q ss_pred CCCCCCCCCcccCCCCCCCEEeCCCCCCC
Q 047576 300 SNKLSGKIPSQIASMEDLTWLDLSNNNIK 328 (602)
Q Consensus 300 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 328 (602)
+|+|+...+..+. ..+|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred CCCCcccChhhhc-cccccccccCCCccc
Confidence 7777744333443 336777777777775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.2e-14 Score=152.88 Aligned_cols=103 Identities=24% Similarity=0.275 Sum_probs=67.7
Q ss_pred CEEEEEecCCCCCCCcccccCCCCCCCCCccchhccccCCcc----ccCCccCCCCCCCCEEECcCCcCcc---------
Q 047576 103 SIIGLHLSKDNVNFNGRLSHLNFSCFPNLESLRILAYYDGFT----GSIPSEISALSKLQLLDLSSNRLRG--------- 169 (602)
Q Consensus 103 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~~~~~~~----~~ip~~l~~L~~L~~L~Ls~N~i~~--------- 169 (602)
.+..|+++...+.-.+-. . -+..+++++.|++. +++++ ..++..+..+++|++|||++|+|+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~-~-l~~~l~~l~~L~L~--~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~ 78 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWA-E-LLPLLQQCQVVRLD--DCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78 (460)
T ss_dssp EEEEEEEESCCCCHHHHH-H-HHHHHTTCSEEEEE--SSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred CCCEEEeeCCcCChHHHH-H-HHHhCCCCCEEEeC--CCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHH
Confidence 356777765544321100 0 13456677777776 33443 2445667788889999999998852
Q ss_pred ---cCCCcCEEECcCCcCCCC----CchhhhCCCCCCEEEecCCCCC
Q 047576 170 ---RLTNLNYMSLSRNMLGGL----LPQEIGNLKNLIELDVGDNSLI 209 (602)
Q Consensus 170 ---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 209 (602)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 79 l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 79 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 124799999999988754 4556777888999999888763
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=3.2e-12 Score=114.41 Aligned_cols=101 Identities=21% Similarity=0.119 Sum_probs=45.0
Q ss_pred EECcCCcCCCCCchhhhCCCCCCEEEecCCC-CCCCCcccccCcCCCceeecccccCCCC-cccccCCCCCcEEEccCCC
Q 047576 177 MSLSRNMLGGLLPQEIGNLKNLIELDVGDNS-LIGPIPLTLSRLTSLKILILAQNQLSGL-PQEIGNLKNLMLLDVGNND 254 (602)
Q Consensus 177 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~ 254 (602)
++.+++.+. ..|..+..+++|++|++++|+ |+...+..|.++++|+.|+|++|+|+.| |..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 334444433 223444445555555554332 4433344455555555555555555553 2334445555555555555
Q ss_pred CCCCCCCccCCCCCCccccCCCCcC
Q 047576 255 IIGPIPSTLGLFSDLSYLDLSCNQF 279 (602)
Q Consensus 255 l~~~~p~~l~~l~~L~~L~L~~N~l 279 (602)
|+...+..+.. .+|+.|+|++|.+
T Consensus 92 l~~l~~~~~~~-~~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LESLSWKTVQG-LSLQELVLSGNPL 115 (156)
T ss_dssp CSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred CcccChhhhcc-ccccccccCCCcc
Confidence 54322222222 2344444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=1.1e-12 Score=137.31 Aligned_cols=164 Identities=20% Similarity=0.200 Sum_probs=109.3
Q ss_pred hhhCCCCCCEEEecCCCCCC-----CCcccccCcCCCceeecccccCCCC-----cccccCCCCCcEEEccCCCCCCCCC
Q 047576 191 EIGNLKNLIELDVGDNSLIG-----PIPLTLSRLTSLKILILAQNQLSGL-----PQEIGNLKNLMLLDVGNNDIIGPIP 260 (602)
Q Consensus 191 ~~~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~~i-----p~~~~~l~~L~~L~L~~N~l~~~~p 260 (602)
.+...+.++.+++++|.+.. ..+........++.|++++|.+... ...+...+.++.+++++|.++....
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34556788888888887542 1223344567888899998888752 2345567888888888888764222
Q ss_pred Ccc-----CCCCCCccccCCCCcCCCCCchh----hhCCCCCCEEeccCCCCCCC----CCcccC-CCCCCCEEeCCCCC
Q 047576 261 STL-----GLFSDLSYLDLSCNQFNSSIPNE----LTRLTQLFHLDLSSNKLSGK----IPSQIA-SMEDLTWLDLSNNN 326 (602)
Q Consensus 261 ~~l-----~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~ 326 (602)
..+ .....|+.+++++|.++...... +...++|++|+|++|+|++. ++..+. ..+.|++|+|++|.
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~ 380 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 380 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred chhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCC
Confidence 111 23457888888888887653333 34456788888888888643 223332 45678888888888
Q ss_pred CCCC----CCcccccccccccccccCCcCCCc
Q 047576 327 IKGS----IPGEITKLSRLDYLNLSGNKLSGR 354 (602)
Q Consensus 327 l~~~----~p~~~~~l~~L~~L~l~~N~l~g~ 354 (602)
|+.. ++..+...++|++|++++|+++.+
T Consensus 381 i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 8743 344556678888888888888753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=1e-09 Score=98.37 Aligned_cols=120 Identities=22% Similarity=0.130 Sum_probs=62.7
Q ss_pred CCEEEecCCCCCCCCcccccCcCCCceeecccccCCCCcccccCCCCCcEEEccCCCCCCCC--CCccCCCCCCccccCC
Q 047576 198 LIELDVGDNSLIGPIPLTLSRLTSLKILILAQNQLSGLPQEIGNLKNLMLLDVGNNDIIGPI--PSTLGLFSDLSYLDLS 275 (602)
Q Consensus 198 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~ 275 (602)
.+.|+++++... ..+..+..+..++..+|....++....++++|++|+|++|+|+..- +..+..+++|+.|+|+
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls 99 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCT
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccc
Confidence 445555544321 1234444445555555444434444455666777777777766432 2334556666666666
Q ss_pred CCcCCCCCchhhhCCCCCCEEeccCCCCCCCCCc-------ccCCCCCCCEEe
Q 047576 276 CNQFNSSIPNELTRLTQLFHLDLSSNKLSGKIPS-------QIASMEDLTWLD 321 (602)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 321 (602)
+|.++...+-.+....+|+.|+|++|+++..... .+..+|+|+.||
T Consensus 100 ~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 6666644332333344566666666666544332 134455565554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=2e-09 Score=96.44 Aligned_cols=44 Identities=27% Similarity=0.355 Sum_probs=20.4
Q ss_pred hhCCCCCCEEEecCCCCCCCC--cccccCcCCCceeecccccCCCC
Q 047576 192 IGNLKNLIELDVGDNSLIGPI--PLTLSRLTSLKILILAQNQLSGL 235 (602)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~i 235 (602)
+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.++.+
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l 106 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 106 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCG
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccc
Confidence 344555555555555554321 22234444555555555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.84 E-value=1.8e-06 Score=76.89 Aligned_cols=18 Identities=11% Similarity=0.265 Sum_probs=8.7
Q ss_pred hhCCCCCCEEEecCCCCC
Q 047576 192 IGNLKNLIELDVGDNSLI 209 (602)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~ 209 (602)
+...++|++|+|++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp HTTCSCCCEEECTTSCCB
T ss_pred HhhCCccceeeccccccc
Confidence 334444555555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.80 E-value=9.3e-06 Score=72.12 Aligned_cols=103 Identities=16% Similarity=0.135 Sum_probs=68.9
Q ss_pred CCCCCCCEEECcCC-cCcc-----------cCCCcCEEECcCCcCCCC----CchhhhCCCCCCEEEecCCCCCCCCc--
Q 047576 152 SALSKLQLLDLSSN-RLRG-----------RLTNLNYMSLSRNMLGGL----LPQEIGNLKNLIELDVGDNSLIGPIP-- 213 (602)
Q Consensus 152 ~~L~~L~~L~Ls~N-~i~~-----------~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p-- 213 (602)
.+.++|++|+|+++ .++. ..+.|++|+|++|.++.. +...+...+.|++|+|++|.++....
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34578899999874 5652 356799999999988732 33455667889999999998874322
Q ss_pred --ccccCcCCCceeecccccCCCCc--------ccccCCCCCcEEEccCCC
Q 047576 214 --LTLSRLTSLKILILAQNQLSGLP--------QEIGNLKNLMLLDVGNND 254 (602)
Q Consensus 214 --~~l~~l~~L~~L~L~~N~l~~ip--------~~~~~l~~L~~L~L~~N~ 254 (602)
..+..-++|++|++++|.+..+. ..+...++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 23555677888888877665432 233445667777665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.35 E-value=6.2e-05 Score=66.38 Aligned_cols=103 Identities=16% Similarity=0.109 Sum_probs=52.0
Q ss_pred CCCCCCCCEEECcC-CcCcc-----------cCCCcCEEECcCCcCCCCC----chhhhCCCCCCEEEecCCCCCCCC--
Q 047576 151 ISALSKLQLLDLSS-NRLRG-----------RLTNLNYMSLSRNMLGGLL----PQEIGNLKNLIELDVGDNSLIGPI-- 212 (602)
Q Consensus 151 l~~L~~L~~L~Ls~-N~i~~-----------~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~-- 212 (602)
..+.++|++|+|++ |.|+. ..++|++|+|++|.++... ...+...++|+.|++++|.+....
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34557777777776 44541 2456666666666665332 223444566666666666654321
Q ss_pred --cccccCcCCCceeec--ccccCCC-----CcccccCCCCCcEEEccCC
Q 047576 213 --PLTLSRLTSLKILIL--AQNQLSG-----LPQEIGNLKNLMLLDVGNN 253 (602)
Q Consensus 213 --p~~l~~l~~L~~L~L--~~N~l~~-----ip~~~~~l~~L~~L~L~~N 253 (602)
-..+...++|+.++| ++|.+.. +...+...++|+.|+++.|
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 123344455554333 3444432 2233344455555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.19 E-value=3.6e-05 Score=67.99 Aligned_cols=39 Identities=21% Similarity=0.146 Sum_probs=18.4
Q ss_pred CcCCCceeecccccCCC-----CcccccCCCCCcEEEccCCCCC
Q 047576 218 RLTSLKILILAQNQLSG-----LPQEIGNLKNLMLLDVGNNDII 256 (602)
Q Consensus 218 ~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~ 256 (602)
..++|++|++++|.++. +-..+...++++.+++++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 44455555555555443 1122334455555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.54 E-value=0.0014 Score=61.48 Aligned_cols=29 Identities=21% Similarity=0.316 Sum_probs=25.2
Q ss_pred eEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 470 VVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 470 ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
++|+|+.|.||++++++.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 78999999999999877677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.30 E-value=0.011 Score=54.80 Aligned_cols=30 Identities=23% Similarity=0.230 Sum_probs=25.7
Q ss_pred CeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 469 SVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 469 ~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999877778999987743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.30 E-value=0.0094 Score=57.88 Aligned_cols=30 Identities=27% Similarity=0.347 Sum_probs=24.6
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
..++||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45899997754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.46 E-value=0.0098 Score=57.30 Aligned_cols=31 Identities=23% Similarity=0.280 Sum_probs=27.7
Q ss_pred CCCeEEeCCCCCCeeeCCCCcceeecccccc
Q 047576 467 SPSVVHRDISSNNILLNSKLEAFVADFGTAR 497 (602)
Q Consensus 467 ~~~ivH~DLkp~NILld~~~~~kL~DFG~a~ 497 (602)
..++||+|+.++||+++++...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999998777899999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.19 E-value=0.013 Score=58.37 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=25.8
Q ss_pred CCeEEeCCCCCCeeeCCCCcceeeccccccc
Q 047576 468 PSVVHRDISSNNILLNSKLEAFVADFGTARL 498 (602)
Q Consensus 468 ~~ivH~DLkp~NILld~~~~~kL~DFG~a~~ 498 (602)
..++|||+.|.|||++++. ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4689999999999998764 89999987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=88.21 E-value=0.3 Score=47.98 Aligned_cols=27 Identities=15% Similarity=0.156 Sum_probs=18.8
Q ss_pred cccccccccceeeecCC--------CcEEeeeccC
Q 047576 376 CIGTGAYGSVYKAQLPN--------GRVFALKKLN 402 (602)
Q Consensus 376 ~LG~G~~g~Vy~~~~~~--------g~~vavK~l~ 402 (602)
.++.|-...+|++..++ .+.|.+++..
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g 83 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF 83 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecC
Confidence 46778888999997643 3457777664
|